0001292814-23-001738.txt : 20230425 0001292814-23-001738.hdr.sgml : 20230425 20230424203402 ACCESSION NUMBER: 0001292814-23-001738 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 197 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230425 DATE AS OF CHANGE: 20230424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRASKEM SA CENTRAL INDEX KEY: 0001071438 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-14862 FILM NUMBER: 23841349 BUSINESS ADDRESS: STREET 1: RUA ETEND NO 1561 CITY: CAMARACI BAHIA BRAZIL STATE: D5 ZIP: 42810-000 BUSINESS PHONE: 011551134439744 MAIL ADDRESS: STREET 1: RUA ETENO NO 1561 CITY: CAMACARI BAHIA BRAZI STATE: D5 ZIP: 42810-000 FORMER COMPANY: FORMER CONFORMED NAME: COPENE PETROQUIMICA DO NORDESTE SA DATE OF NAME CHANGE: 20000428 20-F 1 bakform20f_2022.htm
0001071438 false 2022 FY BRASKEM SA 0001071438 2022-01-01 2022-12-31 0001071438 dei:BusinessContactMember 2022-01-01 2022-12-31 0001071438 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 2021-12-31 0001071438 2021-01-01 2021-12-31 0001071438 2020-01-01 2020-12-31 0001071438 bak:CommonSharesMember 2022-01-01 2022-12-31 0001071438 bak:CommonSharesMember 2021-01-01 2021-12-31 0001071438 bak:CommonSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassAPreferredSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferredSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassAPreferredSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassBPreferredSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassBPreferredSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferredSharesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2019-12-31 0001071438 ifrs-full:CapitalReserveMember 2019-12-31 0001071438 ifrs-full:StatutoryReserveMember 2019-12-31 0001071438 bak:TaxIncentiveMember 2019-12-31 0001071438 bak:RetentionOfProfitsMember 2019-12-31 0001071438 bak:AdditionalDividendsProposedMember 2019-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2019-12-31 0001071438 bak:LongTermIncentivePlansMember 2019-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001071438 ifrs-full:TreasurySharesMember 2019-12-31 0001071438 ifrs-full:RetainedEarningsMember 2019-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2019-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2019-12-31 0001071438 2019-12-31 0001071438 ifrs-full:IssuedCapitalMember 2020-12-31 0001071438 ifrs-full:CapitalReserveMember 2020-12-31 0001071438 ifrs-full:StatutoryReserveMember 2020-12-31 0001071438 bak:TaxIncentiveMember 2020-12-31 0001071438 bak:RetentionOfProfitsMember 2020-12-31 0001071438 bak:AdditionalDividendsProposedMember 2020-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2020-12-31 0001071438 bak:LongTermIncentivePlansMember 2020-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-12-31 0001071438 ifrs-full:RetainedEarningsMember 2020-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2020-12-31 0001071438 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2021-12-31 0001071438 ifrs-full:CapitalReserveMember 2021-12-31 0001071438 ifrs-full:StatutoryReserveMember 2021-12-31 0001071438 bak:TaxIncentiveMember 2021-12-31 0001071438 bak:RetentionOfProfitsMember 2021-12-31 0001071438 bak:AdditionalDividendsProposedMember 2021-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2021-12-31 0001071438 bak:LongTermIncentivePlansMember 2021-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-12-31 0001071438 ifrs-full:RetainedEarningsMember 2021-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001071438 ifrs-full:IssuedCapitalMember 2020-01-01 2020-12-31 0001071438 ifrs-full:CapitalReserveMember 2020-01-01 2020-12-31 0001071438 ifrs-full:StatutoryReserveMember 2020-01-01 2020-12-31 0001071438 bak:TaxIncentiveMember 2020-01-01 2020-12-31 0001071438 bak:RetentionOfProfitsMember 2020-01-01 2020-12-31 0001071438 bak:AdditionalDividendsProposedMember 2020-01-01 2020-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2020-01-01 2020-12-31 0001071438 bak:LongTermIncentivePlansMember 2020-01-01 2020-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:RetainedEarningsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-01-01 2020-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001071438 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001071438 ifrs-full:StatutoryReserveMember 2021-01-01 2021-12-31 0001071438 bak:TaxIncentiveMember 2021-01-01 2021-12-31 0001071438 bak:RetentionOfProfitsMember 2021-01-01 2021-12-31 0001071438 bak:AdditionalDividendsProposedMember 2021-01-01 2021-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2021-01-01 2021-12-31 0001071438 bak:LongTermIncentivePlansMember 2021-01-01 2021-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-01-01 2021-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001071438 ifrs-full:CapitalReserveMember 2022-01-01 2022-12-31 0001071438 ifrs-full:StatutoryReserveMember 2022-01-01 2022-12-31 0001071438 bak:TaxIncentiveMember 2022-01-01 2022-12-31 0001071438 bak:RetentionOfProfitsMember 2022-01-01 2022-12-31 0001071438 bak:AdditionalDividendsProposedMember 2022-01-01 2022-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2022-01-01 2022-12-31 0001071438 bak:LongTermIncentivePlansMember 2022-01-01 2022-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:IssuedCapitalMember 2022-12-31 0001071438 ifrs-full:CapitalReserveMember 2022-12-31 0001071438 ifrs-full:StatutoryReserveMember 2022-12-31 0001071438 bak:TaxIncentiveMember 2022-12-31 0001071438 bak:RetentionOfProfitsMember 2022-12-31 0001071438 bak:AdditionalDividendsProposedMember 2022-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2022-12-31 0001071438 bak:LongTermIncentivePlansMember 2022-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-12-31 0001071438 ifrs-full:RetainedEarningsMember 2022-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001071438 bak:OdebrechtSAMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-06-29 2022-06-30 0001071438 2023-03-29 2023-03-31 0001071438 bak:BraskemIdesaOneMember 2023-03-29 2023-03-31 0001071438 bak:Subsidiary1Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary1Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary1Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary2Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary2Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary2Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary3Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary3Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary4Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary4Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary4Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary5Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary5Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary6Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary6Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary6Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary7Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary7Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary7Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary8Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary8Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary8Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary9Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary9Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary9Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary10Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary101Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary11Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary11Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary11Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary12Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary13Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary13Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary13Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary14Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary14Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary14Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary15Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary15Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary15Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary16Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary16Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary16Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary17Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary17Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary17Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary18Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary18Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary18Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary19Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary19Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary19Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary20Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary20Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary20Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary21Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary21Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary21Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary22Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary22Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary23Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary23Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary23Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary24Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary25Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary26Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary26Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary26Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary27Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary27Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary27Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary28Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary29Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary30Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary30Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity1Member 2022-01-01 2022-12-31 0001071438 bak:SpecificPurposeEntity1Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity1Member 2020-01-01 2020-12-31 0001071438 bak:SpecificPurposeEntity2Member 2022-01-01 2022-12-31 0001071438 bak:SpecificPurposeEntity2Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity2Member 2020-01-01 2020-12-31 0001071438 bak:BraskemAlemanhaMember 2022-01-01 2022-12-31 0001071438 bak:BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember 2022-01-01 2022-12-31 0001071438 bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:BraskemChileMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIndiaMember 2022-01-01 2022-12-31 0001071438 bak:CarryingAmountOneMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 bak:EarlyPaymentdebtMember ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 bak:DomesticMarketMember 2022-12-31 0001071438 bak:DomesticMarketMember 2021-12-31 0001071438 bak:ForeignMarketMember 2022-12-31 0001071438 bak:ForeignMarketMember 2021-12-31 0001071438 bak:ForeignMarketMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:ForeignMarketMember bak:BraskemIdesaMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtAmortisedCostMember bak:TimeDepositInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:LFTAndLFMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:LFTAndLFMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:OtherFinancialInvestmentsMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:OtherFinancialInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember bak:InterbankDepositRateMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember bak:InterbankDepositRateMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-01-01 2021-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartyMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartyMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2021-12-31 0001071438 bak:NotPastDueMember bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:NotPastDueMember bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:NotPastDueMember 2022-12-31 0001071438 bak:NotPastDueMember bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:NotPastDueMember bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:NotPastDueMember 2021-12-31 0001071438 bak:NotLaterThanNinetyDaysMember bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:NotLaterThanNinetyDaysMember bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:NotLaterThanNinetyDaysMember 2022-12-31 0001071438 bak:NotLaterThanNinetyDaysMember bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:NotLaterThanNinetyDaysMember bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:NotLaterThanNinetyDaysMember 2021-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2022-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2022-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2021-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2021-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2022-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:RelatedPartiesMember 2022-01-01 2022-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:RelatedPartiesMember 2021-01-01 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:RelatedPartiesMember 2020-01-01 2020-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2022-01-01 2022-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2021-01-01 2021-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2020-01-01 2020-12-31 0001071438 bak:NewOrRenewedagreementsWithRelatedCompaniesMember ifrs-full:TopOfRangeMember 2022-12-31 0001071438 bak:NewOrRenewedagreementsWithRelatedCompaniesMember 2022-12-31 0001071438 bak:NovonorAndItsDirectAndIndirectSubsidiariesMember 2022-02-01 2022-02-28 0001071438 bak:PetrobrasTransporteSAMember 2021-01-01 2021-12-31 0001071438 bak:PetrocoqueSAIndustriaComercioMember 2021-03-01 2021-03-31 0001071438 bak:RefinariaAlbertoPasqualiniMember 2021-10-01 2021-10-31 0001071438 bak:AgreementWithPetrocoqueMember 2021-12-31 0001071438 bak:RefinariaDuqueDeCaxiasMember 2021-12-31 0001071438 bak:RefinariaHenriqueLageMember 2021-12-31 0001071438 bak:RefinariaPlanaltodePauliniaMember 2021-12-31 0001071438 bak:RefinariaPresidenteGetulioVargasMember 2021-12-31 0001071438 bak:ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:ICMSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:ICMSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:SocialIntegrationProgramPISAndSocialContributionOnRevenueMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:SocialIntegrationProgramPISAndSocialContributionOnRevenueMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:REINTEGRAProgramMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:REINTEGRAProgramMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:FederalSupervenienceMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:FederalSupervenienceMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:OtherTaxesRecoverableMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:OtherTaxesRecoverableMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:ValueAddedTaxIVAMember srt:SubsidiariesMember 2022-12-31 0001071438 bak:ValueAddedTaxIVAMember srt:SubsidiariesMember 2021-12-31 0001071438 bak:OtherTaxesRecoverableMember srt:SubsidiariesMember 2022-12-31 0001071438 bak:OtherTaxesRecoverableMember srt:SubsidiariesMember 2021-12-31 0001071438 bak:PISAndCOFINSTaxesMember 2019-12-31 0001071438 bak:Investment1Member 2022-01-01 2022-12-31 0001071438 bak:Investment1Member 2021-01-01 2021-12-31 0001071438 bak:Investment1Member 2020-01-01 2020-12-31 0001071438 bak:Investment1Member 2022-12-31 0001071438 bak:Investment1Member 2021-12-31 0001071438 bak:Investment2Member 2022-01-01 2022-12-31 0001071438 bak:Investment2Member 2022-12-31 0001071438 bak:AssociateMember 2022-01-01 2022-12-31 0001071438 bak:AssociateMember 2021-01-01 2021-12-31 0001071438 bak:AssociateMember 2020-01-01 2020-12-31 0001071438 bak:AssociateMember 2022-12-31 0001071438 bak:AssociateMember 2021-12-31 0001071438 bak:Associate1Member 2020-12-31 0001071438 bak:Associate2Member 2020-12-31 0001071438 bak:Associate3Member 2020-12-31 0001071438 bak:Associate4Member 2020-12-31 0001071438 bak:Associate1Member 2021-01-01 2021-12-31 0001071438 bak:Associate2Member 2021-01-01 2021-12-31 0001071438 bak:Associate3Member 2021-01-01 2021-12-31 0001071438 bak:Associate4Member 2021-01-01 2021-12-31 0001071438 bak:Associate1Member 2021-12-31 0001071438 bak:Associate2Member 2021-12-31 0001071438 bak:Associate3Member 2021-12-31 0001071438 bak:Associate4Member 2021-12-31 0001071438 bak:Associate1Member 2022-01-01 2022-12-31 0001071438 bak:Associate2Member 2022-01-01 2022-12-31 0001071438 bak:Associate3Member 2022-01-01 2022-12-31 0001071438 bak:Associate4Member 2022-01-01 2022-12-31 0001071438 bak:Associate1Member 2022-12-31 0001071438 bak:Associate2Member 2022-12-31 0001071438 bak:Associate3Member 2022-12-31 0001071438 bak:Associate4Member 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2021-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2022-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2021-12-31 0001071438 bak:EliminationsMember 2022-12-31 0001071438 bak:EliminationsMember 2021-12-31 0001071438 bak:TotalMember 2022-12-31 0001071438 bak:TotalMember 2021-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2022-01-01 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2021-01-01 2021-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2020-01-01 2020-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2021-01-01 2021-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2020-01-01 2020-12-31 0001071438 bak:EliminationsMember 2022-01-01 2022-12-31 0001071438 bak:EliminationsMember 2021-01-01 2021-12-31 0001071438 bak:EliminationsMember 2020-01-01 2020-12-31 0001071438 bak:TotalMember 2022-01-01 2022-12-31 0001071438 bak:TotalMember 2021-01-01 2021-12-31 0001071438 bak:TotalMember 2020-01-01 2020-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2020-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2019-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2020-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2019-12-31 0001071438 bak:EliminationsMember 2020-12-31 0001071438 bak:EliminationsMember 2019-12-31 0001071438 bak:TotalMember 2020-12-31 0001071438 bak:TotalMember 2019-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2022-01-01 2022-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2021-01-01 2021-12-31 0001071438 ifrs-full:BuildingsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:BuildingsMember 2021-01-01 2021-12-31 0001071438 bak:MachineryAndFacilitiesMember 2022-01-01 2022-12-31 0001071438 bak:MachineryAndFacilitiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FixturesAndFittingsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FixturesAndFittingsMember 2021-01-01 2021-12-31 0001071438 bak:ItEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:ItEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:LabEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:LabEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:SecurityEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:SecurityEquipmentMember 2021-01-01 2021-12-31 0001071438 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 ifrs-full:LandMember 2020-01-01 2020-12-31 0001071438 ifrs-full:BuildingsMember 2020-01-01 2020-12-31 0001071438 bak:MachineryAndFacilitiesMember 2020-01-01 2020-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2020-01-01 2020-12-31 0001071438 bak:OtherMember 2020-01-01 2020-12-31 0001071438 ifrs-full:LandMember 2020-12-31 0001071438 ifrs-full:BuildingsMember 2020-12-31 0001071438 bak:MachineryAndFacilitiesMember 2020-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2020-12-31 0001071438 bak:OtherMember 2020-12-31 0001071438 ifrs-full:LandMember 2021-01-01 2021-12-31 0001071438 ifrs-full:LandMember 2021-12-31 0001071438 ifrs-full:BuildingsMember 2021-12-31 0001071438 bak:MachineryAndFacilitiesMember 2021-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2021-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 ifrs-full:LandMember 2022-01-01 2022-12-31 0001071438 ifrs-full:LandMember 2022-12-31 0001071438 ifrs-full:BuildingsMember 2022-12-31 0001071438 bak:MachineryAndFacilitiesMember 2022-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2022-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:BrazilMember 2022-12-31 0001071438 bak:BrazilMember 2021-12-31 0001071438 bak:MexicoMember 2022-12-31 0001071438 bak:MexicoMember 2021-12-31 0001071438 bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 bak:UnitedStatesOfAmericaMember 2021-12-31 0001071438 bak:GermanyMember 2022-12-31 0001071438 bak:GermanyMember 2021-12-31 0001071438 bak:NetherlandMember 2022-12-31 0001071438 bak:NetherlandMember 2021-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2020-01-01 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2020-01-01 2020-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-01-01 2020-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2020-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2020-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2021-01-01 2021-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-01-01 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2021-12-31 0001071438 ifrs-full:BrandNamesMember 2021-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2021-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2021-01-01 2021-12-31 0001071438 ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2022-12-31 0001071438 ifrs-full:BrandNamesMember 2022-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2022-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001071438 bak:NortheasternPetrochemicalComplexMember 2022-12-31 0001071438 bak:SouthernPetrochemicalComplexMember 2022-12-31 0001071438 bak:VinylsUnityMember 2022-12-31 0001071438 bak:BrandsAndPatentsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:BrandsAndPatentsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:SoftwareLicensesAndRightsOfUseMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:SoftwareLicensesAndRightsOfUseMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:CustomersAndSuppliersAgreementsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:CustomersAndSuppliersAgreementsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:RailCarsMember 2021-12-31 0001071438 bak:RailCarsMember 2022-01-01 2022-12-31 0001071438 bak:RailCarsMember 2022-12-31 0001071438 bak:MachineryAndEquipmentsMember 2021-12-31 0001071438 bak:MachineryAndEquipmentsMember 2022-01-01 2022-12-31 0001071438 bak:MachineryAndEquipmentsMember 2022-12-31 0001071438 ifrs-full:ShipsMember 2021-12-31 0001071438 ifrs-full:ShipsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ShipsMember 2022-12-31 0001071438 bak:BuildingsAndConstructionsMember 2021-12-31 0001071438 bak:BuildingsAndConstructionsMember 2022-01-01 2022-12-31 0001071438 bak:BuildingsAndConstructionsMember 2022-12-31 0001071438 ifrs-full:VehiclesMember 2021-12-31 0001071438 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:VehiclesMember 2022-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2021-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2022-12-31 0001071438 bak:RailCarsMember 2020-12-31 0001071438 bak:RailCarsMember 2021-01-01 2021-12-31 0001071438 bak:MachineryAndEquipmentsMember 2020-12-31 0001071438 bak:MachineryAndEquipmentsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ShipsMember 2020-12-31 0001071438 ifrs-full:ShipsMember 2021-01-01 2021-12-31 0001071438 bak:BuildingsAndConstructionsMember 2020-12-31 0001071438 bak:BuildingsAndConstructionsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:VehiclesMember 2020-12-31 0001071438 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2020-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:UninitiatedLeaseArrangementsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001071438 bak:LaterThanFiveYearsAndNotLaterThanSixYearsMember 2022-12-31 0001071438 bak:LaterThanSixYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesForfaitMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesForfaitMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesForfaitMember 2022-12-31 0001071438 bak:ThirdPartiesForfaitMember 2021-12-31 0001071438 bak:RelatedPartieMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartieMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartieForfaitMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartieForfaitMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartieForfaitMember 2022-12-31 0001071438 bak:RelatedPartieForfaitMember 2021-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:ExportPrepaymentMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:ExportPrepaymentMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:TransactionsCostsMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:TransactionsCostsMember 2021-12-31 0001071438 bak:ForeignCurrencyMember 2022-12-31 0001071438 bak:ForeignCurrencyMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:AgribusinessCreditNotesMember 2022-01-01 2022-12-31 0001071438 bak:AgribusinessCreditNotesMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:ExportCreditNotes1Member 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:ExportCreditNotes1Member 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:TransactionsCostsMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:TransactionsCostsMember 2021-12-31 0001071438 bak:LocalCurrencyMember 2022-12-31 0001071438 bak:LocalCurrencyMember 2021-12-31 0001071438 bak:TwentyTwentyThreeMember 2021-12-31 0001071438 bak:TwentyTwentyFourMember 2022-12-31 0001071438 bak:TwentyTwentyFourMember 2021-12-31 0001071438 bak:TwentyTwentyFiveMember 2022-12-31 0001071438 bak:TwentyTwentyFiveMember 2021-12-31 0001071438 bak:TwentyTwentySixMember 2022-12-31 0001071438 bak:TwentyTwentySixMember 2021-12-31 0001071438 bak:TwentyTwentySevanMember 2022-12-31 0001071438 bak:TwentyTwentySevanMember 2021-12-31 0001071438 bak:TwentyTwentyEightMember 2022-12-31 0001071438 bak:TwentyTwentyEightMember 2021-12-31 0001071438 bak:TwentyTwentyNineMember 2022-12-31 0001071438 bak:TwentyTwentyNineMember 2021-12-31 0001071438 bak:TwentyThirtyMember 2022-12-31 0001071438 bak:TwentyThirtyMember 2021-12-31 0001071438 bak:TwentyThirtyOneMember 2022-12-31 0001071438 bak:TwentyThirtyOneMember 2021-12-31 0001071438 bak:ThirtyThreeAndThereafterMember 2022-12-31 0001071438 bak:ThirtyThreeAndThereafterMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI7Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI7Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI8Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI8Member 2022-12-31 0001071438 bak:ForeignCurrencyThreeMember 2022-12-31 0001071438 bak:ForeignCurrencyThreeMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA2Member 2022-12-31 0001071438 bak:BondMember 2022-01-01 2022-12-31 0001071438 bak:BondMember 2022-12-31 0001071438 bak:BondMember 2021-12-31 0001071438 bak:BondIIMember 2022-01-01 2022-12-31 0001071438 bak:BondIIMember 2022-12-31 0001071438 bak:BondIIMember 2021-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:TransactionsCostsMember 2022-12-31 0001071438 bak:TransactionsCostsMember 2021-12-31 0001071438 bak:TwentyTwentyTwoMember 2021-12-31 0001071438 bak:DebenturesMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember 2022-12-31 0001071438 bak:DebenturesMember 2021-12-31 0001071438 bak:Debentures1Member 2022-01-01 2022-12-31 0001071438 bak:Debentures1Member 2022-12-31 0001071438 bak:Debentures1Member 2021-12-31 0001071438 bak:Debentures2Member 2022-01-01 2022-12-31 0001071438 bak:Debentures2Member 2022-12-31 0001071438 bak:Debentures3Member 2022-01-01 2022-12-31 0001071438 bak:Debentures3Member 2022-12-31 0001071438 bak:Debentures4Member 2022-01-01 2022-12-31 0001071438 bak:Debentures4Member 2022-12-31 0001071438 bak:Debentures5Member 2022-01-01 2022-12-31 0001071438 bak:Debentures5Member 2022-12-31 0001071438 bak:Debentures6Member 2022-01-01 2022-12-31 0001071438 bak:Debentures6Member 2022-12-31 0001071438 bak:Debentures7Member 2022-01-01 2022-12-31 0001071438 bak:Debentures7Member 2022-12-31 0001071438 bak:Debentures7Member 2021-12-31 0001071438 bak:TwentyTwentyThirtyMember 2022-12-31 0001071438 bak:TwentyTwentyThirtyOneMember 2022-12-31 0001071438 bak:TwentyTwentyThirtyTwoMember 2022-12-31 0001071438 bak:BorrowingMember 2021-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2021-12-31 0001071438 bak:BraskemIdesaFinancingMember 2021-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2021-12-31 0001071438 bak:LeaseMember 2021-12-31 0001071438 bak:DividendsMember 2021-12-31 0001071438 bak:BorrowingMember 2022-01-01 2022-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaFinancingMember 2022-01-01 2022-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:LeaseMember 2022-01-01 2022-12-31 0001071438 bak:DividendsMember 2022-01-01 2022-12-31 0001071438 bak:LoanToNonControllingShareholdersOfBraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:BorrowingMember 2022-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2022-12-31 0001071438 bak:BraskemIdesaFinancingMember 2022-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2022-12-31 0001071438 bak:LeaseMember 2022-12-31 0001071438 bak:DividendsMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember bak:CashAndBanksMember ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember bak:CashAndBanksMember ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:CashAndCashEquivalentMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:CashAndCashEquivalentMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:LetrasFinanceirasDoTesouroLFTMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember bak:LetrasFinanceirasDoTesouroLFTMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:TimeDepositInvestmentsMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001071438 bak:TradePayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:TradePayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001071438 bak:BorrowingMember bak:LocalCurrencyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001071438 bak:BorrowingMember bak:LocalCurrencyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001071438 bak:BorrowingMember 2022-12-31 0001071438 bak:BorrowingMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:BondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:BondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember 2021-12-31 0001071438 bak:DebenturesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:DebenturesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:LoanToNoncontrollingShareholderOfBraskemIdesaMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:LoanToNoncontrollingShareholderOfBraskemIdesaMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:LeniencyAgreementMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:LeniencyAgreementMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraksemAmericaSwapC3PGPMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraksemAmericaSwapC3PGPMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSASwapCRAMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSASwapCRAMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:PutOptionsMember 2022-12-31 0001071438 bak:PutOptionsMember 2021-12-31 0001071438 bak:CallOptionsMember 2022-12-31 0001071438 bak:CallOptionsMember 2021-12-31 0001071438 bak:FutureExportsMember 2017-12-31 0001071438 bak:FutureExportsMember 2019-12-31 0001071438 bak:FutureExportsOneMember 2019-12-31 0001071438 bak:FutureExportsMember 2020-12-31 0001071438 bak:FutureExportsOneMember 2020-12-31 0001071438 bak:FutureExportsMember 2020-01-01 2020-12-31 0001071438 bak:FutureExportsOneMember 2020-01-01 2020-12-31 0001071438 bak:FutureExportsMember 2021-12-31 0001071438 bak:FutureExportsOneMember 2021-12-31 0001071438 bak:FutureExportsMember 2021-01-01 2021-12-31 0001071438 bak:FutureExportsOneMember 2021-01-01 2021-12-31 0001071438 bak:FutureExportsMember 2022-12-31 0001071438 bak:FutureExportsOneMember 2022-12-31 0001071438 bak:SwapsCRAMember 2022-12-31 0001071438 bak:SwapsCRAMember 2022-01-01 2022-12-31 0001071438 bak:SwapsCRA1Member 2022-12-31 0001071438 bak:SwapsCRA1Member 2022-01-01 2022-12-31 0001071438 ifrs-full:DerivativesMember 2022-12-31 0001071438 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember bak:USDMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember bak:USDMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember bak:USDMember 2022-12-31 0001071438 bak:LaterThanEightYearsAndNotLaterThanNineYearsMember bak:USDMember 2022-12-31 0001071438 ifrs-full:LaterThanSevenYearsAndNotLaterThanTenYearsMember bak:USDMember 2022-12-31 0001071438 bak:LaterThanTenYears1Member bak:USDMember 2022-12-31 0001071438 ifrs-full:LaterThanTenYearsAndNotLaterThanFifteenYearsMember bak:USDMember 2022-12-31 0001071438 currency:USD 2022-12-31 0001071438 currency:USD bak:FutureExportsMember 2021-12-31 0001071438 currency:USD bak:FutureExportsMember 2022-01-01 2022-12-31 0001071438 currency:USD bak:FutureExportsMember 2022-12-31 0001071438 currency:USD bak:FirstQuarterMember 2022-12-31 0001071438 bak:FirstQuarterMember 2022-12-31 0001071438 currency:USD bak:SecondQuarterMember 2022-12-31 0001071438 bak:SecondQuarterMember 2022-12-31 0001071438 currency:USD bak:ThirdQuarterMember 2022-12-31 0001071438 bak:ThirdQuarterMember 2022-12-31 0001071438 currency:USD bak:FourthQuarterMember 2022-12-31 0001071438 bak:FourthQuarterMember 2022-12-31 0001071438 bak:ExchangeVariationMember 2021-12-31 0001071438 bak:IRAndCSLMember 2021-12-31 0001071438 bak:ExchangeVariationMember 2022-01-01 2022-12-31 0001071438 bak:IRAndCSLMember 2022-01-01 2022-12-31 0001071438 bak:ExchangeVariationMember 2022-12-31 0001071438 bak:IRAndCSLMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanSevenYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTenYearsAndNotLaterThanFifteenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember 2022-12-31 0001071438 bak:LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember 2022-12-31 0001071438 bak:LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember 2022-12-31 0001071438 currency:USD bak:FirstQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:FirstQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 currency:USD bak:SecondQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:SecondQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 currency:USD bak:ThirdQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:ThirdQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 currency:USD bak:FourthQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:FourthQuarterMember bak:BraskemIdesaMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2021-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2021-12-31 0001071438 bak:BraskemIdesaMember 2021-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2022-12-31 0001071438 bak:MinimumRiskMember 2022-12-31 0001071438 bak:MinimumRiskMember 2021-12-31 0001071438 bak:LowRiskMember 2022-12-31 0001071438 bak:LowRiskMember 2021-12-31 0001071438 bak:ModerateRiskMember 2022-12-31 0001071438 bak:ModerateRiskMember 2021-12-31 0001071438 bak:HighRiskMember 2022-12-31 0001071438 bak:HighRiskMember 2021-12-31 0001071438 bak:VeryHighRiskMember 2022-12-31 0001071438 bak:VeryHighRiskMember 2021-12-31 0001071438 bak:AAAMember 2022-12-31 0001071438 bak:AAAMember 2021-12-31 0001071438 bak:AAPlusMember 2022-12-31 0001071438 bak:AAPlusMember 2021-12-31 0001071438 bak:AAMember 2022-12-31 0001071438 bak:AAMember 2021-12-31 0001071438 bak:AAMinusMember 2022-12-31 0001071438 bak:AAMinusMember 2021-12-31 0001071438 bak:APlusMember 2022-12-31 0001071438 bak:APlusMember 2021-12-31 0001071438 bak:AMember 2022-12-31 0001071438 bak:AMember 2021-12-31 0001071438 bak:AMinusMember 2022-12-31 0001071438 bak:AMinusMember 2021-12-31 0001071438 bak:BBBPlusMember 2022-12-31 0001071438 bak:BBBPlusMember 2021-12-31 0001071438 bak:BBBMember 2022-12-31 0001071438 bak:BBBMember 2021-12-31 0001071438 bak:BBBMinusMember 2021-12-31 0001071438 bak:BBPlusMember 2021-12-31 0001071438 bak:BBMember 2021-12-31 0001071438 bak:BBMinusMember 2022-12-31 0001071438 bak:SharesOfInvestmentFundsMember 2021-12-31 0001071438 bak:OtherFinancialAssetMember 2022-12-31 0001071438 bak:OtherFinancialAssetMember 2021-12-31 0001071438 bak:BondMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:InvestmentMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:SaceMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarCallAndPutOptionsMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapCDIMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:MONFORTEMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:NexiMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInvestmentsAbroadMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapIPCAMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:NexiMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:SaceMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:MONFORTEMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:InvestmentMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:OutrosMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember bak:CDIInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInvestmentsInBrazilMember bak:CDIInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:BNDESMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:BNBFINEPFUNDESFINISAFINAMEFNEMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:CRAMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapIPCAMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:LeniencyAgreementMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportCreditNotesMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:IPIMember bak:DomesticMember 2022-12-31 0001071438 bak:IPIMember bak:DomesticMember 2021-12-31 0001071438 bak:ICMSMember bak:DomesticMember 2022-12-31 0001071438 bak:ICMSMember bak:DomesticMember 2021-12-31 0001071438 bak:PISAndCOFINSMember bak:DomesticMember 2022-12-31 0001071438 bak:PISAndCOFINSMember bak:DomesticMember 2021-12-31 0001071438 bak:OtherMember bak:DomesticMember 2022-12-31 0001071438 bak:OtherMember bak:DomesticMember 2021-12-31 0001071438 bak:ValueAddedTaxMember bak:OtherCountriesMember 2022-12-31 0001071438 bak:ValueAddedTaxMember bak:OtherCountriesMember 2021-12-31 0001071438 bak:OtherMember bak:OtherCountriesMember 2022-12-31 0001071438 bak:OtherMember bak:OtherCountriesMember 2021-12-31 0001071438 bak:OtherCountriesMember 2022-12-31 0001071438 bak:OtherCountriesMember 2021-12-31 0001071438 2022-08-01 2022-08-31 0001071438 bak:SubsidiaryOneMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryTwoMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryThreeMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryFourMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryFiveMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiarySixMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiarySevenMember 2022-01-01 2022-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2020-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2021-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2022-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2020-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2021-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2022-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2020-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2021-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2020-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2022-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2020-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2021-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2020-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2022-12-31 0001071438 bak:OtherMember bak:AssetMember 2020-12-31 0001071438 bak:OtherMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember bak:AssetMember 2021-12-31 0001071438 bak:OtherMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:AssetMember 2022-12-31 0001071438 bak:AssetMember 2020-12-31 0001071438 bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:AssetMember 2021-12-31 0001071438 bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:NetMember 2020-12-31 0001071438 bak:NetMember 2021-01-01 2021-12-31 0001071438 bak:NetMember 2021-12-31 0001071438 bak:NetMember 2022-01-01 2022-12-31 0001071438 bak:NetMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemHolandaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemHolandaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemIdesaServicosMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaServicosMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2021-12-31 0001071438 bak:AssetMember bak:CetrelMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:CetrelMember 2022-12-31 0001071438 bak:AssetMember bak:CetrelMember 2021-12-31 0001071438 bak:AssetMember bak:DACMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:DACMember 2022-12-31 0001071438 bak:AssetMember bak:DACMember 2021-12-31 0001071438 bak:AssetMember bak:TerminalQuimicaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:TerminalQuimicaMember 2022-12-31 0001071438 bak:AssetMember bak:VoqenMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:VoqenMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemArgentinaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemHolandaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemHolandaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BTCMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BTCMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:VoqenMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:VoqenMember 2022-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2022-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2021-12-31 0001071438 bak:ProvisionForCustomersRebatesMember 2022-12-31 0001071438 bak:ProvisionForCustomersRebatesMember 2021-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2020-12-31 0001071438 bak:RebateMember 2020-12-31 0001071438 bak:OtherMember 2020-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2021-01-01 2021-12-31 0001071438 bak:RebateMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 bak:RebateMember 2021-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2022-01-01 2022-12-31 0001071438 bak:RebateMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:RebateMember 2022-12-31 0001071438 bak:LaborClaimsMember 2022-12-31 0001071438 bak:LaborClaimsMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:IRAndCSLMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:IRAndCSLMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:PISAndCOFINSMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:PISAndCOFINSMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:ICMSMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:ICMSMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:OtherTaxClaimsMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:OtherTaxClaimsMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:NormalOperationMember 2021-12-31 0001071438 bak:CorporateClaimsMember 2022-12-31 0001071438 bak:CorporateClaimsMember 2021-12-31 0001071438 bak:CivilClaimsAndOtherMember 2022-12-31 0001071438 bak:CivilClaimsAndOtherMember 2021-12-31 0001071438 bak:TaxClaimsICMSMember 2022-01-01 2022-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:TaxClaimsICMSMember 2022-01-01 2022-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:TaxClaimsICMSMember 2021-01-01 2021-12-31 0001071438 bak:IRAndCSLMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember 2021-01-01 2021-12-31 0001071438 bak:IRPJAndCSLLForeignEarnedIncomeMember ifrs-full:TaxContingentLiabilityMember 2022-01-01 2022-12-31 0001071438 bak:IRPJAndCSLLForeignEarnedIncomeMember ifrs-full:TaxContingentLiabilityMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember bak:PISAndCOFINSTaxesMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsICMSMember bak:PISAndCOFINSTaxesMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:PISAndCOFINSSundryMember 2022-12-31 0001071438 bak:PISAndCOFINSSundryMember 2021-12-31 0001071438 bak:IRRFIRAndCSLCommissionExpensesMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IRRFIRAndCSLCommissionExpensesMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:IsolatedFineFailureToRatifyDCOMPSMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IsolatedFineFailureToRatifyDCOMPSMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:SocialSecurityContributionsMember 2022-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:SocialSecurityContributionsMember 2021-12-31 0001071438 bak:PISAndCOFINSDCideFuelsTaxOffsetMember ifrs-full:TaxContingentLiabilityMember 2022-01-01 2022-12-31 0001071438 bak:PISAndCOFINSDCideFuelsTaxOffsetMember ifrs-full:TaxContingentLiabilityMember 2021-01-01 2021-12-31 0001071438 bak:CivilClaimsResaleOfSolventsMember 2022-12-31 0001071438 bak:CivilClaimsResaleOfSolventsMember 2021-12-31 0001071438 bak:EnvironmentalMember 2022-01-01 2022-12-31 0001071438 bak:EnvironmentalMember 2021-01-01 2021-12-31 0001071438 bak:SocialSecurityMember 2022-01-01 2022-12-31 0001071438 bak:SocialSecurityMember 2021-01-01 2021-12-31 0001071438 bak:IRPJCSLLNegativeBalanceOffsetMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IRPJCSLLNegativeBalanceOffsetMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:LaborClaimsMember 2020-12-31 0001071438 bak:TaxClaimsNetMember 2020-12-31 0001071438 bak:CorporateClaimMember 2020-12-31 0001071438 bak:CivilClaimsAndOtherMember 2020-12-31 0001071438 bak:LaborClaimsMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsNetMember 2021-01-01 2021-12-31 0001071438 bak:CorporateClaimMember 2021-01-01 2021-12-31 0001071438 bak:CivilClaimsAndOtherMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsNetMember 2021-12-31 0001071438 bak:CorporateClaimMember 2021-12-31 0001071438 bak:LaborClaimsMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsNetMember 2022-01-01 2022-12-31 0001071438 bak:CorporateClaimMember 2022-01-01 2022-12-31 0001071438 bak:CivilClaimsAndOtherMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsNetMember 2022-12-31 0001071438 bak:CorporateClaimMember 2022-12-31 0001071438 bak:TaxClaimsMember 2022-12-31 0001071438 bak:TaxClaimsMember 2021-12-31 0001071438 bak:CivilClaimsOneMember 2022-12-31 0001071438 bak:CivilClaimsOneMember 2021-12-31 0001071438 bak:CivilClaimsTwoMember 2022-12-31 0001071438 bak:CivilClaimsTwoMember 2021-12-31 0001071438 bak:EnvironmentalClaimsMember 2022-12-31 0001071438 bak:EnvironmentalClaimsMember 2021-12-31 0001071438 bak:SocialSecurityClaimsMember 2022-12-31 0001071438 bak:SocialSecurityClaimsMember 2021-12-31 0001071438 bak:OtherLawsuitsMember 2022-12-31 0001071438 bak:OtherLawsuitsMember 2021-12-31 0001071438 currency:USD bak:FederalProsecutionOfficeAndUSSwissAuthoritiesMember bak:LeniencyAgreementsMember 2016-12-01 2016-12-31 0001071438 bak:FederalProsecutionOfficeAndUSSwissAuthoritiesMember bak:LeniencyAgreementsMember 2016-12-01 2016-12-31 0001071438 bak:FederalControllerGeneralAndAttorneyGenerallAgreementMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:DepartmentOfJusticeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:SwissOfficeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:FederalProsecutionOfficeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:SecuritiesAndExchangeCommissionMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasMember 2021-12-31 0001071438 bak:AlagoasMember 2020-12-31 0001071438 bak:AlagoasMember 2019-12-31 0001071438 bak:AlagoasMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasMember 2021-01-01 2021-12-31 0001071438 bak:AlagoasMember 2020-01-01 2020-12-31 0001071438 bak:AlagoasMember 2022-12-31 0001071438 bak:AlagoasStateFederalProsecutionOfficeMember bak:TechnicalCooperationAgreementMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasStateFederalProsecutionOfficeMember bak:TechnicalCooperationAgreementMember 2021-01-01 2021-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2022-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2021-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2022-01-01 2022-12-31 0001071438 bak:HealthCareBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:HealthCareBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:HealthCareBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:PrivatePensionBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:PrivatePensionBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:PrivatePensionBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:TransportBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:TransportBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:TransportBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:FeedingBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:FeedingBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:FeedingBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:TrainingBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:TrainingBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:TrainingBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:OtherBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:OtherBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:OtherBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:Plan2019Member bak:SettlementMethodologySharesMember 2022-01-01 2022-12-31 0001071438 bak:Plan2019Member bak:SettlementMethodologySharesMember 2021-01-01 2021-12-31 0001071438 bak:Plan2019Member bak:SettlementMethodologyCashMember 2022-01-01 2022-12-31 0001071438 bak:Plan2019Member bak:SettlementMethodologyCashMember 2021-01-01 2021-12-31 0001071438 bak:Plan2020Member bak:SettlementMethodologySharesMember 2022-01-01 2022-12-31 0001071438 bak:Plan2020Member bak:SettlementMethodologySharesMember 2021-01-01 2021-12-31 0001071438 bak:Plan2020Member bak:SettlementMethodologyCashMember 2022-01-01 2022-12-31 0001071438 bak:Plan2020Member bak:SettlementMethodologyCashMember 2021-01-01 2021-12-31 0001071438 bak:Plan2021Member bak:SettlementMethodologySharesMember 2022-01-01 2022-12-31 0001071438 bak:Plan2021Member bak:SettlementMethodologySharesMember 2021-01-01 2021-12-31 0001071438 bak:Plan2021Member bak:SettlementMethodologyCashMember 2022-01-01 2022-12-31 0001071438 bak:Plan2021Member bak:SettlementMethodologyCashMember 2021-01-01 2021-12-31 0001071438 bak:Plan2022Member bak:SettlementMethodologySharesMember 2022-01-01 2022-12-31 0001071438 bak:Plan2022Member bak:SettlementMethodologyCashMember 2022-01-01 2022-12-31 0001071438 bak:DefinedBenefitMember bak:NovamontBraskemAmericaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:NovamontBraskemAmericaMember 2021-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemAlemanhaAndBraskemHolandaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemAlemanhaAndBraskemHolandaMember 2021-12-31 0001071438 bak:DefinedBenefitMember 2022-12-31 0001071438 bak:DefinedBenefitMember 2021-12-31 0001071438 bak:HealthCarePlanMember bak:BradescoSaudeMember 2022-12-31 0001071438 bak:HealthCarePlanMember bak:BradescoSaudeMember 2021-12-31 0001071438 bak:NovamontBraskemAmericaMember 2022-12-31 0001071438 bak:NovamontBraskemAmericaMember 2021-12-31 0001071438 bak:BraskemAlemanhaMember 2022-12-31 0001071438 bak:BraskemAlemanhaMember 2021-12-31 0001071438 bak:HealthInsuranceMember 2021-12-31 0001071438 bak:BenefitPlansMember 2021-12-31 0001071438 bak:HealthInsuranceMember 2020-12-31 0001071438 bak:BenefitPlansMember 2020-12-31 0001071438 bak:HealthInsuranceMember 2019-12-31 0001071438 bak:BenefitPlansMember 2019-12-31 0001071438 bak:HealthInsuranceMember 2022-01-01 2022-12-31 0001071438 bak:BenefitPlansMember 2022-01-01 2022-12-31 0001071438 bak:HealthInsuranceMember 2021-01-01 2021-12-31 0001071438 bak:BenefitPlansMember 2021-01-01 2021-12-31 0001071438 bak:HealthInsuranceMember 2020-01-01 2020-12-31 0001071438 bak:BenefitPlansMember 2020-01-01 2020-12-31 0001071438 bak:HealthInsuranceMember 2022-12-31 0001071438 bak:BenefitPlansMember 2022-12-31 0001071438 bak:UnitedStateOfAmericaMember 2022-12-31 0001071438 bak:MexicoMember 2022-12-31 0001071438 bak:GermanyMember 2022-12-31 0001071438 bak:NetherlandsMember 2022-12-31 0001071438 bak:UnitedStateOfAmericaMember 2021-12-31 0001071438 bak:MexicoMember 2021-12-31 0001071438 bak:GermanyMember 2021-12-31 0001071438 bak:NetherlandsMember 2021-12-31 0001071438 bak:UnitedStateOfAmericaMember 2020-12-31 0001071438 bak:MexicoMember 2020-12-31 0001071438 bak:GermanyMember 2020-12-31 0001071438 bak:NetherlandsMember 2020-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:MexicoMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:GermanyMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:NetherlandsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfMortalityRatesMember bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember 2022-12-31 0001071438 bak:NovonorMember bak:CommonSharesMember 2022-12-31 0001071438 bak:NovonorMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:NovonorMember 2022-12-31 0001071438 bak:PetrobrasMember bak:CommonSharesMember 2022-12-31 0001071438 bak:PetrobrasMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:PetrobrasMember 2022-12-31 0001071438 bak:AdrsMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:AdrsMember 2022-12-31 0001071438 bak:OtherMember bak:CommonSharesMember 2022-12-31 0001071438 bak:OtherMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:OtherMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:Other2Member 2022-12-31 0001071438 bak:TotalMember bak:CommonSharesMember 2022-12-31 0001071438 bak:TotalMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:TotalMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:TotalMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-12-31 0001071438 bak:CommonSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:CommonSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:AuthorisedMember 2022-12-31 0001071438 bak:CommonSharesMember 2020-12-31 0001071438 bak:CommonSharesMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember 2021-12-31 0001071438 bak:TotalMember 2020-12-31 0001071438 bak:TotalMember 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-12-31 0001071438 bak:LTIProgram2018Member 2021-01-01 2021-12-31 0001071438 bak:ProfitReservesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassBPreferenceSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2019-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2019-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-01-01 2020-12-31 0001071438 bak:BrazilMember 2022-01-01 2022-12-31 0001071438 bak:BrazilMember 2021-01-01 2021-12-31 0001071438 bak:BrazilMember 2020-01-01 2020-12-31 0001071438 bak:UnitedStatesMember 2022-01-01 2022-12-31 0001071438 bak:UnitedStatesMember 2021-01-01 2021-12-31 0001071438 bak:UnitedStatesMember 2020-01-01 2020-12-31 0001071438 bak:MexicoMember 2022-01-01 2022-12-31 0001071438 bak:MexicoMember 2021-01-01 2021-12-31 0001071438 bak:MexicoMember 2020-01-01 2020-12-31 0001071438 bak:ARMember 2022-01-01 2022-12-31 0001071438 bak:ARMember 2021-01-01 2021-12-31 0001071438 bak:ARMember 2020-01-01 2020-12-31 0001071438 bak:DEMember 2022-01-01 2022-12-31 0001071438 bak:DEMember 2021-01-01 2021-12-31 0001071438 bak:DEMember 2020-01-01 2020-12-31 0001071438 bak:CHMember 2022-01-01 2022-12-31 0001071438 bak:CHMember 2021-01-01 2021-12-31 0001071438 bak:CHMember 2020-01-01 2020-12-31 0001071438 bak:ITMember 2022-01-01 2022-12-31 0001071438 bak:ITMember 2021-01-01 2021-12-31 0001071438 bak:ITMember 2020-01-01 2020-12-31 0001071438 bak:CLMember 2022-01-01 2022-12-31 0001071438 bak:CLMember 2021-01-01 2021-12-31 0001071438 bak:CLMember 2020-01-01 2020-12-31 0001071438 bak:NLMember 2022-01-01 2022-12-31 0001071438 bak:NLMember 2021-01-01 2021-12-31 0001071438 bak:NLMember 2020-01-01 2020-12-31 0001071438 bak:LUMember 2022-01-01 2022-12-31 0001071438 bak:LUMember 2021-01-01 2021-12-31 0001071438 bak:LUMember 2020-01-01 2020-12-31 0001071438 bak:SGMember 2022-01-01 2022-12-31 0001071438 bak:SGMember 2021-01-01 2021-12-31 0001071438 bak:SGMember 2020-01-01 2020-12-31 0001071438 bak:PEMember 2022-01-01 2022-12-31 0001071438 bak:PEMember 2021-01-01 2021-12-31 0001071438 bak:PEMember 2020-01-01 2020-12-31 0001071438 bak:JPMember 2022-01-01 2022-12-31 0001071438 bak:JPMember 2021-01-01 2021-12-31 0001071438 bak:JPMember 2020-01-01 2020-12-31 0001071438 bak:ESMember 2022-01-01 2022-12-31 0001071438 bak:ESMember 2021-01-01 2021-12-31 0001071438 bak:ESMember 2020-01-01 2020-12-31 0001071438 bak:GBMember 2022-01-01 2022-12-31 0001071438 bak:GBMember 2021-01-01 2021-12-31 0001071438 bak:GBMember 2020-01-01 2020-12-31 0001071438 bak:UYMember 2022-01-01 2022-12-31 0001071438 bak:UYMember 2021-01-01 2021-12-31 0001071438 bak:UYMember 2020-01-01 2020-12-31 0001071438 bak:PLMember 2022-01-01 2022-12-31 0001071438 bak:PLMember 2021-01-01 2021-12-31 0001071438 bak:PLMember 2020-01-01 2020-12-31 0001071438 bak:BOMember 2022-01-01 2022-12-31 0001071438 bak:BOMember 2021-01-01 2021-12-31 0001071438 bak:BOMember 2020-01-01 2020-12-31 0001071438 bak:SEMember 2022-01-01 2022-12-31 0001071438 bak:SEMember 2021-01-01 2021-12-31 0001071438 bak:SEMember 2020-01-01 2020-12-31 0001071438 bak:CAMember 2022-01-01 2022-12-31 0001071438 bak:CAMember 2021-01-01 2021-12-31 0001071438 bak:CAMember 2020-01-01 2020-12-31 0001071438 bak:FRMember 2022-01-01 2022-12-31 0001071438 bak:FRMember 2021-01-01 2021-12-31 0001071438 bak:FRMember 2020-01-01 2020-12-31 0001071438 bak:PYMember 2022-01-01 2022-12-31 0001071438 bak:PYMember 2021-01-01 2021-12-31 0001071438 bak:PYMember 2020-01-01 2020-12-31 0001071438 bak:COMember 2022-01-01 2022-12-31 0001071438 bak:COMember 2021-01-01 2021-12-31 0001071438 bak:COMember 2020-01-01 2020-12-31 0001071438 bak:CNMember 2022-01-01 2022-12-31 0001071438 bak:CNMember 2021-01-01 2021-12-31 0001071438 bak:CNMember 2020-01-01 2020-12-31 0001071438 bak:KRMember 2022-01-01 2022-12-31 0001071438 bak:KRMember 2021-01-01 2021-12-31 0001071438 bak:KRMember 2020-01-01 2020-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2020-01-01 2020-12-31 0001071438 bak:PEPPMember 2022-01-01 2022-12-31 0001071438 bak:PEPPMember 2021-01-01 2021-12-31 0001071438 bak:PEPPMember 2020-01-01 2020-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2022-01-01 2022-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2021-01-01 2021-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2020-01-01 2020-12-31 0001071438 bak:EthylenePropyleneMember 2022-01-01 2022-12-31 0001071438 bak:EthylenePropyleneMember 2021-01-01 2021-12-31 0001071438 bak:EthylenePropyleneMember 2020-01-01 2020-12-31 0001071438 bak:ETBEGasolineMember 2022-01-01 2022-12-31 0001071438 bak:ETBEGasolineMember 2021-01-01 2021-12-31 0001071438 bak:ETBEGasolineMember 2020-01-01 2020-12-31 0001071438 bak:PVCCausticSodaEDCMember 2022-01-01 2022-12-31 0001071438 bak:PVCCausticSodaEDCMember 2021-01-01 2021-12-31 0001071438 bak:PVCCausticSodaEDCMember 2020-01-01 2020-12-31 0001071438 bak:ButadieneMember 2022-01-01 2022-12-31 0001071438 bak:ButadieneMember 2021-01-01 2021-12-31 0001071438 bak:ButadieneMember 2020-01-01 2020-12-31 0001071438 bak:SolventsMember 2022-01-01 2022-12-31 0001071438 bak:SolventsMember 2021-01-01 2021-12-31 0001071438 bak:SolventsMember 2020-01-01 2020-12-31 0001071438 bak:CumeneMember 2022-01-01 2022-12-31 0001071438 bak:CumeneMember 2021-01-01 2021-12-31 0001071438 bak:CumeneMember 2020-01-01 2020-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2022-01-01 2022-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2021-01-01 2021-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2020-01-01 2020-12-31 0001071438 bak:Other1Member 2022-01-01 2022-12-31 0001071438 bak:Other1Member 2021-01-01 2021-12-31 0001071438 bak:Other1Member 2020-01-01 2020-12-31 0001071438 bak:OneClientMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:FreightsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:FreightsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:FreightsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember 2020-01-01 2020-12-31 0001071438 bak:FinancialInterestIncomeMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInterestIncomeMember 2021-01-01 2021-12-31 0001071438 bak:FinancialInterestIncomeMember 2020-01-01 2020-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2022-01-01 2022-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2021-01-01 2021-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2020-01-01 2020-12-31 0001071438 bak:GainOnDerivativesMember 2022-01-01 2022-12-31 0001071438 bak:GainOnDerivativesMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialIncomeMember 2022-01-01 2022-12-31 0001071438 bak:OtherFinancialIncomeMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialIncomeMember 2020-01-01 2020-12-31 0001071438 bak:FinancialInterestExpensesMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInterestExpensesMember 2021-01-01 2021-12-31 0001071438 bak:FinancialInterestExpensesMember 2020-01-01 2020-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2022-01-01 2022-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2021-01-01 2021-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2020-01-01 2020-12-31 0001071438 bak:DiscountsGrantedMember 2022-01-01 2022-12-31 0001071438 bak:DiscountsGrantedMember 2021-01-01 2021-12-31 0001071438 bak:DiscountsGrantedMember 2020-01-01 2020-12-31 0001071438 bak:LoansTransactionCostsMember 2022-01-01 2022-12-31 0001071438 bak:LoansTransactionCostsMember 2021-01-01 2021-12-31 0001071438 bak:LoansTransactionCostsMember 2020-01-01 2020-12-31 0001071438 bak:AdjustmentToPresentValueMember 2022-01-01 2022-12-31 0001071438 bak:AdjustmentToPresentValueMember 2021-01-01 2021-12-31 0001071438 bak:AdjustmentToPresentValueMember 2020-01-01 2020-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2022-01-01 2022-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2021-01-01 2021-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2020-01-01 2020-12-31 0001071438 bak:LossesOnDerivativesMember 2022-01-01 2022-12-31 0001071438 bak:LossesOnDerivativesMember 2021-01-01 2021-12-31 0001071438 bak:LossesOnDerivativesMember 2020-01-01 2020-12-31 0001071438 bak:OtherFinancialExpensesMember 2022-01-01 2022-12-31 0001071438 bak:OtherFinancialExpensesMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialExpensesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:FinancialAssetsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialAssetsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2020-01-01 2020-12-31 0001071438 bak:USDollarBrazilianRealMember 2022-12-31 0001071438 bak:USDollarBrazilianRealMember 2021-12-31 0001071438 bak:USDollarBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:USDollarBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:USDollarBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:EuroBrazilianRealMember 2022-12-31 0001071438 bak:EuroBrazilianRealMember 2021-12-31 0001071438 bak:EuroBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:EuroBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:EuroBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2022-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2021-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:USDollarMexicanPesoMember 2022-12-31 0001071438 bak:USDollarMexicanPesoMember 2021-12-31 0001071438 bak:USDollarMexicanPesoMember 2022-01-01 2022-12-31 0001071438 bak:USDollarMexicanPesoMember 2021-01-01 2021-12-31 0001071438 bak:USDollarMexicanPesoMember 2020-01-01 2020-12-31 0001071438 bak:USDollarEuroMember 2022-12-31 0001071438 bak:USDollarEuroMember 2021-12-31 0001071438 bak:USDollarEuroMember 2022-01-01 2022-12-31 0001071438 bak:USDollarEuroMember 2021-01-01 2021-12-31 0001071438 bak:USDollarEuroMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember 2022-01-01 2022-12-31 0001071438 bak:OtherSegmentsMember 2022-01-01 2022-12-31 0001071438 bak:CorporateUnitMember 2022-01-01 2022-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2022-01-01 2022-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember 2021-01-01 2021-12-31 0001071438 bak:OtherSegmentsMember 2021-01-01 2021-12-31 0001071438 bak:CorporateUnitMember 2021-01-01 2021-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2021-01-01 2021-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember 2020-01-01 2020-12-31 0001071438 bak:OtherSegmentsMember 2020-01-01 2020-12-31 0001071438 bak:CorporateUnitMember 2020-01-01 2020-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2020-01-01 2020-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2021-12-31 0001071438 bak:ReportingSegmentsMember 2022-12-31 0001071438 bak:ReportingSegmentsMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:UnallocatedMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:UnallocatedMember 2021-12-31 0001071438 bak:EnergyAgreementMember 2022-12-31 0001071438 bak:EnergyAgreementMember 2021-12-31 0001071438 bak:EventsAfterReportingPeriodMember 2023-02-28 0001071438 bak:EventsAfterReportingPeriodMember 2023-02-02 2023-02-28 0001071438 bak:EventsAfterReportingPeriodMember bak:WiseMember 2023-02-02 2023-02-28 0001071438 bak:EventsAfterReportingPeriodMember 2023-03-02 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:BRL xbrli:pure iso4217:BRL xbrli:shares bak:Number iso4217:MXN

As filed with the Securities and Exchange Commission on April 24, 2023

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 20-F

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR

12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

OR

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-14862

BRASKEM S.A.

(Exact Name of Registrant as Specified in its Charter)

   
N/A The Federative Republic of Brazil
(Translation of Registrant’s Name into English) (Jurisdiction of Incorporation or Organization)

Rua Lemos Monteiro, 120 – 24° andar
Butantã – São Paulo, SP – CEP 05501-050Brazil

(Address of Principal Executive Offices)

Pedro van Langendonck Teixeira de Freitas

Braskem S.A.

Rua Lemos Monteiro, 120 – 24° andar

Butantã – São Paulo, SP – CEP 05501-050Brazil

Telephone: + 55 11 3576-9000

Fax: + 55 11 3576-9532

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

     

Title of Each Class

Trading Symbol

Name of Each Exchange on which Registered

Preferred Shares, Class A, without par value per share, each represented by American Depositary Shares BAK New York Stock Exchange

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

The total number of issued shares of each class of stock of Braskem S.A. as of December 31, 2022 was:

451,668,652 Common Shares, without par value

345,060,392 Preferred Shares, Class A, without par value

478,790 Preferred Shares, Class B, without par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes No

 
   

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer Non-accelerated filer Emerging growth company

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP International Financial Reporting Standards as issued by the International
Accounting Standards Board
Other

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 
   

TABLE OF CONTENTS

Page

PRESENTATION OF FINANCIAL AND OTHER INFORMATION   i
CAUTIONARY STATEMENT WITH RESPECT TO FORWARD-LOOKING STATEMENTS   xiii
PART I   1
Item 1. Identity of Directors, Senior Management and Advisers   1
Item 2. Offer Statistics and Expected Timetable   1
Item 3. Key Information   1
Item 4. Information on the Company   67
Item 4A. Unresolved Staff Comments   108
Item 5. Operating And Financial Review and Prospects   108
Item 6. Directors, Senior Management and Employees   149
Item 7. Major Shareholders and Related Party Transactions   172
Item 8. Financial Information   180
Item 9. The Offer and Listing   197
Item 10. Additional Information   198
Item 11. Quantitative and Qualitative Disclosures About Market Risk   218
Item 12. Description of Securities Other than Equity Securities   222
PART II   223
Item 13. Defaults, Dividend Arrearages and Delinquencies   223
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds   223
Item 15. Controls and Procedures   223
Item 16A. Audit Committee Financial Expert   224
Item 16B. Code of Ethics   224
Item 16C. Principal Accountant Fees and Services   225
Item 16D. Exemptions From the Listing Standards for Audit Committees   225
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers   226
Item 16F. Change in Registrant’s Certifying Accountant   226
Item 16G. Corporate Governance   226
Item 16H. Mine Safety Disclosure   229
PART III   230
Item 17. Financial Statements   230
Item 18. Financial Statements   230
Item 19. Exhibits   230

 

 

 

PRESENTATION OF FINANCIAL AND OTHER INFORMATION

All references herein to “real,” “reais” or “R$” are to the Brazilian real, the official currency of the Federative Republic of Brazil, or Brazil. All references to “U.S. dollars,” “dollars” or “US$” are to U.S. dollars, the official currency of the United States. All references to “CHF” are to Swiss francs, the official currency of Switzerland.

On March 31, 2023, the real/U.S. dollar exchange rate was R$5.0804 to US$1.00, based on the selling rate as reported by the Central Bank. The selling rate was R$5.2177 to US$1.00 as of December 31, 2022, R$5.5805 to US$1.00 as of December 31, 2021 and R$5.1967 to US$1.00 as of December 31, 2020, as reported by the Central Bank. The real/U.S. dollar exchange rate fluctuates widely, and these selling rates may not be indicative of future selling rates.

Solely for the convenience of the reader we have translated, to the extent applicable, real amounts in this annual report into U.S. dollars at the selling rate as reported by the Central Bank as of December 31, 2022 of R$5.2177 to US$1.00. These translations should not be considered representations that any such amounts have been, could have been or could be converted into U.S. dollars at that or at any other exchange rate.

All references herein to (1) “we,” “us,” “the Company” or “our Company” are references to Braskem S.A., its consolidated subsidiaries and jointly controlled entities, and (2) “Braskem” are references solely to Braskem S.A. All references herein to “Braskem Europe” are to Braskem Europe GmbH and its consolidated subsidiaries, including Braskem America, Inc., or Braskem America.

Financial Statements

Braskem Financial Statements

We maintain our books and records in reais. Our consolidated financial statements as of December 31, 2022 and 2021 and for the three years ended December 31, 2022 have been audited, as stated in the report appearing therein, and are included in this annual report. These financial statements and related notes included elsewhere in this annual report are collectively referred to as our audited consolidated financial statements herein and throughout this annual report.

We have prepared our consolidated financial statements in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB.

Market Share and Other Information

We make statements in this annual report about our market share in the petrochemical industry in Brazil and our production capacity relative to that of other petrochemical producers in Brazil, other countries in Latin America, the United States and the world. We have made these statements on the basis of information obtained from third-party sources that we believe are reliable. We have calculated our Brazilian market share with respect to specific products by dividing our domestic net sales volumes of these products by the total Brazilian domestic consumption of these products. We derive information regarding the production capacity of other companies in the global petrochemical industry, international market prices for petrochemicals products and per capita consumption in certain geographic regions principally from reports published by Chemical Market Analytics by OPIS, a Dow Jones Company (“CMA”). We derive information relating to Brazilian imports and exports from ComexStat, produced by the Brazilian Ministry of Development, Industry, Trade and Services (Ministério do Desenvolvimento, Indústria, Comércio e Serviços, the “MDIC”). We also derive information from reports published by Brazilian Association of the Alkali, Chlorine and Derivatives Industry (Associação Brasileira da Indústria de Álcalis, Cloro e Derivados, the “Abiclor”). We also include information and statistics regarding economic growth in emerging economies obtained from the International Monetary Fund, and statistics regarding gross domestic product, growth in Brazil, the United States, Europe and Mexico obtained from independent public sources, such as the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística); the U.S. Bureau of Economic Analysis of the U.S. Department of Commerce; the statistical office of the European Union (Eurostat); and the Mexican Institute of Statistics and Geography (Instituto Nacional de Estadística y Geografía).

   
  i 

We provide information regarding domestic apparent consumption of some of our products based on information available from ComexStat, produced by the MDIC and reports published by Abiclor. Domestic apparent consumption is equal to domestic production plus imports minus exports. Domestic apparent consumption for any period may differ from actual consumption because this measure does not give effect to variations of inventory levels in the petrochemical supply chain.

We have no reason to believe that any of this information is inaccurate in any material respect. However, we have not independently verified the production capacity, market share, market size or similar data provided by third parties or derived from industry or general publications.

Certain Industry Terms

Glossary of Selected Terms in the Petrochemical Industry and in the Context of Our Business

Term

Meaning

Main uses

In the context of our business

Aliphatics Aliphatics are open-chain hydrocarbons that contain no stable rings connecting their atoms, in contrast to aromatics. Used as fuels, solvents and as basic chemicals in the petrochemical industry. We produce aliphatics, such as ethylene and propylene, in our chemicals operations that are part of our Brazil Segment.
Aromatics Aromatics are cyclic hydrocarbons with stable bonds connecting their carbon atoms. Used as fuel additives, solvents, and basic chemicals in the petrochemical industry. We produce aromatics, such as benzene, toluene and xylenes, as co-products in our chemicals operations that are part of our Brazil Segment.
Benzene An aromatic hydrocarbon. It is a natural constituent of crude oil. Used primarily for the manufacture of chemicals with more complex structure, such as ethylbenzene and cumene. We produce benzene as a by-product in our chemicals operations that are part of our Brazil Segment.
BTX products A mixture of benzene, toluene and the three xylene isomers (ortho, meta and para), all of which are aromatic hydrocarbons. Used as fuel additives, solvents, and basic chemicals in the petrochemical industry. We produce benzene, toluene and xylenes as BTX by-products in our chemicals operations that are part of our Brazil Segment.
   
  ii 

 

Butadiene An organic compound and a colorless gas. Used industrially as a monomer in the production of synthetic rubber. We produce butadiene as a by-product in our chemicals operations that are part of our Brazil Segment.
Butene A colorless gas present in crude oil. Used as a monomer in the production of polymers, as well as a petrochemical intermediate. We use butene for the production of HDPE and LLDPE in our polyolefins operations that are part of our Brazil Segment. Butene is supplied by our chemicals operations that are part of our Brazil Segment.
Caustic soda Caustic soda, or sodium hydroxide, is an inorganic compound. A colorless crystalline solid, caustic soda is toxic, corrosive and highly soluble in water. Used in the manufacture of pulp and paper, textiles, drinking water, soaps and detergents, and as a drain cleaner. We produce caustic soda in our vinyls operations that are part of our Brazil Segment. Caustic soda is a by-product of chlorine production required to produce PVC.
Chlor-alkali Electrolysis process used in the manufacture of chlorine, hydrogen and sodium hydroxide (caustic soda). Main industrial process for the production of caustic soda. We operate chlor-alkali plants in Brazil.
Chlorine Chlorine is a chemical element (Cl), a toxic, greenish yellow gas at room temperature. It has a pungent suffocating odor. Used in the production of paper products, antiseptics, plastics, dyes, textiles, medicines, insecticides, solvents and to treat swimming pools. We use salt to produce chlorine in our vinyls operations that are part of our Brazil Segment.
Condensate Condensate, or natural gas condensate, is a low-density mixture of hydrocarbon liquids that are present as gaseous components in the raw natural gas. Condensate is used as an input for petrochemical plants, burned for heat and cooking, and blended into vehicle fuel. We use condensate as a raw material in our chemicals operations that are part of our Brazil Segment.
   
  iii 

 

Cumene An organic compound based on an aromatic hydrocarbon with an aliphatic substitution, cumene is a colorless liquid constituent of crude oil and refined fuels. Used for the production of phenol and acetone. We produce cumene as a by-product in our chemicals operations that are part of our Brazil Segment.
Dicyclopentadiene Dicyclopentadiene, or DCPD, is a yellow liquid with an acrid odor. Used in polyester resins, inks, adhesives and paint. We produce DCPD in our chemicals operations that are part of our Brazil Segment.
Ethane A type of natural gas liquid (NGL), ethane is a colorless, odorless gas in standard temperature and pressure, extracted from natural gas in liquid form. Used as a feedstock for ethylene production. Ethane is one of the main raw materials that we use to produce ethylene in our chemicals operations that are part of our Brazil Segment.
Ethanol A simple alcohol, produced by the fermentation of sugars by yeasts or via petrochemical processes. Used as a fuel for vehicles, as a disinfectant and as a chemical intermediate. We use ethanol as a raw material to produce green polyethylene in our chemical operations that are part of our Brazil Segment, which are located in Triunfo, Brazil.
Ethyl tertiary-butyl ether Ethyl tertiary-butyl ether, or ETBE, is a colorless liquid manufactured by the acid etherification of isobutylene with ethanol. Used commonly as an additive in the production of gasoline. We produce ETBE in our chemicals operations that are part of our Brazil Segment.
       
   
  iv 

 

Ethylene A hydrocarbon, colorless gas and the most widely used organic compound in the chemical industry. Produced mainly via steam cracking of raw materials such as naphtha and NGLs. Used mainly for the production of polyolefins, primarily polyethylene, the most used thermoplastic resin in the world. We produce ethylene in our chemicals operations that are part of our Brazil Segment, as a main product of the steam cracking of raw materials.
EVA Ethylene-vinyl acetate, or EVA, is a co-polymer of ethylene and vinyl acetate. Used to produce rubber-like materials, with applications in adhesives, packaging, molding, and membranes for electronic devices. We produce EVA in our polyolefins operations that are part of our Brazil Segment.
Gasoline A flammable liquid obtained by refining crude oil. Used primarily as a fuel in combustion engines. We produce gasoline as a by-product in our chemicals operations that are part of our Brazil Segment.
GHG emissions Emissions of the six gases listed in the Kyoto Protocol: carbon dioxide (CO2); Methane (CH4); Nitrous Oxide (N2O); Hydrofluorocarbons (HFCs); Perfluorocarbons (PFCs); and Sulfur hexafluoride (SF6). Used as a metric for our management and in accordance with applicable laws to measure GHG emissions We use the metric to assess our performance and define a strategy for reducing GHG emissions
HDPE High-density polyethylene, or HDPE, is a thermoplastic resin produced by the polymerization of ethylene. Used in a variety of industries, to produce plastic bottles, toys, chemical containers, pipe systems, and other plastic products. We produce HDPE in our polyolefins operations that are part of our Brazil Segment.
Hexene An aliphatic, hexane is a clear, colorless liquid with a petroleum-like odor. Used as a solvent, paint thinner, and chemical reaction medium. Also used as a co-monomer for the production of HDPE. We use hexene in our Mexico Segment as a raw material to produce HDPE.
       
   
  v 

 

Hydrocarbon resins Also called petroleum resins, they are produced from the polymerization of aromatic hydrocarbons. Generally used together with other kinds of resins, in the paint, ink, adhesive and rubber industry. We produce hydrocarbon resins in our chemicals operations that are part of our Brazil Segment.
Hydrogen A chemical element, hydrogen is a colorless, odorless gas. Used to make ammonia in the production of fertilizers and as an intermediate chemical in the production of plastics and pharmaceuticals. We produce hydrogen in our vinyls operations that are part of our Brazil Segment.
Hydrogenated solvents Odorless, colorless solvents treated with hydrogen. Used in the manufacture of paints. We produce hydrogenated solvents in our chemicals operations that are part of our Brazil Segment.
Isoprene A common organic compound that is a component of natural rubber. Also a by-product of oil refining. Used to produce synthetic rubber. We produce isoprene in our chemicals operations that are part of our Brazil Segment.
LDPE Low-density polyethylene, or LDPE, is a thermoplastic resin made from the polymerization of ethylene. Used for manufacturing containers, dispensing bottles, wash bottles, tubing, plastic bags and molded laboratory equipment. We produce LDPE in our polyolefins operations that are part of our Brazil Segment.
Liquefied petroleum gas (LPG) Liquefied petroleum gas, or LPG, is a mixture of propane and butane, which are two natural gas liquids. Used in fuel heating appliances, cooking equipment, vehicle fuel, aerosol propellant, and as a refrigerant. We produce LPG in our chemicals operations that are part of our Brazil Segment.
LLDPE Linear low-density polyethylene, or LLDPE, is a linear polymer made by the copolymerization of ethylene with longer-chain olefins. Used in plastic bags and sheets, plastic wrap, stretch wrap, pouches, toys, covers, lids, pipes, buckets and containers, covering of cables and flexible tubing, among others. We produce LLDPE in our polyolefins operations that are part of our Brazil Segment.
   
  vi 

 

Methanol Methanol is the simplest alcohol, a liquid produced industrially by hydrogenation of carbon monoxide. Used as a precursor to other commodity chemicals, including formaldehyde, acetic acid and MTBE. We use methanol as a raw material to produce MTBE in our chemicals operations that are part of our Brazil Segment.
Methyl tertiary-butyl ether (MTBE) An intermediate hydrocarbon liquid stream derived mainly from the refining of crude oil Used almost exclusively as a fuel additive in gasoline to raise the oxygen content. We produce MTBE in our chemicals operations that are part of our Brazil Segment.
Naphtha An intermediate hydrocarbon liquid stream derived mainly from the refining of crude oil. Used as a solvent, fuel additive and as a raw material in the petrochemical industry. We use naphtha as a raw material for the production of petrochemical products in our chemicals operations that are part of our Brazil Segment.
Natural gas A naturally occurring hydrocarbon gas mixture, consisting primarily of methane. Used as a source of energy for heating, cooking and electricity generation, as a fuel for vehicles and as a chemical feedstock. We use natural gas for electricity generation in our production processes.
Natural gas liquids (NGL) A mixture of hydrocarbon components of natural gas, primarily ethane, propane and butane, which are separated from the raw natural gas in the form of liquids. Used as raw materials in the petrochemical industry, as fuel and in applications for heating and cooking. We use NGLs such as ethane and propane as raw materials at our plants in Rio de Janeiro and Mexico.
N-hexane A hydrocarbon, obtained by refining crude oil. Used mixed with other solvents, to extract vegetable oils from crops, and as a cleaning agent in the printing, textile, furniture, and shoemaking industries. We use n-hexane in our polyolefins operations that are part of our Brazil Segment as a raw material in the production of HDPE and LLDPE.
Nonene A hydrocarbon, nonene is a colorless liquid with an odor reminiscent of gasoline. Used as a plasticizer to make rigid plastics flexible, and to produce chemical intermediates. We produce nonene in our chemicals operations that are part of our Brazil Segment.
   
  vii 

 

Olefins Unsaturated hydrocarbons that contain at least one carbon–carbon double bond, such as ethylene, propylene and butene. Obtained from steam cracking of raw materials. Used as chemical intermediates for the production of other chemicals and resins. We produce olefins in our chemicals operations that are part of our Brazil Segment.
Para-xylene An aromatic hydrocarbon, para-xylene is produced mainly in refineries and during the steam cracking of naphtha. Used as a chemical feedstock in the production of polymers, especially PET. We produce para-xylene as a by-product in our chemicals operations that are part of our Brazil Segment.
PDH Propane dehydrogenation, or PDH, is an on-purpose technology used for conversion of propane into propylene. Industrial process for the production of propylene. We use propylene from PDH units as a raw material in our plants in the United States.
Piperylene A volatile, flammable hydrocarbon in liquid form, obtained as a by-product of ethylene production. Used as a monomer in the manufacture of plastics, adhesives and resins. We produce piperylene in our chemicals operations that are part of our Brazil Segment.
Polyethylene (PE) PE is the most common type of thermoplastic resin. It is lightweight and durable, and is obtained from the polymerization of ethylene. PE has a large number of applications, such as: packaging, consumer goods, fibers, textiles, pipes, automotive, wiring, cables, construction, among others. We produce PE in our polyolefins operations that are part of our Brazil Segment.
   
  viii 

 

Polyisobutylene (PIB) PIB is a gas-permeable synthetic rubber produced by the polymerization of isobutylene with isoprene. Used as a fuel and lubricant additive, in explosives, as the base for chewing gum, and to improve the environmental stress-cracking resistance of polyethylene. We produce PIB in our chemicals operations that are part of our Brazil Segment.
Polyolefins Macromolecules formed by the polymerization of olefin monomer units. The most common are polypropylene (PP) and polyethylene (PE). Used in a broad range of consumer and industrial applications. We produce polyolefins in our polyolefins operations that are part of our Brazil Segment.
Polypropylene (PP) PP is a thermoplastic resin and the second most widely produced commodity plastic, after PE. Obtained by the polymerization of propylene, PP is generally harder and more heat resistant than PE. Widely used in the automotive and furniture industry, in consumer goods, for packaging and labeling, and in other industrial applications. We produce PP in our polyolefins operations that are part of our Brazil Segment.
Polyvinyl chloride (PVC) PVC is the world’s third-most widely produced synthetic plastic polymer, after PE and PP, obtained by the polymerization of vinyl chloride monomer (VCM), a monomer generally made of ethylene and chlorine. Used mainly in infrastructure and construction for pipes and profile applications, such as doors and windows, and also in plumbing, electrical cables, flooring, and as a replacement for rubber. We produce PVC in our vinyls operations that are part of our Brazil Segment.
   
  ix 

 

Propane A type of natural gas liquid (NGL), propane is a gas in standard temperature and pressure, and is extracted from natural gas in liquid form. Commonly used together with butane in heating and cooking applications, and also as a raw material in the petrochemical industry. We use propane together with ethane as a raw materials to produce petrochemical products in our chemicals operations that are part of our Brazil Segment.
Propylene A hydrocarbon, propylene is a colorless gas, and the second most widely used olefin in the chemical industry, after ethylene. It can be obtained as a co-product of steam cracking or refining, and from on-purpose production. Used mainly to produce polypropylene resins and a wide variety of other chemicals, such as propylene oxide and acrylonitrile. We produce propylene in our chemicals operations that are part of our Brazil Segment as a by-product of steam cracking. Propylene is also the main raw material that we use to produce polypropylene in our polyolefins operations that are part of our Brazil Segment, and USA and Europe Segment.
Refinery off gas Gas that is produced as a by-product of the refining of crude oil. It is a mixture of methane, ethane, hydrogen and other gases. Used as a feedstock in the petrochemical industry. We use refinery off gas as a raw material in our chemicals operations that are part of our Brazil Segment to produce ethylene.
Salt Salt is a mineral composed primarily of sodium chloride. Used in a wide variety of industries, mainly in the chlor-alkali process to produce caustic soda and chlorine, and as a food additive. We use salt to produce chlorine and caustic soda in our vinyls operations that are part of our Brazil Segment.
Sodium hypochlorite Sodium hypochlorite is a chlorine compound. Used as a disinfectant or a bleaching agent and to produce other chemicals. We produce sodium hypochlorite in our vinyls operations that are part of our Brazil Segment.
Tetramer Tetramer, or propylene tetramer, is an olefin. Used as a plasticizer, surfactant, lubricating oil additive and polymerization agent. We produce propylene tetramer in our chemicals operations that are part of our Brazil Segment.
   
  x 

 

Thermoplastic resins Raw, unshaped polymers, such as PE, PP and PVC. Used in the plastic industry and other industries. We produce thermoplastic resins in our chemicals operations that are part of our Brazil Segment.
Toluene An aromatic hydrocarbon. Used predominantly as an industrial feedstock and a solvent. We produce toluene in our chemicals operations that are part of our Brazil Segment.
UHMWPE Ultra-high molecular weight polyethylene, or UHMWPE, is a special type of thermoplastic polyethylene. Used in industrial applications that require durability, low friction, and chemical resistance, including wear strips, chain guides, and marine dock fender pads, among others. We produce UHMWPE in our USA and Europe Segment.
Vinyls Vinyls, or vinyl polymers, are a group of polymers derived from vinyl monomers. The most common type of vinyl is PVC. Used in the plastic industry and other industries. We produce vinyls in our vinyls operations that are part of our Brazil Segment.

 

Certain Other Selected Terms Used in This Annual Report

As used in this annual report:

·“first generation products” means basic petrochemical products such as ethylene and propylene produced from naphtha, natural gas, and ethane. The basic petrochemical products are used as feedstocks for the production of second generation products. We also sell certain first generation products to our customers;
·“second generation products” means thermoplastics resins, such as PE, PP and PVC;
·“third generation” means plastics converters;
·“third generation products” means finished plastic products produced by molding thermoplastic resins into end-use applications;
·“annual production capacity” means the annual nominal capacity for a particular facility, calculated based on operations during the 24 hours of the day for an entire year;
·“production capacity” means the annual projected capacity for a particular facility, calculated based upon operations for 24 hours each day of a year and deducting scheduled downtime for regular maintenance;
·“kton” means a kiloton, which is equal to 1,000 tons, or 2,204,622.62 pounds;
·“ton” means a metric ton, which is equal to 1,000 kilograms or 2,204.62 pounds.
   
  xi 

Rounding

We have made rounding adjustments to some of the amounts included in this annual report. As a result, numerical figures shown as totals in some tables may not be arithmetic aggregations of the amounts that precede them.

   
  xii 

CAUTIONARY STATEMENT WITH RESPECT TO FORWARD-LOOKING STATEMENTS

This annual report contains forward-looking statements. Some of the matters discussed concerning our business operations and financial performance include forward-looking statements within the meaning of the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates” and similar expressions are forward-looking statements. Although we believe that these forward-looking statements are based upon reasonable assumptions, these statements are subject to several risks and uncertainties and are made in light of information currently available to us.

Our forward-looking statements may be influenced by numerous factors, including, without limitation, the following:

·the cyclical and volatile nature of the global petrochemical industry and its adverse effects, which may have negative impacts on us and in the petrochemical sector;
·global macroeconomic conditions (including a United States recession) and their adverse effects on the margins of our products;
·the adverse effect of war and other armed conflicts, such as the conflict involving Russia and Ukraine, on our sales and operations in Brazil and internationally, and on the Brazilian and international petrochemical industry;
·a deterioration in the world economy and its potential adverse effect on demand for petrochemicals and thermoplastic products;
·any adverse effect of China’s economy deceleration on global demand and on our Brazilian and international business;
·the adverse effect of global health crises, such as the coronavirus pandemic (the “COVID-19 pandemic”) and consequently the Chinese “Zero Covid” policy on our Brazilian and international sales and operations, and on the Brazilian and international petrochemical industry;
·the adverse effect of inflation globally on our Brazilian and international business;
·the adverse effect of a more contractionary monetary policy globally on our Brazilian and international business;
·demand for our petrochemical products, our manufacturing facilities, price of raw materials and other inputs of our production, global logistics for our products, raw materials and other inputs of our production, and supply chains;
·general economic, political and business conditions in the markets or jurisdictions in which we operate or sell to, including governmental and electoral changes, and demand and supply for, and prices of, petrochemical and thermoplastic products;
·interest rate fluctuations, inflation and exchange rate movements of the real in relation to the U.S. dollar and other currencies;
   
  xiii 
·our ability to successfully carry out our sustainable development strategy, and to successfully develop initiatives to adapt to and mitigate climate change;
·competition in the global petrochemical and biopolymer industry;
·our ability to successfully develop our innovation projects, in particular in renewable and recycling initiatives;
·prices of naphtha, ethane, ethanol, propane, propylene and other raw materials and the terms and conditions of the supply agreements related thereto;
·international prices of petrochemical and biopolymer products;
·actions taken by our controlling shareholder;
·inherent risks related to any change of our corporate control;
·our ability to implement our financing strategy and to obtain financing on satisfactory terms;
·our progress in integrating the operations of companies or assets that we may acquire in the future, so as to achieve the anticipated benefits of these acquisitions;
·changes in laws and regulations, including, among others, laws and regulations affecting tax and environmental matters and import tariffs in other markets or jurisdictions in which we operate or to which we export our products;
·political conditions in the countries where we operate, particularly in Brazil and Mexico;
·future changes in governmental policies, including the adoption of new environmental policies and related actions undertaken by the governments of the locations in which we operate;
·unfavorable decisions rendered in major pending or future tax, labor, environmental and other legal proceedings; and
·other factors identified or discussed under “Item 3. Key Information—Risk Factors.”

Our forward-looking statements are not a guarantee of future performance, and our actual results of operations or other developments may differ materially from the expectations expressed in our forward-looking statements. As for forward-looking statements that relate to future financial results and other projections, actual results will be different due to the inherent uncertainty of estimates, forecasts and projections. Because of these uncertainties, readers should not rely on these forward-looking statements.

All forward-looking statements attributed to us or a person acting on our behalf are qualified in their entirety by this cautionary statement, and you should not place undue reliance on any forward-looking statement included in this annual report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them as a result of new information or future developments.

For additional information on factors that could cause our actual results of operations to differ from expectations reflected in forward-looking statements, please see “Item 3. Key Information—Risk Factors.”

   
  xiv 

PART I

  Item 1. Identity of Directors, Senior Management and Advisers

 

Not applicable.

  Item 2. Offer Statistics and Expected Timetable

 

Not applicable.

  Item 3. Key Information

 

Exchange Rates

The current laws and regulations governing the Brazilian foreign exchange system allow the purchase and sale of foreign currency and the international transfer of reais by any person or legal entity, regardless of the amount, subject to certain regulatory procedures. Since 1999, the Central Bank has allowed the U.S. dollar-real exchange rate to float freely, and, since then, the U.S. dollar-real exchange rate has fluctuated considerably.

In the past, the Central Bank has intervened occasionally to control unstable movements in foreign exchange rates. We cannot predict whether the Central Bank or the Brazilian government will continue to permit the real to float freely or will intervene in the exchange rate market through the return of a currency band system or otherwise. The real may depreciate or appreciate against the U.S. dollar substantially. Furthermore, Brazilian law provides that, whenever there is a serious imbalance in Brazil’s balance of payments or there are serious reasons to foresee a serious imbalance, temporary restrictions may be imposed on remittances of foreign capital abroad. We cannot assure you that such measures will not be taken by the Brazilian government in the future. See “—Risk Factors—Risks Relating to Brazil—Brazilian government exchange control policies could increase the cost of servicing our foreign currency-denominated debt, adversely affect our ability to make payments under our foreign currency-denominated debt obligations and impair our liquidity” and “—Risk Factors—Risks Relating to Our Equity and Debt Securities—If holders of the ADSs exchange them for class A preferred shares, they may risk temporarily losing, or being limited in, the ability to remit foreign currency abroad and certain Brazilian tax advantages.”

  Item 3.A (Reserved)
  Item 3.B CAPITALIZATION AND INDEBTEDNESS

Not applicable.

 

   
 1 

 

  Item 3.C REASONS FOR THE OFFER AND USE OF PROCEEDS

Not applicable.

 

  Item 3.D RISK FACTORS

Summary of Risk Factors

Below is a summary of certain material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address all of the risks and uncertainties that we face. This summary is qualified in its entirety by a more complete discussion of such risks and uncertainties. In evaluating an investment in our securities, investors should carefully read the risks described below, as well as other risks and uncertainties that we face, which can be found under “—Risk Factors” in this section of this annual report. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment. Such risks include, but are not limited to:

Risks Relating to Us and the Petrochemical Industry

·We may be affected by instability in the global economy and by financial turmoil, including as a result of military conflict between Russia and Ukraine.
·Global or regional health pandemics or epidemics, including that related to the COVID-19 pandemic, may adversely affect our business, financial condition and results of operations.
·The cyclical nature of the petrochemical industry may reduce our net revenue and gross margin.
·Adverse conditions in the petrochemical industry may adversely affect demand for our products.
·Global macroeconomic factors have had, and may continue to have, adverse effects on the margins that we realize on our products.
·We face competition from suppliers of polyethylene, polypropylene, PVC and other products.
·We may face competition from producers of substitutes for our products as a result of evolving technology, consumer and industry trends and preferences, and regulatory changes.
·Higher raw materials costs would increase our cost of products sold and may reduce our gross margin and negatively affect our overall financial performance.
·We depend on Petrobras to supply us with a substantial portion of our naphtha, ethane, propane and propylene needs, and also on logistics services.
·We depend on ethane supplied by Pemex TRI in Mexico.
·We rely on limited or sole-source suppliers for our raw materials, inputs and energy, including transportation thereof.
·We may be materially adversely affected if there is an imbalance in global logistics, which may cause disruptions to our transport, storage and distribution operations, negatively impacting the costs related thereto.
·We rely on access to third-party licensed technology and related intellectual property, and if such rights cease to be available to us on commercially reasonable terms, or at all, or if any such third party ceases to provide us with technical support under license or technical services agreements, certain of our production facilities, our operating results and financial condition could be adversely affected.
·Some of our shareholders may have the ability to determine the outcome of corporate actions or decisions, which could affect the holders of our class A preferred shares and the ADSs.
   
 2 
·We may be subject to attempts to acquire our control, which may lead to significant changes in management, the strategies that we are currently pursuing, or in our current corporate governance practices.
·We may face conflicts of interest in transactions with related parties.
·Under our growth strategy, we may pursue strategic acquisitions, investments, and investments in new businesses. The failure of an acquisition, investment, or investments in new businesses to produce the anticipated results, or the inability to integrate an acquired company, could adversely affect our business financial condition and results of operations.
·Adjustments in tariffs on imports that compete with our products could cause us to lower our prices.
·Changes in U.S. and global trade policies and other factors beyond our control may adversely impact our business, financial condition and results of operations.
·A failure to comply with export control or economic sanctions laws and regulations could have a material adverse impact on our results of operations, financial condition and reputation.
·Our business and operations are inherently subject to environmental, health and safety risks. As a result, our business is also subject to several stringent regulations, including environmental regulations.
·Unfavorable outcomes in pending or future litigation may reduce our liquidity and negatively affect our financial performance and financial condition.
·We could be materially affected by violations of the FCPA, the Brazilian Anti Corruption Law and similar anti-corruption laws.
·Climate change may negatively affect our business, financial condition, results of operations and cash flow.
·If we are unable to comply with the restrictions and covenants in the agreements governing our indebtedness, there could be a default under the terms of these agreements, which could result in an acceleration of payment of funds that we have borrowed and could affect our ability to make principal and interest payments on our debt obligations.
·Unauthorized disclosure or loss of intellectual property, trade secrets, other sensitive business or personal information, or disruption in information technology by cyberattacks or other security breaches, as well as our failure to comply with data protection laws and information security requirements can subject us to significant penalties or liability and can adversely impact our operations, reputation, and financial results.
·There can be no assurance that Novonor will remain our controlling shareholder. Novonor and Petrobras may enter into transactions or other arrangements that may result in us not having a controlling shareholder. If no single shareholder or group of shareholders holds more than 50% of our voting stock or exercise a controlling interest, there may be increased opportunity for alliances between shareholders and conflicts between them.
·Novonor and Petrobras have requested us to conduct studies for a potential migration of Braskem to the Novo Mercado listing segment of the B3, which, if completed, would lead to the conversion of all of our class A and class B preferred shares into common shares and the revision of our corporate governance practices to conform to the Novo Mercado rules.
·The intended corporate reorganization communicated by Novonor and Petrobras to us may not be approved or implemented, and the migration to the Novo Mercado listing segment of the B3 may not occur.
·We expect to lose the right of preference set forth in the current shareholders’ agreement with respect to new business opportunities in the petrochemical sector, and as result, Petrobras, which is our largest supplier of raw materials in Brazil, will be able to invest in the petrochemical sector independently from us and without first giving us a preference to do so.
·Changes in tax laws may result in increases in certain direct and indirect taxes, which could reduce our gross margin and negatively affect our overall financial performance.

Risks Relating to Brazil

·Brazilian political, economic and business conditions, and the Brazilian government’s economic and other policies, may negatively affect demand for our products as well as our net revenue and overall financial performance.
   
 3 
·Fluctuations in the real/U.S. dollar exchange rate could increase inflation in Brazil, raise the cost of servicing our foreign currency-denominated debt and negatively affect our overall financial performance.
·Fluctuations or changes in, or the replacement of, interest rates could impact the cost of servicing our debt or reduce our financial revenue, affecting our financial performance.

Risks Relating to Mexico

·A renegotiation of commercial treaties or changes in foreign policy among Mexico, Canada and the United States may negatively affect our business, financial condition, results of operations and prospects.
·Political events in Mexico could affect the Mexican economic policy and our business, financial condition and results of operations.
·We source part of our ethane feedstock from Pemex TRI in Mexico, which we expect to be our primary source of ethane until the Ethane Import Terminal is operational.

Risks Relating to Our Equity and Debt Securities

·All of the shares issued by Braskem and owned by NSP Inv. are secured for the benefit of certain secured creditors of the Novonor Group.
·Holders of our class A preferred shares or the ADSs may not receive any dividends or interest on shareholders’ equity.
·If holders of the ADSs exchange them for class A preferred shares, they may risk temporarily losing, or being limited in, the ability to remit foreign currency abroad and certain Brazilian tax advantages.
·The relative volatility and liquidity of the Brazilian securities markets may adversely affect holders of our class A preferred shares and ADSs.
·Brazilian bankruptcy laws may be less favorable to holders of our shares, ADSs and outstanding debt securities than bankruptcy and insolvency laws in other jurisdictions.
   
 4 

Risk Factors

Risks Relating To Us And The Petrochemical Industry

We may be affected by instability in the global economy and by financial turmoil, including as a result of military conflict between Russia and Ukraine.

Instability in the global markets and in the geopolitical environment in many parts of the world as well as other disruptions may continue to put pressure on global economic conditions. Concerns over recession, inflation, higher interest rates, geopolitical issues, the global financial markets, unstable global credit markets and financial conditions and the COVID-19 pandemic, have led to periods of significant economic instability, declines in consumer confidence and discretionary spending, diminished expectations for the global economy and expectations of slower global economic growth going forward, and increased unemployment rates. In addition, we face several risks associated with international business and are subject to global events beyond our control, including war, public health crises, such as pandemics and epidemics, trade disputes, economic sanctions, trade wars and their collateral impacts and other international events. Any of these changes could have a material adverse effect on our reputation, business, financial condition or results of operations.

There may be changes to our business if there is instability, disruption or destruction in a significant geographic region, regardless of cause, including war, terrorism, riot, civil insurrection or social unrest; and natural or man-made disasters, including famine, flood, fire, earthquake, storm or disease.

In particular, global markets are currently operating in a period of economic uncertainty, volatility and disruption following Russia’s invasion of Ukraine on February 24, 2022. Although the length and impact of the ongoing military conflict is highly unpredictable, it and any other geopolitical tensions could have an adverse effect on the economy and business activity globally, including the following:

·credit and capital market disruptions;
·significant volatility in commodity prices (such as oil and gas and raw materials to our business);
·significant volatility in petrochemical product prices;
·increased expenses related to direct and indirect materials used in our production process (i.e., logistics and inputs, among others);
·increased costs of resources (such as energy, natural gas and coal) for our operations;
·slowdown or disruption of the global and local supply chain, which may lead to shortages and lack of critical materials, commodities and products in the market and to our business;
·local and foreign currencies volatility;
·increase in interest rates and inflation in the markets in which we operate, which may contribute to further increases in the prices of energy, oil and other commodities; and
·lower or negative global growth, impacting demand for our products.

Additionally, the recent military conflict between Russia and Ukraine has led to sanctions and other penalties being imposed, proposed and threatened by the United States, European Union and other countries on Russia. Such sanctions are rapidly evolving, and the United States and other countries could impose wider sanctions and take other actions should the conflict further escalate. Russian military actions counter measures or retaliatory actions (including cyberattacks and espionage) could adversely affect the global economy and financial markets and lead to further instability and lack of liquidity in capital markets, potentially leading, for example, to difficulties in obtaining additional funds and sources of financing for our operations. Already the conflict has caused market volatility, a sharp increase in certain commodity prices, such as oil and natural gas, and an increasing number and frequency of cybersecurity threats. Actual and threatened responses to such military action, as well as a rapid peaceful resolution to the conflict, may also impact the markets for certain Russian products, such as oil, natural gas and other commodities, and may likely have collateral impacts and disruptions on such sectors globally. It is not possible to predict the length and impact of the ongoing military conflict or its broader consequences, which could include further sanctions, embargoes, regional instability, geopolitical shifts and adverse effects on macroeconomic conditions, currency exchange rates and financial markets. Any such event may increase our costs, decrease our revenues or limit our production and sales volume and adversely affect our business, results of operations and financial condition.

   
 5 

Geopolitical and economic risks have also increased over the past few years as a result of trade tensions between the United States and China, Brexit, and the rise of populism. Growing tensions may lead, among others, to a deglobalization of the world economy, an increase in protectionism or barriers to immigration, a general reduction of international trade in goods and services and a reduction in the integration of financial markets, any of which could materially and adversely affect our business, financial condition and results of operations.

Global or regional health pandemics or epidemics, including that related to the COVID-19 pandemic, may adversely affect our business, financial condition and results of operations.

Our business, financial condition and results of operations may be adversely affected by the COVID-19 pandemic, which was reported to have surfaced in China in December 2019 and spread to the rest of the world, or by other pandemics or epidemics of similar nature. In 2020, the COVID-19 pandemic significantly impacted economic activity and markets around the world, and its severity, magnitude and duration are highly uncertain, rapidly changing and difficult to predict. At this time, our management cannot fully predict with certainty the effects that the COVID-19 pandemic will have on our business, financial condition and results of operations and whether these effects will be material to us. The spread of COVID-19 has caused us to modify certain of our business practices, and we may take further actions as required by government authorities or that we determine are in the best interests of our employees, customers, partners and suppliers. Based on operating data for the year 2021 and the publicly reported expected impact on certain industries that are customers to our products (such as automotive and construction), we believe that COVID-19 has affected our business in numerous ways, including, but not limited to, reduction of our production, sales volume and net revenue, increase of some of our costs, and decrease of our gross margin.

We have closely monitored the effects of the COVID-19 pandemic on our business and the communities located in the regions in which we operate, and we intend to continue to do so.

During 2022, China continued its “zero-COVID” policy, which led the industry in which we operate to reduced or suspended production globally, affecting the demand for chemical and petrochemical products around the world. As a result, in 2022, the capacity utilization rates of our petrochemical complexes in Brazil decreased compared to the previous year, from 80.7% in 2021 to 77.6% in 2022, which was mainly due to lower demand for resins, impacting spreads in the international market.

It is expected that, even after mostly lifting its “zero-COVID” policy, China will still be dealing with the virus, resulting in partial closures that could cause significant disruptions to the global economy. As a consequence, petrochemical demand is expected to continue to be affected until global economic activity returns to pre-pandemic levels.

While we are actively managing our response to potential impacts that are identified, we may not be able to respond to all impacts on a timely basis to prevent adverse effects on our business, financial condition and results of operations.

   
 6 

The cyclical nature of the petrochemical industry may reduce our net revenue and gross margin.

The petrochemical industry, including the global markets in which we compete, is cyclical and sensitive to changes in global supply and demand. This cyclicality may reduce our net revenue, increase our costs and decrease our gross margin, including as follows:

·downturns in general business and global economic activity may cause demand for our products to decline;
·when global demand falls, we may face competitive pressures to lower our prices;
·increases in prices of the main raw materials we use, including naphtha, ethane and propylene; and
·if we decide to expand our plants or construct new plants, we may do so based on an estimate of future demand that may never materialize or materializes at levels lower than we predicted.

Historically, the international petrochemical markets have experienced alternating periods of limited supply, which have caused prices and profit margins to increase, followed by expansion of production capacity, which has resulted in oversupply and reduced prices and profit margins. Prices in the petrochemical industry follow the global petrochemical industry, and we establish the prices for the products we sell in Brazil, other countries in Latin America, the United States, Europe and the world with reference to international market prices. Therefore, our net revenue, feedstock costs and gross margin are linked to global industry conditions that we cannot control, and which may adversely affect our results of operations and financial position.

In addition, relevant events, or changes in the cycle and in the petrochemical industry, including technological innovations, and regulatory changes including related to climate change, may materially affect the future profitability of our business and consequently reduce the recoverable value of our assets, which is reviewed by the annual impairment test, which may adversely affect the profit attributable to our shareholders.

Adverse conditions in the petrochemical industry may adversely affect demand for our products.

Sales of our petrochemical and chemical products are tied to global production levels and demand, which can be affected by macro-economic factors such as interest rates, international oil prices, shifts to alternative products, consumer confidence, employment trends, regulatory and legislative oversight requirements, trade agreements, regulatory developments including related to climate change, as well as regional disruptions, armed conflicts, natural disasters, epidemics, pandemics, or other global events. Therefore, our net revenue, feedstock costs and gross margin are linked to global conditions that we cannot control, and which may adversely affect our results of operations and financial position. For example, the persistence of the COVID-19 pandemic or the conflict involving Russia and Ukraine (including economic sanctions and other regulations imposed by the United States and other international countries as a result thereof) could negatively impact supply chains worldwide and demand for our products and the raw materials we use. Should the conflict in Ukraine or other international locations further escalate, it is difficult to anticipate the extent to which the consequences of such conflict, including without limitation effects on the price of oil and current or future sanctions could increase our costs, disrupt our supplies, reduce our sales, or otherwise affect our operations. Moreover, the extent to which the COVID-19 pandemic, including the continuity of restrictions and lockdowns in China impacting global demand for our products, impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including the severity of the COVID-19 pandemic, actions to contain it or treat its impact, among others.

   
 7 

Our revenue from certain of our customers is significant, and the credit risks associated with these customers could adversely affect our results of operations.

We engage in several transactions where counterparty credit risk is a relevant factor, including transactions with certain of our customers and those businesses we work with to provide services, among others. These risks are dependent upon market conditions and also the real and perceived viability of the counterparty. The failure or perceived weakness of any of our counterparties has the potential to expose us to risk of loss in certain situations. Our revenue from certain of our customers may be significant, and the credit risks associated with these customers could adversely affect our results of operations. Certain contracts and arrangements that we enter into with counterparties may provide us with indemnification clauses to protect us from financial loss. To the extent the credit quality of these customers deteriorates, or these customers seek bankruptcy protection, our ability to collect our receivables, and ultimately our results of operations, may be adversely affected. In addition, delays in payment cycles by significant customers may adversely affect our liquidity and working capital.

In addition, If the viability of the business of certain of our customers deteriorates, it could have a material adverse effect on our cash flows and results of operations.

Our results of operations may be adversely affected by increases in expected credit losses.

We have a large balance of accounts receivable and have established a provision for the portion of such accounts receivable that we estimate will not be collected because of our customers’ non-payment. As of December 31, 2022, our total trade accounts receivable, net of expected credit losses (R$112.1 million) was R$ 3,231.9 million.

If the viability of the business of certain of our customers deteriorates or our credit policies are ineffective in reducing our exposure to credit risk relating to such customers, additional increases in expected credit losses accounts may be necessary, which could have a material adverse effect on our cash flows and results of operations. We record expected credit losses in an amount we consider sufficient to cover estimated losses on the realization of our trade accounts receivable, considering our loss experience and the average aging of our accounts receivable, but we cannot assure you that these amounts will be sufficient to cover eventual losses. In addition, delays in payment cycles by significant customers may adversely affect our liquidity and ability to obtain financing for working capital such as sales of receivables.

Global macroeconomic factors have had, and may continue to have, adverse effects on the margins that we realize on our products.

Our results of operations may be materially affected by adverse conditions in the financial markets and depressed economic conditions generally. Economic downturns in geographic areas or jurisdictions in which we sell our products may substantially reduce demand for our products and result in decreased sales volumes. Recessionary environments, including global inflation, adversely affect our business because demand for our products is reduced and our costs increase.

Overview of GDP outlook follows below:

·According to the latest report released by the International Monetary Fund (the “IMF”) in January 2023, the world’s GDP growth for 2023 is estimated at 2.8%. In 2022, the world’s GDP grew 3.4%.
·According to the latest report released by the IMF in January 2023, Brazil’s GDP growth for 2023 is estimated at 0.9%. In 2022, Brazil’s GDP grew 3.1%.
·According to the latest report released by the IMF in January 2023, the United States GDP growth for 2023 is estimated at 1.4%. In 2022, the United States GDP grew 2.0%.
·According to the latest report released by the IMF in January 2023, the Euro Area GDP growth for 2023 is estimated at 0.7%. In 2022, the Euro Area GDP grew 3.5%.
   
 8 
·According to the latest report released by the IMF in January 2023, Mexico’s GDP growth for 2023 is estimated at 1.7%. In 2022, the Mexico’s GDP grew 3.1%.

In addition, raw materials and other costs in our business are subject to wide fluctuations depending on market conditions and government policies. These costs are influenced by several factors over which we have little or no control, including, but not limited to, international and national economic conditions, including higher natural gas costs in Europe, regulations, government policies (including those applicable to the pricing policies of Petrobras, which is one of our main suppliers in Brazil), tariff adjustments and global effects of supply and demand, particularly on commodity prices. We cannot assure that the prices of our products may be increased in a timely manner or be sufficient to keep pace with, or offset, increases in inflation, operation costs and expenses, amortization of investments and taxes. As a result, we might not be able to pass on the increased costs to our customers, which could decrease our profit margin and result in a material adverse effect on our business, financial condition and results of operations.

Our ability to export to other countries depends on the level of economic growth in those countries and other economic conditions, including prevailing inflation and interest rates. In addition, disruptions in the global balance between supply and demand and logistics constraints may impair our ability to export our products. Prolonged volatility in economic activity in our key export markets, including the United States, South America, Europe, and Asia, could continue to reduce demand for some of our products, which would adversely affect our results of operations.

We face competition from suppliers of polyethylene, polypropylene, PVC and other products.

We face strong competition across all of our products. Some of our foreign competitors are substantially larger and have greater financial, manufacturing, technological and/or marketing resources than us. Our U.S. operations face competition in the United States from other North American suppliers that serve the North American market. Our European operations face competition in Europe and the other export markets that it serves from European and other foreign suppliers of polypropylene. Our Mexico operations face competition from Mexican and U.S. producers of polyethylene. Competitors from South America may export to Brazil with reduced or no import duties. In addition, suppliers of almost all continents have regular or specific sales to trading companies and direct customers in Brazil for our products, including resins.

We generally follow the international markets with respect to the prices for our products sold in Brazil. The domestic price is determined by the import parity, which is based on converters’ imports into Brazil and typically represents spot market price, plus exchange rate fluctuations, plus import tariffs that the Brazilian government uses to implement economic policies. Adjustments of tariffs could lead to increased competition from imports and cause us to lower our domestic prices and impact the demand for our products, which would likely result in lower net revenue and could negatively affect our overall financial performance. This effect combined would have a negative impact on our gross margins and overall financial performance. We have no control over the import tax rate policy in Brazil or Mercosur (the Southern Common Market, or Mercosur in Spanish), a common market that serves as a regional integration process and was initially established by Argentina, Brazil, Paraguay and Uruguay, and subsequently joined by Venezuela and Bolivia. Petrochemical import taxes that are currently in place have changed in the past and may change in the future. We generally follow the international markets with respect to the prices for our products sold in Brazil. We generally set the prices for our products exported from Brazil based on international market prices. We set the prices for products sold in the United States and Europe based on market pricing in such region. The price for polyethylene in Mexico is based on prices in the U.S. Gulf Coast region.

As a result of the commissioned fractioned gas-based ethylene and polyethylene new capacities and of the expected new capacities for production of resins and petrochemicals, coupled with the competitive pricing of feedstock for petrochemicals production such as ethane, we anticipate that we may experience increased competition from producers of thermoplastic resins, especially from North American, Middle Eastern and Chinese producers, in the markets in which we sell our products. In addition, the Chinese government has exercised, and continues to exercise, significant influence over the Chinese economy including governmental actions to incentivize and achieve self-sufficiency production in some specific chains, such as PE and PP. Those new capacities could lead to a rebalancing of global export flows and an increase in global competition from our competitors, which are larger and have greater competitive advantages than us.

   
 9 

In addition, exchange rates variation may affect the competitiveness dynamics in different regions in which we operate. For instance, the appreciation of the real against the U.S. dollar may increase the competitiveness of imported productswhich may increase the competition in Brazil from resins producers. Also, (i) the appreciation of the Euro against the U.S dollar may increase the competitiveness of imported products and, as a consequence, increase competition from imports and (ii) the appreciation of Mexican peso against the U.S. dollar may increase the competition from other resins producers in Mexico.

We may face competition from producers of substitutes for our products as a result of evolving technology, consumer and industry trends and preferences, and regulatory changes.

We compete in a market that relies on technological innovation and the ability to adapt to evolving consumer and global industry trends and preferences. Petrochemical products and other products produced with our petrochemical products, such as consumer plastic items, are subject to changing consumer and industry trends, demands and preferences, as well as stringent and constantly evolving regulatory and environmental requirements. Therefore, products once favored may, over time, become disfavored by consumers or industries or no longer be perceived as the best option, which may, therefore, affect our results of operations and financial position.

Plastic waste and climate change are global environmental concerns that receive growing attention from the society in general, national and local governments, private companies, trendsetters, and consumers worldwide. There has been a growing trend to attempt to move away from the use of plastic products, which has been backed by governmental and lawmaking initiatives.

In 2019, the European Union parliament approved regulations banning as of 2021 single-use plastic items such as plates, cutlery, straws, and cotton buds sticks and adopting a strategy for disposal of plastic products in a circular economy that aims to significantly increase recycling and targets the plastic products most often found on beaches and in seas. The European Union is now currently revising such rules to increase recycling and recycled content targets, as well as to establish new regulation on the design and labelling of plastic products. In addition, state and local governments in other countries, for example in China and in Brazil, have also proposed or implemented bans on single-use plastic products. Regarding regulatory issues related to plastic for single use in Brazil, proposed regulations are being discussed in the federal, state and municipal levels. Additionally, legislative proposals on carbon border adjustment mechanisms aiming at preventing carbon leakage have been under discussion in several countries. So far, none of the proposals have yet affected chemicals and plastic resins, but this might change in the future. Recently, UNEP has started conversations to negotiate an international legally binding instrument aiming at eliminating plastics pollution. These rounds of negotiations are expected to take at least two years, but some of the proposals include reducing and even prohibiting the production of certain plastic products considered “problematic”. The expansion of regulation or the prohibition of plastic products use, and sale could increase the costs incurred by our customers or otherwise limit the application of these products and could lead to a decrease in demand for resins and other products we make. Such a decrease in demand could adversely affect our business, results of operations and financial condition.

We have as a core part of our strategy to grow our renewables and recycling business. We are supporting several initiatives to foster a low-carbon circular economy (reusing and repurposing resources within the economy), including, but not limited to: (i) partnerships to develop new products and applications to improve efficiency and promote recycling and reuse (circular design); (ii) development of a portfolio of innovative products with recycled and biobased contents; (iii) development of recycling technology, supporting the advancement of studies and tests, for both chemical and mechanical recycling (iv) environmental education and consumer engagement initiatives focused on educational actions, aimed at conscious consumption and proper disposal, with a positive impact on the recovery of plastic waste; and (v) circular design, which consists of the co-creation of new packaging solutions and businesses focused on circular solutions. We cannot predict the outcome of such initiatives since there still are many goals to be accomplished to reduce plastic waste and marine litter, which may lead to decreased interest in our products by our customers and consumers, impacting our results of operations and financial condition. Moreover, we may not be able to successfully implement our strategy to grow our renewables and recycling business, which could adversely affect our financial condition and results of operations.

   
 10 

Also, new competitors could develop new technologies to offer less carbon-intensive products, which could result in a loss of our competitiveness and a reduction of our revenues.

Factors that may affect consumer perception of our products, or of consumer goods produced with our products, may include health trends and attention to substitute products perceived as more environmentally friendly. For example, in recent years, we have witnessed a shift in consumer preference moving away from plastic straws and in favor of straws made from other materials, such as paper or other compounds. A failure to react to similar trends in the future could enable our competitors to grow or secure their market share before we have a chance to respond.

In addition, regulations may be amended or enacted in the future that would make it more difficult to appeal to our customers, end consumers, or marketing the products that we produce. For example, failure to comply with applicable policies, which could lead to lower demand for our products, banning of plastic products without allowing the search for alternatives employing efficient solutions, including resins produced by Braskem, could have a material adverse effect on our business, results of operations and financial condition. Also, even if we are able to continue to promote our products, there can be no assurance that our competitors (including producers of substitutes) will not be successful in persuading consumers of our products to switch to their products. Some of our competitors may have greater access to financial or other resources than we do, which may better position them to react and adapt to evolving trends, preferences, and regulatory changes. Any loss of interest in our products, or consumer products produced with our products, may have a material adverse effect on our business, results of operations and financial condition.

Higher raw materials costs would increase our cost of products sold and may reduce our gross margin and negatively affect our overall financial performance.

Naphtha, a crude oil derivative, is the principal raw material used by our Brazil Segment. For the year ended December 31, 2022, Naphtha accounted for 35.5% of our consolidated cost of products sold. Comparatively, it represented 37.0% in 2021. In addition, Ethane and propane are the principal raw materials that we use to produce our basic petrochemical products in our petrochemical complex located in Duque de Caxias, in the State of Rio de Janeiro, or the Rio de Janeiro Complex, and represent the principal production and operating cost of such Complex. In connection with our Brazil Segment, ethane and propane accounted for 1.3% and 1.4%, respectively, of our consolidated cost of products sold during the year ended December 31, 2022. Comparatively, they accounted for 0.9% and 1.3%, respectively, in 2021.

Propylene is the principal raw material that we use to produce polypropylene in the United States and Europe and represents the principal production and operating cost of our United States and Europe Segment. We also purchase propylene in the Brazilian market for certain of our Brazilian polypropylene plants. Propylene accounted for 21.2% and 29.6% of our consolidated costs of products sold during the year ended December 31, 2022 and 2021, respectively.

Ethane is the principal raw material that we use to produce ethylene in the Mexico Complex and represents the principal production and operating cost of the Mexico Complex. In connection with our Mexico Segment, ethane accounted for 2.6% and 1.3% of our consolidated costs of products sold during the year ended December 31, 2022 and in 2021, respectively. The price of ethane is highly correlated with that of natural gas, and in 2022, due to rising energy prices as a result of a changing geopolitical scenario, the average price of ethane (reference Mont Belvieu) increased 64.3% from 2021, affecting the ethane price and the production and operating cost of the Mexico Complex.

   
 11 

In Brazil, we purchase the naphtha used by our chemicals operations that are part of our Brazil Segment at prices based on the Amsterdam-Rotterdam-Antwerp naphtha price, or the ARA price, and the ethane and propane based on United States market references. We purchase ethane used by our Mexico Segment at prices based on Mont Belvieu ethane. We purchase the propylene used in Brazil and United States plants at prices based on U.S. Gulf reference price, or the USG price. We purchase the propylene used in our Europe plants as reported by international references based on monthly contract price for propylene for Europe. We purchase light refinery hydrocarbon used in the São Paulo petrochemical complex at a price related to imported natural gas price.

The ARA price of naphtha fluctuates primarily based on Brent crude oil, but also follows the markets of fuels and petrochemicals. During the year ended December 31, 2022, the average price of naphtha increased 21.3% when compared to 2021, reaching US$770.0 per ton, as a result of the commodities shock, after the Russian invasion of Ukraine. However, compared to the 43.1% increase in Brent prices over the same time period, robust fuel demand resulted in an excess of naphtha, keeping its price stable in the face of declining petrochemical demand. 

For the year ended December 31, 2022, the average price of ethane (Mont Belvieu market reference) was US$0.48 per gallon, or US$356.2 per ton, an increase of 55.5% per ton from 2021. This led to a higher price for natural gas in the region after the geopolitical scenario caused energy prices to rise in the first and second quarters of 2022. However, these factors were partially offset by: (i) an improvement in healthier inventories in the United States at the end of the fourth quarter of 2022; and (ii) a decrease in demand for petrochemicals and derivatives, reflecting the uncertainties in the global economic scenario in the third and fourth quarters of 2022.

During the year ended December 31, 2022, the average price of the USG reference propylene was US$1,120.7 per ton, representing a decrease of 29.4% compared to 2021, which is explained by: (i) higher product availability after the normalization of production in some facilities, associated with the high propylene derivates inventories, such as polypropylene, of American producers; and (ii) lower demand during the year.

For the year ended December 31, 2022, the average price of propylene in Europe was US$1,457.4 per ton, representing an increase of 13.9% compared to 2021, which is explained by higher oil and energy prices in the international market, reflecting the geopolitical tensions in Europe.

The price of naphtha, ethane, propane and propylene in U.S. dollars has been, and may continue to be, volatile. In addition, fluctuations of the U.S. dollar in the future may effectively increase our naphtha, ethane, propane and propylene costs in reais. Any increase in naphtha, ethane, propane or propylene costs would reduce our gross margin and negatively affect our overall financial performance to the extent we are unable to pass on these increased costs to our customers and could result in reduced sales volumes of our products.

We do not hedge against price changes in our raw materials and, as a result, we are exposed to such fluctuations.

Currently, we do not hedge our exposure to feedstock price changes beyond transit periods when buying cargoes from foreign sources. We believe there is a natural hedge in the petrochemical industry dynamic, mainly due to the historical correlation observed between naphtha, the principal feedstock of a marginal producer and with higher production costs, and its final products (PE, PP, PVC, and others). Historically, naphtha price fluctuations show a high correlation with changes in the first- and second-generation petrochemical products.

   
 12 

Therefore, any hedge solely with respect to naphtha’s price would break this natural protection, most likely making our results more volatile. Compared to naphtha and propylene, ethane and propane prices shows a lower correlation to our products. As a result, final consumer prices may not reflect feedstock cost fluctuations.

We depend on Petrobras to supply us with a substantial portion of our naphtha, ethane, propane and propylene needs, and also on logistics services.

Petrobras is a relevant Brazilian supplier of naphtha for us and has historically supplied up to 70% of the naphtha consumed by our chemicals operations that are part of our Brazil Segment. Currently, Petrobras is also our primary supplier of ethane, propane and light refinery hydrocarbon and has historically supplied the ethane, propane and light refinery hydrocarbon consumed at our petrochemical complex located in the Rio de Janeiro Complex and our chemical complex located in Capuava, in the State of São Paulo, or the São Paulo Complex, respectively.

We are a party to several propylene contracts with Petrobras refineries, which have historically supplied 40% of our propylene need to produce polypropylene in Brazil at prices based on international references. As a result of limited infrastructure in Brazil to allow the importation of propylene in large quantities and substantial costs associated with the storage and transportation of the product, we depend on propylene supplied by Petrobras to operate our PP plants at optimal operational levels.

We have five propylene supply agreements with Petrobras that will expire between 2026 and 2029. We cannot assure that these agreements will be renewed and, if renewed, whether we will be able to keep the same terms and conditions currently in force, including with respect to pricing, volume, pipeline and other infrastructure access.

In June 2020, we entered into new agreements with Petrobras for the supply of petrochemical naphtha to our industrial units in Bahia and Rio Grande do Sul. The agreements, with a term of five years following the expiration of the prior agreement with Petrobras, establish the supply of a minimum annual volume of 650,000 tons and, at the option of Petrobras, an additional volume of up to 2.85 million of tons per year, at the price of 100% of the international reference ARA. In addition, to guarantee access to the naphtha logistics system in Rio Grande do Sul, we also renewed the storage agreement with Petrobras until 2025 at REFAP located in the city of Canoas, and until June 2024 for the storage at TEDUT located in the city of Osório.

In December 2021, Petrobras concluded the sale of its refinery in Bahia (RLAM) to Acelen. With the conclusion of the sale, our agreement for the supply of 450,000 tons of naphtha with Petrobras to supply to our industrial unit in Bahia was transferred to Acelen, which became our supplier for the same volume.

In December 2020, we concluded the renewal of our feedstock supply agreements in Brazil with Petrobras for the supply of petrochemical naphtha to our industrial unit in São Paulo and ethane and propane to our industrial unit in Rio de Janeiro. The agreements, with a term of five years following the expiration of the prior agreements, establish the supply of up to 2.0 million tons per year of petrochemical naphtha to our industrial unit in São Paulo and up to 580,000 tons of ethylene equivalent (volume of ethylene per ton of ethane and propane) per year to our industrial unit in Rio de Janeiro, with prices based on international reference.

Petrobras controls a substantial portion of the pipeline infrastructure used to transport naphtha across Brazil and is our primary supplier of naphtha, ethane, propane, propylene and light refinery hydrocarbon. A failure to renew or extend our existing agreements for the supply of raw materials or pipeline infrastructure use, or a termination of such agreements with Petrobras could lead to difficulties in accessing Petrobras’ pipeline infrastructure. The alternative would be to access pipeline infrastructure by negotiating with Transpetro and, if necessary, the National Petroleum Agency, or the ANP, which would grant access to the pipeline infrastructure at a cost defined by the ANP.

   
 13 

Therefore, our production volumes and net revenue would likely decrease, while our costs would likely increase, and adversely affect our overall financial performance in the event of the occurrence of one or more of the following:

·significant damage to Petrobras’ supply infrastructure through which Petrobras and Braskem import naphtha, or to any of the pipelines connecting our plants to Petrobras’ facilities, whether as a result of an accident, natural disaster, fire or otherwise;
·termination by Petrobras of the naphtha, ethane, propane, propylene and light refinery hydrocarbon supply contracts with us, which provide that Petrobras may terminate the contracts for certain reasons;
·considering that Petrobras (and/or its subsidiaries) controls a substantial portion of the logistics infrastructure of our raw material across Brazil and our existing agreements for using its assets and their operation over certain Braskem’s assets, we could also assume that we would face difficulties to import and ensure access of raw material to our crackers in a scenario that these agreements are terminated by Petrobras (and/or its subsidiaries) and therefore with a substantial impact on the infrastructure that we currently access; or
·failure to renew or extend our existing agreements for the supply of raw materials or pipeline infrastructure use considering that Petrobras is conducting a divestment plan of its assets that also includes certain refineries that supply naphtha and propylene to us and some logistic infrastructure assets.

If the supply agreements are terminated or not renewed, our production volumes and net revenue would likely decrease, while our costs would likely increase, and adversely affect our overall financial performance.

In addition, although regulatory changes have ended Petrobras’ monopoly in the Brazilian naphtha market and have allowed us to import naphtha, any restrictions imposed on the importation of naphtha into Brazil could increase our production costs which would reduce our gross margin and negatively affect our overall financial performance.

We depend on propylene and ethylene supplied by third parties in the United States and Europe.

Our reliance on third party suppliers poses significant risks to our results of operations, business and prospects. We rely upon third parties to supply our plants with propylene and ethylene. We acquire propylene and ethylene for our polypropylene plants in the United States under long-term supply agreements and through the spot market. As of December 31, 2022, we had nineteen propylene supply agreements and two ethylene supply agreements with several suppliers. The pricing formulas for propylene and ethylene under these supply agreements are generally based on market prices. We cannot assure you that these agreements will be renewed and, if renewed, whether we will be able to keep the same terms and conditions currently in force, including with respect to pricing, volume, pipeline and other infrastructure access.

We acquire propylene for our polypropylene plants in Germany under long-term supply agreements that provide for the supply of 90% of the propylene requirements of these plants. We have two main supply agreements in Germany. One agreement has a five-year term effective since October 1, 2021 with a term until September 30, 2026, and thereafter will automatically be renewable for consecutive one-year terms, unless terminated by one of the parties. The other agreement expires in December 2026, and thereafter will also be automatically renewable for consecutive one-year terms, unless terminated by one of the parties. We have entered into a third contract that will expire at the end of 2023, increasing the supply of our plants to 93% of the propylene required. The pricing formula for propylene under these supply agreements is based on market prices.

   
 14 

We cannot assure you that these agreements will be renewed and, if renewed, whether we will be able to keep the same terms and conditions currently in force, including with respect to pricing, volume, pipeline and other infrastructure access.

Delays in the availability of propylene of acceptable quality, or our inability to obtain such acceptable propylene in the quantities we need over what has been contracted, or at all, may adversely affect our revenue and results of operations.

We depend on ethane supplied by Pemex TRI in Mexico.

We currently source a significant portion of our supply of ethane, which is the primary feedstock used in our polyethylene production process, from Pemex Transformación Industrial (“Pemex TRI”), a state-owned Mexican entity, which is a subsidiary of Petróleos Mexicanos, Pemex, the state-owned Mexican oil and gas company, pursuant to an ethane supply agreement (the “ethane supply agreement”), entered into by Braskem Idesa S.A.P.I. (“Braskem Idesa”), which is our joint venture with Grupo Idesa, S.A. de C.V.(“Idesa”), with Pemex TRI under competitive commercial conditions at prices that reference the Mont Belvieu purity ethane price, a U.S. dollar-based international reference price. As a result, our production volumes, net revenue and profit margins would likely decrease and materially adversely affect our overall financial performance in case one or more of the following events occur:

·significant damage to Pemex TRI’s gas processing centers or to any of the pipelines connecting our complex to Pemex TRIs facilities, whether as a consequence of an accident, natural disaster, fire or otherwise;
·any further decrease in the amount of ethane currently being delivered by Pemex TRI to our petrochemical complex;
·any dispute with Pemex TRI and Pemex Exploración y Producción or Pemex PEP, related to the ethane supply agreement, including the non-recognition or non-payment of shortfall penalties and the decrease or failure to supply the contracted volume of ethane;
·any material default by us or by Pemex TRI to supply/receive ethane in the contractually agreed volumes or qualities under the ethane supply agreement;
·any material breach or termination by Pemex TRI or by us of the ethane supply agreement, or any material breach or termination by other Mexican state-owned companies of related supply (including those for the transportation of supplies) agreements; or
·delays in the availability of ethane of acceptable quality, or our inability to obtain acceptable ethane in the quantities and quality that we need, or at all, or at reasonable prices.

Under the ethane supply agreement with Pemex, if Pemex TRI fails to deliver the contracted minimum daily volume during a given quarter, it may offset for this shortfall by delivering additional quantities of ethane during the two immediately subsequent quarters. If it does not do so, Pemex TRI will be required to pay Braskem Idesa a penalty equivalent to the average price of the ethane that was not delivered in the period in question. On the other hand, if Braskem Idesa fails to purchase the contracted minimum daily volume, we may be able to offset this deficit by purchasing additional amounts of ethane during the two immediately subsequent quarters. If it does not do so, Braskem Idesa will be required to pay a penalty to Pemex TRI equivalent to the average price of ethane that was not purchased during the period in question.

Furthermore, the ethane supply agreement could also be impacted by changes in laws and regulations, terminated or modified by Pemex TRI as a result of political pressure or be subject to expropriation or other adverse measures by the Mexican government or government entities. Braskem Idesa may also renegotiate the terms of the ethane supply agreement, voluntarily or as a result of changes in laws and regulations, or otherwise.

   
 15 

The provisions for early termination by Pemex TRI under the Ethane Supply Agreement include: (i) failure by Braskem Idesa to pay that continues for more than six months after notice; or (ii) an emergency stoppage in operations or force majeure event due to which Braskem Idesa’s insurers consider the complex to be a total loss, or after which Braskem Idesa cannot or does not resume operations for 48 months.

If Pemex TRI (i) delivers less than an average of 75% of the agreed volume over a six-month period, (ii) reaches the annual limit in respect of shortfall penalties owed by Pemex TRI to Braskem Idesa and such limit is not waived by Braskem Idesa, or (iii) materially breaches any of its obligations related to the supply of ethane thereunder; Braskem Idesa has the right to notify Pemex TRI trough a notice of breach. If such breach continues for more than six months after notice, or an extended period if the parties agree, Braskem Idesa has the right to terminate the ethane supply agreement and require Pemex TRI and Pemex PEP to repay certain outstanding debt and compensate Braskem and Idesa according to an agreed valuation formula including the repayment of certain of our debt in the form of a put option right under the ethane supply agreement.

On September 27, 2021, Braskem Idesa entered into: (i) an amendment to the ethane supply agreement (the “amendment to the ethane supply agreement”) with Pemex Tri and Pemex Exploración y Producción to settle certain prior contractual outstanding issues; and (ii) an agreement with Pemex, Pemex Logística and other Mexican government entities, establishing certain support measures to the project to build an ethane import terminal with the capacity to meet all of Braskem Idesa’s feedstock requirements (the “terminal agreement”).

The amendment to the ethane supply agreement changed the minimum volume commitment to 30,000 barrels per day until the earliest of: (i) the operational startup of the ethane import terminal, scheduled for the second half of 2024, or (ii) February 2025 (which could be extended if there are delays in obtaining licenses). The amendment to the ethane supply agreement also gave Braskem Idesa the preemptive right to acquire all of the ethane that Pemex has available and has not consumed in its own production process until 2045, at international benchmark prices. The terminal project is designed to complement the ethane supply in Mexico and enables Braskem Idesa to operate at full capacity by accessing new feedstock sources.

Braskem Idesa and its operations in Mexico, including agreements entered into with state-owned or state-controlled entities, are subject to political interference by the Mexican government, which may lead to the termination or repudiation of certain contractual relationships and interference on Braskem Idesa’s operations that may materially and adversely affect us.

Any termination, cancelation or modification of the ethane supply agreement or reduction in the amount of shortfall penalties owed to us by Pemex TRI for any other reason, could have an adverse effect on our results of operations and financial position.

We depend on services and products supplied by a Mexican state-owned company

Braskem Idesa has entered into agreements with Mexican state-owned companies for the transportation of natural gas and water supply, among others. Any termination, cancelation or modification of such agreements could have an adverse effect on our results of operations and financial condition.

Furthermore, such agreements could also be impacted as a result of changes in laws and regulations, terminated or modified as a result of political pressure or be subject to expropriation or other adverse measures by the Mexican government or government entities. We may also renegotiate the terms of such agreements, voluntarily or as a result of changes in laws and regulations, or otherwise. In early December 2020, Braskem Idesa received a notification from Cenagas (Centro Nacional de Control del Gas Natural), a Mexican state-owned agency responsible for all natural gas pipelines and transportation in Mexico, related to the unilateral termination of the service of natural gas transportation, an essential energy input for the production of PE in our Mexico Segment. As a result, in compliance with safety protocols, Braskem Idesa initiated procedures for the immediate interruption of its operating activities. Later in January 2021, Braskem Idesa partially resumed its operations based on an experimental business model to produce PE. Braskem Idesa has taken legal measures pursuant to the ethane supply agreement entered into with Pemex. Braskem Netherlands B.V, which is Braskem Idesa’s direct shareholder, has also taken legal measures under applicable international investment protection standards to protect the interests of Braskem Idesa and its parent company with regard to their investment in Mexico. Such measures include a negotiation period to attempt to resolve the dispute between the parties.

   
 16 

In the first quarter of 2021, Braskem Idesa entered into the following agreements under a strict reservation of all of its rights: (i) a memorandum of understanding with Pemex TRI setting out certain understandings regarding potential amendments to the ethane supply agreement and the development of an ethane import terminal, subject to further negotiation, a definitive agreement and approval by Braskem Idesa’s shareholders and creditors; and (ii) a natural gas transport service agreement with Cenagas for a term of 15 years, which was conditioned upon the execution of the definitive agreement referenced in item (i) above. Following the execution of these agreements by Braskem Idesa, it resumed receiving natural gas transportation services from Cenagas, which had been unilaterally terminated by Cenagas in December 2020. On September 27, 2021, Braskem Idesa signed the following documents: (i) an amendment to the ethane supply agreement with Pemex revising certain of its terms; and (ii) an agreement with Pemex and other government entities that establishes support measures for the project to build an ethane import terminal, with the capacity to meet all of Braskem Idesa’s raw material needs. In October 2021, Braskem Idesa obtained the applicable corporate approvals, including the final approval of its shareholders and creditors regarding the executed agreements, resulting in the entry into force of the agreements describe above.

Failure by Cenagas to renew the agreement for transportation of natural gas or any other agreement with a Mexican state-owned company could have a material adverse effect on our business, results of operations and financial condition.

Political conditions in Mexico may affect actions or decisions by the Mexican government, including Pemex TRI, Cenagas, CFE and CENACE, which are, respectively, Braskem Idesa’s main suppliers of ethane, a provider of natural gas transportation services, an electricity back-up supplier, and the controller of national grid and dispatches of energy power generators, all of which are Mexican state-owned enterprises subject to political interference and related risks.

The Mexican government has exercised, and continues to exercise, significant influence over the Mexican economy. Accordingly, Mexican governmental actions concerning the Mexican economy and state-owned enterprises could have a significant impact on Mexican private sector entities in general and on our operations in particular. We cannot predict the impact that political conditions will have on the Mexican economy or on our operations. We can give no assurances that changes in Mexican federal government policies will not adversely affect our business, financial condition, results of operations and prospects. We currently do not have and do not intend to obtain political risk insurance.

In 2021, the Mexican government took measures that would strengthen Pemex and the Federal Electricity Commission (Comisión Federal de Electricidad) power over Mexico’s energy market and threaten the country’s prospects for private renewable energy generation, including the annulment of certain previous energy policies and the proposed amendments to Mexico’s Energy Sector Law (Ley de la Industria Eléctrica) and to the Hydrocarbons Law (Ley de Hidrocarburos). Additionally, on September 30, 2021, President Andrés Manuel Lopez Obrador presented a constitutional initiative to reform the energy sector in Mexico before the Chamber of Deputies (the “Reform”). The Reform consists of amending certain guidelines and precepts of the Mexican energy sector by revising Articles 25, 27 and 28 of the Mexican Constitution and corresponding amendment to secondary laws, mainly the Electricity Industry Law (Ley de la Industria Eléctrica).

   
 17 

On April 17, 2022, the Reform was voted on in the Chamber of Deputies. With 275 votes in favor, 223 against and zero abstentions, the Reform was not approved despite having more votes in favor, as it did not gather the sufficient votes to reach the qualified majority on the Chamber of Deputies (333 votes in favor) required for the Energy Reform to pass. As a consequence, the energy sector, at a constitutional level, remains unchanged as it was approved during the 2013 Energy Reform.

One of our main ethane suppliers, Pemex TRI, is a subsidiary of Pemex, a state-owned entity of the Mexican government. The Mexican government controls Pemex, as well as its annual budget, which is approved by the Mexican Congress. The Mexican government may cut or reallocate spending in the future. Any cutbacks or reallocation could adversely affect Pemex’s annual budget and its ability to provide us with our contracted supply of ethane. In addition, Cenagas, a Mexican state-owned agency, is responsible for all natural gas pipelines and transportation in Mexico. As a result, Cenagas’ interruptions in transportation of natural gas to our Mexico Complex, could have a material adverse effect on our business, results of operations and financial condition and on our ability to develop and operate the ethane import terminal.

Pemex also produces polyethylene and competes in the same commercial market as we do. The Mexican government may intentionally interfere with us and our operations in various ways in order to limit our commercial competitiveness. According to Pemex’s public disclosure, its production of oil, natural gas and ethane, over which we have no control, has decreased in recent years, and no assurance can be given that there will not be a decrease in the delivery of ethane in the future.

In light of the allegations of undue payments related to the Ethylene XXI project, which were originally published in the media in Mexico and were included in the testimony by the former CEO of Pemex to the Office of the Attorney General of Mexico, Braskem S.A., together with Braskem Idesa, in compliance with the standards established by Braskem’s Global Compliance System Policy and Braskem Idesa’s governance guidelines, approved the hiring of an U.S. law firm with proven experience in similar cases to conduct an independent internal investigation of the allegations (the “Investigation”). The investigation was concluded in February 2022 and did not find evidence to support the allegations by the former CEO of Pemex regarding allegedly improper payments in connection with or otherwise related to the Ethylene XXI project.

We rely on limited or sole-source suppliers for our raw materials, inputs and energy, including transportation thereof.

We rely on Petrobras for most or all of our supply of ethane, propane, light refinery hydrocarbon and propylene in Brazil, a few companies for a large portion of our supply of propylene in our United States and Europe Segment, and Pemex TRI for most of our supply of ethane in Mexico. In Mexico, Cenagas (Centro Nacional de Control del Gas Natural), which is a state-owned agency, is the sole provider of gas transportation services. We rely on Cenagas for the transportation of natural gas to our Mexico Complex. For ethane supply to Mexico, we rely on several international suppliers for most of the purchases to the cracker located in Mexico.

For naphtha supply to Brazil we rely on several international suppliers for most of the purchases to the crackers in the states of Bahia and Rio Grande do Sul, and we rely on Petrobras for the most of the supply only to the cracker located in the state of São Paulo and we rely on Petrobras for the major part of our supply of ethane and propane in the state of Rio de Janeiro. Also, we are subject to substantial risks because of our reliance on these and other limited or sole-source suppliers of raw materials, additives, catalyzers, other inputs, energy and other utilities, including the following risks:

·if a supplier does not provide naphtha, ethane, propane, light refinery hydrocarbon, propylene, sea salt, other inputs (including natural gas) or energy, as the case may be, that meet our or their specifications in sufficient quantities and with acceptable performance or quality on time or deliver when required, then sales, production, delivery of our products to our customers on a timely manner and revenue from our plants could be adversely affected;
   
 18 
·if our relationship with a key supplier changes or is adversely affected, for example, due to competitive pressures (or conflicting interests), we may be unable to obtain naphtha, ethane, propane or propylene, natural gas or other inputs, as the case may be, on satisfactory financial terms;
·if an interruption of supply of naphtha, ethane, propane, light refinery hydrocarbon, propylene, sea salt, other inputs (including natural gas) or energy, as the case may be, occurs because a supplier changes its technology roadmap, suffers damage to its manufacturing facilities, decides to no longer provide those products or services, increases the price of those products or services significantly or imposes reduced delivery allocations on its customers, it could take us a considerable period of time to identify and qualify alternative suppliers;
·some of our key suppliers are small companies with limited financial and other resources, and as a result, they may be more likely to experience financial and operational difficulties than larger, well-established companies, which increases the risk that they will be unable to deliver products as needed;
·some of our suppliers are state-owned enterprises subject to political interference, including in Mexico; and
·if a key supplier is acquired or has a significant change in business, the production and sales of our systems and services may be delayed or adversely affected, or our development programs may be delayed or may be impossible to complete.

Delays in the availability of naphtha, ethane, propane, light refinery hydrocarbon, propylene, sea salt, other inputs (including natural gas) or energy of acceptable quality, or our inability to obtain such acceptable naphtha, ethane, propane, light refinery hydrocarbon, propylene, sea salt, other inputs (including natural gas) or energy in the quantities we need or at all, may adversely affect our revenue and results of operations.

Our Brazil Segment depends on our chemicals operations to supply them with their ethylene and propylene requirements. In addition, our Brazil Segment depends on certain providers of environmental services for the treatment of effluents, industrial waste and water supply for industrial use.

Our chemicals operations, which form a part of our Brazil Segment, are the only supplier of ethylene to our vinyls operations, the only supplier of ethylene to the polyethylene plants and the principal supplier of propylene to the polypropylene plants of our polyolefins operations. Additionally, as the cost of storing and transporting ethylene and its derivatives, including butadiene and other chemical products, is significant and there is no adequate infrastructure in Brazil that allows for the storage of large volumes, a relevant reduction in sales of these products may impact the operating rate of our chemical operations, impacting product availability for the polyolefins and vinyls operations in Brazil.

Our polyolefins and vinyls operations in Brazil are highly dependent on the supply of these products by our chemicals operations. Consequently, our production volumes of, and net revenue from, polyolefins and vinyls operations would decrease, and our overall financial performance would be negatively affected, in the event of the following:

·any significant damage to the facilities of our chemicals operations through which ethylene or propylene is produced, or to the pipeline or other facilities that connect our polyolefins plants or vinyls plants to our chemicals operations, whether as a consequence of an accident, natural disaster, fire or otherwise;
·any significant reduction in the supply of naphtha to our chemicals operations, as naphtha is the principal raw material used by our chemicals operations in the production of ethylene and propylene; or
   
 19 
·any significant reduction in the supply of ethane or propane to our basic petrochemical plant in Rio de Janeiro, as ethane and propane are the principal raw materials used in the production of ethylene and propylene by our petrochemical complex located in the Rio de Janeiro Complex.

Also, our production volumes of, and net revenue from, our chemicals operations products could decrease, and our overall financial performance would be negatively affected in the event of any significant damage to the facilities of our vinyls and polyolefins operations that are part of our Brazil Segment through which ethylene is consumed.

Our Brazil Segment depends on Cetrel S.A. (“Cetrel”), Água de Camaçari (“DAC”), both of which are our subsidiaries, Distribuidora de Água Triunfo (“DAT”), Companhia Riograndense de Saneamento (“CORSAN”), Aquapolo Ambiental S.A (“Aquapolo”), Refinaria de Paulínia (“REPLAN”) and Refinaria Duque de Caixas (“REDUC”) for the services such as: (i) treatment of effluents and industrial waste; (ii) supply of reuse water; (iii) supply of demineralized, clarified and potable water; and (iv) management of water reservoirs. An interruption in the operations of Cetrel, DAC, DAT, CORSAN, Aquapolo, REPLAN or REDUC may result in the shutdown of all of our plants at the Northeastern Complex, Southern Complex, São Paulo Complex, Paulinia plants and Rio de Janeiro Complex, in addition to increased environmental risks. If such a shutdown were to happen, our production volumes and net revenue from sales from our plants referred to above would decrease, and our financial performance and results of operations would be adversely affected.

We may be materially adversely affected if there is an imbalance in global logistics, which may cause disruptions to our transport, storage and distribution operations, negatively impacting the costs related thereto.

Our operations are dependent upon uninterrupted transportation, storage and distribution of our products. Transportation, storage or distribution of our products could be partially or completely, temporarily or permanently shut down as the result of any number of circumstances that are not within our control, such as:

·catastrophic events;
·strikes or other labor difficulties;
·disruption in the global supply chain, including container shortages;
·war and other armed conflicts, such as the conflict involving Russia and Ukraine; and
·other disruptions in means of transportation.

For example, in May 2018, Brazil experienced a national truck drivers’ strike that severely impacted the logistics operations of many companies throughout Brazil, including the delivery of our raw materials, our products, and other goods. In response to such strike, we gradually reduced the utilization rate of our petrochemical complexes in Brazil, which operated at 50% of their nominal capacity in May 2018. We cannot assure, however, that we will be able to act in the same way in potential new strikes that may arise in the future. Following the strike, Brazil introduced a national freight cost schedule that set forth minimum prices for freight services provided by truck drivers and freight companies countrywide, which may have a lasting impact on freight prices in Brazil and lead to sustained increased transportation costs in the future in connection with our operations.

In addition, due to shipowners’ and market uncertainties with respect to the future propulsion technology adopted by the world’s merchant fleets, we are currently witnessing a lack of investment in the renewal of the world’s merchant fleet. This might lead to a shortage of ships available to us, which could drive our logistic costs higher.

   
 20 

Any significant interruption at our distribution facilities, an inability to transport our products to or from these facilities, or to or from our domestic or foreign customers or suppliers, or an increase in transportation costs, for any reason, would materially adversely affect us.

We rely on access to third-party licensed technology and related intellectual property, and if such rights cease to be available to us on commercially reasonable terms, or at all, or if any such third party ceases to provide us with technical support under license or technical services agreements, certain of our production facilities, our operating results and financial condition could be adversely affected.

We use technology and intellectual property licensed from third parties in the regular operation of our business, particularly in the operation of certain machinery and equipment required for the production of certain of our products such as our first- and second-generation products, and we may continue to rely on access to third-party technology and intellectual property in the future.

There can be no assurance that we will be able to continue to obtain or renew any such necessary technology and licenses on acceptable terms, or at all. Failure to obtain or renew the right to use third-party technology or intellectual property on commercially reasonable terms, or to maintain access to satisfactory technical support, could ultimately lead to stoppages in our production processes and preclude us from selling certain products, which could have a material adverse impact on our operating results and financing condition.

Additionally, our inability to maintain existing access to third-party technology, licenses and technical support on commercially reasonable terms, or at all, or to obtain additional technology, licenses or technical support necessary to manufacture current products or develop new ones, could require us to obtain substitute technology or licenses at a greater cost or of lower quality or performance standards, or require us to carry out unscheduled interruptions of our production facilities. There can be no assurance that we will be able to replace any such third-party technology, intellectual property or technical support service for any adequate substitute technology, intellectual property or technical support in a timely manner to avoid any unscheduled interruption of our production processes or facilities, or in a cost-efficient manner. Any of these circumstances could harm our business, financial condition and results of operations.

Capital projects can take many years to complete, and market conditions could deteriorate significantly between the project approval date and the project startup date, negatively impacting project returns. If we are unable to complete projects and investments at their expected cost and in a timely manner, or if the market conditions assumed as a basis for our project economics deteriorate, our business, financial condition, results of operations and cash flows could be materially and adversely affected.

Delays or cost increases related to investment programs involving engineering, procurement and construction of facilities could materially adversely affect our ability to achieve forecasted rates of return and results of operations and financial position. Delays due to required changes or upgrades to our facilities could subject us to fines or penalties as well as affect our ability to contract with our customers and supply certain products we produce.

Such delays or cost increases may arise as a result of unpredictable factors, many of which are beyond our control, including, but not limited to:

·denial of or delay in receiving requisite regulatory approvals or permits;
·unplanned increases in the cost of construction materials or labor;
·disruptions in transportation of gear or construction materials;
·change in the market conditions assumed as a basis for our project economics;
   
 21 
·adverse weather conditions, natural disasters, epidemics, pandemics or other events (such as equipment malfunctions, explosions, fires or spills) affecting our facilities, or those of vendors or suppliers, shortages of sufficiently skilled labor, or labor disagreements resulting in unplanned work stoppages; and
·non-performance by, or disputes with, vendors, suppliers (including those responsible for transportation of supplies), contractors or subcontractors. Any one or more of these factors could have a significant impact on our ongoing projects.

For example, in September 2021, Braskem Idesa announced a project to construct an ethane import terminal with the capacity of 80,000 barrels per day of ethane, providing conditions for Braskem Idesa to import all its feedstock needs. In addition, in July 2022, Braskem Idesa has entered into agreements with Advario B.V for the sale of a 50% stake in Terminal Química Puerto México (“TQPM”), a subsidiary of BI responsible for the development and operation of the ethane import terminal Project in Mexico. If we are unable to complete that project at their expected cost and in a timely manner, or if the market conditions or financing assumed as a basis for our project economics deteriorate, our business, financial condition, results of operations and cash flows could be materially and adversely affected.

If we are unable to make up the delays associated with such factors or to recover the related costs, or if market conditions change, it could materially and adversely affect our business, financial condition, results of operations and cash flows.

Our insurance coverage may be ineffective, either due to the lack of coverage for any claim, or due to insufficient coverage limits in the event of damage.

We maintain property, business interruption, general liability, environmental, construction, marine, credit and other types of insurance that we believe are appropriate for our business and operations as well as in line with industry practices. However, we are not fully insured against all potential hazards and incidents inherent in our business. Changes in insurance market conditions have caused, and may in the future cause, premiums and deductibles for certain insurance policies to increase substantially and, in some instances, for certain insurance to become unavailable or available only for reduced amounts of coverage. If we were to incur a significant liability for which we were not fully insured, we might not be able to finance the amount of the uninsured liability on terms acceptable to us or at all and might be obligated to divert a significant portion of our cash flow from normal business operations. Also, in the event of an accident, we are required to undergo a regulatory assessment through which the insurance coverage needs to be confirmed. If coverage is not confirmed, there will be no indemnity to be paid.

In addition, adaptation actions, including those related to climate change, could be considered insufficient by insurance companies and may make it difficult for us to obtain insurance for our business. Also, premiums and deductibles for certain insurance policies could increase substantially and, in some instances, certain insurance coverage could become unavailable or available only in reduced coverage amounts.

Our level of indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit the ability to react to changes in the economy or our industry and prevent us from meeting our obligations under our financing agreements.

Our level of indebtedness and our leverage, together with changes to our ratings and those of our debt securities by the main credit rating agencies, could have certain material consequences to us, including the following:

·limit our ability to obtain additional financing for working capital, additions to fixed assets, product development, debt service requirements, acquisitions and general corporate or other purposes;
   
 22 
·limit our ability to pay dividends;
·a portion of our cash flows from operations must be set aside for the payment of interest on existing indebtedness and is therefore not available for other purposes, including for operations, additions to fixed assets and future business and investments opportunities;
·limit our ability to adjust to changing market conditions and place us at a competitive disadvantage compared to our competitors that have less debt;
·we may become vulnerable in a downturn in general economic conditions; and
·we may be required to adjust the level of funds available for additions to fixed assets.

As a result of the factors listed above, our financial condition and results of operations may be adversely affected.

Any downgrade in the ratings of Brazil, our Company or our debt securities would likely result in increased interest and other financial expenses related to our borrowings and debt securities and could reduce our liquidity.

Currently, Standard & Poor’s Ratings Group, a division of McGraw Hill, Inc., or Standard & Poor’s, and Fitch Ratings Ltd., or Fitch, maintain our ratings on a global and national basis. Moody’s Investors Service, Inc., or Moody’s, only maintains our ratings on a global basis. On a global basis, we maintain ratings at: (i) Standard & Poor’s of BBB- with a stable outlook (ii) Fitch Ratings of BBB- with a stable outlook and (iii) Moody’s of Ba1 with a stable outlook. Our ratings are higher than the Brazilian sovereign rating by all these three main rating agencies. On a national basis, we maintain investment grade rating at: (i) Standard & Poors of brAAA with a stable outlook and (ii) Fitch Ratings of AAA with a stable outlook.

Our credit rating is sensitive to any change in the Brazilian sovereign credit rating. The credit rating of the Brazilian federal government was downgraded in January 2018.

In 2020, the COVID-19 pandemic significantly impacted economic activity and markets around the world, and its severity, magnitude and duration are highly uncertain, rapidly changing and difficult to predict. Actual and potential impacts of the COVID-19 pandemic on the global economy, the economies of certain countries and certain companies has led ratings agencies to review and downgrade the credit ratings of sovereigns and issuers of securities around the world. In May 2020, Fitch Ratings revised the outlook of the Brazilian sovereign credit rating to negative from stable. In November 2020, Fitch Ratings affirmed the negative outlook and later in December 2021, Fitch Ratings reaffirmed Brazil’s rating of BB- maintaining the same outlook.

Any decision by these rating agencies to downgrade the Brazilian sovereign credit rating, our ratings and the ratings of our debt securities in the future would likely result in higher interest rates and other financial expenses related to the loans and debt securities, and the inclusion of financial covenants in the agreements regulating such new debts, which may significantly reduce our ability to raise funds under satisfactory conditions or in the amounts necessary to ensure our liquidity, as well as force us to issue cash collateral as a result of our covenants, or letters of credit to back collaterals given by us.

Some of our shareholders may have the ability to determine the outcome of corporate actions or decisions, which could affect the holders of our class A preferred shares and the ADSs.

Novonor S.A. – Em Recuperação Judicial, directly or through its wholly-owned subsidiary NSP Inv., owns 38.3% of our total share capital, including 50.1% of our voting share capital, and Petrobras holds 36.1% of our total share capital, including 47.0% of our voting share capital. Nominees of Novonor constitute a majority of the members of our board of directors. Under a shareholders’ agreement to which Novonor and Petrobras are parties, which we refer to as the Braskem S.A. Shareholders’ Agreement, all matters that may be resolved at a shareholder’s meeting or by our board of directors shall be decided by consensus among Novonor and Petrobras (except for our business plan, which is approved separately by the directors appointed by Novonor, as described under “Item 7. Major Shareholders and Related Party Transactions—Major Shareholders—Shareholders’ Agreements”), taking into account our best interest. Furthermore, the shareholders’ agreement provides for the possibility (and not the obligation), if deemed necessary, to hold prior meetings, as a legitimate mechanism for alignment between Novonor and Petrobras, with a view to ensuring consistency and uniformity in their decisions, which could affect holders of class A Preferred Shares and American Depositary Shares, or ADSs.

   
 23 

Furthermore, on June 17, 2019, Novonor, together with certain of its controlling and controlled entities, filed a petition for judicial restructuring before the First Judicial Bankruptcy Court of the State of São Paulo, Brazil, seeking a judicial restructuring and emergency relief staying certain foreclosure actions by their secured creditors, or the Novonor Judicial Restructuring Proceedings. The Novonor Judicial Restructuring Proceedings does not include us.

We are exposed to certain risks related to the Novonor Judicial Restructuring Proceedings, such as risks related to the change of our corporate control resulting from decisions taken and/or agreed in the context of such proceedings and the consequences derived thereto, including but not limited to significant changes in our management and our strategy that may be undertaken by any new controlling shareholders that may arise from the conclusion of these proceedings. We have no control over the Novonor Judicial Restructuring Proceedings, and no assurance can be given on the outcome of the Novonor Judicial Restructuring Proceedings or their effect on us.

We may be subject to attempts to acquire our control, which may lead to significant changes in management, the strategies that we are currently pursuing, or in our current corporate governance practices.

We may be subject to attempts to acquire our control. In the event there is a change in our corporate control, there might be significant changes in management, the strategies that we are currently pursuing, or in our current corporate governance practices.

On August 7, 2020, we received a correspondence from our controlling shareholder, Novonor, informing that, in order to fulfill certain commitments assumed with bankruptcy and non-bankruptcy creditors (credores concursais e extraconcursais), it had taken preliminary measures to structure a process for the private sale of up to its total equity ownership in our company, which, if implemented, will result in the change of our corporate control, adopting the necessary measures to organize such process, with the support of legal and financial advisors.

On December 15, 2021, we received a letter sent jointly by our shareholders Novonor and Petrobras – Petróleo Brasileiro S.A. (“Petrobras”) regarding the progress of discussions for the potential sale of their equity interests in us. In such communication, Novonor and Petrobras disclosed that they agreed to seek the adoption of the necessary measures: (i) for the sale, through a secondary public offering, of up to all our class A preferred shares held directly or indirectly by them; (ii) to enable Braskem’s migration to the Novo Mercado listing segment of the B3, including in relation to necessary changes to Braskem’s corporate governance, which shall be subject to applicable approvals at the appropriate time and negotiation of a new shareholders’ agreement to conform their rights and obligations to such amended governance structure; and (iii) after the conclusion of Braskem’s potential migration to the Novo Mercado listing segment, carry out the sale of the remaining common shares held directly or indirectly by them and issued by us. The effective implementation of the commitments assumed by Novonor and Petrobras is subject, among other factors, to relevant approvals and market conditions. We are unable to predict the result of the implementation of the commitments assumed, as well as their possible impacts. On January 28, 2022, we received a communication sent jointly by our shareholders Novonor and Petrobras whereby they decided to temporarily cancel the shares offering due to volatility conditions in the financial and capital markets.

   
 24 

On November 3, 2022, we received a correspondence from Novonor, informing that, due to the discussions and analysis currently underway relating to a possible transaction, it may be necessary for Braskem to interact with potential interested parties, for which Novonor asked for our support and for that of our officers. Novonor further informed that, at that moment, there was no exclusivity agreement with any interested party, no binding offer, and no definition or decision on the structure to be adopted or on any alternative related to the disposal process.

In addition, although we are not currently a party to any pending bankruptcy or other judicial restructuring proceedings in Brazil or elsewhere, we are exposed to certain risks related to the Novonor Judicial Restructuring Proceedings, including risks related to the change of our corporate control resulting from decisions taken or agreed under such proceedings and the consequences derived therefrom. We have no control over the Novonor Judicial Restructuring Proceedings, and no assurance can be given on the outcome of the Novonor Judicial Restructuring Proceedings or their effect on us.

Additionally, all common and preferred shares issued by Braskem and held by NSP Investimentos S.A., or NSP Inv. were pledged with fiduciary assignment (alienação fiduciária) as a collateral given under certain financing agreements entered into by Novonor and certain of its subsidiaries with specific non-bankruptcy creditors (credores extraconcursais). It is possible that, under certain circumstances, the pledge over such shares may be enforced, with the consequent sale of the shares, which could result in a change of Braskem’s control and other consequences arising therefrom.

We may face conflicts of interest in transactions with related parties.

We maintain trade accounts receivable and current and long-term payables with related parties, including Petrobras and its subsidiaries, which is our Brazilian supplier of naphtha and other raw materials such as propylene, ethane, propane and light refinery hydrocarbon, and Novonor and its subsidiaries. These trade accounts receivable and trade accounts payable balances result mainly from purchases and sales of goods, which are mainly made based on international price references. These and other transactions between us and our related parties can result in conflicting interests, which may adversely affect our results of operations and financial condition.

Under our growth strategy, we may pursue strategic acquisitions, investments and investments in new businesses. The failure of an acquisition, investment or investments in new businesses to produce the anticipated results, or the inability to integrate an acquired company, could adversely affect our business financial condition and results of operations.

We have a adopted a growth strategy that is based on organic and inorganic growth, including investments and capital expenditures focused on sustainable development, renewable and recyclable products, mitigation of climate change, green initiatives and strengthening the circular economy. Pursuant to such growth strategy, we may from time to time acquire or invest in complementary companies or businesses with a similar or equal focus. Such acquisitions or investments may include businesses that operate in modern, innovative, and ground-breaking fields, all of which may have an increased level of uncertainty and risk, as they often develop or adopt new technologies and initiatives that may not yet have been proven to work as expected and may not have been sufficiently settled or consolidated. Certain of these businesses may also involve greenfield or brownfield operations, which may take longer periods of time to mature, if they ever mature, and also pose increased uncertainties, challenges and risks.

For example, in partnership with Valoren, a company specialized in developing and operating technologies for transforming solid waste, we built the first mechanical recycling line in Brazil. The plant, located in Indaiatuba, in the State of São Paulo, started its production by the end of 2021 and has the capacity to transform approximately 250 million pieces of packaging into 14,000 tons of high-quality postconsumer resin per year.

   
 25 

In 2022, we acquired a minority equity interest in Nexus Circular LLC, a company that operates in advanced recycling that converts landfill-bound plastics into circular feedstocks used in the production of sustainable virgin plastic. We also established a joint venture, based in the Netherlands, with Terra Circular, whose majority partner has developed and implemented innovative technology with the capacity to convert low-quality plastic waste into consumer products. Also in 2022, we acquired a minority equity interest in the special purpose entities (SPEs) engaged in wind power generation Ventos de Santa Amélia and Ventos de Santo Abelardo, both of which are subsidiaries of the private equity fund FIP Salus of the Casa dos Ventos group.

 

In February 2023, we completed the process of acquiring shares and subscribing to new shares issued by Wise Plásticos S.A. (“Wise”), a Brazilian company in the mechanical recycling sector, now holding a 61.1% equity interest in Wise.

The success of any acquisition or investment pursuant to our growth strategy will also depend on our ability to make accurate assumptions regarding the valuation, operations, growth potential, integration and synergies, technology, international market and other factors related to that business. We cannot assure you that our acquisitions or investments will produce the results that we expect at the time we enter into or complete a given transaction. Furthermore, acquisitions may result in difficulties integrating the acquired companies, and may result in the diversion of our management’s attention from other business issues and opportunities. We may not be able to integrate successfully the operations that we acquire, including their personnel, financial systems, distribution or operating procedures. If we fail to integrate acquisitions successfully, our business, financial condition and results of operations could suffer. In addition, the expense of integrating any acquired business and their results of operations may adversely affect our results of operations.

Certain acquisitions, partnerships and joint ventures we make may prevent us from competing for certain clients or in certain lines of business and may lead to a loss of clients. We may spend time and money on projects that do not increase our revenue in the foreseeable future or at all, including those investments related to industrial decarbonization and recycling, renewable products, and the circular economy. To the extent we pay the purchase price of any acquisition in cash, it would reduce our cash reserves, and to the extent the purchase price is paid with any of our shares, it could be dilutive to our shareholders. To the extent, we pay the purchase price with proceeds from the incurrence of debt, it would increase our level of indebtedness and could negatively affect our liquidity and restrict our operations. Our competitors may be willing or able to pay more than us for acquisitions, which may cause us to lose certain acquisitions that we would otherwise desire to complete. We cannot ensure that any acquisition, partnership or joint venture we make will not have a material adverse effect on our business, financial condition and results of operations.

 

We may face unforeseen challenges in the operation of our Mexico Complex, which could result in this business unit failing to provide expected benefits to us.

During the first half of 2016, we concluded the construction phase of an olefins complex, or the Mexico Complex, located in the Mexican state of Veracruz.

To develop our Mexico Complex, Braskem Idesa disbursed significant capital and incurred significant debt. Our ability to achieve the strategic objectives of this business unit will depend largely on its successful operation. Factors that could affect the operation of this business unit include:

·general economic, political and business conditions in Mexico;
·global demand for, and supply balance of, PE;
·the occurrence of unforeseen technical and mechanical difficulties that may interrupt production or lead to unexpected downtime of the Mexico Complex’s plants;
·any material default by Pemex TRI under the ethane supply agreement;
   
 26 
·any termination, cancelation or modification of the ethane supply agreement for any other reason;
·the failure to renew any material agreement with Mexican state-owned companies;
·the ability of Braskem Idesa to service its debt;
·an unstable and non-continuous supply (including the transportation of supplies) of ethane, natural gas and other inputs, including energy and water; and
·increased competition from domestic or foreign competitors and/or the emergence of new domestic or foreign competitors.

In the first quarter of 2021, Braskem Idesa entered into a natural gas transport service agreement with Cenagas for a term of 15 years. Following the execution of this agreement by Braskem Idesa, it resumed receiving natural gas transportation services from Cenagas, which had been unilaterally terminated by Cenagas in December 2020.

On September 27, 2021, Braskem Idesa signed the following documents: (i) an amendment to the ethane supply agreement with Pemex revising certain of its terms (“Amendment”); and (ii) an agreement with Pemex and other government entities that establishes support measures for the project to build an ethane import terminal, with the capacity to meet all of Braskem Idesa’s raw material needs.

The Amendment changes the minimum volume commitment to 30,000 barrels per day until the earliest of: (i) the operational startup of the ethane import terminal, scheduled for the second semester of 2024, or (ii) February 2025 (which could be extended if there are delays in obtaining licenses). The Amendment also gives Braskem Idesa the preemptive right to acquire all the ethane that PEMEX has available and has not consumed in its own production process until 2045, at international benchmark prices.

In September 2021, Braskem Idesa started the Ethane Import Terminal project in Mexico. In October 2021, Braskem Idesa constituted the Terminal Química Puerto México (“TQPM”), a company created to be responsible for the construction and operation of the terminal. In June 2022, Braskem Idesa announced the sale of 50% of TQPM’s stake to Advario B.V., a global storage company, in TQPM. The TQPM ethane import terminal was designed to have a capacity of 80,000 daily barrels, providing conditions for Braskem Idesa to import all its need for raw material. We cannot assure you that the Mexico Complex will provide the expected benefits to us, even after having completed six calendar year of operations. Any significant interruption could hinder or prevent the implementation of our business plan as originally conceived, and result in revenue and net income below what is expected. Further, any material adverse effect on the financial condition or results of operations of the Mexican complex may adversely impact our own financial condition and results of operations.

Adjustments in tariffs on imports that compete with our products could cause us to lower our prices.

The Brazilian government has used import tariffs to implement economic policies. As a result, import tariffs imposed on petrochemical products have varied in the past and may vary in the future. Until November 2021, tariffs on imports of first-generation petrochemical products varied between 0% and 4%, and tariffs on polyethylene, polypropylene and PVC resins were 14.0%. In November 2021, the Brazilian government unilaterally reduced by 10% the import tariff rates of 87% of all its internationally commercialized goods. In May 2022, Brazil reduced, unilaterally, by an additional 10% tariffs on certain exports, which were expected to remain in force until December 2023 at the level of 11.2%.

In July 2022, Mercosur decided to reduce permanently the Common External Tariff (TEC) by 10%, which was applicable to all Mercosur members. Following these changes, tariffs on imports of first-generation petrochemical products from Mercosur members now vary between 0% and 3.6%, and tariffs on polyethylene, polypropylene and PVC resins are set at 12.6%.

   
 27 

In August 2022, the Brazilian government also enacted Resolutions Nos. 369 and 381 of the Executive Management Committee of Chamber of Foreign Trade (“Gecex”) approving a reduction in the import tax, by inclusion in the List of Exceptions to the Mercosur Common External Tariff (“Letec”) for the following of our products: (i) ethylene and alpha-olefin copolymers with density lower than 0.94, from 11.2% to 3.3%; (ii) S-PVC resin obtained from suspension processes, from 11.2% to 4.4%; (iii) PP (propylene copolymer) resin, from 11.2% to 4.4%; and (iv) PP (propylene homopolymer), from 11.2% to 6.5%. This reduction is valid for one year, from August 5, 2022 until August 2023, and, during this period, this change is expected to adversely affect our results of operations in Brazil. We have historically prioritized supply to the Brazilian market, and currently there are no signs of shortages of the products we supply to the Brazilian market.

On March, 21, 2023, the Executive Management Committee (“Gecex”) of the Foreign Trade Chamber (“Camex”) decided to exclude the following products from the Letec, establishing the import tax rate that had been reduced as follows: ethylene and alpha-olefin copolymers, with a density of less than 0.94, from 3.3% to 11.2%; PVC-S resin, obtained by a 4.4% suspension process to 11.2%; and Resin PP “cup” (propylene copolymer) from 4.4% to 11.2%. This measure will be effective from April 1, 2023. PP (propylene homopolymer) is still part of the exception list of Letec until December 2023.

Adjustments of tariffs could lead to increased competition from imports and cause us to lower our domestic prices and impact the demand for our products, which would likely result in lower net revenue and could negatively affect our overall financial performance. Additionally, the products we export to the United States and Europe are subject to tariffs in the amount of 6.5% in each jurisdiction, subject to certain preferences. These tariffs generally balance the level of competition of our products produced locally and any future adjustments to these tariff structures could negatively impact our sales in these jurisdictions. Future trade agreements entered into by Brazil, the Mercosur, the United States or the European Union could also lead to increased competition from imports and lower domestic prices.

Changes in U.S. and global trade policies and other factors beyond our control may adversely impact our business, financial condition and results of operations.

The international environment in which we operate is affected from inter-country trade agreements and tariffs. As a result of recent revisions in the U.S. administrative policy, there are, and there may be additional changes to existing trade agreements, greater restrictions on free trade and significant increases in tariffs on goods imported into the United States, particularly those manufactured in China, Mexico and Canada. Future actions of the U.S. administration and that of foreign governments, including China, with respect to tariffs or international trade agreements and policies remains currently unclear.

The escalation of a trade war, tariffs, retaliatory tariffs or other trade restrictions on products and materials including those exported by us to China or raw materials imported by us from China, or other countries, may significantly hinder our ability to provide our products to customers in China or other affected locations. Such developments may result in a decrease in demand for our products as well as delays in payments from our customers. Furthermore, other governmental action related to tariffs or international trade agreements, changes in U.S. social, political, regulatory and economic conditions, or in laws and policies governing foreign trade, manufacturing, development and investment in the territories and countries where our customers are located, could lead to a rebalancing of global export flows and an increase in global competition, which in turn could adversely affect our business, financial condition, results of operations and cash flows.

A failure to comply with export control or economic sanctions laws and regulations could have a material adverse impact on our results of operations, financial condition and reputation.

We operate on a global basis and face risks related to compliance with export control and economic sanctions laws and regulations, including those administered by the United Nations, the European Union and the United States, including the U.S. Treasury Department’s Office of Foreign Assets Control. Economic sanctions programs restrict our dealings with certain sanctioned countries, territories, individuals and entities.

   
 28 

Economic sanctions are complex, frequently changing, and often increase in number, and may impose incremental prohibitions, fines, restrictions on dealings with additional countries, territories, individuals or entities or compliance obligations on our dealings in certain countries and territories. We have conducted, and may in the future seek to conduct, business in certain countries that are subject to sanctions under the laws of the United States, the European Union, or other countries. Although we have pursued these transactions, and intend to pursue any future transactions, in full compliance with applicable laws and regulations, we may not be successful in ensuring compliance with limitations or restrictions on business with companies in any such countries. Additionally, Russia’s annexation of Crimea, recognition of two separatist republics in the Donetsk and Luhansk regions of Ukraine, and the military interventions in Ukraine have led to sanctions and other penalties being imposed by the United States, the European Union and other countries on Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk Peoples Republic, including the agreement to remove certain Russian financial institutions from the Society for Worldwide Interbank Financial Telecommunication (“SWIFT”) payment system. Additional potential sanctions and penalties have also been proposed and/or threatened and the United States and other countries could impose wider sanctions and take other actions should the conflict further escalate. If we are found to be in violation of applicable sanctions laws or regulations, we may face criminal or civil fines or other penalties, we may suffer reputational harm and our results of operations and financial condition may be adversely affected. Additionally, even though we have adopted a global trade control directive and provide regular training to our employees, there can be no assurance that our employees, directors, officers, partners or any third parties that we do business with, including, among others, any distributors, or suppliers, will not violate sanctions laws and regulations. We may ultimately be held responsible for any such violation of sanctions laws and regulations by these persons, which could result in criminal or civil fines or other penalties, have a material adverse impact on our results of operations and financial condition and damage our reputation.

We may not be able to specify in details technical specifications required by our customers’ or updated mechanisms to promptly attend regulatory requirements, and we could be subject to damages based on claims brought against us or our customers as a result of the failure of our products specification.

Our products specification may not meet certain technical or regulatory requirements, specifications or standards. In addition, our customers may impose stricter requirements on our products or governments may enact stricter regulations for the distribution, sale or use of our products. Failure to meet such standards could materially adversely affect our business, financial condition and results of operations if we are unable to sell our products in one or more markets or to important customers in such markets.

As with all quality control systems, any failure or deterioration of our quality control systems could result in defects in our products, which in turn may subject us to contractual, regulatory, product liability and other claims, which could have a material adverse effect on our reputation, business, financial condition and results of operations.

We may not be able to obtain or renew all licenses, permits and authorizations necessary for conducting our business.

We are subject to a wide variety of federal, state and municipal laws, regulations and licensing requirements, and depend on obtaining licenses, permits and authorizations to carry out our activities.

We cannot guarantee that we will be able to maintain, renew or obtain any new authorization, license, grant, or permit, in a timely manner, or that any additional requirements will not be imposed in connection with such renewal order.

Failure to obtain or maintain the permits, authorizations and licenses necessary for our operations, or failure to obtain or timely maintain them, may result in fines, loss or early termination of permits, authorizations and/or licenses, as well as closing of facilities, or breach of financing and commercial contracts, which could have a material adverse effect on our results of operations and financial condition.

   
 29 

Our business and operations are inherently subject to environmental, health and safety risks. As a result, our business is also subject to several stringent regulations, including environmental regulations.

As a company operating in the petrochemical industry, our operations, operated by us or third parties, including the companies and businesses that we have acquired, involve the generation, use, handling, storage, transportation (mainly by pipeline, road, train, fluvial and maritime), treatment, discharge and disposal of hazardous substances and waste into the environment. Notwithstanding our environmental, health and safety standards, policies and controls, our operations remain subject to incidents or accidents that could adversely affect our business or reputation. Our industry is generally subject to significant risks and hazards, including fire, explosions, toxic gas leaks, contamination of soil and water, spilling of polluting substances or other hazardous materials, smoke or odor emission, failure of operational structures and incidents involving mobile equipment, vehicles or machinery, associated or not with the manufacture of petrochemicals and the storage and transportation of feedstock and petrochemical products. These events may occur due to technical failures, human errors or natural events, among other factors, and could result in significant environmental and social impacts, damage to or destruction of production facilities and communities, personal injury, illness or death of employees, contractors or community members close to our operations or close to our logistic routes, terminals and pipelines, environmental damage, delays in production, and, in certain circumstances, liability in civil, labor, criminal and administrative lawsuits, difficulties in obtaining or maintaining operating permits and environmental licenses, and impacts on our reputation, among other consequences.

In addition, our operations, operated by us or third parties, could generate impacts to the communities, from our regular operations, as well as in the management of the existing environmental liabilities, which may result in environmental, material and human damages, fines and sanctions, including loss of operating license, in addition to damage to our image and reputation, which could have a material adverse effect on our results of operations and financial condition.

For example, over 30 years ago, a leak of chemical products occurred from a tank installed on a property owned by the company Companhia Carbonos Coloidais (“CCC”), located in Madre de Deus, in the State of Bahia. These products were property of the company Tecnor Tecnolumen Química do Nordeste Ltda. (“Tecnor”) and may have been acquired by domestic producers at the time, including by Companhia Petroquímica de Camaçari, a company that subsequently was merged into Braskem. Both CCC and Tecnor are companies that have never had any corporate relations with Braskem and no longer have any operating activities.

Given our experience in the chemical and petrochemical industry and related products, the authorities requested Braskem’s collaboration for analysis, studies and environmental remediation, with monitoring by local authorities, which has been occurring since 2003. Following the agreement between the City of Madre de Deus, the Public Ministry of the State of Bahia and the “CCC” in 2015, by means of an Amendment to this Term of Commitment, Braskem is supporting the implementation of a vacancy program of an area near to the “CCC” property, declared as public utility by the City Hall in February of 2021. About 200 properties were necessary for the safe continuity of the remediation efforts.

Our business could be adversely affected by safety or product liability issues. Failure to appropriately manage occupational safety, process safety, product safety, human health, product liability and environmental risks inherent in the chemical and petrochemical businesses and associated with our products, product life cycles and production processes could result in unexpected incidents, including releases, fires, or explosions resulting in personal injury, loss of life, environmental damage, loss of revenue, legal liability, and/or operational disruptions. Public perception of the risks associated with our products and production processes could impact product acceptance and influence the regulatory environment in which we operate.

Changes to applicable laws may impose changes on standards we have already implemented, which can take time to review and update. For example, we have concluded or are currently concluding studies related to dams located at certain of our industrial sites as a result of a change in Brazilian law that now requires that all water and waste dams have a safety plan for these structures. The detailed assessments of our dams indicated some risks with regard to two structures located in Triunfo, in the State of Rio Grande do Sul. Environmental studies that we have commissioned have indicated instances of environmental contamination of the soil and underground water at certain of our plants. If the laws and regulations applicable to risks and safety plans change, we may be required to revise the studies that we have carried out or take further action to rectify potential issues that would not need to be addressed under current laws and regulations. In addition, we and certain of our executive officers have received certain notices related to minor environmental violations and are or have been subject to investigations or legal proceedings with respect to certain alleged environmental violations. These environmental issues, and any future environmental issues that may arise, could subject us to fines or other civil or criminal penalties imposed by Brazilian authorities.

   
 30 

Also, under Brazilian federal and state environmental laws and regulations, we are required to obtain operating licenses and permits for our manufacturing facilities. If any of our environmental licenses or permits lapse or are not renewed or if we fail to obtain any required environmental licenses or permits or does not to meet the conditions established in the licenses or environmental permits, we may be subject to fines ranging from R$500 to R$50 million, and the Brazilian government may reverse mentioned licenses or permits, partially or totally suspend our activities and impose other civil and criminal sanctions on us, including our managers.

Pursuant to Brazilian environmental legislation and regulations, our corporate veil may be pierced to ensure that sufficient financial resources are available to parties seeking compensation for damage caused to the environment. In this sense, officers, shareholders and/or business partners or affiliates may, together with the polluting company, be held liable for damage to the environment.

In addition, our production and logistics processes are subject to inherent safety risks, which may lead to injuries, disability or death of our employees or individuals participating in such processes and communities, as well negatively impact the environment. Such risks cannot be entirely eliminated or fully mitigated even with full compliance with all safety measures applicable to us or required by laws or regulations. We may face a negative impact on our image and reputation, and on our business, financial condition and results of operations.

Until May 2019, we operated rock salt extraction wells located in Maceió, in the state of Alagoas. The operation was permanently interrupted due to the indication that it would have contributed to the occurrence of relevant subsidence in the region of four districts, with the occurrence of damage to properties and public roads located in the region. Several individual and collective lawsuits were filed in the state of Alagoas in relation to this geological event.

We have been taking the necessary actions for closing and monitoring the salt wells, environmental actions and other technical matters. Based on the findings of sonar and technical studies, Braskem has defined stabilization and monitoring actions for all 35 existing salt mining wells. Considering the discussions held in December 2021, based on studies of the specialists, the recommendation was to fill five additional salt wells with solid material, for a total of nine wells to be filled, a process that should last for four years. For the remaining 26 existing salt mining wells, the recommended actions are: (i) conventional closure using the tamponade technique, which consists of promoting the cavity pressurization, applied worldwide for post-operation cavities; (ii) confirmation of natural filling status; and (iii) for some wells, sonar monitoring.

In June 2022, in compliance with the Agreement for Socio-Environmental Reparation, Braskem submitted to the MPF an environmental diagnosis containing the evaluation of the potential environmental impacts and damages arising from salt mining activities and the environmental plan with proposals of the measures required to be carried out. As established in the agreement, the parties jointly defined the specialized company that will evaluate and monitor the environmental plan. In December 2022, the second opinion report on the environmental plan was filed with the MPF. In February 2023, the MPF agreed to the environmental plan, with incorporation of the suggestions provided in the second opinion report. Braskem initiated the actions described in the plan, implementing the commitments established in the agreement and sharing the results of its actions with the relevant local authorities, which also includes an update of the environmental diagnosis by December 2025.

   
 31 

Our actual costs related to this matter, considering the actions for closing and monitoring the salt wells, environmental actions and other technical matters for which the amount of R$1.4 billion, net of the adjustment to present value, has been provisioned as of December 31, 2022. The provision amount may change in the future, in accordance with the results of the monitoring of the wells, the progress of implementing the plans to close wells, possible changes to the environmental plan that may be required, the monitoring of the ongoing measures, and other possible natural alterations, and it may be materially altered based on a variety of other factors, including, but not limited to, the result of the monitoring and backfilling actions of the wells, potential future determinations by ANM, unforeseen technical difficulties or costs, or other factors.

Also due to the geological event, we have entered into agreements to terminate three public-interest civil actions or civil public actions filed by the competent authorities:

·ACP Labor settlement: we committed to disbursing R$40 million to fund a Business Recovery and Promotion of Educational Activities Program for residents and workers in the districts of Mutange, Bom Parto, Pinheiro and Bebedouro in Maceió, in the state of Alagoas. This agreement has been fulfilled in its entirety.
·ACP of Residents settlement: we committed to supporting the relocation and to compensate residents, business owners and owners of vacated properties located in the risk areas defined in the Civil Defense Map through the Financial Compensation and Support for Relocation Program (Programa de Compensação Financeira e Apoio à Realocação – PCF), by offering proposals for financial compensation and entering into individual agreements ratified by court (as of December 31, 2021, the risk area encompasses approximately 15,000 properties); and
·ACP Socio-environmental settlement: we committed to (i) adopting the necessary measures to stabilize the cavities and monitor the soil, implementing the measures of the mine closure planning presented to ANM and subject to its approval; (ii) repairing, mitigating or compensating potential environmental impacts and damages resulting from the mining activities (salt extraction) in the city of Maceió, to be defined by an Environmental Diagnosis developed by an expert and independent company approved by the Prosecutor’s Office; (iii) allocating R$1.58 billion to implement measures in the vacated area, actions related to urban mobility and to compensate potential socio-urbanistic impacts and damages, and for social collective moral damages.

On February 2, 2021, we were notified of the filing of a lawsuit by Companhia Brasileira de Trens Urbanos (“CBTU”), initially requesting only a preliminary injunction for maintaining the terms of the cooperation agreement previously signed by the parties. The request was denied in lower and appellate courts, given the fulfillment of the obligations undertaken by Braskem. On February 24, 2021, CBTU filed an amendment to the initial request claiming the payment of compensation for losses and damages in the amount of R$222 million and for moral damages in the amount of R$500 thousand, as well as the imposition of obligations, including the construction of a new rail line to replace the stretch that passed through the risk area. On December 31, 2022, the updated value of this lawsuit was R$1.4 billion. Braskem entered into a memorandum of understanding with CBTU to seek a consensual solution and suspend the lawsuit during the negotiation period and has made progress in the technical understanding about the topic. As a result of a joint petition filed by the parties, the lawsuit was suspended until June 2023.

In March 2023, we became aware of the following actions: (a) Public Civil Action (“ACP”) filed by the Public Defender’s Office of the State of Alagoas (“DPE-AL”) against us, the Federal Government, the State of Alagoas and the Municipality of Maceió, which pleads for measures related to the Flexais region, including (i) the registration of residents of this region so that they can opt for relocation through the Company’s Relocation and Financial Compensation Program (“PCF”); and (ii) the claim for compensation in the amount of R$1.7 billion for moral and material damages allegedly owed to residents of this region, with a subsidiary claim for judicial blocking of said amount. The injunction relief requests were rejected by the court, and the decision is subject to appeal by the DPE; (b) Action filed by the State of Alagoas against the Company, which claims: (i) compensation for alleged damages caused to that State, including loss of tax revenue and loss of properties located in the risk area and; (ii) on an injunction relief, the State of Alagoas requested the cautionary blocking of R$1.1 billion in our bank accounts as a guarantee to indemnify for material and non-material damages allegedly suffered by the State Public Administration. On April 19, 2023, this injunction relief request was accepted by the court, which ordered a cautionary blocking of approximately R$1.1 billion in our bank accounts. Upon presentation of a performance bond by us, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court. 

   
 32 

The current provisions related to the geological event in Alagoas are based on current estimates and assumptions and may be updated in the future due to new facts and circumstances, including changes in time, extension and way of execution of action plans; new repercussions or developments relating to the geological event; and the conclusion of possible studies that indicate recommendations of experts, and other new developments on the topic.

The measures related to the mine closure plan are also subject to the analysis and approval of ANM, the monitoring of results of the measures under implementation, as well as the changes related to the dynamic nature of the geological event.

Continuous monitoring is essential for confirming the result of current recommendations. Accordingly, the plans to close the wells may be updated based on the need to adopt technical alternatives to stabilize the subsidence phenomena arising from the extraction of salt. In addition, the assessment of the future behavior of the cavities monitored using sonar and piezometers could indicate the need for certain additional measure to stabilize them.

The actions to repair, mitigate or offset potential environmental impacts and damages, as provided for in the Socio-Environmental Remediation Agreement, will be defined considering the environmental diagnosis already prepared by a specialized and independent company. After the conclusion of all discussions with the authorities and regulatory agencies, as per the process established in the agreement, an action plan will be agreed to be a part of the measures for a Plan for Recovering Degraded Areas (“PRAD”).

Additionally, the Socio-Environmental Remediation Agreement provides for the potential adhesion by other parties, including the Municipality of Maceió. Also in the context of the understandings with authorities to address claims related to the event in Alagoas, on October 26, 2022, the 3rd Federal Court in Alagoas ratified the Term of Agreement for Implementation of Socioeconomic Measures for the Requalification of the Flexais Area (the “Flexais Agreement”), entered into by Braskem and the MPF, the MPE, the DPU, and the Municipality of Maceió for the adoption of actions for requalification in the Flexais region, payment of compensation to the Municipality of Maceió and of indemnities to the residents of this location.

We have been making progress with local authorities with respect to other indemnification requests, resulting in advances in the understanding between the parties that may result in an agreement. Although future disbursements may occur as a result of progress in the negotiations, as of the date of this annual report, we are unable to predict the results and timeframe for concluding these negotiations or their possible scope, and the total associated costs in addition to those already provisioned.

It is not possible to anticipate all of the new claims related to damages or other nature that may be brought by individuals or groups, including public or private entities, that understand they suffered impacts or damages related to the geological phenomenon and the relocation of people from risk areas, as well as new notices of infraction or administrative penalties of diverse nature. Braskem continues to face and could still face administrative procedures and various lawsuits filed by individuals or legal entities not included in the PCF or that disagree with the financial compensation offer for individual settlement, as well as new collective actions and new lawsuits filed by public utilities, entities of the direct or indirect administration of the State of Alagoas, the Municipality of Maceió or the Brazilian federal government. Therefore, the number of such actions or lawsuits, their nature or the amounts involved cannot be accurately estimated at this time.

   
 33 

Consequently, we cannot rule out the possibility of future developments related to the geological event in Alagoas, the relocation process and actions in vacated and adjacent areas, so that the final amount of expenses to be incurred to resolve related disputes may differ from current estimates and provisions.

In addition, we and other petrochemical producers are subject to stringent federal, state and local environmental laws and regulations concerning human health, the handling, storage, transportation, treatment, discharge and disposal of hazardous substances and waste into the environment. Our operations in Brazil, including those of our subsidiaries Cetrel and DAC, which are responsible for providing environmental services, waste water treatment and water supply to the Camaçari Complex in the state of Bahia, for example, are subject to extensive federal, state and local laws, regulations, rules and ordinances relating to pollution, protection of the environment and the generation, storage, handling, transportation, treatment and disposal of hazardous substances and waste materials. The Brazilian government enacted the Environmental Crimes Law in 1998 that imposes criminal penalties on corporations and individuals that cause environmental damage. Corporations found to be guilty of polluting the environment may be fined up to R$50.0 million, have their operations suspended, be prohibited from contracting with the government, be required to repair damage that they caused and lose certain tax benefits and incentives. Executive officers, directors and other individuals may also be imprisoned for up to five years if environmental violations activities are found to have taken place.

Our operations in the United States, Germany and Mexico are subject to extensive U.S., German, European and Mexican federal, state and local laws, regulations, rules and ordinances relating to pollution, protection of the environment and the generation, storage, handling, transportation, treatment, disposal and remediation of hazardous substances and waste materials. U.S. environmental laws and regulations may impose liability on us for the conduct of third parties, or for actions that complied with applicable requirements when taken, regardless of negligence or fault. Of particular significance to us are (1) regulatory programs to be established to implement air quality standards under the National Ambient Air Quality Standards for ozone and fine particles promulgated by the U.S. Environmental Protection Agency, or the EPA, and (2) various legislative and regulatory measures in the United States that are under review, discussion or implementation to address GHG emissions. In Mexico, we adhere to the comprehensive responsibility program promoted by the Mexican National Chemical Industry Association (Asociación Nacional de la Industria Química de Mexico—ANIQ), which is based on the responsible care standard adopted in the United States and Canada. We are also signatories of the Responsible Care program in the United States and Brazil that was launched by certain entities of the chemical industry sector worldwide.

Such existing stringent environmental and related regulations require significant capital expenditures, including investments, waste and wastewater treatment, emissions management, environment licenses, environmental liabilities and other environmental expenditures. In addition, evolving regulatory requirements could require significant additional capital expenditures depending on the timing of the adoption and enforcement of specific standards imposing such requirements. In addition, changes in environmental regulations could inhibit or interrupt our operations or require modifications to our facilities. Accordingly, environmental, health or safety regulatory matters may result in significant unanticipated costs or liabilities.

We may also, from time to time, be involved in certain claims, disputes or litigation proceedings concerning environmental risks and liabilities, health and safety hazards, among others.

   
 34 

We could be materially adversely affected by the impacts of the Global Settlement.

On December 14, 2016, we entered into a leniency agreement with the MPF (the “Leniency Agreement”), which was ratified by the competent Brazilian court on June 6, 2017. On December 21, 2016, we filed a plea agreement in the United States District Court for the Eastern District of New York under which we agreed to plead guilty to a one-count criminal information charging us with conspiracy to violate the anti-bribery provisions of the U.S. Foreign Corrupt Practices Act (the “FCPA”). On the same date, we consented to the entry of a final judgment in a civil action brought by the SEC based on civil violations of the anti-bribery, books and records and internal accounting controls provisions of the FCPA. The competent federal courts in the United States approved the U.S. Department of Justice (the “DoJ) and SEC resolutions on January 26, 2017 and February 28, 2017, respectively. In addition, on December 21, 2016, the OAG closed its investigation of these matters. We refer to these actions as the “Global Settlement”. Under the Global Settlement, we agreed to pay to the governmental authorities in these jurisdictions an aggregate amount of US$957 million (equivalent to R$3.1 billion), based on the exchange rate of R$3.27 per U.S. Dollar, applicable at the time of the negotiation.

The MPF will distribute the majority of the amount it receives as restitution to third parties for damages caused by the misconduct. Pursuant to the Global Settlement, the MPF agreed to communicate with other public authorities or entities, as well as stated-owned companies and mixed-capital companies with which Braskem enters into discussions to address the facts under the Global Settlement and avoid making duplicate restitution payments. In this context, as announced to the market on July 10, 2018, and disclosed in a material fact on May 27, 2019, we have cooperated and engaged in negotiations with the Ministry of Transparency and Controllership (CGU) and the Office of the Attorney General (AGU) in Brazil, and our Board of Directors approved the signing of a leniency agreement with the CGU and the AGU (the “CGU/AGU Agreement”) ..

The CGU/AGU Agreement, in the amount of R$2.9 billion, to be adjusted by the SELIC rate, addresses the same facts that are the object of the Global Settlement executed in December 2016 with the Brazilian Federal Prosecution Office (MPF), the DoJ, the SEC and the Swiss Office of the Attorney General (“Global Settlement”). Of this amount, R$3.1 billion will be offset by the amount that Company already had undertaken to pay under the scope of the Global Settlement, resulting in an additional disbursement of R$409.9 million.

As of December 31, 2022, we had paid R$3.1 billion, as follows:

·R$877.8 million to the AGU, CGU and MPF;
·R$296.6 million to the DoJ;
·R$407.3 million to the OAG;
·R1,282.5 million to the MPF; and
·R$206.5 million to the SEC

There is still R$903.1 million (R$392.5 million and R$510.6 million as current and non-current liabilities, respectively), under the MPF Agreement and CGU/AGU Agreement, which will be paid in three annual installments updated by the variation in the Selic rate and payable until January 30, 2025. To guarantee payment of these installments coming due, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment.

By reason of the Global Agreement, we will continue to cooperate with these relevant governmental authorities and improve our governance and anti-corruption compliance practices. Over the three years between 2017 and 2020, we were subject to independent monitoring as a result of the Agreements (the “CGU/AGU Agreement” and, together with the Global Agreement, the “Agreements”). Such monitors were responsible for verifying compliance with the Global Agreement, as well as the effectiveness of our internal controls, policies and procedures to reduce the risk of non-compliance with anti-corruption laws.

   
 35 

In March 2020, based on the certification report issued by the independent monitors who have monitored us for the past three years, the MPF confirmed the monitoring conclusion, the effectiveness of our compliance program and compliance with the obligations of the MPF Agreement. Later, on May 13, 2020, the DoJ and the SEC confirmed the end of the monitoring provided for in the agreements with such authorities.

The CGU concluded its monitoring of the Company, and no pending issues involving the Company remained. The CGU is currently expected to present a final monitoring report and prepare a closing term. Moreover, the Company is in compliance with all of its obligations under the Agreements and continues to cooperate with government authorities.

The Global Settlement does not prevent Braskem from being held liable to any legitimate third party, which may seek indemnification for damages for the facts subject to the agreements, including other authorities with jurisdiction over us may seek to impose monetary sanctions or fines on, or to initiate investigative proceedings against us, which could adversely affect our results of operations and financial condition.

We cannot guarantee that the total amount agreed will be sufficient to fully repair any harm.

Unfavorable outcomes in pending or future litigation may reduce our liquidity and negatively affect our financial performance and financial condition.

We are, and in the future may be, involved in numerous tax, civil, environmental and labor disputes, among others, involving monetary claims. If unfavorable decisions are rendered in one or more of these lawsuits, we could be required to pay substantial amounts. For certain of these lawsuits, we have not established any provision on our balance sheet or have established provisions only for a portion of the amounts in controversy, based on our judgments as to the risk of loss for these lawsuits.

In July 2015, two putative class action lawsuits were filed against us and certain of our then-current and former officers and directors in the United States District Court for the Southern District of New York. The lead plaintiff, Boilermaker-Blacksmith National Pension Trust, alleged that the defendants made misrepresentations or omissions that inflated the price of Braskem’s stock in violation of United States securities laws.

On February 21, 2018, a hearing was held and a decision was rendered for the final approval of the settlement agreement regarding the entire class of investors and the dismissal of the lawsuit, and such agreement does not represent the admission of any wrongdoing or liability by Braskem. Such decision became final and binding.

On August 25, 2020, a class action was filed against us and some of our current and former executives in the U.S. District Court for the District of New Jersey, on behalf of an alleged class of investors who acquired Braskem’s securities. The lawsuit was grounded in the Exchange Act, and its rules, based on allegations that the defendants made false statements or omissions related to the geological event in Alagoas.

On December 15, 2022, the parties entered into an agreement to settle the class action with a payment of US$3 million, which was made in January 2023. On December 20, 2022, as the first measure for approval of the agreement, the lead plaintiff filed a preliminary approval motion, and the U.S. District Court for the District of New Jersey is expected to follow the required procedure for the approval of the settlement agreement. The extinction of the class action is expected to be declared only after the final approval of the settlement agreement and after the obligations assumed by the parties to the settlement agreement are met.

   
 36 

We cannot reliably predict all of the costs related to solving this dispute. We may be named as a defendant in other similar legal actions. We may also be named as a defendant in other lawsuits.

In the context of the geological events occurred in Maceió, we entered into agreements for the termination of three public-interest civil actions (ACP Labor, ACP Socio-environmental and ACP of Residents). The terms of the settlements were as follows:

·ACP Labor settlement: we committed to investing R$40 million to fund a Business Recovery and Promotion of Educational Activities Program for residents and workers in the districts of Mutange, Bom Parto, Pinheiro and Bebedouro in Maceió, in the state of Alagoas. This agreement has been fulfilled in its entirety.
·ACP of Residents settlement: we committed to supporting the relocation and compensating residents, merchants, business owners and property owners located in the risk areas defined in the Civil Defense Map subject to relocation, by offering proposals for financial compensation and entering into individual agreements ratified in court (as of December 31, 2021, the risk area encompasses approximately 15,000 properties); and
·ACP Socio-environmental settlement: we committed to (i) adopting the necessary measures to stabilize the cavities and monitor the soil, implementing the measures of the mine closure planning presented to ANM and subject to its approval; (ii) repairing, mitigating or compensating potential environmental impacts and damages resulting from the mining activities (salt extraction) in the city of Maceió, to be defined by an Environmental Diagnosis developed by an expert and independent company approved by the Prosecutor’s Office; (iii) allocating R$1.28 billion to implement measures in the vacated area, actions related to urban mobility and to compensate potential socio-urbanistic impacts and damages; and (iv) allocating R$300 million for social collective moral damages.

It is not possible to anticipate all of the new claims related to damages or other nature that may be brought by individuals or groups, including public or private entities, that understand they suffered impacts or damages related to the geological phenomenon and the relocation of people from risk areas, as well as new notices of infraction or administrative penalties of diverse nature. Braskem continues to face and could still face administrative procedures and various lawsuits filed by individuals or legal entities not included in the PCF or that disagree with the financial compensation offer for individual settlement, as well as new collective actions and new lawsuits filed by public utilities, entities of the direct or indirect administration of the State of Alagoas, the Municipality of Maceió or the Brazilian federal government. Therefore, the number of such actions or lawsuits, their nature or the amounts involved cannot be accurately estimated at this time.

Labor strikes may materially and adversely affect our operations.

 

Labor strikes in our plants and facilities, operated by us or third parties, and in our main suppliers and customers plants and facilities may have a material adverse effect on our financial condition or results of operations. Future labor actions, including strikes, could have a material adverse effect on our financial performance.

We could be materially affected by violations of the FCPA, the Brazilian Anti-Corruption Law and similar anti-corruption laws.

We, our subsidiaries and our joint venture partners are subject to a number of anti-corruption laws, including Law No. 12,846/2013, or the Brazilian Anti-Corruption Law, which entered into effect on January 28, 2014, the FCPA and various other anti-corruption and anti-bribery laws of other jurisdictions.

The FCPA, the Brazilian Anti-Corruption Law and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials or other persons for the purpose of obtaining or retaining business. Violations of these laws may result in criminal or civil sanctions, inability to do business with existing or future business partners, injunctions against future conduct, profit disgorgements, disqualifications from directly or indirectly engaging in certain types of businesses, the loss of business permits or other restrictions which could have a material adverse effect on our business, financial condition, results of operations or liquidity. Any negative reflection on our image or our brand from any violation of these laws could have a negative impact on our results of operations, as well as our ability to achieve our growth strategy. Furthermore, the Brazilian Anti-Corruption Law provides for joint and several liabilities between companies of the same economic group.

   
 37 

Given the size of our operations and the complexity of our production chain, there can be no assurance that our internal policies and procedures will be sufficient to prevent or detect all inappropriate or unlawful practices, including fraud or violations of law or violations of our internal policies and procedures by our employees, directors, officers, partners or any third-party agents or service providers. Furthermore, there can be no assurance that such persons will not take actions in violation of our policies and procedures (or otherwise in violation of applicable laws and regulations) for which we or they may ultimately be held responsible. Violations of anti-fraud, anti-corruption, anti-money laundering or other international laws and regulations could have a material adverse effect on our business, reputation, brand, selling prices, results of operations and financial condition, including as a result of the closure of international markets. We may be subject to one or more enforcement actions, investigations or proceedings by authorities for alleged infringement of these laws. These proceedings may result in penalties, fines, sanctions or other forms of liability.

Natural disasters, severe weather and climate conditions, or health epidemics could have a material adverse effect on our overall business.

We are subject to increasing climate-related risks and uncertainties, many of which are outside of its control. Climate change may result in more frequent severe weather events, potential changes in precipitation patterns and extreme variability in weather patterns which can disrupt our operations as well as those of its customers, partners and suppliers. Some of our facilities are in places that could be affected by natural disasters, such as floods, earthquakes, hurricanes, tornados and other natural disasters, which could disrupt our operations, operated by us or third parties, or the operations of our customers or suppliers and could damage or destroy infrastructure necessary to transport our products as part of the supply chain. Additionally, other unanticipated problems such as health epidemics or pandemics, including the COVID-19 outbreak that began in China and spread to the rest of the world, could also cause operational disruptions of varied duration. Such events could require maintenance shutdowns, delay shipments of products or supplies or result in costly repairs, replacements or other costs, which could have a material adverse effect on our financial performance.

Brazilian power generation capacity is mainly based on hydroelectric facilities. If the amount of water available to energy producers becomes scarce due to drought or diversion for other uses, the cost of energy may increase due to burdens and additional costs to guarantee the operation of the system, which could lead to price increases in long-term price contracts. The reliability of energy production can also be impacted, leading to an increase of the risk of interruptions and shutdowns at our facilities. In addition, if the amount of water available to industrial facilities becomes scarce, there may be a need to reduce production at the affected sites. Such conditions could have a material adverse effect on our sales and margins.

Additionally, the military conflict between Russia and Ukraine has caused market volatility, a sharp increase in certain commodity prices, including oil, natural gas and energy. It is not possible to predict the length and impact of the ongoing military conflict or its broader consequences, which could include further adverse effects on macroeconomic conditions, availability of natural gas impacting energy prices. Any such event may increase our costs, decrease our revenues or limit our production and sales volume and adversely affect our business, results of operations and financial condition.

   
 38 

Climate change may negatively affect our business, financial condition, results of operations and cash flow.

A considerable number of experts, international organizations, regulators and other analysts argue that global climate change has contributed, and will continue to contribute, to the increase in the unpredictability, frequency and severity of natural disasters (among but not limited to hurricanes, droughts, tornadoes, freezes, other storms and fires) in some parts of the world. As a result, several legal and regulatory measures, in addition to social measures, have been and will be established in several countries to reduce carbon and other GHG emissions and combat climate change globally. Such reductions in GHG emissions are expected to lead to an increase in energy, transport and input costs, in addition to requiring us to make additional investments in facilities and equipment. It is not possible to predict the impact of global climate change, if any, or legal, regulatory and social measures in response to climate change concerns, and whether such factors could negatively affect the business, financial condition, results of operations and operating cash flows.

Also, several countries are evaluating and seeking to implement carbon pricing policies for carbon emitting companies that are producers in these countries or that export products to these countries. If this occurs, our costs may be negatively impacted as we, as a petrochemical company, have a material carbon footprint. International market restrictions or taxation on products imported from countries with insufficient climate policies could lead to a loss of our global competitiveness and reduce our revenues.

Since 2008, we account for the emissions our operations and publish the results in a GHG inventory, which currently follows the operational control approach, contemplating our global emissions of scopes 1, 2, and 3, and which is annually verified by an independent third party. In 2022, Braskem recorded 10.7 million tons in carbon emissions and any carbon tax mechanism could negatively affect our business, financial condition, results of operations and operating cash flows.

For example, The European Commission has published in 2021 its “Fit for 55 Package” climate package, which includes extensive policy towards tougher emissions targets including the carbon border adjustment mechanism (CBAM) as holding wide ranging implications for the export industry into Europe.

Laws and regulations that seek to reduce GHG it is being defined in some regions and may be defined globally in the future, which could have a material adverse impact on our operating results, cash flows and financial condition. One of the possible effects of the increase in requirements related to the reduction of GHG emissions is the increase in costs, mainly due to the demand for the reduction of fossil fuel consumption and the implementation of new technologies in the production chain. Removing subsidies or levying taxes on fossil energy sources could increase fuel prices for large consumers and thus production costs. Levying taxes on carbon-intensive suppliers could increase associated production costs. Taxation on carbon intensive suppliers could increase production costs that could negatively affect our business, financial condition, results of operations and operating cash flows. Additionally, the difficulty of adapting to climate change and reducing the emission of GHG in production processes and the value chain could negatively affect our business, financial condition, results of operations and cash flows.

Climate change-related risks and uncertainties, legal or regulatory responses to climate change and failure to meet our sustainable development goals could negatively impact our results of operations, financial condition or reputation.

In 2020, we announced long term sustainable development goals, including (i) to reach in 2030 an absolute 15% reduction in greenhouse gas emissions (GHG) in scopes 1 and 2 – in relation to the average of the years 2018, 2019, and 2020 – and to achieve carbon neutrality by 2050 and (ii) to expand our green biopolymer production capacity to 1 million tons and (iii) to expand the commercialization of resins with recycled content to 300,000 tons in 2025 and 1 million tons by 2030, as well as recovering 1.5 million tons of plastic waste by this same year.

Execution and achievement of these goal within the currently projected costs and expected timeframes are also subject to risks and uncertainties which include, but are not limited to: advancement, availability, development and affordability of technology necessary to achieve these commitments; unforeseen design, operational and technological difficulties; availability of necessary materials and components; adapting products to customer preferences and customer acceptance of sustainable supply chain solutions; changes in public sentiment and political leadership; our ability to comply with changing regulations, taxes, mandates or requirements related to greenhouse gas emissions or other climate-related matters.

   
 39 

The transition to lower greenhouse gas emissions technology, the effects of carbon pricing and changes in public sentiment, regulations, taxes, public mandates or requirements and increases in climate-related lawsuits, insurance premiums and implementation of more robust disaster recovery and business continuity plans could increase costs to maintain or resume our operations or achieve our sustainability goals in the expected timeframes, negatively affect our business, financial condition, results of operations and operating cash flows.

We are exposed to behaviors of our employees, non-employees and third parties that may be incompatible with our ethics and compliance standards, and failure to timely prevent, detect or remedy any such behavior and/or process vulnerabilities may have a material adverse effect on our results of operations and financial condition.

We are subject to the risk that our employees, partners, counterparties or any person doing business with us may engage in fraudulent activity, corruption or bribery, circumvent or override our internal controls and procedures or misappropriate or manipulate our assets for their personal or business advantage. Investigations conducted by us internally or through outside counsel on potential violations of any applicable anti-corruption laws, including the FCPA by our employees or agents can be expensive and require significant time and attention from senior management. Our Anti-Corruption Program may not be completely effective for identifying, monitoring and mitigating these risks.

In addition, we cannot guarantee the existence of a socially responsible value chain that offers decent working conditions. Any breach of work-related regulations could result in human rights violations, impacts on people’s quality of life, and poor work conditions, which in turn could have an impact on our results of operations due to potential financial implications and lawsuits brough by individuals, public authorities or other agents, which could impact our reputation and image.

In the future, we may be required to conduct additional procedures and analyses with respect to our internal processes and controls that may lead to a delay in the conclusion of our audited financial statements and, as a result, prevent us from filing future annual reports in a timely manner. Any failure to timely file our annual reports in the future may have an adverse effect on our business.

If we are unable to comply with the restrictions and covenants in the agreements governing our indebtedness, there could be a default under the terms of these agreements, which could result in an acceleration of payment of funds that we have borrowed and could affect our ability to make principal and interest payments on our debt obligations.

Any default under the agreements governing our indebtedness that is not cured or waived by the required lenders or noteholders could result in the holders of any such indebtedness accelerating the payment of amounts outstanding, which could render us unable to pay principal and interest on those and other obligations. If we are unable to generate sufficient cash flow or are otherwise unable to obtain funds necessary to meet required payments of principal and interest on our indebtedness, or if we otherwise fail to comply with the various covenants in the agreements governing our indebtedness, we could be in default under the terms of such agreements. In the event of such default:

·the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest;
   
 40 
·the lenders or noteholders under such agreements could elect to terminate their commitments thereunder and cease making further loans;
·the acceleration under such indebtedness may trigger cross-acceleration provisions under other financing arrangements entered into by us; and
·we could be forced into bankruptcy or liquidation.

Certain of our contractual arrangements, including debt obligations, contain certain change of control provisions that provide our counterparties with a termination right or the ability to accelerate the maturity of our indebtedness in the event of a change of our control without their consent and/or a ratings decline, as applicable.

In addition, pursuant to the indentures governing our 6.45% Notes due 2024, 4.50% Notes due 2028, 4.500% Notes due 2030, 7.250% Senior Notes due 2033, 7.125% Notes due 2041, 5.875% Notes due 2050, Subordinated Resettable Fixed Rate Notes due 2081, 15th Debentures Issuance (used as a security for the issuance of a CRA – Agribusiness Receivables Certificates), 16th Debentures Issuance, 17th Debentures Issuance and 18th Debentures Issuance a “change of control” with a “ratings decline” (as such terms may be defined in each agreement governing our indebtedness) would require a repurchase of, or an offer to repurchase, any such outstanding notes or debentures, plus accrued and unpaid interest, if any, to the repurchase date.

These provisions would be triggered, for example, in the event a third party acquires, directly or indirectly, more than 50% of our voting capital stock outstanding and if, because of such a “change of control” (as such term may be defined in each agreement governing our indebtedness) our ratings are downgraded under certain thresholds (a “ratings decline,” as such term may be defined in each agreement governing our indebtedness) within a certain period of time.

In the case of our 6.45% Notes due 2024, 4.50% Notes due 2028, 4.500% Notes due 2030, 7.125% Notes due 2041, 5.875% Notes due 2050 and Subordinated Resettable Fixed Rate Notes due 2081, a “ratings decline” would occur if, at any time within 90 days after the earlier of the date of public notice of a “change of control” and the date on which Braskem and/or any other “person” (as applicable, and as defined in each agreement governing our indebtedness) publicly declares its intention to effect a “change of control,” (i) in the event the notes are assigned an investment grade rating by at least two rating agencies prior to such public notice or declaration, the rating assigned to the notes by at least two of the rating agencies is below an investment grade rating; or (ii) in the event the ratings assigned to the notes by at least two of the rating agencies prior to such public notice or declaration are below an investment grade rating, the rating assigned to the notes by at least two of the rating agencies is decreased by one or more categories (i.e., notches); provided that, in each case, any such “ratings decline” is expressly stated by the applicable rating agencies to have been the result of the “change of control.”

In the case of our 7.250% Senior Notes due 2033, a “ratings decline” would occur if, at any time within 90 days after the date of public notice of a “change of control,” (i) in the event the notes are assigned an investment grade rating by at least two rating agencies prior to such public notice, the rating assigned to the notes by any two or more of the rating agencies is below an investment grade rating; or (ii) in any other case, the rating assigned to the notes by at least two of the rating agencies is decreased by one or more categories (i.e., notches); provided that, in each case, any such “ratings decline” is expressly stated by the applicable rating agencies to have been the result of the “change of control.”

As a result, if a third party acquires our control, whether as a result of the Novonor Judicial Restructuring Proceedings (or agreements entered into within the context of the Novonor Judicial Restructuring Proceedings) or otherwise, such acquisition may result in a ratings downgrade that constitutes a “ratings decline.” In such cases, if appropriate consents or waivers are not obtained, such creditors could accelerate the maturity of our indebtedness or, as applicable, require a repurchase of, or an offer to repurchase, our outstanding notes or debentures.

   
 41 

The termination of any of our contractual arrangements, the acceleration of the maturity of, or the requirement to repurchase or offer to repurchase any of our indebtedness may have a material adverse effect on our business, financial condition, results of operations and cash flows, and ultimately result in the cross-acceleration of all of our indebtedness.

Unauthorized disclosure or loss of intellectual property, trade secrets, other sensitive business or personal information, or disruption in information technology by cyberattacks or other security breaches, as well as our failure to comply with data protection laws and information security requirements can subject us to significant penalties or liability and can adversely impact our operations, reputation, and financial results.

We collect, store, process, and use certain confidential information and other personal data in connection with our business operations. We must ensure that any personal data activity such as processing, collection, use, storage, dissemination, transfer, and disposal of data for which we are responsible complies with relevant data protection and privacy laws. The protection of information relating to our business partners (customers and suppliers), employees and confidential information related to our business is critical to us. We rely on commercially available systems, software, and monitoring tools to provide secure processing, transmission and storage of relevant information, such as business confidential information and personal data including sensitive information.

The Brazilian Constitution, Law No. 10,406/2002 (Civil Code), Law No. 8.078/1990 (Consumer Protection and Defense Code), Law No. 12.965/2014 (Brazilian Civil Rights Framework for the Internet), Decree No. 8771/2016 and the recent Law No. 13.709/2018 (Brazilian General Data Protection Law or LGPD), which entered into force on September 18, 2020, are the main laws governing the practice of processing personal data in Brazil.

The LGPD is a comprehensive legislation, which regulates practices related to the processing of personal data, through a set of rules that impacts all sectors of the economy and organizations of all sizes, both digitally and physically. The LGPD establishes a new legal framework to be observed in personal data processing transactions and provides, among other measures, the duty of transparency on the part of the data controller, the rights of the holders of personal data, hypotheses in which the processing of personal data is allowed (legal bases), obligation to designate a data controller, rules related to information security, incidents involving personal data, requirements and obligations related to international data transfer and data sharing. The LGPD also provides for administrative sanctions that can be applied in case of non-compliance with its provisions by the National Data Protection Authority (“ANPD”), responsible for preparing guidelines and supervising compliance with the law. Non-compliance with any provisions provided for in the LGPD may result in the following consequences: (i) the filing of lawsuits or administrative proceedings by individual or collective competent bodies seeking compensation for damages arising from violations, among others, that are based not only on the LGPD, but also on sparse or specific data protection regulation still in force; and (ii) the enforcement by consumer protection agencies of penalties provided for in the sparse data protection regulation, such as those set forth in the Consumer Protection and Defense Code and the Brazilian Civil Rights Framework for the Internet, once that even before the LGPD enters into force and the ANPD is finally structured such agencies have already acted in this regard, mainly in cases concerning security incidents that result in improper access to personal data.

Since August 1, 2021, with the entry into force of the LGPD’s administrative sanctions, if the ANPD understands that we are not in compliance with the LGPD, we may be subject to individual or cumulative sanctions, warning, requirement to disclose the incident, temporary blocking and/or exclusion of personal data to which the violation refers, daily fine, simple fine of up to 2% of the company, group or conglomerate’s revenue in Brazil in its last fiscal year, excluding taxes, and up to the aggregate amount of R$50.0 million per infringement. In case of recurrence, more severe administrative penalties provided for in the LGPD may be applied, such as partial suspension of the database operation to which the infringement refers for a maximum period of six months, extendable for an equal period, until the regularization of the activity of processing by the controller, suspension of the exercise of the activity of processing the personal data to which the infringement refers for a maximum period of six months, extendable for an equal period or partial or total prohibition of the activities related to the processing of data.

   
 42 

In addition, we may be held liable for material, moral, individual or collective damages caused to the holders of personal data, including when caused by our subsidiaries or by third parties that process personal data on our behalf or as controllers together with us due to non-compliance with the obligations provided by the LGPD. In this sense, we cannot guarantee that we will be successful in adapting our activities, procedures, documentation and the relationship with third parties hired by us to meet the high standards provided by the LGPD. Administrative sanctions or legal convictions may cause material financial impacts, in addition to adversely affecting our reputation in the market.

Even if we adopt practices in line with the provisions and obligations set forth in the LGPD, it cannot be guaranteed that the measures adopted to adapt our personal data processing activities will be considered adequate or sufficient by ANPD, by other public authorities, such as the Public Ministry and consumer protection bodies, or by the court.

Any additional privacy laws or regulations enacted or approved in Brazil or in other jurisdictions in which we operate could seriously harm our business, financial condition or results of operations. On May 25, 2018, the Regulation No. 2016/279 of the European Parliament and of the Council of April 27, 2016 on the protection of personal data (the General Data Protection Regulation), or the GDPR, became directly applicable in all member states of the European Union. The GDPR has introduced new obligations relating to data privacy, control and retention, including, among others: (i) accountability and transparency requirements; (ii) enhanced data consent requirements; (iii) obligations to consider data privacy as any new products or services are developed and limit the amount of information collected, processed, stored and its accessibility; (iv) constraints on using data to profile data subjects; (v) providing data subjects with personal data in a useable format upon request and erasing personal data in certain circumstances; and (vi) reporting breaches without undue delay.

As we seek to expand our business and operations, we expect to be increasingly subject to laws and regulations relating to personal data activity such as collection, use, retention, security, and transfer of our employee and customer data. These may change over time and may vary by jurisdiction, and it is possible they will be interpreted and applied in ways that will materially and adversely affect our business. Any failure—real or perceived—by Braskem to comply with any applicable privacy or data protection-related laws and regulations could cause our customers to reduce their use of our products and services.

Compliance with data protection laws requires us to expend resources to revise our procedures and policies. There are no guarantees that we have sufficient resources to comply with new regulations or to successfully comply with this changing regulatory environment. Further, there is a risk of improper implementation and sanctions or reputational damage for noncompliance, both of which could have a material adverse effect on our operations, financial condition, and prospects.

In addition, despite the information security measures that we have in place, our facilities and systems—and those of our third-party service providers—may be vulnerable to security breaches, cyberattacks (including ransomware and phishing), computer viruses, misplaced or lost data, programming or human errors, or other similar events. The ongoing military conflict between Russia and Ukraine has led to an increasing number of cyberattacks globally. Any security breach or perceived threat resulting in the loss or other unauthorized disclosure of confidential information could damage our reputation, expose us to litigation risk and liability, subject us to negative publicity, disrupt our operations and harm our business.

   
 43 

Cyberattacks or security breaches could compromise critical information and cause a disruption in our operations, which are heavily dependent on information technology and telecommunication systems and services. Information assets, including intellectual property, trade secrets, personal data and other business-sensitive critical information are an attractive asset to cyber criminals, cyberterrorism or other external agents. A significant cyberattack, a human error, including from our employees and partners, or obsolescence of technology could result in the loss of critical business information and/or negatively impact our operations, which could have a negative impact on our financial results.

Our own security measures cannot be guaranteed and are susceptible to new cyberattacks. On October 4, 2020, we detected a cyberattack on our information technology environment and several improvements in people, processes and technologies have been and are being applied in the company’s environment, significantly increasing the maturity of information security at Braskem. All these actions ensured that no new incidents happened to date.

There can be no assurance that Novonor will remain our controlling shareholder. Novonor and Petrobras may enter into transactions or other arrangements that may result in us not having a controlling shareholder. If no single shareholder or group of shareholders holds more than 50% of our voting stock or exercise a controlling interest, there may be increased opportunity for alliances between shareholders and conflicts between them.

Currently, Novonor, directly or through its wholly-owned subsidiary NSP Inv., owns 38.3% of our total share capital, including 50.1% of our voting share capital, and Petrobras holds 36.1% of our total share capital, including 47.0% of our voting share capital. Each of Novonor (our indirect controlling shareholder) and Petrobras are currently a party to a shareholders’ agreement governing the exercise of their voting rights, appointment of directors and officers and other matters related to our corporate governance and their interests in us. In the event there is a change in our corporate control, we may be subject to significant changes to our management, business plan and strategies, as well as to our current corporate governance practices, all of which may have a material adverse effect on our results of operations and financial condition.

On November 3, 2022, we received a correspondence from Novonor, informing that, due to the discussions and analysis currently underway relating to a possible transaction, it may be necessary for Braskem to interact with potential interested parties, for which Novonor asked for our support and for that of our officers. Novonor further informed that, at that moment, there was no exclusivity agreement with any interested party, no binding offer, and no definition or decision on the structure to be adopted or on any alternative related to the disposal process.

In addition, as disclosed by us on December 16, 2021, we were notified by Novonor and Petrobras that each of their governance bodies approved, on December 15, 2021, the execution of a term sheet providing for Novonor’s and Petrobras’ mutual commitment to take necessary measures that could, if implemented, ultimately result in a change of control of our company (the “Notice”).

Pursuant to the Notice, Novonor and Petrobras agreed to seek the adoption of the necessary measures: (i) for the sale, through this secondary public offering, of up to all our class A preferred shares held directly or indirectly by them; (ii) to enable Braskem’s migration to the Novo Mercado listing segment of the B3, including in relation to necessary changes to Braskem’s corporate governance, which shall be subject to applicable approvals at the appropriate time and negotiation of a new shareholders’ agreement to conform their rights and obligations to such amended governance structure; and (iii) after the conclusion of Braskem’s potential migration to the Novo Mercado listing segment, carry out the sale of the remaining common shares held directly or indirectly by them and issued by us. On January 28, 2022, we received a communication sent jointly by our shareholders Novonor and Petróleo Brasileiro S.A. whereby they decided to temporarily cancel the shares offering due to volatility conditions in the financial and capital markets. Also, Novonor and Petrobras ratified their interest in resuming the equity offering in the future, at a time when a more favorable economic situation with less volatility exists, and the term sheet entered into between the parties remains in force and the commitment of both to dispose of their respective equity interests in the Company through a secondary public offering, in addition to taking all necessary measures to enable the Company to migrate to the Novo Mercado segment of the B3, including the necessary amendments to its governance, as the studies in this regard being carried out by the Company and referred to in the material fact disclosed on Form 6-K December 16, 2021 are concluded and to the extent that market conditions are favorable.

   
 44 

If Braskem effectively migrates to the Novo Mercado in the future, all of our class A and class B preferred shares will be converted into common shares, resulting in Novonor no longer holding indirectly the majority of our voting stock. Even if Novonor and Petrobras enter into a new shareholders’ agreement, the potential material sale of our common shares held by either or both of them could leave Novonor and Petrobras with less than 50% plus one share of our voting stock.

Irrespective of whether the transactions described in the Notice are implemented, Novonor or Petrobras may initiate discussions regarding other transactions that could ultimately have similar effects in the future.

Should Novonor and Petrobras cease to hold more than 50% of our voting stock, there can be no assurance that the influence by such shareholders will be maintained, including, without limitation, in relation to corporate governance, business plan, strategical, and key management matters. If a control group emerges with decision-making power over us, we may experience sudden and unexpected changes to our corporate governance and strategic policies, including through the replacement of directors and key executive officers.

The absence of a controlling shareholder or controlling group of shareholders may also affect our decision-making process, as the minimum quorum required by Brazilian law for certain decisions by shareholders may not be reached. In that case, we may be unable to effectively pursue our business plan and strategies. Additionally, we may be more vulnerable to a hostile takeover.

Additionally, all common and preferred shares issued by Braskem and held by NSP Inv. were pledged with fiduciary assignment (alienação fiduciária) as a collateral given under certain financing agreements entered into by Novonor and certain of its subsidiaries with specific non-bankruptcy creditors (credores extraconcursais). It is possible that, under certain circumstances, the pledge over such shares may be enforced, with the consequent sale of the shares, which could result in a change of Braskem’s control and other consequences arising therefrom.

Any unexpected change to our management team, business plan and strategies, any dispute between our shareholders, or any attempt to acquire our control may divert our management’s attention and also have an adverse effect on our business plan, strategies, financial condition and results of operations.

Novonor and Petrobras have requested us to conduct studies for a potential migration of Braskem to the Novo Mercado listing segment of the B3, which, if completed, would lead to the conversion of all of our class A and class B preferred shares into common shares and the revision of our corporate governance practices to conform to the Novo Mercado rules.

In order to be listed on the Novo Mercado listing segment of the B3, a company may only have common shares outstanding. If we were to migrate to the Novo Mercado listing segment of the B3, we would be required to convert all of our class A and class B preferred shares into common shares. Such change to our capital structure would lead to significant changes to our corporate governance, which could have a potential impact on our ability to pursue and implement our business plan and strategies.

Our class A preferred shares may be converted into common shares that will be listed on the Novo Mercado listing segment of the B3 in Brazil. The changes to our corporate governance (including amendments to our by-laws) in connection with a potential migration to the Novo Mercado listing segment, as well as the terms and timing of such migration, including the conversion ratio of the class A and class B preferred shares into common shares, are still subject to studies, discussions and approvals involving us and our shareholders, and we cannot foresee or assure how this process will unfold or what its end result will be. The listing of our shares on the Novo Mercado listing segment of the B3 would require us to take certain steps related to corporate governance matters, including the approval, by our shareholders at a shareholders’ meeting, of the conversion of class A and class B preferred shares into common shares, migration to the Novo Mercado listing segment of the B3, and changes to our bylaws to comply with the Novo Mercado listing rules. In addition, pursuant to applicable Brazilian law, holders of our common shares are not entitled to the same dividend and liquidation preferences that holders of our preferred shares have.

   
 45 

The intended corporate reorganization communicated by Novonor and Petrobras to us may not be approved or implemented, and the migration to the Novo Mercado listing segment of the B3 may not occur.

As disclosed by us on December 16, 2021, we were notified by Novonor and Petrobras that each of their governance bodies approved, on December 15, 2021, the execution of a term sheet providing for Novonor’s and Petrobras’ mutual commitment to take necessary measures that could, if implemented, lead to the migration of Braskem to the Novo Mercado listing segment of the B3 (the Notice, as defined above).

Pursuant to the Notice, Novonor and Petrobras agreed to seek the adoption of the necessary measures: (i) for the sale, through this secondary public offering, of up to all our class A preferred shares held directly or indirectly by them; (ii) to enable Braskem’s migration to the Novo Mercado listing segment of the B3, including in relation to necessary changes to Braskem’s corporate governance, which shall be subject to applicable approvals at the appropriate time and negotiation of a new shareholders’ agreement to conform their rights and obligations to such amended governance structure; and (iii) after the conclusion of Braskem’s potential migration to the Novo Mercado listing segment, carry out the sale of the remaining common shares held directly or indirectly by them and issued by us. We are unable to predict the result of the implementation of the commitments assumed, as well as their possible impacts. On January 28, 2022, we received a communication sent jointly by our shareholders Novonor and Petróleo Brasileiro S.A. whereby they decided to temporarily cancel the shares offering due to volatility conditions in the financial and capital markets. Also, Novonor and Petrobras ratified their interest in resuming the equity offering in the future, at a time when a more favorable economic situation with less volatility exists, and the term sheet entered into between the parties remains in force and the commitment of both to dispose of their respective equity interests in the Company through a secondary public offering, in addition to taking all necessary measures to enable the Company to migrate to the Novo Mercado segment of the B3, including the necessary amendments to its governance, as the studies in this regard being carried out by the Company and referred to in the material fact disclosed on Form 6-K December 16, 2021 are concluded and to the extent that market conditions are favorable.

A potential migration of Braskem to the Novo Mercado listing segment of the B3 is subject to certain measures and steps that would need to be taken and conditions that would need to be fulfilled, many of which are outside our control, including the satisfactory conclusion of the current studies being conducted by us, as well as the approval by the applicable listing commission of the B3, the approval by our shareholders at a general shareholders’ meeting of Braskem’s revised by-laws to comply with the Novo Mercado listing rules, and the approval by the holders of our class A and class B preferred shares at a separate shareholders’ meetings for each class.

As a result of the foregoing, we may not be able to migrate to the Novo Mercado listing segment of the B3 in a timely manner, or at all.

We expect to lose the right of preference set forth in the current shareholders’ agreement with respect to new business opportunities in the petrochemical sector, and as result, Petrobras, which is our largest supplier of raw materials in Brazil, will be able to invest in the petrochemical sector independently from us and without first giving us a preference to do so.

Novonor and Petrobras are currently parties to a shareholders’ agreement that provides, among other matters, for the commitment between them to use their best efforts in the development of new business opportunities in the “petrochemical sector” (defined as business opportunities that involve: (i) the use of ethylene and propylene for the manufacture of PE, PP, PVC and cumene; (ii) petrochemical investments for the production of butadiene, paraxylene, PE, PP, PVC, cumene, PTA and PET, as well as the sale of these products; (iii) investments based on pyrolysis of hydrocarbons for the petrochemical industry; and (iv) other investments or products that Novonor and Petrobras may agree in good faith to include in the definition of the “petrochemical sector” relating to new production processes that may be developed in the future), with a right of preference given to us.

   
 46 

Subject to some exceptions related to specific projects, if there is a direct or indirect business initiative, opportunity, undertaking, investment or participation that each of Novonor or Petrobras intends to pursue in the petrochemical sector (an “Opportunity”) that overlaps with certain objectives described in such shareholders’ agreement, the party that identified the Opportunity (the “Identifying Party”) shall grant Braskem a preference to explore the Opportunity.

If we do not express an interest in exercising the right of preference over a given Opportunity, and the Identifying Party subsequently decides to pursue such Opportunity, the Identifying Party shall offer us the right to market the products related to the Opportunity under mutually satisfactory market conditions.

On December 15, 2021, Novonor and Petrobras entered into an amendment to such shareholders’ agreement, generally providing that, if Braskem’s potential migration to the Novo Mercado listing segment of the B3 is not implemented, Braskem’s right of preference with regard to any future Opportunity will lapse by October 31, 2024. As a result, if the potential migration of Braskem to the Novo Mercado listing segment of the B3 is not completed by October 31, 2024, or, if before October 31, 2024 such migration is completed but such shareholders’ agreement expires or terminates for any reason and no new agreement on preference rights is agreed upon by the parties, Braskem would lose its right of preference with regard to any future Opportunity. The execution of such shareholders’ agreement amendment by Braskem, as an intervening party, is still subject to the appropriate governance approvals. On January 28, 2022, we received a communication sent jointly by our shareholders Novonor and Petróleo Brasileiro S.A. whereby they decided to temporarily cancel the shares offering due to volatility conditions in the financial and capital markets. Also, Novonor and Petrobras ratified their interest in resuming the equity offering in the future, at a time when a more favorable economic situation with less volatility exists, and the term sheet entered into between the parties remains in force and the commitment of both to dispose of their respective equity interests in the Company through a secondary public offering, in addition to taking all necessary measures to enable the Company to migrate to the Novo Mercado segment of the B3, including the necessary amendments to its governance, as the studies in this regard being carried out by the Company and referred to in the material fact disclosed on Form 6-K December 16, 2021 are concluded and to the extent that market conditions are favorable.

The loss of the right of preference with regard to an Opportunity may result in a decision by Petrobras, which is Braskem’s largest supplier of raw materials in Brazil, to invest in the petrochemical sector, which may affect the implementation of our strategic and growth plans and adversely affect our revenues and results of operations.

We are subject to audit by the tax authorities in the jurisdictions in which we operate, which may adversely affect our operating results and financial condition.

We operate in and sell our products into several countries, such as Brazil, Argentina, Colombia, Chile, the United States, Germany, Netherlands, Mexico and Singapore, each with its own tax legislation and specific audit procedures. The tax legislations in each country are frequently ambiguous and subject to interpretation, which may lead to divergent views between the tax authorities in each country and us and/or our advisors.

   
 47 

We are routinely audited by the tax authorities in different countries and other sub-national authorities in Brazil and abroad. As a result of such audits, our tax positions may be questioned by the tax authorities. We cannot guarantee that we will make provisions in amounts sufficient for lawsuits resulting from inspection, nor that there will be no identification of additional tax exposure. As a result, the increase in the amount of taxation as a result of disputes over our tax positions may adversely affect our business, operating results and financial condition.

Changes in tax laws may result in increases in certain direct and indirect taxes, which could reduce our gross margin and negatively affect our overall financial performance.

We operate in several countries, such as Brazil, Argentina, Colombia, Chile, the United States, Germany, Netherlands, Mexico and Singapore. Besides, we sell our products to several other countries through different commercial approaches.

Each of these countries has its own tax legislation, and these tax laws undergo frequent changes according to specific government purposes in each country. An example is the Brazilian government, which implements, from time to time, changes to tax regimes that may increase our and our customers’ tax burdens. These changes include modifications in the rate of assessments and, on occasion, enactment of temporary taxes.

We cannot predict the changes to Brazilian tax law or in any other jurisdiction in which we operate that may be proposed and enacted in the future. However, future changes in these tax laws may result in increases in our overall tax burden, which could reduce our gross margin and negatively affect our overall financial performance.

Risks Relating to Brazil

Brazilian political, economic and business conditions, and the Brazilian government’s economic and other policies, may negatively affect demand for our products as well as our net revenue and overall financial performance.

The Brazilian economy has been characterized by frequent and occasionally extensive intervention by the Brazilian government and unstable economic cycles. The Brazilian government has often changed monetary, taxation, credit, tariff and other policies to influence the course of Brazil’s economy. The Brazilian government’s actions to control inflation and implement other policies have at times involved wage and price controls, blocking access to bank accounts, imposing capital controls and limiting imports into Brazil.

Our results of operations and financial condition may be adversely affected by factors such as:

·expansion or contraction of the Brazilian economy, as measured by rates of growth in GDP;
·fluctuations in exchange rates;
·exchange control policies;
·interest rates;
·inflation;
·tax policies and tax reforms;
·liquidity of domestic capital and lending markets; and
·other political, diplomatic, social, economic and business developments in or affecting Brazil.

Brazilian markets have experienced heightened volatility due to the uncertainties derived from the ongoing corruption investigations by the Federal Prosecutor’s Office under Operations Car Wash, Zelotes, Greenfield, Efficiency and others, and their impact on the Brazilian economy and political environment. Certain current and former members of the Brazilian government and of the legislative branch, as well as former senior officers of the state-owned oil company and our shareholder Petrobras have been prosecuted for political corruption.

   
 48 

These government officials and former senior officers allegedly accepted bribes by means of kickbacks on contracts granted by Petrobras to several infrastructure, oil and gas and construction companies, including Novonor, our controlling shareholder. We cannot currently predict how the Operation Car Wash investigation, related investigations and any future decisions and actions by authorities or developments in relation to our shareholders, may impact us. The profits of these kickbacks allegedly financed the political campaigns of political parties of federal, state and city governments that were unaccounted for or not publicly disclosed, as well as served to personally enrich the recipients of the bribery scheme. As a result of the ongoing Operation Car Wash investigation, a number of current and former senior politicians, including congressman and officers of the major state-owned companies in Brazil have resigned or have been arrested. Senior elected officials and other public officials in Brazil have been investigated for allegations of unethical and illegal conduct identified during the Operation Car Wash investigation.

The potential outcome of these investigations is uncertain, but they have adversely affected and may continue to adversely affect the Brazilian markets and trading prices of securities issued by Brazilian issuers. We cannot predict whether the allegations will lead to further political and economic instability or whether new allegations against government officials or other companies in Brazil will arise in the future. Luiz Inácio Lula da Silva, who served two terms as Brazil’s president from 2003 to 2011 and later spent over one year in prison on charges of corruption and money laundering recovered his political rights and was elected in 2022 for a third term as president of Brazil. In the aftermath of the 2022 election results, there were mass protests and demonstrations throughout Brazil highlighting a deeply polarized electorate amidst a political climate characterized by uncertainty as the country awaits definition regarding the political and economic agenda of the new administration, which could contribute to increased macroeconomic and political instability. As a result of the past corruption allegations against president Luiz Inácio Lula da Silva, his political actions are a matter of controversy in Brazil, and such controversy could lead to further political uncertainty and impasse, which could have negative macroeconomic impacts. Further, during the term of former president, Jair Messias Bolsonaro, there were several inquiries related to potential misconduct, including a Supreme Court investigation following allegations made by the former Minister of Justice as well as a Parliamentary Committee Inquiry (Comissão Parlamentar de Inquérito, or “CPI”) focused on the president’s handling of the COVID-19 pandemic, including the potential misuse of government funds.

The potential outcome of these and other inquiries, as well as potential new inquiries involving former president Jair Messias Bolsonaro and any new inquiries involving current president Luiz Inácio Lula da Silva, are uncertain, but they have had a negative impact on the general perception of the Brazilian economy and the securities of Brazilian companies and affected and may continue to adversely affect our business, our financial condition and results of operations.

Additionally, uncertainties in relation to the implementation by a new government of changes relating to monetary, tax, labor and pension funds policies as well as to the relevant legislation may contribute to economic instability. These uncertainties and measures adopted by the new administration could materially adversely affect our operations and may increase market volatility of Brazilian securities issued abroad.

Changes in industrial policy and related actions undertaken by the Brazilian government and local state governments in Brazil may negatively affect demand for our products as well as our net revenue and overall financial performance.

We currently benefit from certain industrial policies and related actions undertaken by the Brazilian government and local state governments in Brazil intended to strengthen the domestic economy and certain local industries. Some of these policies and actions have recently included reductions in payroll taxes for plastic manufacturers, a program to improve the competitiveness of Brazilian producers in the export markets by refunding, in part or in full, the federal taxes levied on their export sale, intervention of the federal government to reduce incentives to imports at local ports, increases in import duties on certain products, including polyethylene, and the reduction in the rates of the Social Integration Program (Programa de Integração Social,

   
 49 

or PIS), a federal value-added tax, and Contribution for Social Security Financing (Contribuição para Financiamento da Seguridade Social, or COFINS), taxes on feedstock purchases by first- and second-generation petrochemical producers, reduction of the tax burden and tax incentives in certain regions to foster local industries.

In July 2021, the former President of Brazil sanctioned the Conversion Bill No. 12/2021, arising from the approved amendments of Provisional Measure No. 1,034/2021, later converted into Law No. 14,183/2021, providing for the gradual reduction of the Petrochemical Industry Special Regime (“REIQ”) until January 1, 2025, when it was expected to terminate.

However, in December 2021, the Brazilian government issued a new Provisional Measure No. 1,095/2021 amending the Law No. 14,183/2021 in order to extinguish REIQ starting in the beginning of 2022. However, in May 2022, the Brazilian National Congress approved its suspension until the end of 2022, resumption in 2023 and a new gradual reduction until the end of 2027, subject to the regulation of labor and environmental conditions. In this sense, in the absence of regulation, the REIQ will not come back into force until the Brazilian government publishes it. In addition, the Brazilian National Congress also approved the insertion of a provision that would grant a further 1.5% REIQ increase for investments to expand installed capacity between 2024 and 2027.

We cannot predict or control which policies will be renewed or discontinued and whether future changes to Brazilian industrial policy will be proposed and enacted in the future. If industrial policies that benefit us expire, or policies detrimental to us are implemented, our business, results of operations and financial condition may be adversely affected.

Fluctuations in the real/U.S. dollar exchange rate could increase inflation in Brazil, raise the cost of servicing our foreign currency-denominated debt and negatively affect our overall financial performance.

The exchange rate between the real and the U.S. dollar and the relative rates of depreciation and appreciation of the real have affected our results of operations and may continue to do so.

The Brazilian real has been devalued on several occasions. Throughout the last several decades, the Brazilian government has implemented various economic plans and various exchange rate policies, including sudden devaluations, periodic mini-devaluations (during which the frequency of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate markets and a floating exchange rate system. From time to time, there have been significant fluctuations in the exchange rate between the Brazilian currency and the U.S. dollar and other currencies. The real depreciated by 4.0% during 2019, 28.9% during 2020, 7.4% during 2021, and appreciated by 6.5% during 2022.

Depreciation of the real relative to the U.S. dollar also could result in inflationary pressures in Brazil by generally increasing the price of imported products and services. On the other hand, the appreciation of the real against the U.S. dollar may lead to a deterioration of the country’s current account and the balance of payments and may dampen export-driven growth.

We had total foreign currency-denominated debt obligations, all of which were denominated in U.S. dollars, in an aggregate amount of R$42,435.8 million (US$8,133.0 million) as of December 31, 2022 (including an aggregate amount of R$11,370.3 million (US$2,179.1 million) outstanding as of December 31, 2022, in connection with our secured debt related to our Mexico Complex), representing 90.1% of our consolidated indebtedness. As of December 31, 2022, we had R$8,264.2 million (US$1,583.9 million) in foreign currency-denominated cash and cash equivalents, including the aggregate amount of R$2,184.3 million (US$418.6 million) of Braskem Idesa’s cash and cash equivalents.

   
 50 

A significant depreciation of the real in relation to the U.S. dollar or other currencies could increase our financial expenses as a result of foreign exchange losses that we must record and could reduce our ability to meet debt service requirements of our foreign currency-denominated obligations. To enable us to manage the effects of exchange rate fluctuations on our results, in 2013 we decided to designate part of our U.S. dollar-denominated liabilities as a hedge for our future exports. However, we cannot assure that the designation of part of our U.S. dollar-denominated liabilities as a hedge for our future exports will be enough to not affect our financial results.

The prices of naphtha, our most important raw material, and of some of our other raw materials, are denominated in or linked to the U.S. dollar. For the year ended December 31, 2022, naphtha accounted, directly and indirectly, for 34.5% of our consolidated cost of products sold. When the real depreciates against the U.S. dollar, the cost in reais of our U.S. dollar-denominated and U.S. dollar-linked raw materials increases, and our operating income in reais may decrease to the extent that we are unable to pass on these cost increases to our customers.

The Brazilian government’s actions to combat inflation may contribute significantly to economic uncertainty in Brazil and reduce demand for our products.

Historically, Brazil has experienced high rates of inflation. Inflation, as well as government efforts to combat inflation, had significant negative effects on the Brazilian economy, particularly prior to 1995. The inflation rate, as measured by the General Price Index—Internal Availability (Índice Geral de Preços—Disponibilidade Interna, or the “IGP-DI”), reached 2,708% in 1993. Although inflation rates have been substantially lower since 1995 than in previous years, inflationary pressures persist. Inflation rates, as measured by the IGP-DI, were negative 0.4% in 2017, 7.1% in 2018, 7.3% in 2019, 23.1% in 2020, 17.7% in 2021 and 5.03% in 2022. The Brazilian government’s measures to control inflation have often included maintaining a tight monetary policy with high interest rates, thereby restricting availability of credit, and reducing economic growth. Inflation, actions to combat inflation and public speculation about possible additional actions also may contribute to economic uncertainty in Brazil and to heightened volatility in the Brazilian securities markets.

Brazil may experience high levels of inflation. Increasing prices for petroleum, the depreciation of the real and future governmental measures seeking to maintain the value of the real in relation to the U.S. dollar may trigger increases in inflation in Brazil. Periods of higher inflation may slow the rate of growth of the Brazilian economy, which would lead to reduced demand for our products in Brazil and decreased net revenue. Inflation is also likely to increase some of our costs and expenses, which we may not be able to pass on to our customers and, as a result, may reduce our profit margins and net income. In addition, high inflation generally leads to higher domestic interest rates, and, as a result, the costs of servicing our real-denominated debt may increase, causing our net income to be reduced. Inflation and its effect on domestic interest rates can in addition, lead to reduced liquidity in the domestic capital and lending markets, which could adversely affect our ability to refinance our indebtedness in those markets. Any decline in our net revenue or net income and any deterioration in our financial condition would also likely lead to a decline in the market price of our securities, including class A preferred shares and the ADSs.

Fluctuations or changes in, or the replacement of, interest rates could impact the cost of servicing our debt or reduce our financial revenue, affecting our financial performance.

Our financial expenses are affected by changes in the interest rates that apply to our floating rate debt. As of December 31, 2022, we had, among other debt obligations:

·R$3,401.3 million of loans and financing that were subject to the Interbank Deposit Certificate (Certificado de Depósito Interbancário, or “CDI”), rate;
   
 51 
·R$1,263.3 million of loans and financing that were subject to the Extended National Consumer Price Index (Índice de Preços ao Consumidor Amplo, or “IPCA”);
·R$3,798.3 million of certain of our loans and financing that were subject to the London Interbank Offered Rate (LIBOR); and
·R$1,514.7 million of certain of our loans and financing that were subject to the Secured Overnight Financing Rate (SOFR).

The CDI and the IPCA rates have fluctuated significantly in the past in response to the expansion or contraction of the Brazilian economy, inflation, Brazilian government policies and other factors. A significant increase in any of these interest rates could adversely affect our financial expenses and negatively affect our overall financial performance.

Due to the concerns regarding LIBOR, there had been market initiatives to enact its replacement. In June 2021, the Federal Reserve’s Alternative Reference Rates Committee selected the Secured Overnight Financing Rate (“SOFR”), as the preferred alternative to U.S. Dollar LIBOR. Subsequently, a schedule was announced for the cessation of LIBOR. The ICE Benchmark Association, or IBA, announced that it has ceased to publish the 1-week and 2-month LIBOR after December 31, 2021. The remaining tenors of LIBOR would remain in publication until June 2023, on a representative basis; after this date, publication would cease altogether. New risk-free rates, or RFRs, are also being introduced alongside SOFR for interbank offered rates in other currencies, such as the Euro, British pound, Swiss franc and Japanese yen. Due to these changes, interest rates on future indebtedness may be adversely affected, in which case we would need to renegotiate the terms of our existing facilities to replace LIBOR with the new standard, and to otherwise agree with lenders, trustees or agents, as applicable, on a new means of calculating interest. The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR could have a material adverse effect on our financial expenses and/or financial revenue and materially adversely affect our overall financial performance.

Brazilian government exchange control policies could increase the cost of servicing our foreign currency-denominated debt, adversely affect our ability to make payments under our foreign currency-denominated debt obligations and impair our liquidity.

The purchase and sale of foreign currency in Brazil is subject to governmental control. The current laws and regulations governing the Brazilian foreign exchange system allow the purchase and sale of foreign currency and the international transfer of reais by any person or legal entity, regardless of the amount, subject to certain regulatory procedures. Many factors could cause the Brazilian government to institute more restrictive exchange control policies, including the extent of Brazil’s foreign currency reserves, the availability of sufficient foreign exchange on the date a payment is due, the size of Brazil’s debt service burden relative to the economy as a whole, Brazil’s policy towards the IMF and political constraints to which Brazil may be subject. A more restrictive policy could increase the cost of servicing, and thereby reduce our ability to pay, our foreign currency-denominated debt obligations and other liabilities.

Our foreign-currency debt denominated in U.S. dollars represented an aggregate of 90.1% of our indebtedness on a consolidated basis as of December 31, 2022, including transaction costs and Braskem Idesa Financing. If we fail to make payments under any of these obligations, we will be in default under those obligations, which could reduce our liquidity as well as the market price of our securities, including our class A preferred shares and ADSs.

   
 52 

Risks Relating to Mexico

Political and economic conditions and government policies in Mexico, including political interferences in state-owned companies such as Pemex TRI and Cenagas, and elsewhere may have a material impact on our operations.

Deterioration in Mexico’s economic condition, social instability, political unrest or other adverse social developments in Mexico could adversely affect our business and financial condition. These events could also lead to increased volatility in the financial markets, thereby affecting our ability to maintain financial liquidity and service our debt. Additionally, spending cuts related to Pemex or other government expenditures, or lack of investments in natural gas and ethane recovery, could adversely affect Pemex, Pemex’s ability to produce and recover ethane, the Mexican economy and, consequently, our business, financial condition, operating results and prospects.

In the past, Mexico has experienced several periods of slow or negative economic growth, high inflation, high interest rates, currency devaluation and other economic problems. These problems may worsen or reemerge, as applicable, in the future and could adversely affect our business and ability to service our debt. A worsening of international financial or economic conditions, such as a slowdown in growth or recessionary conditions in Mexico’s trading partners, including the United States, or the emergence of a new financial crisis, could have adverse effects on the Mexican economy, our financial condition and our ability to service our debt.

Furthermore, our long-term supply agreement to purchase ethane from Pemex TRI, a state-owned Mexican entity, could be modified through regulatory means, terminated or jeopardized by them as a result of political pressure to not comply with the agreement, to change the terms of the agreement, expropriation measures, or change in laws regulations by the Mexican government. Any non-compliance, modification, termination or interruption of this supply agreement could have a material adverse effect on the results of our operations or our financial condition.

Mexico has experienced adverse economic conditions, which may adversely affect our business.

Mexico has historically experienced uneven periods of economic growth. Mexican GDP increased by 2.2% in 2018, before two subsequent decrease by 0.1% and by 8.2% in 2019 and 2020, respectively, and then increasing by 5.0% in 2021 and 3.1% in 2022. We cannot assure you that these estimates and forecasts will prove to be accurate. Any future economic downturn, including downturns in the United States, Europe, Asia or anywhere else in the world, could affect our financial condition and results of operations.

Decreases in the growth rate of the Mexican economy, periods of negative growth or reductions in disposable income may result in lower demand for our products. The Mexican government recently cut spending in response to an austerity, and it may further cut spending in the future. These cuts could adversely affect the Mexican economy and, consequently, our business, financial condition, operating results and prospects. In addition, there can be no assurance that the recent Mexican sovereign debt rating downgrades will not adversely affect our business, financial condition or results of operations.

Our revenues are subject to risk of loss from unfavorable political and diplomatic developments, social instability, and changes in governmental policies, including expropriation, nationalization, international ownership legislation, interest-rate caps and tax policies. As a result, the actions of the Mexican government concerning the economy and regulating certain industries could have a significant effect on Mexican private sector entities, including us, and on market conditions, prices and returns on Mexican securities, including our securities.

   
 53 

A renegotiation of commercial treaties or changes in foreign policy among Mexico, Canada and the United States may negatively affect our business, financial condition, results of operations and prospects.

In recent years, economic conditions in Mexico have become increasingly correlated with economic conditions in the United States as a result of the North American Free Trade Agreement, or NAFTA, and increased economic activity between the two countries. Adverse economic conditions in the United States or other related events could have a significant adverse effect on the Mexican economy, which could adversely affect our business. As a result of talks to renegotiate NAFTA, on November 30, 2018, the United States, Canada, and Mexico signed the United States-Mexico-Canada Agreement (the “USMCA”). The USMCA replaced NAFTA and, although it entered into force on July 1, 2020, it may fail to be implemented. If such event occur, it could adversely impact our business and operations. Although the USMCA, which replaced NAFTA as the principal trade agreement between the U.S., Mexico and Canada, went into force in July 2020, its long-term impact on our operations remains uncertain. With the current U.S. Administration having taken power in January 2021, the status of U.S. trade policy and U.S. involvement in international trade agreements going forward remains to be determined and could drastically shift in a manner that increases or mitigates adverse effects on our businesses. The last U.S. Administration also implemented changes to U.S. immigration policy and other policies that impact trade, including increasing tariffs, and the current U.S. Administration has taken steps to reverse some of these changes and could take other relevant measures concerning these matters. Such policy changes or other measures could adversely affect imports and exports between Mexico and the U.S. and negatively impact the U.S., Mexican and other economies and the companies with whom we conduct business, which could materially adversely affect our business, financial condition, results of operations, cash flows and/or prospects.

In July 2022, the USA and Canada requested dispute settlement consultations with Mexico under the USMCA arguing potential discriminatory policies against U.S. and Canadian companies in favor of CFE and PEMEX. Under the USMCA, after 75 days of consultations, the affected parties could have requested a dispute panel paving the way for potential retaliatory actions against Mexico. In October 2022, the three countries agreed to extend such period and in December, 2022, they published a working outline to solve the pending issues and continue the consultations. The outcome of the consultations is still pending. Such outcome and any retaliatory actions against Mexico could adversely affect our business, results of operations and financial condition.

Since 2003, exports of petrochemical products from Mexico to the United States have enjoyed a zero-tariff rate under NAFTA. Any action taken by the current U.S., Mexico or Canada administrations, including changes to or non-compliance with the USMCA requirements that would increase the tariff rate between the countries, could have a negative impact on the Mexican economy, such as reductions in the levels of remittances, reduced commercial activity or bilateral trade, or declining foreign direct investment in Mexico. In addition, increased or perceptions of increased economic protectionism in the United States and other countries could potentially lead to lower levels of trade and investment and economic growth, which could have a similarly negative impact on the Mexican economy. These economic and political consequences could adversely affect our business, results of operations and financial condition.

Our profitability is affected by numerous factors including demand for the products we provide. The demand for our products in Mexico, Central and South America, the Caribbean, Europe the U.S. and in the other countries in which we operate may be adversely affected by the tightening of credit markets and economic downturns. As a global company, we depend on the demand from customers in Mexico, the U.S. and the other countries in which we operate, and reduced consumer spending that falls short of our projections could adversely affect our business, results of operations and financial condition.

   
 54 

Political events in Mexico could affect the Mexican economic policy and our business, financial condition and results of operations.

In Mexico, political instability has been a determining factor that investors, in general, take into consideration when deciding on business investment. Political circumstances in Mexico may significantly affect Mexican economic policies, which could affect our operations. Significant changes in laws, public policies and/or regulations, or the use of public referendums (consultas populares) could affect Mexico’s political and economic situation, which could, in turn, adversely affect our business. We cannot provide any assurances that political developments in Mexico, over which we have no control, will not have an adverse effect on our business, results of operations, financial condition and prospects.

We cannot assure you that changes in the Mexican federal government policies or regulations will not adversely affect our business, financial condition and results of operations.

In general, changes that may be made to the existing legal framework, as well as the impact of new regulations, may result in increased costs to us or our customers and may require us to amend existing permits, secure additional permits to operate natural gas, ethane or render our services, or take additional measures to secure permits for our projects. Specifically, Mexican tax legislation is subject to continuous change, and we cannot assure you that the Mexican government will maintain existing political, social, economic or other policies or that such changes would not have a material adverse effect on our business, financial condition, results of operations and prospects.

The administration of Mr. López Obrador has taken actions that have significantly undermined investor’s confidence in private ventures following the results of public referendums, such as the cancellation of public and private projects authorized by previous administrations, including the construction of the new Mexican airport, which immediately prompted the revision of Mexico’s sovereign rating from stable to negative and the cancellation of the construction of a brewing facility of “Constellation Brands” in Baja California, Mexico. Investors and credit rating agencies may be cautious about the president’s political party administration’s policies, which could contribute to a decrease in the Mexican economy’s resilience in the event of a global economic downturn. We cannot assure you that similar measures will not be taken in the future, which could have a negative effect on Mexico’s economy.

Additionally, President López Obrador has conducted and expressed his intentions to move forward with certain substantial changes in Mexico’s policies and laws, including various austerity measures, the cancellation of government trusts, amendments to the pension system and the national energy generation and distribution system, among others. Also, he has declared that he will seek government de-centralization, meaning that there could be important changes to the constitution, laws, policies and regulations, or a decrease or elimination of the independence of government agencies, which may change the economic and political situation of the country. We cannot predict if the new administration will implement substantial changes in law, policy and regulations pertaining to the petrochemical sector in Mexico, any of which could negatively affect our business, financial condition, operations and prospects.

Measures adopted by the Mexican government with respect to the economy and productive state-owned companies could have a significant effect on the private sector companies in general, including the Company, as well as on Mexican market conditions, securities and commodities prices and the return on investment of certain Mexican securities issuers.

Developments in other countries could adversely affect the Mexican economy, our financial performance and the price of our shares.

The Mexican economy and the market value of Mexican companies may be affected to varying degrees by global economic and market conditions, and the economic and market conditions in other emerging market countries and major trading partners, in particular the United States. In recent years, economic conditions in Mexico have become increasingly correlated with economic conditions in the United States as a result of the North American Free Trade Agreement, or NAFTA, increased economic activity between the two countries, and the remittance of funds from Mexican immigrants working in the United States to Mexican residents. Therefore, adverse economic conditions in the United States, the termination of, or modifications to, NAFTA or its successor agreement, USMCA, or other related events, including global trade disputes and instability, could have a significant adverse effect on the Mexican economy. We cannot assure you that events in other emerging market countries, in the United States or elsewhere will not adversely affect our financial performance.

   
 55 

Mexico has experienced a period of increased criminal activity, including violence associated with drug trafficking and organized crime, and such activities could adversely affect our financing costs and exposure to our customers and counterparties.

During recent years, Mexico has experienced a period of increased criminal activity and violence, primarily due to organized crime. This violence has taken place throughout Mexico, including the State of Veracruz, where our Mexico Complex is located. Despite the efforts of the Mexican government to increase security measures by strengthening its military and police forces, drug-related violence and crime continues to threaten the Mexican economy and the peace and security of certain regions, resulting in economic and political instability and uncertainty in Mexico. Systematic criminal activity and isolated criminal events could interrupt Braskem Idesa’s operations, affect its ability to generate revenue and increase the cost of its operations. Continued violence could result in the Mexican government adopting additional security measures, such as transport restrictions, prohibiting the transit of goods and people at certain times, and cross-border trade. We cannot assure you that these activities, their escalation and the violence associated with them, over which we have no control, could have a negative impact on the business environment in which we operate, and therefore on our results of operations and financial condition.

We may interpret certain provisions of our ethane supply agreement differently than our counterparty Pemex TRI.

Our Mexico Segment currently sources part of the ethane for the production of polyethylene at our Mexico Complex from Pemex TRI pursuant to the ESA and the Amended ESA. The ESA, including the Amended ESA, is a complex agreement and, for that reason, we may interpret certain of its provisions differently than Pemex TRI does. For example, if Pemex TRI fails to supply a determined percentage of the ethane contractually specified under the Amended ESA for six consecutive months, we will have the right to terminate the Amended ESA and require Pemex TRI to pay to the other parties involved in the project an amount equal to the termination value of the project (the value of which is determined pursuant to the ESA and takes into consideration, among other factors, the outstanding debt of the project and the amount invested in the project at such time). A difference of interpretation between us and Pemex TRI of certain provisions of the Amended ESA, including the termination provisions, could have an adverse effect on our results of operations and financial position. Further, under Mexican law any dispute regarding the interpretation of the Amended ESA shall be resolved by mediation and/or arbitration before International Chambers of Commerce.

We source part of our ethane feedstock from Pemex TRI in Mexico, which we expect to be our primary main source of ethane until the Ethane Import Terminal is operational.

We currently source part of our supply of ethane, which is the primary feedstock used in our polyethylene production process, from Pemex Transformación Industrial, or Pemex TRI, a state-owned Mexican entity, which is a subsidiary of Petróleos Mexicanos (“Pemex”), the state-owned Mexican oil and gas company. Pursuant to the Amended ESA, ethane prices negotiated under such an agreement are referenced to the Mont Belvieu purity ethane price, which is a U.S. dollar-based international reference price. As a result, in case one or more of the following events occurs, our production volumes, net revenue and profit margins would likely decrease, materially adversely affecting our overall financial performance:

   
 56 
·significant damage to Pemex TRI’s gas processing centers or to any of the pipelines connecting our complex to Pemex TRI’s facilities, whether as a consequence of an accident, natural disaster, fire or otherwise;
·any further decrease in the amount of ethane currently being delivered by Pemex TRI to our petrochemical complex;
·any dispute with Pemex TRI and Pemex Exploración y Producción (“Pemex PEP”), (which engages in exploration and production activities) related to the Amended ESA, including the non-recognition or non-payment of shortfall penalties and the decrease or failure to supply the contracted volume of ethane;
·any material default by us or by Pemex TRI to supply ethane in the contractually agreed volumes or qualities negotiated under the ESA;
·any repudiation or termination by Pemex TRI or by us of the Amended ESA, or any repudiation or termination by other Mexican state-owned companies of related supply (including those for the transportation of supplies) agreements, such as Cenagas (Centro Nacional de Control del Gas Natural); or
·delays in the availability of ethane of acceptable quality, or our inability to obtain acceptable ethane in the quantities and quality that we need, or at all, or at reasonable prices.

As provided in the Amended ESA, any daily volume rejected by us must be purchased in installments in subsequent deliveries until the deficit has been resolved, and the same mechanics apply to Pemex TRI delivery obligations. If Pemex TRI delivers to us less than the volumes required under the ESA and fails to compensate for the shortfall in subsequent deliveries, it needs to pay compensation for shortfall penalties to us.

Furthermore, the Amended ESA could also be impacted by changes in laws and regulations, terminated or repudiated by Pemex TRI as a result of political pressure or be subject to expropriation or other adverse measures by the Mexican government or government entities. We may also renegotiate the terms of the Amended ESA, voluntarily or as a result of changes in laws and regulations, or otherwise.

The provisions for early termination by Pemex TRI under the Amended ESA include: (i) our failure to pay that continues for more than six months after notice; or (ii) an emergency stoppage in operations or force majeure event due to which our insurers consider the petrochemical complex to be a total loss, or after which we cannot or do not resume operations for 48 months.

Delays in the availability of ethane of acceptable quality, or our inability to obtain acceptable ethane in the quantities and quality that we need or at all, or at reasonable prices, have in the past and would in the future have a material adverse effect on our business, results of operations and financial condition.

We may be unable to operate the Mexican Complex at full capacity or at all if one or more of our sources of ethane is disrupted.

 

During 2022, our Mexican petrochemical complex had an operating rate of approximately 75% primarily due to the shortfall in ethane supplied under the ESA offset by imported ethane supplied by the Fast Track solution. We diversified our sources of feedstock supply with the Fast-Track Solution, and we are planning to further increase its import capacity in the future by adding additional discharge stations, both at the port and at our plant by implementing Fast Track 3.0 and the Ethane Import Terminal in 2024. In addition, we cannot guarantee that we will be able to import ethane at current market prices, which could also adversely affect our business, results of operations and financial condition.

   
 57 

The performance of the Fast-Track Solution for the importation of ethane (including the construction of Fast Track 3.0) may involve significant risks and uncertainties, such as:

·failure to obtain or maintain requisite approvals and permits from the applicable regulators and governmental entities;
·failure of equipment involved with performance of Fast Track;
·failure or accidents related to trucks that transport ethane to the Mexican Complex;
·failure to achieve expected results;
·no long-term contracted supply for ethane that will cover needs of Mexican Complex, which exposes BI to volatility in ethane prices;
·unanticipated liabilities; or
·failure of vessels to deliver cryogenic ethane at the port in the city of Coatzacoalcos.

The operation of existing facilities and any future projects we are able to complete involves many risks, including, among others, the potential for unforeseen design flaws, engineering challenges, equipment failures or trucks accidents or the breakdown for other reasons of the import facilities; labor disputes; fuel interruption; environmental contamination; and operating performance below expected levels. In addition, weather-related incidents and other natural disasters, pandemics, cyber- or other attacks by third parties and other similar events can disrupt storage, transmission and distribution systems and have other impacts than those that we discuss in this section. The occurrence of any of these events could lead to our facilities being idle for an extended period of time or our facilities operating below expected capacity levels, which may result in lost revenues or increased expenses, including higher maintenance costs and penalties. Any such occurrence could materially adversely affect our businesses, financial condition, cash flows, results of operations and/or prospects.

We depend on authorizations to import ethane for our production activities

 

On June 11, 2021, the Tax Administration Service amended the General Rules of Foreign Trade (Reglas Generales de Comercio Exterior) in connection with the authorizations to import or export products through places other than those authorized (Autorización para el despacho en lugar distinto al autorizado), in order to establish that said authorizations would only be granted to “productive” state-owned companies (empresas productivas del Estado) (i.e. PEMEX and CFE), regarding hydrocarbons, oil products, petrochemicals and biofuels, among others.

Our or our contractor’s impossibility, failure to obtain, renew or comply with any authorizations to import ethane may cause increased costs, delays or even suspension of our production activities and may impact our operations and have a material effect on our business, results of operations and financial condition.

 

The development of the Ethane Import Terminal may not be successful and may not commence operation as scheduled, be completed within budget or operate at expected levels, which could have a material adverse effect on our businesses, financial condition, cash flows, results of operations and/or prospects.

 

We intend to develop the Ethane Import Terminal. The acquisition, development, construction and operation of this project involves numerous risks. We may be required to spend significant sums for preliminary engineering, permitting, fuel supply, infrastructure development, legal and other expenses.

 

   
 58 

If the Ethane Import Terminal is not completed, we may have to impair or write off amounts that we have invested in the development of the Ethane Import Terminal and never receive any return on these preliminary investments.

 

Success in developing the Ethane Import Terminal is contingent upon, among other things:

 

·our financial condition and cash flows and may be influenced by a number of external factors outside our control, including the global economy and global energy and financial markets;
·any dispute, material default or termination of the engineering, procurement and construction agreement (“TQPM EPC Agreement”), including its renegotiation may result in failures to meet specified deadlines with respect to the Ethane Import Terminal;
·any dispute, material default, termination or failure to implement the stock purchase agreement with Advario, B.V.;
·timely receipt of required governmental permits, licenses and other authorizations, including any required authorizations to import and store ethane, that do not impose material conditions and are otherwise granted under terms we find reasonable, as well as maintenance of these authorizations;
·our Ethane Import Terminal partner’ willingness and financial or other ability to make their required investments on a timely basis;
·our contractors and other counterparties’ willingness and financial or other ability to fulfill their contractual commitments;
·timely, satisfactory and on-budget completion of construction, which could be negatively affected by engineering problems, adverse weather conditions or other natural disasters, pandemics, cyber or other attacks by third parties, work stoppages, equipment unavailability, contractor performance shortfalls and a variety of other factors;
·obtaining adequate and reasonably priced financing for the Ethane Import Terminal;
·the existence of hidden defects or inherited environmental liabilities; or
·fast and cost-effective resolution of any litigation or unsettled property rights affecting the Ethane Import Terminal.

Any failures with respect to the above factors or other factors material to the Ethane Import Terminal could involve significant additional costs to us and otherwise materially adversely affect the successful completion of the Ethane Import Terminal. If we are unable to complete the Ethane Import Terminal, if we experience substantial delays, or if construction, financing or other project costs exceed our estimated budgets and we are required to make additional capital contributions, our businesses, financial condition, cash flows, results of operations and/or prospects could be materially adversely affected.

The Ethane Import Terminal is expected to be completed and to reach full capacity in 2024, but there may be delays. We cannot guarantee that a delay in the start of operations at the Ethane Import Terminal will not cause a blacklash against us, whether by the Mexican government or other market participants. The overall investment expected to build such terminal is R$2,327.1 million (US$446.0 million) (exclusive of financing costs). We expect to participate with up to 50% ownership in the project after condition precedents of stock purchase agreement with Advario, B.V. have been fulfilled.

   
 59 

Risks Relating to Our Equity and Debt Securities

All of the shares issued by Braskem and owned by NSP Inv. are secured for the benefit of certain secured creditors of the Novonor Group.

Pursuant to a shares fiduciary assignment agreement (alienação fiduciária em garantia) entered into by the Novonor Group and some non-bankruptcy creditors (credores extraconcursais) on November 27, 2013, as amended on May 13, 2016, July 19, 2016, April 24, 2017, May 23, 2018, March 29, 2019 and October 9, 2020, all ordinary and preferred shares issued by Braskem and held by NSP Inv. are secured for the benefit of certain secured creditors of the Novonor group in connection with certain financing agreements entered into by Novonor and certain of its subsidiaries. In the event that Novonor and certain of its subsidiaries default on such financing agreements, or if such financing agreements are accelerated and, as a result, or if creditors consolidate the ownership of the shares and dispose them (assuming that Petrobras does not exercise its preemptive rights to acquire such shares) we may be subject to a change of control following statutory, legal and procedural formalities required pursuant to our shareholders’ agreement. A change of control under these circumstances may adversely affect us.

The foreclosure or sale of our shares held by NSP Inv. - whether in the Novonor Judicial Restructuring Proceedings or agreements entered into within the context of the Novonor Judicial Restructuring Proceedings may result in a change of our control. As we do not have the ability to consent to or otherwise influence or control the Novonor Judicial Restructuring Proceedings or the acquirer of the shares from any such disposal, we may be subject to a change in our corporate control in the foreseeable future.

Holders of our class A preferred shares or the ADSs may not receive any dividends or interest on shareholders’ equity.

As permitted by Brazilian Corporate Law, our by-laws specify that 25% of our Adjusted Net Income for each fiscal year must be distributed to shareholders as mandatory dividends, or the Mandatory Distribution of Dividends. Under our by-laws, our class A and class B preferred shareholders are entitled to an annual non-cumulative preferential dividend, or the Minimum Preferred Dividend, equal to 6% of their pro rata share of our capital before dividends may be paid to our common shareholders. The Brazilian Corporate Law allows a publicly traded company like ours to not distribute the Mandatory Distribution of Dividends in any particular year if our board of directors informs in connection with an annual shareholders’ meeting that such distributions would be incompatible with our financial condition, provided that such suspension does not affect the Minimum Preferred Dividend, which is still payable to the holders of preferred shares. However, the shareholders, including the holders of our class A preferred shares or the ADSs, may not receive any dividends or interest on shareholders’ equity in any given year if we do not record a profit. The non-payment of dividends may frustrate expectations of cash return on the part of our investors and may lead to a loss in the value of our shares in the market.

In addition, the income tax exemption on the dividends distribution and the taxation currently levied on the payment of interest on equity provided for in current legislation may be revised through tax reforms carried out by the Brazilian government, and both dividends received and distributed by the Company may become taxed or, in the case of interest on equity, have its taxation increased in the future, reducing the net amount to be paid to shareholders, which may have an adverse effect on the price of the securities we issue.

Our class A preferred shares and the ADSs have limited voting rights and are not entitled to vote to approve corporate transactions, including mergers or consolidations of our Company with other companies, or the declaration of dividends.

Under the Brazilian Corporate Law and our by-laws, holders of our class A preferred shares and, consequently, the ADSs underlying these shares are not entitled to vote at meetings of our shareholders, except in very limited circumstances. These limited circumstances directly relate to key rights of the holders of class A preferred shares, such as modifying basic terms of our class A preferred shares or creating a new class of preferred shares with superior rights. Holders of preferred shares without voting rights are entitled to elect one member and his or her respective alternate to our board of directors and our fiscal council, depending on specific requirements provided in the Brazilian Corporate Law. Holders of our class A preferred shares and the ADSs are not entitled to vote to approve corporate transactions, including mergers or consolidations of our Company with other companies, or the declaration of dividends. However, if we do not pay dividends for three consecutive years, holders of our class A preferred shares and the ADSs will be granted voting rights.

   
 60 

Holders of the ADSs may find it difficult to exercise even their limited voting rights at our shareholders’ meetings.

Under Brazilian Corporate Law, only shareholders registered as such in our corporate books may attend our shareholders’ meetings. All class A preferred shares underlying the ADSs are registered in the name of the depositary. ADS holders may exercise the limited voting rights with respect to our class A preferred shares represented by the ADSs only in accordance with the deposit agreement relating to the ADSs, which provides that voting rights are only available to ADS holders at our discretion. There are practical limitations upon the ability of ADS holders to exercise their voting rights due to the additional steps involved in communicating with ADS holders. For example, we are required to publish a notice of our shareholders’ meetings in certain newspapers in Brazil. To the extent that holders of our class A preferred shares are entitled to vote at a shareholders’ meeting, they will be able to exercise their voting rights by attending the meeting in person, voting by proxy or by remote voting, if applicable. By contrast, holders of the ADSs will receive notice of a shareholders’ meeting by mail from the depositary following our notice to the ADS depository requesting the ADS depository to do so. To exercise their voting rights, ADS holders must instruct the depositary on a timely basis. This noticed voting process will take longer for ADS holders than for holders of class A preferred shares. If it fails to receive timely voting instructions for all or part of the ADSs, the depositary will assume that the holders of those ADSs are instructing it to give a discretionary proxy to a person designated by us to vote their ADSs, except in limited circumstances.

In the limited circumstances in which holders of the ADSs have voting rights, they may not receive the voting materials in time to instruct the depositary to vote the class A preferred shares underlying their ADSs. In addition, the depositary and its agents are not responsible for failing to carry out the voting instructions of the holders of the ADSs or for the manner of carrying out those voting instructions. Accordingly, holders of the ADSs may not be able to exercise their voting rights, and they will have no recourse if the class A preferred shares underlying their ADSs are not voted as requested.

If holders of the ADSs exchange them for class A preferred shares, they may risk temporarily losing, or being limited in, the ability to remit foreign currency abroad and certain Brazilian tax advantages.

The Brazilian custodian for the preferred shares underlying the ADSs must obtain an electronic registration number with the Central Bank to allow the depositary to remit U.S. dollars abroad. ADS holders benefit from the electronic certificate of foreign capital registration from the Central Bank obtained by the custodian for the depositary, which permits it to convert dividends and other distributions with respect to the class A preferred shares into U.S. dollars and remit the proceeds of such conversion abroad. If holders of the ADSs decide to exchange them for the underlying preferred shares, they will only be entitled to rely on the custodian’s certificate of registration with the Central Bank for five business days after the date of the exchange. Thereafter, they will be unable to remit U.S. dollars abroad unless they obtain a new electronic certificate of foreign capital registration in connection with the preferred shares, which may result in expenses and may cause delays in receiving distributions.

   
 61 

Also, if holders of the ADSs that exchange the ADSs for our Class A preferred shares do not qualify under the foreign investment regulations, they will generally be subject to less favorable tax treatment of dividends and distribution on, and the proceeds from any sale of, our preferred shares.

Restrictions on the movement of capital out of Brazil may impair the ability of holders of our shares, ADSs and debt securities to receive payments on their respective obligations or guarantees and may restrict our ability to make payments in U.S. dollars.

In the past, the Brazilian economy has experienced balance of payment deficits and shortages in foreign exchange reserves, and the government has responded by restricting the ability of Brazilian or foreign persons or entities to convert reais into foreign currencies. The government may institute a restrictive exchange control policy in the future. Any restrictive exchange control policy could prevent or restrict our access to U.S. dollars, and consequently our ability to meet our U.S. dollar obligations under our shares, ADSs and the guarantees we granted pursuant to our outstanding debt securities and could also have a material adverse effect on our business, financial condition and results of operations.

The foreign exchange policy of Brazil may affect the ability of Braskem to make money remittances outside Brazil in respect of our equity securities or debt securities.

Under current Brazilian regulations, Brazilian companies are not required to obtain authorization from the Central Bank in order to make payments under guarantees in favor of foreign persons, such as the holders of our shares, ADSs or our outstanding debt securities. We cannot assure you that these regulations will continue to be in force in the event that Braskem is required to perform its payment obligations under its shares, ADSs or the guarantees under our outstanding debt securities. If these regulations or their interpretation are modified and an authorization from the Central Bank is required, Braskem would need to seek an authorization from the Central Bank to transfer the amounts under such obligations out of Brazil or, alternatively, make such payments with funds held by Braskem outside Brazil. We cannot assure you that such an authorization will be obtained or that such funds will be available. If such authorization is not obtained, we may be unable to make payments to holders of our shares, ADSs or the applicable debt securities in foreign currency. If we are unable to obtain the required approvals, if needed for the payment of amounts owed by Braskem through remittances from Brazil, we may have to seek other lawful mechanisms to effect payment of amounts due under the shares, ADSs or debt securities. However, we cannot assure you that other remittance mechanisms will be available in the future, and even if they are available in the future, we cannot assure you that payment on the outstanding debt securities would be possible through such mechanism.

Holders of the ADSs may face difficulties in protecting their interests because we are subject to different corporate rules and regulations as a Brazilian company and our shareholders may have fewer and less well-defined rights than under the laws of other jurisdictions, including in a jurisdiction in the Unites States.

Holders of the ADSs are not our direct shareholders and are unable to enforce the rights of shareholders under our by-laws and the Brazilian Corporate Law.

Our corporate affairs are governed by our by-laws and the Brazilian Corporate Law, which differ from the legal principles that would apply if we were incorporated in a jurisdiction in the United States, such as the State of Delaware or New York, or elsewhere outside Brazil. Even if a holder of ADSs surrenders its ADSs and becomes a direct shareholder, its rights as a holder of the class A preferred shares underlying the ADSs under the Brazilian Corporate Law to protect its interests relative to actions by our board of directors may be fewer and less well-defined than under the laws of those other jurisdictions.

Although insider trading and price manipulation are crimes under Brazilian law and are the subject of continuously evolving regulations promulgated by the Brazilian Securities Commission, or the CVM, the Brazilian securities markets are not as highly regulated and supervised as the U.S. securities markets or the markets in some other jurisdictions. In addition, rules and policies against self-dealing or for preserving shareholder interests may be less well-defined and enforced in Brazil than in the United States and certain other countries, which may put holders of our class A preferred shares and the ADSs at a potential disadvantage when compared to holders of shares of companies incorporated in other jurisdictions. Corporate disclosures also may be less complete or informative than for a public company in the United States or in certain other countries.

   
 62 

Holders of the ADSs may face difficulties in serving process on or enforcing judgments against us and other persons.

We are a corporation (sociedade por ações) organized under the laws of Brazil, and all of our directors and executive officers and our independent public accountants reside or are based in Brazil. Most of our assets and those of these other persons are located in Brazil. As a result, it may not be possible for holders of the ADSs to effect service of process upon us or these other persons within the United States or other jurisdictions outside Brazil or to enforce against us or these other persons judgments obtained in the United States or other jurisdictions outside Brazil. In addition, because a substantial portion of our assets, and all of our directors and officers reside outside the United States, any judgment obtained in the United States against us or any of our directors or officers may not be collectible within the United States. Because judgments of U.S. courts for civil liabilities based upon the U.S. federal securities laws may only be enforced in Brazil if certain conditions are met, holders may face greater difficulties in protecting their interests in the case of actions by us or our directors or executive officers than would shareholders of a U.S. corporation.

Judgments of Brazilian courts enforcing Braskem’s obligations under our equity securities, debt securities or related guarantees would be payable only in reais.

If proceedings are brought in the courts of Brazil seeking to enforce our obligations under our equity securities, ADSs, the guarantees under our outstanding debt securities or our other indebtedness, we would not be required to discharge our obligations in a currency other than reais. Any judgment obtained against us in Brazilian courts in respect of any payment obligations under such equity securities, ADSs, guarantees or other indebtedness would be expressed in reais. We cannot assure you that this amount in reais will afford the holders of the shares, ADSs, notes or our other indebtedness full compensation of the amount sought in any such litigation.

Actual or anticipated sales of a substantial number of class A preferred shares could decrease the market prices of our class A preferred shares and the ADSs.

Sales of a substantial number of our class A preferred shares could negatively affect the market prices of our class A preferred shares and the ADSs. If substantial sales of shares are made through the securities markets by our controlling shareholder or other class A preferred shares, the market price of our class A preferred shares and, by extension, the ADSs may decrease significantly. As a result, holders of the ADSs may not be able to sell the ADSs at or above the price they paid for them.

Holders of the ADSs or class A preferred shares in the United States may not be entitled to the same preemptive rights as Brazilian shareholders have, pursuant to Brazilian legislation, in the subscription of shares resulting from capital increases made by us.

Under Brazilian law, if we issue new shares in exchange for cash or assets as part of a capital increase, subject to certain exceptions, we must grant our shareholders preemptive rights at the time of the subscription of shares, corresponding to their respective interest in our share capital, allowing them to maintain their existing shareholding percentage. We may not legally be permitted to allow holders of ADSs or class A preferred shares in the United States to exercise any preemptive rights in any future capital increase unless (1) we file a registration statement for an offering of shares resulting from the capital increase with the SEC, or (2) the offering of shares resulting from the capital increase qualifies for an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the “Securities Act”). At the time of any future capital increase, we will evaluate the costs and potential liabilities associated with filing a registration statement for an offering of shares with the SEC and any other factors that we consider important in determining whether to file such a registration statement. We cannot assure the holders of the ADSs or class A preferred shares in the United States that we will file a registration statement with the SEC to allow them to participate in any of our capital increases. As a result, the equity interest of such holders into us may be diluted.

   
 63 

Brazilian tax laws may have an adverse impact on the taxes applicable to the disposition of our ADSs and preferred shares.

According to Law No. 10,833, of December 29, 2003, if a nonresident of Brazil disposes of assets located in Brazil, the transaction will be subject to taxation in Brazil, even if such disposition occurs outside Brazil or if such disposition is made to another nonresident. Dispositions of our ADSs between nonresidents, however, are currently not subject to taxation in Brazil. Nevertheless, in the event that the concept of “disposition of assets” is interpreted to include the disposition between nonresidents of assets located outside Brazil, this tax law could result in the imposition of withholding taxes in the event of a disposition of our ADSs made between nonresidents of Brazil. Due to the general and broad scope of Law No. 10,833/2003, and the absence of judicial precedent, we are unable to predict whether an interpretation applying such tax laws to dispositions of our ADSs between nonresidents could ultimately prevail in Brazilian courts.

The relative volatility and liquidity of the Brazilian securities markets may adversely affect holders of our class A preferred shares and ADSs.

The Brazilian securities markets are substantially smaller, less liquid and more volatile than major securities markets in the United States and other jurisdictions and may be regulated differently from the manner in which U.S. investors are accustomed. Factors that may specifically affect the Brazilian equity markets may limit the ability of holders of the ADSs to sell class A preferred shares underlying ADSs at a price and at a time when they wish to do so and, as a result, could negatively impact the market price of the ADSs themselves.

Economic developments and investor perceptions of risk in other countries, including both in developed or emerging market economies, may adversely affect the trading price of Brazilian securities, including our common shares and ADSs, as well as any outstanding debt securities.

The market value of securities of Brazilian issuers is affected in varying degrees by economic and market conditions in other countries, including in developed countries, such as the United States and certain European countries, and in emerging market countries. Although economic conditions in such countries may differ significantly from economic conditions in Brazil, the reaction of investors to developments in these other countries may have an adverse effect on the market value of securities of Brazilian issuers. The price of shares traded in the Brazilian capital markets, for example, has been historically subject to fluctuation of interest rates in the United States and the variation in the main U.S. stock exchanges. In addition, crisis in other emerging countries may diminish investor interest in securities of Brazilian issuers, including our shares and ADSs and our debt securities. This could adversely affect the market price of our shares, ADSs and outstanding debt securities and could also make it more difficult for us to access capital markets, affecting our ability to finance our operations on acceptable terms.

We are exposed to disruption and volatility of global financial markets due to their effects on the economic and financial environment, particularly in Brazil, such as economic downturn, increased unemployment rate, decreased purchasing power of consumers and unavailability of credit.

In addition, the persistence of the COVID-19 pandemic could negatively impact the market value of securities of Brazilian issuers, including our shares and ADSs and our debt securities. The extent to which the COVID-19 pandemic impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including the severity of the COVID-19 pandemic, actions to contain it or treat its impact, among others.

   
 64 

These disruptions or volatility in global financial markets may increase even further the negative effects on the Brazilian economic and financial environment, adversely affecting us.

Because Braskem Finance Limited and Braskem Netherlands Finance B.V. have no operations of their own, holders of our outstanding debt securities issued by Braskem Finance Limited or Braskem Netherlands Finance B.V. depend on Braskem to provide Braskem Finance Limited or Braskem Netherlands Finance B.V., respectively, with sufficient funds to make payments on these debt securities when they become due.

Braskem Finance Limited, a wholly-owned subsidiary of Braskem incorporated in the Cayman Islands, and Braskem Netherlands Finance B.V., or Braskem Netherlands Finance, an indirect wholly-owned subsidiary of Braskem incorporated under the laws of The Netherlands, have no operations of their own other than the issuing and making of payments on their respective debt securities and other indebtedness, and using the proceeds therefrom as permitted by the agreements governing these issuances, including lending the net proceeds of the debt securities and other indebtedness incurred by Braskem Finance Limited and Braskem Netherlands Finance to Braskem and subsidiaries of Braskem. Accordingly, the ability of either Braskem Finance Limited or Braskem Netherlands Finance to pay principal, interest and other amounts due on the outstanding debt securities issued by it and other indebtedness will depend on our financial condition and results of operations and those of our subsidiaries that are debtors of Braskem Finance Limited or Braskem Netherlands Finance, respectively. In the event of an adverse change in our financial condition or results of operations or those our subsidiaries that are debtors of Braskem Finance Limited or Braskem Netherlands Finance, these entities may be unable to service their indebtedness to Braskem Finance Limited or Braskem Netherlands Finance, as the case may be, which would result in the failure of Braskem Finance Limited or Braskem Netherlands Finance, as the case may be, to have sufficient funds to repay all amounts due on or with respect to the respective outstanding debt securities.

Payments on Braskem’s guarantees are junior to Braskem’s secured debt obligations and effectively junior to debt obligations of Braskem’s subsidiaries and jointly controlled companies.

The outstanding debt securities are fully guaranteed by Braskem. The Braskem guarantees constitute senior unsecured obligations of Braskem. The guarantees rank equal in right of payment with all of Braskem’s other existing and future senior unsecured indebtedness. Although the guarantees provide the holders of the debt securities with a direct, but unsecured claim on Braskem’s assets and property, payment on the guarantees is subordinated to secured debt of Braskem to the extent of the assets and property securing such debt.

Upon any liquidation or reorganization of Braskem, any right of the holders of the debt securities, through enforcement of Braskem’s guarantees (i) to participate in the assets of Braskem, including the capital stock of its subsidiaries and jointly controlled entities, will be subject to the prior claims of Braskem’s secured creditors, and (ii) to participate in the assets of Braskem’s subsidiaries and jointly controlled entities will be subject to the prior claims of the creditors of such subsidiaries and jointly controlled entities. The indentures relating to the outstanding debt securities include a covenant limiting the ability of Braskem and its subsidiaries to create liens, although this limitation is subject to significant exceptions.

The construction of our Mexico Complex was financed under a project finance structure, in which the construction loan must be repaid using exclusively the cash generated by us with shareholders pledging limited guarantees. Accordingly, this financing structure includes guarantees typical to transactions of this kind, such as assets, receivables, cash generation and other rights of Braskem Idesa. In October 2021, Braskem Idesa issued sustainability-linked debt securities in the aggregate amount of US$1.2 billion, maturing in ten years. The coupon of 7.0% can be increased by up to 37.5 basis points in case of non-compliance with the sustainability target. The proceeds obtained from the sale of the bonds, plus a credit line of US$150 million, were used to pay off the Project Finance signed in 2012.

   
 65 

As of December 31, 2022, Braskem had (1) consolidated corporate debt, of R$35,716.7 million (US$6,845.3 million), and (2) consolidated Braskem Idesa debt related to our Mexico Complex of R$11,370.3 million (US$2,179.2 million).

Braskem conducts a portion of its business operations through subsidiaries and jointly controlled companies. In servicing payments to be made on its guarantees of the outstanding debt securities, Braskem may rely, in part, on cash flows from its subsidiaries and jointly controlled companies, mainly in the form of dividend payments. The ability of these subsidiaries and jointly controlled entities to make dividend payments to Braskem will be affected by, among other factors, the obligations of these entities to their creditors, requirements of Brazilian corporate and other law, and restrictions contained in agreements entered into by or relating to these entities. In the event that these subsidiaries and jointly controlled entities are unable to make dividend payments to Braskem due to insufficient cash flows, Braskem may be required to utilize its own cash flows to service payments. Further, if these subsidiaries and jointly controlled entities are unable to pay their debt, they may become subject to bankruptcy or insolvency proceedings. Any bankruptcy or insolvency proceedings of these subsidiaries and jointly controlled entities may have an adverse effect on our financial condition and results of operations.

Braskem’s obligations under the guarantees of the outstanding debt securities are subordinated to certain statutory preferences.

Under Brazilian law, Braskem’s obligations under the guarantees of the outstanding debt securities are subordinated to certain statutory preferences. In the event of a liquidation, bankruptcy or judicial restructuring of Braskem, such statutory preferences, including post-petition claims, claims for salaries, wages, social security, taxes and court fees and expenses and claims secured by collateral, among others, will have preference over any other claims, including claims by any investor in respect of the guarantees. In such event, enforcement of the guarantees may be unsuccessful, and holders of the outstanding debt securities may be unable to collect amounts due under the outstanding debt securities.

Brazilian bankruptcy laws may be less favorable to holders of our shares, ADSs and outstanding debt securities than bankruptcy and insolvency laws in other jurisdictions.

If we are unable to pay our indebtedness, including our obligations under the shares, ADSs and guarantees under the outstanding debt securities, then we may become subject to bankruptcy proceedings in Brazil. The bankruptcy laws of Brazil currently in effect are significantly different from, and may be less favorable to creditors than, those of certain other jurisdictions. For example, holders of our outstanding debt securities may have limited voting rights at creditors’ meetings in the context of a court reorganization proceeding. In addition, any judgment obtained against us in Brazilian courts in respect of any payment obligations under the guarantees normally would be expressed in the real equivalent of the U.S. dollar amount of such sum at the exchange rate in effect (1) on the date of actual payment, (2) on the date on which such judgment is rendered, or (3) on the date on which collection or enforcement proceedings are started against us. Consequently, in the event of our bankruptcy, all of our debt obligations that are denominated in foreign currency, including the guarantees, will be converted into reais at the prevailing exchange rate on the date of declaration of our bankruptcy by the court. We cannot assure you that such rate of exchange will afford full compensation of the amount invested in our outstanding debt securities plus accrued interest.

 

   
 66 

 

  Item 4. INFORMATION ON THE COMPANY

We are the largest producer of plastics in the Americas, based on the annual production capacity of our plants in Brazil, in the United States and in Mexico as of December 31, 2022, according to CMA. We are the only integrated petrochemical company producing basic chemicals and polymers in Brazil, and the largest producer of PE in Mexico and of PP in the Unites States according to CMA, serving customers in 70 countries.

Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives to address their essential needs related to food packaging, home furnishings, industrial and automotive components, paints, and coatings.

We believe that the transition of plastics and chemical production from fossil raw materials to sustainable renewable sources represents one of the key opportunities for growth and sustainability in the global chemical industry. We are the global leader in green PE production and benefit from our proximity to Brazil, which is one of the largest renewable energy producers in the world.

As of December 31, 2022, our business operations were organized into three segments, which corresponded to our principal production processes, products and services. Our reportable segments were as follows:

·our Brazil Segment (former Polyolefins, Chemicals and Vinyls segments), which includes:
(i)production and sale of chemicals at the chemical complex located in Camaçari, in the State of Bahia, or the Northeastern Complex, the chemical complex located in Triunfo, in the State of Rio Grande do Sul, or the Southern Complex, the chemical complex located in Capuava, in the State of São Paulo, or the São Paulo Complex and the chemical complex located in Duque de Caxias, in the State of Rio de Janeiro, or the Rio de Janeiro Complex;
(ii)supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes;
(iii)production and sale of PE, including the production of “green PE” from renewable resources, and PP produced by us in Brazil; and
(iv)our production and sale of PVC and caustic soda;

The Brazil Segment accounted for net revenue of R$69,079.7 million, including exports from Brazil, or 70.2% of our consolidated net revenue of all reportable segments;

·our USA and Europe Segment, which includes our production, operations, and sale of polypropylene in the United States and Germany. This segment accounted for net revenue of R$ 23,421.1 million, or 23.8% of our consolidated net revenue of all reportable segments; and
·our Mexico Segment, which includes our production, operations and sale of ethylene, HDPE (high-density polyethylene) and LDPE (low-density polyethylene) in Mexico. This segment accounted for net revenue of R$5,834.0 million, or 6.0% of our consolidated net revenue of all reportable segments.

In 2022, 2021 and 2020, 58.2%, 52.9% and 55.3% of our net revenue, respectively, related to sales performed in Brazil, and 41.8%, 47.1% and 44.7% of our net revenue in 2022, 2021 and 2020 was derived from our international operations.

   
 67 

Our Competitive Strengths

Leading Plastics Producer in the Americas

We are the largest producer of plastics in the Americas, based on the annual production capacity of our plants in Brazil, in the United States and in Mexico as of December 31, 2022, according to CMA. We are the only integrated petrochemical company producing basic chemicals and polymers in Brazil, and the largest producer of PE in Mexico and PP in the Unites States. Globally, we have a global installed capacity of 21.4 million tons per year.

We produce a diversified portfolio of petrochemical and thermoplastic products, including polyethylene, green polyethylene (biopolymer), polypropylene, and PVC. Our products are typically used in large volume applications, and we benefit from our world-scale plants to enhance our competitiveness.

According to CMA, global demand for PE, PP, and PVC in 2022 was estimated to be 117 million metric tons, 85 million metric tons, and 49 million metric tons, respectively. Between 2023 and 2027, global demand for PE, PP, and PVC is expected to grow on average by 3.3%, 3.7%, and 2.8% per year, respectively, according to CMA. This is driven by strong end market dynamics, global gross domestic product growth, and infrastructure and construction projects spending. Polymers will likely continue to replace traditional materials, such as aluminum, steel, wood, and glass, in applications where they can provide cost advantages and better performance.

Global Leader in Green PE, Pioneer in Renewable Plastics

We are the global leader in green PE production and benefit from our presence in Brazil, which is the world’s largest producer of ethanol from sugarcane, with ample access to bio-ethanol feedstock. Our green PE made from ethanol from sugarcane is the first PE of renewable origin to be produced in industrial scale in the world. We have developed a robust global portfolio of clients, and our green PE has more than 204 customers in 38 countries. Green PE also has an attractive price point, as demand for sustainable products generally outstrips supply.

We believe that our green PE has distinctive capabilities compared to other alternative solutions. Compared to biodegradable, recycled and fossil-based PE, we believe our renewable product has: (i) negative carbon footprint, (ii) higher feedstock sustainability, (iii) lower risk and better equipment fit as process uses same existing equipment, (iv) proven technology and scale, (v) better applicability with same properties and applications as fossil-PE, and (vi) better recyclability as products as 100% recyclable.

Green PE and Green Ethylene could represent a US$10.0 billion addressable market by 2025 and US$15.0 billion by the end of 2030, according to CMA. This represents an expansion of 18.5% per year between 2025 and 2030 for Green PE and Green Ethylene that would together represent approximately 5.0% of the total market for PE and ethylene including fossil and bio-based products by 2030.

Benchmark Operator, With World Class Safety Practices and Track Record

We are widely recognized as an experienced and capable operator of petrochemicals plants. Our plants have recorded low accident rates and high utilization levels compared to industry peers.

Between 2012 and 2022, our ethylene plants in Brazil achieved an average utilization rate of 86.8% compared to a global industry average of 88.1%, according to CMA. In addition, our PP plants in the United States and Europe achieved in the same period an average utilization rate of 90.7% compared to global industry average of 87.0% according to CMA.

   
 68 

Competitive Asset and Raw Material Base

Our plants are located close to customer demand. In Brazil in particular competitors need to bring in products from locations as far away as the Middle East and face import tariffs which reduces their competitiveness compared to us. Considering freight and import tariffs, Brazilian producers have an advantage with respect to PE, PP and PVC on average 35.4% higher than average international reference prices from CMA for these products in 2022.

We rely on a diversified mix of raw materials, such as naphtha, ethane, propane, propylene and ethanol. We also source our raw materials from a diversified base of suppliers, which we continuously work to expand in the regions where we operate.

Our green PE is made from ethanol from renewable sugarcane in Brazil, the main producer for sugarcane globally. Our other Brazilian businesses operate on naphtha, ethane, propane, and propylene sourced from Brazil and several other sources abroad. As a result of our continued efforts to further diversify our feedstock base, 41.5% of our naphtha consumption was sourced by local suppliers as of December 31, 2022.

Our businesses in the United States and in Mexico benefit from propylene and ethane availability from producers that are well situated on their respective global cost curves. Our PP plants in the Northeast region of the United States are able to source refinery-grade and chemical-grade propylene from non-U.S. Gulf Coast refineries and steam crackers at an advantaged cost compared to polymer-grade propylene. In the United States Gulf Coast, we have a well-diversified supply base with well- developed pipeline connectivity that allow us to source feedstock at a competitive cost in the region. With 19 sources of supply in North America, our geographic and logistics diversity allows for redundancy in supply and flexibility at our PP plants.

Global Marketing Platform

We are a client-focused organization and have built a deep network of local relationships with 2,221 clients worldwide as of December 31, 2022. We have a lengthy history of development of long-term and close partnerships with clients, focusing on their needs and individual value creation solutions. Our market orientation and wide network are underpinned by a global platform with commercial offices in the Americas, Europe and Asia. Our global marketing platform combines market-focused teams for key market segments as well as regional teams for broader coverage. We encourage innovative thinking, an entrepreneurship mindset, a focus on the value chain and on product quality and service level.

Innovation and Technology, and Research and Development Capabilities

We drive innovation to extract value from our existing assets and create new value propositions to our customers. As a result of our innovation efforts, 12.2% of our current products have been introduced in the last five years. We employ 360 employees globally in innovation and technology, spread across our research and development centers in Pittsburg (United States), Wesseling (Germany), Coatzacoalcos (Mexico), Triunfo, Campinas and São Paulo (Brazil).

Additionally, in November 2021, Braskem and Lummus Technology, a worldwide leader in ethylene, petrochemical, energy transition and other process technologies, executed a memorandum of understanding to jointly license Braskem’s green ethylene technology to two projects in different regions of the world, displaying a global interest in the technology. In 2022, we formalized our partnership for licensing technology to produce green ethylene. The partnership will accelerate the use of bioethanol for the production of chemicals and plastics.

   
 69 

In November 2022, we announced the launch of a new Renewable Innovation Center in Lexington, Massachusetts (United States). The innovation center will focus on accelerating innovation in renewable chemicals and sustainable materials. Capabilities at the new center are expected to expand our competencies in biotechnology, catalysis, process engineering, and open innovation (a partnership that Braskem has with universities and technical institutes, aiming to achieve better results regarding innovation). A particular focus will be given to early-stage science and engineering related to the conversion of biomass-based feedstocks, including sugars, cellulose, plant oils, and lignin, to sustainable chemicals and materials. This will enhance our resources focused on the discovery of technologies that are expected to drive new growth-oriented offerings centered around carbon circularity.

Qualified Management Team with Proven Success

Our senior management team combines deep operational expertise and knowledge of petrochemical global markets developed over long tenures. We have a strong mergers and acquisitions track record that supported our global expansion in the last decade, including into the US and Europe.

We have proven success in executing large, complex projects. Through our subsidiary Braskem Idesa, we built and operated the largest petrochemical complex in Latin America, which started operations in April 2016. In September 2020, we successfully started the production of PP from our Project Delta greenfield in La Porte, Texas, with a production capacity of 450 kilotons per year.

Robust Financial Performance Through the Industry Cycles

We have a track record of robust financial performance through the cycle, based on our scale and competitiveness. Our net cash generated from operating activities was R$8,951.7 million (US$1,715.6 million) for the year ended December 31, 2022, R$14,786.5 million (US$2,649.7 million) for the year ending in December 31, 2021 and R$6,293.0 million (US$1,127.6 million) for the year ending in December 31, 2020, which represents our ability to generate positive, robust results across the industry cycles and varying macroeconomic circumstances.

Our Global Strategy

In 2022, we reviewed and consolidated our global strategy for the period ending in 2030. Our global strategy is anchored in strategic pillars and foundations with a focus on creating value through balanced capital allocation, prioritization of investments in growth avenues, and the objective of returning value to our shareholders over the petrochemical cycles.

Foundations

The foundations of our global strategy are:

·Safety: safe operations as a permanent and non-negotiable value;
·People: human-centered company that promotes diversity, inclusion and human rights; and
·Governance: governance and compliance in line with the best global market practices.

Strategic Pillars and Goals:

The strategic pillars of our global strategy and our goals are:

·Productivity and competitiveness: to move towards the first quartile of the global cash-cost curve in the petrochemical industry, focusing on de-carbonization initiatives and high-aggregated-value investments;
   
 70 
·Sustainability: to be a reference in the chemical and plastics sector in sustainable development globally;
·Growth and diversification: to increase global diversification in bio and circular feedstock and products; and
·Innovation: to deliver high-value sustainable solutions through chemical and plastic innovation.

Growth Avenues

Pursuant to our global strategy, the principal growth avenues we intend to pursue are:

1.Traditional businesses: to grow our current businesses through selective investments, including improvements in productivity and competitiveness, without impacting the continuous implementation of the decarbonization of our current assets, in line with the commitments for achieving carbon neutrality by 2050 and reducing scope 1 and 2 emissions by 15% by 2030. With respect to this growth avenue, the following projects are examples of focus areas, among others:
(i)Ethane import terminal construction project in Mexico: to advance the construction of an ethane import terminal in Mexico, which will allow the diversification of the feedstock supply and operation of Braskem Idesa at full capacity;
(ii)Transform for value program: to advance the global efficiency program to accelerate improvement initiatives in different areas of the Company, generating value through process optimization; and
(iii)Industrial de-carbonization program: to advance initiatives that aim to reduce scope 1 and 2 carbon emissions in line with the commitments we expect to be fulfilled by 2030.
2.Bio-based: to continue to grow in bio-based resins and chemical products and expand the use of renewable feedstocks, in line with our commitment to increase our Green products production capacity to one million tons by 2030. With respect to this growth avenue, the following projects are examples of focus areas, among others:
(i)Expand the current production capacity of green ethylene at the Triunfo Petrochemical Complex in the State of Rio Grande do Sul: to conclude the expansion of current green ethylene production capacity from 200 thousand tons per year to 260 thousand tons per year, using feedstock derived from sugarcane ethanol;
(ii)Build a new green ethylene plant in Thailand (MOU with SCG Chemicals): to move forward with feasibility studies to invest jointly with SCG Chemicals in the construction of a new green ethylene plant in Thailand;
(iii)Joint licensing of green ethylene technology: to advance the partnership to develop and license Braskem’s technology to produce green ethylene in partnership with Lummus Technology; and
(iv)Joint-venture for the production and commercialization of bioMEG and bioMPG: to move forward with the joint-venture formed by Sojitz and Braskem to produce monoethylene glycol (“bioMEG”) and monopropylene glycol (“bioMPG”) from sustainable raw materials.
3.Recycling: to grow our circular products portfolio through mechanical recycling, and to increase the use of circular feedstocks through chemical recycling, in line with the commitment to grow to one million tons of resins and chemicals products with recycled content by 2030. With respect to this growth avenue, the following projects are examples of focus areas, among others:
   
 71 
(i)Construction of the first chemical recycling unit in Brazil: to advance the partnership with Valoren for the construction of the first chemical recycling unit in Brazil;
(ii)Partnership for the development of recycling technology: to move forward with the joint-venture with Terra Circular to develop technology capable of converting low-quality plastic waste into final products;
(iii)Acquisition of equity interest in a recycling company: to move forward with the strategic plan for doubling the current production capacity of Wise Plásticos S.A., reaching around 50 thousand tons by 2026.

Industry Overview

In 2022, the growth of the global economy was mainly impacted by three main factors: (i) the geopolitical conflict between Russia and Ukraine; (ii) the restrictive policies and lockdowns in China due to the COVID-19 pandemic; and (iii) the increase in global interest rates due to rising inflation. Therefore, according to the IMF, the global economy is expected to grow 3.4% in 2022, 1.2 p.p. lower than the IMF projection of 4.4% in early 2022.

Regarding the petrochemical scenario, the combination of lower global demand due to the macroeconomic scenario, and the increase in product supply, with new capacities of PE and PP coming online in the United States and China, contributed to the decline in our petrochemical spreads in the international market throughout 2022, mainly in the second half of the year. These factors, combined with higher costs of energy, raw materials and labor, adversely affected sales volume, cost of sales and, consequently, profit margins in our sector and our business. This uncertain and challenging scenario is expected to continue in the first half of 2023 and potentially during the remainder of the year.

In response to these conditions, during 2022 we adapted the utilization rates of petrochemical plants in all regions to adjust our production levels to a scenario of low international spreads. In Brazil, the utilization rate of petrochemical plants in 2022 was 78%, in the United States and Europe, the average utilization rate of the two regions was 80%. On the other hand, in Mexico, the utilization rate increased by 7 p.p. from 66% in 2021 to 73% in 2022, which is explained by the increase in ethane supply through the Fast Track solution, which reached an average of 18.5 thousand barrels per day in 2022, representing an increase of 20% compared to 2021.

Additionally, we have noticed resilient demand for Green PE, which, even in a scenario of lower demand for resins globally, remained at healthy levels and, in 2022, had an annual sales record. To meet this demand, the utilization rate of our green ethylene plant reached 95% in 2022, higher than all of our other plants.

Industry Trends

In January 2023, the IMF revised its projection for the world’s GDP growth in 2023 to 2.9%, an estimate 0.2 p.p higher than that forecasted in October 2022. The increase in basic interest rates by central banks to combat inflation and the uncertainties related to the conflict between Russia and Ukraine continue to impact global economic activity. Additionally, the maintenance of restriction policies and lockdowns in China to contain COVID reduced the speed of world GDP growth in 2022. However, the recent reopening of the Chinese economy is expected to lead to a faster-than-expected recovery of the global economy. In this sense, the IMF also revised its forecast for China’s GDP growth in January 2023 to 5.2%, an estimate of 0.8 p.p. higher than that forecasted in October 2022.

   
 72 

The IMF also expects a reduction in global inflation of 8.8% in 2022 to 6.6% in 2023. With the maintenance of inflation at levels above pre-pandemic levels, the priority of the largest economies continues to be disinflation, resulting in more restrictive monetary policies, lower growth and deterioration of the fiscal scenario.

Regarding the global petrochemical scenario, the expectation of external consulting firms for 2023 is a scenario with lower petrochemical spreads in the first quarter of 2023, mainly impacted by: (i) the new resins production capacities coming online globally; and (ii) globally consumption weakened due to inflationary pressure and high interest rates. However, it is possible to observe that recent positive market movements related to the Chinese GDP growth expected for 2023, may indicate a potential increase in the petrochemical’s spreads throughout the year.

In this context, in 2023 we intend to maintain our focus on: (i) initiatives to optimize and maximize the operation of our industrial assets as a way to capture commercial opportunities and synergies between our businesses; (ii) initiatives related to cost discipline through the reduction of fixed and variable costs and the implementation of the Transform for Value program; (iii) prioritizing and executing high-value investments and projects, aligned with our growth avenues in traditional businesses, renewables and recycling; and (iv) progress on the fronts related to the geological event in Alagoas, including the Financial Compensation and Relocation Support Program and the stabilization of salt wells.

Our History

Creation of Braskem

In July 2001, in partnership with the Mariani Group, Novonor (formerly called Odebrecht S.A.) acquired a controlling interest in Copene (Camaçari Petrochemical Complex) in the state of Bahia. In August 2002, with the merger of Copene with five other companies, Braskem was created.

Consolidation of the Brazilian petrochemical industry

Between 2006 and 2010, we have invested in the consolidation of the petrochemical industry in Brazil. Two relevant steps in this stage of our growth were conducted in partnership with Petrobras, which led to the increase of their stake in the Company: the consolidation of our Southern Complex, which was executed between March 2007 and May 2009; and the acquisition of Quattor, which owned significant assets in São Paulo and Rio de Janeiro, announced in January 2010.

This consolidation strengthened the Brazilian petrochemical sector and allowed us to reach a new level of scale to face the challenges of the international market.

Beginning and consolidation of our internationalization

In February 2010, we announced the acquisition of the PP assets of Sunoco Chemicals and in July 2011, we announced the acquisition of Dow Chemical’s PP business, including four plants (two plants in the United States and two plants in Germany). This acquisition represented an important step in the consolidation of our growth strategy in the Americas, consolidating us as the largest producer of polypropylene in the United States and strengthening our position in Europe.

In April 2016, our subsidiary Braskem Idesa, our former joint venture with the Mexican Idesa group, reached an important milestone with the production of the first batch of PE in the Mexico petrochemical complex, strengthening our internationalization strategy and ensuring greater access to competitive gas-based feedstocks.

   
 73 

In September 2020, we successfully started the greenfield Project Delta to produce PP in La Porte, Texas, with a production capacity of 450 kilotons per year. We believe that this investment reinforces our PP leadership position in the region and strengthens our strategy to diversify the raw materials matrix and geographic expansion in the Americas.

Beginning of our renewable’s operations

In September 2010, Braskem started up its green ethylene plant in Triunfo, in the state of Rio Grande do Sul, Brazil, with a capacity to produce 200 kilotons per year, becoming the world leader producer in biopolymers and products made from renewable sources.

In February 2021, we announced a new project at the Triunfo petrochemical complex in Rio Grande do Sul to expand our current production capacity of green ethylene. With an estimated investment of US$87.0 million, this project is expected to add 60 kilotons per year to the production of green ethylene in the Company’s portfolio and is expected to be completed in April 2023.

In September 2021, we entered into a memorandum of understanding to perform feasibility studies to jointly invest with SCG Chemicals in a new bio-ethanol dehydration plant in Thailand to produce green ethylene. SCG Chemicals is one of the largest integrated petrochemical companies in Thailand and an industry leader in Asia. The investment is subject to the conclusion of the studies, mutual agreement of Braskem and SCG Chemicals, and approval by competent governance bodies.

Additionally, in November 2021, Braskem and Lummus Technology, through our subsidiary Braskem Netherlands B.V., executed a memorandum of understanding to jointly develop and license our green ethylene technology. On April 28, 2022, we entered into a partnership agreement with Lummus Technology LLC (“Lummus”), through our subsidiary Braskem Netherlands B.V., to develop and license our green ethylene production technology, reflecting our global interest in the technology. We are a pioneer in the production of resins made from renewable feedstock and have undertaken a commitment to reach production capacity of 1.0 million tons of I’m green® biobased polyethylene by 2030. Lummus has the technical capacity and experience in licensing to support us in developing and marketing our technology for producing green ethylene. The partnership brings the complementary expertise needed to accelerate the achievement of our commitment, expand the geographic footprint of green ethylene production technology globally and accelerate the use of bioethanol in chemical and plastic products, supporting the industry’s efforts towards a carbon neutral circular economy. In addition, the partnership is aligned with our sustainability goals.

In 2022, we formed Sustainea, a joint venture between Sojitz and Braskem, which we believe will provide cutting-edge plant-based chemicals with lower CO2 production footprints. The joint venture offers two products: (i) bioMEG, a raw material used to produce PET, a product used to create bottles, textiles, and other types of packaging; and (ii) bioMPG, a raw material utilized in industrial, cosmetic, and personal care goods.

Our Corporate Structure

The following chart presents our simplified ownership structure and corporate structure of our principal subsidiaries as of the date of this annual report. The percentages in bold and italics represent the direct or indirect percentage of the voting share capital owned by each entity, and the percentages not in bold and italics represent the direct or indirect percentage of the total share capital owned by each entity.

   
 74 

 

For a complete list of our subsidiaries, please see note 2.3 to our audited consolidated financial statements included elsewhere in this annual report.

The SEC maintains an internet website at www.sec.gov that contains reports, proxy and information statements and other information regarding companies that file or furnish documents electronically to the SEC, including us. Our internet website is www.braskem.com.br, and the internet website of our investors relations’ department is www.braskem-ri.com.br. The information included on our internet website, the internet website of our investor relations’ department, or the information that might be accessed through such websites is not included in this annual report and is not incorporated into this annual report by reference.

We are a corporation (sociedade por ações) organized under the laws of Brazil. Our registered office is at Rua Eteno, 1561, Pólo Petroquímico, Camaçari, Bahia, CEP 42810-000, Brazil, and our telephone number at this address is +55 71 3413-2102. Our principal executive office is at Rua Lemos Monteiro, 120 – 24º andar, Butantã, São Paulo, SP, CEP 05501-050, Brazil, and our telephone number at this address is +55 11 3576-9000.

Reportable Segments

Brazil Segment

We have four petrochemical complexes in the Brazil Segment that mainly use naphtha, ethane/propane and refinery light hydrocarbons (RLH) as feedstock to produce ethylene, propylene, and its respective chemical products, which subsequently are used as feedstock to make thermoplastic resins (PE, PP and PVC) or sold to third parties.

As of December 31, 2022, our Brazil Segment had the largest annual PE, PP and PVC production capacity in South America, according to CMA. Our Brazil Segment generated net revenue of R$69,079.7 million during 2022, or 70.2% of the net revenue of all of our reportable segments. The following table sets forth our net revenue derived from sales of our Brazil Segment for the years indicated:

   
 75 

 

 

For the Year Ended December 31,

 

2022

2021

2020

  (in millions of reais)
Net revenue:      
Brazil 69,079.7 69,494.9 40,794.4

 

Chemicals Operations that are Part of our Brazil Segment

Our chemicals operations that are part of our Brazil Segment are comprised of the chemical’s operations conducted by us in the Northeastern Complex, the Southern Complex, the São Paulo Complex and the Rio de Janeiro Complex.

Our chemicals operations that are part of our Brazil Segment produce:

·olefins, such as ethylene, polymer and chemical grade propylene, butadiene and butene-1;
·BTX products;
·fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE;
·intermediates, such as cumene;
·aliphatics, aromatics and hydrogenated solvents; and
·specialties such as isoprene, dicyclopentadiene, or DCPD, piperylene, nonene, tetramer, polyisobutylene, or PIB, and hydrocarbon resins.

The products of our chemicals operations that are part of our Brazil Segment are used primarily in the manufacture of intermediate second-generation petrochemical products, including those manufactured by our polyolefins and vinyls operations that are part of our Brazil Segment. Our chemicals operations that are part of our Brazil Segment also supply other second-generation producers in each of the petrochemical complexes in which we operate, and other companies located outside of these complexes, and renders services to those producers.

Products of Our Chemicals Operations that are Part of our Brazil Segment

Our other business units and third-party petrochemical producers use ethylene and propylene produced by our chemicals operations that are part of our Brazil Segment to produce second generation products such as polyethylene, polypropylene, and PVC. We also sell butadiene, a variety of aromatics, including BTX products, and intermediates, such as cumene, to third-party petrochemical producers for use as raw materials in the production of a variety of second generation products, including synthetic rubber, elastomers, resins, nylon fibers, ethyl benzene (which is used to make styrene monomer/polystyrene), linear alkyl benzene, purified terephthalic acid, dimethyl terephthalate, bisphenol A, a feedstock for the production of polycarbonate resins, phthalic anhydride, plasticizers and paint.

The following table sets forth the sales volume of basic petrochemical products by our chemicals operations that are part of our Brazil Segment (excluding our intra-company sales) for the periods indicated.

 

   
 76 

 

 

Year Ended December 31,

 

2022

2021

2020

  (in thousands of tons)
Domestic sales:      
Ethylene  477.3 516.8 486.3
Propylene  320.4 370.7 282.1
Cumene  212.6 204.2 186.6
Butadiene  166.5 172.2 122.9
BTX products(1)  730.0 741.9 676.6
Gasoline  981.3 1,058.9 953.9
Others

424.6

439.1

430.8

Total domestic sales of Chemicals  3,312.7 3,503.8 3,139.2
Total export sales of Chemicals

703.7

842.0

785.1

Total sales of chemicals

4,016.4

4,345.8

3,924.3

 

  (1) Includes benzene, toluene and para-xylene.

 

 

Production Facilities of Our Chemicals Operations that are Part of our Brazil Segment

We believe that the technological processes we use at plants in our chemicals operations that are part of our Brazil Segment are among the most advanced in the world. Our chemicals operations that are part of our Brazil Segment currently include owning and operating:

·five major production facilities in the Northeastern Complex (two olefins units, two aromatics units and one utilities unit);
·five major production facilities in the Southern Complex (two olefins units, one green ethylene unit, one aromatics unit and one utilities unit);
·three production facilities in the São Paulo Complex (one olefins unit, one aromatics unit and one utilities unit); and
·two production facilities in the Rio de Janeiro Complex (one olefins unit and one utilities unit).

We define the term “unit” to mean several production lines that are linked together to produce olefins, aromatics, or utilities.

The table below sets forth the primary products of our chemicals operations that are part of our Brazil Segment, annual production capacity as of December 31, 2022 and annual production for the years presented.

 

Annual Production

Production
For the Year Ended December 31,

Primary Products

Capacity

2022

2021

2020

  (in tons) (in tons)
Olefins:        
Ethylene 3,952,000 2,911,688 3,026,634 3,027,070
Propylene 1,585,000 1,194,126 1,290,537 1,232,053
Butadiene 480,000 351,312 380,927 339,487
Aromatics:        
BTX products(1) 1,367,000 814,163 912,907 893,097

 

  (1) Consists of benzene, toluene and para-xylene.
   
 77 

Raw Materials of Our Chemicals Operations that are Part of our Brazil Segment

The main raw material that we use for chemical production is naphtha, with a total consumption capacity of up to 10 million tons per year. Up to one-and-a-half million tons of naphtha can be substituted by condensate, which in recent years was about one million tons. Natural gasoline is also a feedstock that can be used as a replacement for naphtha. The cracker located in Rio de Janeiro uses ethane and propane, and its consumption is 0.4 million tons of each of these raw materials per year. The São Paulo cracker can also consume refinery off gas in a quantity equivalent to about 15% of the ethylene production capacity.

Naphtha

Naphtha is the main raw material that we use to produce our chemical products and represents the principal production and operating cost of our chemicals operations that are part of our Brazil Segment. We also use condensate as a raw material in the Southern Complex. The following table shows the average Amsterdam-Rotterdam-Antwerp, or the ARA price, of naphtha for the periods indicated.

 

2022

2021

2020

  (in US$/t)
Average(1) US$769.7 US$635.4 US$355.0
Month ended:      
January 777.0 501.0 528.0
February 862.0 556.0 466.0
March 1,012.0 574.0 248.0
April 907.0 559.0 140.0
May 888.0 594.0 227.0
June 803.0 635.0 342.0
July 766.0 674.0 382.0
August 660.0 649.0 382.0
September 625.0 681.0 367.0
October 673.0 764.0 375.0
November 669.0 737.0 370.0
December 594.0 701.0 433.0

 

  (1) The information in the “Average” row represents the mean average monthly naphtha prices during each respective year.

Source: Braskem Global Market Intelligence.

Supply Contracts and Pricing of the Chemicals Operations that are Part of our Brazil Segment

Naphtha and Condensate

The following table shows the distribution of the naphtha plus condensate purchases by our chemicals operations that are part of our Brazil Segment for the periods indicated by geographic location of the suppliers.

 

Year Ended December 31,

 

2022

2021

2020

Brazil 42% 31% 54%
       
Europe 18% 23% 14%
South America 1% 2% 5%
North America 20% 30% 16%
Africa 19% 15% 12%
Others 0% 0% 0%
Total

100%

100%

100%

   
 78 

Supply Contracts with Petrobras

Throughout 2022, Braskem and Petrobras had existing naphtha supply contracts to provide naphtha for our plants in the Southern Complex, the Northeastern Complex, and the São Paulo Complex. All current contracts have a term of five years until the end of 2025.

Under the terms of these agreements:

·Petrobras has agreed to sell and deliver naphtha, for a period of five years, to our chemical plants in the Northeastern, Southeastern and the Southern Complex exclusively for our use as a feedstock;
·we are required to purchase a minimum monthly volume of naphtha for each of our Complexes;
·we have the option to purchase additional volume for the São Paulo Complex and Petrobras has an option to sell us additional volume for our Northeastern and Southern Complexes;
·we may request volumes of naphtha that exceed a monthly firm commitment order, which Petrobras may supply at its discretion;
·the price we pay for naphtha is based on international price references;
·the contract could be terminated or amended in the event that unforeseen extraordinary events occur that cause a disruption in the economic-financial equilibrium of the contract;
·either party may terminate the contract, without prior notice, in the event of: (1) failure to cure any breach of the contract following a 30-day grace period; (2) a force majeure event that continues for more than 90 days; (3) transfer or offer as a guaranty all or part of either party’s rights and obligations under the contract to a third party without the other party’s consent; (4) an alteration of ownership or corporate purposes that conflicts with the purpose of the contract; (5) dissolution; or (6) failure to comply with the compliance obligations of the contract; and
·Petrobras may terminate the contract, without prior notice, in the event of our bankruptcy or liquidation.

In December 2021, ACELEN concluded the acquisition of REFMAT, a refinery previously owned by Petrobras, located in the state of Bahia, and one of the suppliers for our Northeastern Complex. As per the terms and conditions of the sale and purchase agreement, the supply agreement was assigned to ACELEN, which, as of December 2021, replaced Petrobras as Braskem’s supplier in connection with such refinery.

Other Supply Contracts

As part of our strategy to diversify our sources of supply of naphtha, we are acquiring naphtha and condensate under annual supply arrangements with international suppliers.

Spot Market Purchases of Naphtha

In addition to our supplies of feedstock under the agreements described above, we purchase naphtha on the spot market from time to time from foreign suppliers located in Africa, Europe, North America and Latin America.

Spot Market Purchases of Condensate

In addition to our supplies of feedstock under the agreements described above, we purchase condensate on the spot market from time to time from foreign suppliers.

   
 79 

Ethane and Propane

Ethane and propane are the principal feedstocks that we use to produce our chemical products in the Rio de Janeiro Complex and represent the principal production and operating cost of the chemical operations that are part of our Brazil Segment in the Rio de Janeiro Complex. The price of ethane and propane that we purchase varies primarily based on changes in the U.S. dollar-based international price of these feedstocks.

In December 2000, we and Petrobras entered into an ethane and propane supply agreement. The term of this contract ended in December 2020, and the agreement was not renewed.

In December 2020, we and Petrobras entered into a new ethane and propane supply agreement with a term of five years, from January 1, 2021 to December 31, 2025 as follows:

·we are required to purchase and Petrobras is required to deliver a minimum annual volume of ethane and/or propane
·we agree to provide Petrobras with a firm commitment order for ethane and propane each month, together with an estimate of the volume of ethane and propane that we will purchase over the immediately succeeding four months;
·the prices for ethane and propane are based on international price references; and
·Petrobras may terminate the contract, without prior notice, in the event of: (1) our failure to cure any breach of the contract following a 60-day grace period; (2) a force majeure event that continues for more than 365 days; (3) we transfer or offer as a guaranty all or part of our rights and obligations under the contract to a third party without Petrobras’ consent; and (4) the dissolution, bankruptcy or liquidation of RioPol.

Braskem also has an ethane supply contract with Enterprise Products Operating LLC, or Enterprise Products, to supply ethane from the United States to Brazil. This agreement will remain valid until 2027. The price of ethane is based on the Mont Belvieu ethane price plus a Terminal Fee, basis FOB USGC. The logistics to move the ethane to Brazil is managed by Braskem.

Since February 2017, Braskem has had the capability to receive imported ethane at the Rio de Janeiro Complex.

The imported ethane is marginal to domestic supply and the quantity imported in 2022 was 26.5 ktons, in 2021 was 30.9 ktons and in 2020 was 30.9 ktons.

Since November 2017, Braskem has the capacity to consume ethane in the cracker in Bahia, partially replacing naphtha. Braskem has invested to create the flexibility to substitute naphtha for ethane in a ratio equivalent to 15% of the ethylene production of the site. 2018 was the first year in which we operated our cracker in Bahia using imported ethane as feedstock. Of the total ethylene produced by the cracker, there was consumption of 0.4% of ethane feedstock in 2022, no consumption in 2021 and consumption of 1.8% in 2020.

Refinery Off Gas

In January 2005, we entered into an agreement with Petrobras for the purchase and sale of steam from refinery off gas, from which we separate ethylene and propylene. This agreement was valid for a term of 15 years and contained a provision requiring the parties to negotiate its extension prior to its expiration in 2020. This agreement also contained a provision pursuant to which Petrobras was required to notify us at least two years prior to its expiration of its intention to renew the agreement, and if Petrobras notified us of its intention not to renew it, then the agreement would remain valid under its original terms and conditions for eight additional years until 2028.

   
 80 

In December 2017, Petrobras informed us that they would not renew this agreement on the same terms and conditions. Therefore, the contract will remain valid under its original terms and conditions until 2028.

The impact of the new terms and conditions of a possible future agreement after 2028 and any failure to successfully negotiate such terms with Petrobras could impair our ability to satisfy our refinery off gas needs.

Under the terms of this agreement, which represents 100% of our refinery off gas supply:

·we are required to purchase a minimum daily volume of refinery off gas, and Petrobras is required to sell a minimum daily volume to us;
·the price for refinery off gas is based on a variety of market references;
·the contract will be amended in the event that unforeseen extraordinary events occur that cause a disruption in the economic-financial equilibrium of the contract;
·Petrobras may terminate the contract, without prior notice, in the event of: (1) our failure to cure any breach of the contract following a 30-day grace period; (2) a force majeure event that prevents the execution of the contract; (3) a transfer or pledge by us, as a guarantee for indebtedness, of all or part of our rights, obligations and credits under this contract to a third party without Petrobras’ consent, unless the third party is a member of our economic group; (4) the dissolution or bankruptcy of Braskem S.A.; or (5) a change in business structure, merger, sale, spin-off or any other corporate reorganization of Braskem S.A. that conflicts with or impedes the execution of contract’s purpose.

Electricity

To supply our industrial operations in Brazil, which represented 76.4% of our global electric consumption in 2022, we self-generated 24.2% of our electrical energy consumption. 33.1% of our demand in 2022 was supplied by Companhia Hidrelétrica do São Francisco, or CHESF, a Brazilian government-owned electric power generation company, pursuant to a power purchase agreement that will remain valid until 2037. The remaining energy is supplied primarily under long-term contracts with several suppliers in the free energy market (Mercado Livre de Energia).

Braskem’s electricity consumption in 2022 was 76.4% from renewable sources, considering the purchase of renewable energy, including renewables certificates, renewables asset contracts and renewable percentage of the grid. This percentage was 5% higher than in 2021.

Natural Gas

Natural gas is supplied to our industrial operations in Brazil under long-term contracts in the regulated market by companies that have government licenses and exclusivity to deliver it in each state. The natural gas consumed by our operations in Brazil in 2022 represented 63.4% of our consolidated consumption.

Others

In the Southern Complex until June 2021, we also buy methanol to produce MTBE and ethanol to produce the “green polyethylene.” After June 2021 we purchased ethanol to produce the “green polyethylene” and ETBE. Methanol is imported and its price is based on international market quotations. Ethanol is bought in the domestic market from several producers. In the Bahia Complex, we also buy ethanol to produce ETBE.

   
 81 

Sales and Marketing of Our Chemicals Operations that are Part of our Brazil Segment

We sell most of our chemical products in Brazil to third-party petrochemical producers. We sell the remainder of our chemical products to customers in the United States, Europe, South America and Asia.

Domestic Sales of Chemicals

As part of our commercial strategy, our chemicals operations that are part of our Brazil Segment focuses on developing long-term relationships with our customers and entering into long-term supply contracts that provide for minimum and maximum quantities to be purchased on a monthly basis. The domestic market pricing is based on international market references.

Export Sales of Chemicals

International market prices are also based on international market references, which usually vary according to the region to which the product is exported.

We are focused on maintaining our leading position in the Brazilian market, while continuing to use our exports to optimize our operations and adjust the imbalances between demand and production. Since we export large volumes of certain products, we also develop long-term relationships with international customers through contracts that minimize our exposure to market conditions and mitigate risk.

Competition

Our chemical customers, which are mostly second generation petrochemical producers with plants located in the Brazilian petrochemical complexes, would have difficulty obtaining their feedstocks from other sources at lower prices due to the high cost of transportation of these products, as well as other logistical difficulties. In addition, because Brazil produces enough olefins to meet domestic demand, imports of these products are generally sporadic and usually related to scheduled plant maintenance shutdowns or to meet unsatisfied domestic demand.

During the past several years, as the relative cost of naphtha and gas as feedstock for petrochemical crackers has diverged, many crackers using gas as a feedstock have become low-cost producers in the global markets and have seen their margins improve as compared to naphtha crackers. Competition in the international markets for these products is primarily based on the price of delivered products and competition has increased since mid-2008 as the balance between supply and demand was disrupted due to the impact of the global economic downturn on consumers of these products. In the international markets for our Chemical products, we compete with many producers, some of which are substantially larger and have substantially greater financial, manufacturing, technological and marketing resources than us.

Polyolefins Operations that are Part of our Brazil Segment

As of December 31, 2022, our polyolefins production facilities had the largest annual production capacity of all second-generation producers of polyolefins products in Latin America. Our polyolefins operations that are part of our Brazil Segment is comprised of the operations conducted by us at nine polyethylene plants and five polypropylene plants located in the Northeastern Complex, the Southern Complex, the São Paulo Complex and the Rio de Janeiro Complex.

Products of Our Polyolefins Operations that are Part of our Brazil Segment

Our polyolefins operations that are part of our Brazil Segment produce:

   
 82 
·polyethylene, including LDPE, LLDPE, HDPE, UHMWPE, EVA and “green polyethylene” from renewable resources; and
·polypropylene.

We manufacture a broad range of polyolefins for use in consumer and industrial applications, including:

·plastic films for food, agricultural and industrial packaging;
·bottles, shopping bags and other consumer goods containers;
·automotive parts;
·engineering and infra-structure goods; and
·household appliances.

The following table sets forth a breakdown of the sales volume of our polyolefins operations that are part of our Brazil Segment by product and by market for the years indicated.

 

Year Ended December 31,

 

2022

2021

2020

  (in thousands of tons)
Domestic sales:      
Polyethylene(1) 1,835.2 1,789.7 1,886.7
Polypropylene 1,183.8 1,208.7 1,250.3
Total domestic sales 3,019.0 2,998.4 3,137.0
Total export sales 826.7 822.0 1,051.8
Total polyolefins sales

3,845.7

3,820.4

4,188.8

 

  (1) Includes EVA and Green PE.
     

We provide technical assistance to our customers to meet their specific needs by adapting and modifying our polyethylene and polypropylene products. We believe that the variety of technological processes at our polyolefins plants provides us with a competitive advantage in meeting our customers’ needs.

Production Facilities of Our Polyolefins Operations that are Part of our Brazil Segment

As of December 31, 2022, our polyolefins operations that are part of our Brazil Segment owned 14 production plants. Our polyolefins operations that are part of our Brazil Segment operate five plants located in the Southern Complex, three plants located in the Northeastern Complex, four plants located in the São Paulo Complex and two plants located in the Rio de Janeiro Complex.

The table below sets forth our annual production capacity for each of our primary polyolefins products as of December 31, 2022 and annual production for the years presented.

  Annual Production

Production
For the Year Ended December 31,

Primary Products

Capacity

2022

2021

2020

  (in tons)
Polyethylene:        
LDPE/EVA(1) 795,000 611,380 586,205 644,747
HDPE/LLDPE/UHMWPE(2) 2,260,000 1,841,043 1,858,824 1,927,512
Polypropylene(3) 1,850,000 1,397,811 1,511,794 1,568,723

 

  (1) Represents capacity and production at five production facilities, part of them with swing line capacity capable of producing two types of resins.

 

   
 83 

 

  (2) Represents capacity and production at seven production facilities, part of them with swing line capacity capable of producing two types of resins. Capacity varies depending on actual production demands.

 

  (3) Represents capacity and production at five plants.

 

In September 2010, we commenced production of ethylene at a new plant located in the Southern Complex that produces “green” ethylene using sugar cane ethanol received through the Santa Clara Terminal as its primary raw material. This plant has an annual production capacity of 200,000 tons of ethylene, which is expected to be expanded to 260,000 tons of green ethylene in 2023.

Raw Materials, Other Materials and Utilities of Our Polyolefins Operations that are Part of our Brazil Segment

Raw Materials

Ethylene and Propylene

The most significant feedstock of our production of polyethylene and polypropylene are ethylene and propylene that are produced by our chemicals operations that are part of our Brazil Segment. In 2022, our polyolefins operations that are part of our Brazil Segment consumed all of the ethylene and part of the propylene produced by our chemicals operations that are part of our Brazil Segment.

Other Materials and Utilities

Our polyolefins operations that are part of our Brazil Segment use butene and n-hexane as raw materials in the production of HDPE and LLDPE. Butene is consumed from our chemicals operations that are part of our Brazil Segment, and we import n-hexane from suppliers located in the U.S. Gulf Coast.

Our Unipol polyethylene plants in the Northeastern Complex and Rio de Janeiro Complex use catalysts supplied by Univation Technologies. Our HDPE plant in the São Paulo Complex uses catalysts supplied by W.R. Grace & Co. The catalysts for our swing line LLDPE/HDPE plants are purchased from Basell Poliolefine Italia S.R.L. and Equistar Chemicals, L.P (collectively, “Basell”). We produce our own catalysts for our HDPE slurry plants in the Southern and Northeastern Complexes, and we purchase the inputs that we need to produce these catalysts from various suppliers at market prices. Our polypropylene plants use catalysts primarily supplied by Basell, while we import certain catalysts from suppliers in the United States and Europe.

Supply of Our Polyolefins Operations that are Part of our Brazil Segment

Propylene Contracts with Petrobras and its Subsidiaries

We have entered into multiple propylene agreements, which had initial terms expiring at various dates between May 2021 and December 2029, some of which were automatically renewed for five additional years and are priced based on international references to assure competitiveness of feedstock.

In 2016, Braskem entered into an agreement with Petrobras for a five-year propylene supply contract with Refap S.A., a subsidiary of Petrobras. This supply contract is also priced based on international references. In October 2021, Petrobras and Braskem renewed for one year the propylene supply contract with REFAP. The contract lasted between November 2021 and October 2022 and had the same volume and pricing conditions as the previous contract.

In December 2021, Petrobras and Braskem entered into five new propylene contracts, to be supplied by REPLAN, REVAP, REPAR, REDUC and RECAP, which replaced the existing contracts. These contracts expire between 2026 and 2029 and are priced on international references to assure the competitiveness of feedstock.

   
 84 

Petrobras may terminate these contracts, without prior notice, in the event of: (1) our failure to cure any breach of the contract following a 30-day grace period; (2) a force majeure event occurs, although some of these contracts require that the force majeure event continues for more than 180 days; (3) we transfer or offer as a guaranty all or part of its rights and obligations under the contract to a third party without Petrobras’ consent; (4) an alteration of Braskem management or corporate purposes that conflicts with the purpose of the contract; (5) the dissolution, bankruptcy or liquidation of Braskem; and (6) a change of entity type, merger, sale, spin-off or any other corporate reconstruction of Braskem that conflicts with or impedes the execution of contract’s purpose.

Ethanol Supply Contracts

We buy ethanol from Brazilian producers to supply our facility that produces ethylene and ETBE, using sugar cane ethanol. We have two major ethanol supply agreements that expire in 2024. We also purchase ethanol on the spot market from time to time to supplement the contracted volumes. Under the contracts we have, we are or will be required to purchase an annual supply of ethanol sufficient to meet at least 90% of the capacity of this ethylene plant. The price we pay under these contracts is or will be determined by reference to the price of combustible hydrated alcohol as published by the Center for Advanced Studies in Applied Economics of the Superior School of Agriculture (Centro de Estudos Avançados em Economia Aplicada da Escola Superior de Agricultura– CEPEA/ESALQ).

Other Materials and Utilities

Our polyolefins operations that are part of our Brazil Segment use butene and n-hexane as raw materials in the production of HDPE and LLDPE. Butene is consumed from our chemicals operations that are part of our Brazil Segment, and we import n-hexane from suppliers located in U.S. Gulf Coast.

Our Unipol polyethylene plants in the Northeastern Complex and Rio de Janeiro Complex use catalysts supplied by Univation Technologies. Our HDPE plant in the São Paulo Complex uses catalysts supplied by W.R. Grace & Co. The catalysts for our swing line LLDPE/HDPE plants are purchased from Basell Poliolefine Italia S.R.L. and Equistar Chemicals, L.P, or, collectively, Basell. We produce our own catalysts for our HDPE slurry plants in the Southern and Northeastern Complexes, and we purchase the inputs that we need to produce these catalysts from various suppliers at market prices. Our polypropylene plants use catalysts primarily supplied by Basell, while we import certain catalysts from suppliers in the United States and Europe.

Sales and Marketing of Our Polyolefins Operations that are Part of our Brazil Segment

Through our polyolefins operations that are part of our Brazil Segment, we sell polyethylene and polypropylene products to 1,475 customers worldwide. We have a diversified product mix that allows us to serve a broad range of end users in several industries. The customers of our polyolefins operations that are part of our Brazil Segment generally are third generation petrochemical producers that manufacture a wide variety of plastic-based consumer and industrial goods.

Domestic Sales

We are focused on developing long-term relationships with our customers. Given the cyclical nature of the markets for our polyolefins products, we believe that we can strengthen customer loyalty during periods of reduced demand for polyethylene or polypropylene by providing a reliable source of supply to these customers during periods of high demand. We work closely with our customers to provide technical assistance and to coordinate the production and delivery of our products. Despite having a regular client basis in the domestic market, prices in such market are driven by monthly spot negotiations. Both sales volume per client and the types of products our clients purchase may vary on a monthly basis.

   
 85 

In addition to direct sales of polyolefins to our customers, through our polyolefins operations that are part of our Brazil Segment we sell products in Brazil through exclusive independent distributors. Our polyolefins operations that are part of our Brazil Segment is served by five distributors, through which we distribute our products pursuant to formal agreements and spot market transactions. We have selected our distributors based on their ability to provide full service to their customers, and also based on their background. These distributors sell our polyethylene and polypropylene products to manufacturers with lower volume requirements and are able to aggregate multiple orders for delivery. They have a wide coverage network in Brazil and, as a result, expand the Braskem brand.

Furthermore, by providing customized services and serving smaller customers through a network of distributors, our account managers focus their efforts on delivering high quality service to a smaller number of large and medium direct customers.

Export Sales

Our volume of polyolefins export sales has generally varied based upon the level of domestic demand and the total production availability for our products. Our polyolefins operations that are part of our Brazil Segment has sales office in Argentina, Chile, Peru and Colombia. These offices are used to consolidate our marketing efforts in South America, one of our key markets outside of Brazil for this business unit. Our polyolefins operations that are part of our Brazil Segment also uses our European, Mexican and U.S. sales force in order to improve the profitability of our sales. In each of these regions, we have specific commercial strategies in connection with exports coming from Brazil, which complements our local product availability.

We have established a strategic position in the polyolefins business in South America, North America, Europe and Asia through regular direct sales, local distributors and agents who understand their respective markets. Our strategy to increase our presence in these foreign markets is intended, among other things, to reduce our exposure to the cyclicality of the international spot market for polyolefins through the development of long-term relationships with customers in neighboring countries. Our local presence allows us to further enhance our position in those markets and sell our polyolefins operations that are part of our Brazil Segments products through our USA and Europe Segment.

The main focus of our polyolefins operations that are part of our Brazil Segment is to maintain our leading position in the Brazil and South America reinforcing our commitment to the plastic industry chain in the region, maintaining our position as a leader in polyolefins through a continued local presence and regular product supply.

Prices and Sales Terms

We determine the prices of our products in accordance with international pricing references. In addition, we consider segment, volume, and other information when we set our prices. Our customers in Brazil may pay in full on delivery or elect credit terms that require payment in full within three to 60 days following delivery. We charge interest based on prevailing market rates to our Brazilian customers that elect to pay on credit.

In addition, besides our strategic sales to South America, Europe, Mexico and the United States, our polyolefins operations that are part of our Brazil Segment generally conducts export sales to buyers in Asia and Africa through the international spot market. Our customer base in these markets consists primarily of trading houses and distributors. Pricing is based on international spot market prices.

   
 86 
Competition

We are the only producer of polyethylene and polypropylene in Brazil. We compete with polyolefins producers worldwide. In 2022, Brazilian polyethylene and polypropylene imports decreased by 0.4% and represented 35.8% of Brazilian polyolefin consumption.

We compete for export sales of our polyolefins products in other countries in Latin America and in the North American, Asian and European markets. Similar to Braskem, those competitors also have a wide portfolio, ample research and development capabilities and sufficient production capacity. Our competitive position in the export markets that we serve is based on customer relationship, extensive product portfolio, product quality and customer service and support.

We are the only green polyethylene producer in the world, made by sugar cane that is 100% verified by ASTM D6866.

Vinyls Operations that are Part of our Brazil Segment

We were the leading producer of PVC in Brazil, based on sales volumes and installed capacity in 2022. As of December 31, 2022, our PVC production facilities had the largest annual production capacity in South America, according to CMA.

Our PVC production is integrated through our production of chlorine, ethylene and other raw materials. The main use of PVC is for pipes and fittings and other products related to the civil construction market. Our vinyls operations that are part of our Brazil Segment also manufacture caustic soda, which is mainly used by producers of alumina, pulp and paper, and in the soap industry.

In 2022, we had an approximate 51.0% share of the Brazilian PVC market and 29.5% of market share of the Brazilian caustic soda market (excluding consumption of alumina by companies located in the North and Northeast of Brazil), based on sales volumes of our vinyls operations that are part of our Brazil Segment.

Products of Our Vinyls Operations that are Part of our Brazil Segment

The following table sets forth a breakdown of the sales volume of our vinyls operations that are part of our Brazil Segment by product line for the years indicated.

 

For the Year Ended December 31,

 

2022

2021

2020

  (in thousands of tons)
PVC 498.7 495.4 525.7
Caustic soda 402.6 315.7 150.6
Other(1)  23.7 22.4

34.4

Total domestic sales

925.0

833.5

710. 7

Total export sales

0.6

8.9

21.7

Total vinyls sales

925.6

842.4

732.4

 

  (1) Includes chlorine, hydrogen, caustic soda flake and sodium hypochlorite.

Production Facilities of Our Vinyls Operations that are Part of our Brazil Segment

We own four vinyls production facilities. One of our facilities is located in the Northeastern Complex, and three others are located in the State of Alagoas.

In January 2020, Braskem announced the permanent shutdown of its chlor-alkali production facility located in Camaçari, in the State of Bahia, whose operations started in 1979 with annual production capacity of 79,000 tons of caustic soda and 64,000 tons of chlorine. The shutdown is explained by the end of the facility’s useful life and started in April 2020, following applicable safety standards and seeking to protect people, local communities and the environment.

   
 87 

The table below sets forth for each of our primary vinyls products, our annual production capacity as of December 31, 2022 and annual production for the years presented.

  Annual Production

Production
For the Year Ended December 31,

Primary Products

Capacity

2022

2021

2020

    (in thousands of tons)
PVC 710.0 469.8 465.0 448.5
Caustic Soda 460.0 242.2 187.5 9.0

Raw Materials of the Vinyls Operations that are Part of our Brazil Segment

Ethylene

The most significant feedstock associated with the production of PVC is ethylene. Our chemicals operations that are part of our Brazil Segment supply all of the ethylene required by our vinyls operations that are part of our Brazil Segment.

Electricity

Electric power is a significant cost component in our production of chlorine and caustic soda. Our vinyls operations that are part of our Brazil Segment obtains its electric power requirements from various generators under long-term power purchase agreements (see “Chemicals Operations that are Part of our Brazil Segment—Supply Contracts and Pricing of the Chemicals Operations that are Part of our Brazil Segment—Electricity”).

Salt

We used 508,632 tons of salt during 2022.

However, salt mining operations at our mine were halted in May 2019, as described in “Item 3. D Risk Factors—Risks Relating to Us and the Petrochemical Industry—Our business and operations are inherently subject to environmental, health and safety hazards. As a result, our business is also subject to stringent environmental and other regulations” and “Item 8. Financial Information—Legal Proceedings—Alagoas – Mining Activities.” Production of caustic soda and ethylene dichloride at our chlor-alkali facility located in the state of Alagoas was also interrupted due to the lack of salt. Ethylene dichloride, or EDC, is consumed in PVC production. In 2022, we needed to import 206,000 tons of caustic soda to supply our customers and 119,830 tons of EDC to supply our PVC facilities located in the state of Alagoas and in the Northeastern Complex.

Seeking to resume our chlor-alkali operations, we launched a project to modify the feedstock base of our chlor-alkali plants by acquiring sea salt from third parties in Brazil or abroad. The product was stocked, dissolved in water to make brine and then treated and sent for processing. After concluding the commissioning process in accordance with applicable safety standards, we started production of chlor-alkali and dichloroethane at our unit located in the Pontal da Barra district of Maceió, in the state of Alagoas, which had been idled since May 2019.

Sales and Marketing of Our Vinyls Operations that are Part of our Brazil Segment

There is a structural link between the PVC and caustic soda markets because caustic soda is a co-product of the production of chlorine required to produce PVC. Most of the time, when demand for PVC is high, greater amounts of caustic soda are produced, leading to an increase in supply and generally lower prices for caustic soda. Conversely, when demand for PVC is low, prices for caustic soda tend to rise.

   
 88 

We make most of our sales of PVC and caustic soda directly to Brazilian customers, but we use third-party distributors to serve smaller caustic soda customers. However, our vinyls operations that are part of our Brazil Segment maintain contractual relationships through five distribution centers that provide logistical support, located in Paulínia and Barueri, both in the State of São Paulo, Joinville, in the State of Santa Catarina, Extrema, in the State of Minas Gerais, and Araucaria, in the State of Paraná. In addition, we operate 12 warehouse facilities for PVC, on a non-exclusive basis, and five terminal tank facilities for caustic soda strategically located along the Brazilian coast to enable us to deliver our products to our customers on a “just-in-time” basis. Our vinyls operations that are part of our Brazil Segment develops its business through close collaboration with its customers, working together to improve existing products as well as to develop new applications for PVC. Our marketing and technical assistance groups also advise current customers and potential customers that are considering the installation of manufacturing equipment for PVC downstream products.

In addition, our vinyls operations that are part of our Brazil Segment supplies the Brazilian market with emulsion PVC and other copolymers with higher value by imports through traders. Our primary customers operate in the laminated, shoe and automobile sectors. These products represented 0.3% of our consolidated sales volume in 2022.

Prices and Sales Terms

The domestic price for PVC resins is based on the import parity of PVC imported by converters in Brazil, which generally reflects the Northeast Asian spot market price, plus exchange rate variation. Delivery time, quality and technical service also affect the levels of sales of PVC resins. We establish our domestic price for caustic soda based on North American spot market prices, plus exchange rate variation.

Competition

PVC

Unipar Indupa (formerly Carbocloro and Solvay), or Unipar, and Braskem are the only two producers of PVC in Brazil. Unipar’s total Brazilian installed annual production capacity is 300,000 tons, compared to our annual production capacity of 710,000 tons. Unipar’s Brazilian production facilities are located in São Paulo, which is closer to the primary PVC market in Brazil than our facilities. However, we believe that our vertically integrated production capabilities, our strong relationship with our customers and our technical assistance programs enable us to make up for any competitive disadvantage due to distance and compete effectively with Unipar.

Braskem also competes with Unipar’s Argentina production facilities and other importers of PVC. Unipar has a PVC plant in Argentina in addition to its plants in Brazil. Imports from all regions accounted for 29.5% of Brazilian PVC consumption in 2022. Domestically produced PVC is currently competitively priced with imported PVC, considering that our price is based on the international market.

In addition, Braskem competes with other producers of thermoplastics that manufacture the same PVC products or substitutes for products in our PVC product line. Thermoplastic resins, principally polyethylene and polypropylene, are used in certain applications as substitutes for PVC. Wood, glass and metals also are used in some cases as substitutes for PVC.

Caustic Soda

According to CMA and Abiclor (Associação Brasileira da Indústria de Álcalis, Cloro e Derivados), the three largest Brazilian producers of caustic soda, including Braskem, accounted for 91% of capacity in Brazil

   
 89 

in 2022. Most domestic producers operate on a local or regional basis, with the exception of Braskem and another producer located in the Northeast region of Brazil that operate in the whole country through terminal tanks located on the Brazilian coast. Imports accounted for 31.5% of Brazil’s total caustic soda consumption in 2022, excluding Braskem imports. Due to the mining event in Alagoas, our chlor-alkali plant was idled in 2019 and we have been importing caustic soda from various sources to keep supplying customers in Brazil since then.

Our principal competitors in the caustic soda market elsewhere in South America are other international petrochemical companies operating in Brazil and producers located on the U.S. Gulf Coast.

USA and Europe Segment

Our USA and Europe Segment includes:

·the operations of Braskem America, which consist of five polypropylene plants in the United States and one Ultra High Molecular Weight Polyethylene – the UTEC® plant; and
·the operations of two polypropylene plants in Germany.

As of December 31, 2022, our USA and Europe Segment’s facilities had the largest annual polypropylene production capacity in the United States. Our USA and Europe Segment generated net revenue of R$23,421.1 million during 2022, or 23.8% of the net revenue of all reportable segments.

In June 2014, we announced the construction of an UHMWPE production line in our La Porte, Texas site, which began producing UTEC® in the first quarter of 2017. We believe that the production of specialized UHMWPE at this line complements our existing portfolio of products and will enable us to access new markets and to develop close relationships with new and existing clients.

In June 2017, we announced the construction of a Polypropylene Unit (“Delta”) at our La Porte, Texas site. Aligned with the strategy to diversify the raw materials matrix and geographic expansion in the Americas, this is a new world-class PP production facility with an annual polypropylene production capacity of 450,000 tons. In September 2020, we announced that after completing the commissioning phase, we have started commercial production of PP at this new plant. We believe that this investment reinforces our PP leadership position in the region, as it will enable us to replace imported PP volumes in the North American domestic market and also scale up our exports supporting structural global demand with existing global clients.

Products of Our USA and Europe Segment

Our USA and Europe Segment produces polypropylene. The sales volume of polypropylene by this unit was 2,156,289 tons in 2022, 2,217,055 tons in 2021 and 1,968,146 tons in 2020. For a description of the uses of our polypropylene products, see “—Polyolefins Operations that are Part of our Brazil Segment.”

Production Facilities of our USA and Europe Segment

The table below sets forth the annual production capacity as of December 31, 2022 of the USA and Europe Segment’s polypropylene plants in the United States and Germany and the annual production for the years presented.

   
 90 

 

 

Annual

Production

Capacity

Production
For the Year Ended December 31,

Plant

 

2022

2021

2020

  (in thousands of tons)
United States 2,021,000 1,603.7          1,728.6 1,446.1
Germany 625,000 504.3             570.2 493.3

Raw Materials of Our USA and Europe Segment

Propylene

The most significant direct cost associated with the production of polypropylene by our USA and Europe Segment is the cost of purchasing propylene.

As a result of rising natural gas production and related production of natural gas liquids, several companies have announced plans to build propane dehydrogenation, or PDH plants, which would produce on-purpose propylene. We have secured a long-term propylene agreement of 15 years with one such company, Enterprise Products, which completed construction of a PDH plant in Texas in 2017 with an annual capacity of 750,000 tons. We expect this agreement with an established producer to provide us with a competitive, long-term supply of propylene, using shale gas and other nontraditional sources as its feedstock. This plant commenced operations in 2017. Under this arrangement, the pricing of these contracts will be based on market prices for propane and other market costs.

Supply Contracts of Our USA and Europe Segment

 

We acquire propylene for our polypropylene plants in the Unites States under a variety of long-term supply agreements and through the spot market. As of December 31, 2022, we had 19 propylene supply agreements and two ethylene supply agreements. The pricing formulas for propylene under these supply agreements are generally based on international market prices.

We acquire propylene for our polypropylene plants in Germany under long-term supply agreements that provide for the supply of 90% of the propylene requirements of these plants. We have two main supply agreements in Germany. One has a five-year agreement effective since October 1, 2021 with a term until September 30, 2026, and thereafter will automatically be renewable for consecutive one-year terms, unless terminated by one of the parties. The other agreement expires in December 2023, and thereafter will also be automatically renewable for consecutive one-year terms, unless terminated by one of the parties. We have entered into a third contract that will expire at the end of 2022, increasing the supply of our plants to 93% of the propylene required. The pricing formula for propylene under these supply agreements is based on market prices. We purchase the propylene used in our Europe plants based on monthly contract price for propylene for Europe (as reported by ICIS-LOR).

Sales and Marketing of Our USA and Europe Segment

Our USA and Europe Segment sells polypropylene products to 407 customers. We have a diversified product mix that allows us to serve a broad range of end users in several industries. The customers of our USA and Europe Segment generally are third generation petrochemical producers that manufacture a wide variety of plastic-based consumer and industrial goods.

The following table sets forth our net revenue derived from sales of our USA and Europe Segment for the years indicated:

   
 91 

 

 

For the Year Ended December 31,

 

2022

2021

2020

  (in millions of reais)
Net revenue:      
USA and Europe 23,421.1 32,403.6 14,638.7

 

In the USA and Europe Segment, contracts or general supply agreements with our clients account for 74.9% of polypropylene sales. These contracts typically last one year and have the option of being renewed at the end of the term. Additionally, these agreements specify required minimum and maximum purchase quantities as well as monthly deliveries.

The remainder of the polypropylene production of the USA and Europe Segment is sold through (1) our direct sales force that seeks to establish supply relationships with customers; (2) a select number of distributors authorized to represent the Braskem brand in the U.S. and European markets; (3) resellers that trade these products under private labels in the North American and European markets; and (4) traders that resell these products in the export markets.

Prices and Sales Terms

The domestic price for PP resins in the USA and Europe Segment reflects the market price, considering the differences between contract and spot prices, or propylene plus pricing. Delivery time, quality and technical service also affect the levels of sales of resins and usually export prices for PP are based on spot market references.

Competition

The USA and Europe Segment is largely a commodities business and competes with local, regional, national, and international companies, some of which have greater financial, research and development, production and other resources than us. Although competitive factors may vary among product lines, our competitive position is primarily based on raw material and production costs, selling prices, product quality, product technology, manufacturing technology, access to new markets, proximity to the market and customer service and support.

Our primary competitors for sales in the polypropylene industry in North America and Europe are other large international petrochemical companies. In general, demand is a function of economic growth in North America, Europe and elsewhere in the world.

Mexico Segment

Braskem and Idesa, one of Mexico’s leading petrochemical groups, formed Braskem Idesa S.A.P.I. in April 2010, with Braskem holding 75% of the total share capital and Idesa holding the remaining 25%, to develop, construct and operate the Mexico Complex, located in the Mexican state of Veracruz. During April 2016, Braskem Idesa commenced commercial operations of the Mexico Complex.

As of December 31, 2022, our Mexico Segment had the largest annual polyethylene production capacity in Mexico. Our Mexico Segment generated net revenue of R$5,834.0 million during 2022, or 6.0% of the net revenue of all of our reportable segments.

   
 92 

Products of Our Mexico Segment

Our Mexico business unit produces ethylene, HDPE and LDPE at our Mexico Complex. We use all of the ethylene produced by our Mexico Complex as raw material for the production of polyethylene by this complex. The sales volume of polyethylene by this unit was 766,558 tons in 2022. Our Mexico Complex manufactures a broad range of polyethylene grades for use in consumer and industrial applications, including plastic films for food and industrial packaging, bottles, shopping bags and other consumer goods containers, automotive parts, and household appliances.

Technologies selected for the Mexico Segment are proven and considered stated of the art with excellent track records in the petrochemical market and we believe it provides a competitive advantage in serving our customers to meet their specific needs by adapting and modifying our polyethylene products.

Production Facilities of Our Mexico Segment

Our Mexico Segment operates four plants located in the Mexico Complex, consisting of:

·an ethylene cracker, with an annual production capacity of 1,050,000 tons of ethylene, which commenced operations in March 2016;
·two high-density polyethylene plants, with a combined annual production capacity of 750,000 tons, which commenced operations in April 2016;
·a low-density polyethylene plant, with an annual production capacity of 300,000 tons, which commenced operations in June 2016;
·a 150-megawatt power generation plant consisting of one gas turbine and two steam turbines; and
·an effluents treatment plant and a water treatment plant, which return water to the community in a condition that exceeds the applicable regulatory requirements.
  Annual Production

Production
For the Year Ended December 31,

Plant

Capacity

2022

2021

2020

 
 
   
Mexico (Polyethylene) 1,050,000 765,314 696,142    780,176
         

Raw Materials of Our Mexico Segment

The principal raw material used in our Mexico Complex is ethane, in addition to other raw materials such as hexane, propylene and polyaldehyde (PAL). Other chemicals, catalyzers, additives and utilities such as natural gas, electricity and nitrogen are used to produce polyethylene in the Mexico Complex.

Ethane

Ethane is the principal raw material that we use to produce ethylene in the Mexico Complex and represents the principal production and operating cost of the Mexico Complex. The price of ethane that we purchase varies based on changes in the U.S. dollar-based U.S. reference price of these feedstocks. We currently source ethane, from two main sources. Approximately 50% to 60% of total ethane needs is sourced under the Ethane Supply Agreement with Pemex TRI, a state-owned Mexican entity, while the remaining is complemented with imported ethane coming from the United States and delivered to our Complex through freight trucks that transport cryogenic isocontainers as part of the Fast Track Solution.

   
 93 

Braskem Idesa also intends to develop the Ethane Import Terminal, a long-term alternative source of imported ethane, and a pipeline that will connect the terminal directly to our Complex, through its subsidiary Terminal Química Puerto Mexico, S.A.P.I. (“TQPM”). The expected ethane capacity of the Ethane Import Terminal would be enough to fulfill the total ethane needs for the Mexico Complex. This terminal would provide the capacity to import more ethane than we currently require. As a result, our Mexico Segment will be able to source its total needs towards increasing our polyethylene production and taking advantage of the forecasted demand for polyethylene products in North America and globally.

The estimated cost of the Ethane Import Terminal and related infrastructure investment was revised to US$446 million (R$2,087.1 million), after the conclusion of several activities related to licenses, purchase of land and easement contracts, and a review of project and implementation costs for the new company. Our Mexico segment expects to participate with up to 50% of the shares issued by the company that will develop the Ethane Import Terminal. We intend to fund our investment in the Ethane Import Terminal with a combination of equity and debt, through a joint venture.

On June 13, 2022, Braskem Idesa and TQPM entered into a stock purchase agreement with Advario, B.V., a carve-out of Oiltanking GmbH for a 50% equity stake in TQPM, subject to certain conditions precedent. The Mexican Antitrust agency (COFECE) approved such purchase on October 3, 2022.

On March 1, 2023, Braskem Idesa met the conditions precedent for the conclusion of the investment agreement signed with Advario, receiving the payment of R$292.2 million (US$56 million) referring to the capital contribution disbursed, which was equivalent to 50% interest in TQP’s capital by Braskem Idesa until the respective date, totaling R$584.4 (US$112 million). The Ethane Import Terminal is expected to be completed and to reach full capacity by the end of 2024, but there may be delays.

For additional information, see “Item 3. D Risk Factors— Risks Relating to Us and the Petrochemical Industry — We depend on ethane supplied by Pemex TRI in Mexico,” and “—We rely on limited or sole-source suppliers for our raw materials, inputs and energy, including transportation thereof.”

Ethylene

All of the ethylene produced by our Mexico Complex is used by the polyethylene plants in our Mexico Complex.

Other Materials and Utilities

Our Mexico Segment uses natural gas as the main fuel for its production process, which is supplied mainly private suppliers using the pipelines that are the property of the Centro Nacional de Control del Gas Natural (“Cenagas”).

In the first quarter of 2021, Braskem Idesa entered into a natural gas transport service agreement with Cenagas for a term of 15 years, which is in full force and effect.

For additional information, see “Item 3.D Risk Factors—Risks Relating to Us and the Petrochemical Industry—We depend on ethane supplied by Pemex TRI in Mexico,” “—We rely on limited or sole-source suppliers for our raw materials, inputs and energy, including transportation thereof” and “—Political and economic conditions and government policies in Mexico, including political interferences in state-owned companies such as Pemex TRI and Cenagas, and elsewhere may have a material impact on our operations.”

   
 94 

Our Mexico Segment uses hexene as a raw material in the production of HDPE. We import hexene for the Mexico Complex from suppliers located in the United States.

Our Mexico Segment uses catalysts supplied by Ineos Europe Limited.

Supply Contracts of the Mexico Segment

Ethane

The primary feedstock in our polyethylene production process is ethane. Braskem Idesa currently sources ethane from two main sources: (i) locally, pursuant to the Ethane Supply Agreement with Pemex TRI, a state-owned Mexican entity; and (ii) imports from the United States and delivered to our Complex through freight trucks that transport cryogenic isocontainers as part of the Fast Track Solution. As of the years ended December 31, 2020, 2021 and 2022, ethane supply from Pemex TRI was 87%, 65% and 60% respectively and 13%, 35% and 40% respectively, from the Fast Track Solution.

Ethane Supply Agreement (Pemex TRI).

Braskem Idesa is party to an ethane supply agreement with Pemex TRI, a subsidiary of Pemex, dated February 19, 2010, based on commercial conditions (“BI’s Ethane Supply Agreement”).

On September 27, 2021, we signed the third amendment to the BI’s Ethane Supply Agreement (the “Amended ESA”). Upon effectiveness, the Amended ESA modified certain terms of the BI’s Ethane Supply Agreement, including:

·with respect to our Mexico Segment, we agreed to reduce the contractual volume to be purchased on a deliver or pay basis from 66,000 to 30,000 barrels of ethane per day (“Contractual Volume”), until February 2025, provided that, if we suffer delays in obtaining licenses and permits to operate the Ethane Import Terminal attributable to Mexican governmental authorities or Pemex, Pemex TRI will deliver the contractual volume after February 2025 for the time caused by these delays, on a day-by-day basis. Currently, Pemex TRI and Braskem Idesa have entered into a semi-annual agreement to extend the contractual volume until May 31 2025. In the event of any extension concerning the supply period of the Contractual Volume or non-achievement of the commencement of the Ethane Import Terminal’s commercial operations due to the longstop date under the Amended ESA (the “Contractual Volume Longstop Date”), then Pemex TRI will supply, for an additional period of up to 12 months, 15,000 barrels per day of ethane to Braskem Idesa during the period from the Contractual Volume Longstop Date (or such later date) until the Ethane Import Terminal COD (the “Extended Volume”);
·with respect to our Mexico segment, we have a right of first refusal to acquire ethane that Pemex TRI and its affiliates do not consume for their own processes or for the production of ethylene and derivative products, in a daily volume of up to: (i) for as long as Pemex TRI must supply the Contractual Volume, 1,625,576 cubic meters (approximately 36,000 barrels per day); and (ii) after Pemex TRI no longer should supply the Contractual Volume, 2,980,220 cubic meters (approximately 66,000 barrels per day).
·the ethane purchase price under the Amended ESA is based on commercial conditions at prices that reference the Mont Belvieu purity ethane price, a U.S. dollar-based international reference price, plus logistics and other applicable costs. The conditions set out in the Amended ESA will have retroactive effects until February 26, 2021.If Pemex TRI fails to deliver an average daily volume of ethane below the Contractual Volume during any quarterly period, it will compensate us by providing additional volumes of ethane over the following two quarterly periods; provided that we will not have the obligation to take ethane above the contractual maximum daily volume. If Pemex TRI does not compensate for such supply shortfall during mentioned cure period, it will pay us liquidated damages at a rate equal to 50% of the volume that Pemex TRI failed to deliver and did not compensate. The cap on such liquidated damages is R$1,563.3 million (US$300.0 million) during any given year. We may terminate the Amended ESA and exercise the put option thereunder if Pemex TRI fails to deliver at least 75% of the Contractual Volume for 180 consecutive days.
   
 95 
·if Braskem Idesa fails to take an average daily volume of ethane at least equal to the Contractual Volume during any quarterly period, Braskem Idesa will compensate Pemex TRI by purchasing additional volumes of ethane over the succeeding two quarterly periods (not exceeding the contractual maximum daily volume). If our Mexico Segment does not purchase such additional volumes of ethane during such a cure period, Braskem Idesa will pay Pemex TRI liquidated damages at a rate equal to 50% of the average price of the volume that we failed to purchase and did not compensate. The cap on such liquidated damages is R$1,565.3 million (US$300.0 million) during any given year.
·as stated under the Amended ESA, the revised term is 20 years starting from the commencement date of supply under the BI’s Equity Supply Agreement, which occurred in June 2015, with three periods of extension of ten years each, being the first extension period mandatory for Pemex TRI and Braskem Idesa.
·Pemex TRI may terminate the Amended ESA in the event of (i) our failure to pay that continues for more than six months after notice; or (ii) an emergency stoppage in operations or force majeure event due to which our insurers consider the complex to be a total loss, or after which we cannot or do not resume operations for 48 months. If Pemex TRI (i) delivers less than an average of 75% of the 30,000 barrels of ethane per day over six months, (ii) reaches the annual limit in respect of liquidated damages owed by Pemex TRI to us and such limit is not waived by Pemex TRI or (iii) materially breaches any of its obligations related to the supply of ethane thereunder and such breach continues for more than six months after notice, Braskem Idesa has the right to terminate the Amended ESA, require Pemex TRI to repay certain of our outstanding debt and under termination scenarios provide compensation for equity investments according to an agreed valuation formula.

Ethane Supply Agreement (Fast Track).

On February 25, 2020, Braskem Idesa entered into an open order quantity agreement with Braskem Netherlands for the supply of liquid ethane with a minimum purity level of 95% in effect until 2021, the BNL Ethane Supply Agreement. (the “BI-BNL Ethane Supply Agreement”).

On October 9, 2021, January 24, 2022 and September 27, 2022 we entered into an amendment to the BI-BNL Ethane Supply Agreement (the “BI-BNL Ethane Supply Agreement Amendment”) in order to enhance the alternate ethane supply provided to us by the Fast-Track Solution. The purpose of the BI-BNL Ethane Supply Agreement Amendment is the additional acquisition of the supply volume of liquid ethane above the maximum amount of the BI-BNL Ethane Supply Agreement loaded from February 2021 to December 31, 2022.

Electricity and Water

The Mexico Complex has its own power generation plant consisting of one gas turbine and two steam turbines, which can generate more than 100% of the Mexico Complex’s energy consumption. In addition, the Mexico Complex is also connected to the high-voltage power grid of Comisión Federal de Electricidad (the Mexican government-owned electricity company) as an alternative power source. The Mexico complex generates all of its requirements of steam and its water requirements are supplied by the Comisión Nacional del Agua (the Mexican government-owned water commission) pursuant to an agreement that expires in 2029 and is subject to renewal.

The main feedstock used for power generation is natural gas, which is mainly supplied by private suppliers and Pemex through Cenagas. In December 2020, we received a notification from Cenagas (Centro Nacional de Control del Gas Natural), a Mexican state-owned agency solely responsible for the natural gas pipelines and transportation in Mexico, related to the unilateral non-renewal of the service of natural gas transportation, an essential energy input for the production of PE in our Mexico Segment.

   
 96 

However, in February 2021, Braskem Idesa, after negotiations with Cenagas, entered into a natural gas transport service agreement for a term of 15 years. Following the execution of this agreement by Braskem Idesa, it continued receiving natural gas transportation services from Cenagas. For additional information, see “Item 3.D Risk Factors—Risks Relating to Mexico—Political and economic conditions and government policies in Mexico, including political interferences in state-owned companies such as Pemex TRI and Cenagas, and elsewhere may have a material impact on our operations.”

Sales and Marketing of Our Mexico Segment

As of December 31, 2022, our Mexico Segment sold polyethylene products to 213 customers in the Mexican market. We have a diversified product mix that allows us to serve a broad range of end users in several industries. The customers of our Mexico Segment generally are third generation petrochemical producers that manufacture a wide variety of plastic-based consumer and industrial goods.

The following table sets forth our net revenue derived from sales of our Mexico Segment for the years indicated:

 

For the Year Ended December 31,

 

2022

2021

2020

  (in millions of reais)
Net revenue:      
Mexico 5,834.0 6,506.3 4,000.8

Domestic Mexican Sales

One of our priorities has been to develop long-term relationships with our customers and, given the cyclical nature of the markets for our polyethylene products, we believe that we can strengthen customer loyalty during periods of reduced demand for polyethylene by providing a reliable source of supply to these customers during periods of high demand. We work closely with our customers to determine their needs, to provide technical assistance and to coordinate the production and delivery of our products.

Considering our Mexico Complex’s logistical infrastructure and logistics centers in different regions, we are able to project and being able to respond faster to customer demand by region. Thus, we can anticipate and plan our production and logistics in order to make the products available on time and at the points of shipment. As our products portfolio can adjust to the nature of the demand of the Mexican market, we have greater flexibility to adapt and better serve the market.

In addition to direct sales of polyethylene to our customers, our Mexico Segment sells products in Mexico through independent distributors. Our Mexico Segment is served by distributors through which we distribute our products pursuant to formal agreements and spot market transactions.

We have selected our distributors based on their ability to provide full service to their customers, including the ability to prepare our products on a customized basis. These distributors sell our polyethylene products to manufacturers with lower volume requirements and are able to aggregate multiple orders for delivery to customers that would otherwise be uneconomical for us to serve. Furthermore, by serving smaller customers through a network of distributors, our account managers focus their efforts on delivering high quality service to a smaller number of large, direct customers.

   
 97 

Export Sales

The main focus of our Mexico Segment is to maintain our leading position in the Mexican market while continuing to export in order to manage the relationship between our production capacity and domestic demand for our products. We believe that our continued presence in export markets is essential to help manage any overcapacity in the Mexican market. The excess volume is exported to several regions such North and South America, Asia, and Europe, using our existing sales force and complementing our portfolio in those regions, in order to use the already established Braskem sales channels in the United States and Europe, the strategy of exports of the Mexico Segment production, for these regions, is to develop and retain customers, in order to seek a greater added value in exports, especially considering the competitive logistics for serving the United States. This new polyethylene complex reinforces our position with polyethylene customers worldwide, which enhances our position in North America.

Prices and Sales Terms

We determine the Mexican domestic prices for polyethylene by reference to North American export prices. Our customers in Mexico may pay in full on delivery or elect credit terms that require payment in full within 60 days, on average, following delivery for most customers.

Our Mexico Segment’s export sales consist of volumes to South America, Europe and the United States through traders and distributors. Pricing is based on international market price references. As discussed under “—Export Sales” above, since the beginning of 2017, the Mexico Segment has been focused on export sales directly to customers in the United States, Europe, Central America and the Caribbean and South America, so the price in the local of the sale, excluding the logistics costs to move the product until that place and the other variable costs, ex-raw material, of exports has been increasing.

Competition

We have the largest annual production capacity of polyethylene in Mexico. We compete in Mexico with a subsidiary of Pemex and with importers of polyethylene, primarily producers located in the United States and Canada. We compete for export sales of our polyethylene products with producers from other countries in Latin America and in markets in the United States, Latin America and Europe. Our export business is a commodity business and we compete with a variety of resin producers, some of which have greater financial, research and development, production and other resources than us. Our competitive position in the export markets that we serve is primarily based on raw material costs, selling prices, product quality and customer service and support.

Technology, Research and Development

Research and Development

Research and development (“R&D”) is key to developing a sustainable portfolio of solutions that address competitiveness, differentiation, carbon emission reductions and circularity. Our main priority is to enable growth through the development of new technologies to ensure business perpetuity. A close relationship with the innovation eco-system, our customers, and the market strengthens our ability to understand and address current needs and foresee future opportunities.

We develop new technologies at the following research and development centers: (1) Innovation and Technology Center in Triunfo, in the State of Rio Grande do Sul, Brazil; (2) Innovation and Technology Center in Pittsburgh, Pennsylvania, in the United States; (3) Braskem Laboratory for Biotechnology Development in Campinas, in the State of São Paulo, Brazil; (4) Process Technology Development Center in Mauá, in the State of São Paulo, Brazil; (5) European Technical Center in Wesseling, in the State of North Rhein Westphalia, Germany; (6) Mexican Technical Center in Nanchital, in the State of Vera Cruz, Mexico; and (7) Braskem Renewable Innovation Center, in Lexington, Massachusetts, in the United States, where we develop new processes, technologies, products and applications for several market segments.

As of December 31, 2022, we had 360 employees dedicated to R&D. Through these centers, we coordinate and conduct our research and development activities that include scale-up (pilot plants operation), analytical testing, catalyst development and testing, advanced materials characterization, process technology development and research capabilities on renewable sources and biotechnology.

   
 98 

In 2022, we invested R$187.8 million (US$36.0 million) in innovation and technology as capital expenditures, which included:

·the facility and capacity expansion of the Technology and Innovation Centers in the State of Rio Grande do Sul, in Brazil, with expected investments of approximately US$12.0 million in total. As of December, 2022, we had expend the amount of US$2.0 million. These new laboratories will support: (1) research focused on catalysts, chemicals, specialties polyolefins and additive manufacturing businesses; (2) the development of catalysis projects, polymer science; and (3) the analytical team of our Technological Centers;
·and the Lexington laboratory, with an initial investment in the amount of US$4.0 million in 2022, which will be focused on discovering and reducing the risk of new renewable chemicals and materials technologies.

85% of the projects of our R&D portfolio have a positive sustainability score, and 15% have a neutral score, which means that we are launching and developing products and technologies with a mostly positive impact on the environment.

In 2022, we launched different products used in durable good applications, including in the PP portfolio with respect to the evolution of the automotive sector in Brazil, the United States and Europe, as well as the launch of a new PE grade product for large-diameter pipes used for potable water transportation. Because plastic is less likely to leak, the use of PE in this application helps prevent water loss. In addition, we launched a new PP grade product for home appliances in the United States. All of these products are expected to contribute to greater sustainability by reducing plastic waste. We also enhanced our effort in recycling, upgrading our portfolio with the launches of new PP and PE post-consumer resin (PCR) grade products.

We expanded our 3D printing grades portfolio with the introduction of new Bio-based and Recycled Solutions that reinforce our focus on more sustainable products. Our portfolio includes the novel FL600EVA-BIO, a bio-based ethylene-vinyl-acetate (EVA) filament that provides a more sustainable alternative to traditional flexible materials currently available on the market. Another example of new product is the FL600R, primarily sourced from recycled bottle caps. This product is a recycled PE/PP blend containing sustainably sourced materials, providing a more sustainable solution without sacrificing printability.

Besides the addition of new grades to our existing portfolio sustaining our current businesses, we also looked for new sustainable technologies with new partners that could potentially change the petrochemical industry in the future. By leveraging our internal R&D resources with collaborative open innovation projects with R&D institutions, universities, startups and established companies, we are able to explore new and disruptive technology routes and scale up current processes. In 2022, the external funding pipeline reached US$29.0 million in granted funds, and new projects were approved by funding agencies. An example is the grant by FAPESP (the Foundation for the Support of Research in the State of São Paulo) in Brazil of US$1.5 million for CIRCULA, a project that will focus on R&D activities to develop solutions for the post-consumer waste from packaging and products.

We also use technology scouting to bring new project opportunities with startups and technology providers, capture early-stage technologies, manage a pipeline of ideas, and evaluate the strategic alignment and feasibility of new ideas. This resulted in the creation of 16 new I&T projects and several proof-of-concepts (PoCs), dealing with relevant subjects, such as plastic waste recycling, CO2 capture and utilization, new process technologies, advanced and new bio-based materials.  

In addition, we have also created an acceleration program named Braskem Labs, which has accelerated more than 100 startups since 2015. Our ability to collaborate with the entrepreneurship ecosystem has been enhanced by the addition of the Cazoolo Lab, an initiative that aims to accelerate sustainable solutions in packaging and the launch of the Corporate Venture arm of Braskem, Oxygea Ventures. This new venture company is designed to be a hub dedicated to startups that will drive sustainable innovation and digital transformation to the chemical industry and is expected to receive investments of R$782.7 million (US$150.0 million) in the next five years to perform venture building and corporate venture capital activities.

   
 99 

Additionally, we have other initiatives to develop new technologies through internal projects and partnerships with several third parties, including two main initiatives, carbon neutrality and advanced recycling technology:

·with respect to carbon neutrality, in 2022 we had the following initiatives: (i) an advance in biotechnology and catalytical research with focus on proof of concept of routes to produce new chemicals and materials of renewable origin; (ii) a partnership between the Braskem and the Danish company Topsoe, which is a relevant player in catalysis and surface science segment. In 2022, we continued to advance the technology to produce bio-based monoethylene glycol (bio-MEG) and bio-based propylene glycol (bio-MPG) moving towards the final steps of the development, reinforcing our commitment to expanding our portfolio of renewable products; Also, a joint venture between Braskem and Japan-based Sojitz Corporation named Sustainea Bioglycols was created in 2022 to produce and commercialize bio-MEG and bio-MPG; (iii) a partnership with Lummus Technology to support the target of the producing one million tons of “I’m Green” bio-based polyethylene by 2030; this partnership is expected to bring additional expertise and competencies designed to accelerate progress towards this goal, while expanding the technology’s geographical reach; additionally, it is expected to speed up the use of bioethanol for the production of chemicals and plastics, supporting the industry’s efforts towards a carbon neutral circular economy; (iv) a partnership with Coolbrook, entered into in November 2022, to scale up their rotor dynamic reactor (RDR) technology to industrial stage aiming to a potential use of RDR in its steam crackers; this technology may contribute to the replacement of fossil fuels by electrification, thereby lowering CO2 emissions by 300 million tons per year; RDR may also improve cracker energy efficacy and increase ethylene yields; and
·with respect to advanced recycling technology, a project that is relevant for the development of a new catalyst that reduces the need for external energy source, with optimized energy use and is able to break down plastic residues to produce basic chemicals (monomers), which are then used to produce new circular plastic. The results in lab scale presented high yields and the pilot is planned to start in 2025, with the technology being commercially available in 2030. This technology’s key benefits are its reduced carbon footprint and versatility in terms of plastic feedstocks.

Maintenance

Most of our maintenance is performed by third-party service providers. For example, we have contracts with Tenenge – Montagem e Manutenção Ltda. (a subsidiary of Novonor S.A.), Asea Brown Boveri Ltd, Rip Serviços Industriais S.A, In Haus Industrial and other service providers to perform maintenance for our basic petrochemical plants and other units. We also perform some of our ordinary course maintenance with our small team of maintenance technicians, which also coordinate the planning and execution of maintenance services performed by third parties.

Chemicals Plants

Regular chemicals plant maintenance requires complete plant shutdowns from time to time, and these shutdowns usually take 30 to 45 days to complete. We occasionally undertake brief shutdowns of the chemical operations at our basic petrochemical plants that do not materially affect our production output, primarily for maintenance purposes, catalyst regeneration and equipment cleaning. In addition, because we have two independent olefins units and two independent aromatics units at the Northeastern Complex and two independent olefins units at the Southern Complex, we may continue production of chemicals at these complexes without interruption, even while we perform certain maintenance services.

The next scheduled general maintenance shutdown of:

   
 100 
·the Northeastern complex’s olefins II and aromatics II units is scheduled to take place in 2023;
·the Mexico complex’s olefins unit is scheduled to take place in 2024;
·the Rio de Janeiro complex’s olefins unit is scheduled to take place in 2025; and
·the Southern complex’s aromatics and olefins units (plant II) is scheduled to take place in 2026.

Plants of Our Brazil, and USA and Europe Segment

We have a regular maintenance program for each of our polyolefin plants. Production at each of our polyolefin plants generally is shut down for 15 to 20 days every 3 to 4 years to allow for regular inspection and maintenance. In addition, we undertake other brief shutdowns for maintenance purposes that do not materially affect our production of polyolefins. We coordinate the maintenance cycles of our polyolefin plants with those of our basic petrochemicals plants. While our chemicals facilities must be shut down for up to 45 days every 6 to 8 years for maintenance, our polyolefins facilities may be shut down for shorter periods because these facilities are less complex to operate and maintain than our chemicals plants. Similarly, plants of our USA and Europe Segment attempt to coordinate their maintenance cycles with the routines of their largest suppliers.

We have a regular maintenance program for each of our vinyls plants. Our Northeast PVC plants are generally shut down for 15 to 35 days every two or three years to allow for regular inspection and maintenance. Our caustic soda and chlorine plant in Alagoas shuts down once a year for twenty days of maintenance in different parts of the plant.

Environmental Regulation

We, like other petrochemical producers, are subject to stringent federal, state and local environmental laws and regulations concerning human health, the handling and disposal of solid and hazardous wastes and discharges of pollutants into the air, water and soil, among others. Petrochemical producers are sometimes subject to unfavorable market perceptions as a result of the environmental impact of their business, which can have an adverse effect on their results of operations.

Costs and capital expenditures relating to environmental, health or safety matters are subject to evolving regulatory requirements and will depend on the timing of the promulgation and enforcement of specific standards which impose the requirements.

Compliance with Environmental Laws in Brazil

The Brazilian government enacted an Environmental Crimes Law in 1998 that imposes criminal penalties on corporations and individuals causing environmental damage. Corporations found to be polluting can be fined up to R$50.0 million, have their operations suspended, be prohibited from government contracting, be required to repair damage that they cause and lose certain tax benefits and incentives. Executive officers, directors and other individuals may be imprisoned for up to five years for environmental violations.

We make all reasonable efforts to ensure that our operations are in compliance in all material respects with applicable Brazilian environmental laws and regulations currently in effect. Our internal audit processes and our management system in place aim to ensure that the permits that will expire be renewed in a timely manner. However, changes to applicable laws and regulations may require us to revise our standards, which may take time to implement. Some environmental studies that we have commissioned have indicated instances of environmental contamination at certain of our plants. In addition, we and certain of our executive officers have received notices from time to time related to minor environmental violations and are or have been subject to investigations or legal proceedings with respect to certain alleged environmental violations. These environmental issues, and any future environmental issues that may arise, could subject us to fines or other civil or criminal penalties imposed by Brazilian authorities.

   
 101 

Operating Permits

Under Brazilian federal and state environmental laws and regulations, we are required to obtain operating permits for our manufacturing facilities. If any of our environmental licenses and permits lapse or are not renewed or if we fail to obtain any required environmental licenses and permits, we may be subject to fines ranging from R$500 to R$50.0 million, and the Brazilian government may partially or totally suspend our activities and impose civil and criminal sanctions on us.

Each State in which we operate has its own environmental standards and state authorities in each state have issued operating permits that must be renewed periodically. Additionally, all projects for the installation and operation of industrial facilities in the Northeastern Complex, Southern Complex, São Paulo Complex, Rio de Janeiro Complex and Alagoas plants are subject to approval by various environmental protection agencies, which must approve installed projects prior to their commencement of operations and must renew such approval periodically thereafter. State authorities have issued operating permits for all of our plants, as follows: the Northeastern Complex (State of Bahia); Southern Complex (State of Rio Grande do Sul), São Paulo Complex and Cubatão, Santo André, Mauá and Paulínia plants (State of São Paulo), Rio de Janeiro Complex (State of Rio de Janeiro) and our Alagoas plants (State of Alagoas). We make all reasonable efforts to ensure that our operations in Brazil are in compliance in all material respects with applicable Brazilian federal, state and local environmental laws and regulations currently in effect, and we have an internal audit process and a management system in place assuring that the permits that will expire be renewed in a timely manner.

Industrial Waste

Companhia Riograndense de Saneamento, or Corsan, a state-owned sanitation company, operates an integrated system for liquid effluents treatment, or Sitel, in the Southern Complex. Sitel treats wastewater generated by us and the other petrochemical producers at the Southern Complex at a liquid effluents treatment station located in the Southern Complex. This treatment station also includes a system for the collection of contaminated wastewater and disposal after treatment. We treat wastewater generated by us at the Rio de Janeiro Complex at a liquid effluents treatment station located in the Rio de Janeiro Complex. This treatment station also includes a system for the collection and disposal of contaminated wastewater. Hazardous solid waste is co-processed in cement kilns or incinerated and other kinds of solid waste are disposed of in landfills at facilities approved by us.

We treat wastewater generated by us at the São Paulo Complex at a liquid effluents treatment station located in the São Paulo Complex. This treatment station also includes a system for the collection and disposal of contaminated wastewater. Hazardous waste generated at the São Paulo Complex is co-processed in cement kilns or incinerated and other kinds of solid waste are disposed of in landfills.

In our Bahia facilities, all wastewater is transported to our wastewater treatment facility at Cetrel. Hazardous liquid and solid waste are incinerated at high temperatures and non-hazardous solid waste is coprocessed and sent to cement customers to be used as energy in cement kilns.

In our Alagoas plants, organochlorines waste is incinerated, producing steam and wastewater. All wastewater is treated at a treatment station located in the complex. Solid waste is separated and disposed of in landfills.

Additionally, we have a series of recycling programs that include recycling of solid waste and wastewater. We recycle or reuse 56.8% of the solid waste generated by our facilities and 13.8% of the water used in our production processes.

   
 102 

Mercury

As of December 31, 2019, Braskem had a chlor-alkali plant in Bahia based on mercury cell technology. On April 8, 2020, our chlor-alkali plant in Bahia shut down following the end of the facility’s useful life, and it has been decommissioned. The decommissioning strategy involves equipment’s decontamination/dismantling, and the most appropriate waste destination.

Currently, the Company is dismantling the entire Unit (except the areas of demercurization of effluents and solid waste), disposing of its properly decontaminated waste, as well as planning the most appropriate strategies for diagnosis and remediation of potentially contaminated areas, which should be implemented as soon as the disassembly of the Unit and demolition of the Cell House shed are completed.

Compliance with Environmental Laws in the United States

Our operations in the United States are subject to federal, state and local laws and regulations governing the discharge of effluents and emissions into the environment; the generation, storage, handling, management, transportation and disposal of hazardous waste, industrial waste and other types of waste; the use, storage, and handling of various types of products and materials; and the protection of human health, safety and the environment. In many instances, specific permits must be obtained for particular types of operations, emissions or discharges. For example, our facilities in Texas, Pennsylvania, and West Virginia are required to maintain various permits relating to air quality and treatment of industrial wastewater, and to comply with regulatory requirements relating to waste management. We are in possession of necessary permits to operate our facilities. We make all reasonable efforts to ensure that our operations in the United States comply with applicable U.S. federal, state and local environmental laws and regulations.

As with the U.S. petrochemical industry generally, compliance with existing and anticipated laws and regulations increases the overall cost of operating our U.S. plants, including operating costs and capital costs to construct, maintain and upgrade equipment and facilities. These laws and regulations have required, and are expected to continue to require us to make expenditures of both a capital and an expense nature.

The Clean Air Act, which was last amended in 1990, requires the United States Environmental Protection Agency, or the EPA, to set National Ambient Air Quality Standards, or the NAAQS, for pollutants considered harmful to public health and the environment. The Clean Air Act requires periodic review of the science upon which the standards are based and the standards themselves. NAAQS for ozone and fine particulate matter (referred to as PM2.5), promulgated by the EPA have resulted in identification of nonattainment areas throughout the country, including certain areas within Texas, Pennsylvania, and West Virginia, where Braskem America operates facilities. As a result of these nonattainment designations by the EPA, state or local air pollution control agencies are required to apply permitting and/or control requirements intended to reduce emissions of ozone precursors (nitrogen oxides and volatile organic compounds), and fine particles (including PM2.5 precursors), in order to demonstrate attainment with the applicable NAAQS. Such requirements may include imposition of offset requirements and could result in enhanced emission control standards. In addition, on August 24, 2016, the EPA finalized requirements for state and local agencies charged with the current PM2.5 NAAQS. These requirements could in turn translate into additional state-specific requirements to further reduce allowable emission rates for PM2.5 or its precursor pollutants. In October 2015, the EPA lowered the primary and secondary NAAQS for ozone from 0.075 ppm to 0.070 ppm. Such state-specific requirements would become applicable, if at all, following a multi-year process. Regulations implementing this change will likely not be promulgated for several years.

In addition to permitting and/or control requirements that may result from the implementation of the NAAQS at the state or local level, the EPA may promulgate new or revised federal New Source Performance Standards or National Emission Standards for Hazardous Air Pollutants that would apply directly to certain facility operations and may require the installation or upgrade of control equipment in order to satisfy applicable emission limits and/or operating standards under these regulatory programs. The EPA’s proposed regulations in this area would not specifically apply to Braskem America’s operations.

   
 103 

Additionally, there are various legislative and regulatory measures to address GHG emissions which are in various stages of review, discussion or implementation by Congress and the EPA. In October 2015, the EPA finalized new regulations (known as the Clean Power Plan) aimed at lowering GHG emissions from existing, new and reconstructed electric generating units. In February 2016, the Supreme Court stayed implementation of the Clean Power Plan pending judicial review. On October 16, 2017, the EPA proposed repealing the Clean Power Plan, but this proposal has not been finalized. On August 21, 2018, the EPA proposed a replacement to the Clean Power Plan, the Affordable Clean Energy Rule. While it is currently not possible to predict the final impact, if any, that these regulations may have on Braskem America or the U.S. petrochemical industry in general, they could result in increased utility costs to operate our facilities in the United States. In addition, future regulations limiting GHG emissions of carbon content of products, which target specific industries such as petrochemical manufacturing could adversely affect our ability to conduct Braskem America’s business and also may reduce demand for its products. The EPA’s proposed regulations in this area would not specifically apply to Braskem America’s operations.

Compliance with Environmental Laws in Mexico

Braskem Idesa in Mexico is subject to federal, state and local laws and regulations that govern the discharge of effluents and emissions to the environment; the generation, storage, handling, management, transportation and disposal of hazardous waste, industrial waste and other types of waste; the use, storage and handling of various types of products and materials; and the protection of human health, safety and the environment. Specific permits may be required for certain types of operations.

Ethylene and Aromatic Hydrocarbons Mixture production require permission of the Secretary of Energy and Federal Commission for Sanitary Risks (COFEPRIS) related to risk management and public health, The Mexican legislation regulates the emission of particles, ozone, fixed sources and everything related to GHGs. There are regulations on water, effluent treatments and specific conditions for discharge of the effluent. We make all reasonable efforts to ensure that our operations in Mexico are in compliance in all material respects with applicable Mexican federal, state and local environmental laws and regulations currently in effect.

In Mexico, the Federal Attorney’s Office for Federal Environmental Protection (PROFEPA) verifies compliance with the Mexican Regulation and Permits through audits.

Failure to comply with Mexican regulations may lead to economic and administrative penalties, including Operations shutdown in certain cases.

Compliance with Environmental Laws in Germany and the European Union

Our operations in Germany are subject to German federal, state and local laws and regulations governing the discharge of effluents and emissions into the environment and the handling and disposal of industrial waste and otherwise relating to the protection of the environment and waste management. Our operations in Germany are in compliance in all material respects with applicable German federal, state and local environmental laws and regulations currently in effect.

As with the petrochemical industry in the European Union generally, compliance with existing and anticipated German laws and regulations increases the overall cost of operating our European business, including operating costs and capital costs to construct, maintain and upgrade equipment and facilities. These laws and regulations have required and are expected to continue to require us to make expenditures of both a capital and an expense nature.

At our Schkopau and Wesseling facilities in Germany, we are required to maintain air, radiation, waste water and waste management permits. We are in possession of all necessary permits.

   
 104 

Furthermore, our Wesseling and Schkopau facilities in Germany are subject to existing European GHG regulations and a cap and trade program relating to emissions. We have purchased sufficient carbon dioxide emissions permits for our operations until 2023, provided it operates under normal business conditions. We will purchase any additional permits that may be required on the emission trade market. We are not aware of any new environmental regulations that would materially affect our European operations. Accordingly, we cannot estimate the potential financial impact of any future European Union or German environmental regulations.

 

Sustainability

 

In April 2018, our board of directors approved our policy on global sustainable development. Its objective is to encourage economic growth, environmental preservation and social justice by developing sustainable solutions related to chemical and plastic production. In connection with these goals, we have developed a three-pronged approach: (1) seek and develop sustainable sources and operations, (2) develop and deliver a portfolio of sustainable products and services, and (3) work with our clients to offer sustainable solutions that benefit society as a whole.

Circular Economy

Consistent with our purpose of contributing to the transition from a linear economy into a circular economy, effectively demonstrating our commitment to sustainable development, we announced in 2018 our global positioning statement titled “Braskem’s Positioning in the Circular Economy.”

In the statement, we announced eight key global initiatives, which are: (i) partnerships with clients and value chain to develop new products that increase efficiency, recycling and reuse; (ii) more investments in renewable products; (iii) development and support of new technologies and the recycling chain; (iv) programs to engage consumers in conscientious consumerism, proper disposal and recycling; (v) use of science tools to select the most sustainable options; (vi) adoption of recycling indicators for plastic packaging; (vii) partnerships to understand, prevent and solve the problem of marine debris; and (viii) incentives for policies to improve solid waste management.

Property, Plant and Equipment

Our properties consist primarily of petrochemical production facilities in:

·Camaçari, in the State of Bahia;
·Triunfo, in the State of Rio Grande do Sul;
·Duque de Caxias, in the State of Rio de Janeiro;
·São Paulo, Paulínia, Cubatão, Santo André and Mauá, in the State of São Paulo;
·Maceió and Marechal Deodoro, in the State of Alagoas;
·the United States, in La Porte, Freeport and Seadrift, Texas; Marcus Hook, in Pennsylvania; Neal and West Virginia;
·Germany, in Schkopau and Wesseling; and
·Coatzacoalcos, in Mexico.

For more information, see note 12 to our audited consolidated financial statements included elsewhere in this annual report.

   
 105 

Our principal executive offices are located in São Paulo, in the State of São Paulo, and we have an administrative support office in the City of Salvador, in the State of Bahia, Brazil, in Philadelphia, in the State of Pennsylvania, in the United States, and in Rotterdam, in Netherlands. We also have equity interests in investments located in other parts of the country. We own all of our production facilities, but we generally lease our administrative offices.

The following table sets forth our properties as of December 31, 2022 by location of facilities, products produced and size of plant.

Type of Product or Service

Location of Facilities

Size of Plant

    (in hectares)(1)
Chemicals Triunfo 152.8
Chemicals Santo André 74.1
Chemicals Camaçari 65.5
Chemicals Duque de Caxias 53.0
Chemicals Mexico 23.6
Polypropylene Paulínia 39.7
Polyethylene Triunfo 30.5
Polyethylene Camaçari 24.5
Polyethylene Cubatão 17.6
Polyethylene Santo André 15.8
Polyethylene Duque de Caxias 15.0
Polyethylene Mexico 14.9
Polypropylene La Porte, Texas 87.0
Polypropylene Neal, West Virginia 27.1
Polypropylene Mauá 15.8
Polypropylene Duque de Caxias 15.0
Polypropylene Camaçari 13.2
Polypropylene Triunfo 10.0
Polypropylene Marcus Hook, Pennsylvania 6.9
Polypropylene Freeport, Texas 8.9
Polypropylene Seadrift, Texas 2.5
Polypropylene Schkopau, Germany 3.7
Polypropylene Wesseling, Germany 26.0
Caustic soda/chlorine Maceió 15.0
PVC/caustic soda(2)/chlorine(2) Camaçari 12.6
PVC Marechal Deodoro 186.7
Distribution Center Vila Prudente/Capuava 3.2

 

  (1) One hectare equals 10,000 square meters.

 

  (2) In January 2020, Braskem announced the permanent shutdown of its chlor-alkali production facility located in Camaçari, in the State of Bahia. The shutdown is explained by the end of the facility’s useful life and started in April 2020, following the applicable safety standards and seeking to protect people, local communities and the environment.

We believe that all of our operating facilities are in good operating condition. As of December 31, 2022, the consolidated net book value of our property, plant and equipment was R$37,763.3 million.

The following properties are mortgaged or pledged to secure certain of our financial transactions: (1) our chemicals plant, our polypropylene plant and our polyethylene plant located in the Southern Complex; (2) our chlor-alkali plant and PVC plant located in the Northeastern Complex; (3) our chemicals plant, polypropylene plant and polyethylene plant located in the State of São Paulo; (4) our chlor-alkali plant and PVC plant located in the State of Alagoas; (5) our chemicals plant, our polyethylene plant and our polypropylene plant located in the Rio de Janeiro Complex; and (6) our chemical plant and our polyethylene plants located in Mexico.

   
 106 

Insurance

In addition to the policies described below for our Brazilian and international operations, we maintain other insurance policies for specific risks, including general and product liability, directors and officers liability, workers’ compensation, marine cargo and charterer’s liability insurance, among others.

We believe that our insurance coverage is reasonable in amount and consistent with industry standards applicable to chemical companies operating globally.

Operations in Brazil, Mexico, the United States and Germany

We carry insurance for all our plants against material damage and consequent business interruption through comprehensive “all risk” insurance policies.

This insurance program is underwritten through separate policies in Brazil, Mexico, the United States and Germany by large insurance companies. The leading insurers are Mapfre (rating S&P A-), Inbursa (rating S&P AAA). These policies are valid until April 2023.

Set forth is a table with additional information related to our all-risk insurance policies.

Policy / Region
US$ bn

Value at risk —
P D + BI (1)

Indemnity Limit

PD + BI(1)

Brazil 24.4 3.25
Mexico(2) 5.1 2.4
USA and Germany(2) 3.9 0.63

 

  (1) PD = Property Damage; BI = Business Interruption.
  (2) Includes coverage for acts of terrorism.

 

Our policies provide coverage for losses that arise from accidents caused by or resulting from fire, explosion, and machinery breakdown, among others, and consequential business interruption, with maximum indemnity periods ranging from 12 to 34 months, depending on the plant and/or coverage.

As part of our program, we also contract other insurance policies to cover specific risks, including general civil liability, the civil liability of directors and offices (“D&O”), environmental risks, domestic and international charter operations, charter’s liability, etc.

New projects can be covered for construction/erection all risks under the existing Property policies or through a standalone project-specific policy.

We have relevant exposure to operational risks, and our insurance policy requires coverage to be contracted through a complex insurance program involving multiple insurers and reinsurers in the commercial market, which have limited and variable capacity to offer insurance policies over time. In order to seek alternatives for the composition of hedges, the possibility of transferring operational risks through the mutual insurer “OIL” was identified. OIL is the global leader in the energy sector, including oil and gas, refining, chemical and petrochemicals, electric power and mining and has a portfolio of selected participants. In addition to providing a stable capacity to Braskem, OIL has a structure in which there is reciprocal cooperation among the insured companies participating in a known risk environment, in addition to a lower administrative cost compared to the commercial insurance market, providing less volatile and potentially more competitive premiums.

Compliance

We have adopted a Code of Conduct, a Compliance System Policy and an Anti-corruption Policy, and several internal directives designed to guide our management, employees and counterparties and to reinforce our principles and rules for ethical behavior and professional conduct. We maintain an Ethics Line managed by a third party available for employees and non-employees. Every whistleblower complaint is impartially investigated by an independent team. The Ethics Committee and the Statutory Compliance and Audit Committee are notified on the results and upcoming plans.

   
 107 

In addition to the above, the company has normative documents in place that rule and/or establish standards concerning, among others, risk management, purchases, sales, internal controls, internal audit, corporate credit card, delegation of authority, due diligence, conflicts of interest, business courtesies, investigations, sponsorships and donations, travels, interactions with public agents, transactions with related parties.

We have also put into practice specific compliance goals for our leadership and formal engagement with certain initiatives, such as the UN Global Compact and the Business Pact for Integrity and Against Corruption established by the Ethos Institute in Brazil.

In March 2020, based on the certification report issued by the independent monitors who have monitored us for the past three years, Brazil’s Federal Prosecutor’s Office (Ministério Público Federal), or the MPF confirmed the monitoring conclusion, the effectiveness of our compliance program and compliance with the obligations of the MPF Agreement. Later, on May 13, 2020, the DoJ and the SEC confirmed the end of the monitoring provided for in the agreements with such authorities.

In 2021, the Company was granted the certification ISO 37001 – Anti-bribery Management Systems, published by the International Organization for Standardization (ISO), attesting that Braskem’s anti-bribery management system complies with the rule’s standards developed by ISO. In 2022 we continued to be certified by ISO 37001 after a maintenance audit conduct by an external audit company.

  Item 4A. Unresolved Staff Comments

Not Applicable.

  Item 5. Operating And Financial Review and Prospects

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements as of December 31, 2022 and 2021 and for the three years ended December 31, 2022, included in this annual report, as well as with the information presented under “Presentation of Financial and Other Information.”

The following discussion contains forward-looking statements that involve risks and uncertainties, in particular with respect to the COVID-19 pandemic and related impacts on our historical and future results of operations and financial condition. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in “Cautionary Statement with Respect to Forward-Looking Statements” and “Item 3. Key Information—Risk Factors.”

Overview

Our results of operations for the years ended December 31, 2022, 2021 and 2020 have been influenced, and our results of operations will continue to be influenced, by a variety of factors, including:

·GDP growth in the regions where we operate, including as follows:
oBrazil’s GDP, which grew 2.9% in 2022, as compared to growth of 5.0% in 2021 and to a 3.3% contraction in 2020, which affected the demand for our products and, consequently, our sales volume;
   
 108 
othe U.S. GDP, which grew 2.9% in 2022, as estimated in a report released by BEA on January 2023, as compared to a growth of 7.0% in 2021 and 3.4% contraction in 2020, which affected the demand for our products and, consequently, our sales volume;
oEurope’s GDP, which grew 3.4% in 2022, as estimated in a report released by the European Central Bank on December 15, 2022, as compared to a growth of 5.38% in 2021 and 5.66% contraction in 2020, which affected the demand for our products and, consequently, our sales volume;
oMexico’s GDP, which grew 2.9% in 2022, as estimated in a report released by INEGI on December 12, 2022, as compared to a growth of 4.7% and 8.0% contraction in 2020, which affected the demand for our products and, consequently, our sales volume; and
oaccording to the IMF, despite the adverse effects of the COVID-19 pandemic on the economy of several countries in 2020 and 2021, which led to a global GDP contraction of 3.0%, in 2020 the world’s GDP expanded 6.0% in 2021 and is expected to expand 3.2% in 2022;
·the expansion or contraction of global production capacity for the products that we sell and the growth rate of the global economy;
·the international market price of propylene in the Unites States, one of our main raw materials, expressed in U.S. dollars, which has a significant impact on the cost of producing our products and which experienced a high level of volatility during the year ended December 31, 2022, fluctuating in a range between US$705 and US$1,587 per ton during such period, compared to fluctuation in a range between US$1,235 and US$1,951 per ton during 2021;
·the international market price of naphtha, one of our main raw materials, expressed in U.S. dollars, which has a significant impact on the cost of producing our products and which experienced a high level of volatility during the year ended December 31, 2022, fluctuating in a range between US$594.0 and US$1,012.0 per ton during such period, compared to fluctuation in a range between US$501 and US$764 per ton during 2021;
·the average Brazilian prices of resins expressed in U.S. dollars, which fluctuate to a significant extent based on international prices for these products and which also have a high correlation to our raw material costs;
·our crackers’ average capacity utilization rates, which in 2022 were lower (3.0% less), explained mainly by the lower spreads in the international market due to lower demand and the average utilization rate of petrochemical crackers in 2022, which was impacted by the scheduled maintenance shutdown at the petrochemical complex in Rio Grande do Sul and Alagoas;
·government industrial policies in the countries and regions in which we operate;
·changes in the real/U.S. dollar exchange rate, including the appreciation of the real against the U.S. dollar by 6.5% in 2022, and a depreciation of 7.4% in 2021 and of 28.9% in 2020.
·the level of our outstanding indebtedness and fluctuations in benchmark interest rates in Brazil, which affect our interest expenses on our real-denominated floating rate debt and financial income on our cash and cash equivalents, and fluctuations in the LIBOR rate, which affect our interest expenses on our U.S. dollar-denominated floating rate debt;
·the inflation rate in Brazil, which was 5.8% in 2022, as measured by the IBGE (Índice Nacional de Preços ao Consumidor Amplo, or “IPCA”), and the effects of inflation on our operating expenses denominated in reais and our real-denominated debt that is indexed to consider the effects of inflation or bears interest at rates that are partially adjusted for inflation; and
   
 109 
·tax policies and tax obligations.

Our financial condition and liquidity are influenced by various factors, including:

·our ability to generate cash flows from our operations;
·prevailing Brazilian and international interest rates and movements in exchange rates, which affect our debt service requirements;
·our ability to continue to be able to borrow funds from international and Brazilian financial institutions and to sell our debt securities in the international and Brazilian securities markets, which is influenced by a number of factors discussed below, including the adverse effect of the COVID-19 pandemic on the world economy and our business, financial condition and results of operations;
·our capital expenditure requirements, which consist primarily of maintenance of our operating facilities, expansion of our production capacity and research and development activities; and
·the requirement under Brazilian law and our by-laws that we pay dividends on an annual basis in an amount equal to at least 25% of our adjusted net income (calculated as net income for the financial year, after absorption of accumulated losses and for reserves, including legal reserves, pursuant to applicable law, or “Adjusted Net Income”), unless our board of directors, in accordance with applicable law, reports to our annual shareholders’ meeting that the distribution would be incompatible with our financial condition at that time, provided that payment of any minimum preferred dividends is not affected. Our fiscal council must opine on any suspension of the mandatory distribution.

Recent Developments

New Bond Issuance

In February 2023, our subsidiary Braskem Netherlands Finance issued R$5.2 billion (US$1.0 billion) of 7.250% Senior Notes due 2033, which are unconditionally and irrevocably guaranteed by Braskem.

Acquisition of Wise Plásticos

In February 2023, we completed the acquisition of a share equity interest in Wise Plásticos S.A. (“Wise”), a Brazilian company engaged in mechanical recycling, for R$138.0 million. After such transaction, we currently hold a 61.1% equity interest in Wise.

Alagoas

In March 2023, the Public Defender’s Office of the State of Alagoas (“DPE”) filed a Public-interest civil lawsuit (“ACP”) against us, the Brazilian federal government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, entered into by Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, which had been ratified on October 26, 2022 by the 3rd Federal Court in Alagoas. The DPE attributed to the lawsuit the amount of R$1.7 billion, with a request of injunction relief for the Municipality of Maceió and Braskem to initiate the registration of all residents who requested to be relocated and their inclusion in the Financial Compensation and Support for Relocation Program (“PCF”), or, subsidiarily, to freeze money in bank accounts in the same amount of the lawsuit. The injunction relief requests were rejected by the court, but the decision is subject to appeal by the DPE. We have already presented an answer.

   
 110 

In March 2023, the State of Alagoas filed against us a lawsuit requesting compensation for alleged damages caused to the State. In addition, as an injunction relief, the State of Alagoas requested the cautionary blocking of R$ 1.1 billion in our bank accounts as a guarantee to indemnify for material and non-material damages allegedly suffered by the State Public Administration. On April 19, 2023, this injunction relief request was accepted by the court, which ordered a cautionary blocking of approximately R$1.1 billion in our bank accounts. Upon presentation of a performance bond by the us, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court.

For additional information on these two lawsuits, see “Item 8. Financial Information—Legal Proceedings—Civil Proceedings—Alagoas—Mining Activities.”

Financial Presentation and Accounting Policies

Presentation of Financial Statements

We have prepared our audited consolidated financial statements as of December 31, 2022 and 2021 and for each of the years ended December 31, 2022, 2021 and 2020 in accordance with IFRS, as issued by the IASB.

Operating Segments and Presentation of Segment Financial Data

As of December 31, 2022, our business operations were organized into three segments, which corresponded to our principal production processes, products and services. Our reportable segments were as follows:

·our Brazil Segment (former Polyolefins, Chemicals and Vinyls segments), which includes:
(i)production and sale of chemicals at the chemical complex located in Camaçari, in the State of Bahia, or the Northeastern Complex, the chemical complex located in Triunfo, in the State of Rio Grande do Sul, or the Southern Complex, the chemical complex located in Capuava, in the State of São Paulo, or the São Paulo Complex and the chemical complex located in Duque de Caxias, in the State of Rio de Janeiro, or the Rio de Janeiro Complex;
(ii)supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes;
(iii)production and sale of PE, including the production of “green PE” from renewable resources, and PP produced by us in Brazil; and
(iv)our production and sale of PVC and caustic soda;
·The Brazil Segment accounted for net revenue of R$69,079.7 million, including exports from Brazil, or 70.2% of our consolidated net revenue of all reportable segments;
·our USA and Europe Segment, which includes our production, operations and sale of polypropylene in the United States and Germany. This segment accounted for net revenue of R$23,421.1 million, or 23.8% of our consolidated net revenue of all reportable segments; and
·our Mexico Segment, which includes our production, operations and sale of ethylene, HDPE (high-density polyethylene) and LDPE (low-density polyethylene) in Mexico. This segment accounted for net revenue of R$5,834.0 million, or 6.0% of our consolidated net revenue of all reportable segments.

In 2022, 2021 and 2020, 58.2%, 52.9% and 55.3% of our net revenue, respectively, related to sales performed in Brazil, and 41.8%, 47.1% and 44.7% of our net revenue in 2022, 2021 and 2020 was derived from our international operations.

   
 111 

New or revised pronouncements

New standards and pronouncements adopted in the current fiscal year:

·Onerous Contracts: costs of fulfilling a contract (amendments to IAS 37);
·Annual improvements of IFRS Standards 2018-2020;
·Property, Plant and Equipment: proceeds before intended use (amendments to IAS 16); and
·Reference to Conceptual Framework (amendments to IFRS 3).

These amendments to standards did not impact the financial statements.

New standards and interpretations not yet in force

The main standards issued by the IASB that have not yet come into force and have not been adopted by the Company are listed below. These new or amended standards are not expected to have a significant impact on Company’s financial statements:

·Classification of Liabilities as Current or Non-Current (amendments to IAS 1);
·IFRS 17 Insurance Contracts;
·Disclosure of Accounting Policies (amendments to IAS1 and IFRS Practice Statement 2);
·Definition of Accounting Estimates (amendment to IAS 8); and
·Deferred Tax related to Assets and Liabilities arising from a Single Transaction (amendments to IAS 12).

We plan to adopt these new and amended standards and interpretations, if applicable, when they become effective. Our management does not expect the adoption of the standards listed above to have a significant impact on our financial statements in future periods.

Principal Factors Affecting Our Results of Operations

Macroeconomic Environment in the Countries in which we Operate and Demand for Our Products

Our sales in Brazil and exports from Brazil represented 70.2% of our net revenue in the year ended December 31, 2022. We are significantly affected by economic conditions in Brazil and in the other countries in which we operate, and our results of operations and financial condition have been, and will continue to be, affected by the growth or contraction rates of the GDP of Brazil, the United States, Europe and Mexico, and by global growth or contraction rates.

The following table shows inflation, interest rates and exchange rate data for Brazil as of and for the periods indicated.

 

December 31,

 

2022

2021

2020

2019

2018

GDP growth / Reduction(1) 2.9% 5.0% (4.1)% 1.1% 1.1%
Inflation (IGP-M)(2) 5.5% 17.8% 23.1% 7.3% 7.5%
Inflation (IPCA)(3) 5.8% 10.1% 4.5% 4.3% 3.7%
CDI rate(4) 13.7% 8.8% 1.9% 4.6% 6.4%
(Appreciation) depreciation of the real vs. U.S. dollar (6.5)% 7.4% 28.9% 4.0% 17.1%
Period-end exchange rate—US$1.00 R$5.2177 R$5.5805 R$5.1967 R$4.0307 R$3.8748

 

Sources:

Fundação Getúlio Vargas, the Brazilian Central Bank and Bloomberg.

 (1) Brazilian GDP measured according to Sistema IBGE de Recuperação Automática SIDRA.
 (2) Inflation measured according to the general market price index (Índice Geral de Preços-Mercado) (IGP-M) by Fundação Getúlio Vargas.
 (3) Inflation measured according to the national broad consumer price index (Índice Nacional de Preços ao Consumidor Amplo) (IPCA) by the IBGE.
 (4) The CDI rate is average of inter-bank overnight rates in Brazil (as of the last date of the respective period).
   
   
 112 

Brazilian GDP growth has fluctuated significantly, and we believe that it will likely continue to do so. Our management believes that the impact on growth in Brazil will positively affect our future net revenue and results of operations, and a continued recession or low growth in Brazil would likely reduce our future net revenue and have a negative effect on our results of operations.

According to the IMF, despite the adverse effects of the COVID-19 pandemic on the economy of several countries in 2020 and 2021, which led to a global GDP contraction of 3.0%, in 2020. The world’s GDP expanded 6.0% in 2021, 3.4% in 2022 and it is expected to be 2.8% in 2023.

Effects of Fluctuations in Exchange Rates between the Real and the U.S. Dollar

Our results of operations and financial condition have been, and will continue to be, affected by the rate of depreciation or appreciation of the real against the U.S. dollar because:

·a substantial portion of our net revenue is denominated in or linked to U.S. dollars;
·our costs for our raw materials and certain catalysts required in our production processes, are incurred in U.S. dollars or are linked to U.S. dollars;
·we have operating expenses, and make other expenditures, that are denominated in or linked to U.S. dollars; and
·we have significant amounts of U.S. dollar-denominated liabilities that require us to make principal and interest payments in U.S. dollars.

Virtually, all of our sales are of petrochemical products for which there are international market prices expressed in U.S. dollars. We generally attempt to set prices that consider (1) the international market prices for our petrochemical products, and (2) in Brazil, variations in the real/U.S. dollar exchange rate. As a result, although a significant portion of our net revenue is denominated in reais, substantially all of our products are sold at prices that are based on international market prices that are quoted in U.S. dollars.

Fluctuations in the real will affect the cost of naphtha, ethylene, propane, propylene and other U.S. dollar-linked or imported raw materials. The prices of raw materials that are under all of Petrobras’ contracts are linked to the U.S. dollar. The pricing formula includes a factor that adjusts the price to reflect the real/U.S. dollar exchange rate variations.

The depreciation of the real against the U.S. dollar generally increases the production cost for our products and we generally attempt to increase the Brazilian prices for our products in reais (to the extent possible in light of then-prevailing market conditions in Brazil), which may result in reduced sales volumes of our products. To the extent that our price increases are not sufficient to cover the increased costs for raw materials, our gross profit decreases. Conversely, the appreciation of the real against the U.S. dollar generally decreases the production cost for our products and we generally decrease the Brazilian prices for our products in reais, which may result in increased sales volumes of our products. In periods when the real/U.S. dollar exchange rate is highly volatile, there is usually a lag between the time when the U.S. dollar appreciates or depreciates and the time when we are able to pass on increased costs, or are required to pass on reduced costs, in reais to our customers in Brazil. These pricing discrepancies decrease when the real/U.S. dollar exchange rate is less volatile.

   
 113 

Braskem can enter into financial derivatives transactions to mitigate exchange rate risk associated with exposure to costs in reais. Those operations can include call and put options and related strategies. For example, Braskem may apply a hedging strategy referred to as collar, which is composed of the purchase of a put option associated with the simultaneous sale of a call option, where both options having the same maturity. In this case, if the real depreciates and the strike price of the call exceeds the exchange rate of the option’s exercise date, we may incur significant financial losses. However, since those strategies will be implemented only for non-speculative purposes (in accordance with our financial policy), potential losses on derivatives transactions should be offset by more competitive fixed costs in reais.

Our consolidated U.S. dollar-denominated indebtedness represented 90.1% of our outstanding indebtedness as of December 31, 2022, including our debt related to Braskem Idesa. Excluding the latter, our consolidated U.S. dollar-denominated indebtedness represented 87.0% of our outstanding indebtedness as of December 31, 2022.

As a result, when the real depreciates against the U.S. dollar:

·the interest costs on our U.S. dollar-denominated indebtedness increase in reais, which adversely affects our results of operations in reais;
·the amount of our U.S. dollar-denominated indebtedness increases in reais, and our total liabilities and debt service obligations in reais increase; and
·our financial expenses tend to increase as a result of foreign exchange losses that we must record, mitigated by our decision to designate, on May 1, 2013, October 10, 2017, February 2, 2019, May 2, 2019, November 1, 2019, December 31, 2019, January 2, 2020, and March 31, 2020, as part of our U.S. dollar-denominated liabilities as a hedge for our future exports.

Export sales and sales by our USA and Europe Segment, which enable us to generate receivables payable in foreign currencies, tend to provide a hedge against a portion of our U.S. dollar-denominated debt service obligations, but they do not fully match them. To further mitigate our exposure to exchange rate risk, we try, where possible, to enter into trade finance loans for our working capital needs, which funding is generally available at a lower cost because it is linked to U.S. dollar exports.

The real/U.S. dollar exchange rate varied significantly over time. The real depreciated against the U.S. dollar from mid-2011 to early 2016, and again from early 2018 to 2020. As of December 31, 2020, the real/U.S. dollar exchange rate reported by the Central Bank was R$5.1967 per US$1.00, as of December 31, 2021, the real/U.S. dollar exchange rate reported by the Central Bank was R$5.5805 to US$1.00, and as of December 31, 2022, the real/U.S. dollar exchange rate reported by the Central Bank was R$5.2177 to US$1.00. There can be no assurance that the real will not depreciate or appreciate further against the U.S. dollar.

Effects of Brazilian Inflation

Brazilian inflation affects our financial performance by increasing some of our operating expenses denominated in reais (and not linked to the U.S. dollar). A significant portion of our cost of products sold, however, are denominated in or linked to the U.S. dollar and are not substantially affected by the Brazilian inflation rate. Some of our real-denominated debt is indexed to take into account the effects of inflation. Under this debt, the principal amount generally is adjusted with reference to the General Price Index—Market (Índice Geral de Preços—Mercado), an inflation index, so that inflation results in increases in our financial expenses and debt service obligations. In addition, a significant portion of our real-denominated debt bears interest at the TLP or the CDI rate, which are partially adjusted for inflation.

   
 114 

Effect of Sales outside Brazil on Our Financial Performance

We have significant production capacity located outside of Brazil from our plants located in the United States, Germany, and Mexico.

During the year ended December 31, 2022, 41.8% of our net revenue was derived from sales of our products outside Brazil as compared to 47.1% during 2021 and 44.7% during 2020.

During the year ended December 31, 2022, sales to customers in the Americas (outside Brazil) accounted for 29.1% of our total sales, Sales to customers in Europe accounted for 8.4% of our total sales, and sales to customers in Asia and Other accounted for 4.2% of our total sales.

Sales outside Brazil are important to us for diversification purposes in relation to regional supply and demand balance, macroeconomic factors, and the political environment. In line with our strategy, sales outside Brazil affect our financial performance by hedging our operations against risks linked to Brazil.

According to the IMF, because of the adverse effects of the COVID-19 pandemic on the economy of several countries, the world’s GDP and the GDP of the United States, Europe and Mexico shrank significantly in 2020, leading to an economic contraction and a recession in these countries or regions. As a result, our sales outside Brazil were adversely affected.

In 2021, the worldwide economy continued to be affected by the adverse effects caused by the COVID-19 pandemic and in the last quarter of 2021, according to the IMF, the Omicron variant led to increased mobility restrictions and greater financial market volatility.

In 2022, the worldwide economy continued to be affected by geopolitical uncertainties, the conflict between Russia and Ukraine, increasing inflation rates worldwide and the “zero-COVID” policy implemented by China during 2022. The combination of these factors caused reduction or suspension of production, directly affecting the market for petrochemical products and other products around the world.

Petrochemical Cycles and Disruptive Scenarios

Historically, the global petrochemical market has experienced alternating periods of limited supply, leading to the increase of global prices and profit margins, followed by periods of capacity additions, which puts downward pressure on utilization rates, global prices, and consequently operating margins, until demand catches up again, with new levels of product availability. This economic scenario is known as the petrochemical cycle.

Sales of petrochemicals and chemical products are linked to the global demand and production levels (supply x demand), which may be affected by macroeconomic factors, such as interest rates, oil prices, shifts to alternative products, innovation, consumer trends, regulatory and legislative oversight requirements, trade agreements, as well as disruptions, pandemics, or other global events. Therefore, our results are influenced not only by our activities but also by the industry and macroeconomic scenarios, over which we have no control, and which may adversely affect our results of operations.

However, sometimes new opportunities emerge from externalities, such as the shift in consumer behavior. An example derived from COVID-19 is that, from 2020 to 2022, a large part of the population shifted to home-office working, and as a consequence, increased the demand for several segments, such as packaging, healthcare, and construction. We believe that this outcome resulted in a less pronounced downward movement in the petrochemical industry.

   
 115 

It is expected that these cyclical trends in international selling prices and operating margins, relating to global capacity shortfalls and additions, will likely persist, mostly due to the continuity of four general factors:

·cyclical trends in general business and macroeconomic activity produce swings in demand for petrochemicals;
·during periods of reduced demand, the high fixed cost structure of the petrochemicals industry generally leads producers to compete aggressively on price in order to maximize capacity utilization;
·significant capacity additions, whether through plant expansion or construction, can take three to four years to implement and are therefore necessarily based upon estimates of future demand; and
·as competition in petrochemical products is, in most cases, focused on commodities prices, being a low-cost producer is critical to improved profitability. This favors producers with larger plants that maximize economy of scale, but construction of plants with high capacity may result in significant increases in capacity that can outstrip demand growth for a period of time.

In the long-term, the trend is for the down cycle to soften and eventually turn into an upcycle again, as the industry waits to make decisions on new investments while global trade rebalances, and the world demand absorbs new capacity. Additionally, projects that are announced to start up further into the future have a greater chance of being postponed or cancelled, as the scenario may change, feedstocks may become less advantageous, and cash cost curves may shift.

During the first few months of 2022, the global economy shifted from hoping for the end of COVID-19 restrictions to the fear of a world war, following the conflict between Russia and Ukraine. The conflict between Russia and Ukraine caused a shock in commodities prices, with oil prices reaching US$140 per barrel, given the relevance of Russia as a key supplier of oil and gas. Severe trade sanctions were imposed on Russia, which also affected the global economy, especially Europe, because of its dependency on Russian oil and gas. The conflict also prompted a rise in global inflation, which reached levels not seen since the 1980s. Meanwhile, China struggled significantly with COVID-19 restrictions in 2022, and its harsh “COVID-zero” policy challenged the economy of the most important price maker for petrochemicals. Demand started to slow down in the second quarter of 2022 with central banks around the world significantly increasing interest rates in an attempt to control rising inflation. The second half of 2022 was marked by the beginning of a new down cycle for the petrochemicals industry, as significant new capacity additions, which had been postponed since 2020, became operational, and further increased capacity is expected in 2023 and 2024, which may lead to further reduced spreads for the period.

In 2021, the world suffered significant impacts on global supply chains. Global supply chains started to struggle with lack of raw materials as there was a shortage of containers available to move materials across different countries due to lockdowns, strikes in rail and road transportation globally. These logistic constraints led to increased freight rates, which, despite helping domestic markets (and especially protecting those exposed to China imports), also helped fuel inflation. Also, in 2021 the United States was exposed to harsh winter storm and hurricane seasons, which paralyzed several petrochemicals plants in Texas. These events led to improved prices and spreads, as supply became short for some time. Furthermore, in the second half of 2021, as vaccination rates improved, consumption start to accelerate, heating consumer demand in North America.

The year 2020 was marked by atypical uncertainties and volatilities and impacted mainly by extraordinary external factors, such as the global spread of COVID-19, the lower global demand for fuels, impacting oil prices in the international market and the elections in the Unites States. Regarding the global petrochemical scenario, the dynamics observed were more positive than initially expected by external consultants in early 2020, with healthier spreads of thermoplastic resins in the international market in all regions where Braskem has productive capacity. In Brazil, the sharp drop in the price of naphtha during the months of March and April, influenced by the fall in the price of oil in the international market, was not accompanied by a similar decrease in resins prices, due to the rapid recovery of demand in the second half of 2020, driven mainly by demand from the packaging, construction, and hygiene and personal care sectors.

   
 116 

Effects of Fluctuations in Naphtha, Ethane, Propane and Propylene Prices

Fluctuations in the international market price of naphtha have significant effects on our costs of goods sold and the prices that we are able to charge our customers for our first and second-generation products. Political instability in the Middle East or similar events that may occur, including the military conflict between Russia and Ukraine, may lead to unpredictable effects on the global economy or the economies of the affected regions. These events have had and may continue to have negative impacts on oil production and price volatility, consequently driving naphtha and petrochemical prices higher worldwide.

The price of ethane and propane in the Mont Belvieu region in Texas and Henry Hub in the United States are used as a reference for our feedstock costs. Any future developments that affect the U.S. supply/demand balance for natural gas may adversely affect the Mont Belvieu and Henry Hub price of natural gas (and thus ethane, propane and butane) and increase our production costs or decrease the price of petrochemical products. External factors and natural events such as hurricanes, harsh winters or industry developments, such as shale gas exploration, may disrupt the supply of natural gas, thereby increasing the cost, which may materially adversely affect our cost of products sold and results of operations.

The price of propylene is based on the US reference and is determined by three different processes: (i) refineries production (FCC – Fluidized Catalytic Cracking), steam cracking, and on-purpose production (PDH – Propane Dehydrogenation), since refineries are the major source of propylene in the United States; however, (ii) refineries can use propylene to make a few different products. Their desire to sell propylene on the open market depends on demand and price for gasoline along with a few other chemicals. For the steam cracker process, propylene is a co-product derived from the ethane, propane, and butane cracking processes, whose price dynamics correlate to the price of crude oil; and/or (iii) natural gas, as explained above. Steam cracker feedstock choice has a significant effect on propylene supply to the market since its volume production is different for each feedstock. During the last few years, ethane has been the main feedstock, due to its lower price and to the high polyethylene demand. For the PDH process, propane prices play an important role in propylene pricing, but it mostly sets the price floor, not the ceiling. This is because PDHs are the marginal propylene producer. The price ceiling is determined by the ability to sell propylene products, domestically and internationally.

Effects on Cost of Products Sold

Naphtha is the principal raw material used by our chemicals operations that are part of our Brazil Segment. Naphtha and condensate accounted for 34.5% of our consolidated cost of products sold during 2022.

The cost of naphtha varies in accordance with international market prices, which fluctuate depending upon the supply and demand for oil and other refined petroleum products. We purchase naphtha under a long-term supply contract with Petrobras and Acelen, and we import naphtha from other suppliers through our terminal at Aratú, in the State of Bahia and Petrobras’ terminal at Osório, in the State of Rio Grande do Sul. The prices that we pay for naphtha under these arrangements, other than our supply contract with Petrobras, are based on the Amsterdam-Rotterdam-Antwerp (ARA) market price for naphtha. As a result, fluctuations in the ARA market price for naphtha have had a direct impact on the cost of our first-generation products.

   
 117 

Our contracts with Petrobras and Acelen provide for naphtha prices based on ARA quotations. The volatility of the quotation of this product in the international market, the real/U.S. dollar exchange rate, and the level of carbon disulfide, a contaminant of the naphtha that is delivered, also influence the price of naphtha that we purchase from Petrobras. We believe that these contracts have reduced the exposure of the cost of our first-generation products to fluctuations in the ARA market price for naphtha.

The international price of naphtha has fluctuated significantly in the past, and we expect that it will continue to do so in the future. Significant increases in the price of naphtha and, consequently, the cost of producing our products, generally reduce our gross margins and our results of operations to the extent that we are unable to pass all of these increased costs on to our customers and may result in reduced sales volumes of our products. Conversely, significant decreases in the price of naphtha and, consequently, the cost of producing our products, generally increase our gross margins and our results of operations and may result in increased sales volumes if this lower cost leads us to lower our prices. In periods of high volatility in the U.S. dollar price of naphtha, there is usually a lag between the time that the U.S. dollar price increases or decreases and the time that we are able to pass on increased, or required to pass on reduced, costs to our customers in Brazil. These pricing discrepancies decrease when the U.S. dollar price of naphtha is less volatile.

We do not currently hedge our exposure to changes in the prices of naphtha because a portion of our sales are exports payable in foreign currencies and linked to the international market prices of naphtha and also because the prices of our polyethylene, polypropylene and PVC products sold in Brazil generally reflect changes in the international market prices of these products.

Effects on Prices of Our Products

In Brazil, the prices we charge for many of our chemical products and thermoplastic resins in general are determined by international references linked to the contract prices for these products. Prices for second-generation products exported from Brazil are generally based on international spot market prices. We set the prices for products sold in the United States and Europe based on market pricing in such regions. The price for PE in Mexico is based on prices in the U.S. Gulf Coast region.

We negotiate the prices in reais for part of our products, principally polyethylene, polypropylene and PVC, on a monthly basis with our domestic customers. We attempt to revise our prices to reflect (1) changes in the international market prices of these products, which tend to fluctuate in tandem with naphtha prices, especially for polyethylene, and (2) the appreciation or depreciation of the real against the U.S. dollar. However, during periods of high volatility in international market prices or exchange rates, we are sometimes unable to fully reflect these changes in our prices in a prompt manner.

The international market prices of our petrochemical products have fluctuated significantly, and we believe that they will continue to do so. Volatility of the price of naphtha and the price of petroleum have effects on the price competitiveness of our naphtha-based crackers and our resins. Because pricing trends for naphtha and ethane have diverged in recent years to a greater extent than has been the case historically, producers of ethylene and resin products derived from ethane generally have experienced lower unit raw material costs than naphtha-based producers of these products. As a consequence, significant increases in the pricing differential between naphtha and gas, as a consequence of higher oil prices, increases the competitiveness of products derived from ethane and may result in an effect on our results of operations to the extent that we are able to maintain our operating margins and increased prices do not reduce pressure in the international markets.

Significant increases in the international market prices of our petrochemical products and, consequently, the prices that we are able to charge, generally increase our net revenue and our results of operations due to increased sales volumes of our products. Conversely, significant decreases in the international prices of our petrochemical products, and, consequently, the prices that we charge, generally reduce our net revenue and our results of operations if we are unable to increase our operating margins or these reduced prices do not result in increased sales volumes of our products.

   
 118 

Capacity Utilization

Our operations are capital-intensive. Accordingly, to obtain lower unit production costs and maintain adequate operating margins, we seek to maintain a high capacity utilization rate at all of our production facilities.

The table below sets forth capacity utilization rates with respect to the production facilities for some of our principal products for the periods presented.

 

Year Ended December 31,

 

2022

2021

2020

       
Ethylene Brazil 78% 81% 81%
PE Brazil 80% 80% 84%
PP Brazil 76% 82% 85%
PVC Brazil 66% 65% 63%
PP USA and Europe 80% 87% 89%
PE Mexico 73% 66% 74%

 

In 2022, the average ethylene capacity utilization was mainly affected by lower spreads in the international market due to lower demand. Additionally, the average utilization rate of petrochemical crackers in Brazil was impacted by: (i) the scheduled maintenance shutdown at the petrochemical complex in Rio Grande do Sul for 47 days and the scheduled maintenance shutdown at the PVC plant in Alagoas for 37 days, impacting the utilization rate of the petrochemical complex in Bahia; and (ii) the feedstock shortage at the petrochemical complexes of Rio de Janeiro and ABC, in the State of São Paulo, due to the lower supply given the scheduled maintenance shutdowns of a supplier. In Mexico, the utilization rate was higher by 7.0% compared to 2021, as a result of the expansion of the Fast Track solution for importing ethane, which reached 18,500 barrels per day on average for the year, representing an increase of 20.4% compared to 2021 and a 74% utilization rate of this solution.

Average polypropylene capacity utilization decreased due to a scheduled shutdown that occurred in the second quarter of 2022 in our petrochemical complex in Rio Grande do Sul, and lower demand in the period. Average PVC capacity utilization increased due to better industrial performance in the period. With respect to polypropylene in USA and Europe, average capacity utilization decreased due to: (i) weaker demand in such regions; and (ii) minor unscheduled shutdowns at PP plants in the period. With respect to polyethylene in Mexico, average capacity utilization increased mainly due to the higher ethane volume supplied by PEMEX and ethane imported in the period.

In 2021, average ethylene capacity utilization was mainly affected due to a scheduled general maintenance turnaround carried out at our petrochemical complex in ABC, São Paulo In the United States and Europe, the Company continued to operate above the industry average and ended the year with a utilization rate of 87%, considering the average of the two regions. In Mexico, Braskem Idesa ended the year with a utilization rate of 66%, and the main focus was to increase the availability of raw materials through the Fast Track, which represents 35% of the total ethane supply in the year.

In 2020, average ethylene capacity utilization was mainly affected by: (i) lower utilization rate of our cracker in Rio Grande do Sul due to unscheduled turnaround at the PE integrated unit in the first quarter of 2020; and (ii) weaker demand for resins and main chemicals as a result of the COVID-19 pandemic significantly impacting economic activity and markets around the world.

   
 119 

Effects of Brazilian Industrial Policy

The Brazilian government has a significant influence in some sectors of the domestic economy, including the petrochemical sector in which we operate. The Brazilian government has adopted, or is considering adopting, measures to boost the competitiveness of domestic companies, as described below.

SUDENE – Income Tax Reduction

Since 2015, Braskem obtained favorable decisions in administrative proceedings and lawsuits claiming the reduction of 75% of CIT on income from the following industrial units: (i) PVC and chlor-alkali (cloro soda) units, established in the state of Alagoas; and (ii) Chemicals, PE, PVC and chlor-alkali units, established in the city of Camaçari (BA). It benefits legal entities with projects for the implementation, modernization, or expansion of industrial enterprises. The benefit can be used for a period of 10 years. In 2022, the operations in Brazil recorded tax losses, therefore it was impossible to obtain a deduction in such year.

PRODESIN – ICMS Tax Incentive

Braskem has ICMS tax incentives in the state of Alagoas, through the state of Alagoas Integrated Development Program, or PRODESIN, which aimed at implementing and expanding a plant in that state. This incentive is considered an offsetting entry to sales taxes. In 2022, the amount was R$87.4 million (R$176.3 million in 2021). As PRODESIN is considered an investment subsidy, it was allocated to our tax incentive reserve, pursuant to the Brazilian Corporate Law.

REIQ – PIS/COFINS Tax Incentive

In 2013 the Brazilian government approved a PIS and COFINS tax rates relief on raw material purchases by first-generation and second-generation producers, which serve various sectors of the economy. The measure aimed to restore some of the industry’s competitiveness, which was weakened by factors related to infrastructure, productivity, feedstock and energy costs and the exchange rate that pressured the chemical industry’s trade deficit, according to ABIQUIM, which ended 2022 at R$401.7 million.

In March 2021, Brazilian tax authorities edited a Bill of Law that would extinguish the REIQ by August. In July of the same year, this document was converted into Law No. 14,183/21, maintaining the REIQ benefit until 2024. A different Law No. 14,374/22 approved the gradual reduction of the REIQ until 2027. In this sense, as of July, the credit on PIS/COFINS rates concerning the purchase of petrochemical raw materials had a rebate of 2.92%, reducing annually until 2027.

Additionally, on December 31, 2021, the Federal Government issued Bill of Law No. 1,095, which again aims to end the REIQ, as of April 1, 2022. Pursuant to Brazilian laws, such provisional measure has been approved by the Chamber of Deputies and by the Federal Senate by June 21, 2022 and therefore continues to produce effects.

Reintegra

In December 2011, the Brazilian government implemented the “Reintegra” program, which is designed to improve the competitiveness of Brazilian manufacturers in the export markets by refunding the federal taxes levied on their export sales. As a result of this incentive, exports of third generation products by Brazilian companies have increased. The original program ended on December 31, 2013. In August 2014, the Brazilian government permanently reinstated Reintegra on a permanent basis and with variable rates that could vary by up to 5% of the revenue of the companies with exports. The refund tax rate was set at 0.1% in August 2014. In October 2014, the Brazilian government restored the rate to 3.0% until the end of 2015. However, in March 2015, the Brazilian federal government again decreased the rate to 1.0% for 2015 and 2016. In October 2015, according to the Decree No. 8,543, the Brazilian federal government decreased the refund rate to 0.1% as of December 1, 2015, which remained in effect until December 31, 2016. On August 28, 2017, pursuant to Decree No. 9,148 that amended the Decree No. 8,543, the Reintegra rate increased to 2% effective, as of January 1, 2017 until December 31, 2018. However, on May 30, 2018, the Brazilian government issued Decree No. 9,393, decreasing the refund rate to 0.1%, effective June 1, 2018, for an undefined term.

   
 120 

Import Tariffs at Local Ports

Historically, tariffs on imports have been set by the Brazilian federal government. However, in recent years, some Brazilian states have established tax incentives to attract imports to local ports in order to increase revenue and develop the local infrastructure of such ports, mainly through the granting of discounts on the ICMS tax rates that would be due to such states. Industry leaders and labor associations allege that such laws create subsidies for imported products, which would harm the Brazilian market.

On January 1, 2013, the legislation came into force that reduces the maximum rate of ICMS to be charged by the states from 12.0% to 4.0% on interstate sales of raw materials and other imported goods or that have a share of imports greater than 40.0%. With limited exceptions, the rate of 4.0% is not applicable to imported goods without a domestic equivalent, to goods produced in accordance with the basic production processes and to operations that send gas imported from abroad to other states. As a result, the current tax incentives offered by some Brazilian states to attract imports of products in the form of a discount on the ICMS tax rates that would otherwise be due have become less attractive.

Pricing and Tariffs

We set prices for ethylene, the principal first generation petrochemical product that we sell to third-party second-generation producers, by reference to international market prices. See “Item 4. Information on the Company—Chemicals Operations that are Part of our Brazil Segment—Sales and Marketing of Our Chemicals Operations that are Part of our Brazil Segment.” Prices paid by second generation producers for imported first generation petrochemical products partly reflect transportation and tariff costs. We establish the prices of ethylene by-products, such as butadiene, by reference to several market factors, including the prices paid by second generation producers for imported products. Prices paid for such imports also reflect transportation and tariff costs.

The Brazilian government has used import tariffs to implement economic policies. As a result, import tariffs imposed on petrochemical products have varied in the past and may vary in the future. Until November 2021, tariffs on imports of first-generation petrochemical products varied between 0% and 4%, and tariffs on polyethylene, polypropylene and PVC resins were 14.0%. In November 2021, the Brazilian government unilaterally reduced by 10%, the import tariff rates of almost 87% of internationally commercialized goods. Accordingly, tariffs on imports of first-generation petrochemical products now vary between 0% and 3.6% and tariffs on polyethylene, polypropylene and PVC resins were set at 12.6%. This decision shall remain in force until at least December 31, 2022. The possibility of reducing rates permanently is under discussion within the Brazilian federal government.

In August 2022, the Brazilian government also enacted Resolutions Nos. 369 and 381 of the Chamber of Foreign Trade Management Committee approving a reduction in the import tax, by inclusion in the list of exceptions to the Mercosur Common External Tariff (“Letec”), referring supply problems in the Brazilian market, for the following Company products: (i) ethylene and alpha-olefin copolymers with density lower than 0.94, from 11.2% to 3.3%; (ii) S-PVC resin obtained from the suspension process, from 11.2% to 4.4%; and (iii) PP (propylene copolymer) resin, from 11.2% to 4.4%. This reduction is effective for one year as from August 5, 2022, and, during this period, is expected to adversely affect the Company’s results in Brazil. Braskem has always prioritized supply to the Brazilian market and currently there are no signs of lack of the product in this market.

Before that, in December 2020, the Brazilian federal government temporarily reduced to 4%, for an initial period of three months, and a quota of 160,000 tons, the import tariffs levied on imports of PVC resins from countries that do not benefit from preferential import rates in Brazil. This reduction was later extended in April 2021 for an additional three-month period and an additional quota of 160,000 tons. In that same month, the Brazilian federal government temporarily reduced to 0% during a three-month period and applied a quota of 77,000 tons of the import tariffs levied on imports of PP resins.

   
 121 

Imports and exports within the free trade area in South America (Southern Common Market), or Mercosur, which is composed of Argentina, Brazil, Paraguay, and Uruguay, have not been subject to tariffs since December 2001. Imports of suspension PVC from Bolivia, Chile, Colombia, Cuba, Ecuador, Israel, Peru, and Venezuela are not subject to tariffs, due to a number of trade agreements. Imports of suspension PVC from Mexico to reduced tariffs of 80% of MFN, due to trade agreements.

Also, since the 1990s, imports of suspension PVC from the United States and Mexico have been subject to anti-dumping duties of 16.0% and 18.0%, respectively, that were imposed by the Brazilian Foreign Trade Chamber (Câmara de Comércio Exterior, or “CAMEX”). Since 2008, imports of suspension PVC from China have also been subject to anti-dumping duties of 21.6%. Such duties had been temporarily suspended in August 2020 but were re-instated in September 2021. Imports of suspension PVC from South Korea were subject to anti-dumping duties ranging between 0% and 18.9%, depending on the producer, between 2008 and August 2020, when they were terminated. The duties imposed on imports from the United States and Mexico were revised in 2022 by the Brazilian government, which decided to extend until 2027 the application of anti-dumping duties for imports from the United States with an ad valorem rate reduced to 8.2%, and from Mexico at the rate of 13.6%, but with an immediate suspension of the application of anti-dumping duties for imports from Mexico, while the duties imposed on imports from China will expire in 2025.

Additionally, in December 2010, CAMEX imposed an anti-dumping duty of 10.6% on PP imports from the United States, which was extended in November 2016. In August 2014, the Brazilian government imposed anti-dumping duties on PP imports from South Africa, India and South Korea of 16.0%, 6.4% to 9.9%, and 2.4% to 6.3%, respectively. The duties imposed on imports of PP from the United States were revised by the Brazilian government, which decided to extend until 2027 the application of anti-dumping duties from the United States with at an ad valorem rate of 10.6%, but with an immediate suspension of the application of the anti-dumping duties. In December 2020, the Brazilian government extended the anti-dumping duties imposed on PP imports from India, reduced the anti-dumping duties for South Africa to a range from 4.6% to 16% and terminated the duties applied against South Korea. The current anti-dumping duties applied on imports from South Africa and India are set to expire in December 2025.

In August 2022, the Brazilian government also enacted Resolutions Nos. 369 and 381 of the Chamber of Foreign Trade Management Committee approving a reduction in the import tax, by inclusion in the list of exceptions to the Mercosur Common External Tariff (“Letec”), referring supply problems in the Brazilian market, for the following Company products: (i) ethylene and alpha-olefin copolymers with density lower than 0.94, from 11.2% to 3.3%; (ii) S-PVC resin obtained from the suspension process, from 11.2% to 4.4%; and (iii) PP (propylene copolymer) resin, from 11.2% to 4.4%. This reduction is effective for one year as from August 5, 2022 and, during this period, is expected to adversely affect the Company’s results in Brazil. Braskem has always prioritized supply to the Brazilian market and currently there are no signs of lack of the product in this market.

In 2022, approximately 34.3% of Brazilian PE, PP and PVC resins were imported, which reflected a 8.2% annual decrease in the volume of resins imported.

In 2021, approximately 36.4% of Brazilian PE, PP and PVC resins were imported, which reflected a 17.1% annual increase in the volume of resins imported.

In 2020, 31.9% of Brazilian PE, PP and PVC resins were imported products, which reflected an 11.6% annual increase in the volume of resins imported.

   
 122 

Effect of Level of Indebtedness and Interest Rates

As of December 31, 2022, our total outstanding consolidated indebtedness was R$47,087.1 million (US$9,024.5 million), including R$11,370.3 million (US$2,179.2 million) related to Braskem Idesa. The level of our indebtedness results in significant financial expenses that are reflected in our statement of profit or loss. Financial expenses consist of interest expense, exchange variations of U.S. dollar and other foreign currency-denominated debt, foreign exchange losses or gains, and other items as set forth in note 33 to our audited consolidated financial statements. In the year ended December 31, 2022, we recorded total financial expenses, net of R$5,662.7 million, of which: (i) R$3,125.2 million consisted of interest expenses; (ii) R$260.5 million is related to loans transaction costs – amortization; (iii) R$581.0 million is related to adjustment to present value – appropriation; and (iv) R$203.3 million is related to interest expenses on leases.

In addition, we recorded a loss of R$572.2 million in connection foreign exchange variation on our financial assets and liabilities. The interest rates that we pay depend on a variety of factors, including prevailing Brazilian and international interest rates and our risk assessments, our industry and the Brazilian economy made by our potential lenders, potential purchasers of our debt securities and the rating agencies that assess us and our debt securities.

Effect of Taxes on Our Income

We are subject to a variety of generally applicable federal and state taxes in multiple jurisdictions on our operations and results. We are generally subject to Brazilian federal income tax at 25% (including surtax), combined with Social Contribution on Net Income (Contribuição Social Sobre o Lucro Líquido, or “CSLL”) at 9%, totalizing a nominal rate of 34%, which is the standard corporate tax rate in Brazil.

We have available certain federal tax exemptions based upon federal law that offers tax incentives to companies that locate their manufacturing operations in the Brazilian states of Bahia and Alagoas. These exemptions represent a 75% reduction of our tax burden, and, as a result, we are entitled to pay 25% of the statutory income tax rate on the profits arising from the sale of:

·polyethylene manufactured at one of our polyethylene plants in the Northeastern Complex (State of Bahia) until 2026; and
·polyethylene manufactured at one of our polyethylene plants in the Northeastern Complex and caustic soda, chlorine, ethylene dichloride and PVC produced at our plants in the Northeastern Complex (State of Bahia and Alagoas) until 2024.

The exemption of 75% of income tax rate combined with CSLL at 9%, entitles us to pay only 44.9% of the 34% standard corporate tax rate on the profits arising from products manufactured at these plants.

Income tax loss carryforwards available for offset in Brazil do not expire. However, the annual offset is limited to 30% of our adjusted net taxable basis profit. This limit also affects the social contribution on net profit, or CSLL.

The consolidated amount includes the impact from the different tax rates in countries where foreign subsidiaries are located, as follows:

·Braskem Europe (Germany): 31.09%;
·Braskem America and Braskem America Finance (United States): 21.00%;
·Braskem Argentina (Argentina): 27.00%;
   
 123 
·Braskem Petroquímica Chile (Chile): 27.00%;
·Braskem Netherlands, Braskem Netherlands Finance and Braskem Netherlands Inc. (The Netherlands): 25.80%;
·Braskem Idesa, Braskem Idesa Serviços, Braskem México, Braskem México Serviços and Braskem México Sofom (Mexico): 30.00%; and
·Braskem India (India): 30.00%.

The consolidated amount also includes the impact of taxation on universal bases, which was introduced in Brazil by articles 76 and 77 of Law No. 12,973/2014. This law determines that positive portions of results earned by subsidiaries abroad will be computed in the corporate income tax (Imposto de Renda da Pessoa Jurídica, or “IRPJ”) calculation base and CSLL in Brazil on an individual basis. In case the subsidiary has previous losses, these may be deducted up to the amount of the calculated profit, therefore, the taxpayer is obliged to inform the tax authority of the accumulated losses.

All profits earned by the subsidiaries described above must be subject for IRPJ and CSLL taxation in Brazil, with the exception of profits earned by subsidiaries headquartered in countries with which Brazil has a treaty to avoid double taxation. Profits earned by companies headquartered in those countries will only be taxed when they are distributed to their respective controlling entities.

In addition, the universal basis taxation mechanism also allows the use, as a tax credit, of the tax that was proven to be paid by subsidiaries abroad up to the limit of the tax due by taxation at the rate of 34% of the profit of the subsidiary in Brazil, and compensation exceeding this is prohibited. In addition, the legislation also allowed that, until 2022, the parent company in Brazil can apply a presumed tax credit at the rate of 9.0% on the profit earned by subsidiaries abroad that have industrial activity. Braskem has been applying this mechanism to its subsidiaries Braskem Europe GmbH, Braskem America Inc. and Braskem Idesa SAPI.

Bill of Law No. 2,502/21 is currently pending before the Brazilian Senate, which, among other things, proposes extending the horizon for using the presumed tax credit until 2032, as well as the inclusion of the “provision of services” activity in the list of benefited activities.

Our export sales are currently exempt from (1) PIS – Contribution to the Social Integration Plan, (2) COFINS – Contribution for Social Security Financing, a federal value-added tax, (3) IPI, a federal excise tax on industrialized goods, and (4) ICMS, a state value-added tax on sales and services.

Statement of Profit or Loss

The discussion of the results of our segments is based upon financial information reported for each of the segments of our business, as presented in the following tables, which set forth the results of each of our segments and the reconciliation of these results of our segments to our consolidated results of operations. This segment information was prepared on the same basis as the information that our Chief Operating Decision Maker uses to allocate resources among segments and evaluate their performance. We evaluate and manage the performance of our segments based on information generated from our accounting records maintained in accordance with IFRS as issued by IASB and reflected in our audited consolidated financial statements.

The discussion summarizing the significant factors affecting the results of operations for the year ended December 31, 2022, can be found in Part I, “Item 5. Operating and Financial Review and Prospects” of this annual report.

 

 

   
 124 

 

 

Year Ended December 31, 2022

 

Net revenue

Cost of products sold

Gross profit

Selling, general and distribution expenses

Results from equity investments

Other operating income (expense), net

Profit (loss) before net financial expenses and taxes

  (in millions of reais)
Brazil 69,079.7 (63,195.6) 5,884.1 (1,853.0) (1,889.0) 2,142.1
USA and Europe 23,421.1 (19,986.2) 3,434.9 (838.5) 56.9 2,653.4
Mexico

5,834.0

(5,069.5)

764.5

(451.6)

(33.4)

279.5

Total 98,334.8 (88,251.3) 10,083.5 (3,143.1)     (1,865.4) 5,075.0
Other(1) 403.0 (262.4) 140.6 82.5 34.8 5.6 263.6
Corporate unit (2,196.5) 19.4 (2,177.1)
Reclassifications and eliminations(2)

(2,218.5)

3,353.2

1,134.6

(28.2)

4.2

1,110.7

Consolidated

96,519.3

(85,160.5)

11,358.7

(5,285.3)

34.8

(1,836.2)

4,272.0

 

  (1) Represents income (expenses) of Braskem that are not allocated to any particular segment.

 

  (2) Eliminations consist primarily of inter-segment sales.

 

 

 

Year Ended December 31, 2021

 

Net revenue

Cost of products sold

Gross profit

Selling, general and distribution expenses

Results from equity investments

Other operating income (expense), net

Operating (loss) profit

  (in millions of reais)
Brazil 69,494.9 (49,309.6) 20,185.4 (1,608.2) (2,210.6) 16,366.6
USA and Europe 32,403.6 (23,343.2) 9,060.4 (900.9) (25.6) 8.134.0
Mexico

6,506.3

(3,413.7)

3,092.6

(471.8)

(15.3)

2,605.5

Total 108,404.9 (76,066.4) 32,338.4 (2,980.9) (2,251.5) 7,106.1
Other(1) 363.7 (233.1) 130.6 76.8 4.6 (28.7) 183.4
Corporate unit(2) (1,963.1) 1,161.5 (801.6)
Reclassifications and eliminations(3)

(3,143.3)

2,731.3

(412.1)

(16.1)

(16.2)

(444.3)

Consolidated

105,625.2

(73,568.2)

32,057.0

(4,883.3)

4.6

(1,134.8)

26,043.5

 

  (1) Represents income (expenses) of Braskem that are not allocated to any particular segment.

 

  (2) Includes the amount of R$(1,031.1) million related to PIS and COFINS tax credits – exclusion of ICMS from the calculation base (note 10b to our audited consolidated financial statements).

 

  (3)

Eliminations consist primarily of inter-segment sales.

 

In the following discussion, references to increases or declines in any period are made by comparison with the corresponding prior period, except as the context otherwise indicates.

   
 125 

Year Ended December 31, 2022 Compared with Year Ended December 31, 2021

The following table sets forth our consolidated financial information for the years ended December 31, 2022 and 2021.

  2022   2021   % Change
  (in millions of reais)  
Net revenue 96,519.3   105,625.2   (8.6)%
Cost of products sold

(85,160.5)

(73,568.2)

15.8%

Gross profit 11,358.7   32,057.0   (64.6)%
Income (expenses):          
Selling and distribution (2,108.4)   (2,055.6)   2.6%
(Loss) for impairment of trade accounts receivable and others from clients (38.4)   (8.9)   331.5%
General and administrative (2,764.0)   (2,522.1)   9.6%
Research and development (374.5)   (296.6)   26.3%
Results from equity-accounted investees 34.8   4.6   656.5%
Other income 507.3   1,534.5   (66.9)%
Other expenses

(2,343.5)

(2,669.3)

(12.2)%

(Loss) profit before net financial expenses and taxes 4,272.1   26,043.5   (83.6)%
Financial results:          
Financial expenses (5,662.7)   (5,907.2)   (4.1)%
Financial income 2,010.1   1,827.4   10.0%
Exchange rate variations, net

(572.2)

(4,002.8)

(85.7)%

Financial expenses, net

(4,224.7)

(8,082.5)

(47.7)%

Profit before income tax 47.3   17,961.0   (99.7)%
Income taxes

(867.7)

(3,999.4)

(78.3)%

(Loss) net profit for the year

(820.4)

13,961.6

(105.9)%

Net revenue

Net revenue decreased by R$9,105.9 million, or 8.6%, to R$96,519.3 million in 2022, from to R$105,625.2 million in 2021, attributable mainly to: (i) a decrease of R$8,982.5 million in net revenue from our USA and Europe segment; (ii) an decrease of R$415.2 million in net revenue from our Brazil segment; and (iii) a decrease of R$672.3 million in net revenue from our Mexico segment, which was partially offset by an increase of R$39.3 million from other segments.

Net Revenue of Brazil Segment

Net revenue of our Brazil segment remained relatively stable at R$69,079.7 million in 2022, compared to R$69,494.9 million in 2021, attributable mainly to (i) a decrease in main chemicals sales volume by 299.4 ktons, or 8.5%, to 3,219.6 ktons in 2022, from 3,519.0 ktons in 2021, which was partially compensated by an increase in our main chemicals average sales price of 15.3%; and (ii) a decrease of 9.4% in resins average sales price. The combined effect of average sales prices and volume in the Brazil segment resulted in a negative impact of R$3,161.7 million, or 4.6% of the segment’s revenue, which was partially offset by an appreciation of the real against the U.S. dollar in the period, resulting in an impact of R$2,948.4 million, or 4.3% of the segment’s revenue.

The table below sets forth information regarding the weighted average international prices of main chemicals and resins that are generally used as a reference for our Brazil Segment for the periods indicated:

 

   
 126 

 

International References1

 

Year Ended December 31,

 

2022

2021

% Change

    (in US$/ton)  
Main Chemicals(2)   1,262.4 1,090.8 15.7%
Resins(3)   1,200.7 1,508.1 (20.4)%

(1) Source: External consulting (spot price).

(2) Average prices weighted based on Braskem’s capacity production: ethylene (20%), butadiene (10%), propylene (10%), cumene (5%), benzene (20%), paraxylene (5%), gasoline (25%) and toluene (5%).

(3) PE US (54%), PP Asia (33%) and PVC Asia (13%).

Net Revenue of USA and Europe Segment

Net revenue of our USA and Europe Segment decreased by R$8,982.5 million, or 27.7%, to R$23,421.1 million in 2022, from R$32,403.6 million in 2021, primarily as a result of: (i) a decrease in sales volume in the USA Segment by 69.7 ktons, or 4.2%, to 1,589.0 ktons in 2022, from 1,658.7 ktons in 2021, explained mainly by lower demand in the United States region associated with higher inventory levels in the converter chain and the fear of an economic recession in the country, and a decrease in PP sales volume in Europe by 50,453.1 ktons, or 9.0%, to 507.9 ktons in 2022, from 558.3 ktons in 2021, due to the lower demand associated with lower consumption, high inventory levels in the converter chain, expectation of lower prices in subsequent periods and high levels of PP imports to Europe; and (ii) a decrease of 24.8% in average sales prices due to lower demand for the products associated with higher inflation, higher interest rates and higher supply of products due to new PP capacities coming online in the United States and China. The combined effect of average sales prices and volume in USA and Europe segment resulted in a negative impact of R$7,573.8 million, or 32.3%, of the segment’s revenue.

International References1

 

Year Ended December 31,

 

2022

2021

% Change

    (in US$/ton)  
PP US and Europe2   2,083.5 2,580.3 (19.3)%

(1) Source: External consulting (spot price).

(2) Average prices weighted based on Braskem’s capacity production: PP USA (72%) and PP Europe (28%).

 

Net Revenue of Mexico Segment

Net revenue of our Mexico segment decreased by R$672.3 million, or 10.3%, to R$5,834.0 million in 2022, from R$6,506.3 million in 2021, attributable mainly to as a result of (i) a decrease of 26.6% in average polyethylene sales prices in the period due to an increase in the supply of products by new PE capacities coming online, and (ii) lower global demand due to higher inflation during 2022 and higher levels of inventories in the converter chain. These effects were partially offset by an increase in polyethylene sales volume by 128.8 ktons, or 20.2%, to 766.6 ktons in 2022, from 637.8 ktons in 2021, due to the higher product availability for sale, due to higher ethane supply from PEMEX and by the Fast Track solution we built in our Mexico complex. The combined effect of average sales prices and volume in Mexico segment resulted in a negative impact of R$1,078.2 million, or 18.5% of the segment’s revenue, which was partially offset by an appreciation of real against the U.S. dollar in the period resulting in a positive impact of R$249.0 million, or 4.3% of the segment’s revenue.

International References1

Year Ended December 31,

2022

2021

% Change

  (in US$/ton)  
PE US 1,248.1 1,764.4 (29.3)%

(1) Source: External consulting (spot price).

   
 127 

 

Cost of Products Sold and Gross Profit

Cost of products sold increased by R$11,592.3 million, or 15.8%, to R$85,160.5 million in 2022, from R$73,568.2 million in 2021, primarily as a result of: (i) a 28.2% increase in the cost of products sold in our Brazil segment; and (ii) a 48.5% increase in the cost of products sold in our Mexico segment. The effects of these increases were partially offset by a 14.4% decrease in the cost of products sold in our USA and Europe segment.

As a result of the above, consolidated gross profit decreased by R$20,698.3 million, or 64.6%, to R$11,358.7 million in 2022, from R$32,057.0 million in 2021. Gross margin (gross profit as a percentage of net revenue) decreased to 11.8% in 2022, from 30.3% in 2021.

Cost of Products Sold of the Brazil Segment

Cost of products sold of our Brazil segment increased by R$13,886.0 million, or 28.2%, to R$63,195.6 million in 2022, from R$49,309.6 million in 2021, primarily as a result of: (i) a 21.3% increase in the average Amsterdam-Rotterdam-Antwerp (ARA) naphtha price; and (ii) a 52.6% increase in the average U.S. Gulf reference price (USG price) of ethane, which was influenced mainly by higher oil and natural gas average prices in the international markets.

International References

 

Year Ended December 31,

 

2022

2021

% Change

    (in US$/ton)  
Naphtha ARA   770.0 635.0 21.3%
Ethane U.S.   356.2 229.0 52.6%
Propane U.S.   575.8 545.0 5.6%
EDC U.S.   519.4 730.6 28.9%

(1)       Source: External consulting (spot price).

 

Gross profit of our Brazil segment decreased by R$14,301.3 million, or 70.8%, to R$5,884.1 million in 2022, from R$20,185.4 million in 2021, due to a decrease in resin spread of 48.6%, to US$432.9 per ton during the year ended December 31, 2022, from US$842.0 per ton during the corresponding period of 2021, which was partially compensated by an increase in main chemicals spread of 7.9%, to US$492.4 per ton during the year ended December 31, 2022, from US$456.2 per ton during the corresponding period of 2021.

Gross margin (gross profit as a percentage of net revenue) of our Brazil segment decreased to 8.5% in 2022, from 29.0% in 2021.

Cost of Products Sold of USA and Europe Segment

Cost of products sold of our USA and Europe segment decreased by R$3,357.0 million, or 14.4%, to R$19,986.2 million in 2022, from R$23,343.2 million in 2021, primarily as a result of lower sales volume and lower international price reference of propylene in the United States and Europe.

International References1

Year Ended December 31,

2022

2021

% Change

  (in US$/ton)  
Propylene US and Europe2 1,215.0 1,501.2 (19.1)%

(1) Source: External consulting (spot price).

(2) Average prices weighted based on Braskem’s capacity production: Propylene USA (72%) and Propylene Europe (28%).

   
 128 

Gross profit of our USA and Europe segment decreased by R$5,625.5 million, or 62.1% to R$3,434.9 million in 2022, from R$9,060.4 million in 2021, mainly due to a decrease of 19.5% in the PP spreads in the USA and Europe segment, to US$868.6 per ton during the year ended December 31, 2022, from US$1,079.1 per ton during the corresponding period of 2021. Gross margin (gross profit as a percentage of net revenue) of our USA and Europe segment decreased to 14.7% in 2022, from 28.0% in 2021.

Cost of Products Sold by Mexico Segment

Cost of products sold of our Mexico segment increased by R$1,655.8 million, or 48.5%, to R$5,069.5 million in 2022, from R$3,413.7 million in 2021, as a result of higher international ethane average prices and higher sales volume in the period.

International References1

Year Ended December 31,

2022

2021

% Change

  (in US$/ton)  
Ethane U.S. 356.2 229.0 55.6%

(1)              Source: External consulting (spot price).

 

Gross profit of our Mexico segment decreased by R$2,328.1 million, or 75.3% to R$764.5 million in 2022, from R$3,092.6 million in 2021, as a result of higher international ethane average prices in the period. Gross margin (gross profit as a percentage of net revenue) of our Mexico segment decreased to 13.1% in 2022, compared to 47.5% in 2021, as a result of the aforementioned factors.

Selling and Distribution Expenses

Selling and distribution expenses increased by R$52.8 million, or 2.6%, to R$2,108.4 million in 2022, from R$2,055.6 million in 2021, primarily due to an increase in third parties, storage, and logistics expenses in our Brazil segment. Selling and distribution expenses as a percentage of net revenue were 2.2% during the year ended December 31, 2022, compared to 1.9% in the corresponding period of 2021.

Loss for Impairment of Trade Accounts Receivable and Others from Clients

Impairment of trade accounts receivable and others from clients increased by R$29.5 million, or 331.5%, to an impairment expense of R$38.4 million in 2022, from an impairment expense of R$8.9 million in 2021, mainly due to (i) customer defaults in the United States due to bankruptcy in the amount of R$13.4 million; and (ii) an increase in the payment period for customers in Argentina, due to government measures increasing the payment period for imported products, resulting in an increase in expected credit losses of R$19.2 million.

General and Administrative Expenses

General and administrative expenses increased by R$241.9 million, or 9.6%, to R$2,764.0 million in 2022, from R$2,522.1 million in 2021, primarily as a result of higher expenses resulting from advertising and publicity, consulting services, industrial maintenance services at our facility in the State of Alagoas, and higher expenses related to information technology services and wage agreements. General and administrative expenses as a percentage of net revenue were 2.9% during the year ended December 31, 2022, compared to 2.4% in the corresponding period of 2021.

Research and Development Expenses

Research and development expenses increased by R$77.9 million, or 26.3%, to R$374.5 million in 2022, from R$296.6 million during the corresponding period of 2021, mainly due to higher expenses with third parties to carry out market studies for our new strategic information and technology projects. Research and development expenses as a percentage of net revenue were 0.4% during the year ended December 31, 2022, compared to 0.3% in the corresponding period of 2021.

   
 129 

Results from Equity-Accounted Investees

Results from equity investments increased by R$30.2 million, or 656.5%, to a profit of R$34.8 million in 2022, from a profit of R$4.6 million in 2021, due to increased gains from our investees Refinaria de Petróleo Riograndense (RPR) and Borealis Brasil S.A.

Other Income

Other income decreased by R$1,027.2 million, or 66.9%, to R$507.3 million in 2022, from R$1,534.5 million in 2021, mainly due to the effect from a PIS/COFINS tax credit of R$1,031.1 million recorded in June 2021, which did not occur in 2022.

Other Expenses

Other expenses decreased by R$325.8 million, or 12.2%, to R$2,343.5 million in 2022, from R$2,669.3 million in 2021, primarily due to: (i) lower expenses in take-or-pay penalties in 2022; (ii) lower provision related to the geological event of Alagoas; and (iii) a decrease in provision costs related to environmental liabilities. Other expenses as a percentage of net revenue were 2.4% during the year ended December 31, 2022, compared to 2.5% in the corresponding period of 2021.

(Loss)Profit Before Net Financial Expenses and Taxes

As a result of the foregoing:

·operating profit before net financial expenses and taxes of our Brazil segment decreased by R$14,224.5 million, or 86.9%, to R$2,142.1 million in 2022, from to R$16,366.6 million in 2021. Operating margin, defined as a percentage of operating profit before net financial expenses and taxes divided by net revenue, of our Brazil segment decreased to 3.1% in 2022, compared to 23.6% in 2021, mainly due to: (i) lower sales volume of resins and main chemicals, which is explained by lower demand in the year, lower consumption due to interest rates increase and high inventories in the global supply chain; and (ii) lower international spreads for PE, PP and PVC in the period, which were partially compensated by the appreciation of the real against the U.S. dollar between the periods.
·profit before net financial expenses and taxes of our USA and Europe segment decreased by R$5,480.6 million, or 67.4%, to R$2,653.4 million in 2022, compared to R$8,134.0 million in 2021. Operating margin, defined as a percentage of operating profit before net financial expenses and taxes divided by net revenue, of our USA and Europe segment decreased to 11.3% in 2022, compared to an operating margin of 25.1% in 2021 in 2020 due to: (i) lower sales volume of PP in Europe due to lower demand; and (ii) lower PP spread in the United States and Europe; and
·profit before net financial expenses and taxes of our Mexico segment decreased by R$2,326.0 million, or 89.3% to R$279.5 million in 2022, from R$2,605.5 million in 2021. Operating margin, defined as a percentage of operating profit before net financial expenses and taxes divided by net revenue, of our Mexico segment was 4.8% in 2022, compared to an operating margin of 40.0% in 2021, mainly due to: (i) lower PE sales volume due to lower demand; (ii) lower PE spreads; (iii) higher ethane and natural gas prices in the international market; and (iv) the appreciation of the real against the U.S. dollar between the periods.

As a result of the above, profit before net financial expenses and taxes on a consolidated basis decreased by R$21,771.4 million, to R$4,272.1 in 2022, from R$26,043.5 million in 2021. Operating margin, defined as a percentage of operating profit before net financial expenses and taxes divided by net revenue decreased to 4.4% in 2022, from 24.7% during the corresponding period of 2021.

   
 130 

Financial Expenses, Net

Financial Expenses

Financial expenses decreased by R$244.5 million, or 4.1%, to R$5,662.7 million in 2022, from R$5,907.2 million in 2021, primarily due to (i) lower recognition of amounts related to transaction costs due to fewer prepayments; (ii) lower expenses with derivatives due to lower exchange rate; and (iii) recognition of the financial expense related to the withholding of income tax on the loan receivable from Braskem Idesa.

Financial Income

Financial income increased by R$182.7 million, or 10.0%, to R$2,010.1 million in 2022, from R$1,827.4 million in 2021, primarily due to: (i) higher returns on financial investments in Brazilian real given the higher average interest rates in the period; and (ii) higher income with derivatives during the period.

Exchange Variations, Net

Exchange rate variations, net decreased by R$3,430.6 million, or 85.7%, to an expense of R$572.2 million in 2022, from an expense of R$4,002.8 million in 2021, primarily as a result of: (i) the effects of the depreciation of the U.S. dollar against the Brazilian real on the net exposure of the financial result not designated as hedge accounting in the amount of US$3.0 billion as of December 31, 2022; (ii) the effects of the depreciation of the U.S. dollar against the Mexican peso, relating to the net exposure of Braskem Idesa in the amount of US$2.2 billion as of December 31, 2022; and (iii) lower expenses with export hedge accounting recorded in shareholder’' equity, in the amount of R$1.8 billion.

Income Taxes

Income Tax

Income tax decreased by R$3,131.70 million, or 78.3%, to an expense of R$867.7 million in 2022, compared to an expense of R$3,999.4 million in 2021, as a result of a decrease in the profit before income tax mainly due to lower profit before income taxes, which was mainly impacted by lower petrochemical spreads in all of our segments in the period.

The effective tax rate applicable to our profit before income taxes was 1,832.8% in 2022, compared to an effective tax rate of 22.3% during the corresponding period of 2021, mainly due to: (i) thin capitalization which includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules in the amount of R$359.6 million (ii) use of tax losses in Braskem Idesa in the amount of R$891.7 million; (iii) different jurisdictional taxes for companies abroad and taxis basis in the amount of R$1,029.6 million; (iv) taxes on dividend distribution in the amount of R$454.7 million; and (v) other permanent adjustments in the amount of R$226.6 million. For more information, see note 22 to our audited consolidated financial statements included elsewhere in this annual report.

(Loss) Net Profit For the Year

As a result of the above, we recorded a loss of R$820.4 million, or 0.8% of net revenue, in 2022, compared to a net profit of R$13,961.6 million, or 13.2% of net revenue, in 2021, mainly due to lower petrochemical spreads in the international market in all of our segments in the period.

   
 131 

Liquidity and Capital Resources

Our principal cash requirements for 2022 consisted of the following:

·servicing our indebtedness;
·capital expenditures related to investments in operations, maintenance and construction;
·payments related to the geological event in Alagoas; and
·payments under the Global Settlement described in this annual report.

Our principal sources of liquidity have traditionally consisted of the following:

·cash flows from operating activities;
·short-term and long-term borrowings;
·issuance of debt in Brazilian capital markets; and
·sales of debt securities in Brazilian capital markets.

As of December 31, 2022, our consolidated cash and cash equivalents and financial investments amounted to R$14,779.1 million and included R$2,184.3 million held by Braskem Idesa, which was restricted to its exclusive use.

Projected Sources and Uses of Cash

Considering our short-term financial contractual obligations and commitments as of December 31, 2022 and budgeted capital expenditures for 2023, we expected that we will be required to spend R$4.3 billion during 2023 mainly for (1) our operations, and (2) our debt service through new financing activities, including new debt financings and the refinancing of our existing short-term indebtedness as it becomes due, and (3) interest payment in the total amount of R$2,152.4 million (excluding Braskem Idesa) and R$752.5 million of Braskem Idesa. We have firm commitments from several financial institutions to provide us with financing in the future, subject to conditions precedent and the payment of commitment fees.

Cash Flows

The following table sets forth certain consolidated cash flow information for the periods indicated:

 

As of December 31,

 

2022

2021

2020

  (in millions of reais)
Net cash generated from operating activities 8,951.7 14,786.5 6,293.0
Net cash used in investing activities (4,947.3) (3,380.7) (2,721.8)
Net cash generated (used) in financing activities 225.1 (16,965.5) 2,173.2
Exchange variation on cash of foreign subsidiaries

(443.8)

377.5

1,314.6

Increase (decrease) in cash and cash equivalents

3,785.7

(5,182.2)

7,059.0

 

Net Cash Generated from Operating Activities

Net cash generated from operating activities was R$8,951.7 million during 2022, and R$14,786.5 million during 2021. Net cash generated from operating activities decreased by R$5,834.8 million during 2022, as compared to 2021, which was the result of:

   
 132 
·a decrease in the results of operations in the period, due to lower spreads in the international market and lower sales volume of resins and the main chemicals in Brazil, PP in the United States and Europe, and PE in Mexico.

The effects of these factors were partially offset by:

·the positive variation in working capital mainly due to (i) lower international price references; (ii) lower volume of finished products; and (iii) the higher volume of raw material with extended payment terms from our suppliers;
·monetization of PIS/COFINS credits; and
·lower corporate income tax and social contribution on net income (IR/CSLL) payments in the period.

Net cash generated from operating activities was R$14,786.5 million during 2021, compared to R$6,293.0 million during 2020. Net cash generated from operating activities increased by R$8,493.5 million during 2021, as compared to 2020, which was the result of the:

·increase of the results of operations in the period due to higher spreads in the international market of resins and main chemicals in Brazil, PP in the United States and Europe, and PE in Mexico, and higher sales volume of main chemicals and PP in the United States and Europe; and
·offset of R$2,235.2 million of the PIS/COFINS balance (excluded from the ICMS calculation base).

The effects of these factors were partially offset by:

·the negative variation in working capital, mainly due to the higher cost and volume of finished products in inventories;
·the payments related to the geological event of Alagoas;
·the interest payments of debt securities in the year;
·the payment of income tax due to the recurring results of operations;
·the consumption of our operating and strategic capital expenditures; and
·payments under the Global Settlement in the aggregate amount of R$ 302.6 million to the Brazilian federal government, on February 1, 2021 and CHF16.0 million (R$86.4 million) to the OAG, on June 28, 2021;

Net Cash Used in Investing Activities

Net cash used in investing activities was R$4,947.3 million during 2022, R$3,380.7 million during 2021 and R$2,721.8 million during 2020.

During 2022, investing activities for which we used cash on a consolidated basis primarily consisted of: (1) acquisitions to property, plant and equipment of R$3,715.9 million, in Brazil Segment, which were allocated primarily to industrial operations, including the investments related to operating efficiency, health, environmental and safety, or HES, productivity and modernization, (2) acquisitions to property, plant and equipment of R$694.6 million in Mexico, considering operating and strategic investments such as the construction of the ethane import terminal; and (3) acquisitions to property, plant and equipment of R$373.2 million in the USA and Europe Segment, allocated both to industrial operations and strategic projects.

   
 133 

During 2021, investing activities for which we used cash on a consolidated basis primarily consisted of: (1) acquisitions to property, plant and equipment of R$3,055.8 million, in Brazil Segment, which were allocated primarily to industrial operations, including the investments related to operating efficiency, health, environmental and safety, or HES, productivity and modernization, (2) acquisitions to property, plant and equipment of R$472.1 million in the USA and Europe Segment, allocated both to industrial operations and strategic projects, such as the new polypropylene plant, and (3) acquisitions to property, plant and equipment of R$175.9 million in Mexico.

During 2020, investing activities for which we used cash on a consolidated basis primarily consisted of: (1) acquisitions to property, plant and equipment of R$1,635.7 million, in Brazil Segment, which were allocated primarily to industrial operations, including the investments related to operating efficiency, health, environmental and safety, or HES, productivity and modernization, (2) acquisitions to property, plant and equipment of R$1,163.0 million in the USA and Europe Segment, allocated both to industrial operations and strategic projects, such as the new polypropylene plant, and (3) acquisitions to property, plant and equipment of R$103.3 million in Mexico.

Net Cash Generated (Used) in Financing Activities

Net cash generated in financing activities was R$225.1 million in 2022, as compared to net cash used in financing activities of R$16,965.5 million during 2021 and net cash generated in financing activities of R$2,173.2 million during 2020.

During 2022, we raised mainly:

·R$2,950.0 million, through the issuance of debentures in Brazil;
·R$2,783.0 million, through export credit facilities; and
·R$697.5 million, through the issuance of agribusiness receivables certificates in Brazil.

During 2022, we mainly used cash to pay:

·R$2,281.1 million, relating to the full redemption of our outstanding 3.500% Notes due 2023 and partial redemption of our outstanding 6.450% Notes due 2024;
·R$1,050.1 million, relating to the line of pre-payment of export credit lines with international and national financial institutions;
·R$928.9 million, relating to the aggregate expenses of lease agreements; and
·R$1,350.3 million relating to the payment of dividends for the year ended December 31, 2021 to holders of our common shares and class A preferred shares.

During 2021:

·we issued subordinated resettable fixed rate notes due February 2032 for an aggregate principal amount of R$6.7 billion (US$1.2 billion) in the fourth quarter of 2021 related to Braskem Idesa’s Project Finance;
   
 134 
·in October 2021, Braskem Idesa entered into a term loan agreement in the aggregate amount of R$837.1 (US$150 million). As of December 31, 2021, the aggregate amount outstanding of such loan agreement plus interest was R$848.3 million (US$152.0 million).

During 2021, we used cash to pay:

·R$892.1 million, related to export prepayment facility with local and international financial institutions;
·R$508.0 million related to promissory note with international financial institutions;
·R$652.9 million related to the aggregate principal amount under a financing agreement with international governmental entities;
·R$6.9 billion related to the full redemption of the outstanding notes maturing in 2022 and of our perpetual bonds, and the partial redemption of outstanding notes maturing in 2023, 2024, 2028 and 2041;
·R$8.0 billion, related the fully repayment of Braskem Idesa’s project finance facility and the partial amortization of the Braskem Idesa project finance facility;
·R$841.7 million, related to aggregate expenses related to lease agreements; and
·R$6.0 billion related to dividends payment for the fiscal year ended December 31, 2021 to holders of our common shares, class A preferred shares and class B preferred shares;

During 2020:

·we issued subordinated resettable fixed rate notes maturing in January 2081 for an aggregate principal amount of R$3,098.8 million (US$600.0 million) in the third quarter of 2020;
·we drew down the amount of R$5,240.4 million under our revolving credit facility and R$1,603.1 million under other credit facility agreements;
·we entered into certain agreements for advance on exchange contracts (adiantamentos sobre contratos de câmbio), or ACCs, with international commercial banks under which we borrowed an aggregate principal amount of R$2,427.2 million;
·we entered into export prepayment agreements in the aggregate amount of R$311.1 million; and
·we received under a financing agreement with certain governmental entities proceeds in the aggregate amount of R$209.5 million.

During 2020, we used cash to pay:

·R$138.3 million, representing aggregate interest expenses of our lease agreements;
·R$2,494.1 million, representing ACCs with commercial banks;
·R$960.5 related to the partial amortization of the Braskem Idesa project finance facility;
   
 135 
·R$348.9 million, representing corporate loans (advance exports contracts, credit facilities, promissory notes and others), with local and international institutions;
·R$415.9 million, representing export prepayments with local and international institutions;
·R$70.3 million, representing aggregate principal under a financing agreement with BNDES and certain governmental entities; and
·R$5,203.4 million, representing payments related to a revolving credit line.

Unless our board of directors deems it inconsistent with our financial position and the decision of our board of directors is ratified by our shareholders, payment of minimum dividends is mandatory under Brazilian Corporate Law and our by-laws and also is required under agreements with two of our shareholders and, consequently, may give rise to significant cash requirements in future periods. For additional information, see “Item 8. Financial Information—Dividends and Dividend Policy—Mandatory Distributions.”

Contractual Commitments

The following table summarizes significant contractual obligations and commitments as of December 31, 2022 that have an impact on our liquidity.

We have adopted a calculation methodology to determine minimum cash needs for a 30-day timeframe (the “monthly vision”) and minimum cash needs for a 12-month timeframe (the “yearly vision”) for the purpose, respectively, of: (i) ensuring the liquidity needed to meet obligations coming due in the following month; and (ii) ensuring that we maintain liquidity during potential crises. Minimum cash needed for our “yearly vision” is calculated mainly based on the projected operating cash generation, less short-term debts and working capital needs. Minimum cash needed for our “monthly vision” considers the projected operating cash disbursements, debt service and contributions to projects, as well as the planned disbursement for derivatives maturing in the following month, among other items. For our financial policy, we adopt the greater of these two references to determine the amount of minimum cash needed.

In line with our commitment to maintaining our financial liquidity, in December 2021 we renewed the revolving credit facility in the amount of R$5,164.8 million (US$1,000.0 billion), which expires in 2026. This line of credit may be used without restrictions to improve our credit quality or in the event of deterioration in the macroeconomic scenario. As of December 31, 2022, this new credit line had not been used.

The Company’s financial liabilities, including the amounts due under the Leniency Agreement, are shown in the table below. These amounts are calculated based on cash flows not discounted and may not be reconciled with the amounts disclosed in the balance sheet.

    Within one year  

Between one

and two

years

 

Between two

and five

years

 

More than

five years

  Total
   

(in millions of reais)

Trade payables   12,410.2   3.1       12,413.3
Borrowings   1,360.7   3,139.2   3,931.3   57,625.4   66,056.7
Debentures   136.1   102.1     6,168.0   6,406.2
Braskem Idesa borrowings   996.7       17,274.8   18,271.5
Derivatives   192.2   5.7     88.3   286.2
Loan from non-controlling shareholder of Braskem Idesa         4,391.8   4,391.8
Leniency agreement   434.8   658.1       1,092.9
Lease   1,109.0   855.8   581.592   2,436.7   4,983.2
At December 31, 2022   16,639.9   4,764.1   4.512.907   87,985.0   113,901.9

 

   
 136 

Indebtedness and Financing Strategy

As of December 31, 2022, our total outstanding consolidated indebtedness was R$47,087.1 million (US$9,024.5 million), including R$11,370.3 million (US$2,179.2 million) in connection with the debt related to our Mexico Complex. As of December 31, 2022, we had R$2,498.1 million (US$478.8 million), translated solely for the convenience at the selling rate reported by the Central Bank as of December 31, 2022 of R$5,2177 to US$1.00, in outstanding indebtedness relating to a loan payable to the non-controlling shareholder of Braskem Idesa, maturing in December 2029 with interest of 7% p.a., whose proceeds were used by Braskem Idesa to fund its construction project.

On a consolidated basis, our real-denominated indebtedness as of December 31, 2022, was R$4,651.3 million (9.9% of our total indebtedness), and our foreign currency-denominated indebtedness was R$42,435.8 million (90.1% of our total indebtedness).

 

  2023 2024 2025 2026 2027 2028 2029 Thereafter Total
                                                                       (in millions of reais)      
Debt Related to Braskem 1,382.4 2,202.2 627.8 581.6 2,356.7 7,281.8 2,888.2 18,396.1 35,716.8
Debt Related to Braskem Idesa 868.6 4,337.6 6,164.1 11,370.3
Total 2,251.0 2,202.2 627.8 581.6 2,356.7 7,281.8 7,225.8 24,560.2 47,087.1

 

Short-Term Indebtedness

As of December 31, 2022, the amount of our short-term borrowings and debentures, including interest, was R$2,251.0 million (4.8% of our total indebtedness), of which R$868.6 million was short-term indebtedness of Braskem Idesa. We have short-term lines of credit with a number of international and Brazilian financial institutions.

Long-Term Indebtedness

As of December 31, 2022, the outstanding amount of our long-term borrowings and debentures was R$44,836.1 million (95.2% of our total indebtedness), including the amount of R$10,501.7 million in connection with the secured debt related to Braskem Idesa.

Our principal sources of long-term debt are:

·fixed-rate unsecured notes issued in the international market;
·debentures issued in the Brazilian capital market;
   
 137 
·export credit facilities; and
·borrowings under bank credit facilities;

As of December 31, 2022, R$4,446.1 million of our long-term indebtedness was denominated in Brazilian reais, and R$29,888.3 million of our long-term indebtedness was denominated in foreign currencies.

Certain of the instruments governing our indebtedness contain covenants that could restrict, among other things, our and most of our subsidiaries’ ability to incur liens or merge or consolidate with any other entity or sell or otherwise dispose of all or substantially all of our or their assets. In addition, the instruments governing a substantial portion of our indebtedness contain cross-default or cross-acceleration clauses among Braskem S.A. and its subsidiaries’ indebtedness, such that the occurrence of an event of default under one of these instruments could trigger an event of default under other indebtedness or enable the creditors under other indebtedness to accelerate that indebtedness. As of December 31, 2022, except for Braskem Idesa, Braskem and its subsidiaries were in compliance with the covenants under their underlying indebtedness instruments.

Braskem Idesa expected that it would be in breach of a financial leverage covenant under a financing agreement as of December 31, 2022. Regarding this financing agreement, on December 22, 2022 Braskem Idesa obtained a preemptive waiver related to such breach of a leverage ratio (covenant) until June 30, 2023. Because of such waiver, currently Braskem Idesa is not in default under such financing agreement. The non-current portion of the loan, in the amount of R$649.6 million, was reclassified from non-current liabilities to current liabilities as of December 31, 2022, considering that the waiver does not cover at least 12 months, as required by accounting standards in situations in which the breach of certain contractual obligations would entitle creditors to accelerate indebtedness.

Braskem Idesa is in compliance with its debt service obligations under such financing agreement.

The instruments governing a substancial portion of our indebtedness also contain change-of-control provisions that provide our counterparties with a termination right or the ability to accelerate the maturity of our indebtedness in the event of a change of our control without their consent and/or ratings decline, as applicable. For additional information, see “Item 3. Risk Factors—Risks Relating To Us And The Petrochemical Industry—If we are unable to comply with the restrictions and covenants in the agreements governing our indebtedness, there could be a default under the terms of these agreements, which could result in an acceleration of payment of funds that we have borrowed and could affect our ability to make principal and interest payments on our debt obligations.”

Bonds

We have issued bonds in the international capital markets. All of these securities pay interest semi-annually in arrears, except for our perpetual bonds, on which interest is payable quarterly in arrears.

In February 2023, we issued US$1,000,000,000 of 7.250% Senior Notes due 2033. The net proceeds of such issuance were used (i) to fully redeem the 6.45% Notes due 2024 and (ii) for general corporate purposes.

The table below sets forth our outstanding bonds issued in the international capital markets as of December 31, 2022, the outstanding principal amount of these securities and their maturity dates:

   
 138 

 

Security Outstanding Principal plus Interest Amount as of December 31, 2022 Final Maturity
  (in millions of US$) (in millions of reais)  
6.45% Notes due 2024(1) 304.5 1,588.70 February 2024
4.50% Notes due 2028(2) 1,197.70 6,249.30 January 2028
4.500% Notes due 2030(2) 1,521.00 7,936.10 January 2030
7.125% Notes due 2041(3) 583.6 3,044.90 July 2041
5.875% Notes due 2050(2) 768.4 4,009.10 January 2050
Subordinated Resettable Fixed Rate Notes due 2081(2) 631.7 3,296.00 January 2081

(1) Represents notes issued by Braskem Finance Limited and guaranteed by Braskem. The 6.45% Notes due 2024 were fully redeemed on February 23, 2023.

(2) Represents notes issued by Braskem Netherlands Finance B.V. and guaranteed by Braskem.

(3) Represents notes issued by Braskem America Finance and guaranteed by Braskem.

(4) The U.S. dollar amounts have been translated into Brazilian real amounts at the December 31, 2022 selling rate of R$5.2177 per US$1.00, as reported by the Brazilian Central Bank. The Brazilian real equivalent information presented is provided solely for the convenience of the reader and should not be construed as implying that the amounts in Brazilian reais represent, or could have been or could be converted into, U.S. dollars at such rates or any other rate.

 

We have fully, unconditionally and irrevocably, guaranteed the bonds issued by Braskem Finance, Braskem America Finance and Braskem Netherlands Finance. Braskem’s guarantees for issues carried out between 2011 and 2019 comprise senior unsecured obligations of Braskem, ranking equal in right of payment with all of its other existing and future senior unsecured debt. As for the issuance carried out in 2020, the guarantee comprises obligations without collateral subordinated to all current or future senior debts of Braskem.

Debt Securities issued in the Brazilian capital market

In 2022, we issued debt securities in the Brazilian capital markets. All of these securities pay interest semi-annually in arrears.

The table below sets forth our outstanding debt securities issued in the Brazilian capital markets, the outstanding principal amount of these securities and their maturity dates:

Security

Outstanding Principal plus Interest Amount as of December 31, 2022

Interest Rate

Final Maturity

  (in millions of US$) (in millions of reais)    
Debentures CRA – 1st tranche(1) 118.1 616.0 IPCA + 5.54% December 2028
Debentures CRA – 2nd tranche(1) 28.2 147.4 IPCA + 5.57% December 2031
Debentures issued in May 2022 – 1st tranche 147.7 770.9 CDI + 1.75% May 2029
Debentures issued in May 2022 – 2nd tranche 47.7 249.0 CDI + 2.00% May 2030 to 2032
Debentures issued in August 2022 150.8 786.8 CDI + 1.75% August 2029
Debentures issued in November 2022 – 1st tranche 213.5 1,114.0 CDI + 1.70% November 2029
Debentures issued in November 2022 – 2nd tranche 18.6 97.2 CDI + 1.95% November 2030 to November 2032
(1) Issuance of private debentures that were used as security for the issuance of Agribusiness Receivables Certificates (certificados de recebíveis do agronegócio – “CRA”) by Eco Securitizadora de Direitos Creditórios do Agronegócio S.A.

Credit Facilities with Governmental Agencies Denominated in U.S. Dollars

   
 139 

In August 2020, Braskem Netherlands Finance, as borrower, and Braskem S.A., as guarantor, entered into a credit facility insured by NEXI, in an aggregate principal amount of US$225.0 million. This facility bears interest at a rate equivalent to LIBOR plus 1.70% per year and payable semi-annually to maturity in February 2031. The principal amount is amortized semi-annually from August 4, 2021. As of December 31, 2022, the outstanding amount under this facility was R$1,007.1 million (US$193.0 million).

In October 2021, Braskem Idesa entered into a term loan in the aggregate amount of US$150.0 million. This facility bears interest at a rate equivalent to LIBOR plus 4.00% per year and payable quarterly to maturity in February 2029. As of December 31, 2022, the outstanding amount under this facility was R$734.8 million (US$140.8 million).

 

Issue Date Outstanding  Principal plus Interest Amount as of December 31, 2021 Interest Rate Amortization Schedule Final Maturity
  (in millions of US$) (in millions of reais)    
Mar-17(1) 68.5 357.5 LIBOR + 1.61% p.a. Semi-annual March 2027
Jul-18(2) 145.2 757.8 LIBOR + 0.65% p.a. Semi-annual December 2028
Nov-18(3) 178.1 929.1 LIBOR + 0.90% p.a. Semi-annual November 2028
Dec-19(3) 105.3 549.6 LIBOR + 0.90% p.a. Semi-annual December 2029
Aug-20 193.0 1,007.1 LIBOR + 1.70% p.a. Semi-annual February 2031
Oct-21 140.8 734.8 LIBOR + 4.00% p.a. Quarterly October 2026

(1) Credit facility contracted by the subsidiaries Braskem Netherlands Finance and Braskem Netherlands Inc., secured by NEXI, the Japanese export credit agency, and guaranteed by Braskem.

(2) Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of US$225 million. The amount of US$19 million was not disbursed and has been cancelled.

(3) Credit facility contracted by the subsidiaries Braskem Netherlands Finance and Braskem Netherlands Inc. secured by SACE, an Italian export credit agency, and guaranted by Braskem.

(4) Represents notes issued by Braskem America Finance and guaranteed by Braskem

 

Credit Facilities with Governmental Agencies Denominated in Brazilian Reais

In December 2018, we entered into a new credit facility with a commercial bank as as indirect transfer of BNDES funds (FINAME), in the aggregate principal amount of R$476.0 million, maturing in January 2031, with proceeds used to finance our capital expenditures in Brazil. This facility bears interest at a rate equivalent to IPCA plus 6.04% per year, payable quarterly after an initial grace period, from the first installment until January 2021, and afterwards monthly to maturity until January 2031. The principal amount is payable in 120 successive monthly installments beginning in February 2021. As of December 31, 2022, the outstanding principal plus interest amount under this facility was R$386.5 million (US$74.1 million).

The table below sets forth selected information with respect to our BNDES credit facility as of December 31, 2022.

   
 140 

 

Facility

Outstanding Principal plus Interest Amount as of December 31, 2021

Weighted Average
Interest Rate

Expiration of Commitment

  (in millions of US$) (in millions of reais)    
January 2019  —  Fixed rate 74.1 386.5 IPCA + 6.04% p.a. January 2031
           

 

Revolving Credit Facility Agreement

On December 20, 2021, we entered into a revolving credit facility with a syndicate of global lenders, in the aggregate amount of up to US$1,000.0 million, maturing in December 2026. The new agreement replaced our previous revolving credit facility. As of December 31, 2022, we had not drawn any amount under the new revolving credit facility.

Credit Facilities with Banks Denominated in Dollars

On April 8, 2019, we entered into a sale-leaseback agreement with an international institution in the aggregate principal amount of R$417.8 million (US$80.4 million) with a term of seven years. To consummate this agreement, certain assets of the Company’s plants were transferred to the financial institutions and, by the maturity date, Braskem has the option to repurchase them for a residual value. In accordance with IFRS15, this transfer is not considered a sale. This facility bears interest at a rate equivalent to LIBOR minus 1.00% per year, payable semi-annually to maturity in April 2026. The principal amount is payable in successive semi-annual installments beginning in September 2019. As of December 31, 2022, the outstanding principal plus interest amount under this facility was R$197.2 million (US$37.8 million).

In June 2022, we entered into four export prepayment facilities and one export credit note facility with financial institutions in the aggregate principal amount of R$1,513.1 million (US$290.0 million), with a term of five years. In July 2022, Braskem amended two of the export prepayment facilities to include ESG KPIs related to the sales volume of the Green PE I’m greenTM bio-based, in the aggregate principal amount of R$782.7 million (US$150.0) million.

Issue Date

Outstanding Principal plus Interest Amount
as of December 31, 2022

Interest Rate

Amortization
Schedule

Final
Maturity

  (in millions of US$) (in millions of reais)      
April 2019(1) 37.8 197.2 LIBOR – 1.00% Semi-annual April 2026
June 2022 290.0 1,514.7 Term SOFR 1.79% Quarterly June 2027
           

(1)      Credit facility contracted by the subsidiaries Braskem Netherlands Finance and Braskem Netherlands Inc, secured by NEXI, the Japanese export credit agency, and guaranteed by Braskem.

 

On March 25, 2022, we entered into an export prepayment facility with a financial institution in the aggregate principal amount of R$1,043.5 million (US$200.0 million) with a term of one year. On June 28 2022, a portion of R$521.8 million (US$100.0 million) of this facility was prepaid. On December 27, 2022, the remaining amount of R$521.8 million (US$100.0 million) was prepaid.

Credit Facilities with Banks Denominated in Euros

In August 2022, Braskem Netherlands B.V. and Terra Circular Industries B.V. concluded a transaction of sale of outstanding shares and issuance of new shares, which resulted in Terra Circular Industries B.V. owning 40% and Braskem owning 60% of the capital of B&TC B.V. which is the sole shareholder of ERPlastics B.V. (“ER Plastics”), a mechanical recycling company based in the Netherlands. ER Plastics develops and manufactures a range of durable products for a variety of industries, such as mats and transportation pallets made from recycled plastic waste.

   
 141 

As of December 2022, ERPlastics B.V. had the following financings, guaranteed by the assets of ERPlastics and by Braskem to the extent of its shareholding participation:

 

Issue Date Outstanding Principal plus Interest Amount as of December 31, 2022 Interest Rate Amortization Schedule Final Maturity
  (in millions of reais) (in millions of US$)      
August 2020(1) 79.7 14.9 Between 2.40% and 7.41% Monthly May 2029
November 2020(1) 2.2 0.4 Euribor monthly + 4.10% - no maturity
(1)Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.

 

Credit Facilities with Banks Denominated in Brazilian Reais

In July 2022, we entered into an export credit note facility with a financial institution in the aggregate principal amount of R$327.4 million with a term of five years.

Issue Date

Outstanding Principal plus Interest Amount as of December 31, 2022

Interest Rate

Amortization
Schedule

Final
Maturity

  (in millions of US$) (in millions of reais)      
July 2022 66.9 348.9 CDI + 1.30% Bullet July 2027

Indebtedness Of Braskem Idesa

As of December 31, 2022, the principal amount outstanding under the financing agreements relating to our Mexico complex, net of transaction costs, was R$11,370.3 million (US$2,179.2 million). The Braskem Idesa financing agreements and bond issuance include certain covenants that require, among other things, the presentation of audited financial statements within a certain timeframe.

On December 2012, Braskem Idesa entered into a common terms agreement with certain financial institutions to finance the development, design, construction and initial operation of the Mexico Complex. The Mexico Complex includes an ethane cracker with annual capacity of 1.05 million tons to produce ethylene, two high density polyethylene plants and a low density polyethylene plant. In connection with the common terms agreement, Braskem Idesa entered into eight separate financing agreements with international and Brazilian financial institutions and development banks in an aggregate principal amount of up to US$3.2 billion, or the Braskem Idesa Financing. All amounts disbursed under these credit facilities were secured by our shares in Braskem Idesa. In September 2015, Braskem Idesa received the final disbursement pursuant to the common terms agreement, reaching an aggregate principal amount of R$17.4 billion (US$3.2 billion).

On November 25, 2019, Braskem Idesa issued R$4,667.0 million (US$900.0 million) in aggregate principal amount of 7.450% senior secured notes due 2029. The 2029 notes are senior secured obligations of Braskem Idesa and rank pari passu with the existing Braskem Idesa senior secured obligations due 2032 and the credit facility. After the full amortization of the outstanding amount of the Braskem Idesa 2032 notes and the credit facility, Braskem Idesa’s 2029 notes will convert into senior unsecured notes. Interest on the notes is payable semi-annually, and the principal amount becomes due at maturity. The proceeds of the notes were used to partially refinance Braskem Idesa’s existing secured project finance indebtedness incurred in 2012 to construct a Complex in Mexico. Excess proceeds of the issuance were used to prepay certain other indebtedness of Braskem Idesa.

   
 142 

As of December 31, 2020, the waivers and consent package granted in October 2019 were no longer effective, then the non-current portion of the project finance debt obligations was reclassified as current liabilities, which caused an excess of current liabilities over current assets. In accordance with the aforementioned accounting standards, reclassification is required in situations in which the breach of certain contractual obligations entitles creditors to accelerate indebtedness. None of the project finance lenders requested said prepayment of obligations.

On October 11, 2021, Braskem Idesa entered into a senior secured syndicated term loan facility of up to R$3,338.3 million (US$600 million) with Morgan Stanley Senior Funding, Inc., Credit Agricole Corporate and Investment Bank, Deutsche Bank AG, London Branch and Itaú Unibanco S.A., Miami Branch, as lenders. The credit facility is secured by first priority security interest in favor of the lenders and all lenders share the collateral equally with the holders of the 2029 and 2032 notes and potential additional secured parties as permitted under the credit facility and the indenture governing the notes. The credit facility has a five-year term and will bear interest at a rate equal to three-month LIBOR plus an applicable margin ranging from 2.25% to 4.25% (depending on Braskem Idesa credit rating), to be paid quarterly. The principal amount will be repaid in semi-annual installments commencing 24 months after the closing date. The loan under the credit facility was partially drawn, R$837.1 million (US$150 million) on October 20, 2021 in order to fully prepaid the project finance indebtedness incurred in 2012, along with the 2032 notes issued by Braskem Idesa.

On October 20, 2021, Braskem Idesa issued R$6,696.6 million (US$1,200 million) in aggregate principal amount of 6.990% senior secured sustainability linked notes due 2032. The notes are senior secured obligations of Braskem Idesa and rank pari passu with the existing Braskem Idesa senior secured notes due 2029 and the credit facility. Interest on the notes is payable semi-annually, and the principal amount becomes due at maturity. The 2032 notes accrue an interest step-up by 37.5 basis points to 7.365% per annum if Braskem Idesa does not satisfy the sustainability performance target to reduce absolute GHG emissions by 15% from a 2017 baseline by year-end 2028. The proceeds of the notes were used (jointly with the credit facility) to fully refinance Braskem Idesa’s existing secured project finance indebtedness incurred in 2012 to construct a Complex in Mexico. With this financing, Braskem Idesa concluded its debt refinancing plan, replacing the remaining balance of US$1,350.0 million from its project finance facility with new debt instruments with a longer maturity, which extended its average debt maturity term from five to nine years. With the repayment of the project finance facility, the financial guarantees granted by Braskem for the benefit of Braskem Idesa, in the total amount of US$358.0 million, were extinguished.

Braskem Idesa expected that it would be in breach of a financial leverage covenant under a financing agreement as of December 31, 2022. Regarding this financing agreement, on December 22, 2022 Braskem Idesa obtained a preemptive waiver related to such breach of a leverage ratio (covenant) until June 30, 2023. Because of such waiver, currently Braskem Idesa is not in default under such financing agreement. The non-current portion of the loan, in the amount of R$649.6 million, was reclassified from non-current liabilities to current liabilities as of December 31, 2022, considering that the waiver does not cover at least 12 months, as required by accounting standards in situations in which the breach of certain contractual obligations would entitle creditors to accelerate indebtedness.

Braskem Idesa is in compliance with its debt service obligations under such financing agreement. 

   
 143 

 

Security(1)

Outstanding Principal plus Interest Amount

as of December 31, 2022

Final Maturity

  (in millions of US$) (in millions of reais)  
       
7.45% Notes due 2029(2) 899.0 4,690.6 November 2029
6.990% Notes due 2032(3) 1,217.6 6,352.9 February 2032
Credit Facilities(4) 140.8 734.8 October, 2026

 

(1) Represents notes issued by Braskem Idesa.

(2) Unsecured bond

(3) Sustainability-linked bonds. The bonds have a 10-year term and bear interest at 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.

(4) For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral, limited to US$71 million (R$372 million).

Capital Expenditures

During 2022, investing activities for which we used cash on a consolidated basis primarily consisted of acquisitions to property, plant and equipment of R$3,715.9 million in our Brazil segment, which was allocated primarily to: (i) industrial operations, including investments related to operating efficiency, health, environmental and safety, and productivity; (ii) the scheduled maintenance shutdown of the petrochemical cracker at the Triunfo Petrochemical Complex in Rio Grande do Sul carried out in the second quarter of 2022; (iii) the scheduled maintenance shutdown of the PVC plant in Alagoas carried out during the second quarter of 2022; and (vi) the scheduled shutdowns at the PE plants in Bahia; (v) the project to expand green ethylene production capacity at the Triunfo Petrochemical Complex in Rio Grande do Sul; (vi) investments related to the acquisition of strategic inputs that accelerate chemical reactions, applied in industrial production processes; (vii) innovation and technology initiatives; (viii) projects associated with energy efficiency at plants; and (ix) the construction of a recycling line for high-quality post-consumer resin in Brazil.

We invested R$373.2 million in our USA and Europe segment, which were allocated to industrial operations and scheduled shutdowns.

We plan to invest R$694.6 million in our Mexico segment, especially in operational and strategic projects, such as the construction of the ethane import terminal and the Fast Track Solution. For additional information, see “Item 5. Operating and Financial Review and Prospects—Capital Expenditures—Other Investments—Solution to import ethane for the Braskem Idesa facility in Mexico.

Capital Expenditure Budget

We plan to invest R$4,003.2 million in 2023, which will be used mainly for (i) the scheduled maintenance shutdown at the petrochemical plant in the State of Bahia in the fourth quarter of 2023; (ii) the scheduled maintenance shutdown in the United States; (iii) the scheduled maintenance shutdown of the PVC plant in the State of Alagoas; (iv) the expansion of our biopolymers business; and (v) projects associated with energy efficiency and decarbonization of industrial assets.

With respect to the Mexico segment, we plan to invest R$618.0 million in 2023, which will be allocated mainly to projects related to operational efficiency, such as maintenance, productivity and SSMA, and to the strategic investment related to continuation of the construction of the ethane import terminal, through Terminal Química Puerto Mexico (TQPM).

Joint Ventures Related to Our Mexico Segment

Mexico Complex

   
 144 

Braskem and Idesa formed Braskem Idesa in April 2010 to develop, construct and operate the Mexico Complex, located in the Mexican state of Veracruz. The Mexico Complex includes an ethylene cracker that produces 1.05 million tons of ethylene per year from ethane based on technology licensed from Technip Italy S.p.A., or Technip, two high density polyethylene plants based on Innovene S technology licensed from Ineos Commercial Services UK Limited (as successor to Ineos Europe Limited) and a low-density polyethylene plant based on Lupotech T technology licensed from Basell Polyolefin GmbH. The three polyethylene plants have a combined annual production capacity of 1.0 million tons of HDPE and LDPE.

Braskem Idesa is a party to an ethane supply agreement with Pemex TRI, a subsidiary of Pemex, dated February 19, 2010 (“BI’s Ethane Supply Agreement”). As per the terms and conditions provided in BI’s Ethane Supply Agreement, ethane supply is assured through a 20-year contract with Pemex TRI at a price pegged to the U.S. gas price.

In early December 2020, Braskem Idesa received a notification from Cenagas (Centro Nacional de Control del Gas Natural), a Mexican state-owned agency responsible for all natural gas pipelines and transportation in Mexico, related to the unilateral termination of the service of natural gas transportation, an essential energy input for the production of PE in our Mexico Segment in the first quarter of 2021, Braskem entered into a natural gas transport service agreement with Cenagas for a term of 15 years, which is in full force and effect.

On September 27, 2021, Braskem Idesa signed the following documents: (i) Amended ESA with PEMEX, with settlement of any pending contractual amounts; and (ii) Terminal Agreement.

The Amended ESA changes the minimum contractual volume commitment to 30,000 barrels/day until February 2025 (subject to extensions in the event of delay in obtaining the licenses for the terminal’s construction). Pemex TRI and Braskem Idesa have agreed to extend semi-annually the contractual volume until May 31, 2025, with the terminal’s startup expected in the second half of 2024.

The Amended ESA further establishes first-refusal rights, which consists of a preemptive right for Braskem Idesa in the acquisition of all ethane that PEMEX has available and does not consume in its own production process through 2045, at prices based on international references. The terminal project is designed to supplement ethane supply in Mexico by gaining access to new feedstock sources.

In February 2010, we and Idesa entered into the Braskem Idesa shareholders’ agreement to govern our relationship with respect to Braskem Idesa, which was amended in November 2012, December 2012, April 2015, April 2017 and October 2021. The Braskem Idesa shareholders’ agreement, as amended, sets forth the understanding of the parties regarding the implementation of this project and the relationship of Braskem and Idesa as shareholders of Braskem Idesa. Under the Braskem Idesa shareholders’ agreement, as amended:

·the parties agree to use their best efforts to use Braskem Idesa as their commercialization vehicle for polyethylene in Mexico;
·the parties agree that the polyethylene production of Braskem Idesa shall be strategically focused on supplying the Mexican market;
·we have the right to appoint five members and Idesa has the right to appoint two members of Braskem Idesa’s board of directors; decisions considered at Braskem Idesa’s general shareholders’ meetings require the approval of at least 50% plus one of the voting shares of Braskem Idesa. Decisions considered by Braskem Idesa’s board of directors require the approval by a simple majority of votes of its members;
·upon the failure of Braskem and Idesa to agree to vote in favor of certain matters requiring a supermajority vote in an extraordinary shareholders’ meeting, (1) we will have the right to seek approval of such matters by a simple majority vote of Braskem Idesa’s shareholders, (2) in the event that such matters are approved by a simple majority vote of Braskem Idesa’s shareholders, we will have the option to purchase all of the shares then held by Idesa, and (3) in the event that we do not exercise this right, Idesa will have the option to sell all of its shares of Braskem Idesa to us; and
   
 145 
·any disputes between Braskem and Idesa arising out of or in connection with the Braskem Idesa shareholders’ agreement will be resolved through arbitration.

The Braskem Idesa shareholders’ agreement also contains rights of first refusal, tag along rights and drag along rights in connection with the disposition of Braskem Idesa shares.

The original estimated total cost of the Mexico Complex of US$4.5 billion, including financial costs during construction and initial working capital requirements, was revised in 2015 to US$5.2 billion primarily as a result of (1) a change in the scope of the power generating unit in order to ensure the self-sufficiency of the complex and improve the reliability of energy supply, with the possibility of selling any surplus energy to the grid; and (2) additional costs arising from infrastructure and local services.

We and Idesa contributed an aggregate of 38% of the total costs as equity in proportion to our ownership interests in Braskem Idesa, and the remainder was borrowed by Braskem Idesa under project finance facilities secured by the assets of this project, with multilateral credit agencies, export credit agencies, development banks and private banks.

Construction of the Mexico Complex began in 2012 and it commenced operations with the production of the first batch of polyethylene in April 2016.

Amendments to Braskem Idesa Shareholders' Agreement Relating to Project Ethylene XXI

In February 2010, Braskem and Idesa entered into a shareholders’ agreement, which we refer to as the Braskem Idesa shareholders’ agreement, to govern our relationship with respect to Braskem Idesa. In November 2012, Braskem and Idesa entered into the first amendment to the Braskem Idesa shareholders’ agreement, under which our ownership interest in Braskem Idesa was increased to 75% minus one share of the equity interest in Braskem Idesa and Idesa’s ownership interest in Braskem Idesa was reduced to 25% plus one share of the equity interest. In December 2012, we and Idesa entered into the second amendment to the Braskem Idesa shareholders’ agreement to include the commitment of both Sponsors to fund certain primary and secondary contingent equity to the project. In April 2015, we and Idesa entered into the third amendment to the Braskem Idesa shareholders’ agreement to include additional base equity contribution and reaffirm the new commitments of contingent equity, under which we agreed to fund up to 100% of the contingent equity commitment under the equity support agreement up to start-up date. The primary contingent equity commitment is US$208 million. In April 2017, we and Idesa amended and restated the Braskem Idesa shareholders’ agreement to update the terms to reflect the progress of the company since the original signing in 2010 and to reflect the understanding among the shareholders as to the shareholders’ rights and obligations in connection with the payment of fees and interest by Idesa related to any funding by Braskem of Idesa’s portion of contingent equity or the working capital needs of Braskem Idesa, and the eventual dilution of Idesa’s equity interests in Braskem Idesa as a result of the same. Finally, in October, 2021, we and Idesa executed the second amendment and restatement shareholder agreement of Braskem Idesa in order to update the excess commitment fee regarding the contingent equity funded by us and modifying the fee rate related to it.

Solution to import ethane for the Braskem Idesa facility in Mexico

Braskem Idesa has been investing in logistics infrastructure to import ethane from the United States to maintain and increase the capacity utilization rate of its cracker. Concerning to ethane supply, Braskem Idesa has entered into a long-term agreement to acquire ethane and could also import in the sport market.

   
 146 

To ensure the Fast-Track Solution’s feasibility, Braskem Idesa executed agreements with Smart Pass, a logistics operator, and with Enestas, a company specialized in cryogenic gas transportation. Smart Pass will be responsible for receiving liquefied ethane at the Port of Coatzacoalcos docks and unloading it from the vessels in cryogenic tanks. Enestas will transport the ethane by truck to the Braskem Idesa petrochemical complex, where the ethane will be stored in existing tanks and regasified for use in the production process.

With an approximate investment of R$49.9 million (US$9.6 million), this complementary solution for acquiring feedstock had made it possible to import up to 12,800 barrels per day of ethane to the Petrochemical Complex in Mexico, which represents 19% of its ethane needs. In February 2020, Braskem Idesa started its operation to import ethane (the “Fast Track Solution”), and imported its first shipment of ethane.

The total investment in the Fast Track Solution, considering expansion, is an approximate total investment of R$67.5 million (US$12.1 million), with approximately R$55.2 million (US$9.9 million) spent by the end of 2020. The expansion of this complementary solution for acquiring feedstock will make it possible to import up to 25,000 barrels per day of ethane to the Petrochemical Complex in Mexico, which represents 40% of its ethane needs. In December 2020, Braskem Idesa concluded the first phase of expansion of the Fast Track Solution to 20 kbpd and, in April 2021 we concluded the second phase of expansion to a total capacity of 25 kbpd. By 2022 Braskem Idesa expects to increase the total capacity up to 35 kbpd as a result of additional investment of approximately R$86.5 million (US$15.5 million).

By 2021, our petrochemical complex had an operating rate of approximately 75% primarily due to the shortfall in ethane supplied under the ESA, which was partially offset by imported ethane supplied by the Fast Track Solution. We diversified our sources of feedstock supply with the Fast-Track Solution and we are planning to further increase its import capacity in the future by adding additional discharge stations, both at the port and at our plant. Once the Ethane Import Terminal is operational, we expect to rely less on the Fast-Track Solution.

In addition, to implement the Fast-Track Solution, we executed the BNL Ethane Supply Agreement, a contract for the purchase of a target volume of ethane per year with Braskem Netherlands in February 2020, which has a term of twenty-four months, extendable for one optional period of six months. The price of ethane is determined by a contractual formula, and penalties would apply for delivery delays or if incorrect quantities are delivered. In addition, we have purchased additional volumes of ethane from Braskem Netherlands by entering into the BNL Ethane Supply Agreement Amendment.

Besides, Braskem Idesa continues to assess a complementary solution for larger-scale ethane imports whose scope consists of building a terminal for importing ethane and a pipeline to transport it to its petrochemical complex. For additional information, particularly relating to the risks associated with this project, please see “Item 3.D Risk Factors—Risks Relating to Mexico—We source part of our ethane feedstock from Pemex TRI in Mexico, which we expect to be our primary source of ethane until the Ethane Import Terminal is operational.”

Braskem Idesa also intends to develop the Ethane Import Terminal, a long-term alternative source of imported ethane and a pipeline that will connect the terminal directly to our Complex. The expected ethane capacity of the Ethane Import Terminal would be enough to fulfill the total ethane needs for the Mexico Complex. This terminal would provide the capacity to import more ethane than we currently require. With this, our Mexico Segment will be able to source the total needs of our Mexico Complex to increase our polyethylene production and take advantage of the forecasted increase in demand for polyethylene products in North America and around the world.

On October 12, 2021, Braskem Idesa and Braskem Idesa Servicios incorporated Terminal Química Puerto México, S.A.P.I., incorporated under the laws of Mexico, with the main purpose of design, construct and develop the ethane import terminal. In addition, on December 09, 2021, Braskem Idesa’s board of directors approved the Final Investment Decision (“FID”) in order to invest in the Ethane Import Terminal Project.

   
 147 

The estimated cost of the Ethane Import Terminal and related infrastructure investment is approximately R$2,327.1 million (US$446.0 million) (inclusive of financing costs and VAT). Our Mexico segment expects to participate with up to 50% of the shares issued by the company that will develop the Ethane Import Terminal. We intend to fund our investment in the Ethane Import Terminal with a combination of equity and debt, through a joint venture. In this sense, on June 13, 2022, Braskem Idesa and TQPM, entered into a stock purchase agreement with Advario, B.V., a carve-out of Oiltanking GmBH for a 50% of TQPM, subject to certain conditions precedents. The Mexican Antitrust agency (COFECE) approved such purchase on October 3, 2022 and Braskem Idesa expects that the outstanding conditions to consummate the purchase could be satisfied during first quarter of 2023.

On October 7, 2022, TQPM entered into a land purchase agreement with Administración del Sistema Portuario Nacional Coatzacoalcos, S.A. de C.V. (“ASIPONA”) for the land that will be used for the construction of the storage system of the Ethane Import Terminal. Also, TQPM obtained the construction licence for construction of the storage system on December 22, 2022.

On October 31, 2022, TQPM entered into an Alliance Engineering, Procurement and Construction Contract with ICA Flour Daniel, S. de R.L. de C.V. (“ICAF”), in order to ICAF be responsible for the design, engineering, procurement, construction, commissioning and deliver turnkey the Ethane Import Terminal to TQPM. (“TQPM EPC Agreement”).

The Ethane Import Terminal is expected to be completed and to reach full capacity by the end of 2024, but there may be delays. Please see “Item 3. D Risk Factors—Risks Relating to Mexico—We source part of our ethane feedstock from Pemex TRI in Mexico, which we expect to be our primary source of ethane until the Ethane Import Terminal is operational.”

Other Investments

Energy efficiency project in our cracker at the São Paulo Complex

To improve energy efficiency and competitiveness of the cracker at the São Paulo Complex, Braskem Siemens will invest approximately R$600.0 million to improve the thermoelectric system of the unit at the complex by replacing some of the steam-powered turbines with high-efficiency electric engines supported by a new co-generation plant that will consume the residual gas from the unit’s own production process. To enable the investment by Siemens in the new co-generation plant, Braskem signed an agreement with Siemens for a term of 15 years under a build, own and operate model. With startup in 2021, the project will not only reduce the site’s energy consumption, but also reduces the cracker’s water consumption by 11.4% and its GHG emissions by 6.3%.

As of December 31, 2022, R$272.1 million (US$52.1 million) had already been invested and the project is expected to be completed by June 2023.

Sulfur removal system (DeSOx) – Rio Grande do Sul, Brazil

In 2022, we installed a desulphurization unit (DeSOx) that will capture the sulfur present in boiler exhaust gases and repower a dedusting system. This new system will allow a more competitive local energy sources in our matrix. After the implementation of the project, the levels of atmospheric emissions from the boiler will decrease. This project reduces CO2e emissions by 9,000 tons per year by eliminating the logistics of using imported coal (which has a lower sulfur level).

   
 148 

As of December 31, 2022, the Company had disbursed R$24 million, representing physical progress of 36% of the investment.

Technology change at our chlor-alkali facility in Alagoas

We are investing R$67.7 million in a project at our chlor-alkali facility located in the district of Pontal da Barra, in Maceió, in the state of Alagoas, which aims to change the raw material processing from brine to sea salt.

With this project, we were able to resume operations of our chlor-alkali and dichloroethane plants in the region that have been suspended since May 2019 following the developments stemming from the publication of Report no. 1 by the Brazilian Geological Service (CPRM). See “Item 3. D Risk Factors—Risks Relating to Us and the Petrochemical Industry—Our business and operations are inherently subject to environmental, health and safety hazards. As a result, our business is also subject to stringent environmental and other regulations.”

The new technology consists of sourcing salt from third parties. Salt could be sourced from the Northeast region of Brazil by road or imported from other regions using the port of Maceió, which is located near the chlor-alkali facility. Salt sourced from third parties will be initially stored, dissolved into water to produce brine, treated and then sent to be processed in the chlor-alkali facility.

The unit has been operating using the new raw material since December 2020. In 2021, the project’s activities were performed to close out the project and to conclude its facilities’ infrastructure.

For the year ended December 31, 2022, R$1.9 million was invested.

  Item 6. Directors, Senior Management and Employees

Directors and Senior Management

Our board of directors (“conselho de administração”) and our board of executive officers (“diretoria estatutária”) are responsible for operating our business.

Board of Directors of Braskem

Our by-laws provide for a board of directors of eleven members and its alternate directors. During periods of absence or temporary unavailability of a regular member of our board of directors, the corresponding alternate member substitutes for the absent or unavailable regular member. Our board of directors is a decision-making body responsible for, among other things, determining policies and guidelines, as well as the approval for acquisition of products and material and execution of certain contracts for our business and our wholly owned subsidiaries and controlled companies, when applicable. Our board of directors also supervises our board of executive officers and monitors its implementation of the policies and guidelines that are established from time to time by the board of directors. Under the Brazilian Corporate Law, our board of directors is also responsible for hiring independent accountants.

The members of our board of directors are elected at general meetings of shareholders for a two-year unified term and are eligible for reelection. The terms of all current members will expire at our annual shareholders’ meeting to be held in 2024. Members of our board of directors are subject to removal at any time at a general shareholders’ meeting, observing the provisions in the Shareholders’ Agreement filed at the Company’s headquarters. The position of Chief Executive Officer and Chairman of the board of directors cannot be held at the same time by the same individual according to the Brazilian Corporate Law. Our by-laws do not contain any citizenship or residency requirements for members of our board of directors and they do not have to be our shareholders. Our board of directors is presided over by the chairman of the board of directors, and, in his absence or temporary unavailability, by the vice-chairman of the board of directors. The chairman and the vice-chairman of our board of directors are elected at a general shareholders’ meeting from among the members of our board of directors to serve for two-year terms and are eligible for reelection.

   
 149 

Our board of directors ordinarily meets every month and extraordinarily whenever called by the chairman, the vice-chairman or any two other members of our board of directors. Decisions of our board of directors require a quorum of a majority of the current directors and are taken by majority vote, other than certain actions which require the consensus of the nominees of Novonor S.A. – Em Recuperação Judicial (“Novonor”), formerly called Odebrecht S.A., and Petrobras Brasileiro S.A.–Petrobras (“Petrobras”) under the Braskem S.A. Shareholders’ Agreement. SeeItem 7. Major Shareholders and Related Party Transactions—Major Shareholders—Shareholders’ Agreements—Braskem S.A. Shareholders’ Agreement.”

The following table sets forth certain information with respect to the current members of our board of directors and their alternates as of the date of this annual report:

 

Name

Member Since

Position Held

Age

José Mauro Mettrau Carneiro da Cunha December 20, 2019 Chairman of the Board 73
Eduardo Bacellar Leal Ferreira (1) April 19, 2022 Vice-Chairman of the Board 70
José Luis Bringel Vidal (1) April 19, 2022 Board Member 57
Gesner José de Oliveira Filho (1) June 27, 2017 Board Member 66
-João Pinheiro Nogueira Batista (1) April 16, 2019 Board Member 66
Juliana Sá Vieira Baiardi April 19, 2022 Board Member 49
Héctor Nuñez November 18, 2021 Board Member 60
Roberto Faldini May 22, 2019 Board Member 74
Charles Lenzi (1) April 19, 2022 Board Member 64
Marcelo Klujsza August 24, 2020 Board Member 60
André Amaro da Silveira (1) June 8, 2016 Board Member 59
Rodrigo Tiradentes Montecchiari April 19, 2022 Alternate 46
Daniel Pereira de Alburquerque Ennes May 29, 2020 Alternate 43
Laura Maniero Gadelho April 13, 2021 Alternate 39
Guilherme Simões de Abreu May 29, 2020 Alternate 71
Marco Antônio Zacarias April 19, 2022 Alternate 62
Lineu Fachin Leonardo April 19, 2022 Alternate 41

 

  (1) Independent director.

The following is a summary of the business experience, areas of expertise and principal outside business interests of our current directors and their alternates.

Directors

José Mauro Mettrau Carneiro da Cunha. Mr. José Mauro Mettrau Carneiro da Cunha was elected as an effective member and Chairman of the Company’s Board of Directors on May 29, 2020, and he has been appointed by shareholder Novonor. Mr. José Mauro was reelected as an effective member and Chairman of the Company’s Board of Directors on May 29, 2020 and on April 19, 2022 He was Chief Executive Officer of Novonor from April 2021 to March 2022 and was a member of the Board of Directors of Oi S.A. from September 2018 to September 2020, having previously served as Chairman of the Board of Directors of Oi S.A. since 2009. Mr. José Mauro began his career as an employee of BNDES, where he held several positions and held various executive positions (from 1974 to 1990), having also been appointed Director (from 1991 to 1998) and Vice President, responsible for the Industrial Operations, Legal and Tax Affairs areas (from 1998 to 2002). His main professional experiences include: (i) Full Member of the Board of Directors of Telemar Participações S.A. (from 2008 until the merger of Telemar Participações S.A., in September 2015); (ii) Full Member of the Board of Directors of Vale S.A. (from 2010 to April 2015); (iii) Interim Chief Executive Officer of Oi S.A. in 2013; (iv) Chairman of the Board of Directors of the following companies: Tele Norte Leste Participações S.A. (from 1999 to 2003 and from 2007 to 2012), where he also served as an Alternate Member of the Board of Directors in 2006; Telemar Norte Leste S.A. (from 2007 to 2012); TNL PCS S.A. (from 2007 to 2012); Tele Norte Celular Participações S.A. (from 2008 to 2012); Coari Participações S.A. (from 2007 to 2012); Dommo Empreendimentos Imobiliários S.A., formerly Calais Participações S.A. (from 2007 to December 2016); (v) Member of the Board of Directors of Log-In Logística Intermodal S.A. (from 2007 to 2011); (vi) Member of the Board of Directors of Lupatech S.A. (from 2006 to 2012); (vii) Member of the Board of Directors of Santo Antonio Energia S.A. (from 2008 to 2016); (viii) Full member of the Board of Directors of the following companies: (a) Braskem S.A. (from 2007 to 2010), where he previously held the position of Vice President of Strategic Planning (from 2003 to 2005); (b) LIGHT Serviços de Eletricidade S.A. (from 1997 to 2000); (c) Aracruz Celulose S.A. (from 1997 to 2002); (d) Politeno Indústria e Comércio S.A. (from 2003 to 2004); (e) BANESTES S.A. - Banco do Estado do Espírito Santo (from 2008 to 2009); and (f) Pharol, SGPS, S.A. (from 2015 to 2017). Mr. José Mauro graduated in mechanical engineering from Universidade Católica de Petrópolis, in Rio de Janeiro, in 1971. He completed an Executive Program in Management at the Anderson School, University of California, in December 2002.

   
 150 

Eduardo Bacellar Leal Ferreira (independent member). Mr. Eduardo Bacellar Leal Ferreira was elected as an effective member of the Company’s Board of Directors on April 19, 2022, and he has been appointed by shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Eduardo Bacellar Leal Ferreira was Chairman of the Board of Directors of Petrobras from 2019 to April 2022. In addition to the Petrobras Board, he participated in the Admiralty (Navy High Command) from 2013 to 2019, having chaired it from 2015 to 2019; the navy’s Financial and Administrative Council, from 2015 to 2019; the Interministerial Commission for the Resources of the Sea (coordinator), from 2015 to 2019; the Management Councils in the various Military Organizations he directed or commanded; and the Officer Promotion Commission, in 2007. He served in the Brazilian Navy from 1971 to 2019, in the positions of Director of Ports and Coasts, from 2010 to 2011; Commander-in-Chief of the Fleet, in 2012; Commander of the National War College, from 2013 to 2015; and Commander of the Navy, from 2015 to 2019. Before 2010, he served in numerous positions and functions inherent to his career, including a total of 13 years in command and direction of ships and land-based organizations, including the Captaincy of Ports Department of Rio de Janeiro, the Admiral Alexandrino Training Center, the Brazilian Naval Academy and the Seventh Naval District Command (Brasilia, Goiás and Tocantins). He was a celestial navigation instructor at the American Naval Academy, in Annapolis (Maryland), for two years. He also served in the Chilean Navy, taking a General Staff course. He is a graduate of the Officer’s Graduation Course and of Operations Engineering, mechanical modality, by the Naval School, from 1971 to 1975. He took the Electronics Course for Officers, at the Admiral Wandenkolk Training Center, from 1976 to 1977; Command and General Staff Course, in 1990, Superior Course, in 1991, Maritime Policy and Strategy Course, in 2000, at the Naval War College; General Staff Course at the Chilean Navy, in 1992; Module of Economic Sciences, from the Faculty of Economic and Administrative Sciences of the Universidad Marítima de Chile, in 1992; Professional Master of Naval Sciences, from the Naval War College, in 1992; and Professional Doctorate in Naval Sciences, Maritime Policy and Strategy at the EGN, in 2000.

 

José Luis Bringel Vidal (independent member). Mr. José Luis Bringel Vidal was elected as an effective member of the Company’s Board of Directors on April 19, 2022, and he has been appointed by shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. José Luis Bringel Vidal has been a founding member and coordinator of the Infrastructure and Logistics Committee, of RGB - Rede de Governança do Brasil, since April 2021; Senior Government Relations Consultant of Norsk Hydro do Brasil, since February 2021; Member of the Board of Directors of Santos Brasil S.A., since May 2018, and of BEMISA - Brasil Exploração Mineral S.A., since March 2011. He is a Shareholder and Member of the Board of Directors of WV Logistics, since January 2020, and was Founding Partner and C&O from November 2003 until January 2020. He was Director of the Logistics and Transportation Division of the Infrastructure Department of FIESP - Federation of Industries of the State of São Paulo, from February 2020 to January 2022; Member of the Advisory Board of the Port of Angra dos Reis, from March 2020 to May 2021; Member of the Advisory Board of ABPM - Brazilian Association of Mineral Research Companies, from March 2017 until September 2020; Senior Consultant at Rio Tinto Alvan (Alcan), from December 2017 until July 2018; Founding Partner at TACV - Transport System Development, from August 2013 until July 2017; Senior Consultant at Piaui State Government - BR, from March 2015 until March 2016; Senior Consultant at Zamin Resources Limited, from November 2015 until January 2016; Senior Consultant at Warburg Pincus LLC, from January 2015 until May 2015; Senior Consultant at Itochu Corp & JFE Steel & Posco Group & China Steel, from March 2014 until October 2014; Senior Consultant at Hatch - CODELCO, from July 2014 until September 2014; Senior Consultant at Rio Tinto Alcan, from May 2011 until March 2013; Senior Consultant at SNC - LAVALIN, from February 2012 until May 2012; Senior Consultant at Itochu Corporation & JFE Steel & Nippon Steel & Posco Group & China Steel, from March 2008 until November 2008; Logistics Director at BEMISA - Brasil Exploração Mineral S. A., from June 2007 until September 2008; Senior Advisor of Bahia Mineração S.A. - BAMIN, from March 2005 until April 2006; National Coordinator of the Logistics Council of FECOMÉRCIO - Federação do Comércio do Estado de São Paulo, from June 2001 until March 2005; General Manager of Pasha Brasil, of The Pasha Group - Rio Doce Pasha Terminais L.P., from July 2001 to October 2003; Manager of the São Paulo Business Unit of Ferrovia Centro Atlântica S.A. - FCA, from January 1997 to June 2001. He is an Electrical Engineer from Escola de Engenharia de Mauá, in 1992. He holds a Post-Graduate degree in Market-Oriented Business Administration from Escola Superior de Propaganda e Marketing, in 1994; Board of Directors Program, from Instituto Brasileiro de Governança Corporativa, in 2012; Certification as Experienced Board Member (CCA+), from Instituto Brasileiro de Governança Corporativa, in 2019 – Certificate renewed in August 2022 (credential code 31581/2022); Update for Certified Board Members, from Instituto Brasileiro de Governança Corporativa, in 2020; Corporate Risk Management 1st Edition, by the Brazilian Institute of Corporate Governance, in 2020; Advanced Course for Board Members 14th Edition, by the Brazilian Institute of Corporate Governance, in 2020; Professional Education Specialization Leadership in Innovation, by MIT - Massachusetts Institute of Technology, in 2021; Specialization in Risk Management and Financial Decision Making, by the University of Chicago, in 2021. ESG: how to rethink and innovate business in a changing world - Integrated Leadership Training Program, in 2022; and Coordinator & Professor of the 1st Improvement Program in Governance, Compliance and Risk Management with Emphasis on Transport and Infrastructure promoted by the Latin American Institute of Governance and Public Compliance (IGCP) for Members of the National Transport Confederation (CNT) and Institute of Transport and Logistics (ITL), in 2022.

   
 151 

 

Gesner José de Oliveira Filho (independent member). Mr. Gesner José de Oliveira Filho was elected as an independent and effective member of the Company’s Board of Directors on June 27, 2017, he has been appointed by the shareholder Novonor. Mr. Gesner Oliveira was reelected on April 30, 2018, on May 29, 2020 and on April 14, 2022. Mr. Gesner Oliveira also holds the position of Coordinator of the Company’s Statutory Compliance and Audit Committee since April 27, 2022. He is certified by IBGC as independent director and as member of Audit Committee CCoAud+; he is member of the Board of Directors of TIM, where he coordinates the Statutory Audit Committee and is also a member of the “ESG” Committee; he is Chairman of the Board of Directors of Estre Ambiental and member of the Self-Regulation Board of FEBRABAN. He was member of the Global Consultive Board of UBER and of the Board of Directors of Iguá, Usiminas, Sabesp, CESP, Banco Nossa Caixa and Varig. He currently participates, as a volunteer, at the Instituto Brasileiro de Ética Concorrencial (ETCO), Centro de Integração Empresa-Escola (CIEE), acts as a member of the Consultive Council of GRAPE ESG and as a member of the Consultive Council of Climatic Actions and Politics at Secretaria Executiva de Mudanças Climáticas (SECLIMA) and of the São Paulo Municipal’s Secretary. He is partner at GO Associados, Professor at FGV, where he coordinates the Infrastructure and Environmental Solutions Study Centre. From 2007 to 2011 he was president of Sabesp – Companhia de Saneamento do Estado de São Paulo. From 1996 to 2000 he was president of CADE. Mr. Gesner Oliveira holds a PhD degree from California University (Berkeley), a Master’s degree from Unicamp and a bachelor’s degree from FEA-USP, in Economics area.

João Pinheiro Nogueira Batista (independent member). Mr. João Pinheiro Nogueira Batista was elected as an effective member of the Company’s Board of Directors on April 16, 2019, and he has been appointed by the shareholder Novonor. Mr. João Nogueira was reelected on May 29, 2020 and on April 19, 2022. Mr. João Pinheiro Nogueira Batista has served for more than 10 years on the Board of Directors of companies in Brazil and abroad. Until January 2022 Mr. João Nogueira was CEO of Evoltz Participações S.A. Mr. João Nogueira has been an independent board member at Wiz Soluções e Corretagem de Seguros S.A. since April 2020, as well as at two third sector organizations: Associação Maria Helen Drexel and Instituto de Reciclagem do Adolescente-Recicla. In the Novonor Group, he was an independent member of the Boards of Directors of Odebrecht Engenharia e Construção since June 2017 and of Ocyan since April 2018, in which he remained until January 2019, when he joined the Board of Directors of Novonor S.A. and remained until April 2021. In his broad executive career built in the public and private sectors, he was CEO of Swiss Re, Bertin S.A. and Suzano Petroquímica, as well as held directorships in companies such as Petrobras, Dresdner Bank, Citibank, Radiobras and Siderbras. Mr. João Nogueira Batista holds a degree in economics from PUC - RJ and an MBA in Economic Engineering from Universidade Gama Filho, Rio de Janeiro.

   
 152 

Juliana Sá Vieira Baiardi. Ms. Juliana Sá Vieira Baiardi was elected as an effective member of the Company’s Board of Diretors on April 19, 2022, and she has been appointed by the shareholder Novonor. Ms. Juliana Baiardi joined Odebrecht Group in August 2011. Ms. Juliana Baiardi acts as member of the Board of Diretors of OTP and since June 2022 as Leader of Business-Participations of Novonor. From April 2021 until June 2022, she has been an advisor to Novonor's CEO and Vice-Chairman of the Board of Odebrecht Engenharia e Construção until June 2022. Ms. Juliana Baiardi acted as CEO at Atvos from May 2019 to February 2021; CEO of OTP from May 2017 to May 2019; CEO of Odebrecht Ambiental from September 2016 to April 2017; CFO of Odebrecht Ambiental from February 2016 to September 2016; and Director of Logistics of OTP from August 2011 to February 2016. Before joining Odebrecht Group, Ms. Juliana Baiardi worked 10 years at J P Morgan in the Investment Banking Latin America and Private Equity areas. She also worked at Dresdner Bank in Brazil in the Project Finance sector from 1997 to 1999. Ms. Juliana Baiardi holds a degree in Civil Engineering from UFBA Universidade Federal da Bahia and an MBA from Columbia Business School in New York.

Héctor Nuñez. Mr. Héctor Nuñez was elected as an effective member of the Company’s Board of Directors on November 18, 2021, and he has been appointed by the shareholder Novonor. Mr. Héctor Nuñez was reelected on April 19, 2022. Mr. Héctor Nuñez is a senior executive, customer-focused, international business strategist with over 25 years of success managing growth, re-engineering troubled operations and starting up startups throughout the United States and South America. He holds a bachelor and an MBA in Business Administration from Florida International University. He served as CEO of Ri Happy Brinquedos S.A. for 9 years, leading transactions to acquire the largest specialty retailers in Brazil. He also served as CEO of Walmart Stores, Inc. and various leadership positions at The Coca-Cola Company and its group companies. Since March 2022, he holds the position of CEO of Novonor, a company where he also held the position of Chairman of the Board of Directors from April 2021 to March 2022. He acted, from January 2011 to December 2021, as an Independent Board Member of Vulcabrás and; as Chairman of the Board of Directors of Marisa S.A until April 2017. He is also a board member of the NGO Amigos do Bem.

Roberto Faldini. Mr. Roberto Faldini was elected as an effective member of the Company’s Board of Directors on May 22, 2019, and he has been appointed by the shareholder Novonor. Mr. Roberto Faldini was reelected on May 29, 2020 and on April 19, 2022. He is CEO and partner of Faldini Participações Administração e Investimentos Ltda. Besides the Board of Braskem SA, he is currently a member of the Boards of Irani Papel e Embalagens SA, Cia. Habitasul de Participações and Novonor. He voluntarily participates as a member of the Board of Trustees of the Dorina Nowill Foundation for the Blind, the Crespi Prado Foundation, where he is also the CEO, and the Norberto Odebrecht Foundation. He is the director of Fundação Cultural Ema Gordon Klabin. Mr. Roberto Faldini is a professor at the IBGC – Brazilian Institute of Corporate Governance and a guest professor at Fundação Dom Cabral and an arbitrator at CAM - Arbitrage Chamber of the Exchange Market of B3. Since the 80’s he has participated as a member of the Board of Directors and Advisory Board of several companies in Brazil and abroad, among them BOVESPA, Metal Leve, Maraú, Livrarias Siciliano, CPFL, Inpar, Klicknet, Sadia, BRF, Banco BMG, Vulcabrás and Marfrig. He was a co-founder of IBGC - Brazilian Institute of Corporate Governance in 1995 and is still active in several of its committees. He is an associate member of IBEF - Brazilian Institute of Financial Executives and of FBN - Family Business Network. Mr. Faldini is also an Honorary Board Member of Abrasca - Brazilian Association of the Public Traded Companies. For over 20 years he was an executive officer, shareholder and member of the Board of Directors of Metal Leve S.A., he was Chairman and President of CVM (Brazilian Securities Exchange Comission) in 1992. He was coordinator for 5 years (2002 - 2007) in São Paulo of the Núcleo da Empresa Familiar - PDA, of the Dom Cabral Foundation.

   
 153 

He graduated in Business Administration at Fundação Getúlio Vargas (1972) and has specialization in (i) Advanced Management from Fundação Dom Cabral and INSEAD Fontainebleau – France (1991); (ii) Entrepreneurship at Babson College (2004) and (iii) Corporate Governance (IFC and IBGC - 2009, 2011, 2013 and 2016). From 2016 to the present, he continued and continues to participate in several courses and seminars in Brazil and abroad, as well as, events related to Business Strategy, Business Administration, Corporate and Family Governance aiming his continuous learning.

Charles Lenzi (independent member). Mr. Charles Lenzi was elected as an independent and effective member of the Company’s Board of Directors on April 19, 2022 and holds the position of member of the Statutory Compliance and Audit Committee since April 27, 2022, and he has been appointed by the shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Charles Lenzi is Executive Chairman of ABRAGEL, since 2018; Independent Member of the Board of Directors and Member of the Audit Committee of AES Brasil, since 2019; and Independent Member of the Board of Directors, Member of the Audit Committee and Member of the People and Sustainability Committee of BEVAP - Bioenergética Vale do Paracatu, since 2020. He was CEO of Eletropaulo, from 2016 to 2018; COO of AES Brasil, CEO of Eletropaulo and CEO of AES Sul from 2016 to 2017; Executive President of ABMGEL from 2010 to 2016; Managing Director of Grupo Stefani, from 2008 to 2010; Vice-President of Distribution AES Brasil, Eletropaulo and AES Sul, from 2006 to 2008; General Director of AES Sul, from 2004 to 2006; Vice-President of Operations of Eletropaulo, from 2002 to 2003; Regional Director of AES EDC - La Eletricidad de Caracas, from 2001 to 2002; President Director of AES CESCO - India, from 2000 to 2001; Business Unit Manager of AES Sul, from 1998 to 1999; General Manager of Gazola S/A from 1988 to 1998; Sales Engineer of lntral S/A from 1982 to 1986. He is an Electrical Engineer from PUCRS, from 1977 to 1981. He holds a Specialization Degree in Industrial Automation from UNICAMP, from 1986 to 1988; MBA in Finance from UCS, from 1996 to 1998; MBA in Strategic Planning and Business Management from FGV, in 1999; Leadership Development Program from Darden Business School, University of Virginia, in 2006; PGA Advanced Management Program, from Dom Cabral INSEAD Foundation, in 2007; Master in Business Administration and Business from PUCRS, in 2015; Board Member Course from IBGC, in 2016; and Global Executive Leadership Retreat, from Georgetown University, in 2017.

Marcelo Klujsza. Mr. Marcelo Klujsza was elected as an effective member of the Company’s Board of Directors on August 24, 2020, and he has been appointed by the shareholder Petróleo Brasileiro – Petrobras. Mr. Marcelo Klujsza was reelected on April 19, 2022 and is a member of its Support Committee - Finance and Investment Committee. Mr. Marcelo Klujsza has served in senior management positions in consulting companies - CEO of Metal Data S.A. and Vice President of Alexander Proudfoot Consultoria - in addition to acting as a consultant through his own company - Metakarp Value Consulting, offering support to the management and board of directors of companies, especially in the mineral and metallurgical industry segment. He has also worked in technical, management and senior management positions at Vale, Rio Paracatu Mineração, Rio Tinto Brasil, IBM Brasil and Grupo Solmucci Entretenimento. At Petrobras, he held the position of Assistant to the Board of Directors from 06/2015 to 11/2015 and Advisor to the Presidency from 12/2018 to 04/2021. He held the position of Chairman of the Board of Directors of Liquigás Distribuidora S.A. from 06/2019 to 12/2020. He holds a degree in mechanical engineering from Pontifícia Universidade Católica do Rio de Janeiro, a master's degree in Geosciences/Geology from Universidade Federal do Rio de Janeiro, a specialization in Business Administration from Pontifícia Universidade Católica do Rio de Janeiro and has a professional career spanning 35 years.

André Amaro da Silveira (independent member). Mr. André Amaro was elected as an effective member of the Company’s Board of Directors on January 26, 2023, and holds the position of member of the Statutory Compliance and Audit Committee since April 27, 2022. He has been appointed by the shareholder Novonor. Mr. Amaro acted as an alternate member of the Board of Directors from 2016 until 2023. He also worked with Novonor Group from 1988 to 2018. In addition to the aforementioned office at the Company, Mr. is an effective member of the Board of Directors of the Ocyan S.A., working also as coordinator of the Culture, Communication, Personnel and Sustainability Committee and as a member of the Compliance and Audit Committee, he is an effective member of the Board of Directors of the OTP, and also acts as coordinator of the Personnel and Organization Committee and as member of the Finance and Investment Committee, and member of the Advisory Board of Supermix S.A. He began his career in heavy infrastructure projects and led Odebrecht investments in the concession of public services in Brazil, Argentina and Portugal. During this period, he was also Director of Project Finance and Export at Construtora Norberto Odebrecht, Vice President of Planning and People at Braskem, Director of Human Resources at Novonor S.A., President of Odebrecht Properties and of Odebrecht Defesa e Tecnologia and Chairman of the Board of Directors of Redram Construtora de Obras S.A. He holds a graduate degree in Civil Engineering from Universidade Federal de Minas Gerais and a Master’s degree in Business Administration from IMD.

   
 154 

Alternate Directors

Rodrigo Tiradentes Montecchiari. Mr. Rodrigo Tirandentes Montecchiari was elected as an alternate member of the Company’s Board of Directors on April 19, 2022, and he has been appointed by the shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Rodrigo Montecchiari is Commercialization Control Operations manager at Petrobras since December 2022 and member of the Fiscal Council of Refinarias de Mucuripe S.A. since November 2020. Additionally, he was Chief Financial Officer (CFO) of PB-LOG since April 2017 until December 2021. He acted as a member of the Fiscal Council at Cia Petroquímica de Pernambuco from April 2013 until June 2017; Cia de Gás do Estado do Mato Grosso do Sul from April 2013 until April 2015; Paraná Xisto S.A. from December 2020 until November 2022; Refinaria de Manaus S.A. from December 2020 until November 2022; Refinaria Mataripe S.A. from December 2020 until November 2021; Alternate Member of the Fiscal Council at Logum Logísitica S.A. from May 2018 until April 2021 and at Petros, from April 2013 to March 2018; Corporate Finance at Petrobras, from December 2012 to March 2017; Chief Financial and Administrative Officer at Petrobras Namibia, from March 2012 to November 2012; at Petrobras Angola, from March 2010 until February 2012; at Petrobras Nigeria, from May 2007 until February 2010; and Coordinator of Audit and Joint Ventures at Petrobras, from 2003 until April 2007. He holds a degree in economics from Universidade Federal Fluminense, an Executive MBA from Fundação Dom Cabral and a Master's degree in Corporate Finance from the University of Liverpool.

Daniel Pereira de Albuquerque Ennes. Mr. Daniel Pereira de Albuquerque Ennes was elected as an alternate member of the Company’s Board of Directors on May, 29, 2020, and he has been appointed by the shareholder Petróleo Brasileiro S.A. – Petrobras. He is currently the Bank and Structured Finance Manager of Petrobras. He was previously an effective member of the Board of Directors of Liquigás Distribuidora S.A. and Bank Market Coordinator, Domestic Capital Market Coordinator and Export Credit Agency Coordinator of Petrobras. Mr. Daniel Pereira holds a graduate degree in Economics from Universidade Federal do Rio de Janeiro (UFRJ), a bachelor’s degree in Law from Universidade do Estado do Rio de Janeiro (UERJ) and a Master’s degree in Industrial Economics from Universidade Federal do Rio de Janeiro (UFRJ).

Laura Maniero Gadelho. Ms. Laura Maniero Gadelho was elected as an alternate member of the Company’s Board of Directors on April 13, 2021, and she has been appointed by the shareholder Novonor S.A.. Ms. Laura Maniero Gadelho is currently a lawyer in the corporate area of Novonor S.A., a position she has held since April/2016, having previously worked at Odebrecht Properties (January/2013 to April/2016) as a lawyer in the corporate and business areas. She also worked as a senior lawyer in the litigation and arbitration department at Lefosse Advogados/Linklaters LLP (October/2007 to January/2013), in São Paulo and New York, as a trainee and lawyer in the litigation and arbitration department at Dourado Fialdini Penna Tilkian Advogados Associados (November/2005 to October/2007) and as a trainee in the administrative law department at Tojal Teixeira Ferreira Serrano e Renault Advogados (May/2005 to November/2005). Ms. Laura Maniero Gadelho has a law degree from Universidade de São Paulo (USP) (2002 to 2006), a Continuing Education Course in Arbitration from Escola de Direito da Fundação Getúlio Vargas - FGV (2008) and an LL.M. (Master of Laws) from Columbia University School of Law (August/2010 to May/2011), having also participated in the International Commercial Arbitration Association and the Latin American Association of Business Law.

   
 155 

Guilherme Simões de Abreu. Mr. Guilherme Simões de Abreu was elected as an alternate member of Braskem’s Board of Directors on May 29, 2020, and he has been appointed by shareholder Novonor. He currently holds the position of Responsible for People, Communication and Organization at Novonor S.A., since January 2020. From June 2018 to December 2019, he held the position of Executive Secretary of the Board of Directors of Novonor S.A. From 2013 to March 2017, he was Manager of Novonor, for People and Organization matters.

Marco Antonio Zacarias. Mr. Marcos Antonio Zacarias was elected as an alternate member of the Company’s Board of Directors on April 19, 2022. He has been appointed by the shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Marcos Antonio is the Legal Representant and Operation and Commercialization Manager at Petrobras Colombia Combustíveis S.A. since August 3, 2022, and has been CEO of Petrobras Uruguay S.A. de lnversión and of Petrobras Uruguay Servicios y Operaciones S.A, since March 1, 2020 until November 22, 2022. He was CEO of Petrobras Uruguay Distribuición S.A. and Misurol S.A., from 03/01/2020 to 02/05/2021; Director of Petrobras Uruguay S.A. de lnversión, Vice President of Petrobras Uruguay Distribuición S.A., Vice President of Mirusol S.A., and Vice President of Petrobras Uruguay Servicios y Operaciones S.A., from 01/01/2018 to 02/29/2020; Vice President of Distribuidora de Gas Montevideo S.A. and Director of Conecta S.A., from 01/02/2019 until 09/30/2019; General Manager of Company Management and Benefits, from 2016 until 2017, General Manager of Financial Management, in 2016, Executive Manager of Corporate Finance, from 2015 until 2016, General Manager of Financial Management, from 2006 until 2015, Manager of Subsidiary Coordination, from 2005 until 2006, Accounting Manager of International Business, from 2000 until 2005, at Petrobras - Petróleo Brasileiro S.A.; Financial Control Manager, at Petrobras lnternacional S.A. - Braspetro, from 1999 to 2000; and Financial and Administrative Manager, at Petrobras Colombia, from 1995 to 1999. He worked at Amil Assistência Médica lnternacional Ltda., at Cobra Computadores S.A., at Banco Mercantil de São Paulo S.A. and at the Ministério da Aeronáutica during his mandatory military service. He graduated in Accountancy from the Universidade do Estado do Rio de Janeiro in 1987. He holds an MBA in Business, Controlling, Auditing and Accounting from Fundação GetúÍio Vargas, in 1994; an MBA in Accounting Management from the University of São Paulo, in 2005; an Advanced Management Program from INSEAD Business School, Fontainebleau, France, in 2008; and an Advanced International Program in Oil and Gas Financial Management from the University of Texas at Dallas, USA, in 1997.

Lineu Fachin Leonardo. Mr. Lineu Fachin Leonardo was elected as an alternate member of the Company's Board of Directors on April 19, 2022. He has been appointed by the shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Lineu Fachin has been The Head of Development, Career and Leadership at Petrobras - Petróleo Brasileiro S.A., since September 2020. He has held several leadership positions at Petrobras in the last 10 years, and has also worked at a company controlled by Petrobras in the Human Resources area. Among the managerial experiences at Petrobras, the highlights are the conduction of Career, Succession and Performance, Development, and Organizational Learning topics, in addition to having acted as International HR manager at Petrobras. At Transpetro (Petrobras Transporte S.A.) he was in charge of Career, Remuneration, Performance, and Labor and Union Relations during his time at the company. Before working for Petrobras, he worked in the education business, having implemented distance learning courses at Universidade Norte do Paraná. He holds a Bachelor's degree in Business Administration from the State University of Londrina (1999-2003), and a degree in Tourism and Hospitality from the University of Northern Paraná (1999-2003). He holds a Specialization in International Relations from Universidade Candido Mendes (2007-2008); Specialization in People Management from IBMEC (2008-2009). He holds a Master in Administration - Business Management, from Fundação Getúlio Vargas/RJ (2019-2020). He has also international executive training abroad at schools such as INSEAD - Institut Européen d'Administration des Affaires, Center for Creative Leadership, Kellogg School of Management, TIAS Business School and Rutgers Business School.

   
 156 

Board of Executive Officers of Braskem

Our board of executive officers is our executive management body. Our executive officers are our legal representatives and are responsible for our internal organization, day-to-day operations and the implementation of the general policies and guidelines established from time to time by our board of directors.

Our by-laws require that the board of executive officers consist of a chief executive officer and between three and nine additional members, each responsible for business areas that our board of directors assigns to them. The members of our board of executive officers, and our chief executive officer and, have no formal titles (other than the title of executive officer or director) but have the informal titles set forth in the table below.

The members of our board of executive officers are elected by our board of directors for a three-year terms unified terms and are eligible for reelection. The current term of all of our executive officers ends at the first board of directors meeting held immediately after our annual shareholders’ meeting to be held in 2021. Our board of directors may remove any executive officer from office at any time with or without cause. Company’s by-laws do not require the members of our board of directors to be a resident in Brazil or become our shareholders. Our board of executive officers holds meetings when called by our chief executive officer.

The following table lists the current members of our board of executive officers as of the date of this annual report:

Name

Year of First
Appointment

Position Held

Age

Roberto Bischoff 2023 Chief Executive Officer 67
Pedro van Langendonck Teixeira de Freitas 2016 Chief Financial Officer and Head of Procurement and Institutional Relation 47
Edison Terra Filho 2017 Executive Officer and Head of the Olefins & Polyolefins South America 51
Marcelo Arantes de Carvalho 2015 Executive Officer and Head of People, Communication, Marketing and Sustainable Development 54
Marcelo de Oliveira Cerqueira 2013 Executive Officer and Head of Brazil Manufacturing and Global Industrial Operations 57
Daniel Sales Corrêa 2020 Executive Officer and Head of Investments & Digital Technologies 55

 

Summarized below is information regarding the business experience, areas of expertise and principal outside business interests of our current executive officers:

Roberto Bischoff. Mr. Roberto Bischoff is the current Chief Executive Officer of Braskem elected on January 1, 2023. Mr. Bischoff was the business leader of Ocyan S.A from 2019 until 2022. He was, from 2017 to 2019, the global head of business support for HSE, industrial excellence, energy, automation, procurement, projects & processes, and knowledge management at Braskem. From 2010 to 2017, he was CEO of Braskem Idesa and he was Director of Vinyl Business at Braskem, from 2009 until 2010. He also acted as CEO of Ipiranga Petroquímica S.A., from 2007 to 2008; Director of International Project Development, from 2006 to 2007; Commercial Director of the Basic Input Unit, from 2005 to 2006; and Director of Raw Materials at Braskem, from 2003 to 2004. He was Chief of Mechanical Maintenance, Maintenance Manager, and Engineering and Procurement Manager (1984 to 1992) and Mechanical Engineer and Chief of Mechanical Maintenance (1979 to 1983) at Poliolefinas S.A. Mr. Bischoff is a Mechanical Engineer, Business Administrator, and Public Administrator, all of them degress from the Federal University of Rio Grande do Sul. He also holds a post-graduate degree in Materials Science from the Federal University of Rio Grande do Sul. He has a specialization in Maintenance Engineering (CEMANT) from the agreement Petrobras/UFRGS; MBA from SDE (now IBMEC) and specialization in Administration from INSEAD, in France.

 

Pedro Van Langendonck Teixeira de Freitas. Mr. Pedro van Langendonck Teixeira de Freitas was elected as the Company’s Financial and Investors Relations Officer on April 1, 2016 and was reelected on May 9, 2018 and on April 14, 2021. He is also currently responsible for Procurement and Institutional Relations. In this office, he globally leads the financial, investors relations, procurement and supplies and strategic planning areas, and coordinates the institutional relations in Brazil. In this context, he is responsible for the Company's management and financial management, for the innovation in the search for efficiency in the management processes and for the motivation of a high-performance team. From 2011 to 2016, he was responsible of Braskem's Corporate Strategy Management, elaborating the business plan and evaluating investments and M&A opportunities. Previously, he worked in strategy consulting, having participated in the definition of business and M&A strategies in various industries, including petrochemicals, agribusiness, consumer goods and pharmaceuticals. Mr. Pedro Freitas holds an Industrial Engineering degree from the Polytechnic School of Universidade de São Paulo USP, and an MBA from INSEAD.

   
 157 

Edison Terra Filho. Mr. Edison Terra Filho was elected as a member of the Company’s Executive Management on January 9, 2017, and was reelected on May 9, 2018 and on April 14, 2021 and he is currently responsible for the South America Olefinas & Poliolefinas Unit. Mr. Edison Terra joined Braskem in 2002, and he worked in the Marketing, Supply Chain and Exportation areas, as leader of the Polyethylene Business, Europe and Renewable, and of UNIB and quantiQ. Before working for Braskem, he worked nine years for Rhodia. Mr. Edison Terra holds a graduate degree in Production Engineering from the Polytechnic School of Universidade de São Paulo USP and a Master’s degree in Business Administration from EAESP-FGV/SP. He has also attended extension courses in Global Leadership in Wharton Business School and in Disruptive Technologies in Singularity University. He is executive president of INP (Instituto Nacional do Plástico) and officer of FIESP (Federação das Indústrias do Estado de São Paulo).

Marcelo de Oliveira Cerqueira. Mr. Marcelo de Oliveira Cerqueira has been appointed as a member of the Company’s Executive Management on May 6, 2015 and was reelected on May 9, 2018 and April 14, 2021 and he is currently the Executive Vice-President of Manufatura Brasil e Operações Industriais Globais. Mr. Cerqueira has more than 30 years of experience in the chemical and petrochemical industry. He has started his career in 1987 at Companhia Alcoolquímica Nacional and COPERBO (currently Arlanxeo). In 1989 he joined Companhia Petroquímica Camaçari, where he worked on Production, Logistics, Health, Safety and Environment – SSMA and Supplies areas. At Braskem, he has already worked as Responsible Person for the Vinyls Unit, Industrial Vinyls Officer and Production Manager of the PVC Unit of Alagoas and Bahia and responsible for the Chemicals and Vinyls Unit at Braskem. Mr. Marcelo Cerqueira holds a degree in Chemical Engineering from Universidade de Pernambuco and an MBA in Business Management from FGV, and he has attended the Global Leadership Program at Wharton Business School - University of Pennsylvania.

Marcelo Arantes de Carvalho. Mr. Marcelo Arantes de Carvalho was elected as a member of the Company’s Executive Management on May 6, 2015 and was reelected on May 9, 2018 and April 14, 2021 and he is currently the Responsible Person for People, Communication, Marketing and Press Relation of the Company, with 34 years of professional experience. He has acted in various large-sized companies and in several offices related to Human Resources. He started his career as an intern in Fiat Group in 1988, and then he worked at Celite S.A. from 1989 to 1991, in the Remuneration and Union Relations area. From 1991 to 1998, he worked as Human Resources Manager at Asea Brown Boveri Ltda., and then he joined Unilever to work as Human Resources Development Manager. In 2000 he became Human and Organizational Development Officer of Intelig Telecomunicações. Later, in 2005, he joined Reckitt Benckiser, where he remained until 2008 as Human Resources Officer. Between 2008 and 2010 he was the Human Resources Officer for Latin America at Fiat Group, after which he came to Braskem. Mr. Marcelo Arantes holds a degree in Business Administration from Faculdade de Ciências Gerenciais (UNA) and an Executive MBA from Dom Cabral Foundation (Fundação Dom Cabral), and he has attended the Global Leadership Program at Wharton Business School - University of Pennsylvania.

Daniel Sales Corrêa. Mr. Daniel Sales Corrêa was elected as a member of the Company’s Executive Management on August 6, 2020 and was reelected on April 14, 2021 and he is currently responsible for Investments and Digital Technologies. During the 26 years he worked for Petrobras in various refineries, and held offices in Engineering, Production, Process Optimization and Commercialization. At the company's headquarters, he has been operational efficiency general manager, including all refineries, and more recently he was the general manager of the company's refining, transport, and commercialization business restructuring programs, where he leaded initiatives to reposition Petrobras in the “Downstream” focused on the carve out of the refineries and terminals to be disinvested. During the period from 2019 to July 2020, he was also a member of the board of directors of Refinaria de Petróleo Riogranense S.A. – RPR. Mr. Daniel Corrêa holds a graduate degree in Electrical Engineering from Universidade Federal do Amazonas (UFAM), a postgraduate degree in Equipment Engineering and in Oil Refining Engineering from Universidade Petrobras, and in Quality and Productivity Management from FUCAPI/UFRGS, and an Executive MBA in Strategic Business Management from FIA/USP.

   
 158 

Board Committees

 

On June 22, 2022 our board of directors approved a revision of its internal rules, and between 2021 and 2022 also updated the board committees’ internal rules. Under these revised rules, our bylaws and the Braskem shareholders’ agreement, our board of directors has established four permanent committees and has the power to establish ad-hoc committees. Permanent committees must have at least three and no more than five members. Ad-hoc committees may be convened for a limited period to consider temporary issues and are dissolved when their purpose has been achieved or when the term established upon the creation of such committees expires. The number of members of the ad-hoc committees is defined upon the creation of such committees. An English translation of the internal rules of our board of directors and each of its committees is available on our investor relations website at www.braskem-ri.com.br.

We currently have the following four permanent committees: (1) the Finance and Investment Committee, (2) the People and Organization Committee, (3) the Strategy, Communication and ESG Committee and (4) the Statutory Compliance and Audit Committee. The duties of each permanent committee are established in their respective internal rules, all approved by our board of directors. The members of each permanent committee are appointed by the chairman of the board of directors, solely from among its members and alternate members, and the committee’s coordinators are appointed by the chairman of the board of directors. The members of the Statutory Compliance and Audit Committee are elected by the board of directors after being appointed by the chairman. Our board of directors does not delegate the power to take actions on behalf of our Company to the permanent committees; rather the role of the permanent committees is to examine certain matters to assist in deliberations under the board of directors’ responsibility, except the Statutory Compliance and Audit Committee which has certain specific duties.

Finance and Investment Committee

Our Finance and Investment Committee meets at least quarterly and has its duties fixed at its Internal Rule, such as: (1) to analyze existing policies relating to financial management, investments dividends, interest on equity and securities trading and guarantees, (2) analyze the constant risks in the Corporate Risk Matrix and the respective mitigation plans related to the topics within its competence, (3) to analyze opportunities related to financing and investment transactions that may improve our capital structure, (4) to analyze guidelines and protocols for our business planning execution cycle. Our Finance and Investment Committee is currently composed of Mr. João Pinheiro Nogueira Batista (coordinator), Mr. Héctor Nuñez, Mr. Marcelo Klujsza, and Mr. Rodrigo Montecchiari.

People and Organization Committee

Our People and Organization Committee conducts work meetings at least six times per year and has the following duties: (1) to evaluate new policies and review existing policies relating to people and organizational matters, (2) to analyze processes relating to identification, training, development and succession of executives for or in strategic positions, (3) to analyze processes relating to the determination of fixed and variable compensation for executives in strategic positions, and (4) to evaluate new policies and review existing policies relating the maintenance and strengthening of our corporate culture. Our People and Organization Committee is currently composed of Mr. Eduardo Leal Ferreira (coordinator), Mr. Guilherme Abreu and Mr. Roberto Faldini.

   
 159 

Strategy, Communication and ESG Committee

Our Strategy, Communication and ESG Committee conducts work meetings at least five times per year and has the following duties: (1) to evaluate determinations relating to the foundation of our business plan, (2) to evaluate the business direction being pursued to achieve objectives defined by our board of directors, (3) to evaluate new policies and review existing policies relating to the capital markets and social responsibility, (4) to evaluate our image projected to and perceived in the market and make recommendations to our board of directors to maintain or to redefine our social communications programs, and (5) to analyze guidelines and protocols for our business planning and execution cycle. Our Strategy, Communication and “ESG” Committee is currently composed of Mr. José Mauro da Cunha (coordinator), Mr. José Luis Vidal, and Ms. Juliana Sá Vieira Baiardi.

Statutory Compliance and Audit Committee

On July 30, 2021, our shareholders approved, at the Extraordinary General Meeting, the transformation of the Compliance Committee into the Statutory Compliance and Audit Committee, with the consequent amendment of the Bylaws to include this provision.

On November 9, 2021, our board of directors approved the formation of Braskem’s Statutory Compliance and Audit Committee (Comitê de Conformidade e Auditoria Estatutário, the “CCAE”), a permanent advisory body to our board of directors, in compliance with CVM Resolution No. 23/21 and the U.S. Sarbanes-Oxley Act of 2002 (the “SOX”), which allows us to rely on the exemption from the audit committee requirements of the SEC contained in paragraph (c)(3) of Rule 10A-3 under the Securities Exchange Act of 1934, as amended, in accordance with our strategy to follow the best corporate governance practices. See “Item 16D. Exemptions from the Listing Standards for Audit Committees.”

The Statutory Compliance and Audit Committee is a statutory committee which meets monthly and has five members, elected by the Board itself pursuant to the nomination made by the chairman of the Board (observed the specificities about external members highlighted below), being one of the nominees indicated as the coordinator of the Statutory Compliance and Audit Committee. The committee must have in its composition (i) three (3) independent members of the Company's Board of Directors, as defined in the Company's policies; and (ii) two (2) members that are not part of the Board of Directors (external members), which are independent members, pursuant to CVM Resolution No. 23 of 2021, and shall be chosen by said body among those indicated in a list to be submitted by the Chairman of the Board of Directors, prepared by a specialized company, with evidenced experience, provided that the indication of names by the shareholders not being allowed.

The main duties and objectives are to (1) evaluate internal controls, risk exposure and compliance with applicable laws and regulations, (2) monitor investigations related to ethics complaints, (3) analyze and periodically update the Compliance System Policy, the Anticorruption Policy and the Related Party Transactions Policy, (4) opine about the selection and dismissal of the our independent external auditors, (5) monitor the quality and integrity of the quarterly information, interim statements, and financial statements, (6) develop training programs for board members, senior managers and certain employees, and (7) evaluate, prior to the appreciation by the Board of Directors, the appropriateness of transactions subject to the approval of the Board of Directors between the Company and its related parties, as provided for in the Company’s Bylaws and in the Policy of Transactions with Related Parties of the Company, as well as to carry out the monitoring, including the respective evidences, jointly with the Management and the internal audit area. The detailing of the competencies of the Statutory Compliance and Audit Committee can be found in its Internal Rules. Our Statutory Compliance and Audit Committee is currently composed of Mr. Gesner Oliveira (coordinator), Mr. André Amaro, Mr. Charles Lenzi, Mr. José Écio Pereira da Costa Júnior (external member) and Ms. Maria Helena Pettersson (external member).

   
 160 

NYSE rules require that listed companies have an audit committee that (i) is composed of a minimum of three independent directors who are all financially literate, (ii) meets the SEC rules regarding audit committees for listed companies, (iii) has at least one member who has accounting or financial management expertise and (iv) is governed by a written charter addressing the committee’s required purpose and detailing its required responsibilities. However, as a foreign private issuer, we only need to comply with the requirement that our CCAE meet the SEC rules regarding audit committees for listed companies.

The SEC has recognized that, for foreign private issuers, local legislation may delegate some of the functions of the audit committee to other advisory bodies. We have established a CCAE as approved at the board of directors meeting held on November 9, 2021. Our CCAE meets the requirements for the exemption available to foreign private issuers under paragraph (c)(3) of Rule 10A-3 under the Exchange Act. The CCAE is not the equivalent of, or wholly comparable to, a U.S. audit committee. Among other differences, it is not required to meet the standards of “independence” established in Rule 10A-3 and is not fully empowered to act on all the matters that are required by Rule 10A-3 to be within the scope of an audit committee’s authority.

External Members

José Écio Pereira da Costa Junior. Mr. José Écio Pereira da Costa Junior was elected as an effective member of the Company’s Statutory Compliance and Audit Committee on November 9, 2021 and reelected on April 27, 2022 by the Company’s board of directors. He holds a graduate degree in Business Administration and Accounting Sciences. He entered the auditing career in 1974 at Arthur Andersen & Co and was promoted to International Partner in 1986 and later, in June 2002, became a partner at Deloitte Touche Tohmatsu in Brazil, remaining there until May 2007, when he retired. From October 1993 until May 2004 he was the managing partner responsible for the Curitiba office of these auditing and consulting firms. Founding partner of JEPereira Consultoria em Gestão de Negócios S/S, in January 2008, acting with emphasis on consultancies related to: strategic management, consultancy in the preparation of companies and their shareholders to act in the New Capital Market, besides acting as adviser in Audit Committees with the Boards of Public Companies. He was a member of the Board of Directors of GAFISA S.A. from June 2008 to April 2018 and Coordinator of the Audit Committee from June 2008 to April 2016, becoming a member of this Committee from then until April 2018. He also served as a Member of the Statutory Audit Committee of FIBRIA S.A. from April 2013 to March 2018, and was also Chairman of the Fiscal Council from December 2009 to March 2013. He served as Coordinator of the Audit Committee of VOTORANTIM INDUSTRIAL S.A - VID from June 2012 to June 2014 and served as Coordinator of the Audit Committee of VOTORANTIM METAIS S.A (currently NEXA S.A) from June 2014 to December 2017 and for VE VOTORANTIM ENERGIA S.A from June 2017 until February 2022. He served as Member of the Audit Committee of CESP S.A from April 2019 to April 2021. He also served as a member of the Board of Directors of Ouro Verde Locação e Serviço S.A in the period from October 2018 to June 2019. He also served as a member of the Board of Directors of BRMALLS S.A. (shopping center management company registered with the CVM - Novo Mercado) from April 2010 to April 2014. He also served as a member of the Board of Directors of Grupo NOSTER (privately-held company in the area of public transportation in Curitiba, and power generation) from January 2011 to September 2013. He serves as Coordinator of the Audit Committee of VOTORANTIM CIMENTOS S.A since October 2013 and at CITROSUCO S.A since December 2014. He serves as Coordinator of the Audit Committee since June 2014 at CBA – COMPANHIA BRASILEIRA DE ALUMÍNIO S.A.. He also serves as a member of the Audit Committee at Mobly S.A since June 2021. He has served as Coordinator of the Audit Committees of CITROSUCO S.A since December 2014 and at CBA - Companhia Brasileira de Aluminio and VE Votorantim Energia since June 2017. He also serves as a member of the Board of Directors of Princecampos Participações S.A., elected in April 2010 and as Chairman of the Fiscal Council at Demercado Investimentos S.A., elected in November 2020.

   
 161 

Maria Helena Pettersson was elected as an effective member of the Company’s Statutory Compliance and Audit Committee on November 9, 2021 and reelected on April 27, 2022. Ms. Maria Helena Pettersson has a bachelor's degree in Accounting and Business Administration with several improvement courses in finance, business management, internal controls, business and asset valuation etc. Board member and senior consultant with 40 years of experience in accounting, financial statements, corporate governance, internal and external financial reporting, internal controls, internal policy compliance, compliance with laws and regulations, risk governance and international accounting. She has served as an audit and consulting partner, coordinating services to large multinational companies, large Brazilian business groups, publicly traded companies in Brazil and SEC-listed companies, in various industries, such as media and entertainment, airlines, telecommunications, manufacturing, retail and trade, services, healthcare, among others. She is currently a member of the Advisory Board of CARLAB at Rutgers University, member of the Audit Committee of Tecnisa S.A., member of the Audit Committee of China Three Gorges Brasil Energia S.A. (CTG Brasil), member of the Board of Directors of U&M Mineração e Construção S.A., and member of the Fiscal Council of Confederação Brasileira de Rugby – CBRU and of the Audit Committtee of Associação Umane, both of which are not-for-profit entities. She provides independent consulting services in the areas of corporate governance and compliance for large companies, committee structuring at the Board level, preparation for M&A and IPO due diligence, and professionalization of the management of family-owned companies. She worked for nearly 30 years in independent auditing, led audits of financial statements for local and international purposes, and conducted large and complex consulting engagements, including IPOs, mergers, acquisitions and post-transaction integration, debt restructurings and judicial restructurings. She has experience in the areas of accounting and financial statements, corporate financial reporting, compliance with capital markets laws and regulations, financial planning, business valuation, risk management, internal and external auditing, and masters the Brazilian and international regulatory framework of the auditing profession, in addition to familiarity with global best practices in corporate governance.

Chief Compliance Officer

Our chief compliance officer, or CCO, has a full-line report directly to the Statutory Compliance and Audit Committee, and dotted-line report to the CEO of the company. Our CCO exercises independent judgment and acts in an impartial manner. Our CCO is responsible for developing a compliance system, assist the CEO in implementing the compliance system and continually monitor developments in this respect. Our CCO is also responsible for global activities involving Internal Audit, Corporate Risk Management, Internal Controls, Compliance and Data Protection.

Everson Bassinello. Mr. Bassinello has served as our CCO since August 2016 and has led our global initiatives related to risk management, internal controls, compliance, data protection and internal audit. He served in leadership positions at Companies of the Votorantim Group, including VCP and Fibria between June 2000 and July 2016. Mr. Bassinello holds a degree in mechanical engineering from Universidade Federal de Itajubá (UNIFEI), a graduate degree in business administration from Fundação Getúlio Vargas (FGV), an MBA degree from the Business School São Paulo (BSP) and a specialization degree in corporate governance from the Kellogg School of Management.

Ethics Committee

Our Ethics Committee supports our Statutory Compliance and Audit Committee with the enforcement of compliance rules and with matters involving the violation of the commitment to ethics, integrity and transparency. Our Ethics Committee is formed by our Chief Compliance Officer, who is also its coordinator, and three additional members: vice-presidents in our Legal, People & Organization and Finance areas. The main objectives of our Ethics Committee are to (1) evaluate the results of internal investigations of ethics complaints, (2) submit to the Statutory Compliance and Audit Committee proposed revisions to the Company’s orientation materials, including the Code of Conduct, and (3) provide guidance on questions of ethical conduct and ensure consistent evaluation and treatment of ethical matters.

   
 162 

Fiscal Council

The Brazilian Corporate Law requires us to establish a permanent or non-permanent fiscal council (“conselho fiscal”), with a minimum of 3 and up to 5 members, with alternate members. Our by-laws provide for a permanent fiscal council composed of up to five members and their respective alternate members. The fiscal council is a separate corporate body, independent of our management and our independent directors.

The members of our fiscal council and theirs alternate members are elected by our shareholders at the annual general shareholders’ meeting for one-year terms and are eligible for reelection. The terms of the members of our fiscal council expire at the next annual general shareholders’ meeting, which will be held in 2023. Under the Brazilian Corporate Law, the fiscal council may not contain members who are members of our board of directors or of our board of executive officers or be employees of the Company or of its controlled companies or of companies from the same group, or spouses or relatives, up to third degree of relatives, of any member of our management. To be eligible to serve on our fiscal council, a person must be a resident of Brazil and either be a university graduate or have been an officer or fiscal council member of another Brazilian Company for at least three years prior to election to our fiscal council. Holders of (1) preferred shares without voting rights, or with restricted vote, and (2) non-controlling common shareholders that together hold at least 10.0% of our voting share capital are each entitled to elect, in a separate voting, one member and his or her respective alternate to the fiscal council.

The responsibilities of a fiscal council are established by the Brazilian Corporate Law. In accordance with the Brazilian Corporate Law, our fiscal council has the right and obligation to, among other things:

·supervise, through any of its members, the actions of our managers and to verify the fulfillment of their duties;
·give an opinion on the annual report of our management, including the supplementary information deemed necessary or useful for deliberation at a general meeting;
·at least every three months examine the trial balance sheet and other financial statements periodically prepared by the company;
·examine the accounts and financial statements for the financial year and give an opinion on them;
·opine on any management proposals to be submitted to a vote of our shareholders related to:
ochanges in our share capital;
oissuances of debentures or rights offerings entitling the holder to subscribe for equity securities;
odistributions of dividends; and
otransformation of our corporate form and any corporate restructuring, such as takeovers, mergers and spin-offs;
·inform our management of any error, fraud or detected and suggest measures we should take in order to protect our primary interests. If our management fails to take the measures required to protect our interests, inform our shareholders at a shareholders’ meeting of these facts;
·call general shareholders’ meetings if management delays the general shareholders’ meeting for more than one month and call special shareholders’ meetings in the event that important matters arise;
   
 163 
·to attend the Board of Directors’ Meetings in which it must give an opinion on the subjects to be resolved upon the council;
·to attend or be represented, by at least one of its members, in the Company’s General Meetings, answering the requests for information made by our Shareholders; and
·to request that the Company’s Management, upon request of any of its members, provide clarifications or information about specific facts, provided that they are related to its supervisory duty, under the law and the Company’s Bylaws.

The following table lists the current members of our fiscal council:

Name

Year of First Appointment

Ismael Campos de Abreu 2003
Gilberto Braga 2015
Marcilio José Ribeiro Junior 2021
Carlos Henrique Vieira Candido da Silva 2022
Marcos Aurélio Pamplona da Silva 2022

The following is a summary of the business experience, areas of expertise and principal outside business interests of the current members of our fiscal council and their alternates.

Members of Fiscal Council

Ismael Campos de Abreu. Mr. Ismael Campos de Abreu was elected as an effective member of the Company’s Fiscal Council on April 29, 2003, and he has been appointed by the shareholder Novonor. Mr. Ismael Campos was reelected on April 19, 2022. Mr. Ismael Campos served as an Officer at Kieppe Participações e Administração Ltda. - Em recuperação judicial from April 2011 to May 2017. Between 1995 and March 2011 he served as Controller of Novonor. He was Manager of the tax consulting division of PricewaterhouseCoopers (1978/1985) and of Arthur Andersen (1989/1991). He was a partner at Performance Auditoria e Consultoria Empresarial (1992/1995). He was a member of the Board of Directors of Hospital Cardio Pulmonar and member of the Fiscal Council of several companies operating in the petrochemical sector. Mr. Ismael holds a degree in Accounting from Fundação Visconde de Cairú and a post-graduate degree in Economic Engineering from the Inter-American Development Center. Mr. Ismael Campos de Abreu does not hold a management position in any third sector organization.

Gilberto Braga. Mr. Gilberto Braga was elected as an effective member of the Company’s Fiscal Council on April 9, 2015, and he has been appointed by the shareholder Novonor. Mr. Gilberto Braga was reelected on April 19, 2022. Mr. Gilberto Braga is a business consultant in the areas of finance, capital markets, corporate, tax, forensics and forensic assistance, besides acting as fiscal council, management and audit committee member for publicly held companies and professional associations. He was a member of the CVM's Investment Funds Accounting Standards Advisory Committee, is a university and post-graduation professor of corporate governance at Fundação Dom Cabral, IBMEC, PUC and FGV, a commentator for Radio CBN, Radio Roquete Pinto in Rio de Janeiro and an article writer for the newspaper O Dia. He has a degree in Economics from UCAM Ipanema and Accounting from UGF, a post-graduate degree in Financial Administration from IAG-PUC Rio and a Master’s in Administration (Finance and Capital Markets) from IBMEC-Rio. He is a member of IBGC.

Marcílio José Ribeiro Júnior. Mr. Ribeiro was elected as an effective member of the Company’s Fiscal Council on April 13, 2021, and he has been appointed by the shareholder Petróleo Brasileiro S.A. – Petrobras. Mr. Marcílio Ribeiro was reelected as an effective member on April 19, 2022, assuming the position of Chairman of the Fiscal Council. Currently, Mr. Marcílio acts in the Financial Department at Petrobras, having previously held other positions at the same company (since October 2006). He acted as Fiscal Director at METANOR - Metanol do Nordeste S.A. and at Stratura Asfaltos S.A. He has also worked at Queiroz Galvão Óleo e Gás S/A (currently Enauta Participações S.A.), as Controller; at Starfish Oil & Gas S.A., as Accounting Manager at Gaspart Gás Participações Ltda. (currently MITSUI Gás do Brasil) and at others companies, always in the accounting and financial departments. He holds a Bachelor's degree in Accounting Sciences from Universidade Federal do Rio de Janeiro (February/1993 - August/1997); an MBA in Economic and Financial Engineering from Universidade Federal Fluminense (September/2000 - November/2001); and an LL.M. in Corporate Law from IBMEC (March/2014 - February/2016). Marcilio Jose Ribeiro Jr. does not hold a management position in any third-sector organization.

   
 164 

Carlos Henrique. Mr. Carlos Henrique was elected as an effective member of the Company’s Fiscal Council on April 19, 2022, and he has been appointed by the shareholder Petróleo Brasileiro S.A. - Petrobras. Mr. Carlos Henrique has held the position of General Manager of Accounting Operations since 2020 at Petrobras, where he joined in 1990 as an accountant, having held various leadership and management positions in the technical accounting area. He acted as a member of the Fiscal Council of Ibiritermo S.A., from 2020 to 2022 and was a member of the Fiscal Council of Petrobras Logística de Exploração e Produção S.A. (2018-2020); Metanol do Nordeste S.A. (2014-2018); Companhia de Gás do Rio de Janeiro S.A. (2010 -2014), Companhia Paranaense de Gás (2006 - 2010) and Gás de Alagoas S.A. (2003-2006). He holds a bachelor's degree in accounting and a specialization degree in accounting, both from Universidade Federal do Rio de Janeiro, in addition to an Executive MBA in Business Management from PDG - Educational Programs for Executives.

Marcos Aurélio Pamplona da Silva. Mr. Marcos Aurélio Pamplona da Silva was elected as an effective member of the Company’s Fiscal Council on April 19, 2022, and he has been appointed by the minority shareholders. Mr. Marcos Aurélio Pamplona da Silva graduated in Law from UNIVALI (University of Vale do Itajaí) in December 2004. He was approved in the examination of the Santa Catarina Bar Association (OAB/SC) in January 2005 and he holds a postgraduate degree in Management Development from ESAG – 1997. He also holds a postgraduate degree in Labor and Social Security Law from the University of the South of Santa Catarina (UNISUL) in December 2008; a specialization course in Commercial Law from the University of Vale do Itajaí (UNIVALI) – (2010); certificate course for Administrators for Public Companies and Mixed Economy Societies of the State of Santa Catarina, by Fundação Escola de Governo SC – ENA (2021-2022). Mr. Marcos Aurélio Pamplona da Silva was also a regional commercial manager Florianópolis of the distributor Polipetro Comércio de Combustíveis Ltda (currently Alesat) (2003-2006); a director of Citizen Security of the Public Security Department of Santa Catarina (2007-2010); a general coordinator of the First State Conference on Public Security in the State of Santa Catarina – April, 2009 and a natural member of the First National Conference on Public Security (June, 2009). Mr. Marcos Aurélio was the personnel training and management officer at the Santa Catarina Public Security Department from April 2010 to December 2010. Mr. Marcos Aurélio Pamplona da Silva also worked as a manager of administrative litigation of the Social Security Institute of the State of Santa Catarina (2011-2018); a substitute legal director of the Social Security Institute of the State of Santa Catarina (2011-2018); a legal advisor of the Social Security Institute of the State of Santa Catarina (2019-2021); a legal consultant of Gaspart S/A; a legal consultant of Grupo TKW Transportes Ltda.. Mr. Marcos Aurélio is the CEO of the Kuerten e Pamplona Consultoria Empresarial Ltda since 1995 and has served as a consultant to several companies in the legal area. Mr. Marcos Aurélio Pamplona da Silva is the CEO of Gaspart Participações S/A, and a board member of Gaspart Participações S.A.

Compensation

According to our by-laws, our shareholders are responsible for establishing the aggregate compensation we pay to the members of our board of directors, our board of executive officers and our fiscal council. Our shareholders determine this aggregate compensation at the general shareholders’ meeting each year. Once aggregate compensation is established, the members of the board of directors are responsible for distributing such aggregate compensation individually to the members of our board of directors, our board of executive officers and our fiscal council in compliance with our by-laws.

   
 165 

Compensation and Benefits

The aggregate compensation payable by us refers to compensation relating to each fiscal year to all members of our board of directors, board of executive officers and our fiscal council for services in all capacities.

On April 19, 2022, at our annual general and extraordinary shareholders’ meeting, our shareholders approved the preliminary compensation amount to be payable to the members of our board of directors, our board of executive officers and the members of our fiscal council for the year 2022 in the aggregate amount of up to R$85.5 million.

The actual aggregate compensation to be paid relating to the fiscal year ended December 31, 2022, however, depends on certain personal and corporate goals and the final approval of our shareholders. The actual aggregate compensation relating to the fiscal year ended December 31, 2022 will be part of the management proposal for the annual shareholders meeting to be held on April 26, 2023.

The aggregate compensation for the years ended December 31, 2021, 2020 and 2019, was R$75.5 million net in 2021, R$67.5 million gross (R$56.3 million net) in 2020, and R$63.3 million (R$52.7 million net).

The members of the board of directors receive a fixed monthly compensation, which is not affected by the numbers of meetings that take place each month. The coordinators and members of the committees, according to the responsibilities and participation in each committee receive differentiates monthly fees.

The members of the fiscal council receive a fixed monthly compensation, which is not affected by the numbers of meetings that take place each month. The alternate members of the board of directors and of the fiscal council do not receive any compensation.

Our executive officers receive a fixed monthly, an annual variable compensation and the same benefits generally provided to our employees, such as medical (including dental) assistance, private pension plan and meal voucher. Members of our board of directors and fiscal council are not entitled to these benefits.

Members of our board of directors, board of executive officers and fiscal council are not parties to contracts providing for benefits upon the termination of employment other than, in the case of executive officers, the benefits described above.

Long-Term Incentive Plan

At an extraordinary general meeting held on March 21, 2018, or the March 21 Meeting, our shareholders approved the Restricted Share Award Plan, or the Incentive Plan. The Incentive Plan establishes the general terms and conditions for the granting of certain restricted shares in our Company to eligible employees.

Eligibility

Persons who are legally employed by us or the companies controlled by us, including officers and non-officers approved by our board of directors, may participate in the Incentive Plan upon execution of an award agreement (such persons, the “participants”).

   
 166 

Administration

Our board of directors administers the Incentive Plan. Our board of directors has, subject to the general conditions of the Incentive Plan and the yearly programs that may be created, approved and / or cancelled by our board of directors and by the governing bodies of the companies controlled by us, as applicable, in observance of the terms and conditions of the Incentive Plan (such programs, the “Programs”), and the guidelines fixed by the March 21 Meeting, and to the extent fully permitted by law and under our by-laws, full powers to take all measures required and convenient for management of the Incentive Plan and such Programs, including (i) approving the eligible persons, and authorizing the grant of Restricted Shares on such persons’ behalf on the terms and conditions set forth in the corresponding award agreements; (ii) authorizing the disposal or grant of treasury shares to satisfy the delivery of the Restricted Shares under the Incentive Plan, the applicable award agreements and applicable laws and regulations, and (iii) approving objective criteria for the acquisition, by us or companies controlled by us of the Restricted Shares to be delivered to the participants. Our board of directors and the governing bodies of the companies controlled by us, as applicable, may annually approve the grant of Restricted Shares within the scope of each Program, and will determine the eligible persons on whose behalf the Restricted Shares may be granted under the Incentive Plan and such respective Program.

Restricted Shares

The grant of Restricted Shares will be made upon and subject to the execution of award agreements pursuant to the Incentive Plan. Participants may receive shares and/or depositary receipts representing shares issued by us negotiated abroad, representing at most one and a half percent (1.5%) of our entire share capital on the date of the Incentive Plan, subject to adjustment as set forth in the Incentive Plan.

The grant of Restricted Shares is contingent upon the (i) voluntary acquisition by the participants of shares or depositary receipts issued by us (the “Owned Shares”) at the participants’ own expense, from the stock exchanges where such shares are traded within a period of time set out in the applicable award agreements for the acquisition of such Owned Shares and (ii) participants’ continuous employment with us for three years and maintaining uninterrupted ownership of Owned Shares during such time (such three year period, the “Waiting Period”). The minimum investment amount is 10% of the planned gross amount of participants’ short-term income pursuant to our annual profit sharing program, and the maximum investment amount is 20% of such amount.

The target of the Incentive Plan is to award for each one (1) Owned Share two (2) Restricted Shares. However, our board of directors may define, in an exceptional and justified manner as set forth in the Incentive Plan and pursuant to the terms and conditions of the applicable award agreements, for each Program, a different number of Restricted Shares to be delivered for each Owned Share, in compliance with the minimum of one (1) Restricted Share and the maximum of three (3) Restricted Shares for each one (1) Owned Share, based on an analysis by our board of directors in its sole discretion.

Change of Control

In the event of (i) a Change of Control of our Company (as defined in the Incentive Plan), (ii) a holding of a public offer of closing of our capital (i.e., a “going private” transaction), or (iii) a corporate restructuring that results in a significant decrease of the liquidity of the Restricted Shares, in comparison with the average price and volume traded over the six (6) months prior to the corporate restructuring, the participants will be entitled to receive within sixty (60) days from the occurrence of any of the events set forth in clauses (i) through (iii): (a) all vested Restricted Shares whose rights have vested in the participants, even if the Restricted Shares have not been effectively transferred by us or companies controlled by us; and (b) all unvested Restricted Shares which will become fully vested as a result of automatic vesting acceleration.

   
 167 

Vesting

Under the Incentive Plan, full vesting of the Restricted Shares is contingent upon participants continuously remaining employed by us and maintaining uninterrupted ownership of Owned Shares, in each case, during the Waiting Period.

Termination from the Company

In the event of a termination of a participant for (i) dismissal by us and / or by the companies controlled by us without cause, (ii) removal from the manager position without violation of their duties and responsibilities, or (iii) transfer of the participant to occupy a position in a company in the same group as ours, which is not a participant in the Incentive Plan, the participant will be entitled to receive (a) the vested Restricted Shares, and (b) a pro rata number of unvested Restricted Shares, calculated based on the number of complete months in which such participant worked for us or a company controlled thereby relative to the number of months in the Waiting Period, with the remaining Restricted Shares being automatically terminated on such participant’s termination date, by operation of law, regardless of prior notice or warning, and with no right whatsoever of indemnification to such participant. The delivery of the Restricted Shares to such participant will be made on the original delivery dates (unless delivered earlier in our exclusive direction to the extent permitted under the applicable award agreement).

In the event of a termination of a participant (i) upon dismissal for cause or removal from office due to a violation of the duties and responsibilities of a manager, (ii) upon request from such participant (including redundancy / voluntary solicitation or resignation) or (iii) any event of retirement that is not a mutually agreed retirement, such participant will lose any and all rights connected to the Restricted Shares under the Incentive Plan or under any program or award agreement in connection therewith, which will be automatically terminated on the termination date of such participant.

In the event of a termination of a participant by reason of a retirement mutually agreed by such participant and us or companies controlled by us, such participant will be entitled to receive (a) the vested Restricted Shares; and (b) the entirety of the unvested Restricted Shares. The delivery of the Restricted Shares to such participant will be made on the original delivery dates (unless delivered earlier in our exclusive direction to the extent permitted under the applicable award agreement).

In the event of a termination of a participant due to (i) death or (ii) permanent disability, the legal heirs or successors or the legal representative will be entitled to receive, within sixty (60) days from such event: (a) the vested Restricted Shares of such participant; and (b) all unvested Restricted Shares.

Adjustments of Awards

In the event of change to the number, nature or class of our shares as a result of bonus, splitting, reverse split, or conversion of shares into other nature or class, or conversion of other securities issued by us into shares, our board of directors will assess the need to make adjustments to the Incentive Plan, the applicable and the award agreements in connection therewith, so that the relationship between the parties remains balanced without any material windfall or detriment to the participants.

Amendments and Termination

Our board of directors may propose any amendments to the Incentive Plan and, in case necessary, submit such amendments for approval in an extraordinary general meeting. The Incentive Plan will remain in force until the delivery of the Restricted Shares granted pursuant to award agreements executed in the fifth year of the Plan.

   
 168 

The right to receive the Restricted Shares under the Incentive Plan and applicable program and award agreement in connection therewith will automatically terminate with no right to indemnification, ceasing all effects, if we are wound up, liquidated or adjudicated bankrupt.

Corporate Governance Practices

The significant differences between our corporate governance practices and the standards of the NYSE are described in “Item 16G. Corporate Governance.”

Share Ownership of Directors and Officers

As of the date of this annual report, no member of Braskem’s board of directors or executive officer owned more than 0.1% of Braskem’s share capital. All shares owned by our directors and executive officers were purchased at market prices through the B3.

Employees

The following table sets forth the number of our employees by geographic location at the end of each year indicated.

Number of Employees by Geographic Location

2022

2021

2020

State of Bahia 1,628 1,611 1,593
State of Rio Grande do Sul 1,567 1,545 1,528
State of São Paulo 2,226 2,114 2,027
State of Alagoas 672 646 554
State of Rio de Janeiro 398 390 384
Other Brazilian states

2

2

2

Brazil 6,493 6,278 6,088
United States 831 758 764
Germany 172 155 151
Mexico 959 939 831
Other countries

213

182

159

Total

8,668

8,312

7,993

 

Employees in Brazil

In Brazil, both employees and employers have the right to organize into unions. Employees belong to a specific “professional category” and employers constitute a specific “economic category” and they may be represented by a single union in a particular geographic area. Individual unions generally belong to statewide union federations, which in turn belong to nationwide union confederations. Braskem is part of the Petrochemicals and Synthetic Resins Industries Union of the States of Bahia, Alagoas, Rio de Janeiro, Rio Grande do Sul and São Paulo, and our employees are organized within the Petrochemicals Industries Workers’ Unions in each of these states. As of December 31, 2022, 25.1% of our employees in Brazil were union members.

Braskem maintains a good relationship with the employee union. We have not experienced a strike in Brazil since Trikem was privatized in 1995. In general, our current collective bargaining agreements and conventions establish, with each trade union, clauses valid for up two years, being able to negotiate economic clauses annually. The clauses of collective labor instruments signed with the unions cover all Members, whether they are union members or not.

   
 169 

Post-Employment Benefits

Vexty Defined Contribution Plan

The majority of our employees participate in the Vexty Pension Plan (former Odebrecht Previdência). We pay part of the monthly payments made by our employees to Vexty. This pension fund is a defined contribution plan that pays pension and retirement amounts that supplement those paid by the Brazilian government’s pension system and are intended to provide its members with income upon retirement. In 2022, the number of active participants in Vexty was 6,391, and the contributions made by the sponsors in the year amounted to R$92.2 million.

Other Benefits in Brazil

Our employees in Brazil and their dependents receive medical and dental assistance through a network of accredited doctors in an insurance company. We pay most of the costs for these services, with a small monthly portion being paid by our employees. A small fee is also charged to our employees according to the use of some medical services (copayment system). In 2022, we spent R$121.3 million on this benefit.

Employees in the United States

The employees of Braskem America are not represented by any union, other than employees of Braskem America Neal, West Virginia plant. As of December 31, 2022, 7% of the employees were represented by the United Steel, Paper & Forestry, Rubber, Manufacturing, Energy Allied-Industrial & Service Workers International Union. The collective bargaining agreement with this union expires on May 3, 2029.

Post-Employment Benefits in the United States

Braskem America administers a closed defined benefit pension plan. In 2022, there were 36 active participants, 32 employees with deferred benefits along with 101 employees receiving benefits as stated within the current year actuarial report. Due to the current funding levels of the pension plan, Braskem America was not required to contribute to the plan since 2020 plan year and, as a consequence, there were no additional cash contributions made in 2022. Additionally, there were no participant contributions in 2022.

Other Benefits in the United States

Braskem America offers its employees the ability to participate in a variety of health and welfare benefit plans, including medical, dental vision, life and disability coverage.

Employees in Germany

Employees of Braskem Europe GmbH in Germany are not represented by any union. However, they are represented by local works councils (Betriebsrat).

Post-Employment Benefits in Germany

Pension Plan Germany

In October 2011, the obligations of Dow under German pension plans were assumed by Braskem Europe as a result of the Dow Polypropylene Acquisition and for that pension plans Braskem has 62 active participants, 53 with deferred benefits and 9 receiving benefits.

In 2013, Braskem Europe implemented a new defined contribution pension plan. As of the date of this annual report, the plans have 172 participants, and no contributions were made by Braskem Europe or the participants in 2022 and 2021.

   
 170 

Other Benefits in Germany

Braskem GmbH offers its employees the ability to participate in benefit plans, including pension, life and disability coverage.

Pension plan Netherlands

In the Netherlands, Braskem started a pension plan in 2009 with Delta Lloyd in a defined contribution scheme. Participation is mandatory for locals that reside in NL. As of December 31, 2022, the plans had 12 participants (nine participants in 2021), and no contributions were made by the subsidiary or the participants in 2021 and 2020.

Other Benefits in the Netherlands

Braskem BV offers its employees the ability to participate in benefit plans, including pension, life and disability coverage, health insurance (by reimbursement).

Employees in Mexico

Post-Employment Benefits in Mexico

Braskem Idesa employees are granted a government retirement benefit plan when they retire or reach retirement age. On December 31, 2022, 965 employees of Braskem Idesa were active participants in this government retirement plan. In 2022, the contributions made by Braskem Idesa in the year amounted to R$4.4 million. During 2022 and 2021, there were no contributions from participants.

Mexican Labor Law Reform

On April 23, 2021, amendments to the Mexican Federal Labor Law and other Mexican statutes were published in the Official Gazette of the Federation (Diario Oficial de la Federación) (the “Subcontracting Amendments”). The Subcontracting Amendments sets a new general rule that prohibits the subcontracting of employees or personnel; that is, for a company (the “operating company”) to contract or engage another company (the “service company”) to provide or make available employees of the service company for the benefit of the operating company.

On July 22, 2021, Braskem Idesa undertook an employer replacement (sustitución patronal) permitted by the Subcontracting Amendments, which requires the mere delivery of individual notices to each of the employees by the Braskem Idesa.

Other Benefits in Mexico

Braskem Idesa offers other benefits, including saving plans, food coupons, meals vouchers, canteen, and life and health insurance.

Performance-Based Employee Compensation Plan

We have adopted and applied a personnel management philosophy which emphasizes a performance related pay structure and a decentralized management structure. Employees in each of our business units participate in setting and achieving their business unit’s annual objectives. As a result, employees in those business units that meet or exceed their goals share in our financial performance through performance-based employee compensation plans. During 2022 and 2021, we provisioned the amounts of R$421.5 million and R$802.7 million, respectively, related to this program with respect to 9,273 employees and former employees, including our executive officers. The members of our board of directors do not participate in this program.

   
 171 

 

  Item 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

Major Shareholders

As of December 31, 2022, we had a share capital of R$8,043,222,080.50 equal to 797,207,834 total shares (including treasury shares), consisting of 451,668,652 common shares, 345,060,392 class A preferred shares and 478,790 class B preferred shares. As of December 31, 2022, all of our authorized shares were issued, other than 665,408 class A preferred shares held in treasury. All of our share capital is fully paid. All of our shares are without par value.

Generally, only our common shares have voting rights. Our preferred shares have voting rights only in exceptional circumstances.

As permitted by the Brazilian Corporate Law, our by-laws specify that no less than 25% of our Adjusted Net Income for each fiscal year must be distributed to shareholders as dividends or interest attributable to shareholders’ equity. Under our by-laws, our preferred shareholders are entitled to an annual non-cumulative preferential dividend, or the Minimum Preferred Dividend, equal to 6% of their pro rata share of our capital before dividends may be paid to our common shareholders.

Pursuant to our by-laws, all of our shares are entitled to tag along rights equivalent to 100% of the price paid in the event of a change of control, subject to certain exceptions set forth in article 12 of our by-laws. Notwithstanding the provisions of our by-laws, pursuant to the Brazilian Corporate Law, our common shares are entitled to tag along rights equivalent to at least 80% of the price paid for such common shares in the event of a change of control.

In addition, in the event of our liquidation and following the payment of all of our outstanding liabilities, holders of our shares are entitled to receive their pro rata interest in any remaining assets, in accordance with their respective participation in our capital.

Our shareholders have preemptive rights to subscribe for new shares issued by us, pursuant to the Brazilian Corporate Law, but are not obligated to subscribe for future capital increases. Pursuant to the Brazilian Corporate Law, our by-laws provide that the preemptive right may be excluded in the event of an issuance of shares to be sold on a stock exchange or publicly subscribed, except if involving voting shares or securities convertible into voting shares.

Pursuant to the Brazilian Corporate Law, neither our by-laws nor actions taken at a shareholders meeting may deprive a shareholder of: (i) the right to participate in the distribution of net income; (ii) the right to participate equally and proportionally in any residual assets in the event of liquidation of the Company; (iii) preemptive rights in the event of issuance of new shares, convertible debentures or subscription warrants, as per Brazilian Corporate Law, except as described in the preceding paragraph; (iv) the right to hold management accountable in accordance with the provisions of the Brazilian Corporate Law; and (v) the right to withdraw from us in the cases specified in the Brazilian Corporate Law, including merger with another company or consolidation in a transaction in which our Company is not the surviving entity.

The following table sets forth information concerning the ownership of our common shares and class A preferred shares as of February 28, 2023, by each person whom we know to be the owner of more than 5.0% of our common shares and our class A preferred shares, and by all of our directors and executive officers as a group. Our principal shareholders have the same voting rights with respect to each class of our shares that they own as other holders of shares of that class.

   
 172 

 

 

Common Shares

Class A Preferred Shares

Total

 

Number of Shares

%

Number of Shares

%

Number of Shares

%

Novonor 226,334,623 50.1 79,182,498 22.9 305,517,121 38.3
Petrobras 212,426,952 47.0 75,761,739 22.0 288,188,691 36.1
Other 12,907,077 2.9 190,116,155 55.1 203,502,022 25.6
All directors, fiscal council members, their alternates and executive officers as a group (35 persons) 898 * 370,260 * 371,158 *

 

  (*) Less than 1%

We currently have no management or employee option plans or management or employee options outstanding, we have only the Long-Term Incentive Plan described above. See “Item 6. Directors, Senior Management and Employees—Compensation—Long-Term Incentive Plan.”

On December 15, 2021, our shareholders Novonor and Petrobras sent us a joint communication, which we made public the following day, on December 16, 2021, regarding the progress of discussions for the potential sale of their equity interest in Braskem. In such communication, they informed us that they entered into an agreement on December 15, 2021 formalizing their commitment to take the measures necessary to: (i) sell the class A preferred shares of Braskem that they hold, directly or indirectly, in a secondary public offering; (ii) migrate the listing of our common shares to the Novo Mercado segment of the B3, including necessary corporate governance changes, which are subject to applicable corporate approvals at the appropriate time and the negotiation of a new shareholders’ agreement to conform rights and obligations set forth therein to such amended governance structure; and (iii) sell the remaining common shares that they hold, directly or indirectly, in a subsequent secondary public offering once the migration to the Novo Mercado segment is completed.

On January 14, 2022, we launched an offering of up to 154,886,547 class A preferred shares of Braskem S.A. to be sold by NSP Investimentos S.A. – Em Recuperação Judicial (Under Judicial Reorganization) and Petróleo Brasileiro S.A. – Petrobras, in a global offering that consisted of an international offering outside Brazil and a concurrent public offering in Brazil. On January 27, 2022, the global offering was cancelled. Despite the cancelation of the offering, our shareholders Novonor and Petrobras ratified their interest in resuming the offering in the future and taking all necessary measures to enable the migration of Braskem’s common shares to the Novo Mercado segment of the B3, as disclosed in the material fact notice made public on January 28, 2022.

On November 3, 2022, we received a correspondence from Novonor, informing that, due to the discussions and analysis currently underway relating to a possible transaction, it may be necessary for Braskem to interact with potential interested parties, for which Novonor asked for our support and for that of our officers. Novonor further informed that, at that moment, there was no exclusivity agreement with any interested party, no binding offer, and no definition or decision on the structure to be adopted or on any alternative related to the disposal process.

Shareholders’ Agreements

Braskem S.A. Shareholders’ Agreement

Novonor; NSP Inv.; Petrobras; and Petrobras Química S.A. – Petroquisa, or Petroquisa, with Braskem S.A. and BRK Investimentos Petroquímicos S.A., or BRK, as intervening parties, entered into a shareholders’ agreement, or Braskem S.A. Shareholders’ Agreement, effective February 8, 2010, which has a term of 35 years, as amended on September 21, 2018 and on December 15, 2021. The Braskem S.A. Shareholders’ Agreement superseded the shareholders’ agreement that formerly governed the relationship between Petrobras, Petroquisa, Novonor and Nordeste Química S.A. regarding our shares.

   
 173 

Under the Braskem S.A. Shareholders’ Agreement, for so long as Petrobras owns a direct or indirect stake in us:

·six members of our board of directors and their alternates shall be designated by Grupo Novonor; and (ii) four members of our board of directors and their alternates shall be designated by Petrobras for so long as Petrobras owns, directly or indirectly, an aggregate of 30% or more of our voting share capital;
·six members of our board of directors and their alternates shall be designated by Grupo Novonor; and (ii) three members of our board of directors and their alternates shall be designated by Petrobras for so long as Petrobras owns, directly or indirectly, an aggregate of 18%, but less than 30%, of our voting share capital;
·two members of our fiscal council and their alternates shall each be designated by Grupo Novonor and Petrobras, one of which will serve as president and be designated by Petrobras, for so long as Petrobras owns, directly or indirectly, an aggregate of 30% or more of our voting share capital; and
·two members of our fiscal council and their alternates shall be designated by Petrobras for so long as they own, directly or indirectly, an aggregate of 18%, but less than 30%, of our voting share capital and for so long as Grupo Novonor has the right to elect more than a majority of the members.

In any of the abovementioned events, for so long as Grupo Novonor owns, directly or indirectly, an aggregate of 50.1% of our voting share capital, the designation of at least the absolute majority of members of our board of directors shall always be secured.

Under the Braskem S.A. Shareholders’ Agreement, Grupo Novonor is entitled to elect the chairman of the board of directors, and Petrobras, as long as it holds a direct and indirect stake in excess of 18% of our voting share capital, is entitled to elect the vice president of our board of directors.

Under the Braskem S.A. Shareholders’ Agreement, Grupo Novonor is entitled to nominate our chief executive officer, and the parties to it shall make the members of the board of directors appointed by them vote to ratify the appointment made by Grupo Novonor. Our chief executive officer must choose our chief financial officer from among three nominees submitted by Grupo Novonor and the executive officer responsible for our investment and portfolio area from among three nominees submitted by Petrobras, whereas Grupo Novonor and Petrobras shall cause the members of the board of directors appointed by them to vote so as to ratify the choices made by the chief executive officer. Our chief executive officer has the power to nominate the other members of our board of executive officers. After being submitted to the People and Organization Committee for review and after these nominations, the officers will be elected at a board of directors’ meeting.

Under the Braskem S.A. Shareholders’ Agreement, the simple majority of the members of the board of directors has the power to approve our business plan. However, for so long as Petrobras owns, directly or indirectly, an aggregate of less than 30% and more than 18% of our voting share capital, we are prohibited from taking certain strategic actions unless a consensus regarding those actions is reached between Grupo Novonor and Petrobras, including, among others:

·actions affecting our share capitalization or the rights of holders of our shares;
·mergers, spin-offs or similar transactions;
·investments and purchases of non-current assets with a value in excess of 30% of our non-current assets;
·dispositions of non-current assets with a value in excess of 10% of our non-current assets;
   
 174 
·creation of liens on our non-current assets with a value in excess of the lesser of R$350 million and 20% of our non-current assets; and
·actions that would result in our violating specified financial covenants.

Under the Braskem S.A. Shareholders’ Agreement, we have agreed that investments that we make to increase our capacity in petrochemical inputs, resins and other products must be supported by an evaluation demonstrating profitability under standards such as net present value or internal rate of return. Each of the parties to it has granted a right of first refusal to us with respect to the development of any petrochemical project that such parties propose to pursue. In the event that we decide not to participate in any such proposed project, each of such parties has agreed that we will have the right to market the products produced by the proposed project on conditions satisfactory to us and such parties.

On December 15, 2021, Novonor, NSP Inv. and Petrobras entered into a second amendment to the Braskem S.A. Shareholders’ Agreement and agreed that, if Braskem’s migration to the Novo Mercado segment of the B3 is not implemented, the rights and obligations provided for in the Braskem S.A. Shareholders’ Agreement related to the right of first refusal granted to us with respect to the development of any petrochemical project shall lapse by October 31, 2024. Under the Braskem S.A. Shareholders’ Agreement, each party to it has the right to sell a pro rata portion of its common shares of us in connection with any direct or indirect sale of our common shares by the other party to a third party.

Under the Braskem S.A. Shareholders’ Agreement, each of the parties to it has agreed:

·subject to certain exceptions, not to grant any liens on any of its Braskem shares held by each of them; to grant a right of first refusal and tag along rights to the other parties to the Braskem S.A. Shareholders’ Agreement with respect to any sale of its Braskem shares;
·in the event that a party’s interest in our voting share capital is diluted in a transaction involving one or more of the other parties to the Braskem S.A. Shareholders’ Agreement, the diluted party will have the right, but not the obligation, to purchase shares of Braskem from the diluting parties in an amount that would, after giving effect to such purchase, result in the diluted party holding the same percentage interest in our voting share capital that it held immediately prior to the dilution event; and
·in the event that any party acquires or receives a right to acquire common shares of Braskem from a third party, to offer to sell to the other parties to the Braskem S.A. Shareholders’ Agreement an amount of common shares of Braskem that would, after giving effect to such sale, result in each of such parties to the Braskem S.A. Shareholders’ Agreement holding the same direct and/or indirect proportion of the common shares of Braskem that such parties held prior to the acquisition of common shares of Braskem from the third party.

Related Party Transactions

As provided for in our bylaws, our board of directors has the exclusive power to decide on any contract with related parties that exceeds the amount of R$20 million per transaction or R$60 million in the aggregate, per fiscal year. This is valid for contracts between Braskem and its subsidiaries and: (i) direct or indirect subsidiaries of Braskem in whose capital an interest is held by the controlling shareholder, by any direct or any of their indirect subsidiaries or by key personnel of such entities; (ii) affiliates of Braskem and subsidiaries of such entities; and (iii) joint ventures in which Braskem participates and any of their subsidiaries.

Prior to the appreciation by the board of directors, our Statutory Compliance and Audit Committee is responsible to assess the appropriateness of transactions subject to the approval of the board of directors between the Company and its related parties.

   
 175 

Pursuant to the Brazilian Corporate Law, officers and directors are prohibited from: (i) entering into any transaction using the company’s assets and in its detriment; (ii) intervening in any operations in which these officers and directors have a conflict of interest with the company or in resolutions in which they participate; and (iii) receiving, based on their position, any type of personal advantage from third parties, directly or indirectly, without first obtaining an authorization pursuant to our bylaws or at a shareholders’ meeting.

As part of our controls to identify related parties, we require key personnel to annually inform whether they, or their close relatives, hold full or shared control of any company.

Under the Brazilian Corporate Law, each of our directors, their alternates and our executive officers cannot vote on any matter in which they have a conflict of interest and such transactions can only be approved on reasonable and fair terms and conditions that are no more favorable than the terms and conditions prevailing in the market or offered by third parties. In addition, pursuant to our Policy on Ethics, Compliance and Transparency none of our shareholders or any other individual with authority over our activities may participate in the negotiation and decision-making process of a transaction in which they have a conflict of interest.

We have engaged in extensive transactions with our principal shareholders and their affiliates and we expect to continue to do so in the future. We also have commercial relationships with some of our affiliates and, as a result, record trade accounts receivable and current and long-term liabilities mainly from purchases and sales of goods and services at prices and on terms equivalent to the average terms and prices of transactions that we enter into with third parties. In addition, we have entered into financial and other transactions with our principal shareholders and their affiliates, including, among others, as a party to three shareholders’ agreements or memoranda of understanding with our shareholders. See “—Major Shreholders—Shareholders’ Agreements.”

The following summarizes the material transactions that we have entered into with our principal shareholders and their affiliates since January 1, 2022.

The Novonor Group (formerly called Odebrecht Group)

Industrial Maintenance, Operation and Loads Machines Maintenance Services

In February 2022, we entered into an electromechanical assembly service agreement for the investment to expand the production capacity of the ethylene-ethanol unit located in Trunfio, in the State of Rio Grande do Sul, with Tenenge, with a term from February 9, 2022 to July 31, 2023. The estimated amount of the agreement was R$120 million and, in January 2023, the service agreement was amended to increase the estimated amount to R$142.5 million. The aggregate amount of services purchased under this agreement was R$78.0 million in 2022.

Acquisition of Cetrel

In October 2012, we entered into an agreement with Cetrel for the purchase of 4 million cubic meters per year of recycled water by sites located in the Industrial Pole of Camaçari. The agreement expires in April 2028 and has a total value of R$120.0 million.

In March 2013, we entered into an agreement for the supply of industrial water with Distribuidora de Águas de Camaçari S.A, incorporated by Cetrel, a subsidiary of Novonor, formerly called Odebrecht. This agreement expires in March 2043 and has an estimated total value of R$2,250 million. The aggregate amount we purchased under this agreement was R$106.1 million in 2022.

   
 176 

In July 2016, we entered into a services agreement with Cetrel under which we appointed Cetrel as an exclusive service provider for the treatment of liquid effluents produced in our industrial units located at the Camaçari petrochemical complex. Such agreement was initially limited to the maximum amount of R$77.0 million and with a term until December 31, 2019, but it was amended in June 2020 to extend it to September 2020 and increase the maximum amount up to R$78.5 million. The aggregate amount of services we purchased under this agreement was R$15.4 million in 2020 and we had no services provided under this agreement.

In December 2017, we entered into a services agreement with Cetrel as a service provider for incineration of hazardous industrial waste produced in our industrial units located at the Camaçari/BA petrochemical complex. Service expenses under the agreement are capped at R$61 million, and the agreement expires in December 2020. The aggregate amount of services we purchased under this agreement was R$22.2 million in 2022.

 

Petrobras

Commercial Transactions with Petrobras

We have entered into the following supply contracts with Petrobras:

·An agreement for the purchase and sale of a chain of refinery off gas that Quattor Química S.A. which was merged into Quattor Participações S.A., formerly known as Braskem Qpar, before it merged into us on December 1, 2014 and Petrobras entered into in January 2005. See “Item 4—Information on the Company—Supply Contracts and Pricing of the Chemicals Operations that are Part of our Brazil Segment—Refinery Off Gas” for more information.
·Five propylene supply agreements that Braskem Petroquímica (formerly known as Quattor Petroquímica, which was merged into our Company in November 2017) and Petrobras signed between September 1997 and February 2006. See “Item 4—Information on the Company—Supply Contracts and Pricing of the Chemicals Operations that are Part of our Brazil Segment” for more information.
·In October 2021, we entered into a purchase agreement with Petrobras for 108 kton per year of polymer-grade propylene from the Alberto Pasqualini Refinery (“REFAP”), with delivery to Braskem’s polypropylene industrial units, PP1 and PP2, located in Triunfo, Rio Grande do Sul. This agreement remained in force from November 1, 2021 to October 31, 2022. The maximum amount of the agreement was estimated at R$630.0 million. In the fiscal year ended December 31, 2022, the transactions amounted to R$460.0 million. The term of this agreement expired, and it was not renewed.
·In December 2021, we entered into a purchase agreement with Petrobras for 220 kton per year of polymer-grade propylene from Refinaria Planalto de Paulínia (REPLAN), with delivery to Braskem’s PP3 industrial unit (“PP3”) in Paulínia, São Paulo. The agreement is in force from January 1, 2022 to May 3, 2028. The maximum amount of the agreement is estimated at R$8.1 billion for the purchase of propylene;
·In December 2021, we entered into a purchase agreement with Petrobras for 120 kton per year and 40 kton per year of polymer-grade propylene from Refinaria Henrique Lage (REVAP), with delivery to Braskem’s PP3 and PP4 industrial units, respectively. This agreement is in force from January 1, 2022 to May 3, 2028 for the first 120 kton/year and from May 4, 2028 to June 30, 2029 for the remaining 40 kton/year. The maximum amount of the agreement is estimated at R$4.7 billion;
·In December 2021, we entered into a purchase agreement with Petrobras for 150 kton per year of polymer-grade propylene from Refinaria Presidente Getúlio Vargas (REPAR), with delivery to Braskem’s PP3 and PP4 industrial units. The agreement is in force from January 1, 2022 to December 6, 2029. The maximum amount of the agreement is estimated at R$6.8 billion;
·In December 2021, we entered into a purchase agreement with Petrobras for 100 kton per year of polymer-grade propylene from Refinaria Duque de Caxias (REDUC), with delivery to Braskem’s PP5 industrial unit (“PP5”) in Rio de Janeiro. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$2.4 billion for the purchase of propylene;
   
 177 
·In December 2021, we entered into a purchase agreement with Petrobras for 140 kton/year of polymer-grade propylene from Refinaria Capuava (RECAP), with delivery to Braskem’s PP4 industrial unit (“PP4”) in Mauá, São Paulo. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$3.3 billion for the purchase of propylene.
·We entered into an agreement with Petrocoque S.A. Indústria e Comércio in 2008 for the supply of steam, which was amended in September 2020 to extend its term until March 2021. In March 2021, the Company executed an amendment to extend the agreement with Petrocoque for the purchase of steam to be used as energy by polyethylene plants and it is valid until March 2024. The aggregate amount of this agreement, as amended, is R$433 million.
·A two-year contract, entered into in November 2018, which was amended in June 2020 to extend the term of the agreement by 44 months, i.e. until June 2024, for logistics services related to feedstock discharge, storage and transportation in the TEDUT (Terminal Almirante Dutra), part of Southern Complex, between Braskem and Transpetro. The aggregate amount of services related to this contract was R$77.2 million in 2022.
·A two-year contract, entered into in November 2018, which was amended in June 2020 to extend the term of the agreement by 62 months, i.e. until December 2025, for logistics services related to feedstock storage in the REFAP (Refinaria Alberto Pasqualini), part of the Southern Complex between Braskem and Petrobras. The aggregate amount of services related to this contract was R$34.9 million in 2022.
·A two-year contract, entered into in November 2018, which was amended in June 2020 to extent the term of the agreement by 44 months, i.e. until June 2024, for storage tanks leasing and pipeline leasing related to feedstock storage in the Southern Complex between Transpetro and Braskem. The aggregate amount of services related to this contract in 2022 for pipeline leasing was R$17.1 million and storage tanks leasing was R$6.5 million, for a total amount of R$23.5 million.
·In January 2021, the Company entered into an agreement with Transpetro involving the provision of services to Braskem, namely tanker vessel unloading in the Madre de Deus Waterway Terminal (“TEMADRE”), tank storage, product transportation via the pipeline “ORMADRE” that connects TEMADRE to the Landulfo Alves de Mararipe Refinery (“RLAM”), and the transportation of naphtha via pipeline from TEMADRE to the facilities of the carrier located in the municipality of Camaçari/BA. The duration of the agreement is from February 1, 2021 to December 31, 2025, and the total estimated amount of the agreement is R$203.3 million. In the fiscal year ended December 31, 2022, the transactions amounted to R$23.5 million.
·In September 2019, we signed an amendment to our agreement with Gás de Alagoas S.A. (“Algás”) for the supply of natural gas to Braskem to extend the agreement for two years until December 31, 2021. In December 2020, we signed an amendment to our natural gas purchase agreement with Algás to increase the amount of gas to be supplied (“QDC”) from January to December 2021. The estimated aggregate amount throughout the term of the agreement, as amended, is R$770.0 million. In December 2021, the Company entered into the third amendment to the agreement with Algás for the supply of natural gas to Braskem units located in the state of Alagoas, via a local gas distribution pipeline. The agreement was extended until December 2024 by means of an amendment entered into in March 2022. The estimated value of the agreement, as amended, is R$1.5 billion. On July 2022, Gaspetro sold the equity stake it held in Algás and, upon which Algás ceased to be a related party.
   
 178 
·In December 2019, we signed an amendment to our natural gas purchase agreement with Companhia de Gás da Bahia (“Bahiagás”), with a term from January to December 2020 and an additional amount of R$820.0 million relating to the amendment. On December 2020, we signed an amendment to our natural gas purchase agreement with Bahiagás, with a term from January to December 2021 and an additional amount of approximately R$482.4 million relating to the amendment. The estimated aggregate amount to be paid throughout the term of the agreement, as amended, is R$3.45 billion. The aggregate amount we purchased under this agreement was R$759.7 million in 2021. In December 2021, the Company entered into an amendment to the agreement governing the supply of natural gas by Bahiagás to Braskem, via local gas pipelines, effective until December 2022. The estimated amount of the agreement, as amended, is R$752 million. In July 2022, Gaspetro sold its equity interest in Bahiagás, upon which Bahiagás ceased to be a related party.
·We entered into two agreements with Companhia de Gás do Estado do Rio Grande do Sul (“Sulgás”) for the supply of natural gas (industrial and power generation). In December 2021, we entered into the first amendment to the agreement governing the supply of natural gas (industrial) by Sulgás to Braskem, via local gas pipeline, in force to March 2022. In March 2022, we signed a second amendment to the agreement governing the supply of natural gas (industrial) by Sulgás to us from April 2022 to June 2023. On September 2022, we signed a third amendment to increase the amount of gas to be supplied (“QDC”) from September to December 2022. The estimated maximum amount of the agreement, as amended, is R$270 million. In July 2022, Gaspetro and the State of Rio Grande do Sul sold the shareholder stake on Sulgás, and from that moment on, Sulgás is no longer related parties of us.
·In June 2020, the Company entered into a naphtha supply agreement with Petrobras for 450 kton/year, from the Alberto Pasqualini Refinery (“REFAP”) to our unit in the State of Rio Grande do Sul. The term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount of the agreements is R$2.5 billion. In the fiscal year ended December 31, 2022, transactions under the agreements amounted R$3,145 million from the REFAP.
·In June 2020, the Company entered into a sales option agreement for up to 2,850 kton/y of petrochemical naphtha to Petrobras with mandatory purchase by Braskem. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$30 billion. In the year ended December 31, 2022, transactions under the agreement amounted to R$3,587 million.
·In December 2020, the Company entered into a sale agreement with Petrobras for up to 2 million tons of petrochemical naphtha per year, for our industrial unit in the State of São Paulo. This term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount under the agreement is R$25 billion. In the year ended December 31, 2022, transactions under the agreement amounted to R$7,600 million.
·In December 2020, the Company entered into an agreement with Petrobras to purchase ethane and propane to produce up to 580,000 tons of ethylene equivalent and sell up to 58.4 million Nm³ of hydrogen. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$9.2 billion. In the year ended December 31, 2022, transactions under the agreement amounted to R$2,354 million. In December 2020, the Company entered into an agreement with Petrobras to purchase ethane and propane to produce up to 580,000 tons of ethylene equivalent and sell up to 58.4 million cubic meters (m³) of hydrogen. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$9.2 billion. In the year ended December 31, 2022, transactions under the agreement amounted to R$2,354 million.

 

   
 179 

Other Related Party Transactions

Our Jointly Controlled Company

Refinaria de Petróleo Rio-grandense S.A. (“RPR”)

The revenue from the sale of gasoil, gasoline, blendstocks, fuel oil, BTE oil and solvents to RPR and from the purchase of turpentine from RPR was approved in 2020 for a total amount of R$845.0 million per year. Purchase and sales prices are determined on a spot basis. Additionally, in 2022, Braskem provided an aggregate of R$21.0 million of blendstocks and solvents to RPR.

Our Associated Companies

Borealis Brasil S.A.

In February 2020, we executed the fifth amendment to the polypropylene and polyethylene thermoplastic resins sales agreement with Borealis. The agreement has an estimated maximum amount of R$1,260.0 and is valid through December 2025. We recorded revenue to Borealis of R$303.1 million in 2022. We account for Borealis under the equity method of accounting.

Non-controlling shareholders of Braskem Idesa

As of December 31, 2022, we had R$2,498.1 million in outstanding indebtedness relating to a loan payable to the non-controlling shareholder of Braskem Idesa, maturing in December 2029 and accruing interest at 7% p.a., whose proceeds were used by Braskem Idesa to fund its construction project.

Related Party Transactions Policy

In December 2018, we adopted a related party transactions policy, or the Related Party Transactions Policy, which lays out the procedures for approving transactions with our controlling shareholder and shareholder that has Material Influence over Braskem, controlled entities and certain other parties. Pursuant to our bylaws and the Related Party Transactions Policy, (i) our Board of Directors is responsible for approving certain related party transactions and revisions to the Related Party Transactions Policy, (ii) our Compliance and Audit Committee is responsible for evaluating related party transactions prior to submission for approval to our Board of Directors, if applicable, as well as ensuring that the provisions contained in the Related Party Transactions Policy are observed by our other areas, and (iii) our Ethics Committee is responsible for evaluating related party transactions that do not require approval by our Board of Directors. Pursuant to this policy, we have, and may in the future, engage in transactions with our controlling shareholder and shareholder that has Material Influence over Braskem or controlled entities with respect to our services or products, or other related party transactions, as defined in our Related Party Transactions Policy.

  Item 8. Financial Information

Consolidated Statements and Other Financial Information

Reference is made to Item 19 for a list of all financial statements filed as part of this annual report.

Legal Proceedings

We are currently a party to numerous tax, civil and labor disputes, among others, involving monetary claims arising in the normal course of our business. If any of these legal proceedings were decided adversely to us, we do not believe that our results of operations or financial condition would be materially and adversely affected.

   
 180 

We establish provisions for probable and reasonable estimable losses, which we may incur in connection with pending proceedings.

Tax Proceedings

We are a party to several legal proceedings with tax authorities for which we have established provisions in an aggregate amount of R$735.9 million as of December 31, 2022 related to tax claims for which our outside legal counsel considers that the likelihood of loss is probable. In addition, there are currently certain legal proceedings pending in which we are involved for which we have not established provisions, since there is no trigger in accordance to IAS 37 to record such provisions. The aggregate amount of tax contingency proceedings was R$18,270.7 million as of December 31, 2022, with respect to which our management believes, based on the opinion of our outside legal counsel, that the risk of loss is possible.

IR/CSLL Tax Assessment Notices:

a)Charges with goodwill amortization: in 2013, 2014 and 2017, we received tax assessment notices from the Brazilian Federal Revenue Service claiming that the amortization of the goodwill, from 2007 to 2013, recorded in 2002 in connection with the purchase of shares of certain companies related to the formation of Braskem was not deductible for purposes of calculating our income tax. On December 31, 2022, the updated contingency was estimated at R$1.1 billion.

These administrative proceedings are expected to be concluded by 2025, while the current court proceeding is expected to be concluded by 2030.

We offered a performance bond that covers the total amount involved in the court proceedings.

b)Unlimited offsetting: in December 2009 and March 2017, we received tax deficiency notices from the Brazilian Federal Revenue Service claiming that the methodology used to offset tax losses and tax loss carryforwards failed to observe the limit of 30% of the taxable profit and social contribution calculation base when offsetting such liabilities with corporate income tax and social contribution liabilities in merger operations, respectively, in November 2007 and August 2013.

As of December 31, 2022, the updated value of the contingency amounted to R$461.7 million. The lawsuits are expected to be concluded by 2031.

We offered a performance bond that covers the total amount involved in the court proceeding.

c)Commission expenses: in December 2017, we received a tax deficiency notice from the Brazilian Federal Revenue Service arising from: (i) the disallowance of commission expenses paid by Braskem in 2011; (ii) the disallowance of commission expenses paid by Braskem Inc. in 2013 and 2014; (iii) lack of payment of withholding income tax (“IRRF”) on the payments referred to in the previous item; and (iv) the disallowance of advertising expenses incurred in 2013.

As of December 31, 2022, the updated amount of taxes and tax effects from disallowances of income tax losses and social contribution tax loss carryforwards in the tax deficiency notice was R$153.4 million.

This administrative proceeding is expected to be concluded by 2024.

d)Exchange variation on naphtha imports: in 2017 and 2020, we received tax assessment notices from the Brazilian Federal Revenue Service claiming unpaid income tax in connection with exchange variation losses recorded by Braskem in the elapsed time between the due date of naphtha import invoices and their payments. The Brazilian Federal Revenue Service considered that these losses, recorded in 2012 and in 2015, respectively, were not deductible. We challenged this assessment notice because: (i) the use of trading companies in import operations is regular; (ii) exchange variation expense is ancillary to the principal and, therefore, deductible; (iii) the fluctuation of exchange rates is not predictable; (iv) there are mistakes in determining the profit margin of the subsidiary and (v) the 150% qualified fine is unjustified.
   
 181 

 

As of December 31, 2022, the amount relating to this uncertain tax treatment was R$1.2 billion, including fiscal years already filed and not yet filed. The administrative proceedings are expected to be concluded by 2026.

 

e)Negative Balance – Offset: from 2003 to 2019, we received notifications from the Brazilian Federal Revenue Service rejecting compensatory statements aimed at the discharge of federal taxes with credits arising from negative balance of income tax (IR/CSL). As of December 31, 2022, the updated value of the taxes whose offset was not approved amounted to R$175.6 million.

These administrative proceedings are expected to be concluded by 2024, while the lawsuits are expected to be concluded by 2030. We offered a performance bond that covers the total amount involved in the current court proceedings.

f)Foreign earned income – Braskem Netherlands: in 2020, we received a deficiency notice from the Brazilian Federal Revenue Service, referring to fiscal years 2015 and 2016, stating its disagreement with applying the agreement between Brazil and the Netherlands to avoid double taxation, which establishes that Dutch companies’ profits may be taxed in Brazil.

On December 31, 2022, the amount of this uncertain tax treatment was R$10.6 billion, including fiscal years already filed and not yet filed. The administrative proceeding is expected to be concluded by 2026.

ICMS Tax Assessment Notices:

a)ICMS: from 1999 to 2022, the internal revenue service of the States of Bahia, Alagoas, Pernambuco, São Paulo, Rio Grande do Sul and Rio de Janeiro issued tax assessment notices against Braskem claiming unpaid ICMS taxes in connection with several alleged violations of certain provisions of the ICMS tax legislation, including, among others:
·ICMS credit on the acquisition of assets that are considered by the tax authority as being for use and consumption, which as such do not produce a right to the credit because they are not physically part of the end product;
·ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by the tax authority as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.;
·internal transfer of finished products for an amount lower than the production cost;
·omission of the entry or shipment of goods based on physical count of inventories;
·lack of evidence of exports of goods with shipment presumably taxed for the domestic market;
·non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;
·fines for the failure to register invoices; and
·nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market of the Electric Power Trading Chamber.
   
 182 

As of December 31, 2022, the updated value of these proceedings was R$767.5 million.

These administrative proceedings are expected to be concluded by 2027, while the court proceedings are expected to be concluded by 2031. We offered performance bonds that cover the total amount involved in the current court proceedings.

b)ICMS tax on interstate purchases: in 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment of ICMS in view of the following alleged violations:
·undue use of tax credits in the amount of R$58.2 million, due to the recording of credits indicated in the invoices for the sale of certain products, issued by Acrinor Acrilonitrila do Nordeste S.A. and Proquigel Química S.A., since the products were to be exported, and were therefore exempt from payment of ICMS tax;
·the fine for the abovementioned tax offense corresponds to 100% of the principal value recorded;
·fine in the amount of 30% on R$480.4 million, which corresponds to the sum of the amounts indicated in tax documents whose outflow of goods was not identified by the tax authority; and
·fine due to lack of presentation of tax documents requested.

After ending the discussions at the administrative level, with the partial reduction in contingency, we filed lawsuits to continue the discussion, which were guaranteed by a judicial bond. On December 31, 2022, the balance of this provision was R$329.1 million. Our management, based on its assessment and that of our outside legal counsel, estimates the legal procedures will conclude in 2026.

c)Credit reversal on output with tax deferral: in July and December 2020, we were notified, by the State of Alagoas, of the lack of ICMS tax payment arising from the alleged lack of reversal of the tax credited in operations prior to outflows with tax deferral. On December 31, 2022, the value of these cases was R$639.4 million. The administrative proceedings are expected to be concluded by 2025.

 

PIS and COFINS Non-Cumulative Tax Assessment Notices:

 

a)In 2006, from 2010 to 2015, and from 2017 to 2022 we received tax assessment notices from the Brazilian Federal Revenue Service alleging that we had inappropriately claimed certain PIS and COFINS credits in relation to: (1) charges for electricity transmission; (2) freight related to the storage of finished goods; (3) credits claimed at inappropriate times, relating to various acquisitions; (4) fixed assets; and (5) Prodesin. We challenged these assessment notices because we believe that there are reasonable grounds on which we can successfully defend against these assessments. As of December 31, 2022, the amount under discussion was R$1.4 billion, including interest and fines. We believe that a loss of these claims is possible, and our outside legal counsel expects that the administrative discussions will end in 2026 and the judicial discussion will end in 2032. We had made no provision with respect to these claims and there is no deposit or guarantee related to the administrative proceedings. We offered guarantees in the amount of the judicial proceedings.

 

b)From 2010 to 2012, and from 2017 to 2022 we received tax assessment notices from the Brazilian Federal Revenue Service rejecting the compensation of PIS and COFINS credits in the years 2005 to 2010 and in the period from 2012 to 2018 for the following reasons: (1) the amount of the credits informed in the compensation files were greater than the amount informed in the PIS and COFINS declaration (DACON); (2) freight expenses not linked to sales operations or without a proven connection, link to the national territory, but related to imported products; (3) credits relating to the acquisition of fixed assets from incorporated companies whose documentation was not found; and (4) taxation of taxable revenues erroneously classified as exempt, at zero rate or not taxed.
   
 183 

 

As of December 31, 2022, the balance of this provision was R$212.2 million. Our management, based on its assessment and that of our outside legal counsel, estimates that the administrative procedures will be concluded by 2026.

 

PIS and COFINS Tax Assessment Notices:

a)PIS and COFINS taxes: in 2004, 2007, 2009 and 2010 we were involved in several judicial proceedings related to the payment of PIS and COFINS, including (1) unpaid COFINS from March 1999 to December 2000, February 2001 to March 2002, May 2002 to July 2002 and during September 2002, (2) inappropriately claimed credits due to the additional 1% in the COFINS rate; and (3) undue compensation of PIS and COFINS debts with PIS credits (Decree-Law Nos. 2,445 and 2,449) which were considered to have expired by the tax authorities. We challenged these assessment notices because we believe that there are reasonable grounds on which we can successfully defend against these assessments. As of December 31, 2022, the amount under discussion was R$ 80.0 million including interest and fines. We believe that a loss of these claims is possible and our outside legal counsel expects the cases will end by 2030. We had established related provisions in the amount of R$69.6 million. We offered a guarantee in the amount of the judicial litigations.

 

b)Taxation of liability reductions settled in connection with the installment plan under Provisional Executive Order No. 470/2009: in 2014, we received a tax assessment notice from the Brazilian Federal Revenue Service claiming that the fines and interest exonerations afforded in installments of the Provisional Measure No. 470/09 are taxable. We had challenged this assessment notice because we believed that these claims are based on a misinterpretation of both the applicable law and facts by the tax authorities, especially because exonerations are not taxable income and, even if they were financial income, at the time, they were taxed at zero rate. We received notice for not applying to PIS and COFINS taxes the reductions for fines and interest, in view of the adoption of the installment plan offered by the Brazilian federal government under Provisional Measure No. 470/2009.

 

In March 2023, the court of last resort (the Superior Chamber of the Tax Resources Administrative Board) ruled in our favor, cancelling the full collection. Our management, based on its assessment and that of our outside legal counsel, understands that an appeal from the Brazilian federal government is not applicable and, hence, the probability of loss was changed from possible to remote. We are awaiting the publication of such decision.

On December 31, 2022, the updated value of this proceeding was R$966.6 million.

a)PIS and COFINS sundry: in 2004, 2011 and 2016: we and our affiliates were involved in several lawsuits related to PIS and COFINS assessments in the judicial courts, which discuss the alleged undue offsetting of credits arising from other proceedings, including: (i) income tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees – Federal Laws Nos. 2,445 and 2,449; and (v) the COFINS tax arising from the undue payment or payment in excess.

As of December 31, 2022, the updated amounts involved in these assessments was R$136.3 million. These judicial proceedings are expected to be concluded by 2025. We offered guarantees that cover the total amount involved in the court proceedings.

b)PIS and COFINS: Cide-Fuels Tax Offset: in 2014 and 2018 we were involved in lawsuits claiming PIS and COFINS tax liabilities arising from their offset using Cide-Fuels tax credits, as authorized under Federal Law No.10,336/2001.

As of December 31, 2022, the updated value of these lawsuits was R$123 million. The lawsuits are expected to be concluded by 2030. We offered a performance bond that covers the total amount involved in the court proceedings.

 

   
 184 
c)From 2015 to 2022, we received tax assessment notices from the Brazilian Federal Revenue Service imposing isolated fines due to the use of credits of: (i) non-cumulative PIS/COFINS; (ii) negative Balance of IRPJ/CSLL; (iii) REINTEGRA and (iv) other credits, offset and not homologated.

Exemption of IR/CSL on ICMS tax incentives and benefits

In October 2021, we obtained a preliminary injunction to exclude the ICMS tax incentives and benefits applicable to our operations, granted by the governments of the Brazilian States and the Federal District, from the income tax calculation base as from 2021. Since it is an uncertain tax treatment, as of December 31, 2021 it remained booked on the balance sheet as income taxes payable.

In August 2022, a judgment was rendered restricting relief only to presumed ICMS credits. Accordingly, the amount related to ICMS tax incentives and benefits was paid amounting to R$1,038.3 million.

Exclusion of inflation adjustment by Selic (economy’s basic interest rate) on undue tax payments from taxable income

In July 2010, we and companies merged into us in previous years filed lawsuits claiming exceptions from the levying of Brazilian income taxes (IR/CSL) on amounts they received as interest on late payment, since they do not represent any equity increase. On September 24, 2021, through Special Appeal No. 1,603,187, the Brazilian Supreme Court (STF) recognized the unconstitutionality of levying of IR/CSL on amounts updated by the Selic rate, received due to repetition of undue tax payments.

We benefited from this decision through a reduction in the amount of R$540 million in income taxes calculated until 2022 (R$501 million until 2021). In 2021, deferred tax assets amounting to R$68 million were recognized for the periods in which tax losses increased.

Other Fine Tax Assessment Notices

In October 2021, we obtained a preliminary injunction to exclude the ICMS tax incentives and benefits applicable to our operations, granted by the governments of Brazilian States and the Federal District, from the income tax calculation base as from 2021. Since it is an uncertain tax treatment, as of December 31, 2021, it remained booked on the balance sheet as income taxes payable. In August 2022, a judgment was rendered restricting relief only to presumed ICMS credits. Accordingly, the amount related to ICMS tax incentives and benefits was paid amounting to R$1,038.3 million.

We had challenged these assessment notices because we believed that there are reasonable grounds on which we can successfully defend against these assessments and in March 2023, when judging the leading cases on the matter (Extraordinary Appeal No. 796,939 and Direct Action for the Declaration of Unconstitutionality No. 4905), the Brazilian Supreme Court established the understanding that such fines are unconstitutional, which changes the probability of loss from possible to remote.

As of December 31, 2022, the updated value of these deficiency notices amounted to R$352.9 million.

Social Security Contributions – Hazardous Agents

We are a party to other proceedings, which claim payments of additional contribution for occupational environmental risk to fund the special retirement plan due to the alleged exposure of workers to hazardous agents: (i) (a) at the administrative level in the period from April 1999 to February 2006, jointly with a fine due to failure to declare the generating factor of the contribution to GFIP, and (b) in the period from January 2016 to July 2018; and (ii) at the judicial level, in the periods from November 2000 to January 2001 and November 2001 to June 2002.

   
 185 

On December 31, 2022, the adjusted amount of these proceedings was R$202.7 million.

The administrative proceedings are expected to be concluded by 2025, while the only current court proceeding is expected to be concluded by 2028. We pledged a performance bond that covers the total amount involved in the current court proceeding.

Contingent Assets

Contingent assets are potential assets whose existence will be confirmed by the occurrence or non-occurrence of uncertain future events that are not wholly within the Company’s control. Contingent assets are not recognized but are disclosed when it is more likely than not that an inflow of benefits from such assets will occur. However, when the inflow of benefits is virtually certain, an asset is recognized in the financial position statement because that asset is no longer considered contingent.

Compulsory loans to Eletrobrás – Centrais Elétricas Brasileiras S.A.

The compulsory loan in favor of Eletrobrás was established by Federal Law No. 4,156/62, to finance the energy industry and remained effective until 1993. It was collected through the energy bills of industrial consumers with monthly consumption equal to or higher than 2000kwh and, after successive amendments to the law, the reimbursement, plus compensatory interest of 6% per year, was extended to 20 years, which can be anticipated through conversion of credits into shares issued by Eletrobrás.

Between 2001 and 2009, the companies that merged into Braskem S.A. filed proceedings seeking the recovery of amounts related to differences in the inflation adjustment of the compulsory loan, interest on arrears and compensatory interest and other related payments.

We obtained a favorable final and unappealable decision in the cases of the merged companies Alclor Química de Alagoas Ltda., Companhia Alagoas Industrial – Cinal, Companhia Petroquímica do Sul S.A. – Copesul and Trikem S. A., which are in the execution phase, discussing the amounts to be effectively returned. The cases of the merged companies Ipiranga Petroquímica S.A., Petroquímica Triunfo Ltda. and Quattor Química S.A are in the cognizance phase.

The term, form and amount to be realized are still uncertain, so it is not possible to determine the amount to be received and, for such reason, the asset does not meet the conditions to be recorded in the financial statements.

Class Action Proceedings

In July 2015, two putative class action lawsuits were filed against us and certain of our then-current and former officers and directors in the United States District Court for the Southern District of New York. The lawsuits were subsequently consolidated under the caption In re Braskem, S.A. Securities Litigation, No. 15-cv-5132. In November 2015, Boilermaker-Blacksmith National Pension Trust, the lead plaintiff, filed a consolidated class action complaint, which asserted claims under Section 10(b) and Section 20(a) of the Exchange Act, on behalf of a putative class of purchasers of our ADSs, from June 1, 2010 to March 11, 2015. In the complaint, the lead plaintiff alleged that the defendants made misrepresentations or omissions that inflated the price of our stock in violation of United States securities laws. We filed a motion to dismiss on July 6, 2016. On March 31, 2017, the court ruled on the motion to dismiss, granting it in part and denying it in part. The parties signed a proposed settlement agreement on September 14, 2017 and the U.S. court granted final approval to the settlement and entered a judgment to dismiss the action and discharge the claims of the class members on February 21, 2018. Under the terms of the settlement, we paid US$10 million (R$31.7 million) to resolve all claims of the settlement class consisting of purchasers of our ADSs during the period from July 15, 2010 through March 11, 2015, that arise out of or relate to the subject matter of the class action. We paid the settlement amount into an escrow account (which is subject to the jurisdiction of the Court) on October 2, 2017 and the Claims Administrator shall arrange its distribution after the entry by the court of a class distribution order. We have made no admission of any wrongdoing or liability as part of the settlement.

   
 186 

On August 25, 2020, a class action was filed against us and some of our current and former executives in the U.S. District Court for the District of New Jersey, on behalf of an alleged class of investors who acquired Braskem’s securities. The lawsuit was grounded in the Exchange Act, and its rules, based on allegations that the defendants made false statements or omissions related to the geological event in Alagoas.

On December 15, 2022, the parties entered into an agreement to settle the class action with a payment of US$3 million, which was made in January 2023. On December 20, 2022, as the first measure for approval of the agreement, the lead plaintiff filed a preliminary approval motion, and the U.S. District Court for the District of New Jersey is expected to follow the required procedure for the approval of the settlement agreement. The extinction of the class action is expected to be declared only after the final approval of the settlement agreement and after the obligations assumed by the parties to the settlement agreement are met.

We cannot reliably predict all of the costs related to solving this dispute. We may be named as a defendant in other similar legal actions. We may also be named as a defendant in other lawsuits.

Global Settlement

In the context of allegations of improper payments in connection with the so-called Operation Car Wash (Operação Lava Jato) in Brazil, we engaged independent expert firms to conduct an investigation into such allegations (the “Investigation”) and report their findings.

On December, 2016, Company entered into a leniency agreement with the the Federal Prosecutors’ Office (“MPF Agreement”) and the authorities of the United States and Switzerland (“Global Agreement”), in the approximate amount of US$957.0 million (approximately R$3.1 billion at the time), which were duly approved. Furthermore, the Company engaged in a process of cooperation and negotiation with the Ministry of Transparency and Controllership (“CGU”) and the Attorney General (“AGU”), which culminated in the signing of a leniency agreement with said authorities on May 31, 2019 (“CGU/AGU Agreement” and, together with the Global Agreement, the “Agreements”), which deals with the same facts object of the Global Agreement and provides for an additional disbursement of R$409,877, due to calculations and parameters used by CGU and AGU. Additionally, in 2019, the Public Ministry of Bahia and the Public Ministry of Rio Grande do Sul joined the MPF Agreement, although there is no provision for additional payments by the Company.

AGU, CGU and MPF agreed to allocate most of the amounts received based on the Agreements for the reparation of victims of illicit acts, including other authorities and public entities, and to undertake actions with those third parties with which Braskem will start negotiations in relation to the facts object of the Agreements to avoid double reimbursement.

As of December 31, 2022, we had paid R$3.1 billion of the total fine established in the Global Settlement, in the following manner:

·R$877.8 million to the AGU, CGU and MPF;
·R$296.6 million to the DoJ;
·R$407.3 million to the OAG;
·R$1,282.5 million to the MPF; and
·R$206.5 million to the SEC.
   
 187 

As of December 31, 2022, the outstanding amount of R$903.1 million (R$392.5 and R$510.7 as current and non-current liabilities, respectively) was due under the MPF Agreement and CGU/AGU Agreement, in four annual installments adjusted by the variation in the SELIC rate and due by January 30, 2025. To guarantee payment of these upcoming installments, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment. The Global Settlement does not prevent us from responding to any legitimate third party, which may seek indemnification against us from damages for the facts subject to the Global Settlement. Other authorities with jurisdiction over us may seek to impose monetary sanctions or fines on, or to initiate investigative proceedings against the Company.

We do not anticipate the requirement to make additional disbursements but cannot assure that the aggregate amount disbursed as a requirement pursuant to the agreement will be sufficient to cover indemnification claims of all of the victims.

We continue to cooperate with the governmental authorities and improving our governance and anti-corruption compliance practices. For three years, we were subject to external monitorship. The monitor assessed compliance with the Global Settlement, including the effectiveness of our internal controls, policies and procedures to reduce the risk of any anti-corruption violations.

On March, 2020, based on the certification emitted by the independent monitors who assessed us by three years, MPF had confirmed the effectiveness of the compliance program and the conclusion of the independent monitorship. On May 13, 2020, the MPF, the DoJ and the SEC confirmed the conclusion of the independent compliance monitorship at Braskem, which had been established in the settlement agreements entered into by Braskem.

We successfully completed all the activities related to CGU’s monitoring of the Company, and no pending issues involving the Company remained. The CGU will present the final monitoring report and prepare a final agreement. Moreover, the Company is in compliance with all of its obligations under the Agreements and continues to cooperate with government authorities.

We are in compliance with all obligations arising from the agreements mentioned above and we are cooperating with the public authorities from all jurisdictions.

Labor Proceedings

Employment and Occupational Health and Safety Proceedings

We have provisioned R$212.7 million, as of December 31, 2022, with respect to employment and occupational health and safety proceedings, relating to 472 labor proceedings, including cases of occupational health and safety (in 2021, there were 529 proceedings). Our outside legal counsel estimates that the time for completion of each of such proceedings in Brazil is more than five years. Estimates related to the completion of the proceedings and the possibility of future disbursement may change as a result of new decisions of higher courts.

Social Security

The Company withdrew its sponsorship of the pension plans Petros Copesul and Petros PQU in 2012 and in 2009 of Petros Copene, all of them managed by the pension fund Petros. Due to this procedure, it was assumed an outstanding obligation under the sponsorship withdrawal instrument which was to pay the mathematical reserves of beneficiaries pursuant to Complementary Law No. 109/2001, this obligation was met in 2015. However, after the payment, several beneficiaries filed individual and collective lawsuits regarding various claims relating to: (i) differences of the individual withdrawal fund; (ii) change of the base date; (iii) age limit; (iv) 90% supplement; (vi) return of contributions; (vii) difference in savings account reserve; (viii) objection against legality of sponsorship withdrawal.

   
 188 

Currently, this portfolio is comprised of 729 active cases (in 2021, there were 783 active cases), based on the opinion of our outside legal counsel, have a chance of loss classified as possible, representing as of December 31, 2022, an estimated aggregated disbursement of R$378.5 million.

Civil Proceedings

Resale of solvents

In January 2017, the Company became the defendant in a civil lawsuit filed by former reseller of solvents, claiming alleged breach of a tacit distribution agreement. The lawsuit is pending judgment.

As of December 31, 2022, the claims amounted to R$302.4 million.

Incentivized Preferred Shares

We are also currently subject to the liquidation of an award related to a lawsuit filed in 1988, which required Polialden Petroquímica S.A. (“Polialden”), a company merged into Braskem, to pay certain non-controlling shareholders that hold preferred shares in Polialden the distribution of the remaining net profit of the company.

The liquidation of the award aims to determine the value of the dividends to be paid in accordance with the terms of the decision. The process is awaiting the start of the expert evidence.

As of December 31, 2022, based on our management’s assessment and that of our outside legal counsel, the Company recorded a provision of R$21.1 million in connection with this lawsuit. The amount considered as possible loss is R$262.2 million, and the total amount of the lawsuit is R$283.3 million.

Hashimoto Civil Action

 

A civil class action was filed in June 2018 by the Public Prosecutor’s Office of the State of São Paulo against us and other companies that operate in the Capuava Petrochemical Complex, seeking the reparation and/or remediation of environmental damages supposedly arising from the emission of air pollutants, as well as a joint judgement against companies that comprise such complex, seeking environmental moral damages in in the inflation-adjusted amount of R$ 201.0 million. Braskem filed its defense in December 2020. The defense of the other defendants and the subsequent decision of the judge is pending. Our management, based on its assessment and that of our outside legal counsel, believes that the lawsuit will possibly be dismissed within a period of eight years.

Environmental

A public interest civil action was filed in September 2011 by the municipality of Ulianópolis, in the State of Pará, against Braskem and other companies, claiming reparation and/or remediation of environmental damages allegedly resulting from the delivery of waste to the company CBB, which were allegedly not disposed of properly, polluting an area of the municipality Ulianópolis, as well as joint and several liability of these companies for the payment of indemnification for environmental damage in the adjusted amount of R$363 million. The companies filed their reply and a decision is pending. Our management, based on the opinion of our outside legal counsel, believes that the lawsuit will be dismissed within a period of eight years.

Alagoas – Mining Activities

On April 2, 2019, we became aware that the Alagoas State Prosecutors’ Office (Ministério Público do Estado de Alagoas) and the State of Alagoas Public Defenders’ Office (Defensoria Pública do Estado de Alagoas) filed a lawsuit (public-interest civil action or civil public action or ação civil pública) claiming the payment of compensation for property and personal damages caused to buildings and residents of areas affected in the Pinheiro district and surroundings (“ACP of Residents”), in the minimum amount of R$6.7 billion, with an initial request for provisional measures to freeze Company’s assets in the same amount. The case was sent to the Federal Court, when the Federal Prosecutors’ Office (Ministério Público Federal) and the Federal Public Defenders’ Office (Defensoria Pública da União) joined as plaintiffs.

   
 189 

Parties to the ACP of Residents entered into a first agreement on January 3, 2020, to establish cooperative actions to vacate properties in risk areas, defined by the Civil Defense of Maceió, State of Alagoas, (“Civil Defense Map”), providing the necessary support to relocate people from those areas and provide financial compensation for them under the Financial Compensation and Support for Relocation Program (“PCF”) implemented by Braskem. After updates of the Civil Defense Map, two legal instruments were signed by parties, in July and October 2020, to include properties in the PCF. On December 30, 2020, a second amendment to the agreement was signed to terminate the public-interest civil action (“Agreement for Compensation of Residents”), including the area currently affected by the geological event, according to the Civil Defense, and the areas with potential future impacts indicated in the independent technical and specialized studies engaged by the Company on the potential impact of the geological event on the surface of the region (as of December 31, 2022, the risk area encompasses a total of approximately 15,000 properties).

To implement the Agreement for Compensation of Residents, the Company assumed the obligation to deposit a total of R$2.7 billion (R$1.7 billion under the Agreement in a checking account, with minimum working capital of R$100 million, whose transactions will be verified by an external audit company and also agreed to create a technical group to monitor the geological event and study the areas adjacent to the Civil Defense Map for a period of five years and maintain a perfomance bond in the amount of R$1.2 billion. The Agreement for Compensation of Residents was ratified by Court on January 6, 2021 which resulted in the termination of ACP of Residents.

On May 8, 2019, we became aware of the Report No. 1, prepared by the Mineral Resources Research Company (Companhia de Pesquisa de Recursos Minerais), or CPRM, an entity of the Brazilian Energy and Mining Ministry (Ministério de Minas e Energia), indicating that the geological phenomenon observed in the region, could be related to the rock salt exploration activities developed by Braskem. In this context, due to the developments from the report’s publication and in accordance with applicable safety standards, on May 9, 2019, we suspended all salt extraction and, consequently, the operations of the chlor-alkali and dichloroethane plants located in the district of Pontal da Barra in Maceió, state of Alagoas, and also reducing production in the Camaçari Petrochemical Complex in the state of Bahia, since they are integrated into the production chain. Given that, Braskem put in place a non-integrated business model according to which the Company will import: (i) caustic soda to supply the Brazilian market using its logistics structure and terminals along the Brazilian coast; (ii) EDC to continue to operate its PVC plants in the states of Alagoas and Bahia, in Brazil; and (iii) sea salt to supply the Chlorine Soda plant in the State of Bahia. We have continuously cooperated with relevant authorities and the local community.

On July 25, 2019, we were informed of a public-interest civil action filed against us by the Labor Prosecutors’ Office of the State of Alagoas (Ministério Público do Trabalho do Estado de Alagoas or MPT-AL), requesting a compensation of R$3.6 billion for damages that workers affected by the geological event might have suffered and an injunctive relief to freeze the amount of R$2.5 billion (“ACP Labor”). Parties reached an agreement on February 14, 2020, to terminate the claim, with the commitment from Braskem to invest R$40.0 million to fund a Business Recovery and Promotion of Educational Activities Program for residents and workers in the districts of Mutange, Bom Parto, Pinheiro and Bebedouro in Maceió, in the state of Alagoas. Such program consists in constructing day care centers and schools, implementing vocational training programs and providing support to the Civil Defense authorities in hiring qualified personnel for continuing the process of monitoring the areas at risk in these districts. Braskem fulfilled its obligation on March 3, 2020, and the ACP Labor was terminated.

On July 29, 2019, we were notified of an individual claim filed by Construtora Humberto Lobo, a construction company, seeking the payment of approximately R$151 million for damages related to the termination of a property purchase contract celebrated with Braskem and allegedly due to the geological event. A previous decision, on July 4, 2019, had issued a freeze order of R$4.8 million from Braskem’s assets. On October 15, 2019, the Court partially decided the claim to determine the immediate payment of R$4.5 million to the plaintiff. Braskem’s appeal against such decisions awaits ruling by the Court of Appeal. The remaining part of the claim proceeds before Court to evidentiary stage (on December 31, 2022, it amounts to R$306 million).

   
 190 

On August 19, 2019, we became aware of the filing of another public-interest civil action by the Federal Prosecutors’ Office (Ministério Público Federal) against us and other parties, requesting indemnification for socio-environmental damages and other collectives damages, as well as the adoption of corrective and environmental compliance measures, with preliminary injunction requiring the freezing of assets and profits not yet distributed, the set-up of a fund of R$3.1 billion for the benefit of social and environmental programs and emergency measures to be carried out, the posting of bonds in the amount of R$20.5 billion, the suspension of government financings and government incentives, as well as acceleration of existing indebtedness with BNDES (a federal development bank), among other obligations (“ACP Socio-environmental”). Parties reached an agreement to terminate the claim against Braskem on December 30, 2020 (“Agreement for Socio-environmental Remediation”).

According to the Agreement for Socio-environmental Remediation, the Company commits, primarily, to (i) adopt the necessary measures to stabilize the cavities and monitor the soil; (ii) repair, mitigate or compensate potential environmental impacts and damages resulting from the mining activities (salt extraction) in the city of Maceió, defined after the conclusion of the Environmental Diagnosis, to be conducted by a specialized and independent company; and (iii) repair, mitigate or compensate for potential socio-urbanistic impacts and damages resulting from mining activities (salt extraction) in the city of Maceió, as detailed below.

Under the Agreement for Socio-environmental Remediation, the Company undertook the following measures:

·with respect to the stabilization of the cavities and monitoring of the soil, the Company will continue with the implementation of the measures of the mine closure planning presented by Braskem to ANM and subject to its approval;
·with respect to potential environmental impacts and damages resulting from the salt extraction activities in the city of Maceió a well-known expert and independent company was engaged to assess and recommend measures for repairment, mitigation or compensation of the environmental impacts that may be identified as a result of the salt extraction activities in the city of Maceió. After the completion of such study, the Company will implement and fund the potential measures recommended by such study with the previous accordance of the Federal Prosecutor’s Office (Ministério Público Federal); and
·with respect to socio-urbanistic impacts and damages resulting from the salt extraction activities in the city of Maceió, the Company will allocate the total amount of R$1.28 billion to implement actions and measures in the vacated areas, and actions relating urban mobility and social compensation.

Additionally, the Company agreed under the Agreement for Socio-environmental Remediation: (i) to allocate the additional amount of R$300 million for social damages and collective moral damages indemnification and for eventual contingencies related to actions in the vacated areas and urban mobility actions; (ii) with the constitution of a secured interest on certain of the Company's assets in the amount of R$2.8 billion to replace the surety bond previously presented by Braskem to the Court in the amount of R$1 billion, as Material Fact disclosed on January 3, 2020; and (iii) to engage specialized consultants to support the definition of the measures established in the Agreement for Socio-environmental Remediation and to update the socio-environmental compliance program of the Company.

   
 191 

On November 14, 2019, as informed to the market, we submitted to the Brazilian National Mining Agency (Agência Nacional de Mineração, or “ANM”) a plan with measures to permanently end salt extraction activities in Maceió and close all of its wells, indicating actions based on a study conducted by the Institute of Geomechanics of Leipzig (IFG).

On June 19, 2020, the Company became aware of a public civil inquiry initiated by the State of Alagoas Prosecutor’s Office (Ministério Público do Estado de Alagoas) into the extent of the urban damage caused by the geological event, seeking solutions for recovery and utilization of the area, and assessing liability for possible reparations for damages caused (“Urban Damage Civil Inquiry”). This public civil inquiry was terminated with the execution of the Agreement for Socio-Environmental Reparation.

On February 2, 2021, we were notified of the filing of a lawsuit by Companhia Brasileira de Trens Urbanos (CBTU), initially requesting only a preliminary injunction for maintaining the terms of the cooperation agreement previously signed by the parties. The request was denied in lower and appellate courts, given the fulfillment of the obligations undertaken by Braskem. On February 24, 2021, CBTU filed an amendment to the initial request claiming the payment of compensation for losses and damages in the amount of R$222 million and for moral damages in the amount of R$500 thousand, as well as the imposition of obligations, including the construction of a new rail line to replace the stretch that passed through the risk area. On December 31, 2022, the updated value of this lawsuit was R$1.43 billion. Braskem entered into a memorandum of understanding with CBTU to seek a consensual solution and suspend the lawsuit during the negotiation period and has made progress in the technical understanding about the topic. As a result of a joint petition filed by the parties, the lawsuit was suspended until June 2023.

On February 12, 2021, ANM granted our motion requesting that ANM reconsider its order directing the implementation of additional measures for the mine closure plan proposed by the Company. ANM’s decision maintained the implementation of the measures contemplated in the mine closure plan originally proposed by the Company. Lastly, considering that the mine closure plan is a dynamic process with complex execution, ANM will continue to oversee the results of the measures that are being taken by the Company for closing and monitoring the mine and, accordingly, further evaluations, requirements and provisions may be necessary in the future.

On November 9, 2021 we were notified of a Public-interest Civil Action filed by Federal Public Defenders’ Office (Defensoria Pública da União) against insurers linked to SFH, financial agents, the regulatory agency and Braskem, questioning the denial of necessary insurance for contracts under the SFH to acquire properties located within a radius of 1 km outside the risk area defined by the version 4 map of Civil Defense authorities, which is the subject matter of the Residents PCA agreement. The main claim is only against the insurers, financial agents and the regulatory agency on the grounds that the refusal to contract the insurance is abusive and has no technical or legal grounds. There is a secondary and eventual claim to sentence Braskem to pay indemnification in an amount to be settled in the future, if the judge understands that the refusal somehow has grounds due to in the subsidence phenomenon. It is not possible to estimate the indemnification amount, which will depend on the evidence of damages submitted by people whose insurance was denied.

Additionally, the Socio-Environmental Remediation Agreement provides for the potential adhesion by other parties, including the Municipality of Maceió. Also in the context of the understandings with authorities to address claims related to the event in Alagoas, on October 26, 2022, the 3rd Federal Court in Alagoas ratified the Term of Agreement for Implementation of Socioeconomic Measures for the Requalification of the Flexais Area (the “Flexais Agreement”), entered into by Braskem and the MPF, the MPE, the DPU, and the Municipality of Maceió for the adoption of actions for requalification in the Flexais region, payment of compensation to the Municipality of Maceió and of indemnities to the residents of this location.

We have been making progress with local authorities with respect to other indemnification requests, resulting in advances in the understanding between the parties that may result in an agreement. Although future disbursements may occur as a result of progress in the negotiations, as of the date of this annual report, we are unable to predict the results and timeframe for concluding these negotiations or their possible scope, and the total associated costs in addition to those already provisioned.

   
 192 

On October 7, 2022 we entered into an greement for the implementation of socioeconomic measures for the requalification of the Flexais region (“Flexais Agreement”) with the Federal Prosecutors’ Office (“MPF”), State Prosecutors’ Office (“MPE”), the Federal Public Defender’s Office (“DPU”) and the Municipality of Maceió for the adoption of actions for the requalification of the Flexais region, compensation to the Municipality of Maceió and payment of indemnification to the residents of this region. On October 26, 2022, the 3rd Federal Circuit in the State of Alagoas ratified the Flexais Agreement.

In March 2023, a public-interest civil action was filed by the State of Alagoas Public Defenders’ Office (“DPE”) against the Company, the Brazilian federal government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of certain terms and conditions of the Flexais Agreement and requesting the inclusion of residents of the Flexais region who so choose, with the consequent reallocation of these residents and payment of compensation to such residents for moral and material damages. The amount attributed to this lawsuit is R$1.7 billion. Braskem has already presented an answer.

In March 2023, the State of Alagoas filed against us a lawsuit requesting compensation for alleged damages caused to the State. In addition, as a preliminary injunction, the State of Alagoas requested the cautionary blocking of R$1.1 billion in our bank accounts as a guarantee to indemnify for material and non-material damages allegedly suffered by the State. On April 19, 2023, this injunction relief request was accepted by the court, which ordered a cautionary blocking of approximately R$1.1 billion in our bank accounts. Upon presentation of a performance bond by us, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court.

We cannot reliably predict the future developments of these matters or the expenses arising from them, including rates and costs in solving the disputes.

As of December 31, 2022, Braskem was a defendant in several individual claims, that, in aggregate, involved the amount of approximately R$1 billion, filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió.

For additional information, see “Item 8. Financial Information—Legal Proceedings—Alagoas—Mining Activities.” 

Dividends and Dividend Policy

Payment of Dividends

When we pay dividends on an annual basis, they are declared at our annual shareholders’ meeting, which we are required by the Brazilian Corporate Law and our by-laws to hold by April 30 of each year. When we declare dividends, we are generally required to pay them within 60 days of declaring them unless the shareholders’ reslution establishes another payment date. If we declare dividends, we must pay them by the end of the fiscal year for which they are declared. Any holder of record of shares at the time that a dividend is declared is entitled to receive dividends, unless another record date is approved. Our payment of annual dividends is based on our audited financial statements prepared for our preceding fiscal year. Pursuant to Brazilian Corporate Law, our by-laws and our dividend distribution policy, we have historically distributed annual dividends (except in years in which we have not had Adjusted Net Income or our management has informed the annual shareholders’ meeting that such payment is incompatible with our financial condition).

   
 193 

Our Finance and Investments Committee will review, prior to the review by our board of directors, any management proposal regarding the distribution of dividends or interest on capital stock.

Our board of directors may declare interim dividends based on the accrued profits recorded or the realized profits in our annual or interim financial statements. In addition, we may pay dividends approved by our board of directors from net income based on our unaudited interim financial statements. We may pay dividends based on quarterly interim financial statements, provided that the sum of the dividends paid in each semester does not exceed the amounts included in our capital reserve accounts. We may set off any payment of interim dividends against the amount of the mandatory distributable amount for the year in which the interim dividends were paid.

The following table sets forth the dividends and/or interest attributable to shareholders’ equity paid to holders of our common shares, class “A” preferred shares and “class B” preferred shares since January 1, 2020 in reais and in U.S. dollars translated from reais at the commercial market selling rate in effect as of their respective payment date.

   

Nominal Brazilian Currency per

US$ equivalent per

Year

Payment Date

Common
shares

Class A
Preferred
Shares

Class B
Preferred
Shares

Common
shares

Class A
Preferred
Shares

Class B
Preferred
Shares

2021 May 2, 2022 1.7 1.7 0.33 0.33
2021 December 20, 2021 7.54 7.54 0.61 1.32 1.32 0.11

Before any allocation of dividends is made, 5% of Adjusted Net Income is allocated in accordance with Brazilian Corporate Law and our by-laws to the legal reserve, subject to the limits established in Brazilian Corporate Law. Our shareholders will be entitled to receive as mandatory dividend 25% of the Adjusted Net Income for the fiscal year, in accordance with Article 202 of Brazilian Corporate Law, except in a year in which our management has informed the annual shareholders’ meeting that such payment is incompatible with our financial condition, in which case such retained amount shall be allocated to a special reserve and distributed as soon as our financial condition permits unless it is absorbed by subsequent losses.

Dividends are allocated to preferred shares as follows: (i) class A and class B preferred shares have the same priority in the distribution, in each fiscal year, of non-cumulative dividends corresponding to 6% of their unit value (as defined below); (ii) common shares are entitled to dividends only after payment of the priority dividend referred to in item (i) above; (iii) only common shares and class A preferred shares participate in the distribution of shares resulting from the incorporation of reserves into capital; and (iv) the “unit value” of shares is calculated by dividing the capital by the total outstanding shares (considering, for such effect, the total shares issued by the Company, including shares held in treasury).

The value of the priority dividend is calculated for the purposes of the mandatory dividend, but it is not limited by it, in accordance with Article 203 of Brazilian Corporate Law. Therefore, the priority dividend must be paid in full even if it is greater than the mandatory dividend, being limited only by the amount of net profit eligible for distribution.

After payment of the priority dividend, if there is any remaining dividend to be distributed (mandatory and/or complementary), the remaining amount of the dividend will be allocated successively as follows: (i) upon payment to the common shares of a dividend up to the limit of the priority dividend, i.e., upon payment to each common share of up to 6% of the unit value (as defined above) of the shares; and (ii) if there is still an amount remaining, upon payment to the common shares and class A preferred shares, under equal condition, so that each common share or class A preferred share receives the same dividend. Class B preferred shares do not participate in the distribution of remaining amounts after payment of the priority dividend.

   
 194 

The annual shareholders meeting is responsible for considering and voting on the allocation of the Company’s net profit for the year, determined annually based on the audited financial statements, which must be held within the four months following the end of the fiscal year, based on proposal of our management. The Company may, as decided by the board of directors, declare interim dividends, as described above, subject to certain conditions established in section 5.2 of our dividend policy, as referred to above, including the requirement that a proposal for complementary dividend distribution must take into account the impact of such distribution on the Net Debt/EBITDA ratio of the Company measured in U.S. dollars and that such ratio, after any distribution, may not be greater than 2.5 times in the year of the distribution and in the two subsequent years, based on long- term projections of the Company, considering the risks of theses projection being lower. Without prejudice to the aforementioned, the Net Debt/EBITDA ratio may remain temporarily above 2.5 times during a period in which the Company is making strategic investments that create value for shareholders and there is an expectation of generating future cash flow that contributes to this leverage ratio returning to a level not greater than 2.5 times. In this scenario, the management of the Company will not make a proposal for complementary distributions.

The Company also may, by decision of the board of directors, pay interest on capital payable to its shareholders, in accordance with Article 9, paragraph 7, of Brazilian Law No. 9,249/95 and the pertinent legislation.

Unless decided otherwise at the shareholders’ meeting, the interim dividends and interest on capital payable (the latter based on the amount net of withholding income tax) are calculated towards the priority dividend and the mandatory dividend.

Pursuant to the Brazilian Corporate Law, dividend entitlements lapse after three years from the date their payment was due.

Calculation of Adjusted Net Income

At each annual shareholders’ meeting, our board of directors is required to recommend how to allocate our net profits for the preceding fiscal year, which recommendation our board of executive officers initially submits to our board of directors for approval. This allocation is subject to approval by our common shareholders. The Brazilian Corporate Law defines “net profits” for any fiscal year as our net income for that fiscal year, net of any accumulated losses from prior fiscal years and any amounts allocated to employees’ participation in our net profits in that fiscal year. Under the Brazilian Corporate Law, our Adjusted Net Income available for distribution is equal to our net profits in any fiscal year, reduced by amounts allocated to our legal reserve and other applicable reserves, and increased by any reversals of reserves that we constituted in prior years.

Dividend Preference of Preferred Shares

Under our by-laws, our preferred shareholders are entitled to a Minimum Preferred Dividend, equal to 6% of the unit value (as defined above) of such shares, before dividends may be paid to our common shareholders. Distributions of dividends in any year are made:

·first, to the holders of preferred shares, up to the amount of the Minimum Preferred Dividend for such year;
·then, to the holders of common shares, until the amount distributed in respect of each common share is equal to the amount distributed in respect of each preferred share; and
·thereafter, to the holders of our common shares and our class A preferred shares on a pro rata basis.
   
 195 

Our class B preferred shareholders are not entitled to receive any additional dividend amounts after they have received the Minimum Preferred Dividend. If the Minimum Preferred Dividend is not paid for a period of three years, holders of preferred shares will be entitled to full voting rights until the Minimum Preferred Dividend is paid.

Mandatory Distributions

As permitted by the Brazilian Corporate Law, our by-laws specify that no less than 25% of our Adjusted Net Income for each fiscal year must be distributed to shareholders as dividends or interest attributable to shareholders’ equity. We refer to this amount as the mandatory distributable amount.

Under the Brazilian Corporate Law, the amount by which the mandatory distributable amount exceeds the “realized” portion of net income for any particular year may be allocated to the unrealized profit reserve, and the mandatory distribution may be limited to the “realized” portion of net income. The “realized” portion of net income is the amount by which our net income exceeds the sum of (1) our net positive results, if any, from the equity method of accounting for earnings and losses of our subsidiaries and certain associated companies, and (2) the profits, gains or income obtained on transactions maturing after the end of the following fiscal year. As amounts allocated to the unrealized profit reserve are realized in subsequent years, and if not absorbed by subsequent losses, such amounts must be added to the dividend payment relating to the year of realization.

The Brazilian Corporate Law permits us to suspend the mandatory distribution if our board of directors reports to our annual shareholders’ meeting that the distribution would be incompatible with our financial condition at that time, provided that this does not affect the payment of the Minimum Preferred Dividend. Our fiscal council must opine on any suspension of the mandatory distribution. In addition, our management must report the reasons of any suspension of the mandatory distribution to the CVM. We must allocate net profits not distributed by us as a result of a suspension to a special reserve and, if not absorbed by subsequent losses, we must distribute these amounts as soon as our financial condition permits. In case our profits reserves, as defined in the Brazilian Corporate Law, exceed our share capital, the excess must be credited to shareholders’ equity or used for the payment of distributions.

Interest Attributable to Shareholders’ Equity

Brazilian companies, including us, are permitted to pay interest attributable to shareholders’ equity as an alternative form of payment of dividends to their shareholders. These payments may be deducted when calculating Brazilian income tax and social contribution tax. The interest rate applied to these distributions generally cannot exceed the long-term interest rate (Taxa de Juros de Longo Prazo – TJLP) for the applicable period. The amount of interest paid that we can deduct for tax purposes cannot exceed the greater of:

·50% of our net income (after the deduction of the provision for social contribution tax and before the deduction of the provision for corporate income tax) before taking into account any such distribution for the period for which the payment is made; and
·50% of the sum of our retained earnings and profit reserves.

Any payment of interest attributable to shareholders’ equity to holders of common shares, preferred shares or ADSs, whether or not they are Brazilian residents, is subject to Brazilian withholding tax at the rate of 15%, except that a 25% withholding tax rate applies if the recipient is a resident of a tax haven jurisdiction. A tax haven jurisdiction is a country (i) that does not impose income tax or whose income tax rate is lower than 20% or (ii) which does not permit disclosure of the identity of shareholders of entities organized under its jurisdiction. Under our by-laws, we may include the amount distributed as interest attributable to shareholders’ equity, net of any withholding tax, as part of the mandatory distributable amount.

   
 196 

Public Tender Offer upon Sale of Control

Pursuant to our by-laws, all of our shares are entitled to tag along rights equivalent to 100% of the price paid in the event of a change of control, subject to certain exceptions set forth in article 12 of our by-laws. Notwithstanding the provisions of our by-laws, pursuant to the Brazilian Corporate Law, our common shares are entitled to tag along rights equivalent to at least 80% of the price paid for such common shares in the event of a change of control.

Significant Changes

Other than as disclosed in this annual report, no significant change has occurred since the date of the audited consolidated financial statements included in this annual report.

  Item 9. The Offer and Listing

Markets for Our Equity Securities

The principal trading market for our common shares, class A preferred shares and class B preferred shares is the B3, where they are traded under the symbols “BRKM3,” “BRKM5” and “BRKM6,” respectively. Our common shares and class A preferred shares began trading on the B3 (formerly the BM&FBOVESPA) on November 11, 1980, and our class B preferred shares began trading on the B3 on August 19, 1983.

On December 21, 1998, ADSs representing our class A preferred shares began trading on the NYSE. Our ADSs are traded under the symbol “BAK.” As of December 31, 2022, there were 21,434,660 ADSs outstanding, representing 42,869,320 class A preferred shares, or 12.4% of our outstanding class A preferred shares. Each ADS represents two class A preferred shares.

On October 8, 2003, we listed our class A preferred shares on the LATIBEX, a stock market for Latin American issuers that is quoted in Euros on the Madrid Stock Exchange, under the symbol “XBRK.” Our class A preferred shares are traded on the LATIBEX in lots of one share.

Regulation of Brazilian Securities Markets

The Brazilian securities markets are regulated by the CVM, which has regulatory authority over the stock exchanges and the securities markets generally, the National Monetary Council and the Central Bank, which has, among other powers, licensing authority over brokerage firms and which regulates foreign investment and foreign exchange transactions. The Brazilian securities markets are governed by (1) Law No. 6,385, as amended and supplemented, which is the principal law governing the Brazilian securities markets and which we refer to as the Brazilian Securities Law; (2) the Brazilian Corporate Law; and (3) the regulations issued by the CVM, the National Monetary Council and the Central Bank.

Trading on the B3

Overview of the B3

In 2000, the Bolsa de Valores de São Paulo S.A. – BVSP (the São Paulo Stock Exchange), or BOVESPA was reorganized through the execution of memoranda of understanding by the Brazilian stock exchanges. Following this reorganization, the BOVESPA was a non-profit entity owned by its member brokerage firms and trading on the BOVESPA was limited to these members brokerage firms and a limited number of authorized nonmembers. Under the memoranda, all securities are now traded only on the BOVESPA, except for electronically traded public debt securities and privatization auctions, which are traded on the Rio de Janeiro Stock Exchange.

   
 197 

In August 2007, the BOVESPA underwent a corporate restructuring that resulted in the creation of BOVESPA Holding S.A., a public corporation, whose wholly owned subsidiaries were (1) the BOVESPA, which is responsible for the operations of the stock exchange and the organized over-the-counter markets, and (2) the Brazilian Settlement and Custodial Company (Companhia Brasileira de Liquidação e Custódia), or CBLC, which is responsible for settlement, clearing and depositary services. In the corporate restructuring, all holders of membership certificates of the BOVESPA and of shares of CBLC became shareholders of BOVESPA Holding S.A. As a result of the corporate restructuring, access to the trading and other services rendered by the BOVESPA is not conditioned on stock ownership in BOVESPA Holding S.A. In May 2008, the BOVESPA merged with the Commodities and Futures Exchange (Bolsa de Mercadorias & Futuros) to form the BM&FBOVESPA. In November 2008, the CBLC merged with the BM&FBOVESPA. As a result, the BM&FBOVESPA performed its own settlement, clearing and depositary services.

On March 30, 2017, the BM&FBOVESPA merged with CETIP, a provider of financial services for the organized over-the-counter market, to form the B3 – Brasil Bolsa Balcão S.A., or B3.

Regulation of Foreign Investments

Trading on the B3 by a holder not deemed to be domiciled in Brazil for Brazilian tax and regulatory purposes (a “non-Brazilian holder”) is subject to certain limitations under Brazilian foreign investment regulations. With limited exceptions, non-Brazilian holders may trade on the B3 only in accordance with the requirements of Resolution No. 4,373 of the Brazilian National Monetary Council. Resolution No. 4,373 requires that securities held by non-Brazilian holders be maintained in the custody of, or in deposit accounts with, financial institutions that are authorized by the Brazilian Central Bank and the CVM. In addition, Resolution No. 4,373 requires non-Brazilian holders to restrict their securities trading to transactions on the B3 or qualified over-the-counter markets. With limited exceptions, non-Brazilian holders may not transfer the ownership of investments made under Resolution No. 4,373 to other non-Brazilian holders through private transactions.

  Item 10. Additional Information

Description of Our By-laws

The following is a summary of the material provisions of our by-laws and of the Brazilian Corporate Law. In Brazil, a company’s by-laws (estatuto social) is the principal governing document of a corporation (sociedade por ações).

Corporate Purposes

Article 2 of our by-laws establishes our corporate purposes to include:

·the manufacture, trading, import and export of chemical and petrochemical products and petrochemical derivatives;
·the production, distribution and trading of utilities such as: steam, water, compressed air, industrial gases, as well as the provision of industrial services;
·the production, distribution and trading of electricity for its own consumption and that of other companies;
·holdings of equity stakes in other companies, pursuant to the Brazilian Law No. 6,404/1976 (the “Brazilian Corporate Law”), as a holder of quotas or shares;
   
 198 
·the manufacture, distribution, trading, import and export of gasoline, diesel oil, liquefied petroleum gas, and other oil derivatives.
·the transportation, representation and consignment of petrochemical products and by-products, compounds and derivatives, such as polypropylene, polypropylene films, polyethylene, elastomers and their respective manufactured products;
·the free lease or loan of assets that are owned or possessed thereby because of a commercial leasing agreement, provided that this is carried out as an ancillary activity to the main corporate purpose of our Company; and
·the provision of services related to the activities above.

Board of Directors

Under the Brazilian Corporate Law, any matters subject to the approval of our board of directors can be approved by a simple majority of votes of the members present at a duly convened meeting, unless our by-laws otherwise specify. Under our by-laws, our board of directors may only deliberate if a majority of its members are present at a duly convened meeting. Any resolutions of our board of directors may be approved by the affirmative vote of a majority of the members present at the meeting; provided, however, that certain matters may only be approved by mutual agreement between the parties under the Braskem S.A. Shareholders’ Agreement. See “Item 7. Major Shareholders and Related Party Transactions—Major Shareholders—Shareholders Agreements—Braskem S.A. Shareholders’ Agreement.” The majority of the members of our board of directors are elected by Novonor. However, at least 20% of the members of our board of directors must be independent directors. In addition, any director appointed by a shareholder pursuant to a shareholder’s agreement is bound by the terms of such agreement. See “Item 7. Major Shareholders and Related Party Transactions—Major Shareholders—Shareholders Agreements.” The members of our board of directors are elected at general meetings of shareholders for concurrent two-year terms. Our by-laws do not require the members of our board of directors to be a resident in Brazil or become our shareholders. Under our by-laws, the shareholders of our common shares approve the aggregate compensation payable to our directors, executive officers, and members of our fiscal council. Subject to this approval, our board of directors establishes the compensation of its members and of our executive officers. See “Item 6. Directors, Senior Management and Employees—Compensation.” Neither the Brazilian Corporate Law nor our by-laws establish any mandatory retirement age for our directors or executive officers.

Compliance

Our by-laws provide for a Compliance and Audit Committee comprised of: (i) three (3) independent members of our board of directors under the terms of the Company’s own policy; and (ii) two (2) members that are not also members of the board of directors, and who must be independent members, under the terms of CVM Resolution No. 23/21, or any other regulation that may replace it, and will be chosen by the board of directors among those nominees indicated on a list to be submitted by the Chairman of the board of directors, prepared by a specialized company with recognized experience. Shareholders are not allowed to nominate members. In addition, our compliance department, led by our Chief Compliance Officer, has a full-line report directly to the Compliance and Audit Committee and a dotted-line report to the CEO of our Company. See “Item 6—Directors, Senior Management and Employees—Directors and Senior Management—Board Committees—Compliance Committee.”

Share Capital

Under the Brazilian Corporate Law and under our by-laws, the number of issued and outstanding non-voting shares or shares with limited voting rights, such as our class A preferred shares and class B preferred shares, may not exceed two thirds of total share capital. Each of our common shares entitles its holder to one vote at our shareholders’ meetings. Holders of our common shares are not entitled to any preference in respect of our dividends or other distributions or otherwise in case of our liquidation. Our class A preferred shares and class B preferred shares are non-voting, except in limited circumstances, and have priority over our common shares in the case of our liquidation. See “—Voting rights for information regarding the voting rights of our preferred shares, “—Liquidation” for information regarding the liquidation preferences of our preferred shares, and “Item 8. Financial Information—Dividends and Dividend Policy—Calculation of Adjusted Net Income” and “Item 8. Financial Information—Dividends and Dividend Policy—Dividend Preference of Preferred Shares” for information regarding the distribution preferences of our preferred shares.

   
 199 

Shareholders’ Meetings

Under the Brazilian Corporate Law and our by-laws, we must hold an annual shareholders’ meeting by April 30 of each year in order to:

·approve or reject the management financial plan (prestação de contas) and financial statements approved by our board of directors and prepared by the board of executive officers;
·approve or reject the allocation of net profits and distribution of dividends;
·elect members of our board of directors (upon expiration of their two-year term) and members of our fiscal council, subject to the right of minority shareholders to elect members of our board of directors and our fiscal council; and
·approve or reject the annual aggregate compensation of our executive officers and directors, as well as the compensation of the members of the Company’s fiscal council.

In addition to the annual shareholders’ meetings, holders of our common shares have the power to determine any matters related to changes in our corporate purposes and to pass any resolutions they deem necessary to protect and enhance our development whenever our interests so require, by means of extraordinary shareholders’ meetings.

Under the Brazilian Corporate Law, the holders of our common shares have the power, among other powers, to vote at shareholders’ meetings to:

·amend our by-laws;
·approve any capital increase in excess of the amount of our authorized capital;
·approve any capital reduction;
·accept or reject the valuation of assets contributed by any of our shareholders in exchange for the issuance of our share capital;
·suspend the rights of any of our shareholders in default of their obligations established by law or by our by-laws;
·authorize the issuance of convertible debentures, in excess of the amount of our authorized capital;
·approve any reorganization of our legal form or any merger, consolidation or spin-off involving us;
   
 200 
·authorize our dissolution and liquidation, the election and dismissal of liquidators appointed in connection with any dissolution or liquidation of our Company, and the examination of the liquidators’ accounts;
·participate in a centralized group of companies (as defined under the Brazilian Corporate Law);
·approve the aggregate compensation payable to our directors and executive officers;
·authorize management to declare us insolvent or bankrupt and to request judicial reorganization (recuperação judicial) (a procedure involving our protection from our creditors similar in many respects to a reorganization under the U.S. bankruptcy code);
·elect and substitute members of our board of directors and fiscal council;
·modify the number of members on our board of directors;
·alter our dividend policy; and
·authorize the delisting of our shares.

We convene our shareholders’ meetings, including our annual shareholders’ meeting, by publishing a notice in a newspaper designated by our shareholders with general circulation in Bahia, where we maintain our registered office. Recently enacted rules have made publication requirements more flexible and less onerous. As a general rule, on the first call of any meeting, the notice must be published no fewer than three times, beginning at least 21 calendar days prior to the scheduled meeting date. Due to certain remote voting requirements, we convene our annual shareholders’ meetings at least 30 days prior to the scheduled meeting date. The notice must contain the meeting’s place, date, time, agenda and, in the case of a proposed amendment to our by-laws, a description of the subject matter of the proposed amendment.

In order for a valid action to be taken at a shareholders’ meeting, shareholders representing at least 25% of our issued and outstanding voting share capital must be present on first call. However, shareholders representing at least two-thirds of our issued and outstanding voting share capital must be present at a shareholders’ meeting called to amend our by-laws. If a quorum is not present, our board of directors may issue a second call by publishing a notice as described above at least eight calendar days prior to the scheduled meeting. The quorum requirements do not apply to a meeting held on the second call, and the shareholders’ meetings may be convened with the presence of shareholders representing any number of shares (subject to the voting requirements for certain matters described below). A shareholder without a right to vote may attend a shareholders’ meeting and take part in the discussion of matters submitted for consideration.

Voting Rights

Under the Brazilian Corporate Law and our by-laws, each of our common shares entitles its holder to one vote at our shareholders’ meetings. Our preferred shares generally do not confer voting rights, except under certain limited circumstances. Whenever the shares of any class of share capital are entitled to vote, each share is entitled to one vote.

Holders of our preferred shares are not entitled to vote on any matter, except (i) with respect to the election of one member of our board of directors by (1) preferred shareholders holding at least 10% of our total share capital, or, (2) if no group of common or preferred shareholders meets the thresholds described above, shareholders holding at least 10% of our total share capital, and (ii) in the limited circumstances described above and as provided below. Preferred shareholders are also entitled to appoint one member of the fiscal council and the respective alternate.

   
 201 

The Brazilian Corporate Law and our by-laws provide that our preferred shares will acquire unrestricted voting rights after the third consecutive fiscal year that we fail to pay the minimum dividends to which our preferred shares are entitled. This voting right will continue until the Minimum Preferred Dividend is paid in full. Our preferred shareholders will also obtain unrestricted voting rights if we enter into a liquidation process.

Liquidation

We may be liquidated in accordance with the provisions of Brazilian law. In the event of our extrajudicial liquidation, a shareholders’ meeting will determine the manner of our liquidation, appoint our liquidator and our fiscal council that will function during the liquidation period.

Upon our liquidation, our preferred shares have a liquidation preference over our common shares in respect of the distribution of our net assets. In the event of our liquidation, the assets available for distribution to our shareholders would be distributed first to our preferred shareholders in an amount equal to their pro rata share of our legal capital, prior to making any distributions to our common shareholders. If the assets to be so distributed are insufficient to fully compensate our preferred shareholders for their legal capital, each of our preferred shareholders would receive a pro rata amount (based on their pro rata share of our legal capital, excluding our common shares in such calculation) of any assets available for distribution.

Preemptive Rights

Under the Brazilian Corporate Law, each of our common and class A preferred shareholders has a general preemptive right to subscribe for our shares or securities convertible into our shares in any capital increase, in proportion to the number of our shares held by such shareholder. In accordance with the applicable legislation and our by-laws, the holders of class B preferred shares (which are special shares paid up with resources provided for in certain tax incentive legislation) do not have preemptive rights in case of capital increases resulting from capitalization of profits or reserves (bonus shares). In the event of a capital increase that would maintain or increase the proportion of our capital represented by our class A preferred shares, holders of our class A preferred shares would have preemptive rights to subscribe to newly issued class A preferred shares only. In the event of a capital increase that would reduce the proportion of our capital represented by our class A preferred shares, holders of such preferred shares would have preemptive rights to subscribe to any new class A preferred shares in proportion to the number of our shares that they hold, and to our common shares only to the extent necessary to prevent dilution of their interests in our total capital.

Under our by-laws, except when issuing voting shares or securities convertible into voting shares, our board of directors or our shareholders, as the case may be, may decide to reduce the term of preemptive rights or not to extend preemptive rights to our shareholders with respect to any issuance of our non-voting shares, debentures convertible into our shares or warrants made in connection with a public exchange made to acquire control of another company or in connection with a public offering or through a stock exchange. The preemptive rights are transferable and must be exercised within a period of at least 30 days following the publication of notice of the issuance of shares or securities convertible into our shares. Holders of ADSs may not be able to exercise the preemptive rights relating to our class A preferred shares underlying their ADSs unless a registration statement under the Securities Act, is effective with respect to those rights and the securities to which the rights relate or an exemption from the registration requirements of the Securities Act is available. We are not obligated to file a registration statement with respect to the shares relating to these preemptive rights or to take any other action to make preemptive rights available to holders of the ADSs, and we may not file any such registration statement.

Redemption, Amortization and Tender Offers

Our by-laws or our shareholders at a shareholders’ meeting may authorize us to use our profits or reserves to redeem or amortize our shares in accordance with conditions and procedures established for such redemption or amortization. The Brazilian Corporate Law defines “redemption” (resgate de ações) as the payment of the value of the shares in order to permanently remove such shares from circulation, with or without a corresponding reduction of our share capital. The Brazilian Corporate Law defines “amortization” (amortização) as the distribution to shareholders, without a corresponding capital reduction, of amounts that they would otherwise receive if we were liquidated. If an amortization distribution has been paid prior to our liquidation, then upon our liquidation, the shareholders who did not receive an amortization distribution will have a preference equal to the amount of the amortization distribution in the distribution of our capital.

   
 202 

The Brazilian Corporate Law authorizes us, by means of a decision made at our shareholders’ meeting, to redeem shares not held by our controlling shareholder, if, after a tender offer effected as a consequence of delisting, our controlling shareholder increases its participation in our total share capital to more than 95%. The redemption price in such case would be the same price paid for our shares in any such tender offer.

Rights of Withdrawal

The Brazilian Corporate Law provides that, in certain limited circumstances, a dissenting shareholder may withdraw its equity interest from our Company and be reimbursed by us for the book value of our common or preferred shares that it then holds.

This right of withdrawal may be exercised by the holders of the adversely affected common or preferred shares if we decide:

·to create a new class of our preferred shares with greater privileges than the existing classes of our preferred shares;
·to increase an existing class of our preferred shares relative to the other classes of our preferred shares (unless such actions are provided for or authorized by our by-laws); or
·to modify a preference, privilege or condition of redemption or amortization conferred on one or more classes of our preferred shares.

In addition, holders of our common and preferred shares may exercise their right of withdrawal if we decide to undertake any of the following actions:

·to merge with another company or to consolidate with another company in a transaction in which our Company is not the surviving entity;
·to transfer all of our shares to another company or to acquire all of the shares of another company in exchange for their or our shares (“incorporação de ações”);
·to participate in a centralized group of companies as defined under the Brazilian Corporate Law;
·to reduce the mandatory distribution of dividends;
·to change our corporate purposes; or
·to spin-off a portion of our Company.

Only shareholders who own shares on the date of publication of the first notice convening the relevant shareholders’ meeting or the press release concerning the relevant shareholders’ meeting is published, whichever is earlier, will be entitled to withdrawal rights.

   
 203 

Shareholders will not be entitled to this right of withdrawal if the shares of the entity resulting from a merger, incorporation, consolidation of our Company or participation of our Company in a group of companies have a minimum level of market liquidity and are dispersed among a sufficient number of shareholders. For this purpose, shares that are part of general indices representative of portfolios of securities traded in Brazil or abroad are considered liquid, and sufficient dispersion will exist if the controlling shareholder holds less than half of the class and type of the outstanding shares. In case of a spin-off, the right of withdrawal will only exist if there is a significant change in the corporate purpose or a reduction in the mandatory dividend.

The redemption of shares arising out of the exercise of any withdrawal rights would be made at book value per share, determined on the basis of their most recent audited balance sheet approved by our dissenting shareholders. However, if the shareholders’ meeting approving the action that gave rise to withdrawal rights occurred more than 60 days after the date of the most recent approved audited balance sheet, a shareholder may demand that its shares be valued on the basis of a balance sheet prepared specifically for this purpose. The right of withdrawal lapses 30 days after the date of publication of the minutes of the shareholders’ meeting that approved one of the matters described above. Our shareholders may reconsider any resolution giving rise to withdrawal rights within 10 days following the expiration date for such rights if we believe that the withdrawal of shares of dissenting shareholders would jeopardize our financial stability.

Disclosures of Share Ownership

Brazilian regulations require that (i) our controlling shareholder, directly or indirectly, (ii) shareholders who have elected members of our board of directors or fiscal council, and (iii) any person or group of persons representing a person that has directly or indirectly acquired or sold an interest that exceeds upwards or downwards, the threshold of 5%, 10%, 15%, and so on, of any class or type of shares of our capital stock to disclose its or their share ownership or divestment to the CVM and to the São Paulo Stock Exchange (Brasil, Bolsa, Balcão – B3).

Form and Transfer

Our preferred shares and common shares are held in book-entry form, registered in the name of each shareholder or its nominee. The transfer of our shares is governed by Article 35 of the Brazilian Corporate Law, which provides that a transfer of shares is effected by our transfer agent, Banco Itaú S.A., by an entry made by the transfer agent in its books, upon presentation of valid written share transfer instructions to us by a transferor or its representative. When preferred shares or common shares are acquired or sold on a Brazilian stock exchange, the transfer is effected on the records of our transfer agent by a representative of a brokerage firm or the stock exchange’s clearing system. The transfer agent also performs all the services of safe-keeping of our shares. Transfers of our shares by a non-Brazilian investor are made in the same manner and are executed on the investor’s behalf by the investor’s local agent. If the original investment was registered with the Brazilian Central Bank pursuant to foreign investment regulations, the non-Brazilian investor is also required to amend, if necessary, through its local agent, the electronic certificate of registration to reflect the new ownership.

The B3 operates a central clearing system. A holder of our shares may choose, at its discretion, to participate in this system, and all shares that such shareholder elects to be put into the clearing system are deposited in custody with the clearing and settlement chamber of the B3 (through a Brazilian institution that is duly authorized to operate by the Brazilian Central Bank and maintains a clearing account with the clearing and settlement chamber of the B3). Shares subject to the custody of the clearing and settlement chamber of the B3 are noted as such in our registry of shareholders. Each participating shareholder will, in turn, be registered in the register of the clearing and settlement chamber of the B3 and will be treated in the same manner as shareholders registered in our books.

   
 204 

Material Contracts

We have not entered into any material contracts, other than those described elsewhere in this annual report or entered into in the ordinary course of business. For additional information about material agreements that we have recently entered into, please see “Item 5. Operating and Financial Review and Prospects—Recent Developments” and “—Liquidity and Capital Resources” and “Item 7. Major Shareholders and Related Party Transactions—Related Party Transactions.”

Exchange Controls

There are no restrictions on ownership or voting of our capital stock by individuals or legal entities domiciled outside Brazil. However, the right to convert dividend payments, interest on shareholders’ equity payments and proceeds from the sale of our share capital into foreign currency and to remit such amounts outside Brazil is subject to exchange control procedures under foreign investment legislation and foreign exchange regulations, which generally require, among other things, the registration of the relevant investment with the Brazilian Central Bank and/or the CVM, as the case may be.

Investments in our class A preferred shares by (i) a holder not deemed to be domiciled in Brazil for Brazilian tax purposes, (ii) a non-Brazilian holder who is registered with the CVM under Annex I of Resolution No. 4,373 or (iii) the Depositary (as defined herein), are eligible for registration with the Brazilian Central Bank. This registration (the amount so registered is referred to as registered capital) allows the remittance outside Brazil of foreign currency, converted at the commercial market rate, acquired with the proceeds of distributions on, and amounts realized through, dispositions of our class A preferred shares.

Depositary Receipts (Annex II of Resolution No. 4,373)

Annex II of Resolution No. 4,373 of the National Monetary Council, as amended, provides for the issuance of depositary receipts in foreign markets in respect of shares of Brazilian issuers. The ADS program was approved by the Central Bank and the CVM prior to the issuance of the ADSs. Accordingly, as a general rule, the proceeds from the sale of ADSs by non-Brazilian resident holders of ADSs outside Brazil are not subject to Brazilian foreign investment controls, and holders of the ADSs who are not domiciled in a favorable tax haven jurisdiction are entitled to favorable tax treatment. See “—Taxation—Brazilian Tax Considerations.”

We pay dividends and other cash distributions with respect to our class A preferred shares in reais. We have obtained an electronic certificate of foreign capital registration from the Central Bank in the name of the depositary with respect to our ADSs to be maintained by the custodian. Pursuant to this registration, the custodian is able to convert dividends and other distributions with respect to our class A preferred shares represented by ADRs into foreign currency and remit the proceeds outside Brazil to the depositary so that the depositary may distribute these proceeds to the holders of record of the ADSs.

Foreign Direct Investment and Portfolio Investment

Investors (individuals, legal entities, mutual funds, and other collective investment entities) domiciled, residing or headquartered outside Brazil may register their investments in our capital stock as foreign portfolio investments under Annex I of Resolution No. 4,373 (described below) or as foreign direct investments under Law No. 4,131 (described below). Registration under Annex I of Resolution No. 4,373 or Law No. 4,131 generally enables the conversion of dividends, other distributions and sales proceeds received in connection with registered investments into foreign currency and the remittance of such amounts outside Brazil.

Registration under Annex I of Resolution No. 4,373 affords favorable tax treatment to non-Brazilian portfolio investors who are not resident in favorable tax jurisdictions (países com tributação favorecida) pursuant to articles 24, 24-A and 24-B of Law no. 9,430/96. See “—Taxation—Brazilian Tax Considerations.”

   
 205 

Annex I of Resolution No. 4,373

All investments made by a non-Brazilian investor under Annex I of Resolution No. 4,373 are subject to electronic registration with the Brazilian Central Bank. Such registration permits the conversion of dividend payments, payments of interest on shareholders’ equity and proceeds from the sale of our capital stock into foreign currency and the remission of such amounts outside Brazil.

Under Annex I of Resolution No. 4,373, non-Brazilian investors registered with the CVM may invest in almost all financial assets and engage in almost all transactions available to Brazilian investors in the Brazilian financial and capital markets without obtaining a separate Central Bank registration for each transaction, provided that certain requirements are fulfilled. Under Annex I of Resolution No. 4,373, the definition of a non-Brazilian investor includes individuals, legal entities, mutual funds and other collective investment entities, domiciled or headquartered outside Brazil.

Pursuant to Annex I of Resolution No. 4,373, non-Brazilian investors must:

·appoint at least one representative in Brazil with powers to take action relating to its investments, which must be a financial institution duly authorized by the Central Bank;
·appoint an authorized custodian in Brazil for its investments, which must be a financial institution duly authorized by the CVM;
·complete the appropriate foreign investor registration forms;
·which must be a financial institution duly authorized by the Central Bank;
·through its representative, register as a non-Brazilian investor with the CVM;
·through its representative, register its investments with the Central Bank; and
·obtain a taxpayer identification number from the Brazilian federal tax authorities.

The securities and other financial assets held by a non-Brazilian investor pursuant to Annex I of Resolution No. 4,373 must be registered or maintained in deposit accounts or under the custody of an entity duly licensed by the Central Bank or the CVM, as applicable, or be registered on registration, clearing and custody systems authorized by the Central Bank or by the CVM, as applicable. Subject to limited exceptions provided in the CVM regulation or previous CVM authorization, the trading of securities held under Annex I of Resolution No. 4,373 is restricted to transactions carried out on stock exchanges or through organized over-the-counter markets licensed by the CVM.

The offshore transfer or assignment of the securities or other financial assets held by non-Brazilian investors pursuant to Annex I of Resolution No. 4,373 are prohibited, except for transfers (1) resulting from consolidation, spin-off, merger or merger of shares or occurring upon the death of an investor by operation of law or will; (2) resulting from a corporate reorganization effected abroad, as long as the final beneficiaries and the amount of the assets remain the same, or (3) authorized by the CVM.

Law No. 4,131

Foreign direct investors under Law No. 4,131 may sell their shares in both private and open market transactions, but these investors will generally be subject to less favorable tax treatment on gains with respect to our class A preferred shares. See “—Taxation—Brazilian Tax Considerations.

To obtain a certificate of foreign capital registration from the Brazilian Central Bank under Law No. 4,131, a foreign direct investor must:

   
 206 
·register as a foreign direct investor with the Central Bank;
·obtain a taxpayer identification number from the Brazilian tax authorities;
·appoint a tax representative in Brazil; and
·appoint a representative in Brazil for service of process in respect of suits based on the Brazilian Corporate Law.

Foreign investors must be registered with the Federal Brazilian Revenue Service pursuant to Normative Instruction 1,683, dated as of December 27, 2016. This registration process is undertaken by the investor’s legal representative in Brazil. Investors that are foreign legal entities are required to report their final individual beneficiaries. Some exceptions apply (e.g., publicly listed corporations).

Taxation

The following summary contains a description of certain U.S. federal income and Brazilian tax consequences of the acquisition, ownership and disposition of Class A preferred shares and ADSs, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase Class A preferred shares or ADSs. This summary is not applicable to all categories of investors, some of which may be subject to special rules, and does not address all of the U.S. federal income and Brazilian tax considerations applicable to any particular holder. The summary is based upon the tax laws of the United States and Brazil and regulations thereunder, all as of the date hereof, and all of which are subject to change.

Prospective purchasers of Class A preferred shares and ADSs should consult their own tax advisors about the particular U.S. federal income and Brazilian tax consequences to them of the acquisition, ownership and disposition of Class A preferred shares and ADSs, as well as any state, local and other tax consequences that may apply to them.

Brazilian Tax Considerations

The following topics summarizes the material Brazilian tax consequences of the acquisition, ownership and disposition of class A preferred shares or ADSs by an individual, entity, trust or organization that is not domiciled or resident in Brazil for purposes of Brazilian taxation and, in the case of a holder of class A preferred shares, which has registered its investment with the Central Bank, or a non-resident holder. The following information is based on the tax laws of Brazil as in effect on the date of this annual report, which are subject to change, with possible retroactive effect, and to differing interpretation. Furthermore, the following discussion does not specifically address all of the Brazilian tax considerations applicable to any particular non-resident holder, and each non-resident holder should consult his or her own tax advisor concerning the Brazilian tax consequences of an investment in any of such securities.

Pursuant to Brazilian law, a non-resident holder may invest in class A preferred under Resolution No. 4,373, of September 2014, of the National Monetary Council (a “4,373 Holder”).

Acquisition of ADSs or Class A Preferred Shares

The acquisition of ADSs or class A preferred shares by non-resident holders is not a taxable event in Brazil. See “—Taxation of Gains with Respect to Class A Preferred Shares” for further information on the tax implications arising from the exchange of existing class A preferred shares for ADSs, as well as those arising from the exchange of ADSs for class A preferred shares.

   
 207 

Taxation of Dividends

Dividends paid by a Brazilian corporation with respect to profits generated as of January 1, 1996, including dividends paid in kind to the depositary in respect of our class A preferred shares underlying the ADSs or to a non-resident holder in respect of class A preferred shares, are not subject to withholding income tax in Brazil.

Dividends paid from profits generated before January 1, 1996 may be subject to Brazilian withholding income tax at variable rates, according to the tax legislation applicable to each corresponding year.

In this context, it should be noted that Law No. 11,638, dated December 28, 2007, significantly altered the Brazilian corporate law in order to align the generally accepted Brazilian accounting standards to the International Financial Reporting Standards (“IFRS”). Nonetheless, Law No. 11,941, dated May 27, 2009, introduced the Transitory Tax Regime (“RTT”) in order to render neutral, from a tax perspective, all of the changes provided by Law No. 11,638. Under the RTT, for tax purposes, legal entities should observe the accounting methods and criteria as in force on December 31, 2007.

Profits determined pursuant to Law No. 11,638 (“IFRS Profits”) may differ from the profits calculated pursuant to the accounting methods and criteria as in force on December 31, 2007 (“2007 Profits”).

While it was a general market practice to distribute exempted dividends with reference to the IFRS Profits, Normative Ruling No. 1,397, issued by the Brazilian tax authorities on September 16, 2013, has established that legal entities should observe the 2007 Profits, in order to determine the amount of profits that could be distributed as exempted income to their beneficiaries.

Any profits paid in excess of said 2007 Profits (“Excess Dividends”) should, in the tax authorities’ view and in the specific case of non-resident beneficiaries, be subject to the following rules of taxation: (i) 15% withholding tax, in case of case of beneficiaries domiciled abroad, but not in a Low or Nil Tax Jurisdiction (as defined below), and (ii) 25% withholding tax, in case of beneficiaries domiciled in a Low or Nil Tax Jurisdiction (as defined below).

In order to mitigate potential disputes on the subject, Law No. 12,973, dated May 13, 2014, in addition to revoking the RTT, introduced a new set of tax rules, or the New Tax Regime, including new provisions with respect to Excess Dividends. Under these new provisions: (i) Excess Dividends related to profits assessed from 2008 to 2013 will be exempt; (ii) potential disputes remain concerning the Excess Dividends related to 2014 profits, unless a company voluntarily elected to apply the New Tax Regime in 2014; and (iii) as of 2015, once the New Tax Regime became mandatory and completely replaced the RTT, dividends calculated based on IFRS standards should be considered fully exempt.

There are proposed bills currently under discussion by the Brazilian federal government regarding a potential amendment to the tax legislation aiming at taxing dividends. Therefore, the mentioned dividend exemption may be revoked with prospective effects.

Interest on Shareholders’ Equity

Law No. 9,249/95, as amended, allows a Brazilian corporation to make distributions to shareholders characterized as distributions of interest on shareholders’ equity on top of or as an alternative to dividend distributions. Such interest is calculated by multiplying the long-term interest rate (TJLP), as determined by the Brazilian Central Bank from time to time, by the sum of determined Brazilian company’s net equity accounts.

Distributions of interest on shareholders’ equity in respect of our class A preferred shares or the ADSs are generally subject to Brazilian withholding tax at the rate of 15%. However, the rate of 25% is applicable if the non-resident holder is domiciled in a Low or Nil Tax Jurisdiction (as defined below).

   
 208 

Interest on shareholders’ equity is deductible for purposes of calculating the Brazilian social contribution on net profit (CSLL) and the corporate income tax, provided that such distribution is approved by our shareholders in a general meeting and complies with the limits established by Brazilian tax legislation. The amount of such deduction cannot exceed the greater of:

·50% of net profits (after social contribution on net profits and before taking into account such distribution and any deduction for corporate income tax) related to the period in respect of which the payment is made; or
·50% of the sum of retained profits and profit reserves as of the date of the beginning of the period in respect of which the payment is made.

Payments of interest on shareholders’ equity may be included, at their net value, as part of any mandatory dividend. To the extent payment of interest on shareholders’ equity is so included, the corporation is required to distribute to shareholders an additional amount to ensure that the net amount received by them, after payment of the applicable withholding income tax plus the amount of declared dividends, is at least equal to the mandatory dividend.

No assurance can be given that our board of directors will not recommend that future distributions of income should be made by means of interest on shareholders’ equity instead of dividends.

Distributions of interest on shareholders’ equity to a non-resident holder may be converted into U.S. dollars and remitted outside Brazil, subject to applicable exchange controls, to the extent that the investment is registered with the Central Bank.

Taxation of Gains with Respect to ADSs

According to Brazilian Law No. 10,833/03, gains realized on the disposition or sale of assets located in Brazil are subject to income tax in Brazil, regardless of whether the sale or the disposition is made by the non-resident holder to a Brazilian resident or to another non-resident of Brazil.

Holders of the ADSs outside of Brazil may have grounds to assert that Brazilian Law No. 10,833/03 does not apply to sales or other dispositions of ADSs as ADSs are not assets located in Brazil (i.e., ADSs are issued and registered abroad). However, considering that ADSs derive their value from underlying shares in Brazil and the lack of case law on the matter, we are unable to predict whether such understanding will ultimately prevail in Brazilian courts.

As a result, in case the ADSs are deemed to be assets located in Brazil, gains recognized by a non-resident holder from their sale or other disposition to either a non-resident of Brazil or a resident of Brazil may be subject to income tax in Brazil at progressive rates as follows: (1) 15% for the portion of the gain that does not exceed R$5 million, (2) 17.5% for the portion of the gain that exceeds R$5 million but does not exceed R$10 million, (3) 20% for the portion of the gain that exceeds R$10 million but does not exceed R$30 million, and (4) 22.5% for the portion of the gain that exceeds R$30 million, or at a flat tax rate of 25% if such non-resident holder is located in a Low or Nil Tax Jurisdiction (as defined below), unless, in each case, a lower rate is provided for in an applicable tax treaty between Brazil and the country where the non-resident holder has its domicile. In the event of any such income tax, the person responsible for the withholding and collection of the income tax will be: (i) the ADSs acquirer (if resident in Brazil); or (ii) the attorney in fact or legal representative of the non-resident acquirer, according to Section 26 of Law No. 10,833/03.

Under certain circumstances, if income tax is not paid, the amount of tax charged could be subject to an upward adjustment, as if the amount received by the non-resident holder were net of taxes in Brazil (gross-up).

   
 209 

Taxation of Gains with Respect to Class A Preferred Shares

The sale or other disposition of class A preferred shares or the receipt of the underlying class A preferred shares in exchange for ADSs abroad may be subject to the provisions of Brazilian Law No. 10,833/03. In addition to the case where from the outset an investor holds class A preferred shares, a disposition of class A preferred shares can only occur abroad if any investor decides to cancel its investment in ADSs and register the underlying class A preferred shares as a direct foreign investment in Brazil under Law No. 4,131/62.

As a rule, gains realized as a result of a disposition or sale of class A preferred shares are determined by the positive difference between the amount realized on the disposition or sale of the relevant class A preferred shares and their acquisition cost.

Under Brazilian law, income tax rules on such gains can vary depending on the domicile of the non-resident holder, the type of registration of the investment held by the non-resident holder with the Central Bank and how the disposition is carried out, as described below.

Gains realized by a non-resident holder on a sale or disposition of class A preferred shares carried out on a Brazilian stock exchange, which includes the transactions carried out on the organized over-the-counter market, are:

·exempt from income tax when realized by a non-resident holder that (i) is a 4,373 Holder and (ii) is not resident or domiciled in a Low or Nil Tax Jurisdiction (as defined below); or
·subject to income tax at a rate of up to 25% in any other case, including the gains realized by a non-resident holder that (i) is not a 4,373 Holder and/or (ii) is a 4,373 Holder resident or domiciled in a Low or Nil Tax Jurisdiction (as defined below). In these cases, a withholding income tax of 0.005% of the sale value shall be applicable and can be later used to offset the eventual income tax due on the capital gain. Day trade transactions are subject to the rate of 1%.

Any other gains realized on a disposition of class A preferred shares that is not carried out on Brazilian stock exchanges are subject to income tax at rates of up to 22.5%, except for a non-resident holder that is not a 4,373 Holder and is resident or domiciled in a Low or Nil Tax Jurisdiction (as defined below), which, in this case, is subject to income tax at a rate of up to 25%. In case the gains are related to transactions conducted on the Brazilian non-organized over-the-counter market with intermediation of a financial institution, the withholding income tax of 0.005% will apply and can be later used to offset the eventual income tax due on the capital gain.

The deposit of class A preferred shares in exchange for ADSs is not subject to Brazilian tax, provided that these shares are held by the non-resident holder as a foreign portfolio investment under Resolution No. 4,373/14. In the event our class A preferred shares are held by the non-resident holder as a foreign direct investment under Law No. 4,131/62, the deposit of these shares in exchange for ADSs is subject to payment of Brazilian capital gains tax at the progressive rate of 15% to 22.5% (25% in the case of a non-resident holder located in a Low or Nil Tax Jurisdiction).

The current preferential treatment for non-resident holders of ADSs and non-resident holders of class A preferred shares under Resolution No. 4,373/14 may not continue in the future.

Any exercise of preemptive rights relating to our class A preferred shares will not be subject to Brazilian taxation. Gains realized by a non-resident holder on the sale or assignment of preemptive rights relating to our class A preferred shares will be subject to Brazilian taxation according to the same rules applicable to the sale or disposition of such class A preferred shares.

   
 210 

Discussion on Low or Nil Tax Jurisdictions

The concept of Low or Nil Tax Jurisdiction encompasses those countries that do not tax income or tax it at a maximum rate lower than 20%, or where the local legislation does not allow access to information related to the shareholding composition of legal entities, to their ownership or to the identity of the effective beneficiary of the income attributed to non-residents (“Low or Nil Tax Jurisdictions”).

The statutory definition of a Low or Nil Tax Jurisdiction for the purpose of income taxation on gains should differ depending on whether the holder is a 4,373 Holder. In the case of a 4,373 Holder, the definition of Low or Nil Tax Jurisdiction should not comprise jurisdictions where the local legislation imposes restrictions on disclosing the shareholding composition or ownership of the investment (ultimate beneficial ownership – UBO). However, the list provided for in Normative Ruling No. 1,037/10 does not seem to differ the Low or Nil Tax Jurisdiction definition for the purposes of 4,373 Holders.

On June 23, 2008, Law No. 11,727 introduced the concept of “Privileged Tax Regime,” which encompasses the countries and jurisdictions that (i) do not tax income or tax income at a maximum rate lower than 20%, or 17% in certain cases as detailed below; (ii) grant tax advantages to a non-resident entity or individual (a) with no requirement to carry out a substantial economic activity within the country or dependency, or (b) on the condition that they do not carry out a substantial economic activity within the country or dependency; (iii) do not tax income generated outside the jurisdiction, or that tax such income at a maximum rate lower than 20%, or 17% in certain cases as detailed below; or (iv) do not provide access to information on the ownership and beneficial ownership of assets or on transactions within its territory, or impose restrictions on disclosure of that information.

In addition, on June 4, 2010, the Brazilian tax authorities enacted Normative Ruling No. 1,037, as amended, listing (i) the countries and jurisdictions considered as Low or Nil Tax Jurisdictions, and (ii) the Privileged Tax Regimes.

On its turn, Ordinance No. 488, of November 28, 2014, issued by the Brazilian Ministry of Finance, reduced the rate for purposes of the definition of Low or Nil Tax Jurisdiction and Privileged Tax Regime from 20% to 17%, but only to countries and regimes aligned with international standards of fiscal transparency, in accordance with the rules established by Normative Ruling n. 1,530, issued on December 19, 2014. Under Brazilian law, the aforementioned commitment is present if the relevant jurisdiction (i) has entered into (or concluded the negotiation of) an agreement or convention authorizing the exchange of information for tax purposes with Brazil and (ii) is committed to the actions discussed in international forums on tax evasion in which Brazil has been participating, such as the Global Forum on Transparency and Exchange of Information.

As of December 29, 2022 the Provisional Measure No. 1,152 had entered into force to establish that countries and jurisdictions considered as Low or Nil Tax Jurisdictions are the ones that do not tax income or tax income at a maximum rate lower than 17%. The change from 20% to 17% will be considered a definitive change in Brazilian law as from April 2, 2023, in case the Provisional Measure No. 1,152 is converted into law. Otherwise, such change would be effective only for the period during which the Provisional Measure was in force.

In the past, it was not clear whether the concept of Privileged Tax Regime was also applicable to interest payments made to residents outside Brazil. Notwithstanding, in December 2017, the Brazilian Federal Revenue Service (“RFB”) published Answer to Tax Ruling Cosit Ruling No. 575/2017, stating that only payments to countries deemed as a Low or Nil Tax Jurisdiction by Normative Ruling No. 1,037 would be subject to withholding tax at a 25% rate.

Therefore, under the RFB’s current interpretation, we believe that the best interpretation of the current tax legislation leads to the conclusion that the concept of Privileged Tax Regime should apply solely for purposes of Brazilian transfer pricing and thin capitalization/cross-border interest deductibility rules. Nevertheless, we cannot assure you that subsequent legislation or interpretations by the Brazilian tax authorities regarding the definition of a Privileged Tax Regime provided by Law No. 11,727, will not also apply to a non-resident holder on payments of interest on shareholders’ equity.

   
 211 

Regardless of the above, potential investors should consult with their own tax advisors regarding the consequences of the implementation of Law No. 11,727, Normative Ruling No. 1,037 and of any related Brazilian tax law or regulation concerning Low or Nil Tax Jurisdictions.

Other Brazilian Taxes

There are no Brazilian inheritance, gift or succession taxes applicable to the ownership, transfer or disposition of class A preferred shares or ADSs by a non-resident holder except for gift and inheritance taxes imposed by some states of Brazil on gifts made or inheritances bestowed by individuals or entities not resident or domiciled in Brazil or domiciled within the state to individuals or entities resident or domiciled within such state in Brazil. There are no Brazilian stamp, issue, registration or similar taxes or duties payable by holders of class A preferred shares or ADSs.

Tax on Foreign Exchange and on Bonds and Securities Transactions

Foreign Exchange Transactions

IOF/Exchange Tax

Pursuant to Decree No. 6,306/07, the conversion of Brazilian currency into foreign currency and the conversion of foreign currency into Brazilian currency may be subject to the “IOF/Exchange” tax. Currently, for most exchange transactions, the rate of IOF/Exchange is 0.38%. However, foreign currency exchange transactions carried out for the inflow of funds into Brazil for investment in the Brazilian financial and capital market made by a foreign investor, including a non-resident holder who registers his/her investment under Resolution No. 4,373/14, are subject to IOF/Exchange at a current rate of zero.

The IOF/Exchange rate will be also zero for the outflow of resources from Brazil related to the return of the investments mentioned above, including payments of dividends and interest on shareholders’ equity and the repatriation of funds invested in the Brazilian market.

The Brazilian government may increase the rate of the IOF/Exchange tax to a maximum of 25% of the amount of the foreign exchange transaction at any time, but such an increase would only apply to future foreign exchange transactions.

IOF/Bonds Tax

Pursuant to Decree No 6,306/07, the “IOF/Bonds” tax may be imposed on any transactions involving bonds and securities, including those carried out on Brazilian stock, futures and commodities exchanges. The rate of IOF/ Bonds applicable to most transactions involving common or preferred shares is currently zero percent, including transactions related to transfers of shares traded on the stock exchange with the purpose of enabling the issuance of ADSs to be traded outside Brazil. The Brazilian government may increase the rate of the IOF/Bonds up to 1.5% per day, but only in respect of future transactions.

Registered Capital

The amount of an investment in class A preferred shares held by a non-Brazilian holder as a foreign direct investment under Law No. 4,131/62 or a foreign portfolio investment under Resolution No. 4,373/14 or in ADSs held by the depositary representing such holder, as the case may be, is eligible for registration with the Central Bank; such registration (the amount so registered is referred to as “registered capital”) allows the remittance outside Brazil of foreign currency, converted at the commercial market rate, acquired with the proceeds of distributions on, and amounts realized with respect to disposition of, such class A preferred shares. The registered capital for class A preferred shares purchased in the form of ADSs, or purchased in Brazil and deposited with the depositary in exchange for an ADS, is equal to their purchase price in U.S. dollars paid by the purchaser. The registered capital for class A preferred shares that are withdrawn upon surrender of ADSs is the U.S. dollar equivalent of (1) the average price of our class A preferred shares on the Brazilian stock exchange on which the greatest number of such class A preferred shares was sold on the day of withdrawal, or (2) if no class A preferred shares were sold on such day, the average price of class A preferred shares that were sold in the fifteen trading sessions immediately preceding such withdrawal. The U.S. dollar value of our class A preferred shares is determined on the basis of the average commercial market rates quoted by the Central Bank on such date (or, if the average price of class A preferred shares is determined under clause (2) of the preceding sentence, the average of such average quoted rates on the same fifteen dates used to determine the average price of our class A preferred shares).

   
 212 

A non-Brazilian holder of class A preferred shares may experience delays in effecting the registration of registered capital, which may delay remittances abroad. Such a delay may adversely affect the amount, in U.S. dollars, received by the non-Brazilian holder. See “—Exchange Controls” and “Item 3. D Risk Factors—Risks Relating to Our Equity and Debt Securities.”

U.S. Federal Income Tax Considerations

The following is a discussion of the material U.S. federal income tax consequences that may be relevant with respect to the acquisition, ownership and disposition of our class A preferred shares or the ADSs, which are evidenced by ADRs. This discussion addresses only the U.S. federal income tax considerations of U.S. holders (as defined below) that will hold our class A preferred shares or the ADSs as capital assets. This discussion does not address tax considerations applicable to holders that may be subject to special tax rules, such as banks and other financial institutions, insurance companies, real estate investment trusts, grantor trusts, regulated investment companies, dealers or traders in securities or currencies, tax-exempt entities, pension funds, persons that received our class A preferred shares or the ADSs pursuant to an exercise of employee stock options or rights or otherwise as compensation for the performance of services, persons that will hold our class A preferred shares or the ADSs as a position in a “straddle” or as a part of a “hedging,” “conversion” or other risk reduction transaction for U.S. federal income tax purposes, persons that have a “functional currency” other than the U.S. dollar, persons that will own our class A preferred shares or the ADSs through partnerships or other pass through entities, persons that are required to accelerate the recognition of any item of gross income with respect to our class A preferred shares or the ADSs as a result of such income being recognized on an applicable financial statement, holders subject to the alternative minimum tax, certain former citizens or long-term residents of the United States or holders that own (or are deemed to own) 10% or more (by voting power or value) of our shares.

This discussion does not contain a detailed description of all the U.S. federal income tax consequences to U.S. holders in light of their particular circumstances and does not address any state, local or non-U.S. tax consequences of the acquisition, ownership and disposition of our class A preferred shares or the ADSs. In addition, this discussion does not address the Medicare tax on net investment income or the consequences of any U.S. federal tax other than income tax, including but not limited to the U.S. federal estate and gift taxes. This discussion is based on (1) the Internal Revenue Code of 1986, as amended (the “Code”), existing, proposed and temporary U.S. Treasury Regulations and judicial and administrative interpretations thereof, in each case as in effect and available on the date of this annual report and (2) the assumption that each obligation in the deposit agreement and any related agreement will be performed in accordance with its terms. All of the foregoing are subject to change, which change could apply retroactively and could affect the tax consequences described below.

   
 213 

As used below, a “U.S. holder” is a beneficial owner of our class A preferred shares or the ADS that is, for U.S. federal income tax purposes, (1) an individual citizen or resident of the United States, (2) a corporation organized under the laws of the United States, any state thereof or the District of Columbia, (3) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (4) a trust if (i) a court within the United States is able to exercise primary supervision over its administration and (ii) one or more U.S. persons have the authority to control all of the substantial decisions of such trust.

If a partnership (or any other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds our class A preferred shares or the ADSs, the tax treatment of a partner in such partnership will generally depend on the status of the partner and the activities of the partnership. In the case of a partnership or a partner of a partnership holding class A preferred shares or the ADSs, the recommendation is to consult a tax advisor.

This discussion is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of class A preferred shares or the ADSs. Tax advisors should be consulted regarding the U.S. federal income tax consequences of the acquisition, ownership and disposition of class A preferred shares or the ADSs, as well as the consequences arising under other U.S. federal tax laws and the laws of any other taxing jurisdiction.

Except as specifically noted below under “—Passive Foreign Investment Company Rules,” the following discussion assumes we are not, and will not be, a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes.

Class A Preferred Shares

The class A preferred shares will be treated as equity for U.S. federal income tax purposes.

ADSs

In general, for U.S. federal income tax purposes, a holder of an ADS will be treated as the beneficial owner of our class A preferred shares represented by the applicable ADS.

Taxation of Dividends

In general, the gross amount of a distribution made with respect to a class A preferred share or ADS (which for this purpose shall include any amounts withheld in respect of Brazilian taxes and any distribution of interest on shareholders’ equity, as described above under “—Brazilian Tax Considerations”) will, to the extent made from the current or accumulated earnings and profits of our Company, as determined under U.S. federal income tax principles, constitute a dividend to a U.S. holder for U.S. federal income tax purposes. If a distribution exceeds the amount of our Company’s current and accumulated earnings and profits, it will be treated as a non-taxable return of capital to the extent of (and in reduction of) the U.S. holder’s tax basis in the class A preferred share or ADS on which it is paid, and thereafter will be treated as capital gain recognized on a sale or exchange (as discussed below under “—Sale, Exchange or Other Disposition of Class A Preferred Shares or ADSs”). We do not maintain calculations of our earnings and profits under U.S. federal income tax principles. Therefore, U.S. holders should expect that distributions by our Company generally will be reported as dividends for U.S. federal income tax purposes.

Subject to applicable limitations (including a minimum holding period requirement), non-corporate U.S. holders may be taxed on dividends from a qualified foreign corporation at the lower rates applicable to long-term capital gains (i.e., gains with respect to capital assets held for more than one year). A foreign corporation is treated as a qualified foreign corporation with respect to dividends received from that corporation on shares or ADSs that are readily tradable on an “established securities market” in the United States. U.S. Treasury Department guidance indicates that the ADSs (which are listed on the NYSE), but not our class A preferred shares, are readily tradable on an established securities market in the United States. Thus, we believe that any dividends that we pay on the ADSs, but not on our class A preferred shares, to non-corporate U.S. holders will be potentially eligible for these reduced tax rates. However, non-corporate U.S. holders will not be eligible for reduced tax rates on any dividends received from us if we are a PFIC (as discussed below under “—Passive Foreign Investment Company Rules”) in the taxable year in which such dividends are paid or in the preceding taxable year. There also can be no assurance that the ADSs will be considered readily tradable on an established securities market in the United States in later years. Dividends from our Company will not be eligible for the dividends received deduction generally allowed to corporate U.S. holders.

   
 214 

A dividend paid in reais will be includible in the income of a U.S. holder at its value in U.S. dollars calculated by reference to the prevailing spot market exchange rate in effect on the day it is received by the U.S. holder in the case of our class A preferred shares or, in the case of a dividend received in respect of ADSs, on the date the dividend is received by the depositary, whether or not the dividend is converted into U.S. dollars. Assuming the payment is not converted at that time, the U.S. holder will have a tax basis in reais equal to that U.S. dollar amount, which will be used to measure gain or loss from subsequent changes in exchange rates. Any gain or loss realized by a U.S. holder that subsequently sells or otherwise disposes of reais, which gain or loss is attributable to currency fluctuations after the date of receipt of the dividend, will be U.S. source ordinary gain or loss. The amount of any distribution of property other than cash will generally be the fair market value of such property on the date of distribution.

The gross amount of any dividend paid (which will include any amounts withheld in respect of Brazilian taxes) with respect to a class A preferred share or ADS will be subject to U.S. federal income taxation as foreign source dividend income, which may be relevant in calculating a U.S. holder’s foreign tax credit limitation. Subject to limitations under U.S. federal income tax law and certain exceptions for short-term and hedged positions, any Brazilian withholding tax may be treated as a foreign income tax eligible for credit against a U.S. holder’s U.S. federal income tax liability. However, recently issued U.S. Treasury Regulations (the “Foreign Tax Credit Regulations”) impose additional requirements for foreign taxes to be eligible for a foreign tax credit, and there can be no assurance that those requirements will be satisfied. The limitation on foreign taxes eligible for the U.S. foreign tax credit is calculated separately with respect to specific “baskets” of income. For this purpose, the dividends should generally constitute “passive category income,” or in the case of certain U.S. holders, “general category income.” Instead of claiming a foreign tax credit, a U.S. holder may be able to deduct any Brazilian withholding tax in computing the U.S. holder’s taxable income, subject to generally applicable limitations under U.S. law (including that a U.S. holder is not eligible for a deduction for otherwise creditable foreign income taxes paid or accrued in a taxable year if such U.S. holder claims a foreign tax credit for any foreign income taxes paid or accrued in the same taxable year).The rules with respect to foreign tax credits and deductions for foreign taxes are complex, and U.S. holders are urged to consult their own tax advisors regarding the availability of the foreign tax credit or a deduction under their particular circumstances.

Sale, Exchange or Other Disposition of Class A Preferred Shares or ADSs

A deposit or withdrawal of class A preferred shares by a holder in exchange for an ADS that represents such shares will not result in the realization of gain or loss for U.S. federal income tax purposes. A U.S. holder generally will recognize capital gain or loss upon a sale, exchange or other disposition of a class A preferred share or ADS in an amount equal to the difference between the amount realized on the sale, exchange or other disposition and the U.S. holder’s adjusted basis in the class A preferred share or ADS, both determined in U.S. dollars. If a Brazilian tax is withheld on the sale, exchange or other disposition of a class A preferred share or ADS, the amount realized by a U.S. holder will include the gross amount of the proceeds of that sale, exchange or other disposition before deduction of the Brazilian tax. In the case of a non-corporate U.S. holder, the maximum marginal U.S. federal income tax rate applicable to capital gain will generally be lower than the maximum marginal U.S. federal income tax rate applicable to ordinary income (other than, as discussed above, certain dividends) if such holder’s holding period for such class A preferred share or ADS exceeds one year (i.e., such gain is a long-term capital gain). Capital gain, if any, realized by a U.S. holder on the sale, exchange or other disposition of a class A preferred share or ADS generally will be treated as U.S. source income for U.S. foreign tax credit purposes. Consequently, in the case of a disposition of a class A preferred share or ADS that is subject to Brazilian tax, the U.S. holder may not be eligible for a foreign tax credit for that Brazilian tax unless it can apply the credit against U.S. tax payable on other income from foreign sources in the appropriate income category. However, pursuant to the Foreign Tax Credit Regulations, any such Brazilian tax would generally not be a foreign income tax eligible for a foreign tax credit (regardless of any other income that a U.S. holder may have that is derived from foreign sources). In such case, however, the non-creditable Brazilian tax may reduce the amount realized on the sale, exchange or other disposition of the Class A preferred share or ADS. U.S. holders are urged to consult their own tax advisors regarding the tax consequences if Brazilian tax is imposed on a disposition of a Class A preferred share or ADS, including the effect of the Foreign Tax Credit Regulations and the availability of the foreign tax credit under their particular circumstances.

   
 215 

The initial tax basis of class A preferred shares to a U.S. holder that purchases such shares for non-U.S. currency is the U.S. dollar value of the purchase price determined on the date of purchase. If our class A preferred shares are treated as traded on an “established securities market,” a cash basis U.S. holder, or, if it elects, an accrual basis U.S. holder, will determine the U.S. dollar value of the cost of any such class A preferred shares by translating the amount paid at the spot rate of exchange on the settlement date of the purchase. The conversion of U.S. dollars to non-U.S. currency and the immediate use of that currency to purchase class A preferred shares generally will not result in taxable gain or loss for a U.S. holder.

With respect to the sale, exchange or other disposition of class A preferred shares for non-U.S. currency, the amount realized generally will be the U.S. dollar value of the payment received determined on (1) the date of receipt of payment in the case of a cash basis U.S. holder and (2) the date of disposition in the case of an accrual basis U.S. holder. If our class A preferred shares are treated as traded on an “established securities market, a cash basis U.S. holder, or, if it elects, an accrual basis U.S. holder, will determine the U.S. dollar value of the payment received on the sale, exchange or other disposition of any such class A preferred shares by translating the amount received at the spot rate of exchange on the settlement date of the sale, exchange or other disposition.

Passive Foreign Investment Company Rules

Based on the past and projected composition of our income and assets, and the valuation of our assets, including goodwill, we do not believe we were a PFIC for our most recent taxable year, and we do not expect to become a PFIC in the current taxable year or the foreseeable future, although there can be no assurance in this regard.

In general, we will be a PFIC for any taxable year in which (1) at least 75% of our gross income is passive income, or (2) at least 50% of the value (generally determined based on a quarterly average) of our assets is attributable to assets that produce or are held for the production of passive income. For this purpose, passive income generally includes dividends, interest, royalties and rents (other than royalties and rents derived in the active conduct of a trade or business and not derived from a related person). In addition, cash and other assets readily convertible into cash are generally considered passive assets. If we own at least 25% (by value) of the stock of another corporation, for purposes of determining whether we are a PFIC, we will be treated as owning our proportionate share of the other corporation’s assets and receiving our proportionate share of the other corporation’s income.

The determination of whether we are a PFIC is made annually. Accordingly, it is possible that we may become a PFIC in the current or any future taxable year due to changes in our asset or income composition. If we are a PFIC for any taxable year during which a U.S. holder holds our class A preferred shares or the ADSs, such holder will be subject to special tax rules discussed below.

   
 216 

If we are a PFIC for any taxable year during which a U.S. holder holds our class A preferred shares or the ADSs, such holder will be subject to special tax rules with respect to any “excess distribution” received and any gain realized from a sale or other disposition, including a pledge, of the class A preferred shares or ADSs. Distributions received in a taxable year will be treated as excess distributions to the extent that they are greater than 125% of the average annual distributions received during the shorter of the three preceding taxable years or the U.S. holder’s holding period for the class A preferred shares or ADSs. Under these special tax rules:

·the excess distribution or gain will be allocated ratably over the U.S. holder’s holding period for the class A preferred shares or ADSs;
·the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC, will be treated as ordinary income; and
·the amount allocated to each other year will be subject to tax at the highest tax rate in effect for that year for individuals or corporations, as applicable, and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.

Although the determination of whether we are a PFIC is made annually, if we are a PFIC for any taxable year in which a U.S. holder holds our class A preferred shares or the ADSs, such holder will generally be subject to the special tax rules described above for that year and for each subsequent year in which such holder holds the class A preferred shares or ADSs (even if we do not qualify as a PFIC in such subsequent years). However, if we cease to be a PFIC, a U.S. holder can avoid the continuing impact of the PFIC rules by making a special election to recognize gain as if the class A preferred shares or ADSs had been sold on the last day of the last taxable year during which we were a PFIC. U.S. holders are urged to consult their own tax advisor about this election.

If we are a PFIC for any taxable year during which a U.S. holder holds our class A preferred shares or the ADSs and any of our non-U.S. subsidiaries is also a PFIC, such holder will be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of the PFIC rules. U.S. holders are urged to consult their tax advisor about the application of the PFIC rules to any of our subsidiaries.

A U.S. holder will generally be required to file U.S. Internal Revenue Service Form 8621 if such holder holds our class A preferred shares or the ADSs in any year in which we are classified as a PFIC. U.S. holders are urged to consult their tax advisor concerning the U.S. federal income tax consequences of holding class A preferred shares or ADSs if we are considered a PFIC in any taxable year, including the potential availability and effect of any elections which would provide for alternative treatment.

Foreign Asset Reporting

Certain U.S. holders are required to report information relating to an interest in our class A preferred shares or the ADSs, subject to certain exceptions (including an exception for class A preferred shares or ADSs held in custodial accounts maintained with certain financial institutions). U.S. holders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our class A preferred shares or the ADSs.

Information Reporting and Backup Withholding

In general, information reporting will apply to dividends in respect of our class A preferred shares or the ADSs and the proceeds from the sale, exchange or other disposition of our class A preferred shares or the ADSs that are paid to a U.S. holder within the United States (and in certain cases, outside the United States), unless such holder establishes that it is an exempt recipient. A backup withholding tax may apply to such payments if a U.S. holder fails to provide a taxpayer identification number and a certification that such holder is not subject to backup withholding or if the U.S. holder fails to report in full dividend and interest income.

   
 217 

The backup withholding tax rate is currently 24%. Backup withholding is not an additional tax. Holders generally will be entitled to a credit for any amounts withheld under the backup withholding rules against their U.S. federal income tax liability or a refund of the amounts withheld, provided the required information is furnished to the U.S. Internal Revenue Service in a timely manner.

Documents on Display

Statements contained in this annual report regarding the contents of any contract or other document filed as an exhibit to this annual report summarize their material terms, but are not necessarily complete, and each of these statements is qualified in all respects by reference to the full text of such contract or other document.

We are subject to the periodic reporting and other informational requirements of the Exchange Act applicable to a foreign private issuer. Accordingly, we are required to file with or furnish to the SEC, reports and other information, including annual reports on Form 20-F and reports on Form 6-K.

As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and members of our board of directors and board of executive officers and our principal shareholders are exempt from reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, as a foreign private issuer, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.

You may inspect and copy reports and other information that we file with or furnish to the SEC at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington D.C. 20549. Copies of these materials may be obtained by mail from the SEC’s Public Reference Room at prescribed rates. The public may obtain information on the operation of the SEC’s Public Reference Room by calling the SEC in the United States at 1-800-SEC-0330. In addition, the SEC maintains an internet website at www.sec.gov from which you can electronically access these materials.

We also file financial statements and other periodic reports with the CVM, which are available for investor inspection at the CVM’s offices located at Rua Sete de Setembro, 111, 2nd floor, Rio de Janeiro, RJ, and Rua Cincinato Braga, 340, 2nd, 3rd and 4th floors, São Paulo, SP. The telephone numbers of the CVM in Rio de Janeiro and São Paulo are +55-21-3554-8686 and +55-11-2146- 2097, respectively.

Copies of our annual report on Form 20-F and documents referred to in this annual report and our by-laws, as well as certain other documents that we are required to file with, or make available to, the SEC and the CVM, are available for inspection upon request at our headquarters at Rua Lemos Monteiro, 120 – 24º andar, Butantã—São Paulo—SP, CEP 05501-050, Brazil. Our filings are also available to the public through the internet on our website at www.braskem-ri.com.br. The information included on our website or that might be accessed through our website is not included in this annual report and is not incorporated into this annual report by reference.

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the potential loss arising from adverse changes in market rates and prices. We have exposure to market risks arising from our day-to-day business activities. These risks are beyond our control and consist, principally, in the possibility that changes in interest rates, exchange rates, or commodity prices will adversely affect the value of our financial assets and liabilities or future cash flows and earnings.

   
 218 

In order to mitigate the market risks to which we are exposed, we have used, and we may use, foreign currency, interest rate and commodity derivative instruments, as well as cash and receivables. As of December 31, 2022, we had currency options with an aggregate notional amount of US$2.1 billion (R$10.96 billion) in puts with an average strike price of US$1/R$4.7 and of US$1.4 billion (R$7.3 billion) in calls with an average strike price of US$1/R$7.06. We assess the potential and consolidated impact of market risks and seek to mitigate those risks following our risk management policy.

Our current risk management policy, adopted on March 30, 2017 by our Board of Directors and updated in July, 2019 and in August, 2022 covers cash flow management and liquidity, investment of cash and cash equivalents, funding activities and guarantees, and management of foreign exchange and commodity risks. This policy reflects our conservative financial practices and risk management procedures. Its objective is to manage and anticipate risks by continuously evaluating several key factors, including the overall financial health of our Company, any financial operations we have with related parties, our ratings, counterparty risk and hedging strategy. Additionally, the policy aims to ensure the alignment of the objectives of the financial teams with the overall objectives of Braskem.

We do not enter into derivative transactions with speculative purposes.

As of December 31, 2022, we had R$8.3 billion (US$1.6 billion) in foreign currency-denominated cash and cash equivalents, including the aggregate amount of R$2,184.3 million (US$418.6 million) of Braskem Idesa’s cash and cash equivalents.

Interest Rate Risk

Our variable interest rate exposure is primarily subject to the variations of the LIBOR rate and, for real-denominated borrowings and short-term cash investments, variations of the CDI rate and IPCA rate.

Our variable interest rate exposure is primarily subject to the variations of the LIBOR and SOFR rate and, for real-denominated borrowings and short-term cash investments, variations of the CDI rate and IPCA rate.

With respect to Brazilian interest rates:

·the short-term domestic CDI rate increased to 13.65% per annum as of December 31, 2022, from 4.4% per annum as of December 31, 2021 and from 1.9% per annum as of December 31, 2020; and
·IPCA recorded in in 2022 was 5.79%, decreasing from 10.1% in 2021, and it was 4.5% in 2020.
   
 219 

The table below provides information about our significant interest-rate sensitive instruments:

Payment Schedule—Breakdown by Type of Interest Rate
  As of December 31, 2022
  Expected Maturity Date
  2023 2024 2025 2026 2027 Thereafter Total Fair Value(1)
  (in millions of reais, unless otherwise indicated)
Liabilities:            
Loans and financings:            
Fixed rate, denominated in U.S. dollars 621.3 1,547.7 - - - 24,016.3 26,185.3 23,336.1
Average interest rate 6.1% 6.5% - - - 5.7%    
Variable rate, denominated in U.S. dollars 633.5 609.7 610.7 584.5 2,028.5 84.1 5,304.0 5,159.0
Bond Idesa fixed rate, denominated in U.S. dollars 199.7 - - - - 10,843.8 11,043.5 8,301.9
Average interest rate 7.1% - - - - 7.2%    
Variable rate, denominated in U.S. dollars (Braskem Idesa) 76.5 116.2 116.2 426.0 - - 734.8 796.5
Average interest rate 4.0% 4.0% 4.0% 4.0% - -    
Fixed rate, denominated in reais 6.4 5.0 4.9 2.4 - - 18.7 16.5
Average interest rate 5.9% 6.5% 6.5% 6.5% - -    
Variable rate, denominated in reais 102.0 12.5 9.4 - 327.4 2,950.0 3,401.3 3,289.9
Average interest rate (CDI) 14.1% 17.3% 17.3% - 13.7% 13.7%    
Variable rate, denominated in reais 101.9 94.6 62.7 48.1 47.8 908.2 1,263.3 1,821.3
Average interest rate (over IPCA) 6.0% 6.0% 6.0% 6.0% 6.0% 5.6%    
Total Loan and financings 1,741.2 2,385.7 803.9 1,061.0 2,403.7 39,564.4 47,959.9 42,721.3
Assets:            
Cash and cash equivalents and other instruments:                
Fixed rate, denominated in foreign currency 8,902.5 8,902.5 8,902.5
Variable rate, denominated in reais 5,876.6 5,876.6 5,876.6
Total cash and cash equivalents and other investments 14,779.1 14,779.1 14,779.1

 (1) Represents the net present value of the future cash flows from the obligations converted into reais at fair market value as of December 31, 2022.

 

In the event that the average interest rate applicable to our financial assets and debt in 2023 is one percentage point higher than the average interest rate in 2022, our financial income would increase by R$147.8 million and our financial expenses would increase by R$479.6 million.

Foreign Currency Exchange Rate Risk

Our liabilities with exposure to foreign currency exchange rate risk are mainly U.S. dollar-denominated. To partially offset the risk of a devaluation of the real against the U.S. dollar, we currently maintain liquid assets denominated in U.S. dollars available. Additionally, in order to provide a better representation of the actual exchange rate risk related to future exports, we designated part of our U.S. dollar-denominated liabilities as a hedging instrument, implementing the hedge accounting treatment since May 1, 2013. We borrow in the international markets to support our operations and investments; we have exposure to market risks from changes in foreign exchange rates and interest rates.

The table below provides information about our significant foreign currency exposures:

   
 220 

 

Payment Schedule—Breakdown by Currency
  As of December 31, 2022 Expected Maturity Date
  2023 2024 2025 2026 2027 Thereafter Total Fair Value(1)
  (in millions of reais)
Liabilities:                
Loans, financings and trade payables:                
Loans and financings denominated in U.S. dollars 1,530.9 2,273.6 726.8 1,010.5 2,028.5 35,706.2 43,276.6 37,860.8
Accounts payable denominated in U.S. dollars 7,035.1 7,035.1 7,035.1
Total loans, financings and trade payables 8,566.0 2,273.6 726.8 1,010.5 2,028.5 35,706.2 50,311.7 44,895.9
Assets:                
Cash and cash equivalents and other investments Denominated in foreign currency 8,902.5 8,902.5 8,902.5
Total cash and cash equivalents and other investments 8,902.5 8,902.5 8,902.5
Hedge Accounting:                
Hedge Accounting designated Exports/Sales 65.2 1,624.6 4,291.6 430.5 32,610.6 39,022.4 39,022.4

(1) Represents the net present value of the future cash flows from the obligations converted into reais at fair market value as of December 31, 2022.

Our foreign currency exposures give rise to market risks associated with exchange rate movements of the real against the U.S. dollar. Foreign currency-denominated liabilities as of December 31, 2022 consisted primarily of U.S. dollar-denominated debt. Our U.S. dollar-denominated debt, including short-term debt and current portion of long-term debt, was R$43.3 billion (US$8.3 billion) as of December 31, 2022 and $47.8 billion (US$8.6 billion) as of December 31, 2021. This foreign currency exposure is represented by debt in the form of notes, bonds, pre-export finance facilities and working capital loans.

Our cash and funds available in U.S. dollars partially protect us against exposure arising from the U.S. dollar-denominated debt. Similarly, revenue from future sales and exports partially offsets this foreign currency exposure for U.S. dollar-denominated debt, and we therefore adopted hedge accounting treatment to provide a better representation of our actual exposure. Since 2016, Braskem has recognized the exchange rate variation, held on “Other Comprehensive Income,” to the income statement, following the future sales and exports designation schedule (for further information, see note 28.7 to our audited consolidated financial statements elsewhere in this annual report).

In the event that the real depreciated by 10% against the U.S. dollar during 2022 as compared to the real/U.S. dollar exchange rate as of December 31, 2021, our financial expenses indexed to the dollar in 2022 would have increased by R$4.3 billion, and our financial income would have increased by R$890.3 million.

Commodity Prices

We do not hedge the exposure to the price of naphtha, our principal raw material. This is, in part, because a portion of our sales are exports payable in foreign currencies and linked to the international market prices of these commodities denominated in U.S. dollars and, in part, because the prices of our polyethylene, polypropylene and PVC products sold in domestic markets generally reflect changes in the international market prices of these products denominated in U.S. dollars, converted into reais. In periods of high volatility in the U.S. dollar price of naphtha or the real/U.S. dollar exchange rate, there is usually a lag between the time that the U.S. dollar price of naphtha increases or the U.S. dollar appreciates and the time that we can effectively pass on the resulting increased cost in reais to our customers in Brazil. Accordingly, if the U.S. dollar price of naphtha increases precipitously or the real devalues precipitously against the U.S. dollar in the future, we may not immediately be able to pass on all of the corresponding increases in our naphtha costs to our customers in Brazil, which could materially adversely affect our results of operations and financial condition. See “Item 3. D Risk Factors—Risks Relating to Us and the Petrochemical Industry.”

   
 221 
  Item 12. Description of Securities Other than Equity Securities

The Bank of New York Mellon, which was designated our depositary in December 2016, collects its fees for the delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs or from intermediaries acting for them. The depositary also collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deductions from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may generally refuse to provide services subject to the payment of fees until its fees for those services are paid.

Fees and Expenses

Persons depositing or withdrawing shares or ADS holders must pay:   For:
     
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)  

·         Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property

·         Cancellation of ADSs for the purpose of withdrawal, including if the Deposit Agreement terminates

$.05 (or less) per ADS

 

  ·         Any cash distribution to ADS holders

A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs

 

  ·         Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the Depositary to ADS holders

$.05 (or less) per ADS per calendar year

 

  ·         Depositary services
Registration or transfer fees   ·         Transfer and registration of shares on our share register to or from the name of the Depositary or its agent when you deposit or withdraw shares
Expenses of the Depositary  

·         Cable (including SWIFT) and facsimile transmissions (when expressly provided in the Deposit Agreement)

·        Converting foreign currency to U.S. dollars

Taxes and other governmental charges the Depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes

 

  ·         As necessary
Any charges incurred by the Depositary or its agents for servicing the deposited securities   ·         As necessary

 

   
 222 

During the year ended December 31, 2022, we received from the depositary of our ADSs US$611.9 thousand, which was used for general corporate purposes such as the payment of costs and expenses associated with (1) the preparation and distribution of proxy materials, (2) the preparation and distribution of marketing materials and (3) consulting and other services related to investor relations.

 

PART II

  Item 13. Defaults, Dividend Arrearages and Delinquencies

Not applicable.

  Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds

Not applicable.

  Item 15. Controls and Procedures

Disclosure Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2022. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is being recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it was accumulated for and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding the required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objective. Based on our management’s evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2022, our disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of the effectiveness of internal control to future periods are also subject to the risk that controls may become inadequate because of changes in conditions, and that the degree of compliance with the policies or procedures may deteriorate.

   
 223 

Our management, with the participation of the CEO and CFO, under the oversight of the Board of Directors, assessed the effectiveness of our internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Based on its assessment, our management has concluded that we maintained effective internal control over financial reporting as of December 31, 2022, based on criteria in Internal Control-Integrated Framework, issued by the COSO (2013).

Audit of the Effectiveness of Internal Control over Financial Reporting

Our independent registered accounting firm has audited the effectiveness of our internal control over financial reporting as of December 31, 2022, as stated in their report, which is included herein.

Remediation Actions Taken in 2022 Addressing Material Weakness Reported as of December 31, 2021

Our management took certain actions to address the material weakeness reported as of December 31, 2021 as described below:

Realization of the hedged items for certain debt at Braskem Idesa, a Mexican subsidiary

Our management has revised the review attributes that surround the accounting of hedged items. The following actions were executed and will be executed going forward to enhance the internal control:

·improve the hedge accounting control description to facilitate the activity understanding and execution by the control operator;
·provide training sessions to people involved in the transactional activities to deal with unusual transactions (such as prepayments) related to the hedge accounting process;
·enhance the level of the documentation that supports the accounting reconciliation process.

As a result of this activities and the assessment conducted during 2022, our management concluded that this material weakness was remediated as of December 31, 2022.

Changes in Internal Control over Financial Reporting

Other than certain of the changes and certain of the remediation activities described above, there were no changes to internal control over financial reporting during the year ended December 31, 2022 that would have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  Item 16A. Audit Committee Financial Expert

Our Statutory Compliance and Audit Committee currently includes two “audit committee financial experts” within the meaning of this Item 16A and as such term is defined in the SEC rules. See “Item 6. – A. Directors, Senior Management and Employees— Statutory Compliance and Audit Committee” for information regarding the experience of Mr. José Écio Pereira da Costa Júnior and Ms. Maria Helena Pettersson. They meet the standards of independence for external members of an audit committee under the Company’s policy and of Comissão de Valores Mobiliários Resolution No. 23 of 2021.

   
 224 
  Item 16B. Code of Ethics

We have adopted a code of conduct that applies to members of our board of directors, fiscal council and board of executive officers, as well as to our other employees. Our current code of conduct was approved by our board of directors in April 2018 and amended in June 2020. A copy of our code of conduct may be found on our website at www.braskem.com.br. The information included on our website or that might be accessed through our website is not included in this annual report and is not incorporated into this annual report by reference.

  Item 16C. Principal Accountant Fees and Services

Audit and Non-Audit Fees

The following table sets forth the fees billed to us by our independent registered public accounting firm KPMG Auditores Independentes during the fiscal years ended December 31, 2022 and December 31, 2021.

 

Year Ended December 31,

 

2022

2021

  (in millions of reais)
Audit fees(1) 34.3 25.7
Audit-related fees(2) 1.3 5.8
Tax fees(3) 2.8  
All other fees
 
 
Total fees

38.5

31.5

 

  (1) Audit fees consist of the aggregate fees billed by our independent registered public accounting firms in connection with the audit of our annual financial statements, interim reviews and related reserves in connection with the audit and review of financial statements and review of documents filed with the SEC.
  (2) Audit-related fees refer to services provided in connection with debt offerings or sustentability assessments.
  (3) Tax fees consist of the aggregate fees billed by our independent registered public accounting firms for tax compliance reviews.

Pre-Approval Policies and Procedures

The Company has an Audit and Non-Audit Services Pre-Approval Policy, initially approved by the Company’s Board of Directors on June 22, 2005 and amended on December 8, 2021, with prior analysis by the CCAE, which is now in effect under the name “Policy for hiring Independent Auditors.” The purpose of the Policy for hiring Independent Auditors is to regulate the process and the conditions for hiring the Company's Independent Auditors, including the services that can be provided by them to the Company or its Subsidiaries, the services that are not allowed and the annual list of pre-approved external audit and non-audit services. Our Management should, whenever requested by the CCAE’s Coordinator, present an update on the progress of the External Audit and Non-Audit Services previously approved by the CCAE and respective compensation, to enable the CCAE to ascertain full compliance with the Policy.

  Item 16D. Exemptions From the Listing Standards for Audit Committees

Our CCAE meets the requirements for the exemption available to foreign private issuers under paragraph (c)(3) of Rule 10A-3 under the Exchange Act. The CCAE is not the equivalent of, or wholly comparable to, a U.S. audit committee. Among other differences, it is not required to meet the standards of “independence established in Rule 10A-3 and is not fully empowered to act on all the matters that are required by Rule 10A-3 to be within the scope of an audit committee’s authority. Nonetheless, with the attributes provided to the CCAE under our bylaws and CCAE’s chart to the extent permitted by Brazilian law, we believe that its corporate governance system, taken as a whole, is materially equivalent to a system having an audit committee functioning as a committee of its board of directors. Accordingly, the Company does not believe that its reliance on the exemption in paragraph (c)(3) of Rule 10A-3 materially adversely affects the ability of the CCAE to act independently and to satisfy the other requirements of Rule 10A-3 to the extent permitted by Brazilian Corporate Law.

   
 225 

We also have a permanent fiscal council. However, as of November 9, 2021, we no longer rely on the fiscal council to avail ourselves of the exemption contained in paragraph (c)(3) of Rule 10A-3 under the Exchange Act.

  Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

Not applicable.

  Item 16F. Change in Registrants Certifying Accountant

Not applicable.

  Item 16G. Corporate Governance

On November 4, 2003, the SEC approved the final corporate governance rules established by the NYSE. According to these rules, foreign private issuers that are listed on the NYSE, such as Braskem, are subject to a more limited set of corporate governance requirements than those imposed on U.S. domestic issuers. As a foreign private issuer, Braskem must comply with the following four requirements imposed by the NYSE:

·Braskem must satisfy the audit committee requirements of Rule 10A-3 under the Exchange Act;
·Braskem’s chief executive officer must promptly notify the NYSE in writing if any executive officer of Braskem becomes aware of any material non-compliance with any of the applicable NYSE corporate governance rules;
·Braskem must provide a brief description of any significant ways in which Braskem’s corporate governance practices differ from those required to be followed by U.S. domestic issuers under the NYSE corporate governance rules; and
·Braskem must submit an executed written affirmation annually to the NYSE and an interim written affirmation to the NYSE each time a change occurs to Braskem’s board of directors or any committees of Braskem’s board of directors that are subject to Section 303A, in each case in the form specified by the NYSE.

Significant Differences

The significant differences between Braskem’s corporate governance practices and the NYSE’s corporate governance standards are mainly due to the differences between the U.S. and Brazilian legal systems. Braskem must comply with the corporate governance standards set forth under the Brazilian Corporate Law, the rules of the CVM and the applicable rules of the B3, as well as those set forth in Braskem’s bylaws.

The significant differences between Braskem’s corporate governance practices and the NYSE’s corporate governance standards are set forth below.

Independence of Directors and Independence Tests

In general, the NYSE corporate governance standards require listed companies to have a majority of independent directors and set forth the principles by which a listed company can determine whether a director is independent. However, under the NYSE corporate governance standards, a listed company (whether U.S. or foreign) of which more than 50% of the voting power is held by another company (a “controlled company”), need not comply with the following NYSE corporate governance standards:

   
 226 
·A controlled company need not have a majority of independent directors;
·A controlled company doesn’t need to have a nominating/corporate governance committee composed of independent directors with Internal Rules that comply with the NYSE corporate governance rules; and
·A controlled company doesn’t need to have a compensation committee composed of independent directors with Internal Rules that comply with the NYSE corporate governance rules.

Because a majority of the voting power of Braskem’s capital stock is directly controlled by Novonor S.A. (formerly Odebrecht S.A.), Braskem is a controlled company, and would therefore not be required to have a majority of independent directors.

Although Brazilian Corporate Law and Braskem’s bylaws establish rules in relation to certain qualification requirements of its directors, neither Brazilian Corporate Law nor Braskem’s bylaws require that Braskem has a majority of independent directors nor require Braskem’s board of directors or management to test the independence of Braskem’s directors before such directors are appointed. However, according to our policies, at least 20% of the members of our board of directors must be independent. Currently Braskem has six (6) independent members, from a total of eleven (11) members.

Executive Sessions

The NYSE corporate governance standards require non-management directors of a listed company to meet at regularly scheduled executive sessions without management.

According to Law No. 6,404/76 (the “Brazilian Corporate Law”), up to one-third of the members of Braskem’s board of directors may be elected to board of executive officer’s positions. Currently all Braskem’s directors are non-management directors. There is no legal requirement that those directors meet regularly without management.

Nominating/Corporate Governance and Compensation Committees

The NYSE corporate governance standards require that a listed company have a nomination/corporate governance committee and a compensation committee, each composed entirely of independent directors and each with a written Internal Rules that address certain duties. However, as a controlled company, Braskem would not be required to comply with these requirements if it were a U.S. domestic company.

Braskem is not required under Brazilian Corporate Law to have, and accordingly does not have, a nominating/corporate governance committee or a compensation committee. Currently, all Braskem’s directors are nominated by certain of its shareholders, including Novonor S.A. (formerly Odebrecht S.A.), pursuant to shareholders agreements and Braskem’s by-laws. However, Braskem has the People and Organization Committee, which is a committee of its board of directors that is responsible for, among other things:

·contributes to the preparation and oversight of the effective compliance regarding rules that govern the nomination of members of the board of directors, of its supporting committees and statutory executive Board;
·evaluate, prior to board of directors’ analysis, the CEO’s proposal regarding the statutory executive board’s composition, as well as its possible alternate; and
·analyze, prior to board of directors’ analysis, market references regarding the parameters and criteria presented by the Company’s management for administrators’ compensation and to submit a proposal for board of directors’ approval; and
   
 227 
·contribute with the board of directors in the annual performance assessment of the CEO based on the targets defined in its action plan and approved by the board of directors, and to analyze the results of the annual performance assessment held by the CEO of members of the statutory executive board, which results shall be presented to the board of directors.

Under Brazilian Corporate Law, Braskem’s shareholders establish the global compensation of its directors, fiscal council, and executive officers, including benefits and allowances, at a general shareholders’ meeting based on the recommendation of Braskem’s board of directors. Under Braskem’s Bylaws, the shareholders establish the global compensation and the board of directors establishes the individual compensation.

Audit Committee and Audit Committee Additional Requirements

The NYSE corporate governance standards require that a listed company have an audit committee with a written Internal Rules that address certain specified duties and that is composed of at least three independent members, all of whom satisfy the independence requirements of Rule 10A-3 under the Exchange Act and Section 303A.02 of the NYSE’s Listed Company Manual. As a foreign private issuer that qualifies for the general exemption from the listing standards relating to audit committees set forth in Section 10A-3(c)(3) under the Exchange Act, Braskem is not subject to the independence requirements of the NYSE corporate governance standards. See “Item 16D. Exemptions From the Listing Standards for Audit Committees.”

The SEC has recognized that, for foreign private issuers, local legislation may delegate some of the functions of the audit committee to other bodies. We established the CCAE upon approval at the board of directors meeting held on November 9, 2021. Our CCAE meets the requirements for the exemption available to foreign private issuers under paragraph (c)(3) of Rule 10A-3 under the Exchange Act. The CCAE is not the equivalent of, or wholly comparable to, a U.S. audit committee. Among other differences, it is not required to meet the standards of “independence” established in Rule 10A-3 and is not fully empowered to act on all the matters that are required by Rule 10A-3 to be within the scope of an audit committee’s authority.

Shareholder Approval of Equity Compensation Plans

The NYSE corporate governance standards require that shareholders of a listed company must be given the opportunity to vote on all equity compensation plans and material revisions thereto, subject to certain exceptions.

Under the Instruction No. 567/2009 of the Brazilian Securities Commission (Comissão de Valores Mobiliários – “CVM”), shareholder pre-approval is required for the adoption and revision of any equity compensation plans. On March 21, 2018, our shareholders approved our Long Term Incentive Plan, which is an equity incentive compensation plan that provides the yearly opportunity for certain members of our Company, selected by the Board of Directors, to voluntarily adhere to the plan by acquisition of our shares and receive matching shares after the vesting period of three years provided the member continuously holds the shares acquired and remains a member of the company during the entire vesting period.

Corporate Governance Guidelines

The NYSE corporate governance standards require that a listed company must adopt and disclose corporate governance guidelines that address certain minimum specified standards which include: (1) director qualification standards; (2) director responsibilities; (3) director access to management and independent advisors; (4) director compensation; (5) director orientation and continuing education; (6) management succession; and (7) annual performance evaluation of the board of directors.

Braskem has adopted the Brazilian Stock Exchange (B3 S.A. - Brasil, Bolsa e Balcão) corporate governance rules for Level 1 companies and must also comply with certain corporate governance standards set forth under Brazilian Corporate Law. See Item 9. The Offer and Listing—Trading on the B3.” The Level 1 rules do not require Braskem to adopt and disclose corporate governance guidelines covering the matters set forth in the NYSE’s corporate governance standards. However, certain provisions of Brazilian Corporate Law that are applicable to Braskem address certain aspects of director qualifications standards and director responsibilities.

   
 228 

Code of Conduct

The NYSE corporate governance standards require that a listed company must adopt and disclose a code of business conduct and ethics for directors, officers and employees and promptly disclose any waivers of the code for directors or officers. Each code of business conduct and ethics should address the following matters: (1) conflicts of interest; (2) corporate opportunities; (3) confidentiality; (4) fair dealing; (5) protection and proper use of company assets; (6) compliance with laws, rules and regulations (including insider trading laws); and (7) encouraging the reporting of any illegal or unethical behavior.

Braskem has adopted a Code of Conduct applicable to its directors, officers and employees, which addresses each of the items listed above. Braskems Code of Conduct is available on our investor relations website at www.braskem.com.br. No waivers of the provisions of the Code of Conduct are permitted, except if the restrictions on outside activities do not apply to Braskem’s directors and members of its fiscal council.

The main purpose of Braskem’s Code of Conduct is to establish the principles, values and standards that guide the business conduct of Team Members in their internal and external relations. Braskem also has a Code of Conduct for Contractors, which focuses on its relations with suppliers and partners.

  Item 16H. Mine Safety Disclosure

The information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and this Item is included in exhibit 99.01.

  Item 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

   
 229 

 

PART III

  Item 17. Financial Statements

We have responded to Item 18 in lieu of responding to this item.

  Item 18. Financial Statements

Reference is made to Item 19 for a list of all financial statements filed as part of this annual report.

  Item 19. Exhibits

(a) Financial Statements

Independent Auditor’s Reports on the Consolidated Financial Statements F-1
Consolidated Statement of Financial Position as of December 31, 2022, 2021 and 2020 F-4
Consolidated Statement of Profit or Loss as of December 31, 2022, 2021 and 2020 F-6
Consolidated Statement of Comprehensive Income as of December 31, 2022, 2021 and 2020 F-7
Consolidated Statement of Changes in Equity as of December 31, 2022, 2021 and 2020 F-8
Consolidated Statement of Cash Flows as of December 31, 2022, 2021 and 2020 F-10
Notes to the Consolidated Financial Statements F-12

(b) List of Exhibits

Exhibit Number

Exhibit

   
1.01 Bylaws of Braskem S.A., as amended (English translation) (incorporated by reference to Form 6-K of Braskem S.A. filed on April 21, 2022).
2.01 Amended and Restated Form of Deposit Agreement, dated as of January 4, 2017, among Braskem S.A., The Bank of New York Mellon, as Depositary, and Owners and Holders of American Depositary Shares issued thereunder (incorporated by reference to Exhibit 1 to Form F-6 of Braskem S.A. filed on December 22, 2016).
2.02 Description of Securities.
3.01 Shareholders’ Agreement of BRK Investimentos Petroquímicos S.A. and Braskem S.A., dated as of February 8, 2010, among Odebrecht S.A., Odebrecht Serviços e Participações S.A., Petrobras Química S.A.–Petroquisa, Petróleo Brasileiro S.A. Petrobras, and BRK Investimentos Petroquímicos S.A. and Braskem S.A., as intervening parties (English translation), as amended on September 24, 2018 and as adhered to by OSP Investimentos S.A. on December 31, 2018 (incorporated by reference to Exhibit 1 to Form 6-K of Braskem S.A. filed on February 28, 2019).
3.02 Second Amendment to the Shareholders ’ Agreement of BRK Investimentos Petroquímicos S.A. and Braskem S.A., entered into by Novonor S.A.– Em Recuperação Judicial, NSP Investimentos S.A. – Em Recuperação Judicial, and Petróleo Brasileiro S.A. – Petrobras, on December 15, 2021 (English translation) (incorporated by reference to Exhibit 1 to Report on Form 6-K of Braskem S.A. filed on December 16, 2021.
4.03 Restricted Share Award Plan of Braskem S.A. approved at the Extraordinary Shareholders’ Meeting held on March 21, 2018 (English translation) (incorporated by reference to Exhibit 1 to Form 6-K of Braskem S.A. filed on March 22, 2018).
   
 230 

 

4.04 English Summary of Petrochemical Naphtha Purchase and Sale Agreement by and Between Petróleo Brasileiro S.A. – Petrobras and Braskem S.A. dated June 8, 2020 (incorporated by reference to Exhibit 4.04 to Form 20-F of Braskem S.A. filed on May 14, 2021).
4.05 English Summary of Petrochemical Naphtha Purchase and Sale Agreement by and Between Petróleo Brasileiro S.A. – Petrobras and Braskem S.A. dated June 8, 2020 (incorporated by reference to Exhibit 4.05 to Form 20-F of Braskem S.A. filed on May 14, 2021).
4.06 English Summary of Petrochemical Naphtha Purchase and Sale Agreement by and Between Petróleo Brasileiro S.A. – Petrobras and Braskem S.A. dated June 8, 2020 (incorporated by reference to Exhibit 4.06 to Form 20-F of Braskem S.A. filed on May 14, 2021).
4.07 English Summary of Petrochemical Naphtha Purchase and Sale Agreement by and Between Petróleo Brasileiro S.A. – Petrobras and Braskem S.A. dated December 22, 2020 (incorporated by reference to Exhibit 4.07 to Form 20-F of Braskem S.A. filed on May 14, 2021).
4.08 English Summary of Ethane, Propane and Hydrogen Purchase and Sale Agreement by and Between Petróleo Brasileiro S.A. – Petrobras and Braskem S.A. dated December 22, 2020 (incorporated by reference to Exhibit 4.08 to Form 20-F of Braskem S.A. filed on May 14, 2021).
8.01 List of subsidiaries (incorporated by reference to note 2.3 to our audited consolidated financial statements included elsewhere in this annual report).
11.01 Code of Conduct of Braskem S.A., as amended (English translation) (incorporated by reference to Exhibit 1 to Form 6-K of Braskem S.A. filed on April 20, 2021).
12.01 Certification of Principal Executive Officer dated April 24, 2023 pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e).
12.02 Certification of Principal Financial Officer dated April 24, 2023 pursuant to Rules 13a-15(e) and 15d-15(e).
13.01 Certifications of Principal Executive Officer and Principal Financial Officer dated April 24, 2023 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.01 Disclosure of Mine Safety and Health Administration Safety Data.

 

   
 231 

 

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

Date: April 24, 2023

 

BRASKEM S.A.

By: /s/ Roberto Bischoff

Name: Roberto Bischoff

Title: Chief Executive Officer

   
 232 

INDEX TO FINANCIAL STATEMENTS

Independent Auditors’s Reports on the Consolidated Financial Statements (Auditor Firm ID: 1124) F-1
Consolidated Statement of Financial Position as of December 31, 2022, 2021 and 2020 F-4
Consolidated Statement of Profit or Loss as of December 31, 2022, 2021 and 2020 F-6
Consolidated Statement of Comprehensive Income as of December 31, 2022, 2021 and 2020 F-7
Consolidated Statement of Changes in Equity as of December 31, 2022, 2021 and 2020 F-8
Consolidated Statement of Cash Flows as of December 31, 2022, 2021 and 2020 F-10
Notes to the Consolidated Financial Statements F-12
   
 233 

 

Exhibit
Number

 

Exhibit

     
2.02   Description of Securities.
12.01   Certification of Principal Executive Officer dated April 24, 2023 pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e).
12.02   Certification of Principal Financial Officer dated April 24, 2023 pursuant to Rules 13a-15(e) and 15d-15(e).
13.01   Certifications of Principal Executive Officer and Principal Financial Officer dated April 24, 2023 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.01   Disclosure of Mine Safety and Health Administration Safety Data.

 

 

   
 234 

 

 

 

 
 

 

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors
Braskem S.A.:

Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated statement of financial position of Braskem S.A. and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of profit or loss, comprehensive income (loss), changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

   
 F-1 
 

 

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matter

The critical audit matter communicated below is matter arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

Evaluation of the provision and disclosures related to the geological phenomenon in the state of Alagoas

As discussed in note 26 to the consolidated financial statements, the Company has recorded a provision related to the geological phenomenon in the vicinity of the Company’s salt mining wells in the state of Alagoas of R$ 6,626,558 thousand as of December 31, 2022. The provision is for the estimated future outflows of resources required to settle the Company’s commitments under agreements signed with Brazilian government authorities following the occurrence of the geological phenomenon as well as for other obligations related to the geological phenomenon for which it is probable that an outflow of economic benefits will be required. The commitments made by the Company include taking measures to close and stabilize the salt mines, relocating and compensating residents and businesses in the region and adopting actions and measures in vacated areas, urban mobility and social compensation.

We identified the evaluation of the provision and disclosures related to the geological phenomenon in the vicinity of the Company’s salt mining wells in Alagoas as a critical audit matter. The evaluation of the estimates and assumptions used by the Company to determine the provision amount required challenging auditor judgment and the use of professionals with specialized skills and knowledge. The key estimates and assumptions related to the extent and cost of the remediation actions required to stabilize and close the wells, the market value of the properties of residents and businesses in the region, other costs to compensate third parties and the estimate of probable outflows of economic benefits to settle other obligations.

 

   
 F-2 
 

  

The following are the primary procedures we performed to address this critical audit matter:

We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s provision estimation process, including controls related to the key estimates and assumptions used in the provision estimation process and evaluation of information from external specialists, as well as controls over the financial statement disclosures.

We involved infrastructure valuation professionals, with specialized skills and knowledge, who assisted in:

·evaluating the technical appraisal reports regarding the stability of the salt mining wells and the required remediation actions to stabilize and close the wells, the remediation plans established by the Company and the Company’s estimate of the significant costs to implement these plans;
·evaluating the assumptions used by the Company to estimate the market value of properties and the significant components of the other costs to compensate third parties impacted by the geological phenomenon, by comparing them to internal and external information, as applicable, including publicly available information on real estate values in the region and property sizes, contracts with third party service providers and estimates received from external legal advisors; and
·performing a sensitivity analysis of certain of the assumptions used by the Company to estimate the market value of properties.

We questioned management about the other obligations related to the geological phenomenon and inspected internal and external documents related to them.

We read letters received directly from the Company’s external legal counsel, that included their assessment of the likelihood of there being an outflow of economic resources to settle the other obligations related to the geological phenomenon as well as the estimation of the amount involved and compared these assessments and estimates to those of the Company and with the disclosures made.

We evaluated the disclosures related to the geological phenomenon in Alagoas State.

 

1124

KPMG Auditores Independentes Ltda.

 

We have served as the Company’s auditor since 2018.

São Paulo, Brazil
April 24, 2023

   
 F-3 
 

 

Braskem S.A.        
           
Statement of consolidated financial position at December 31 
All amounts in thousands of Reais      

           
Assets Note   2022   2021
           
Current assets          
Cash and cash equivalents 5   12,466,474    8,680,686
Financial investments 6     2,295,497    3,492,710
Trade accounts receivable 7     3,231,934    7,153,565
Inventories 8   14,030,064     16,335,101
Taxes recoverable 10     1,156,355    1,428,658
Recoverable income taxes 22.1     392,062    1,189,812
Derivatives 20.5     157,906   33,816
Other receivables       727,364    979,097
           
Current Assets      34,457,656     39,293,445
           
Non-current assets          
Financial investments 6    17,134   16,845
Trade accounts receivable 7     -   13,395
Taxes recoverable 10     1,617,669    1,252,058
Recoverable income taxes 22.1     252,995    230,069
Deferred tax assets 22.2     6,358,601    8,257,252
Judicial deposits        215,274    194,212
Derivatives 20.5    71,544    51
Other receivables       170,536    365,652
Investments 11     149,023   58,923
Property, plant and equipment 12   37,763,295     37,225,130
Intangible assets 13     3,022,144    2,877,299
Right of use of assets 14 (a)     3,952,987    2,780,037
           
Non-Current Assets      53,591,202     53,270,923
           
Total assets     88,048,858     92,564,368

 

   
 F-4 
 
Braskem S.A.        
           
Statement of consolidated financial position at December 31 
All amounts in thousands of Reais      

 

           
Liabilities and shareholders' equity Note   2022   2021
           
Current liabilities          
Trade payables 15   12,246,782   12,053,266
Borrowings 16     1,254,550     1,343,494
Braskem Idesa borrowings 17     868,635    86,765
Debentures 18     127,801    59,088
Derivatives 20.5     195,169     256,131
Payroll and related charges       827,826     1,170,346
Taxes payable 21     491,051     1,012,116
Income taxes payable       381,117     1,672,844
Leniency agreement 25     392,486     353,385
Sundry provisions 23     530,814     465,051
Provision - geological event in Alagoas 26     4,247,609     4,378,071
Lease 14 (b)     1,039,706     675,366
Other payables       1,581,701     1,667,600
           
Current Liabilities      24,185,247   25,193,523
           
Non-current liabilities          
Trade payables 15   3,069     111,464
Borrowings 16   31,310,710   33,553,766
Braskem Idesa borrowings 17   10,501,683   12,224,770
Debentures 18     3,023,674     137,830
Derivatives 20.5    81,917     362,915
Taxes payable 21     298,026     260,497
Loan from non-controlling shareholders of Braskem Idesa 9     2,498,093     3,646,538
Deferred tax liabilities 22.2     1,153,481     1,407,434
Post-employment benefits 27.3(a)     493,743     487,697
Legal provisions 24.1     1,171,498     1,153,830
Leniency agreement 25     510,654     769,911
Sundry provisions 23     846,133     824,212
Provision - geological event in Alagoas 26     2,378,949     3,283,188
Lease 14 (b)     3,200,824     2,481,048
Other payables       282,940     461,917
           
Non-Current Liabilities      57,755,394   61,167,017
           
Shareholders' equity 28        
Capital       8,043,222     8,043,222
Capital reserve     6,175   3,473
Profit reserves       1,825,616     3,483,935
Additional paid in capital     (488,388)   (488,388)
Long-term incentive plans      39,413    31,932
Other comprehensive income     (2,076,066)   (3,170,158)
Treasury shares       (28,173)     (38,197)
           
Total attributable to the  Company's shareholders       7,321,799     7,865,819
           
Non-controlling interest in subsidiaries     (1,213,582)   (1,661,991)
           
Shareholders’ Equity        6,108,217     6,203,828
           
Total liabilities and shareholders' equity     88,048,858   92,564,368

 

   
 F-5 
 
Braskem S.A.        
           
Statement of consolidated profit or loss    
Years ended December 31      
All amounts in thousands of Reais, except earnings (loss) per share  

 

                 
    Note   2022   2021   2020
                 
Net revenue   30   96,519,284    105,625,201   58,543,494
Cost of products sold   32    (85,160,548)    (73,568,231)    (47,331,414)
                 
Gross profit       11,358,736   32,056,970   11,212,080
                 
Income (expenses)                 
Selling and distribution   32   (2,108,417)   (2,055,640)   (1,852,055)
Loss  for impairment of trade accounts receivable and others from clients   32     (38,426)    (8,914)     (55,252)
General and administrative    32   (2,763,983)   (2,522,127)   (1,918,747)
Research and development   32   (374,493)   (296,583)   (250,648)
Results from equity-accounted investees   11(b)    34,848   4,644     (19,398)
Other income   32     507,333     1,534,487     750,749
Other expenses   32   (2,343,525)   (2,669,290)   (7,938,621)
                 
Profit (loss) before net financial expenses and taxes         4,272,073   26,043,547   (71,892)
                 
Financial results   33            
Financial expenses        (5,662,693)   (5,907,155)   (4,913,365)
Financial income         2,010,134     1,827,438     600,184
Exchange rate variations, net       (572,170)   (4,002,807)   (5,298,711)
                 
Finance income (cost)         (4,224,729)    (8,082,524)    (9,611,892)
                 
Profit (loss) before income tax         47,344   17,961,023    (9,683,784)
                 
Income taxes   22.1(d)   (867,735)   (3,999,403)     2,668,478
                 
(Loss) net profit for the year        (820,391)   13,961,620    (7,015,306)
                 
Attributable to:                
Company's shareholders       (335,677)   13,984,946   (6,691,720)
Non-controlling interest in subsidiaries       (484,714)     (23,326)   (323,586)
                 
(Loss) net profit for the year        (820,391)   13,961,620    (7,015,306)
                 
Earnings (loss) per share - R$   29            
Basic                
Common       (0.42)   17.57   (8.41)
Preferred shares class "A"       (0.42)   17.57   (8.41)
Preferred shares class "B"       (0.42)     0.58   (8.41)
                 
Diluted                
Common       (0.42)   17.57   (8.41)
Preferred shares class "A"       (0.42)   17.52   (8.38)
Preferred shares class "B"       (0.42)     0.58   (8.41)

 

   
 F-6 
 
Braskem S.A.        
           
Statement of consolidated comprehensive income  
Years ended December 31      
All amounts in thousands of Reais      

 

                 
    Note   2022   2021   2020
                 
(Loss) net profit for the year         (820,391)    13,961,620     (7,015,306)
                 
Other comprehensive income:                
Items that will be reclassified subsequently to profit or loss                
Fair value of cash flow hedge, net of taxes       292,486   324,374    (397,558)
Fair value of cash flow hedge from jointly-controlled, net of taxes        267     (968)    1,260
Cash flow hedges,net of tax        292,753   323,406    (396,298)
                 
Exchange variation of foreign sales hedge, net of taxes   20.6(a)   1,121,938    (1,260,781)    (4,541,581)
Sales Hedge - transfer to profit or loss, net of taxes   20.6(a)   938,118   1,255,983   1,448,079
Exchange variation of foreign sales hedge - Braskem Idesa, net of taxes   20.6(b)   489,773    (143,223)    (311,795)
Sales Hedge - transfer to profit or loss - Braskem Idesa, net of taxes   20.6(b)   296,803   355,060   330,210
Sales hedges, net of tax        2,846,632   207,039    (3,075,087)
                 
Foreign subsidiaries currency translation adjustment        (1,805,667)   1,503,148   2,658,042
                 
Total        1,333,718    2,033,593     (813,343)
                 
Item that will not be reclassified to profito or loss                
Actuarial gain (loss) with post-employment benefits, net of taxes         10,670     23,014     (647)
                 
Total         10,670     23,014     (647)
                 
Total comprehensive income for the year        523,997    16,018,227     (7,829,296)
                 
Attributable to:                
Company's shareholders       714,899    16,015,874    (7,108,541)
Non-controlling interest in subsidiaries        (190,902)    2,353    (720,755)
                 
Total comprehensive income for the year        523,997    16,018,227     (7,829,296)

   
 F-7 
 
Braskem S.A.        
           
Statement of changes in equity      
Years ended December 31      
All amounts in thousands of Reais      

 

                                                           
                                    Attributed to shareholders' interest            
              Profit reserves                                 
  Note   Capital   Capital reserve  

Legal

reserve

 

Tax

incentive

 

Retention

of profits

 

Additiona

dividends

proposed

 

Additional paid in

capital

  Long-term Incentive Plans   Other comprehensive income   Treasury shares  

Retained earnings/

Accumulated losses

 

Total

Braskem shareholders' interest

  Non-controlling interest in subsidiaries   Total shareholders' equity (net capital deficiency)
                                                           
As of December 31, 2019      8,043,222     232,472     577,476   153,478     1,174,301     -   (488,388)   19,980   (4,777,519)    (49,724)     -    4,885,298    (940,592)    3,944,706
                                                           
Comprehensive income for the year                                                          
Net profit (loss) for the year         -         -     -           -     (6,691,720)     (6,691,720)   (323,586)     (7,015,306)
Exchange variation of foreign sales hedge, net of taxes         -         -     -         (3,079,691)       -     (3,079,691)     4,604     (3,075,087)
Fair value of cash flow hedge, net of taxes         -         -     -         (390,608)       -     (390,608)    (5,690)     (396,298)
Actuarial (loss) gain with post-employment benefits, net of taxes         -         -     -          (648)       -   (648)   1   (647)
                                                         
Foreign subsidiaries currency translation adjustment         -         -     -          3,054,126       -    3,054,126   (396,084)   2,658,042
 Total Comprehensive income for the period      -     -    -   -     -     -    -   -   (416,821)   -   (6,691,720)     (7,108,541)   (720,755)     (7,829,296)
                                                           
Comprehensive income (loss)                                                          
Realization of additional property, plant and equipment price-level restatement, net of taxes         -         -     -           (26,302)      26,302       -  
Realization of deemed cost of jointly-controlled investment, net of taxes         -         -     -          (741)     741       -  
Fair value adjustments of trade accounts receivable, net of taxes         -         -     -           113       -     113     -    113
Exchange variation in hyperinflationary economy, net of taxes         -         -     -           8,077       -     8,077     -    8,077
Long term incentive plan, net of taxes         -         -     -       11,629     -       -   11,629    (415)     11,214
Other         -         -     -           3,695      (3,695)       -  
Comprehensive income       -     -    -   -     -     -    -     11,629     (15,158)   -    23,348   19,819    (415)     19,404
Contributions and distributions to shareholders                                                          
Dividends-lapse of statute of limitation         -         -     -           -     1,110     1,110     -    1,110
Additional dividends of subsidiary         -         -     -           -       -      (2,450)   (2,450)
Absorption of losses         (232,460)     (577,476)   (153,478)   (1,174,301)     -           -       2,137,715       -  
Gain on transfer of shares in custody long term incentive plan      -     (12)    -   -     -     -    -         -     20     -   8     -     8
 Total Contributions to shareholders         (232,472)     (577,476)   (153,478)   (1,174,301)     -         -     20     2,138,825     1,118    (2,450)   (1,332)
                                                           
As of December 31, 2020      8,043,222     -    -   -     -     -   (488,388)   31,609   (5,209,498)    (49,704)    (4,529,547)   (2,202,306)   (1,664,212)     (3,866,518)
                                                           
                                                           
Comprehensive income for the year:                                                          
Net profit (loss) for the year         -         -     -                 13,984,946     13,984,946     (23,326)    13,961,620
Exchange variation of foreign sales hedge, net of taxes         -         -     -        154,080       -    154,080   52,959   207,039
Fair value of cash flow hedge, net of taxes         -         -     -        262,726       -    262,726   60,680   323,406
Actuarial gain (loss) with post-employment benefits, net of taxes         -         -     -       23,028       -   23,028   (14)     23,014
Foreign subsidiaries currency translation adjustment         -         -     -        1,591,094       -    1,591,094     (87,946)   1,503,148
 Total Comprehensive income for the period      -     -    -   -     -     -    -   -    2,030,928   -   13,984,946     16,015,874     2,353    16,018,227
                                                           
Equity valuation adjustments:                                                          
Realization of additional property, plant and equipment price-level restatement, net of taxes         -         -     -         (26,164)      26,164       -  
Realization of deemed cost of jointly-controlled investment, net of taxes         -         -     -        (719)     719       -  
Long term incentive plan         -         -     -      323     -       -     323    (132)    191
Fair value adjustments of trade accounts receivable, net of taxes         -         -     -        (130)       -   (130)     -   (130)
Exchange variation in hyperinflationary economy, net of taxes         -         -     -       35,425       -   35,425     -     35,425
 Equity valuation Adjustments      -     -    -   -     -     -    -    323     8,412   -    26,883   35,618    (132)     35,486
Contributions and distributions to shareholders:                                                          
Dividends-lapse of statute of limitation         -         -     -         -     1,653     1,653     -    1,653
Dividends         -         -     -         -     (6,000,000)     (6,000,000)     -     (6,000,000)
Incentive long term plan payments with treasury shares         3,473         -     -         -    11,507     -   14,980     -     14,980
Legal reserve         -    472,770       -     -         -     (472,770)       -  
Tax incentive reserve         -       1,017,546     -     -         -     (1,017,546)       -  
Retention of profits         -         643,619     -         -     (643,619)       -  
Additional proposed dividends      -     -    -   -     -    1,350,000    -   -     -   -   (1,350,000)    -     -    -
 Total Contributions to shareholders         3,473    472,770     1,017,546     643,619    1,350,000         -    11,507   (9,482,282)     (5,983,367)     -     (5,983,367)
                                                           
As of December 31, 2021      8,043,222    3,473     472,770   1,017,546   643,619     1,350,000   (488,388)   31,932   (3,170,158)    (38,197)     -    7,865,819   (1,661,991)    6,203,828
                                                           
                                                           
As of December 31, 2021      8,043,222    3,473     472,770   1,017,546   643,619     1,350,000   (488,388)   31,932   (3,170,158)    (38,197)     -    7,865,819   (1,661,991)    6,203,828

   
 F-8 
 
Braskem S.A.        
           
Statement of changes in equity      
Years ended December 31      
All amounts in thousands of Reais      

                                                           
      Attributed to shareholders' interest            
              Profit reserves                                 
  Note   Capital   Capital reserve  

Legal

 reserve

  Tax incentive   Retention of profits   Additional dividends proposed   Additional paid in capital   Long-term Incentive Plans   Other comprehensive income   Treasury shares  

Retained earnings/ Accumulated 

losses

 

Total

Braskem shareholders' interest

  Non-controlling interest in subsidiaries   Total shareholders' equity (net capital deficiency)
                                                         
As of December 31, 2021      8,043,222    3,473     472,770   1,017,546   643,619     1,350,000   (488,388)   31,932   (3,170,158)    (38,197)     -    7,865,819   (1,661,991)    6,203,828
                                                           
Comprehensive income for the year:                                                          
Net profit (loss) for the year         -         -     -         -     (335,677)     (335,677)   (484,714)     (820,391)
Exchange variation of foreign sales hedge, net of taxes         -         -     -        2,649,988       -    2,649,988    196,644   2,846,632
Fair value of cash flow hedge, net of taxes         -         -     -        292,753       -    292,753     -   292,753
Actuarial gain on defined benefit and health plan, net of taxes         -         -     -       10,186       -   10,186     484     10,670
Foreign subsidiaries currency translation adjustment      -     -    -   -     -     -    -   -   (1,902,351)   -     -     (1,902,351)   96,684     (1,805,667)
Total Comprehensive income for the period          -         -     -        1,050,576     (335,677)    714,899   (190,902)   523,997
                                                           
Equity valuation adjustments:                                                          
Realization of additional property, plant and equipment price-level restatement, net of taxes         -         -     -         (26,164)      26,164       -  
Realization of deemed cost of jointly-controlled investment, net of taxes         -         -     -        (719)     719       -  
Long term incentive plan, net of taxes         -         -     -       20,207     -       -   20,207     -     20,207
Fair value adjustments of trade accounts receivable, net of taxes         -         -     -       (35)       -     (35)     -     (35)
Fair value of financial transactions of non-controlling subsidiaries         -         -     -         -       -      609,827   609,827
Exchange variation in hyperinflationary economy, net of taxes         -         -     -       70,434       -   70,434     -     70,434
Equity valuation adjustments      -     -    -   -     -     -    -     20,207   43,516   -    26,883   90,606    609,827   700,433
Contributions and distributions to shareholders:                                                          
Incentive long term plan payments with treasury shares         2,702         -     -     (12,726)     -    10,024     -       -  
SUDENE tax incentive supplement         -       108,975     -     -         -     (108,975)       -  
Non-controlling interest in acquired entity 2.3 (iii)       -         -     -         -       -     30,720     30,720
Other         -         -     -         -     475     475     -    475
Additional dividends approved in the board meeting         -         -   (1,350,000)         -       -     (1,350,000)     -     (1,350,000)
Absorption of losses 28.6       -       (417,294)     -         -       417,294       -    
Proposed dividends         -         -     -         -       -      (1,236)   (1,236)
 Total Contributions to shareholders      -     2,702    -     108,975   (417,294)   (1,350,000)    -   (12,726)     -    10,024     308,794     (1,349,525)   29,484     (1,320,041)
                                                           
As of December 31, 2022      8,043,222    6,175     472,770   1,126,521   226,325     -   (488,388)   39,413   (2,076,066)    (28,173)     -    7,321,799   (1,213,582)    6,108,217

 

 

   
 F-9 
 
Braskem S.A.        
           
Statement of consolidated cash flow    
Years ended December 31      
All amounts in thousands of Reais      

 

               
  Note   2022   2021   2020
               
Profit (loss) before income taxes      47,344   17,961,023   (9,683,784)
               
Adjustments for reconciliation of profit              
Depreciation and amortization 32     4,733,165     4,178,433     4,048,081
Results from equity-accounted investees 11(b)     (34,848)    (4,644)    19,398
Interest foreign exchange gain/losses       2,702,636     6,311,431   10,457,272
Provisions, net       370,153     819,130     336,838
Provision - geological event in Alagoas 26     1,520,019     1,339,765     6,901,828
PIS and Cofins credits - exclusion of ICMS from the calculation basis 32     -   (1,031,099)   (310,557)
Loss for impairment of trade accounts receivable and others from clients 32    38,426   8,914    55,252
Write-offs of long-lived assets       130,995     115,187   8,794
               
Adjustments for reconciliation of profit        9,507,890   29,698,140   11,833,122
               
Changes in operating working capital              
Judicial deposits - unfreezing (blocking) Public Civil Action 26.1(i)     -     -     3,746,107
Financial investments       1,530,050     296,957   (1,860,827)
Trade accounts receivable       3,661,267   (2,175,285)   (2,187,826)
Inventories        2,138,161   (7,574,285)   (252,534)
Taxes recoverable       682,457     4,963,587     1,532,554
Other receivables       310,789   (198,556)     690,888
Trade payables       514,079     1,199,614   (3,001,564)
Taxes payable     (1,009,356)   (3,007,488)     449,761
Leniency agreement     (317,867)   (389,087)   (349,842)
Sundry provisions     (406,587)   (314,194)   (145,355)
Geological event in Alagoas 26   (2,742,791)   (2,928,081)   (1,181,931)
Other payables     (390,727)     805,452    14,801
               
Cash generated from operations     13,477,365   20,376,774     9,287,354
               
Interest paid     (2,904,879)   (2,883,433)   (2,736,821)
Income taxes     (1,620,747)   (2,706,856)   (257,542)
               
Net cash generated from operating activities       8,951,739   14,786,485     6,292,991
               
Proceeds from the sale of fixed and intangible assets     2,438    40,353    33,140
Dividends received     5,660   295   4,822
Acquisition of subsidiary       (42,121)        
Acquisition of other investments       (64,969)     -    
Acquisitions to property, plant and equipment and intangible assets     (4,848,281)   (3,421,324)   (2,759,789)
               
Net cash used in investing activities      (4,947,273)    (3,380,676)    (2,721,827)
               
Short-term and Long-term debt              
Acquired       6,418,208    16,308   13,049,459
Payments     (3,855,662)   (9,413,909)   (8,734,505)
Braskem Idesa borrowings              
Acquired       -     7,271,658     -
Payments       (45,311)   (7,995,045)   (905,210)
Loan payment to non-controlling shareholders of Braskem Idesa       (34,122)    (9,545)     (37,618)
Lease 14(b)   (928,890)   (841,706)   (662,068)
Dividends paid     (1,350,293)   (5,993,265)    (2,380)
Non-controlling interest in subsidiaries      21,162     -    
Other financial liabilities       -     -   (534,456)
               
Net cash generated (used) in financing activities     225,092    (16,965,504)     2,173,222
               
Exchange variation on cash of foreign subsidiaries     (443,770)     377,529     1,314,586
               
Increase (decrease) in cash and cash equivalents       3,785,788    (5,182,166)     7,058,972
               
Represented by              
Cash and cash equivalents at the beginning of the year       8,680,686   13,862,852     6,803,880
Cash and cash equivalents at the end of the year     12,466,474     8,680,686   13,862,852
               
Increase (decrease) in cash and cash equivalents       3,785,788    (5,182,166)     7,058,972
   
 F-10 
 

Summary of Notes

1 Operations 9
2 Basis of preparation of the consolidated financial statements 9
3 Application of estimates and judgments 14
4 Risk management 15
5 Cash and cash equivalents 18
6 Financial investments 19
7 Trade accounts receivable 20
8 Inventories 21
9 Related parties 22
10 Taxes recoverable 26
11 Investments 27
12 Property, plant and equipment 31
13 Intangible assets 34
14 Right-of-use assets and lease liability 36
15 Trade payables 39
16 Borrowings 40
17 Braskem Idesa Financing 43
18 Debentures 44
19 Reconciliation of borrowing activities in the statement of cash flow 45
20 Financial instruments 46
21 Taxes payable 62
22 Income taxes 62
23 Sundry provisions 66
24 Provisions for legal proceedings and contingent liabilities 68
25 Leniency agreement with authorities 78
26 Geological event - Alagoas 79
27 Benefits offered to team members 87
28 Equity 92
29 Earnings (loss) per share 97
30 Net revenues 99
31 Tax incentives 100
32 Expenses by nature and function 101
33 Financial results 101
34 Segment information 103
35 Contractual obligations 106
36 Subsequent events 106

 

   
 F-11 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

1 Operations

Braskem S.A. is a public corporation headquartered in Camaçari, Bahia (“BA”), which, jointly with its subsidiaries (hereinafter “Braskem” or “Company”), is controlled by Novonor S.A. (“Novonor”), which directly and indirectly holds interests of 50.11% and 38.32% in its voting and total capital, respectively. The ultimate parent company of Braskem is Kieppe Patrimonial S.A.

The Braskem’s shares are traded on B3 S.A. Brasil, Bolsa, Balcão (“B3”), under the tickers BRKM3, BRKM5 and BRKM6, and on the New York Stock Exchange (“NYSE”) under the ticker BAK and on the Madrid Stock Exchange (“LATIBEX”) under the ticker XBRK.

Braskem also is engaged, among others, in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air and industrial gases, as well as the provision of industrial services and the production, supply and sale of electric energy and natural gas for its own use and use by other companies. Braskem also invests in other companies.

The Company has industrial plants in Brazil, the United States, Germany, and Mexico. The units produce thermoplastic resins, such as polyethylene (“PE”), polypropylene (“PP”), polyvinyl chloride (“PVC”) and other basic petrochemicals.

Operations of subsidiary Braskem Idesa S. A. P. I. (“Braskem Idesa”)

On September 27, 2021, Braskem Idesa signed the following documents:

(i) amendment to the ethane supply agreement (“Amendment”) with PEMEX; and

(ii) agreement with Petróleos Mexicanos, PEMEX Logística and other Mexican government entities, establishing administrative support measures, especially to obtain of licenses, permits and rights of way for the project to build an ethane import terminal with the capacity to meet all Braskem Idesa's feedstock requirements ("Terminal Agreement”).

The Amendment changed the minimum contractual volume commitment to 30,000 barrels/day until the limit date of February 2025 (subject to extensions in the event of delay in obtaining the licenses for the terminal's construction). The terminal's startup is expected in the second half of 2024. The terminal project is designed to supplement ethane supply in Mexico by gaining access to new feedstock sources.

The Amendment further established first-refusal rights for Braskem Idesa in the acquisition of all ethane that PEMEX has available and does not consume in its own production process through 2045, at prices based on international references. The approvals required for the Amendment and Terminal Agreement to come into force were obtained in October 2021 and the Amendment started producing effects retroactive to February 26, 2021, the execution date of the memorandum of understanding.

On June 14, 2022, Braskem Idesa signed agreements with Advario B.V. to sell 50% of the capital stock of Terminal Química Puerto México (“Terminal Química”), the subsidiary of Braskem Idesa responsible for developing and operating the ethane import terminal in Mexico.

In March 2023, the conditions for the conclusion of the agreement were fulfilled and Advario B.V. made a payment of US$56 million (R$292 million) to Braskem Idesa for the acquisition of 50% of equity interest in Terminal Química.

 

   
 F-12 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

2 Basis of preparation of the financial statements

2.1 Basis of accounting

The consolidated financial statements were prepared and presented in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

2.2 Basis of presentation

The Company’s consolidated financial statements (“financial statements”) were prepared under the historical cost basis, unless stated otherwise in the accounting policies. These consolidated financial statements have been prepared on a going concern basis.

The significant accounting policies applied in the preparation of these consolidated financial statements were included in the respective notes and are consistent in the fiscal years presented.

The issue of these consolidated financial statements was authorized by the Executive Board on April 24, 2023.

   
 F-13 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

2.3 Basis of consolidation

The consolidated financial statements include the financial statements of Braskem S.A. and the following entities:

                   
          Total and voting interest (%)
              2022, 2021 and 2020
          Headquarter   2022   2021   2020
 BM Insurance Company Limited ("BM Insurance")        Bermuda    100   100     100
 Braskem Argentina S.A. (“Braskem Argentina”)        Argentina    100   100     100
 Braskem Energy Ltda.    (i)   Brazil       100    
 Braskem Finance Limited (“Braskem Finance”)        Cayman Islands    100   100     100
 Braskem Green S.A.        Brazil    100   100    
 Braskem Incorporated Limited ("Braskem Inc.")        Cayman Islands    100   100     100
 Braskem Mexico, S. de RL de C.V. ("Braskem México")        Mexico    100   100     100
 Braskem Netherlands B.V. ("Braskem Holanda")        Netherlands    100   100     100
 Braskem Petroquímica Chile Ltda. (“Braskem Chile”)        Chile    100   100     100
 Braskem Ventures Ltda. ("Braskem Ventures")    (ii)   Brazil    100        
 Lantana Trading Co. Inc. (“Lantana”)    (iii)   Bahamas       100     100
 Voqen Energia Ltda. ("Voqen")    (i)   Brazil    100    -    
 Braskem America Finance Company ("Braskem America Finance")        USA    100   100     100
 Braskem America, Inc. (“Braskem America”)        USA    100   100     100
 Braskem Europe GmbH ("Braskem Alemanha")        Germany    100   100     100
 Braskem Idesa S.A.P.I. ("Braskem Idesa")        Mexico   75   75     75
 Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")        Mexico   75   75     75
 Braskem India Private Limited ("Braskem India")        India    100   100     100
 Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")        Mexico    100   100     100
 Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")        Mexico    100   100     100
 Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)        Netherlands    100   100     100
 Braskem Netherlands Green B.V. (“Braskem Holanda Green”)        Netherlands    100   100    
 Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)        Netherlands    100   100     100
 Builder Brasil Ltda. ("Builder Brasil")    (ii)   Brazil    100        
 Builder USA LLC. ("Builder USA")    (ii)   USA    100        
 Cetrel S.A. ("Cetrel")        Brazil   63.70   63.70     63.70
 Distribuidora de Água Camaçari S.A. ("DAC")        Brazil   63.70   63.70     63.70
 B&TC B.V. ("B&TC")    (iv)   Netherlands   60        
 ER Plastics B.V. ("ER Plastics")    (iv)   Netherlands   60        
 Terminal Química Puerto México ("Terminal Química")        Mexico   75   75    
 Special Purpose Entities                     
Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado
Longo Prazo ("FIM Júpiter")
      Brazil    100   100     100
Fundo de Investimento Santander Netuno Multimercado Crédito Privado
Longo Prazo ("FIM Netuno")
      Brazil    100   100     100

 

(i) Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.
(ii) Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.
(iii) Lantana was a non-operational entity that had the operations closed in November 2022.
(iv) B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).

 

(a) Subsidiaries

The Company controls an entity when it is exposed to, or entitled to, the variable returns originating from its involvement with the entity and has the capacity to affect such returns by exercising its power over the entity.

   
 F-14 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

The financial statements of subsidiaries are included in these consolidated financial statements as from the date the Company obtains control until the date of the loss of control.

(b) Equity method Investees

The Company’s investments in entities with accounting treatment using the equity method consist of their interests in associates and joint ventures.

Associates are those in which the Company, directly or indirectly, has significant influence, but not control or shared control, over the financial and operating policies. To be classified as a joint venture, a contractual agreement must exist that gives the Company shared control of the entity and granting to the Company the right to the net assets of the joint venture, and not the right to its specific assets and liabilities.

Such investments are initially recognized at cost, which includes the expenses with the transaction costs. After initial recognition, the consolidated financial statements include the Company’s interest in the net profit or loss for the fiscal year profit or loss and other comprehensive income of equity-accounted investees, in the investee until the date on which the significant influence or joint control ceases to exist.

(c) Conversion of functional currency to presentation currency

The assets and liabilities of foreign operations are translated into Reais at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into Reais at the exchange rates at the dates of the transactions. Foreign currency differences (Note 2.4) from translation to presentation currency are recognized in other comprehensive income.

Since Argentina’s economy is considered hyperinflationary, to translate the financial information of the subsidiary Braskem Argentina, the assets, liabilities, equity, income and expenses are translated into Reais at the exchange rate at the reporting date.

(d) Transactions eliminated in consolidation

Intragroup balances and transactions and any unrealized revenues or expenses arising from intragroup transactions are eliminated. Unrealized gains originating from transactions with investees recorded using the equity method are eliminated against the investment proportionately to the Company’s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment loss.

   
 F-15 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

2.4 Functional and foreign currency

These consolidated financial statements are presented in Brazilian Real, which is the functional currency of the Company. All amounts have been rounded to the nearest thousand, unless otherwise stated.

The subsidiaries with a functional currency different from Brazilian Real (R$) are listed below:

   
Subsidiaries   Functional currency
       
  Braskem Alemanha, B&TC and ER Plastics   Euro
  BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.   U.S.dollar ("US$")
  Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços    Mexican peso
  Braskem Argentina   Argentinean peso
  Braskem Chile   Chilenean peso
  Braskem Índia   Rupee

 

2.5 New standards or amendments for the current fiscal year and future requirements

(a) New standards and pronouncements adopted in the current fiscal year

In the current fiscal year, the Company identified a series of amendments under the IFRS accounting standards that became effective for accounting periods starting on or after January 1, 2022:

- Onerous contracts: costs of fulfilling a contract (amendments to IAS 37).

- Annual improvements of IFRS Standards 2018-2020.

- Property, Plant and Equipment: revenue before intended use (amendments to IAS 16).

- Reference to the Conceptual Framework (amendments to IFRS 3).

The adoption of these amendments did not have any material impact on the disclosures or amounts presented in these consolidated financial statements.

(b) Future requirements

The new and amended standards and interpretations already issued but not yet effective as of the reporting date are described below:

- Classification of liabilities as current or non-current (amendments to IAS 1).

- Definition of accounting estimates (amendments to IAS 8).

- Definition of materiality for disclosure of accounting policies (amendments to IAS1 and IFRS Practice Statement 2).

- Deferred taxes related to assets and liabilities arising from a single transaction (amendments to IAS 12).

- Insurance contracts (IFRS17).

The Company plans to adopt these new and amended standards and interpretations, if applicable, when they become effective. Management does not expect the adoption of the standards listed above to have a significant impact on the Company’s consolidated financial statements in future periods.

   
 F-16 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

2.6 Impacts from Russia-Ukraine conflict

The Company formed a committee to monitor the consequences of sanctions applied to Russia and the developments in the conflict as well as to take any measures to minimize potential impacts on the Company, its team members and the communities where it operates.

The conflict has caused an increase in the international price of commodities related to the Company's business, such as oil and natural gas, affecting the cost of the Company's inputs used in the production process. The European geopolitical scenario also affected the demand for petrochemical products, global supply chain and pressured inflation in several countries. For this reporting period, it has not caused significant adverse impacts on the Company's equity and financial position, although it is not possible to accurately predict significant adverse effects in the future.

Further sanctions, embargoes, regional instability, geopolitical changes, dysfunctions in the logistics chain, adverse effects on macroeconomic conditions, currency exchange rates and interest rates could affect the prices of products and costs of inputs in the international market, interrupt the supply chain, reduce sales and/or affect operations of the Company. As of the reporting date, the Company has not identified any relevant impacts on its business arising from the sanctions applied to date and adverse scenario caused by the geopolitical conflict.

3 Application of estimates and judgments

In preparing these consolidated financial statements, Management has made judgments and estimates that affect the application of the Company’ accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results can differ from these estimates due to differences in the variables, assumptions or conditions used in making estimates.

Judgments and estimates are reviewed on an ongoing basis and are based on historical experience and other factors, including expectations of future events that are deemed reasonable under the circumstances. Revision to estimates is recognized prospectively.

Critical judgments and estimates applied by the Company in the preparation of these consolidated financial statements are presented in the following notes:

3.1 Assumptions and estimation uncertainties

- Note 12(b): The useful lives and discount rate of impairment testing of property, plant and equipment.

- Note 13(a): Determination of the discount rate and the recoverable amount of goodwill.

- Note 20.2: Application of hedge accounting: determining the fair value of financial instruments and judgment of highly probable forecast transaction.

- Note 22.2: Recognition of deferred tax assets, expectation of future taxable income against which deductible temporary differences and tax losses carryforward can be utilized.

- Note 23(a): Recognition and measurement of provisions for recovery of environmental damages: identifying potential environmental impacts, evaluate technical solutions and time of the remediation involve judgment as to the probability and magnitude of the outflow of resources.

- Note 24: Recognition and measurement of provisions for tax, labor and civil lawsuits: judgement on interpretation of the matter under discussion and estimate as to the probability and magnitude of the outflow of resources.

   
 F-17 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

- Note 26: Recognition and measurement of provision for costs arising from the geological event in Alagoas: uncertainties regarding the outcome of actions to close and monitor wells, future studies by experts, changes related to the dynamics of the geological event, individual lawsuits, adherence by the municipality of Maceió and other parties, that could affect the probability and magnitude of the outflow of resources.

4 Risk management

The Company is exposed to market risks arising from variations in commodity prices, foreign exchange rates and interest rates, credit risks of its counterparties in cash equivalents, financial investments and trade accounts receivable, and liquidity risks to meet its obligations from financial liabilities.

The Company adopts procedures for managing market and credit risks that are in conformity with its Financial Policy, which is reviewed by the Board of Directors quarterly. The purpose of risk management is to protect the Company’s cash flows and reduce the threats to the financing of its operating working capital and investment programs.

4.1 Market risks

The Company prepares a sensitivity analysis for foreign exchange rate and interest rate risks to which it is exposed, presented in Note 20.8.

Management of the interest rate benchmark reform and associated risks

Overview

The planning for an organized replacement of interbank offered rates (“IBORs”) for alternative, nearly risk-free interest rates (RFRs, or “Risk-Free Rates”) is in progress. Initiatives are being adopted to adapt the market before the discontinuation of IBORs, which is expected for June 2023.

The Company uses IBORs as reference rates on several of its financial instruments, and as part of these market-wide initiatives, RFRs will eventually replace such reference rates. While the transition will force modifications on contracts that use IBORs as reference rates, the Company expects no significant impact on its risk management after its completion. However, it will continue to monitor the transition and implement whatever changes or new controls are deemed to be appropriate as potential issues arise.

Derivatives

The derivative instruments traded on over-the-counter market are governed by contracts based on the master agreements of the International Swaps and Derivatives Association (“ISDA”) and agreed with counterparties in the international banking market.

As part of the IBOR reform, the ISDA published a protocol that changed all master agreements in force to include RFRs as replacement rates (fallback) for use upon discontinuation of the various IBORs. The protocol came into force as of January 25, 2021. The Company and the subsidiaries Braskem America, Braskem Idesa and Braskem Holanda Finance already have carried out its adoption.

Liabilities

As of December 31, 2022, the Company has bank loans with interest rates linked to LIBOR in US$ (see notes 16 and 17), which consequently will be subject to IBOR reform. The Company expects the benchmark interest rate of these loans to be changed to guaranteed forward rates at the Security Overnight Financing Rate (SOFR) by June 2023. The Company estimates that the updated cash flows will be economic equivalent to the original and has no expectation of material impacts.

   
 F-18 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(a)Exposure to commodity risks

Most of Company’s feedstocks (naphtha, ethane, propane and propylene) and main products (PE, PP and PVC) are commodities quoted on international markets. A series of factors determine the dynamics of these quotes, nevertheless our sales prices are also impacted in a similar proportion when compared with our feedstock supply chain.

(b)Exposure to foreign exchange risk

Considering the dynamics of the international petrochemical market, where prices are mostly pegged to international US dollar-denominated references, the Company’s sales in Brazil and Mexico are strongly correlated to the US$.

To mitigate the long-term exchange risk, since September 2016, the Company started to contract financial derivatives to compose a Long-Term Foreign Exchange Hedge Program, by US dollar call and put option contracts, hedging expected cash flows over an 18-month horizon, as detailed in Note 20.5.

In addition to this program, to maintain the balance of the US dollar-denominated assets and liabilities exposure, as established in its Financial Policy, the Company will maintain at least 70% of the net debt exposed to the US dollar. If convenient, the Company may maintain a percentage of more than 70%, although subject to a sensitivity analysis of key financial indicators and proof of the inexistence of significant risk of deterioration of these indicators.

As of December 31, 2022, the Company prepared a sensitivity analysis for its exposure to the fluctuation in US$, as disclosed in Note 20.8.

(c)Exposure to interest rate risk

The Company is exposed to the risk that a variation in floating interest rates causes an increase in its financial expenses due to payments of future interest. Debt denominated in foreign currency subject to floating rates is mainly subject to fluctuations in LIBOR. Debt denominated in R$ is mainly subject to the variation in the Interbank Certificate of Deposit (“CDI”) rate.

As of December 31, 2022, the Company prepared a sensitivity analysis for the exposure to the floating interest rates LIBOR, CDI, SELIC, SOFR and Extended National Consumer Price Index (“IPCA”), as disclosed in Note 20.8.

4.2 Exposure to credit risk

The transactions that subject the Company to the concentration of credit risks are mainly in bank checking accounts, financial investments, and trade accounts receivable in which the Company is exposed to the risk of the financial institution or customer involved. In order to manage this risk, the Company maintains bank current accounts and financial investments with major financial institutions, weighting concentrations in accordance with the credit rating and the daily prices observed in the Credit Default Swap market for the institutions, as well as netting contracts that minimize the total credit risk arising from the many financial transactions entered into by the parties.

As of December 31, 2022, 33.8% of the amounts recorded as “Cash and cash equivalents” (Note 5) and “Financial Investments” (Note 6) were allocated to financial institutions that had offset agreements with the Company. The obligations under these agreements are accounted for under “Borrowings” (Note 16). The effective netting of these amounts is possible only in the event of default by one of the parties.

With respect to the credit risk of customers, the Company protects itself by performing analysis before granting credit and obtaining secured and unsecured guarantees when considered necessary, including credit insurance.

   
 F-19 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

The maximum exposure to credit risk of non-derivative financial instruments on the reporting date is the sum of their carrying amounts less any impairment losses.

4.3 Liquidity risk

The Company has a calculation methodology to determine a minimum cash “monthly vision” (30-day horizon) and a minimum cash “yearly vision” (up to 12-month horizon) for the purpose of, respectively: (i) monitoring the liquidity needed to comply with obligations of the following month; and (ii) monitoring the Company´s liquidity during potential crisis.

The amounts to determine the minimum cash “yearly vision” are calculated based on the projected operating cash generation, less short-term debts and working capital needs. The amounts used for determining the minimum cash “monthly vision” consider the projected operating cash disbursement, debt service and investments in projects, as well as the planned disbursement for derivatives maturing in the period, among other items. According to its Financial Policy, the Company uses as a minimum cash the greater of these two references.

In December 2021, the Company, in keeping with its commitment to maintain its financial liquidity, renewed an international revolving credit facility in the amount of US$1 billion (R$5.22 billion), which expires in 2026. This credit line may be used without restrictions to improve the Company’s credit quality or in the event of deterioration in the macroeconomic scenario. As of December 31, 2022, this new credit line had not been used.

The Company's financial liabilities, including the amounts due under the Leniency Agreement (Note 25), are shown in the table below by maturity. These amounts are calculated based on cash flows not discounted that consider future financial charges and may not be reconciled with the amounts disclosed in the statement of financial position.

                       
                      Consolidated
      Until   Between one   Between two   More than    
      one year   and two years   and five years   five years   Total
                       
Trade payables     12,410,232   3,069             12,413,301
Borrowings       1,360,722     3,139,258     3,931,315   57,625,391     66,056,686
Debentures       136,142     102,090   -     6,167,985    6,406,217
Braskem Idesa borrowings       996,697           17,274,826     18,271,523
Derivatives       192,226   5,691   -    88,273    286,190
Loan from non-controlling shareholder of Braskem Idesa                   4,391,832    4,391,832
Leniency agreement        434,804     658,154   -   -    1,092,958
Lease       1,109,048     855,803     581,592     2,436,734    4,983,177
At December 31, 2022     16,639,871   4,764,065   4,512,907   87,985,041   113,901,884

 

   
 F-20 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

4.4 Capital management

The Company’s policy is to maintain capital management to ensure the continuity and development of its business and to maintain the trust of investors, creditors and the general market. The capital structure, according to the Management, considers the balance between own capital and net debt. This composition meets the Company’s policy of providing a consistent return to shareholders and other stakeholders. This structure also allows borrowing costs to maximize shareholder remuneration.

Due to the impact of US$ on the Company’s operations, Management believes that the own capital used for capital management purposes should be measured in US$. Moreover, the Company may temporarily maintain another capital structure, for example, during periods of growth, when the Company may finance a large portion of its projects through borrowings, provided that this option maximizes return for shareholders once the financed projects start operating. In order to adjust and maintain the capital structure, the Management may also consider the sale of non-strategic assets, the issue of new shares or even adjustments to dividend payments.

As is the case of liquidity, capital is managed at the consolidated level, except for the liquidity and capital of the subsidiary Braskem Idesa and other subsidiaries with non-controlling interest, whose specific management is concentrated at the subsidiaries level. 

5 Cash and cash equivalents

           
          2022   2021
               
Cash            
  Domestic market         517,236     676,083
  Foreign market     (i)   5,556,972     4,374,739
Cash equivalents            
  Domestic market         3,684,999     1,141,221
  Foreign market     (i)   2,707,267     2,488,643
Total       12,466,474     8,680,686

 

(i) On December 31, 2022, it includes R$931,991 of cash and R$1,252,341 of cash equivalents (2021: R$1,267,582 of cash and R$505,749 of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.

Cash equivalents are represented mainly by fixed-income instruments and time deposits, such as bank deposit certificates (“CDBs”), treasury bonds, financial bills, debentures, and shares of fixed income investment funds. These assets may be directly held by the Company or through its exclusive funds, FIM Júpiter and FIM Netuno. Average yield of cash equivalents is presented jointly with financial investments (see note 6).

The cash equivalents abroad consist of fixed income instruments (Time Deposit) and interest bearing accounts.

   
 F-21 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

6 Financial investments

         
        2022   2021
Amortized cost          
  Time deposit investments     -     106,271
Fair value through profit or loss        
  LFT´s and LF´s (i)   1,789,375     2,337,171
  Restricted funds investments (ii)   305,485     852,362
  Other     217,771     213,751
Total       2,312,631     3,509,555
             
Current assets       2,295,497     3,492,710
Non-current assets      17,134    16,845
Total       2,312,631     3,509,555

(i) These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.
(ii) Includes the following amounts: R$175,153 (2021: R$835,517) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$130,332 (2021: R$16,845) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.

 

In 2022, financial investments and cash equivalents (Note 5) in Brazilian R$ had an average yield of 102.59% of the CDI p.a. (2021: 102.50%) and financial investments and cash equivalents in foreign currency (Note 5) had an average yield of 1.18% p.a. (2021: 0.45% p.a.).

   
 F-22 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

 

7 Trade accounts receivable

The Company’s average receivables term is generally 30 days; therefore, the carrying value of the trade accounts receivable approximates their fair value. The Company realizes part of its trade accounts receivable through the sale of trade notes to funds and financial institutions that acquire receivables. These operations are not entitled to recourse and the risks and benefits over the receivables are transferred and the trade accounts receivable are derecognized.

As of December 31, 2022, the amounts of trade accounts receivable transferred and derecognized maturing after December 31, 2022, was R$3.5 billion (2021: R$3.5 billion). Loss recognized at the date of transfer of the abovementioned receivables were R$73 million (2021: R$39 million), recorded under Financial Expenses.

 

           
      Note   2022   2021
Customers            
Domestic market            
  Third parties         1,533,675     2,851,701
  Related parties   9    13,791    12,240
            1,547,466     2,863,941
Foreign market            
  Third parties         1,796,559     4,434,653
            1,796,559     4,434,653
Expected credit losses   (i)   (112,091)   (131,634)
Total       3,231,934   7,166,960
               
Current assets         3,231,934     7,153,565
Non-current assets       -    13,395
Total       3,231,934   7,166,960

 

(i) According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; (ii) receivables past due 90 to 180 days; (iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:

 

                         
            2022           2021
    Trade accounts receivable   Expected credit losses   Total   Trade accounts receivable   Expected credit losses   Total
                         
Accounts receivables not past due   2,687,775    (34,931)   2,652,844   6,705,123    (12,291)   6,692,832
Past due securities:    -    -                
Up to 90 days   536,289   (6,783)   529,506   431,899   (2,264)   429,635
Between 91 to 180 days     25,015   (3,010)     22,005     45,134   (1,390)     43,744
Above 180 days     94,946    (67,367)     27,579   116,438     (115,689)    749
                         
Total    3,344,025   (112,091)    3,231,934    7,298,594   (131,634)    7,166,960

   
 F-23 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The changes in the expected credit loss are presented below:

               
          2022   2021   2020
                   
Balance at the beginning of the year     (131,634)   (173,007)   (229,323)
Additions         (87,898)   (144,888)     (65,571)
Reversals        71,400     149,681    28,563
Write-off of securities considered uncollectible      36,041    36,580    93,324
Balance at the end of the year      (112,091)   (131,634)    (173,007)

Write-off

The gross carrying amount of a financial asset is written-off when the Company has no reasonable expectations of recovering a financial asset in its entirety or a portion thereof.

 

8 Inventories

Inventories are measured at the lower of cost and net realizable value. The cost of inventories is recorded at the weighted average cost. In the case of manufactured inventories, besides raw materials and other consumables, cost includes an appropriate share of production overheads based on normal operating capacity.

           
               
          2022   2021
               
Finished goods       8,558,025   9,271,708
Semi-finished goods       663,182   568,914
Raw materials, production inputs and packaging     2,747,525   3,356,660
Maintenance materials       869,953   766,994
Advances to suppliers       124,285     62,573
Imports in transit       1,067,094   2,308,252
Total         14,030,064    16,335,101

The effect of the provision for inventories at the year is shown below:

                 
        2022   2021   2020
                 
Balance at the beginner of the year       82,218   122,572   82,195
                 
Additions      (i)  533,471     97,911   120,483
Utilization/reversals      (103,583)    (138,265)    (80,106)
                 
Balance at the end of the year     512,106     82,218   122,572

(i) The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.

 

   
 F-24 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

9 Related parties

 

     
  Balances at December 31, 2022    Balances at December 31, 2021 
  Novonor and               Novonor and            
  subsidiaries   Petrobras and           subsidiaries   Petrobras and        
Balance sheet and associates   subsidiaries   Other (i)   Total   and associates   subsidiaries   Other (i)   Total
Assets                              
Current                              
Trade accounts receivable   -    11,924     1,867     13,791    -   4,894     7,346   12,240
Inventories  (advance to suppliers)   -    61,428     -     61,428    -   9,927     -     9,927
Dividends and interest on capital   -   -     4,296    4,296    -     -     -    -
Other receivabels 11,348   287     -     11,635    -   287     -     287
                               -
Non-current                              -
Other receivables    -   5,657     -    5,657    -    38,987     -   38,987
Total assets   11,348     79,296    6,163    96,807    -     54,095    7,346    61,441
                               
Liabilities                              
Current                              
Trade payables  126,014     137,764   14,189   277,967   103,259     134,063   11,113    248,435
Other payables 4     233,133     314   233,451    -     296,984     345    297,329
                               
Non-current                              
Trade payables   3,069   -     -    3,069    -     -     -    
Loan to non-controlling shareholders of Braskem Idesa   -   -    2,498,093   2,498,093    -     -    3,646,538    3,646,538
Total liabilities   129,087   370,897     2,512,596    3,012,580    103,259   431,047     3,657,996    4,192,302

 

  Year ended December 31, 2022   Year ended December 31, 2021   Year ended December 31, 2020
  Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total
Transactions                                              
Sales of products   -     182,218    437,514   619,732       171,665    540,855    712,520       182,521    326,825   509,346
Purchases of raw materials, finished goods services and utilities (334,363)    (22,900,140)     (24,813)   (23,259,316)     (306,426)    (19,833,063)    (6,953)   (20,146,442)     (133,127)    (14,566,840)    (20,350)   (14,720,317)
Financial income (expenses), net  (854)     (33,656)   41,082    6,572   (141)     (11,758)   (245,819)     (257,718)   (452)    (3,810)   (818)   (5,080)
General and administrative expenses   -       (45,329)    (45,329)       -     (67,273)    (67,273)        (46,738)    (46,738)
Other income (expenses)   -    51,248     -     51,248     (217,497)     -     (217,497)         -  
                                               
(i) Borealis, Grupo Idesa, Refinaria de Petróleo Riograndense S.A e Vexty                                            

 

   
 F-25 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(a)New and/or renewed agreements with related companies

As provided for in Braskem’s bylaws, the Board of Directors has the exclusive power to approve any contract with related parties that exceed R$20,000 per transaction or R$60,000 collectively per year. This is valid for contracts between Braskem and its subsidiaries and: (i) direct or indirect subsidiaries of Braskem in whose capital an interest is held by the controlling shareholder, by any direct or indirect subsidiaries thereof or by Key Management Personnel of such entities; (ii) associates of Braskem and subsidiaries of such entities; and (iii) joint ventures in which Braskem participates and any subsidiaries thereof.

The related parties that have significant relationship with the Company are as follows:

Novonor and its direct and indirect subsidiaries:

- Tenenge Montagem e Manutenção Ltda. (“Tenenge”)

In February 2022, the Company entered into an electromechanical assembly service agreement to expand the production capacity of the Ethylene-Ethanol Unit located in Trunfio, Rio Grande do Sul with Tenenge, with duration from February 9, 2022 to July 31, 2023. The estimated amount of the agreement is R$142 million.

Petrobras and its indirect joint ventures:

Petrobras

In June 2020, the Company entered into a sales option agreement for up to 2,850 kton/y of petrochemical naphtha to Petrobras with mandatory purchase by Braskem. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$30 billion.

In December 2020, the Company entered into a sale agreement with Petrobras for up to 2 million tons of petrochemical naphtha per year, for our industrial unit in the State of São Paulo. This term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount under the agreement is R$25 billion.

In December 2020, the Company entered into an agreement with Petrobras to purchase ethane and propane to produce up to 580,000 tons of ethylene equivalent and sell up to 58.4 million Nm³ of hydrogen. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$9.2 billion.

- Petrobras Transporte S.A. (“Transpetro”)

In January 2021, the Company entered into an agreement with Transpetro involving the provision of services to Braskem, namely tanker vessel unloading in the Madre de Deus Waterway Terminal (“TEMADRE”), tank storage, product transportation via the pipeline “ORMADRE” that connects TEMADRE to REFMAT, and the transportation of naphtha via pipeline from TEMADRE to the facilities of the carrier located in the municipality of Camaçari/BA. The duration of the agreement is from February 1, 2021 to December 31, 2025, and the total estimated amount of the agreement is R$203 million.

- Petrocoque S.A. Indústria e Comércio (“Petrocoque”)

In March 2021, the Company executed an amendment to extend the agreement with Petrocoque, for purchase of steam to be used as energy by Polyethylene plants. This amendment, summed to total amount of the original agreement, executed in September 2009, amounts to R$433 million and is valid until March 2024.

- Refinaria Alberto Pasqualini (“REFAP”)

In June 2020, the Company entered into a naphtha supply agreement with Petrobras for 450 kton/y, from the REFAP to our unit in the State of Rio Grande do Sul. The term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount of the agreement is R$2.5 billion.

In October 2021, the Company entered into a purchase agreement with Petrobras for 108 kton/year of polymer-grade propylene from REFAP, with delivery to Braskem’s polypropylene industrial units, PP1 and PP2, in Triunfo, Rio Grande do Sul. This agreement is in force from November 1, 2021 to October 31, 2022. The maximum amount of the agreement is estimated at R$630 million.

   
 F-26 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

- Refinaria Capuava (“RECAP”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 140 kton/year of polymer-grade propylene from RECAP, with delivery to Braskem’s PP4 industrial unit (“PP4”) in Mauá, São Paulo,. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$3.3 billion for the purchase of propylene.

- Refinaria Duque de Caxias (“REDUC”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 100 kton per year of polymer-grade propylene from REDUC, with delivery to Braskem’s PP5 industrial unit (“PP5”) in Rio de Janeiro. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$2.4 billion for the purchase of propylene.

- Refinaria Henrique Lage (“REVAP”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 120 kton per year and 40 kton per year of polymer-grade propylene from REVAP, with delivery to Braskem’s PP3 and PP4 industrial units, respectively. This agreement is in force from January 1, 2022 to May 3, 2028 for the first 120 kton/year and from May 4, 2028 to June 30, 2029 for the remaining 40 kton/year. The maximum amount of the agreement is estimated at R$4.7 billion.

- Refinaria Planalto de Paulínia (“REPLAN”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 220 kton per year of polymer-grade propylene from REPLAN, with delivery to Braskem’s PP3 industrial unit (“PP3”) in Paulínia, São Paulo. The agreement is in force from January 1, 2022 to May 3, 2028. The maximum amount of the agreement is estimated at R$8.1 billion for the purchase of propylene.

- Refinaria Presidente Getúlio Vargas (“REPAR”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 150 kton per year of polymer-grade propylene from REPAR, with delivery to Braskem’s PP3 and PP4 industrial units. The agreement is in force from January 1, 2022 to December 6, 2029. The maximum amount of the agreement is estimated at R$6.8 billion.

- Companhia de Gás da Bahia (“Bahiagás”)

In December 2021, the Company entered into an amendment to the agreement governing the supply of natural gas by Bahiagás to Braskem, via local gas pipeline, effective until December 2022. The estimated amount of the amendment is R$752 million.

- Companhia de Gás do Estado do Rio Grande do Sul (“Sulgás”)

In March 2022, the Company entered into the agreement with Sulgás to acquire natural gas, via a local gas distribution pipeline, its terms to June 2023. The estimated amount of the amendment is R$270 million.

- Gás de Alagoas S.A. (“Algás”)

In March 2022, the Company entered into an amendment with Algás for the supply of natural gas to Braskem units located in the state of Alagoas, via a local gas distribution pipeline, its terms to December 2024. The estimated value of the amendment is R$1.5 billion.

Since July 2022, Petrobras has no more equity interest in Bahiagás, Sulgás and Algás and, upon which they ceased to be a related party to Braskem.

Non-controlling shareholders of Braskem Idesa:

- Grupo Idesa, S.A. de C.V.

- Etileno XXI, S.A. de C.V.

Loan payable to the non-controlling shareholders of Braskem Idesa, with maturity in December 2029 and contractual interest rate of 7% p.a. These funds were used by Braskem Idesa to finance the construction of its operational assets.

   
 F-27 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

 

(b) Key management personnel compensation

The expenses related to the remuneration of key management personnel, including the Board of Directors, the Chief Executive Officer and vice-presidents, recorded in the profit or loss for the year, are shown as follows:

             
Statement of profit or loss transactions   2022   2021   2020
Remuneration            
Short-term benefits    83,466     119,734    74,943
Post-employment benefit   1,636   2,121   961
Long term incentive plan    16,938    14,394   7,456
Total   102,040   136,249     83,360

Compensation of the Company’s key management personnel includes salaries, short and long-term incentives, non-cash benefits and contributions to a post-employment defined benefit plan (see Note 27).

 

10 Taxes recoverable

       
        2022   2021
             
Parent Company and subsidiaries in Brazil        
  Value-added tax on sales and services (ICMS)    410,138   291,424
  ICMS - credits from PP&E   302,940   224,308
  Social integration program (PIS) and social contribution on revenue (Cofins) (a) 560,002   250,491
  PIS and Cofins - credits from PP&E   546,427   447,476
  REINTEGRA program       20,504     21,764
  Federal tax credits   (b) 153,960   948,448
  Other       68,514     89,205
             
Foreign subsidiaries        
  Value-added tax ("IVA")   579,672   348,021
  Other     131,867     59,579
Total     2,774,024   2,680,716
             
Current assets     1,156,355   1,428,658
Non-current assets   1,617,669   1,252,058
Total     2,774,024   2,680,716

(a) PIS and COFINS

Complementary Law 194/2022 was published, which reduced to zero the rates of the contributions levied on sales of fuels, which increased the respective credits.

(b) Federal tax credits

Up to December 31, 2021, the balance was primarily composed of federal tax credits related to exclusion of ICMS from the PIS and Cofins tax calculation base. As of December 31, 2022, of the total tax credit recorded by the Company related to this tax, since 2019, R$5,093,151 has been offset, with the decision on the credit becoming final and unappealable.

 

   
 F-28 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

11 Investments

See the accounting policy in Note 2.3 Basis of Consolidation.

(a) Information on investments

                           
              Net profit (loss) for the year   Equity
              2022   2021   2020   2022   2021
Jointly-controlled investment                          
  RPR       (i)    76,450   312   (63,525)     110,040    50,064
  Bioglycols LLC     (ii)     (3,977)   -      80,757   -
Associate                            
  Borealis     (iii)    53,617    45,490   6,019     252,053     205,568

 

(i)RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is 33.20% (2021: 33.20%).
(ii)Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).
(iii)Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is 20% (2021: 20%).

 

(b) Changes in investments

                     
    Borealis   RPR   Bioglycols LLC   Other   Total
                     
Balance at 2020   32,272   10,697   -      184   43,153
                     
Dividends and interest on equity     (295)   -             (295)
Equity in results of investees   9,136   103   -        9,239
Other comprehensive income       5,825           5,825
Other               1,001   1,001
                     
Balance at 2021   41,113   16,625       1,185   58,923
                     
Dividends and interest on equity     (5,013)     (4,296)             (9,309)
Equity in results of investees    11,296    25,384   (1,832)        34,848
Other comprehensive income         (1,174)    1,299     (788)     (663)
Capital increase             41,908    23,061    64,969
Other               255   255
                     
Balance at 2022   47,396   36,539    41,375   23,713   149,023

  

   
 F-29 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(c) Impact on the consolidation of Braskem Idesa

The Company presents the financial information of the subsidiary Braskem Idesa, which holds a non-controlling interest with material effects on the Company’s consolidated statements:

                                 
Statement of Financial Position     Consolidated Braskem without the effect off Braskem Idesa consolidated     Consolidated Braskem Idesa (i)     Eliminations     Consolidated 
    2022   2021   2022   2021   2022   2021   2022   2021
Assets                                
Curent                                
Cash and cash equivalents    10,282,142   6,907,355   2,184,332    1,773,331   -   -     12,466,474    8,680,686
Financial investments   2,295,497   3,492,710   -     -   -   -    2,295,497    3,492,710
Trade accounts receivable   3,621,335   6,607,762     73,195    1,225,479   (462,596)   (679,676)    3,231,934    7,153,565
Inventories    12,921,617    15,325,001   1,108,447    1,010,100   -   -     14,030,064     16,335,101
Taxes recoverable   905,844   1,402,100   250,511   26,558   -   -    1,156,355    1,428,658
Recoverable income taxes   392,062   1,189,812   -     -   -   -    392,062    1,189,812
Derivatives   157,906     33,816   -     -   -   -    157,906   33,816
Other receivables   628,447   841,473     68,544    137,624    30,373   -    727,364    979,097
                                 
Total current assets     31,204,850    35,800,029   3,685,029     4,173,092    (432,223)    (679,676)     34,457,656     39,293,445
                                 
Non-current                                
Taxes recoverable   1,328,695   983,655   288,974    268,403   -   -    1,617,669    1,252,058
Recoverable income taxes   252,995   230,069   -     -   -   -    252,995    230,069
Deferred tax assets   6,671,492   6,481,642   488,116    1,775,610   (801,007)   -    6,358,601    8,257,252
Related parties   7,250,756    10,064,320   -     - (ii) (7,250,756)    (10,064,320)    -     -
Derivatives     71,544   51   -     -   -   -   71,544    51
Judicial deposits    215,274   194,212   -     -   -   -    215,274    194,212
Other receivables   187,107   370,928    563   24,964   -   -    187,670    395,892
Investments   149,023     58,923   -     -   -   -    149,023   58,923
Property, plant and equipment    24,319,015    23,510,588    14,126,939     14,483,720 (iii) (682,659)   (769,178)     37,763,295     37,225,130
Intangible   2,730,124   2,572,675   292,020    304,624   -   -    3,022,144    2,877,299
Right of use of assets   3,638,507   2,427,633   910,900    352,404 (v) (596,420)   -    3,952,987    2,780,037
                                 
Total non current assets     46,814,532    46,894,696    16,107,512   17,209,725    (9,330,842)     (10,833,498)     53,591,202     53,270,923
                                 
Total assets    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368
                                 
Liabilities and shareholders' equity                                
Current                                
Trade payables    11,418,031    11,861,563   1,291,347    871,379   (462,596)   (679,676)     12,246,782     12,053,266
Borrowings   1,254,550   1,343,494   -     -   -   -    1,254,550    1,343,494
Debentures   127,801     59,088   -     -   -   -    127,801   59,088
Braskem Idesa Borrowings   -   -   868,635   86,765   -   -    868,635   86,765
Payroll and related charges   789,441   1,095,040     38,385   75,306   -   -    827,826    1,170,346
Taxes payable   481,729   1,003,813    9,322     8,303   -   -    491,051    1,012,116
Income taxes payable   381,117   1,672,844   -     -   -   -    381,117    1,672,844
Lease   955,225   598,523   195,518   76,843 (v) (111,037)   -    1,039,706    675,366
Provision - geological event in Alagoas   4,247,609   4,378,071   -     -   -   -    4,247,609    4,378,071
Other payables   2,645,828   2,495,544     24,283    246,623    30,059   -    2,700,170    2,742,167
                                 
 Total current liabilities    22,301,331    24,507,980   2,427,490     1,365,219    (543,574)    (679,676)     24,185,247     25,193,523
                                 
Non-current                                
Loan agreements    31,310,710    33,553,766   -     -   -   -     31,310,710     33,553,766
Braskem Idesa Borrowings   -   -    10,501,683     12,224,770   -   -     10,501,683     12,224,770
Debentures   3,023,674   137,830   -     -   -   -    3,023,674    137,830
Accounts payable to related parties   -   -   7,175,837     10,134,287 (ii) (7,175,837)    (10,134,287)    -     -
Loan to non-controlling shareholders of Braskem Idesa   -   -   2,498,093    3,646,538   -   -    2,498,093    3,646,538
Deferred tax liabilities   904,521   1,407,434   1,049,967     -   (801,007)   -    1,153,481    1,407,434
Provision for losses on subsidiaries   4,094,535   5,284,666   -     - (iv) (4,094,535)   (5,284,666)    -     -
Lease   2,942,284   2,147,745   746,285    333,303 (v) (487,745)   -    3,200,824    2,481,048
Provision - geological event in Alagoas   2,378,949   3,283,188   -     -   -   -    2,378,949    3,283,188
Other payables   3,590,317   4,406,733     97,663   25,710   -   -    3,687,980    4,432,443
                                 
 Total non current liabilities    48,244,990    50,221,362    22,069,528   26,364,608     (12,559,124)     (15,418,953)     57,755,394     61,167,017
                                 
Shareholders' equity                                
Attributable to the  Company's shareholders   7,321,798   7,865,819    (4,704,477)   (6,347,010)     4,704,478     6,347,010    7,321,799    7,865,819
                                 
Non-controlling interest in subsidiaries   151,263     99,564   -     -   (1,364,845)   (1,761,555)     (1,213,582)     (1,661,991)
                                 
Total shareholders equity    7,473,061   7,965,383     (4,704,477)   (6,347,010)   3,339,633   4,585,455    6,108,217     6,203,828
                                 
Total liabilities and shareholders' equity    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368

(i) Consolidation of Braskem Idesa with its subsidiaries Braskem Idesa Servicios and Terminal Química.
(ii) Loan from Braskem Holanda to the Braskem Idesa project.
(iii) Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.
(iv) Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.
(v) Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.
   
 F-30 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

 

                                                 
 Statement of profit or loss   Consolidated Braskem without the effect of                        
     Braskem Idesa consolidated     Consolidated Braskem Idesa     Eliminations     Consolidated 
    2022   2021   2020   2022   2021   2020   2022   2021   2020   2022   2021   2020
                                                 
                                                 
Net revenue     93,038,949     101,448,155   55,779,528   5,953,229   6,333,199   4,046,581     (2,472,894)     (2,156,153)     (1,282,615)     96,519,284     105,625,201     58,543,494
Cost of products sold   (82,624,987)     (72,471,291)    (45,563,723)   (5,074,693)   (3,321,601)   (3,112,129)   2,539,132   2,224,661   1,344,438   (85,160,548)     (73,568,231)   (47,331,414)
                                                 
Gross profit     10,413,962    28,976,864   10,215,805   878,536   3,011,598   934,452   66,238   68,508   61,823     11,358,736    32,056,970     11,212,080
                                                 
Income (expenses)                                                 
Selling and distribution     (1,890,181)    (1,834,303)   (1,609,844)   (218,236)   (221,337)   (242,211)           (2,108,417)    (2,055,640)     (1,852,055)
(Loss) reversals for impairment of trade accounts receivable    (38,248)     (8,736)     (55,074)    (178)    (178)    (178)          (38,426)     (8,914)    (55,252)
General and administrative      (2,545,044)    (2,292,884)   (1,739,541)   (216,098)   (229,334)   (179,350)     (2,841)   91    144     (2,763,983)    (2,522,127)     (1,918,747)
Research and development     (374,493)    (296,583)   (250,648)                 (374,493)    (296,583)     (250,648)
Results from equity-accounted investees   (1,078,115)   (82,709)   (1,026,922)    7       1,112,956     87,353   1,007,524   34,848    4,644    (19,398)
Other income    505,629   1,530,443     748,923   1,704   4,044   1,826          507,333   1,534,487   750,749
Other expenses     (2,305,411)    (2,651,425)   (7,573,874)     (38,114)     (17,865)   (364,747)   -   -   -     (2,343,525)    (2,669,290)     (7,938,621)
                                                 
Operating profit    2,688,099    23,340,667    (1,291,175)   407,621   2,546,928   149,792   1,176,353    155,952   1,069,491     4,272,073    26,043,547     (71,892)
                                                 
Financial results                                                
Financial expenses      (5,013,176)    (4,750,895)   (3,851,233)   (1,817,551)   (1,618,020)   (1,505,628)   1,168,034   461,760   443,496     (5,662,693)    (5,907,155)     (4,913,365)
Financial income    2,558,268   2,276,312     1,032,530     610,792    12,886    11,150    (1,158,926)    (461,760)    (443,496)    2,010,134   1,827,438   600,184
Exchange rate variations, net     (643,377)    (2,884,292)   (4,823,269)     235,314   (1,164,697)   (482,125)    (164,107)     46,182    6,683     (572,170)    (4,002,807)     (5,298,711)
                                                 
Finance income (cost)   (3,098,285)     (5,358,875)    (7,641,972)    (971,445)    (2,769,831)    (1,976,603)     (154,999)   46,182     6,683   (4,224,729)     (8,082,524)     (9,611,892)
                                                 
(Loss) profit before income tax                                                

 and social contribution

  (410,186)    17,981,792    (8,933,147)    (563,824)    (222,903)    (1,826,811)   1,021,354    202,134   1,076,174    47,344    17,961,023     (9,683,784)
                                                 
Income taxes   95,651    (3,991,055)     2,253,684   (963,386)    (8,348)     414,794   -   -   -     (867,735)    (3,999,403)   2,668,478
                                                 
(Loss) net profit for the year   (314,535)    13,990,737    (6,679,463)    (1,527,210)    (231,251)    (1,412,017)   1,021,354    202,134   1,076,174   (820,391)    13,961,620     (7,015,306)

   
 F-31 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

                                                 
  Statement of cash flows    Consolidated Braskem without the effect of                                  
       Braskem Idesa consolidated     Consolidated Braskem Idesa             Eliminations             Consolidated 
      2022   2021   2020   2022   2021 2020   2022   2021   2020   2022   2021   2020
                                                 
(Loss) profit before taxes     (410,186)   18,348,774   (8,933,147)   (563,824)    (222,903)  (1,826,811)   1,021,354     (164,848)   1,076,174   47,344   17,961,023    (9,683,784)
                                                 
Adjustments for reconciliation of profit (loss)                                        
  Depreciation and amortization    3,944,259     3,432,816     2,995,609    901,194   796,861 1,114,439     (112,288)    (51,244)   (61,967)    4,733,165     4,178,433   4,048,081
  Results from equity-accounted investees    1,078,108     (78,567)     1,026,922         (1,112,956)     73,923    (1,007,524)    (34,848)    (4,644)     19,398
  Interest and  monetary and exchange variations, net    1,788,259     3,604,357     8,541,980    759,378   2,564,905 1,921,975   154,999   142,169     (6,683)    2,702,636     6,311,431    10,457,272
  Reversal of provisions    370,153     819,130     336,838              370,153     819,130   336,838
  Provision - geological event in Alagoas    1,520,019     1,339,765     6,901,828              1,520,019     1,339,765   6,901,828
  PIS and Cofins credits - exclusion of ICMS from the calculation basis     (1,031,099)   (310,557)               (1,031,099)    (310,557)
  Loss for impairment of trade accounts receivable   38,426    10,134    55,252       (1,220)         38,426   8,914     55,252
  Provision for losses and write-offs of long-lived assets    130,366     114,148   8,794     629    1,039          130,995     115,187    8,794
                                                 
  Adjustments for reconciliation of profit     8,459,404   26,559,458   10,623,519     1,097,377   3,138,682 1,209,603     (48,891)        9,507,890   29,698,140    11,833,122
                                                 
Changes in operating working capital                                   
  Judicial deposits - unfreezing (blocking) Public Civil Action         3,746,107                 3,746,107
  Financial investments    1,530,050     296,957   (1,860,827)              1,530,050     296,957    (1,860,827)
  Trade accounts receivable    2,751,788   (1,739,822)   (2,247,729)    1,126,559    (619,688)  (152,971)     (217,080)   184,225   212,874    3,661,267   (2,175,285)    (2,187,826)
  Inventories    2,246,770   (7,176,104)   (309,492)   (108,609)    (398,181)   56,958          2,138,161   (7,574,285)    (252,534)
  Taxes recoverable    928,181     4,958,779     1,584,911   (245,724)    4,808 (52,357)          682,457     4,963,587   1,532,554
  Prepaid expenses        (172,027)      465,812              293,785
  Other receivables    297,209   (269,721)    44,513   13,580     71,165 352,590          310,789   (198,556)   397,103
  Trade payables    (73,230)     955,475   (2,926,585)    370,229   428,364 137,895   217,080     (184,225)    (212,874)    514,079     1,199,614    (3,001,564)
  Taxes payable     (1,085,427)   (2,878,056)     965,191   76,071    (129,432)  (515,430)           (1,009,356)   (3,007,488)   449,761
  Advances from customers        224,764     (25,776)             198,988
  Leniency agreement     (317,867)   (389,087)   (349,842)     -             (317,867)   (389,087)    (349,842)
  Sundry provisions     (219,313)   (482,565)   (158,915)   (187,274)   168,371   13,560           (406,587)   (314,194)    (145,355)
  Geological event in Alagoas     (2,742,791)   (2,928,081)   (1,181,931)     -             (2,742,791)   (2,928,081)    (1,181,931)
  Other payables     (384,838)     823,515   (217,997)    (5,889)   (18,063)   33,810           (390,727)     805,452    (184,187)
                                                 
Cash generated from operations     11,389,936   17,730,748     7,763,660     2,136,320   2,646,026 1,523,694     (48,891)         13,477,365   20,376,774    9,287,354
                                                 
  Interest paid     (2,118,043)   (2,207,196)   (1,946,931)   (786,836)    (676,237)  (789,890)           (2,904,879)   (2,883,433)    (2,736,821)
  Income taxes     (1,620,616)   (2,697,829)   (252,479)    (131)     (9,027)   (5,063)           (1,620,747)   (2,706,856)    (257,542)
                                                 
Net cash generated by operating activities    7,651,277   12,825,723     5,564,250     1,349,353   1,960,762  728,741     (48,891)        8,951,739   14,786,485    6,292,991
                                                 
Proceeds from the sale of fixed assets and intangible assets     2,438    40,353    33,140                 2,438    40,353     33,140
Additions to investment in subsidiaries     (107,090)                           (107,090)    
Dividends received     5,660   295   4,822                 5,660   295    4,822
Acquisitions to property, plant and equipment and intangible assets     (4,153,707)   (3,249,132)   (2,653,009)   (694,574)    (172,192)  (106,780)           (4,848,281)   (3,421,324)    (2,759,789)
                                                 
Net cash used in investing activities   (4,252,699)    (3,208,484)    (2,615,047)    (694,574)     (172,192)   (106,780)         (4,947,273)    (3,380,676)     (2,721,827)
                                                 
Short-term and long-term debt                                              
  Acquired    6,418,208    16,308   13,049,459     -            6,418,208    16,308    13,049,459
  Payments     (3,855,662)   (9,413,909)   (8,734,505)     -             (3,855,662)   (9,413,909)    (8,734,505)
Braskem Idesa borrowings                                        
  Acquired             -   7,271,658               7,271,658  
  Payments             (45,311)    (7,995,045)  (905,210)            (45,311)   (7,995,045)    (905,210)
Related parts       216,862         (34,122)    (226,407)              (34,122)    (9,545)  
Loan to non-controlling shareholders of Braskem Idesa - payment                     (37,618)                   (37,618)
Lease     (836,718)   (787,932)   (610,392)   (141,063)   (53,774) (51,676)     48,891         (928,890)   (841,706)    (662,068)
Dividends paid     (1,350,293)   (5,993,265)    (2,380)               (1,350,293)   (5,993,265)     (2,380)
Non-controlling interest in subsidiaries   21,162     (534,456)             21,162      (534,456)
                                                 
Cash generated (used) in financing activities     396,697     (15,961,936)     3,167,726    (220,496)     (1,003,568)   (994,504)    48,891         225,092     (16,965,504)    2,173,222
                                                 
Exchange variation on cash of foreign subsidiaries     (420,488)     293,633     1,054,845     (23,282)     83,896 259,741           (443,770)     377,529   1,314,586
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972
                                                 
Represented by                                              
  Cash and cash equivalents at the beginning for the period    6,907,355   12,958,419     5,786,645    1,773,331   904,433 1,017,235          8,680,686   13,862,852   6,803,880
  Cash and cash equivalents at the end for the period     10,282,142     6,907,355   12,958,419    2,184,332   1,773,331 904,433           12,466,474     8,680,686    13,862,852
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972

 

12 Property, plant and equipment

Items of property, plant and equipment are measured at the historical cost of acquisition or construction, which includes capitalized borrowing costs, less accumulated depreciation and any accumulated impairment losses.

The machinery, equipment and facilities require inspections, replacement of components and maintenance at regular intervals. The Company makes shutdowns at regular intervals that vary from two to six years to perform these activities. These shutdowns can involve the plant as a whole, a part of it, or only relevant pieces of equipment, such as industrial boilers, turbines and tanks. Expenses with each scheduled shutdown are included in property, plant and equipment items that were the stoppage’s subject matter and are fully depreciated until the beginning of the following related stoppage.

Depreciation starts when the assets become available and is calculated using the straight-line method, based on the useful life estimated by the Company’s technicians in the management of the plants. The useful lives of assets are reviewed at each reporting date.

   
 F-32 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

The main factors taken into consideration in the definition of the useful life of the assets that compose the Company’s industrial plants are the information of manufacturers of machinery and equipment, level of the plants’ operations, quality of preventive and corrective maintenance and the prospects of technological obsolescence of assets.

The estimated useful lives applied to the assets determined the following average percentage of rates per year:

       
      2022   2021
Buildings and improvements      3.03    2.92
Machinery, equipment and installations      7.32    6.74
Furniture and fixtures      10.06    10.06
IT equipment      21.03    21.18
Lab equipment      9.59    9.53
Security equipment      10.50    10.04
Vehicles      19.51    18.82
Other      18.09    17.05

 

Borrowing costs are capitalized when associated with ongoing projects, using: (i) the average rate of the financings; and (ii) the exchange variation portion that corresponds to any positive difference between the average rate of financing in the domestic market and the rate cited in item (i).

In 2022, capitalized borrowing costs amounted to R$203,135 (2021: R$192,207). The average rate of these charges in the year was 8.51% p.a. (2021: 8.33% p.a.).

As of December 31, 2022, the acquisition of property, plant and equipment with payment installments is R$525,192 (2021: R$295,056).

   
 F-33 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(a) Reconciliation of carrying amount

                         
       Land     Buildings and Improvements     Machinery, Equipment and Facilities     Projects and Stoppage in Progress (i)     Other     Total 
                           
Cost       683,031     8,281,424   53,401,832    4,389,105   2,038,666    68,794,058
Accumulated depreciation and amortization       -   (3,159,185)   (28,268,867)    -   (1,436,857)   (32,864,909)
Balance as of December 31, 2020       683,031     5,122,239   25,132,965    4,389,105   601,809    35,929,149
                           
Acquisitions       -   338     160,297    3,388,078    3,421   3,552,134
Capitalized financial charges       -    -    -    192,207   -   192,207
Foreign currency translation adjustment                          
  Cost      17,046     287,866     1,118,655   74,428     23,859   1,521,854
  Depreciation       -   (88,406)   (313,267)    -   (16,760)   (418,433)
Transfers by concluded projects     244    13,965     3,207,833   (3,412,665)   190,623   -
Transfers to inventory       -    -    -   (16,838)   -   (16,838)
Transfers to intangible       -    31,495   (11,673)   (73,397)   (11,847)   (65,422)
Disposals                          
Cost     (10,856)   9,723   (353,274)   (91,485)   (41,066)   (486,958)
Depreciation       -   168     387,005    -    9,206   396,379
Depreciation       -   (195,900)   (3,038,176)    -   (143,164)   (3,377,241)
Transfers to "non-current assets held for sale"     (1,701)    -   (2)    -     2   (1,701)
Transfers Others       -         118,629   (40,095)   (78,534)    
Net book value       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
Cost       687,764     8,591,020   57,535,343    4,449,433   2,215,503    73,479,063
Accumulated depreciation       -   (3,409,532)   (31,126,351)   (40,095)   (1,677,954)   (36,253,933)
Balance as of December 31, 2021       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
                           
Acquisitions       -   1,709     296,719    4,643,953    7,603   4,949,985
Additions through acquisition of ER Plastics       -    20,868    56,288    -    362     77,518
Capitalized financial charges       -    -    -    203,135   -   203,135
Foreign currency translation adjustment                         -
  Cost     (19,916)   (173,496)   (941,271)   (38,966)   (28,592)   (1,202,241)
  Depreciation       -    51,263     285,016    -     20,269   356,548
Transfers by concluded projects       -    86,609     2,688,220   (2,915,496)   140,667  
Transfers to intangible       -    -    -   (13,597)   -   (13,597)
Disposals                         -
  Cost     (3)   (7)   (926,944)   (20,665)   (16,689)   (964,308)
  Depreciation       -    -     815,220    -     13,715   828,934
Depreciation       -   (203,358)   (3,347,376)    -   (147,074)   (3,697,809)
Net book value       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295
Cost       667,845     8,526,704   58,708,355    6,307,797   2,318,854    76,529,554
Accumulated depreciation       -   (3,561,627)   (33,373,492)   (40,095)   (1,791,045)   (38,766,259)
Balance as of December 31, 2022       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295

 

(i) As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.

 

   
 F-34 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

Property, plant and equipment by country

         
      2022   2021
           
Brazil       17,204,824     15,867,387
Mexico       13,444,279     13,714,543
United States of America      6,729,469    7,281,077
Germany      294,612    356,288
Netherland     89,841     5,691
Other       270     144
        37,763,295     37,225,130

 

(b) Impairment loss

Annually, or whenever there is any indication that an asset has suffered devaluation, the Company conducts an analysis to determine if there are indicators that the book value of property, plant and equipment may not be recoverable. This analysis is conducted to assess the existence of scenarios that could adversely affect its cash flow and, consequently, its ability to recover the investment in such assets. These scenarios arise from issues of a macroeconomic, legal, competitive, or technological nature.

The following are considered by the Company as relevant points and are observed in this analysis:

(i) the possibility of an oversupply of products manufactured by the Company or of a significant reduction in demand due to adverse economic factors;

(ii) the prospects of material fluctuations in the prices of products and inputs;

(iii) the likelihood of the development of new technologies or raw materials that could materially reduce production costs and consequently impact sales prices, ultimately leading to the full or partial obsolescence of the industrial facilities of the Company; and

(iv) changes in the general regulatory environment that make the production process of Braskem infeasible or that significantly impact the sale of its products.

The recoverable value of an asset or Cash Generating Unit (“CGU”) is the greatest of the value in use and its fair value less sales costs. The value in use is based on estimated future cash flows, discounted to present value using a discount rate before tax that reflects the current market assessments of the time value of money and the specific risks related to the asset or CGU.

When identifying whether cash inflows from an asset (or group of assets) are largely independent of cash inflows from other assets (or groups of assets), the Company considers several factors, such as: product lines, individual locations and the way Management monitors and makes decisions about its business.

No events indicated that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.

 

   
 F-35 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

13 Intangible assets

                   
                 Customers     
         Brands     Software      and Suppliers     
     Goodwill     and Patents     licenses     Agreements     Total 
Cost     3,187,678     499,515     1,010,201    392,246    5,089,640
Accumulated amortization   (1,128,804)   (214,455)   (683,157)   (234,533)   (2,260,949)
Balance as of December 31, 2020     2,058,874     285,060     327,044    157,713    2,828,691
                     
Acquisitions     -   670    67,686     420   68,776
Foreign currency translation adjustment     -               14,271
Cost     -    12,443    13,023    -   25,466
Amortization     -   (2,711)   (8,484)    -   (11,195)
Transfers from property, plant and equipment     -    28,770    36,652    -   65,422
Other write-offs, net of amortization     -    -   (3,393)    -   (3,393)
Amortization     -   (10,444)   (64,008)   (22,016)   (96,468)
Net book value     2,058,874     313,789     368,520    136,117    2,877,299
Cost     3,187,678     549,196     1,123,619    392,666    5,253,159
Accumulated amortization   (1,128,804)   (235,408)   (755,099)   (256,549)   (2,375,860)
Balance as of December 31, 2021     2,058,874     313,789     368,520    136,117    2,877,299
                     
Acquisitions     -   1,307     144,930     913    147,150
Additions through acquisition of ER Plastics     -    21,162    -   66,571   87,733
Goodwill acquisition of ER Plastics    28,402    -    -    -   28,402
Foreign currency translation adjustment     -            -    -
Cost     -   (7,407)   (19,762)    -   (27,170)
Amortization     -   2,711    14,440    -   17,150
Transfers from property, plant and equipment     -    -    13,597    -   13,597
Other write-offs, net of amortization     -    -   (10,011)    -   (10,011)
Amortization     -   (10,575)   (79,774)   (21,659)   (112,008)
Net book value   2,087,276     320,986     431,939    181,943    3,022,144
Cost   3,216,080     564,258     1,252,373    460,150    5,492,861
Accumulated amortization   (1,128,804)   (243,272)   (820,434)   (278,207)   (2,470,717)
Balance as of December 31, 2022   2,087,276     320,986     431,939    181,943    3,022,144

 

(a)Goodwill

Goodwill is measured as the excess between the consideration transferred and to be transferred to obtain control and the fair value of the identified assets and liabilities assumed from the acquired entity. Goodwill is allocated to the CGUs or groups of assets that are expected to benefit from the synergies of the business combination. Goodwill arising before the adoption of the IFRS pronouncements was amortized in the accounting books until December 2008. From 2009 on, it has been subjected to annual impairment tests.

Impairment testing is based on estimated cash generation in each CGU or groups of assets, extracted from the Company’s five-year Business Plan (see Note 22.2) and from the Management plan for a period greater than 5 years to reflect the industry cycle patterns, with a total projection period of 10 years.

Perpetuity is also calculated based on the long-term vision and excluding real growth. Cash flows and perpetuity are adjusted to present value at a discount rate based on the Weighted Average Cost of Capital (“WACC”).

   
 F-36 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The table below shows the results obtained in the tests conducted by the Company in December 2022:

             
     Allocated     Recoverable     Book         Discount 
     goodwill     amount     value (i)     CF/Book value     rate 
                     
Northeastern petrochemical complex   475,780   7,305,045   3,124,332    2.3   14.68%
Southern petrochemical complex   1,390,741    20,840,873   6,781,881    3.1   15.85%
Vinyls   192,353   5,050,166   2,880,156    1.8   14.70%

 

(i) The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.

 

The inflation rate considered for perpetuity was 3%.

Given the potential impact on cash flows of the “discount rate” and “perpetuity”, the Company conducted a sensitivity analysis based on changes in these variables, with cash flows shown in the table below:

Schedule of potential impact on cash flows of the discount rate and perpetuity            
      +0.5% on   -0.5% on
         discount rate    perpetuity
CGU            
Northeastern petrochemical complex       6,822,642   7,044,458
Southern petrochemical complex        19,744,124    20,351,277
Vinyls       4,741,224   4,930,076

 

The main assumptions used for projecting cash flows are related to the projection of macroeconomic indicators, international prices, and global and local demand in the countries where the Company has operational plants. Macroeconomic indicators include items such as: foreign exchange rates, inflation, and interest rates, among others.

Prices for key petrochemical products are obtained from a specialized third-party consulting firm, drawing on projections reviewed and supplemented based on Management’s experience. Final prices take into consideration the meetings of specific internal committees and the knowledge of the Company’s experts in preparing the benchmarks for each market.

Similar to prices, indicators for global demand also are prepared with specialized consulting firms. In the markets where the Company operates more directly, they consider additional variables for the local demand composition.

(b)Intangible assets with definite useful lives

These intangible assets are measured at historical cost of acquisition or at fair value when acquired in a business combination, deducted from accumulated amortization and, if applicable, accumulated impairment loss. Subsequent costs are capitalized only when they increase the future economic benefits incorporated into the specific asset to which they are related.

Amortization is calculated using the straight-line method based on the estimated useful life of the items, and reviewed every reporting date, as follows, for consolidated purposes:

 

 
- Brands and patents 10-20 years
- Software licenses and rights of use 5-10 years
- Customers and suppliers’ agreements 14-28 years 

 

   
 F-37 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Expenditure on research activities is recognized in profit or loss as incurred. Development expenditure is capitalized only when the expenditure can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable and the Company intends to and has sufficient resources to complete development and to use or sell the asset.

Based on Management’s assessment, there were no events indicating that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.

(c)Intangible assets by country
         
      2022   2021
           
Brazil      2,571,011    2,526,999
Mexico      292,020    304,624
Netherland      122,447  
United States of America     22,820   24,404
Germany     13,839   21,253
Other     7    19
       3,022,144   2,877,299

 

14 Right-of-use assets and lease liability

The Company assesses whether a contract is or contains a lease if the contract transfers the right to control the use of an asset identified for a period in exchange for consideration. The Company leases various offices, railcars, vessels, pieces of equipment and vehicles. Such leases are negotiated individually and are subject to various terms and conditions.

As a lessee, the Company, to determine the enforceable term of the lease, considers all facts and circumstances that create an economic incentive for exercising the option to extend the lease.

(a)Right-of-use assets

Leases are recognized as a right-of-use asset and a corresponding liability on the date on which the leased asset becomes available to the Company.

The right-of-use asset is measured at the cost composed of:

• The amount initially measured of the lease liabilities;

• Any payment made up to the start of the lease, deducting any incentive received;

• Any initial direct cost; and

• Renovation costs.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property and equipment.

   
 F-38 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Changes in right-of-use assets:

                               
            Balance as of               Foreign currency   Balance as of
            31/12/2021   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2022
Rail cars             986,061     72,506    (173,272)   (5,359)     (53,740)     826,196
Machinery and equipment             793,254   1,147,145    (330,971)   (5,970)    (804)     1,602,654
Vessels             696,661   811,372    (385,968)    -    (1,793)     1,120,272
Buildings and constructions             265,312   102,040   (75,319)    -    (213)     291,820
Vehicles            29,449   102,827   (26,158)    -    (120)     105,998
Computer equipment and goods           9,300    417     (3,590)    -   (80)   6,047
Total           2,780,037   2,236,307     (995,278)     (11,329)   (56,750)     3,952,987
                                 
                                 
            Balance as of               Foreign currency   Balance as of
            12/31/2020   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2021
Rail cars             1,007,336   102,648    (187,915)    -   63,992     986,061
Machinery and equipment             749,728   281,113    (207,985)    (30,245)     643     793,254
Vessels             834,848   258,201    (399,677)    -     3,289     696,661
Buildings and constructions             259,896     52,897   (52,997)   (6,333)   11,849     265,312
Vehicles            33,888     51,171   (24,078)    (31,667)     135    29,449
Computer equipment and goods            16,699    542     (4,334)   (3,682)    75   9,300
Total           2,902,395    746,573     (876,986)     (71,928)     79,983     2,780,037

 

In 2022, the expense related to the short-term and low-value leases was R$42 million (2021: R$7.2 million).

To optimize lease costs during the lease term, the Company must provide guaranteed residual amounts for the leased asset. For certain lease agreements for rail cars, the Company guaranteed any difference between the flow of contractual payments and the fair value of these assets upon the end of the enforceable term, limited to R$65,529 as of December 31, 2022 (2021: R$70,085).

(b)Lease liability

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, the Company’s incremental borrowing rate. The lease liability considers the net present value of the following lease payments:

• Fixed payments discounting any incentive received;

• Variable payments based on rates or indexes;

• Expected payables to the lessor referring to the guaranteed residual amount;

• Exercise price of a purchase option, if it is reasonably certain that lessee will exercise such option; and

• Payment of fines for termination of the lease if the contractual terms provide for lessee’s exercise option.

The Company’s incremental borrowing rate corresponds to the one the Company would have pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use in a similar economic environment. The weighted average incremental rate applied in 2022 was 5.8% p.a. (2021: 5.18% p.a.). The lease liability is measured at amortized cost.

Changes in lease liabilities:

   
 F-39 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

     
  2022   2021
       
As of December 31  3,156,414    3,207,886
       
Acquired 2,232,043   746,573
Additions through acquisition of ER Plastics  4,264    
Disposals  (12,568)    (50,473)
Interests and monetary and exchange variations, net   83,871   206,375
Currancy translation adjustments   (73,585)     85,984
Payments   (928,890)     (841,706)
Interest paid   (221,019)     (198,225)
As of December 31  4,240,530    3,156,414
       
Current liability 1,039,706   675,366
Non-current liability 3,200,824   2,481,048
Total  4,240,530    3,156,414

The table below presents the obligations (minimum annual commitments) related to undiscounted lease agreements, by maturity, and therefore may not correspond to the respective operations in the statement of financial position.

                 
              2022   2021
                   
2022                   777,410
2023               1,109,048     633,141
2024               855,803     493,147
2025               630,074     399,924
2026+               2,388,252     1,073,620
Total             4,983,177     3,377,242

(c)Extension Options

Some leases contain extension options that can be exercised by the Company. The extension options held are exercised only by the Company and not by the lessors. The Company assesses at lease commencement date whether it is reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control.

(d)Non-cash transactions

In 2022, non-cash transactions are R$1,909,816 (2021: R$565,774).

   
 F-40 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(e)Uninitiated lease arrangements

The Company has committed to lease agreements not yet effective as of December 31, 2022. The present value of the commitments corresponds to R$ 546 million, and the main agreements refer to: (i) construction of two vessels for ethane gas transportation; and (ii) a research and development laboratory located in Boston, United States. All have an expected completion date by 2024.

The cash flows related to the contracts are shown below:

       
     Discounted     Undiscounted 
    2022   2022
2023     1,014     1,080
2024   52,258   55,678
2025   49,390   56,067
2026   46,687   56,468
2027+    396,669    712,541
Total     546,017     881,835

  

15 Trade payables

         
    Note   2022   2021
Trade payables:          
Domestic market          
Third parties      1,748,853     1,492,223
Third parties (forfait) (i)    682,396     487,806
Total Third parties      2,431,249     1,980,029
             
Related parties      196,440     208,287
Related parties (forfait) (i)   81,527    40,148
Total Related parties 9     277,967     248,435
             
Foreign market (ii)        
Third parties      9,540,635     9,936,266
        12,249,851   12,164,730
             
Current liabilities       12,246,782   12,053,266
Non-current liabilities       3,069     111,464
Total       12,249,851   12,164,730

(i) The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.
(ii) Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.

 

   
 F-41 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

16 Borrowings

(a) Borrowings

                 
        Annual financial charges (%)   2022   2021
Foreign currency                
Bonds       Note 16 (b)     26,124,158   30,322,998
Export prepayment and export credit notes   (i)   US$ exchange variation + Term SOFR quarterly + 1,79    1,514,651   -
Other       Note 16 (c)    3,880,165     4,703,059
Transactions costs             (453,532)   (594,048)
              31,065,442   34,432,009
                 
Current liabilities            1,177,144     1,284,483
Non-current liabilities             29,888,298   33,147,526
Total             31,065,442   34,432,009
                 
Local currency                
Agribusiness Credit Notes ("CRA")       Note 16 (d)    763,396   -
BNDES       IPCA + 6.04    386,534     435,778
Export credit notes       100.00 of CDI + 1.30    348,885   -
Other fixed interest loans       Interest between 3.5 and 6.5   18,671    24,864
Other variable interest loans       IPCA + interest between 2.39 and 2.78     3,525   4,616
Transactions costs            (21,193)     (7)
             1,499,818   465,251
                 
Current liabilities           77,406    59,011
Non-current liabilities            1,422,412     406,240
Total            1,499,818   465,251
                 
Foreign currency and local currency                
Current liabilities            1,254,550     1,343,494
Non-current liabilities             31,310,710   33,553,766
Total             32,565,260   34,897,260
(i) Maturity in June 2027.

 

 

   
 F-42 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The maturity profile of the long-term borrowings is as follows:

           
        2022   2021
             
2023         -     1,199,143
2024         2,143,624     3,965,917
2025         603,743     645,517
2026         581,625     622,032
2027         2,356,678     552,171
2028         7,281,841     7,081,301
2029         287,178     230,557
2030         7,995,727     8,535,493
2031         106,661    61,617
2033 and thereafter         9,953,633   10,660,018
Total       31,310,710   33,553,766

(b) Bonds

                   
            Interest    
Issue date       Maturity   (% per year)   2022   2021
Jul-2011 and jul-2012 (i)   jul-2041   7.125    3,044,911    3,296,917
Feb-2014 and may-2014 (ii)   fev-2024   6.450    1,588,729    3,417,741
Oct-2017   (ii)   jan-2023   3.500      593,964
Oct-2017   (i)   jan-2028   4.500    6,249,333    6,695,263
Nov-2019   (i)   jan-2030   4.500    7,936,089    8,527,701
Nov-2019       jan-2050   5.875    4,009,069    4,287,829
Jul-2020   (iii)   jan-2081   8.500    3,296,027    3,503,583
Total               26,124,158     30,322,998

 

(i) Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.
(ii) Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.
(iii) The bond can be repaid by the Company at par value, with the first payment between October 2025 and January 2026 and the other payments after each period of 5 years as from the first payment.

 

Braskem has fully, unconditionally and irrevocably, guaranteed the bonds issued by Braskem Finance, Braskem America Finance and Braskem Holanda Finance. Braskem’s guarantees for issues carried out between 2011 and 2019 comprise senior unsecured obligations of Braskem, ranking equal in right of payment with all of its other existing and future senior unsecured debt. As for the issuance carried out in 2020, in case of default the guarantee comprises obligations subordinated to all current or future senior debts of Braskem.

   
 F-43 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(c) Other

               
Issue date   Maturity   Charges (% per year)   2022   2021
nov-2018 (i) nov-2028   Us dollar exchange variation + semianual Libor + 0.90    929,112    1,154,146
dec-2019 (i) dec-2029   Us dollar exchange variation + semianual Libor + 0.90    549,610    670,124
dec-2019 (ii) apr-2026   Us dollar exchange variation + semianual Libor - 1.00     197,209    266,403
sep-2017 (iii) mar-2027   Us dollar exchange variation + semianual Libor + 1.61    357,488    462,490
jul-2018 (iv) dec-2028   Us dollar exchange variation + semianual Libor + 0.65    757,832    947,898
aug-2020 (iii) feb-2031   Us dollar exchange variation + semianual Libor + 1.70    1,007,067    1,201,998
aug-2020 (v) aug-2028 to jun-2029   Euro exchange variation + interest between 2.40 and 7.41   79,698    
nov-2020 (v) no maturity   Euro exchange variation + Euribor monthly + 4.10     2,149    
             3,880,165   4,703,059
(i)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.
(ii)Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.
(iii)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.
(iv)Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million.
(v)Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.

 

(d) CRA

On January 5, 2022, Eco Securitizadora de Direitos Creditórios do Agronegócio S.A. issued CRA in the Brazilian debt capital markets backed by a private debenture issued by Braskem.

                             
      Issue amount                    
Issue date       Issuer   Series   Maturity   Charges (% per year)   2022   2021
Jan-2022       581,602    Braskem S.A.      Dec-2028   IPCA + 5.54%   616,025   -
Jan-2022       139,134    Braskem S.A.      Dec-2031   IPCA + 5.57%   147,371   -
Total     720,736                    763,396    

 

   
 F-44 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

17 Braskem Idesa Borrowings

                 
             
Identification   Maturity   Charges (% per year)   2022   2021
                 
Bonds                
Bond I   nov-2029   Us dollar exchange variation + 7.45 (i)   4,690,619    5,104,463
Bond II   feb-2032   Us dollar exchange variation + 6.99 (ii)   6,352,864    6,834,805
             11,043,483     11,939,268
                 
Others (a) Oct-2026   Us dollar exchange variation + quarterly Libor + 4.00 (iii) 734,837     849,859
                 
Transactions costs            (408,002)     (477,592)
                 
Total            11,370,318     12,311,535
                 
Current liabilities             868,635   86,765
Non-current liabilities           10,501,683     12,224,770
Total            11,370,318     12,311,535

(i)Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.
(ii)Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.
(iii)For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.
(a) Regarding this financing, on December 22, 2022 Braskem Idesa obtained the waiver related to a leverage ratio (covenant) until June 30, 2023. In this sense, even though Braskem Idesa is not in default and creditors did not request to accelerate this debt, because the waiver did not cover at least 12 months, the entire balance, in the amount of R$649,560, was reclassified from non-current liabilities to current liabilities on December 31, 2022.

 

Braskem Idesa is in full compliance with its debt service obligation defined in the financing agreement and maintains a cash position equivalent to R$2,184,332 as of December 31, 2022.

The amount of the financings with maturities in the long term are as follows:

       
    2022   2021
         
2023   -   67,649
2024   -   68,694
2025   -   69,530
2026   -    408,445
2029     4,337,567    4,900,399
2032     6,164,116    6,710,053
Total   10,501,683     12,224,770

 

   
 F-45 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

18 Debentures

                       
                Annual    
Issue date   Issuer   Series   Maturity   financial charges (%)   2022   2021
mar-2013 (i) DAC   Only   mar-2025   IPCA + 6%   109,877   150,352
sep-2013 (i) Cetrel   Only   Sep-2025   126.5% of CDI     34,604     47,109
may-2022   Braskem     may-2029   CDI + 1,75   770,910    -
may-2022   Braskem     may-2030 to 2032   CDI + 2,00   248,970    -
aug-2022 (i) Braskem    Only   aug-2029   CDI + 1,75   786,770    -
nov-2022   Braskem      nov-2029   CDI + 1,70   1,113,987    -
nov-2022   Braskem      nov-2030 to 2032   CDI + 1,95     97,159    -
Transactions costs                    (10,802)   (543)
                     3,151,475    196,918
                         
Current liabilities                   127,801     59,088
Non-current liabilities                 3,023,674   137,830
Total                    3,151,475    196,918

(i) These debentures were secured by mandatory deposits as disclosed in Note 6.

 

The maturity profile of the long-term debentures is as follow:

           
        2022   2021
             
2023         -   57,045
2024        58,550   57,096
2025        24,059   23,689
2029         2,600,998    -
2030         113,291    -
2031         113,360    -
2032         113,416    -
Total         3,023,674     137,830

   
 F-46 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

19 Reconciliation of borrowing activities in the statement of cash flow

                           
    Borrowings, debentures and Braskem Idesa financing              
            Total       Non-controlling           
            borrowings   Braskem Idesa   shareholders            
    Borrowings   Debentures   and debentures   financing   of Braskem Idesa   Lease   Dividends  
                               
 Balances at December 31, 2021    34,897,260   196,918   35,094,178   12,311,535   3,646,538     3,156,414    10,538  
                               
 Acquired  3,479,224     2,938,984     6,418,208     -   -         -  
 Payments    (3,753,427)   (102,235)   (3,855,662)     (45,311)   (34,122)   (928,890)     (1,350,293)  
 Cash used in financing activities  (274,203)   2,836,749   2,562,546   (45,311)    (34,122)    (928,890)   (1,350,293)  
                               
 Other changes                             
 Interest paid    (1,880,611)     (34,548)   (1,915,159)   (752,489)   (16,212)   (221,019)     -  
 Interest and monetary and exchange variations, net  1,524,983     152,356     1,677,339     170,180   (47,784)   83,871     -  
 VAT on loan                  (75,640)          
 New contracts                       2,232,043      
 Disposal                        (12,568)      
 Additions through acquisition of ER Plastics    99,702        99,702     -         4,264     -  
 Currency translation adjustments    (1,801,871)       (1,801,871)   (313,597)   (84,720)     (73,585)      
 Fair value of financial transactions of non-controlling subsidiaries                 (889,967)          
 Additional dividends approved in the board meeting      -         -            1,350,000  
 Additional dividends of subsidiary      -         -             1,236  
 Other      -         -           (474)  
      (2,057,797)   117,808    (1,939,989)    (895,906)    (1,114,323)     2,013,006     1,350,762  
                               
 Balances at December 31, 2022    32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  
                               
Current 1,254,550     127,801     1,382,351     868,635        1,039,706   11,007 (i)
No Current  31,310,710     3,023,674   34,334,384   10,501,683     2,498,093    3,200,824      
Total   32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  

 

(i) Amount classified in "Other payables" under current liabilities.

 

   
 F-47 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

20 Financial instruments

20.1 Initial recognition and measurement

Trade receivables and bonds issued are initially recognized when they are originated. All other financial assets and liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.

A financial asset (unless it is a trade receivable without a significant financing component) is initially measured at fair value, plus transaction costs directly attributable to their acquisition. A financial liability is initially recognized at fair value, excluding transaction costs. For financial assets and liabilities measured subsequently at fair value through profit or loss (“FVTPL”), transactions costs that are directly recognized in profit or loss. A trade receivable without a significant financing component is initially measured at the transaction price.

(a) Classification, subsequent measurement and gains and losses

Financial Assets

On initial recognition, a financial asset is classified as measured at: amortized cost; fair value through other comprehensive income (“FVOCI”) or fair value through profit or loss (“FVTPL”).

A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as measured at fair value:

(i) It is held within a business model whose objective is to hold assets to collect contractual cash flows; and

(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

A financial asset can also be measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:

(i) It is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and

(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. This includes all derivative financial assets (see Note 20.5).

Financial assets at FVTPL are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2).

Financial assets at amortized cost are subsequently measured at amortized cost using the effective interest method and, if applicable, reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.

Financial assets at FVOCI are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and, when applicable, impairment loss are recognized in profit or loss. Other net gains and losses are recognized in Other Comprehensive Income (“OCI”). On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.

   
 F-48 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Financial liabilities

Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is a derivative.

Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2). Any gain or loss on derecognition is also recognized in profit or loss.

 

(b) Derecognition of financial instruments

Financial Asset

The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire or when the Company transfers the rights to receive the contractual cash flows in a transaction in which either:

(i) Substantially all of the risks and rewards of ownership of the financial asset are transferred; or

(ii) The Company does not retain substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.

When the Company enters into transactions whereby it transfers assets recognized in its statement of financial position but retains either all or substantially all of the risks and rewards of the transferred assets, the financial assets are not derecognized.

Financial liabilities

The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.

On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.

Interest rate reform

When the base for determining the contractual cash flows of a financial asset or financial liability measured at amortized cost changes as a result of interest rate reform, the Company updates the effective interest rate of the financial asset or financial liability to reflect the change required by the reform.

A change in the base for determining the contractual cash flows is required by the interest rate benchmark reform if the following conditions are met: (i) the change is necessary as a direct consequence of the reform; and (ii) the new base for determining contractual cash flows is economically equivalent to the previous base, i.e., the base immediately prior to the change.

When changes are made in a financial asset or financial liability in addition to changes in the base for determining the contractual cash flows required by the interest rate benchmark reform, the Company updates first the effective interest rate of the financial asset or financial liability to reflect the change required by the interest rate benchmark reform. Then the Company applies the accounting policies for changes from the additional modifications.

   
 F-49 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(c) Offsetting

Financial assets or financial liabilities are offset, and the net amount presented in the statement of financial position when, and only when, the Company currently has a legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realize the asset and settle the liability simultaneously.

20.2 Derivative financial instruments and hedge accounting

The Company holds derivative financial instruments to hedge its foreign currency and interest rate risk exposures. Embedded derivatives are separated from the host contract and accounted for separately if the host contract is not a financial asset and certain criteria are met.

Derivatives are initially measured at fair value. After initial recognition, derivatives are measured at fair value, and changes therein are generally recognized in profit or loss.

The Company designates certain derivatives and non-derivative financial liabilities as hedging instruments to hedge the variability in cash flows associated with highly probable forecast transactions arising from changes in foreign exchange rates and interest rates.

At inception of designated hedging relationships, the Company documents the risk management objective and strategy for undertaking the hedge. The Company also documents the economic relationship between the hedged item and the hedging instrument, including whether the changes in cash flows of the hedged item and hedging instrument are expected to offset each other.

Cash flow hedges

When a derivative is designated as a cash flow hedging instrument, the effective portion of changes in the fair value of the derivative is recognized in OCI. The effective portion of changes in the fair value of the derivative that is recognized in OCI is limited to the cumulative change in fair value of the hedged item, determined on a present value basis, from inception of the hedge. Any ineffective portion of changes in the fair value of the derivative is recognized immediately in profit or loss.

If the hedge no longer meets the criteria for hedge accounting, or the hedging instrument is sold, expires, is terminated or is exercised, then hedge accounting is discontinued prospectively. When hedge accounting for cash flow hedges is discontinued, the amount that has been accumulated in OCI remains recognized until it is reclassified under profit or loss in the same period or periods as the expected future cash flows affect the profit or loss.

If the hedged future cash flows are no longer expected to occur, then the amounts that have been accumulated in OCI are immediately reclassified to profit or loss.

   
 F-50 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

20.3 Fair Value

(a) Fair value measurement

Fair value is the price to be received in the sale of an asset or paid for the transfer of a liability in a transaction not forced between market players on the measurement date, in the main market or, in the case of a lack of one, the most advantageous market in which the Company has access on said date.

The Company recognizes derivative financial instruments at their fair value and the main sources of information are the stock exchanges, commodities and futures markets, published by Central Bank of Brazil (“BACEN”), Bloomberg and Reuters. Nevertheless, the volatility of the foreign exchange and interest rate markets in Brazil has been resulting in significant changes in future rates and interest rates over short periods of time, leading to significant changes in the fair value of derivatives and other financial instruments.

The fair values of non-derivative quoted financial instruments are based on current bid prices. If the market for a financial asset and for unlisted securities is not active, the Company establishes fair value by using valuation techniques. These include the use of recent arm’s length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, and option pricing models that make maximum use of market inputs and rely as little as possible on information provided by the Management.

The following methods and assumptions were used to estimate the fair value:

(i) Financial assets classified as VFTPL or FVOCI are measured in accordance with the fair value hierarchy (Level 1 and Level 2), with inputs used in the measurement processes obtained from sources that reflect the most recent observable market prices.

(ii) Trade accounts receivable and trade payables, mostly classified as amortized cost, correspond to their respective carrying amounts due to the short-term maturity of these instruments. When purchase or sale prices include material financial charges, the securities are adjusted to their present value.

(iii) The fair value of borrowings is estimated by discounting future contractual cash flows at the market interest rate, which is available to the Company in similar financial instruments.

(iv) The fair value of bonds is based on prices negotiated in financial markets, plus the respective carrying amount of interest.

The fair values of the remaining assets and liabilities correspond to their carrying amount. The valuation of liabilities (Note 20.4) considers the present value of expected payments, discounted by a discount rate adjusted to the risk.

   
 F-51 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(b) Fair value hierarchy

Level 1: fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and

Level 2: fair value obtained from financial models using directly observable market data, such as discounted cash flow, when the instrument is a forward purchase/sale or a swap contract, or such as the Black-Scholes model, when the instrument has the characteristics of an option. To measure the credit risk of the parties involved in derivative instruments, the Company uses Credit Valuation Adjustment (“CVA”) or Debt Valuation Adjustment (“DVA”) models, applied flow by flow on the fair value of each instrument. The Company adopts the ratings of the other parties for positive flows and its own rating for negative flows, both available in the market and disclosed by renowned rating agencies, as a necessary assumption to define the probability of default.

20.4 Non-derivative financial instruments and other liabilities

                         
          Fair value   Book value   Fair value
  Note   Classification by category   hierarchy   2022   2021   2022   2021
                           
Cash and cash equivalents 5                        
Cash and banks     Amortized cost         6,074,208     5,050,822     6,074,208     5,050,822
Financial investments in Brazil     Fair value through profit or loss   Level 2     6,392,266     3,629,864     6,392,266     3,629,864
               12,466,474   8,680,686    12,466,474   8,680,686
                           
Financial investments  6                        
LFT´s and LF´s     Fair value through profit or loss   Level 2     1,789,375     2,337,171     1,789,375     2,337,171
Time deposit investments     Amortized cost       -     106,271   -     106,271
Other     Fair value through profit or loss   Level 2     523,256     1,066,113     523,256     1,066,113
              2,312,631   3,509,555 2,312,631   3,509,555
                           
Trade accounts receivable  7   Amortized cost       3,199,223   7,118,452   3,199,223   7,118,452
Trade accounts receivable  7   Fair value through other comprehensive income   Level 2   32,711   48,508   32,711   48,508
                           
Trade payables 15   Amortized cost        12,249,851    12,164,730    12,249,851    12,164,730
                           
Borrowings  16   Amortized cost                    
Foreign currency - Bond         Level 1   26,124,158   30,322,998   23,165,942   33,690,876
Foreign currency - other borrowings         Level 2     5,394,816     4,703,059     5,329,174     4,696,970
Local currency         Level 2     1,521,011     465,258     1,937,255     451,899
              33,039,985   35,491,315   30,432,371   38,839,745
                           
Braskem Idesa borrowings 17   Amortized cost                    
Bond         Level 1   11,043,483   11,939,268     8,301,948   12,197,524
Others         Level 2     734,837     849,859     796,510     931,141
              11,778,320   12,789,127   9,098,458   13,128,665
                           
Debentures 18   Amortized cost   Level 2   3,162,277   196,918   3,190,417   195,570
                           
Loan ton non-controlling
  shareholder of Braskem Idesa
 9(a)    Amortized cost       2,498,093   3,646,538   2,498,093   3,646,538
                           
Leniency agreement  25   Amortized cost       903,140   1,123,296   903,140   1,123,296

 

   
 F-52 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

20.5 Derivative financial instruments

                         
    Operation characteristics     Net (Asset)/           Net (Asset)/
    Principal exposure         Liability   Change in   Financial   Liability
Identification     Derivatives     2021   fair value   settlement   2022
                           
Non-hedge                           
accounting transactions                          
Braksem America - Swap C3/PGP   Propane   Propene      14,299     (2,158)    (12,141)     -
Braskem Holanda - Swap Nafta/Gasoline   Gasoline   Naphtha        (16,847)     (25,733)   26,584     (15,996)
Braskem Argentina - Exchange swap   Argentine peso Dollar     3   61   (63)   1
                (2,545)     (27,830)   14,380     (15,995)
                           
Hedge accounting                          
transactions                          
Braskem S.A. - Dollar call and put options   Real   Dollar      85,216     (227,871)   77,285     (65,370)
Braskem S.A. - Dollar swap CDI   Real   Dollar+Fixed rates    502,508     (194,055)    (156,740)    151,713
Braskem S.A. - Swap CRA   Real   Dollar+Fixed rates     -     (32,828)   10,116     (22,712)
               587,724     (454,754)    (69,339)    63,631
                           
Derivatives                          
Assets                          
Current assets              33,816            157,906
Non-current assets             51            71,544
Total              33,867            229,450
Liabilities                          
Current liabilities              256,131            195,169
Non-current liabilities              362,915            81,917
Total              619,046            277,086
Net (Asset)/Liability              585,179            47,636

 

The counterparties in these contracts are constantly monitored based on the analysis of their respective ratings and Credit Default Swap (“CDS”). The Company has many bilateral risk mitigators in its derivative contracts, such as the possibility of depositing or requesting deposits of a guaranteed margin from the counterparties.

Derivative financial instruments held on December 31, 2022 were contracted on both international stock exchanges and on Over the Counter (“OTC”) markets with large financial counterparties under global derivative contracts in Brazil or abroad.

The Company’s Financial Policy provides for the active management and continued protection against fluctuations in currencies and rates arising from its operations and financial items, with the possibility of contracting derivative instruments (swaps, NDFs, options, etc.). The other market risks are addressed on a case-by-case basis for each transaction. In general, the Company assesses the need for hedging in the analysis of prospective transactions and seeks to customize the hedge and keeps it in place for the hedged period transaction.

In general, the Company elects to designate derivative financial instruments in a hedge accounting relationship when the application is expected to provide a significant improvement in presenting the offsetting effect on the changes in the hedged items.

   
 F-53 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

Hedge accounting transactions

(a.i) US Dollar call and put option

As of December 31, 2022, the Company holds a total notional amount of put options of US$2.1 billion (R$10.96 billion), with an average strike price of US$1/R$4.7 and notional amount of call options of US$1.4 billion (R$7.3 billion), with an average strike price of US$1/R$7.06. The operations have a maximum term of 18 months.

US Dollar-denominated future sales in Brazilian Real were designated for hedge accounting, with the months of revenue recognition always coinciding with the months of the options. The future elements of forward exchange contracts are excluded from the designation of hedge instrument and are separately recorded as hedging cost, recognized in the OCI.

(a.ii) US Dollar Swap

In 2018, the Company contracted foreign exchange derivative operations (“swaps”) in the aggregate amount of R$1.27 billion, with annual maturities over the following 5 years starting January 2019. The amount payable in January 2020 was subject to the variation in the IPCA index. The remaining maturities are subject to the variation in the CDI. These operations were designated to cash flow hedge accounting, where the hedging instruments are foreign exchange derivatives, and the hedged objects are highly probable future revenues in the domestic market subject to fluctuations in Brazilian R$/US$ price.

Accordingly, the fair value adjustment of the effective portion of the hedge is recognized under shareholders equity in OCI and is recognized in the financial result upon the maturity of each installment.

(a.iii) US Dollar Swap - CRA

In 2022, the Company contracted foreign exchange derivative operations (“swaps”) with semiannual maturities for the next 10 years as from March 2022. These operations were designated for cash flow hedge accounting, in which the hedge instruments are foreign exchange derivatives, and the hedge objects are highly probable future revenue subject to the R$/US$ exchange rate.

Accordingly, the fair value adjustment in the effective hedge portion will be recorded in equity in OCI and will be recognized in financial result upon the realization of each of the hedge objects.

                     
Identification   Total nominal   Hedge   Maturity       Fair value, net
  value R$   (interest rate per year)     2022   2021
Swaps CRA    600,218   3.5388%   dec-2028    12,603     -
Swaps CRA    141,298   3.3742%   dec-2031    10,109    
Total     741,516             22,712     -
                     
Derivatives                    
Assets                    
Current assets                13,274     -
Non-Current assets                49,613     -
Total                62,887     -
Liabilities                    
Non-Current liabilities                40,175     -
Total                40,175     -
Net (Asset)/Liability                 22,712     -

 

   
 F-54 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

20.6 Non-derivative financial liabilities designated to hedge accounting

(a) Future exports in US$ (Braskem S.A.)

The Company designated non-derivate financial liabilities in foreign currency to hedge the future cash flows generated by its exports. This decision was based on two important concepts and judgments: (i) ) the high probability of performing exports according to its business plan, (see Note 22.2), which are inherent to the market and business where it operates, and (ii) the Company’s capacity to finance its liabilities in US$, since its guidance and strategy determine the financing priority in US$ and its Financial Policy requires maintaining a minimum level of net liabilities in US$.

On May 1, 2013, Braskem designated non-derivative financial liabilities, denominated in US$, as a hedge for the flow of its highly probable future exports. Thus, the impact of exchange rates on future cash flows in US dollar derived from these exports is offset by the foreign exchange variation on the designated liabilities, partly eliminating the volatility of results. The exchange rate on the date of the designation was US$1/ R$2.0017.

The main actions carried out in the program are detailed below:

• 2017: designation of R$6.52 billion (US$1.25 billion) of future sales with maturity in 2028 (hedged exchange rate of US$1/3.1688);

• 2019: designations of R$11.5 billion (US$2.2 billion) with maturity in 2025, 2030 and 2031 (hedged exchange rate of US$1/3.9492);

• 2020: designation of R$3,131 million (US$600 million) of future sales with maturity in 2032 (hedged exchange rate of US$1/R$4.0213); discontinuation of hedge accounting of R$1,889 million (U$$362 million) in 2020 (discontinuation rate of US$1/R$5.1987).

• 2021: designation of hedge accounting of R$2,087 million (US$400 million) in 2025 (hedged exchange rate of US$1/R$5.5832); discontinuation of hedge accounting of R$2,087 million (US$400 million) in 2024 (discontinuation rate of US$1/R$5.6430); discontinuation of hedge accounting of R$1,044 million (US$200 million) in 2023 (discontinuation rate of US$1/R$5.1433);

• 2022: designation of R$2,609 million (US$500 million) of future sales with maturity in 2029 (hedged exchange rate of US$1/R$5.5832).

• Over the past two years, Braskem exported an average R$88.7 billion (US$17 billion) per year, which represents around 3 to 4 times the annual exports of the hedged exports.

• Hedged exports represent approximately 30% of the export flows planned by the Company.

• The exports of the Company are not sporadic or occasional but constitute an integral part of its strategy and of the petrochemical business, in which competition is global. Several of the products produced by the Company are primarily and recurrently intended for export.

   
 F-55 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

On December 31, 2022, the exports that were designated not yet realized and not discontinued and the maturities of financial liabilities designated, all consolidated, were as follows:

               
                 
                Total nominal value
            US$   R$
              0  
2024             288,854    1,507,154
2025             800,000    4,174,160
2028             1,250,000    6,522,125
2029             500,000    2,608,850
2030             800,000    4,174,160
2031             800,000    4,174,160
2032             800,000    4,174,160
Total nominal value             5,238,854     27,334,769

The following table shows the changes in financial instruments designated for this hedge in the year:

             
             
            US$
              
    2021   Designations   2022
             
Designated balance    4,738,854    500,000     5,238,854

 

   
 F-56 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The following table provides the balances of exchange variation recognized in the Company’s net financial income (expenses) due to the realization of exports designated, for this hedge in the fiscal year ended December 31, 2022:

               
        Conversion rate        
    Total nominal   at Inception   Closing rate   Gross nominal
    value US$   R$/US$   R$/US$   value - R$
                 
First quarter    175,000   2.0017   3.9786     345,958
Second quarter    208,000   2.0017   3.9786     411,195
Third quarter    186,000   2.0017   3.9786     367,703
Fourth quarter    150,000   2.0017   3.9786     296,535
      719,000           1,421,391

The changes in foreign exchange variation and income taxes under other comprehensive income of this hedge are as follows:

         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021 (13,102,558)    4,454,869     (8,647,689)
           
Exchange variation recorded in the period / IR and CSL 1,699,906     (577,968)   1,121,938
           
Exchange variation transferred to profit or loss / IR and CSL 1,421,391     (483,273)   938,118
           
Balances at December 31, 2022   (9,981,261)    3,393,628     (6,587,633)

   
 F-57 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(b) Future sales in US$ (Braskem Idesa)

As of December 31, 2022, designated and unrealized sales and financial liabilities designated to hedge them were as follows:

           
             
            Nominal value
             
2023           65,221
2024            117,398
2025            117,398
2026            430,460
2030            1,173,983
2031            1,173,983
2032            2,739,293
2033            2,739,293
2034            1,565,310
2035            1,565,310
Nominal value             11,687,649

 

The following table provides the balances of exchange variation recognized in Braskem Idesa’s financial income (expenses) due to the maturity of the sales designated in this hedge for the 12-month period ended December 31, 2022:

                     
        Conversion rate            
    Total nominal   at Inception   Closing rate   Total nominal   Gross nominal
    value US$   MXN/US$   MXN/US$   value MXN   value - R$
                     
First quarter    29,136   13.6218   20.2827   194,072   49,302
Second quarter    72,612   13.6507   20.1297   470,453   116,361
Third quarter    72,612   13.6507   20.1297   470,453   120,341
Fourth quarter    78,844   13.6521   20.1224   510,144   137,999
    253,204           1,645,123   424,003

The changes in foreign exchange variation and income taxes under other comprehensive at Braskem Idesa income are as follows:

         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021   (2,231,511)    670,192     (1,561,319)
           
Exchange variation recorded in the period / IR 699,677     (209,903)   489,774
           
Exchange variation transferred to profit or loss / IR 424,003     (127,201)   296,802
           
Balances at December 31, 2022   (1,107,831)    333,088   (774,743)

Effectiveness tests were conducted, and all operations were deemed effective in reducing the dispersion of revenue from sales designated for hedge, when evaluated in Mexican Pesos.

   
 F-58 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

20.7 Credit quality of financial assets

(a) Trade accounts receivable

The Company’s clients do not have risk ratings assigned by credit rating agencies. For this reason, the Company developed its own credit rating methodology for all accounts receivable from clients in Brazil and abroad.

Considering the expected credit losses, the percentage of trade accounts receivable by risk ratings was as follows:

         
          (%)
      2022   2021
1 Minimal Risk   72.15   65.39
2 Low Risk   21.65   26.65
3 Medium Risk   3.36   6.02
4 High Risk   2.56   1.54
5 Very High Risk (i) 0.28   0.40

 

(i) Clients in this group that are still active buy from Braskem and pay in advance.

 

For the export market, around 85% of the portfolio has guarantees, consisting primarily of credit insurance. For the domestic market, around 22% of the portfolio has guarantees, mainly suretyships by the partners of counterparties, complemented by credit insurance.

   
 F-59 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(b) Cash and cash equivalents and financial investments

In order to determine the credit ratings of counterparties classified under cash and cash equivalents, and financial investments, the Company uses the risk rating of agencies Standard & Poor’s, Moody’s and Fitch Ratings, within the limits established in its Financial Policy:

                       
             
            2022           2021
     Domestic market     Foreign market    Total    Domestic market     Foreign market    Total
Financial assets with risk classification                        
AAA   5,130,140   2,420,741    7,550,881     4,080,884   2,783,151    6,864,035
AA+   162,650   -     162,650   109,165   -     109,165
AA   289,574   107,545     397,119   188,742   629,671     818,413
AA-   149,178   -     149,178     63,675   -    63,675
A+     3,423   4,459,700    4,463,123    5,788   2,914,269    2,920,057
A   57,650   1,392,854    1,450,504   107,225   -     107,225
A-   -   387,478     387,478     634   236,335     236,969
BBB+     118     375    493     856     38    894
BBB     788   52,389    53,177     129   1,026,104    1,026,233
BBB-            -     554   -    554
BB+            -    50   -   50
BB       -    -    1,479   -   1,479
BB-        7     7            
    5,793,521   8,821,089     14,614,610     4,559,181   7,589,568     12,148,749
Financial assets without risk classification                        
Shares of investment funds
in credit rights
      -    -    1,721   -   1,721
Other financial assets   (i)  83,070   81,425     164,495     25,989   13,782    39,771
    83,070   81,425     164,495     27,710   13,782    41,492
                         
Total   5,876,591   8,902,514     14,779,105     4,586,891   7,603,350     12,190,241

 

(i) Investments approved by the Management, in accordance with the Financial Policy.

 

20.8 Sensitivity analysis

Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:

(a) Selection of risks

On December 31, 2022, the main risks that can affect the value of Company’s financial instruments are:

· US$/R$ exchange rate;

· LIBOR floating interest rate;

· IPCA inflation rate;

· Selic and CDI interest rates; and

· SOFR interest rate.

   
 F-60 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

For the purposes of the risk sensitivity analysis, the Company presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.

(b) Value at risk

The value at risk of the derivatives held by the Company which is defined as the impact on fair value adjustment that could result in one month as from December 31, 2022, with a probability of 5%, and under normal market conditions, was estimated by the Company at R$129 million (US$24.7 million) for put options and call options (Note 20.5(a.i)) and R$96.7 million (US$18.5 million) for the US dollar swap (Note 20.5(a.ii)) and R$4.5 million (US$872 thousand) for the CRA swap (Note 20.2(a.iii)).

(c) Selection of scenarios

The Focus Market Readout published by BACEN was used to create the probable scenario for the US$-R$ exchange rate, the Selic interest rate and the CDI interest rate as of December 31, 2022.

According to the Market Readout, at the end of 2023, US$1 will remain at approximately R$5.27, while the Selic rate should reach 12.25% p.a. at the end of the period. The Selic rate is used as benchmark for sensitivity analysis of the CDI rate.

Since the Market Readout report does not include consensus forecasts for the LIBOR rate, the projection of the U.S. Federal Reserve for the Federal Funds rate at the end of the year was used, whose most recent version was published in December 2022, in comparison with the current level of the Federal Funds rate on December 31, 2022.

For each variable analyzed in the sensitivity analysis, the Company has considered estimating annualized variations corresponding to 1 and 3 standard deviations of monthly averages of the last five years. They are equivalent to approximately 15.866% and a 0.135% probability of occurrence for the reasonably possible and possible scenarios, respectively. Then, these changes are applied to the current market levels of each variable.

 

Uncertainties of the current context

The assumptions of the future value adopted in the construction of the probable scenario and the current value of each variable in this analysis are referenced to the reporting date December 31, 2022. Given the instability in the current economic scenario caused by the COVID-19 pandemic and the global effects resulting from the conflict in Ukraine, interest rates and foreign exchange rates are affected daily. The Company’s gains and losses in these probable stress scenarios are analyzed by increasing each variable according to the aforementioned.

   
 F-61 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The sensitivity values in the table below represent the changes in the value of the financial instruments in each scenario, jointly with the absolute amounts of each of the risk factors considered:

                   
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity   Note   as December 31, 2022   (USDBRL 5.27)   (USDBRL 5.93)   (USDBRL 7.35)
                     
Brazilian real/U.S. dollar exchange rate                    
Bonds         (37,167,641)    (372,553)   (5,051,899)    (15,155,696)
Export prepayments        (1,028,473)   (10,309)    (139,792)    (419,376)
Investments        (1,985,932)   (19,906)    (269,932)    (809,795)
SACE   16(c.i)    (1,478,722)   (14,822)    (200,991)    (602,973)
Dollar call and put options   (i)   65,370    9,809    (160,742)   (1,023,396)
Dollar swap x CDI         (151,713)     (6,216)    (189,181)    (466,381)
MONFORTE   16(c.ii)     (197,209)     (1,977)   (26,805)   (80,415)
Nexi   16(c.iii.iv)     (100,707)     (1,009)   (13,688)   (41,065)
Other         (734,837)     (7,366)   (99,881)    (299,642)
Financial investments abroad       6,718,183     67,340     913,149     2,739,446
Dollar swap x IPCA       22,713   (607)   (63,356)    (194,841)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.58%)   (7.89%)   (14.13%)
                     
Libor floating interest rate                    
Export prepayments        (35,749)   (887)     (3,388)   (10,163)
Nexi   16(c.iii.iv)     (100,707)     (3,920)   (14,970)   (44,909)
SACE   16(c.i)    (1,478,722)   (49,107)    (187,520)    (562,560)
MONFORTE   16(c.ii)     (197,209)     (4,094)   (15,635)   (46,906)
Investments        (1,985,932)   (63,201)    (241,339)    (724,017)
Outros         (734,837)   (16,887)   (64,483)    (193,449)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
CDI interest rate                    
Debentures        (3,052,400)     302,796    (898,725)   (3,331,635)
Financial investments in local currency       5,876,590   (80,242)     206,257     619,489
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.31%)   (6.72%)   (8.35%)
                     
IPCA interest rate                    
Debentures         (109,877)    1,494     (2,085)     (6,315)
BNDES         (386,534)     26,403   (38,283)    (121,208)
BNB/ FINEP/ FUNDES/FINISA/FINAME/FNE       (3,525)    59     (83)   (252)
CRA         (763,396)     45,429   (65,630)    (206,889)
Dollar swap x IPCA       22,713   (99,748)     31,958     99,871
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
Selic interest rate                    
Leniency agreement         (865,311)    6,856   (17,443)   (51,656)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (4.59%)   (10.58%)   (22.57%)
                     
Selic interest rate                    
Export prepayments         (992,725)   (25,698)    (195,867)    (587,602)
Export credit notes         (521,926)   (13,571)    (103,435)    (310,306)

(i) The Company is in the short position of a possible counterparty call.

 

   
 F-62 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

21 Taxes payable

           
               
          2022   2021
Brazil            
  IPI        74,219     131,290
  ICMS         218,179     485,302
  PIS and Cofins        20,406    33,516
  Other         103,549    46,117
               
Other countries            
  Value-added tax         150,260     229,571
  Tax on financial income       222,464     346,817
Total       789,077   1,272,613
               
Current liabilities         491,051     1,012,116
Non-current liabilities         298,026     260,497
Total       789,077   1,272,613

22 Income taxes

Income taxes comprises current and deferred taxes. It is recognized in profit or loss except to the extent that it relates to items directly recognized in other comprehensive income.

22.1 Current income taxes

Current income taxes comprise the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted at the reporting date. Current tax also includes any tax arising from dividends. Current tax assets and liabilities are offset only if certain criteria are met.

As of December 31, 2022, the amount presented as recoverable income taxes under current assets is R$392,062 (2021: R$1,189,812) and non-current assets is R$252,995 (2021: R$230,069). In 2021: R$984.4 million refers to taxes recoverable at Braskem America arising from the tax program offered by the U.S. government, for aid and support to U.S. companies in response to the economic impacts of Covid-19.

(a) Exclusion of inflation adjustment by Selic (economy´s basic interest rate) on undue tax payments from taxable income

In July 2010, Braskem and the merged companies in previous years, filed lawsuits claiming exception from the levying of Brazilian income taxes (hereinafter “IR/CSL”) on amounts they received as interest on late payment, since they do not represent any equity increase. On September 24, 2021, through Special Appeal 1.603.187, the Federal Supreme Court (“STF”) stated that “the levying of IR/CSL on amounts updated by the Selic rate, received due to repetition of undue tax payments, is unconstitutional.”

Braskem benefited from this decision in the amount of R$540 million reduction in income taxes calculated until 2022 (R$501 million until 2021). In 2021, deferred tax assets amounting to R$68 million were recognized for the periods in which tax losses increased.

   
 F-63 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(b) Exemption of IR/CSL on ICMS tax incentives and benefits

In October 2021, the Company obtained a preliminary injunction to exclude the ICMS tax incentives and benefits applicable to its operations, granted by the governments of States and the Federal District, from the income tax calculation base as from 2021. Since it is an uncertain tax treatment, as of December 31, 2021, it remains booked in the balance sheet as income taxes payable.

In August 2022, a judgment was rendered restricting relief only to presumed ICMS credits. Accordingly, the amount related to ICMS tax incentives and benefits was paid amounting to R$1,038,255.

(c) Use of tax losses in Braskem Idesa

Mexico’s federal revenue service (“SAT”) has been questioning Braskem Idesa and Braskem SOFOM about the criteria and assumptions adopted in the calculation of income tax. With the intermediation from the Taxpayer Defense Attorney of Mexico (“Prodecon”), on February 3, 2023, Braskem Idesa and Braskem SOFOM signed an agreement, in which Braskem Sofom agreed to settle the income taxes proposed by SAT and Braskem Idesa reviewed the accrued tax losses in certain periods, resulting in a reduction in deferred tax credits of R$892 million, with a corresponding entry under deferred income tax expense.

   
 F-64 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(d) Reconciliation of effective tax rate

             
           
      2022   2021   2020
               
Profit (loss) before income taxes       47,344   17,961,023    (9,683,784)
               
Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)       (16,097)   (6,106,748)     3,292,487
               
Permanent adjustments to income taxes calculation basis              
Income taxes on equity in results of investees      11,849   1,578   6,595
Thin capitalization   (i) (359,598)    (6,628)   (695,741)
Tax benefits (Sudene and PAT)     -     137,338   -
Reduction of tax loss   22.1(c) (891,669)       -
Effect of the refund of Braskem America´s tax benefit             (737,841)
Different jurisdictional taxes rates for companies abroad and tax basis   (ii)   1,029,618     1,980,358     994,811
Effect from the retrospective tax rate on bonus depreciation of Braskem America         -     334,460
Taxes on dividends distribution     (454,663)   (265,454)   (131,240)
Exclusion of inflation adjustement by Selic on undue tax payments from taxable income   22.1(a)  39,395     501,382    
Other permanent adjustments     (226,570)   (241,229)   (395,053)
               
Effect of income taxes on results of operations      (867,735)    (3,999,403)   2,668,478
               
Breakdown of income taxes              
               
Current income taxes              
Current year     (1,003,705)   (3,834,437)     (52,830)
Total current expenses      (1,003,705)   (3,834,437)     (52,830)
               
Deferred income taxes              
Origination and reversal of temporary differences       1,192,438   (246,294)     2,677,328
Tax losses     (1,056,468)    81,328    43,980
Total Deferred income taxes        135,970   (164,966)     2,721,308
               
Total      (867,735)    (3,999,403)   2,668,478
               
Effective rate   (iii) 1832.8%   22.3%   27.6%

 

(i) Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.
(ii) Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:

 

             
          Income tax rate (%)
               
          Headquarters (Country)   2022
             
Braskem Alemanha       Germany    31.09
Braskem America and Braskem America Finance       USA    21.00
Braskem Argentina       Argentina    25.00
Braskem Chile       Chile    27.00
Braskem Holanda, Braskem Holanda Finance, Braskem Holanda Inc, B&TC and ER Plastics       Netherlands    25.80
Braskem Idesa, Braskem Idesa Serviços, Braskem México            
  Braskem México Serviços, Braskem México Proyectos and Terminal Química       Mexico    30.00
Braskem India       India    30.00

(iii) The effects presented in the reconciliation of the effective rate, in relation to the profit before taxes of R$47,344, resulted in an effective rate of 1,832.8%, the main effect is described in Note 22.1(c).

 

   
 F-65 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

22.2 Deferred income taxes

Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.

Deferred tax assets are recognized for unused tax losses and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, based on the business plans for the Company.

The measurement of deferred taxes reflects the tax consequences that would follow from how the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. Annually, the Company revises its projection of taxable income based on its Business Plan.

The Business Plan is prepared annually by the Executive Board, and its main variables include projections for the prices of the products produced by the Company, the prices of raw materials, the growth in gross domestic product of each country in which the Company operates, exchange rate variation, interest rates, inflation rates and fluctuations in supply and demand for inputs and finished goods.

In evaluating the plan, the Company uses its historical performance, strategic planning and market projections produced by third party consulting firms, which are reviewed and supplemented based on Management´s experience.

Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves. Unrecognized deferred tax assets are reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used.

Deferred tax assets and liabilities are offset only if certain criteria are met.

   
 F-66 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(a) Movement in deferred tax balances

                             
                             
Assets   As of December 31, 2020   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2021   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2022
                             
Tax losses (IR) and negative base (CSL)   3,278,184   76,532       3,354,716   (957,184)       2,397,532
Goodwill amortized   6,520   (4,061)       2,459   (364)       2,095
Exchange variations   3,817,615   696,849   (234,402)   4,280,062   611,838   (1,549,020)   3,342,880
Temporary adjustments   4,996,337   (214,060)       4,782,277   (134,745)       4,647,532
Business combination   56,211   (29,327)       26,884   (26,884)       0
Tax credits (i) 77,032   (77,032)       0   697,662       697,662
Other   45,366   72,523       117,889   (1,197)       116,692
    12,277,265   521,424   (234,402)   12,564,287   189,126   (1,549,020)   11,204,393
                             
Liabilities                            
Amortization of goodwill based on future profitability   722,222   2,875       725,097   (2,664)       722,433
Tax depreciation   3,737,169   439,781       4,176,950   (125,488)       4,051,462
PIS/COFINS credit - exclusion of ICMS from the calculation basis   0   331,479       331,479   (141,830)       189,649
Temporary adjustments   158,232   (69,239)       88,993   331,322       420,315
Present value adjustments and amortized cost   79,920   74,771       154,691   7,906   261,354   423,951
Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar   279,321   (46,888)       232,433   (45,796)       186,637
Other   4,827   (46,389)   46,388   4,826   29,706   (29,706)   4,826
    4,981,691   686,390   46,388   5,714,469   53,156   231,648   5,999,273
                             
Net   7,295,574   (164,966)   (280,790)   6,849,818   135,970   (1,780,668)   5,205,120
                             
Presentation in the balance sheet:                            
Non-current assets   8,529,972           8,257,252           6,358,601
(-) Non-current liabilities   1,234,398           1,407,434           1,153,481

(i) Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.  

 

   
 F-67 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(b) Offset for the purpose of presentation in the consolidated statement of financial position

                               
          2022   2021
                               
    Headquarters (Country)   Tax calculation   Offsetting   Balance   Tax calculation   Offsetting   Balance
                             
Assets                            
Braskem S.A.   Brazil   8,356,402    (2,584,962)     5,771,440    8,841,886     (2,496,637)     6,345,249
Braskem Argentina   Argentina     21,339   (16,174)   5,165     3,271    -   3,271
Braskem America   USA   356,598    (356,598)   -    294,328     (294,328)   -
Braskem Alemanha   Germany     23,038   -    23,038   44,417    -    44,417
Braskem Chile   Chile   47         47    92         92
Braskem Holanda   Netherlands   195,042    (39,696)   155,346    -        
Braskem Idesa   Mexico   2,078,206    (1,840,669)     237,537    3,282,125     (1,506,541)     1,775,584
Braskem Idesa Serviços   Mexico    -   -   -    26    -     26
Braskem México Serviços   Mexico     13,628        13,628     2,502       2,502
Braskem México   Mexico     86,368        86,368   16,181        16,181
Cetrel   Brazil     39,387     (5,405)    33,982   40,434   (7,586)    32,848
DAC   Brazil     32,617     (2,262)    30,355   39,025   (1,943)    37,082
Terminal Química   Mexico    1,618       1,618            
Voqen   Brazil    103    (26)     77            
            11,204,393     (5,001,138)   6,358,601     12,564,287   (4,307,035)   8,257,252
                               
Liabilities                            
Braskem S.A.   Brazil   2,584,962    (2,584,962)   -    2,496,637     (2,496,637)   -
Braskem America   USA   1,493,471    (356,598)     1,136,873    1,701,762     (294,328)     1,407,434
Braskem Argentina   Chile     16,174   (16,174)   -           -
Braskem Holanda   Netherlands     39,696   (39,696)   -           -
Braskem Idesa   Mexico   1,840,669    (1,840,669)   -    1,506,541     (1,506,541)   -
B&TC   Netherlands     16,608        16,608           -
Cetrel   Brazil    5,405     (5,405)   -     7,586   (7,586)   -
DAC   Brazil    2,262     (2,262)   -     1,943   (1,943)   -
Voqen   Brazil   26    (26)   -           -
           5,999,273     (4,845,792)   1,153,481    5,714,469   (4,307,035)   1,407,434

  

23 Sundry provisions

     
     
    2022   2021
Provision for environmental damages   1,120,188     1,035,426
Provision for customers rebates   126,754     101,253
Other     130,005     152,584
Total   1,376,947   1,289,263
         
Current liabilities     530,814     465,051
Non-current liabilities   846,133     824,212
Total   1,376,947   1,289,263

   
 F-68 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(a) Provision for environmental damages

The provision for environmental damages is estimated based on current legal and constructive requirements, technology, price levels and expected remediation plans.

Realized costs and cash outflows may differ from current estimates due to the changes in laws and regulations, public expectations, prices, new findings by the ongoing studies and analysis of local conditions and changes in remediation technologies.

The time and value of future expenses related to environmental liabilities are reviewed annually, as well as the interest rate used for discounting them to present value.

The Company operates in several countries and is subject to different environmental laws and regulations inherent to the operations and activities areas. Remediation expenses are incurred over several years due to their complexity and extension. New information on websites, new technologies or future developments, such as involvement in investigations by regulatory agencies, may require that we reevaluate our potential exposure related to environmental matters.

The provision is recorded based on the areas in which remediation actions will be necessary. Due to the high complexity in identifying potential environmental impacts, alternative solutions and recovery costs estimations, these estimates can only be made with reasonable assurance after the completion of all phases of the process to identify and investigate environmental liabilities, which are in accordance with the phases and protocols established by environmental agencies.

The Company monitors the areas under study to capture any new facts and changes in circumstances that change the prognosis of actions to be adopted and consequently affect the estimation of provision for environmental remediations.

(b) Rebates

Some sales agreements of the Company provide for a rebate in products should certain sales volumes be achieved within the year, six-month period or three-month period, depending on the agreement. The bonus is recognized monthly in a provision, assuming that the minimum contractual amount will be achieved.

(c) Changes in provisions

               
    Recovery of            
    environmental             
    damage   Rebate   Other   Total
                 
December 31, 2020   602,490     123,465     148,253   874,208
                 
Additions, monetary adjustments and exchange variation     576,086    144,710    114,395     835,191
Payments and reversals   (143,150)     (166,922)     (110,064)    (420,136)
                -
December 31, 2021     1,035,426     101,253     152,584   1,289,263
                 
Additions, monetary adjustments and exchange variation     299,241    184,142   19,777     503,161
Payments and reversals   (214,479)     (158,641)    (42,357)    (415,477)
                -
December 31, 2022     1,120,188     126,754     130,005   1,376,947

  

   
 F-69 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

24 Provisions for legal proceedings and contingent liabilities

Braskem is a defendant in lawsuits and administrative proceedings arising from the normal course of its business. The Management, based on its assessment and that of its external legal advisors, classifies these proceedings in terms of probability of loss as follows:

Probable chance of loss: present obligation for which there is a higher probability of loss than of a favorable outcome. For these claims, a provision is recognized based on an estimated amount of the obligation that reflects the expected outflow of resources (see Note 24.1).

Possible chance of loss: present obligation for which the possibility of loss is greater than remote and less than probable. For these claims, the Company does not recognize a provision and discloses the most significant matters (see Note 24.2).

The Management believes that the estimates related to the outcome of the proceedings and the possibility of future disbursement may change in view of the following: (i) higher courts may decide in a similar case involving another company, adopting a final interpretation of the matter and, consequently, advancing the termination of the proceeding involving the Company, without any disbursement or implying the need of any financial settlement of the proceeding; and (ii) programs encouraging the payment of the debts implemented in Brazil at the Federal and State levels, in favorable conditions that may lead to a disbursement that is lower than the one that is recognized in the provision or lower than the value of the matter.

In addition, the Company also is a plaintiff in several lawsuits. In these cases, the Company discloses the contingent asset when the receipt of economic benefits is probable. However, when the realization of the benefit is virtually certain, the related asset no longer constitutes a contingent asset, and as such amount is recognized.

Any changes in the court’s understanding of the position could cause future impacts on the consolidated financial statements of the Company due to such proceedings.

24.1 Lawsuits with probable losses

       -
      2022   2021
Labor claims   (a)   212,657     268,758
           
Tax claims   (b)      
IR and CSL      51,756    61,946
PIS and COFINS       311,433     299,202
ICMS       348,544     331,094
Other tax claims      24,160    22,857
      735,893   715,099
           
Corporate claims       103,387    94,826
           
Civil claims and other     119,561    75,147
           
      1,171,498   1,153,830

 

(a) Labor claims

As of December 31, 2022, the provision is related to 472 labor claims, including occupational health and security cases (2021: 529). The Management, based on its assessment and that of its external legal advisors, estimate that the term for the termination of these types of claims in Brazil exceeds five years. The estimates related to the outcome of proceedings and the possibility of future disbursement may change in view of new decisions in higher courts.

   
 F-70 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(b) Tax claims

As of December 31, 2022, the main claims are the following:

(i) Non-cumulative PIS and COFINS

The Company is charged amounts arising from compensation of Non-Cumulative PIS and COFINS tax credits in the years 2005, 2010 and in the period from 2012 to 2018 that were not approved by the Federal Revenue Service of Brazil ("RFB"), mainly related to the following topics:

- Offsetting Statements, with credits in amounts that exceeded those declared in the respective Statement of Calculation of Social Contributions;

- freight expenses: not associated with sales operations and/or operations without proven association and contracted in the country, but concerning imported products;

- credits arising from the acquisition of property, plant and equipment mostly related to acquired companies, whose documentation was not found;

- taxation of revenues incorrectly classified as tax exempt, subject to zero tax rate or not taxed.

As of December 31, 2022, the balance of this provision was R$212,223 (2021: R$202,737). The Management, based on its assessment and that of its external legal advisors and considering the precedents on the matters at the Administrative Council of Tax Appeals (“CARF”), estimates that the administrative procedures will be concluded in 2026.

(ii) PIS and COFINS taxes

The Company is assessed for the payment of these taxes in many legal claims, such as:

- insufficient payment of COFINS for the period from March 1999 to December 2000, from February 2001 to March 2002, from May to July 2002 and September 2002 due to alleged calculation errors, and non-compliance with the widening the tax calculation base and increasing the contribution rate envisaged in Law 9.718/1998;

- offset of the COFINS dues relating to September and October 1999 using the credit resulting from the addition of 1% to the COFINS rate;

- rejection of the offset of PIS and COFINS dues relating to the period from February to April 2002 using the PIS credits under Decree-Laws 2.445 and 2.449, calculated between June 1990 and October 1995, under the argument that the time period for using said credits had expired; and

On December 31, 2022, the balance of this provision was R$69,641 (2021: R$67,403). Management, based on its assessment and that of its external legal advisors, estimates these procedures will conclude by 2030.

The Company offered guarantees in the form of bank guarantees and finished products, which, together, fully cover the amount of claims.

(iii) ICMS tax on interstate purchases

In 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment of ICMS in view of alleged violations:

- undue use of tax credits in the amount of R$58,164, due to the recording of credits indicated in the invoices for the sale of certain products, issued by Acrinor Acrilonitrila do Nordeste S.A. and Proquigel Química S.A., since the products were to be exported, and were therefore exempt from payment of ICMS tax;

   
 F-71 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

- the fine for the abovementioned tax offense corresponds to 100% of the principal value recorded; 

- fine in the amount of 30% on R$480,389, which corresponds to the sum of the amounts indicated in tax documents whose outflow of goods was not identified by the tax authority; and

- fine due to lack of presentation of tax documents requested.

After ending the discussions in the administrative sphere, with the partial reduction in contingency, the Company proposed lawsuits to continue the discussion, which were secured by a guarantee insurance. On December 31, 2022, the balance of this provision was R$329,125 (2021: R$313,380). The Management, based on its assessment and that of its external legal advisors, estimates the legal procedures will conclude in 2026.

 

(c) Changes in claims with probable chance of loss

                   
                Civil claims    
    Labor claims   Tax claims   claims   and other   Total
                     
December 31, 2020     280,066     692,735     126,057    52,229     1,151,087
                     
Additions, inflation adjustments and exchange variation    172,574   46,849   14,357   76,111    309,891
Payments    (70,968)   (3,659)    (40,109)   (2,770)     (117,506)
Reversals (*)     (112,914)    (20,826)   (5,479)    (50,423)     (189,642)
                     
December 31, 2021     268,758     715,099    94,826    75,147     1,153,830
                     
Additions, monetary adjustments and exchange variation   128,682   60,627     9,048   76,227   274,584
Payments    (57,750)   (8,792)     -   (3,243)    (69,785)
Reversals (*)     (127,033)    (31,041)   (487)    (28,570)     (187,131)
                      -
December 31, 2022   212,657     735,893     103,387     119,561   1,171,498

 

(*) A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.

 

24.2 Contingent liabilities

The contingent liabilities whose loss is assessed as possible (possibility of loss greater than remote and less than probable) by the Company’s Management, based on its evaluation and that of its external legal advisors, are disclosed as follows:

       
  Note   2022   2021
           
Tax claims (a)      18,270,680   17,224,429
Civil claims - Alagoas 26     5,489,479     2,614,344
Civil claims - Other (b)    786,441     737,083
Labor claims (c)    605,546     763,555
Environmental claims (d)    639,880     571,057
Social security claims (e)    515,506     398,783
Other lawsuits (f)    380,862     337,807
Total        26,688,394   22,647,058

   
 F-72 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(a) Tax claims

(i) IR/CSL: Charges with goodwill amortization

The subsidiaries Cetrel and DAC were notified by the Brazilian Federal Revenue Service, (Secretaria da Receita Federal do Brasil, hereinafter “RFB”), in December 2020 and June 2021, respectively, for the deduction of tax amortization charges on goodwill arising from the acquisition of equity interests in 2012.

As of December 31, 2022, the updated amount of these claims was R$194,695 (2021: R$179,370). The cases are pending in the administrative sphere with conclusion expected by 2026.

(ii) IR/CSL: Exchange variation on naphtha imports

In December 2017 and December 2020, the Company received a tax deficiency notice related to the disallowance of exchange variation expenses between the due date of commercial invoices and the effective payment of obligations related to naphtha imports, related to calendar years 2012 and 2015, respectively. In relation to year 2012, disallowances led to the adjustment of tax losses and social contribution tax loss carryforwards. For 2015, a tax credit was considered along with a qualified fine corresponding to 150% of the tax deficiency notice amount.

The tax deficiency notice issued in December 2020 also resulted in partial disallowance of the cost of naphtha imported from its subsidiary abroad, in an amount corresponding to the profit margin calculated by the subsidiary in the naphtha resale operations, carried out in 2014 and 2015.

As of December 31, 2022, this uncertain tax treatment is R$1.2 billion (2021: R$1.1 billion), including fiscal years already filed and non-filed. The administrative proceedings should be concluded by 2026.

(iii) ICMS: Credit reversal on output with tax deferral

In July and December 2020, the Company was notified, by the State of Alagoas, due to the lack of ICMS tax payment arising from the alleged lack of reversal of the tax credited in operations prior to outflows with tax deferral. On December 31, 2022, the value of these cases was R$639 million (2021: R$587 million).

The administrative proceedings should be concluded by 2025.

(iv) IR/CSL: Foreign earned income – Braskem Holanda

The Company received a deficiency notice from RFB, referring to fiscal years 2015 and 2016, stating its disagreement with applying the Agreement between Brazil and the Netherlands to avoid double taxation, which establishes that Dutch companies' profits cannot be taxed in Brazil.

On December 31, 2022, the amount of the uncertain tax treatment is R$10.6 billion (2021: R$8.8 billion), including fiscal years already filed and non-filed.

The administrative proceedings should be concluded by 2026.

(v) PIS and COFINS: taxation of liability reductions settled in connection with the installment plan under Provisional Executive Order (“MP”) 470/2009

The Company received notice for not applying to PIS and COFINS taxes the reductions for fines and interest, in view of the adoption of the installment plan offered by the Federal Government under MP 470/2009.

In March 2023, the Company obtained favorable opinion from court of last resort (the Superior Chamber of the Tax Resources Administrative Board) cancelling the full collection. In accordance to the Management, based on its evaluation and that of its external legal advisor, an appeal from the National Treasury is not applicable and, hence, the probability of loss was changed from possible to remote. 

   
 F-73 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

On December 31, 2022, the updated value of this proceeding is R$967 million (2021: R$910 million).

(vi) IR/CSL: Charges with goodwill amortization

The Company was served by the RFB for deducting amortization charges, from 2007 to 2013, relating to goodwill originated from acquisitions of shareholding interests in 2002. In 2002, Braskem foundation was fulfilled due to petrochemical assets disposals from several business groups. On December 31, 2022, the updated contingency estimate is R$1.1 billion (2021: R$1.1 billion).

These administrative proceedings should be concluded by 2025, while the current court proceeding should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(vii) Non-cumulative PIS and COFINS taxes

The Company received a deficiency notice from the RFB due to the use of non-cumulative PIS and COFINS tax credits in the acquisition of certain goods and services consumed in its production process in matters that have already been contested at the administrative and court level and comprise the period from 2004 to 2018.

As of December 31, 2022, the amount under discussion of these notices is R$1.4 (2021: R$1.3 billion).

The administrative proceedings should be concluded by 2026, while the lawsuits should be concluded by 2032.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(viii) IR/CSL: Unlimited offsetting

In December 2009 and March 2017, the Company received tax deficiency notices claiming that the methodology used to offset tax losses and tax loss carryforwards that failed to observe the limit of 30% of the Taxable Profit and Social Contribution calculation base when offsetting such liabilities with Corporate Income Tax and Social Contribution liabilities in merger operations, respectively, in November 2007 and August 2013.

As of December 31, 2022, the updated value of the contingency amounted to R$462 million (2021: R$430 million). The lawsuits should be concluded by 2031.

The Company offered performance bonds that cover the total amount involved in the court proceeding.

(ix) ICMS

The Company challenges ICMS collection drawn up in the States of São Paulo, Rio de Janeiro, Rio Grande do Sul, Bahia, Pernambuco and Alagoas, which materialized in administrative and court proceedings, including the following topics:

· ICMS credit on the acquisition of assets that are considered by tax authority as being for use and consumption, which as such do not produce a right to the credit because they are not physically part of the end product;

· ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by tax authority as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.;

· internal transfer of finished products for an amount lower than the production cost;

   
 F-74 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

· omission of the entry or shipment of goods based on physical count of inventories;

· lack of evidence of exports of goods with shipment presumably taxed for the domestic market;

· non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;

· fines for the failure to register invoices; and

· nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market of the Electric Power Trading Chamber.

As of December 31, 2022, the updated value of these proceedings was R$768 million (2021: R$756 million).

These administrative proceedings are expected to be terminated in 2027, while the court proceedings are expected to be terminated in 2031.

The Company offered performance bonds that cover the total amount involved in the current court proceedings.

(x) PIS and COFINS sundry

The Company is involved in collection actions related to PIS and COFINS assessments in the judicial courts, which discuss the alleged undue offsetting of credits arising from other proceedings, including: (i) Income Tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees – Federal Laws 2.445 and 2.449; and (v) the COFINS tax arising from the undue payment or payment in excess.

As of December 31, 2022, the updated amounts involved of these assessments total R$136 million (2021: R$131 million).

These judicial proceedings are expected to be terminated in 2025.

The Company offered guarantees that cover the total amount involved in the court proceedings.

(xi) IRRF and IR/CSL: Commission expenses

In December 2017, the Company received a tax deficiency notice from the RBF arising from: (i) the disallowance of commission expenses paid by Braskem in 2011; (ii) the disallowance of commission expenses paid by Braskem Inc. in 2013 and 2014; (iii) lack of payment of withholding income tax (“IRRF”) on the payments referred to in the previous item; and (iv) the disallowance of advertising expenses incurred in 2013.

On December 31, 2022, the updated amount of taxes and tax effects from disallowances of income tax losses and social contribution tax loss carryforwards in the tax deficiency notice is R$153 million (2021: R$142 million).

This administrative proceeding should be concluded by 2024.

(xii) Fines on tax credits used

In 2015 through 2022, the Company received notifications of individual fines imposed due to the use of credits from: (i) non-cumulative PIS/COFINS taxes; (ii) negative balances of IR/CSL taxes; (iii) REINTEGRA credits; and (iv) other credits, for offsets not approved by the RFB.

As of December 31, 2022, the updated value of these deficiency notices amounted to R$353 million (2021: R$310 million).

These administrative proceedings should be concluded by 2027.

   
 F-75 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(xiii) IR/CSL: Negative Balance – Offset

The Company claims, at the administrative and judicial levels, that RFB denies offsets seeking to settle federal taxes with credits arising from negative balance of IR/CSL.

As of December 31, 2022, the updated value of the taxes whose offset was not approved amounted to R$176 million (2021: R$173 million).

These administrative proceedings should be concluded by 2024, while the lawsuits should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the current court proceedings.

(xiv) PIS and COFINS: Cide-Fuels Tax Offset

The Company is a party to lawsuits claiming PIS and COFINS tax liabilities arising from their offset using Cide-Fuels tax credits, as authorized under Federal Law 10.336/2001.

As of December 31, 2022, the updated value of these cases was R$123 million (2021: R$118 million). The lawsuits should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(b) Civil claims

(i) Resale of solvents

In January 2017, the Company became defendant in a civil lawsuit filed by former reseller of solvents, claiming alleged breach of a tacit distribution agreement. The lawsuit is pending judgment.

As of December 31, 2022, the claims prepared by the other party amounted to R$302 million (2021: R$265 million).

(ii) Hashimoto Public-Interest Civil Action

The Public-Interest Civil Action was filed in June 2018 by the São Paulo State Public Prosecutor’s Office against the Company and other firms that operate in the Capuava Petrochemical Complex, claiming the reparation and/or remediation of environmental damages supposedly arising from the emission of pollutants into the air, as well as the joint judgement of companies that comprise said complex seeking environmental moral damages in the updated amount of R$201 million (2021: R$175 million).

Braskem filed its defense in December 2020, which is awaiting expert evidence. This lawsuit should be concluded by 2030.

(c) Labor claims

Lawsuits filed by former team members and contractors who provided services to Braskem, and are chiefly related to overtime, wage parity and other amounts established in labor laws.

(d) Environmental claims

Public-Interest Civil Action filed in September 2011 by the Local Government of the city Ulianópolis in Pará State against Braskem and other companies, claiming reparation and/or remediation of environmental damage allegedly resulting from the delivery of waste to the Brazilian Bauxite Company , which had not disposed of it properly, polluting an area of the Municipality of Ulianópolis, as well as the joint and several liability of these companies for the payment of indemnification for environmental damage in the updated amount of R$363 million (2021: R$325 million).

   
 F-76 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The companies filed their defense, however, a decision was rendered determining the temporary dismissal of the action for one year. This action should be concluded by 2030.

(e) Social security claims

In 2012, the Company withdrew sponsorship of the plans Petros Copesul and Petros PQU, and, in 2009, Petros Copene, whose private pension entity was Petros, remaining the obligation established under the Sponsorship Withdrawal Instrument to pay the mathematical reserves of Members, pursuant to Complementary Law 109/2001, which was met in 2015. However, after the payment, several beneficiaries filed individual and collective action regarding various claims, such as: (i) Difference of the Individual Withdrawal Fund; (ii) Change in base date; (iii) age limiter; (iv) 90% of supplementation; (v) Return of Contributions; (vi) Difference in Savings Account Reserve; (vii) Objection against legality of Sponsorship Withdrawal.

Currently, this portfolio is composed of 729 active cases (2021: 783), of a financial contingency nature, representing an estimated amount of R$379 million (2021: R$332 million).

(f) Other lawsuits

(i) Incentivized Preferred Shares

The Company currently is subject to the liquidation of an award related to a lawsuit filed in 1988, whose decision required Polialden Petroquímica S.A. (“Polialden”), a company merged into Braskem, to pay certain non-controlling shareholders that hold preferred shares in Polialden the distribution of the remaining net profit of the company.

The liquidation of award aims to determine the value of the dividends to be paid in accordance with the terms of the decision. The process is awaiting the start of the expert evidence.

As of December 31, 2022, based on Management’s assessment and that of its external legal advisors, the Company recorded a provision of R$21 million (2021: R$19 million). The amount considered as possible loss is R$262 million, and the total amount of the lawsuit is R$283 million (2021: R$257 million).

(ii)Social security – hazardous agents

The Company is a party to other proceedings, which claim payments of additional contribution for Occupational Environmental Risk to fund the special retirement plan due to the alleged exposure of workers to hazardous agents: (a) in the administrative sphere (a.1) in the period from April 1999 to February 2006, jointly with a fine due to failure to declare the generating factor of the contribution to GFIP, and (a.2) in the period from January 2016 to July 2018; (b) in the legal sphere, in the periods from November 2000 to January 2001 and November 2001 to June 2002.

On December 31, 2022, the adjusted amount of these proceedings is R$203 million (2021: R$187 million).

The administrative proceedings should be concluded by 2025, while the only current court proceeding should be concluded by 2028.

The Company pledged a performance bond that covers the total amount involved in the current court proceeding.

   
 F-77 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

24.3 Class action

On August 25, 2020, an action was filed against Braskem and some of its current and former executives in the US District Court for the District of New Jersey, in the United States, on behalf of an alleged class of investors who acquired Braskem's shares. The action was grounded in the U.S. Securities Exchange Act of 1934 and its rules, based on allegations that the defendants made false statements or omissions related to the geological event in Alagoas.

On December 15, 2022, the parties entered into Agreement to terminate the Class Action via payment of US$3 million, which was carried out in January 2023. On December 20, 2022, as the first measure for approval of the Agreement, the lead plaintiff filed a preliminary approval motion, and the U.S. District Court for the District of New Jersey will follow the required procedure for approval of the Agreement. The extinction of Class Action will be declared only after approval of the Agreement and after the obligations assumed by the parties of the Agreement are met.

Braskem cannot predict precisely all costs in solving this dispute. The Company may be named as a defendant in other similar legal actions.

24.4 Contingent assets

Contingent assets normally arise from unplanned or unexpected events that give rise to the possibility of an inflow of economic benefits to the Company. Contingent assets are not recognized in the consolidated financial statements, but they are disclosed when it is likely that an inflow of economic benefits will occur. However, when the inflow of benefits is virtually certain, the asset is recognized in the financial position statement because that asset is no longer considered contingent.

(i) Compulsory loans: Centrais Elétricas Brasileiras S.A. (“Eletrobras”)

The compulsory loan in favor of Eletrobras was established by Federal Law 4.156/62, to finance the energy industry and remained effective until 1993. It was collected through the energy bills of industrial consumers with monthly consumption equal to or higher than 2000kwh and, after successive amendments to the law, the reimbursement was extended to 20 years, plus compensatory interest of 6% per year, which can be anticipated through conversion of credits into shares issued by Eletrobras.

Between 2001 and 2009, the companies merged into Braskem S/A filed proceedings seeking the recovery of amounts related to differences in the inflation adjustment of the compulsory loan, interest on arrears and compensatory interest and other related payments.

The Company obtained a favorable final and unappealable decision in the cases of the merged companies Alclor Química de Alagoas Ltda., Companhia Alagoas Industrial – Cinal, Companhia Petroquímica do Sul S.A. – Copesul and Trikem S. A., which are currently in the execution phase. The cases of the merged companies Ipiranga Petroquímica S.A., Petroquímica Triunfo Ltda. and Quattor Química S.A are in the cognizance phase.

The term, form and amount to be realized are still uncertain, so it is not possible to determine the amount to be received and, for such reason, the asset does not meet the conditions to be recorded in the consolidated financial statements.

   
 F-78 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

25 Leniency agreement with authorities

In the context of allegations of undue payments in connection with Operation Car Wash in Brazil, the Company hired external experts in investigation to conduct an independent investigation into such allegations (“Investigation”) and to report their findings.

In December 2016, the Company entered into Leniency Agreements with the Federal Prosecution Office (Ministério Público Federal, hereinafter “MPF Agreement”) and with U.S. and Swiss authorities (“Global Settlement”), in the amount of US$957 million (R$3.1 billion, at the time), which were duly ratified. Further, the Company engaged in a process of cooperation and negotiation with the Ministry of Transparency and the Office of The Federal Controller General (Controladoria-Geral da União, hereinafter “CGU”) and the Office of the Attorney General (Advocacia-Geral da União, hereinafter “AGU”), which culminated in the execution of the leniency agreement with such authorities on May 31, 2019 (“CGU/AGU Agreement” and, jointly with the Global Settlement, “Agreements”), which addresses the same facts that are the subject of the Global Settlement and provides for an additional disbursement of R$409,877 due to the calculations and parameters adopted by CGU/AGU. In addition, in 2019, the State Prosecution Office of Bahia and the State Prosecution Office Rio Grande do Sul adhered to the MPF Agreement. Therefore, no additional payments are expected to be made by the Company.

   
 F-79 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

As of December 31, 2022, the Company paid R$3,070,578, distributed as shown below:

                               
          AGU                    
Agreements signed with:   . CGU and MPF   DoJ (i)   OAG (i)   MPF   SEC (i)   Total
                               
 Amounts paid         877,763     296,591     407,300     1,282,464     206,460     3,070,578

(i) U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").

 

As of December 31, 2022, the outstanding amount is R$903,140 (R$392,486 and R$510,654 as current and non-current liabilities, respectively), under the MPF Agreement and CGU/AGU Agreement, which will be paid in three annual installments updated by the variation in the Selic rate and payable until January 30, 2025. To guarantee payment of the installments of these installments coming due, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment.

Braskem’s activities related to the monitoring by the CGU of the Company were successfully concluded, and no pending issues involving the Company remained, the CGU will present the Final Monitoring Report and prepare the Agreement. Moreover, the Company is in compliance with all of its obligations under the Agreements and continues to cooperate with government authorities.

 

26 Geological event - Alagoas

The Company operated, since its formation and subsequently as the successor of the company Salgema, salt mining wells located in Maceió city, with the purpose of supplying raw material to its chlor-alkali and dichloroethane plant. In March 2018, an earthquake hit certain districts of Maceió, Alagoas, where the wells are located, and cracks were found in buildings and public streets of Pinheiro, Bebedouro, Mutange and Bom Parto districts.

In May 2019, the Geological Survey of Brazil (“CPRM”) issued a report, indicating that the geological phenomenon observed in the region, could be related to the rock salt exploration activities developed by Braskem. In view of these events, on May 9, 2019, Braskem preventively decided to suspend its salt mining activities and the operation of its chlor-alkali and dichloroethane plant.

Since then, the Company has been devoting its best efforts to understand the geological event: (i) possible surface effects; and (ii) the analyses of well’s stability. The results are being shared with the Brazilian National Mining Agency (“ANM”) and other pertinent authorities, which the Company has been maintaining constant dialogue.

Braskem presented to ANM the measures for shutting down its salt mining fronts in Maceió, with measures for the closure of its wells, and, on November 14, 2019, it proposed the creation of a protective area surrounding certain wells as a precautionary measure to ensure public safety. These measures are based on a study conducted by the Institute of Geomechanics of Leipzig (IFG), in Germany, an international reference in the geomechanical analysis of areas of salt extraction by dissolution and are being adopted in coordination with the Civil Defense of Maceió and other authorities.

As a result of the geological phenomenon, negotiations were conducted with public and regulatory authorities that resulted in the Agreements executed, including:

i)Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents"), entered into with State Prosecution Office (“MPE”), the State Public Defender’s Office (“DPE”), the Federal Prosecution Office (“MPF”) and the Federal Public Defender’s Office (“DPU”), which was ratified by the court on January 3, 2020, adjusted by its resolutions and subsequent amendments, , which establish cooperative actions for relocating residents from risk areas, defined in the Map of Sectors of Damages and Priority Action Lines by the Civil Defense of Maceió (“Civil Defense Map”), as updated in December 2020 (version 4), and guaranteed their safety, which provides support, under the Financial Compensation and Support for Relocation Program (“PCF”) implemented by Braskem to the population in the areas of the Civil Defense Map, as well as the dismissal of the Public-Interest Civil Action (Reparations for Residents), as detailed in Note 26.1 (i).
   
 F-80 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(ii) Agreement to Dismiss the Public-Interest Civil Action on Socio-Environmental Reparation and the Agreement to define the measures to be adopted regarding the preliminary injunctions of the Public-Interest Civil Action on Socio-Environmental Reparation (jointly referred to as “Agreement for Socio-Environmental Reparation”), signed with the MPF with the MPE as the intervening party, on December 30, 2020, in which the Company mainly undertook to: (i) adopt measures to stabilize and monitor the subsidence phenomenon arising from salt mining; (ii) repair, mitigate or compensate possible environmental impacts and damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate possible socio-environmental impacts and damages arising from salt mining in the Municipality of Maceió, as well as the termination of the Public-Interest Civil Action (Socio-environmental Reparation) related to the Company, as detailed in Note 26.1 (ii). Moreover, the Agreement for Socio-Environmental Reparation envisages the inclusion of other parties, which depends on specific negotiation with such potential parties.

Thus, the Company has been meeting all obligations assumed with the authorities and acting proactively on all fronts to resolve the issues arising from the geological event. Highlights: (i) PCF significant advances on assisting public authorities to vacate properties located in the risk areas and submitting full financial compensation offers with a high level of acceptance; (ii) the actions for closing and monitoring the salt wells, which are following the mining closure plan approved by the ANM, seeking to stabilize the subsidence phenomenon resulting from salt mining; and (iii) the social and environmental diagnoses conducted in connection with the Socio-Environmental Reparation Agreement.

As assessed by the Company and its external advisors, considering the measures recommended on technical studies in the short and long-term and the existing information and refined estimates of expenses for implementing several measures connected with the geological event in Alagoas, the provision recorded on December 31, 2022, shows the following changes in the period:

             
               
      2022   2021   2020
               
Balance at the beginning of the year     7,661,259   9,175,777   3,383,067
               
Additions     1,520,019   1,339,765   6,901,827
Payments and reclassifications (*)      (2,742,791)    (2,928,081)    (1,181,931)
Realization of present value adjusment     188,071     73,798     72,814
Balance at the end of the year      6,626,558   7,661,259   9,175,777
               
Current liability     4,247,609   4,378,071   4,349,931
Non-current liability     2,378,949   3,283,188   4,825,846
Total     6,626,558   7,661,259   9,175,777

(*) Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.

 

The current provision can be segregated into the following action fronts:

a. Support for relocating and compensating for the residents, business and real state owners of properties located in the Civil Defense Map (version 4) updated in December 2020, including establishments that requires special measures for their relocation, such as hospitals, schools and public equipment.

   
 F-81 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

These actions have a provision of R$2,087,142 (2021: R$3,390,849) comprises expenses related to relocation actions, such as relocation allowance, rent allowance, household goods transportation and negotiation of individual agreements for financial compensation.

b. Actions for closing and monitoring the salt wells, environmental actions and other technical matters. Based on the findings of sonar and technical studies, stabilization and monitoring actions were defined for all 35 existing salt mining wells. Based on studies of the specialists, the recommendation was to fill 5 more salt wells with solid material, bringing the total wells to be filled to 9, a process that should take 4 years. For the remaining 26, the recommended actions are: conventional closure using the tamponade technique, which consists of promoting the cavity pressurization, applied worldwide for post-operation cavities; confirmation of natural filling status; and, for some wells, sonar monitoring.

The provisioned amount of R$1,367,269 (2021: R$1,691,032) to implement the measures described in this item was calculated based on existing techniques and the solutions planned for the current conditions of the wells, including expenses with technical studies and monitoring, as well as environmental actions already identified. The provision amount may change in the future, in accordance with the results of the monitoring of the wells, the progress of implementing the plans to close wells, possible changes that may be required in the environmental plan, the monitoring of the ongoing measures and other possible natural alterations.

The monitoring system implemented by Braskem envisages actions developed during and after the closure of wells, focusing on safety and monitoring of the region’s stability.

The Company’s actions are based on technical studies conducted by outsourced specialists, with the recommendations presented to the competent authorities. The Company is implementing the actions approved by ANM.

In June 2022, in compliance with the Agreement for Socio-environmental Reparation, Braskem submitted to the MPF the environmental diagnosis containing the assessment of the potential environmental impacts and damages arising from salt mining activities and the environmental plan with proposals of the measures required. As established in the agreement, the parties jointly defined the specialized company that will evaluate and monitor the environmental plan. In December 2022, an additional report on the environmental plan was filed with the MPF. In February 2023, MPF expressed its agreement with this environmental plan, incorporating the suggestions provided in the additional report. Braskem initiated the actions foreseen by the plan, implementing the commitments established in the agreement and sharing the results of its actions with the authorities. Also is agreed that the environmental diagnosis will be updated in December 2025.

c. Social and urban measures, under the Agreement for Socio-environmental Reparation signed on December 30, 2020, allocating R$1,580,000 for the adoption of actions and measures in vacated areas, urban mobility and social compensation actions, of which R$300 million going to indemnification for social damages and collective pain and suffering and possible contingencies related to the actions in the vacated areas and urban mobility actions. The provision amount, updated by inflation index established in the agreement, is R$1,567,842 (2021: R$1,577,186).

d. Additional measures, for which the provision amounts to R$1,604,305 (2021: R$1,002,192), for expenses with: (i) actions related to the Technical Cooperation Agreements entered into by the Company; (ii) the hiring of external advisors to support the execution of the relocation actions and compensation of the families; (iii) infrastructure for assisting residents; (iv) expenses with managing the geological event in Alagoas relating to communication, compliance, legal services, etc.; (v) additional measures to assist the region and maintenance of areas, including actions for requalification and indemnification directed to Flexais region; and (vi) other matters classified as a present obligation for the Company, even if not yet formalized.

   
 F-82 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

The provisions of the Company are based on current estimates and assumptions and may be updated in the future due to new facts and circumstances, including, but not limited to: changes in the execution time, scope and method; the success of action plans; new repercussions or developments arising from the geological event, including possible revision of the Civil Defense map; and possible studies that indicate recommendations from specialists, including the Technical Monitoring Committee, according to Agreement for Compensation of Residents, and other new developments in the matter.

The measures related to the mine closure plans are also subject to the analysis and approval by ANM, the monitoring of results of the measures under implementation as well as changes related to the dynamic nature of geological event.

Continuous monitoring is essential for confirming the results of the current recommendations. Accordingly, the plans to close the wells may be updated based on the need to adopt technical alternatives to stabilize the subsidence phenomena arising from the extraction of salt. In addition, the assessment of the future behavior of cavities monitored using sonar and piezometers could indicate the need for certain additional measures to stabilize them.

The actions to repair, mitigate or offset potential environmental impacts and damages, as provided for in the Socio-environmental Reparation Agreement, will be defined considering the environmental diagnosis already prepared by a specialized and independent company. After the conclusion of all discussions with authorities and regulatory agencies, as per the process established in the agreement, an action plan will be agreed to be part of the measures for a Plan to Recover Degraded Areas (“PRAD”).

Furthermore, the Socio-Environmental Reparation Agreement envisages the potential adherence by other parties, including the Municipality of Maceió.

Also in the context of understandings with the authorities to address claims related to the event in Alagoas, on October 26, 2022, the 3rd Federal Court of Alagoas ratified the Term of Agreement for Implementation of Socioeconomic Measures for the Requalification of the Flexal Area (“Flexais Agreement”), entered into by Braskem and the MPF, the MPE, the DPU, and Municipality of Maceió for the adoption of action for requalification in the Flexais region, compensation to the Municipality of Maceió and indemnities to the residents of this location. The expected disbursement amounts to the execution of the obligations defined in the Term of Agreement are part of the provision under (d) Additional Measures.

The Company has been making progress with local authorities about other indemnification requests to understand them better, resulting in advances in the understanding between the parties that may result in an agreement. Although future disbursements may occur as a result of progress in negotiations, as of the reporting date, the Company is unable to predict the results and timeframe for concluding these negotiations or its possible scope and the total associated costs in addition to those already provisioned for.

It is not possible to anticipate all new claims, related to damages or other nature, that may be brought by individuals or groups, including public or private entities, that understand they suffered impacts or damages somehow related to the geological phenomenon and the relocation of people from risk areas, as well as new notices of infraction or administrative penalties of diverse natures. Braskem continues to face and could still face administrative procedures and various lawsuits filed by individuals or legal entities not included in the PCF or that disagree with the financial compensation offer for individual settlement, as well as new collective actions and new lawsuits filed by public utility concessionaires, entities of the direct or indirect administration of the State, Municipality or Federal level. Therefore, the number of such actions, their nature or the amounts involved cannot be estimated at this moment.

   
 F-83 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Consequently, the Company cannot eliminate the possibility of future developments related to the geological event in Alagoas, the relocation process and actions in vacated and adjacent areas, so the expenses to be incurred may differ from its estimates and provisions.

In February 2023, the Company signed a settlement agreement with the insurance companies related to the claim for the geological event in Alagoas. 

   
 F-84 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

26.1 Lawsuits pending

In the context of this event, the following lawsuits were filed against the Company:

(i) Public-Interest Civil Action (“ACP”) filed by the Alagoas State Prosecution Office and the Alagoas State Public Defender’s Office – Reparation for Residents

Public-Interest Civil Action claiming the payment of indemnification for damages caused to the buildings and the residents of areas affected in the Pinheiro district and surrounding areas, in the total minimum amount of R$6.7 billion, with initial request for provisional measure to freeze the Company’s financial and other assets in the same amount. Successive orders to freeze funds resulted in the court blocking of R$3.7 billion in assets in 2019, and the unfreezing occurred in January 2020. Once the case was sent to the Federal Courts, the Federal Prosecution Office started to participate in the action.

The first agreement under this Public-Interest Civil Action (Reparation for Residents) was ratified on January 3, 2020. The Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents”), entered into by Braskem and the MPE, the DPE, the MPF and the DPU (“Authorities”), establishes cooperative actions for relocating people in risk areas and guaranteeing their safety, which provides support under the Financial Compensation and Support for Relocation Program implemented by Braskem, for the population in specified risk areas.

After updates of the Civil Defense Map, two legal instruments were entered into with the Authorities, in July and October 2020, to include properties in the PCF.

On December 30, 2020, the Company and the Authorities executed a second amendment to the Agreement for Compensation of Residents to terminate the Public-Interest Civil Action, through which the parties agreed to include in PCF the relocation of additional properties defined in the updated version of the Civil Defense Map, of December 2020, and in the independent technical and specialized studies engaged by the Company on the potential impact of the geological event on the surface of the region (“Studies”). The Agreement for Compensation of Residents includes the area currently affected by the geological event, according to the Civil Defense, and the areas with potential future impacts indicated in the Studies.

To implement the actions envisaged in the Public-Interest Civil Action, the Company undertook to maintain R$2.7 billion in a checking account (R$1.7 billion under the Agreement for Compensation of Residents and an additional R$1 billion under the second amendment), with minimum working capital of R$100 million, whose transactions will be verified by an external audit company. On December 31, 2022, arising from the costs incurred related to the PCF, the balance of this checking account corresponded to R$175,153 under current assets (2021: R$835,517). In addition, the Company and the Authorities agreed to: (i) create a technical group (Technical Monitoring Committee) to monitor the geological event and study the areas adjacent to the Civil Defense Map for a period of five years; and (ii) maintain a performance bond in the current amount of R$1.2 billion (down from the R$2 billion performance bond envisaged in the Agreement for Compensation of Residents).

With the judicial ratification by the courts of the Agreement for Compensation of Residents on January 6, 2021, this Public-Interest Civil Action was terminated.

   
 F-85 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(ii) Public-Interest Civil Action filed by the Alagoas State Federal Prosecution Office – Social-environmental reparation

Public-Interest Civil Action claiming the payment by the Company of indemnification for socio-environmental damages and other collective damages, as well as the adoption of corrective and environmental compliance measures, with preliminary injunction requiring the freezing of assets, suspension of borrowings with the BNDES, formation of an own private fund in the initial amount of R$3.1 billion and the pledging of guarantees in the amount of R$20.5 billion. The amount of the action was R$27.6 billion.

(i)On December 30, 2020, the Agreement for Socio-environmental Reparation was executed, with the Company mainly undertaking to: (i) adopt measures to stabilize and monitor the subsidence phenomenon resulting from salt mining; (ii) repair, mitigate or compensate potential impacts and environmental damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate potential impacts and social and urban damages arising from salt mining in the Municipality of Maceió, as detailed below: To stabilize the cavities and monitor the soil, the Company continues to implement the action plans involving the closure of mining fronts prepared by Braskem and approved by the ANM, whose measures can be adjusted until the stability of the subsidence phenomenon resulting from salt mining is verified.
(ii)Regarding the potential environmental impacts and damages resulting from salt mining in the Municipality of Maceió: as agreed with the MPF, the Company hired a specialized independent company to identify and recommend measures for recovering, mitigating or compensating any environmental impacts identified as the result of salt mining activities in Maceió. The study and the second opinion report on the environmental planning were delivered to the MPF on June 30, 2022 and December 7, 2022, respectively, and will follow the procedures as per the agreement for final consolidation of the actions to be adopted in the mutual agreement between the Company and the MPF, but it is not possible to predict the outcome or if it will result in additional amounts other than those already recorded in the provision. Regarding potential impacts and social and urban damages arising from salt mining in the city of Maceió: to allocate the maximum amount of R$1,280 million for adopting actions and measures in vacated areas, urban mobility actions and social compensation actions. For these social compensation actions and measures, on June 30, 2022, the Company filed with the MPF the report and the respective plan of social action that will be used as base to define the measures to be adopted. Braskem also will allocate the amount of R$300 million for indemnification for social and collective pain and suffering and possible contingencies related to actions in vacated areas and in urban mobility actions.

The Company and the Federal Prosecution Office also agreed to hire a specialized consultancy to evaluate the Company’s Social and Environmental Management Program and on the pledging of security interest involving certain assets of the Company in the amount of R$2.8 billion to substitute the performance bond of R$1 billion.

The Agreement for Socio-environmental Reparation was ratified by Court on January 6, 2021, with the termination of the Public-Interest Civil Action for Socio-environmental Reparation regarding to Braskem. Moreover, this agreement provides for the possibility of adhesion by other parties, including the Municipality of Maceió.

Finally, under the Agreement for Socio-environmental Reparation, on January 21, 2021 the Civil Investigation launched in June 2020 by the MPE was terminated. It aimed to: (i) calculate the extent of the urban damages caused by the geological event that occurred in Maceió; (ii) seek, from liable parties, necessary and adequate architectural solutions for the destination, restoration and/or use of the cited empty spaces left in the districts impacted; (iii) calculate, if applicable, potential compensatory liabilities for the damages caused to the urban order.

   
 F-86 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(iii) Public-Interest Civil Action filed by the Federal Public Defender’s Office (“DPU”): refusal of insurance within the scope of Housing Financial System (“SFH”)

Public-interest civil action filed by DPU to question the denial of necessary insurance for contracts under the SFH to acquire properties located within a radius of 1 km outside the risk area defined by the version 4 map of Civil Defense authorities, which is the subject matter of the Residents PCA agreement – see item (i).

Insurers linked to SFH, financial agents, the regulatory agency and Braskem are the defendants. The main claim is only against the insurers, financial agents and the regulatory agency on the grounds that the refusal to contract the insurance is abusive and has no technical or legal grounds. There is a secondary and eventual claim to sentence Braskem to pay indemnification in an amount to be settled in the future, if the judge understands that the refusal somehow has grounds due to the subsidence phenomenon.

It is not possible to estimate the indemnification amount, which will depend on the evidence of damages submitted by people whose insurance was denied.

(iv) Public-Interest Civil Action filed by the Alagoas State Public Defender’s Office – Review of terms of the Flexais Agreement

Public-interest civil action filed by DPE against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the 3rd Federal Court of Alagoas.

Through of this lawsuit, the DPE seeks, among other claims, the inclusion of residents of Flexais region, who choose to adhere the PCF, program created under the agreement in ACP (Reparation for Residents), with consequent reallocation of these residents and compensation for moral and material damages in parameters specified in the ACP.

As injunction relief, DPE also requested, that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the PCF, or, alternatively, requested the freeze of Braskem bank accounts in the amount of R$ 1.7 billion, to guarantee the compensation for moral and material damages to residents of the Flexais region, this being the amount attributed to the lawsuit. The injunction relief requests were rejected by the court; decision subjected to appeal by DPE.

The Management, supported by the opinion of the external legal advisor, classifies the probability of loss in this lawsuit as possible.

(v) Indemnity Claim: Companhia Brasileira de Trens Urbanos (“CBTU”)

On February 2, 2021, the Company was notified of the filing of a lawsuit by Companhia Brasileira de Trens Urbanos, formulating initially only a preliminary injunction for maintaining the terms of the cooperation agreement signed previously by the parties. The request was denied in lower and appellate courts, given the fulfillment of the obligations undertaken by Braskem. On February 24, 2021, CBTU filed an amendment to the initial request claiming the payment of compensation for losses and damages in the amount of R$222 million and for moral damages in the amount of R$500 thousand, as well as the imposition of obligations, including the construction of a new rail line to substitute the stretch that passed through the risk area.

On December 31, 2022, the updated value of this lawsuit is R$1.43 billion (2021: R$1.40 billion). Braskem entered into a memorandum of understanding with CBTU to seek a consensual solution and suspend the lawsuit during the negotiation period and has made progress in the technical understanding about the topic. As a result of a joint petition filed by the parties, the lawsuit was suspended until June 2023.

   
 F-87 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

The Management, based on its assessment and that of its external legal advisors, classifies the probability of loss in this case as possible.

(vi) Indemnity Claim: Pinheiro District Property

Indemnity claim filed by Construtora H. Lobo (under court-supervised reorganization), a Contractor that claimed it suffered damages and loss of profits due to an agreement to purchase from Braskem a property in the District of Pinheiro. Said agreement was terminated by Braskem due to lack of payment by the Contractor. Nevertheless, the Contractor claims that Braskem omitted information on the existence of structural problems in the deactivated salt mining wells located on said property. As of December 31, 2022, the amount of this action is R$306 million (2021: R$264 million). The lawsuit is ongoing, and Management, supported by the opinion of its external legal advisors, classifies the probability of loss in this case as possible.

(vii) Indemnity Claim: State of Alagoas

Indemnity claim filed by the State of Alagoas, requesting compensation for alleged damages resulting, among others claims, from the loss of properties within the risk area defined by the Civil Defense of Maceió, alleged investments initiated by the State of Alagoas and that would have become void unusable due to the evacuation of the risk area and alleged loss of tax revenue, with a request that such damages to be determined by a court appraiser.

As injunction relief, the State of Alagoas requested the blocking of R$ 1.1 billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration, this being the amount attributed to the lawsuit. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court. 

The Management, supported by the opinion of its external legal advisor, classifies the probability of loss in this lawsuit as possible.

(viii) Other individual actions: Indemnifications related to the impacts of subsidence and relocation of areas affected

On December 31, 2022, Braskem was defendant in several other actions, that, in aggregate, involve the amount of R$1 billion (2021: R$895 million), filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió.

The Management, supported by the opinion of its external legal advisor, classifies the probability of loss of the other individual lawsuits, in the total amount mentioned above, as possible.

 

27 Benefits offered to employees

27.1 Short-term benefits

The obligations of short-term benefits for employees are recognized as personnel expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered by an employee in the past and the obligation can be reliably estimated.

   
 F-88 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

       
  2022   2021   2020
           
Health care 243,620   235,681   197,683
Private pension 127,954   136,851     94,302
Transport   86,217     77,201     66,752
Feeding   62,786     51,240     38,400
Life insurance   10,400     10,324    9,875
Training   27,032     15,723     14,892
Other   16,027     12,546     14,117
   574,036    539,566    436,021

 

27.2 Long-term incentive plan (“ILP Plan”)

On March 21, 2018, the Extraordinary Shareholders Meeting approved the Long-Term Incentive Plan with the grant of Restricted Shares (“ILP Plan”) to align the interests of shareholders and executive officers (participants) and to promote their continued employment at the Company.

The grant is subject to the voluntary investment of own financial resources by participants in the shares issued by the Company (tickers BRKM5 or BAK). To acquire the right, participants must maintain their employment relationship with the Company and hold uninterruptedly the shares acquired during the three-year vesting period.

When the conditions to obtain the right are met, the Company transfers to participants the number of restricted shares to which they are entitled, which are held in treasury or acquired through repurchase program.

If the transfer is not possible, the Company will pay to participants, in cash, the amount equivalent to the shares granted at the share price traded on stock exchange on the second business day immediately prior to the respective payment date.

The fair value of shares on the grant date is recognized on a straight-line basis under personnel expenses during the vesting period, reflecting the expected number of shares that will meet the conditions to obtain the right, in such a way that the end amount recognized as an expense is based on the number of shares that effectively meet the conditions on the vesting date.

The form of settlement of the ILP Plan determines the corresponding entry of expenses, which is recognized under equity for payment of shares and recognized under liabilities for cash payment, with the liability remeasured on each reporting date and on the settlement date, based on the American Depositary Receipt price. Any changes in the fair value of the liability are recognized as personnel expenses.

The programs listed below were approved by the Board of Directors under the terms and conditions of the Long-Term Incentive Plan, which includes a list of eligible people, the period for acquisition of own shares by the participants and the number of restricted shares to be delivered to participants as consideration for each share acquired.

   
 F-89 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

                                                 
Flat   Grant Date   End of Grace Period   Settlement Method   Granted quantities   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2021   (+) Granted   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2022   Fair value of the share*
                                                 
2019 Plan   03/19/19   03/19/22   Shares     417,234    (71,905)   -    345,329    -    (18,802)    (326,527)   -    
2019 Plan   03/19/19   03/19/22   Cash    82,128   (8,433)   -   73,695    -   (1,297)   (72,398)   -    
                                                 
2020 Plan   04/01/20   04/01/23   Shares    1,007,883    (72,743)   (2,373)    932,767    -    -   -    932,767   R$ 16.27
2020 Plan   04/01/20   04/01/23   Cash     314,333    (47,943)   -    266,390    -    -   -    266,390   USD 9.67
                                                 
2021 Plan   05/10/21   05/10/24   Shares     557,888   (9,598)   -    548,290    -    -   -    548,290   R$ 51.39
2021 Plan   05/10/21   05/10/24   Cash     144,779    -   -    144,779    -    -   -    144,779   USD 9.67
                                                 
2022 Plan   05/17/22   05/17/25   Shares    -    -   -   -     537,870    -   -    537,870   R$ 44.15
2022 Plan   05/17/22   05/17/25   Cash    -    -   -   -     132,902    -   -    132,902   USD 9.67

(*) Values in monetary units.

 

On December 31, 2022, the amount recorded in equity is R$39,413 (2021: R$31,932).

27.3 Post-employment benefits

The obligations for contributions to defined contribution plans are recognized in profit or loss as personnel expenses when the related services are provided by employees. The contributions paid in advance are recognized as an asset to the extent that a cash reimbursement or a reduction in future payments is possible.

The Company’s net obligation for defined benefit plans is calculated for each of the plans based on the estimated amount of future benefit that employees will receive in return for services rendered in the current and prior periods. Such amount is discounted to its present value and is reported net of the fair value of any of the plan’s assets.

The calculation of the obligation of the defined benefit plan is made annually by a qualified accountant using the projected unit credit method. When calculations result in a potential asset for the Company, the asset to be recognized is limited to the present value of economic benefits available as future plan reimbursements or as a reduction in future contributions to the plan. To calculate the present value of economic benefits, any applicable minimum cost requirements are taken into account. Remeasurements of net obligation, which include: actuarial gains and losses, return on plan assets (excluding interest) and the effects of the asset cap (if any, excluding interest), are immediately recognized in other comprehensive income.

Braskem and subsidiaries in Brazil

Braskem and the subsidiaries in Brazil sponsor a defined contribution plan for its team members managed by Vexty, a private pension plan entity. Vexty offers its participants, which are employees of the sponsoring companies, an optional defined contribution plan in which monthly and additional participant contributions and monthly and annual sponsor contributions are made to individual pension savings accounts. For this plan, the sponsors pay contributions to private pension plan on contractual or voluntary bases. As soon as the contributions are paid, the sponsors do not have any further obligations related to additional payments.

As of December 31, 2022, the number of active participants in Vexty sums 6,391 (2021: 6,113) and the contributions made by the sponsors in the year amount to R$92,208 (2021: R$68,744) and the contributions made by the participants amounted to R$77,263 (2021: R$83,599).

According to Brazilian laws, the type of health plan offered by Braskem, named contributory plan, ensures to the participant who retires or is dismissed without cause the right to remain in the plan with the same assistance coverage conditions they had during the employment term, provided they assume the full payment of the plan (Company’s part + participant’s part).

   
 F-90 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Braskem America

Braskem America administers the Novamont, which is a closed defined benefit pension plan for the employees of a plant located in the State of West Virginia. On December 31, 2022, there were 36 active participants, 32 employees with deferred benefits along and 101 assisted participants (2021: 36 active participants, 141 employees with deferred benefits and 173 assisted participants).

During 2022, the number of participants in the pension plan decreased, and 173 participants received a fixed payment or opted for insurance annuity.

Due to the current funding levels of the pension plan, the subsidiary was not required to contribute to the plan during the 2022 plan year and, therefore, there were no additional cash contributions made by the subsidiary or the participants in 2022 and 2021.

Braskem Alemanha (“Germany”)

Braskem Alemanha is the sponsor of the defined benefit plans and defined contribution plans of its employees. As of December 31, 2022, the plans have 172 participants (2021: 158) and no contributions were made by the subsidiary or the participants in 2022 and 2021.

Braskem Holanda (“Netherlands”)

The subsidiary Braskem Holanda is the sponsor of the defined contribution plans of its employees. As of December 31, 2022, the plans have 12 participants (9 participants in 2021) and no contributions were made by the subsidiary or the participants in 2021 and 2020.

Braskem Idesa

Braskem Idesa is the sponsor of defined benefit plans for its team members. As of December 31, 2022, the plan was composed of 965 active participants (2021: 936 active participants). The contributions the subsidiary made in the year amounted to R$4,370 (2021: R$3,810). During 2022 and 2021, there were no contributions from participants.

(a) Amounts in statement of financial position

                 
                   
                2022   2021
Defined benefit                    
Novamont Braskem America               58,221    117,509
Braskem Idesa                 23,053   22,960
Braskem Alemanha and Netherlands             147,562    223,193
                228,836    363,662
Health care                    
Bradesco saúde               321,520    243,706
Total obligations                550,356     607,368
                     
Fair value of plan assets                  
Novamont Braskem America             (54,665)   (117,509)
Braskem Alemanha                (1,948)    (2,162)
                (56,613)   (119,671)
                     
Consolidated net balance (non-current liabilities)              493,743     487,697

 

   
 F-91 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Change in obligations

                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
                                     
Balance at beginning of year   243,706     363,662    607,368     217,089    370,860    587,949     224,852    245,565    470,417
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Benefits paid   (12,639)   (34,208)    (46,847)     (10,712)   (7,191)    (17,903)    (5,949)   (7,409)    (13,358)
Actuarial losses (gain)  65,325   (83,485)    (18,160)    16,820    (26,668)   (9,848)     (23,589)   25,803     2,214
Exchange variation        (36,779)    (36,779)         7,074   7,074     -   87,933   87,933
Balance at the end of the year 321,520   228,836     550,356   243,706   363,662   607,368   217,089     370,860     587,949

 

(b) Change in fair value plan assets

           
    2022   2021   2020
             
Balance at beginning of year   119,671     115,875   81,342
Actual return on plan assets (25,929)   722   15,791
Benefits paid   (32,264)     (5,301)   (4,973)
Exchange variation     (4,866)   8,375   23,715
Balance at the end of the year 56,613   119,671     115,875

 

On December 31, 2022, the balance of the fair value of assets is represented by the assets of the Novamont defined benefit plan, which has a level-1 fair value hierarchy.

Amounts recognized in profit and loss

                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
              -                        
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Actuarial (losses) gains     (83,485)    (83,485)      (24,203)   (24,203)     -   15,461   15,461
    25,128    (63,839)   (38,711)   20,509     (4,616)   15,893     21,775    34,429    56,204

 

(c) Actuarial assumptions

                                                                   
                                                                  (%)
                          2022                   2021                   2020
          Health   United               Health   United               Health   United            
          insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
                                                                   
Discount rate         5.97   5.10    8.00     1.20     3.60     5.33    2.90    8.00    1.20    1.20    3.99    2.60    7.25     0.70   0.70
Inflation rate         3.00    n/a     4.00     2.00     2.00     3.00    n/a     4.00    2.00    2.00    3.25    n/a     4.00     2.00   2.00
Expected return on plan assets        n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels      n/a     n/a     5.00     3.00     3.25    n/a     n/a     5.00    3.00    3.00    n/a     n/a     5.00     3.00   3.00
Rate of increase in future pension plan      n/a     n/a     n/a      1.75     2.25    n/a     n/a     n/a     1.75    1.75    n/a     n/a     n/a      1.75   1.75
Aging factor         2.50    n/a     n/a      n/a      n/a      2.50    n/a     n/a      n/a      n/a     2.50    n/a     n/a     n/a     n/a 
Medical inflation         3.50    n/a     n/a      n/a      n/a      3.50    n/a      n/a      n/a      n/a     3.50    n/a     n/a     n/a     n/a 
Duration         12.83    n/a     n/a      n/a      n/a    14.16    n/a      n/a      n/a      n/a      14.99    n/a     n/a     n/a     n/a 

 

   
 F-92 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Sensitivity analysis

 

                                                         
                                                               
      Impact on the defined benefit obligation
                      Premise change                   Premise increase                   Premise reduction
      Health   United               Health   United               Health   United            
      insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
Discount rate     1.0%   1.0%   1.0%   0.25%   0.25%    32,758   5,536     1,646     5,477     297    (39,621)   (6,605)   (1,935)   (5,836)     (315)
Real medical inflation   n/a   n/a   n/a   n/a   n/a    n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels n/a   n/a   n/a   0.5%   0.5%    n/a     n/a     n/a      8,604     468    n/a     n/a     n/a    (8,114)     (442)
Rate of increase in future pension plan 1.0%   n/a   n/a   0.25%   0.25%    (7,740)    n/a     n/a      4,241     231     8,098    n/a     n/a    (4,115)     (224)
Life expectancy     1.0%   n/a   n/a   1 ano   1 ano    48,527    n/a     n/a      3,637     198    (39,355)    n/a     n/a    (3,797)     (207)
Mortality rate     n/a   10.0%   n/a   n/a   n/a    n/a    1,681    n/a     n/a     n/a     n/a    (1,839)    n/a     n/a     n/a 

 

 

                                                               
                                          Health insurance - Impact on cost of services and interests costs
                                          Premise change   Premise increase   Premise reduction
                                          Cost of   Iterests   Cost of   Iterests   Cost of   Iterests
                                          services   costs   services   costs   services   costs
Discount rate                                         1.0%   1.0%     730     106   (933)     11
Life expectancy                                         1.0%   1.0%     542     4,441   (464)     (3,602)
Rate of increase in future pension plan                                     1.0%   1.0%     123     708   (129)     (741)

 

28 Equity

28.1 Capital

On December 31, 2022 and 2021, the Company's subscribed and paid-up capital stock amounted to R$8,043,222 and comprised 797,207,834 shares with no par value, distributed as follows:

                                 
                                   
      Amount of shares
      Common       Preferred shares       Preferred shares            
      shares   %   class A   %   class B   %   Total   %
                                   
Novonor     226,334,623   50.11     79,182,498   22.95     -   -   305,517,121   38.32
Petrobras     212,426,952   47.03     75,761,739   21.96     -   -   288,188,691   36.15
ADR (i)     -   -     42,869,320   12.42     -   -     42,869,320     5.38
Other       12,907,077     2.86   146,581,427   42.48    478,790    100.00   159,967,294   20.07
Total     451,668,652     100.00   344,394,984     99.81     478,790     100.00   796,542,426     99.92
Treasury shares       -   -    665,408     0.19     -   -    665,408     0.08
Total     451,668,652     100.00   345,060,392     100.00     478,790     100.00   797,207,834     100.00
                                   
Authorised     535,661,731       616,682,421         593,818       1,152,937,970    

(i) American Depository Receipt ("ADR") on the New York Stock Exchange – NYSE (USA).

 

Changes in shares during the year:

                         
                         
        Amount of shares
    Note   2020   Changes   2021   Changes   2022
Outstanding shares                      
  Commom shares     451,668,652     -   451,668,652     -   451,668,652
  Preferred Class A  28.4   343,824,794    333,432   344,158,226    236,758   344,394,984
  Preferred Class B      500,230    (21,440)    478,790     -    478,790
        795,993,676     311,992   796,305,668     236,758   796,542,426
                         
 Treasury shares                      
  Preferred Class A 28.4    1,224,878     (322,712)    902,166     (236,758)    665,408
                         
Total       797,218,554   (10,720)   797,207,834     -   797,207,834

   
 F-93 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

28.2 Capital reserves

This reserve includes part of the shares issued in the Company’s several capital increases. This reserve can be used to absorb losses, to redeem, reimburse or purchase shares, and to incorporate into the capital stock.

28.3 Profit reserves

(a) Legal reserve

Under Brazilian Corporation Law, companies must transfer 5% of net profit for the year to a legal reserve until this reserve is equivalent to 20% of the paid-up capital. The legal reserve can be used for capital increase or absorption of losses.

(b) Tax incentive reserve

This reserve results from the allocation of part of net income for the year equivalent to tax incentives, arising from governmental subsidies (see Note 31). This reserve may only be used to offset losses with subsequent reconstitution or increase share capital.

 

(c) Profit retention

Under Brazilian Corporation Law, portions of net income for the fiscal year may be allocated to reserves or retained based on the capital budget. Profits not allocated as such may be distributed to shareholders in the form of dividends. In 2022, this reserve was partially used to absorb losses for the year (Note 28.6).

28.4 Share rights

Preferred shares carry no voting rights, but they ensure priority, non-cumulative annual dividend of 6% of their unit value, according to profits available for distribution. The unit value of the shares is obtained through the division of capital by the total number of outstanding shares. As common shares, only class “A” preferred shares will have the same claim on the remaining profit that exceeds the minimum mandatory dividend of 6% and will be entitled to dividends only after the priority dividend is paid to preferred shareholders. Only class “A” preferred shares also have the same claim as common shares on the distribution of shares resulting from capitalization of other reserves. Class “A” preferred shares can be converted into common shares upon resolution of majority voting shareholders present at a General Meeting. Class “B” preferred shares can be converted into class “A” preferred shares at any time, at the ratio of two class “B” preferred shares for one class “A” preferred share, upon a simple written request to the Company, provided that the non-transferability period provided for in specific legislation that allowed for the issue and payment of such shares with tax incentive funds has elapsed.

In 2022, 236,758 shares held in treasury were delivered to participants of the LTI Program 2019, which was fully settled in April 2022. In 2021, 322,712 shares were granted as payment of the LTI Program 2018.

28.5 Payment of dividends

On April 19, 2022, the Annual and Extraordinary Shareholders Meeting approved distribution of the proposed additional dividends on the 2021 results, corresponding to R$1.696348838321 per outstanding common share and class “A” preferred share, in the amount of R$1.35 billion, payment of which was made as from May 2, 2022.

 

 

   
 F-94 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

28.6 Accumulated losses

Accumulated losses in 2022 were absorbed as follows:

     
      2022
       
Loss for the year of the Company's shareholders       (335,677)
Amounts posted directly to the Retained Earnings account:      
SUDENE tax incentive supplement       (108,975)
Comprehensive income     26,883
Other       475
      (417,294)
Loss absorption using profit reserve:      
Profit reserves - Retention of profits      417,294
        417,294

 

29 Earnings (loss) per share

Basic earnings (loss) per share is calculated by means of the division of profit (loss) for the year attributable to the Company’s common and preferred shareholders by the weighted average number of these shares held by shareholders, excluding those held in treasury and following the rules for the distribution of dividends provided for in the Company’s bylaws, as described in Note 28.4, particularly in relation to the limited rights enjoyed by class “B” preferred shares. The calculation of the diluted earnings (loss) per share is based on the weighted average of class “A” preferred shares, assuming the conversion of all preferred shares into treasury that would cause the dilution.

Class A preferred shares participate in dividends with common shares after the mandatory dividends has been attributed in accordance with the formula provided for in the Company’s bylaws, as described in Note 28.4 and there is no highest limit for their participation.

The table below shows the reconciliation of profit or loss for the period adjusted for the amounts used to calculate basic and diluted earnings (losses) per share.

   
 F-95 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

                         
        2022       2021       2020
    Basic   Diluted   Basic   Diluted   Basic   Diluted
                         
(Loss) profit  for the year attributed to Company's shareholders     (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Distribution of priority dividends attributable to:                        
Preferred shares class "A"    -    -    208,574    208,574    -    -
Preferred shares class "B"    -    -     290     290    -    -
     -    -    208,864    208,864    -    -
                         
Distribution of 6% ​​of unit price of common shares    -    -    273,729    273,729    -    -
                         
Distribution of excess profits, by class:                        
Common shares    -    -    7,664,208    7,664,208    -    -
Preferred shares class "A"    -    -    5,838,145    5,838,145    -    -
     -    -     13,502,353     13,502,353    -    -
                         
Reconciliation of income available for distribution,
by class (numerator):
                       
Common shares     (190,357)     (190,357)    7,937,937    7,937,937     (3,797,070)     (3,797,071)
Preferred shares class "A"     (145,118)     (145,118)    6,046,719    6,046,719     (2,890,445)     (2,890,444)
Preferred shares class "B"   (202)   (202)     290     290   (4,205)   (4,205)
      (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Weighted average number of shares,
by class (denominator):
                       
Common shares   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652
Preferred shares class "A"   344,329,470   344,329,470   344,054,700   345,049,701   343,823,811   345,049,672
Preferred shares class "B"    478,790    478,790    500,171    500,171    500,230    500,230
    796,476,912   796,476,912   796,223,523   797,218,524   795,992,693   797,218,554
                         
Profit (loss) per share (in R$)                        
Common shares     (0.42)     (0.42)     17.57     17.57     (8.41)     (8.41)
Preferred shares class "A"     (0.42)     (0.42)     17.57     17.52     (8.41)     (8.38)
Preferred shares class "B"     (0.42)     (0.42)    0.58    0.58     (8.41)     (8.41)

   
 F-96 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

Weighing of shares

                 
                2022
                Basic
                Preferred shares
            Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of the year            344,158,226    344,158,226
                 
Incentive long term plan payments with treasury shares             236,758     171,244
                 
Amount at the end of the year            344,394,984    344,329,470

 

                 
                2021
                Basic
                Preferred shares
    Class "A"   Class "B"
    Outstanding   Weighted   Outstanding   Weighted
    shares   average   shares   average
                 
Amount at beginning of the year    343,824,794    343,824,794   500,230   500,230
                 
Incentive long term plan payments with treasury shares     322,712     229,877   -   -
Conversion shares class "B" into shares class "A"    10,720     29     (21,440)   (59)
                 
Amount at the end of the year    344,158,226    344,054,700   478,790   500,171

 

                 
                2020
                Basic
                Preferred shares
                Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of year            343,823,073    343,823,073
                 
Incentive long term plan payments with treasury shares           1,721   738
                 
Amount at the end of the year            343,824,794    343,823,811

  

   
 F-97 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

30 Net revenue

                 
        2022   2021   2020
          96,519,284   105,625,201     58,543,494

Revenue from sales of products is recognized when the control of assets is transferred to the customer for an amount that reflects the consideration to which the Company expects to be entitled in exchange of these assets. The performance obligations are met at a specific moment in time. The Company does not make sales with continued management involvement. Most of the Company’s sales are made to industrial customers and, in a lower volume, to resellers.

(i)The specific moment when the Company satisfies a performance obligation by transferring a promised good or service to the client is determined as follows: for contracts under which the Company is responsible for the freight and insurance, the legal right and the risks and benefits are transferred to the client when the risk of the goods is delivered at the destination established in the contract;
(i)(ii) for agreements under which the freight and insurance are a responsibility of the client, risks and benefits are transferred when the products are delivered to the client’s carrier; and for contracts under which product delivery involves the use of pipelines, especially basic petrochemicals, the risks and benefits are transferred immediately after the Company’s official markers, which is the point of delivery of the products and transfer of their ownership.

(a) Net revenue by country

           
      2022   2021   2020
               
Brazil      56,217,472    55,830,330    32,369,199
United States      18,085,607    24,232,413    10,848,609
Mexico     4,468,827   5,505,893   2,765,815
Argentina     2,092,700   2,068,023   1,267,967
Germany     1,695,009   1,912,373   1,106,877
Switzerland     1,492,922   1,230,541   633,512
Italy     1,095,133   1,304,113   811,787
Chile     870,858   1,230,493   544,329
Netherlands     816,678   642,844   432,897
Luxembourg     756,297   987,656   592,777
Singapore     755,971   1,175,133   1,183,838
Peru     740,011   666,867   471,847
Japan     723,757   1,162,226   618,940
Spain     546,646   517,532   282,362
United Kingdom     490,801   585,766   204,953
Uruguay     469,555   495,120   405,946
Poland     455,458   649,825   285,714
Bolivia     427,237   296,138   190,447
Sweden     401,251   481,289   310,984
Canada     393,504   558,730   297,756
France     359,946   326,570   247,062
Paraguay     316,460   318,842   254,255
Colombia     263,695   274,335   174,381
China     172,656   354,071   496,920
South Korea     159,944   669,055   360,704
Other     2,250,890   2,149,023   1,383,616
       96,519,284     105,625,201    58,543,494

 

   
 F-98 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(b) Net revenue by product

           
      2022   2021   2020
               
PE/PP     61,145,093    73,306,089    41,137,288
Benzene, toluene and xylene     7,279,584   5,819,696   3,051,752
Ethylene, Propylene     5,819,345   6,872,999   3,600,276
ETBE/Gasoline     5,722,767   4,321,371   2,170,289
PVC/Caustic Soda/EDC     5,710,838   5,806,011   3,134,617
Butadiene     3,028,048   3,019,836   1,372,428
Solvents     1,522,025   1,129,484   654,793
Cumene     1,425,097   1,342,811   636,635
Naphtha, condensate and crude oil     422,359   1,648,581   915,807
Other     4,444,130   2,358,324   1,869,609
       96,519,284     105,625,201     58,543,494

(c) Main clients

The Company does not have any revenue arising from transactions with only one client that is equal to or higher than 10% of its total net revenue. In 2022, the most significant revenue from a single client amounts to approximately 2.4% of total net revenues of the Company and refers to the sale of chemicals and resins.

 

31 Tax incentives

(a) SUDENE–- IR

Since 2015, the Company obtained grant in lawsuits claiming the reduction of 75% of IRPJ and additional taxes on income from the following industrial units: (i) PVC and Chlor-Alkali (Cloro Soda), established in the state of Alagoas; and (ii) Chemicals, PE, PVC and Chlor-Alkali units, established in the city of Camaçari (in Bahia State). The tax incentive granted by the Northeast Development Department (“SUDENE”) is calculated based on the Profit from Exploration of the incentivized activity, with an enjoyment period of 10 years. In 2020, the operations in Brazil recorded tax loss, therefore it is not possible to make any deductions as a tax incentive.

In 2022, the Company recorded a tax loss and, for such reason, did not make use of tax benefits.

(b) PRODESIN–- ICMS

The Company has ICMS tax incentives granted by the state of Alagoas, through the state of Alagoas Integrated Development Program (“PRODESIN”), which are aimed at implementing and expanding a plant in that state.

The Company obtained a final and unappealable decision (Case No. 0042875-86.2015.4.01.3300) that exempted it from the payment of IR/CSL on tax incentives granted under PRODESIN, ensuring their treatment as a reducer of taxes on sales, in the period between the calendar years 2010 to 2017, in the accumulated amount of R$425,913. In 2022, the amount was R$87,415 (2021: R$176,284).

 

   
 F-99 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

32 Expenses by nature and function

             
          2022   2021   2020
                   
Classification by nature:              
  Raw materials other inputs     (73,181,706)   (63,570,499)   (37,913,921)
  Personnel expenses       (3,223,477)     (3,478,323)     (3,074,305)
  Outsourced services       (3,411,818)     (3,193,970)     (2,219,413)
  Depreciation and amortization       (4,733,165)     (4,178,433)     (4,048,081)
  Freights       (4,034,901)     (2,966,229)     (2,321,740)
  Idle industrial plants       (414,441)     (338,987)     (518,528)
  Provision - geological event in Alagoas (Note 26)       (1,520,019)     (1,339,765)     (6,901,828)
  PIS and Cofins credits - exclusion of ICMS from the calculation basis       1,031,099   310,557
  Other income     507,333   1,843,153   440,192
  Other general and administrative expenses       (2,269,865)     (3,394,344)     (2,348,921)
  Total     (92,282,059)   (79,586,298)   (58,595,988)
                   
Classification by function:              
  Cost of products sold     (85,160,548)   (73,568,231)   (47,331,414)
  Selling and distribution       (2,108,417)     (2,055,640)     (1,852,055)
  (Loss) reversals for impairment of trade accounts receivable      (38,426)   (8,914)    (55,252)
  General and administrative       (2,763,983)     (2,522,127)     (1,918,747)
  Research and development       (374,493)     (296,583)     (250,648)
  Other income (i)     507,333   1,534,487   750,749
  Other expenses (ii)       (2,343,525)     (2,669,290)     (7,938,621)
  Total     (92,282,059)   (79,586,298)   (58,595,988)

(i) In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.
(ii) Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).

 

33 Financial results

Transactions in foreign currencies are translated into the respective functional currency of the Company’s subsidiaries at the exchange rates in effect on the transaction dates.

Monetary assets and liabilities denominated and measured in foreign currency on the reporting date are re-translated into the functional currency at the exchange rate on said date. Non-monetary assets and liabilities measured at fair value in foreign currency are re-translated into the functional currency at the exchange rate on the date on which the fair value was determined. Non-monetary items that are measured based on the historical cost in foreign currencies are translated at the exchange rate on the date of the transaction. The differences in foreign currencies resulting from conversion are recognized in financial income or loss, unless the liability involves a cash flow hedge accounting relationship.

   
 F-100 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

                   
          2022   2021   2020
Financial income                
  Interest income         1,049,745     439,891     310,202
  Inflation indexation income on tax assets (i)    16,489     1,041,917     170,857
  Gain on derivatives       635,779     246,459   -
  Other         308,121    99,171     119,125
          2,010,134   1,827,438   600,184
                   
Financial expenses                
  Interest expenses       (3,125,206)   (2,922,958)   (2,928,803)
  Inflation indexation expenses on tax liabilities     (266,281)   (93,722)   (138,410)
  Discounts granted       (129,249)   (75,677)   (81,920)
  Loans transaction costs - amortization     (260,511)   (691,243)   (172,269)
  Adjustment to present value - appropriation     (580,994)   (179,461)   (225,889)
  Interest expense on leases     (203,257)   (173,536)   (164,166)
  Losses on derivatives     (596,501)   (1,003,502)   (809,150)
  Other       (500,694)   (767,056)   (392,758)
          (5,662,693)   (5,907,155)   (4,913,365)
                   
Exchange rate variations, net              
  On financial assets     (522,251)     230,370     336,527
  On financial liabilities       (49,919)   (4,233,177)   (5,635,238)
           (572,170)    (4,002,807)    (5,298,711)
                   
Total        (4,224,729)    (8,082,524)    (9,611,892)

 

(i) In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).

 

   
 F-101 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

The effects from exchange variation on the Company’s transactions are mainly due to the variations in the following currencies:

                               
  End of year rate   Average rate
                              Variation
  2022   2021   Variation   2022   2021   Dec/20   2022-2021   2021-2020
U.S. dollar - Brazilian real 5.2177   5.5805   -6.50%   5.1655   5.3956   5.1578   -4.26%   4.61%
Euro - Brazilian real 5.5694   6.3210   -11.89%   5.4420   6.3784   5.8989   -14.68%   8.13%
Mexican peso - Brazilian real 0.2667   0.2730   -2.31%   0.2569   0.2660   0.2402   -3.44%   10.75%
U.S. dollar - Mexican peso 19.5720   20.4519   -4.30%   20.1249   20.2900   21.5098   -0.81%   -5.67%
U.S. dollar - Euro 0.9416   0.8853   6.36%   0.9510   0.8458   0.8775   12.44%   -3.61%

 

34 Segment information

The Company’s organizational structure is formed by the following segments:

- Brazil: includes: (i) the production and sale of chemicals at the Camaçari Petrochemical Complex in Bahia, the Triunfo Petrochemical Complex in Rio Grande do Sul, the Capuava Petrochemical Complex in the state of São Paulo, and the Duque de Caxias Petrochemical Complex in the state of Rio de Janeiro; (ii) the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; (iii) the production and sale of PE, including the production of green PE made from renewable resources, and of PP; and (iv) the production and sale of PVC and caustic soda.

- United States and Europe: operations related to PP production and sale in the United States and Europe, through the subsidiaries Braskem America and Braskem Alemanha, respectively.

- Mexico: comprises the activities relation to the PE production and sale in Mexico, through the subsidiary Braskem Idesa.

- Other segments: substantially comprises the activities of Cetrel.

(a) Presentation, measurement and reconciliation of segment results

Information by segment is generated in accounting records, which are reflected in the consolidated financial statements. The operating segments are stated based on the results of operations.

The eliminations and reclassifications line are mainly represented by purchases and sales between the Company’s reportable segments.

Corporate Unit comprises items not allocated directly to the reportable segments and are disclosed to reconcile the segments to the consolidated financial information.

   
 F-102 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

(b) Results by segment

      2022
                               
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,079,724     (63,195,629)   5,884,095     (1,853,039)    -     (1,888,999)     2,142,057
  USA and Europe   23,421,096     (19,986,176)   3,434,920     (838,474)    -    56,944     2,653,390
  Mexico   5,834,017    (5,069,531)   764,486     (451,605)    -     (33,370)     279,511
Total    98,334,837     (88,251,336)   10,083,501     (3,143,118)    -     (1,865,425)     5,074,958
                               
  Other segments   402,991    (262,402)   140,589   82,498    34,848   5,644     263,579
  Corporate unit   -   -   -     (2,196,506)    -    19,375   (2,177,131)
                               
Braskem consolidated before 
eliminations and reclassifications
  98,737,828     (88,513,738)   10,224,090     (5,257,126)    34,848     (1,840,406)     3,161,406
                               
  Eliminations and reclassifications    (2,218,544)   3,353,190   1,134,646    (28,193)    -   4,214     1,110,667
                               
Total   96,519,284     (85,160,548)   11,358,736     (5,285,319)    34,848     (1,836,192)     4,272,073
                               
                               
      2021
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,494,923     (49,309,552)   20,185,371     (1,608,185)    -     (2,210,601)   16,366,585
  USA and Europe   32,403,632     (23,343,205)   9,060,427     (900,885)    -     (25,580)     8,133,962
  Mexico   6,506,297    (3,413,652)   3,092,645     (471,821)    -     (15,302)     2,605,522
Total     108,404,852     (76,066,409)   32,338,443     (2,980,891)    -     (2,251,483)   27,106,069
                               
  Other segments   363,684    (233,084)   130,600   76,830   4,644     (28,674)     183,400
  Corporate unit   -   -   -     (1,963,137)    -    1,161,517  (i)   (801,620)
                               
Braskem consolidated before 
eliminations and reclassifications
   108,768,536     (76,299,493)   32,469,043     (4,867,198)   4,644     (1,118,640)   26,487,849
                               
  Eliminations and reclassifications    (3,143,335)   2,731,262    (412,073)    (16,066)    -     (16,163)    (444,302)
                               
Total    105,625,201     (73,568,231)   32,056,970     (4,883,264)   4,644     (1,134,803)   26,043,547
                               
      2020
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   40,794,387     (32,498,003)   8,296,384     (1,471,722)    -     (7,082,604)    (257,942)
  USA and Europe   14,638,660     (12,337,486)   2,301,174     (721,191)    -     (82,695)     1,497,288
  Mexico   4,000,805    (3,075,001)   925,804     (436,859)    -   (364,259)     124,686
Total    59,433,852     (47,910,490)   11,523,362     (2,629,772)    -     (7,529,558)     1,364,032
                               
  Other segments   302,374    (188,350)   114,024   63,874     (19,398)     (320)     158,180
  Corporate unit   -   -   -     (1,493,479)    -    359,071   (1,134,408)
                               
Braskem consolidated before 
eliminations and reclassifications
  59,736,226     (48,098,840)   11,637,386     (4,059,377)     (19,398)     (7,170,807)     387,804
                               
  Eliminations and reclassifications    (1,192,732)   767,426    (425,306)    (17,325)    -     (17,065)    (459,696)
                               
Total   58,543,494     (47,331,414)   11,212,080     (4,076,702)     (19,398)     (7,187,872)   (71,892)

 

See comment in Note 32(i).

 

   
 F-103 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

(b) Property, plant and equipment and intangible assets by segment

         
      2022   2021
Reporting segments        
  Brazil   19,428,926   18,072,312
  USA and Europe     7,075,743     7,688,713
  Mexico   13,736,298   14,019,167
Total     40,240,967    39,780,192
Unallocated amounts     544,472     322,237
Total     40,785,439    40,102,429

 

   
 F-104 

Braskem S.A.

 

Notes to the consolidated financial statements

at December 31, 2022

All amounts in thousands of Reais, except as otherwise stated

 

35 Contractual obligations

The Company has long-term contractual obligations arising from agreements entered into for the purchase of power inputs. As of December 31, 2022, these obligations amounted to R$8,286,502 (2021: R$6,079,568) and are expected to be settled by 2044.

 

36 Subsequent events

(a)In February 2023, the subsidiary Braskem Holanda Finance issued US$1 billion in bonds due in 2033, with coupon of 7.25% p.a. and Braskem guarantee.
(b)In February 2023, Braskem completed the process for acquiring shares and subscribing to new shares issued by Wise Plásticos S.A. (“Wise”), a Brazilian company engaged in mechanical recycling, now holding a 61.1% equity interest in Wise. In this context, Braskem disbursed R$138 million, with the usual considerations for this kind of transaction.
(c)

In March 2023, according to the Note 26.1 (iv), Alagoas State Public Defender’s Office (“DPE”) filed a Public-interest civil action (“ACP”) against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the 3rd Federal Court of Alagoas. DPE attributes to the lawsuit the amount of R$1.7 billion, with a request of injunction relief so that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the Financial Compensation and Support for Relocation Program (“PCF”), or, on a subsidiary basis, the freeze of bank accounts in the same amount of the lawsuit. The injunction relief requests were rejected by court; decision subjected to appeal by DPE. Braskem has already presented contestation.

(d)In March 2023, according to the Note 26.1 (vii), the State of Alagoas filed a lawsuit, requesting compensation for alleged damages caused to the State. In addition, as an injunction relief, the State of Alagoas requested the blocking of R$ 1.1 billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court.

 

   
 F-105 

EX-2.02 2 ex2-2.htm EX-2.02

Exhibit 2.02

Description of the Registrant’s Securities

Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

A. Description of Capital Stock and Class A Preferred Shares

General

Braskem S.A. (“Company,” “we” or “us”) is a corporation (sociedade por ações) organized under the laws of Brazil. Our registered office is located at Rua Eteno, 1561, Pólo Petroquímico, Camaçari, BA, Brazil, 42810-000. Our principal executive office is located at Rua Lemos Monteiro, 120, 24th floor, Butantã, São Paulo, SP, Brazil, 05501-050. We are registered with the Commercial Registry of the state of Bahia (Junta Comercial do Estado da Bahia) under NIRE No. 29.300.006.939 and with the Brazilian Securities Commission (Comissão de Valores Mobiliários, or the “CVM”), under No. 482-0. We are enrolled with the Brazilian Taxpayers’ Registry (Cadastro Nacional de Pessoas Jurídicas – CNPJ) under No. 42.150.391/0001-70.

Our by-laws are governed by the laws of Brazil. An English translation of our by-laws is incorporated by reference as an exhibit to our annual report on Form 20-F. In Brazil, a company’s by-laws (estatuto social) is the principal governing document of a corporation (sociedade por ações).

The following description of our capital stock and Brazilian laws and regulations is a summary and does not purport to be complete.

Capital Stock

As of December 31, 2022, we had a share capital of R$8,043,222,080.50, equal to 797,207,834 total shares (including treasury shares), consisting of 451,668,652 common shares, 344,394,984 class A preferred shares and 478,790 class B preferred shares. As of December 31, 2022, all of our authorized shares were issued, other than 665,408 class A preferred shares held in treasury. All of our share capital is fully paid. All of our shares are without par value.

We are authorized, by resolution of our board of directors and without amending our by-laws, to issue up to 1,152,937,970 total shares, consisting of 535,661,731 common shares, 616,682,421 class A preferred shares and 593,818 class B preferred shares.

Under Brazilian Law No. 6,404/1976 (the “Brazilian Corporate Law”), and under our by-laws, the number of issued and outstanding non-voting shares or shares with limited voting rights, such as our class A preferred shares and class B preferred shares, may not exceed two thirds of our total outstanding share capital. Each of our common shares entitles its holder to one vote at our shareholders’ meetings. Holders of our common shares are not entitled to any preference in respect of our dividends or other distributions or otherwise in case of our liquidation. Our class A preferred shares and class B preferred shares are non-voting, except in limited circumstances, and have priority over our common shares in the case of our liquidation.

Corporate Purpose

Article 2 of our by-laws establishes our corporate purposes, which include:

·the manufacture, trading, import and export of chemical and petrochemical products and petrochemical derivatives;
·the production, distribution and trading of utilities such as: steam, water, compressed air, industrial gases, as well as the provision of industrial services;
 
 
·the production, distribution and trading of electricity for its own consumption and that of other companies;
·holdings of equity stakes in other companies, pursuant to the Brazilian Corporate Law, as a holder of quotas or shares;
·the manufacture, distribution, trading, import and export of gasoline, diesel oil, liquefied petroleum gas, and other oil derivatives.
·the transportation, representation and consignment of petrochemical products and by-products, compounds and derivatives, such as polypropylene, polypropylene films, polyethylene, elastomers and their respective manufactured products;
·the free lease or loan of assets that are owned or possessed thereby because of a commercial leasing agreement, provided that this is carried out as an ancillary activity to the main corporate purpose of our Company; and
·the provision of services related to the activities above.

Rights of Holders of our Shares

Generally, only our common shares have voting rights. Our preferred shares have voting rights only in exceptional circumstances, according to applicable law.

As permitted by the Brazilian Corporate Law, our by-laws specify that no less than 25% of our adjusted net income for each fiscal year must be distributed to shareholders as dividends or interest attributable to shareholders’ equity. Under our by-laws, our preferred shareholders are entitled to an annual non-cumulative preferential dividend (the “Minimum Preferred Dividend”) equal to 6% of their pro rata share of our capital before dividends may be paid to our common shareholders.

Pursuant to our by-laws, all of our shares are entitled to tag along rights equivalent to 100% of the price paid in the event of a change of control, subject to certain exceptions set forth in article 12 of our by-laws. Notwithstanding the provisions of our by-laws, pursuant to the Brazilian Corporate Law, our common shares are entitled to tag along rights equivalent to at least 80% of the price paid for such common shares in the event of a change of control.

In addition, in the event of our liquidation and following the payment of all of our outstanding liabilities, holders of our shares are entitled to receive their pro rata interest in any remaining assets, in accordance with their respective participation in our capital.

Our shareholders have preemptive rights to subscribe for new shares issued by us, pursuant to the Brazilian Corporate Law, but are not obligated to subscribe for future capital increases. Pursuant to the Brazilian Corporate Law, our by-laws provide that the preemptive right may be excluded in the event of an issuance of shares to be sold on a stock exchange or publicly subscribed, except if involving voting shares or securities convertible into voting shares.

Pursuant to the Brazilian Corporate Law, neither our by-laws nor actions taken at a shareholders’ meeting may deprive a shareholder of: (i) the right to participate in the distribution of net income; (ii) the right to participate equally and proportionally in any residual assets in the event of liquidation of the Company; (iii) preemptive rights in the event of issuance of new shares, convertible debentures or subscription warrants, as per Brazilian Corporate Law, except as described in the preceding paragraph; (iv) the right to hold management accountable in accordance with the provisions of the Brazilian Corporate Law; and (v) the right to withdraw from us in the cases specified in the Brazilian Corporate Law, including merger with another company or consolidation in a transaction in which our Company is not the surviving entity.

 
 

Dividends and Dividend Policy

Payment of Dividends

When we pay dividends on an annual basis, they are declared at our annual shareholders’ meeting, which we are required by the Brazilian Corporate Law and our by-laws to hold by April 30 of each year. When we declare dividends, we are generally required to pay them within 60 days of declaring them unless the shareholders’ resolution establishes another payment date. If we declare dividends, we must pay them by the end of the fiscal year for which they are declared. Any holder of record of shares at the time that a dividend is declared is entitled to receive dividends, unless another record date is approved. Our payment of annual dividends is based on our audited financial statements prepared for our preceding fiscal year. Pursuant to Brazilian Corporate Law, our by-laws and our dividend distribution policy, we have historically distributed annual dividends (except in years in which we have not had adjusted net income or our management has informed the annual shareholders’ meeting that such payment is incompatible with our financial condition).

Our Finance and Investments Committee will review, prior to the review by our board of directors, any management proposal regarding the distribution of dividends or interest on capital stock.

Our board of directors may declare interim dividends based on the accrued profits recorded or the realized profits in our annual or interim financial statements. In addition, we may pay dividends approved by our board of directors from net income based on our unaudited interim financial statements. We may pay dividends based on quarterly interim financial statements, provided that the sum of the dividends paid in each semester does not exceed the amounts included in our capital reserve accounts. We may set off any payment of interim dividends against the amount of the mandatory distributable amount for the year in which the interim dividends were paid.

Before any allocation of dividends is made, 5% of adjusted net income is allocated in accordance with Brazilian Corporate Law and our by-laws to the legal reserve, subject to the limits established in Brazilian Corporate Law. Our shareholders will be entitled to receive as mandatory dividend 25% of the adjusted net income for the fiscal year, in accordance with Article 202 of Brazilian Corporate Law, except in a year in which our management has informed the annual shareholders’ meeting that such payment is incompatible with our financial condition, in which case such retained amount shall be allocated to a special reserve and distributed as soon as our financial condition permits unless it is absorbed by subsequent losses.

Dividends are allocated to preferred shares as follows: (i) class A and class B preferred shares have the same priority in the distribution, in each fiscal year, of non-cumulative dividends corresponding to 6% of their unit value (as defined below); (ii) common shares are entitled to dividends only after payment of the priority dividend referred to in item (i) above; (iii) only common shares and class A preferred shares participate in the distribution of shares resulting from the incorporation of reserves into capital; and (iv) the “unit value” of shares is calculated by dividing the capital by the total outstanding shares (considering, for such effect, the total shares issued by the Company, including shares held in treasury).

The value of the priority dividend is calculated for the purposes of the mandatory dividend, but it is not limited by it, in accordance with Article 203 of Brazilian Corporate Law. Therefore, the priority dividend must be paid in full even if it is greater than the mandatory dividend, being limited only by the amount of net profit eligible for distribution.

After payment of the priority dividend, if there is any remaining dividend to be distributed (mandatory and/or complementary), the remaining amount of the dividend will be allocated successively as follows: (i) upon payment to the common shares of a dividend up to the limit of the priority dividend, i.e., upon payment to each common share of up to 6% of the unit value (as defined above) of the shares; and (ii) if there is still an amount remaining, upon payment to the common shares and class A preferred shares, under equal condition, so that each common share or class A preferred share receives the same dividend. Class B preferred shares do not participate in the distribution of remaining amounts after payment of the priority dividend.

 
 

The annual shareholders meeting is responsible for considering and voting on the allocation of the Company’s net profit for the year, determined annually based on the audited financial statements, which must be held within the four months following the end of the fiscal year, based on proposal of our management. The Company may, as decided by the board of directors, declare interim dividends, as described above, subject to certain conditions established in section 5.2 of our dividend policy, as referred to above, including the requirement that a proposal for complementary dividend distribution must take into account the impact of such distribution on the net debt/EBITDA ratio of the Company measured in U.S. dollars and that such ratio, after any distribution, may not be greater than 2.5 times in the year of the distribution and in the two subsequent years, based on long- term projections of the Company, considering the risks of theses projection being lower. Without prejudice to the aforementioned, the net debt/EBITDA ratio may remain temporarily above 2.5 times during a period in which the Company is making strategic investments that create value for shareholders and there is an expectation of generating future cash flow that contributes to this leverage ratio returning to a level not greater than 2.5 times. In this scenario, the management of the Company will not make a proposal for complementary distributions.

The Company also may, by decision of the board of directors, pay interest on capital payable to its shareholders, in accordance with Article 9, paragraph 7, of Brazilian Law No. 9,249/95 and the pertinent legislation.

Unless decided otherwise at the shareholders’ meeting, the interim dividends and interest on capital payable (the latter based on the amount net of withholding income tax) are calculated towards the priority dividend and the mandatory dividend.

Pursuant to the Brazilian Corporate Law, dividend entitlements lapse after three years from the date their payment was due.

Calculation of Adjusted Net Income

At each annual shareholders’ meeting, our board of directors is required to recommend how to allocate our net profits for the preceding fiscal year, which recommendation our board of executive officers initially submits to our board of directors for approval. This allocation is subject to approval by our common shareholders. The Brazilian Corporate Law defines “net profits” for any fiscal year as our net income for that fiscal year, net of any accumulated losses from prior fiscal years and any amounts allocated to employees’ participation in our net profits in that fiscal year. Under the Brazilian Corporate Law, our adjusted net income available for distribution is equal to our net profits in any fiscal year, reduced by amounts allocated to our legal reserve and other applicable reserves, and increased by any reversals of reserves that we constituted in prior years.

Dividend Preference of Preferred Shares

Under our by-laws, our preferred shareholders are entitled to a Minimum Preferred Dividend, equal to 6% of the unit value (as defined above) of such shares, before dividends may be paid to our common shareholders. Distributions of dividends in any year are made:

·first, to the holders of preferred shares, up to the amount of the Minimum Preferred Dividend for such year;
·then, to the holders of common shares, until the amount distributed in respect of each common share is equal to the amount distributed in respect of each preferred share; and
·thereafter, to the holders of our common shares and our class A preferred shares on a pro rata basis.

Our class B preferred shareholders are not entitled to receive any additional dividend amounts after they have received the Minimum Preferred Dividend. If the Minimum Preferred Dividend is not paid for a period

 
 

of three years, holders of preferred shares will be entitled to full voting rights until the Minimum Preferred Dividend is paid.

Mandatory Distributions

As permitted by the Brazilian Corporate Law, our by-laws specify that no less than 25% of our adjusted net income for each fiscal year must be distributed to shareholders as dividends or interest attributable to shareholders’ equity. We refer to this amount as the mandatory distributable amount.

Under the Brazilian Corporate Law, the amount by which the mandatory distributable amount exceeds the “realized” portion of net income for any particular year may be allocated to the unrealized profit reserve, and the mandatory distribution may be limited to the “realized” portion of net income. The “realized” portion of net income is the amount by which our net income exceeds the sum of (1) our net positive results, if any, from the equity method of accounting for earnings and losses of our subsidiaries and certain associated companies, and (2) the profits, gains or income obtained on transactions maturing after the end of the following fiscal year. As amounts allocated to the unrealized profit reserve are realized in subsequent years, and if not absorbed by subsequent losses, such amounts must be added to the dividend payment relating to the year of realization.

The Brazilian Corporate Law permits us to suspend the mandatory distribution if our board of directors reports to our annual shareholders’ meeting that the distribution would be incompatible with our financial condition at that time, provided that this does not affect the payment of the Minimum Preferred Dividend. Our fiscal council must opine on any suspension of the mandatory distribution. In addition, our management must report the reasons of any suspension of the mandatory distribution to the CVM. We must allocate net profits not distributed by us as a result of a suspension to a special reserve and, if not absorbed by subsequent losses, we must distribute these amounts as soon as our financial condition permits. In case our profits reserves, as defined in the Brazilian Corporate Law, exceed our share capital, the excess must be credited to shareholders’ equity or used for the payment of distributions.

Interest Attributable to Shareholders’ Equity

Brazilian companies, including us, are permitted to pay interest attributable to shareholders’ equity as an alternative form of payment of dividends to their shareholders. These payments may be deducted when calculating Brazilian income tax and social contribution tax. The interest rate applied to these distributions generally cannot exceed the long-term interest rate (Taxa de Juros de Longo Prazo – TJLP) for the applicable period. The amount of interest paid that we can deduct for tax purposes cannot exceed the greater of:

·50% of our net income (after the deduction of the provision for social contribution tax and before the deduction of the provision for corporate income tax) before taking into account any such distribution for the period for which the payment is made; and
·50% of the sum of our retained earnings and profit reserves.

Any payment of interest attributable to shareholders’ equity to holders of common shares, preferred shares or American Depositary Shares (“ADSs”), whether or not they are Brazilian residents, is subject to Brazilian withholding tax at the rate of 15%, except that a 25% withholding tax rate applies if the recipient is a resident of a tax haven jurisdiction. A tax haven jurisdiction is a country (i) that does not impose income tax or whose income tax rate is lower than 20% or (ii) which does not permit disclosure of the identity of shareholders of entities organized under its jurisdiction. Under our by-laws, we may include the amount distributed as interest attributable to shareholders’ equity, net of any withholding tax, as part of the mandatory distributable amount.

 
 

Public Tender Offer upon Sale of Control

Pursuant to our by-laws, all of our shares are entitled to tag along rights equivalent to 100% of the price paid in the event of a change of control, subject to certain exceptions set forth in article 12 of our by-laws. Notwithstanding the provisions of our by-laws, pursuant to the Brazilian Corporate Law, our common shares are entitled to tag along rights equivalent to at least 80% of the price paid for such common shares in the event of a change of control.

Shareholders’ Meetings

Under the Brazilian Corporate Law and our by-laws, we must hold an annual shareholders’ meeting by April 30 of each year in order to:

·approve or reject the management financial plan (prestação de contas) and financial statements approved by our board of directors and prepared by the board of executive officers;
·approve or reject the allocation of net profits and distribution of dividends;
·elect members of our board of directors (upon expiration of their two-year term) and members of our fiscal council, subject to the right of minority shareholders to elect members of our board of directors and our fiscal council; and
·approve or reject the annual aggregate compensation of our executive officers and directors, as well as the compensation of the members of the Company’s fiscal council.

In addition to the annual shareholders’ meetings, holders of our common shares have the power to determine any matters related to changes in our corporate purposes and to pass any resolutions they deem necessary to protect and enhance our development whenever our interests so require, by means of extraordinary shareholders’ meetings.

Under the Brazilian Corporate Law, the holders of our common shares have the power, among other powers, to vote at shareholders’ meetings to:

·amend our by-laws;
·approve any capital increase in excess of the amount of our authorized capital;
·approve any capital reduction;
·accept or reject the valuation of assets contributed by any of our shareholders in exchange for the issuance of our share capital;
·suspend the rights of any of our shareholders in default of their obligations established by law or by our by-laws;
·authorize the issuance of convertible debentures, in excess of the amount of our authorized capital;
·approve any reorganization of our legal form or any merger, consolidation or spin-off involving us;
·authorize our dissolution and liquidation, the election and dismissal of liquidators appointed in connection with any dissolution or liquidation of our Company, and the examination of the liquidators’ accounts;
·participate in a centralized group of companies (as defined under the Brazilian Corporate Law);
 
 
·approve the aggregate compensation payable to our directors and executive officers;
·authorize management to declare us insolvent or bankrupt and to request judicial reorganization (recuperação judicial) (a procedure involving our protection from our creditors similar in many respects to a reorganization under the U.S. bankruptcy code);
·elect and substitute members of our board of directors and fiscal council;
·modify the number of members on our board of directors;
·alter our dividend policy; and
·authorize the delisting of our shares.

We convene our shareholders’ meetings, including our annual shareholders’ meeting, by publishing a notice in a newspaper designated by our shareholders with general circulation in Bahia, where we maintain our registered office. Recently enacted rules have made publication requirements more flexible and less onerous. As a general rule, on the first call of any meeting, the notice must be published no fewer than three times, beginning at least 21 calendar days prior to the scheduled meeting date. Due to certain remote voting requirements, we convene our annual shareholders’ meetings at least 30 days prior to the scheduled meeting date. The notice must contain the meeting’s place, date, time, agenda and, in the case of a proposed amendment to our by-laws, a description of the subject matter of the proposed amendment.

In order for a valid action to be taken at a shareholders’ meeting, shareholders representing at least 25% of our issued and outstanding voting share capital must be present on first call. However, shareholders representing at least two-thirds of our issued and outstanding voting share capital must be present at a shareholders’ meeting called to amend our by-laws. If a quorum is not present, our board of directors may issue a second call by publishing a notice as described above at least eight calendar days prior to the scheduled meeting. The quorum requirements do not apply to a meeting held on the second call, and the shareholders’ meetings may be convened with the presence of shareholders representing any number of shares (subject to the voting requirements for certain matters described below). A shareholder without a right to vote may attend a shareholders’ meeting and take part in the discussion of matters submitted for consideration.

Voting Rights

Under the Brazilian Corporate Law and our by-laws, each of our common shares entitles its holder to one vote at our shareholders’ meetings. Our preferred shares generally do not confer voting rights, except under certain limited circumstances. Whenever the shares of any class of share capital are entitled to vote, each share is entitled to one vote.

Holders of our preferred shares are not entitled to vote on any matter, except (i) with respect to the election of one member of our board of directors by (1) preferred shareholders holding at least 10% of our total share capital, or, (2) if no group of common or preferred shareholders meets the thresholds described above, shareholders holding at least 10% of our total share capital, and (ii) in the limited circumstances described above and as provided below. Preferred shareholders are also entitled to appoint one member of the fiscal council and the respective alternate.

The Brazilian Corporate Law and our by-laws provide that our preferred shares will acquire unrestricted voting rights after the third consecutive fiscal year that we fail to pay the minimum dividends to which our preferred shares are entitled. This voting right will continue until the Minimum Preferred Dividend is paid in full. Our preferred shareholders will also obtain unrestricted voting rights if we enter into a liquidation process.

 
 

Liquidation

We may be liquidated in accordance with the provisions of Brazilian law. In the event of our extrajudicial liquidation, a shareholders’ meeting will determine the manner of our liquidation, appoint our liquidator and our fiscal council that will function during the liquidation period.

Upon our liquidation, our preferred shares have a liquidation preference over our common shares in respect of the distribution of our net assets. In the event of our liquidation, the assets available for distribution to our shareholders would be distributed first to our preferred shareholders in an amount equal to their pro rata share of our legal capital, prior to making any distributions to our common shareholders. If the assets to be so distributed are insufficient to fully compensate our preferred shareholders for their legal capital, each of our preferred shareholders would receive a pro rata amount (based on their pro rata share of our legal capital, excluding our common shares in such calculation) of any assets available for distribution.

Preemptive Rights

Under the Brazilian Corporate Law, each of our common and class A preferred shareholders has a general preemptive right to subscribe for our shares or securities convertible into our shares in any capital increase, in proportion to the number of our shares held by such shareholder. In accordance with the applicable legislation and our by-laws, the holders of class B preferred shares (which are special shares paid up with resources provided for in certain tax incentive legislation) do not have preemptive rights in case of capital increases resulting from capitalization of profits or reserves (bonus shares). In the event of a capital increase that would maintain or increase the proportion of our capital represented by our class A preferred shares, holders of our class A preferred shares would have preemptive rights to subscribe to newly issued class A preferred shares only. In the event of a capital increase that would reduce the proportion of our capital represented by our class A preferred shares, holders of such preferred shares would have preemptive rights to subscribe to any new class A preferred shares in proportion to the number of our shares that they hold, and to our common shares only to the extent necessary to prevent dilution of their interests in our total capital.

Under our by-laws, except when issuing voting shares or securities convertible into voting shares, our board of directors or our shareholders, as the case may be, may decide to reduce the term of preemptive rights or not to extend preemptive rights to our shareholders with respect to any issuance of our non-voting shares, debentures convertible into our shares or warrants made in connection with a public exchange made to acquire control of another company or in connection with a public offering or through a stock exchange. The preemptive rights are transferable and must be exercised within a period of at least 30 days following the publication of notice of the issuance of shares or securities convertible into our shares. Holders of ADSs may not be able to exercise the preemptive rights relating to our class A preferred shares underlying their ADSs unless a registration statement under the U.S. Securities Act of 1933, as amended (the “Securities Act”), is effective with respect to those rights and the securities to which the rights relate or an exemption from the registration requirements of the Securities Act is available. We are not obligated to file a registration statement with respect to the shares relating to these preemptive rights or to take any other action to make preemptive rights available to holders of the ADSs, and we may not file any such registration statement.

Redemption, Amortization and Tender Offers

Our by-laws or our shareholders at a shareholders’ meeting may authorize us to use our profits or reserves to redeem or amortize our shares in accordance with conditions and procedures established for such redemption or amortization. The Brazilian Corporate Law defines “redemption” (resgate de ações) as the payment of the value of the shares in order to permanently remove such shares from circulation, with or without a corresponding reduction of our share capital. The Brazilian Corporate Law defines “amortization” (amortização) as the distribution to shareholders, without a corresponding capital reduction, of amounts that they would otherwise receive if we were liquidated. If an amortization distribution has been paid prior to our liquidation, then upon our liquidation, the shareholders who did not receive an amortization distribution will have a preference equal to the amount of the amortization distribution in the distribution of our capital.

 
 

The Brazilian Corporate Law authorizes us, by means of a decision made at our shareholders’ meeting, to redeem shares not held by our controlling shareholder, if, after a tender offer effected as a consequence of delisting, our controlling shareholder increases its participation in our total share capital to more than 95%. The redemption price in such case would be the same price paid for our shares in any such tender offer.

Rights of Withdrawal

The Brazilian Corporate Law provides that, in certain limited circumstances, a dissenting shareholder may withdraw its equity interest from our Company and be reimbursed by us for the book value of our common or preferred shares that it then holds.

This right of withdrawal may be exercised by the holders of the adversely affected common or preferred shares if we decide:

·to create a new class of our preferred shares with greater privileges than the existing classes of our preferred shares;
·to increase an existing class of our preferred shares relative to the other classes of our preferred shares (unless such actions are provided for or authorized by our by-laws); or
·to modify a preference, privilege or condition of redemption or amortization conferred on one or more classes of our preferred shares.

In addition, holders of our common and preferred shares may exercise their right of withdrawal if we decide to undertake any of the following actions:

·to merge with another company or to consolidate with another company in a transaction in which our Company is not the surviving entity;
·to transfer all of our shares to another company or to acquire all of the shares of another company in exchange for their or our shares (“incorporação de ações”);
·to participate in a centralized group of companies as defined under the Brazilian Corporate Law;
·to reduce the mandatory distribution of dividends;
·to change our corporate purposes; or
·to spin-off a portion of our Company.

Only shareholders who own shares on the date of publication of the first notice convening the relevant shareholders’ meeting or the press release concerning the relevant shareholders’ meeting is published, whichever is earlier, will be entitled to withdrawal rights.

Shareholders will not be entitled to this right of withdrawal if the shares of the entity resulting from a merger, incorporation, consolidation of our Company or participation of our Company in a group of companies have a minimum level of market liquidity and are dispersed among a sufficient number of shareholders. For this purpose, shares that are part of general indices representative of portfolios of securities traded in Brazil or abroad are considered liquid, and sufficient dispersion will exist if the controlling shareholder holds less than half of the class and type of the outstanding shares. In case of a spin-off, the right of withdrawal will only exist if there is a significant change in the corporate purpose or a reduction in the mandatory dividend.

The redemption of shares arising out of the exercise of any withdrawal rights would be made at book value per share, determined on the basis of their most recent audited balance sheet approved by our dissenting shareholders. However, if the shareholders’ meeting approving the action that gave rise to withdrawal rights occurred more than 60 days after the date of the most recent approved audited balance sheet, a shareholder may demand that its shares be valued on the basis of a balance sheet prepared specifically for this purpose. The right of withdrawal lapses 30 days after the date of publication of the minutes of the shareholders’ meeting that approved one of the matters described above. Our shareholders may reconsider any resolution giving rise to withdrawal rights within 10 days following the expiration date for such rights if we believe that the withdrawal of shares of dissenting shareholders would jeopardize our financial stability.

 
 

Shareholders’ Agreements

Braskem S.A. Shareholders’ Agreement

Novonor S.A. – Em Recuperação Judicial (“Novonor”), previously known as Odebrecht S.A.; NSP Investimentos S.A. (“NSP Inv.” together with Novonor, “Grupo Novonor”), previously known as OSP Investimentos S.A.; Petróleo Brasileiro S.A. – Petrobras (“Petrobras”); and Petrobras Química S.A. – Petroquisa (“Petroquisa”), with Braskem S.A. and BRK Investimentos Petroquímicos S.A. (“BRK”), as intervening parties, entered into a shareholders’ agreement (the “Braskem S.A. Shareholders’ Agreement”), effective February 8, 2010, which has a term of 35 years, as amended on September 21, 2018 and on December 15, 2021. The Braskem S.A. Shareholders’ Agreement superseded the shareholders’ agreement that formerly governed the relationship between Petrobras, Petroquisa, Novonor and Nordeste Química S.A. regarding our shares.

Under the Braskem S.A. Shareholders’ Agreement, for so long as Petrobras owns a direct or indirect stake in us:

·six members of our board of directors and their alternates shall be designated by Grupo Novonor; and (ii) four members of our board of directors and their alternates shall be designated by Petrobras for so long as Petrobras owns, directly or indirectly, an aggregate of 30% or more of our voting share capital;
·six members of our board of directors and their alternates shall be designated by Grupo Novonor; and (ii) three members of our board of directors and their alternates shall be designated by Petrobras for so long as Petrobras owns, directly or indirectly, an aggregate of 18%, but less than 30%, of our voting share capital;
·two members of our fiscal council and their alternates shall each be designated by Grupo Novonor and Petrobras, one of which will serve as president and be designated by Petrobras, for so long as Petrobras owns, directly or indirectly, an aggregate of 30% or more of our voting share capital; and
·two members of our fiscal council and their alternates shall be designated by Petrobras for so long as they own, directly or indirectly, an aggregate of 18%, but less than 30%, of our voting share capital and for so long as Grupo Novonor has the right to elect more than a majority of the members.

In any of the abovementioned events, for so long as Grupo Novonor owns, directly or indirectly, an aggregate of 50.1% of our voting share capital, the designation of at least the absolute majority of members of our board of directors shall always be secured.

Under the Braskem S.A. Shareholders’ Agreement, Grupo Novonor is entitled to elect the chairman of the board of directors, and Petrobras, as long as it holds a direct and indirect stake in excess of 18% of our voting share capital, is entitled to elect the vice president of our board of directors.

Under the Braskem S.A. Shareholders’ Agreement, Grupo Novonor is entitled to nominate our chief executive officer, and the parties to it shall make the members of the board of directors appointed by them vote to ratify the appointment made by Grupo Novonor. Our chief executive officer must choose our chief financial officer from among three nominees submitted by Grupo Novonor and the executive officer responsible for our investment and portfolio area from among three nominees submitted by Petrobras, whereas Grupo Novonor and Petrobras shall cause the members of the board of directors appointed by them to vote so as to ratify the choices made by the chief executive officer. Our chief executive officer has the power to nominate the other members of our board of executive officers. After being submitted to the People and Organization Committee for review and after these nominations, the officers will be elected at a board of directors’ meeting.

 
 

Under the Braskem S.A. Shareholders’ Agreement, the simple majority of the members of the board of directors has the power to approve our business plan. However, for so long as Petrobras owns, directly or indirectly, an aggregate of less than 30% and more than 18% of our voting share capital, we are prohibited from taking certain strategic actions unless a consensus regarding those actions is reached between Grupo Novonor and Petrobras, including, among others:

·actions affecting our share capitalization or the rights of holders of our shares;
·mergers, spin-offs or similar transactions;
·investments and purchases of non-current assets with a value in excess of 30% of our non-current assets;
·dispositions of non-current assets with a value in excess of 10% of our non-current assets;
·creation of liens on our non-current assets with a value in excess of the lesser of R$350 million and 20% of our non-current assets; and
·actions that would result in our violating specified financial covenants.

Under the Braskem S.A. Shareholders’ Agreement, we have agreed that investments that we make to increase our capacity in petrochemical inputs, resins and other products must be supported by an evaluation demonstrating profitability under standards such as net present value or internal rate of return. Each of the parties to it has granted a right of first refusal to us with respect to the development of any petrochemical project that such parties propose to pursue. In the event that we decide not to participate in any such proposed project, each of such parties has agreed that we will have the right to market the products produced by the proposed project on conditions satisfactory to us and such parties.

On December 15, 2021, Novonor, NSP Inv. and Petrobras entered into a second amendment to the Braskem S.A. Shareholders’ Agreement and agreed that, if Braskem’s migration to the Novo Mercado segment of the São Paulo Stock Exchange (Brasil, Bolsa, Balcão, or the “B3”) is not implemented, the rights and obligations provided for in the Braskem S.A. Shareholders’ Agreement related to the right of first refusal granted to us with respect to the development of any petrochemical project shall lapse by October 31, 2024.

Under the Braskem S.A. Shareholders’ Agreement, each party to it has the right to sell a pro rata portion of its common shares of us in connection with any direct or indirect sale of our common shares by the other party to a third party.

Under the Braskem S.A. Shareholders’ Agreement, each of the parties to it has agreed:

·subject to certain exceptions, not to grant any liens on any of its Braskem shares held by each of them; to grant a right of first refusal and tag along rights to the other parties to the Braskem S.A. Shareholders’ Agreement with respect to any sale of its Braskem shares;
 
 
·in the event that a party’s interest in our voting share capital is diluted in a transaction involving one or more of the other parties to the Braskem S.A. Shareholders’ Agreement, the diluted party will have the right, but not the obligation, to purchase shares of Braskem from the diluting parties in an amount that would, after giving effect to such purchase, result in the diluted party holding the same percentage interest in our voting share capital that it held immediately prior to the dilution event; and
·in the event that any party acquires or receives a right to acquire common shares of Braskem from a third party, to offer to sell to the other parties to the Braskem S.A. Shareholders’ Agreement an amount of common shares of Braskem that would, after giving effect to such sale, result in each of such parties to the Braskem S.A. Shareholders’ Agreement holding the same direct and/or indirect proportion of the common shares of Braskem that such parties held prior to the acquisition of common shares of Braskem from the third party.

Disclosures of Share Ownership

Brazilian regulations require that (i) our controlling shareholder, directly or indirectly, (ii) shareholders who have elected members of our board of directors or fiscal council, and (iii) any person or group of persons representing a person that has directly or indirectly acquired or sold an interest that exceeds upwards or downwards, the threshold of 5%, 10%, 15%, and so on, of any class or type of shares of our capital stock to disclose its or their share ownership or divestment to the CVM and to the B3.

Form and Transfer

Our preferred shares and common shares are held in book-entry form, registered in the name of each shareholder or its nominee. The transfer of our shares is governed by Article 35 of the Brazilian Corporate Law, which provides that a transfer of shares is effected by our transfer agent, Banco Itaú S.A., by an entry made by the transfer agent in its books, upon presentation of valid written share transfer instructions to us by a transferor or its representative. When preferred shares or common shares are acquired or sold on a Brazilian stock exchange, the transfer is effected on the records of our transfer agent by a representative of a brokerage firm or the stock exchange’s clearing system. The transfer agent also performs all the services of safe-keeping of our shares. Transfers of our shares by a non-Brazilian investor are made in the same manner and are executed on the investor’s behalf by the investor’s local agent. If the original investment was registered with the Brazilian Central Bank pursuant to foreign investment regulations, the non-Brazilian investor is also required to amend, if necessary, through its local agent, the electronic certificate of registration to reflect the new ownership.

The B3 operates a central clearing system. A holder of our shares may choose, at its discretion, to participate in this system, and all shares that such shareholder elects to be put into the clearing system are deposited in custody with the clearing and settlement chamber of the B3 (through a Brazilian institution that is duly authorized to operate by the Brazilian Central Bank and maintains a clearing account with the clearing and settlement chamber of the B3). Shares subject to the custody of the clearing and settlement chamber of the B3 are noted as such in our registry of shareholders. Each participating shareholder will, in turn, be registered in the register of the clearing and settlement chamber of the B3 and will be treated in the same manner as shareholders registered in our books.

Regulation of Foreign Investments

Trading on the B3 by a holder not deemed to be domiciled in Brazil for Brazilian tax and regulatory purposes (a “non-Brazilian holder”) is subject to certain limitations under Brazilian foreign investment regulations. With limited exceptions, non-Brazilian holders may trade on the B3 only in accordance with the requirements of Resolution No. 4,373 of the Brazilian National Monetary Council. Resolution No. 4,373 requires that securities held by non-Brazilian holders be maintained in the custody of, or in deposit accounts with, financial institutions that are authorized by the Brazilian Central Bank and the CVM. In addition, Resolution No. 4,373 requires non-Brazilian holders to restrict their securities trading to transactions on the B3 or qualified over-the-counter markets. With limited exceptions, non-Brazilian holders may not transfer the ownership of investments made under Resolution No. 4,373 to other non-Brazilian holders through private transactions.

 
 

Exchange Controls

There are no restrictions on ownership or voting of our capital stock by individuals or legal entities domiciled outside Brazil. However, the right to convert dividend payments, interest on shareholders’ equity payments and proceeds from the sale of our share capital into foreign currency and to remit such amounts outside Brazil is subject to exchange control procedures under foreign investment legislation and foreign exchange regulations, which generally require, among other things, the registration of the relevant investment with the Brazilian Central Bank and/or the CVM, as the case may be.

Investments in our class A preferred shares by (i) a holder not deemed to be domiciled in Brazil for Brazilian tax purposes, (ii) a non-Brazilian holder who is registered with the CVM under Annex I of Resolution No. 4,373 or (iii) the Depositary (as defined herein), are eligible for registration with the Brazilian Central Bank. This registration (the amount so registered is referred to as registered capital) allows the remittance outside Brazil of foreign currency, converted at the commercial market rate, acquired with the proceeds of distributions on, and amounts realized through, dispositions of our class A preferred shares.

B. Description of American Depositary Shares

General

The following description of our ADSs is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the amended and restated deposit agreement (the “Deposit Agreement”) dated January 4, 2017 among Braskem S.A., The Bank of New York Mellon (the “Depositary”), as depositary, and the holders from time to time of ADSs issued thereunder, including the form of American Depositary Receipts (“ADRs”).

American Depositary Shares

The Bank of New York Mellon, as Depositary, will register and deliver ADSs. Each ADS will represent two class A preferred shares, which are referred to in this section as “shares” (or a right to receive two shares) deposited with Itaú Unibanco S.A., as custodian for the Depositary in Brazil. Each ADS will also represent any other securities, cash or other property that may be held by the Depositary. The deposited shares together with any other securities, cash or other property held by the Depositary are referred to as the deposited securities. The Depositary’s office at which the ADSs will be administered and its principal executive office are located at 240 Greenwich Street, New York, New York 10286.

You may hold ADSs either (A) directly (i) by having an ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (ii) by having uncertificated ADSs registered in your name, or (B) indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in The Depository Trust Company (“DTC”). If you hold ADSs directly, you are a registered ADS holder (an “ADS holder”). This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are. Registered holders of uncertificated ADSs will receive statements from the Depositary confirming their holdings.

As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Brazilian law governs shareholder rights. The Depositary will be the holder of the shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. The Deposit Agreement among us, the Depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the Depositary. New York law governs the Deposit Agreement and the ADSs.

 
 

The following is a summary of the material provisions of the Deposit Agreement. For more complete information, you should read the entire Deposit Agreement and the form of ADR. Directions on how to obtain copies of those documents are provided in the section “Where You Can Find More Information” in this annual report.

Dividends and Other Distributions

How will you receive dividends and other distributions on the shares?

The Depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.

 
 

 

Cash

 

The Depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. Any cash distribution will be net of any expenses of conversion into U.S. dollars and will be without regard to any distinctions among ADS holders because of exchange restrictions, the date of delivery of any ADSs or otherwise. If that is not possible or if any government approval is needed and cannot be obtained, the Deposit Agreement allows the Depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.

Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See the section “Item 10. Additional Information—Taxation” in our annual report. The Depositary will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the Depositary cannot convert the foreign currency, you may lose some of the value of the distribution.

 

Shares

The Depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The Depositary will only distribute whole ADSs. It will sell shares which would require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way as it does with cash. If the Depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares. The Depositary may sell a portion of the distributed shares (or ADSs representing those shares) sufficient to pay its fees and expenses in connection with that distribution.

 

Rights to purchase additional shares

If we offer holders of our securities any rights to subscribe for additional shares or any other rights, the Depositary may (i) make these rights available to ADS holders and, upon their instruction, exercise those rights on behalf of ADS holders, (ii) distribute those rights to ADS holders or (iii) sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the Depositary does not do any of those things, it will allow the rights to lapse. In that case, you will receive no value for them. The Depositary will exercise or distribute rights only if we ask it to and provide satisfactory assurances to the Depositary that it is legal to do so. If the Depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case of shares, new ADSs representing the new shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the Depositary. U.S. securities laws may restrict the ability of the Depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

 

Other distributions

The Depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the Depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash, or it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the Depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The Depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the Depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

 

 
 

The Depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.

Deposit, Withdrawal and Cancellation

How are ADSs issued?

The Depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the Depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit.

How can ADS holders withdraw the deposited securities?

You may surrender your ADSs to the Depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the Depositary will deliver the shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the Depositary will deliver the deposited securities at its office, if feasible. However, the Depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other security. The Depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities.

How do ADS holders interchange between certificated ADSs and uncertificated ADSs?

You may surrender your ADR to the Depositary for the purpose of exchanging your ADR for uncertificated ADSs. The Depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the Depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the Depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs.

Voting Rights

How do you vote?

In any situation where holders of shares have a right to vote, ADS holders may instruct the Depositary how to vote the number of deposited shares their ADSs represent. If we request the Depositary to solicit your voting instructions (and we are not required to do so), the Depositary will notify you of a shareholders’ meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the Depositary how to vote. For instructions to be valid, they must reach the Depositary by a date set by the Depositary. The Depositary will try, as far as practical, subject to the laws of Brazil and the provisions of our articles of association or similar documents, to vote or to have its agents vote the shares or other deposited securities as instructed by ADS holders. If we do not request the Depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the Depositary may try to vote as you instruct, but it is not required to do so.

Except by instructing the Depositary as described above, you won’t be able to exercise voting rights unless you surrender your ADSs and withdraw the shares. However, you may not know about the meeting enough in advance to withdraw the shares. In any event, the Depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed.

 
 

We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the Depositary to vote the shares represented by your ADSs. In addition, the Depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to exercise voting rights and there may be nothing you can do if the shares represented by your ADSs are not voted as you requested.

In order to give you a reasonable opportunity to instruct the Depositary as to the exercise of voting rights relating to Deposited Securities, if we request the Depositary to act, we agree to give the Depositary notice of any such meeting and details concerning the matters to be voted upon at least 30 days in advance of the meeting date.

Fees and Expenses

The Depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The Depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The Depositary may collect its annual fee for Depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The Depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

From time to time, the Depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and expenses for services provided to us by the Depositary or share revenue from the fees collected from ADS holders. In performing its duties under the Deposit Agreement, the Depositary may use brokers, dealers, foreign currency dealers or other service providers that are owned by or affiliated with the Depositary and that may earn or share fees, spreads or commissions.

The Depositary may convert currency itself or through any of its affiliates, or the custodian or we may convert currency and pay U.S. dollars to the Depositary. Where the Depositary converts currency itself or through any of its affiliates, the Depositary acts as principal for its own account and not as agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the currency conversion made under the Deposit Agreement and the rate that the Depositary or its affiliate receives when buying or selling foreign currency for its own account. The Depositary makes no representation that the exchange rate used or obtained by it or its affiliate in any currency conversion under the Deposit Agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the Depositary’s obligation to act without negligence or bad faith. The methodology used to determine exchange rates used in currency conversions made by the Depositary is available upon request. Where the custodian converts currency, the custodian has no obligation to obtain the most favorable rate that could be obtained at the time or to ensure that the method by which that rate will be determined will be the most favorable to ADS holders, and the Depositary makes no representation that the rate is the most favorable rate and will not be liable for any direct or indirect losses associated with the rate. In certain instances, the Depositary may receive dividends or other distributions from us in U.S. dollars that represent the proceeds of a conversion of foreign currency or translation from foreign currency at a rate that was obtained or determined by us and, in such cases, the Depositary will not engage in, or be responsible for, any foreign currency transactions and neither it nor we make any representation that the rate obtained or determined by us is the most favorable rate and neither it nor we will be liable for any direct or indirect losses associated with the rate.

 
 

Payment of Taxes

You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs. The Depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until those taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the Depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes.

Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities

The Depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do so by an ADS holder surrendering ADSs and subject to any conditions or procedures the Depositary may establish.

If deposited securities are redeemed for cash in a transaction that is mandatory for the Depositary as a holder of deposited securities, the Depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs.

If there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the Depositary receives new securities in exchange for or in lieu of the old deposited securities, the Depositary will hold those replacement securities as deposited securities under the Deposit Agreement. However, if the Depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the Depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs.

If there is a replacement of the deposited securities and the Depositary will continue to hold the replacement securities, the Depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADSs in exchange for new ADSs identifying the new deposited securities.

If there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently worthless, the Depositary may call for surrender of those ADSs or cancel those ADSs upon notice to the ADS holders.

Amendment and Termination

How may the Deposit Agreement be amended?

We may agree with the Depositary to amend the Deposit Agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the Depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30 days after the Depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the Deposit Agreement as amended.

How may the Deposit Agreement be terminated?

The Depositary will initiate termination of the Deposit Agreement if we instruct it to do so. The Depositary may initiate termination of the Deposit Agreement if:

·60 days have passed since the Depositary told us it wants to resign but a successor Depositary has not been appointed and accepted its appointment;
 
 
·we delist our shares from an exchange outside the United States on which they were listed and do not list the shares on another exchange outside the United States;
·the Depositary has reason to believe the ADSs have become, or will become, ineligible for registration on Form F-6 under the Securities Act;
·we appear to be insolvent or enter insolvency proceedings;
·all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities;
·all or substantially all of the deposited securities have been redeemed for cash or otherwise purchased for cash in a transaction that is mandatory and binding on the Depositary;
·there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or
·there has been a replacement of deposited securities.

If the Deposit Agreement will terminate, the Depositary will notify ADS holders at least 90 days before the termination date. At any time after the termination date, the Depositary may sell the deposited securities. After that, the Depositary will hold the money it received on the sale, as well as any other cash it is holding under the Deposit Agreement, unsegregated and without liability for interest, for the pro rata benefit of the ADS holders that have not surrendered their ADSs. Normally, the Depositary will sell as soon as practicable after the termination date.

After the termination date and before the Depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the Depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind that have not settled if it would interfere with the selling process. The Depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The Depositary will continue to collect distributions on deposited securities, but, after the termination date, the Depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the Deposit Agreement except as described in this paragraph.

Limitations on Obligations and Liability

Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs

The Deposit Agreement expressly limits our obligations and the obligations of the Depositary. It also limits our liability and the liability of the Depositary. We and the Depositary:

·are only obligated to take the actions specifically set forth in the Deposit Agreement without negligence or bad faith;
·are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its control from performing our or its obligations under the Deposit Agreement;
·are not liable if we or it exercises discretion permitted under the Deposit Agreement;
·are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the Deposit Agreement, or for any special, consequential or punitive damages for any breach of the terms of the Deposit Agreement;
 
 
·have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the Deposit Agreement on your behalf or on behalf of any other person;
·may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person;
·are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and
·the Depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs.

In the Deposit Agreement, we and the Depositary agree to indemnify each other under certain circumstances.

Requirements for Depositary Actions

Before the Depositary deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the Depositary may require: 

·payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;
·satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and
·compliance with regulations it may establish, from time to time, consistent with the Deposit Agreement, including presentation of transfer documents.

The Depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the Depositary or our transfer books are closed or at any time if the Depositary or we think it advisable to do so.

Your Right to Receive the Shares Underlying your ADSs

ADS holders have the right to cancel their ADSs and withdraw the underlying shares at any time except:

·when temporary delays arise because: (i) the Depositary has closed its transfer books or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders' meeting; or (iii) we are paying a dividend on our shares;
·when you owe money to pay fees, taxes and similar charges; or
·when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of shares or other deposited securities.

This right of withdrawal may not be limited by any other provision of the Deposit Agreement.

Direct Registration System

In the Deposit Agreement, all parties to the Deposit Agreement acknowledge that the Direct Registration System (“DRS”), and Profile Modification System (“Profile”), will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the Depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the Depositary of prior authorization from the ADS holder to register that transfer.

 
 

In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the Deposit Agreement understand that the Depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the Deposit Agreement, the parties agree that the Depositary’s reliance on and compliance with instructions received by the Depositary through the DRS/Profile system and in accordance with the Deposit Agreement will not constitute negligence or bad faith on the part of the Depositary.

Shareholder Communications; Inspection of Register of Holders of ADSs

The Depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The Depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.

Jury Trial Waiver

The Deposit Agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the Depositary arising out of or relating to our shares, the ADSs or the Deposit Agreement. If we or the Depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law.

You will not, by agreeing to the terms of the Deposit Agreement, be deemed to have waived our or the Depositary’s compliance with U.S. federal securities laws or the rules and regulations promulgated thereunder.

EX-12.1 3 ex12-1.htm EX-12.1

Exhibit 12.01

CERTIFICATION PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, Roberto Bischoff, certify that:

1. I have reviewed this annual report on Form 20-F of Braskem S.A.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 24, 2023.

 

   
  By: /s/ Roberto Bischoff
    Roberto Bischoff
Chief Executive Officer

 

 

 

 

EX-12.2 4 ex12-2.htm EX-12.2

Exhibit 12.02

CERTIFICATION PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, Pedro van Langendonck Teixeira de Freitas, certify that:

1. I have reviewed this annual report on Form 20-F of Braskem S.A.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 24, 2023.

 

   
  By: /s/ Pedro van Langendonck Teixeira de Freitas
    Pedro van Langendonck Teixeira de Freitas
Chief Financial Officer

 

EX-13.1 5 ex13-1.htm EX-13.1

Exhibit 13.01

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of Braskem S.A. (the “Company”), does hereby certify, to such officer’s knowledge, that:

The annual report on Form 20-F for the fiscal year ended December 31, 2022 (the “Form 20-F”) of the Company, as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 24, 2023.

 

   
  By: /s/ Roberto Bischoff
    Roberto Bischoff
Chief Executive Officer

 

   
  By: /s/ Pedro van Langendonck Teixeira de Freitas
    Pedro van Langendonck Teixeira de Freitas
Chief Financial Officer

EX-99.01 6 ex99-1.htm EX-99.01

Exhibit 99.01

DISCLOSURE OF MINE SAFETY AND

HEALTH ADMINISTRATION SAFETY DATA

We operated a salt mine located in our Alagoas Plants until May 2019, as discussed in “Item 4. Information on the Company—Reportable Segments—Raw Materials of the Vinyls Operations that are Part of our Brazil Segment—Salt” of our annual report. This mine used a system of wells for salt extraction and did not expose any workers to the interior of the mine. Because the mine is located in Brazil, it is not, and none of our mining operations are, subject to the Mine Safety and Health Administration, or MSHA, regulation under the Federal Mine Safety and Health Act of 1977, or the Mine Act. Also, during the 2022 fiscal year, none of our mining operations received written notice from MSHA of (i) a violation under section 104 of the Mine Act or unwarrantable failure of the mine operator to comply with section 104(d) of the Mine Act; (ii) a flagrant violation under section 110(b)(2) of the Mine Act; (iii) an imminent danger order under section 107(a) of the Mine Act; (iv) a proposed assessment under the Mining Act or (v) a pattern of violations of mandatory health or safety standards that are of such nature as could have significantly and substantially contributed to the cause and effect of our mine health or safety hazards under section 104(e) of the Mine Act or the potential to have such a pattern.

For the 2022 fiscal year, we experienced no mining-related fatalities nor were we involved in any pending legal action before the Federal Mine Safety and Health Review Commission involving our mine or our mining operations.

Braskem’s mining operations in the State of Alagoas held an environmental license issued by the State’s environmental protection agency valid through March 31, 2022, and are grounded in mining law formalized by the Mining Concession awarded by the Federal Government of Brazil. In view of the summarized report issued by the Mineral Resources Research Company (CPRM), an agency of the Brazilian Ministry of Mines and Energy, on May 8, 2019, we voluntarily suspended the salt extraction activities at the wells that were the object of the environmental licenses on such date. On May 9, 2019, we received two separate orders to cease operations issued by the Institute for the Environment of the State of Alagoas (IMA), a state-level environmental regulatory agency, and the National Mining Agency (ANM), the Brazilian federal regulatory and oversight agency for mining activities, both of which we complied with.

GRAPHIC 7 bak20f_001.jpg GRAPHIC begin 644 bak20f_001.jpg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end GRAPHIC 8 bakform20f2022_001.jpg GRAPHIC begin 644 bakform20f2022_001.jpg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�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end EX-101.SCH 9 bak-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Statement of consolidated financial position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Statement of consolidated profit or loss link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statement of consolidated comprehensive income link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statement of changes in equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statement of consolidated cash flow link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of preparation of the financial statements link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Application of estimates and judgments link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Risk management link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Cash and cash equivalents link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Financial investments link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Trade accounts receivable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Related parties link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Taxes recoverable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Property, plant and equipment link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Intangible assets link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Right-of-use assets and lease liability link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Trade payables link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Braskem Idesa Borrowings link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Debentures link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Financial instruments link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Taxes payable link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Sundry provisions link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Provisions for legal proceedings and contingent liabilities link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Leniency agreement with authorities link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Geological event - Alagoas link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Benefits offered to employees link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Earnings (loss) per share link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Net revenue link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Tax incentives link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Expenses by nature and function link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Financial results link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Segment information link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Contractual obligations link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Subsequent events link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Basis of preparation of the financial statements (Policies) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Basis of preparation of the financial statements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Risk management (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Cash and cash equivalents (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Financial investments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Trade accounts receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Related parties (Tables) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Taxes recoverable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Property, plant and equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Intangible assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Right-of-use assets and lease liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Trade payables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Braskem Idesa Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Debentures (Tables) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Tables) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Financial instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Taxes payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Income taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Sundry provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Provisions for legal proceedings and contingent liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Leniency agreement with authorities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Geological event - Alagoas (Tables) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - Benefits offered to employees (Tables) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - Earnings (loss) per share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - Net revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - Expenses by nature and function (Tables) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - Financial results (Tables) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - Segment information (Tables) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - Basis of preparation of the financial statements (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - Basis of preparation of the financial statements (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - Risk management (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - Cash and cash equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - Financial investments (Details) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - Financial investments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - Trade accounts receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - Trade accounts receivable (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - Trade accounts receivable (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - Inventories (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - Related parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - Related parties (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - Related parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - Taxes recoverable (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - Taxes recoverable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - Investments (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - Investments (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - Property plant and equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - Property plant and equipment (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - Property plant and equipment (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - Property, plant and equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000099 - Disclosure - Intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000100 - Disclosure - Intangible assets (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000101 - Disclosure - Intangible assets (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000102 - Disclosure - Intangible assets (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000103 - Disclosure - Intangible assets (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000104 - Disclosure - Intangible assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000105 - Disclosure - Right-of-use assets and lease liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000106 - Disclosure - Right-of-use assets and lease liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000107 - Disclosure - Right-of-use assets and lease liability (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000108 - Disclosure - Right-of-use assets and lease liability (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000109 - Disclosure - Right-of-use assets and lease liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000110 - Disclosure - Trade payables (Details) link:presentationLink link:calculationLink link:definitionLink 00000111 - Disclosure - Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 00000112 - Disclosure - Borrowings (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000113 - Disclosure - Borrowings (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000114 - Disclosure - Borrowings (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000115 - Disclosure - Borrowings (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000116 - Disclosure - Braskem Idesa Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 00000117 - Disclosure - Braskem Idesa Borrowings (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000118 - Disclosure - Braskem Idesa Borrowings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000119 - Disclosure - Debentures (Details) link:presentationLink link:calculationLink link:definitionLink 00000120 - Disclosure - Debentures (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000121 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Details) link:presentationLink link:calculationLink link:definitionLink 00000122 - Disclosure - Financial instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000123 - Disclosure - Financial instruments (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000124 - Disclosure - Financial instruments (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000125 - Disclosure - Financial instruments (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000126 - Disclosure - Financial instruments (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000127 - Disclosure - Financial instruments (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000128 - Disclosure - Financial instruments (Details 6) link:presentationLink link:calculationLink link:definitionLink 00000129 - Disclosure - Financial instruments (Details 7) link:presentationLink link:calculationLink link:definitionLink 00000130 - Disclosure - Financial instruments (Details 8) link:presentationLink link:calculationLink link:definitionLink 00000131 - Disclosure - Financial instruments (Details 9) link:presentationLink link:calculationLink link:definitionLink 00000132 - Disclosure - Financial instruments (Details 10) link:presentationLink link:calculationLink link:definitionLink 00000133 - Disclosure - Financial instruments (Details 11) link:presentationLink link:calculationLink link:definitionLink 00000134 - Disclosure - Financial instruments (Details 12) link:presentationLink link:calculationLink link:definitionLink 00000135 - Disclosure - Financial instruments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000136 - Disclosure - Taxes payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000137 - Disclosure - Income taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000138 - Disclosure - Income taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000139 - Disclosure - Income taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000140 - Disclosure - Income taxes (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000141 - Disclosure - Income taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000142 - Disclosure - Sundry provisions (Details) link:presentationLink link:calculationLink link:definitionLink 00000143 - Disclosure - Sundry provisions (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000144 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000145 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000146 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000147 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000148 - Disclosure - Leniency agreement with authorities (Details) link:presentationLink link:calculationLink link:definitionLink 00000149 - Disclosure - Leniency agreement with authorities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000150 - Disclosure - Geological event - Alagoas (Details) link:presentationLink link:calculationLink link:definitionLink 00000151 - Disclosure - Geological event - Alagoas (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000152 - Disclosure - Benefits offered to team members (Details) link:presentationLink link:calculationLink link:definitionLink 00000153 - Disclosure - Benefits offered to team members (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000154 - Disclosure - Benefits offered to team members (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000155 - Disclosure - Benefits offered to team members (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000156 - Disclosure - Benefits offered to team members (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000157 - Disclosure - Benefits offered to team members (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000158 - Disclosure - Benefits offered to team members (Details 6) link:presentationLink link:calculationLink link:definitionLink 00000159 - Disclosure - Benefits offered to team members (Details 7) link:presentationLink link:calculationLink link:definitionLink 00000160 - Disclosure - Benefits offered to employees (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000161 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000162 - Disclosure - Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000163 - Disclosure - Equity (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000164 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000165 - Disclosure - Earnings per share (Details) link:presentationLink link:calculationLink link:definitionLink 00000166 - Disclosure - Net revenue (Details) link:presentationLink link:calculationLink link:definitionLink 00000167 - Disclosure - Net revenue (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000168 - Disclosure - Net revenue (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000169 - Disclosure - Net revenue (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000170 - Disclosure - Tax incentives (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000171 - Disclosure - Expenses by nature and function (Details) link:presentationLink link:calculationLink link:definitionLink 00000172 - Disclosure - Financial results (Details) link:presentationLink link:calculationLink link:definitionLink 00000173 - Disclosure - Financial results (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000174 - Disclosure - Segment information (Details) link:presentationLink link:calculationLink link:definitionLink 00000175 - Disclosure - Segment information (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000176 - Disclosure - Contractual obligations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000177 - Disclosure - Subsequent events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 bak-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 bak-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 12 bak-20221231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Classes of ordinary shares [axis] Class A Preference Shares [Member] Class B Preference Shares [Member] Common shares member Class A Preferred Shares [Member] Class B Preferred Shares [Member] Components of equity [axis] Issued capital [member] Capital reserve [member] Statutory reserve [member] Tax Incentive [Member] Retention Of Profits [Member] Additional Dividends Proposed [Member] Additional paid-in capital [member] Long Term Incentive Plans [Member] Accumulated other comprehensive income [member] Treasury shares [member] Retained earnings [member] Equity attributable to owners of parent [member] Non-controlling interests [member] Subsidiaries [axis] Odebrecht s a member Braskem Idesa [Member] Braskem Idesa One [Member] Subsidiary1 member Subsidiary2 member Subsidiary3 member Subsidiary4 member Subsidiary5 member Subsidiary6 member Subsidiary7 member Subsidiary8 member Subsidiary9 member Subsidiary 10 [Member] Subsidiary101 member Subsidiary11 member Subsidiary12 member Subsidiary13 member Subsidiary14 member Subsidiary15 member Subsidiary16 member Subsidiary17 member Subsidiary18 member Subsidiary19 member Subsidiary20 member Subsidiary21 member Subsidiary22 member Subsidiary 23 [Member] Subsidiary 24 [Member] Subsidiary 25 [Member] Subsidiary 26 [Member] Subsidiary 27 [Member] Subsidiary 28 [Member] Subsidiary 29 [Member] Subsidiary 30 [Member] Specific purpose entity1 member Specific purpose entity2 member Braskem alemanha member B m insurance braskem america braskem america finance braskem holanda braskem holanda finance braskem holanda inc and braskem mexico sofom member Braskem idesa braskem idesa servicos braskem mexico and braskem mexico servicos member Braskem argentina member Braskem chile member Braskem india member Carrying Amount [Axis] Carrying Amount One [Member] Types of risks [axis] Liquidity risk [member] Maturity [axis] Not later than one year [member] Later than one year and not later than two years [member] Categories of financial liabilities [axis] Early paymentdebt member Later than two years and not later than five years [member] Geographical areas [axis] Domestic market member Foreign market member Measurement [axis] Financial assets at amortised cost, class [member] Types of financial assets [axis] Time deposit investments member Financial assets at fair value through profit or loss, category [member] L f t and l f member Restricted funds investments member Other financial investments member Types of interest rates [axis] Interbank deposit rate member Categories of related parties [axis] Third parties member Related party member Not past due member Trade Accounts Receivables [Member] Expected Credit Losses [Member] Not later than ninety days member Later than ninety days and not later than one hundred and eighty days member Later than one hundred and eighty days member Petrobras and subsidiaries [member] Other related parties [member] Odebrecht and subsidiaries and associates [member] Related parties [member] New or renewedagreements with related companies member Range [axis] Top of range [member] Novonor And Its Direct And Indirect Subsidiaries [Member] Petrobras Transporte S A [Member] Petrocoque S A Industria Comercio [Member] Refinaria Alberto Pasqualini [Member] Agreement With Petrocoque [Member] Refinaria Duque De Caxias [Member] Refinaria Henrique Lage [Member] Refinaria Planaltode Paulinia [Member] Refinaria Presidente Getulio Vargas [Member] Classes of assets [axis] Value added tax on sales and services i c m s normal pperations member Parent companys member I c m s credits from property plant and equipment member Social integration program p i s and social contribution on revenue member P i s and c o f i n s credits from property plant and equipment member R e i n t e g r a program member Federal supervenience member Other taxes recoverable member Value added tax i v a member Subsidiaries [Member] P i s and c o f i n s taxes member Associates [axis] Investment1 member Investment 2 [Member] Associate member Associate 1 [Member] Associate 2 [Member] Associate 3 [Member] Associate 4 [Member] Consolidated and separate financial statements [axis] Consolidated Braskem Without The Effect Of Braskem Idesa Consolidated [Member] Braskem Idesa Consolidated [Member] Eliminations [Member] Total [Member] Classes of property, plant and equipment [axis] Projects and stoppage in progress [member] Buildings [member] Machinery and facilities [member] Fixtures and fittings [member] It equipment member Lab equipment member Security equipment member Vehicles [member] Other [member] Land [member] Brazil [member] Mexico [member] United states of america [member] Germany [member] Netherland [Member] Classes of intangible assets and goodwill [axis] Goodwill based on expected future profitability member Brand names [member] Computer software [member] Customer-related intangible assets [member] Segments [axis] Northeastern petrochemical complex member Southern petrochemical complex member Vinyls unity member Brands And Patents [Member] Bottom of range [member] Software Licenses And Rights Of Use [Member] Customers And Suppliers Agreements [Member] Rail cars member Machinery and equipments member Ships [member] Buildings and constructions member Computer equipment [member] Service concession arrangements [axis] Uninitiated lease arrangements [member] Later than two years and not later than three years [member] Later than three years and not later than four years [member] Later than four years and not later than five years [member] Later than five years [member] Later Than Five Years And Not Later Than Six Years [Member] Later Than Six Years And Not Later Than Seven Years [Member] Counterparties [axis] Third parties forfait member Related partie member Related partie forfait member Currency [Axis] Foreign currency member Borrowings by name [axis] Bond member Export prepayment member Other borrowings member Transactions costs member Local currency member Agribusiness Credit Notes [Member] B N D E S [Member] Export credit notes1 member Other Fixed Interest Loans [Member] Other Variable Interest Loans [Member] Twenty Twenty Three [Member] Twenty Twenty Four [Member] Twenty Twenty Five [Member] Twenty Twenty Six [Member] Twenty Twenty Sevan [Member] Twenty Twenty Eight [Member] Twenty Twenty Nine [Member] Twenty Thirty [Member] Twenty Thirty One [Member] Thirty Three And Thereafter [Member] Bonds1 member Bonds2 member Bonds3 member Bonds4 member Bonds5 member Bonds6 member Bonds7 member Other n e x i1 member Other n e x i2 member Other n e x i3 member Other N E X I 4 [Member] Other N E X I 5 [Member] Other N E X I 6 [Member] Other N E X I 7 [Member] Other N E X I 8 [Member] Foreign currency three member Other C R A 1 [Member] Other C R A 2 [Member] Bond i i member Twenty Twenty Two [Member] Debentures member Debentures1 member Debentures 2 [Member] Debentures 3 [Member] Debentures 4 [Member] Debentures 5 [Member] Debentures 6 [Member] Debentures 7 [Member] Twenty Twenty Thirty [Member] Twenty Twenty Thirty One [Member] Twenty Twenty Thirty Two [Member] Borrowing [Member] Borrowings And Debentures [Member] Braskem Idesa Financing [Member] Shareholders Of Braskem Idesa [Member] Lease [Member] Dividends [Member] Loan to non controlling shareholders of braskem idesa member Categories of financial assets [axis] Cash and cash equivalent member Classes of financial assets [axis] Cash and banks member Financial assets at amortised cost, category [member] Levels of fair value hierarchy [axis] Level 2 of fair value hierarchy [member] Financial investments member Letras financeiras do tesouro l f t member Trade payables member Types of financial liabilities [axis] Financial liabilities at amortised cost, category [member] Classes of financial liabilities [axis] Foreign Currency Bond [Member] Level 1 of fair value hierarchy [member] Braskem idesa borrowings member Loan to noncontrolling shareholder of braskem idesa member Leniency agreement member Hedged items [axis] Braksem America Swap C 3 P G P [Member] Types of hedges [axis] Non hedge accounting transactions member Braskem Holanda Swap Nafta Gasolina [Member] Braskem Argentina Exchange Swap [Member] Braskem S A Dollar Call And Put Options [Member] Hedge accounting transactions member Braskem S A Dollar Swap C D I [Member] Braskem S A Swap C R A [Member] Put options member Call options member Future exports member Future Exports One [Member] Swaps C R A [Member] Swaps C R A 1 [Member] Derivatives [member] U S D [Member] Later than five years and not later than ten years [member] Later than five years and not later than seven years [member] Later Than Eight Years And Not Later Than Nine Years [Member] Later than seven years and not later than ten years [member] Later Than Ten Years 1 [Member] Later than ten years and not later than fifteen years [member] United States of America, Dollars Hedging instruments [axis] First Quarter [Member] Second Quarter [Member] Third Quarter [Member] Fourth Quarter [Member] Exchange variation member I r and c s l member Later than fifteen years and not later than twenty years [member] Later than twenty years and not later than twenty-five years [member] Later Than Thirty Years And Not Later Than Thirtyfive Years [Member] Later Than Fourty Years And Not Later Than Fourtyfive Years [Member] Minimum risk member Low risk member Moderate risk member High risk member Very high risk member External credit grades [axis] A a a member A a plus member A a member A a minus member A plus member A member A minus member B b b plus member B b b member B b b minus member B b plus member B b member B B Minus [Member] Shares Of Investment Funds [Member] Other Financial Asset [Member] Classes of financial instruments [axis] Brazilian real u s dollar exchange rate member Export prepayments member Investment [Member] Sace member Dollar call and put options member Dollar swap c d i member M o n f o r t e member Nexi member Financial investments abroad member Dollar Swap I P C A [Member] Libor floating interest rate member Outros [Member] C d i interest rate member Financial investments in brazil member I p c a interest rate member B n b f i n e p f u n d e s f i n i s a f i n a m e f n e member C R A [Member] Selic interest rate member Export Credit Notes [Member] Classes of liabilities [axis] I p i member Domestic member I c m s member P i s and c o f i n s member Value added tax member Other countries member Subsidiary one member Subsidiary two member Subsidiary three member Subsidiary four member Subsidiary five member Subsidiary six member Subsidiary seven member Assets and liabilities [axis] Tax losses i r and negative base c s l member Asset member Goodwill amortized member Exchange variations member Temporary adjustment member Business combination member Tax credits member Amortization of fair value adjustments on the assets from the acquisiton of quattor member Liabilities category member Tax depreciation member Exclusion of i c m s in basis of calculation member Present value adjustment and amortized cost member Amortization of fair value adjustments on the assets from the acquisiton of braskem qpar member Net member Braskem s a member Braskem america member Braskem holanda member Braskem idesa servicos member Braskem Mexico Servicos [Member] Braskem Mexico [Member] Cetrel member D a c member Terminal Quimica [Member] Voqen [Member] B T C [Member] Classes of other provisions [axis] Recovery of environmental damage member Provision for customers rebates member Rebate member Litigation cases [axis] Labor claims member Tax claims member Type of claim [axis] Type of operation [axis] Normal operation member Other tax claims member Type of oeration [axis] Corporate claims member Civil claims and other member Income Tax Authority One [Axis] Tax Claims I C M S [Member] Classes of contingent liabilities [axis] Tax contingent liability [member] Business combinations [axis] I r p j and c s l l foreign earned income member P i s and c o f i n s sundry member I r r f i r and c s l commission expenses member Isolated fine failure to ratify d c o m p s member Social security contributions member P i s and c o f i n s d cide fuels tax offset member Civil claims resale of solvents member Environmental member Social security member I r p j c s l l negative balance offset member Tax claims net member Corporate claim member Civil claims one member Civil claims two member Environmental claims member Social security claims member Other lawsuits member Federal prosecution office and u s swiss authorities member Contract duration [axis] Leniency agreements member Federal controller general and attorney generall agreement member Department of justice member Swiss office member Federal prosecution office member Securities and exchange commission member Alagoas member Alagoas state federal prosecution office member Technical cooperation agreement member Defined benefit plans [axis] Health care benefits member Private pension benefits member Transport benefits member Feeding benefits member Life insurance benefits member Training benefits member Other benefits member Plan 2019 [Member] Settlement [Axis] Settlement Methodology Shares [Member] Settlement Methodology Cash [Member] Plan 2020 [Member] Plan 2021 [Member] Plan 2022 [Member] Defined benefit member Novamont braskem america member Braskem alemanha and braskem holanda member Health care plan member Bradesco saude member Health insurance member Benefit plans member United state of america member Netherlands [member] Actuarial assumptions [axis] Actuarial assumption of discount rates [member] Actuarial assumption of expected rates of salary increases [member] Actuarial assumption of expected rates of pension increases [member] Actuarial assumption of life expectancy after retirement [member] Actuarial assumption of mortality rates [member] Novonor member Petrobras member Adrs member Other2 member Authorised [Member] L T I Program 2018 [Member] Profit Reserves [Member] Weighted average [member] United states member A r member D E [Member] C H [Member] I t member C l member N l member L u member S g member P e member J p member E s member G b member U y member P l member B o member S e member C a member F r member P y member C o member C n member K r member Products and services [axis] P e p p member Benzene toluene and xylene member Ethylene propylene member E t b e gasoline member P v c caustic soda e d c member Butadiene member Solvents member Cumene member Naphtha condensate and crude oil member Other1 member Major customers [axis] One client member Classification of expenses [axis] Nature member Type of expenses [axis] Raw materials other inputs member Personnel expenses member Outsourced services member Depreciation amortization and depletion member Freights member Costs of idle industrial plants member Provision geological event in alagoas member P i s and c o f i n s credits exclusion of i c m s from the calculation basis member Other Incomes [Member] Other General And Administrative Expenses [Member] Function member Cost of products sold member Selling and distribution member Loss reversals for impairment of trade accounts receivable member General and administrative member Research and development member Other income expenses net member Other expenses member Financial income expense [axis] Financial interest income member Monetary variations on tax credits member Gain On Derivatives [Member] Other financial income member Financial interest expenses member Monetary variations on fiscal debts member Discounts granted member Loans transaction costs member Adjustment to present value member Interest expense on leases member Losses on derivatives member Other financial expenses member Financial assets, class [member] Financial liabilities, class [member] Exchange variation effects [axis] U s dollar brazilian real member Euro brazilian real member Mexican peso brazilian real member U s dollar mexican peso member U s dollar euro member Segment consolidation items [axis] Reporting segments member U s a and europe member Other segments member Corporate unit member Braskem consolidated before eliminations and reclassifications member Eliminations and reclassifications member Unallocated member Energy agreement member Non-adjusting events after reporting period [axis] Events after reporting period member Legal Entity [Axis] Wise [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Contact Personnel Fax Number ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of financial position [abstract] Assets Current assets Cash and cash equivalents Financial investments Trade accounts receivable Inventories Taxes recoverable Recoverable income taxes Derivatives Other receivables Current Assets  Non-current assets Financial investments Trade accounts receivable Taxes recoverable Recoverable income taxes Deferred tax assets Judicial deposits  Derivatives Other receivables Investments Property, plant and equipment Intangible assets Right of use of assets Non-Current Assets  Total assets Liabilities and shareholders' equity Current liabilities Trade payables Borrowings Braskem Idesa borrowings Debentures Derivatives Payroll and related charges Taxes payable Income taxes payable Leniency agreement Sundry provisions Provision - geological event in Alagoas Lease Other payables Current Liabilities  Non-current liabilities Trade payables Borrowings Braskem Idesa borrowings Debentures Derivatives Taxes payable Loan from non-controlling shareholders of Braskem Idesa Deferred tax liabilities Post-employment benefits Legal provisions Leniency agreement Sundry provisions Provision - geological event in Alagoas Lease Other payables Non-Current Liabilities  Shareholders' equity Capital Capital reserve Profit reserves Additional paid in capital Long-term incentive plans Other comprehensive income Treasury shares Total attributable to the  Company's shareholders Non-controlling interest in subsidiaries Shareholders’ Equity  Total liabilities and shareholders' equity Earnings per share [table] IfrsStatementLineItems [Line Items] Net revenue Cost of products sold Gross profit Income (expenses)  Selling and distribution Loss  for impairment of trade accounts receivable and others from clients General and administrative  Research and development Results from equity-accounted investees Other income Other expenses Profit (loss) before net financial expenses and taxes Financial results Financial expenses  Financial income Exchange rate variations, net Finance income (cost)  Profit (loss) before income tax Income taxes (Loss) net profit for the year Attributable to: Company's shareholders Non-controlling interest in subsidiaries Earnings (loss) per share - R$ Earnings (loss) per share - basic Earnings (loss) per share - diluted Profit or loss [abstract] (Loss) net profit for the year Other comprehensive income: Items that will be reclassified subsequently to profit or loss Fair value of cash flow hedge, net of taxes Fair value of cash flow hedge from jointly-controlled, net of taxes Cash flow hedges,net of tax  Exchange variation of foreign sales hedge, net of taxes Sales Hedge - transfer to profit or loss, net of taxes Exchange variation of foreign sales hedge - Braskem Idesa, net of taxes Sales Hedge - transfer to profit or loss - Braskem Idesa, net of taxes Sales hedges, net of tax  Foreign subsidiaries currency translation adjustment Total Item that will not be reclassified to profito or loss Actuarial gain (loss) with post-employment benefits, net of taxes Total Total comprehensive income for the year Attributable to: Company's shareholders Non-controlling interest in subsidiaries Statement of changes in equity [table] As of December 31, 2021 Comprehensive income for the year: Net profit (loss) for the year Exchange variation of foreign sales hedge, net of taxes Fair value of cash flow hedge, net of taxes Actuarial gain on defined benefit and health plan, net of taxes Total Comprehensive income for the period  Realization of additional property, plant and equipment price-level restatement, net of taxes Realization of deemed cost of jointly-controlled investment, net of taxes Long term incentive plan Fair value adjustments of trade accounts receivable, net of taxes Exchange variation in hyperinflationary economy, net of taxes Long term incentive plan, net of taxes Other Comprehensive income  Contributions and distributions to shareholders: Dividends-lapse of statute of limitation Dividends Additional dividends of subsidiary Absorption of losses Gain on transfer of shares in custody long term incentive plan  Total Contributions to shareholders Equity valuation adjustments: Equity valuation adjustments Incentive long term plan payments with treasury shares SUDENE tax incentive supplement Non-controlling interest in acquired entity Legal reserve Tax incentive reserve Retention of profits Additional proposed dividends Fair value of financial transactions of non-controlling subsidiaries Additional dividends approved in the board meeting Absorption of losses Proposed dividends As of December 31, 2022 Statement of cash flows [abstract] Profit (loss) before income taxes Adjustments for reconciliation of profit Depreciation and amortization Results from equity-accounted investees Interest foreign exchange gain/losses Provisions, net Provision - geological event in Alagoas PIS and Cofins credits - exclusion of ICMS from the calculation basis Loss for impairment of trade accounts receivable and others from clients Write-offs of long-lived assets Adjustments for reconciliation of profit  Changes in operating working capital Judicial deposits - unfreezing (blocking) Public Civil Action Financial investments Trade accounts receivable Inventories  Taxes recoverable Other receivables Trade payables Taxes payable Leniency agreement Sundry provisions Geological event in Alagoas Other payables Cash generated from operations Interest paid Income taxes Net cash generated from operating activities Proceeds from the sale of fixed and intangible assets Dividends received Acquisition of subsidiary Acquisition of other investments Acquisitions to property, plant and equipment and intangible assets Net cash used in investing activities Short-term and Long-term debt Acquired Payments Braskem Idesa borrowings Acquired Payments Loan payment to non-controlling shareholders of Braskem Idesa Lease Dividends paid Non-controlling interest in subsidiaries Other financial liabilities Net cash generated (used) in financing activities Exchange variation on cash of foreign subsidiaries Increase (decrease) in cash and cash equivalents Represented by Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year Increase (decrease) in cash and cash equivalents Operations Operations Basis Of Preparation Of Financial Statements Basis of preparation of the financial statements Application Of Estimates And Judgments Application of estimates and judgments Risk Management Risk management Cash and cash equivalents [abstract] Cash and cash equivalents Financial Investments Financial investments Trade Accounts Receivable Trade accounts receivable Inventories Inventories Related Parties Related parties Taxes Recoverable Taxes recoverable Investments Investments Property, plant and equipment [abstract] Property, plant and equipment Intangible Assets Intangible assets Right-of-use Assets And Lease Liability Right-of-use assets and lease liability Trade Payables Trade payables Borrowings [abstract] Borrowings Braskem Idesa Borrowings Debentures Debentures Reconciliation Of Borrowing Activities In Statement Of Cash Flow Reconciliation of borrowing activities in the statement of cash flow Financial Instruments Financial instruments Taxes Payable Taxes payable Income Taxes Income taxes Sundry Provisions Sundry provisions Provisions For Legal Proceedings And Contingent Liabilities Provisions for legal proceedings and contingent liabilities Leniency Agreement With Authorities Leniency agreement with authorities Geological Event - Alagoas Geological event - Alagoas Benefits Offered To Employees Benefits offered to employees Equity [abstract] Equity Earnings Loss Per Share Earnings (loss) per share Net Revenue Net revenue Tax Incentives Tax incentives Expenses By Nature And Function Expenses by nature and function Financial Results Financial results Segment Information Segment information Contractual Obligations Contractual obligations Subsequent Events Subsequent events Basis of accounting Basis of presentation Basis of consolidation Functional and foreign currency New standards or amendments for the current fiscal year and future requirements Impacts from Russia-Ukraine conflict Schedule of consolidated financial statements Schedule of subsidiaries with a functional currency Schedule of financial liabilities by maturity Schedule of cash and cash equivalents Schedule of financial investments Schedule of trade accounts receivable Schedule of trade accounts receivable by maturity Schedule of changes in allowance for doubtful accounts Schedule of inventory Schedule of provision for inventories Schedule of related party transactions Schedule of key management personnel Schedule of taxes recoverable Schedule of Information on investments Schedule of Changes in investments Schedule of financial information of the subsidiary in which the non-controlling shareholder holds interests Schedule of estimated useful lives Schedule of reconciliation of carrying amount Schedule of property plant and equipment by country Schedule of changes in intangible assets Schedule of goodwill impairment testing [custom:ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity] Schedule of amortization estimated useful life Schedule of intangible assets by country Schedule of changes in right-of-use assets Schedule of changes in lease liabilities Schedule of payment schedule by maturity Schedule of cash flows related to the contracts Schedule or trade account payables Schedule of borrowings Schedule of long-term maturities Schedule of bonds Schedule of others Schedule of others - CRA Schedule of braskem idesa financing Schedule of long-term maturities of these financing Schedule of debentures Schedule of long-term debenture maturity Schedule of reconciliation of borrowing activities in the statement of cash flow Schedule of non-derivative financial instruments and other liabilities Schedule of changes in derivative financial instruments Schedule of Fair Value Adjustment Schedule of non-derivative financial liabilities designated to hedge accounting Schedule of financial instruments designated for hedge Schedule of exchange variation Schedule of changes in foreign exchange variation and income tax and social contribution Schedule of designated and unrealized sales Schedule of exchange variation - Braskem Idesa Schedule of changes in foreign exchange variation and income tax and social contribution - Braskem Idesa Schedule of trade accounts receivable by credit ratings Schedule of financial assets with and without risk assessment The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario Schedule of taxes payable Schedule of income tax and social contribution reconciliation Schedule of changes in balances of deferred tax assets and liabilities Schedule of changes in balances of deferred tax assets and liabilities Schedule of deferred taxes offset for the purpose of presentation in the balance sheet Schedule of sundry provisions Schedule of changes in sundry provisions Claims with probable chance of loss and contingent liabilities Schedule of changes in claims with probable chance of loss Schedule of claims with probable chance of loss Schedule of Company already has paid distributed as shown below: Schedule of following table shows the changes in the provision in the period Schedule of short-term benefits Schedule of Long-term incentive plan Schedule of defined benefit obligations Change in obligations Change in fair value plan assets Amounts recognized in profit and loss Schedule of Actuarial assumptions Sensitivity analysis Schedule of shares distributed Schedule of Changes in shares during the year Schedule of Accumulated losses Schedule of reconciliation of profit or loss Schedule of sales and service revenue Schedule of revenue by country Schedule of revenue by product Schedule of Expenses by nature and function Schedule of results by segment Schedule of effects from exchange variation on the Company?transactions are mainly due to the variations Schedule of Results by segment Schedule of property, plant and equipment and intangible assets by segment Disclosure of subsidiaries [table] Proportion of ownership interest Proportion of voting rights Number of barrels Made payment Subsidiary/Special Purpose Entity name Headquarters Total voting interest Functional currency Disclosure of risk management strategy related to hedge accounting [table] Trade payables Borrowings Debentures Braskem Idesa borrowings Derivatives Loan to noncontrolling shareholders Leniency agreement (Note 25) Lease Total Disclosure of disaggregation of revenue from contracts with customers [table] Cash Cash equivalents Total Disclosure of fair value measurement of assets [table] Total Current assets Non current assets Restricted fund Bank deposits Deposits yields rate Disclosure of transactions between related parties [table] Trade accounts receivable, gross Expected credit losses Total Current assets Non-current assets Trade accounts receivable, Total Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Total Balance of provision at the beginning of the year Provision in the year Reversal in the year Write-offs Balance of provision at the end of the year Finished goods Semi-finished goods Raw materials, production inputs and packaging Maintenance materials Advances to suppliers Imports in transit Total  Balance at the beginner of the year Additions Utilization/reversals Balance at the end of the year Trade accounts receivable Inventories Dividends and interest on capital Other receivabels Other receivabels non current Assets Assets1 Trade and other current payables1 Other current payables Other current payables1 Trade payables Loan to non-controlling shareholders of Braskem Idesa Total liabilities Sales of products Sales of products Purchases of raw materials, finished goods services and utilities Purchases of raw materials, finished goods services and utilities Financial income (expenses), net Finance income cost1 General and administrative expenses Other expenses Other operating income expense1 Short-term benefits Post-employment benefit Long term incentive plan Total Related parties amount Estimated amount Related parties estimated value Receivables from taxes other than income tax Current receivables from taxes other than income tax Non-current receivables from taxes other than income tax Taxes recoverable Disclosure of associates [table] Equity Interest in total and voting capital (%) Balance at 2021 Dividends and interest on equity Equity in results of investees Other comprehensive income Other Capital increase Balance at 2022 IfrsStatementTable [Table] Curent Total current assets  Non-current Recoverable income taxes Deferred tax assets Related parties Derivatives Judicial deposits  Investments Intangible Total non current assets  Total assets Current Debentures Braskem Idesa Borrowings Payroll and related charges Income taxes payable Other payables  Total current liabilities Non-current Loan agreements Braskem Idesa Borrowings Debentures Accounts payable to related parties Deferred tax liabilities Provision for losses on subsidiaries Provision - geological event in Alagoas  Total non current liabilities Attributable to the  Company's shareholders Total shareholders equity  Total liabilities and shareholders' equity Gross profit Selling and distribution (Loss) reversals for impairment of trade accounts receivable Results from equity-accounted investees Other expenses Operating profit Finance income (cost) (Loss) profit before income tax  and social contribution Income taxes (Loss) net profit for the year (Loss) profit before taxes Adjustments for reconciliation of profit (loss)                   Changes in operating working capital                              Cash generated from operations     Net cash generated by operating activities Proceeds from the sale of fixed assets and intangible assets Additions to investment in subsidiaries Net cash used in investing activities Short-term and long-term debt         Related parts Loan to non-controlling shareholders of Braskem Idesa - payment Lease Cash generated (used) in financing activities Increase in cash and cash equivalents     Disclosure of detailed information about property, plant and equipment [table] Estimates useful lives Cost Accumulated depreciation Beginning balance Acquisitions Capitalized financial charges Cost Depreciation Transfers by concluded projects Transfers to inventory Transfers to intangible Cost Depreciation Depreciation and amortization Transfers to "non-current assets held for sale" Disposals property plant and equipment transfer others Net book value Additions through acquisition of ER Plastics Ending balance Description of property, plant and equipment shutdowns duration Depreciation rate, property, plant and equipment Acquisition of property, plant and equipment with payment installments Disclosure of reconciliation of changes in intangible assets and goodwill [table] Cost Accumulated amortization Balance as of beginning Acquisitions Foreign currency translation adjustment Cost Amortization Transfers from property, plant and equipment projects and stoppage in progress Other write-offs net of amortization Amortization Balance as of end Additions through acquisition of ER Plastics Goodwill acquisition of ER Plastics Allocated goodwill Recoverable amount Book value Discount rate Discount rate Perpetuity Amortization estimated useful life Intangible assets Inflation rate for perpetuity Right-of-use assets, beginning balance Acquisitions Depreciation Disposal Foreign currency translation adjustment Right-of-use assets, Ending balance As of December 31 Acquired Additions through acquisition of ER Plastics Disposals Interests and monetary and exchange variations, net Currancy translation adjustments  Payments Interest paid As of December 31 Lease current liabilities Lease non current liabilities Lease liabilities Total Cash flows related to the contracts discounted Cash flows related to the contracts undiscounted Disclosure of detailed information about service concession arrangements [table] Low-value leases expense Contractual payments Weighted average incremental rate Non-cash investing and financing activity Commitments of lease agreement Disclosure of offsetting of financial assets [table] Trade account payables Trade account payables, current Trade account payables, current Disclosure of detailed information about borrowings [table] Description of borrowing interest rate Borrowings Current borrowings Non-current portion of non-current borrowings Borrowings, noncurrent Issue date Maturity Interest (% per year) Borrowings Borrowings, maturity Borrowings, interest rate basis Borrowings one Borrowings two Notional amount Maturity Borrowings interest rate basis Braskem idesa borrowings Non current braskem idesa borrowings3 Current braskem idesa borrowings Non current braskem idesa borrowings1 Original Long-Term Maturities Cash position equivalent Annual financial charges (%) Annual financial charges (%) Debentures Debentures Debentures, current Debentures, non current Debentures, noncurrent Beginning balance Proceeds from debt classified as financing activities Payments Cash used in financing activities Interest paid Interest and monetary and exchange variations, net Initial adoption of lease New contracts Disposal Additions through acquisition of ER Plastic Currency translation adjustments Other Total other changes Ending balance Borrowings current Debentures current Borrowings and debentures current financing current Lease current Dividends current Borrowings non current Debentures non current Borrowings and debentures non current financing non current Non-controlling shareholders non current Lease non current Borrowings total Debentures total Borrowings and debentures total Financing total Shareholders total Lease total Dividends total Disclosure of financial assets [table] Book value financial assets Fair value financial assets Fair value financial liabilities Book value financial liabilities Disclosure of detailed information about hedged items [table] Credit derivative, fair value at end of period Increase (decrease) in credit derivative, fair value Credit derivative financial settlement Current derivative financial assets Non-current derivative financial assets Derivative financial assets Current derivative financial liabilities Non-current derivative financial liabilities Derivative financial liabilities Derivative financial assets and liabilities Total nominal Interest rate per year Maturity date Fair value, net Financial liability maturities nominal value Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table] Designated balance, beginning Designations Exports designated for hedge nominal value Opening foreign exchange rate Closing foreign exchange rate Exports designated for hedge gross nominal value Disclosure of detailed information about hedges [table] Beginning balance Exchange variation recorded in the period on OCI / IR and CSL Exchange variation transferred to profit or loss / IR and CSL Ending balance Designated and unrealized sales nominal value Beginning balance Exchange variation recorded in the period / IR Exchange variation transferred to profit or loss / IR Ending balance Expected credit loss rate Disclosure of external credit grades [table] Financial assets with risk assessment domestic market Financial assets with risk assessment foreign market Financial assets with risk assessment Financial assets without risk assessment domestic market Financial assets without risk assessment foreign market Financial assets without risk assessment Financial assets domestic market Financial assets foreign market Financial assets Disclosure of detailed information about financial instruments [table] Exposure value Probable gain (loss) Reasonably possible gain (loss) Possible gain (loss) Notional amount Average export Designated Hedge accounting discontinued Hedge accounting discontinued Decription of fair value at risk Disclosure of fair value measurement of liabilities [table] Payables on social security and taxes other than income tax Current payables on social security and taxes other than income tax Non-current payables on social security and taxes other than income tax Profit (loss) before income taxes Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%) Permanent adjustments to income taxes calculation basis Income taxes on equity in results of investees Thin capitalization Tax benefits (Sudene and PAT) Reduction of tax loss Effect of the refund of Braskem America´s tax benefit Different jurisdictional taxes rates for companies abroad and tax basis Effect from the retrospective tax rate on bonus depreciation of Braskem America Taxes on dividends distribution Exclusion of inflation adjustement by Selic on undue tax payments from taxable income Other permanent adjustments Effect of income taxes on results of operations Breakdown of income taxes Current income taxes Current year Total current expenses  Deferred income taxes Origination and reversal of temporary differences Tax losses Total Deferred income taxes  Total Effective rate Headquarters country Official rate Disclosure of assets and liabilities with significant risk of material adjustment [table] Ending balance Ending balance Other comprehensive income Impact on the equity Deferred tax assets1 Deferred tax liabilities1 Tax calculation, assets IR and CSL offsetting, assets Balance, assets Tax calculation, liabilities IR and CSl offsetting, liabilites Balance, liabilities Income taxes current Income taxes noncurrent Taxes recoverable Payment of tax incentives Deferred tax credits Disclosure of other provisions [table] Sundry provisions, current Sundry provisions, current Sundry provisions, current Beginning balance Additions, monetary adjustments and exchange variation Write-offs through usage and payments Ending balance Contingencies Beginning balance Additions, inflation adjustments and exchange variation Payments Reversals Ending balance Claims with possible chance of loss Disclosure of contingent liabilities in business combination [table] IncomeTaxAuthorityOneAxis [Axis] Percentage fine for tax offense Amounts indicated in tax Provisions for fine for tax offense Amount of these claims Percentage amount of the tax deficiency notice Adjusted amount of uncertain tax treatment Adjusted value of cases Updated value of this proceeding amounted Adjusted amount of uncertain tax estimate Amount under discussion Claims with possible chance of loss Labor claims for health and security cases Other administrative proceedings Payment for indemnifiction Amount of provision for possibility of outflow of resources Amount evaluated as possible loss Possible amount chance to loss Settlement amount Settlement liabilities Outstanding amount Current liabilities Noncurrent liabilities Balance at beginning Balance at ending Additions Payments and reclassifications Realization of present value adjustment Balance at ending Current liability Non-current liability Provision Net of adjustment to present value Provision accrued amount Description of reparation for social-environmental Description of reparation for residents Lawsuit compensation Key management personnel compensation, share-based payment Description of individual actions Disclosure of defined benefit plans [table] Short-term benefits Disclosure of detailed information about business combination [table] SettlementAxis [Axis] Name of flat Date of grant End of grace period Settlement Method Granted quantities, shares Shares canceled Quantity of acquisition, shares Shares exercised Fair value of the share Fair value of the share, value Total obligations Fair value of plan assets Consolidated net balance (non-current liabilities) Balance at beginning of year Current service cost Interest cost Benefits paid Actuarial losses (gain) Exchange variation Balance at the end of the year Benefits Offered To Team Members Balance at beginning of year Actual return on plan assets Benefits paid Exchange variation Balance at the end of the year Actuarial losses Amounts recognized in profit and loss Discount rate Inflation rate Rate of increase in future salary levels Rate of increase in future pension plan Aging factor Medical inflation Duration Disclosure of sensitivity analysis for actuarial assumptions [table] Premise change Premise increase Premise reduction Life expectancy Premise change Percentage of reasonably possible increase in interest cost actuarial assumption Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption Fair value, net of taxes Sponsors expenses Participants expenses Shares outstanding Percent of shares outstanding Shares outstanding Changes in shares Loss for the year of the Companys shareholders SUDENE tax incentive supplement Comprehensive income Other Loss for allocation Profit reserves retention of profits Shares granted Profit (loss) for the year attributed to Company's shareholders Profit loss from continuing operations attributable diluted to owners of parent Distribution of priority dividends attributable to basic Distribution of priority dividends attributable to diluted Distribution of 6% ??ofunit price of common shares, basic Distribution of 6% ??ofunit price of common shares, diluted Distribution of excess profits, by class basic Distribution of excess profits, by class diluted Reconciliation of income available for distribution, by class (numerator), basic Reconciliation of income available for distribution, by class (numerator), diluted Weighted average number of shares, basic Weighted average shares diluted Profit (loss) per share, basic Profit (loss) per share, diluted Amount at beginning of the year Incentive long term plan payments with treasury shares Amount at the end of the year Amount at beginning of the year Conversion shares class "B" into shares class "A" Amount at the end of the year Amount at beginning of year Amount at the end of the year Net sales and services revenue Disclosure of major customers [table] Percentage of entity's revenue Percentage of tax reduction Realization period ICMS tax incentives ICMS tax incentives Expenses, by nature Finance income Finance costs Gains (losses) on exchange differences on translation of foreign operations, before tax Closing foreign exchange rate variations Average foreign exchange rate Average foreign exchange rate variations Disclosure of operating segments [table] Cost of products sold Selling, general and distribuition expenses Other operating income (expenses), net Operating profit (loss) Results from equity-accounted investee Property, plant and equipment and intangible assets Contractual capital commitments Disclosure of non-adjusting events after reporting period [table] Finance issued in bonds Interest rate Equity interest rate Considerations on share transaction Gains (losses) on litigation settlements The element represents class a preference shares member. The element represents class b preference shares member. The element represents non current recoverable income taxes. The element represents noncurrent leniency agreements. The element represents common shares member. The element represents gains losses on sales hedges before tax. The element represents noncontrolling interest reclassification adjustments on exchange differences on translation before tax. The element represents other comprehensive income net of tax sales hedges. The element represents changes in operating working capital abstract. The element represents realization of additional property plant and equipment pricelevel restatement net of taxes. The element represents realization of deemed cost of jointly controlled investment net of taxes. The element represents fair value adjustments of trade accounts receivable. The element represents exchange variation in hyperinflationary economy net of taxes. The element represents additional dividends of subsidiary. The element represents absorption of losses. The element represents gain on transfer of shares in custody long term incentive p lan. The element represents incentive long term plan payments with treasury shares. The element represents legal reserve. The element represents tax incentive reserve. The element represents retention of profits. The element represents additional proposed dividends. The element represents odebrecht s a member. The element represents number of barrels. The element represents subsidiary1 member. The element represents subsidiary2 member. The element represents subsidiary3 member. The element represents subsidiary4 member. The element represents subsidiary5 member. The element represents subsidiary6 member. The element represents subsidiary7 member. The element represents subsidiary8 member. The element represents subsidiary9 member. The element represents subsidiary101 member. The element represents subsidiary11 member. The element represents subsidiary12 member. The element represents subsidiary13 member. The element represents subsidiary14 member. The element represents subsidiary15 member. The element represents subsidiary16 member. The element represents subsidiary17 member. The element represents subsidiary18 member. The element represents subsidiary19 member. The element represents subsidiary20 member. The element represents subsidiary21 member. The element represents subsidiary22 member. The element represents specific purpose entity1 member. The element represents specific purpose entity2 member. The element represents braskem alemanha member. The element represents b m insurance braskem america braskem america finance braskem holanda braskem holanda finance braskem holanda inc and braskem mexico sofom member. The element represents braskem idesa braskem idesa servicos braskem mexico and braskem mexico servicos member. The element represents braskem argentina member. The element represents braskem chile member. The element represents braskem india member. The element represents trade payables. The element represents debentures. The element represents loan to noncontrolling shareholders. The element represents leniency agreements. The element represents early paymentdebt member. The element represents domestic market member. The element represents foreign market member. The element represents l f t and l f member. The element represents restricted funds investments member. The element represents other financial investments member. The element represents time deposit investments member. The element represents restricted fund. The element represents interbank deposit rate member. The element represents bank deposits. The element represents deposits yields rate. The element represents gross trade receivables. The element represents third parties member. The element represents related party member. The element represents expected credit losses. The element represents not past due member. The element represents not later than ninety days member. The element represents later than ninety days and not later than one hundred and eighty days member. The element represents later than one hundred and eighty days member. The element represents provision allowance accounts for credit losses of financial assets. The element represents provision for inventories. The element represents addition to inventories. The element represents reversal to inventories. The element represents provision for inventories end. The element represents other receivabels. The element represents odebrecht and subsidiaries and associates member. The element represents petrobras and subsidiaries member. The element represents other receivabels non current. The element represents current trade receivables1. The element represents inventories1. The element represents trade and other current payables1. The element represents other current payables1. The element represents assets1. The element represents cost of sales1. The element represents revenue1. The element represents finance income cost1. The element represents other operating income expense1. The element represents new or renewedagreements with related companies member. The element represents value added tax on sales and services i c m s normal pperations member. The element represents parent companys member. The element represents i c m s credits from property plant and equipment member. The element represents social integration program p i s and social contribution on revenue member. The element represents p i s and c o f i n s credits from property plant and equipment member. The element represents r e i n t e g r a program member. The element represents federal supervenience member. The element represents other taxes recoverable member. The element represents value added tax i v a member. The element represents p i s and c o f i n s taxes member. The element represents investment1 member. The element represents associate member. The element represents other1. The element represents capital increases. The element represents deferred tax assets non current. The element represents derivatives non current. The element represents judicial deposits non current. The element represents current notes and debentures issued and current portion of noncurrent notes and debentures issued1. The element represents current provisions for employee benefits1. The element represents loan agreements. The element represents braskem idesa borrowings non current. The element represents debentures noncurrent. The element represents provision geological event in alagoas non current. The element represents distribution costs1. The element represents estimated useful lives. The element represents machinery and facilities member. The element represents it equipment member. The element represents lab equipment member. The element represents security equipment member. The element represents other member. The element represents description of property plant and equipment shutdowns duration. The element represents financial charges capitalized. The element represents projects and stoppage in progress member. The element represents depreciation rate property plant and equipments. The element represents acquisition of property plant and equipment with payment installments. The element represents property plant and equipment cost value. The element represents property plant and equipment accumulated depreciation. The element represents increase decrease through net exchange differences property plant and equipment cost. The element represents increase decrease through net exchange differences property plant and equipment depletion. The element represents transfers to inventory. The element represents disposals property plant and equipment cost. The element represents disposals property plant and equipment depletion. The element represents transfers to noncurrent assets held for sale. The element represents disposals property plant and equipment transfer others. The element represents property plant and equipment net book value. The element represents mexico member. The element represents united states of america member. The element represents brazil member. The element represents germany member. The element represents goodwill based on expected future profitability member. The element represents increase decrease through net exchange differences intangible assets and goodwill cost. The element represents other increase decrease in intangible assets and goodwill amortization. The element represents allocated goodwill. The element represents northeastern petrochemical complex member. The element represents recoverable amount. The element represents book value. The element represents southern petrochemical complex member. The element represents vinyls unity member. The element represents sensitivity analysis discount rates. The element represents sensitivity analysis perpetuity one. The element represents intangible assets and goodwill1. The element represents rail cars member. The element represents acquisitions rightofuse assets. The element represents disposal of rightofuse assets. The element represents foreign currency translation adjustment rightofuse assets. The element represents machinery and equipments member. The element represents buildings and constructions member. The element represents weighted average incremental rate. The element represents acquired of lease liabilities. The element represents disposals of lease liabilities. The element represents interests and monetary and exchange variations net of lease liabilities. The element represents currancy translation adjustments of lease liabilities. The element represents payments of lease liabilities. The element represents lease current liabilities. The element represents lease non current liabilities. The element represents minimum annual commitments. The element represents commitments of lease agreement. The element represents type of agreement axis. The element represents uninitiated lease arrangements member. The element represents third parties forfait member. The element represents related partie member. The element represents related partie forfait member. The element represents description of borrowing interest rate. The element represents foreign currency member. The element represents bond member. The element represents export prepayment member. The element represents other borrowings member. The element represents transactions costs member. The element represents local currency member. The element represents export credit notes1 member. The element represents borrowings issue date. The element represents bonds1 member. The element represents borrowings maturity1. The element represents bonds2 member. The element represents bonds3 member. The element represents bonds4 member. The element represents bonds5 member. The element represents bonds6 member. The element represents bonds7 member. The element represents other n e x i1 member. The element represents other n e x i2 member. The element represents other n e x i3 member. The element represents borrowings one. The element represents borrowings two. The element represents foreign currency three member. The element represents bond i i member. The element represents braskem idesa borrowings. The element represents non current braskem idesa borrowings3. The element represents non current braskem idesa borrowings1. The element represents original longterm maturities. The element represents debentures member. The element represents debentures1 member. The element represents proceeds from debt classified as financing activities. The element represents repayments of debt classified as financing activities. The element represents debt cash flows from used in financing activities. The element represents interest and monetary and exchange variations net classified as financing activities. The element represents currency translation adjustments classified as financing activities. The element represents cash and cash equivalent member. The element represents cash and banks member. The element represents financial investments member. The element represents letras financeiras do tesouro l f t member. The element represents trade payables member. The element represents braskem idesa borrowings member. The element represents loan to noncontrolling shareholder of braskem idesa member. The element represents leniency agreement member. The element represents non hedge accounting transactions member. The element represents hedge accounting transactions member. The element represents credit derivative financial settlement. The element represents derivative financial assets and liabilities. The element represents future exports member. The element represents hedge instrument designations. The element represents exports designated for hedge nominal value. The element represents exports designated for hedge gross nominal value. The element represents exchange variation member. The element represents i r and c s l member. The element represents exchange variation recorded in period on oci ir and csl. The element represents exchange variation transferred to profit or loss ir and csl. The element represents hedged item liabilities1. The element represents minimum risk member. The element represents low risk member. The element represents moderate risk member. The element represents high risk member. The element represents very high risk member. The element represents dervative notional amount. The element represents put options member. The element represents call options member. The element represents initial adoption of lease. The element represents loan to non controlling shareholders of braskem idesa member. The element represents hedge accounting discontinued. The element represents other financial assets with risk assessment. The element represents a a a member. The element represents a a plus member. The element represents a a member. The element represents a a minus member. The element represents a plus member. The element represents a member. The element represents a minus member. The element represents b b b plus member. The element represents b b b member. The element represents b b b minus member. The element represents b b plus member. The element represents b b member. The element represents other financial assets without risk assessment. The element represents decription of fair value at risk. The element represents exposure value. The element represents brazilian real u s dollar exchange rate member. The element represents probable sensitivity gain loss. The element represents possible adverse sensitivity gain loss. The element represents extreme adverse sensitivity gain loss. The element represents export prepayments member. The element represents sace member. The element represents dollar call and put options member. The element represents dollar swap c d i member. The element represents m o n f o r t e member. The element represents nexi member. The element represents financial investments abroad member. The element represents libor floating interest rate member. The element represents c d i interest rate member. The element represents financial investments in brazil member. The element represents i p c a interest rate member. The element represents b n b f i n e p f u n d e s f i n i s a f i n a m e f n e member. The element represents selic interest rate member. The element represents i p i member. The element represents domestic member. The element represents i c m s member. The element represents other countries member. The element represents p i s and c o f i n s member. The element represents value added tax member. The element represents income taxes current. The element represents braskem holanda member. The element represents permanent adjustments to i r an c s ll calculation basis abstract. The element represents income tax ans social contribution on equity in results of investees. The element represents thin capitalization. The element represents tax benefits. The element represents effect of refund of braskem americas tax benefit. The element represents effect from retrospective tax rate on bonus depreciation of braskem america. The element represents taxes on dividends distribution. The element represents exclusion of inflation adjustement by selic on undue tax payments from taxable income. The element represents breakdown of income taxes. The element represents current ir and csl expense abstract. The element represents current year income tax and social contribution. The element represents origination and reversal of temporary differences. The element represents income taxnd social contribution. The element represents subsidiary one member. The element represents subsidiary two member. The element represents subsidiary three member. The element represents subsidiary four member. The element represents subsidiary five member. The element represents subsidiary six member. The element represents subsidiary seven member. The element represents deferred tax liability asset1. The element represents tax losses i r and negative base c s l member. The element represents asset member. The element represents goodwill amortized member. The element represents exchange variations member. The element represents other comprehensive income1. The element represents liabilities category member. The element represents temporary adjustment member. The element represents business combination member. The element represents tax credits member. The element represents amortization of fair value adjustments on the assets from the acquisiton of quattor member. The element represents tax depreciation member. The element represents exclusion of i c m s in basis of calculation member. The element represents present value adjustment and amortized cost member. The element represents amortization of fair value adjustments on the assets from the acquisiton of braskem qpar member. The element represents net member. The element represents deferred tax assets1. The element represents deferred tax liabilities1. The element represents braskem s a member. The element represents braskem america member. The element represents braskem idesa servicos member. The element represents cetrel member. The element represents d a c member. The element represents income tax and social contribution tax calculation assets. The element represents income tax and social contribution tax i r and c s l offsetting assets. The element represents deferred tax assets2. The element represents income tax and social contribution tax calculation liabilities. The element represents income tax and social contribution tax i r and c s l offsetting liabilies. The element represents deferred tax liabilities2. The element represents provisions1. The element represents recovery of environmental damage member. The element represents provision for customers rebates member. The element represents rebate member. The element represents longterm legal proceedings provision1. The element represents litigation cases axis. The element represents labor claims member. The element represents tax claims member. The element represents type of claim axis. The element represents type of operation axis. The element represents normal operation member. The element represents other tax claims member. The element represents type of oeration axis. The element represents corporate claims member. The element represents civil claims and other member. The element represents adjusted amount of uncertain tax treatment. The element represents tax claims net member. The element represents corporate claim member. The element represents longterm legal proceedings provision additions. The element represents longterm legal proceedings provision payments. The element represents longterm legal proceedings provision reversals. The element represents possible legal proceedings provision. The element represents civil claims one member. The element represents civil claims two member. The element represents environmental claims member. The element represents social security claims member. The element represents other lawsuits member. The element represents amount of these claims. The element represents percentage amount of tax deficiency notice. The element represents adjusted value of cases. The element represents i r p j and c s l l foreign earned income member. The element represents updated value of this proceeding amounted. The element represents amount under discussion. The element represents claims with possible chance of loss. The element represents p i s and c o f i n s sundry member. The element represents i r r f i r and c s l commission expenses member. The element represents isolated fine failure to ratify d c o m p s member. The element represents other administrative proceedings. The element represents social security contributions member. The element represents p i s and c o f i n s d cide fuels tax offset member. The element represents civil claims resale of solvents member. The element represents payment for indemnifiction. The element represents environmental member. The element represents social security member. The element represents amount of provision for possibility of outflow of resources. The element represents amount evaluated as possible loss. The element represents possible amount chance to loss. The element represents i r p j c s l l negative balance offset member. The element represents federal prosecution office and u s swiss authorities member. The element represents leniency agreements member. The element represents federal controller general and attorney generall agreement member. The element represents department of justice member. The element represents swiss office member. The element represents federal prosecution office member. The element represents securities and exchange commission member. The element represents outstanding amount1. The element represents current liabilities1. The element represents legal proceedings provision1. The element represents alagoas member. The element represents provision after adjustment. The element represents realization of present value adjustment. The element represents provisions related geological event. The element represents longterm legal proceedings provision2. The element represents net of adjustment to present value. The element represents alagoas state federal prosecution office member. The element represents technical cooperation agreement member. The element represents provision accrued amount. The element represents description of reparation for socialenvironmental. The element represents description of reparation for residents. The element represents health care benefits member. The element represents private pension benefits member. The element represents transport benefits member. The element represents feeding benefits member. The element represents life insurance benefits member. The element represents training benefits member. The element represents other benefits member. The element represents defined benefit obligation at present value2. The element represents defined benefit member. The element represents novamont braskem america member. The element represents braskem alemanha and braskem holanda member. The element represents health care plan member. The element represents bradesco saude member. The element represents plan assets at fair value1. The element represents health insurance member. The element represents benefit plans member. The element represents fair value plan assets benefits paid or payable. The element represents increase decrease through changes in foreign exchange rates net fair value plan assets. The element represents actuarial gains losses net defined benefit total. The element represents actuarial gains losses net defined benefit liability asset. The element represents actuarial assumption of duration1. The element represents united state of america member. The element represents actuarial assumption rate of increase in future salary levels. The element represents actuarial assumption rate of increase in future pension plan. The element represents netherlands member. The element represents increase decrease in defined benefit obligation due to reasonably possible increase in future pension plan. The element represents life expectancy. The element represents percentage of reasonably possible increase in cost of service actuarial assumption. The element represents percentage of reasonably possible increase in interest cost actuarial assumption. The element represents increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption. The element represents increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption. The element represents increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption. The element represents increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption. The element represents sponsors expenses. The element represents participants expenses. The element represents novonor member. The element represents petrobras member. The element represents percentage of shares outstanding. The element represents adrs member. The element represents other2 member. The element represents number of shares outstanding1. The element represents changes in shares. The element represents profit loss from continuing operations attributable basic to owners of parent. The element represents profit loss from continuing operations attributable diluted to owners of parent. The element represents distribution of unit value o priority dividends basic. The element represents distribution of unit value of priority dividends diluted. The element represents distribution of unit value of common shares basic. The element represents distribution of unit value of common shares diluted. The element represents distribution of plus income basic. The element represents distribution of plus income diluted. The element represents profit loss available for distribution basic. The element represents profit loss available for distribution diluted. The element represents weighted average shares basic. The element represents weighted average shares diluted. The element represents united states member. The element represents a r member. The element represents i t member. The element represents c l member. The element represents n l member. The element represents l u member. The element represents s g member. The element represents p e member. The element represents j p member. The element represents e s member. The element represents g b member. The element represents u y member. The element represents p l member. The element represents b o member. The element represents s e member. The element represents c a member. The element represents f r member. The element represents p y member. The element represents c o member. The element represents c n member. The element represents k r member. The element represents solvents member. The element represents other1 member. The element represents butadiene member. The element represents p e p p member. The element represents naphtha condensate and crude oil member. The element represents benzene toluene and xylene member. The element represents ethylene propylene member. The element represents e t b e gasoline member. The element represents cumene member. The element represents p v c caustic soda e d c member. The element represents one client member. The element represents realization period. The element represents classification of expenses axis. The element represents nature member. The element represents type of expenses axis. The element represents raw materials other inputs member. The element represents personnel expenses member. The element represents outsourced services member. The element represents depreciation amortization and depletion member. The element represents freights member. The element represents costs of idle industrial plants member. The element represents provision geological event in alagoas member. The element represents p i s and c o f i n s credits exclusion of i c m s from the calculation basis member. The element represents function member. The element represents cost of products sold member. The element represents selling and distribution member. The element represents loss reversals for impairment of trade accounts receivable member. The element represents general and administrative member. The element represents research and development member. The element represents other income expenses net member. The element represents other expenses member. The element represents financial income expense axis. The element represents financial interest income member. The element represents monetary variations on tax credits member. The element represents other financial income member. The element represents financial interest expenses member. The element represents monetary variations on fiscal debts member. The element represents discounts granted member. The element represents loans transaction costs member. The element represents adjustment to present value member. The element represents interest expense on leases member. The element represents losses on derivatives member. The element represents other financial expenses member. The element represents exchange variation effects axis. The element represents u s dollar brazilian real member. The element represents euro brazilian real member. The element represents mexican peso brazilian real member. The element represents u s dollar mexican peso member. The element represents u s dollar euro member. The element represents closing foreign exchange rate variations. The element represents average foreign exchange rate variations. The element represents energy agreement member. The element represents interest rate. The element represents events after reporting period member. The element represents property plant and equipment and intangible assets and goodwill. The element represents reporting segments member. The element represents unallocated member. The element represents u s a and europe member. The element represents braskem consolidated before eliminations and reclassifications member. The element represents other segments member. The element represents corporate unit member. The element represents eliminations and reclassifications member. Non-current trade receivables Non current recoverable income taxes Other non-current receivables Current borrowings and current portion of non-current borrowings Noncurrent leniency agreements Non-current provisions Non-current refunds provision Non-current lease liabilities Other non-current payables Treasury shares Distribution costs LossReversalsForImpairmentOfTradeAccountsReceivable General and administrative expense Research and development expense Other expense, by function ProfitBeforeNetFinancialIncomeExpenseAndTaxes Finance costs Profit (loss) before tax Tax expense (income) Profit (loss), attributable to non-controlling interests Other comprehensive income, net of tax, cash flow hedges Reclassification adjustments on exchange differences on translation of foreign operations, before tax Noncontrolling interest reclassification adjustments on exchange differences on translation before tax Other comprehensive income that will be reclassified to profit or loss, net of tax Other comprehensive income that will not be reclassified to profit or loss, net of tax Comprehensive income Comprehensive income, attributable to owners of parent Comprehensive income, attributable to non-controlling interests AbsorptionOfLossesAndAdjustments ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods Adjustments for provisions AdjustmentsForIncomeTaxExpenses Adjustments to reconcile profit (loss) other than changes in working capital AdjustmentsForDecreaseIncreaseInFinancialInvestments Adjustments for decrease (increase) in trade accounts receivable AdjustmentsForDecreaseIncreaseInTaxesRecoverable Adjustments for decrease (increase) in other operating receivables Adjustments for increase (decrease) in trade accounts payable AdjustmentsForIncreaseDecreaseInTaxesPayable AdjustmentsForIncreaseDecreaseInLeniencyAgreements Additional provisions, other provisions GeologicalEventInAlagoas Adjustments for increase (decrease) in other operating payables Interest paid, classified as operating activities Income taxes paid, classified as operating activities AcquisitionOfSubsidiary AcquisitionOfOtherInvestments Purchase of property, plant and equipment, classified as investing activities Repayments of borrowings, classified as financing activities ProceedsFromOtherBorrowings RepaymentsOfOtherBorrowings LoanPaymentToNoncontrollingShareholdersOfBraskemIdesa Lease [Default Label] Dividends paid, classified as financing activities NoncontrollingInterestInSubsidiaries OtherFinancialsLiabilities Disclosure of general information about financial statements [text block] Disclosure of cash and cash equivalents [text block] Disclosure of deposits from banks [text block] Disclosure of trade and other receivables [text block] Disclosure of inventories [text block] DisclosureOfTaxRecoverableExplanatory Disclosure of interests in associates [text block] Disclosure of property, plant and equipment [text block] Disclosure of intangible assets [text block] Disclosure of trade and other payables [text block] Disclosure of borrowings [text block] Disclosure of debt instruments [text block] DisclosureOfTaxPayableExplanatory Disclosure of provisions [text block] Disclosure of revenue [text block] Disclosure of finance income (cost) [text block] DisclosureOfChangesInDeferredTaxesExplanatory Trade payables [Default Label] Current portion of non-current borrowings Debentures [Default Label] Other borrowings Investments other than investments accounted for using equity method Trade receivables Allowance account for credit losses of financial assets Current trade receivables1 Inventories1 TradePayablesNonCurrent Cost of sales1 Key management personnel compensation, other long-term employee benefits Key management personnel compensation Dividends received from associates, classified as investing activities Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax Other 1 RecoverableIncomeTaxesNonCurrent Deferred tax assets non current Non-current receivables due from related parties Derivatives non current Judicial deposits non current Investment property Current notes and debentures issued and current portion of noncurrent notes and debentures issued1 Current provisions for employee benefits1 IncomeTaxesPayable Other payables [Default Label] Braskem Idesa Borrowings [Default Label] Debentures noncurrent Net deferred tax liabilities Provision geological event in alagoas non current Impairment loss recognised in profit or loss, trade receivables Other expenses, by nature Profit (loss) from continuing operations Other reversals of provisions Adjustments for income tax expense LossForImpairmentOfTradeAccountsReceivable Prepaid expenses AdvancesFromCustomers Increase decrease through net exchange differences property plant and equipment cost Disposals property plant and equipment cost Disposals property plant and equipment depletion Depreciation, property, plant and equipment IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1 Additions other than through business combinations, intangible assets other than goodwill Increase decrease through net exchange differences intangible assets and goodwill cost Other increase decrease in intangible assets and goodwill amortization AdditionsThroughAcquisitionOfErPlastics Discount rate [Default Label] Intangible assets and goodwill1 Acquisitions rightofuse assets Depreciation, right-of-use assets Foreign currency translation adjustment rightofuse assets Acquired of lease liabilities AdditionsThroughAcquisitionsOfErPlastics Interest expense on lease liabilities Minimum annual commitments Borrowings [Default Label] Net debt Notes and debentures issued NoteAndDebenturesIssued Repayments of debt classified as financing activities LossesOnDisposalsOfInvestment Other [Default Label] Hedged item, liabilities Hedged item liabilities1 Dervative notional amount HedgeAccountingsDiscontinued Income taxnd social contribution Deferred tax expense (income) recognised in profit or loss Other comprehensive income1 TaxesRecoverable Provisions Non-current legal proceedings provision Longterm legal proceedings provision payments Claims with possible chance of loss [Default Label] Current liabilities1 AdditionsRelatedGeologicalEvent Short-term employee benefits expense Defined benefit obligation, at present value Plan assets, at fair value Fair value plan assets benefits paid or payable Exchange variation [Default Label] Actuarial gains losses net defined benefit total Actuarial assumption of discount rates Percentage of reasonably possible increase in cost of service actuarial assumption Number of shares outstanding1 SudeneTaxIncentiveSupplements OtherAccumulatedLosses OutstandingShares1 ConversionOfShares OutstandingShares2 OutstandingShares3 Tax effect of revenues exempt from taxation EX-101.PRE 13 bak-20221231_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
12 Months Ended
Dec. 31, 2022
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2022
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2022
Current Fiscal Year End Date --12-31
Entity File Number 001-14862
Entity Registrant Name BRASKEM SA
Entity Central Index Key 0001071438
Entity Incorporation, State or Country Code D5
Entity Address, Address Line One Rua Lemos Monteiro, 120 – 24° andar
Entity Address, City or Town São Paulo
Entity Address, Country BR
Entity Address, Postal Zip Code 05501-050
Title of 12(b) Security Preferred Shares, Class A, without par value per share, each represented by American Depositary Shares
Trading Symbol BAK
Security Exchange Name NYSE
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Common Stock, Shares Outstanding 451,668,652
Contact Personnel Fax Number 55 11 3576-9532
ICFR Auditor Attestation Flag true
Auditor Firm ID 1124
Auditor Name KPMG Auditores Independentes Ltda.
Auditor Location São Paulo
Class A Preference Shares [Member]  
Entity Addresses [Line Items]  
Entity Common Stock, Shares Outstanding 345,060,392
Class B Preference Shares [Member]  
Entity Addresses [Line Items]  
Entity Common Stock, Shares Outstanding 478,790
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One Rua Lemos Monteiro, 120 – 24° andar
Entity Address, City or Town São Paulo
Entity Address, Country BR
Entity Address, Postal Zip Code 05501-050
City Area Code 55
Local Phone Number 11 3576-9000
Contact Personnel Name Pedro van Langendonck Teixeira de Freitas

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of consolidated financial position - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents R$ 12,466,474 R$ 8,680,686
Financial investments 2,295,497 3,492,710
Trade accounts receivable 3,231,934 7,153,565
Inventories 14,030,064 16,335,101
Taxes recoverable 1,156,355 1,428,658
Recoverable income taxes 392,062 1,189,812
Derivatives 157,906 33,816
Other receivables 727,364 979,097
Current Assets  34,457,656 39,293,445
Non-current assets    
Financial investments 17,134 16,845
Trade accounts receivable 13,395
Taxes recoverable 1,617,669 1,252,058
Recoverable income taxes 252,995 230,069
Deferred tax assets 6,358,601 8,257,252
Judicial deposits  215,274 194,212
Derivatives 71,544 51
Other receivables 170,536 365,652
Investments 149,023 58,923
Property, plant and equipment 37,763,295 37,225,130
Intangible assets 3,022,144 2,877,299
Right of use of assets 3,952,987 2,780,037
Non-Current Assets  53,591,202 53,270,923
Total assets 88,048,858 92,564,368
Current liabilities    
Trade payables 12,246,782 12,053,266
Borrowings 1,254,550 1,343,494
Braskem Idesa borrowings 868,635 86,765
Debentures 127,801 59,088
Derivatives 195,169 256,131
Payroll and related charges 827,826 1,170,346
Taxes payable 491,051 1,012,116
Income taxes payable 381,117 1,672,844
Leniency agreement 392,486 353,385
Sundry provisions 530,814 465,051
Provision - geological event in Alagoas 4,247,609 4,378,071
Lease 1,039,706 675,366
Other payables 1,581,701 1,667,600
Current Liabilities  24,185,247 25,193,523
Non-current liabilities    
Trade payables 3,069 111,464
Borrowings 31,310,710 33,553,766
Braskem Idesa borrowings 10,501,683 12,224,770
Debentures 3,023,674 137,830
Derivatives 81,917 362,915
Taxes payable 298,026 260,497
Loan from non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538
Deferred tax liabilities 1,153,481 1,407,434
Post-employment benefits 493,743 487,697
Legal provisions 1,171,498 1,153,830
Leniency agreement 510,654 769,911
Sundry provisions 846,133 824,212
Provision - geological event in Alagoas 2,378,949 3,283,188
Lease 3,200,824 2,481,048
Other payables 282,940 461,917
Non-Current Liabilities  57,755,394 61,167,017
Shareholders' equity    
Capital 8,043,222 8,043,222
Capital reserve 6,175 3,473
Profit reserves 1,825,616 3,483,935
Additional paid in capital (488,388) (488,388)
Long-term incentive plans 39,413 31,932
Other comprehensive income (2,076,066) (3,170,158)
Treasury shares (28,173) (38,197)
Total attributable to the  Company's shareholders 7,321,799 7,865,819
Non-controlling interest in subsidiaries (1,213,582) (1,661,991)
Shareholders’ Equity  6,108,217 6,203,828
Total liabilities and shareholders' equity R$ 88,048,858 R$ 92,564,368
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of consolidated profit or loss - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Net revenue R$ 96,519,284 R$ 105,625,201 R$ 58,543,494
Cost of products sold (85,160,548) (73,568,231) (47,331,414)
Gross profit 11,358,736 32,056,970 11,212,080
Income (expenses)       
Selling and distribution (2,108,417) (2,055,640) (1,852,055)
Loss  for impairment of trade accounts receivable and others from clients (38,426) (8,914) (55,252)
General and administrative  (2,763,983) (2,522,127) (1,918,747)
Research and development (374,493) (296,583) (250,648)
Results from equity-accounted investees 34,848 4,644 (19,398)
Other income 507,333 1,534,487 750,749
Other expenses (2,343,525) (2,669,290) (7,938,621)
Profit (loss) before net financial expenses and taxes 4,272,073 26,043,547 (71,892)
Financial results      
Financial expenses  (5,662,693) (5,907,155) (4,913,365)
Financial income 2,010,134 1,827,438 600,184
Exchange rate variations, net (572,170) (4,002,807) (5,298,711)
Finance income (cost)  (4,224,729) (8,082,524) (9,611,892)
Profit (loss) before income tax 47,344 17,961,023 (9,683,784)
Income taxes (867,735) (3,999,403) 2,668,478
(Loss) net profit for the year (820,391) 13,961,620 (7,015,306)
Attributable to:      
Company's shareholders (335,677) 13,984,946 (6,691,720)
Non-controlling interest in subsidiaries R$ (484,714) R$ (23,326) R$ (323,586)
Common shares member      
Earnings (loss) per share - R$      
Earnings (loss) per share - basic R$ (0.42) R$ 17.57 R$ (8.41)
Earnings (loss) per share - diluted (0.42) 17.57 (8.41)
Class A Preferred Shares [Member]      
Earnings (loss) per share - R$      
Earnings (loss) per share - basic (0.42) 17.57 (8.41)
Earnings (loss) per share - diluted (0.42) 17.52 (8.38)
Class B Preferred Shares [Member]      
Earnings (loss) per share - R$      
Earnings (loss) per share - basic (0.42) 0.58 (8.41)
Earnings (loss) per share - diluted R$ (0.42) R$ 0.58 R$ (8.41)
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of consolidated comprehensive income - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Profit or loss [abstract]      
(Loss) net profit for the year R$ (820,391) R$ 13,961,620 R$ (7,015,306)
Items that will be reclassified subsequently to profit or loss      
Fair value of cash flow hedge, net of taxes 292,486 324,374 (397,558)
Fair value of cash flow hedge from jointly-controlled, net of taxes 267 (968) 1,260
Cash flow hedges,net of tax  292,753 323,406 (396,298)
Exchange variation of foreign sales hedge, net of taxes 1,121,938 (1,260,781) (4,541,581)
Sales Hedge - transfer to profit or loss, net of taxes 938,118 1,255,983 1,448,079
Exchange variation of foreign sales hedge - Braskem Idesa, net of taxes 489,773 (143,223) (311,795)
Sales Hedge - transfer to profit or loss - Braskem Idesa, net of taxes 296,803 355,060 330,210
Sales hedges, net of tax  2,846,632 207,039 (3,075,087)
Foreign subsidiaries currency translation adjustment (1,805,667) 1,503,148 2,658,042
Total 1,333,718 2,033,593 (813,343)
Item that will not be reclassified to profito or loss      
Actuarial gain (loss) with post-employment benefits, net of taxes 10,670 23,014 (647)
Total 10,670 23,014 (647)
Total comprehensive income for the year 523,997 16,018,227 (7,829,296)
Attributable to:      
Company's shareholders 714,899 16,015,874 (7,108,541)
Non-controlling interest in subsidiaries R$ (190,902) R$ 2,353 R$ (720,755)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of changes in equity - BRL (R$)
R$ in Thousands
Issued capital [member]
Capital reserve [member]
Statutory reserve [member]
Tax Incentive [Member]
Retention Of Profits [Member]
Additional Dividends Proposed [Member]
Additional paid-in capital [member]
Long Term Incentive Plans [Member]
Accumulated other comprehensive income [member]
Treasury shares [member]
Retained earnings [member]
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Total
As of December 31, 2021 at Dec. 31, 2019 R$ 8,043,222 R$ 232,472 R$ 577,476 R$ 153,478 R$ 1,174,301 R$ (488,388) R$ 19,980 R$ (4,777,519) R$ (49,724) R$ 4,885,298 R$ (940,592) R$ 3,944,706
Comprehensive income for the year:                            
Net profit (loss) for the year   (6,691,720) (6,691,720) (323,586) (7,015,306)
Exchange variation of foreign sales hedge, net of taxes   (3,079,691) (3,079,691) 4,604 (3,075,087)
Fair value of cash flow hedge, net of taxes   (390,608) (390,608) (5,690) (396,298)
Actuarial gain on defined benefit and health plan, net of taxes   (648) (648) 1 (647)
Foreign subsidiaries currency translation adjustment   3,054,126 3,054,126 (396,084) 2,658,042
Total Comprehensive income for the period  (416,821) (6,691,720) (7,108,541) (720,755) (7,829,296)
Realization of additional property, plant and equipment price-level restatement, net of taxes   (26,302) 26,302
Realization of deemed cost of jointly-controlled investment, net of taxes   (741) 741
Fair value adjustments of trade accounts receivable, net of taxes   113 113 113
Exchange variation in hyperinflationary economy, net of taxes   8,077 8,077 8,077
Long term incentive plan, net of taxes 11,629 11,629 (415) 11,214
Other   3,695 (3,695)
Comprehensive income  11,629 (15,158) 23,348 19,819 (415) 19,404
Contributions and distributions to shareholders:                            
Dividends-lapse of statute of limitation   1,110 1,110 1,110
Additional dividends of subsidiary   (2,450) (2,450)
Absorption of losses (232,460) (577,476) (153,478) (1,174,301)   2,137,715
Gain on transfer of shares in custody long term incentive plan (12)   20 8 8
 Total Contributions to shareholders (232,472) (577,476) (153,478) (1,174,301) 20 2,138,825 1,118 (2,450) (1,332)
As of December 31, 2022 at Dec. 31, 2020 8,043,222 (488,388) 31,609 (5,209,498) (49,704) (4,529,547) (2,202,306) (1,664,212) (3,866,518)
Comprehensive income for the year:                            
Net profit (loss) for the year       13,984,946 13,984,946 (23,326) 13,961,620
Exchange variation of foreign sales hedge, net of taxes 154,080 154,080 52,959 207,039
Fair value of cash flow hedge, net of taxes 262,726 262,726 60,680 323,406
Actuarial gain on defined benefit and health plan, net of taxes 23,028 23,028 (14) 23,014
Foreign subsidiaries currency translation adjustment 1,591,094 1,591,094 (87,946) 1,503,148
Total Comprehensive income for the period  2,030,928 13,984,946 16,015,874 2,353 16,018,227
Realization of additional property, plant and equipment price-level restatement, net of taxes (26,164) 26,164
Realization of deemed cost of jointly-controlled investment, net of taxes (719) 719
Long term incentive plan 323 323 (132) 191
Fair value adjustments of trade accounts receivable, net of taxes (130) (130) (130)
Exchange variation in hyperinflationary economy, net of taxes 35,425 35,425 35,425
Contributions and distributions to shareholders:                            
Dividends-lapse of statute of limitation 1,653 1,653 1,653
Dividends (6,000,000) (6,000,000) (6,000,000)
 Total Contributions to shareholders 3,473 472,770 1,017,546 643,619 1,350,000 11,507 (9,482,282) (5,983,367) (5,983,367)
Equity valuation adjustments:                            
Equity valuation adjustments 323 8,412 26,883 35,618 (132) 35,486
Incentive long term plan payments with treasury shares 3,473 11,507 14,980 14,980
Legal reserve 472,770 (472,770)
Tax incentive reserve 1,017,546 (1,017,546)
Retention of profits 643,619 (643,619)
Additional proposed dividends 1,350,000 (1,350,000)
As of December 31, 2022 at Dec. 31, 2021 8,043,222 3,473 472,770 1,017,546 643,619 1,350,000 (488,388) 31,932 (3,170,158) (38,197) 7,865,819 (1,661,991) 6,203,828
Comprehensive income for the year:                            
Net profit (loss) for the year (335,677) (335,677) (484,714) (820,391)
Exchange variation of foreign sales hedge, net of taxes 2,649,988 2,649,988 196,644 2,846,632
Fair value of cash flow hedge, net of taxes 292,753 292,753 292,753
Actuarial gain on defined benefit and health plan, net of taxes 10,186 10,186 484 10,670
Foreign subsidiaries currency translation adjustment (1,902,351) (1,902,351) 96,684 (1,805,667)
Total Comprehensive income for the period  1,050,576 (335,677) 714,899 (190,902) 523,997
Realization of additional property, plant and equipment price-level restatement, net of taxes (26,164) 26,164
Realization of deemed cost of jointly-controlled investment, net of taxes (719) 719
Fair value adjustments of trade accounts receivable, net of taxes (35) (35) (35)
Exchange variation in hyperinflationary economy, net of taxes 70,434 70,434 70,434
Long term incentive plan, net of taxes 20,207 20,207 20,207
Other 475 475 475
Comprehensive income                            26,883
Contributions and distributions to shareholders:                            
 Total Contributions to shareholders 2,702 108,975 (417,294) (1,350,000) (12,726) 10,024 308,794 (1,349,525) 29,484 (1,320,041)
Equity valuation adjustments:                            
Equity valuation adjustments 20,207 43,516 26,883 90,606 609,827 700,433
Incentive long term plan payments with treasury shares 2,702 (12,726) 10,024
SUDENE tax incentive supplement 108,975 (108,975)
Non-controlling interest in acquired entity 30,720 30,720
Fair value of financial transactions of non-controlling subsidiaries 609,827 609,827
Additional dividends approved in the board meeting (1,350,000) (1,350,000) (1,350,000)
Absorption of losses (417,294) 417,294  
Proposed dividends (1,236) (1,236)
As of December 31, 2022 at Dec. 31, 2022 R$ 8,043,222 R$ 6,175 R$ 472,770 R$ 1,126,521 R$ 226,325 R$ (488,388) R$ 39,413 R$ (2,076,066) R$ (28,173) R$ 7,321,799 R$ (1,213,582) R$ 6,108,217
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of consolidated cash flow - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of cash flows [abstract]      
Profit (loss) before income taxes R$ 47,344 R$ 17,961,023 R$ (9,683,784)
Adjustments for reconciliation of profit      
Depreciation and amortization 4,733,165 4,178,433 4,048,081
Results from equity-accounted investees (34,848) (4,644) 19,398
Interest foreign exchange gain/losses 2,702,636 6,311,431 10,457,272
Provisions, net 370,153 819,130 336,838
Provision - geological event in Alagoas 1,520,019 1,339,765 6,901,828
PIS and Cofins credits - exclusion of ICMS from the calculation basis (1,031,099) (310,557)
Loss for impairment of trade accounts receivable and others from clients 38,426 8,914 55,252
Write-offs of long-lived assets 130,995 115,187 8,794
Adjustments for reconciliation of profit  9,507,890 29,698,140 11,833,122
Changes in operating working capital      
Judicial deposits - unfreezing (blocking) Public Civil Action 3,746,107
Financial investments 1,530,050 296,957 (1,860,827)
Trade accounts receivable 3,661,267 (2,175,285) (2,187,826)
Inventories  2,138,161 (7,574,285) (252,534)
Taxes recoverable 682,457 4,963,587 1,532,554
Other receivables 310,789 (198,556) 690,888
Trade payables 514,079 1,199,614 (3,001,564)
Taxes payable (1,009,356) (3,007,488) 449,761
Leniency agreement (317,867) (389,087) (349,842)
Sundry provisions (406,587) (314,194) (145,355)
Geological event in Alagoas (2,742,791) (2,928,081) (1,181,931)
Other payables (390,727) 805,452 14,801
Cash generated from operations 13,477,365 20,376,774 9,287,354
Interest paid (2,904,879) (2,883,433) (2,736,821)
Income taxes (1,620,747) (2,706,856) (257,542)
Net cash generated from operating activities 8,951,739 14,786,485 6,292,991
Proceeds from the sale of fixed and intangible assets 2,438 40,353 33,140
Dividends received 5,660 295 4,822
Acquisition of subsidiary (42,121)    
Acquisition of other investments (64,969)  
Acquisitions to property, plant and equipment and intangible assets (4,848,281) (3,421,324) (2,759,789)
Net cash used in investing activities (4,947,273) (3,380,676) (2,721,827)
Short-term and Long-term debt      
Acquired 6,418,208 16,308 13,049,459
Payments (3,855,662) (9,413,909) (8,734,505)
Braskem Idesa borrowings      
Acquired 7,271,658
Payments (45,311) (7,995,045) (905,210)
Loan payment to non-controlling shareholders of Braskem Idesa (34,122) (9,545) (37,618)
Lease (928,890) (841,706) (662,068)
Dividends paid (1,350,293) (5,993,265) (2,380)
Non-controlling interest in subsidiaries 21,162  
Other financial liabilities (534,456)
Net cash generated (used) in financing activities 225,092 (16,965,504) 2,173,222
Exchange variation on cash of foreign subsidiaries (443,770) 377,529 1,314,586
Increase (decrease) in cash and cash equivalents 3,785,788 (5,182,166) 7,058,972
Represented by      
Cash and cash equivalents at the beginning of the year 8,680,686 13,862,852 6,803,880
Cash and cash equivalents at the end of the year 12,466,474 8,680,686 13,862,852
Increase (decrease) in cash and cash equivalents R$ 3,785,788 R$ (5,182,166) R$ 7,058,972
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Operations
12 Months Ended
Dec. 31, 2022
Operations  
Operations

1 Operations

Braskem S.A. is a public corporation headquartered in Camaçari, Bahia (“BA”), which, jointly with its subsidiaries (hereinafter “Braskem” or “Company”), is controlled by Novonor S.A. (“Novonor”), which directly and indirectly holds interests of 50.11% and 38.32% in its voting and total capital, respectively. The ultimate parent company of Braskem is Kieppe Patrimonial S.A.

The Braskem’s shares are traded on B3 S.A. Brasil, Bolsa, Balcão (“B3”), under the tickers BRKM3, BRKM5 and BRKM6, and on the New York Stock Exchange (“NYSE”) under the ticker BAK and on the Madrid Stock Exchange (“LATIBEX”) under the ticker XBRK.

Braskem also is engaged, among others, in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air and industrial gases, as well as the provision of industrial services and the production, supply and sale of electric energy and natural gas for its own use and use by other companies. Braskem also invests in other companies.

The Company has industrial plants in Brazil, the United States, Germany, and Mexico. The units produce thermoplastic resins, such as polyethylene (“PE”), polypropylene (“PP”), polyvinyl chloride (“PVC”) and other basic petrochemicals.

Operations of subsidiary Braskem Idesa S. A. P. I. (“Braskem Idesa”)

On September 27, 2021, Braskem Idesa signed the following documents:

(i) amendment to the ethane supply agreement (“Amendment”) with PEMEX; and

(ii) agreement with Petróleos Mexicanos, PEMEX Logística and other Mexican government entities, establishing administrative support measures, especially to obtain of licenses, permits and rights of way for the project to build an ethane import terminal with the capacity to meet all Braskem Idesa's feedstock requirements ("Terminal Agreement”).

The Amendment changed the minimum contractual volume commitment to 30,000 barrels/day until the limit date of February 2025 (subject to extensions in the event of delay in obtaining the licenses for the terminal's construction). The terminal's startup is expected in the second half of 2024. The terminal project is designed to supplement ethane supply in Mexico by gaining access to new feedstock sources.

The Amendment further established first-refusal rights for Braskem Idesa in the acquisition of all ethane that PEMEX has available and does not consume in its own production process through 2045, at prices based on international references. The approvals required for the Amendment and Terminal Agreement to come into force were obtained in October 2021 and the Amendment started producing effects retroactive to February 26, 2021, the execution date of the memorandum of understanding.

On June 14, 2022, Braskem Idesa signed agreements with Advario B.V. to sell 50% of the capital stock of Terminal Química Puerto México (“Terminal Química”), the subsidiary of Braskem Idesa responsible for developing and operating the ethane import terminal in Mexico.

In March 2023, the conditions for the conclusion of the agreement were fulfilled and Advario B.V. made a payment of US$56 million (R$292 million) to Braskem Idesa for the acquisition of 50% of equity interest in Terminal Química.

 

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation of the financial statements
12 Months Ended
Dec. 31, 2022
Basis Of Preparation Of Financial Statements  
Basis of preparation of the financial statements

2 Basis of preparation of the financial statements

2.1 Basis of accounting

The consolidated financial statements were prepared and presented in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

2.2 Basis of presentation

The Company’s consolidated financial statements (“financial statements”) were prepared under the historical cost basis, unless stated otherwise in the accounting policies. These consolidated financial statements have been prepared on a going concern basis.

The significant accounting policies applied in the preparation of these consolidated financial statements were included in the respective notes and are consistent in the fiscal years presented.

The issue of these consolidated financial statements was authorized by the Executive Board on April 24, 2023.

 

2.3 Basis of consolidation

The consolidated financial statements include the financial statements of Braskem S.A. and the following entities:

                   
          Total and voting interest (%)
              2022, 2021 and 2020
          Headquarter   2022   2021   2020
 BM Insurance Company Limited ("BM Insurance")        Bermuda    100   100     100
 Braskem Argentina S.A. (“Braskem Argentina”)        Argentina    100   100     100
 Braskem Energy Ltda.    (i)   Brazil       100    
 Braskem Finance Limited (“Braskem Finance”)        Cayman Islands    100   100     100
 Braskem Green S.A.        Brazil    100   100    
 Braskem Incorporated Limited ("Braskem Inc.")        Cayman Islands    100   100     100
 Braskem Mexico, S. de RL de C.V. ("Braskem México")        Mexico    100   100     100
 Braskem Netherlands B.V. ("Braskem Holanda")        Netherlands    100   100     100
 Braskem Petroquímica Chile Ltda. (“Braskem Chile”)        Chile    100   100     100
 Braskem Ventures Ltda. ("Braskem Ventures")    (ii)   Brazil    100        
 Lantana Trading Co. Inc. (“Lantana”)    (iii)   Bahamas       100     100
 Voqen Energia Ltda. ("Voqen")    (i)   Brazil    100    -    
 Braskem America Finance Company ("Braskem America Finance")        USA    100   100     100
 Braskem America, Inc. (“Braskem America”)        USA    100   100     100
 Braskem Europe GmbH ("Braskem Alemanha")        Germany    100   100     100
 Braskem Idesa S.A.P.I. ("Braskem Idesa")        Mexico   75   75     75
 Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")        Mexico   75   75     75
 Braskem India Private Limited ("Braskem India")        India    100   100     100
 Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")        Mexico    100   100     100
 Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")        Mexico    100   100     100
 Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)        Netherlands    100   100     100
 Braskem Netherlands Green B.V. (“Braskem Holanda Green”)        Netherlands    100   100    
 Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)        Netherlands    100   100     100
 Builder Brasil Ltda. ("Builder Brasil")    (ii)   Brazil    100        
 Builder USA LLC. ("Builder USA")    (ii)   USA    100        
 Cetrel S.A. ("Cetrel")        Brazil   63.70   63.70     63.70
 Distribuidora de Água Camaçari S.A. ("DAC")        Brazil   63.70   63.70     63.70
 B&TC B.V. ("B&TC")    (iv)   Netherlands   60        
 ER Plastics B.V. ("ER Plastics")    (iv)   Netherlands   60        
 Terminal Química Puerto México ("Terminal Química")        Mexico   75   75    
 Special Purpose Entities                     
Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado
Longo Prazo ("FIM Júpiter")
      Brazil    100   100     100
Fundo de Investimento Santander Netuno Multimercado Crédito Privado
Longo Prazo ("FIM Netuno")
      Brazil    100   100     100

 

(i) Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.
(ii) Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.
(iii) Lantana was a non-operational entity that had the operations closed in November 2022.
(iv) B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).

 

(a) Subsidiaries

The Company controls an entity when it is exposed to, or entitled to, the variable returns originating from its involvement with the entity and has the capacity to affect such returns by exercising its power over the entity.

The financial statements of subsidiaries are included in these consolidated financial statements as from the date the Company obtains control until the date of the loss of control.

(b) Equity method Investees

The Company’s investments in entities with accounting treatment using the equity method consist of their interests in associates and joint ventures.

Associates are those in which the Company, directly or indirectly, has significant influence, but not control or shared control, over the financial and operating policies. To be classified as a joint venture, a contractual agreement must exist that gives the Company shared control of the entity and granting to the Company the right to the net assets of the joint venture, and not the right to its specific assets and liabilities.

Such investments are initially recognized at cost, which includes the expenses with the transaction costs. After initial recognition, the consolidated financial statements include the Company’s interest in the net profit or loss for the fiscal year profit or loss and other comprehensive income of equity-accounted investees, in the investee until the date on which the significant influence or joint control ceases to exist.

(c) Conversion of functional currency to presentation currency

The assets and liabilities of foreign operations are translated into Reais at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into Reais at the exchange rates at the dates of the transactions. Foreign currency differences (Note 2.4) from translation to presentation currency are recognized in other comprehensive income.

Since Argentina’s economy is considered hyperinflationary, to translate the financial information of the subsidiary Braskem Argentina, the assets, liabilities, equity, income and expenses are translated into Reais at the exchange rate at the reporting date.

(d) Transactions eliminated in consolidation

Intragroup balances and transactions and any unrealized revenues or expenses arising from intragroup transactions are eliminated. Unrealized gains originating from transactions with investees recorded using the equity method are eliminated against the investment proportionately to the Company’s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment loss.

 

2.4 Functional and foreign currency

These consolidated financial statements are presented in Brazilian Real, which is the functional currency of the Company. All amounts have been rounded to the nearest thousand, unless otherwise stated.

The subsidiaries with a functional currency different from Brazilian Real (R$) are listed below:

   
Subsidiaries   Functional currency
       
  Braskem Alemanha, B&TC and ER Plastics   Euro
  BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.   U.S.dollar ("US$")
  Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços    Mexican peso
  Braskem Argentina   Argentinean peso
  Braskem Chile   Chilenean peso
  Braskem Índia   Rupee

 

2.5 New standards or amendments for the current fiscal year and future requirements

(a) New standards and pronouncements adopted in the current fiscal year

In the current fiscal year, the Company identified a series of amendments under the IFRS accounting standards that became effective for accounting periods starting on or after January 1, 2022:

- Onerous contracts: costs of fulfilling a contract (amendments to IAS 37).

- Annual improvements of IFRS Standards 2018-2020.

- Property, Plant and Equipment: revenue before intended use (amendments to IAS 16).

- Reference to the Conceptual Framework (amendments to IFRS 3).

The adoption of these amendments did not have any material impact on the disclosures or amounts presented in these consolidated financial statements.

(b) Future requirements

The new and amended standards and interpretations already issued but not yet effective as of the reporting date are described below:

- Classification of liabilities as current or non-current (amendments to IAS 1).

- Definition of accounting estimates (amendments to IAS 8).

- Definition of materiality for disclosure of accounting policies (amendments to IAS1 and IFRS Practice Statement 2).

- Deferred taxes related to assets and liabilities arising from a single transaction (amendments to IAS 12).

- Insurance contracts (IFRS17).

The Company plans to adopt these new and amended standards and interpretations, if applicable, when they become effective. Management does not expect the adoption of the standards listed above to have a significant impact on the Company’s consolidated financial statements in future periods.

 

2.6 Impacts from Russia-Ukraine conflict

The Company formed a committee to monitor the consequences of sanctions applied to Russia and the developments in the conflict as well as to take any measures to minimize potential impacts on the Company, its team members and the communities where it operates.

The conflict has caused an increase in the international price of commodities related to the Company's business, such as oil and natural gas, affecting the cost of the Company's inputs used in the production process. The European geopolitical scenario also affected the demand for petrochemical products, global supply chain and pressured inflation in several countries. For this reporting period, it has not caused significant adverse impacts on the Company's equity and financial position, although it is not possible to accurately predict significant adverse effects in the future.

Further sanctions, embargoes, regional instability, geopolitical changes, dysfunctions in the logistics chain, adverse effects on macroeconomic conditions, currency exchange rates and interest rates could affect the prices of products and costs of inputs in the international market, interrupt the supply chain, reduce sales and/or affect operations of the Company. As of the reporting date, the Company has not identified any relevant impacts on its business arising from the sanctions applied to date and adverse scenario caused by the geopolitical conflict.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Application of estimates and judgments
12 Months Ended
Dec. 31, 2022
Application Of Estimates And Judgments  
Application of estimates and judgments

3 Application of estimates and judgments

In preparing these consolidated financial statements, Management has made judgments and estimates that affect the application of the Company’ accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results can differ from these estimates due to differences in the variables, assumptions or conditions used in making estimates.

Judgments and estimates are reviewed on an ongoing basis and are based on historical experience and other factors, including expectations of future events that are deemed reasonable under the circumstances. Revision to estimates is recognized prospectively.

Critical judgments and estimates applied by the Company in the preparation of these consolidated financial statements are presented in the following notes:

3.1 Assumptions and estimation uncertainties

- Note 12(b): The useful lives and discount rate of impairment testing of property, plant and equipment.

- Note 13(a): Determination of the discount rate and the recoverable amount of goodwill.

- Note 20.2: Application of hedge accounting: determining the fair value of financial instruments and judgment of highly probable forecast transaction.

- Note 22.2: Recognition of deferred tax assets, expectation of future taxable income against which deductible temporary differences and tax losses carryforward can be utilized.

- Note 23(a): Recognition and measurement of provisions for recovery of environmental damages: identifying potential environmental impacts, evaluate technical solutions and time of the remediation involve judgment as to the probability and magnitude of the outflow of resources.

- Note 24: Recognition and measurement of provisions for tax, labor and civil lawsuits: judgement on interpretation of the matter under discussion and estimate as to the probability and magnitude of the outflow of resources.

- Note 26: Recognition and measurement of provision for costs arising from the geological event in Alagoas: uncertainties regarding the outcome of actions to close and monitor wells, future studies by experts, changes related to the dynamics of the geological event, individual lawsuits, adherence by the municipality of Maceió and other parties, that could affect the probability and magnitude of the outflow of resources.

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Risk management
12 Months Ended
Dec. 31, 2022
Risk Management  
Risk management

4 Risk management

The Company is exposed to market risks arising from variations in commodity prices, foreign exchange rates and interest rates, credit risks of its counterparties in cash equivalents, financial investments and trade accounts receivable, and liquidity risks to meet its obligations from financial liabilities.

The Company adopts procedures for managing market and credit risks that are in conformity with its Financial Policy, which is reviewed by the Board of Directors quarterly. The purpose of risk management is to protect the Company’s cash flows and reduce the threats to the financing of its operating working capital and investment programs.

4.1 Market risks

The Company prepares a sensitivity analysis for foreign exchange rate and interest rate risks to which it is exposed, presented in Note 20.8.

Management of the interest rate benchmark reform and associated risks

Overview

The planning for an organized replacement of interbank offered rates (“IBORs”) for alternative, nearly risk-free interest rates (RFRs, or “Risk-Free Rates”) is in progress. Initiatives are being adopted to adapt the market before the discontinuation of IBORs, which is expected for June 2023.

The Company uses IBORs as reference rates on several of its financial instruments, and as part of these market-wide initiatives, RFRs will eventually replace such reference rates. While the transition will force modifications on contracts that use IBORs as reference rates, the Company expects no significant impact on its risk management after its completion. However, it will continue to monitor the transition and implement whatever changes or new controls are deemed to be appropriate as potential issues arise.

Derivatives

The derivative instruments traded on over-the-counter market are governed by contracts based on the master agreements of the International Swaps and Derivatives Association (“ISDA”) and agreed with counterparties in the international banking market.

As part of the IBOR reform, the ISDA published a protocol that changed all master agreements in force to include RFRs as replacement rates (fallback) for use upon discontinuation of the various IBORs. The protocol came into force as of January 25, 2021. The Company and the subsidiaries Braskem America, Braskem Idesa and Braskem Holanda Finance already have carried out its adoption.

Liabilities

As of December 31, 2022, the Company has bank loans with interest rates linked to LIBOR in US$ (see notes 16 and 17), which consequently will be subject to IBOR reform. The Company expects the benchmark interest rate of these loans to be changed to guaranteed forward rates at the Security Overnight Financing Rate (SOFR) by June 2023. The Company estimates that the updated cash flows will be economic equivalent to the original and has no expectation of material impacts.

(a)Exposure to commodity risks

Most of Company’s feedstocks (naphtha, ethane, propane and propylene) and main products (PE, PP and PVC) are commodities quoted on international markets. A series of factors determine the dynamics of these quotes, nevertheless our sales prices are also impacted in a similar proportion when compared with our feedstock supply chain.

(b)Exposure to foreign exchange risk

Considering the dynamics of the international petrochemical market, where prices are mostly pegged to international US dollar-denominated references, the Company’s sales in Brazil and Mexico are strongly correlated to the US$.

To mitigate the long-term exchange risk, since September 2016, the Company started to contract financial derivatives to compose a Long-Term Foreign Exchange Hedge Program, by US dollar call and put option contracts, hedging expected cash flows over an 18-month horizon, as detailed in Note 20.5.

In addition to this program, to maintain the balance of the US dollar-denominated assets and liabilities exposure, as established in its Financial Policy, the Company will maintain at least 70% of the net debt exposed to the US dollar. If convenient, the Company may maintain a percentage of more than 70%, although subject to a sensitivity analysis of key financial indicators and proof of the inexistence of significant risk of deterioration of these indicators.

As of December 31, 2022, the Company prepared a sensitivity analysis for its exposure to the fluctuation in US$, as disclosed in Note 20.8.

(c)Exposure to interest rate risk

The Company is exposed to the risk that a variation in floating interest rates causes an increase in its financial expenses due to payments of future interest. Debt denominated in foreign currency subject to floating rates is mainly subject to fluctuations in LIBOR. Debt denominated in R$ is mainly subject to the variation in the Interbank Certificate of Deposit (“CDI”) rate.

As of December 31, 2022, the Company prepared a sensitivity analysis for the exposure to the floating interest rates LIBOR, CDI, SELIC, SOFR and Extended National Consumer Price Index (“IPCA”), as disclosed in Note 20.8.

4.2 Exposure to credit risk

The transactions that subject the Company to the concentration of credit risks are mainly in bank checking accounts, financial investments, and trade accounts receivable in which the Company is exposed to the risk of the financial institution or customer involved. In order to manage this risk, the Company maintains bank current accounts and financial investments with major financial institutions, weighting concentrations in accordance with the credit rating and the daily prices observed in the Credit Default Swap market for the institutions, as well as netting contracts that minimize the total credit risk arising from the many financial transactions entered into by the parties.

As of December 31, 2022, 33.8% of the amounts recorded as “Cash and cash equivalents” (Note 5) and “Financial Investments” (Note 6) were allocated to financial institutions that had offset agreements with the Company. The obligations under these agreements are accounted for under “Borrowings” (Note 16). The effective netting of these amounts is possible only in the event of default by one of the parties.

With respect to the credit risk of customers, the Company protects itself by performing analysis before granting credit and obtaining secured and unsecured guarantees when considered necessary, including credit insurance.

The maximum exposure to credit risk of non-derivative financial instruments on the reporting date is the sum of their carrying amounts less any impairment losses.

4.3 Liquidity risk

The Company has a calculation methodology to determine a minimum cash “monthly vision” (30-day horizon) and a minimum cash “yearly vision” (up to 12-month horizon) for the purpose of, respectively: (i) monitoring the liquidity needed to comply with obligations of the following month; and (ii) monitoring the Company´s liquidity during potential crisis.

The amounts to determine the minimum cash “yearly vision” are calculated based on the projected operating cash generation, less short-term debts and working capital needs. The amounts used for determining the minimum cash “monthly vision” consider the projected operating cash disbursement, debt service and investments in projects, as well as the planned disbursement for derivatives maturing in the period, among other items. According to its Financial Policy, the Company uses as a minimum cash the greater of these two references.

In December 2021, the Company, in keeping with its commitment to maintain its financial liquidity, renewed an international revolving credit facility in the amount of US$1 billion (R$5.22 billion), which expires in 2026. This credit line may be used without restrictions to improve the Company’s credit quality or in the event of deterioration in the macroeconomic scenario. As of December 31, 2022, this new credit line had not been used.

The Company's financial liabilities, including the amounts due under the Leniency Agreement (Note 25), are shown in the table below by maturity. These amounts are calculated based on cash flows not discounted that consider future financial charges and may not be reconciled with the amounts disclosed in the statement of financial position.

                       
                      Consolidated
      Until   Between one   Between two   More than    
      one year   and two years   and five years   five years   Total
                       
Trade payables     12,410,232   3,069             12,413,301
Borrowings       1,360,722     3,139,258     3,931,315   57,625,391     66,056,686
Debentures       136,142     102,090   -     6,167,985    6,406,217
Braskem Idesa borrowings       996,697           17,274,826     18,271,523
Derivatives       192,226   5,691   -    88,273    286,190
Loan from non-controlling shareholder of Braskem Idesa                   4,391,832    4,391,832
Leniency agreement        434,804     658,154   -   -    1,092,958
Lease       1,109,048     855,803     581,592     2,436,734    4,983,177
At December 31, 2022     16,639,871   4,764,065   4,512,907   87,985,041   113,901,884

 

 

4.4 Capital management

The Company’s policy is to maintain capital management to ensure the continuity and development of its business and to maintain the trust of investors, creditors and the general market. The capital structure, according to the Management, considers the balance between own capital and net debt. This composition meets the Company’s policy of providing a consistent return to shareholders and other stakeholders. This structure also allows borrowing costs to maximize shareholder remuneration.

Due to the impact of US$ on the Company’s operations, Management believes that the own capital used for capital management purposes should be measured in US$. Moreover, the Company may temporarily maintain another capital structure, for example, during periods of growth, when the Company may finance a large portion of its projects through borrowings, provided that this option maximizes return for shareholders once the financed projects start operating. In order to adjust and maintain the capital structure, the Management may also consider the sale of non-strategic assets, the issue of new shares or even adjustments to dividend payments.

As is the case of liquidity, capital is managed at the consolidated level, except for the liquidity and capital of the subsidiary Braskem Idesa and other subsidiaries with non-controlling interest, whose specific management is concentrated at the subsidiaries level. 

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and cash equivalents
12 Months Ended
Dec. 31, 2022
Cash and cash equivalents [abstract]  
Cash and cash equivalents

5 Cash and cash equivalents

           
          2022   2021
               
Cash            
  Domestic market         517,236     676,083
  Foreign market     (i)   5,556,972     4,374,739
Cash equivalents            
  Domestic market         3,684,999     1,141,221
  Foreign market     (i)   2,707,267     2,488,643
Total       12,466,474     8,680,686

 

(i) On December 31, 2022, it includes R$931,991 of cash and R$1,252,341 of cash equivalents (2021: R$1,267,582 of cash and R$505,749 of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.

Cash equivalents are represented mainly by fixed-income instruments and time deposits, such as bank deposit certificates (“CDBs”), treasury bonds, financial bills, debentures, and shares of fixed income investment funds. These assets may be directly held by the Company or through its exclusive funds, FIM Júpiter and FIM Netuno. Average yield of cash equivalents is presented jointly with financial investments (see note 6).

The cash equivalents abroad consist of fixed income instruments (Time Deposit) and interest bearing accounts.

 

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Financial investments
12 Months Ended
Dec. 31, 2022
Financial Investments  
Financial investments

6 Financial investments

         
        2022   2021
Amortized cost          
  Time deposit investments     -     106,271
Fair value through profit or loss        
  LFT´s and LF´s (i)   1,789,375     2,337,171
  Restricted funds investments (ii)   305,485     852,362
  Other     217,771     213,751
Total       2,312,631     3,509,555
             
Current assets       2,295,497     3,492,710
Non-current assets      17,134    16,845
Total       2,312,631     3,509,555

(i) These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.
(ii) Includes the following amounts: R$175,153 (2021: R$835,517) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$130,332 (2021: R$16,845) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.

 

In 2022, financial investments and cash equivalents (Note 5) in Brazilian R$ had an average yield of 102.59% of the CDI p.a. (2021: 102.50%) and financial investments and cash equivalents in foreign currency (Note 5) had an average yield of 1.18% p.a. (2021: 0.45% p.a.).

 

 

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Trade accounts receivable
12 Months Ended
Dec. 31, 2022
Trade Accounts Receivable  
Trade accounts receivable

7 Trade accounts receivable

The Company’s average receivables term is generally 30 days; therefore, the carrying value of the trade accounts receivable approximates their fair value. The Company realizes part of its trade accounts receivable through the sale of trade notes to funds and financial institutions that acquire receivables. These operations are not entitled to recourse and the risks and benefits over the receivables are transferred and the trade accounts receivable are derecognized.

As of December 31, 2022, the amounts of trade accounts receivable transferred and derecognized maturing after December 31, 2022, was R$3.5 billion (2021: R$3.5 billion). Loss recognized at the date of transfer of the abovementioned receivables were R$73 million (2021: R$39 million), recorded under Financial Expenses.

 

           
      Note   2022   2021
Customers            
Domestic market            
  Third parties         1,533,675     2,851,701
  Related parties   9    13,791    12,240
            1,547,466     2,863,941
Foreign market            
  Third parties         1,796,559     4,434,653
            1,796,559     4,434,653
Expected credit losses   (i)   (112,091)   (131,634)
Total       3,231,934   7,166,960
               
Current assets         3,231,934     7,153,565
Non-current assets       -    13,395
Total       3,231,934   7,166,960

 

(i) According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; (ii) receivables past due 90 to 180 days; (iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:

 

                         
            2022           2021
    Trade accounts receivable   Expected credit losses   Total   Trade accounts receivable   Expected credit losses   Total
                         
Accounts receivables not past due   2,687,775    (34,931)   2,652,844   6,705,123    (12,291)   6,692,832
Past due securities:    -    -                
Up to 90 days   536,289   (6,783)   529,506   431,899   (2,264)   429,635
Between 91 to 180 days     25,015   (3,010)     22,005     45,134   (1,390)     43,744
Above 180 days     94,946    (67,367)     27,579   116,438     (115,689)    749
                         
Total    3,344,025   (112,091)    3,231,934    7,298,594   (131,634)    7,166,960

 

The changes in the expected credit loss are presented below:

               
          2022   2021   2020
                   
Balance at the beginning of the year     (131,634)   (173,007)   (229,323)
Additions         (87,898)   (144,888)     (65,571)
Reversals        71,400     149,681    28,563
Write-off of securities considered uncollectible      36,041    36,580    93,324
Balance at the end of the year      (112,091)   (131,634)    (173,007)

Write-off

The gross carrying amount of a financial asset is written-off when the Company has no reasonable expectations of recovering a financial asset in its entirety or a portion thereof.

 

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories
12 Months Ended
Dec. 31, 2022
Inventories Abstract  
Inventories

8 Inventories

Inventories are measured at the lower of cost and net realizable value. The cost of inventories is recorded at the weighted average cost. In the case of manufactured inventories, besides raw materials and other consumables, cost includes an appropriate share of production overheads based on normal operating capacity.

           
               
          2022   2021
               
Finished goods       8,558,025   9,271,708
Semi-finished goods       663,182   568,914
Raw materials, production inputs and packaging     2,747,525   3,356,660
Maintenance materials       869,953   766,994
Advances to suppliers       124,285     62,573
Imports in transit       1,067,094   2,308,252
Total         14,030,064    16,335,101

The effect of the provision for inventories at the year is shown below:

                 
        2022   2021   2020
                 
Balance at the beginner of the year       82,218   122,572   82,195
                 
Additions      (i)  533,471     97,911   120,483
Utilization/reversals      (103,583)    (138,265)    (80,106)
                 
Balance at the end of the year     512,106     82,218   122,572

(i) The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.

 

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Related parties
12 Months Ended
Dec. 31, 2022
Related Parties  
Related parties

9 Related parties

 

     
  Balances at December 31, 2022    Balances at December 31, 2021 
  Novonor and               Novonor and            
  subsidiaries   Petrobras and           subsidiaries   Petrobras and        
Balance sheet and associates   subsidiaries   Other (i)   Total   and associates   subsidiaries   Other (i)   Total
Assets                              
Current                              
Trade accounts receivable   -    11,924     1,867     13,791    -   4,894     7,346   12,240
Inventories  (advance to suppliers)   -    61,428     -     61,428    -   9,927     -     9,927
Dividends and interest on capital   -   -     4,296    4,296    -     -     -    -
Other receivabels 11,348   287     -     11,635    -   287     -     287
                               -
Non-current                              -
Other receivables    -   5,657     -    5,657    -    38,987     -   38,987
Total assets   11,348     79,296    6,163    96,807    -     54,095    7,346    61,441
                               
Liabilities                              
Current                              
Trade payables  126,014     137,764   14,189   277,967   103,259     134,063   11,113    248,435
Other payables 4     233,133     314   233,451    -     296,984     345    297,329
                               
Non-current                              
Trade payables   3,069   -     -    3,069    -     -     -    
Loan to non-controlling shareholders of Braskem Idesa   -   -    2,498,093   2,498,093    -     -    3,646,538    3,646,538
Total liabilities   129,087   370,897     2,512,596    3,012,580    103,259   431,047     3,657,996    4,192,302

 

  Year ended December 31, 2022   Year ended December 31, 2021   Year ended December 31, 2020
  Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total
Transactions                                              
Sales of products   -     182,218    437,514   619,732       171,665    540,855    712,520       182,521    326,825   509,346
Purchases of raw materials, finished goods services and utilities (334,363)    (22,900,140)     (24,813)   (23,259,316)     (306,426)    (19,833,063)    (6,953)   (20,146,442)     (133,127)    (14,566,840)    (20,350)   (14,720,317)
Financial income (expenses), net  (854)     (33,656)   41,082    6,572   (141)     (11,758)   (245,819)     (257,718)   (452)    (3,810)   (818)   (5,080)
General and administrative expenses   -       (45,329)    (45,329)       -     (67,273)    (67,273)        (46,738)    (46,738)
Other income (expenses)   -    51,248     -     51,248     (217,497)     -     (217,497)         -  
                                               
(i) Borealis, Grupo Idesa, Refinaria de Petróleo Riograndense S.A e Vexty                                            

 

(a)New and/or renewed agreements with related companies

As provided for in Braskem’s bylaws, the Board of Directors has the exclusive power to approve any contract with related parties that exceed R$20,000 per transaction or R$60,000 collectively per year. This is valid for contracts between Braskem and its subsidiaries and: (i) direct or indirect subsidiaries of Braskem in whose capital an interest is held by the controlling shareholder, by any direct or indirect subsidiaries thereof or by Key Management Personnel of such entities; (ii) associates of Braskem and subsidiaries of such entities; and (iii) joint ventures in which Braskem participates and any subsidiaries thereof.

The related parties that have significant relationship with the Company are as follows:

Novonor and its direct and indirect subsidiaries:

- Tenenge Montagem e Manutenção Ltda. (“Tenenge”)

In February 2022, the Company entered into an electromechanical assembly service agreement to expand the production capacity of the Ethylene-Ethanol Unit located in Trunfio, Rio Grande do Sul with Tenenge, with duration from February 9, 2022 to July 31, 2023. The estimated amount of the agreement is R$142 million.

Petrobras and its indirect joint ventures:

Petrobras

In June 2020, the Company entered into a sales option agreement for up to 2,850 kton/y of petrochemical naphtha to Petrobras with mandatory purchase by Braskem. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$30 billion.

In December 2020, the Company entered into a sale agreement with Petrobras for up to 2 million tons of petrochemical naphtha per year, for our industrial unit in the State of São Paulo. This term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount under the agreement is R$25 billion.

In December 2020, the Company entered into an agreement with Petrobras to purchase ethane and propane to produce up to 580,000 tons of ethylene equivalent and sell up to 58.4 million Nm³ of hydrogen. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$9.2 billion.

- Petrobras Transporte S.A. (“Transpetro”)

In January 2021, the Company entered into an agreement with Transpetro involving the provision of services to Braskem, namely tanker vessel unloading in the Madre de Deus Waterway Terminal (“TEMADRE”), tank storage, product transportation via the pipeline “ORMADRE” that connects TEMADRE to REFMAT, and the transportation of naphtha via pipeline from TEMADRE to the facilities of the carrier located in the municipality of Camaçari/BA. The duration of the agreement is from February 1, 2021 to December 31, 2025, and the total estimated amount of the agreement is R$203 million.

- Petrocoque S.A. Indústria e Comércio (“Petrocoque”)

In March 2021, the Company executed an amendment to extend the agreement with Petrocoque, for purchase of steam to be used as energy by Polyethylene plants. This amendment, summed to total amount of the original agreement, executed in September 2009, amounts to R$433 million and is valid until March 2024.

- Refinaria Alberto Pasqualini (“REFAP”)

In June 2020, the Company entered into a naphtha supply agreement with Petrobras for 450 kton/y, from the REFAP to our unit in the State of Rio Grande do Sul. The term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount of the agreement is R$2.5 billion.

In October 2021, the Company entered into a purchase agreement with Petrobras for 108 kton/year of polymer-grade propylene from REFAP, with delivery to Braskem’s polypropylene industrial units, PP1 and PP2, in Triunfo, Rio Grande do Sul. This agreement is in force from November 1, 2021 to October 31, 2022. The maximum amount of the agreement is estimated at R$630 million.

- Refinaria Capuava (“RECAP”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 140 kton/year of polymer-grade propylene from RECAP, with delivery to Braskem’s PP4 industrial unit (“PP4”) in Mauá, São Paulo,. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$3.3 billion for the purchase of propylene.

- Refinaria Duque de Caxias (“REDUC”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 100 kton per year of polymer-grade propylene from REDUC, with delivery to Braskem’s PP5 industrial unit (“PP5”) in Rio de Janeiro. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$2.4 billion for the purchase of propylene.

- Refinaria Henrique Lage (“REVAP”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 120 kton per year and 40 kton per year of polymer-grade propylene from REVAP, with delivery to Braskem’s PP3 and PP4 industrial units, respectively. This agreement is in force from January 1, 2022 to May 3, 2028 for the first 120 kton/year and from May 4, 2028 to June 30, 2029 for the remaining 40 kton/year. The maximum amount of the agreement is estimated at R$4.7 billion.

- Refinaria Planalto de Paulínia (“REPLAN”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 220 kton per year of polymer-grade propylene from REPLAN, with delivery to Braskem’s PP3 industrial unit (“PP3”) in Paulínia, São Paulo. The agreement is in force from January 1, 2022 to May 3, 2028. The maximum amount of the agreement is estimated at R$8.1 billion for the purchase of propylene.

- Refinaria Presidente Getúlio Vargas (“REPAR”)

In December 2021, the Company entered into a purchase agreement with Petrobras for 150 kton per year of polymer-grade propylene from REPAR, with delivery to Braskem’s PP3 and PP4 industrial units. The agreement is in force from January 1, 2022 to December 6, 2029. The maximum amount of the agreement is estimated at R$6.8 billion.

- Companhia de Gás da Bahia (“Bahiagás”)

In December 2021, the Company entered into an amendment to the agreement governing the supply of natural gas by Bahiagás to Braskem, via local gas pipeline, effective until December 2022. The estimated amount of the amendment is R$752 million.

- Companhia de Gás do Estado do Rio Grande do Sul (“Sulgás”)

In March 2022, the Company entered into the agreement with Sulgás to acquire natural gas, via a local gas distribution pipeline, its terms to June 2023. The estimated amount of the amendment is R$270 million.

- Gás de Alagoas S.A. (“Algás”)

In March 2022, the Company entered into an amendment with Algás for the supply of natural gas to Braskem units located in the state of Alagoas, via a local gas distribution pipeline, its terms to December 2024. The estimated value of the amendment is R$1.5 billion.

Since July 2022, Petrobras has no more equity interest in Bahiagás, Sulgás and Algás and, upon which they ceased to be a related party to Braskem.

Non-controlling shareholders of Braskem Idesa:

- Grupo Idesa, S.A. de C.V.

- Etileno XXI, S.A. de C.V.

Loan payable to the non-controlling shareholders of Braskem Idesa, with maturity in December 2029 and contractual interest rate of 7% p.a. These funds were used by Braskem Idesa to finance the construction of its operational assets.

 

(b) Key management personnel compensation

The expenses related to the remuneration of key management personnel, including the Board of Directors, the Chief Executive Officer and vice-presidents, recorded in the profit or loss for the year, are shown as follows:

             
Statement of profit or loss transactions   2022   2021   2020
Remuneration            
Short-term benefits    83,466     119,734    74,943
Post-employment benefit   1,636   2,121   961
Long term incentive plan    16,938    14,394   7,456
Total   102,040   136,249     83,360

Compensation of the Company’s key management personnel includes salaries, short and long-term incentives, non-cash benefits and contributions to a post-employment defined benefit plan (see Note 27).

 

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes recoverable
12 Months Ended
Dec. 31, 2022
Taxes Recoverable  
Taxes recoverable

10 Taxes recoverable

       
        2022   2021
             
Parent Company and subsidiaries in Brazil        
  Value-added tax on sales and services (ICMS)    410,138   291,424
  ICMS - credits from PP&E   302,940   224,308
  Social integration program (PIS) and social contribution on revenue (Cofins) (a) 560,002   250,491
  PIS and Cofins - credits from PP&E   546,427   447,476
  REINTEGRA program       20,504     21,764
  Federal tax credits   (b) 153,960   948,448
  Other       68,514     89,205
             
Foreign subsidiaries        
  Value-added tax ("IVA")   579,672   348,021
  Other     131,867     59,579
Total     2,774,024   2,680,716
             
Current assets     1,156,355   1,428,658
Non-current assets   1,617,669   1,252,058
Total     2,774,024   2,680,716

(a) PIS and COFINS

Complementary Law 194/2022 was published, which reduced to zero the rates of the contributions levied on sales of fuels, which increased the respective credits.

(b) Federal tax credits

Up to December 31, 2021, the balance was primarily composed of federal tax credits related to exclusion of ICMS from the PIS and Cofins tax calculation base. As of December 31, 2022, of the total tax credit recorded by the Company related to this tax, since 2019, R$5,093,151 has been offset, with the decision on the credit becoming final and unappealable.

 

 

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
12 Months Ended
Dec. 31, 2022
Investments Abstract  
Investments

11 Investments

See the accounting policy in Note 2.3 Basis of Consolidation.

(a) Information on investments

                           
              Net profit (loss) for the year   Equity
              2022   2021   2020   2022   2021
Jointly-controlled investment                          
  RPR       (i)    76,450   312   (63,525)     110,040    50,064
  Bioglycols LLC     (ii)     (3,977)   -      80,757   -
Associate                            
  Borealis     (iii)    53,617    45,490   6,019     252,053     205,568

 

(i)RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is 33.20% (2021: 33.20%).
(ii)Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).
(iii)Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is 20% (2021: 20%).

 

(b) Changes in investments

                     
    Borealis   RPR   Bioglycols LLC   Other   Total
                     
Balance at 2020   32,272   10,697   -      184   43,153
                     
Dividends and interest on equity     (295)   -             (295)
Equity in results of investees   9,136   103   -        9,239
Other comprehensive income       5,825           5,825
Other               1,001   1,001
                     
Balance at 2021   41,113   16,625       1,185   58,923
                     
Dividends and interest on equity     (5,013)     (4,296)             (9,309)
Equity in results of investees    11,296    25,384   (1,832)        34,848
Other comprehensive income         (1,174)    1,299     (788)     (663)
Capital increase             41,908    23,061    64,969
Other               255   255
                     
Balance at 2022   47,396   36,539    41,375   23,713   149,023

  

 

(c) Impact on the consolidation of Braskem Idesa

The Company presents the financial information of the subsidiary Braskem Idesa, which holds a non-controlling interest with material effects on the Company’s consolidated statements:

                                 
Statement of Financial Position     Consolidated Braskem without the effect off Braskem Idesa consolidated     Consolidated Braskem Idesa (i)     Eliminations     Consolidated 
    2022   2021   2022   2021   2022   2021   2022   2021
Assets                                
Curent                                
Cash and cash equivalents    10,282,142   6,907,355   2,184,332    1,773,331   -   -     12,466,474    8,680,686
Financial investments   2,295,497   3,492,710   -     -   -   -    2,295,497    3,492,710
Trade accounts receivable   3,621,335   6,607,762     73,195    1,225,479   (462,596)   (679,676)    3,231,934    7,153,565
Inventories    12,921,617    15,325,001   1,108,447    1,010,100   -   -     14,030,064     16,335,101
Taxes recoverable   905,844   1,402,100   250,511   26,558   -   -    1,156,355    1,428,658
Recoverable income taxes   392,062   1,189,812   -     -   -   -    392,062    1,189,812
Derivatives   157,906     33,816   -     -   -   -    157,906   33,816
Other receivables   628,447   841,473     68,544    137,624    30,373   -    727,364    979,097
                                 
Total current assets     31,204,850    35,800,029   3,685,029     4,173,092    (432,223)    (679,676)     34,457,656     39,293,445
                                 
Non-current                                
Taxes recoverable   1,328,695   983,655   288,974    268,403   -   -    1,617,669    1,252,058
Recoverable income taxes   252,995   230,069   -     -   -   -    252,995    230,069
Deferred tax assets   6,671,492   6,481,642   488,116    1,775,610   (801,007)   -    6,358,601    8,257,252
Related parties   7,250,756    10,064,320   -     - (ii) (7,250,756)    (10,064,320)    -     -
Derivatives     71,544   51   -     -   -   -   71,544    51
Judicial deposits    215,274   194,212   -     -   -   -    215,274    194,212
Other receivables   187,107   370,928    563   24,964   -   -    187,670    395,892
Investments   149,023     58,923   -     -   -   -    149,023   58,923
Property, plant and equipment    24,319,015    23,510,588    14,126,939     14,483,720 (iii) (682,659)   (769,178)     37,763,295     37,225,130
Intangible   2,730,124   2,572,675   292,020    304,624   -   -    3,022,144    2,877,299
Right of use of assets   3,638,507   2,427,633   910,900    352,404 (v) (596,420)   -    3,952,987    2,780,037
                                 
Total non current assets     46,814,532    46,894,696    16,107,512   17,209,725    (9,330,842)     (10,833,498)     53,591,202     53,270,923
                                 
Total assets    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368
                                 
Liabilities and shareholders' equity                                
Current                                
Trade payables    11,418,031    11,861,563   1,291,347    871,379   (462,596)   (679,676)     12,246,782     12,053,266
Borrowings   1,254,550   1,343,494   -     -   -   -    1,254,550    1,343,494
Debentures   127,801     59,088   -     -   -   -    127,801   59,088
Braskem Idesa Borrowings   -   -   868,635   86,765   -   -    868,635   86,765
Payroll and related charges   789,441   1,095,040     38,385   75,306   -   -    827,826    1,170,346
Taxes payable   481,729   1,003,813    9,322     8,303   -   -    491,051    1,012,116
Income taxes payable   381,117   1,672,844   -     -   -   -    381,117    1,672,844
Lease   955,225   598,523   195,518   76,843 (v) (111,037)   -    1,039,706    675,366
Provision - geological event in Alagoas   4,247,609   4,378,071   -     -   -   -    4,247,609    4,378,071
Other payables   2,645,828   2,495,544     24,283    246,623    30,059   -    2,700,170    2,742,167
                                 
 Total current liabilities    22,301,331    24,507,980   2,427,490     1,365,219    (543,574)    (679,676)     24,185,247     25,193,523
                                 
Non-current                                
Loan agreements    31,310,710    33,553,766   -     -   -   -     31,310,710     33,553,766
Braskem Idesa Borrowings   -   -    10,501,683     12,224,770   -   -     10,501,683     12,224,770
Debentures   3,023,674   137,830   -     -   -   -    3,023,674    137,830
Accounts payable to related parties   -   -   7,175,837     10,134,287 (ii) (7,175,837)    (10,134,287)    -     -
Loan to non-controlling shareholders of Braskem Idesa   -   -   2,498,093    3,646,538   -   -    2,498,093    3,646,538
Deferred tax liabilities   904,521   1,407,434   1,049,967     -   (801,007)   -    1,153,481    1,407,434
Provision for losses on subsidiaries   4,094,535   5,284,666   -     - (iv) (4,094,535)   (5,284,666)    -     -
Lease   2,942,284   2,147,745   746,285    333,303 (v) (487,745)   -    3,200,824    2,481,048
Provision - geological event in Alagoas   2,378,949   3,283,188   -     -   -   -    2,378,949    3,283,188
Other payables   3,590,317   4,406,733     97,663   25,710   -   -    3,687,980    4,432,443
                                 
 Total non current liabilities    48,244,990    50,221,362    22,069,528   26,364,608     (12,559,124)     (15,418,953)     57,755,394     61,167,017
                                 
Shareholders' equity                                
Attributable to the  Company's shareholders   7,321,798   7,865,819    (4,704,477)   (6,347,010)     4,704,478     6,347,010    7,321,799    7,865,819
                                 
Non-controlling interest in subsidiaries   151,263     99,564   -     -   (1,364,845)   (1,761,555)     (1,213,582)     (1,661,991)
                                 
Total shareholders equity    7,473,061   7,965,383     (4,704,477)   (6,347,010)   3,339,633   4,585,455    6,108,217     6,203,828
                                 
Total liabilities and shareholders' equity    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368

(i) Consolidation of Braskem Idesa with its subsidiaries Braskem Idesa Servicios and Terminal Química.
(ii) Loan from Braskem Holanda to the Braskem Idesa project.
(iii) Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.
(iv) Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.
(v) Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.

 

 

                                                 
 Statement of profit or loss   Consolidated Braskem without the effect of                        
     Braskem Idesa consolidated     Consolidated Braskem Idesa     Eliminations     Consolidated 
    2022   2021   2020   2022   2021   2020   2022   2021   2020   2022   2021   2020
                                                 
                                                 
Net revenue     93,038,949     101,448,155   55,779,528   5,953,229   6,333,199   4,046,581     (2,472,894)     (2,156,153)     (1,282,615)     96,519,284     105,625,201     58,543,494
Cost of products sold   (82,624,987)     (72,471,291)    (45,563,723)   (5,074,693)   (3,321,601)   (3,112,129)   2,539,132   2,224,661   1,344,438   (85,160,548)     (73,568,231)   (47,331,414)
                                                 
Gross profit     10,413,962    28,976,864   10,215,805   878,536   3,011,598   934,452   66,238   68,508   61,823     11,358,736    32,056,970     11,212,080
                                                 
Income (expenses)                                                 
Selling and distribution     (1,890,181)    (1,834,303)   (1,609,844)   (218,236)   (221,337)   (242,211)           (2,108,417)    (2,055,640)     (1,852,055)
(Loss) reversals for impairment of trade accounts receivable    (38,248)     (8,736)     (55,074)    (178)    (178)    (178)          (38,426)     (8,914)    (55,252)
General and administrative      (2,545,044)    (2,292,884)   (1,739,541)   (216,098)   (229,334)   (179,350)     (2,841)   91    144     (2,763,983)    (2,522,127)     (1,918,747)
Research and development     (374,493)    (296,583)   (250,648)                 (374,493)    (296,583)     (250,648)
Results from equity-accounted investees   (1,078,115)   (82,709)   (1,026,922)    7       1,112,956     87,353   1,007,524   34,848    4,644    (19,398)
Other income    505,629   1,530,443     748,923   1,704   4,044   1,826          507,333   1,534,487   750,749
Other expenses     (2,305,411)    (2,651,425)   (7,573,874)     (38,114)     (17,865)   (364,747)   -   -   -     (2,343,525)    (2,669,290)     (7,938,621)
                                                 
Operating profit    2,688,099    23,340,667    (1,291,175)   407,621   2,546,928   149,792   1,176,353    155,952   1,069,491     4,272,073    26,043,547     (71,892)
                                                 
Financial results                                                
Financial expenses      (5,013,176)    (4,750,895)   (3,851,233)   (1,817,551)   (1,618,020)   (1,505,628)   1,168,034   461,760   443,496     (5,662,693)    (5,907,155)     (4,913,365)
Financial income    2,558,268   2,276,312     1,032,530     610,792    12,886    11,150    (1,158,926)    (461,760)    (443,496)    2,010,134   1,827,438   600,184
Exchange rate variations, net     (643,377)    (2,884,292)   (4,823,269)     235,314   (1,164,697)   (482,125)    (164,107)     46,182    6,683     (572,170)    (4,002,807)     (5,298,711)
                                                 
Finance income (cost)   (3,098,285)     (5,358,875)    (7,641,972)    (971,445)    (2,769,831)    (1,976,603)     (154,999)   46,182     6,683   (4,224,729)     (8,082,524)     (9,611,892)
                                                 
(Loss) profit before income tax                                                

 and social contribution

  (410,186)    17,981,792    (8,933,147)    (563,824)    (222,903)    (1,826,811)   1,021,354    202,134   1,076,174    47,344    17,961,023     (9,683,784)
                                                 
Income taxes   95,651    (3,991,055)     2,253,684   (963,386)    (8,348)     414,794   -   -   -     (867,735)    (3,999,403)   2,668,478
                                                 
(Loss) net profit for the year   (314,535)    13,990,737    (6,679,463)    (1,527,210)    (231,251)    (1,412,017)   1,021,354    202,134   1,076,174   (820,391)    13,961,620     (7,015,306)

 

                                                 
  Statement of cash flows    Consolidated Braskem without the effect of                                  
       Braskem Idesa consolidated     Consolidated Braskem Idesa             Eliminations             Consolidated 
      2022   2021   2020   2022   2021 2020   2022   2021   2020   2022   2021   2020
                                                 
(Loss) profit before taxes     (410,186)   18,348,774   (8,933,147)   (563,824)    (222,903)  (1,826,811)   1,021,354     (164,848)   1,076,174   47,344   17,961,023    (9,683,784)
                                                 
Adjustments for reconciliation of profit (loss)                                        
  Depreciation and amortization    3,944,259     3,432,816     2,995,609    901,194   796,861 1,114,439     (112,288)    (51,244)   (61,967)    4,733,165     4,178,433   4,048,081
  Results from equity-accounted investees    1,078,108     (78,567)     1,026,922         (1,112,956)     73,923    (1,007,524)    (34,848)    (4,644)     19,398
  Interest and  monetary and exchange variations, net    1,788,259     3,604,357     8,541,980    759,378   2,564,905 1,921,975   154,999   142,169     (6,683)    2,702,636     6,311,431    10,457,272
  Reversal of provisions    370,153     819,130     336,838              370,153     819,130   336,838
  Provision - geological event in Alagoas    1,520,019     1,339,765     6,901,828              1,520,019     1,339,765   6,901,828
  PIS and Cofins credits - exclusion of ICMS from the calculation basis     (1,031,099)   (310,557)               (1,031,099)    (310,557)
  Loss for impairment of trade accounts receivable   38,426    10,134    55,252       (1,220)         38,426   8,914     55,252
  Provision for losses and write-offs of long-lived assets    130,366     114,148   8,794     629    1,039          130,995     115,187    8,794
                                                 
  Adjustments for reconciliation of profit     8,459,404   26,559,458   10,623,519     1,097,377   3,138,682 1,209,603     (48,891)        9,507,890   29,698,140    11,833,122
                                                 
Changes in operating working capital                                   
  Judicial deposits - unfreezing (blocking) Public Civil Action         3,746,107                 3,746,107
  Financial investments    1,530,050     296,957   (1,860,827)              1,530,050     296,957    (1,860,827)
  Trade accounts receivable    2,751,788   (1,739,822)   (2,247,729)    1,126,559    (619,688)  (152,971)     (217,080)   184,225   212,874    3,661,267   (2,175,285)    (2,187,826)
  Inventories    2,246,770   (7,176,104)   (309,492)   (108,609)    (398,181)   56,958          2,138,161   (7,574,285)    (252,534)
  Taxes recoverable    928,181     4,958,779     1,584,911   (245,724)    4,808 (52,357)          682,457     4,963,587   1,532,554
  Prepaid expenses        (172,027)      465,812              293,785
  Other receivables    297,209   (269,721)    44,513   13,580     71,165 352,590          310,789   (198,556)   397,103
  Trade payables    (73,230)     955,475   (2,926,585)    370,229   428,364 137,895   217,080     (184,225)    (212,874)    514,079     1,199,614    (3,001,564)
  Taxes payable     (1,085,427)   (2,878,056)     965,191   76,071    (129,432)  (515,430)           (1,009,356)   (3,007,488)   449,761
  Advances from customers        224,764     (25,776)             198,988
  Leniency agreement     (317,867)   (389,087)   (349,842)     -             (317,867)   (389,087)    (349,842)
  Sundry provisions     (219,313)   (482,565)   (158,915)   (187,274)   168,371   13,560           (406,587)   (314,194)    (145,355)
  Geological event in Alagoas     (2,742,791)   (2,928,081)   (1,181,931)     -             (2,742,791)   (2,928,081)    (1,181,931)
  Other payables     (384,838)     823,515   (217,997)    (5,889)   (18,063)   33,810           (390,727)     805,452    (184,187)
                                                 
Cash generated from operations     11,389,936   17,730,748     7,763,660     2,136,320   2,646,026 1,523,694     (48,891)         13,477,365   20,376,774    9,287,354
                                                 
  Interest paid     (2,118,043)   (2,207,196)   (1,946,931)   (786,836)    (676,237)  (789,890)           (2,904,879)   (2,883,433)    (2,736,821)
  Income taxes     (1,620,616)   (2,697,829)   (252,479)    (131)     (9,027)   (5,063)           (1,620,747)   (2,706,856)    (257,542)
                                                 
Net cash generated by operating activities    7,651,277   12,825,723     5,564,250     1,349,353   1,960,762  728,741     (48,891)        8,951,739   14,786,485    6,292,991
                                                 
Proceeds from the sale of fixed assets and intangible assets     2,438    40,353    33,140                 2,438    40,353     33,140
Additions to investment in subsidiaries     (107,090)                           (107,090)    
Dividends received     5,660   295   4,822                 5,660   295    4,822
Acquisitions to property, plant and equipment and intangible assets     (4,153,707)   (3,249,132)   (2,653,009)   (694,574)    (172,192)  (106,780)           (4,848,281)   (3,421,324)    (2,759,789)
                                                 
Net cash used in investing activities   (4,252,699)    (3,208,484)    (2,615,047)    (694,574)     (172,192)   (106,780)         (4,947,273)    (3,380,676)     (2,721,827)
                                                 
Short-term and long-term debt                                              
  Acquired    6,418,208    16,308   13,049,459     -            6,418,208    16,308    13,049,459
  Payments     (3,855,662)   (9,413,909)   (8,734,505)     -             (3,855,662)   (9,413,909)    (8,734,505)
Braskem Idesa borrowings                                        
  Acquired             -   7,271,658               7,271,658  
  Payments             (45,311)    (7,995,045)  (905,210)            (45,311)   (7,995,045)    (905,210)
Related parts       216,862         (34,122)    (226,407)              (34,122)    (9,545)  
Loan to non-controlling shareholders of Braskem Idesa - payment                     (37,618)                   (37,618)
Lease     (836,718)   (787,932)   (610,392)   (141,063)   (53,774) (51,676)     48,891         (928,890)   (841,706)    (662,068)
Dividends paid     (1,350,293)   (5,993,265)    (2,380)               (1,350,293)   (5,993,265)     (2,380)
Non-controlling interest in subsidiaries   21,162     (534,456)             21,162      (534,456)
                                                 
Cash generated (used) in financing activities     396,697     (15,961,936)     3,167,726    (220,496)     (1,003,568)   (994,504)    48,891         225,092     (16,965,504)    2,173,222
                                                 
Exchange variation on cash of foreign subsidiaries     (420,488)     293,633     1,054,845     (23,282)     83,896 259,741           (443,770)     377,529   1,314,586
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972
                                                 
Represented by                                              
  Cash and cash equivalents at the beginning for the period    6,907,355   12,958,419     5,786,645    1,773,331   904,433 1,017,235          8,680,686   13,862,852   6,803,880
  Cash and cash equivalents at the end for the period     10,282,142     6,907,355   12,958,419    2,184,332   1,773,331 904,433           12,466,474     8,680,686    13,862,852
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972

 

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Property, plant and equipment
12 Months Ended
Dec. 31, 2022
Property, plant and equipment [abstract]  
Property, plant and equipment

12 Property, plant and equipment

Items of property, plant and equipment are measured at the historical cost of acquisition or construction, which includes capitalized borrowing costs, less accumulated depreciation and any accumulated impairment losses.

The machinery, equipment and facilities require inspections, replacement of components and maintenance at regular intervals. The Company makes shutdowns at regular intervals that vary from two to six years to perform these activities. These shutdowns can involve the plant as a whole, a part of it, or only relevant pieces of equipment, such as industrial boilers, turbines and tanks. Expenses with each scheduled shutdown are included in property, plant and equipment items that were the stoppage’s subject matter and are fully depreciated until the beginning of the following related stoppage.

Depreciation starts when the assets become available and is calculated using the straight-line method, based on the useful life estimated by the Company’s technicians in the management of the plants. The useful lives of assets are reviewed at each reporting date.

The main factors taken into consideration in the definition of the useful life of the assets that compose the Company’s industrial plants are the information of manufacturers of machinery and equipment, level of the plants’ operations, quality of preventive and corrective maintenance and the prospects of technological obsolescence of assets.

The estimated useful lives applied to the assets determined the following average percentage of rates per year:

       
      2022   2021
Buildings and improvements      3.03    2.92
Machinery, equipment and installations      7.32    6.74
Furniture and fixtures      10.06    10.06
IT equipment      21.03    21.18
Lab equipment      9.59    9.53
Security equipment      10.50    10.04
Vehicles      19.51    18.82
Other      18.09    17.05

 

Borrowing costs are capitalized when associated with ongoing projects, using: (i) the average rate of the financings; and (ii) the exchange variation portion that corresponds to any positive difference between the average rate of financing in the domestic market and the rate cited in item (i).

In 2022, capitalized borrowing costs amounted to R$203,135 (2021: R$192,207). The average rate of these charges in the year was 8.51% p.a. (2021: 8.33% p.a.).

As of December 31, 2022, the acquisition of property, plant and equipment with payment installments is R$525,192 (2021: R$295,056).

(a) Reconciliation of carrying amount

                         
       Land     Buildings and Improvements     Machinery, Equipment and Facilities     Projects and Stoppage in Progress (i)     Other     Total 
                           
Cost       683,031     8,281,424   53,401,832    4,389,105   2,038,666    68,794,058
Accumulated depreciation and amortization       -   (3,159,185)   (28,268,867)    -   (1,436,857)   (32,864,909)
Balance as of December 31, 2020       683,031     5,122,239   25,132,965    4,389,105   601,809    35,929,149
                           
Acquisitions       -   338     160,297    3,388,078    3,421   3,552,134
Capitalized financial charges       -    -    -    192,207   -   192,207
Foreign currency translation adjustment                          
  Cost      17,046     287,866     1,118,655   74,428     23,859   1,521,854
  Depreciation       -   (88,406)   (313,267)    -   (16,760)   (418,433)
Transfers by concluded projects     244    13,965     3,207,833   (3,412,665)   190,623   -
Transfers to inventory       -    -    -   (16,838)   -   (16,838)
Transfers to intangible       -    31,495   (11,673)   (73,397)   (11,847)   (65,422)
Disposals                          
Cost     (10,856)   9,723   (353,274)   (91,485)   (41,066)   (486,958)
Depreciation       -   168     387,005    -    9,206   396,379
Depreciation       -   (195,900)   (3,038,176)    -   (143,164)   (3,377,241)
Transfers to "non-current assets held for sale"     (1,701)    -   (2)    -     2   (1,701)
Transfers Others       -         118,629   (40,095)   (78,534)    
Net book value       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
Cost       687,764     8,591,020   57,535,343    4,449,433   2,215,503    73,479,063
Accumulated depreciation       -   (3,409,532)   (31,126,351)   (40,095)   (1,677,954)   (36,253,933)
Balance as of December 31, 2021       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
                           
Acquisitions       -   1,709     296,719    4,643,953    7,603   4,949,985
Additions through acquisition of ER Plastics       -    20,868    56,288    -    362     77,518
Capitalized financial charges       -    -    -    203,135   -   203,135
Foreign currency translation adjustment                         -
  Cost     (19,916)   (173,496)   (941,271)   (38,966)   (28,592)   (1,202,241)
  Depreciation       -    51,263     285,016    -     20,269   356,548
Transfers by concluded projects       -    86,609     2,688,220   (2,915,496)   140,667  
Transfers to intangible       -    -    -   (13,597)   -   (13,597)
Disposals                         -
  Cost     (3)   (7)   (926,944)   (20,665)   (16,689)   (964,308)
  Depreciation       -    -     815,220    -     13,715   828,934
Depreciation       -   (203,358)   (3,347,376)    -   (147,074)   (3,697,809)
Net book value       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295
Cost       667,845     8,526,704   58,708,355    6,307,797   2,318,854    76,529,554
Accumulated depreciation       -   (3,561,627)   (33,373,492)   (40,095)   (1,791,045)   (38,766,259)
Balance as of December 31, 2022       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295

 

(i) As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.

 

 

Property, plant and equipment by country

         
      2022   2021
           
Brazil       17,204,824     15,867,387
Mexico       13,444,279     13,714,543
United States of America      6,729,469    7,281,077
Germany      294,612    356,288
Netherland     89,841     5,691
Other       270     144
        37,763,295     37,225,130

 

(b) Impairment loss

Annually, or whenever there is any indication that an asset has suffered devaluation, the Company conducts an analysis to determine if there are indicators that the book value of property, plant and equipment may not be recoverable. This analysis is conducted to assess the existence of scenarios that could adversely affect its cash flow and, consequently, its ability to recover the investment in such assets. These scenarios arise from issues of a macroeconomic, legal, competitive, or technological nature.

The following are considered by the Company as relevant points and are observed in this analysis:

(i) the possibility of an oversupply of products manufactured by the Company or of a significant reduction in demand due to adverse economic factors;

(ii) the prospects of material fluctuations in the prices of products and inputs;

(iii) the likelihood of the development of new technologies or raw materials that could materially reduce production costs and consequently impact sales prices, ultimately leading to the full or partial obsolescence of the industrial facilities of the Company; and

(iv) changes in the general regulatory environment that make the production process of Braskem infeasible or that significantly impact the sale of its products.

The recoverable value of an asset or Cash Generating Unit (“CGU”) is the greatest of the value in use and its fair value less sales costs. The value in use is based on estimated future cash flows, discounted to present value using a discount rate before tax that reflects the current market assessments of the time value of money and the specific risks related to the asset or CGU.

When identifying whether cash inflows from an asset (or group of assets) are largely independent of cash inflows from other assets (or groups of assets), the Company considers several factors, such as: product lines, individual locations and the way Management monitors and makes decisions about its business.

No events indicated that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.

 

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets
12 Months Ended
Dec. 31, 2022
Intangible Assets  
Intangible assets

13 Intangible assets

                   
                 Customers     
         Brands     Software      and Suppliers     
     Goodwill     and Patents     licenses     Agreements     Total 
Cost     3,187,678     499,515     1,010,201    392,246    5,089,640
Accumulated amortization   (1,128,804)   (214,455)   (683,157)   (234,533)   (2,260,949)
Balance as of December 31, 2020     2,058,874     285,060     327,044    157,713    2,828,691
                     
Acquisitions     -   670    67,686     420   68,776
Foreign currency translation adjustment     -               14,271
Cost     -    12,443    13,023    -   25,466
Amortization     -   (2,711)   (8,484)    -   (11,195)
Transfers from property, plant and equipment     -    28,770    36,652    -   65,422
Other write-offs, net of amortization     -    -   (3,393)    -   (3,393)
Amortization     -   (10,444)   (64,008)   (22,016)   (96,468)
Net book value     2,058,874     313,789     368,520    136,117    2,877,299
Cost     3,187,678     549,196     1,123,619    392,666    5,253,159
Accumulated amortization   (1,128,804)   (235,408)   (755,099)   (256,549)   (2,375,860)
Balance as of December 31, 2021     2,058,874     313,789     368,520    136,117    2,877,299
                     
Acquisitions     -   1,307     144,930     913    147,150
Additions through acquisition of ER Plastics     -    21,162    -   66,571   87,733
Goodwill acquisition of ER Plastics    28,402    -    -    -   28,402
Foreign currency translation adjustment     -            -    -
Cost     -   (7,407)   (19,762)    -   (27,170)
Amortization     -   2,711    14,440    -   17,150
Transfers from property, plant and equipment     -    -    13,597    -   13,597
Other write-offs, net of amortization     -    -   (10,011)    -   (10,011)
Amortization     -   (10,575)   (79,774)   (21,659)   (112,008)
Net book value   2,087,276     320,986     431,939    181,943    3,022,144
Cost   3,216,080     564,258     1,252,373    460,150    5,492,861
Accumulated amortization   (1,128,804)   (243,272)   (820,434)   (278,207)   (2,470,717)
Balance as of December 31, 2022   2,087,276     320,986     431,939    181,943    3,022,144

 

(a)Goodwill

Goodwill is measured as the excess between the consideration transferred and to be transferred to obtain control and the fair value of the identified assets and liabilities assumed from the acquired entity. Goodwill is allocated to the CGUs or groups of assets that are expected to benefit from the synergies of the business combination. Goodwill arising before the adoption of the IFRS pronouncements was amortized in the accounting books until December 2008. From 2009 on, it has been subjected to annual impairment tests.

Impairment testing is based on estimated cash generation in each CGU or groups of assets, extracted from the Company’s five-year Business Plan (see Note 22.2) and from the Management plan for a period greater than 5 years to reflect the industry cycle patterns, with a total projection period of 10 years.

Perpetuity is also calculated based on the long-term vision and excluding real growth. Cash flows and perpetuity are adjusted to present value at a discount rate based on the Weighted Average Cost of Capital (“WACC”).

 

The table below shows the results obtained in the tests conducted by the Company in December 2022:

             
     Allocated     Recoverable     Book         Discount 
     goodwill     amount     value (i)     CF/Book value     rate 
                     
Northeastern petrochemical complex   475,780   7,305,045   3,124,332    2.3   14.68%
Southern petrochemical complex   1,390,741    20,840,873   6,781,881    3.1   15.85%
Vinyls   192,353   5,050,166   2,880,156    1.8   14.70%

 

(i) The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.

 

The inflation rate considered for perpetuity was 3%.

Given the potential impact on cash flows of the “discount rate” and “perpetuity”, the Company conducted a sensitivity analysis based on changes in these variables, with cash flows shown in the table below:

Schedule of potential impact on cash flows of the discount rate and perpetuity            
      +0.5% on   -0.5% on
         discount rate    perpetuity
CGU            
Northeastern petrochemical complex       6,822,642   7,044,458
Southern petrochemical complex        19,744,124    20,351,277
Vinyls       4,741,224   4,930,076

 

The main assumptions used for projecting cash flows are related to the projection of macroeconomic indicators, international prices, and global and local demand in the countries where the Company has operational plants. Macroeconomic indicators include items such as: foreign exchange rates, inflation, and interest rates, among others.

Prices for key petrochemical products are obtained from a specialized third-party consulting firm, drawing on projections reviewed and supplemented based on Management’s experience. Final prices take into consideration the meetings of specific internal committees and the knowledge of the Company’s experts in preparing the benchmarks for each market.

Similar to prices, indicators for global demand also are prepared with specialized consulting firms. In the markets where the Company operates more directly, they consider additional variables for the local demand composition.

(b)Intangible assets with definite useful lives

These intangible assets are measured at historical cost of acquisition or at fair value when acquired in a business combination, deducted from accumulated amortization and, if applicable, accumulated impairment loss. Subsequent costs are capitalized only when they increase the future economic benefits incorporated into the specific asset to which they are related.

Amortization is calculated using the straight-line method based on the estimated useful life of the items, and reviewed every reporting date, as follows, for consolidated purposes:

 

 
- Brands and patents 10-20 years
- Software licenses and rights of use 5-10 years
- Customers and suppliers’ agreements 14-28 years 

 

Expenditure on research activities is recognized in profit or loss as incurred. Development expenditure is capitalized only when the expenditure can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable and the Company intends to and has sufficient resources to complete development and to use or sell the asset.

Based on Management’s assessment, there were no events indicating that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.

(c)Intangible assets by country
         
      2022   2021
           
Brazil      2,571,011    2,526,999
Mexico      292,020    304,624
Netherland      122,447  
United States of America     22,820   24,404
Germany     13,839   21,253
Other     7    19
       3,022,144   2,877,299

 

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability
12 Months Ended
Dec. 31, 2022
Right-of-use Assets And Lease Liability  
Right-of-use assets and lease liability

14 Right-of-use assets and lease liability

The Company assesses whether a contract is or contains a lease if the contract transfers the right to control the use of an asset identified for a period in exchange for consideration. The Company leases various offices, railcars, vessels, pieces of equipment and vehicles. Such leases are negotiated individually and are subject to various terms and conditions.

As a lessee, the Company, to determine the enforceable term of the lease, considers all facts and circumstances that create an economic incentive for exercising the option to extend the lease.

(a)Right-of-use assets

Leases are recognized as a right-of-use asset and a corresponding liability on the date on which the leased asset becomes available to the Company.

The right-of-use asset is measured at the cost composed of:

• The amount initially measured of the lease liabilities;

• Any payment made up to the start of the lease, deducting any incentive received;

• Any initial direct cost; and

• Renovation costs.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property and equipment.

Changes in right-of-use assets:

                               
            Balance as of               Foreign currency   Balance as of
            31/12/2021   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2022
Rail cars             986,061     72,506    (173,272)   (5,359)     (53,740)     826,196
Machinery and equipment             793,254   1,147,145    (330,971)   (5,970)    (804)     1,602,654
Vessels             696,661   811,372    (385,968)    -    (1,793)     1,120,272
Buildings and constructions             265,312   102,040   (75,319)    -    (213)     291,820
Vehicles            29,449   102,827   (26,158)    -    (120)     105,998
Computer equipment and goods           9,300    417     (3,590)    -   (80)   6,047
Total           2,780,037   2,236,307     (995,278)     (11,329)   (56,750)     3,952,987
                                 
                                 
            Balance as of               Foreign currency   Balance as of
            12/31/2020   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2021
Rail cars             1,007,336   102,648    (187,915)    -   63,992     986,061
Machinery and equipment             749,728   281,113    (207,985)    (30,245)     643     793,254
Vessels             834,848   258,201    (399,677)    -     3,289     696,661
Buildings and constructions             259,896     52,897   (52,997)   (6,333)   11,849     265,312
Vehicles            33,888     51,171   (24,078)    (31,667)     135    29,449
Computer equipment and goods            16,699    542     (4,334)   (3,682)    75   9,300
Total           2,902,395    746,573     (876,986)     (71,928)     79,983     2,780,037

 

In 2022, the expense related to the short-term and low-value leases was R$42 million (2021: R$7.2 million).

To optimize lease costs during the lease term, the Company must provide guaranteed residual amounts for the leased asset. For certain lease agreements for rail cars, the Company guaranteed any difference between the flow of contractual payments and the fair value of these assets upon the end of the enforceable term, limited to R$65,529 as of December 31, 2022 (2021: R$70,085).

(b)Lease liability

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, the Company’s incremental borrowing rate. The lease liability considers the net present value of the following lease payments:

• Fixed payments discounting any incentive received;

• Variable payments based on rates or indexes;

• Expected payables to the lessor referring to the guaranteed residual amount;

• Exercise price of a purchase option, if it is reasonably certain that lessee will exercise such option; and

• Payment of fines for termination of the lease if the contractual terms provide for lessee’s exercise option.

The Company’s incremental borrowing rate corresponds to the one the Company would have pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use in a similar economic environment. The weighted average incremental rate applied in 2022 was 5.8% p.a. (2021: 5.18% p.a.). The lease liability is measured at amortized cost.

Changes in lease liabilities:

 

     
  2022   2021
       
As of December 31  3,156,414    3,207,886
       
Acquired 2,232,043   746,573
Additions through acquisition of ER Plastics  4,264    
Disposals  (12,568)    (50,473)
Interests and monetary and exchange variations, net   83,871   206,375
Currancy translation adjustments   (73,585)     85,984
Payments   (928,890)     (841,706)
Interest paid   (221,019)     (198,225)
As of December 31  4,240,530    3,156,414
       
Current liability 1,039,706   675,366
Non-current liability 3,200,824   2,481,048
Total  4,240,530    3,156,414

The table below presents the obligations (minimum annual commitments) related to undiscounted lease agreements, by maturity, and therefore may not correspond to the respective operations in the statement of financial position.

                 
              2022   2021
                   
2022                   777,410
2023               1,109,048     633,141
2024               855,803     493,147
2025               630,074     399,924
2026+               2,388,252     1,073,620
Total             4,983,177     3,377,242

(c)Extension Options

Some leases contain extension options that can be exercised by the Company. The extension options held are exercised only by the Company and not by the lessors. The Company assesses at lease commencement date whether it is reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control.

(d)Non-cash transactions

In 2022, non-cash transactions are R$1,909,816 (2021: R$565,774).

 

(e)Uninitiated lease arrangements

The Company has committed to lease agreements not yet effective as of December 31, 2022. The present value of the commitments corresponds to R$ 546 million, and the main agreements refer to: (i) construction of two vessels for ethane gas transportation; and (ii) a research and development laboratory located in Boston, United States. All have an expected completion date by 2024.

The cash flows related to the contracts are shown below:

       
     Discounted     Undiscounted 
    2022   2022
2023     1,014     1,080
2024   52,258   55,678
2025   49,390   56,067
2026   46,687   56,468
2027+    396,669    712,541
Total     546,017     881,835

  

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Trade payables
12 Months Ended
Dec. 31, 2022
Trade Payables  
Trade payables

15 Trade payables

         
    Note   2022   2021
Trade payables:          
Domestic market          
Third parties      1,748,853     1,492,223
Third parties (forfait) (i)    682,396     487,806
Total Third parties      2,431,249     1,980,029
             
Related parties      196,440     208,287
Related parties (forfait) (i)   81,527    40,148
Total Related parties 9     277,967     248,435
             
Foreign market (ii)        
Third parties      9,540,635     9,936,266
        12,249,851   12,164,730
             
Current liabilities       12,246,782   12,053,266
Non-current liabilities       3,069     111,464
Total       12,249,851   12,164,730

(i) The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.
(ii) Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.

 

XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Borrowings

16 Borrowings

(a) Borrowings

                 
        Annual financial charges (%)   2022   2021
Foreign currency                
Bonds       Note 16 (b)     26,124,158   30,322,998
Export prepayment and export credit notes   (i)   US$ exchange variation + Term SOFR quarterly + 1,79    1,514,651   -
Other       Note 16 (c)    3,880,165     4,703,059
Transactions costs             (453,532)   (594,048)
              31,065,442   34,432,009
                 
Current liabilities            1,177,144     1,284,483
Non-current liabilities             29,888,298   33,147,526
Total             31,065,442   34,432,009
                 
Local currency                
Agribusiness Credit Notes ("CRA")       Note 16 (d)    763,396   -
BNDES       IPCA + 6.04    386,534     435,778
Export credit notes       100.00 of CDI + 1.30    348,885   -
Other fixed interest loans       Interest between 3.5 and 6.5   18,671    24,864
Other variable interest loans       IPCA + interest between 2.39 and 2.78     3,525   4,616
Transactions costs            (21,193)     (7)
             1,499,818   465,251
                 
Current liabilities           77,406    59,011
Non-current liabilities            1,422,412     406,240
Total            1,499,818   465,251
                 
Foreign currency and local currency                
Current liabilities            1,254,550     1,343,494
Non-current liabilities             31,310,710   33,553,766
Total             32,565,260   34,897,260
(i) Maturity in June 2027.

 

 

 

The maturity profile of the long-term borrowings is as follows:

           
        2022   2021
             
2023         -     1,199,143
2024         2,143,624     3,965,917
2025         603,743     645,517
2026         581,625     622,032
2027         2,356,678     552,171
2028         7,281,841     7,081,301
2029         287,178     230,557
2030         7,995,727     8,535,493
2031         106,661    61,617
2033 and thereafter         9,953,633   10,660,018
Total       31,310,710   33,553,766

(b) Bonds

                   
            Interest    
Issue date       Maturity   (% per year)   2022   2021
Jul-2011 and jul-2012 (i)   jul-2041   7.125    3,044,911    3,296,917
Feb-2014 and may-2014 (ii)   fev-2024   6.450    1,588,729    3,417,741
Oct-2017   (ii)   jan-2023   3.500      593,964
Oct-2017   (i)   jan-2028   4.500    6,249,333    6,695,263
Nov-2019   (i)   jan-2030   4.500    7,936,089    8,527,701
Nov-2019       jan-2050   5.875    4,009,069    4,287,829
Jul-2020   (iii)   jan-2081   8.500    3,296,027    3,503,583
Total               26,124,158     30,322,998

 

(i) Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.
(ii) Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.
(iii) The bond can be repaid by the Company at par value, with the first payment between October 2025 and January 2026 and the other payments after each period of 5 years as from the first payment.

 

Braskem has fully, unconditionally and irrevocably, guaranteed the bonds issued by Braskem Finance, Braskem America Finance and Braskem Holanda Finance. Braskem’s guarantees for issues carried out between 2011 and 2019 comprise senior unsecured obligations of Braskem, ranking equal in right of payment with all of its other existing and future senior unsecured debt. As for the issuance carried out in 2020, in case of default the guarantee comprises obligations subordinated to all current or future senior debts of Braskem.

 

(c) Other

               
Issue date   Maturity   Charges (% per year)   2022   2021
nov-2018 (i) nov-2028   Us dollar exchange variation + semianual Libor + 0.90    929,112    1,154,146
dec-2019 (i) dec-2029   Us dollar exchange variation + semianual Libor + 0.90    549,610    670,124
dec-2019 (ii) apr-2026   Us dollar exchange variation + semianual Libor - 1.00     197,209    266,403
sep-2017 (iii) mar-2027   Us dollar exchange variation + semianual Libor + 1.61    357,488    462,490
jul-2018 (iv) dec-2028   Us dollar exchange variation + semianual Libor + 0.65    757,832    947,898
aug-2020 (iii) feb-2031   Us dollar exchange variation + semianual Libor + 1.70    1,007,067    1,201,998
aug-2020 (v) aug-2028 to jun-2029   Euro exchange variation + interest between 2.40 and 7.41   79,698    
nov-2020 (v) no maturity   Euro exchange variation + Euribor monthly + 4.10     2,149    
             3,880,165   4,703,059
(i)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.
(ii)Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.
(iii)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.
(iv)Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million.
(v)Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.

 

(d) CRA

On January 5, 2022, Eco Securitizadora de Direitos Creditórios do Agronegócio S.A. issued CRA in the Brazilian debt capital markets backed by a private debenture issued by Braskem.

                             
      Issue amount                    
Issue date       Issuer   Series   Maturity   Charges (% per year)   2022   2021
Jan-2022       581,602    Braskem S.A.      Dec-2028   IPCA + 5.54%   616,025   -
Jan-2022       139,134    Braskem S.A.      Dec-2031   IPCA + 5.57%   147,371   -
Total     720,736                    763,396    

 

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Braskem Idesa Borrowings
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Braskem Idesa Borrowings

17 Braskem Idesa Borrowings

                 
             
Identification   Maturity   Charges (% per year)   2022   2021
                 
Bonds                
Bond I   nov-2029   Us dollar exchange variation + 7.45 (i)   4,690,619    5,104,463
Bond II   feb-2032   Us dollar exchange variation + 6.99 (ii)   6,352,864    6,834,805
             11,043,483     11,939,268
                 
Others (a) Oct-2026   Us dollar exchange variation + quarterly Libor + 4.00 (iii) 734,837     849,859
                 
Transactions costs            (408,002)     (477,592)
                 
Total            11,370,318     12,311,535
                 
Current liabilities             868,635   86,765
Non-current liabilities           10,501,683     12,224,770
Total            11,370,318     12,311,535

(i)Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.
(ii)Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.
(iii)For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.
(a) Regarding this financing, on December 22, 2022 Braskem Idesa obtained the waiver related to a leverage ratio (covenant) until June 30, 2023. In this sense, even though Braskem Idesa is not in default and creditors did not request to accelerate this debt, because the waiver did not cover at least 12 months, the entire balance, in the amount of R$649,560, was reclassified from non-current liabilities to current liabilities on December 31, 2022.

 

Braskem Idesa is in full compliance with its debt service obligation defined in the financing agreement and maintains a cash position equivalent to R$2,184,332 as of December 31, 2022.

The amount of the financings with maturities in the long term are as follows:

       
    2022   2021
         
2023   -   67,649
2024   -   68,694
2025   -   69,530
2026   -    408,445
2029     4,337,567    4,900,399
2032     6,164,116    6,710,053
Total   10,501,683     12,224,770

 

 

XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Debentures
12 Months Ended
Dec. 31, 2022
Debentures Abstract  
Debentures

18 Debentures

                       
                Annual    
Issue date   Issuer   Series   Maturity   financial charges (%)   2022   2021
mar-2013 (i) DAC   Only   mar-2025   IPCA + 6%   109,877   150,352
sep-2013 (i) Cetrel   Only   Sep-2025   126.5% of CDI     34,604     47,109
may-2022   Braskem     may-2029   CDI + 1,75   770,910    -
may-2022   Braskem     may-2030 to 2032   CDI + 2,00   248,970    -
aug-2022 (i) Braskem    Only   aug-2029   CDI + 1,75   786,770    -
nov-2022   Braskem      nov-2029   CDI + 1,70   1,113,987    -
nov-2022   Braskem      nov-2030 to 2032   CDI + 1,95     97,159    -
Transactions costs                    (10,802)   (543)
                     3,151,475    196,918
                         
Current liabilities                   127,801     59,088
Non-current liabilities                 3,023,674   137,830
Total                    3,151,475    196,918

(i) These debentures were secured by mandatory deposits as disclosed in Note 6.

 

The maturity profile of the long-term debentures is as follow:

           
        2022   2021
             
2023         -   57,045
2024        58,550   57,096
2025        24,059   23,689
2029         2,600,998    -
2030         113,291    -
2031         113,360    -
2032         113,416    -
Total         3,023,674     137,830

 

XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Reconciliation of borrowing activities in the statement of cash flow
12 Months Ended
Dec. 31, 2022
Reconciliation Of Borrowing Activities In Statement Of Cash Flow  
Reconciliation of borrowing activities in the statement of cash flow

19 Reconciliation of borrowing activities in the statement of cash flow

                           
    Borrowings, debentures and Braskem Idesa financing              
            Total       Non-controlling           
            borrowings   Braskem Idesa   shareholders            
    Borrowings   Debentures   and debentures   financing   of Braskem Idesa   Lease   Dividends  
                               
 Balances at December 31, 2021    34,897,260   196,918   35,094,178   12,311,535   3,646,538     3,156,414    10,538  
                               
 Acquired  3,479,224     2,938,984     6,418,208     -   -         -  
 Payments    (3,753,427)   (102,235)   (3,855,662)     (45,311)   (34,122)   (928,890)     (1,350,293)  
 Cash used in financing activities  (274,203)   2,836,749   2,562,546   (45,311)    (34,122)    (928,890)   (1,350,293)  
                               
 Other changes                             
 Interest paid    (1,880,611)     (34,548)   (1,915,159)   (752,489)   (16,212)   (221,019)     -  
 Interest and monetary and exchange variations, net  1,524,983     152,356     1,677,339     170,180   (47,784)   83,871     -  
 VAT on loan                  (75,640)          
 New contracts                       2,232,043      
 Disposal                        (12,568)      
 Additions through acquisition of ER Plastics    99,702        99,702     -         4,264     -  
 Currency translation adjustments    (1,801,871)       (1,801,871)   (313,597)   (84,720)     (73,585)      
 Fair value of financial transactions of non-controlling subsidiaries                 (889,967)          
 Additional dividends approved in the board meeting      -         -            1,350,000  
 Additional dividends of subsidiary      -         -             1,236  
 Other      -         -           (474)  
      (2,057,797)   117,808    (1,939,989)    (895,906)    (1,114,323)     2,013,006     1,350,762  
                               
 Balances at December 31, 2022    32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  
                               
Current 1,254,550     127,801     1,382,351     868,635        1,039,706   11,007 (i)
No Current  31,310,710     3,023,674   34,334,384   10,501,683     2,498,093    3,200,824      
Total   32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  

 

(i) Amount classified in "Other payables" under current liabilities.

 

XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments
12 Months Ended
Dec. 31, 2022
Financial Instruments  
Financial instruments

20 Financial instruments

20.1 Initial recognition and measurement

Trade receivables and bonds issued are initially recognized when they are originated. All other financial assets and liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.

A financial asset (unless it is a trade receivable without a significant financing component) is initially measured at fair value, plus transaction costs directly attributable to their acquisition. A financial liability is initially recognized at fair value, excluding transaction costs. For financial assets and liabilities measured subsequently at fair value through profit or loss (“FVTPL”), transactions costs that are directly recognized in profit or loss. A trade receivable without a significant financing component is initially measured at the transaction price.

(a) Classification, subsequent measurement and gains and losses

Financial Assets

On initial recognition, a financial asset is classified as measured at: amortized cost; fair value through other comprehensive income (“FVOCI”) or fair value through profit or loss (“FVTPL”).

A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as measured at fair value:

(i) It is held within a business model whose objective is to hold assets to collect contractual cash flows; and

(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

A financial asset can also be measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:

(i) It is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and

(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. This includes all derivative financial assets (see Note 20.5).

Financial assets at FVTPL are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2).

Financial assets at amortized cost are subsequently measured at amortized cost using the effective interest method and, if applicable, reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.

Financial assets at FVOCI are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and, when applicable, impairment loss are recognized in profit or loss. Other net gains and losses are recognized in Other Comprehensive Income (“OCI”). On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.

Financial liabilities

Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is a derivative.

Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2). Any gain or loss on derecognition is also recognized in profit or loss.

 

(b) Derecognition of financial instruments

Financial Asset

The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire or when the Company transfers the rights to receive the contractual cash flows in a transaction in which either:

(i) Substantially all of the risks and rewards of ownership of the financial asset are transferred; or

(ii) The Company does not retain substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.

When the Company enters into transactions whereby it transfers assets recognized in its statement of financial position but retains either all or substantially all of the risks and rewards of the transferred assets, the financial assets are not derecognized.

Financial liabilities

The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.

On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.

Interest rate reform

When the base for determining the contractual cash flows of a financial asset or financial liability measured at amortized cost changes as a result of interest rate reform, the Company updates the effective interest rate of the financial asset or financial liability to reflect the change required by the reform.

A change in the base for determining the contractual cash flows is required by the interest rate benchmark reform if the following conditions are met: (i) the change is necessary as a direct consequence of the reform; and (ii) the new base for determining contractual cash flows is economically equivalent to the previous base, i.e., the base immediately prior to the change.

When changes are made in a financial asset or financial liability in addition to changes in the base for determining the contractual cash flows required by the interest rate benchmark reform, the Company updates first the effective interest rate of the financial asset or financial liability to reflect the change required by the interest rate benchmark reform. Then the Company applies the accounting policies for changes from the additional modifications.

 

(c) Offsetting

Financial assets or financial liabilities are offset, and the net amount presented in the statement of financial position when, and only when, the Company currently has a legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realize the asset and settle the liability simultaneously.

20.2 Derivative financial instruments and hedge accounting

The Company holds derivative financial instruments to hedge its foreign currency and interest rate risk exposures. Embedded derivatives are separated from the host contract and accounted for separately if the host contract is not a financial asset and certain criteria are met.

Derivatives are initially measured at fair value. After initial recognition, derivatives are measured at fair value, and changes therein are generally recognized in profit or loss.

The Company designates certain derivatives and non-derivative financial liabilities as hedging instruments to hedge the variability in cash flows associated with highly probable forecast transactions arising from changes in foreign exchange rates and interest rates.

At inception of designated hedging relationships, the Company documents the risk management objective and strategy for undertaking the hedge. The Company also documents the economic relationship between the hedged item and the hedging instrument, including whether the changes in cash flows of the hedged item and hedging instrument are expected to offset each other.

Cash flow hedges

When a derivative is designated as a cash flow hedging instrument, the effective portion of changes in the fair value of the derivative is recognized in OCI. The effective portion of changes in the fair value of the derivative that is recognized in OCI is limited to the cumulative change in fair value of the hedged item, determined on a present value basis, from inception of the hedge. Any ineffective portion of changes in the fair value of the derivative is recognized immediately in profit or loss.

If the hedge no longer meets the criteria for hedge accounting, or the hedging instrument is sold, expires, is terminated or is exercised, then hedge accounting is discontinued prospectively. When hedge accounting for cash flow hedges is discontinued, the amount that has been accumulated in OCI remains recognized until it is reclassified under profit or loss in the same period or periods as the expected future cash flows affect the profit or loss.

If the hedged future cash flows are no longer expected to occur, then the amounts that have been accumulated in OCI are immediately reclassified to profit or loss.

 

20.3 Fair Value

(a) Fair value measurement

Fair value is the price to be received in the sale of an asset or paid for the transfer of a liability in a transaction not forced between market players on the measurement date, in the main market or, in the case of a lack of one, the most advantageous market in which the Company has access on said date.

The Company recognizes derivative financial instruments at their fair value and the main sources of information are the stock exchanges, commodities and futures markets, published by Central Bank of Brazil (“BACEN”), Bloomberg and Reuters. Nevertheless, the volatility of the foreign exchange and interest rate markets in Brazil has been resulting in significant changes in future rates and interest rates over short periods of time, leading to significant changes in the fair value of derivatives and other financial instruments.

The fair values of non-derivative quoted financial instruments are based on current bid prices. If the market for a financial asset and for unlisted securities is not active, the Company establishes fair value by using valuation techniques. These include the use of recent arm’s length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, and option pricing models that make maximum use of market inputs and rely as little as possible on information provided by the Management.

The following methods and assumptions were used to estimate the fair value:

(i) Financial assets classified as VFTPL or FVOCI are measured in accordance with the fair value hierarchy (Level 1 and Level 2), with inputs used in the measurement processes obtained from sources that reflect the most recent observable market prices.

(ii) Trade accounts receivable and trade payables, mostly classified as amortized cost, correspond to their respective carrying amounts due to the short-term maturity of these instruments. When purchase or sale prices include material financial charges, the securities are adjusted to their present value.

(iii) The fair value of borrowings is estimated by discounting future contractual cash flows at the market interest rate, which is available to the Company in similar financial instruments.

(iv) The fair value of bonds is based on prices negotiated in financial markets, plus the respective carrying amount of interest.

The fair values of the remaining assets and liabilities correspond to their carrying amount. The valuation of liabilities (Note 20.4) considers the present value of expected payments, discounted by a discount rate adjusted to the risk.

 

(b) Fair value hierarchy

Level 1: fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and

Level 2: fair value obtained from financial models using directly observable market data, such as discounted cash flow, when the instrument is a forward purchase/sale or a swap contract, or such as the Black-Scholes model, when the instrument has the characteristics of an option. To measure the credit risk of the parties involved in derivative instruments, the Company uses Credit Valuation Adjustment (“CVA”) or Debt Valuation Adjustment (“DVA”) models, applied flow by flow on the fair value of each instrument. The Company adopts the ratings of the other parties for positive flows and its own rating for negative flows, both available in the market and disclosed by renowned rating agencies, as a necessary assumption to define the probability of default.

20.4 Non-derivative financial instruments and other liabilities

                         
          Fair value   Book value   Fair value
  Note   Classification by category   hierarchy   2022   2021   2022   2021
                           
Cash and cash equivalents 5                        
Cash and banks     Amortized cost         6,074,208     5,050,822     6,074,208     5,050,822
Financial investments in Brazil     Fair value through profit or loss   Level 2     6,392,266     3,629,864     6,392,266     3,629,864
               12,466,474   8,680,686    12,466,474   8,680,686
                           
Financial investments  6                        
LFT´s and LF´s     Fair value through profit or loss   Level 2     1,789,375     2,337,171     1,789,375     2,337,171
Time deposit investments     Amortized cost       -     106,271   -     106,271
Other     Fair value through profit or loss   Level 2     523,256     1,066,113     523,256     1,066,113
              2,312,631   3,509,555 2,312,631   3,509,555
                           
Trade accounts receivable  7   Amortized cost       3,199,223   7,118,452   3,199,223   7,118,452
Trade accounts receivable  7   Fair value through other comprehensive income   Level 2   32,711   48,508   32,711   48,508
                           
Trade payables 15   Amortized cost        12,249,851    12,164,730    12,249,851    12,164,730
                           
Borrowings  16   Amortized cost                    
Foreign currency - Bond         Level 1   26,124,158   30,322,998   23,165,942   33,690,876
Foreign currency - other borrowings         Level 2     5,394,816     4,703,059     5,329,174     4,696,970
Local currency         Level 2     1,521,011     465,258     1,937,255     451,899
              33,039,985   35,491,315   30,432,371   38,839,745
                           
Braskem Idesa borrowings 17   Amortized cost                    
Bond         Level 1   11,043,483   11,939,268     8,301,948   12,197,524
Others         Level 2     734,837     849,859     796,510     931,141
              11,778,320   12,789,127   9,098,458   13,128,665
                           
Debentures 18   Amortized cost   Level 2   3,162,277   196,918   3,190,417   195,570
                           
Loan ton non-controlling
  shareholder of Braskem Idesa
 9(a)    Amortized cost       2,498,093   3,646,538   2,498,093   3,646,538
                           
Leniency agreement  25   Amortized cost       903,140   1,123,296   903,140   1,123,296

 

 

20.5 Derivative financial instruments

                         
    Operation characteristics     Net (Asset)/           Net (Asset)/
    Principal exposure         Liability   Change in   Financial   Liability
Identification     Derivatives     2021   fair value   settlement   2022
                           
Non-hedge                           
accounting transactions                          
Braksem America - Swap C3/PGP   Propane   Propene      14,299     (2,158)    (12,141)     -
Braskem Holanda - Swap Nafta/Gasoline   Gasoline   Naphtha        (16,847)     (25,733)   26,584     (15,996)
Braskem Argentina - Exchange swap   Argentine peso Dollar     3   61   (63)   1
                (2,545)     (27,830)   14,380     (15,995)
                           
Hedge accounting                          
transactions                          
Braskem S.A. - Dollar call and put options   Real   Dollar      85,216     (227,871)   77,285     (65,370)
Braskem S.A. - Dollar swap CDI   Real   Dollar+Fixed rates    502,508     (194,055)    (156,740)    151,713
Braskem S.A. - Swap CRA   Real   Dollar+Fixed rates     -     (32,828)   10,116     (22,712)
               587,724     (454,754)    (69,339)    63,631
                           
Derivatives                          
Assets                          
Current assets              33,816            157,906
Non-current assets             51            71,544
Total              33,867            229,450
Liabilities                          
Current liabilities              256,131            195,169
Non-current liabilities              362,915            81,917
Total              619,046            277,086
Net (Asset)/Liability              585,179            47,636

 

The counterparties in these contracts are constantly monitored based on the analysis of their respective ratings and Credit Default Swap (“CDS”). The Company has many bilateral risk mitigators in its derivative contracts, such as the possibility of depositing or requesting deposits of a guaranteed margin from the counterparties.

Derivative financial instruments held on December 31, 2022 were contracted on both international stock exchanges and on Over the Counter (“OTC”) markets with large financial counterparties under global derivative contracts in Brazil or abroad.

The Company’s Financial Policy provides for the active management and continued protection against fluctuations in currencies and rates arising from its operations and financial items, with the possibility of contracting derivative instruments (swaps, NDFs, options, etc.). The other market risks are addressed on a case-by-case basis for each transaction. In general, the Company assesses the need for hedging in the analysis of prospective transactions and seeks to customize the hedge and keeps it in place for the hedged period transaction.

In general, the Company elects to designate derivative financial instruments in a hedge accounting relationship when the application is expected to provide a significant improvement in presenting the offsetting effect on the changes in the hedged items.

 

Hedge accounting transactions

(a.i) US Dollar call and put option

As of December 31, 2022, the Company holds a total notional amount of put options of US$2.1 billion (R$10.96 billion), with an average strike price of US$1/R$4.7 and notional amount of call options of US$1.4 billion (R$7.3 billion), with an average strike price of US$1/R$7.06. The operations have a maximum term of 18 months.

US Dollar-denominated future sales in Brazilian Real were designated for hedge accounting, with the months of revenue recognition always coinciding with the months of the options. The future elements of forward exchange contracts are excluded from the designation of hedge instrument and are separately recorded as hedging cost, recognized in the OCI.

(a.ii) US Dollar Swap

In 2018, the Company contracted foreign exchange derivative operations (“swaps”) in the aggregate amount of R$1.27 billion, with annual maturities over the following 5 years starting January 2019. The amount payable in January 2020 was subject to the variation in the IPCA index. The remaining maturities are subject to the variation in the CDI. These operations were designated to cash flow hedge accounting, where the hedging instruments are foreign exchange derivatives, and the hedged objects are highly probable future revenues in the domestic market subject to fluctuations in Brazilian R$/US$ price.

Accordingly, the fair value adjustment of the effective portion of the hedge is recognized under shareholders equity in OCI and is recognized in the financial result upon the maturity of each installment.

(a.iii) US Dollar Swap - CRA

In 2022, the Company contracted foreign exchange derivative operations (“swaps”) with semiannual maturities for the next 10 years as from March 2022. These operations were designated for cash flow hedge accounting, in which the hedge instruments are foreign exchange derivatives, and the hedge objects are highly probable future revenue subject to the R$/US$ exchange rate.

Accordingly, the fair value adjustment in the effective hedge portion will be recorded in equity in OCI and will be recognized in financial result upon the realization of each of the hedge objects.

                     
Identification   Total nominal   Hedge   Maturity       Fair value, net
  value R$   (interest rate per year)     2022   2021
Swaps CRA    600,218   3.5388%   dec-2028    12,603     -
Swaps CRA    141,298   3.3742%   dec-2031    10,109    
Total     741,516             22,712     -
                     
Derivatives                    
Assets                    
Current assets                13,274     -
Non-Current assets                49,613     -
Total                62,887     -
Liabilities                    
Non-Current liabilities                40,175     -
Total                40,175     -
Net (Asset)/Liability                 22,712     -

 

 

20.6 Non-derivative financial liabilities designated to hedge accounting

(a) Future exports in US$ (Braskem S.A.)

The Company designated non-derivate financial liabilities in foreign currency to hedge the future cash flows generated by its exports. This decision was based on two important concepts and judgments: (i) ) the high probability of performing exports according to its business plan, (see Note 22.2), which are inherent to the market and business where it operates, and (ii) the Company’s capacity to finance its liabilities in US$, since its guidance and strategy determine the financing priority in US$ and its Financial Policy requires maintaining a minimum level of net liabilities in US$.

On May 1, 2013, Braskem designated non-derivative financial liabilities, denominated in US$, as a hedge for the flow of its highly probable future exports. Thus, the impact of exchange rates on future cash flows in US dollar derived from these exports is offset by the foreign exchange variation on the designated liabilities, partly eliminating the volatility of results. The exchange rate on the date of the designation was US$1/ R$2.0017.

The main actions carried out in the program are detailed below:

• 2017: designation of R$6.52 billion (US$1.25 billion) of future sales with maturity in 2028 (hedged exchange rate of US$1/3.1688);

• 2019: designations of R$11.5 billion (US$2.2 billion) with maturity in 2025, 2030 and 2031 (hedged exchange rate of US$1/3.9492);

• 2020: designation of R$3,131 million (US$600 million) of future sales with maturity in 2032 (hedged exchange rate of US$1/R$4.0213); discontinuation of hedge accounting of R$1,889 million (U$$362 million) in 2020 (discontinuation rate of US$1/R$5.1987).

• 2021: designation of hedge accounting of R$2,087 million (US$400 million) in 2025 (hedged exchange rate of US$1/R$5.5832); discontinuation of hedge accounting of R$2,087 million (US$400 million) in 2024 (discontinuation rate of US$1/R$5.6430); discontinuation of hedge accounting of R$1,044 million (US$200 million) in 2023 (discontinuation rate of US$1/R$5.1433);

• 2022: designation of R$2,609 million (US$500 million) of future sales with maturity in 2029 (hedged exchange rate of US$1/R$5.5832).

• Over the past two years, Braskem exported an average R$88.7 billion (US$17 billion) per year, which represents around 3 to 4 times the annual exports of the hedged exports.

• Hedged exports represent approximately 30% of the export flows planned by the Company.

• The exports of the Company are not sporadic or occasional but constitute an integral part of its strategy and of the petrochemical business, in which competition is global. Several of the products produced by the Company are primarily and recurrently intended for export.

 

On December 31, 2022, the exports that were designated not yet realized and not discontinued and the maturities of financial liabilities designated, all consolidated, were as follows:

               
                 
                Total nominal value
            US$   R$
              0  
2024             288,854    1,507,154
2025             800,000    4,174,160
2028             1,250,000    6,522,125
2029             500,000    2,608,850
2030             800,000    4,174,160
2031             800,000    4,174,160
2032             800,000    4,174,160
Total nominal value             5,238,854     27,334,769

The following table shows the changes in financial instruments designated for this hedge in the year:

             
             
            US$
              
    2021   Designations   2022
             
Designated balance    4,738,854    500,000     5,238,854

 

 

The following table provides the balances of exchange variation recognized in the Company’s net financial income (expenses) due to the realization of exports designated, for this hedge in the fiscal year ended December 31, 2022:

               
        Conversion rate        
    Total nominal   at Inception   Closing rate   Gross nominal
    value US$   R$/US$   R$/US$   value - R$
                 
First quarter    175,000   2.0017   3.9786     345,958
Second quarter    208,000   2.0017   3.9786     411,195
Third quarter    186,000   2.0017   3.9786     367,703
Fourth quarter    150,000   2.0017   3.9786     296,535
      719,000           1,421,391

The changes in foreign exchange variation and income taxes under other comprehensive income of this hedge are as follows:

         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021 (13,102,558)    4,454,869     (8,647,689)
           
Exchange variation recorded in the period / IR and CSL 1,699,906     (577,968)   1,121,938
           
Exchange variation transferred to profit or loss / IR and CSL 1,421,391     (483,273)   938,118
           
Balances at December 31, 2022   (9,981,261)    3,393,628     (6,587,633)

 

(b) Future sales in US$ (Braskem Idesa)

As of December 31, 2022, designated and unrealized sales and financial liabilities designated to hedge them were as follows:

           
             
            Nominal value
             
2023           65,221
2024            117,398
2025            117,398
2026            430,460
2030            1,173,983
2031            1,173,983
2032            2,739,293
2033            2,739,293
2034            1,565,310
2035            1,565,310
Nominal value             11,687,649

 

The following table provides the balances of exchange variation recognized in Braskem Idesa’s financial income (expenses) due to the maturity of the sales designated in this hedge for the 12-month period ended December 31, 2022:

                     
        Conversion rate            
    Total nominal   at Inception   Closing rate   Total nominal   Gross nominal
    value US$   MXN/US$   MXN/US$   value MXN   value - R$
                     
First quarter    29,136   13.6218   20.2827   194,072   49,302
Second quarter    72,612   13.6507   20.1297   470,453   116,361
Third quarter    72,612   13.6507   20.1297   470,453   120,341
Fourth quarter    78,844   13.6521   20.1224   510,144   137,999
    253,204           1,645,123   424,003

The changes in foreign exchange variation and income taxes under other comprehensive at Braskem Idesa income are as follows:

         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021   (2,231,511)    670,192     (1,561,319)
           
Exchange variation recorded in the period / IR 699,677     (209,903)   489,774
           
Exchange variation transferred to profit or loss / IR 424,003     (127,201)   296,802
           
Balances at December 31, 2022   (1,107,831)    333,088   (774,743)

Effectiveness tests were conducted, and all operations were deemed effective in reducing the dispersion of revenue from sales designated for hedge, when evaluated in Mexican Pesos.

 

20.7 Credit quality of financial assets

(a) Trade accounts receivable

The Company’s clients do not have risk ratings assigned by credit rating agencies. For this reason, the Company developed its own credit rating methodology for all accounts receivable from clients in Brazil and abroad.

Considering the expected credit losses, the percentage of trade accounts receivable by risk ratings was as follows:

         
          (%)
      2022   2021
1 Minimal Risk   72.15   65.39
2 Low Risk   21.65   26.65
3 Medium Risk   3.36   6.02
4 High Risk   2.56   1.54
5 Very High Risk (i) 0.28   0.40

 

(i) Clients in this group that are still active buy from Braskem and pay in advance.

 

For the export market, around 85% of the portfolio has guarantees, consisting primarily of credit insurance. For the domestic market, around 22% of the portfolio has guarantees, mainly suretyships by the partners of counterparties, complemented by credit insurance.

 

(b) Cash and cash equivalents and financial investments

In order to determine the credit ratings of counterparties classified under cash and cash equivalents, and financial investments, the Company uses the risk rating of agencies Standard & Poor’s, Moody’s and Fitch Ratings, within the limits established in its Financial Policy:

                       
             
            2022           2021
     Domestic market     Foreign market    Total    Domestic market     Foreign market    Total
Financial assets with risk classification                        
AAA   5,130,140   2,420,741    7,550,881     4,080,884   2,783,151    6,864,035
AA+   162,650   -     162,650   109,165   -     109,165
AA   289,574   107,545     397,119   188,742   629,671     818,413
AA-   149,178   -     149,178     63,675   -    63,675
A+     3,423   4,459,700    4,463,123    5,788   2,914,269    2,920,057
A   57,650   1,392,854    1,450,504   107,225   -     107,225
A-   -   387,478     387,478     634   236,335     236,969
BBB+     118     375    493     856     38    894
BBB     788   52,389    53,177     129   1,026,104    1,026,233
BBB-            -     554   -    554
BB+            -    50   -   50
BB       -    -    1,479   -   1,479
BB-        7     7            
    5,793,521   8,821,089     14,614,610     4,559,181   7,589,568     12,148,749
Financial assets without risk classification                        
Shares of investment funds
in credit rights
      -    -    1,721   -   1,721
Other financial assets   (i)  83,070   81,425     164,495     25,989   13,782    39,771
    83,070   81,425     164,495     27,710   13,782    41,492
                         
Total   5,876,591   8,902,514     14,779,105     4,586,891   7,603,350     12,190,241

 

(i) Investments approved by the Management, in accordance with the Financial Policy.

 

20.8 Sensitivity analysis

Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:

(a) Selection of risks

On December 31, 2022, the main risks that can affect the value of Company’s financial instruments are:

· US$/R$ exchange rate;

· LIBOR floating interest rate;

· IPCA inflation rate;

· Selic and CDI interest rates; and

· SOFR interest rate.

For the purposes of the risk sensitivity analysis, the Company presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.

(b) Value at risk

The value at risk of the derivatives held by the Company which is defined as the impact on fair value adjustment that could result in one month as from December 31, 2022, with a probability of 5%, and under normal market conditions, was estimated by the Company at R$129 million (US$24.7 million) for put options and call options (Note 20.5(a.i)) and R$96.7 million (US$18.5 million) for the US dollar swap (Note 20.5(a.ii)) and R$4.5 million (US$872 thousand) for the CRA swap (Note 20.2(a.iii)).

(c) Selection of scenarios

The Focus Market Readout published by BACEN was used to create the probable scenario for the US$-R$ exchange rate, the Selic interest rate and the CDI interest rate as of December 31, 2022.

According to the Market Readout, at the end of 2023, US$1 will remain at approximately R$5.27, while the Selic rate should reach 12.25% p.a. at the end of the period. The Selic rate is used as benchmark for sensitivity analysis of the CDI rate.

Since the Market Readout report does not include consensus forecasts for the LIBOR rate, the projection of the U.S. Federal Reserve for the Federal Funds rate at the end of the year was used, whose most recent version was published in December 2022, in comparison with the current level of the Federal Funds rate on December 31, 2022.

For each variable analyzed in the sensitivity analysis, the Company has considered estimating annualized variations corresponding to 1 and 3 standard deviations of monthly averages of the last five years. They are equivalent to approximately 15.866% and a 0.135% probability of occurrence for the reasonably possible and possible scenarios, respectively. Then, these changes are applied to the current market levels of each variable.

 

Uncertainties of the current context

The assumptions of the future value adopted in the construction of the probable scenario and the current value of each variable in this analysis are referenced to the reporting date December 31, 2022. Given the instability in the current economic scenario caused by the COVID-19 pandemic and the global effects resulting from the conflict in Ukraine, interest rates and foreign exchange rates are affected daily. The Company’s gains and losses in these probable stress scenarios are analyzed by increasing each variable according to the aforementioned.

 

The sensitivity values in the table below represent the changes in the value of the financial instruments in each scenario, jointly with the absolute amounts of each of the risk factors considered:

                   
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity   Note   as December 31, 2022   (USDBRL 5.27)   (USDBRL 5.93)   (USDBRL 7.35)
                     
Brazilian real/U.S. dollar exchange rate                    
Bonds         (37,167,641)    (372,553)   (5,051,899)    (15,155,696)
Export prepayments        (1,028,473)   (10,309)    (139,792)    (419,376)
Investments        (1,985,932)   (19,906)    (269,932)    (809,795)
SACE   16(c.i)    (1,478,722)   (14,822)    (200,991)    (602,973)
Dollar call and put options   (i)   65,370    9,809    (160,742)   (1,023,396)
Dollar swap x CDI         (151,713)     (6,216)    (189,181)    (466,381)
MONFORTE   16(c.ii)     (197,209)     (1,977)   (26,805)   (80,415)
Nexi   16(c.iii.iv)     (100,707)     (1,009)   (13,688)   (41,065)
Other         (734,837)     (7,366)   (99,881)    (299,642)
Financial investments abroad       6,718,183     67,340     913,149     2,739,446
Dollar swap x IPCA       22,713   (607)   (63,356)    (194,841)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.58%)   (7.89%)   (14.13%)
                     
Libor floating interest rate                    
Export prepayments        (35,749)   (887)     (3,388)   (10,163)
Nexi   16(c.iii.iv)     (100,707)     (3,920)   (14,970)   (44,909)
SACE   16(c.i)    (1,478,722)   (49,107)    (187,520)    (562,560)
MONFORTE   16(c.ii)     (197,209)     (4,094)   (15,635)   (46,906)
Investments        (1,985,932)   (63,201)    (241,339)    (724,017)
Outros         (734,837)   (16,887)   (64,483)    (193,449)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
CDI interest rate                    
Debentures        (3,052,400)     302,796    (898,725)   (3,331,635)
Financial investments in local currency       5,876,590   (80,242)     206,257     619,489
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.31%)   (6.72%)   (8.35%)
                     
IPCA interest rate                    
Debentures         (109,877)    1,494     (2,085)     (6,315)
BNDES         (386,534)     26,403   (38,283)    (121,208)
BNB/ FINEP/ FUNDES/FINISA/FINAME/FNE       (3,525)    59     (83)   (252)
CRA         (763,396)     45,429   (65,630)    (206,889)
Dollar swap x IPCA       22,713   (99,748)     31,958     99,871
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
Selic interest rate                    
Leniency agreement         (865,311)    6,856   (17,443)   (51,656)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (4.59%)   (10.58%)   (22.57%)
                     
Selic interest rate                    
Export prepayments         (992,725)   (25,698)    (195,867)    (587,602)
Export credit notes         (521,926)   (13,571)    (103,435)    (310,306)

(i) The Company is in the short position of a possible counterparty call.

 

XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes payable
12 Months Ended
Dec. 31, 2022
Taxes Payable  
Taxes payable

21 Taxes payable

           
               
          2022   2021
Brazil            
  IPI        74,219     131,290
  ICMS         218,179     485,302
  PIS and Cofins        20,406    33,516
  Other         103,549    46,117
               
Other countries            
  Value-added tax         150,260     229,571
  Tax on financial income       222,464     346,817
Total       789,077   1,272,613
               
Current liabilities         491,051     1,012,116
Non-current liabilities         298,026     260,497
Total       789,077   1,272,613

XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income taxes

22 Income taxes

Income taxes comprises current and deferred taxes. It is recognized in profit or loss except to the extent that it relates to items directly recognized in other comprehensive income.

22.1 Current income taxes

Current income taxes comprise the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted at the reporting date. Current tax also includes any tax arising from dividends. Current tax assets and liabilities are offset only if certain criteria are met.

As of December 31, 2022, the amount presented as recoverable income taxes under current assets is R$392,062 (2021: R$1,189,812) and non-current assets is R$252,995 (2021: R$230,069). In 2021: R$984.4 million refers to taxes recoverable at Braskem America arising from the tax program offered by the U.S. government, for aid and support to U.S. companies in response to the economic impacts of Covid-19.

(a) Exclusion of inflation adjustment by Selic (economy´s basic interest rate) on undue tax payments from taxable income

In July 2010, Braskem and the merged companies in previous years, filed lawsuits claiming exception from the levying of Brazilian income taxes (hereinafter “IR/CSL”) on amounts they received as interest on late payment, since they do not represent any equity increase. On September 24, 2021, through Special Appeal 1.603.187, the Federal Supreme Court (“STF”) stated that “the levying of IR/CSL on amounts updated by the Selic rate, received due to repetition of undue tax payments, is unconstitutional.”

Braskem benefited from this decision in the amount of R$540 million reduction in income taxes calculated until 2022 (R$501 million until 2021). In 2021, deferred tax assets amounting to R$68 million were recognized for the periods in which tax losses increased.

(b) Exemption of IR/CSL on ICMS tax incentives and benefits

In October 2021, the Company obtained a preliminary injunction to exclude the ICMS tax incentives and benefits applicable to its operations, granted by the governments of States and the Federal District, from the income tax calculation base as from 2021. Since it is an uncertain tax treatment, as of December 31, 2021, it remains booked in the balance sheet as income taxes payable.

In August 2022, a judgment was rendered restricting relief only to presumed ICMS credits. Accordingly, the amount related to ICMS tax incentives and benefits was paid amounting to R$1,038,255.

(c) Use of tax losses in Braskem Idesa

Mexico’s federal revenue service (“SAT”) has been questioning Braskem Idesa and Braskem SOFOM about the criteria and assumptions adopted in the calculation of income tax. With the intermediation from the Taxpayer Defense Attorney of Mexico (“Prodecon”), on February 3, 2023, Braskem Idesa and Braskem SOFOM signed an agreement, in which Braskem Sofom agreed to settle the income taxes proposed by SAT and Braskem Idesa reviewed the accrued tax losses in certain periods, resulting in a reduction in deferred tax credits of R$892 million, with a corresponding entry under deferred income tax expense.

 

(d) Reconciliation of effective tax rate

             
           
      2022   2021   2020
               
Profit (loss) before income taxes       47,344   17,961,023    (9,683,784)
               
Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)       (16,097)   (6,106,748)     3,292,487
               
Permanent adjustments to income taxes calculation basis              
Income taxes on equity in results of investees      11,849   1,578   6,595
Thin capitalization   (i) (359,598)    (6,628)   (695,741)
Tax benefits (Sudene and PAT)     -     137,338   -
Reduction of tax loss   22.1(c) (891,669)       -
Effect of the refund of Braskem America´s tax benefit             (737,841)
Different jurisdictional taxes rates for companies abroad and tax basis   (ii)   1,029,618     1,980,358     994,811
Effect from the retrospective tax rate on bonus depreciation of Braskem America         -     334,460
Taxes on dividends distribution     (454,663)   (265,454)   (131,240)
Exclusion of inflation adjustement by Selic on undue tax payments from taxable income   22.1(a)  39,395     501,382    
Other permanent adjustments     (226,570)   (241,229)   (395,053)
               
Effect of income taxes on results of operations      (867,735)    (3,999,403)   2,668,478
               
Breakdown of income taxes              
               
Current income taxes              
Current year     (1,003,705)   (3,834,437)     (52,830)
Total current expenses      (1,003,705)   (3,834,437)     (52,830)
               
Deferred income taxes              
Origination and reversal of temporary differences       1,192,438   (246,294)     2,677,328
Tax losses     (1,056,468)    81,328    43,980
Total Deferred income taxes        135,970   (164,966)     2,721,308
               
Total      (867,735)    (3,999,403)   2,668,478
               
Effective rate   (iii) 1832.8%   22.3%   27.6%

 

(i) Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.
(ii) Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:

 

             
          Income tax rate (%)
               
          Headquarters (Country)   2022
             
Braskem Alemanha       Germany    31.09
Braskem America and Braskem America Finance       USA    21.00
Braskem Argentina       Argentina    25.00
Braskem Chile       Chile    27.00
Braskem Holanda, Braskem Holanda Finance, Braskem Holanda Inc, B&TC and ER Plastics       Netherlands    25.80
Braskem Idesa, Braskem Idesa Serviços, Braskem México            
  Braskem México Serviços, Braskem México Proyectos and Terminal Química       Mexico    30.00
Braskem India       India    30.00

(iii) The effects presented in the reconciliation of the effective rate, in relation to the profit before taxes of R$47,344, resulted in an effective rate of 1,832.8%, the main effect is described in Note 22.1(c).

 

22.2 Deferred income taxes

Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.

Deferred tax assets are recognized for unused tax losses and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, based on the business plans for the Company.

The measurement of deferred taxes reflects the tax consequences that would follow from how the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. Annually, the Company revises its projection of taxable income based on its Business Plan.

The Business Plan is prepared annually by the Executive Board, and its main variables include projections for the prices of the products produced by the Company, the prices of raw materials, the growth in gross domestic product of each country in which the Company operates, exchange rate variation, interest rates, inflation rates and fluctuations in supply and demand for inputs and finished goods.

In evaluating the plan, the Company uses its historical performance, strategic planning and market projections produced by third party consulting firms, which are reviewed and supplemented based on Management´s experience.

Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves. Unrecognized deferred tax assets are reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used.

Deferred tax assets and liabilities are offset only if certain criteria are met.

(a) Movement in deferred tax balances

                             
                             
Assets   As of December 31, 2020   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2021   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2022
                             
Tax losses (IR) and negative base (CSL)   3,278,184   76,532       3,354,716   (957,184)       2,397,532
Goodwill amortized   6,520   (4,061)       2,459   (364)       2,095
Exchange variations   3,817,615   696,849   (234,402)   4,280,062   611,838   (1,549,020)   3,342,880
Temporary adjustments   4,996,337   (214,060)       4,782,277   (134,745)       4,647,532
Business combination   56,211   (29,327)       26,884   (26,884)       0
Tax credits (i) 77,032   (77,032)       0   697,662       697,662
Other   45,366   72,523       117,889   (1,197)       116,692
    12,277,265   521,424   (234,402)   12,564,287   189,126   (1,549,020)   11,204,393
                             
Liabilities                            
Amortization of goodwill based on future profitability   722,222   2,875       725,097   (2,664)       722,433
Tax depreciation   3,737,169   439,781       4,176,950   (125,488)       4,051,462
PIS/COFINS credit - exclusion of ICMS from the calculation basis   0   331,479       331,479   (141,830)       189,649
Temporary adjustments   158,232   (69,239)       88,993   331,322       420,315
Present value adjustments and amortized cost   79,920   74,771       154,691   7,906   261,354   423,951
Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar   279,321   (46,888)       232,433   (45,796)       186,637
Other   4,827   (46,389)   46,388   4,826   29,706   (29,706)   4,826
    4,981,691   686,390   46,388   5,714,469   53,156   231,648   5,999,273
                             
Net   7,295,574   (164,966)   (280,790)   6,849,818   135,970   (1,780,668)   5,205,120
                             
Presentation in the balance sheet:                            
Non-current assets   8,529,972           8,257,252           6,358,601
(-) Non-current liabilities   1,234,398           1,407,434           1,153,481

(i) Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.  

 

(b) Offset for the purpose of presentation in the consolidated statement of financial position

                               
          2022   2021
                               
    Headquarters (Country)   Tax calculation   Offsetting   Balance   Tax calculation   Offsetting   Balance
                             
Assets                            
Braskem S.A.   Brazil   8,356,402    (2,584,962)     5,771,440    8,841,886     (2,496,637)     6,345,249
Braskem Argentina   Argentina     21,339   (16,174)   5,165     3,271    -   3,271
Braskem America   USA   356,598    (356,598)   -    294,328     (294,328)   -
Braskem Alemanha   Germany     23,038   -    23,038   44,417    -    44,417
Braskem Chile   Chile   47         47    92         92
Braskem Holanda   Netherlands   195,042    (39,696)   155,346    -        
Braskem Idesa   Mexico   2,078,206    (1,840,669)     237,537    3,282,125     (1,506,541)     1,775,584
Braskem Idesa Serviços   Mexico    -   -   -    26    -     26
Braskem México Serviços   Mexico     13,628        13,628     2,502       2,502
Braskem México   Mexico     86,368        86,368   16,181        16,181
Cetrel   Brazil     39,387     (5,405)    33,982   40,434   (7,586)    32,848
DAC   Brazil     32,617     (2,262)    30,355   39,025   (1,943)    37,082
Terminal Química   Mexico    1,618       1,618            
Voqen   Brazil    103    (26)     77            
            11,204,393     (5,001,138)   6,358,601     12,564,287   (4,307,035)   8,257,252
                               
Liabilities                            
Braskem S.A.   Brazil   2,584,962    (2,584,962)   -    2,496,637     (2,496,637)   -
Braskem America   USA   1,493,471    (356,598)     1,136,873    1,701,762     (294,328)     1,407,434
Braskem Argentina   Chile     16,174   (16,174)   -           -
Braskem Holanda   Netherlands     39,696   (39,696)   -           -
Braskem Idesa   Mexico   1,840,669    (1,840,669)   -    1,506,541     (1,506,541)   -
B&TC   Netherlands     16,608        16,608           -
Cetrel   Brazil    5,405     (5,405)   -     7,586   (7,586)   -
DAC   Brazil    2,262     (2,262)   -     1,943   (1,943)   -
Voqen   Brazil   26    (26)   -           -
           5,999,273     (4,845,792)   1,153,481    5,714,469   (4,307,035)   1,407,434

  

XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Sundry provisions
12 Months Ended
Dec. 31, 2022
Sundry Provisions  
Sundry provisions

23 Sundry provisions

     
     
    2022   2021
Provision for environmental damages   1,120,188     1,035,426
Provision for customers rebates   126,754     101,253
Other     130,005     152,584
Total   1,376,947   1,289,263
         
Current liabilities     530,814     465,051
Non-current liabilities   846,133     824,212
Total   1,376,947   1,289,263

 

(a) Provision for environmental damages

The provision for environmental damages is estimated based on current legal and constructive requirements, technology, price levels and expected remediation plans.

Realized costs and cash outflows may differ from current estimates due to the changes in laws and regulations, public expectations, prices, new findings by the ongoing studies and analysis of local conditions and changes in remediation technologies.

The time and value of future expenses related to environmental liabilities are reviewed annually, as well as the interest rate used for discounting them to present value.

The Company operates in several countries and is subject to different environmental laws and regulations inherent to the operations and activities areas. Remediation expenses are incurred over several years due to their complexity and extension. New information on websites, new technologies or future developments, such as involvement in investigations by regulatory agencies, may require that we reevaluate our potential exposure related to environmental matters.

The provision is recorded based on the areas in which remediation actions will be necessary. Due to the high complexity in identifying potential environmental impacts, alternative solutions and recovery costs estimations, these estimates can only be made with reasonable assurance after the completion of all phases of the process to identify and investigate environmental liabilities, which are in accordance with the phases and protocols established by environmental agencies.

The Company monitors the areas under study to capture any new facts and changes in circumstances that change the prognosis of actions to be adopted and consequently affect the estimation of provision for environmental remediations.

(b) Rebates

Some sales agreements of the Company provide for a rebate in products should certain sales volumes be achieved within the year, six-month period or three-month period, depending on the agreement. The bonus is recognized monthly in a provision, assuming that the minimum contractual amount will be achieved.

(c) Changes in provisions

               
    Recovery of            
    environmental             
    damage   Rebate   Other   Total
                 
December 31, 2020   602,490     123,465     148,253   874,208
                 
Additions, monetary adjustments and exchange variation     576,086    144,710    114,395     835,191
Payments and reversals   (143,150)     (166,922)     (110,064)    (420,136)
                -
December 31, 2021     1,035,426     101,253     152,584   1,289,263
                 
Additions, monetary adjustments and exchange variation     299,241    184,142   19,777     503,161
Payments and reversals   (214,479)     (158,641)    (42,357)    (415,477)
                -
December 31, 2022     1,120,188     126,754     130,005   1,376,947

  

XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities
12 Months Ended
Dec. 31, 2022
Provisions For Legal Proceedings And Contingent Liabilities  
Provisions for legal proceedings and contingent liabilities

24 Provisions for legal proceedings and contingent liabilities

Braskem is a defendant in lawsuits and administrative proceedings arising from the normal course of its business. The Management, based on its assessment and that of its external legal advisors, classifies these proceedings in terms of probability of loss as follows:

Probable chance of loss: present obligation for which there is a higher probability of loss than of a favorable outcome. For these claims, a provision is recognized based on an estimated amount of the obligation that reflects the expected outflow of resources (see Note 24.1).

Possible chance of loss: present obligation for which the possibility of loss is greater than remote and less than probable. For these claims, the Company does not recognize a provision and discloses the most significant matters (see Note 24.2).

The Management believes that the estimates related to the outcome of the proceedings and the possibility of future disbursement may change in view of the following: (i) higher courts may decide in a similar case involving another company, adopting a final interpretation of the matter and, consequently, advancing the termination of the proceeding involving the Company, without any disbursement or implying the need of any financial settlement of the proceeding; and (ii) programs encouraging the payment of the debts implemented in Brazil at the Federal and State levels, in favorable conditions that may lead to a disbursement that is lower than the one that is recognized in the provision or lower than the value of the matter.

In addition, the Company also is a plaintiff in several lawsuits. In these cases, the Company discloses the contingent asset when the receipt of economic benefits is probable. However, when the realization of the benefit is virtually certain, the related asset no longer constitutes a contingent asset, and as such amount is recognized.

Any changes in the court’s understanding of the position could cause future impacts on the consolidated financial statements of the Company due to such proceedings.

24.1 Lawsuits with probable losses

       -
      2022   2021
Labor claims   (a)   212,657     268,758
           
Tax claims   (b)      
IR and CSL      51,756    61,946
PIS and COFINS       311,433     299,202
ICMS       348,544     331,094
Other tax claims      24,160    22,857
      735,893   715,099
           
Corporate claims       103,387    94,826
           
Civil claims and other     119,561    75,147
           
      1,171,498   1,153,830

 

(a) Labor claims

As of December 31, 2022, the provision is related to 472 labor claims, including occupational health and security cases (2021: 529). The Management, based on its assessment and that of its external legal advisors, estimate that the term for the termination of these types of claims in Brazil exceeds five years. The estimates related to the outcome of proceedings and the possibility of future disbursement may change in view of new decisions in higher courts.

(b) Tax claims

As of December 31, 2022, the main claims are the following:

(i) Non-cumulative PIS and COFINS

The Company is charged amounts arising from compensation of Non-Cumulative PIS and COFINS tax credits in the years 2005, 2010 and in the period from 2012 to 2018 that were not approved by the Federal Revenue Service of Brazil ("RFB"), mainly related to the following topics:

- Offsetting Statements, with credits in amounts that exceeded those declared in the respective Statement of Calculation of Social Contributions;

- freight expenses: not associated with sales operations and/or operations without proven association and contracted in the country, but concerning imported products;

- credits arising from the acquisition of property, plant and equipment mostly related to acquired companies, whose documentation was not found;

- taxation of revenues incorrectly classified as tax exempt, subject to zero tax rate or not taxed.

As of December 31, 2022, the balance of this provision was R$212,223 (2021: R$202,737). The Management, based on its assessment and that of its external legal advisors and considering the precedents on the matters at the Administrative Council of Tax Appeals (“CARF”), estimates that the administrative procedures will be concluded in 2026.

(ii) PIS and COFINS taxes

The Company is assessed for the payment of these taxes in many legal claims, such as:

- insufficient payment of COFINS for the period from March 1999 to December 2000, from February 2001 to March 2002, from May to July 2002 and September 2002 due to alleged calculation errors, and non-compliance with the widening the tax calculation base and increasing the contribution rate envisaged in Law 9.718/1998;

- offset of the COFINS dues relating to September and October 1999 using the credit resulting from the addition of 1% to the COFINS rate;

- rejection of the offset of PIS and COFINS dues relating to the period from February to April 2002 using the PIS credits under Decree-Laws 2.445 and 2.449, calculated between June 1990 and October 1995, under the argument that the time period for using said credits had expired; and

On December 31, 2022, the balance of this provision was R$69,641 (2021: R$67,403). Management, based on its assessment and that of its external legal advisors, estimates these procedures will conclude by 2030.

The Company offered guarantees in the form of bank guarantees and finished products, which, together, fully cover the amount of claims.

(iii) ICMS tax on interstate purchases

In 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment of ICMS in view of alleged violations:

- undue use of tax credits in the amount of R$58,164, due to the recording of credits indicated in the invoices for the sale of certain products, issued by Acrinor Acrilonitrila do Nordeste S.A. and Proquigel Química S.A., since the products were to be exported, and were therefore exempt from payment of ICMS tax;

- the fine for the abovementioned tax offense corresponds to 100% of the principal value recorded; 

- fine in the amount of 30% on R$480,389, which corresponds to the sum of the amounts indicated in tax documents whose outflow of goods was not identified by the tax authority; and

- fine due to lack of presentation of tax documents requested.

After ending the discussions in the administrative sphere, with the partial reduction in contingency, the Company proposed lawsuits to continue the discussion, which were secured by a guarantee insurance. On December 31, 2022, the balance of this provision was R$329,125 (2021: R$313,380). The Management, based on its assessment and that of its external legal advisors, estimates the legal procedures will conclude in 2026.

 

(c) Changes in claims with probable chance of loss

                   
                Civil claims    
    Labor claims   Tax claims   claims   and other   Total
                     
December 31, 2020     280,066     692,735     126,057    52,229     1,151,087
                     
Additions, inflation adjustments and exchange variation    172,574   46,849   14,357   76,111    309,891
Payments    (70,968)   (3,659)    (40,109)   (2,770)     (117,506)
Reversals (*)     (112,914)    (20,826)   (5,479)    (50,423)     (189,642)
                     
December 31, 2021     268,758     715,099    94,826    75,147     1,153,830
                     
Additions, monetary adjustments and exchange variation   128,682   60,627     9,048   76,227   274,584
Payments    (57,750)   (8,792)     -   (3,243)    (69,785)
Reversals (*)     (127,033)    (31,041)   (487)    (28,570)     (187,131)
                      -
December 31, 2022   212,657     735,893     103,387     119,561   1,171,498

 

(*) A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.

 

24.2 Contingent liabilities

The contingent liabilities whose loss is assessed as possible (possibility of loss greater than remote and less than probable) by the Company’s Management, based on its evaluation and that of its external legal advisors, are disclosed as follows:

       
  Note   2022   2021
           
Tax claims (a)      18,270,680   17,224,429
Civil claims - Alagoas 26     5,489,479     2,614,344
Civil claims - Other (b)    786,441     737,083
Labor claims (c)    605,546     763,555
Environmental claims (d)    639,880     571,057
Social security claims (e)    515,506     398,783
Other lawsuits (f)    380,862     337,807
Total        26,688,394   22,647,058

 

(a) Tax claims

(i) IR/CSL: Charges with goodwill amortization

The subsidiaries Cetrel and DAC were notified by the Brazilian Federal Revenue Service, (Secretaria da Receita Federal do Brasil, hereinafter “RFB”), in December 2020 and June 2021, respectively, for the deduction of tax amortization charges on goodwill arising from the acquisition of equity interests in 2012.

As of December 31, 2022, the updated amount of these claims was R$194,695 (2021: R$179,370). The cases are pending in the administrative sphere with conclusion expected by 2026.

(ii) IR/CSL: Exchange variation on naphtha imports

In December 2017 and December 2020, the Company received a tax deficiency notice related to the disallowance of exchange variation expenses between the due date of commercial invoices and the effective payment of obligations related to naphtha imports, related to calendar years 2012 and 2015, respectively. In relation to year 2012, disallowances led to the adjustment of tax losses and social contribution tax loss carryforwards. For 2015, a tax credit was considered along with a qualified fine corresponding to 150% of the tax deficiency notice amount.

The tax deficiency notice issued in December 2020 also resulted in partial disallowance of the cost of naphtha imported from its subsidiary abroad, in an amount corresponding to the profit margin calculated by the subsidiary in the naphtha resale operations, carried out in 2014 and 2015.

As of December 31, 2022, this uncertain tax treatment is R$1.2 billion (2021: R$1.1 billion), including fiscal years already filed and non-filed. The administrative proceedings should be concluded by 2026.

(iii) ICMS: Credit reversal on output with tax deferral

In July and December 2020, the Company was notified, by the State of Alagoas, due to the lack of ICMS tax payment arising from the alleged lack of reversal of the tax credited in operations prior to outflows with tax deferral. On December 31, 2022, the value of these cases was R$639 million (2021: R$587 million).

The administrative proceedings should be concluded by 2025.

(iv) IR/CSL: Foreign earned income – Braskem Holanda

The Company received a deficiency notice from RFB, referring to fiscal years 2015 and 2016, stating its disagreement with applying the Agreement between Brazil and the Netherlands to avoid double taxation, which establishes that Dutch companies' profits cannot be taxed in Brazil.

On December 31, 2022, the amount of the uncertain tax treatment is R$10.6 billion (2021: R$8.8 billion), including fiscal years already filed and non-filed.

The administrative proceedings should be concluded by 2026.

(v) PIS and COFINS: taxation of liability reductions settled in connection with the installment plan under Provisional Executive Order (“MP”) 470/2009

The Company received notice for not applying to PIS and COFINS taxes the reductions for fines and interest, in view of the adoption of the installment plan offered by the Federal Government under MP 470/2009.

In March 2023, the Company obtained favorable opinion from court of last resort (the Superior Chamber of the Tax Resources Administrative Board) cancelling the full collection. In accordance to the Management, based on its evaluation and that of its external legal advisor, an appeal from the National Treasury is not applicable and, hence, the probability of loss was changed from possible to remote. 

 

On December 31, 2022, the updated value of this proceeding is R$967 million (2021: R$910 million).

(vi) IR/CSL: Charges with goodwill amortization

The Company was served by the RFB for deducting amortization charges, from 2007 to 2013, relating to goodwill originated from acquisitions of shareholding interests in 2002. In 2002, Braskem foundation was fulfilled due to petrochemical assets disposals from several business groups. On December 31, 2022, the updated contingency estimate is R$1.1 billion (2021: R$1.1 billion).

These administrative proceedings should be concluded by 2025, while the current court proceeding should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(vii) Non-cumulative PIS and COFINS taxes

The Company received a deficiency notice from the RFB due to the use of non-cumulative PIS and COFINS tax credits in the acquisition of certain goods and services consumed in its production process in matters that have already been contested at the administrative and court level and comprise the period from 2004 to 2018.

As of December 31, 2022, the amount under discussion of these notices is R$1.4 (2021: R$1.3 billion).

The administrative proceedings should be concluded by 2026, while the lawsuits should be concluded by 2032.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(viii) IR/CSL: Unlimited offsetting

In December 2009 and March 2017, the Company received tax deficiency notices claiming that the methodology used to offset tax losses and tax loss carryforwards that failed to observe the limit of 30% of the Taxable Profit and Social Contribution calculation base when offsetting such liabilities with Corporate Income Tax and Social Contribution liabilities in merger operations, respectively, in November 2007 and August 2013.

As of December 31, 2022, the updated value of the contingency amounted to R$462 million (2021: R$430 million). The lawsuits should be concluded by 2031.

The Company offered performance bonds that cover the total amount involved in the court proceeding.

(ix) ICMS

The Company challenges ICMS collection drawn up in the States of São Paulo, Rio de Janeiro, Rio Grande do Sul, Bahia, Pernambuco and Alagoas, which materialized in administrative and court proceedings, including the following topics:

· ICMS credit on the acquisition of assets that are considered by tax authority as being for use and consumption, which as such do not produce a right to the credit because they are not physically part of the end product;

· ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by tax authority as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.;

· internal transfer of finished products for an amount lower than the production cost;

· omission of the entry or shipment of goods based on physical count of inventories;

· lack of evidence of exports of goods with shipment presumably taxed for the domestic market;

· non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;

· fines for the failure to register invoices; and

· nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market of the Electric Power Trading Chamber.

As of December 31, 2022, the updated value of these proceedings was R$768 million (2021: R$756 million).

These administrative proceedings are expected to be terminated in 2027, while the court proceedings are expected to be terminated in 2031.

The Company offered performance bonds that cover the total amount involved in the current court proceedings.

(x) PIS and COFINS sundry

The Company is involved in collection actions related to PIS and COFINS assessments in the judicial courts, which discuss the alleged undue offsetting of credits arising from other proceedings, including: (i) Income Tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees – Federal Laws 2.445 and 2.449; and (v) the COFINS tax arising from the undue payment or payment in excess.

As of December 31, 2022, the updated amounts involved of these assessments total R$136 million (2021: R$131 million).

These judicial proceedings are expected to be terminated in 2025.

The Company offered guarantees that cover the total amount involved in the court proceedings.

(xi) IRRF and IR/CSL: Commission expenses

In December 2017, the Company received a tax deficiency notice from the RBF arising from: (i) the disallowance of commission expenses paid by Braskem in 2011; (ii) the disallowance of commission expenses paid by Braskem Inc. in 2013 and 2014; (iii) lack of payment of withholding income tax (“IRRF”) on the payments referred to in the previous item; and (iv) the disallowance of advertising expenses incurred in 2013.

On December 31, 2022, the updated amount of taxes and tax effects from disallowances of income tax losses and social contribution tax loss carryforwards in the tax deficiency notice is R$153 million (2021: R$142 million).

This administrative proceeding should be concluded by 2024.

(xii) Fines on tax credits used

In 2015 through 2022, the Company received notifications of individual fines imposed due to the use of credits from: (i) non-cumulative PIS/COFINS taxes; (ii) negative balances of IR/CSL taxes; (iii) REINTEGRA credits; and (iv) other credits, for offsets not approved by the RFB.

As of December 31, 2022, the updated value of these deficiency notices amounted to R$353 million (2021: R$310 million).

These administrative proceedings should be concluded by 2027.

 

(xiii) IR/CSL: Negative Balance – Offset

The Company claims, at the administrative and judicial levels, that RFB denies offsets seeking to settle federal taxes with credits arising from negative balance of IR/CSL.

As of December 31, 2022, the updated value of the taxes whose offset was not approved amounted to R$176 million (2021: R$173 million).

These administrative proceedings should be concluded by 2024, while the lawsuits should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the current court proceedings.

(xiv) PIS and COFINS: Cide-Fuels Tax Offset

The Company is a party to lawsuits claiming PIS and COFINS tax liabilities arising from their offset using Cide-Fuels tax credits, as authorized under Federal Law 10.336/2001.

As of December 31, 2022, the updated value of these cases was R$123 million (2021: R$118 million). The lawsuits should be concluded by 2030.

The Company offered a performance bond that covers the total amount involved in the court proceedings.

(b) Civil claims

(i) Resale of solvents

In January 2017, the Company became defendant in a civil lawsuit filed by former reseller of solvents, claiming alleged breach of a tacit distribution agreement. The lawsuit is pending judgment.

As of December 31, 2022, the claims prepared by the other party amounted to R$302 million (2021: R$265 million).

(ii) Hashimoto Public-Interest Civil Action

The Public-Interest Civil Action was filed in June 2018 by the São Paulo State Public Prosecutor’s Office against the Company and other firms that operate in the Capuava Petrochemical Complex, claiming the reparation and/or remediation of environmental damages supposedly arising from the emission of pollutants into the air, as well as the joint judgement of companies that comprise said complex seeking environmental moral damages in the updated amount of R$201 million (2021: R$175 million).

Braskem filed its defense in December 2020, which is awaiting expert evidence. This lawsuit should be concluded by 2030.

(c) Labor claims

Lawsuits filed by former team members and contractors who provided services to Braskem, and are chiefly related to overtime, wage parity and other amounts established in labor laws.

(d) Environmental claims

Public-Interest Civil Action filed in September 2011 by the Local Government of the city Ulianópolis in Pará State against Braskem and other companies, claiming reparation and/or remediation of environmental damage allegedly resulting from the delivery of waste to the Brazilian Bauxite Company , which had not disposed of it properly, polluting an area of the Municipality of Ulianópolis, as well as the joint and several liability of these companies for the payment of indemnification for environmental damage in the updated amount of R$363 million (2021: R$325 million).

 

The companies filed their defense, however, a decision was rendered determining the temporary dismissal of the action for one year. This action should be concluded by 2030.

(e) Social security claims

In 2012, the Company withdrew sponsorship of the plans Petros Copesul and Petros PQU, and, in 2009, Petros Copene, whose private pension entity was Petros, remaining the obligation established under the Sponsorship Withdrawal Instrument to pay the mathematical reserves of Members, pursuant to Complementary Law 109/2001, which was met in 2015. However, after the payment, several beneficiaries filed individual and collective action regarding various claims, such as: (i) Difference of the Individual Withdrawal Fund; (ii) Change in base date; (iii) age limiter; (iv) 90% of supplementation; (v) Return of Contributions; (vi) Difference in Savings Account Reserve; (vii) Objection against legality of Sponsorship Withdrawal.

Currently, this portfolio is composed of 729 active cases (2021: 783), of a financial contingency nature, representing an estimated amount of R$379 million (2021: R$332 million).

(f) Other lawsuits

(i) Incentivized Preferred Shares

The Company currently is subject to the liquidation of an award related to a lawsuit filed in 1988, whose decision required Polialden Petroquímica S.A. (“Polialden”), a company merged into Braskem, to pay certain non-controlling shareholders that hold preferred shares in Polialden the distribution of the remaining net profit of the company.

The liquidation of award aims to determine the value of the dividends to be paid in accordance with the terms of the decision. The process is awaiting the start of the expert evidence.

As of December 31, 2022, based on Management’s assessment and that of its external legal advisors, the Company recorded a provision of R$21 million (2021: R$19 million). The amount considered as possible loss is R$262 million, and the total amount of the lawsuit is R$283 million (2021: R$257 million).

(ii)Social security – hazardous agents

The Company is a party to other proceedings, which claim payments of additional contribution for Occupational Environmental Risk to fund the special retirement plan due to the alleged exposure of workers to hazardous agents: (a) in the administrative sphere (a.1) in the period from April 1999 to February 2006, jointly with a fine due to failure to declare the generating factor of the contribution to GFIP, and (a.2) in the period from January 2016 to July 2018; (b) in the legal sphere, in the periods from November 2000 to January 2001 and November 2001 to June 2002.

On December 31, 2022, the adjusted amount of these proceedings is R$203 million (2021: R$187 million).

The administrative proceedings should be concluded by 2025, while the only current court proceeding should be concluded by 2028.

The Company pledged a performance bond that covers the total amount involved in the current court proceeding.

24.3 Class action

On August 25, 2020, an action was filed against Braskem and some of its current and former executives in the US District Court for the District of New Jersey, in the United States, on behalf of an alleged class of investors who acquired Braskem's shares. The action was grounded in the U.S. Securities Exchange Act of 1934 and its rules, based on allegations that the defendants made false statements or omissions related to the geological event in Alagoas.

On December 15, 2022, the parties entered into Agreement to terminate the Class Action via payment of US$3 million, which was carried out in January 2023. On December 20, 2022, as the first measure for approval of the Agreement, the lead plaintiff filed a preliminary approval motion, and the U.S. District Court for the District of New Jersey will follow the required procedure for approval of the Agreement. The extinction of Class Action will be declared only after approval of the Agreement and after the obligations assumed by the parties of the Agreement are met.

Braskem cannot predict precisely all costs in solving this dispute. The Company may be named as a defendant in other similar legal actions.

24.4 Contingent assets

Contingent assets normally arise from unplanned or unexpected events that give rise to the possibility of an inflow of economic benefits to the Company. Contingent assets are not recognized in the consolidated financial statements, but they are disclosed when it is likely that an inflow of economic benefits will occur. However, when the inflow of benefits is virtually certain, the asset is recognized in the financial position statement because that asset is no longer considered contingent.

(i) Compulsory loans: Centrais Elétricas Brasileiras S.A. (“Eletrobras”)

The compulsory loan in favor of Eletrobras was established by Federal Law 4.156/62, to finance the energy industry and remained effective until 1993. It was collected through the energy bills of industrial consumers with monthly consumption equal to or higher than 2000kwh and, after successive amendments to the law, the reimbursement was extended to 20 years, plus compensatory interest of 6% per year, which can be anticipated through conversion of credits into shares issued by Eletrobras.

Between 2001 and 2009, the companies merged into Braskem S/A filed proceedings seeking the recovery of amounts related to differences in the inflation adjustment of the compulsory loan, interest on arrears and compensatory interest and other related payments.

The Company obtained a favorable final and unappealable decision in the cases of the merged companies Alclor Química de Alagoas Ltda., Companhia Alagoas Industrial – Cinal, Companhia Petroquímica do Sul S.A. – Copesul and Trikem S. A., which are currently in the execution phase. The cases of the merged companies Ipiranga Petroquímica S.A., Petroquímica Triunfo Ltda. and Quattor Química S.A are in the cognizance phase.

The term, form and amount to be realized are still uncertain, so it is not possible to determine the amount to be received and, for such reason, the asset does not meet the conditions to be recorded in the consolidated financial statements.

XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Leniency agreement with authorities
12 Months Ended
Dec. 31, 2022
Leniency Agreement With Authorities  
Leniency agreement with authorities

25 Leniency agreement with authorities

In the context of allegations of undue payments in connection with Operation Car Wash in Brazil, the Company hired external experts in investigation to conduct an independent investigation into such allegations (“Investigation”) and to report their findings.

In December 2016, the Company entered into Leniency Agreements with the Federal Prosecution Office (Ministério Público Federal, hereinafter “MPF Agreement”) and with U.S. and Swiss authorities (“Global Settlement”), in the amount of US$957 million (R$3.1 billion, at the time), which were duly ratified. Further, the Company engaged in a process of cooperation and negotiation with the Ministry of Transparency and the Office of The Federal Controller General (Controladoria-Geral da União, hereinafter “CGU”) and the Office of the Attorney General (Advocacia-Geral da União, hereinafter “AGU”), which culminated in the execution of the leniency agreement with such authorities on May 31, 2019 (“CGU/AGU Agreement” and, jointly with the Global Settlement, “Agreements”), which addresses the same facts that are the subject of the Global Settlement and provides for an additional disbursement of R$409,877 due to the calculations and parameters adopted by CGU/AGU. In addition, in 2019, the State Prosecution Office of Bahia and the State Prosecution Office Rio Grande do Sul adhered to the MPF Agreement. Therefore, no additional payments are expected to be made by the Company.

 

As of December 31, 2022, the Company paid R$3,070,578, distributed as shown below:

                               
          AGU                    
Agreements signed with:   . CGU and MPF   DoJ (i)   OAG (i)   MPF   SEC (i)   Total
                               
 Amounts paid         877,763     296,591     407,300     1,282,464     206,460     3,070,578

(i) U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").

 

As of December 31, 2022, the outstanding amount is R$903,140 (R$392,486 and R$510,654 as current and non-current liabilities, respectively), under the MPF Agreement and CGU/AGU Agreement, which will be paid in three annual installments updated by the variation in the Selic rate and payable until January 30, 2025. To guarantee payment of the installments of these installments coming due, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment.

Braskem’s activities related to the monitoring by the CGU of the Company were successfully concluded, and no pending issues involving the Company remained, the CGU will present the Final Monitoring Report and prepare the Agreement. Moreover, the Company is in compliance with all of its obligations under the Agreements and continues to cooperate with government authorities.

 

XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Geological event - Alagoas
12 Months Ended
Dec. 31, 2022
Geological Event - Alagoas  
Geological event - Alagoas

26 Geological event - Alagoas

The Company operated, since its formation and subsequently as the successor of the company Salgema, salt mining wells located in Maceió city, with the purpose of supplying raw material to its chlor-alkali and dichloroethane plant. In March 2018, an earthquake hit certain districts of Maceió, Alagoas, where the wells are located, and cracks were found in buildings and public streets of Pinheiro, Bebedouro, Mutange and Bom Parto districts.

In May 2019, the Geological Survey of Brazil (“CPRM”) issued a report, indicating that the geological phenomenon observed in the region, could be related to the rock salt exploration activities developed by Braskem. In view of these events, on May 9, 2019, Braskem preventively decided to suspend its salt mining activities and the operation of its chlor-alkali and dichloroethane plant.

Since then, the Company has been devoting its best efforts to understand the geological event: (i) possible surface effects; and (ii) the analyses of well’s stability. The results are being shared with the Brazilian National Mining Agency (“ANM”) and other pertinent authorities, which the Company has been maintaining constant dialogue.

Braskem presented to ANM the measures for shutting down its salt mining fronts in Maceió, with measures for the closure of its wells, and, on November 14, 2019, it proposed the creation of a protective area surrounding certain wells as a precautionary measure to ensure public safety. These measures are based on a study conducted by the Institute of Geomechanics of Leipzig (IFG), in Germany, an international reference in the geomechanical analysis of areas of salt extraction by dissolution and are being adopted in coordination with the Civil Defense of Maceió and other authorities.

As a result of the geological phenomenon, negotiations were conducted with public and regulatory authorities that resulted in the Agreements executed, including:

i)Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents"), entered into with State Prosecution Office (“MPE”), the State Public Defender’s Office (“DPE”), the Federal Prosecution Office (“MPF”) and the Federal Public Defender’s Office (“DPU”), which was ratified by the court on January 3, 2020, adjusted by its resolutions and subsequent amendments, , which establish cooperative actions for relocating residents from risk areas, defined in the Map of Sectors of Damages and Priority Action Lines by the Civil Defense of Maceió (“Civil Defense Map”), as updated in December 2020 (version 4), and guaranteed their safety, which provides support, under the Financial Compensation and Support for Relocation Program (“PCF”) implemented by Braskem to the population in the areas of the Civil Defense Map, as well as the dismissal of the Public-Interest Civil Action (Reparations for Residents), as detailed in Note 26.1 (i).

 

(ii) Agreement to Dismiss the Public-Interest Civil Action on Socio-Environmental Reparation and the Agreement to define the measures to be adopted regarding the preliminary injunctions of the Public-Interest Civil Action on Socio-Environmental Reparation (jointly referred to as “Agreement for Socio-Environmental Reparation”), signed with the MPF with the MPE as the intervening party, on December 30, 2020, in which the Company mainly undertook to: (i) adopt measures to stabilize and monitor the subsidence phenomenon arising from salt mining; (ii) repair, mitigate or compensate possible environmental impacts and damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate possible socio-environmental impacts and damages arising from salt mining in the Municipality of Maceió, as well as the termination of the Public-Interest Civil Action (Socio-environmental Reparation) related to the Company, as detailed in Note 26.1 (ii). Moreover, the Agreement for Socio-Environmental Reparation envisages the inclusion of other parties, which depends on specific negotiation with such potential parties.

Thus, the Company has been meeting all obligations assumed with the authorities and acting proactively on all fronts to resolve the issues arising from the geological event. Highlights: (i) PCF significant advances on assisting public authorities to vacate properties located in the risk areas and submitting full financial compensation offers with a high level of acceptance; (ii) the actions for closing and monitoring the salt wells, which are following the mining closure plan approved by the ANM, seeking to stabilize the subsidence phenomenon resulting from salt mining; and (iii) the social and environmental diagnoses conducted in connection with the Socio-Environmental Reparation Agreement.

As assessed by the Company and its external advisors, considering the measures recommended on technical studies in the short and long-term and the existing information and refined estimates of expenses for implementing several measures connected with the geological event in Alagoas, the provision recorded on December 31, 2022, shows the following changes in the period:

             
               
      2022   2021   2020
               
Balance at the beginning of the year     7,661,259   9,175,777   3,383,067
               
Additions     1,520,019   1,339,765   6,901,827
Payments and reclassifications (*)      (2,742,791)    (2,928,081)    (1,181,931)
Realization of present value adjusment     188,071     73,798     72,814
Balance at the end of the year      6,626,558   7,661,259   9,175,777
               
Current liability     4,247,609   4,378,071   4,349,931
Non-current liability     2,378,949   3,283,188   4,825,846
Total     6,626,558   7,661,259   9,175,777

(*) Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.

 

The current provision can be segregated into the following action fronts:

a. Support for relocating and compensating for the residents, business and real state owners of properties located in the Civil Defense Map (version 4) updated in December 2020, including establishments that requires special measures for their relocation, such as hospitals, schools and public equipment.

These actions have a provision of R$2,087,142 (2021: R$3,390,849) comprises expenses related to relocation actions, such as relocation allowance, rent allowance, household goods transportation and negotiation of individual agreements for financial compensation.

b. Actions for closing and monitoring the salt wells, environmental actions and other technical matters. Based on the findings of sonar and technical studies, stabilization and monitoring actions were defined for all 35 existing salt mining wells. Based on studies of the specialists, the recommendation was to fill 5 more salt wells with solid material, bringing the total wells to be filled to 9, a process that should take 4 years. For the remaining 26, the recommended actions are: conventional closure using the tamponade technique, which consists of promoting the cavity pressurization, applied worldwide for post-operation cavities; confirmation of natural filling status; and, for some wells, sonar monitoring.

The provisioned amount of R$1,367,269 (2021: R$1,691,032) to implement the measures described in this item was calculated based on existing techniques and the solutions planned for the current conditions of the wells, including expenses with technical studies and monitoring, as well as environmental actions already identified. The provision amount may change in the future, in accordance with the results of the monitoring of the wells, the progress of implementing the plans to close wells, possible changes that may be required in the environmental plan, the monitoring of the ongoing measures and other possible natural alterations.

The monitoring system implemented by Braskem envisages actions developed during and after the closure of wells, focusing on safety and monitoring of the region’s stability.

The Company’s actions are based on technical studies conducted by outsourced specialists, with the recommendations presented to the competent authorities. The Company is implementing the actions approved by ANM.

In June 2022, in compliance with the Agreement for Socio-environmental Reparation, Braskem submitted to the MPF the environmental diagnosis containing the assessment of the potential environmental impacts and damages arising from salt mining activities and the environmental plan with proposals of the measures required. As established in the agreement, the parties jointly defined the specialized company that will evaluate and monitor the environmental plan. In December 2022, an additional report on the environmental plan was filed with the MPF. In February 2023, MPF expressed its agreement with this environmental plan, incorporating the suggestions provided in the additional report. Braskem initiated the actions foreseen by the plan, implementing the commitments established in the agreement and sharing the results of its actions with the authorities. Also is agreed that the environmental diagnosis will be updated in December 2025.

c. Social and urban measures, under the Agreement for Socio-environmental Reparation signed on December 30, 2020, allocating R$1,580,000 for the adoption of actions and measures in vacated areas, urban mobility and social compensation actions, of which R$300 million going to indemnification for social damages and collective pain and suffering and possible contingencies related to the actions in the vacated areas and urban mobility actions. The provision amount, updated by inflation index established in the agreement, is R$1,567,842 (2021: R$1,577,186).

d. Additional measures, for which the provision amounts to R$1,604,305 (2021: R$1,002,192), for expenses with: (i) actions related to the Technical Cooperation Agreements entered into by the Company; (ii) the hiring of external advisors to support the execution of the relocation actions and compensation of the families; (iii) infrastructure for assisting residents; (iv) expenses with managing the geological event in Alagoas relating to communication, compliance, legal services, etc.; (v) additional measures to assist the region and maintenance of areas, including actions for requalification and indemnification directed to Flexais region; and (vi) other matters classified as a present obligation for the Company, even if not yet formalized.

The provisions of the Company are based on current estimates and assumptions and may be updated in the future due to new facts and circumstances, including, but not limited to: changes in the execution time, scope and method; the success of action plans; new repercussions or developments arising from the geological event, including possible revision of the Civil Defense map; and possible studies that indicate recommendations from specialists, including the Technical Monitoring Committee, according to Agreement for Compensation of Residents, and other new developments in the matter.

The measures related to the mine closure plans are also subject to the analysis and approval by ANM, the monitoring of results of the measures under implementation as well as changes related to the dynamic nature of geological event.

Continuous monitoring is essential for confirming the results of the current recommendations. Accordingly, the plans to close the wells may be updated based on the need to adopt technical alternatives to stabilize the subsidence phenomena arising from the extraction of salt. In addition, the assessment of the future behavior of cavities monitored using sonar and piezometers could indicate the need for certain additional measures to stabilize them.

The actions to repair, mitigate or offset potential environmental impacts and damages, as provided for in the Socio-environmental Reparation Agreement, will be defined considering the environmental diagnosis already prepared by a specialized and independent company. After the conclusion of all discussions with authorities and regulatory agencies, as per the process established in the agreement, an action plan will be agreed to be part of the measures for a Plan to Recover Degraded Areas (“PRAD”).

Furthermore, the Socio-Environmental Reparation Agreement envisages the potential adherence by other parties, including the Municipality of Maceió.

Also in the context of understandings with the authorities to address claims related to the event in Alagoas, on October 26, 2022, the 3rd Federal Court of Alagoas ratified the Term of Agreement for Implementation of Socioeconomic Measures for the Requalification of the Flexal Area (“Flexais Agreement”), entered into by Braskem and the MPF, the MPE, the DPU, and Municipality of Maceió for the adoption of action for requalification in the Flexais region, compensation to the Municipality of Maceió and indemnities to the residents of this location. The expected disbursement amounts to the execution of the obligations defined in the Term of Agreement are part of the provision under (d) Additional Measures.

The Company has been making progress with local authorities about other indemnification requests to understand them better, resulting in advances in the understanding between the parties that may result in an agreement. Although future disbursements may occur as a result of progress in negotiations, as of the reporting date, the Company is unable to predict the results and timeframe for concluding these negotiations or its possible scope and the total associated costs in addition to those already provisioned for.

It is not possible to anticipate all new claims, related to damages or other nature, that may be brought by individuals or groups, including public or private entities, that understand they suffered impacts or damages somehow related to the geological phenomenon and the relocation of people from risk areas, as well as new notices of infraction or administrative penalties of diverse natures. Braskem continues to face and could still face administrative procedures and various lawsuits filed by individuals or legal entities not included in the PCF or that disagree with the financial compensation offer for individual settlement, as well as new collective actions and new lawsuits filed by public utility concessionaires, entities of the direct or indirect administration of the State, Municipality or Federal level. Therefore, the number of such actions, their nature or the amounts involved cannot be estimated at this moment.

Consequently, the Company cannot eliminate the possibility of future developments related to the geological event in Alagoas, the relocation process and actions in vacated and adjacent areas, so the expenses to be incurred may differ from its estimates and provisions.

In February 2023, the Company signed a settlement agreement with the insurance companies related to the claim for the geological event in Alagoas. 

 

26.1 Lawsuits pending

In the context of this event, the following lawsuits were filed against the Company:

(i) Public-Interest Civil Action (“ACP”) filed by the Alagoas State Prosecution Office and the Alagoas State Public Defender’s Office – Reparation for Residents

Public-Interest Civil Action claiming the payment of indemnification for damages caused to the buildings and the residents of areas affected in the Pinheiro district and surrounding areas, in the total minimum amount of R$6.7 billion, with initial request for provisional measure to freeze the Company’s financial and other assets in the same amount. Successive orders to freeze funds resulted in the court blocking of R$3.7 billion in assets in 2019, and the unfreezing occurred in January 2020. Once the case was sent to the Federal Courts, the Federal Prosecution Office started to participate in the action.

The first agreement under this Public-Interest Civil Action (Reparation for Residents) was ratified on January 3, 2020. The Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents”), entered into by Braskem and the MPE, the DPE, the MPF and the DPU (“Authorities”), establishes cooperative actions for relocating people in risk areas and guaranteeing their safety, which provides support under the Financial Compensation and Support for Relocation Program implemented by Braskem, for the population in specified risk areas.

After updates of the Civil Defense Map, two legal instruments were entered into with the Authorities, in July and October 2020, to include properties in the PCF.

On December 30, 2020, the Company and the Authorities executed a second amendment to the Agreement for Compensation of Residents to terminate the Public-Interest Civil Action, through which the parties agreed to include in PCF the relocation of additional properties defined in the updated version of the Civil Defense Map, of December 2020, and in the independent technical and specialized studies engaged by the Company on the potential impact of the geological event on the surface of the region (“Studies”). The Agreement for Compensation of Residents includes the area currently affected by the geological event, according to the Civil Defense, and the areas with potential future impacts indicated in the Studies.

To implement the actions envisaged in the Public-Interest Civil Action, the Company undertook to maintain R$2.7 billion in a checking account (R$1.7 billion under the Agreement for Compensation of Residents and an additional R$1 billion under the second amendment), with minimum working capital of R$100 million, whose transactions will be verified by an external audit company. On December 31, 2022, arising from the costs incurred related to the PCF, the balance of this checking account corresponded to R$175,153 under current assets (2021: R$835,517). In addition, the Company and the Authorities agreed to: (i) create a technical group (Technical Monitoring Committee) to monitor the geological event and study the areas adjacent to the Civil Defense Map for a period of five years; and (ii) maintain a performance bond in the current amount of R$1.2 billion (down from the R$2 billion performance bond envisaged in the Agreement for Compensation of Residents).

With the judicial ratification by the courts of the Agreement for Compensation of Residents on January 6, 2021, this Public-Interest Civil Action was terminated.

(ii) Public-Interest Civil Action filed by the Alagoas State Federal Prosecution Office – Social-environmental reparation

Public-Interest Civil Action claiming the payment by the Company of indemnification for socio-environmental damages and other collective damages, as well as the adoption of corrective and environmental compliance measures, with preliminary injunction requiring the freezing of assets, suspension of borrowings with the BNDES, formation of an own private fund in the initial amount of R$3.1 billion and the pledging of guarantees in the amount of R$20.5 billion. The amount of the action was R$27.6 billion.

(i)On December 30, 2020, the Agreement for Socio-environmental Reparation was executed, with the Company mainly undertaking to: (i) adopt measures to stabilize and monitor the subsidence phenomenon resulting from salt mining; (ii) repair, mitigate or compensate potential impacts and environmental damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate potential impacts and social and urban damages arising from salt mining in the Municipality of Maceió, as detailed below: To stabilize the cavities and monitor the soil, the Company continues to implement the action plans involving the closure of mining fronts prepared by Braskem and approved by the ANM, whose measures can be adjusted until the stability of the subsidence phenomenon resulting from salt mining is verified.
(ii)Regarding the potential environmental impacts and damages resulting from salt mining in the Municipality of Maceió: as agreed with the MPF, the Company hired a specialized independent company to identify and recommend measures for recovering, mitigating or compensating any environmental impacts identified as the result of salt mining activities in Maceió. The study and the second opinion report on the environmental planning were delivered to the MPF on June 30, 2022 and December 7, 2022, respectively, and will follow the procedures as per the agreement for final consolidation of the actions to be adopted in the mutual agreement between the Company and the MPF, but it is not possible to predict the outcome or if it will result in additional amounts other than those already recorded in the provision. Regarding potential impacts and social and urban damages arising from salt mining in the city of Maceió: to allocate the maximum amount of R$1,280 million for adopting actions and measures in vacated areas, urban mobility actions and social compensation actions. For these social compensation actions and measures, on June 30, 2022, the Company filed with the MPF the report and the respective plan of social action that will be used as base to define the measures to be adopted. Braskem also will allocate the amount of R$300 million for indemnification for social and collective pain and suffering and possible contingencies related to actions in vacated areas and in urban mobility actions.

The Company and the Federal Prosecution Office also agreed to hire a specialized consultancy to evaluate the Company’s Social and Environmental Management Program and on the pledging of security interest involving certain assets of the Company in the amount of R$2.8 billion to substitute the performance bond of R$1 billion.

The Agreement for Socio-environmental Reparation was ratified by Court on January 6, 2021, with the termination of the Public-Interest Civil Action for Socio-environmental Reparation regarding to Braskem. Moreover, this agreement provides for the possibility of adhesion by other parties, including the Municipality of Maceió.

Finally, under the Agreement for Socio-environmental Reparation, on January 21, 2021 the Civil Investigation launched in June 2020 by the MPE was terminated. It aimed to: (i) calculate the extent of the urban damages caused by the geological event that occurred in Maceió; (ii) seek, from liable parties, necessary and adequate architectural solutions for the destination, restoration and/or use of the cited empty spaces left in the districts impacted; (iii) calculate, if applicable, potential compensatory liabilities for the damages caused to the urban order.

(iii) Public-Interest Civil Action filed by the Federal Public Defender’s Office (“DPU”): refusal of insurance within the scope of Housing Financial System (“SFH”)

Public-interest civil action filed by DPU to question the denial of necessary insurance for contracts under the SFH to acquire properties located within a radius of 1 km outside the risk area defined by the version 4 map of Civil Defense authorities, which is the subject matter of the Residents PCA agreement – see item (i).

Insurers linked to SFH, financial agents, the regulatory agency and Braskem are the defendants. The main claim is only against the insurers, financial agents and the regulatory agency on the grounds that the refusal to contract the insurance is abusive and has no technical or legal grounds. There is a secondary and eventual claim to sentence Braskem to pay indemnification in an amount to be settled in the future, if the judge understands that the refusal somehow has grounds due to the subsidence phenomenon.

It is not possible to estimate the indemnification amount, which will depend on the evidence of damages submitted by people whose insurance was denied.

(iv) Public-Interest Civil Action filed by the Alagoas State Public Defender’s Office – Review of terms of the Flexais Agreement

Public-interest civil action filed by DPE against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the 3rd Federal Court of Alagoas.

Through of this lawsuit, the DPE seeks, among other claims, the inclusion of residents of Flexais region, who choose to adhere the PCF, program created under the agreement in ACP (Reparation for Residents), with consequent reallocation of these residents and compensation for moral and material damages in parameters specified in the ACP.

As injunction relief, DPE also requested, that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the PCF, or, alternatively, requested the freeze of Braskem bank accounts in the amount of R$ 1.7 billion, to guarantee the compensation for moral and material damages to residents of the Flexais region, this being the amount attributed to the lawsuit. The injunction relief requests were rejected by the court; decision subjected to appeal by DPE.

The Management, supported by the opinion of the external legal advisor, classifies the probability of loss in this lawsuit as possible.

(v) Indemnity Claim: Companhia Brasileira de Trens Urbanos (“CBTU”)

On February 2, 2021, the Company was notified of the filing of a lawsuit by Companhia Brasileira de Trens Urbanos, formulating initially only a preliminary injunction for maintaining the terms of the cooperation agreement signed previously by the parties. The request was denied in lower and appellate courts, given the fulfillment of the obligations undertaken by Braskem. On February 24, 2021, CBTU filed an amendment to the initial request claiming the payment of compensation for losses and damages in the amount of R$222 million and for moral damages in the amount of R$500 thousand, as well as the imposition of obligations, including the construction of a new rail line to substitute the stretch that passed through the risk area.

On December 31, 2022, the updated value of this lawsuit is R$1.43 billion (2021: R$1.40 billion). Braskem entered into a memorandum of understanding with CBTU to seek a consensual solution and suspend the lawsuit during the negotiation period and has made progress in the technical understanding about the topic. As a result of a joint petition filed by the parties, the lawsuit was suspended until June 2023.

The Management, based on its assessment and that of its external legal advisors, classifies the probability of loss in this case as possible.

(vi) Indemnity Claim: Pinheiro District Property

Indemnity claim filed by Construtora H. Lobo (under court-supervised reorganization), a Contractor that claimed it suffered damages and loss of profits due to an agreement to purchase from Braskem a property in the District of Pinheiro. Said agreement was terminated by Braskem due to lack of payment by the Contractor. Nevertheless, the Contractor claims that Braskem omitted information on the existence of structural problems in the deactivated salt mining wells located on said property. As of December 31, 2022, the amount of this action is R$306 million (2021: R$264 million). The lawsuit is ongoing, and Management, supported by the opinion of its external legal advisors, classifies the probability of loss in this case as possible.

(vii) Indemnity Claim: State of Alagoas

Indemnity claim filed by the State of Alagoas, requesting compensation for alleged damages resulting, among others claims, from the loss of properties within the risk area defined by the Civil Defense of Maceió, alleged investments initiated by the State of Alagoas and that would have become void unusable due to the evacuation of the risk area and alleged loss of tax revenue, with a request that such damages to be determined by a court appraiser.

As injunction relief, the State of Alagoas requested the blocking of R$ 1.1 billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration, this being the amount attributed to the lawsuit. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court. 

The Management, supported by the opinion of its external legal advisor, classifies the probability of loss in this lawsuit as possible.

(viii) Other individual actions: Indemnifications related to the impacts of subsidence and relocation of areas affected

On December 31, 2022, Braskem was defendant in several other actions, that, in aggregate, involve the amount of R$1 billion (2021: R$895 million), filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió.

The Management, supported by the opinion of its external legal advisor, classifies the probability of loss of the other individual lawsuits, in the total amount mentioned above, as possible.

 

XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to employees
12 Months Ended
Dec. 31, 2022
Benefits Offered To Employees  
Benefits offered to employees

27 Benefits offered to employees

27.1 Short-term benefits

The obligations of short-term benefits for employees are recognized as personnel expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered by an employee in the past and the obligation can be reliably estimated.

 

       
  2022   2021   2020
           
Health care 243,620   235,681   197,683
Private pension 127,954   136,851     94,302
Transport   86,217     77,201     66,752
Feeding   62,786     51,240     38,400
Life insurance   10,400     10,324    9,875
Training   27,032     15,723     14,892
Other   16,027     12,546     14,117
   574,036    539,566    436,021

 

27.2 Long-term incentive plan (“ILP Plan”)

On March 21, 2018, the Extraordinary Shareholders Meeting approved the Long-Term Incentive Plan with the grant of Restricted Shares (“ILP Plan”) to align the interests of shareholders and executive officers (participants) and to promote their continued employment at the Company.

The grant is subject to the voluntary investment of own financial resources by participants in the shares issued by the Company (tickers BRKM5 or BAK). To acquire the right, participants must maintain their employment relationship with the Company and hold uninterruptedly the shares acquired during the three-year vesting period.

When the conditions to obtain the right are met, the Company transfers to participants the number of restricted shares to which they are entitled, which are held in treasury or acquired through repurchase program.

If the transfer is not possible, the Company will pay to participants, in cash, the amount equivalent to the shares granted at the share price traded on stock exchange on the second business day immediately prior to the respective payment date.

The fair value of shares on the grant date is recognized on a straight-line basis under personnel expenses during the vesting period, reflecting the expected number of shares that will meet the conditions to obtain the right, in such a way that the end amount recognized as an expense is based on the number of shares that effectively meet the conditions on the vesting date.

The form of settlement of the ILP Plan determines the corresponding entry of expenses, which is recognized under equity for payment of shares and recognized under liabilities for cash payment, with the liability remeasured on each reporting date and on the settlement date, based on the American Depositary Receipt price. Any changes in the fair value of the liability are recognized as personnel expenses.

The programs listed below were approved by the Board of Directors under the terms and conditions of the Long-Term Incentive Plan, which includes a list of eligible people, the period for acquisition of own shares by the participants and the number of restricted shares to be delivered to participants as consideration for each share acquired.

 

                                                 
Flat   Grant Date   End of Grace Period   Settlement Method   Granted quantities   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2021   (+) Granted   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2022   Fair value of the share*
                                                 
2019 Plan   03/19/19   03/19/22   Shares     417,234    (71,905)   -    345,329    -    (18,802)    (326,527)   -    
2019 Plan   03/19/19   03/19/22   Cash    82,128   (8,433)   -   73,695    -   (1,297)   (72,398)   -    
                                                 
2020 Plan   04/01/20   04/01/23   Shares    1,007,883    (72,743)   (2,373)    932,767    -    -   -    932,767   R$ 16.27
2020 Plan   04/01/20   04/01/23   Cash     314,333    (47,943)   -    266,390    -    -   -    266,390   USD 9.67
                                                 
2021 Plan   05/10/21   05/10/24   Shares     557,888   (9,598)   -    548,290    -    -   -    548,290   R$ 51.39
2021 Plan   05/10/21   05/10/24   Cash     144,779    -   -    144,779    -    -   -    144,779   USD 9.67
                                                 
2022 Plan   05/17/22   05/17/25   Shares    -    -   -   -     537,870    -   -    537,870   R$ 44.15
2022 Plan   05/17/22   05/17/25   Cash    -    -   -   -     132,902    -   -    132,902   USD 9.67

(*) Values in monetary units.

 

On December 31, 2022, the amount recorded in equity is R$39,413 (2021: R$31,932).

27.3 Post-employment benefits

The obligations for contributions to defined contribution plans are recognized in profit or loss as personnel expenses when the related services are provided by employees. The contributions paid in advance are recognized as an asset to the extent that a cash reimbursement or a reduction in future payments is possible.

The Company’s net obligation for defined benefit plans is calculated for each of the plans based on the estimated amount of future benefit that employees will receive in return for services rendered in the current and prior periods. Such amount is discounted to its present value and is reported net of the fair value of any of the plan’s assets.

The calculation of the obligation of the defined benefit plan is made annually by a qualified accountant using the projected unit credit method. When calculations result in a potential asset for the Company, the asset to be recognized is limited to the present value of economic benefits available as future plan reimbursements or as a reduction in future contributions to the plan. To calculate the present value of economic benefits, any applicable minimum cost requirements are taken into account. Remeasurements of net obligation, which include: actuarial gains and losses, return on plan assets (excluding interest) and the effects of the asset cap (if any, excluding interest), are immediately recognized in other comprehensive income.

Braskem and subsidiaries in Brazil

Braskem and the subsidiaries in Brazil sponsor a defined contribution plan for its team members managed by Vexty, a private pension plan entity. Vexty offers its participants, which are employees of the sponsoring companies, an optional defined contribution plan in which monthly and additional participant contributions and monthly and annual sponsor contributions are made to individual pension savings accounts. For this plan, the sponsors pay contributions to private pension plan on contractual or voluntary bases. As soon as the contributions are paid, the sponsors do not have any further obligations related to additional payments.

As of December 31, 2022, the number of active participants in Vexty sums 6,391 (2021: 6,113) and the contributions made by the sponsors in the year amount to R$92,208 (2021: R$68,744) and the contributions made by the participants amounted to R$77,263 (2021: R$83,599).

According to Brazilian laws, the type of health plan offered by Braskem, named contributory plan, ensures to the participant who retires or is dismissed without cause the right to remain in the plan with the same assistance coverage conditions they had during the employment term, provided they assume the full payment of the plan (Company’s part + participant’s part).

Braskem America

Braskem America administers the Novamont, which is a closed defined benefit pension plan for the employees of a plant located in the State of West Virginia. On December 31, 2022, there were 36 active participants, 32 employees with deferred benefits along and 101 assisted participants (2021: 36 active participants, 141 employees with deferred benefits and 173 assisted participants).

During 2022, the number of participants in the pension plan decreased, and 173 participants received a fixed payment or opted for insurance annuity.

Due to the current funding levels of the pension plan, the subsidiary was not required to contribute to the plan during the 2022 plan year and, therefore, there were no additional cash contributions made by the subsidiary or the participants in 2022 and 2021.

Braskem Alemanha (“Germany”)

Braskem Alemanha is the sponsor of the defined benefit plans and defined contribution plans of its employees. As of December 31, 2022, the plans have 172 participants (2021: 158) and no contributions were made by the subsidiary or the participants in 2022 and 2021.

Braskem Holanda (“Netherlands”)

The subsidiary Braskem Holanda is the sponsor of the defined contribution plans of its employees. As of December 31, 2022, the plans have 12 participants (9 participants in 2021) and no contributions were made by the subsidiary or the participants in 2021 and 2020.

Braskem Idesa

Braskem Idesa is the sponsor of defined benefit plans for its team members. As of December 31, 2022, the plan was composed of 965 active participants (2021: 936 active participants). The contributions the subsidiary made in the year amounted to R$4,370 (2021: R$3,810). During 2022 and 2021, there were no contributions from participants.

(a) Amounts in statement of financial position

                 
                   
                2022   2021
Defined benefit                    
Novamont Braskem America               58,221    117,509
Braskem Idesa                 23,053   22,960
Braskem Alemanha and Netherlands             147,562    223,193
                228,836    363,662
Health care                    
Bradesco saúde               321,520    243,706
Total obligations                550,356     607,368
                     
Fair value of plan assets                  
Novamont Braskem America             (54,665)   (117,509)
Braskem Alemanha                (1,948)    (2,162)
                (56,613)   (119,671)
                     
Consolidated net balance (non-current liabilities)              493,743     487,697

 

Change in obligations

                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
                                     
Balance at beginning of year   243,706     363,662    607,368     217,089    370,860    587,949     224,852    245,565    470,417
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Benefits paid   (12,639)   (34,208)    (46,847)     (10,712)   (7,191)    (17,903)    (5,949)   (7,409)    (13,358)
Actuarial losses (gain)  65,325   (83,485)    (18,160)    16,820    (26,668)   (9,848)     (23,589)   25,803     2,214
Exchange variation        (36,779)    (36,779)         7,074   7,074     -   87,933   87,933
Balance at the end of the year 321,520   228,836     550,356   243,706   363,662   607,368   217,089     370,860     587,949

 

(b) Change in fair value plan assets

           
    2022   2021   2020
             
Balance at beginning of year   119,671     115,875   81,342
Actual return on plan assets (25,929)   722   15,791
Benefits paid   (32,264)     (5,301)   (4,973)
Exchange variation     (4,866)   8,375   23,715
Balance at the end of the year 56,613   119,671     115,875

 

On December 31, 2022, the balance of the fair value of assets is represented by the assets of the Novamont defined benefit plan, which has a level-1 fair value hierarchy.

Amounts recognized in profit and loss

                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
              -                        
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Actuarial (losses) gains     (83,485)    (83,485)      (24,203)   (24,203)     -   15,461   15,461
    25,128    (63,839)   (38,711)   20,509     (4,616)   15,893     21,775    34,429    56,204

 

(c) Actuarial assumptions

                                                                   
                                                                  (%)
                          2022                   2021                   2020
          Health   United               Health   United               Health   United            
          insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
                                                                   
Discount rate         5.97   5.10    8.00     1.20     3.60     5.33    2.90    8.00    1.20    1.20    3.99    2.60    7.25     0.70   0.70
Inflation rate         3.00    n/a     4.00     2.00     2.00     3.00    n/a     4.00    2.00    2.00    3.25    n/a     4.00     2.00   2.00
Expected return on plan assets        n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels      n/a     n/a     5.00     3.00     3.25    n/a     n/a     5.00    3.00    3.00    n/a     n/a     5.00     3.00   3.00
Rate of increase in future pension plan      n/a     n/a     n/a      1.75     2.25    n/a     n/a     n/a     1.75    1.75    n/a     n/a     n/a      1.75   1.75
Aging factor         2.50    n/a     n/a      n/a      n/a      2.50    n/a     n/a      n/a      n/a     2.50    n/a     n/a     n/a     n/a 
Medical inflation         3.50    n/a     n/a      n/a      n/a      3.50    n/a      n/a      n/a      n/a     3.50    n/a     n/a     n/a     n/a 
Duration         12.83    n/a     n/a      n/a      n/a    14.16    n/a      n/a      n/a      n/a      14.99    n/a     n/a     n/a     n/a 

 

Sensitivity analysis

 

                                                         
                                                               
      Impact on the defined benefit obligation
                      Premise change                   Premise increase                   Premise reduction
      Health   United               Health   United               Health   United            
      insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
Discount rate     1.0%   1.0%   1.0%   0.25%   0.25%    32,758   5,536     1,646     5,477     297    (39,621)   (6,605)   (1,935)   (5,836)     (315)
Real medical inflation   n/a   n/a   n/a   n/a   n/a    n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels n/a   n/a   n/a   0.5%   0.5%    n/a     n/a     n/a      8,604     468    n/a     n/a     n/a    (8,114)     (442)
Rate of increase in future pension plan 1.0%   n/a   n/a   0.25%   0.25%    (7,740)    n/a     n/a      4,241     231     8,098    n/a     n/a    (4,115)     (224)
Life expectancy     1.0%   n/a   n/a   1 ano   1 ano    48,527    n/a     n/a      3,637     198    (39,355)    n/a     n/a    (3,797)     (207)
Mortality rate     n/a   10.0%   n/a   n/a   n/a    n/a    1,681    n/a     n/a     n/a     n/a    (1,839)    n/a     n/a     n/a 

 

 

                                                               
                                          Health insurance - Impact on cost of services and interests costs
                                          Premise change   Premise increase   Premise reduction
                                          Cost of   Iterests   Cost of   Iterests   Cost of   Iterests
                                          services   costs   services   costs   services   costs
Discount rate                                         1.0%   1.0%     730     106   (933)     11
Life expectancy                                         1.0%   1.0%     542     4,441   (464)     (3,602)
Rate of increase in future pension plan                                     1.0%   1.0%     123     708   (129)     (741)

 

XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Equity
12 Months Ended
Dec. 31, 2022
Shareholders' equity  
Equity

28 Equity

28.1 Capital

On December 31, 2022 and 2021, the Company's subscribed and paid-up capital stock amounted to R$8,043,222 and comprised 797,207,834 shares with no par value, distributed as follows:

                                 
                                   
      Amount of shares
      Common       Preferred shares       Preferred shares            
      shares   %   class A   %   class B   %   Total   %
                                   
Novonor     226,334,623   50.11     79,182,498   22.95     -   -   305,517,121   38.32
Petrobras     212,426,952   47.03     75,761,739   21.96     -   -   288,188,691   36.15
ADR (i)     -   -     42,869,320   12.42     -   -     42,869,320     5.38
Other       12,907,077     2.86   146,581,427   42.48    478,790    100.00   159,967,294   20.07
Total     451,668,652     100.00   344,394,984     99.81     478,790     100.00   796,542,426     99.92
Treasury shares       -   -    665,408     0.19     -   -    665,408     0.08
Total     451,668,652     100.00   345,060,392     100.00     478,790     100.00   797,207,834     100.00
                                   
Authorised     535,661,731       616,682,421         593,818       1,152,937,970    

(i) American Depository Receipt ("ADR") on the New York Stock Exchange – NYSE (USA).

 

Changes in shares during the year:

                         
                         
        Amount of shares
    Note   2020   Changes   2021   Changes   2022
Outstanding shares                      
  Commom shares     451,668,652     -   451,668,652     -   451,668,652
  Preferred Class A  28.4   343,824,794    333,432   344,158,226    236,758   344,394,984
  Preferred Class B      500,230    (21,440)    478,790     -    478,790
        795,993,676     311,992   796,305,668     236,758   796,542,426
                         
 Treasury shares                      
  Preferred Class A 28.4    1,224,878     (322,712)    902,166     (236,758)    665,408
                         
Total       797,218,554   (10,720)   797,207,834     -   797,207,834

28.2 Capital reserves

This reserve includes part of the shares issued in the Company’s several capital increases. This reserve can be used to absorb losses, to redeem, reimburse or purchase shares, and to incorporate into the capital stock.

28.3 Profit reserves

(a) Legal reserve

Under Brazilian Corporation Law, companies must transfer 5% of net profit for the year to a legal reserve until this reserve is equivalent to 20% of the paid-up capital. The legal reserve can be used for capital increase or absorption of losses.

(b) Tax incentive reserve

This reserve results from the allocation of part of net income for the year equivalent to tax incentives, arising from governmental subsidies (see Note 31). This reserve may only be used to offset losses with subsequent reconstitution or increase share capital.

 

(c) Profit retention

Under Brazilian Corporation Law, portions of net income for the fiscal year may be allocated to reserves or retained based on the capital budget. Profits not allocated as such may be distributed to shareholders in the form of dividends. In 2022, this reserve was partially used to absorb losses for the year (Note 28.6).

28.4 Share rights

Preferred shares carry no voting rights, but they ensure priority, non-cumulative annual dividend of 6% of their unit value, according to profits available for distribution. The unit value of the shares is obtained through the division of capital by the total number of outstanding shares. As common shares, only class “A” preferred shares will have the same claim on the remaining profit that exceeds the minimum mandatory dividend of 6% and will be entitled to dividends only after the priority dividend is paid to preferred shareholders. Only class “A” preferred shares also have the same claim as common shares on the distribution of shares resulting from capitalization of other reserves. Class “A” preferred shares can be converted into common shares upon resolution of majority voting shareholders present at a General Meeting. Class “B” preferred shares can be converted into class “A” preferred shares at any time, at the ratio of two class “B” preferred shares for one class “A” preferred share, upon a simple written request to the Company, provided that the non-transferability period provided for in specific legislation that allowed for the issue and payment of such shares with tax incentive funds has elapsed.

In 2022, 236,758 shares held in treasury were delivered to participants of the LTI Program 2019, which was fully settled in April 2022. In 2021, 322,712 shares were granted as payment of the LTI Program 2018.

28.5 Payment of dividends

On April 19, 2022, the Annual and Extraordinary Shareholders Meeting approved distribution of the proposed additional dividends on the 2021 results, corresponding to R$1.696348838321 per outstanding common share and class “A” preferred share, in the amount of R$1.35 billion, payment of which was made as from May 2, 2022.

 

 

28.6 Accumulated losses

Accumulated losses in 2022 were absorbed as follows:

     
      2022
       
Loss for the year of the Company's shareholders       (335,677)
Amounts posted directly to the Retained Earnings account:      
SUDENE tax incentive supplement       (108,975)
Comprehensive income     26,883
Other       475
      (417,294)
Loss absorption using profit reserve:      
Profit reserves - Retention of profits      417,294
        417,294

 

XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (loss) per share
12 Months Ended
Dec. 31, 2022
Earnings Loss Per Share  
Earnings (loss) per share

29 Earnings (loss) per share

Basic earnings (loss) per share is calculated by means of the division of profit (loss) for the year attributable to the Company’s common and preferred shareholders by the weighted average number of these shares held by shareholders, excluding those held in treasury and following the rules for the distribution of dividends provided for in the Company’s bylaws, as described in Note 28.4, particularly in relation to the limited rights enjoyed by class “B” preferred shares. The calculation of the diluted earnings (loss) per share is based on the weighted average of class “A” preferred shares, assuming the conversion of all preferred shares into treasury that would cause the dilution.

Class A preferred shares participate in dividends with common shares after the mandatory dividends has been attributed in accordance with the formula provided for in the Company’s bylaws, as described in Note 28.4 and there is no highest limit for their participation.

The table below shows the reconciliation of profit or loss for the period adjusted for the amounts used to calculate basic and diluted earnings (losses) per share.

                         
        2022       2021       2020
    Basic   Diluted   Basic   Diluted   Basic   Diluted
                         
(Loss) profit  for the year attributed to Company's shareholders     (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Distribution of priority dividends attributable to:                        
Preferred shares class "A"    -    -    208,574    208,574    -    -
Preferred shares class "B"    -    -     290     290    -    -
     -    -    208,864    208,864    -    -
                         
Distribution of 6% ​​of unit price of common shares    -    -    273,729    273,729    -    -
                         
Distribution of excess profits, by class:                        
Common shares    -    -    7,664,208    7,664,208    -    -
Preferred shares class "A"    -    -    5,838,145    5,838,145    -    -
     -    -     13,502,353     13,502,353    -    -
                         
Reconciliation of income available for distribution,
by class (numerator):
                       
Common shares     (190,357)     (190,357)    7,937,937    7,937,937     (3,797,070)     (3,797,071)
Preferred shares class "A"     (145,118)     (145,118)    6,046,719    6,046,719     (2,890,445)     (2,890,444)
Preferred shares class "B"   (202)   (202)     290     290   (4,205)   (4,205)
      (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Weighted average number of shares,
by class (denominator):
                       
Common shares   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652
Preferred shares class "A"   344,329,470   344,329,470   344,054,700   345,049,701   343,823,811   345,049,672
Preferred shares class "B"    478,790    478,790    500,171    500,171    500,230    500,230
    796,476,912   796,476,912   796,223,523   797,218,524   795,992,693   797,218,554
                         
Profit (loss) per share (in R$)                        
Common shares     (0.42)     (0.42)     17.57     17.57     (8.41)     (8.41)
Preferred shares class "A"     (0.42)     (0.42)     17.57     17.52     (8.41)     (8.38)
Preferred shares class "B"     (0.42)     (0.42)    0.58    0.58     (8.41)     (8.41)

Weighing of shares

                 
                2022
                Basic
                Preferred shares
            Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of the year            344,158,226    344,158,226
                 
Incentive long term plan payments with treasury shares             236,758     171,244
                 
Amount at the end of the year            344,394,984    344,329,470

 

                 
                2021
                Basic
                Preferred shares
    Class "A"   Class "B"
    Outstanding   Weighted   Outstanding   Weighted
    shares   average   shares   average
                 
Amount at beginning of the year    343,824,794    343,824,794   500,230   500,230
                 
Incentive long term plan payments with treasury shares     322,712     229,877   -   -
Conversion shares class "B" into shares class "A"    10,720     29     (21,440)   (59)
                 
Amount at the end of the year    344,158,226    344,054,700   478,790   500,171

 

                 
                2020
                Basic
                Preferred shares
                Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of year            343,823,073    343,823,073
                 
Incentive long term plan payments with treasury shares           1,721   738
                 
Amount at the end of the year            343,824,794    343,823,811

  

 

XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue
12 Months Ended
Dec. 31, 2022
Net Revenue  
Net revenue

30 Net revenue

                 
        2022   2021   2020
          96,519,284   105,625,201     58,543,494

Revenue from sales of products is recognized when the control of assets is transferred to the customer for an amount that reflects the consideration to which the Company expects to be entitled in exchange of these assets. The performance obligations are met at a specific moment in time. The Company does not make sales with continued management involvement. Most of the Company’s sales are made to industrial customers and, in a lower volume, to resellers.

(i)The specific moment when the Company satisfies a performance obligation by transferring a promised good or service to the client is determined as follows: for contracts under which the Company is responsible for the freight and insurance, the legal right and the risks and benefits are transferred to the client when the risk of the goods is delivered at the destination established in the contract;
(i)(ii) for agreements under which the freight and insurance are a responsibility of the client, risks and benefits are transferred when the products are delivered to the client’s carrier; and for contracts under which product delivery involves the use of pipelines, especially basic petrochemicals, the risks and benefits are transferred immediately after the Company’s official markers, which is the point of delivery of the products and transfer of their ownership.

(a) Net revenue by country

           
      2022   2021   2020
               
Brazil      56,217,472    55,830,330    32,369,199
United States      18,085,607    24,232,413    10,848,609
Mexico     4,468,827   5,505,893   2,765,815
Argentina     2,092,700   2,068,023   1,267,967
Germany     1,695,009   1,912,373   1,106,877
Switzerland     1,492,922   1,230,541   633,512
Italy     1,095,133   1,304,113   811,787
Chile     870,858   1,230,493   544,329
Netherlands     816,678   642,844   432,897
Luxembourg     756,297   987,656   592,777
Singapore     755,971   1,175,133   1,183,838
Peru     740,011   666,867   471,847
Japan     723,757   1,162,226   618,940
Spain     546,646   517,532   282,362
United Kingdom     490,801   585,766   204,953
Uruguay     469,555   495,120   405,946
Poland     455,458   649,825   285,714
Bolivia     427,237   296,138   190,447
Sweden     401,251   481,289   310,984
Canada     393,504   558,730   297,756
France     359,946   326,570   247,062
Paraguay     316,460   318,842   254,255
Colombia     263,695   274,335   174,381
China     172,656   354,071   496,920
South Korea     159,944   669,055   360,704
Other     2,250,890   2,149,023   1,383,616
       96,519,284     105,625,201    58,543,494

 

(b) Net revenue by product

           
      2022   2021   2020
               
PE/PP     61,145,093    73,306,089    41,137,288
Benzene, toluene and xylene     7,279,584   5,819,696   3,051,752
Ethylene, Propylene     5,819,345   6,872,999   3,600,276
ETBE/Gasoline     5,722,767   4,321,371   2,170,289
PVC/Caustic Soda/EDC     5,710,838   5,806,011   3,134,617
Butadiene     3,028,048   3,019,836   1,372,428
Solvents     1,522,025   1,129,484   654,793
Cumene     1,425,097   1,342,811   636,635
Naphtha, condensate and crude oil     422,359   1,648,581   915,807
Other     4,444,130   2,358,324   1,869,609
       96,519,284     105,625,201     58,543,494

(c) Main clients

The Company does not have any revenue arising from transactions with only one client that is equal to or higher than 10% of its total net revenue. In 2022, the most significant revenue from a single client amounts to approximately 2.4% of total net revenues of the Company and refers to the sale of chemicals and resins.

 

XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Tax incentives
12 Months Ended
Dec. 31, 2022
Tax Incentives  
Tax incentives

31 Tax incentives

(a) SUDENE–- IR

Since 2015, the Company obtained grant in lawsuits claiming the reduction of 75% of IRPJ and additional taxes on income from the following industrial units: (i) PVC and Chlor-Alkali (Cloro Soda), established in the state of Alagoas; and (ii) Chemicals, PE, PVC and Chlor-Alkali units, established in the city of Camaçari (in Bahia State). The tax incentive granted by the Northeast Development Department (“SUDENE”) is calculated based on the Profit from Exploration of the incentivized activity, with an enjoyment period of 10 years. In 2020, the operations in Brazil recorded tax loss, therefore it is not possible to make any deductions as a tax incentive.

In 2022, the Company recorded a tax loss and, for such reason, did not make use of tax benefits.

(b) PRODESIN–- ICMS

The Company has ICMS tax incentives granted by the state of Alagoas, through the state of Alagoas Integrated Development Program (“PRODESIN”), which are aimed at implementing and expanding a plant in that state.

The Company obtained a final and unappealable decision (Case No. 0042875-86.2015.4.01.3300) that exempted it from the payment of IR/CSL on tax incentives granted under PRODESIN, ensuring their treatment as a reducer of taxes on sales, in the period between the calendar years 2010 to 2017, in the accumulated amount of R$425,913. In 2022, the amount was R$87,415 (2021: R$176,284).

 

XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Expenses by nature and function
12 Months Ended
Dec. 31, 2022
Expenses By Nature And Function  
Expenses by nature and function

32 Expenses by nature and function

             
          2022   2021   2020
                   
Classification by nature:              
  Raw materials other inputs     (73,181,706)   (63,570,499)   (37,913,921)
  Personnel expenses       (3,223,477)     (3,478,323)     (3,074,305)
  Outsourced services       (3,411,818)     (3,193,970)     (2,219,413)
  Depreciation and amortization       (4,733,165)     (4,178,433)     (4,048,081)
  Freights       (4,034,901)     (2,966,229)     (2,321,740)
  Idle industrial plants       (414,441)     (338,987)     (518,528)
  Provision - geological event in Alagoas (Note 26)       (1,520,019)     (1,339,765)     (6,901,828)
  PIS and Cofins credits - exclusion of ICMS from the calculation basis       1,031,099   310,557
  Other income     507,333   1,843,153   440,192
  Other general and administrative expenses       (2,269,865)     (3,394,344)     (2,348,921)
  Total     (92,282,059)   (79,586,298)   (58,595,988)
                   
Classification by function:              
  Cost of products sold     (85,160,548)   (73,568,231)   (47,331,414)
  Selling and distribution       (2,108,417)     (2,055,640)     (1,852,055)
  (Loss) reversals for impairment of trade accounts receivable      (38,426)   (8,914)    (55,252)
  General and administrative       (2,763,983)     (2,522,127)     (1,918,747)
  Research and development       (374,493)     (296,583)     (250,648)
  Other income (i)     507,333   1,534,487   750,749
  Other expenses (ii)       (2,343,525)     (2,669,290)     (7,938,621)
  Total     (92,282,059)   (79,586,298)   (58,595,988)

(i) In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.
(ii) Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).

 

XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Financial results
12 Months Ended
Dec. 31, 2022
Financial Results  
Financial results

33 Financial results

Transactions in foreign currencies are translated into the respective functional currency of the Company’s subsidiaries at the exchange rates in effect on the transaction dates.

Monetary assets and liabilities denominated and measured in foreign currency on the reporting date are re-translated into the functional currency at the exchange rate on said date. Non-monetary assets and liabilities measured at fair value in foreign currency are re-translated into the functional currency at the exchange rate on the date on which the fair value was determined. Non-monetary items that are measured based on the historical cost in foreign currencies are translated at the exchange rate on the date of the transaction. The differences in foreign currencies resulting from conversion are recognized in financial income or loss, unless the liability involves a cash flow hedge accounting relationship.

                   
          2022   2021   2020
Financial income                
  Interest income         1,049,745     439,891     310,202
  Inflation indexation income on tax assets (i)    16,489     1,041,917     170,857
  Gain on derivatives       635,779     246,459   -
  Other         308,121    99,171     119,125
          2,010,134   1,827,438   600,184
                   
Financial expenses                
  Interest expenses       (3,125,206)   (2,922,958)   (2,928,803)
  Inflation indexation expenses on tax liabilities     (266,281)   (93,722)   (138,410)
  Discounts granted       (129,249)   (75,677)   (81,920)
  Loans transaction costs - amortization     (260,511)   (691,243)   (172,269)
  Adjustment to present value - appropriation     (580,994)   (179,461)   (225,889)
  Interest expense on leases     (203,257)   (173,536)   (164,166)
  Losses on derivatives     (596,501)   (1,003,502)   (809,150)
  Other       (500,694)   (767,056)   (392,758)
          (5,662,693)   (5,907,155)   (4,913,365)
                   
Exchange rate variations, net              
  On financial assets     (522,251)     230,370     336,527
  On financial liabilities       (49,919)   (4,233,177)   (5,635,238)
           (572,170)    (4,002,807)    (5,298,711)
                   
Total        (4,224,729)    (8,082,524)    (9,611,892)

 

(i) In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).

 

 

The effects from exchange variation on the Company’s transactions are mainly due to the variations in the following currencies:

                               
  End of year rate   Average rate
                              Variation
  2022   2021   Variation   2022   2021   Dec/20   2022-2021   2021-2020
U.S. dollar - Brazilian real 5.2177   5.5805   -6.50%   5.1655   5.3956   5.1578   -4.26%   4.61%
Euro - Brazilian real 5.5694   6.3210   -11.89%   5.4420   6.3784   5.8989   -14.68%   8.13%
Mexican peso - Brazilian real 0.2667   0.2730   -2.31%   0.2569   0.2660   0.2402   -3.44%   10.75%
U.S. dollar - Mexican peso 19.5720   20.4519   -4.30%   20.1249   20.2900   21.5098   -0.81%   -5.67%
U.S. dollar - Euro 0.9416   0.8853   6.36%   0.9510   0.8458   0.8775   12.44%   -3.61%

 

XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Segment information
12 Months Ended
Dec. 31, 2022
Segment Information  
Segment information

34 Segment information

The Company’s organizational structure is formed by the following segments:

- Brazil: includes: (i) the production and sale of chemicals at the Camaçari Petrochemical Complex in Bahia, the Triunfo Petrochemical Complex in Rio Grande do Sul, the Capuava Petrochemical Complex in the state of São Paulo, and the Duque de Caxias Petrochemical Complex in the state of Rio de Janeiro; (ii) the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; (iii) the production and sale of PE, including the production of green PE made from renewable resources, and of PP; and (iv) the production and sale of PVC and caustic soda.

- United States and Europe: operations related to PP production and sale in the United States and Europe, through the subsidiaries Braskem America and Braskem Alemanha, respectively.

- Mexico: comprises the activities relation to the PE production and sale in Mexico, through the subsidiary Braskem Idesa.

- Other segments: substantially comprises the activities of Cetrel.

(a) Presentation, measurement and reconciliation of segment results

Information by segment is generated in accounting records, which are reflected in the consolidated financial statements. The operating segments are stated based on the results of operations.

The eliminations and reclassifications line are mainly represented by purchases and sales between the Company’s reportable segments.

Corporate Unit comprises items not allocated directly to the reportable segments and are disclosed to reconcile the segments to the consolidated financial information.

 

(b) Results by segment

      2022
                               
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,079,724     (63,195,629)   5,884,095     (1,853,039)    -     (1,888,999)     2,142,057
  USA and Europe   23,421,096     (19,986,176)   3,434,920     (838,474)    -    56,944     2,653,390
  Mexico   5,834,017    (5,069,531)   764,486     (451,605)    -     (33,370)     279,511
Total    98,334,837     (88,251,336)   10,083,501     (3,143,118)    -     (1,865,425)     5,074,958
                               
  Other segments   402,991    (262,402)   140,589   82,498    34,848   5,644     263,579
  Corporate unit   -   -   -     (2,196,506)    -    19,375   (2,177,131)
                               
Braskem consolidated before 
eliminations and reclassifications
  98,737,828     (88,513,738)   10,224,090     (5,257,126)    34,848     (1,840,406)     3,161,406
                               
  Eliminations and reclassifications    (2,218,544)   3,353,190   1,134,646    (28,193)    -   4,214     1,110,667
                               
Total   96,519,284     (85,160,548)   11,358,736     (5,285,319)    34,848     (1,836,192)     4,272,073
                               
                               
      2021
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,494,923     (49,309,552)   20,185,371     (1,608,185)    -     (2,210,601)   16,366,585
  USA and Europe   32,403,632     (23,343,205)   9,060,427     (900,885)    -     (25,580)     8,133,962
  Mexico   6,506,297    (3,413,652)   3,092,645     (471,821)    -     (15,302)     2,605,522
Total     108,404,852     (76,066,409)   32,338,443     (2,980,891)    -     (2,251,483)   27,106,069
                               
  Other segments   363,684    (233,084)   130,600   76,830   4,644     (28,674)     183,400
  Corporate unit   -   -   -     (1,963,137)    -    1,161,517  (i)   (801,620)
                               
Braskem consolidated before 
eliminations and reclassifications
   108,768,536     (76,299,493)   32,469,043     (4,867,198)   4,644     (1,118,640)   26,487,849
                               
  Eliminations and reclassifications    (3,143,335)   2,731,262    (412,073)    (16,066)    -     (16,163)    (444,302)
                               
Total    105,625,201     (73,568,231)   32,056,970     (4,883,264)   4,644     (1,134,803)   26,043,547
                               
      2020
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   40,794,387     (32,498,003)   8,296,384     (1,471,722)    -     (7,082,604)    (257,942)
  USA and Europe   14,638,660     (12,337,486)   2,301,174     (721,191)    -     (82,695)     1,497,288
  Mexico   4,000,805    (3,075,001)   925,804     (436,859)    -   (364,259)     124,686
Total    59,433,852     (47,910,490)   11,523,362     (2,629,772)    -     (7,529,558)     1,364,032
                               
  Other segments   302,374    (188,350)   114,024   63,874     (19,398)     (320)     158,180
  Corporate unit   -   -   -     (1,493,479)    -    359,071   (1,134,408)
                               
Braskem consolidated before 
eliminations and reclassifications
  59,736,226     (48,098,840)   11,637,386     (4,059,377)     (19,398)     (7,170,807)     387,804
                               
  Eliminations and reclassifications    (1,192,732)   767,426    (425,306)    (17,325)    -     (17,065)    (459,696)
                               
Total   58,543,494     (47,331,414)   11,212,080     (4,076,702)     (19,398)     (7,187,872)   (71,892)

 

See comment in Note 32(i).

 

(b) Property, plant and equipment and intangible assets by segment

         
      2022   2021
Reporting segments        
  Brazil   19,428,926   18,072,312
  USA and Europe     7,075,743     7,688,713
  Mexico   13,736,298   14,019,167
Total     40,240,967    39,780,192
Unallocated amounts     544,472     322,237
Total     40,785,439    40,102,429

 

 

XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Contractual obligations
12 Months Ended
Dec. 31, 2022
Contractual Obligations  
Contractual obligations

35 Contractual obligations

The Company has long-term contractual obligations arising from agreements entered into for the purchase of power inputs. As of December 31, 2022, these obligations amounted to R$8,286,502 (2021: R$6,079,568) and are expected to be settled by 2044.

 

XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent events
12 Months Ended
Dec. 31, 2022
Subsequent Events  
Subsequent events

36 Subsequent events

(a)In February 2023, the subsidiary Braskem Holanda Finance issued US$1 billion in bonds due in 2033, with coupon of 7.25% p.a. and Braskem guarantee.
(b)In February 2023, Braskem completed the process for acquiring shares and subscribing to new shares issued by Wise Plásticos S.A. (“Wise”), a Brazilian company engaged in mechanical recycling, now holding a 61.1% equity interest in Wise. In this context, Braskem disbursed R$138 million, with the usual considerations for this kind of transaction.
(c)

In March 2023, according to the Note 26.1 (iv), Alagoas State Public Defender’s Office (“DPE”) filed a Public-interest civil action (“ACP”) against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the 3rd Federal Court of Alagoas. DPE attributes to the lawsuit the amount of R$1.7 billion, with a request of injunction relief so that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the Financial Compensation and Support for Relocation Program (“PCF”), or, on a subsidiary basis, the freeze of bank accounts in the same amount of the lawsuit. The injunction relief requests were rejected by court; decision subjected to appeal by DPE. Braskem has already presented contestation.

(d)In March 2023, according to the Note 26.1 (vii), the State of Alagoas filed a lawsuit, requesting compensation for alleged damages caused to the State. In addition, as an injunction relief, the State of Alagoas requested the blocking of R$ 1.1 billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court.
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation of the financial statements (Policies)
12 Months Ended
Dec. 31, 2022
Basis Of Preparation Of Financial Statements  
Basis of accounting

2.1 Basis of accounting

The consolidated financial statements were prepared and presented in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

Basis of presentation

2.2 Basis of presentation

The Company’s consolidated financial statements (“financial statements”) were prepared under the historical cost basis, unless stated otherwise in the accounting policies. These consolidated financial statements have been prepared on a going concern basis.

The significant accounting policies applied in the preparation of these consolidated financial statements were included in the respective notes and are consistent in the fiscal years presented.

The issue of these consolidated financial statements was authorized by the Executive Board on April 24, 2023.

 

Basis of consolidation

2.3 Basis of consolidation

The consolidated financial statements include the financial statements of Braskem S.A. and the following entities:

                   
          Total and voting interest (%)
              2022, 2021 and 2020
          Headquarter   2022   2021   2020
 BM Insurance Company Limited ("BM Insurance")        Bermuda    100   100     100
 Braskem Argentina S.A. (“Braskem Argentina”)        Argentina    100   100     100
 Braskem Energy Ltda.    (i)   Brazil       100    
 Braskem Finance Limited (“Braskem Finance”)        Cayman Islands    100   100     100
 Braskem Green S.A.        Brazil    100   100    
 Braskem Incorporated Limited ("Braskem Inc.")        Cayman Islands    100   100     100
 Braskem Mexico, S. de RL de C.V. ("Braskem México")        Mexico    100   100     100
 Braskem Netherlands B.V. ("Braskem Holanda")        Netherlands    100   100     100
 Braskem Petroquímica Chile Ltda. (“Braskem Chile”)        Chile    100   100     100
 Braskem Ventures Ltda. ("Braskem Ventures")    (ii)   Brazil    100        
 Lantana Trading Co. Inc. (“Lantana”)    (iii)   Bahamas       100     100
 Voqen Energia Ltda. ("Voqen")    (i)   Brazil    100    -    
 Braskem America Finance Company ("Braskem America Finance")        USA    100   100     100
 Braskem America, Inc. (“Braskem America”)        USA    100   100     100
 Braskem Europe GmbH ("Braskem Alemanha")        Germany    100   100     100
 Braskem Idesa S.A.P.I. ("Braskem Idesa")        Mexico   75   75     75
 Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")        Mexico   75   75     75
 Braskem India Private Limited ("Braskem India")        India    100   100     100
 Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")        Mexico    100   100     100
 Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")        Mexico    100   100     100
 Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)        Netherlands    100   100     100
 Braskem Netherlands Green B.V. (“Braskem Holanda Green”)        Netherlands    100   100    
 Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)        Netherlands    100   100     100
 Builder Brasil Ltda. ("Builder Brasil")    (ii)   Brazil    100        
 Builder USA LLC. ("Builder USA")    (ii)   USA    100        
 Cetrel S.A. ("Cetrel")        Brazil   63.70   63.70     63.70
 Distribuidora de Água Camaçari S.A. ("DAC")        Brazil   63.70   63.70     63.70
 B&TC B.V. ("B&TC")    (iv)   Netherlands   60        
 ER Plastics B.V. ("ER Plastics")    (iv)   Netherlands   60        
 Terminal Química Puerto México ("Terminal Química")        Mexico   75   75    
 Special Purpose Entities                     
Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado
Longo Prazo ("FIM Júpiter")
      Brazil    100   100     100
Fundo de Investimento Santander Netuno Multimercado Crédito Privado
Longo Prazo ("FIM Netuno")
      Brazil    100   100     100

 

(i) Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.
(ii) Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.
(iii) Lantana was a non-operational entity that had the operations closed in November 2022.
(iv) B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).

 

(a) Subsidiaries

The Company controls an entity when it is exposed to, or entitled to, the variable returns originating from its involvement with the entity and has the capacity to affect such returns by exercising its power over the entity.

The financial statements of subsidiaries are included in these consolidated financial statements as from the date the Company obtains control until the date of the loss of control.

(b) Equity method Investees

The Company’s investments in entities with accounting treatment using the equity method consist of their interests in associates and joint ventures.

Associates are those in which the Company, directly or indirectly, has significant influence, but not control or shared control, over the financial and operating policies. To be classified as a joint venture, a contractual agreement must exist that gives the Company shared control of the entity and granting to the Company the right to the net assets of the joint venture, and not the right to its specific assets and liabilities.

Such investments are initially recognized at cost, which includes the expenses with the transaction costs. After initial recognition, the consolidated financial statements include the Company’s interest in the net profit or loss for the fiscal year profit or loss and other comprehensive income of equity-accounted investees, in the investee until the date on which the significant influence or joint control ceases to exist.

(c) Conversion of functional currency to presentation currency

The assets and liabilities of foreign operations are translated into Reais at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into Reais at the exchange rates at the dates of the transactions. Foreign currency differences (Note 2.4) from translation to presentation currency are recognized in other comprehensive income.

Since Argentina’s economy is considered hyperinflationary, to translate the financial information of the subsidiary Braskem Argentina, the assets, liabilities, equity, income and expenses are translated into Reais at the exchange rate at the reporting date.

(d) Transactions eliminated in consolidation

Intragroup balances and transactions and any unrealized revenues or expenses arising from intragroup transactions are eliminated. Unrealized gains originating from transactions with investees recorded using the equity method are eliminated against the investment proportionately to the Company’s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment loss.

 

Functional and foreign currency

2.4 Functional and foreign currency

These consolidated financial statements are presented in Brazilian Real, which is the functional currency of the Company. All amounts have been rounded to the nearest thousand, unless otherwise stated.

The subsidiaries with a functional currency different from Brazilian Real (R$) are listed below:

   
Subsidiaries   Functional currency
       
  Braskem Alemanha, B&TC and ER Plastics   Euro
  BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.   U.S.dollar ("US$")
  Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços    Mexican peso
  Braskem Argentina   Argentinean peso
  Braskem Chile   Chilenean peso
  Braskem Índia   Rupee

 

New standards or amendments for the current fiscal year and future requirements

2.5 New standards or amendments for the current fiscal year and future requirements

(a) New standards and pronouncements adopted in the current fiscal year

In the current fiscal year, the Company identified a series of amendments under the IFRS accounting standards that became effective for accounting periods starting on or after January 1, 2022:

- Onerous contracts: costs of fulfilling a contract (amendments to IAS 37).

- Annual improvements of IFRS Standards 2018-2020.

- Property, Plant and Equipment: revenue before intended use (amendments to IAS 16).

- Reference to the Conceptual Framework (amendments to IFRS 3).

The adoption of these amendments did not have any material impact on the disclosures or amounts presented in these consolidated financial statements.

(b) Future requirements

The new and amended standards and interpretations already issued but not yet effective as of the reporting date are described below:

- Classification of liabilities as current or non-current (amendments to IAS 1).

- Definition of accounting estimates (amendments to IAS 8).

- Definition of materiality for disclosure of accounting policies (amendments to IAS1 and IFRS Practice Statement 2).

- Deferred taxes related to assets and liabilities arising from a single transaction (amendments to IAS 12).

- Insurance contracts (IFRS17).

The Company plans to adopt these new and amended standards and interpretations, if applicable, when they become effective. Management does not expect the adoption of the standards listed above to have a significant impact on the Company’s consolidated financial statements in future periods.

 

Impacts from Russia-Ukraine conflict

2.6 Impacts from Russia-Ukraine conflict

The Company formed a committee to monitor the consequences of sanctions applied to Russia and the developments in the conflict as well as to take any measures to minimize potential impacts on the Company, its team members and the communities where it operates.

The conflict has caused an increase in the international price of commodities related to the Company's business, such as oil and natural gas, affecting the cost of the Company's inputs used in the production process. The European geopolitical scenario also affected the demand for petrochemical products, global supply chain and pressured inflation in several countries. For this reporting period, it has not caused significant adverse impacts on the Company's equity and financial position, although it is not possible to accurately predict significant adverse effects in the future.

Further sanctions, embargoes, regional instability, geopolitical changes, dysfunctions in the logistics chain, adverse effects on macroeconomic conditions, currency exchange rates and interest rates could affect the prices of products and costs of inputs in the international market, interrupt the supply chain, reduce sales and/or affect operations of the Company. As of the reporting date, the Company has not identified any relevant impacts on its business arising from the sanctions applied to date and adverse scenario caused by the geopolitical conflict.

XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation of the financial statements (Tables)
12 Months Ended
Dec. 31, 2022
Basis Of Preparation Of Financial Statements  
Schedule of consolidated financial statements
                   
          Total and voting interest (%)
              2022, 2021 and 2020
          Headquarter   2022   2021   2020
 BM Insurance Company Limited ("BM Insurance")        Bermuda    100   100     100
 Braskem Argentina S.A. (“Braskem Argentina”)        Argentina    100   100     100
 Braskem Energy Ltda.    (i)   Brazil       100    
 Braskem Finance Limited (“Braskem Finance”)        Cayman Islands    100   100     100
 Braskem Green S.A.        Brazil    100   100    
 Braskem Incorporated Limited ("Braskem Inc.")        Cayman Islands    100   100     100
 Braskem Mexico, S. de RL de C.V. ("Braskem México")        Mexico    100   100     100
 Braskem Netherlands B.V. ("Braskem Holanda")        Netherlands    100   100     100
 Braskem Petroquímica Chile Ltda. (“Braskem Chile”)        Chile    100   100     100
 Braskem Ventures Ltda. ("Braskem Ventures")    (ii)   Brazil    100        
 Lantana Trading Co. Inc. (“Lantana”)    (iii)   Bahamas       100     100
 Voqen Energia Ltda. ("Voqen")    (i)   Brazil    100    -    
 Braskem America Finance Company ("Braskem America Finance")        USA    100   100     100
 Braskem America, Inc. (“Braskem America”)        USA    100   100     100
 Braskem Europe GmbH ("Braskem Alemanha")        Germany    100   100     100
 Braskem Idesa S.A.P.I. ("Braskem Idesa")        Mexico   75   75     75
 Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")        Mexico   75   75     75
 Braskem India Private Limited ("Braskem India")        India    100   100     100
 Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")        Mexico    100   100     100
 Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")        Mexico    100   100     100
 Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)        Netherlands    100   100     100
 Braskem Netherlands Green B.V. (“Braskem Holanda Green”)        Netherlands    100   100    
 Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)        Netherlands    100   100     100
 Builder Brasil Ltda. ("Builder Brasil")    (ii)   Brazil    100        
 Builder USA LLC. ("Builder USA")    (ii)   USA    100        
 Cetrel S.A. ("Cetrel")        Brazil   63.70   63.70     63.70
 Distribuidora de Água Camaçari S.A. ("DAC")        Brazil   63.70   63.70     63.70
 B&TC B.V. ("B&TC")    (iv)   Netherlands   60        
 ER Plastics B.V. ("ER Plastics")    (iv)   Netherlands   60        
 Terminal Química Puerto México ("Terminal Química")        Mexico   75   75    
 Special Purpose Entities                     
Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado
Longo Prazo ("FIM Júpiter")
      Brazil    100   100     100
Fundo de Investimento Santander Netuno Multimercado Crédito Privado
Longo Prazo ("FIM Netuno")
      Brazil    100   100     100

 

(i) Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.
(ii) Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.
(iii) Lantana was a non-operational entity that had the operations closed in November 2022.
(iv) B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).
Schedule of subsidiaries with a functional currency
   
Subsidiaries   Functional currency
       
  Braskem Alemanha, B&TC and ER Plastics   Euro
  BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.   U.S.dollar ("US$")
  Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços    Mexican peso
  Braskem Argentina   Argentinean peso
  Braskem Chile   Chilenean peso
  Braskem Índia   Rupee
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Risk management (Tables)
12 Months Ended
Dec. 31, 2022
Risk Management  
Schedule of financial liabilities by maturity
                       
                      Consolidated
      Until   Between one   Between two   More than    
      one year   and two years   and five years   five years   Total
                       
Trade payables     12,410,232   3,069             12,413,301
Borrowings       1,360,722     3,139,258     3,931,315   57,625,391     66,056,686
Debentures       136,142     102,090   -     6,167,985    6,406,217
Braskem Idesa borrowings       996,697           17,274,826     18,271,523
Derivatives       192,226   5,691   -    88,273    286,190
Loan from non-controlling shareholder of Braskem Idesa                   4,391,832    4,391,832
Leniency agreement        434,804     658,154   -   -    1,092,958
Lease       1,109,048     855,803     581,592     2,436,734    4,983,177
At December 31, 2022     16,639,871   4,764,065   4,512,907   87,985,041   113,901,884
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and cash equivalents (Tables)
12 Months Ended
Dec. 31, 2022
Cash and cash equivalents [abstract]  
Schedule of cash and cash equivalents
           
          2022   2021
               
Cash            
  Domestic market         517,236     676,083
  Foreign market     (i)   5,556,972     4,374,739
Cash equivalents            
  Domestic market         3,684,999     1,141,221
  Foreign market     (i)   2,707,267     2,488,643
Total       12,466,474     8,680,686

 

(i) On December 31, 2022, it includes R$931,991 of cash and R$1,252,341 of cash equivalents (2021: R$1,267,582 of cash and R$505,749 of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Financial investments (Tables)
12 Months Ended
Dec. 31, 2022
Financial Investments  
Schedule of financial investments
         
        2022   2021
Amortized cost          
  Time deposit investments     -     106,271
Fair value through profit or loss        
  LFT´s and LF´s (i)   1,789,375     2,337,171
  Restricted funds investments (ii)   305,485     852,362
  Other     217,771     213,751
Total       2,312,631     3,509,555
             
Current assets       2,295,497     3,492,710
Non-current assets      17,134    16,845
Total       2,312,631     3,509,555

(i) These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.
(ii) Includes the following amounts: R$175,153 (2021: R$835,517) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$130,332 (2021: R$16,845) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.

XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Trade accounts receivable (Tables)
12 Months Ended
Dec. 31, 2022
Trade Accounts Receivable  
Schedule of trade accounts receivable
           
      Note   2022   2021
Customers            
Domestic market            
  Third parties         1,533,675     2,851,701
  Related parties   9    13,791    12,240
            1,547,466     2,863,941
Foreign market            
  Third parties         1,796,559     4,434,653
            1,796,559     4,434,653
Expected credit losses   (i)   (112,091)   (131,634)
Total       3,231,934   7,166,960
               
Current assets         3,231,934     7,153,565
Non-current assets       -    13,395
Total       3,231,934   7,166,960

 

(i) According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; (ii) receivables past due 90 to 180 days; (iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:
Schedule of trade accounts receivable by maturity
                         
            2022           2021
    Trade accounts receivable   Expected credit losses   Total   Trade accounts receivable   Expected credit losses   Total
                         
Accounts receivables not past due   2,687,775    (34,931)   2,652,844   6,705,123    (12,291)   6,692,832
Past due securities:    -    -                
Up to 90 days   536,289   (6,783)   529,506   431,899   (2,264)   429,635
Between 91 to 180 days     25,015   (3,010)     22,005     45,134   (1,390)     43,744
Above 180 days     94,946    (67,367)     27,579   116,438     (115,689)    749
                         
Total    3,344,025   (112,091)    3,231,934    7,298,594   (131,634)    7,166,960
Schedule of changes in allowance for doubtful accounts
               
          2022   2021   2020
                   
Balance at the beginning of the year     (131,634)   (173,007)   (229,323)
Additions         (87,898)   (144,888)     (65,571)
Reversals        71,400     149,681    28,563
Write-off of securities considered uncollectible      36,041    36,580    93,324
Balance at the end of the year      (112,091)   (131,634)    (173,007)
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories (Tables)
12 Months Ended
Dec. 31, 2022
Inventories Abstract  
Schedule of inventory
           
               
          2022   2021
               
Finished goods       8,558,025   9,271,708
Semi-finished goods       663,182   568,914
Raw materials, production inputs and packaging     2,747,525   3,356,660
Maintenance materials       869,953   766,994
Advances to suppliers       124,285     62,573
Imports in transit       1,067,094   2,308,252
Total         14,030,064    16,335,101
Schedule of provision for inventories
                 
        2022   2021   2020
                 
Balance at the beginner of the year       82,218   122,572   82,195
                 
Additions      (i)  533,471     97,911   120,483
Utilization/reversals      (103,583)    (138,265)    (80,106)
                 
Balance at the end of the year     512,106     82,218   122,572

(i) The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.

XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Related parties (Tables)
12 Months Ended
Dec. 31, 2022
Related Parties  
Schedule of related party transactions
     
  Balances at December 31, 2022    Balances at December 31, 2021 
  Novonor and               Novonor and            
  subsidiaries   Petrobras and           subsidiaries   Petrobras and        
Balance sheet and associates   subsidiaries   Other (i)   Total   and associates   subsidiaries   Other (i)   Total
Assets                              
Current                              
Trade accounts receivable   -    11,924     1,867     13,791    -   4,894     7,346   12,240
Inventories  (advance to suppliers)   -    61,428     -     61,428    -   9,927     -     9,927
Dividends and interest on capital   -   -     4,296    4,296    -     -     -    -
Other receivabels 11,348   287     -     11,635    -   287     -     287
                               -
Non-current                              -
Other receivables    -   5,657     -    5,657    -    38,987     -   38,987
Total assets   11,348     79,296    6,163    96,807    -     54,095    7,346    61,441
                               
Liabilities                              
Current                              
Trade payables  126,014     137,764   14,189   277,967   103,259     134,063   11,113    248,435
Other payables 4     233,133     314   233,451    -     296,984     345    297,329
                               
Non-current                              
Trade payables   3,069   -     -    3,069    -     -     -    
Loan to non-controlling shareholders of Braskem Idesa   -   -    2,498,093   2,498,093    -     -    3,646,538    3,646,538
Total liabilities   129,087   370,897     2,512,596    3,012,580    103,259   431,047     3,657,996    4,192,302

 

  Year ended December 31, 2022   Year ended December 31, 2021   Year ended December 31, 2020
  Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total   Novonor and subsidiaries and associates   Petrobras and subsidiaries   Other (i)   Total
Transactions                                              
Sales of products   -     182,218    437,514   619,732       171,665    540,855    712,520       182,521    326,825   509,346
Purchases of raw materials, finished goods services and utilities (334,363)    (22,900,140)     (24,813)   (23,259,316)     (306,426)    (19,833,063)    (6,953)   (20,146,442)     (133,127)    (14,566,840)    (20,350)   (14,720,317)
Financial income (expenses), net  (854)     (33,656)   41,082    6,572   (141)     (11,758)   (245,819)     (257,718)   (452)    (3,810)   (818)   (5,080)
General and administrative expenses   -       (45,329)    (45,329)       -     (67,273)    (67,273)        (46,738)    (46,738)
Other income (expenses)   -    51,248     -     51,248     (217,497)     -     (217,497)         -  
                                               
(i) Borealis, Grupo Idesa, Refinaria de Petróleo Riograndense S.A e Vexty                                            
Schedule of key management personnel
             
Statement of profit or loss transactions   2022   2021   2020
Remuneration            
Short-term benefits    83,466     119,734    74,943
Post-employment benefit   1,636   2,121   961
Long term incentive plan    16,938    14,394   7,456
Total   102,040   136,249     83,360
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes recoverable (Tables)
12 Months Ended
Dec. 31, 2022
Taxes Recoverable  
Schedule of taxes recoverable
       
        2022   2021
             
Parent Company and subsidiaries in Brazil        
  Value-added tax on sales and services (ICMS)    410,138   291,424
  ICMS - credits from PP&E   302,940   224,308
  Social integration program (PIS) and social contribution on revenue (Cofins) (a) 560,002   250,491
  PIS and Cofins - credits from PP&E   546,427   447,476
  REINTEGRA program       20,504     21,764
  Federal tax credits   (b) 153,960   948,448
  Other       68,514     89,205
             
Foreign subsidiaries        
  Value-added tax ("IVA")   579,672   348,021
  Other     131,867     59,579
Total     2,774,024   2,680,716
             
Current assets     1,156,355   1,428,658
Non-current assets   1,617,669   1,252,058
Total     2,774,024   2,680,716
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
12 Months Ended
Dec. 31, 2022
Investments Abstract  
Schedule of Information on investments
                           
              Net profit (loss) for the year   Equity
              2022   2021   2020   2022   2021
Jointly-controlled investment                          
  RPR       (i)    76,450   312   (63,525)     110,040    50,064
  Bioglycols LLC     (ii)     (3,977)   -      80,757   -
Associate                            
  Borealis     (iii)    53,617    45,490   6,019     252,053     205,568

 

(i)RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is 33.20% (2021: 33.20%).
(ii)Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).
(iii)Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is 20% (2021: 20%).
Schedule of Changes in investments
                     
    Borealis   RPR   Bioglycols LLC   Other   Total
                     
Balance at 2020   32,272   10,697   -      184   43,153
                     
Dividends and interest on equity     (295)   -             (295)
Equity in results of investees   9,136   103   -        9,239
Other comprehensive income       5,825           5,825
Other               1,001   1,001
                     
Balance at 2021   41,113   16,625       1,185   58,923
                     
Dividends and interest on equity     (5,013)     (4,296)             (9,309)
Equity in results of investees    11,296    25,384   (1,832)        34,848
Other comprehensive income         (1,174)    1,299     (788)     (663)
Capital increase             41,908    23,061    64,969
Other               255   255
                     
Balance at 2022   47,396   36,539    41,375   23,713   149,023
Schedule of financial information of the subsidiary in which the non-controlling shareholder holds interests
                                 
Statement of Financial Position     Consolidated Braskem without the effect off Braskem Idesa consolidated     Consolidated Braskem Idesa (i)     Eliminations     Consolidated 
    2022   2021   2022   2021   2022   2021   2022   2021
Assets                                
Curent                                
Cash and cash equivalents    10,282,142   6,907,355   2,184,332    1,773,331   -   -     12,466,474    8,680,686
Financial investments   2,295,497   3,492,710   -     -   -   -    2,295,497    3,492,710
Trade accounts receivable   3,621,335   6,607,762     73,195    1,225,479   (462,596)   (679,676)    3,231,934    7,153,565
Inventories    12,921,617    15,325,001   1,108,447    1,010,100   -   -     14,030,064     16,335,101
Taxes recoverable   905,844   1,402,100   250,511   26,558   -   -    1,156,355    1,428,658
Recoverable income taxes   392,062   1,189,812   -     -   -   -    392,062    1,189,812
Derivatives   157,906     33,816   -     -   -   -    157,906   33,816
Other receivables   628,447   841,473     68,544    137,624    30,373   -    727,364    979,097
                                 
Total current assets     31,204,850    35,800,029   3,685,029     4,173,092    (432,223)    (679,676)     34,457,656     39,293,445
                                 
Non-current                                
Taxes recoverable   1,328,695   983,655   288,974    268,403   -   -    1,617,669    1,252,058
Recoverable income taxes   252,995   230,069   -     -   -   -    252,995    230,069
Deferred tax assets   6,671,492   6,481,642   488,116    1,775,610   (801,007)   -    6,358,601    8,257,252
Related parties   7,250,756    10,064,320   -     - (ii) (7,250,756)    (10,064,320)    -     -
Derivatives     71,544   51   -     -   -   -   71,544    51
Judicial deposits    215,274   194,212   -     -   -   -    215,274    194,212
Other receivables   187,107   370,928    563   24,964   -   -    187,670    395,892
Investments   149,023     58,923   -     -   -   -    149,023   58,923
Property, plant and equipment    24,319,015    23,510,588    14,126,939     14,483,720 (iii) (682,659)   (769,178)     37,763,295     37,225,130
Intangible   2,730,124   2,572,675   292,020    304,624   -   -    3,022,144    2,877,299
Right of use of assets   3,638,507   2,427,633   910,900    352,404 (v) (596,420)   -    3,952,987    2,780,037
                                 
Total non current assets     46,814,532    46,894,696    16,107,512   17,209,725    (9,330,842)     (10,833,498)     53,591,202     53,270,923
                                 
Total assets    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368
                                 
Liabilities and shareholders' equity                                
Current                                
Trade payables    11,418,031    11,861,563   1,291,347    871,379   (462,596)   (679,676)     12,246,782     12,053,266
Borrowings   1,254,550   1,343,494   -     -   -   -    1,254,550    1,343,494
Debentures   127,801     59,088   -     -   -   -    127,801   59,088
Braskem Idesa Borrowings   -   -   868,635   86,765   -   -    868,635   86,765
Payroll and related charges   789,441   1,095,040     38,385   75,306   -   -    827,826    1,170,346
Taxes payable   481,729   1,003,813    9,322     8,303   -   -    491,051    1,012,116
Income taxes payable   381,117   1,672,844   -     -   -   -    381,117    1,672,844
Lease   955,225   598,523   195,518   76,843 (v) (111,037)   -    1,039,706    675,366
Provision - geological event in Alagoas   4,247,609   4,378,071   -     -   -   -    4,247,609    4,378,071
Other payables   2,645,828   2,495,544     24,283    246,623    30,059   -    2,700,170    2,742,167
                                 
 Total current liabilities    22,301,331    24,507,980   2,427,490     1,365,219    (543,574)    (679,676)     24,185,247     25,193,523
                                 
Non-current                                
Loan agreements    31,310,710    33,553,766   -     -   -   -     31,310,710     33,553,766
Braskem Idesa Borrowings   -   -    10,501,683     12,224,770   -   -     10,501,683     12,224,770
Debentures   3,023,674   137,830   -     -   -   -    3,023,674    137,830
Accounts payable to related parties   -   -   7,175,837     10,134,287 (ii) (7,175,837)    (10,134,287)    -     -
Loan to non-controlling shareholders of Braskem Idesa   -   -   2,498,093    3,646,538   -   -    2,498,093    3,646,538
Deferred tax liabilities   904,521   1,407,434   1,049,967     -   (801,007)   -    1,153,481    1,407,434
Provision for losses on subsidiaries   4,094,535   5,284,666   -     - (iv) (4,094,535)   (5,284,666)    -     -
Lease   2,942,284   2,147,745   746,285    333,303 (v) (487,745)   -    3,200,824    2,481,048
Provision - geological event in Alagoas   2,378,949   3,283,188   -     -   -   -    2,378,949    3,283,188
Other payables   3,590,317   4,406,733     97,663   25,710   -   -    3,687,980    4,432,443
                                 
 Total non current liabilities    48,244,990    50,221,362    22,069,528   26,364,608     (12,559,124)     (15,418,953)     57,755,394     61,167,017
                                 
Shareholders' equity                                
Attributable to the  Company's shareholders   7,321,798   7,865,819    (4,704,477)   (6,347,010)     4,704,478     6,347,010    7,321,799    7,865,819
                                 
Non-controlling interest in subsidiaries   151,263     99,564   -     -   (1,364,845)   (1,761,555)     (1,213,582)     (1,661,991)
                                 
Total shareholders equity    7,473,061   7,965,383     (4,704,477)   (6,347,010)   3,339,633   4,585,455    6,108,217     6,203,828
                                 
Total liabilities and shareholders' equity    78,019,382    82,694,725    19,792,541   21,382,817    (9,763,065)     (11,513,174)     88,048,858     92,564,368

(i) Consolidation of Braskem Idesa with its subsidiaries Braskem Idesa Servicios and Terminal Química.
(ii) Loan from Braskem Holanda to the Braskem Idesa project.
(iii) Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.
(iv) Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.
(v) Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.

 

 

                                                 
 Statement of profit or loss   Consolidated Braskem without the effect of                        
     Braskem Idesa consolidated     Consolidated Braskem Idesa     Eliminations     Consolidated 
    2022   2021   2020   2022   2021   2020   2022   2021   2020   2022   2021   2020
                                                 
                                                 
Net revenue     93,038,949     101,448,155   55,779,528   5,953,229   6,333,199   4,046,581     (2,472,894)     (2,156,153)     (1,282,615)     96,519,284     105,625,201     58,543,494
Cost of products sold   (82,624,987)     (72,471,291)    (45,563,723)   (5,074,693)   (3,321,601)   (3,112,129)   2,539,132   2,224,661   1,344,438   (85,160,548)     (73,568,231)   (47,331,414)
                                                 
Gross profit     10,413,962    28,976,864   10,215,805   878,536   3,011,598   934,452   66,238   68,508   61,823     11,358,736    32,056,970     11,212,080
                                                 
Income (expenses)                                                 
Selling and distribution     (1,890,181)    (1,834,303)   (1,609,844)   (218,236)   (221,337)   (242,211)           (2,108,417)    (2,055,640)     (1,852,055)
(Loss) reversals for impairment of trade accounts receivable    (38,248)     (8,736)     (55,074)    (178)    (178)    (178)          (38,426)     (8,914)    (55,252)
General and administrative      (2,545,044)    (2,292,884)   (1,739,541)   (216,098)   (229,334)   (179,350)     (2,841)   91    144     (2,763,983)    (2,522,127)     (1,918,747)
Research and development     (374,493)    (296,583)   (250,648)                 (374,493)    (296,583)     (250,648)
Results from equity-accounted investees   (1,078,115)   (82,709)   (1,026,922)    7       1,112,956     87,353   1,007,524   34,848    4,644    (19,398)
Other income    505,629   1,530,443     748,923   1,704   4,044   1,826          507,333   1,534,487   750,749
Other expenses     (2,305,411)    (2,651,425)   (7,573,874)     (38,114)     (17,865)   (364,747)   -   -   -     (2,343,525)    (2,669,290)     (7,938,621)
                                                 
Operating profit    2,688,099    23,340,667    (1,291,175)   407,621   2,546,928   149,792   1,176,353    155,952   1,069,491     4,272,073    26,043,547     (71,892)
                                                 
Financial results                                                
Financial expenses      (5,013,176)    (4,750,895)   (3,851,233)   (1,817,551)   (1,618,020)   (1,505,628)   1,168,034   461,760   443,496     (5,662,693)    (5,907,155)     (4,913,365)
Financial income    2,558,268   2,276,312     1,032,530     610,792    12,886    11,150    (1,158,926)    (461,760)    (443,496)    2,010,134   1,827,438   600,184
Exchange rate variations, net     (643,377)    (2,884,292)   (4,823,269)     235,314   (1,164,697)   (482,125)    (164,107)     46,182    6,683     (572,170)    (4,002,807)     (5,298,711)
                                                 
Finance income (cost)   (3,098,285)     (5,358,875)    (7,641,972)    (971,445)    (2,769,831)    (1,976,603)     (154,999)   46,182     6,683   (4,224,729)     (8,082,524)     (9,611,892)
                                                 
(Loss) profit before income tax                                                

 and social contribution

  (410,186)    17,981,792    (8,933,147)    (563,824)    (222,903)    (1,826,811)   1,021,354    202,134   1,076,174    47,344    17,961,023     (9,683,784)
                                                 
Income taxes   95,651    (3,991,055)     2,253,684   (963,386)    (8,348)     414,794   -   -   -     (867,735)    (3,999,403)   2,668,478
                                                 
(Loss) net profit for the year   (314,535)    13,990,737    (6,679,463)    (1,527,210)    (231,251)    (1,412,017)   1,021,354    202,134   1,076,174   (820,391)    13,961,620     (7,015,306)

 

                                                 
  Statement of cash flows    Consolidated Braskem without the effect of                                  
       Braskem Idesa consolidated     Consolidated Braskem Idesa             Eliminations             Consolidated 
      2022   2021   2020   2022   2021 2020   2022   2021   2020   2022   2021   2020
                                                 
(Loss) profit before taxes     (410,186)   18,348,774   (8,933,147)   (563,824)    (222,903)  (1,826,811)   1,021,354     (164,848)   1,076,174   47,344   17,961,023    (9,683,784)
                                                 
Adjustments for reconciliation of profit (loss)                                        
  Depreciation and amortization    3,944,259     3,432,816     2,995,609    901,194   796,861 1,114,439     (112,288)    (51,244)   (61,967)    4,733,165     4,178,433   4,048,081
  Results from equity-accounted investees    1,078,108     (78,567)     1,026,922         (1,112,956)     73,923    (1,007,524)    (34,848)    (4,644)     19,398
  Interest and  monetary and exchange variations, net    1,788,259     3,604,357     8,541,980    759,378   2,564,905 1,921,975   154,999   142,169     (6,683)    2,702,636     6,311,431    10,457,272
  Reversal of provisions    370,153     819,130     336,838              370,153     819,130   336,838
  Provision - geological event in Alagoas    1,520,019     1,339,765     6,901,828              1,520,019     1,339,765   6,901,828
  PIS and Cofins credits - exclusion of ICMS from the calculation basis     (1,031,099)   (310,557)               (1,031,099)    (310,557)
  Loss for impairment of trade accounts receivable   38,426    10,134    55,252       (1,220)         38,426   8,914     55,252
  Provision for losses and write-offs of long-lived assets    130,366     114,148   8,794     629    1,039          130,995     115,187    8,794
                                                 
  Adjustments for reconciliation of profit     8,459,404   26,559,458   10,623,519     1,097,377   3,138,682 1,209,603     (48,891)        9,507,890   29,698,140    11,833,122
                                                 
Changes in operating working capital                                   
  Judicial deposits - unfreezing (blocking) Public Civil Action         3,746,107                 3,746,107
  Financial investments    1,530,050     296,957   (1,860,827)              1,530,050     296,957    (1,860,827)
  Trade accounts receivable    2,751,788   (1,739,822)   (2,247,729)    1,126,559    (619,688)  (152,971)     (217,080)   184,225   212,874    3,661,267   (2,175,285)    (2,187,826)
  Inventories    2,246,770   (7,176,104)   (309,492)   (108,609)    (398,181)   56,958          2,138,161   (7,574,285)    (252,534)
  Taxes recoverable    928,181     4,958,779     1,584,911   (245,724)    4,808 (52,357)          682,457     4,963,587   1,532,554
  Prepaid expenses        (172,027)      465,812              293,785
  Other receivables    297,209   (269,721)    44,513   13,580     71,165 352,590          310,789   (198,556)   397,103
  Trade payables    (73,230)     955,475   (2,926,585)    370,229   428,364 137,895   217,080     (184,225)    (212,874)    514,079     1,199,614    (3,001,564)
  Taxes payable     (1,085,427)   (2,878,056)     965,191   76,071    (129,432)  (515,430)           (1,009,356)   (3,007,488)   449,761
  Advances from customers        224,764     (25,776)             198,988
  Leniency agreement     (317,867)   (389,087)   (349,842)     -             (317,867)   (389,087)    (349,842)
  Sundry provisions     (219,313)   (482,565)   (158,915)   (187,274)   168,371   13,560           (406,587)   (314,194)    (145,355)
  Geological event in Alagoas     (2,742,791)   (2,928,081)   (1,181,931)     -             (2,742,791)   (2,928,081)    (1,181,931)
  Other payables     (384,838)     823,515   (217,997)    (5,889)   (18,063)   33,810           (390,727)     805,452    (184,187)
                                                 
Cash generated from operations     11,389,936   17,730,748     7,763,660     2,136,320   2,646,026 1,523,694     (48,891)         13,477,365   20,376,774    9,287,354
                                                 
  Interest paid     (2,118,043)   (2,207,196)   (1,946,931)   (786,836)    (676,237)  (789,890)           (2,904,879)   (2,883,433)    (2,736,821)
  Income taxes     (1,620,616)   (2,697,829)   (252,479)    (131)     (9,027)   (5,063)           (1,620,747)   (2,706,856)    (257,542)
                                                 
Net cash generated by operating activities    7,651,277   12,825,723     5,564,250     1,349,353   1,960,762  728,741     (48,891)        8,951,739   14,786,485    6,292,991
                                                 
Proceeds from the sale of fixed assets and intangible assets     2,438    40,353    33,140                 2,438    40,353     33,140
Additions to investment in subsidiaries     (107,090)                           (107,090)    
Dividends received     5,660   295   4,822                 5,660   295    4,822
Acquisitions to property, plant and equipment and intangible assets     (4,153,707)   (3,249,132)   (2,653,009)   (694,574)    (172,192)  (106,780)           (4,848,281)   (3,421,324)    (2,759,789)
                                                 
Net cash used in investing activities   (4,252,699)    (3,208,484)    (2,615,047)    (694,574)     (172,192)   (106,780)         (4,947,273)    (3,380,676)     (2,721,827)
                                                 
Short-term and long-term debt                                              
  Acquired    6,418,208    16,308   13,049,459     -            6,418,208    16,308    13,049,459
  Payments     (3,855,662)   (9,413,909)   (8,734,505)     -             (3,855,662)   (9,413,909)    (8,734,505)
Braskem Idesa borrowings                                        
  Acquired             -   7,271,658               7,271,658  
  Payments             (45,311)    (7,995,045)  (905,210)            (45,311)   (7,995,045)    (905,210)
Related parts       216,862         (34,122)    (226,407)              (34,122)    (9,545)  
Loan to non-controlling shareholders of Braskem Idesa - payment                     (37,618)                   (37,618)
Lease     (836,718)   (787,932)   (610,392)   (141,063)   (53,774) (51,676)     48,891         (928,890)   (841,706)    (662,068)
Dividends paid     (1,350,293)   (5,993,265)    (2,380)               (1,350,293)   (5,993,265)     (2,380)
Non-controlling interest in subsidiaries   21,162     (534,456)             21,162      (534,456)
                                                 
Cash generated (used) in financing activities     396,697     (15,961,936)     3,167,726    (220,496)     (1,003,568)   (994,504)    48,891         225,092     (16,965,504)    2,173,222
                                                 
Exchange variation on cash of foreign subsidiaries     (420,488)     293,633     1,054,845     (23,282)     83,896 259,741           (443,770)     377,529   1,314,586
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972
                                                 
Represented by                                              
  Cash and cash equivalents at the beginning for the period    6,907,355   12,958,419     5,786,645    1,773,331   904,433 1,017,235          8,680,686   13,862,852   6,803,880
  Cash and cash equivalents at the end for the period     10,282,142     6,907,355   12,958,419    2,184,332   1,773,331 904,433           12,466,474     8,680,686    13,862,852
                                                 
Increase in cash and cash equivalents    3,374,787    (6,051,064)     7,171,774     411,001    868,898   (112,802)    -    -    -    3,785,788    (5,182,166)    7,058,972
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Property, plant and equipment (Tables)
12 Months Ended
Dec. 31, 2022
Property, plant and equipment [abstract]  
Schedule of estimated useful lives
       
      2022   2021
Buildings and improvements      3.03    2.92
Machinery, equipment and installations      7.32    6.74
Furniture and fixtures      10.06    10.06
IT equipment      21.03    21.18
Lab equipment      9.59    9.53
Security equipment      10.50    10.04
Vehicles      19.51    18.82
Other      18.09    17.05
Schedule of reconciliation of carrying amount
                         
       Land     Buildings and Improvements     Machinery, Equipment and Facilities     Projects and Stoppage in Progress (i)     Other     Total 
                           
Cost       683,031     8,281,424   53,401,832    4,389,105   2,038,666    68,794,058
Accumulated depreciation and amortization       -   (3,159,185)   (28,268,867)    -   (1,436,857)   (32,864,909)
Balance as of December 31, 2020       683,031     5,122,239   25,132,965    4,389,105   601,809    35,929,149
                           
Acquisitions       -   338     160,297    3,388,078    3,421   3,552,134
Capitalized financial charges       -    -    -    192,207   -   192,207
Foreign currency translation adjustment                          
  Cost      17,046     287,866     1,118,655   74,428     23,859   1,521,854
  Depreciation       -   (88,406)   (313,267)    -   (16,760)   (418,433)
Transfers by concluded projects     244    13,965     3,207,833   (3,412,665)   190,623   -
Transfers to inventory       -    -    -   (16,838)   -   (16,838)
Transfers to intangible       -    31,495   (11,673)   (73,397)   (11,847)   (65,422)
Disposals                          
Cost     (10,856)   9,723   (353,274)   (91,485)   (41,066)   (486,958)
Depreciation       -   168     387,005    -    9,206   396,379
Depreciation       -   (195,900)   (3,038,176)    -   (143,164)   (3,377,241)
Transfers to "non-current assets held for sale"     (1,701)    -   (2)    -     2   (1,701)
Transfers Others       -         118,629   (40,095)   (78,534)    
Net book value       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
Cost       687,764     8,591,020   57,535,343    4,449,433   2,215,503    73,479,063
Accumulated depreciation       -   (3,409,532)   (31,126,351)   (40,095)   (1,677,954)   (36,253,933)
Balance as of December 31, 2021       687,764     5,181,488   26,408,992    4,409,338   537,549    37,225,130
                           
Acquisitions       -   1,709     296,719    4,643,953    7,603   4,949,985
Additions through acquisition of ER Plastics       -    20,868    56,288    -    362     77,518
Capitalized financial charges       -    -    -    203,135   -   203,135
Foreign currency translation adjustment                         -
  Cost     (19,916)   (173,496)   (941,271)   (38,966)   (28,592)   (1,202,241)
  Depreciation       -    51,263     285,016    -     20,269   356,548
Transfers by concluded projects       -    86,609     2,688,220   (2,915,496)   140,667  
Transfers to intangible       -    -    -   (13,597)   -   (13,597)
Disposals                         -
  Cost     (3)   (7)   (926,944)   (20,665)   (16,689)   (964,308)
  Depreciation       -    -     815,220    -     13,715   828,934
Depreciation       -   (203,358)   (3,347,376)    -   (147,074)   (3,697,809)
Net book value       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295
Cost       667,845     8,526,704   58,708,355    6,307,797   2,318,854    76,529,554
Accumulated depreciation       -   (3,561,627)   (33,373,492)   (40,095)   (1,791,045)   (38,766,259)
Balance as of December 31, 2022       667,845     4,965,077   25,334,863    6,267,702   527,809    37,763,295

 

(i) As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.

Schedule of property plant and equipment by country
         
      2022   2021
           
Brazil       17,204,824     15,867,387
Mexico       13,444,279     13,714,543
United States of America      6,729,469    7,281,077
Germany      294,612    356,288
Netherland     89,841     5,691
Other       270     144
        37,763,295     37,225,130
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Tables)
12 Months Ended
Dec. 31, 2022
Intangible Assets  
Schedule of changes in intangible assets
                   
                 Customers     
         Brands     Software      and Suppliers     
     Goodwill     and Patents     licenses     Agreements     Total 
Cost     3,187,678     499,515     1,010,201    392,246    5,089,640
Accumulated amortization   (1,128,804)   (214,455)   (683,157)   (234,533)   (2,260,949)
Balance as of December 31, 2020     2,058,874     285,060     327,044    157,713    2,828,691
                     
Acquisitions     -   670    67,686     420   68,776
Foreign currency translation adjustment     -               14,271
Cost     -    12,443    13,023    -   25,466
Amortization     -   (2,711)   (8,484)    -   (11,195)
Transfers from property, plant and equipment     -    28,770    36,652    -   65,422
Other write-offs, net of amortization     -    -   (3,393)    -   (3,393)
Amortization     -   (10,444)   (64,008)   (22,016)   (96,468)
Net book value     2,058,874     313,789     368,520    136,117    2,877,299
Cost     3,187,678     549,196     1,123,619    392,666    5,253,159
Accumulated amortization   (1,128,804)   (235,408)   (755,099)   (256,549)   (2,375,860)
Balance as of December 31, 2021     2,058,874     313,789     368,520    136,117    2,877,299
                     
Acquisitions     -   1,307     144,930     913    147,150
Additions through acquisition of ER Plastics     -    21,162    -   66,571   87,733
Goodwill acquisition of ER Plastics    28,402    -    -    -   28,402
Foreign currency translation adjustment     -            -    -
Cost     -   (7,407)   (19,762)    -   (27,170)
Amortization     -   2,711    14,440    -   17,150
Transfers from property, plant and equipment     -    -    13,597    -   13,597
Other write-offs, net of amortization     -    -   (10,011)    -   (10,011)
Amortization     -   (10,575)   (79,774)   (21,659)   (112,008)
Net book value   2,087,276     320,986     431,939    181,943    3,022,144
Cost   3,216,080     564,258     1,252,373    460,150    5,492,861
Accumulated amortization   (1,128,804)   (243,272)   (820,434)   (278,207)   (2,470,717)
Balance as of December 31, 2022   2,087,276     320,986     431,939    181,943    3,022,144
Schedule of goodwill impairment testing
             
     Allocated     Recoverable     Book         Discount 
     goodwill     amount     value (i)     CF/Book value     rate 
                     
Northeastern petrochemical complex   475,780   7,305,045   3,124,332    2.3   14.68%
Southern petrochemical complex   1,390,741    20,840,873   6,781,881    3.1   15.85%
Vinyls   192,353   5,050,166   2,880,156    1.8   14.70%

 

(i) The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.
[custom:ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity]
Schedule of potential impact on cash flows of the discount rate and perpetuity            
      +0.5% on   -0.5% on
         discount rate    perpetuity
CGU            
Northeastern petrochemical complex       6,822,642   7,044,458
Southern petrochemical complex        19,744,124    20,351,277
Vinyls       4,741,224   4,930,076
Schedule of amortization estimated useful life
 
- Brands and patents 10-20 years
- Software licenses and rights of use 5-10 years
- Customers and suppliers’ agreements 14-28 years 
Schedule of intangible assets by country
         
      2022   2021
           
Brazil      2,571,011    2,526,999
Mexico      292,020    304,624
Netherland      122,447  
United States of America     22,820   24,404
Germany     13,839   21,253
Other     7    19
       3,022,144   2,877,299
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Tables)
12 Months Ended
Dec. 31, 2022
Right-of-use Assets And Lease Liability  
Schedule of changes in right-of-use assets
                               
            Balance as of               Foreign currency   Balance as of
            31/12/2021   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2022
Rail cars             986,061     72,506    (173,272)   (5,359)     (53,740)     826,196
Machinery and equipment             793,254   1,147,145    (330,971)   (5,970)    (804)     1,602,654
Vessels             696,661   811,372    (385,968)    -    (1,793)     1,120,272
Buildings and constructions             265,312   102,040   (75,319)    -    (213)     291,820
Vehicles            29,449   102,827   (26,158)    -    (120)     105,998
Computer equipment and goods           9,300    417     (3,590)    -   (80)   6,047
Total           2,780,037   2,236,307     (995,278)     (11,329)   (56,750)     3,952,987
                                 
                                 
            Balance as of               Foreign currency   Balance as of
            12/31/2020   Acquisitions   Depreciation   Disposal    translation adjustment   31/12/2021
Rail cars             1,007,336   102,648    (187,915)    -   63,992     986,061
Machinery and equipment             749,728   281,113    (207,985)    (30,245)     643     793,254
Vessels             834,848   258,201    (399,677)    -     3,289     696,661
Buildings and constructions             259,896     52,897   (52,997)   (6,333)   11,849     265,312
Vehicles            33,888     51,171   (24,078)    (31,667)     135    29,449
Computer equipment and goods            16,699    542     (4,334)   (3,682)    75   9,300
Total           2,902,395    746,573     (876,986)     (71,928)     79,983     2,780,037
Schedule of changes in lease liabilities
     
  2022   2021
       
As of December 31  3,156,414    3,207,886
       
Acquired 2,232,043   746,573
Additions through acquisition of ER Plastics  4,264    
Disposals  (12,568)    (50,473)
Interests and monetary and exchange variations, net   83,871   206,375
Currancy translation adjustments   (73,585)     85,984
Payments   (928,890)     (841,706)
Interest paid   (221,019)     (198,225)
As of December 31  4,240,530    3,156,414
       
Current liability 1,039,706   675,366
Non-current liability 3,200,824   2,481,048
Total  4,240,530    3,156,414
Schedule of payment schedule by maturity
                 
              2022   2021
                   
2022                   777,410
2023               1,109,048     633,141
2024               855,803     493,147
2025               630,074     399,924
2026+               2,388,252     1,073,620
Total             4,983,177     3,377,242
Schedule of cash flows related to the contracts
       
     Discounted     Undiscounted 
    2022   2022
2023     1,014     1,080
2024   52,258   55,678
2025   49,390   56,067
2026   46,687   56,468
2027+    396,669    712,541
Total     546,017     881,835
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Trade payables (Tables)
12 Months Ended
Dec. 31, 2022
Trade Payables  
Schedule or trade account payables
         
    Note   2022   2021
Trade payables:          
Domestic market          
Third parties      1,748,853     1,492,223
Third parties (forfait) (i)    682,396     487,806
Total Third parties      2,431,249     1,980,029
             
Related parties      196,440     208,287
Related parties (forfait) (i)   81,527    40,148
Total Related parties 9     277,967     248,435
             
Foreign market (ii)        
Third parties      9,540,635     9,936,266
        12,249,851   12,164,730
             
Current liabilities       12,246,782   12,053,266
Non-current liabilities       3,069     111,464
Total       12,249,851   12,164,730

(i) The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.
(ii) Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.

XML 70 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Tables)
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Schedule of borrowings
                 
        Annual financial charges (%)   2022   2021
Foreign currency                
Bonds       Note 16 (b)     26,124,158   30,322,998
Export prepayment and export credit notes   (i)   US$ exchange variation + Term SOFR quarterly + 1,79    1,514,651   -
Other       Note 16 (c)    3,880,165     4,703,059
Transactions costs             (453,532)   (594,048)
              31,065,442   34,432,009
                 
Current liabilities            1,177,144     1,284,483
Non-current liabilities             29,888,298   33,147,526
Total             31,065,442   34,432,009
                 
Local currency                
Agribusiness Credit Notes ("CRA")       Note 16 (d)    763,396   -
BNDES       IPCA + 6.04    386,534     435,778
Export credit notes       100.00 of CDI + 1.30    348,885   -
Other fixed interest loans       Interest between 3.5 and 6.5   18,671    24,864
Other variable interest loans       IPCA + interest between 2.39 and 2.78     3,525   4,616
Transactions costs            (21,193)     (7)
             1,499,818   465,251
                 
Current liabilities           77,406    59,011
Non-current liabilities            1,422,412     406,240
Total            1,499,818   465,251
                 
Foreign currency and local currency                
Current liabilities            1,254,550     1,343,494
Non-current liabilities             31,310,710   33,553,766
Total             32,565,260   34,897,260
(i) Maturity in June 2027.

 

Schedule of long-term maturities
           
        2022   2021
             
2023         -     1,199,143
2024         2,143,624     3,965,917
2025         603,743     645,517
2026         581,625     622,032
2027         2,356,678     552,171
2028         7,281,841     7,081,301
2029         287,178     230,557
2030         7,995,727     8,535,493
2031         106,661    61,617
2033 and thereafter         9,953,633   10,660,018
Total       31,310,710   33,553,766
Schedule of bonds
                   
            Interest    
Issue date       Maturity   (% per year)   2022   2021
Jul-2011 and jul-2012 (i)   jul-2041   7.125    3,044,911    3,296,917
Feb-2014 and may-2014 (ii)   fev-2024   6.450    1,588,729    3,417,741
Oct-2017   (ii)   jan-2023   3.500      593,964
Oct-2017   (i)   jan-2028   4.500    6,249,333    6,695,263
Nov-2019   (i)   jan-2030   4.500    7,936,089    8,527,701
Nov-2019       jan-2050   5.875    4,009,069    4,287,829
Jul-2020   (iii)   jan-2081   8.500    3,296,027    3,503,583
Total               26,124,158     30,322,998

 

(i) Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.
(ii) Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.
(iii) The bond can be repaid by the Company at par value, with the first payment between October 2025 and January 2026 and the other payments after each period of 5 years as from the first payment.
Schedule of others
               
Issue date   Maturity   Charges (% per year)   2022   2021
nov-2018 (i) nov-2028   Us dollar exchange variation + semianual Libor + 0.90    929,112    1,154,146
dec-2019 (i) dec-2029   Us dollar exchange variation + semianual Libor + 0.90    549,610    670,124
dec-2019 (ii) apr-2026   Us dollar exchange variation + semianual Libor - 1.00     197,209    266,403
sep-2017 (iii) mar-2027   Us dollar exchange variation + semianual Libor + 1.61    357,488    462,490
jul-2018 (iv) dec-2028   Us dollar exchange variation + semianual Libor + 0.65    757,832    947,898
aug-2020 (iii) feb-2031   Us dollar exchange variation + semianual Libor + 1.70    1,007,067    1,201,998
aug-2020 (v) aug-2028 to jun-2029   Euro exchange variation + interest between 2.40 and 7.41   79,698    
nov-2020 (v) no maturity   Euro exchange variation + Euribor monthly + 4.10     2,149    
             3,880,165   4,703,059
(i)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.
(ii)Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.
(iii)Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.
(iv)Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million.
(v)Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.
Schedule of others - CRA
                             
      Issue amount                    
Issue date       Issuer   Series   Maturity   Charges (% per year)   2022   2021
Jan-2022       581,602    Braskem S.A.      Dec-2028   IPCA + 5.54%   616,025   -
Jan-2022       139,134    Braskem S.A.      Dec-2031   IPCA + 5.57%   147,371   -
Total     720,736                    763,396    

XML 71 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Braskem Idesa Borrowings (Tables)
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Schedule of braskem idesa financing
                 
             
Identification   Maturity   Charges (% per year)   2022   2021
                 
Bonds                
Bond I   nov-2029   Us dollar exchange variation + 7.45 (i)   4,690,619    5,104,463
Bond II   feb-2032   Us dollar exchange variation + 6.99 (ii)   6,352,864    6,834,805
             11,043,483     11,939,268
                 
Others (a) Oct-2026   Us dollar exchange variation + quarterly Libor + 4.00 (iii) 734,837     849,859
                 
Transactions costs            (408,002)     (477,592)
                 
Total            11,370,318     12,311,535
                 
Current liabilities             868,635   86,765
Non-current liabilities           10,501,683     12,224,770
Total            11,370,318     12,311,535

(i)Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.
(ii)Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.
(iii)For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.
(a) Regarding this financing, on December 22, 2022 Braskem Idesa obtained the waiver related to a leverage ratio (covenant) until June 30, 2023. In this sense, even though Braskem Idesa is not in default and creditors did not request to accelerate this debt, because the waiver did not cover at least 12 months, the entire balance, in the amount of R$649,560, was reclassified from non-current liabilities to current liabilities on December 31, 2022.

Schedule of long-term maturities of these financing
       
    2022   2021
         
2023   -   67,649
2024   -   68,694
2025   -   69,530
2026   -    408,445
2029     4,337,567    4,900,399
2032     6,164,116    6,710,053
Total   10,501,683     12,224,770
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Debentures (Tables)
12 Months Ended
Dec. 31, 2022
Debentures Abstract  
Schedule of debentures
                       
                Annual    
Issue date   Issuer   Series   Maturity   financial charges (%)   2022   2021
mar-2013 (i) DAC   Only   mar-2025   IPCA + 6%   109,877   150,352
sep-2013 (i) Cetrel   Only   Sep-2025   126.5% of CDI     34,604     47,109
may-2022   Braskem     may-2029   CDI + 1,75   770,910    -
may-2022   Braskem     may-2030 to 2032   CDI + 2,00   248,970    -
aug-2022 (i) Braskem    Only   aug-2029   CDI + 1,75   786,770    -
nov-2022   Braskem      nov-2029   CDI + 1,70   1,113,987    -
nov-2022   Braskem      nov-2030 to 2032   CDI + 1,95     97,159    -
Transactions costs                    (10,802)   (543)
                     3,151,475    196,918
                         
Current liabilities                   127,801     59,088
Non-current liabilities                 3,023,674   137,830
Total                    3,151,475    196,918

(i) These debentures were secured by mandatory deposits as disclosed in Note 6.

Schedule of long-term debenture maturity
           
        2022   2021
             
2023         -   57,045
2024        58,550   57,096
2025        24,059   23,689
2029         2,600,998    -
2030         113,291    -
2031         113,360    -
2032         113,416    -
Total         3,023,674     137,830
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Reconciliation of borrowing activities in the statement of cash flow (Tables)
12 Months Ended
Dec. 31, 2022
Reconciliation Of Borrowing Activities In Statement Of Cash Flow  
Schedule of reconciliation of borrowing activities in the statement of cash flow
                           
    Borrowings, debentures and Braskem Idesa financing              
            Total       Non-controlling           
            borrowings   Braskem Idesa   shareholders            
    Borrowings   Debentures   and debentures   financing   of Braskem Idesa   Lease   Dividends  
                               
 Balances at December 31, 2021    34,897,260   196,918   35,094,178   12,311,535   3,646,538     3,156,414    10,538  
                               
 Acquired  3,479,224     2,938,984     6,418,208     -   -         -  
 Payments    (3,753,427)   (102,235)   (3,855,662)     (45,311)   (34,122)   (928,890)     (1,350,293)  
 Cash used in financing activities  (274,203)   2,836,749   2,562,546   (45,311)    (34,122)    (928,890)   (1,350,293)  
                               
 Other changes                             
 Interest paid    (1,880,611)     (34,548)   (1,915,159)   (752,489)   (16,212)   (221,019)     -  
 Interest and monetary and exchange variations, net  1,524,983     152,356     1,677,339     170,180   (47,784)   83,871     -  
 VAT on loan                  (75,640)          
 New contracts                       2,232,043      
 Disposal                        (12,568)      
 Additions through acquisition of ER Plastics    99,702        99,702     -         4,264     -  
 Currency translation adjustments    (1,801,871)       (1,801,871)   (313,597)   (84,720)     (73,585)      
 Fair value of financial transactions of non-controlling subsidiaries                 (889,967)          
 Additional dividends approved in the board meeting      -         -            1,350,000  
 Additional dividends of subsidiary      -         -             1,236  
 Other      -         -           (474)  
      (2,057,797)   117,808    (1,939,989)    (895,906)    (1,114,323)     2,013,006     1,350,762  
                               
 Balances at December 31, 2022    32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  
                               
Current 1,254,550     127,801     1,382,351     868,635        1,039,706   11,007 (i)
No Current  31,310,710     3,023,674   34,334,384   10,501,683     2,498,093    3,200,824      
Total   32,565,260   3,151,475   35,716,735   11,370,318   2,498,093     4,240,530    11,007  
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Tables)
12 Months Ended
Dec. 31, 2022
Financial Instruments  
Schedule of non-derivative financial instruments and other liabilities
                         
          Fair value   Book value   Fair value
  Note   Classification by category   hierarchy   2022   2021   2022   2021
                           
Cash and cash equivalents 5                        
Cash and banks     Amortized cost         6,074,208     5,050,822     6,074,208     5,050,822
Financial investments in Brazil     Fair value through profit or loss   Level 2     6,392,266     3,629,864     6,392,266     3,629,864
               12,466,474   8,680,686    12,466,474   8,680,686
                           
Financial investments  6                        
LFT´s and LF´s     Fair value through profit or loss   Level 2     1,789,375     2,337,171     1,789,375     2,337,171
Time deposit investments     Amortized cost       -     106,271   -     106,271
Other     Fair value through profit or loss   Level 2     523,256     1,066,113     523,256     1,066,113
              2,312,631   3,509,555 2,312,631   3,509,555
                           
Trade accounts receivable  7   Amortized cost       3,199,223   7,118,452   3,199,223   7,118,452
Trade accounts receivable  7   Fair value through other comprehensive income   Level 2   32,711   48,508   32,711   48,508
                           
Trade payables 15   Amortized cost        12,249,851    12,164,730    12,249,851    12,164,730
                           
Borrowings  16   Amortized cost                    
Foreign currency - Bond         Level 1   26,124,158   30,322,998   23,165,942   33,690,876
Foreign currency - other borrowings         Level 2     5,394,816     4,703,059     5,329,174     4,696,970
Local currency         Level 2     1,521,011     465,258     1,937,255     451,899
              33,039,985   35,491,315   30,432,371   38,839,745
                           
Braskem Idesa borrowings 17   Amortized cost                    
Bond         Level 1   11,043,483   11,939,268     8,301,948   12,197,524
Others         Level 2     734,837     849,859     796,510     931,141
              11,778,320   12,789,127   9,098,458   13,128,665
                           
Debentures 18   Amortized cost   Level 2   3,162,277   196,918   3,190,417   195,570
                           
Loan ton non-controlling
  shareholder of Braskem Idesa
 9(a)    Amortized cost       2,498,093   3,646,538   2,498,093   3,646,538
                           
Leniency agreement  25   Amortized cost       903,140   1,123,296   903,140   1,123,296
Schedule of changes in derivative financial instruments
                         
    Operation characteristics     Net (Asset)/           Net (Asset)/
    Principal exposure         Liability   Change in   Financial   Liability
Identification     Derivatives     2021   fair value   settlement   2022
                           
Non-hedge                           
accounting transactions                          
Braksem America - Swap C3/PGP   Propane   Propene      14,299     (2,158)    (12,141)     -
Braskem Holanda - Swap Nafta/Gasoline   Gasoline   Naphtha        (16,847)     (25,733)   26,584     (15,996)
Braskem Argentina - Exchange swap   Argentine peso Dollar     3   61   (63)   1
                (2,545)     (27,830)   14,380     (15,995)
                           
Hedge accounting                          
transactions                          
Braskem S.A. - Dollar call and put options   Real   Dollar      85,216     (227,871)   77,285     (65,370)
Braskem S.A. - Dollar swap CDI   Real   Dollar+Fixed rates    502,508     (194,055)    (156,740)    151,713
Braskem S.A. - Swap CRA   Real   Dollar+Fixed rates     -     (32,828)   10,116     (22,712)
               587,724     (454,754)    (69,339)    63,631
                           
Derivatives                          
Assets                          
Current assets              33,816            157,906
Non-current assets             51            71,544
Total              33,867            229,450
Liabilities                          
Current liabilities              256,131            195,169
Non-current liabilities              362,915            81,917
Total              619,046            277,086
Net (Asset)/Liability              585,179            47,636
Schedule of Fair Value Adjustment
                     
Identification   Total nominal   Hedge   Maturity       Fair value, net
  value R$   (interest rate per year)     2022   2021
Swaps CRA    600,218   3.5388%   dec-2028    12,603     -
Swaps CRA    141,298   3.3742%   dec-2031    10,109    
Total     741,516             22,712     -
                     
Derivatives                    
Assets                    
Current assets                13,274     -
Non-Current assets                49,613     -
Total                62,887     -
Liabilities                    
Non-Current liabilities                40,175     -
Total                40,175     -
Net (Asset)/Liability                 22,712     -
Schedule of non-derivative financial liabilities designated to hedge accounting
               
                 
                Total nominal value
            US$   R$
              0  
2024             288,854    1,507,154
2025             800,000    4,174,160
2028             1,250,000    6,522,125
2029             500,000    2,608,850
2030             800,000    4,174,160
2031             800,000    4,174,160
2032             800,000    4,174,160
Total nominal value             5,238,854     27,334,769
Schedule of financial instruments designated for hedge
             
             
            US$
              
    2021   Designations   2022
             
Designated balance    4,738,854    500,000     5,238,854
Schedule of exchange variation
               
        Conversion rate        
    Total nominal   at Inception   Closing rate   Gross nominal
    value US$   R$/US$   R$/US$   value - R$
                 
First quarter    175,000   2.0017   3.9786     345,958
Second quarter    208,000   2.0017   3.9786     411,195
Third quarter    186,000   2.0017   3.9786     367,703
Fourth quarter    150,000   2.0017   3.9786     296,535
      719,000           1,421,391
Schedule of changes in foreign exchange variation and income tax and social contribution
         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021 (13,102,558)    4,454,869     (8,647,689)
           
Exchange variation recorded in the period / IR and CSL 1,699,906     (577,968)   1,121,938
           
Exchange variation transferred to profit or loss / IR and CSL 1,421,391     (483,273)   938,118
           
Balances at December 31, 2022   (9,981,261)    3,393,628     (6,587,633)
Schedule of designated and unrealized sales
           
             
            Nominal value
             
2023           65,221
2024            117,398
2025            117,398
2026            430,460
2030            1,173,983
2031            1,173,983
2032            2,739,293
2033            2,739,293
2034            1,565,310
2035            1,565,310
Nominal value             11,687,649
Schedule of exchange variation - Braskem Idesa
                     
        Conversion rate            
    Total nominal   at Inception   Closing rate   Total nominal   Gross nominal
    value US$   MXN/US$   MXN/US$   value MXN   value - R$
                     
First quarter    29,136   13.6218   20.2827   194,072   49,302
Second quarter    72,612   13.6507   20.1297   470,453   116,361
Third quarter    72,612   13.6507   20.1297   470,453   120,341
Fourth quarter    78,844   13.6521   20.1224   510,144   137,999
    253,204           1,645,123   424,003
Schedule of changes in foreign exchange variation and income tax and social contribution - Braskem Idesa
         
   Exchange         Net 
   variation     IR and CSL     effect 
           
Balances at December 31, 2021   (2,231,511)    670,192     (1,561,319)
           
Exchange variation recorded in the period / IR 699,677     (209,903)   489,774
           
Exchange variation transferred to profit or loss / IR 424,003     (127,201)   296,802
           
Balances at December 31, 2022   (1,107,831)    333,088   (774,743)
Schedule of trade accounts receivable by credit ratings
         
          (%)
      2022   2021
1 Minimal Risk   72.15   65.39
2 Low Risk   21.65   26.65
3 Medium Risk   3.36   6.02
4 High Risk   2.56   1.54
5 Very High Risk (i) 0.28   0.40

 

(i) Clients in this group that are still active buy from Braskem and pay in advance.
Schedule of financial assets with and without risk assessment
                       
             
            2022           2021
     Domestic market     Foreign market    Total    Domestic market     Foreign market    Total
Financial assets with risk classification                        
AAA   5,130,140   2,420,741    7,550,881     4,080,884   2,783,151    6,864,035
AA+   162,650   -     162,650   109,165   -     109,165
AA   289,574   107,545     397,119   188,742   629,671     818,413
AA-   149,178   -     149,178     63,675   -    63,675
A+     3,423   4,459,700    4,463,123    5,788   2,914,269    2,920,057
A   57,650   1,392,854    1,450,504   107,225   -     107,225
A-   -   387,478     387,478     634   236,335     236,969
BBB+     118     375    493     856     38    894
BBB     788   52,389    53,177     129   1,026,104    1,026,233
BBB-            -     554   -    554
BB+            -    50   -   50
BB       -    -    1,479   -   1,479
BB-        7     7            
    5,793,521   8,821,089     14,614,610     4,559,181   7,589,568     12,148,749
Financial assets without risk classification                        
Shares of investment funds
in credit rights
      -    -    1,721   -   1,721
Other financial assets   (i)  83,070   81,425     164,495     25,989   13,782    39,771
    83,070   81,425     164,495     27,710   13,782    41,492
                         
Total   5,876,591   8,902,514     14,779,105     4,586,891   7,603,350     12,190,241

 

(i) Investments approved by the Management, in accordance with the Financial Policy.
The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario
                   
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity   Note   as December 31, 2022   (USDBRL 5.27)   (USDBRL 5.93)   (USDBRL 7.35)
                     
Brazilian real/U.S. dollar exchange rate                    
Bonds         (37,167,641)    (372,553)   (5,051,899)    (15,155,696)
Export prepayments        (1,028,473)   (10,309)    (139,792)    (419,376)
Investments        (1,985,932)   (19,906)    (269,932)    (809,795)
SACE   16(c.i)    (1,478,722)   (14,822)    (200,991)    (602,973)
Dollar call and put options   (i)   65,370    9,809    (160,742)   (1,023,396)
Dollar swap x CDI         (151,713)     (6,216)    (189,181)    (466,381)
MONFORTE   16(c.ii)     (197,209)     (1,977)   (26,805)   (80,415)
Nexi   16(c.iii.iv)     (100,707)     (1,009)   (13,688)   (41,065)
Other         (734,837)     (7,366)   (99,881)    (299,642)
Financial investments abroad       6,718,183     67,340     913,149     2,739,446
Dollar swap x IPCA       22,713   (607)   (63,356)    (194,841)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.58%)   (7.89%)   (14.13%)
                     
Libor floating interest rate                    
Export prepayments        (35,749)   (887)     (3,388)   (10,163)
Nexi   16(c.iii.iv)     (100,707)     (3,920)   (14,970)   (44,909)
SACE   16(c.i)    (1,478,722)   (49,107)    (187,520)    (562,560)
MONFORTE   16(c.ii)     (197,209)     (4,094)   (15,635)   (46,906)
Investments        (1,985,932)   (63,201)    (241,339)    (724,017)
Outros         (734,837)   (16,887)   (64,483)    (193,449)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
CDI interest rate                    
Debentures        (3,052,400)     302,796    (898,725)   (3,331,635)
Financial investments in local currency       5,876,590   (80,242)     206,257     619,489
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (5.31%)   (6.72%)   (8.35%)
                     
IPCA interest rate                    
Debentures         (109,877)    1,494     (2,085)     (6,315)
BNDES         (386,534)     26,403   (38,283)    (121,208)
BNB/ FINEP/ FUNDES/FINISA/FINAME/FNE       (3,525)    59     (83)   (252)
CRA         (763,396)     45,429   (65,630)    (206,889)
Dollar swap x IPCA       22,713   (99,748)     31,958     99,871
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (12.25%)   (17.6%)   (25.31%)
                     
Selic interest rate                    
Leniency agreement         (865,311)    6,856   (17,443)   (51,656)
                     
                    Gain (losses)
        Exposure value   Probable   Reasonably possible   Possible
Instrument / Sensitivity       as December 31, 2022   (4.59%)   (10.58%)   (22.57%)
                     
Selic interest rate                    
Export prepayments         (992,725)   (25,698)    (195,867)    (587,602)
Export credit notes         (521,926)   (13,571)    (103,435)    (310,306)

(i) The Company is in the short position of a possible counterparty call.

XML 75 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes payable (Tables)
12 Months Ended
Dec. 31, 2022
Taxes Payable  
Schedule of taxes payable
           
               
          2022   2021
Brazil            
  IPI        74,219     131,290
  ICMS         218,179     485,302
  PIS and Cofins        20,406    33,516
  Other         103,549    46,117
               
Other countries            
  Value-added tax         150,260     229,571
  Tax on financial income       222,464     346,817
Total       789,077   1,272,613
               
Current liabilities         491,051     1,012,116
Non-current liabilities         298,026     260,497
Total       789,077   1,272,613
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes  
Schedule of income tax and social contribution reconciliation
             
           
      2022   2021   2020
               
Profit (loss) before income taxes       47,344   17,961,023    (9,683,784)
               
Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)       (16,097)   (6,106,748)     3,292,487
               
Permanent adjustments to income taxes calculation basis              
Income taxes on equity in results of investees      11,849   1,578   6,595
Thin capitalization   (i) (359,598)    (6,628)   (695,741)
Tax benefits (Sudene and PAT)     -     137,338   -
Reduction of tax loss   22.1(c) (891,669)       -
Effect of the refund of Braskem America´s tax benefit             (737,841)
Different jurisdictional taxes rates for companies abroad and tax basis   (ii)   1,029,618     1,980,358     994,811
Effect from the retrospective tax rate on bonus depreciation of Braskem America         -     334,460
Taxes on dividends distribution     (454,663)   (265,454)   (131,240)
Exclusion of inflation adjustement by Selic on undue tax payments from taxable income   22.1(a)  39,395     501,382    
Other permanent adjustments     (226,570)   (241,229)   (395,053)
               
Effect of income taxes on results of operations      (867,735)    (3,999,403)   2,668,478
               
Breakdown of income taxes              
               
Current income taxes              
Current year     (1,003,705)   (3,834,437)     (52,830)
Total current expenses      (1,003,705)   (3,834,437)     (52,830)
               
Deferred income taxes              
Origination and reversal of temporary differences       1,192,438   (246,294)     2,677,328
Tax losses     (1,056,468)    81,328    43,980
Total Deferred income taxes        135,970   (164,966)     2,721,308
               
Total      (867,735)    (3,999,403)   2,668,478
               
Effective rate   (iii) 1832.8%   22.3%   27.6%

 

(i) Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.
(ii) Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:
Schedule of changes in balances of deferred tax assets and liabilities
             
          Income tax rate (%)
               
          Headquarters (Country)   2022
             
Braskem Alemanha       Germany    31.09
Braskem America and Braskem America Finance       USA    21.00
Braskem Argentina       Argentina    25.00
Braskem Chile       Chile    27.00
Braskem Holanda, Braskem Holanda Finance, Braskem Holanda Inc, B&TC and ER Plastics       Netherlands    25.80
Braskem Idesa, Braskem Idesa Serviços, Braskem México            
  Braskem México Serviços, Braskem México Proyectos and Terminal Química       Mexico    30.00
Braskem India       India    30.00

(iii) The effects presented in the reconciliation of the effective rate, in relation to the profit before taxes of R$47,344, resulted in an effective rate of 1,832.8%, the main effect is described in Note 22.1(c).

 

22.2 Deferred income taxes

Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.

Deferred tax assets are recognized for unused tax losses and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, based on the business plans for the Company.

The measurement of deferred taxes reflects the tax consequences that would follow from how the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. Annually, the Company revises its projection of taxable income based on its Business Plan.

The Business Plan is prepared annually by the Executive Board, and its main variables include projections for the prices of the products produced by the Company, the prices of raw materials, the growth in gross domestic product of each country in which the Company operates, exchange rate variation, interest rates, inflation rates and fluctuations in supply and demand for inputs and finished goods.

In evaluating the plan, the Company uses its historical performance, strategic planning and market projections produced by third party consulting firms, which are reviewed and supplemented based on Management´s experience.

Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves. Unrecognized deferred tax assets are reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used.

Deferred tax assets and liabilities are offset only if certain criteria are met.

(a) Movement in deferred tax balances

                             
                             
Assets   As of December 31, 2020   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2021   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2022
                             
Tax losses (IR) and negative base (CSL)   3,278,184   76,532       3,354,716   (957,184)       2,397,532
Goodwill amortized   6,520   (4,061)       2,459   (364)       2,095
Exchange variations   3,817,615   696,849   (234,402)   4,280,062   611,838   (1,549,020)   3,342,880
Temporary adjustments   4,996,337   (214,060)       4,782,277   (134,745)       4,647,532
Business combination   56,211   (29,327)       26,884   (26,884)       0
Tax credits (i) 77,032   (77,032)       0   697,662       697,662
Other   45,366   72,523       117,889   (1,197)       116,692
    12,277,265   521,424   (234,402)   12,564,287   189,126   (1,549,020)   11,204,393
                             
Liabilities                            
Amortization of goodwill based on future profitability   722,222   2,875       725,097   (2,664)       722,433
Tax depreciation   3,737,169   439,781       4,176,950   (125,488)       4,051,462
PIS/COFINS credit - exclusion of ICMS from the calculation basis   0   331,479       331,479   (141,830)       189,649
Temporary adjustments   158,232   (69,239)       88,993   331,322       420,315
Present value adjustments and amortized cost   79,920   74,771       154,691   7,906   261,354   423,951
Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar   279,321   (46,888)       232,433   (45,796)       186,637
Other   4,827   (46,389)   46,388   4,826   29,706   (29,706)   4,826
    4,981,691   686,390   46,388   5,714,469   53,156   231,648   5,999,273
                             
Net   7,295,574   (164,966)   (280,790)   6,849,818   135,970   (1,780,668)   5,205,120
                             
Presentation in the balance sheet:                            
Non-current assets   8,529,972           8,257,252           6,358,601
(-) Non-current liabilities   1,234,398           1,407,434           1,153,481

(i) Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.  
Schedule of changes in balances of deferred tax assets and liabilities
                             
                             
Assets   As of December 31, 2020   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2021   Impact on the P&L   Other
comprehensive
income
  As of December 31, 2022
                             
Tax losses (IR) and negative base (CSL)   3,278,184   76,532       3,354,716   (957,184)       2,397,532
Goodwill amortized   6,520   (4,061)       2,459   (364)       2,095
Exchange variations   3,817,615   696,849   (234,402)   4,280,062   611,838   (1,549,020)   3,342,880
Temporary adjustments   4,996,337   (214,060)       4,782,277   (134,745)       4,647,532
Business combination   56,211   (29,327)       26,884   (26,884)       0
Tax credits (i) 77,032   (77,032)       0   697,662       697,662
Other   45,366   72,523       117,889   (1,197)       116,692
    12,277,265   521,424   (234,402)   12,564,287   189,126   (1,549,020)   11,204,393
                             
Liabilities                            
Amortization of goodwill based on future profitability   722,222   2,875       725,097   (2,664)       722,433
Tax depreciation   3,737,169   439,781       4,176,950   (125,488)       4,051,462
PIS/COFINS credit - exclusion of ICMS from the calculation basis   0   331,479       331,479   (141,830)       189,649
Temporary adjustments   158,232   (69,239)       88,993   331,322       420,315
Present value adjustments and amortized cost   79,920   74,771       154,691   7,906   261,354   423,951
Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar   279,321   (46,888)       232,433   (45,796)       186,637
Other   4,827   (46,389)   46,388   4,826   29,706   (29,706)   4,826
    4,981,691   686,390   46,388   5,714,469   53,156   231,648   5,999,273
                             
Net   7,295,574   (164,966)   (280,790)   6,849,818   135,970   (1,780,668)   5,205,120
                             
Presentation in the balance sheet:                            
Non-current assets   8,529,972           8,257,252           6,358,601
(-) Non-current liabilities   1,234,398           1,407,434           1,153,481

(i) Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.  
Schedule of deferred taxes offset for the purpose of presentation in the balance sheet
                               
          2022   2021
                               
    Headquarters (Country)   Tax calculation   Offsetting   Balance   Tax calculation   Offsetting   Balance
                             
Assets                            
Braskem S.A.   Brazil   8,356,402    (2,584,962)     5,771,440    8,841,886     (2,496,637)     6,345,249
Braskem Argentina   Argentina     21,339   (16,174)   5,165     3,271    -   3,271
Braskem America   USA   356,598    (356,598)   -    294,328     (294,328)   -
Braskem Alemanha   Germany     23,038   -    23,038   44,417    -    44,417
Braskem Chile   Chile   47         47    92         92
Braskem Holanda   Netherlands   195,042    (39,696)   155,346    -        
Braskem Idesa   Mexico   2,078,206    (1,840,669)     237,537    3,282,125     (1,506,541)     1,775,584
Braskem Idesa Serviços   Mexico    -   -   -    26    -     26
Braskem México Serviços   Mexico     13,628        13,628     2,502       2,502
Braskem México   Mexico     86,368        86,368   16,181        16,181
Cetrel   Brazil     39,387     (5,405)    33,982   40,434   (7,586)    32,848
DAC   Brazil     32,617     (2,262)    30,355   39,025   (1,943)    37,082
Terminal Química   Mexico    1,618       1,618            
Voqen   Brazil    103    (26)     77            
            11,204,393     (5,001,138)   6,358,601     12,564,287   (4,307,035)   8,257,252
                               
Liabilities                            
Braskem S.A.   Brazil   2,584,962    (2,584,962)   -    2,496,637     (2,496,637)   -
Braskem America   USA   1,493,471    (356,598)     1,136,873    1,701,762     (294,328)     1,407,434
Braskem Argentina   Chile     16,174   (16,174)   -           -
Braskem Holanda   Netherlands     39,696   (39,696)   -           -
Braskem Idesa   Mexico   1,840,669    (1,840,669)   -    1,506,541     (1,506,541)   -
B&TC   Netherlands     16,608        16,608           -
Cetrel   Brazil    5,405     (5,405)   -     7,586   (7,586)   -
DAC   Brazil    2,262     (2,262)   -     1,943   (1,943)   -
Voqen   Brazil   26    (26)   -           -
           5,999,273     (4,845,792)   1,153,481    5,714,469   (4,307,035)   1,407,434
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Sundry provisions (Tables)
12 Months Ended
Dec. 31, 2022
Sundry Provisions  
Schedule of sundry provisions
     
     
    2022   2021
Provision for environmental damages   1,120,188     1,035,426
Provision for customers rebates   126,754     101,253
Other     130,005     152,584
Total   1,376,947   1,289,263
         
Current liabilities     530,814     465,051
Non-current liabilities   846,133     824,212
Total   1,376,947   1,289,263
Schedule of changes in sundry provisions
               
    Recovery of            
    environmental             
    damage   Rebate   Other   Total
                 
December 31, 2020   602,490     123,465     148,253   874,208
                 
Additions, monetary adjustments and exchange variation     576,086    144,710    114,395     835,191
Payments and reversals   (143,150)     (166,922)     (110,064)    (420,136)
                -
December 31, 2021     1,035,426     101,253     152,584   1,289,263
                 
Additions, monetary adjustments and exchange variation     299,241    184,142   19,777     503,161
Payments and reversals   (214,479)     (158,641)    (42,357)    (415,477)
                -
December 31, 2022     1,120,188     126,754     130,005   1,376,947
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities (Tables)
12 Months Ended
Dec. 31, 2022
Provisions For Legal Proceedings And Contingent Liabilities  
Claims with probable chance of loss and contingent liabilities
       -
      2022   2021
Labor claims   (a)   212,657     268,758
           
Tax claims   (b)      
IR and CSL      51,756    61,946
PIS and COFINS       311,433     299,202
ICMS       348,544     331,094
Other tax claims      24,160    22,857
      735,893   715,099
           
Corporate claims       103,387    94,826
           
Civil claims and other     119,561    75,147
           
      1,171,498   1,153,830
Schedule of changes in claims with probable chance of loss
                   
                Civil claims    
    Labor claims   Tax claims   claims   and other   Total
                     
December 31, 2020     280,066     692,735     126,057    52,229     1,151,087
                     
Additions, inflation adjustments and exchange variation    172,574   46,849   14,357   76,111    309,891
Payments    (70,968)   (3,659)    (40,109)   (2,770)     (117,506)
Reversals (*)     (112,914)    (20,826)   (5,479)    (50,423)     (189,642)
                     
December 31, 2021     268,758     715,099    94,826    75,147     1,153,830
                     
Additions, monetary adjustments and exchange variation   128,682   60,627     9,048   76,227   274,584
Payments    (57,750)   (8,792)     -   (3,243)    (69,785)
Reversals (*)     (127,033)    (31,041)   (487)    (28,570)     (187,131)
                      -
December 31, 2022   212,657     735,893     103,387     119,561   1,171,498

 

(*) A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.
Schedule of claims with probable chance of loss
       
  Note   2022   2021
           
Tax claims (a)      18,270,680   17,224,429
Civil claims - Alagoas 26     5,489,479     2,614,344
Civil claims - Other (b)    786,441     737,083
Labor claims (c)    605,546     763,555
Environmental claims (d)    639,880     571,057
Social security claims (e)    515,506     398,783
Other lawsuits (f)    380,862     337,807
Total        26,688,394   22,647,058
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Leniency agreement with authorities (Tables)
12 Months Ended
Dec. 31, 2022
Leniency Agreement With Authorities  
Schedule of Company already has paid distributed as shown below:
                               
          AGU                    
Agreements signed with:   . CGU and MPF   DoJ (i)   OAG (i)   MPF   SEC (i)   Total
                               
 Amounts paid         877,763     296,591     407,300     1,282,464     206,460     3,070,578

(i) U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").

XML 80 R67.htm IDEA: XBRL DOCUMENT v3.23.1
Geological event - Alagoas (Tables)
12 Months Ended
Dec. 31, 2022
Geological Event - Alagoas  
Schedule of following table shows the changes in the provision in the period
             
               
      2022   2021   2020
               
Balance at the beginning of the year     7,661,259   9,175,777   3,383,067
               
Additions     1,520,019   1,339,765   6,901,827
Payments and reclassifications (*)      (2,742,791)    (2,928,081)    (1,181,931)
Realization of present value adjusment     188,071     73,798     72,814
Balance at the end of the year      6,626,558   7,661,259   9,175,777
               
Current liability     4,247,609   4,378,071   4,349,931
Non-current liability     2,378,949   3,283,188   4,825,846
Total     6,626,558   7,661,259   9,175,777

(*) Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.

XML 81 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to employees (Tables)
12 Months Ended
Dec. 31, 2022
Benefits Offered To Employees  
Schedule of short-term benefits
       
  2022   2021   2020
           
Health care 243,620   235,681   197,683
Private pension 127,954   136,851     94,302
Transport   86,217     77,201     66,752
Feeding   62,786     51,240     38,400
Life insurance   10,400     10,324    9,875
Training   27,032     15,723     14,892
Other   16,027     12,546     14,117
   574,036    539,566    436,021
Schedule of Long-term incentive plan
                                                 
Flat   Grant Date   End of Grace Period   Settlement Method   Granted quantities   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2021   (+) Granted   (-) Canceled   (-)
Exercised
  Qty. on 12/31/2022   Fair value of the share*
                                                 
2019 Plan   03/19/19   03/19/22   Shares     417,234    (71,905)   -    345,329    -    (18,802)    (326,527)   -    
2019 Plan   03/19/19   03/19/22   Cash    82,128   (8,433)   -   73,695    -   (1,297)   (72,398)   -    
                                                 
2020 Plan   04/01/20   04/01/23   Shares    1,007,883    (72,743)   (2,373)    932,767    -    -   -    932,767   R$ 16.27
2020 Plan   04/01/20   04/01/23   Cash     314,333    (47,943)   -    266,390    -    -   -    266,390   USD 9.67
                                                 
2021 Plan   05/10/21   05/10/24   Shares     557,888   (9,598)   -    548,290    -    -   -    548,290   R$ 51.39
2021 Plan   05/10/21   05/10/24   Cash     144,779    -   -    144,779    -    -   -    144,779   USD 9.67
                                                 
2022 Plan   05/17/22   05/17/25   Shares    -    -   -   -     537,870    -   -    537,870   R$ 44.15
2022 Plan   05/17/22   05/17/25   Cash    -    -   -   -     132,902    -   -    132,902   USD 9.67

(*) Values in monetary units.
Schedule of defined benefit obligations
                 
                   
                2022   2021
Defined benefit                    
Novamont Braskem America               58,221    117,509
Braskem Idesa                 23,053   22,960
Braskem Alemanha and Netherlands             147,562    223,193
                228,836    363,662
Health care                    
Bradesco saúde               321,520    243,706
Total obligations                550,356     607,368
                     
Fair value of plan assets                  
Novamont Braskem America             (54,665)   (117,509)
Braskem Alemanha                (1,948)    (2,162)
                (56,613)   (119,671)
                     
Consolidated net balance (non-current liabilities)              493,743     487,697
Change in obligations
                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
                                     
Balance at beginning of year   243,706     363,662    607,368     217,089    370,860    587,949     224,852    245,565    470,417
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Benefits paid   (12,639)   (34,208)    (46,847)     (10,712)   (7,191)    (17,903)    (5,949)   (7,409)    (13,358)
Actuarial losses (gain)  65,325   (83,485)    (18,160)    16,820    (26,668)   (9,848)     (23,589)   25,803     2,214
Exchange variation        (36,779)    (36,779)         7,074   7,074     -   87,933   87,933
Balance at the end of the year 321,520   228,836     550,356   243,706   363,662   607,368   217,089     370,860     587,949
Change in fair value plan assets
           
    2022   2021   2020
             
Balance at beginning of year   119,671     115,875   81,342
Actual return on plan assets (25,929)   722   15,791
Benefits paid   (32,264)     (5,301)   (4,973)
Exchange variation     (4,866)   8,375   23,715
Balance at the end of the year 56,613   119,671     115,875
Amounts recognized in profit and loss
                                   
            2022           2021           2020
    Health   Benefit       Health   Benefit       Health   Benefit    
    insurance   plans   Total   insurance   plans   Total   insurance   plans   Total
              -                        
Current service cost   4,928    12,732   17,660   4,817   13,681   18,498   4,678   12,486   17,164
Interest cost    20,200   6,914   27,114    15,692     5,906   21,598    17,097     6,482   23,579
Actuarial (losses) gains     (83,485)    (83,485)      (24,203)   (24,203)     -   15,461   15,461
    25,128    (63,839)   (38,711)   20,509     (4,616)   15,893     21,775    34,429    56,204
Schedule of Actuarial assumptions
                                                                   
                                                                  (%)
                          2022                   2021                   2020
          Health   United               Health   United               Health   United            
          insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
                                                                   
Discount rate         5.97   5.10    8.00     1.20     3.60     5.33    2.90    8.00    1.20    1.20    3.99    2.60    7.25     0.70   0.70
Inflation rate         3.00    n/a     4.00     2.00     2.00     3.00    n/a     4.00    2.00    2.00    3.25    n/a     4.00     2.00   2.00
Expected return on plan assets        n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels      n/a     n/a     5.00     3.00     3.25    n/a     n/a     5.00    3.00    3.00    n/a     n/a     5.00     3.00   3.00
Rate of increase in future pension plan      n/a     n/a     n/a      1.75     2.25    n/a     n/a     n/a     1.75    1.75    n/a     n/a     n/a      1.75   1.75
Aging factor         2.50    n/a     n/a      n/a      n/a      2.50    n/a     n/a      n/a      n/a     2.50    n/a     n/a     n/a     n/a 
Medical inflation         3.50    n/a     n/a      n/a      n/a      3.50    n/a      n/a      n/a      n/a     3.50    n/a     n/a     n/a     n/a 
Duration         12.83    n/a     n/a      n/a      n/a    14.16    n/a      n/a      n/a      n/a      14.99    n/a     n/a     n/a     n/a 
Sensitivity analysis
                                                         
                                                               
      Impact on the defined benefit obligation
                      Premise change                   Premise increase                   Premise reduction
      Health   United               Health   United               Health   United            
      insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands   insurance   States   Mexico   Germany   Netherlands
Discount rate     1.0%   1.0%   1.0%   0.25%   0.25%    32,758   5,536     1,646     5,477     297    (39,621)   (6,605)   (1,935)   (5,836)     (315)
Real medical inflation   n/a   n/a   n/a   n/a   n/a    n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a     n/a 
Rate of increase in future salary levels n/a   n/a   n/a   0.5%   0.5%    n/a     n/a     n/a      8,604     468    n/a     n/a     n/a    (8,114)     (442)
Rate of increase in future pension plan 1.0%   n/a   n/a   0.25%   0.25%    (7,740)    n/a     n/a      4,241     231     8,098    n/a     n/a    (4,115)     (224)
Life expectancy     1.0%   n/a   n/a   1 ano   1 ano    48,527    n/a     n/a      3,637     198    (39,355)    n/a     n/a    (3,797)     (207)
Mortality rate     n/a   10.0%   n/a   n/a   n/a    n/a    1,681    n/a     n/a     n/a     n/a    (1,839)    n/a     n/a     n/a 

 

 

                                                               
                                          Health insurance - Impact on cost of services and interests costs
                                          Premise change   Premise increase   Premise reduction
                                          Cost of   Iterests   Cost of   Iterests   Cost of   Iterests
                                          services   costs   services   costs   services   costs
Discount rate                                         1.0%   1.0%     730     106   (933)     11
Life expectancy                                         1.0%   1.0%     542     4,441   (464)     (3,602)
Rate of increase in future pension plan                                     1.0%   1.0%     123     708   (129)     (741)
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
12 Months Ended
Dec. 31, 2022
Shareholders' equity  
Schedule of shares distributed
                                 
                                   
      Amount of shares
      Common       Preferred shares       Preferred shares            
      shares   %   class A   %   class B   %   Total   %
                                   
Novonor     226,334,623   50.11     79,182,498   22.95     -   -   305,517,121   38.32
Petrobras     212,426,952   47.03     75,761,739   21.96     -   -   288,188,691   36.15
ADR (i)     -   -     42,869,320   12.42     -   -     42,869,320     5.38
Other       12,907,077     2.86   146,581,427   42.48    478,790    100.00   159,967,294   20.07
Total     451,668,652     100.00   344,394,984     99.81     478,790     100.00   796,542,426     99.92
Treasury shares       -   -    665,408     0.19     -   -    665,408     0.08
Total     451,668,652     100.00   345,060,392     100.00     478,790     100.00   797,207,834     100.00
                                   
Authorised     535,661,731       616,682,421         593,818       1,152,937,970    

(i) American Depository Receipt ("ADR") on the New York Stock Exchange – NYSE (USA).

Schedule of Changes in shares during the year
                         
                         
        Amount of shares
    Note   2020   Changes   2021   Changes   2022
Outstanding shares                      
  Commom shares     451,668,652     -   451,668,652     -   451,668,652
  Preferred Class A  28.4   343,824,794    333,432   344,158,226    236,758   344,394,984
  Preferred Class B      500,230    (21,440)    478,790     -    478,790
        795,993,676     311,992   796,305,668     236,758   796,542,426
                         
 Treasury shares                      
  Preferred Class A 28.4    1,224,878     (322,712)    902,166     (236,758)    665,408
                         
Total       797,218,554   (10,720)   797,207,834     -   797,207,834
Schedule of Accumulated losses
     
      2022
       
Loss for the year of the Company's shareholders       (335,677)
Amounts posted directly to the Retained Earnings account:      
SUDENE tax incentive supplement       (108,975)
Comprehensive income     26,883
Other       475
      (417,294)
Loss absorption using profit reserve:      
Profit reserves - Retention of profits      417,294
        417,294
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (loss) per share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Loss Per Share  
Schedule of reconciliation of profit or loss
                         
        2022       2021       2020
    Basic   Diluted   Basic   Diluted   Basic   Diluted
                         
(Loss) profit  for the year attributed to Company's shareholders     (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Distribution of priority dividends attributable to:                        
Preferred shares class "A"    -    -    208,574    208,574    -    -
Preferred shares class "B"    -    -     290     290    -    -
     -    -    208,864    208,864    -    -
                         
Distribution of 6% ​​of unit price of common shares    -    -    273,729    273,729    -    -
                         
Distribution of excess profits, by class:                        
Common shares    -    -    7,664,208    7,664,208    -    -
Preferred shares class "A"    -    -    5,838,145    5,838,145    -    -
     -    -     13,502,353     13,502,353    -    -
                         
Reconciliation of income available for distribution,
by class (numerator):
                       
Common shares     (190,357)     (190,357)    7,937,937    7,937,937     (3,797,070)     (3,797,071)
Preferred shares class "A"     (145,118)     (145,118)    6,046,719    6,046,719     (2,890,445)     (2,890,444)
Preferred shares class "B"   (202)   (202)     290     290   (4,205)   (4,205)
      (335,677)     (335,677)     13,984,946     13,984,946     (6,691,720)     (6,691,720)
                         
Weighted average number of shares,
by class (denominator):
                       
Common shares   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652   451,668,652
Preferred shares class "A"   344,329,470   344,329,470   344,054,700   345,049,701   343,823,811   345,049,672
Preferred shares class "B"    478,790    478,790    500,171    500,171    500,230    500,230
    796,476,912   796,476,912   796,223,523   797,218,524   795,992,693   797,218,554
                         
Profit (loss) per share (in R$)                        
Common shares     (0.42)     (0.42)     17.57     17.57     (8.41)     (8.41)
Preferred shares class "A"     (0.42)     (0.42)     17.57     17.52     (8.41)     (8.38)
Preferred shares class "B"     (0.42)     (0.42)    0.58    0.58     (8.41)     (8.41)

Weighing of shares

                 
                2022
                Basic
                Preferred shares
            Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of the year            344,158,226    344,158,226
                 
Incentive long term plan payments with treasury shares             236,758     171,244
                 
Amount at the end of the year            344,394,984    344,329,470

 

                 
                2021
                Basic
                Preferred shares
    Class "A"   Class "B"
    Outstanding   Weighted   Outstanding   Weighted
    shares   average   shares   average
                 
Amount at beginning of the year    343,824,794    343,824,794   500,230   500,230
                 
Incentive long term plan payments with treasury shares     322,712     229,877   -   -
Conversion shares class "B" into shares class "A"    10,720     29     (21,440)   (59)
                 
Amount at the end of the year    344,158,226    344,054,700   478,790   500,171

 

                 
                2020
                Basic
                Preferred shares
                Class "A"
            Outstanding   Weighted
            shares   average
                 
Amount at beginning of year            343,823,073    343,823,073
                 
Incentive long term plan payments with treasury shares           1,721   738
                 
Amount at the end of the year            343,824,794    343,823,811
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue (Tables)
12 Months Ended
Dec. 31, 2022
Net Revenue  
Schedule of sales and service revenue
                 
        2022   2021   2020
          96,519,284   105,625,201     58,543,494
Schedule of revenue by country
           
      2022   2021   2020
               
Brazil      56,217,472    55,830,330    32,369,199
United States      18,085,607    24,232,413    10,848,609
Mexico     4,468,827   5,505,893   2,765,815
Argentina     2,092,700   2,068,023   1,267,967
Germany     1,695,009   1,912,373   1,106,877
Switzerland     1,492,922   1,230,541   633,512
Italy     1,095,133   1,304,113   811,787
Chile     870,858   1,230,493   544,329
Netherlands     816,678   642,844   432,897
Luxembourg     756,297   987,656   592,777
Singapore     755,971   1,175,133   1,183,838
Peru     740,011   666,867   471,847
Japan     723,757   1,162,226   618,940
Spain     546,646   517,532   282,362
United Kingdom     490,801   585,766   204,953
Uruguay     469,555   495,120   405,946
Poland     455,458   649,825   285,714
Bolivia     427,237   296,138   190,447
Sweden     401,251   481,289   310,984
Canada     393,504   558,730   297,756
France     359,946   326,570   247,062
Paraguay     316,460   318,842   254,255
Colombia     263,695   274,335   174,381
China     172,656   354,071   496,920
South Korea     159,944   669,055   360,704
Other     2,250,890   2,149,023   1,383,616
       96,519,284     105,625,201    58,543,494
Schedule of revenue by product
           
      2022   2021   2020
               
PE/PP     61,145,093    73,306,089    41,137,288
Benzene, toluene and xylene     7,279,584   5,819,696   3,051,752
Ethylene, Propylene     5,819,345   6,872,999   3,600,276
ETBE/Gasoline     5,722,767   4,321,371   2,170,289
PVC/Caustic Soda/EDC     5,710,838   5,806,011   3,134,617
Butadiene     3,028,048   3,019,836   1,372,428
Solvents     1,522,025   1,129,484   654,793
Cumene     1,425,097   1,342,811   636,635
Naphtha, condensate and crude oil     422,359   1,648,581   915,807
Other     4,444,130   2,358,324   1,869,609
       96,519,284     105,625,201     58,543,494
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.23.1
Expenses by nature and function (Tables)
12 Months Ended
Dec. 31, 2022
Expenses By Nature And Function  
Schedule of Expenses by nature and function
             
          2022   2021   2020
                   
Classification by nature:              
  Raw materials other inputs     (73,181,706)   (63,570,499)   (37,913,921)
  Personnel expenses       (3,223,477)     (3,478,323)     (3,074,305)
  Outsourced services       (3,411,818)     (3,193,970)     (2,219,413)
  Depreciation and amortization       (4,733,165)     (4,178,433)     (4,048,081)
  Freights       (4,034,901)     (2,966,229)     (2,321,740)
  Idle industrial plants       (414,441)     (338,987)     (518,528)
  Provision - geological event in Alagoas (Note 26)       (1,520,019)     (1,339,765)     (6,901,828)
  PIS and Cofins credits - exclusion of ICMS from the calculation basis       1,031,099   310,557
  Other income     507,333   1,843,153   440,192
  Other general and administrative expenses       (2,269,865)     (3,394,344)     (2,348,921)
  Total     (92,282,059)   (79,586,298)   (58,595,988)
                   
Classification by function:              
  Cost of products sold     (85,160,548)   (73,568,231)   (47,331,414)
  Selling and distribution       (2,108,417)     (2,055,640)     (1,852,055)
  (Loss) reversals for impairment of trade accounts receivable      (38,426)   (8,914)    (55,252)
  General and administrative       (2,763,983)     (2,522,127)     (1,918,747)
  Research and development       (374,493)     (296,583)     (250,648)
  Other income (i)     507,333   1,534,487   750,749
  Other expenses (ii)       (2,343,525)     (2,669,290)     (7,938,621)
  Total     (92,282,059)   (79,586,298)   (58,595,988)

(i) In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.
(ii) Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).

XML 86 R73.htm IDEA: XBRL DOCUMENT v3.23.1
Financial results (Tables)
12 Months Ended
Dec. 31, 2022
Financial Results  
Schedule of results by segment
                   
          2022   2021   2020
Financial income                
  Interest income         1,049,745     439,891     310,202
  Inflation indexation income on tax assets (i)    16,489     1,041,917     170,857
  Gain on derivatives       635,779     246,459   -
  Other         308,121    99,171     119,125
          2,010,134   1,827,438   600,184
                   
Financial expenses                
  Interest expenses       (3,125,206)   (2,922,958)   (2,928,803)
  Inflation indexation expenses on tax liabilities     (266,281)   (93,722)   (138,410)
  Discounts granted       (129,249)   (75,677)   (81,920)
  Loans transaction costs - amortization     (260,511)   (691,243)   (172,269)
  Adjustment to present value - appropriation     (580,994)   (179,461)   (225,889)
  Interest expense on leases     (203,257)   (173,536)   (164,166)
  Losses on derivatives     (596,501)   (1,003,502)   (809,150)
  Other       (500,694)   (767,056)   (392,758)
          (5,662,693)   (5,907,155)   (4,913,365)
                   
Exchange rate variations, net              
  On financial assets     (522,251)     230,370     336,527
  On financial liabilities       (49,919)   (4,233,177)   (5,635,238)
           (572,170)    (4,002,807)    (5,298,711)
                   
Total        (4,224,729)    (8,082,524)    (9,611,892)

 

(i) In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).
Schedule of effects from exchange variation on the Company?transactions are mainly due to the variations
                               
  End of year rate   Average rate
                              Variation
  2022   2021   Variation   2022   2021   Dec/20   2022-2021   2021-2020
U.S. dollar - Brazilian real 5.2177   5.5805   -6.50%   5.1655   5.3956   5.1578   -4.26%   4.61%
Euro - Brazilian real 5.5694   6.3210   -11.89%   5.4420   6.3784   5.8989   -14.68%   8.13%
Mexican peso - Brazilian real 0.2667   0.2730   -2.31%   0.2569   0.2660   0.2402   -3.44%   10.75%
U.S. dollar - Mexican peso 19.5720   20.4519   -4.30%   20.1249   20.2900   21.5098   -0.81%   -5.67%
U.S. dollar - Euro 0.9416   0.8853   6.36%   0.9510   0.8458   0.8775   12.44%   -3.61%
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Segment information (Tables)
12 Months Ended
Dec. 31, 2022
Segment Information  
Schedule of Results by segment
      2022
                               
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,079,724     (63,195,629)   5,884,095     (1,853,039)    -     (1,888,999)     2,142,057
  USA and Europe   23,421,096     (19,986,176)   3,434,920     (838,474)    -    56,944     2,653,390
  Mexico   5,834,017    (5,069,531)   764,486     (451,605)    -     (33,370)     279,511
Total    98,334,837     (88,251,336)   10,083,501     (3,143,118)    -     (1,865,425)     5,074,958
                               
  Other segments   402,991    (262,402)   140,589   82,498    34,848   5,644     263,579
  Corporate unit   -   -   -     (2,196,506)    -    19,375   (2,177,131)
                               
Braskem consolidated before 
eliminations and reclassifications
  98,737,828     (88,513,738)   10,224,090     (5,257,126)    34,848     (1,840,406)     3,161,406
                               
  Eliminations and reclassifications    (2,218,544)   3,353,190   1,134,646    (28,193)    -   4,214     1,110,667
                               
Total   96,519,284     (85,160,548)   11,358,736     (5,285,319)    34,848     (1,836,192)     4,272,073
                               
                               
      2021
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   69,494,923     (49,309,552)   20,185,371     (1,608,185)    -     (2,210,601)   16,366,585
  USA and Europe   32,403,632     (23,343,205)   9,060,427     (900,885)    -     (25,580)     8,133,962
  Mexico   6,506,297    (3,413,652)   3,092,645     (471,821)    -     (15,302)     2,605,522
Total     108,404,852     (76,066,409)   32,338,443     (2,980,891)    -     (2,251,483)   27,106,069
                               
  Other segments   363,684    (233,084)   130,600   76,830   4,644     (28,674)     183,400
  Corporate unit   -   -   -     (1,963,137)    -    1,161,517  (i)   (801,620)
                               
Braskem consolidated before 
eliminations and reclassifications
   108,768,536     (76,299,493)   32,469,043     (4,867,198)   4,644     (1,118,640)   26,487,849
                               
  Eliminations and reclassifications    (3,143,335)   2,731,262    (412,073)    (16,066)    -     (16,163)    (444,302)
                               
Total    105,625,201     (73,568,231)   32,056,970     (4,883,264)   4,644     (1,134,803)   26,043,547
                               
      2020
                  Operating expenses    
          Cost of       Selling, general   Results from   Other operating   Profit (loss) 
      Net   products   Gross   and distribuition   equity   income   before net financial 
      revenue   sold   profit   expenses   investments   (expenses), net   expenses and taxes
Reporting segments                            
  Brazil   40,794,387     (32,498,003)   8,296,384     (1,471,722)    -     (7,082,604)    (257,942)
  USA and Europe   14,638,660     (12,337,486)   2,301,174     (721,191)    -     (82,695)     1,497,288
  Mexico   4,000,805    (3,075,001)   925,804     (436,859)    -   (364,259)     124,686
Total    59,433,852     (47,910,490)   11,523,362     (2,629,772)    -     (7,529,558)     1,364,032
                               
  Other segments   302,374    (188,350)   114,024   63,874     (19,398)     (320)     158,180
  Corporate unit   -   -   -     (1,493,479)    -    359,071   (1,134,408)
                               
Braskem consolidated before 
eliminations and reclassifications
  59,736,226     (48,098,840)   11,637,386     (4,059,377)     (19,398)     (7,170,807)     387,804
                               
  Eliminations and reclassifications    (1,192,732)   767,426    (425,306)    (17,325)    -     (17,065)    (459,696)
                               
Total   58,543,494     (47,331,414)   11,212,080     (4,076,702)     (19,398)     (7,187,872)   (71,892)
Schedule of property, plant and equipment and intangible assets by segment
         
      2022   2021
Reporting segments        
  Brazil   19,428,926   18,072,312
  USA and Europe     7,075,743     7,688,713
  Mexico   13,736,298   14,019,167
Total     40,240,967    39,780,192
Unallocated amounts     544,472     322,237
Total     40,785,439    40,102,429
XML 88 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Operations (Details Narrative)
R$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2023
BRL (R$)
Jun. 30, 2022
Dec. 31, 2022
Number
IfrsStatementLineItems [Line Items]        
Number of barrels       30,000
Made payment $ 56 R$ 292    
Odebrecht s a member        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest       50.11%
Proportion of voting rights       38.32%
Braskem Idesa [Member]        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest     50.00%  
Braskem Idesa One [Member]        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest 50.00% 50.00%    
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation of the financial statements (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Subsidiary1 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name BM Insurance Company Limited ("BM Insurance")     
Headquarters Bermuda    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary2 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Argentina S.A. (“Braskem Argentina”)    
Headquarters Argentina    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary3 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [1] Braskem Energy Ltda.    
Headquarters [1] Brazil    
Total voting interest [1]   100.00%  
Subsidiary4 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Finance Limited (“Braskem Finance”)    
Headquarters Cayman Islands    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary5 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Green S.A.    
Headquarters Brazil    
Total voting interest 100.00% 100.00%  
Subsidiary6 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Incorporated Limited ("Braskem Inc.")    
Headquarters Cayman Islands    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary7 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Mexico, S. de RL de C.V. ("Braskem México")     
Headquarters Mexico    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary8 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Netherlands B.V. ("Braskem Holanda")    
Headquarters Netherlands    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary9 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Petroquímica Chile Ltda. (“Braskem Chile”)     
Headquarters Chile    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary 10 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [2] Braskem Ventures Ltda. ("Braskem Ventures")     
Subsidiary101 member      
IfrsStatementLineItems [Line Items]      
Headquarters [2] Brazil    
Total voting interest [2] 100.00%    
Subsidiary11 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [3] Lantana Trading Co. Inc. (“Lantana”)     
Headquarters [3] Bahamas    
Total voting interest [3]   100.00% 100.00%
Subsidiary12 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [1] Voqen Energia Ltda. ("Voqen")     
Headquarters [1] Brazil    
Total voting interest [1] 100.00%    
Subsidiary13 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem America Finance Company ("Braskem America Finance")     
Headquarters USA    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary14 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem America, Inc. (“Braskem America”)     
Headquarters USA    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary15 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Europe GmbH ("Braskem Alemanha")    
Headquarters Germany    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary16 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Idesa S.A.P.I. ("Braskem Idesa")     
Headquarters Mexico    
Total voting interest 75.00% 75.00% 75.00%
Subsidiary17 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")     
Headquarters Mexico    
Total voting interest 75.00% 75.00% 75.00%
Subsidiary18 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem India Private Limited ("Braskem India")     
Headquarters India    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary19 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")     
Headquarters Mexico    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary20 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")     
Headquarters Mexico    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary21 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)     
Headquarters Netherlands    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary22 member      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Netherlands Green B.V. (“Braskem Holanda Green”)     
Headquarters Netherlands    
Total voting interest 100.00% 100.00%  
Subsidiary 23 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)     
Headquarters Netherlands    
Total voting interest 100.00% 100.00% 100.00%
Subsidiary 24 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [2] Builder Brasil Ltda. ("Builder Brasil")     
Headquarters [2] Brazil    
Total voting interest [2] 100.00%    
Subsidiary 25 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [2] Builder USA LLC. ("Builder USA")     
Headquarters [2] USA    
Total voting interest [2] 100.00%    
Subsidiary 26 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Cetrel S.A. ("Cetrel")     
Headquarters Brazil    
Total voting interest 63.70% 63.70% 63.70%
Subsidiary 27 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Distribuidora de Água Camaçari S.A. ("DAC")     
Headquarters Brazil    
Total voting interest 63.70% 63.70% 63.70%
Subsidiary 28 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [4] B&TC B.V. ("B&TC")     
Headquarters [4] Netherlands    
Total voting interest [4] 60.00%    
Subsidiary 29 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name [4] ER Plastics B.V. ("ER Plastics")     
Headquarters [4] Netherlands    
Total voting interest [4] 60.00%    
Subsidiary 30 [Member]      
IfrsStatementLineItems [Line Items]      
Subsidiary/Special Purpose Entity name Terminal Química Puerto México ("Terminal Química")     
Headquarters Mexico    
Total voting interest 75.00% 75.00%  
Specific purpose entity1 member      
IfrsStatementLineItems [Line Items]      
Headquarters Brazil    
Total voting interest 100.00% 100.00% 100.00%
Specific purpose entity2 member      
IfrsStatementLineItems [Line Items]      
Headquarters Brazil    
Total voting interest 100.00% 100.00% 100.00%
[1] Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.
[2] Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.
[3] Lantana was a non-operational entity that had the operations closed in November 2022.
[4] B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).
XML 90 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation of the financial statements (Details 1)
12 Months Ended
Dec. 31, 2022
Braskem alemanha member  
IfrsStatementLineItems [Line Items]  
Functional currency Euro
B m insurance braskem america braskem america finance braskem holanda braskem holanda finance braskem holanda inc and braskem mexico sofom member  
IfrsStatementLineItems [Line Items]  
Functional currency U.S.dollar ("US$")
Braskem idesa braskem idesa servicos braskem mexico and braskem mexico servicos member  
IfrsStatementLineItems [Line Items]  
Functional currency Mexican peso
Braskem argentina member  
IfrsStatementLineItems [Line Items]  
Functional currency Argentinean peso
Braskem chile member  
IfrsStatementLineItems [Line Items]  
Functional currency Chilenean peso
Braskem india member  
IfrsStatementLineItems [Line Items]  
Functional currency Rupee
XML 91 R78.htm IDEA: XBRL DOCUMENT v3.23.1
Risk management (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Derivatives R$ 277,086 R$ 619,046  
Lease 4,240,530 R$ 3,156,414 R$ 3,207,886
Liquidity risk [member]      
IfrsStatementLineItems [Line Items]      
Trade payables 12,413,301    
Borrowings 66,056,686    
Debentures 6,406,217    
Braskem Idesa borrowings 18,271,523    
Derivatives 286,190    
Loan to noncontrolling shareholders 4,391,832    
Leniency agreement (Note 25) 1,092,958    
Lease 4,983,177    
Total 113,901,884    
Liquidity risk [member] | Not later than one year [member]      
IfrsStatementLineItems [Line Items]      
Trade payables 3,069    
Borrowings 3,139,258    
Debentures 102,090    
Derivatives 5,691    
Leniency agreement (Note 25) 658,154    
Lease 855,803    
Total 4,764,065    
Liquidity risk [member] | Later than one year and not later than two years [member]      
IfrsStatementLineItems [Line Items]      
Borrowings 3,931,315    
Lease 581,592    
Total 4,512,907    
Liquidity risk [member] | Later than two years and not later than five years [member] | Early paymentdebt member      
IfrsStatementLineItems [Line Items]      
Borrowings 57,625,391    
Debentures 6,167,985    
Braskem Idesa borrowings 17,274,826    
Derivatives 88,273    
Loan to noncontrolling shareholders 4,391,832    
Lease 2,436,734    
Total 87,985,041    
Carrying Amount One [Member] | Liquidity risk [member]      
IfrsStatementLineItems [Line Items]      
Trade payables 12,410,232    
Borrowings 1,360,722    
Debentures 136,142    
Braskem Idesa borrowings 996,697    
Derivatives 192,226    
Leniency agreement (Note 25) 434,804    
Lease 1,109,048    
Total R$ 16,639,871    
XML 92 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and cash equivalents (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Total R$ 12,466,474 R$ 8,680,686 R$ 13,862,852 R$ 6,803,880
Domestic market member        
IfrsStatementLineItems [Line Items]        
Cash 517,236 676,083    
Cash equivalents 3,684,999 1,141,221    
Foreign market member        
IfrsStatementLineItems [Line Items]        
Cash [1] 5,556,972 4,374,739    
Cash equivalents [1] 2,707,267 2,488,643    
Foreign market member | Braskem Idesa [Member]        
IfrsStatementLineItems [Line Items]        
Cash 931,991 1,267,582    
Cash equivalents R$ 1,252,341 R$ 505,749    
[1] On December 31, 2022, it includes R$931,991 of cash and R$1,252,341 of cash equivalents (2021: R$1,267,582 of cash and R$505,749 of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.
XML 93 R80.htm IDEA: XBRL DOCUMENT v3.23.1
Financial investments (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Total R$ 2,312,631 R$ 3,509,555
Current assets 2,295,497 3,492,710
Non current assets 17,134 16,845
Financial assets at amortised cost, class [member] | Time deposit investments member    
IfrsStatementLineItems [Line Items]    
Total   106,271
Financial assets at fair value through profit or loss, category [member] | L f t and l f member    
IfrsStatementLineItems [Line Items]    
Total [1] 1,789,375 2,337,171
Financial assets at fair value through profit or loss, category [member] | Restricted funds investments member    
IfrsStatementLineItems [Line Items]    
Total [2] 305,485 852,362
Financial assets at fair value through profit or loss, category [member] | Restricted funds investments member | Interbank deposit rate member    
IfrsStatementLineItems [Line Items]    
Restricted fund 175,153 835,517
Bank deposits 130,332 16,845
Financial assets at fair value through profit or loss, category [member] | Other financial investments member    
IfrsStatementLineItems [Line Items]    
Total R$ 217,771 R$ 213,751
[1] These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.
[2] Includes the following amounts: R$175,153 (2021: R$835,517) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$130,332 (2021: R$16,845) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.
XML 94 R81.htm IDEA: XBRL DOCUMENT v3.23.1
Financial investments (Details Narrative)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Deposits yields rate 102.59% 102.50%
Financial assets at fair value through profit or loss, category [member]    
IfrsStatementLineItems [Line Items]    
Deposits yields rate 1.18% 0.45%
XML 95 R82.htm IDEA: XBRL DOCUMENT v3.23.1
Trade accounts receivable (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Expected credit losses [1] R$ (112,091) R$ (131,634)
Total 3,231,934 7,166,960
Current assets 3,231,934 7,153,565
Non-current assets 13,395
Trade accounts receivable, Total 3,231,934 7,166,960
Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 1,547,466 2,863,941
Foreign market member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 1,796,559 4,434,653
Third parties member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 1,533,675 2,851,701
Third parties member | Foreign market member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 1,796,559 4,434,653
Related party member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross R$ 13,791 R$ 12,240
[1] According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; (ii) receivables past due 90 to 180 days; (iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:
XML 96 R83.htm IDEA: XBRL DOCUMENT v3.23.1
Trade accounts receivable (Details 1) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Total R$ 3,231,934 R$ 7,166,960
Total (3,231,934) (7,166,960)
Trade Accounts Receivables [Member]    
IfrsStatementLineItems [Line Items]    
Total 3,344,025 7,298,594
Total (3,344,025) (7,298,594)
Expected Credit Losses [Member]    
IfrsStatementLineItems [Line Items]    
Total 112,091 131,634
Total (112,091) (131,634)
Not past due member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 2,652,844 6,692,832
Not past due member | Trade Accounts Receivables [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 2,687,775 6,705,123
Not past due member | Expected Credit Losses [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross (34,931) (12,291)
Not later than ninety days member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 529,506 429,635
Not later than ninety days member | Trade Accounts Receivables [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 536,289 431,899
Not later than ninety days member | Expected Credit Losses [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross (6,783) (2,264)
Later than ninety days and not later than one hundred and eighty days member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 22,005 43,744
Later than ninety days and not later than one hundred and eighty days member | Trade Accounts Receivables [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 25,015 45,134
Later than ninety days and not later than one hundred and eighty days member | Expected Credit Losses [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross (3,010) (1,390)
Later than one hundred and eighty days member    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 27,579 749
Later than one hundred and eighty days member | Trade Accounts Receivables [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross 94,946 116,438
Later than one hundred and eighty days member | Expected Credit Losses [Member]    
IfrsStatementLineItems [Line Items]    
Trade accounts receivable, gross R$ (67,367) R$ (115,689)
XML 97 R84.htm IDEA: XBRL DOCUMENT v3.23.1
Trade accounts receivable (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Trade Accounts Receivable      
Balance of provision at the beginning of the year R$ (131,634) R$ (173,007) R$ (229,323)
Provision in the year (87,898) (144,888) (65,571)
Reversal in the year 71,400 149,681 28,563
Write-offs 36,041 36,580 93,324
Balance of provision at the end of the year R$ (112,091) R$ (131,634) R$ (173,007)
XML 98 R85.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventories Abstract    
Finished goods R$ 8,558,025 R$ 9,271,708
Semi-finished goods 663,182 568,914
Raw materials, production inputs and packaging 2,747,525 3,356,660
Maintenance materials 869,953 766,994
Advances to suppliers 124,285 62,573
Imports in transit 1,067,094 2,308,252
Total  R$ 14,030,064 R$ 16,335,101
XML 99 R86.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Inventories Abstract      
Balance at the beginner of the year R$ 82,218 R$ 122,572 R$ 82,195
Additions [1] 533,471 97,911 120,483
Utilization/reversals (103,583) (138,265) (80,106)
Balance at the end of the year R$ 512,106 R$ 82,218 R$ 122,572
[1] The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.
XML 100 R87.htm IDEA: XBRL DOCUMENT v3.23.1
Related parties (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Trade accounts receivable R$ 3,231,934 R$ 7,153,565  
Trade accounts receivable 13,791 12,240  
Inventories 14,030,064 16,335,101  
Inventories 61,428 9,927  
Other receivabels 11,635 287  
Other receivabels non current 5,657 38,987  
Assets 88,048,858 92,564,368  
Assets1 96,807 61,441  
Trade payables 12,246,782 12,053,266  
Trade and other current payables1 277,967 248,435  
Other current payables 1,581,701 1,667,600  
Other current payables1 233,451 297,329  
Trade payables 3,069    
Loan to non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538  
Total liabilities 3,012,580 4,192,302  
Sales of products 96,519,284 105,625,201 R$ 58,543,494
Purchases of raw materials, finished goods services and utilities 85,160,548 73,568,231 47,331,414
Financial income (expenses), net (4,224,729) (8,082,524) (9,611,892)
Other expenses (1,836,192) (1,134,803) (7,187,872)
Petrobras and subsidiaries [member]      
IfrsStatementLineItems [Line Items]      
Trade accounts receivable 11,924 4,894  
Inventories 61,428 9,927  
Other receivabels 287 287  
Other receivabels non current 5,657 38,987  
Assets 79,296 54,095  
Trade payables 137,764 134,063  
Other current payables 233,133 296,984  
Total liabilities 370,897 431,047  
Sales of products 182,218 171,665 182,521
Purchases of raw materials, finished goods services and utilities (22,900,140) (19,833,063) (14,566,840)
Financial income (expenses), net (33,656) (11,758) (3,810)
Other expenses 51,248 (217,497)  
Other related parties [member]      
IfrsStatementLineItems [Line Items]      
Trade accounts receivable 1,867 7,346  
Dividends and interest on capital 4,296    
Assets 6,163 7,346  
Trade payables 14,189 11,113  
Other current payables 314 345  
Loan to non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538  
Total liabilities 2,512,596 3,657,996  
Sales of products 437,514 540,855 326,825
Purchases of raw materials, finished goods services and utilities (24,813) (6,953) (20,350)
Financial income (expenses), net 41,082 (245,819) (818)
General and administrative expenses (45,329) (67,273) (46,738)
Odebrecht and subsidiaries and associates [member]      
IfrsStatementLineItems [Line Items]      
Other receivabels 11,348    
Assets 11,348    
Trade payables 126,014 103,259  
Other current payables 4    
Trade payables 3,069    
Total liabilities 129,087 103,259  
Financial income (expenses), net (854) (141) (452)
Related parties [member]      
IfrsStatementLineItems [Line Items]      
Sales of products 619,732 712,520 509,346
Purchases of raw materials, finished goods services and utilities (334,363) (306,426) (133,127)
Purchases of raw materials, finished goods services and utilities (23,259,316) (20,146,442) (14,720,317)
Finance income cost1 6,572 (257,718) (5,080)
General and administrative expenses (45,329) (67,273) R$ (46,738)
Other operating income expense1 R$ 51,248 R$ (217,497)  
XML 101 R88.htm IDEA: XBRL DOCUMENT v3.23.1
Related parties (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Related Parties      
Short-term benefits R$ 83,466 R$ 119,734 R$ 74,943
Post-employment benefit 1,636 2,121 961
Long term incentive plan 16,938 14,394 7,456
Total R$ 102,040 R$ 136,249 R$ 83,360
XML 102 R89.htm IDEA: XBRL DOCUMENT v3.23.1
Related parties (Details Narrative) - BRL (R$)
R$ in Thousands
1 Months Ended 12 Months Ended
Feb. 28, 2022
Oct. 31, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2022
Novonor And Its Direct And Indirect Subsidiaries [Member]          
IfrsStatementLineItems [Line Items]          
Estimated amount R$ 142,000        
Petrobras Transporte S A [Member]          
IfrsStatementLineItems [Line Items]          
Estimated amount       R$ 203,000  
Petrocoque S A Industria Comercio [Member]          
IfrsStatementLineItems [Line Items]          
Estimated amount     R$ 433,000    
Refinaria Alberto Pasqualini [Member]          
IfrsStatementLineItems [Line Items]          
Estimated amount   R$ 630,000      
New or renewedagreements with related companies member          
IfrsStatementLineItems [Line Items]          
Related parties amount         R$ 60,000
New or renewedagreements with related companies member | Top of range [member]          
IfrsStatementLineItems [Line Items]          
Related parties amount         R$ 20,000
Agreement With Petrocoque [Member]          
IfrsStatementLineItems [Line Items]          
Related parties estimated value       3,300,000  
Refinaria Duque De Caxias [Member]          
IfrsStatementLineItems [Line Items]          
Related parties estimated value       2,400,000  
Refinaria Henrique Lage [Member]          
IfrsStatementLineItems [Line Items]          
Related parties estimated value       4,700,000  
Refinaria Planaltode Paulinia [Member]          
IfrsStatementLineItems [Line Items]          
Related parties estimated value       8,100,000  
Refinaria Presidente Getulio Vargas [Member]          
IfrsStatementLineItems [Line Items]          
Related parties estimated value       R$ 6,800,000  
XML 103 R90.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes recoverable (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax R$ 2,774,024 R$ 2,680,716
Current receivables from taxes other than income tax 1,156,355 1,428,658
Non-current receivables from taxes other than income tax 1,617,669 1,252,058
Value added tax on sales and services i c m s normal pperations member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 410,138 291,424
I c m s credits from property plant and equipment member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 302,940 224,308
Social integration program p i s and social contribution on revenue member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 560,002 250,491
P i s and c o f i n s credits from property plant and equipment member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 546,427 447,476
R e i n t e g r a program member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 20,504 21,764
Federal supervenience member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 153,960 948,448
Other taxes recoverable member | Parent companys member    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 68,514 89,205
Other taxes recoverable member | Subsidiaries [Member]    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax 131,867 59,579
Value added tax i v a member | Subsidiaries [Member]    
IfrsStatementLineItems [Line Items]    
Receivables from taxes other than income tax R$ 579,672 R$ 348,021
XML 104 R91.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes recoverable (Details Narrative) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Taxes recoverable R$ 2,774,024 R$ 2,680,716  
P i s and c o f i n s taxes member      
IfrsStatementLineItems [Line Items]      
Taxes recoverable     R$ 5,093,151
XML 105 R92.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Net profit (loss) for the year R$ (820,391) R$ 13,961,620 R$ (7,015,306)  
Equity 6,108,217 6,203,828 (3,866,518) R$ 3,944,706
Investment1 member        
IfrsStatementLineItems [Line Items]        
Net profit (loss) for the year [1] 76,450 312 (63,525)  
Equity [1] R$ 110,040 R$ 50,064    
Interest in total and voting capital (%) 33.20% 33.20%    
Investment 2 [Member]        
IfrsStatementLineItems [Line Items]        
Net profit (loss) for the year [2] R$ (3,977)      
Equity [2] 80,757      
Associate member        
IfrsStatementLineItems [Line Items]        
Net profit (loss) for the year [3] 53,617 R$ 45,490 R$ 6,019  
Equity [3] R$ 252,053 R$ 205,568    
Interest in total and voting capital (%) 20.00% 20.00%    
[1] RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is 33.20% (2021: 33.20%).
[2] Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).
[3] Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is 20% (2021: 20%).
XML 106 R93.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Balance at 2021 R$ 58,923 R$ 43,153
Dividends and interest on equity (9,309) (295)
Equity in results of investees 34,848 9,239
Other comprehensive income (663) 5,825
Other 255 1,001
Capital increase 64,969  
Balance at 2022 149,023 58,923
Associate 1 [Member]    
IfrsStatementLineItems [Line Items]    
Balance at 2021 41,113 32,272
Dividends and interest on equity (5,013) (295)
Equity in results of investees 11,296 9,136
Balance at 2022 47,396 41,113
Associate 2 [Member]    
IfrsStatementLineItems [Line Items]    
Balance at 2021 16,625 10,697
Dividends and interest on equity (4,296)
Equity in results of investees 25,384 103
Other comprehensive income (1,174) 5,825
Balance at 2022 36,539 16,625
Associate 3 [Member]    
IfrsStatementLineItems [Line Items]    
Balance at 2021
Equity in results of investees (1,832)
Other comprehensive income 1,299  
Capital increase 41,908  
Balance at 2022 41,375
Associate 4 [Member]    
IfrsStatementLineItems [Line Items]    
Balance at 2021 1,185 184
Other comprehensive income (788)  
Other 255 1,001
Capital increase 23,061  
Balance at 2022 R$ 23,713 R$ 1,185
XML 107 R94.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Curent        
Cash and cash equivalents R$ 12,466,474 R$ 8,680,686 R$ 13,862,852 R$ 6,803,880
Financial investments 2,295,497 3,492,710    
Trade accounts receivable 3,231,934 7,153,565    
Inventories 14,030,064 16,335,101    
Taxes recoverable 1,156,355 1,428,658    
Recoverable income taxes 392,062 1,189,812    
Derivatives 157,906 33,816    
Other receivables 727,364 979,097    
Total current assets  34,457,656 39,293,445    
Non-current        
Taxes recoverable 1,617,669 1,252,058    
Other receivables 170,536 365,652    
Property, plant and equipment 37,763,295 37,225,130 35,929,149  
Right of use of assets 3,952,987 2,780,037 2,902,395  
Total non current assets  53,591,202 53,270,923    
Total assets 88,048,858 92,564,368    
Current        
Trade payables 12,246,782 12,053,266    
Borrowings 1,254,550 1,343,494    
Braskem Idesa Borrowings 868,635 86,765    
Taxes payable 491,051 1,012,116    
Lease 1,039,706 675,366    
Provision - geological event in Alagoas 4,247,609 4,378,071    
 Total current liabilities 24,185,247 25,193,523    
Non-current        
Loan to non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538    
Lease 3,200,824 2,481,048    
Other payables 282,940 461,917    
 Total non current liabilities 57,755,394 61,167,017    
Shareholders' equity        
Attributable to the  Company's shareholders 7,321,799 7,865,819    
Non-controlling interest in subsidiaries (1,213,582) (1,661,991)    
Total shareholders equity  6,108,217 6,203,828 (3,866,518) R$ 3,944,706
Total liabilities and shareholders' equity 88,048,858 92,564,368    
Net revenue 96,519,284 105,625,201 58,543,494  
Cost of products sold (85,160,548) (73,568,231) (47,331,414)  
Gross profit 11,358,736 32,056,970 11,212,080  
Income (expenses)         
General and administrative  (2,763,983) (2,522,127) (1,918,747)  
Research and development (374,493) (296,583) (250,648)  
Results from equity-accounted investees (34,848) (4,644) 19,398  
Other income 507,333 1,534,487 750,749  
Operating profit 4,272,073 26,043,547 (71,892)  
Financial results        
Financial expenses  (5,662,693) (5,907,155) (4,913,365)  
Financial income 2,010,134 1,827,438 600,184  
Exchange rate variations, net (572,170) (4,002,807) (5,298,711)  
Finance income (cost) (4,224,729) (8,082,524) (9,611,892)  
(Loss) profit before income tax        
 and social contribution 47,344 17,961,023 (9,683,784)  
Income taxes 867,735 3,999,403 (2,668,478)  
Adjustments for reconciliation of profit (loss)        
  4,733,165 4,178,433 4,048,081  
  (34,848) (4,644) 19,398  
  2,702,636 6,311,431 10,457,272  
  130,995 115,187 8,794  
  9,507,890 29,698,140 11,833,122  
Changes in operating working capital         
  3,746,107  
  1,530,050 296,957 (1,860,827)  
  3,661,267 (2,175,285) (2,187,826)  
  2,138,161 (7,574,285) (252,534)  
  682,457 4,963,587 1,532,554  
  310,789 (198,556) 690,888  
  514,079 1,199,614 (3,001,564)  
  (1,009,356) (3,007,488) 449,761  
  317,867 389,087 349,842  
  1,520,019 1,339,765 6,901,828  
  (2,742,791) (2,928,081) (1,181,931)  
  (390,727) 805,452 14,801  
Cash generated from operations 13,477,365 20,376,774 9,287,354  
  (2,904,879) (2,883,433) (2,736,821)  
  (1,620,747) (2,706,856) (257,542)  
Net cash generated by operating activities 8,951,739 14,786,485 6,292,991  
Proceeds from the sale of fixed assets and intangible assets 2,438 40,353 33,140  
Dividends received 5,660 295 4,822  
Acquisitions to property, plant and equipment and intangible assets (4,848,281) (3,421,324) (2,759,789)  
Net cash used in investing activities (4,947,273) (3,380,676) (2,721,827)  
Short-term and long-term debt        
  6,418,208 16,308 13,049,459  
  (3,855,662) (9,413,909) (8,734,505)  
Braskem Idesa borrowings        
  7,271,658  
  (45,311) (7,995,045) (905,210)  
Lease 928,890 841,706 662,068  
Dividends paid (1,350,293) (5,993,265) (2,380)  
Non-controlling interest in subsidiaries 21,162    
Cash generated (used) in financing activities 225,092 (16,965,504) 2,173,222  
Exchange variation on cash of foreign subsidiaries (443,770) 377,529 1,314,586  
Increase in cash and cash equivalents 3,785,788 (5,182,166) 7,058,972  
Consolidated Braskem Without The Effect Of Braskem Idesa Consolidated [Member]        
Curent        
Cash and cash equivalents 10,282,142 6,907,355    
Financial investments 2,295,497 3,492,710    
Trade accounts receivable 3,621,335 6,607,762    
Inventories 12,921,617 15,325,001    
Taxes recoverable 905,844 1,402,100    
Recoverable income taxes 392,062 1,189,812    
Derivatives 157,906 33,816    
Other receivables 628,447 841,473    
Total current assets  31,204,850 35,800,029    
Non-current        
Taxes recoverable 1,328,695 983,655    
Recoverable income taxes 252,995 230,069    
Deferred tax assets 6,671,492 6,481,642    
Related parties [1] 7,250,756 10,064,320    
Derivatives 71,544 51    
Judicial deposits  215,274 194,212    
Other receivables 187,107 370,928    
Investments 149,023 58,923    
Property, plant and equipment [2] 24,319,015 23,510,588    
Intangible 2,730,124 2,572,675    
Right of use of assets [3] 3,638,507 2,427,633    
Total non current assets  46,814,532 46,894,696    
Total assets 78,019,382 82,694,725    
Current        
Trade payables 11,418,031 11,861,563    
Borrowings 1,254,550 1,343,494    
Debentures 127,801 59,088    
Braskem Idesa Borrowings    
Payroll and related charges 789,441 1,095,040    
Taxes payable 481,729 1,003,813    
Income taxes payable 381,117 1,672,844    
Lease 955,225 598,523    
Provision - geological event in Alagoas 4,247,609 4,378,071    
Other payables 2,645,828 2,495,544    
 Total current liabilities 22,301,331 24,507,980    
Non-current        
Loan agreements 31,310,710 33,553,766    
Braskem Idesa Borrowings    
Debentures 3,023,674 137,830    
Accounts payable to related parties    
Loan to non-controlling shareholders of Braskem Idesa    
Deferred tax liabilities 904,521 1,407,434    
Provision for losses on subsidiaries [4] 4,094,535 5,284,666    
Lease 2,942,284 2,147,745    
Provision - geological event in Alagoas 2,378,949 3,283,188    
Other payables 3,590,317 4,406,733    
 Total non current liabilities 48,244,990 50,221,362    
Shareholders' equity        
Attributable to the  Company's shareholders 7,321,798 7,865,819    
Non-controlling interest in subsidiaries 151,263 99,564    
Total shareholders equity  7,473,061 7,965,383    
Total liabilities and shareholders' equity 78,019,382 82,694,725    
Net revenue 93,038,949 101,448,155 55,779,528  
Cost of products sold (82,624,987) (72,471,291) (45,563,723)  
Gross profit 10,413,962 28,976,864 10,215,805  
Income (expenses)         
Selling and distribution (1,890,181) (1,834,303) (1,609,844)  
(Loss) reversals for impairment of trade accounts receivable (38,248) (8,736) (55,074)  
General and administrative  (2,545,044) (2,292,884) (1,739,541)  
Research and development (374,493) (296,583) (250,648)  
Results from equity-accounted investees (1,078,115) (82,709) (1,026,922)  
Other income 505,629 1,530,443 748,923  
Other expenses (2,305,411) (2,651,425) (7,573,874)  
Operating profit 2,688,099 23,340,667 (1,291,175)  
Financial results        
Financial expenses  (5,013,176) (4,750,895) (3,851,233)  
Financial income 2,558,268 2,276,312 1,032,530  
Exchange rate variations, net (643,377) (2,884,292) (4,823,269)  
Finance income (cost) (3,098,285) (5,358,875) (7,641,972)  
(Loss) profit before income tax        
 and social contribution (410,186) 17,981,792 (8,933,147)  
Income taxes 95,651 (3,991,055) 2,253,684  
(Loss) net profit for the year (314,535) 13,990,737 (6,679,463)  
(Loss) profit before taxes (410,186) 18,348,774 (8,933,147)  
Adjustments for reconciliation of profit (loss)        
  3,944,259 3,432,816 2,995,609  
  1,078,108 (78,567) 1,026,922  
  1,788,259 3,604,357 8,541,980  
  370,153 819,130 336,838  
  1,520,019 1,339,765 6,901,828  
  (1,031,099) (310,557)  
  38,426 10,134 55,252  
  130,366 114,148 8,794  
  8,459,404 26,559,458 10,623,519  
Changes in operating working capital         
  3,746,107  
  1,530,050 296,957 (1,860,827)  
  2,751,788 (1,739,822) (2,247,729)  
  2,246,770 (7,176,104) (309,492)  
  928,181 4,958,779 1,584,911  
  (172,027)  
  297,209 (269,721) 44,513  
  (73,230) 955,475 (2,926,585)  
  (1,085,427) (2,878,056) 965,191  
  224,764  
  (317,867) (389,087) (349,842)  
  (219,313) (482,565) (158,915)  
  (2,742,791) (2,928,081) (1,181,931)  
  (384,838) 823,515 (217,997)  
Cash generated from operations 11,389,936 17,730,748 7,763,660  
  (2,118,043) (2,207,196) (1,946,931)  
  (1,620,616) (2,697,829) (252,479)  
Net cash generated by operating activities 7,651,277 12,825,723 5,564,250  
Proceeds from the sale of fixed assets and intangible assets 2,438 40,353 33,140  
Additions to investment in subsidiaries (107,090)    
Dividends received 5,660 295 4,822  
Acquisitions to property, plant and equipment and intangible assets (4,153,707) (3,249,132) (2,653,009)  
Net cash used in investing activities (4,252,699) (3,208,484) (2,615,047)  
Short-term and long-term debt        
  6,418,208 16,308 13,049,459  
  (3,855,662) (9,413,909) (8,734,505)  
Braskem Idesa borrowings        
     
     
Related parts 216,862    
Lease (836,718) (787,932) (610,392)  
Dividends paid (1,350,293) (5,993,265) (2,380)  
Non-controlling interest in subsidiaries 21,162 (534,456)  
Cash generated (used) in financing activities 396,697 (15,961,936) 3,167,726  
Exchange variation on cash of foreign subsidiaries (420,488) 293,633 1,054,845  
Increase in cash and cash equivalents 3,374,787 (6,051,064) 7,171,774  
Represented by        
  6,907,355 12,958,419 5,786,645  
  10,282,142 6,907,355 12,958,419  
Braskem Idesa Consolidated [Member]        
Curent        
Cash and cash equivalents 2,184,332 1,773,331    
Financial investments    
Trade accounts receivable 73,195 1,225,479    
Inventories 1,108,447 1,010,100    
Taxes recoverable 250,511 26,558    
Recoverable income taxes    
Derivatives    
Other receivables 68,544 137,624    
Total current assets  3,685,029 4,173,092    
Non-current        
Taxes recoverable 288,974 268,403    
Recoverable income taxes    
Deferred tax assets 488,116 1,775,610    
Related parties [1]    
Derivatives    
Judicial deposits     
Other receivables 563 24,964    
Investments    
Property, plant and equipment [2] 14,126,939 14,483,720    
Intangible 292,020 304,624    
Right of use of assets [3] 910,900 352,404    
Total non current assets  16,107,512 17,209,725    
Total assets 19,792,541 21,382,817    
Current        
Trade payables 1,291,347 871,379    
Borrowings    
Debentures    
Braskem Idesa Borrowings 868,635 86,765    
Payroll and related charges 38,385 75,306    
Taxes payable 9,322 8,303    
Income taxes payable    
Lease 195,518 76,843    
Provision - geological event in Alagoas    
Other payables 24,283 246,623    
 Total current liabilities 2,427,490 1,365,219    
Non-current        
Loan agreements    
Braskem Idesa Borrowings 10,501,683 12,224,770    
Debentures    
Accounts payable to related parties 7,175,837 10,134,287    
Loan to non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538    
Deferred tax liabilities 1,049,967    
Provision for losses on subsidiaries [4]    
Lease 746,285 333,303    
Provision - geological event in Alagoas    
Other payables 97,663 25,710    
 Total non current liabilities 22,069,528 26,364,608    
Shareholders' equity        
Attributable to the  Company's shareholders (4,704,477) (6,347,010)    
Non-controlling interest in subsidiaries    
Total shareholders equity  (4,704,477) (6,347,010)    
Total liabilities and shareholders' equity 19,792,541 21,382,817    
Net revenue 5,953,229 6,333,199 4,046,581  
Cost of products sold (5,074,693) (3,321,601) (3,112,129)  
Gross profit 878,536 3,011,598 934,452  
Income (expenses)         
Selling and distribution (218,236) (221,337) (242,211)  
(Loss) reversals for impairment of trade accounts receivable (178) (178) (178)  
General and administrative  (216,098) (229,334) (179,350)  
Research and development  
Results from equity-accounted investees 7  
Other income 1,704 4,044 1,826  
Other expenses (38,114) (17,865) (364,747)  
Operating profit 407,621 2,546,928 149,792  
Financial results        
Financial expenses  (1,817,551) (1,618,020) (1,505,628)  
Financial income 610,792 12,886 11,150  
Exchange rate variations, net 235,314 (1,164,697) (482,125)  
Finance income (cost) (971,445) (2,769,831) (1,976,603)  
(Loss) profit before income tax        
 and social contribution (563,824) (222,903) (1,826,811)  
Income taxes (963,386) (8,348) 414,794  
(Loss) net profit for the year (1,527,210) (231,251) (1,412,017)  
(Loss) profit before taxes (563,824) (222,903) (1,826,811)  
Adjustments for reconciliation of profit (loss)        
  901,194 796,861 1,114,439  
   
  759,378 2,564,905 1,921,975  
   
   
   
  (1,220)  
  629 1,039  
  1,097,377 3,138,682 1,209,603  
Changes in operating working capital         
   
   
  1,126,559 (619,688) (152,971)  
  (108,609) (398,181) 56,958  
  (245,724) 4,808 (52,357)  
  465,812  
  13,580 71,165 352,590  
  370,229 428,364 137,895  
  76,071 (129,432) (515,430)  
  (25,776)  
   
  (187,274) 168,371 13,560  
   
  (5,889) (18,063) 33,810  
Cash generated from operations 2,136,320 2,646,026 1,523,694  
  (786,836) (676,237) (789,890)  
  (131) (9,027) (5,063)  
Net cash generated by operating activities 1,349,353 1,960,762 728,741  
Proceeds from the sale of fixed assets and intangible assets  
Additions to investment in subsidiaries    
Dividends received  
Acquisitions to property, plant and equipment and intangible assets (694,574) (172,192) (106,780)  
Net cash used in investing activities (694,574) (172,192) (106,780)  
Short-term and long-term debt        
   
   
Braskem Idesa borrowings        
  7,271,658  
  (45,311) (7,995,045) (905,210)  
Related parts (34,122) (226,407)    
Loan to non-controlling shareholders of Braskem Idesa - payment     (37,618)  
Lease (141,063) (53,774) (51,676)  
Dividends paid  
Non-controlling interest in subsidiaries  
Cash generated (used) in financing activities (220,496) (1,003,568) (994,504)  
Exchange variation on cash of foreign subsidiaries (23,282) 83,896 259,741  
Increase in cash and cash equivalents 411,001 868,898 (112,802)  
Represented by        
  1,773,331 904,433 1,017,235  
  2,184,332 1,773,331 904,433  
Eliminations [Member]        
Curent        
Cash and cash equivalents    
Financial investments    
Trade accounts receivable (462,596) (679,676)    
Inventories    
Taxes recoverable    
Recoverable income taxes    
Derivatives    
Other receivables 30,373    
Total current assets  (432,223) (679,676)    
Non-current        
Taxes recoverable    
Recoverable income taxes    
Deferred tax assets (801,007)    
Related parties [1] (7,250,756) (10,064,320)    
Derivatives    
Judicial deposits     
Other receivables    
Investments    
Property, plant and equipment [2] (682,659) (769,178)    
Intangible    
Right of use of assets [3] (596,420)    
Total non current assets  (9,330,842) (10,833,498)    
Total assets (9,763,065) (11,513,174)    
Current        
Trade payables (462,596) (679,676)    
Borrowings    
Debentures    
Braskem Idesa Borrowings    
Payroll and related charges    
Taxes payable    
Income taxes payable    
Lease (111,037)    
Provision - geological event in Alagoas    
Other payables 30,059    
 Total current liabilities (543,574) (679,676)    
Non-current        
Loan agreements    
Braskem Idesa Borrowings    
Debentures    
Accounts payable to related parties (7,175,837) (10,134,287)    
Loan to non-controlling shareholders of Braskem Idesa    
Deferred tax liabilities (801,007)    
Provision for losses on subsidiaries [4] (4,094,535) (5,284,666)    
Lease (487,745)    
Provision - geological event in Alagoas    
Other payables    
 Total non current liabilities (12,559,124) (15,418,953)    
Shareholders' equity        
Attributable to the  Company's shareholders 4,704,478 6,347,010    
Non-controlling interest in subsidiaries (1,364,845) (1,761,555)    
Total shareholders equity  3,339,633 4,585,455    
Total liabilities and shareholders' equity (9,763,065) (11,513,174)    
Net revenue (2,472,894) (2,156,153) (1,282,615)  
Cost of products sold 2,539,132 2,224,661 1,344,438  
Gross profit 66,238 68,508 61,823  
Income (expenses)         
Selling and distribution  
(Loss) reversals for impairment of trade accounts receivable  
General and administrative  (2,841) 91 144  
Research and development  
Results from equity-accounted investees 1,112,956 87,353 1,007,524  
Other income  
Other expenses  
Operating profit 1,176,353 155,952 1,069,491  
Financial results        
Financial expenses  1,168,034 461,760 443,496  
Financial income (1,158,926) (461,760) (443,496)  
Exchange rate variations, net (164,107) 46,182 6,683  
Finance income (cost) (154,999) 46,182 6,683  
(Loss) profit before income tax        
 and social contribution 1,021,354 202,134 1,076,174  
Income taxes  
(Loss) net profit for the year 1,021,354 202,134 1,076,174  
(Loss) profit before taxes 1,021,354 (164,848) 1,076,174  
Adjustments for reconciliation of profit (loss)        
  (112,288) (51,244) (61,967)  
  (1,112,956) 73,923 (1,007,524)  
  154,999 142,169 (6,683)  
   
   
   
   
   
  (48,891)  
Changes in operating working capital         
   
   
  (217,080) 184,225 212,874  
   
   
   
   
  217,080 (184,225) (212,874)  
   
   
   
   
   
   
Cash generated from operations (48,891)  
   
   
Net cash generated by operating activities (48,891)  
Proceeds from the sale of fixed assets and intangible assets    
Additions to investment in subsidiaries      
Dividends received    
Acquisitions to property, plant and equipment and intangible assets  
Net cash used in investing activities  
Short-term and long-term debt        
   
   
Braskem Idesa borrowings        
     
     
Related parts    
Lease 48,891  
Dividends paid  
Non-controlling interest in subsidiaries  
Cash generated (used) in financing activities 48,891  
Exchange variation on cash of foreign subsidiaries  
Increase in cash and cash equivalents  
Represented by        
   
   
Total [Member]        
Curent        
Cash and cash equivalents 12,466,474 8,680,686    
Financial investments 2,295,497 3,492,710    
Trade accounts receivable 3,231,934 7,153,565    
Inventories 14,030,064 16,335,101    
Taxes recoverable 1,156,355 1,428,658    
Recoverable income taxes 392,062 1,189,812    
Derivatives 157,906 33,816    
Other receivables 727,364 979,097    
Total current assets  34,457,656 39,293,445    
Non-current        
Taxes recoverable 1,617,669 1,252,058    
Recoverable income taxes 252,995 230,069    
Deferred tax assets 6,358,601 8,257,252    
Related parties [1]    
Derivatives 71,544 51    
Judicial deposits  215,274 194,212    
Other receivables 187,670 395,892    
Investments 149,023 58,923    
Property, plant and equipment [2] 37,763,295 37,225,130    
Intangible 3,022,144 2,877,299    
Right of use of assets [3] 3,952,987 2,780,037    
Total non current assets  53,591,202 53,270,923    
Total assets 88,048,858 92,564,368    
Current        
Trade payables 12,246,782 12,053,266    
Borrowings 1,254,550 1,343,494    
Debentures 127,801 59,088    
Braskem Idesa Borrowings 868,635 86,765    
Payroll and related charges 827,826 1,170,346    
Taxes payable 491,051 1,012,116    
Income taxes payable 381,117 1,672,844    
Lease 1,039,706 675,366    
Provision - geological event in Alagoas 4,247,609 4,378,071    
Other payables 2,700,170 2,742,167    
 Total current liabilities 24,185,247 25,193,523    
Non-current        
Loan agreements 31,310,710 33,553,766    
Braskem Idesa Borrowings 10,501,683 12,224,770    
Debentures 3,023,674 137,830    
Accounts payable to related parties    
Loan to non-controlling shareholders of Braskem Idesa 2,498,093 3,646,538    
Deferred tax liabilities 1,153,481 1,407,434    
Provision for losses on subsidiaries [4]    
Lease 3,200,824 2,481,048    
Provision - geological event in Alagoas 2,378,949 3,283,188    
Other payables 3,687,980 4,432,443    
 Total non current liabilities 57,755,394 61,167,017    
Shareholders' equity        
Attributable to the  Company's shareholders 7,321,799 7,865,819    
Non-controlling interest in subsidiaries (1,213,582) (1,661,991)    
Total shareholders equity  6,108,217 6,203,828    
Total liabilities and shareholders' equity 88,048,858 92,564,368    
Net revenue 96,519,284 105,625,201 58,543,494  
Cost of products sold (85,160,548) (73,568,231) (47,331,414)  
Gross profit 11,358,736 32,056,970 11,212,080  
Income (expenses)         
Selling and distribution (2,108,417) (2,055,640) (1,852,055)  
(Loss) reversals for impairment of trade accounts receivable (38,426) (8,914) (55,252)  
General and administrative  (2,763,983) (2,522,127) (1,918,747)  
Research and development (374,493) (296,583) (250,648)  
Results from equity-accounted investees 34,848 4,644 (19,398)  
Other income 507,333 1,534,487 750,749  
Other expenses (2,343,525) (2,669,290) (7,938,621)  
Operating profit 4,272,073 26,043,547 (71,892)  
Financial results        
Financial expenses  (5,662,693) (5,907,155) (4,913,365)  
Financial income 2,010,134 1,827,438 600,184  
Exchange rate variations, net (572,170) (4,002,807) (5,298,711)  
Finance income (cost) (4,224,729) (8,082,524) (9,611,892)  
(Loss) profit before income tax        
 and social contribution 47,344 17,961,023 (9,683,784)  
Income taxes (867,735) (3,999,403) 2,668,478  
(Loss) net profit for the year (820,391) 13,961,620 (7,015,306)  
(Loss) profit before taxes 47,344 17,961,023 (9,683,784)  
Adjustments for reconciliation of profit (loss)        
  4,733,165 4,178,433 4,048,081  
  (34,848) (4,644) 19,398  
  2,702,636 6,311,431 10,457,272  
  370,153 819,130 336,838  
  1,520,019 1,339,765 6,901,828  
  (1,031,099) (310,557)  
  38,426 8,914 55,252  
  130,995 115,187 8,794  
  9,507,890 29,698,140 11,833,122  
Changes in operating working capital         
  3,746,107  
  1,530,050 296,957 (1,860,827)  
  3,661,267 (2,175,285) (2,187,826)  
  2,138,161 (7,574,285) (252,534)  
  682,457 4,963,587 1,532,554  
  293,785  
  310,789 (198,556) 397,103  
  514,079 1,199,614 (3,001,564)  
  (1,009,356) (3,007,488) 449,761  
  198,988  
  (317,867) (389,087) (349,842)  
  (406,587) (314,194) (145,355)  
  (2,742,791) (2,928,081) (1,181,931)  
  (390,727) 805,452 (184,187)  
Cash generated from operations 13,477,365 20,376,774 9,287,354  
  (2,904,879) (2,883,433) (2,736,821)  
  (1,620,747) (2,706,856) (257,542)  
Net cash generated by operating activities 8,951,739 14,786,485 6,292,991  
Proceeds from the sale of fixed assets and intangible assets 2,438 40,353 33,140  
Additions to investment in subsidiaries (107,090)  
Dividends received 5,660 295 4,822  
Acquisitions to property, plant and equipment and intangible assets (4,848,281) (3,421,324) (2,759,789)  
Net cash used in investing activities (4,947,273) (3,380,676) (2,721,827)  
Short-term and long-term debt        
  6,418,208 16,308 13,049,459  
  (3,855,662) (9,413,909) (8,734,505)  
Braskem Idesa borrowings        
  7,271,658  
  (45,311) (7,995,045) (905,210)  
Related parts (34,122) (9,545)  
Loan to non-controlling shareholders of Braskem Idesa - payment (37,618)  
Lease (928,890) (841,706) (662,068)  
Dividends paid (1,350,293) (5,993,265) (2,380)  
Non-controlling interest in subsidiaries 21,162 (534,456)  
Cash generated (used) in financing activities 225,092 (16,965,504) 2,173,222  
Exchange variation on cash of foreign subsidiaries (443,770) 377,529 1,314,586  
Increase in cash and cash equivalents 3,785,788 (5,182,166) 7,058,972  
Represented by        
  8,680,686 13,862,852 6,803,880  
  R$ 12,466,474 R$ 8,680,686 R$ 13,862,852  
[1] Loan from Braskem Holanda to the Braskem Idesa project.
[2] Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.
[3] Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.
[4] Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.
XML 108 R95.htm IDEA: XBRL DOCUMENT v3.23.1
Property plant and equipment (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Buildings [member]    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 3 years 10 days 2 years 11 months 1 day
Machinery and facilities [member]    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 7 years 3 months 25 days 6 years 8 months 26 days
Fixtures and fittings [member]    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 10 years 21 days 10 years 21 days
It equipment member    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 21 years 10 days 21 years 2 months 4 days
Lab equipment member    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 9 years 7 months 2 days 9 years 6 months 10 days
Security equipment member    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 10 years 6 months 10 years 14 days
Vehicles [member]    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 19 years 6 months 3 days 18 years 9 months 25 days
Other [member]    
IfrsStatementLineItems [Line Items]    
Estimates useful lives 18 years 1 month 2 days 17 years 18 days
XML 109 R96.htm IDEA: XBRL DOCUMENT v3.23.1
Property plant and equipment (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Cost R$ 76,529,554 R$ 73,479,063 R$ 68,794,058
Accumulated depreciation (38,766,259) (36,253,933) (32,864,909)
Beginning balance 37,225,130 35,929,149  
Acquisitions 4,949,985 3,552,134  
Capitalized financial charges 203,135 192,207  
Cost (1,202,241) 1,521,854  
Depreciation 356,548 (418,433)  
Transfers to inventory   (16,838)  
Transfers to intangible (13,597) (65,422)  
Cost (964,308) (486,958)  
Depreciation 828,934 396,379  
Depreciation and amortization (3,697,809) (3,377,241)  
Transfers to "non-current assets held for sale"   (1,701)  
Net book value 37,763,295 37,225,130  
Additions through acquisition of ER Plastics 77,518    
Ending balance 37,763,295 37,225,130 35,929,149
Land [member]      
IfrsStatementLineItems [Line Items]      
Cost 667,845 687,764 683,031
Beginning balance 687,764 683,031  
Cost (19,916) 17,046  
Transfers by concluded projects   244  
Cost (3) (10,856)  
Transfers to "non-current assets held for sale"   (1,701)  
Net book value 667,845 687,764  
Ending balance 667,845 687,764 683,031
Buildings [member]      
IfrsStatementLineItems [Line Items]      
Cost 8,526,704 8,591,020 8,281,424
Accumulated depreciation (3,561,627) (3,409,532) (3,159,185)
Beginning balance 5,181,488 5,122,239  
Acquisitions 1,709 338  
Cost (173,496) 287,866  
Depreciation 51,263 (88,406)  
Transfers by concluded projects 86,609 13,965  
Transfers to intangible   31,495  
Cost (7) 9,723  
Depreciation   168  
Depreciation and amortization (203,358) (195,900)  
Net book value 4,965,077 5,181,488  
Additions through acquisition of ER Plastics 20,868    
Ending balance 4,965,077 5,181,488 5,122,239
Machinery and facilities [member]      
IfrsStatementLineItems [Line Items]      
Cost 58,708,355 57,535,343 53,401,832
Accumulated depreciation (33,373,492) (31,126,351) (28,268,867)
Beginning balance 26,408,992 25,132,965  
Acquisitions 296,719 160,297  
Cost (941,271) 1,118,655  
Depreciation 285,016 (313,267)  
Transfers by concluded projects 2,688,220 3,207,833  
Transfers to intangible   (11,673)  
Cost (926,944) (353,274)  
Depreciation 815,220 387,005  
Depreciation and amortization (3,347,376) (3,038,176)  
Transfers to "non-current assets held for sale"   (2)  
Disposals property plant and equipment transfer others   118,629  
Net book value 25,334,863 26,408,992  
Additions through acquisition of ER Plastics 56,288    
Ending balance 25,334,863 26,408,992 25,132,965
Projects and stoppage in progress [member]      
IfrsStatementLineItems [Line Items]      
Cost [1] 6,307,797 4,449,433 4,389,105
Accumulated depreciation [1]   (40,095)  
Beginning balance [1] 4,409,338 4,389,105  
Acquisitions [1] 4,643,953 3,388,078  
Capitalized financial charges [1] 203,135 192,207  
Cost [1] (38,966) 74,428  
Transfers by concluded projects [1] (2,915,496) (3,412,665)  
Transfers to inventory [1]   (16,838)  
Transfers to intangible [1] (13,597) (73,397)  
Cost [1] (20,665) (91,485)  
Disposals property plant and equipment transfer others [1]   (40,095)  
Net book value [1] 6,267,702 4,409,338  
Ending balance [1] 6,267,702 4,409,338 4,389,105
Other [member]      
IfrsStatementLineItems [Line Items]      
Cost 2,318,854 2,215,503 2,038,666
Accumulated depreciation (1,791,045) (1,677,954) (1,436,857)
Beginning balance 537,549 601,809  
Acquisitions 7,603 3,421  
Cost (28,592) 23,859  
Depreciation 20,269 (16,760)  
Transfers by concluded projects 140,667 190,623  
Transfers to intangible   (11,847)  
Cost (16,689) (41,066)  
Depreciation 13,715 9,206  
Depreciation and amortization (147,074) (143,164)  
Transfers to "non-current assets held for sale"   2  
Disposals property plant and equipment transfer others   (78,534)  
Net book value 527,809 537,549  
Additions through acquisition of ER Plastics 362    
Ending balance R$ 527,809 R$ 537,549 R$ 601,809
[1] As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.
XML 110 R97.htm IDEA: XBRL DOCUMENT v3.23.1
Property plant and equipment (Details 2) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Property, plant and equipment R$ 37,763,295 R$ 37,225,130 R$ 35,929,149
Brazil [member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment 17,204,824 15,867,387  
Mexico [member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment 13,444,279 13,714,543  
United states of america [member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment 6,729,469 7,281,077  
Germany [member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment 294,612 356,288  
Netherland [Member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment 89,841 5,691  
Other [member]      
IfrsStatementLineItems [Line Items]      
Property, plant and equipment R$ 270 R$ 144  
XML 111 R98.htm IDEA: XBRL DOCUMENT v3.23.1
Property, plant and equipment (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Description of property, plant and equipment shutdowns duration The Company makes shutdowns at regular intervals that vary from two to six years to perform these activities.  
Capitalized financial charges R$ 203,135 R$ 192,207
Depreciation rate, property, plant and equipment 8.51% 8.33%
Acquisition of property, plant and equipment with payment installments R$ 525,192 R$ 295,056
Projects and stoppage in progress [member]    
IfrsStatementLineItems [Line Items]    
Capitalized financial charges [1] R$ 203,135 R$ 192,207
[1] As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.
XML 112 R99.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Cost R$ 5,492,861 R$ 5,253,159 R$ 5,089,640
Accumulated amortization (2,470,717) (2,375,860) (2,260,949)
Balance as of beginning 2,877,299 2,828,691  
Acquisitions 147,150 68,776  
Foreign currency translation adjustment   14,271  
Cost (27,170) 25,466  
Amortization 17,150 (11,195)  
Transfers from property, plant and equipment projects and stoppage in progress 13,597 65,422  
Other write-offs net of amortization (10,011) (3,393)  
Amortization (112,008) (96,468)  
Balance as of end 3,022,144 2,877,299 2,828,691
Additions through acquisition of ER Plastics 87,733    
Goodwill acquisition of ER Plastics 28,402    
Goodwill based on expected future profitability member      
IfrsStatementLineItems [Line Items]      
Cost 3,216,080 3,187,678 3,187,678
Accumulated amortization (1,128,804) (1,128,804) (1,128,804)
Balance as of beginning 2,058,874 2,058,874  
Balance as of end 2,087,276 2,058,874 2,058,874
Goodwill acquisition of ER Plastics 28,402    
Brand names [member]      
IfrsStatementLineItems [Line Items]      
Cost 564,258 549,196 499,515
Accumulated amortization (243,272) (235,408) (214,455)
Balance as of beginning 313,789 285,060  
Acquisitions 1,307 670  
Cost (7,407) 12,443  
Amortization 2,711 (2,711)  
Transfers from property, plant and equipment projects and stoppage in progress   28,770  
Amortization (10,575) (10,444)  
Balance as of end 320,986 313,789 285,060
Additions through acquisition of ER Plastics 21,162    
Computer software [member]      
IfrsStatementLineItems [Line Items]      
Cost 1,252,373 1,123,619 1,010,201
Accumulated amortization (820,434) (755,099) (683,157)
Balance as of beginning 368,520 327,044  
Acquisitions 144,930 67,686  
Cost (19,762) 13,023  
Amortization 14,440 (8,484)  
Transfers from property, plant and equipment projects and stoppage in progress 13,597 36,652  
Other write-offs net of amortization (10,011) (3,393)  
Amortization (79,774) (64,008)  
Balance as of end 431,939 368,520 327,044
Customer-related intangible assets [member]      
IfrsStatementLineItems [Line Items]      
Cost 460,150 392,666 392,246
Accumulated amortization (278,207) (256,549) (234,533)
Balance as of beginning 136,117 157,713  
Acquisitions 913 420  
Amortization (21,659) (22,016)  
Balance as of end 181,943 R$ 136,117 R$ 157,713
Additions through acquisition of ER Plastics R$ 66,571    
XML 113 R100.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details 1)
R$ in Thousands
Dec. 31, 2022
BRL (R$)
Northeastern petrochemical complex member  
IfrsStatementLineItems [Line Items]  
Allocated goodwill R$ 475,780
Recoverable amount 7,305,045
Book value R$ 3,124,332 [1]
Discount rate 14.68%
Southern petrochemical complex member  
IfrsStatementLineItems [Line Items]  
Allocated goodwill R$ 1,390,741
Recoverable amount 20,840,873
Book value R$ 6,781,881 [1]
Discount rate 15.85%
Vinyls unity member  
IfrsStatementLineItems [Line Items]  
Allocated goodwill R$ 192,353
Recoverable amount 5,050,166
Book value R$ 2,880,156 [1]
Discount rate 14.70%
[1] The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.
XML 114 R101.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details 2)
R$ in Thousands
Dec. 31, 2022
BRL (R$)
Northeastern petrochemical complex member  
IfrsStatementLineItems [Line Items]  
Discount rate R$ 6,822,642
Perpetuity 7,044,458
Southern petrochemical complex member  
IfrsStatementLineItems [Line Items]  
Discount rate 19,744,124
Perpetuity 20,351,277
Vinyls unity member  
IfrsStatementLineItems [Line Items]  
Discount rate 4,741,224
Perpetuity R$ 4,930,076
XML 115 R102.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details 3)
12 Months Ended
Dec. 31, 2022
Brands And Patents [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 10 years
Brands And Patents [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 20 years
Software Licenses And Rights Of Use [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 5 years
Software Licenses And Rights Of Use [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 10 years
Customers And Suppliers Agreements [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 14 years
Customers And Suppliers Agreements [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Amortization estimated useful life 28 years
XML 116 R103.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details 4) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Intangible assets R$ 3,022,144 R$ 2,877,299
Brazil [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets 2,571,011 2,526,999
Mexico [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets 292,020 304,624
Netherland [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets 122,447  
United states of america [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets 22,820 24,404
Germany [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets 13,839 21,253
Other [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets R$ 7 R$ 19
XML 117 R104.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible assets (Details Narrative)
Dec. 31, 2022
Intangible Assets  
Inflation rate for perpetuity 3.00%
XML 118 R105.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance R$ 2,780,037 R$ 2,902,395
Acquisitions 2,236,307 746,573
Depreciation (995,278) (876,986)
Disposal (11,329) (71,928)
Foreign currency translation adjustment (56,750) 79,983
Right-of-use assets, Ending balance 3,952,987 2,780,037
Rail cars member    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 986,061 1,007,336
Acquisitions 72,506 102,648
Depreciation (173,272) (187,915)
Disposal (5,359)  
Foreign currency translation adjustment (53,740) 63,992
Right-of-use assets, Ending balance 826,196 986,061
Machinery and equipments member    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 793,254 749,728
Acquisitions 1,147,145 281,113
Depreciation (330,971) (207,985)
Disposal (5,970) (30,245)
Foreign currency translation adjustment (804) 643
Right-of-use assets, Ending balance 1,602,654 793,254
Ships [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 696,661 834,848
Acquisitions 811,372 258,201
Depreciation (385,968) (399,677)
Foreign currency translation adjustment (1,793) 3,289
Right-of-use assets, Ending balance 1,120,272 696,661
Buildings and constructions member    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 265,312 259,896
Acquisitions 102,040 52,897
Depreciation (75,319) (52,997)
Disposal   (6,333)
Foreign currency translation adjustment (213) 11,849
Right-of-use assets, Ending balance 291,820 265,312
Vehicles [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 29,449 33,888
Acquisitions 102,827 51,171
Depreciation (26,158) (24,078)
Disposal   (31,667)
Foreign currency translation adjustment (120) 135
Right-of-use assets, Ending balance 105,998 29,449
Computer equipment [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 9,300 16,699
Acquisitions 417 542
Depreciation (3,590) (4,334)
Disposal   (3,682)
Foreign currency translation adjustment (80) 75
Right-of-use assets, Ending balance R$ 6,047 R$ 9,300
XML 119 R106.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Right-of-use Assets And Lease Liability    
As of December 31 R$ 3,156,414 R$ 3,207,886
Acquired 2,232,043 746,573
Additions through acquisition of ER Plastics 4,264  
Disposals (12,568) (50,473)
Interests and monetary and exchange variations, net 83,871 206,375
Currancy translation adjustments  (73,585) 85,984
Payments (928,890) (841,706)
Interest paid (221,019) (198,225)
As of December 31 4,240,530 3,156,414
Lease current liabilities 1,039,706 675,366
Lease non current liabilities 3,200,824 2,481,048
Lease liabilities R$ 4,240,530 R$ 3,156,414
XML 120 R107.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Details 2) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Total R$ 4,983,177 R$ 3,377,242
Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Total   777,410
Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Total 1,109,048 633,141
Later than three years and not later than four years [member]    
IfrsStatementLineItems [Line Items]    
Total 855,803 493,147
Later than four years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Total 630,074 399,924
Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Total R$ 2,388,252 R$ 1,073,620
XML 121 R108.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Details 3)
R$ in Thousands
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted R$ 546,017
Cash flows related to the contracts undiscounted 881,835
Later than two years and not later than three years [member]  
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted 1,014
Cash flows related to the contracts undiscounted 1,080
Later than three years and not later than four years [member]  
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted 52,258
Cash flows related to the contracts undiscounted 55,678
Later than four years and not later than five years [member]  
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted 49,390
Cash flows related to the contracts undiscounted 56,067
Later Than Five Years And Not Later Than Six Years [Member]  
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted 46,687
Cash flows related to the contracts undiscounted 56,468
Later Than Six Years And Not Later Than Seven Years [Member]  
IfrsStatementLineItems [Line Items]  
Cash flows related to the contracts discounted 396,669
Cash flows related to the contracts undiscounted R$ 712,541
XML 122 R109.htm IDEA: XBRL DOCUMENT v3.23.1
Right-of-use assets and lease liability (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Low-value leases expense R$ 42,000 R$ 7,200
Contractual payments R$ 65,529 R$ 70,085
Weighted average incremental rate 5.80% 5.18%
Non-cash investing and financing activity R$ 1,909,816 R$ 565,774
Uninitiated lease arrangements [member]    
IfrsStatementLineItems [Line Items]    
Commitments of lease agreement R$ 546,000  
XML 123 R110.htm IDEA: XBRL DOCUMENT v3.23.1
Trade payables (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Trade account payables R$ 12,249,851 R$ 12,164,730
Trade account payables, current 12,246,782 12,053,266
Trade account payables, current 3,069 111,464
Third parties member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade account payables 1,748,853 1,492,223
Third parties member | Foreign market member    
IfrsStatementLineItems [Line Items]    
Trade account payables [1] 9,540,635 9,936,266
Third parties forfait member    
IfrsStatementLineItems [Line Items]    
Trade account payables 2,431,249 1,980,029
Third parties forfait member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade account payables [2] 682,396 487,806
Related partie member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade account payables 196,440 208,287
Related partie forfait member    
IfrsStatementLineItems [Line Items]    
Trade account payables 277,967 248,435
Related partie forfait member | Domestic market member    
IfrsStatementLineItems [Line Items]    
Trade account payables [2] R$ 81,527 R$ 40,148
[1] Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.
[2] The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.
XML 124 R111.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Borrowings R$ 32,565,260 R$ 34,897,260
Current borrowings 1,254,550 1,343,494
Non-current portion of non-current borrowings 31,310,710 33,553,766
Agribusiness Credit Notes [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings 763,396  
Foreign currency member    
IfrsStatementLineItems [Line Items]    
Borrowings 31,065,442 34,432,009
Current borrowings 1,177,144 1,284,483
Non-current portion of non-current borrowings R$ 29,888,298 33,147,526
Foreign currency member | Bond member    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate Note 16 (b)  
Borrowings R$ 26,124,158 30,322,998
Foreign currency member | Export prepayment member    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate [1] US$ exchange variation + Term SOFR quarterly + 1,79  
Borrowings [1] R$ 1,514,651  
Foreign currency member | Other borrowings member    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate Note 16 (c)  
Borrowings R$ 3,880,165 4,703,059
Foreign currency member | Transactions costs member    
IfrsStatementLineItems [Line Items]    
Borrowings (453,532) (594,048)
Local currency member    
IfrsStatementLineItems [Line Items]    
Borrowings 1,499,818 465,251
Current borrowings 77,406 59,011
Non-current portion of non-current borrowings 1,422,412 406,240
Local currency member | Transactions costs member    
IfrsStatementLineItems [Line Items]    
Borrowings R$ (21,193) (7)
Local currency member | Agribusiness Credit Notes [Member]    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate Note 16 (d)  
Local currency member | B N D E S [Member]    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate IPCA + 6.04  
Borrowings R$ 386,534 435,778
Local currency member | Export credit notes1 member    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate 100.00 of CDI + 1.30  
Borrowings R$ 348,885  
Local currency member | Other Fixed Interest Loans [Member]    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate Interest between 3.5 and 6.5  
Borrowings R$ 18,671 24,864
Local currency member | Other Variable Interest Loans [Member]    
IfrsStatementLineItems [Line Items]    
Description of borrowing interest rate IPCA + interest between 2.39 and 2.78  
Borrowings R$ 3,525 R$ 4,616
[1] Maturity in June 2027.
XML 125 R112.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details 1) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent R$ 31,310,710 R$ 33,553,766
Twenty Twenty Three [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent   1,199,143
Twenty Twenty Four [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 2,143,624 3,965,917
Twenty Twenty Five [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 603,743 645,517
Twenty Twenty Six [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 581,625 622,032
Twenty Twenty Sevan [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 2,356,678 552,171
Twenty Twenty Eight [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 7,281,841 7,081,301
Twenty Twenty Nine [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 287,178 230,557
Twenty Thirty [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 7,995,727 8,535,493
Twenty Thirty One [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent 106,661 61,617
Thirty Three And Thereafter [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, noncurrent R$ 9,953,633 R$ 10,660,018
XML 126 R113.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details 2) - Foreign currency member - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Borrowings R$ 26,124,158 R$ 30,322,998
Bonds1 member    
IfrsStatementLineItems [Line Items]    
Issue date [1] Jul-2011 and jul-2012  
Maturity [1] jul-2041  
Interest (% per year) [1] 7.125%  
Borrowings [1] R$ 3,044,911 3,296,917
Bonds2 member    
IfrsStatementLineItems [Line Items]    
Issue date [2] Feb-2014 and may-2014  
Maturity [2] fev-2024  
Interest (% per year) [2] 6.45%  
Borrowings [2] R$ 1,588,729 3,417,741
Bonds3 member    
IfrsStatementLineItems [Line Items]    
Issue date [2] Oct-2017  
Maturity [2] jan-2023  
Interest (% per year) [2] 3.50%  
Borrowings [2]   593,964
Bonds4 member    
IfrsStatementLineItems [Line Items]    
Issue date [1] Oct-2017  
Maturity [1] jan-2028  
Interest (% per year) [1] 4.50%  
Borrowings [1] R$ 6,249,333 6,695,263
Bonds5 member    
IfrsStatementLineItems [Line Items]    
Issue date [1] Nov-2019  
Maturity [1] jan-2030  
Interest (% per year) [1] 4.50%  
Borrowings [1] R$ 7,936,089 8,527,701
Bonds6 member    
IfrsStatementLineItems [Line Items]    
Issue date Nov-2019  
Maturity jan-2050  
Interest (% per year) 5.875%  
Borrowings R$ 4,009,069 4,287,829
Bonds7 member    
IfrsStatementLineItems [Line Items]    
Issue date [2] Jul-2020  
Maturity [2] jan-2081  
Interest (% per year) [2] 8.50%  
Borrowings [2] R$ 3,296,027 R$ 3,503,583
[1] Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.
[2] Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.
XML 127 R114.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details 3) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Foreign currency member    
IfrsStatementLineItems [Line Items]    
Borrowings one R$ 763,396  
Foreign currency member | Other n e x i1 member    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [1] nov-2028  
Borrowings, interest rate basis [2] Us dollar exchange variation + semianual Libor + 0.90  
Borrowings one [2] R$ 929,112 R$ 1,154,146
Foreign currency member | Other n e x i2 member    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [1] dec-2029  
Borrowings, interest rate basis [2] Us dollar exchange variation + semianual Libor + 0.90  
Borrowings one [2] R$ 549,610 670,124
Foreign currency member | Other n e x i3 member    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [1] apr-2026  
Borrowings, interest rate basis [1] Us dollar exchange variation + semianual Libor - 1.00   
Borrowings one [1] R$ 197,209 266,403
Foreign currency member | Other N E X I 4 [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [3] mar-2027  
Borrowings, interest rate basis [3] Us dollar exchange variation + semianual Libor + 1.61  
Borrowings one [3] R$ 357,488 462,490
Foreign currency member | Other N E X I 5 [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [4] dec-2028  
Borrowings, interest rate basis [4] Us dollar exchange variation + semianual Libor + 0.65  
Borrowings one [4] R$ 757,832 947,898
Foreign currency member | Other N E X I 6 [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [3] feb-2031  
Borrowings, interest rate basis [3] Us dollar exchange variation + semianual Libor + 1.70  
Borrowings one [3] R$ 1,007,067 1,201,998
Foreign currency member | Other N E X I 7 [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [5] aug-2028 to jun-2029  
Borrowings, interest rate basis [5] Euro exchange variation + interest between 2.40 and 7.41  
Borrowings one [5] R$ 79,698  
Foreign currency member | Other N E X I 8 [Member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity no maturity  
Borrowings, interest rate basis [5] Euro exchange variation + Euribor monthly + 4.10  
Borrowings one [5] R$ 2,149  
Foreign currency three member    
IfrsStatementLineItems [Line Items]    
Borrowings one R$ 3,880,165  
Borrowings two   R$ 4,703,059
[1] Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.
[2] Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.
[3] Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.
[4] Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million.
[5] Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.
XML 128 R115.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details 4) - Foreign currency member
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Notional amount R$ 720,736
Borrowings one R$ 763,396
Other C R A 1 [Member]  
IfrsStatementLineItems [Line Items]  
Issue date Jan-2022
Notional amount R$ 581,602
Maturity Dec-2028
Borrowings interest rate basis IPCA + 5.54%
Borrowings one R$ 616,025
Other C R A 2 [Member]  
IfrsStatementLineItems [Line Items]  
Issue date Jan-2022
Notional amount R$ 139,134
Maturity Dec-2031
Borrowings interest rate basis IPCA + 5.57%
Borrowings one R$ 147,371
XML 129 R116.htm IDEA: XBRL DOCUMENT v3.23.1
Braskem Idesa Borrowings (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Braskem idesa borrowings R$ 11,043,483 R$ 11,939,268
Non current braskem idesa borrowings3 11,370,318 12,311,535
Current braskem idesa borrowings 868,635 86,765
Non current braskem idesa borrowings1 R$ 10,501,683 12,224,770
Bond member    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [1] nov-2029  
Borrowings, interest rate basis [1] Us dollar exchange variation + 7.45  
Braskem idesa borrowings [1] R$ 4,690,619 5,104,463
Bond i i member    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [2] feb-2032  
Borrowings, interest rate basis [2] Us dollar exchange variation + 6.99  
Braskem idesa borrowings [2] R$ 6,352,864 6,834,805
Other [member]    
IfrsStatementLineItems [Line Items]    
Borrowings, maturity [3] Oct-2026  
Borrowings, interest rate basis [3] Us dollar exchange variation + quarterly Libor + 4.00  
Braskem idesa borrowings [3] R$ 734,837 849,859
Transactions costs member    
IfrsStatementLineItems [Line Items]    
Braskem idesa borrowings R$ (408,002) R$ (477,592)
[1] Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.
[2] Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.
[3] For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.
XML 130 R117.htm IDEA: XBRL DOCUMENT v3.23.1
Braskem Idesa Borrowings (Details 1) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities R$ 10,501,683 R$ 12,224,770
Twenty Twenty Two [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities   67,649
Twenty Twenty Three [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities   68,694
Twenty Twenty Four [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities   69,530
Twenty Twenty Five [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities   408,445
Twenty Twenty Six [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities 4,337,567 4,900,399
Twenty Twenty Sevan [Member]    
IfrsStatementLineItems [Line Items]    
Original Long-Term Maturities R$ 6,164,116 R$ 6,710,053
XML 131 R118.htm IDEA: XBRL DOCUMENT v3.23.1
Braskem Idesa Borrowings (Details Narrative)
R$ in Thousands
Dec. 31, 2022
BRL (R$)
Borrowings [abstract]  
Cash position equivalent R$ 2,184,332
XML 132 R119.htm IDEA: XBRL DOCUMENT v3.23.1
Debentures (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Debentures R$ 3,151,475 R$ 196,918
Debentures, current 127,801 59,088
Debentures, non current R$ 3,023,674 137,830
Debentures member    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) [1] mar-2013  
Borrowings, maturity [1] mar-2025  
Annual financial charges (%) [1] IPCA + 6%  
Debentures [1] R$ 109,877 150,352
Debentures1 member    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) [1] sep-2013  
Borrowings, maturity [1] Sep-2025  
Annual financial charges (%) [1] 126.5% of CDI  
Debentures [1] R$ 34,604 47,109
Debentures 2 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) may-2022  
Borrowings, maturity may-2029  
Annual financial charges (%) CDI + 1,75  
Debentures R$ 770,910  
Debentures 3 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) may-2022  
Borrowings, maturity may-2030 to 2032  
Annual financial charges (%) CDI + 2,00  
Debentures R$ 248,970  
Debentures 4 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) [1] aug-2022  
Borrowings, maturity [1] aug-2029  
Annual financial charges (%) [1] CDI + 1,75  
Debentures [1] R$ 786,770  
Debentures 5 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) nov-2022  
Borrowings, maturity nov-2029  
Annual financial charges (%) CDI + 1,70  
Debentures R$ 1,113,987  
Debentures 6 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) nov-2022  
Borrowings, maturity nov-2030 to 2032  
Annual financial charges (%) CDI + 1,95  
Debentures R$ 97,159  
Debentures 7 [Member]    
IfrsStatementLineItems [Line Items]    
Annual financial charges (%) Transactions costs  
Debentures R$ (10,802) R$ (543)
[1] These debentures were secured by mandatory deposits as disclosed in Note 6.
XML 133 R120.htm IDEA: XBRL DOCUMENT v3.23.1
Debentures (Details 1) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent R$ 3,023,674 R$ 137,830
Twenty Twenty Three [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent   57,045
Twenty Twenty Four [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent 58,550 57,096
Twenty Twenty Five [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent 24,059 R$ 23,689
Twenty Twenty Nine [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent 2,600,998  
Twenty Twenty Thirty [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent 113,291  
Twenty Twenty Thirty One [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent 113,360  
Twenty Twenty Thirty Two [Member]    
IfrsStatementLineItems [Line Items]    
Debentures, noncurrent R$ 113,416  
XML 134 R121.htm IDEA: XBRL DOCUMENT v3.23.1
Reconciliation of borrowing activities in the statement of cash flow (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Fair value of financial transactions of non-controlling subsidiaries R$ 609,827  
Additional dividends approved in the board meeting (1,350,000)  
Additional dividends of subsidiary   R$ (2,450)
Borrowings current [1] 1,254,550  
Debentures current [1] 127,801  
Borrowings and debentures current [1] 1,382,351  
financing current [1] 868,635  
Lease current [1] 1,039,706  
Dividends current [1] 11,007  
Borrowings non current 31,310,710  
Debentures non current 3,023,674  
Borrowings and debentures non current 34,334,384  
financing non current 10,501,683  
Non-controlling shareholders non current 2,498,093  
Lease non current 3,200,824  
Borrowings total 32,565,260  
Debentures total 3,151,475  
Borrowings and debentures total 35,716,735  
Financing total 11,370,318  
Shareholders total 2,498,093  
Lease total 4,240,530  
Dividends total 11,007  
Borrowing [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 34,897,260  
Proceeds from debt classified as financing activities 3,479,224  
Payments (3,753,427)  
Cash used in financing activities (274,203)  
Interest paid (1,880,611)  
Interest and monetary and exchange variations, net 1,524,983  
Additions through acquisition of ER Plastic 99,702  
Currency translation adjustments (1,801,871)  
Total other changes (2,057,797)  
Ending balance 32,565,260  
Debentures member    
IfrsStatementLineItems [Line Items]    
Beginning balance 196,918  
Proceeds from debt classified as financing activities 2,938,984  
Payments (102,235)  
Cash used in financing activities 2,836,749  
Interest paid (34,548)  
Interest and monetary and exchange variations, net 152,356  
Total other changes 117,808  
Ending balance 3,151,475  
Borrowings And Debentures [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 35,094,178  
Proceeds from debt classified as financing activities 6,418,208  
Payments (3,855,662)  
Cash used in financing activities 2,562,546  
Interest paid (1,915,159)  
Interest and monetary and exchange variations, net 1,677,339  
Additions through acquisition of ER Plastic 99,702  
Currency translation adjustments (1,801,871)  
Total other changes (1,939,989)  
Ending balance 35,716,735  
Braskem Idesa Financing [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 12,311,535  
Payments (45,311)  
Cash used in financing activities (45,311)  
Interest paid (752,489)  
Interest and monetary and exchange variations, net 170,180  
Currency translation adjustments (313,597)  
Total other changes (895,906)  
Ending balance 11,370,318  
Shareholders Of Braskem Idesa [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 3,646,538  
Payments (34,122)  
Cash used in financing activities (34,122)  
Interest paid (16,212)  
Interest and monetary and exchange variations, net (47,784)  
Currency translation adjustments (84,720)  
Fair value of financial transactions of non-controlling subsidiaries (889,967)  
Total other changes (1,114,323)  
Ending balance 2,498,093  
Lease [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 3,156,414  
Payments (928,890)  
Cash used in financing activities (928,890)  
Interest paid (221,019)  
Interest and monetary and exchange variations, net 83,871  
New contracts 2,232,043  
Disposal (12,568)  
Additions through acquisition of ER Plastic 4,264  
Currency translation adjustments (73,585)  
Total other changes 2,013,006  
Ending balance 4,240,530  
Dividends [Member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 10,538  
Payments (1,350,293)  
Cash used in financing activities (1,350,293)  
Additional dividends approved in the board meeting 1,350,000  
Additional dividends of subsidiary 1,236  
Other (474)  
Total other changes 1,350,762  
Ending balance 11,007  
Loan to non controlling shareholders of braskem idesa member    
IfrsStatementLineItems [Line Items]    
Initial adoption of lease R$ (75,640)  
[1] Amount classified in "Other payables" under current liabilities.
XML 135 R122.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Trade payables member | Financial liabilities at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities R$ 12,249,851 R$ 12,164,730
Book value financial liabilities 12,249,851 12,164,730
Borrowing [Member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 30,432,371 38,839,745
Book value financial liabilities 33,039,985 35,491,315
Braskem idesa borrowings member    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 9,098,458 13,128,665
Book value financial liabilities 11,778,320 12,789,127
Loan to noncontrolling shareholder of braskem idesa member | Financial liabilities at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 2,498,093 3,646,538
Book value financial liabilities 2,498,093 3,646,538
Leniency agreement member | Financial liabilities at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 903,140 1,123,296
Book value financial liabilities 903,140 1,123,296
Level 2 of fair value hierarchy [member] | Borrowing [Member] | Financial liabilities at amortised cost, category [member] | Foreign Currency Bond [Member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 5,329,174 4,696,970
Book value financial liabilities 5,394,816 4,703,059
Level 2 of fair value hierarchy [member] | Borrowing [Member] | Financial liabilities at amortised cost, category [member] | Local currency member    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 1,937,255 451,899
Book value financial liabilities 1,521,011 465,258
Level 2 of fair value hierarchy [member] | Braskem idesa borrowings member | Financial liabilities at amortised cost, category [member] | Other [member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 796,510 931,141
Book value financial liabilities 734,837 849,859
Level 2 of fair value hierarchy [member] | Debentures member | Financial liabilities at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 3,190,417 195,570
Book value financial liabilities 3,162,277 196,918
Level 1 of fair value hierarchy [member] | Borrowing [Member] | Financial liabilities at amortised cost, category [member] | Foreign Currency Bond [Member]    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 23,165,942 33,690,876
Book value financial liabilities 26,124,158 30,322,998
Level 1 of fair value hierarchy [member] | Braskem idesa borrowings member | Financial liabilities at amortised cost, category [member] | Bond member    
IfrsStatementLineItems [Line Items]    
Fair value financial liabilities 8,301,948 12,197,524
Book value financial liabilities 11,043,483 11,939,268
Cash and cash equivalent member    
IfrsStatementLineItems [Line Items]    
Book value financial assets 12,466,474 8,680,686
Fair value financial assets 12,466,474 8,680,686
Cash and cash equivalent member | Financial assets at fair value through profit or loss, category [member] | Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 6,392,266 3,629,864
Fair value financial assets 6,392,266 3,629,864
Cash and cash equivalent member | Cash and banks member | Financial assets at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 6,074,208 5,050,822
Fair value financial assets 6,074,208 5,050,822
Financial investments member    
IfrsStatementLineItems [Line Items]    
Book value financial assets 2,312,631 3,509,555
Fair value financial assets 2,312,631 3,509,555
Financial investments member | Letras financeiras do tesouro l f t member | Financial assets at fair value through profit or loss, category [member] | Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 1,789,375 2,337,171
Fair value financial assets 1,789,375 2,337,171
Financial investments member | Time deposit investments member | Financial assets at amortised cost, class [member] | Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets   106,271
Fair value financial assets   106,271
Financial investments member | Other [member] | Financial assets at fair value through profit or loss, category [member] | Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 523,256 1,066,113
Fair value financial assets 523,256 1,066,113
Trade Accounts Receivables [Member] | Financial assets at fair value through profit or loss, category [member] | Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 32,711 48,508
Fair value financial liabilities 32,711 48,508
Trade Accounts Receivables [Member] | Financial assets at amortised cost, class [member]    
IfrsStatementLineItems [Line Items]    
Book value financial assets 3,199,223 7,118,452
Fair value financial assets R$ 3,199,223 R$ 7,118,452
XML 136 R123.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Current derivative financial assets R$ 157,906 R$ 33,816
Non-current derivative financial assets 71,544 51
Derivative financial assets 229,450 33,867
Current derivative financial liabilities 195,169 256,131
Non-current derivative financial liabilities 81,917 362,915
Derivative financial liabilities 277,086 619,046
Derivative financial assets and liabilities 47,636 585,179
Non hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period (15,995) (2,545)
Increase (decrease) in credit derivative, fair value (27,830)  
Credit derivative financial settlement 14,380  
Hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period 63,631 587,724
Increase (decrease) in credit derivative, fair value (454,754)  
Credit derivative financial settlement (69,339)  
Braksem America Swap C 3 P G P [Member] | Non hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period   14,299
Increase (decrease) in credit derivative, fair value (2,158)  
Credit derivative financial settlement (12,141)  
Braskem Holanda Swap Nafta Gasolina [Member] | Non hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period (15,996) (16,847)
Increase (decrease) in credit derivative, fair value (25,733)  
Credit derivative financial settlement 26,584  
Braskem Argentina Exchange Swap [Member] | Non hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period 1 3
Increase (decrease) in credit derivative, fair value 61  
Credit derivative financial settlement (63)  
Braskem S A Dollar Call And Put Options [Member] | Hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period (65,370) 85,216
Increase (decrease) in credit derivative, fair value (227,871)  
Credit derivative financial settlement 77,285  
Braskem S A Dollar Swap C D I [Member] | Hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period 151,713 R$ 502,508
Increase (decrease) in credit derivative, fair value (194,055)  
Credit derivative financial settlement (156,740)  
Braskem S A Swap C R A [Member] | Hedge accounting transactions member    
IfrsStatementLineItems [Line Items]    
Credit derivative, fair value at end of period (22,712)  
Increase (decrease) in credit derivative, fair value (32,828)  
Credit derivative financial settlement R$ 10,116  
XML 137 R124.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Total nominal R$ 741,516  
Fair value, net 22,712  
Current derivative financial assets 157,906 R$ 33,816
Non-current derivative financial assets 71,544 51
Derivative financial assets 229,450 33,867
Non-current derivative financial liabilities 81,917 362,915
Derivative financial liabilities 277,086 619,046
Derivative financial assets and liabilities 47,636 R$ 585,179
Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Current derivative financial assets 13,274  
Non-current derivative financial assets 49,613  
Derivative financial assets 62,887  
Non-current derivative financial liabilities 40,175  
Derivative financial liabilities 40,175  
Derivative financial assets and liabilities 22,712  
Swaps C R A [Member]    
IfrsStatementLineItems [Line Items]    
Total nominal R$ 600,218  
Interest rate per year 3.5388%  
Maturity date dec-2028  
Fair value, net R$ 12,603  
Swaps C R A 1 [Member]    
IfrsStatementLineItems [Line Items]    
Total nominal R$ 141,298  
Interest rate per year 3.3742%  
Maturity date dec-2031  
Fair value, net R$ 10,109  
XML 138 R125.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 3) - Dec. 31, 2022
R$ in Thousands, $ in Thousands
USD ($)
BRL (R$)
United States of America, Dollars    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value $ 5,238,854 R$ 27,334,769
Later than four years and not later than five years [member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 288,854 1,507,154
Later than five years and not later than ten years [member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 800,000 4,174,160
Later than five years and not later than seven years [member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 1,250,000 6,522,125
Later Than Eight Years And Not Later Than Nine Years [Member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 500,000 2,608,850
Later than seven years and not later than ten years [member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 800,000 4,174,160
Later Than Ten Years 1 [Member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value 800,000 4,174,160
Later than ten years and not later than fifteen years [member] | U S D [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability maturities nominal value $ 800,000 R$ 4,174,160
XML 139 R126.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 4) - United States of America, Dollars - Future exports member - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Designated balance, beginning $ 5,238,854 $ 4,738,854
Designations $ 500,000  
XML 140 R127.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 5)
R$ in Thousands, $ in Thousands
Dec. 31, 2022
USD ($)
Number
Dec. 31, 2022
BRL (R$)
Number
IfrsStatementLineItems [Line Items]    
Exports designated for hedge gross nominal value | R$   R$ 1,421,391
First Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge gross nominal value | R$   345,958
Second Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge gross nominal value | R$   411,195
Third Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge gross nominal value | R$   367,703
Fourth Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge gross nominal value | R$   R$ 296,535
United States of America, Dollars    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge nominal value | $ $ 719,000  
United States of America, Dollars | First Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge nominal value | $ $ 175,000  
Opening foreign exchange rate 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786
United States of America, Dollars | Second Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge nominal value | $ $ 208,000  
Opening foreign exchange rate 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786
United States of America, Dollars | Third Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge nominal value | $ $ 186,000  
Opening foreign exchange rate 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786
United States of America, Dollars | Fourth Quarter [Member]    
IfrsStatementLineItems [Line Items]    
Exports designated for hedge nominal value | $ $ 150,000  
Opening foreign exchange rate 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786
XML 141 R128.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 6)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Beginning balance R$ (8,647,689)
Exchange variation recorded in the period on OCI / IR and CSL 1,121,938
Exchange variation transferred to profit or loss / IR and CSL 938,118
Ending balance (6,587,633)
Exchange variation member  
IfrsStatementLineItems [Line Items]  
Beginning balance (13,102,558)
Exchange variation recorded in the period on OCI / IR and CSL 1,699,906
Exchange variation transferred to profit or loss / IR and CSL 1,421,391
Ending balance (9,981,261)
I r and c s l member  
IfrsStatementLineItems [Line Items]  
Beginning balance 4,454,869
Exchange variation recorded in the period on OCI / IR and CSL (577,968)
Exchange variation transferred to profit or loss / IR and CSL (483,273)
Ending balance R$ 3,393,628
XML 142 R129.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 7)
R$ in Thousands
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value R$ 11,687,649
Later than two years and not later than three years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 65,221
Later than three years and not later than four years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 117,398
Later than four years and not later than five years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 117,398
Later than five years and not later than ten years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 430,460
Later than seven years and not later than ten years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 1,173,983
Later than ten years and not later than fifteen years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 1,173,983
Later than fifteen years and not later than twenty years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 2,739,293
Later than twenty years and not later than twenty-five years [member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 2,739,293
Later Than Thirty Years And Not Later Than Thirtyfive Years [Member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value 1,565,310
Later Than Fourty Years And Not Later Than Fourtyfive Years [Member]  
IfrsStatementLineItems [Line Items]  
Designated and unrealized sales nominal value R$ 1,565,310
XML 143 R130.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 8)
R$ in Thousands, $ in Thousands, $ in Thousands
Dec. 31, 2022
USD ($)
Number
Dec. 31, 2022
BRL (R$)
Number
Dec. 31, 2022
MXN ($)
Number
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   R$ 1,421,391  
Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   424,003  
First Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   345,958  
First Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   49,302  
Second Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   411,195  
Second Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   116,361  
Third Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   367,703  
Third Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   120,341  
Fourth Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   296,535  
Fourth Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge gross nominal value | R$   R$ 137,999  
United States of America, Dollars      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value | $ $ 719,000    
United States of America, Dollars | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value 253,204   $ 1,645,123
United States of America, Dollars | First Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value | $ $ 175,000    
Opening foreign exchange rate 2.0017 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786 3.9786
United States of America, Dollars | First Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value $ 29,136   $ 194,072
Opening foreign exchange rate 13.6218 13.6218 13.6218
Closing foreign exchange rate 20.2827 20.2827 20.2827
United States of America, Dollars | Second Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value | $ $ 208,000    
Opening foreign exchange rate 2.0017 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786 3.9786
United States of America, Dollars | Second Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value $ 72,612   $ 470,453
Opening foreign exchange rate 13.6507 13.6507 13.6507
Closing foreign exchange rate 20.1297 20.1297 20.1297
United States of America, Dollars | Third Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value | $ $ 186,000    
Opening foreign exchange rate 2.0017 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786 3.9786
United States of America, Dollars | Third Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value $ 72,612   $ 470,453
Opening foreign exchange rate 13.6507 13.6507 13.6507
Closing foreign exchange rate 20.1297 20.1297 20.1297
United States of America, Dollars | Fourth Quarter [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value | $ $ 150,000    
Opening foreign exchange rate 2.0017 2.0017 2.0017
Closing foreign exchange rate 3.9786 3.9786 3.9786
United States of America, Dollars | Fourth Quarter [Member] | Braskem Idesa [Member]      
IfrsStatementLineItems [Line Items]      
Exports designated for hedge nominal value $ 78,844   $ 510,144
Opening foreign exchange rate 13.6521 13.6521 13.6521
Closing foreign exchange rate 20.1224 20.1224 20.1224
XML 144 R131.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 9) - Braskem Idesa [Member]
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Beginning balance R$ (1,561,319)
Exchange variation recorded in the period / IR 489,774
Exchange variation transferred to profit or loss / IR 296,802
Ending balance (774,743)
Exchange variation member  
IfrsStatementLineItems [Line Items]  
Beginning balance (2,231,511)
Exchange variation recorded in the period / IR 699,677
Exchange variation transferred to profit or loss / IR 424,003
Ending balance (1,107,831)
I r and c s l member  
IfrsStatementLineItems [Line Items]  
Beginning balance 670,192
Exchange variation recorded in the period / IR (209,903)
Exchange variation transferred to profit or loss / IR (127,201)
Ending balance R$ 333,088
XML 145 R132.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 10)
Dec. 31, 2022
Dec. 31, 2021
Minimum risk member    
IfrsStatementLineItems [Line Items]    
Expected credit loss rate 72.15% 65.39%
Low risk member    
IfrsStatementLineItems [Line Items]    
Expected credit loss rate 21.65% 26.65%
Moderate risk member    
IfrsStatementLineItems [Line Items]    
Expected credit loss rate 3.36% 6.02%
High risk member    
IfrsStatementLineItems [Line Items]    
Expected credit loss rate 2.56% 1.54%
Very high risk member    
IfrsStatementLineItems [Line Items]    
Expected credit loss rate [1] 0.28% 0.40%
[1] Clients in this group that are still active buy from Braskem and pay in advance.
XML 146 R133.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 11) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market R$ 5,793,521 R$ 4,559,181
Financial assets with risk assessment foreign market 8,821,089 7,589,568
Financial assets with risk assessment 14,614,610 12,148,749
Financial assets without risk assessment domestic market 83,070 27,710
Financial assets without risk assessment foreign market 81,425 13,782
Financial assets without risk assessment 164,495 41,492
Financial assets domestic market 5,876,591 4,586,891
Financial assets foreign market 8,902,514 7,603,350
Financial assets 14,779,105 12,190,241
A a a member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 5,130,140 4,080,884
Financial assets with risk assessment foreign market 2,420,741 2,783,151
Financial assets with risk assessment 7,550,881 6,864,035
A a plus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 162,650 109,165
Financial assets with risk assessment 162,650 109,165
A a member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 289,574 188,742
Financial assets with risk assessment foreign market 107,545 629,671
Financial assets with risk assessment 397,119 818,413
A a minus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 149,178 63,675
Financial assets with risk assessment 149,178 63,675
A plus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 3,423 5,788
Financial assets with risk assessment foreign market 4,459,700 2,914,269
Financial assets with risk assessment 4,463,123 2,920,057
A member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 57,650 107,225
Financial assets with risk assessment foreign market 1,392,854  
Financial assets with risk assessment 1,450,504 107,225
A minus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market   634
Financial assets with risk assessment foreign market 387,478 236,335
Financial assets with risk assessment 387,478 236,969
B b b plus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 118 856
Financial assets with risk assessment foreign market 375 38
Financial assets with risk assessment 493 894
B b b member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market 788 129
Financial assets with risk assessment foreign market 52,389 1,026,104
Financial assets with risk assessment 53,177 1,026,233
B b b minus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market   554
Financial assets with risk assessment   554
B b plus member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market   50
Financial assets with risk assessment   50
B b member    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment domestic market   1,479
Financial assets with risk assessment   1,479
B B Minus [Member]    
IfrsStatementLineItems [Line Items]    
Financial assets with risk assessment foreign market 7  
Financial assets with risk assessment 7  
Shares Of Investment Funds [Member]    
IfrsStatementLineItems [Line Items]    
Financial assets without risk assessment domestic market   1,721
Other Financial Asset [Member]    
IfrsStatementLineItems [Line Items]    
Financial assets without risk assessment domestic market [1] 83,070 25,989
Financial assets without risk assessment foreign market [1] 81,425 13,782
Financial assets without risk assessment [1] R$ 164,495 R$ 39,771
[1] Investments approved by the Management, in accordance with the Financial Policy.
XML 147 R134.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details 12)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
Bond member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value R$ (37,167,641)
Probable gain (loss) (372,553)
Reasonably possible gain (loss) (5,051,899)
Possible gain (loss) (15,155,696)
Export prepayments member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (1,028,473)
Probable gain (loss) (10,309)
Reasonably possible gain (loss) (139,792)
Possible gain (loss) (419,376)
Export prepayments member | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (35,749)
Probable gain (loss) (887)
Reasonably possible gain (loss) (3,388)
Possible gain (loss) (10,163)
Export prepayments member | Selic interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (992,725)
Probable gain (loss) (25,698)
Reasonably possible gain (loss) (195,867)
Possible gain (loss) (587,602)
Investment [Member] | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (1,985,932)
Probable gain (loss) (19,906)
Reasonably possible gain (loss) (269,932)
Possible gain (loss) (809,795)
Investment [Member] | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (1,985,932)
Probable gain (loss) (63,201)
Reasonably possible gain (loss) (241,339)
Possible gain (loss) (724,017)
Sace member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (1,478,722)
Probable gain (loss) (14,822)
Reasonably possible gain (loss) (200,991)
Possible gain (loss) (602,973)
Sace member | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (1,478,722)
Probable gain (loss) (49,107)
Reasonably possible gain (loss) (187,520)
Possible gain (loss) (562,560)
Dollar call and put options member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value 65,370 [1]
Probable gain (loss) 9,809 [1]
Reasonably possible gain (loss) (160,742) [1]
Possible gain (loss) (1,023,396) [1]
Dollar swap c d i member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (151,713)
Probable gain (loss) (6,216)
Reasonably possible gain (loss) (189,181)
Possible gain (loss) (466,381)
M o n f o r t e member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (197,209)
Probable gain (loss) (1,977)
Reasonably possible gain (loss) (26,805)
Possible gain (loss) (80,415)
M o n f o r t e member | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (197,209)
Probable gain (loss) (4,094)
Reasonably possible gain (loss) (15,635)
Possible gain (loss) (46,906)
Nexi member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (100,707)
Probable gain (loss) (1,009)
Reasonably possible gain (loss) (13,688)
Possible gain (loss) (41,065)
Nexi member | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (100,707)
Probable gain (loss) (3,920)
Reasonably possible gain (loss) (14,970)
Possible gain (loss) (44,909)
Other [member] | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (734,837)
Probable gain (loss) (7,366)
Reasonably possible gain (loss) (99,881)
Possible gain (loss) (299,642)
Financial investments abroad member | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value 6,718,183
Probable gain (loss) 67,340
Reasonably possible gain (loss) 913,149
Possible gain (loss) 2,739,446
Dollar Swap I P C A [Member] | Brazilian real u s dollar exchange rate member  
IfrsStatementLineItems [Line Items]  
Exposure value 22,713
Probable gain (loss) (607)
Reasonably possible gain (loss) (63,356)
Possible gain (loss) (194,841)
Dollar Swap I P C A [Member] | I p c a interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value 22,713
Probable gain (loss) (99,748)
Reasonably possible gain (loss) 31,958
Possible gain (loss) 99,871
Outros [Member] | Libor floating interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (734,837)
Probable gain (loss) (16,887)
Reasonably possible gain (loss) (64,483)
Possible gain (loss) (193,449)
Debentures member | C d i interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (3,052,400)
Probable gain (loss) 302,796
Reasonably possible gain (loss) (898,725)
Possible gain (loss) (3,331,635)
Debentures member | I p c a interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (109,877)
Probable gain (loss) 1,494
Reasonably possible gain (loss) (2,085)
Possible gain (loss) (6,315)
Financial investments in brazil member | C d i interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value 5,876,590
Probable gain (loss) (80,242)
Reasonably possible gain (loss) 206,257
Possible gain (loss) 619,489
B N D E S [Member] | I p c a interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (386,534)
Probable gain (loss) 26,403
Reasonably possible gain (loss) (38,283)
Possible gain (loss) (121,208)
B n b f i n e p f u n d e s f i n i s a f i n a m e f n e member | I p c a interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (3,525)
Probable gain (loss) 59
Reasonably possible gain (loss) (83)
Possible gain (loss) (252)
C R A [Member] | I p c a interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (763,396)
Probable gain (loss) 45,429
Reasonably possible gain (loss) (65,630)
Possible gain (loss) (206,889)
Leniency agreement member | Selic interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (865,311)
Probable gain (loss) 6,856
Reasonably possible gain (loss) (17,443)
Possible gain (loss) (51,656)
Export Credit Notes [Member] | Selic interest rate member  
IfrsStatementLineItems [Line Items]  
Exposure value (521,926)
Probable gain (loss) (13,571)
Reasonably possible gain (loss) (103,435)
Possible gain (loss) R$ (310,306)
[1] The Company is in the short position of a possible counterparty call.
XML 148 R135.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments (Details Narrative)
R$ in Millions
12 Months Ended
Dec. 31, 2022
BRL (R$)
Number
Dec. 31, 2021
BRL (R$)
Number
Dec. 31, 2020
BRL (R$)
Dec. 31, 2019
BRL (R$)
Dec. 31, 2017
BRL (R$)
IfrsStatementLineItems [Line Items]          
Average export | Number 88.7 17      
Decription of fair value at risk fair value adjustment that could result in one month as from December 31, 2022, with a probability of 5%, and under normal market conditions, was estimated by the Company at R$129 million (US$24.7 million) for put options and call options (Note 20.5(a.i)) and R$96.7 million (US$18.5 million) for the US dollar swap (Note 20.5(a.ii)) and R$4.5 million (US$872 thousand) for the CRA swap (Note 20.2(a.iii)).        
Put options member          
IfrsStatementLineItems [Line Items]          
Notional amount R$ 2,100 R$ 10,960      
Average export | Number 4.7        
Call options member          
IfrsStatementLineItems [Line Items]          
Notional amount R$ 1,400 7,300      
Average export | Number 7.06        
Future exports member          
IfrsStatementLineItems [Line Items]          
Designated R$ 2,609 2,087 R$ 3,131 R$ 11,500 R$ 6,520
Hedge accounting discontinued   2,087 1,889    
Hedge accounting discontinued   1,044      
Future Exports One [Member]          
IfrsStatementLineItems [Line Items]          
Designated R$ 500 400 600 R$ 2,200  
Hedge accounting discontinued   400 R$ 362    
Hedge accounting discontinued   R$ 200      
XML 149 R136.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes payable (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Current payables on social security and taxes other than income tax R$ 491,051 R$ 1,012,116
Non-current payables on social security and taxes other than income tax 298,026 260,497
Other countries member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 789,077 1,272,613
I p i member | Domestic member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 74,219 131,290
I c m s member | Domestic member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 218,179 485,302
P i s and c o f i n s member | Domestic member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 20,406 33,516
Other [member] | Domestic member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 103,549 46,117
Other [member] | Other countries member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax 222,464 346,817
Value added tax member | Other countries member    
IfrsStatementLineItems [Line Items]    
Payables on social security and taxes other than income tax R$ 150,260 R$ 229,571
XML 150 R137.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Taxes      
Profit (loss) before income taxes R$ 47,344 R$ 17,961,023 R$ (9,683,784)
Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%) (16,097) (6,106,748) 3,292,487
Permanent adjustments to income taxes calculation basis      
Income taxes on equity in results of investees 11,849 1,578 6,595
Thin capitalization [1] (359,598) (6,628) (695,741)
Tax benefits (Sudene and PAT) 137,338
Reduction of tax loss (891,669)  
Effect of the refund of Braskem America´s tax benefit     (737,841)
Different jurisdictional taxes rates for companies abroad and tax basis [2] 1,029,618 1,980,358 994,811
Effect from the retrospective tax rate on bonus depreciation of Braskem America   334,460
Taxes on dividends distribution (454,663) (265,454) (131,240)
Exclusion of inflation adjustement by Selic on undue tax payments from taxable income 39,395 501,382  
Other permanent adjustments (226,570) (241,229) (395,053)
Effect of income taxes on results of operations (867,735) (3,999,403) 2,668,478
Current income taxes      
Current year (1,003,705) (3,834,437) (52,830)
Total current expenses  (1,003,705) (3,834,437) (52,830)
Deferred income taxes      
Origination and reversal of temporary differences 1,192,438 (246,294) 2,677,328
Tax losses (1,056,468) 81,328 43,980
Total Deferred income taxes  135,970 (164,966) 2,721,308
Total R$ (867,735) R$ (3,999,403) R$ 2,668,478
Effective rate 1832.80% 22.30% 27.60%
[1] Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.
[2] Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:
XML 151 R138.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Details 1)
12 Months Ended
Dec. 31, 2022
Subsidiary one member  
IfrsStatementLineItems [Line Items]  
Headquarters country Germany
Official rate 31.09%
Subsidiary two member  
IfrsStatementLineItems [Line Items]  
Headquarters country USA
Official rate 21.00%
Subsidiary three member  
IfrsStatementLineItems [Line Items]  
Headquarters country Argentina
Official rate 25.00%
Subsidiary four member  
IfrsStatementLineItems [Line Items]  
Headquarters country Chile
Official rate 27.00%
Subsidiary five member  
IfrsStatementLineItems [Line Items]  
Headquarters country Netherlands
Official rate 25.80%
Subsidiary six member  
IfrsStatementLineItems [Line Items]  
Headquarters country Mexico
Official rate 30.00%
Subsidiary seven member  
IfrsStatementLineItems [Line Items]  
Headquarters country India
Official rate 30.00%
XML 152 R139.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Deferred tax assets1 R$ 6,358,601 R$ 8,257,252 R$ 8,529,972
Deferred tax liabilities1 1,153,481 1,407,434 1,234,398
Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 5,999,273 5,714,469 4,981,691
Ending balance 53,156 686,390  
Other comprehensive income 231,648    
Impact on the equity   46,388  
Net member      
IfrsStatementLineItems [Line Items]      
Ending balance 5,205,120 6,849,818 7,295,574
Ending balance 135,970 (164,966)  
Other comprehensive income (1,780,668)    
Impact on the equity   (280,790)  
Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 11,204,393 12,564,287 12,277,265
Ending balance 189,126 521,424  
Other comprehensive income (1,549,020) (234,402)  
Tax losses i r and negative base c s l member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 2,397,532 3,354,716 3,278,184
Ending balance (957,184) 76,532  
Goodwill amortized member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 2,095 2,459 6,520
Ending balance (364) (4,061)  
Exchange variations member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 3,342,880 4,280,062 3,817,615
Ending balance 611,838 696,849  
Other comprehensive income (1,549,020) (234,402)  
Temporary adjustment member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 4,647,532 4,782,277 4,996,337
Ending balance (134,745) (214,060)  
Temporary adjustment member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 420,315 88,993 158,232
Ending balance 331,322 (69,239)  
Business combination member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance   26,884 56,211
Ending balance (26,884) (29,327)  
Tax credits member | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance [1] 697,662   77,032
Ending balance [1] 697,662 (77,032)  
Other [member] | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 4,826 4,826 4,827
Ending balance 29,706 (46,389)  
Other comprehensive income (29,706)    
Impact on the equity   46,388  
Other [member] | Asset member      
IfrsStatementLineItems [Line Items]      
Ending balance 116,692 117,889 45,366
Ending balance (1,197) 72,523  
Amortization of fair value adjustments on the assets from the acquisiton of quattor member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 722,433 725,097 722,222
Ending balance (2,664) 2,875  
Tax depreciation member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 4,051,462 4,176,950 3,737,169
Ending balance (125,488) 439,781  
Exclusion of i c m s in basis of calculation member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 189,649 331,479  
Ending balance (141,830)    
Exclusion of i c m s in basis of calculation member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance   331,479  
Present value adjustment and amortized cost member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 423,951 154,691 79,920
Ending balance 7,906 74,771  
Other comprehensive income 261,354    
Amortization of fair value adjustments on the assets from the acquisiton of braskem qpar member | Liabilities category member      
IfrsStatementLineItems [Line Items]      
Ending balance 186,637 232,433 R$ 279,321
Ending balance R$ (45,796) R$ (46,888)  
[1] Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.  
XML 153 R140.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Details 3) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Liabilities category member    
IfrsStatementLineItems [Line Items]    
Tax calculation, liabilities R$ 5,999,273 R$ 5,714,469
IR and CSl offsetting, liabilites (4,845,792) (4,307,035)
Balance, liabilities R$ 1,153,481 1,407,434
Braskem s a member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, liabilities R$ 2,584,962 2,496,637
IR and CSl offsetting, liabilites R$ (2,584,962) (2,496,637)
Braskem argentina member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Chile  
Tax calculation, liabilities R$ 16,174  
IR and CSl offsetting, liabilites R$ (16,174)  
Braskem america member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country USA  
Tax calculation, liabilities R$ 1,493,471 1,701,762
IR and CSl offsetting, liabilites (356,598) (294,328)
Balance, liabilities R$ 1,136,873 1,407,434
Braskem holanda member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Netherlands  
Tax calculation, liabilities R$ 39,696  
IR and CSl offsetting, liabilites R$ (39,696)  
Braskem Idesa [Member] | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, liabilities R$ 1,840,669 1,506,541
IR and CSl offsetting, liabilites R$ (1,840,669) (1,506,541)
Cetrel member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, liabilities R$ 5,405 7,586
IR and CSl offsetting, liabilites R$ (5,405) (7,586)
D a c member | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, liabilities R$ 2,262 1,943
IR and CSl offsetting, liabilites R$ (2,262) (1,943)
Voqen [Member] | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, liabilities R$ 26  
IR and CSl offsetting, liabilites R$ (26)  
B T C [Member] | Liabilities category member    
IfrsStatementLineItems [Line Items]    
Headquarters country Netherlands  
Tax calculation, liabilities R$ 16,608  
Balance, liabilities 16,608  
Asset member    
IfrsStatementLineItems [Line Items]    
Tax calculation, assets 11,204,393 12,564,287
IR and CSL offsetting, assets (5,001,138) (4,307,035)
Balance, assets R$ 6,358,601 8,257,252
Asset member | Braskem s a member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, assets R$ 8,356,402 8,841,886
IR and CSL offsetting, assets (2,584,962) (2,496,637)
Balance, assets R$ 5,771,440 6,345,249
Asset member | Braskem argentina member    
IfrsStatementLineItems [Line Items]    
Headquarters country Argentina  
Tax calculation, assets R$ 21,339 3,271
IR and CSL offsetting, assets (16,174)  
Balance, assets R$ 5,165 3,271
Asset member | Braskem america member    
IfrsStatementLineItems [Line Items]    
Headquarters country USA  
Tax calculation, assets R$ 356,598 294,328
IR and CSL offsetting, assets R$ (356,598) (294,328)
Asset member | Braskem alemanha member    
IfrsStatementLineItems [Line Items]    
Headquarters country Germany  
Tax calculation, assets R$ 23,038 44,417
Balance, assets R$ 23,038 44,417
Asset member | Braskem chile member    
IfrsStatementLineItems [Line Items]    
Headquarters country Chile  
Tax calculation, assets R$ 47 92
Balance, assets R$ 47 92
Asset member | Braskem holanda member    
IfrsStatementLineItems [Line Items]    
Headquarters country Netherlands  
Tax calculation, assets R$ 195,042  
IR and CSL offsetting, assets R$ (39,696)  
Asset member | Braskem Idesa [Member]    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, assets R$ 2,078,206 3,282,125
IR and CSL offsetting, assets (1,840,669) (1,506,541)
Balance, assets R$ 237,537 1,775,584
Asset member | Braskem idesa servicos member    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, assets   26
Balance, assets   26
Asset member | Braskem Mexico Servicos [Member]    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, assets R$ 13,628 2,502
Balance, assets R$ 13,628 2,502
Asset member | Braskem Mexico [Member]    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, assets R$ 86,368 16,181
Balance, assets R$ 86,368 16,181
Asset member | Cetrel member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, assets R$ 39,387 40,434
IR and CSL offsetting, assets (5,405) (7,586)
Balance, assets R$ 33,982 32,848
Asset member | D a c member    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, assets R$ 32,617 39,025
IR and CSL offsetting, assets (2,262) (1,943)
Balance, assets R$ 30,355 R$ 37,082
Asset member | Terminal Quimica [Member]    
IfrsStatementLineItems [Line Items]    
Headquarters country Mexico  
Tax calculation, assets R$ 1,618  
Balance, assets R$ 1,618  
Asset member | Voqen [Member]    
IfrsStatementLineItems [Line Items]    
Headquarters country Brazil  
Tax calculation, assets R$ 103  
IR and CSL offsetting, assets (26)  
Balance, assets R$ 77  
XML 154 R141.htm IDEA: XBRL DOCUMENT v3.23.1
Income taxes (Details Narrative) - BRL (R$)
R$ in Thousands
1 Months Ended
Aug. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Income Taxes      
Income taxes current   R$ 392,062 R$ 1,189,812
Income taxes noncurrent   252,995 230,069
Taxes recoverable     R$ 984,400
Payment of tax incentives R$ 1,038,255    
Deferred tax credits   R$ 892,000  
XML 155 R142.htm IDEA: XBRL DOCUMENT v3.23.1
Sundry provisions (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Sundry provisions, current R$ 1,376,947 R$ 1,289,263
Sundry provisions, current 530,814 465,051
Sundry provisions, current 846,133 824,212
Recovery of environmental damage member    
IfrsStatementLineItems [Line Items]    
Sundry provisions, current 1,120,188 1,035,426
Provision for customers rebates member    
IfrsStatementLineItems [Line Items]    
Sundry provisions, current 126,754 101,253
Other [member]    
IfrsStatementLineItems [Line Items]    
Sundry provisions, current R$ 130,005 R$ 152,584
XML 156 R143.htm IDEA: XBRL DOCUMENT v3.23.1
Sundry provisions (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Beginning balance R$ 1,289,263 R$ 874,208
Additions, monetary adjustments and exchange variation 503,161 835,191
Write-offs through usage and payments (415,477) (420,136)
Ending balance 1,376,947 1,289,263
Recovery of environmental damage member    
IfrsStatementLineItems [Line Items]    
Beginning balance 1,035,426 602,490
Additions, monetary adjustments and exchange variation 299,241 576,086
Write-offs through usage and payments (214,479) (143,150)
Ending balance 1,120,188 1,035,426
Rebate member    
IfrsStatementLineItems [Line Items]    
Beginning balance 101,253 123,465
Additions, monetary adjustments and exchange variation 184,142 144,710
Write-offs through usage and payments (158,641) (166,922)
Ending balance 126,754 101,253
Other [member]    
IfrsStatementLineItems [Line Items]    
Beginning balance 152,584 148,253
Additions, monetary adjustments and exchange variation 19,777 114,395
Write-offs through usage and payments (42,357) (110,064)
Ending balance R$ 130,005 R$ 152,584
XML 157 R144.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Contingencies R$ 1,171,498 R$ 1,153,830
Labor claims member    
IfrsStatementLineItems [Line Items]    
Contingencies 212,657 268,758
Tax claims member | Normal operation member    
IfrsStatementLineItems [Line Items]    
Contingencies 735,893 715,099
Tax claims member | I r and c s l member | Normal operation member    
IfrsStatementLineItems [Line Items]    
Contingencies 51,756 61,946
Tax claims member | P i s and c o f i n s member | Normal operation member    
IfrsStatementLineItems [Line Items]    
Contingencies 311,433 299,202
Tax claims member | I c m s member | Normal operation member    
IfrsStatementLineItems [Line Items]    
Contingencies 348,544 331,094
Tax claims member | Other tax claims member | Normal operation member    
IfrsStatementLineItems [Line Items]    
Contingencies 24,160 22,857
Corporate claims member    
IfrsStatementLineItems [Line Items]    
Contingencies 103,387 94,826
Civil claims and other member    
IfrsStatementLineItems [Line Items]    
Contingencies R$ 119,561 R$ 75,147
XML 158 R145.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Beginning balance R$ 1,153,830 R$ 1,151,087
Additions, inflation adjustments and exchange variation 274,584 309,891
Payments (69,785) (117,506)
Reversals [1] (187,131) (189,642)
Ending balance 1,171,498 1,153,830
Labor claims member    
IfrsStatementLineItems [Line Items]    
Beginning balance 268,758 280,066
Additions, inflation adjustments and exchange variation 128,682 172,574
Payments (57,750) (70,968)
Reversals [1] (127,033) (112,914)
Ending balance 212,657 268,758
Tax claims net member    
IfrsStatementLineItems [Line Items]    
Beginning balance 715,099 692,735
Additions, inflation adjustments and exchange variation 60,627 46,849
Payments (8,792) (3,659)
Reversals [1] (31,041) (20,826)
Ending balance 735,893 715,099
Corporate claim member    
IfrsStatementLineItems [Line Items]    
Beginning balance 94,826 126,057
Additions, inflation adjustments and exchange variation 9,048 14,357
Payments   (40,109)
Reversals [1] (487) (5,479)
Ending balance 103,387 94,826
Civil claims and other member    
IfrsStatementLineItems [Line Items]    
Beginning balance 75,147 52,229
Additions, inflation adjustments and exchange variation 76,227 76,111
Payments (3,243) (2,770)
Reversals [1] (28,570) (50,423)
Ending balance R$ 119,561 R$ 75,147
[1] A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.
XML 159 R146.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities (Details 2) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss R$ 26,688,394 R$ 22,647,058
Tax claims member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 18,270,680 17,224,429
Civil claims one member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 5,489,479 2,614,344
Civil claims two member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 786,441 737,083
Labor claims member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 605,546 763,555
Environmental claims member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 639,880 571,057
Social security claims member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 515,506 398,783
Other lawsuits member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss R$ 380,862 R$ 337,807
XML 160 R147.htm IDEA: XBRL DOCUMENT v3.23.1
Provisions for legal proceedings and contingent liabilities (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Amount of these claims R$ 194,695 R$ 179,370,000
Amount under discussion 1,400,000 1,300,000
Amount of provision for possibility of outflow of resources 21,000 19,000
Amount evaluated as possible loss 262,000  
Possible amount chance to loss R$ 283,000 257,000
I r and c s l member    
IfrsStatementLineItems [Line Items]    
Percentage amount of the tax deficiency notice 150.00%  
Adjusted amount of uncertain tax treatment R$ 1,200,000 1,100,000
Adjusted amount of uncertain tax estimate 1,100,000 1,100,000
Claims with possible chance of loss 462,000 430,000
Tax contingent liability [member] | Social security contributions member    
IfrsStatementLineItems [Line Items]    
Other administrative proceedings 176,000 173,000
Tax contingent liability [member] | I r p j and c s l l foreign earned income member    
IfrsStatementLineItems [Line Items]    
Adjusted amount of uncertain tax treatment 10,600,000 8,800,000
Civil claims resale of solvents member    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 302,000 265,000
Environmental member    
IfrsStatementLineItems [Line Items]    
Payment for indemnifiction 363,000 325,000
Social security member    
IfrsStatementLineItems [Line Items]    
Estimated amount R$ 379,000 332,000
Tax Claims I C M S [Member]    
IfrsStatementLineItems [Line Items]    
Percentage fine for tax offense 100.00%  
Amounts indicated in tax R$ 480,389  
Adjusted value of cases 639,000 587,000
Tax Claims I C M S [Member] | P i s and c o f i n s taxes member    
IfrsStatementLineItems [Line Items]    
Updated value of this proceeding amounted 967,000 910,000
Tax Claims I C M S [Member] | Tax contingent liability [member]    
IfrsStatementLineItems [Line Items]    
Provisions for fine for tax offense 329,125 313,380
Claims with possible chance of loss 768,000 756,000
P i s and c o f i n s sundry member    
IfrsStatementLineItems [Line Items]    
Labor claims for health and security cases 136,000 131,000
I r r f i r and c s l commission expenses member | Tax contingent liability [member]    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 153,000 142,000
Isolated fine failure to ratify d c o m p s member | Tax contingent liability [member]    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss 353,000 310,000
P i s and c o f i n s d cide fuels tax offset member | Tax contingent liability [member]    
IfrsStatementLineItems [Line Items]    
Adjusted value of cases 123,000 118,000
I r p j c s l l negative balance offset member | Tax contingent liability [member]    
IfrsStatementLineItems [Line Items]    
Claims with possible chance of loss R$ 203,000 R$ 187,000
XML 161 R148.htm IDEA: XBRL DOCUMENT v3.23.1
Leniency agreement with authorities (Details) - Leniency agreements member
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
IfrsStatementLineItems [Line Items]  
Settlement amount R$ 3,070,578
Federal controller general and attorney generall agreement member  
IfrsStatementLineItems [Line Items]  
Settlement amount 877,763
Department of justice member  
IfrsStatementLineItems [Line Items]  
Settlement amount 296,591 [1]
Swiss office member  
IfrsStatementLineItems [Line Items]  
Settlement amount 407,300 [1]
Federal prosecution office member  
IfrsStatementLineItems [Line Items]  
Settlement amount 1,282,464
Securities and exchange commission member  
IfrsStatementLineItems [Line Items]  
Settlement amount R$ 206,460 [1]
[1] U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").
XML 162 R149.htm IDEA: XBRL DOCUMENT v3.23.1
Leniency agreement with authorities (Details Narrative) - BRL (R$)
R$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2016
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Outstanding amount   R$ 903,140
Current liabilities   392,486
Noncurrent liabilities   510,654
Leniency agreements member    
IfrsStatementLineItems [Line Items]    
Settlement liabilities   R$ 3,070,578
Federal prosecution office and u s swiss authorities member | Leniency agreements member    
IfrsStatementLineItems [Line Items]    
Settlement liabilities R$ 3,100,000  
United States of America, Dollars | Federal prosecution office and u s swiss authorities member | Leniency agreements member    
IfrsStatementLineItems [Line Items]    
Settlement liabilities R$ 957,000  
XML 163 R150.htm IDEA: XBRL DOCUMENT v3.23.1
Geological event - Alagoas (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Provision R$ 1,171,498 R$ 1,153,830  
Alagoas member      
IfrsStatementLineItems [Line Items]      
Balance at beginning 7,661,259 9,175,777 R$ 3,383,067
Balance at ending 6,626,558 7,661,259 9,175,777
Additions 1,520,019 1,339,765 6,901,827
Payments and reclassifications [1] (2,742,791) (2,928,081) (1,181,931)
Realization of present value adjustment 188,071 73,798 72,814
Balance at ending 6,626,558 7,661,259 9,175,777
Current liability 4,247,609 4,378,071 4,349,931
Non-current liability 2,378,949 3,283,188 4,825,846
Provision R$ 6,626,558 R$ 7,661,259 R$ 9,175,777
[1] Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.
XML 164 R151.htm IDEA: XBRL DOCUMENT v3.23.1
Geological event - Alagoas (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Description of reparation for social-environmental allocating R$1,580,000 for the adoption of actions and measures in vacated areas, urban mobility and social compensation actions, of which R$300 million going to indemnification for social damages and collective pain and suffering and possible contingencies related to the actions in the vacated areas and urban mobility actions. The provision amount, updated by inflation index established in the agreement, is R$1,567,842 (2021: R$1,577,186).  
Lawsuit compensation R$ 1,700,000  
Key management personnel compensation, share-based payment R$ 1,100,000  
Description of individual actions Braskem was defendant in several other actions, that, in aggregate, involve the amount of R$1 billion (2021: R$895 million), filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió.  
Technical cooperation agreement member    
IfrsStatementLineItems [Line Items]    
Provision accrued amount R$ 1,367,269 R$ 1,691,032
Description of reparation for residents Public-Interest Civil Action claiming the payment of indemnification for damages caused to the buildings and the residents of areas affected in the Pinheiro district and surrounding areas, in the total minimum amount of R$6.7 billion, with initial request for provisional measure to freeze the Company’s financial and other assets in the same amount. Successive orders to freeze funds resulted in the court blocking of R$3.7 billion in assets in 2019, and the unfreezing occurred in January 2020. Once the case was sent to the Federal Courts, the Federal Prosecution Office started to participate in the action.  
Alagoas state federal prosecution office member | Technical cooperation agreement member    
IfrsStatementLineItems [Line Items]    
Net of adjustment to present value R$ 2,087,142 R$ 3,390,849
XML 165 R152.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Short-term benefits R$ 574,036 R$ 539,566 R$ 436,021
Health care benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 243,620 235,681 197,683
Private pension benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 127,954 136,851 94,302
Transport benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 86,217 77,201 66,752
Feeding benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 62,786 51,240 38,400
Life insurance benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 10,400 10,324 9,875
Training benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits 27,032 15,723 14,892
Other benefits member      
IfrsStatementLineItems [Line Items]      
Short-term benefits R$ 16,027 R$ 12,546 R$ 14,117
XML 166 R153.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 1) - R$ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Plan 2019 [Member] | Settlement Methodology Shares [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2019 Plan  
Date of grant Mar. 19, 2019  
End of grace period 03/19/22  
Settlement Method Shares  
Granted quantities, shares   417,234
Shares canceled (18,802) (71,905)
Quantity of acquisition, shares   345,329
Shares exercised (326,527)  
Plan 2019 [Member] | Settlement Methodology Cash [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2019 Plan  
Date of grant Mar. 19, 2019  
End of grace period 03/19/22  
Settlement Method Cash  
Granted quantities, shares   82,128
Shares canceled (1,297) (8,433)
Quantity of acquisition, shares   73,695
Shares exercised (72,398)  
Plan 2020 [Member] | Settlement Methodology Shares [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2020 Plan  
Date of grant Apr. 01, 2020  
End of grace period 04/01/23  
Settlement Method Shares  
Granted quantities, shares   1,007,883
Shares canceled   (72,743)
Quantity of acquisition, shares 932,767 932,767
Shares exercised   (2,373)
Fair value of the share [1] R$ 16.27  
Plan 2020 [Member] | Settlement Methodology Cash [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2020 Plan  
Date of grant Apr. 01, 2020  
End of grace period 04/01/23  
Settlement Method Cash  
Granted quantities, shares   314,333
Shares canceled   (47,943)
Quantity of acquisition, shares 266,390 266,390
Fair value of the share, value [1] R$ 9.67  
Plan 2021 [Member] | Settlement Methodology Shares [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2021 Plan  
Date of grant May 10, 2021  
End of grace period 05/10/24  
Settlement Method Shares  
Granted quantities, shares   557,888
Shares canceled   (9,598)
Quantity of acquisition, shares 548,290 548,290
Fair value of the share [1] R$ 51.39  
Plan 2021 [Member] | Settlement Methodology Cash [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2021 Plan  
Date of grant May 10, 2021  
End of grace period 05/10/24  
Settlement Method Cash  
Granted quantities, shares   144,779
Quantity of acquisition, shares 144,779 144,779
Fair value of the share, value [1] R$ 9.67  
Plan 2022 [Member] | Settlement Methodology Shares [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2022 Plan  
Date of grant May 17, 2022  
End of grace period 05/17/25  
Settlement Method Shares  
Granted quantities, shares 537,870  
Quantity of acquisition, shares 537,870  
Fair value of the share [1] R$ 44.15  
Plan 2022 [Member] | Settlement Methodology Cash [Member]    
IfrsStatementLineItems [Line Items]    
Name of flat 2022 Plan  
Date of grant May 17, 2022  
End of grace period 05/17/25  
Settlement Method Cash  
Granted quantities, shares 132,902  
Quantity of acquisition, shares 132,902  
Fair value of the share, value [1] R$ 9.67  
[1] Values in monetary units.
XML 167 R154.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 2) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Total obligations R$ 550,356 R$ 607,368
Fair value of plan assets (56,613) (119,671)
Consolidated net balance (non-current liabilities) 493,743 487,697
Novamont braskem america member    
IfrsStatementLineItems [Line Items]    
Fair value of plan assets (54,665) (117,509)
Braskem alemanha member    
IfrsStatementLineItems [Line Items]    
Fair value of plan assets (1,948) (2,162)
Defined benefit member    
IfrsStatementLineItems [Line Items]    
Total obligations 228,836 363,662
Defined benefit member | Novamont braskem america member    
IfrsStatementLineItems [Line Items]    
Total obligations 58,221 117,509
Defined benefit member | Braskem Idesa [Member]    
IfrsStatementLineItems [Line Items]    
Total obligations 23,053 22,960
Defined benefit member | Braskem alemanha and braskem holanda member    
IfrsStatementLineItems [Line Items]    
Total obligations 147,562 223,193
Health care plan member | Bradesco saude member    
IfrsStatementLineItems [Line Items]    
Total obligations R$ 321,520 R$ 243,706
XML 168 R155.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 3) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Balance at beginning of year R$ 607,368 R$ 587,949 R$ 470,417
Current service cost 17,660 18,498 17,164
Interest cost 27,114 21,598 23,579
Benefits paid (46,847) (17,903) (13,358)
Actuarial losses (gain) (18,160) (9,848) 2,214
Exchange variation (36,779) 7,074 87,933
Balance at the end of the year 550,356 607,368 587,949
Health insurance member      
IfrsStatementLineItems [Line Items]      
Balance at beginning of year 243,706 217,089 224,852
Current service cost 4,928 4,817 4,678
Interest cost 20,200 15,692 17,097
Benefits paid (12,639) (10,712) (5,949)
Actuarial losses (gain) 65,325 16,820 (23,589)
Balance at the end of the year 321,520 243,706 217,089
Benefit plans member      
IfrsStatementLineItems [Line Items]      
Balance at beginning of year 363,662 370,860 245,565
Current service cost 12,732 13,681 12,486
Interest cost 6,914 5,906 6,482
Benefits paid (34,208) (7,191) (7,409)
Actuarial losses (gain) (83,485) (26,668) 25,803
Exchange variation (36,779) 7,074 87,933
Balance at the end of the year R$ 228,836 R$ 363,662 R$ 370,860
XML 169 R156.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 4) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Benefits Offered To Employees      
Balance at beginning of year R$ 119,671 R$ 115,875 R$ 81,342
Actual return on plan assets (25,929) 722 15,791
Benefits paid (32,264) (5,301) (4,973)
Exchange variation (4,866) 8,375 23,715
Balance at the end of the year R$ 56,613 R$ 119,671 R$ 115,875
XML 170 R157.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 5) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Current service cost R$ 17,660 R$ 18,498 R$ 17,164
Interest cost 27,114 21,598 23,579
Actuarial losses (83,485) (24,203) 15,461
Amounts recognized in profit and loss (38,711) 15,893 56,204
Health insurance member      
IfrsStatementLineItems [Line Items]      
Current service cost 4,928 4,817 4,678
Interest cost 20,200 15,692 17,097
Amounts recognized in profit and loss 25,128 20,509 21,775
Benefit plans member      
IfrsStatementLineItems [Line Items]      
Current service cost 12,732 13,681 12,486
Interest cost 6,914 5,906 6,482
Actuarial losses (83,485) (24,203) 15,461
Amounts recognized in profit and loss R$ (63,839) R$ (4,616) R$ 34,429
XML 171 R158.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 6)
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Health insurance member      
IfrsStatementLineItems [Line Items]      
Discount rate 5.97% 5.33% 3.99%
Inflation rate 3.00% 3.00% 3.25%
Aging factor 2.50% 2.50% 2.50%
Medical inflation 3.50% 3.50% 3.50%
Duration 12.83% 14.16% 14.99%
United state of america member      
IfrsStatementLineItems [Line Items]      
Discount rate 5.10% 2.90% 2.60%
Mexico [member]      
IfrsStatementLineItems [Line Items]      
Discount rate 8.00% 8.00% 7.25%
Inflation rate 4.00% 4.00% 4.00%
Rate of increase in future salary levels 5.00% 5.00% 5.00%
Germany [member]      
IfrsStatementLineItems [Line Items]      
Discount rate 1.20% 1.20% 0.70%
Inflation rate 2.00% 2.00% 2.00%
Rate of increase in future salary levels 3.00% 3.00% 3.00%
Rate of increase in future pension plan 1.75% 1.75% 1.75%
Netherlands [member]      
IfrsStatementLineItems [Line Items]      
Discount rate 3.60% 1.20% 0.70%
Inflation rate 2.00% 2.00% 2.00%
Rate of increase in future salary levels 3.25% 3.00% 3.00%
Rate of increase in future pension plan 2.25% 1.75% 1.75%
XML 172 R159.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to team members (Details 7)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
BRL (R$)
Actuarial assumption of discount rates [member]  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Percentage of reasonably possible increase in interest cost actuarial assumption 1.00%
Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption R$ 730
Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption 106
Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption (933)
Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption R$ 11
Actuarial assumption of discount rates [member] | Health insurance member  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Premise increase R$ 32,758
Premise reduction R$ (39,621)
Actuarial assumption of discount rates [member] | United states of america [member]  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Premise increase R$ 5,536
Premise reduction R$ (6,605)
Actuarial assumption of discount rates [member] | Mexico [member]  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Premise increase R$ 1,646
Premise reduction R$ (1,935)
Actuarial assumption of discount rates [member] | Germany [member]  
IfrsStatementLineItems [Line Items]  
Premise change 0.25%
Premise increase R$ 5,477
Premise reduction R$ (5,836)
Actuarial assumption of discount rates [member] | Netherlands [member]  
IfrsStatementLineItems [Line Items]  
Premise change 0.25%
Premise increase R$ 297
Premise reduction R$ (315)
Actuarial assumption of expected rates of salary increases [member] | Germany [member]  
IfrsStatementLineItems [Line Items]  
Premise change 0.50%
Premise increase R$ 8,604
Premise reduction R$ (8,114)
Actuarial assumption of expected rates of salary increases [member] | Netherlands [member]  
IfrsStatementLineItems [Line Items]  
Premise change 0.50%
Premise increase R$ 468
Premise reduction R$ (442)
Actuarial assumption of expected rates of pension increases [member]  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Percentage of reasonably possible increase in interest cost actuarial assumption 1.00%
Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption R$ 123
Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption 708
Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption (129)
Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption R$ (741)
Actuarial assumption of expected rates of pension increases [member] | Health insurance member  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Premise increase R$ (7,740)
Premise reduction R$ 8,098
Actuarial assumption of expected rates of pension increases [member] | Germany [member]  
IfrsStatementLineItems [Line Items]  
Premise change 0.25%
Premise increase R$ 4,241
Premise reduction R$ (4,115)
Actuarial assumption of expected rates of pension increases [member] | Netherlands [member]  
IfrsStatementLineItems [Line Items]  
Premise change 25.00%
Premise increase R$ 231
Premise reduction R$ (224)
Actuarial assumption of life expectancy after retirement [member]  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Percentage of reasonably possible increase in interest cost actuarial assumption 1.00%
Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption R$ 542
Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption 4,441
Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption (464)
Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption R$ (3,602)
Actuarial assumption of life expectancy after retirement [member] | Health insurance member  
IfrsStatementLineItems [Line Items]  
Premise change 1.00%
Premise increase R$ 48,527
Premise reduction (39,355)
Actuarial assumption of life expectancy after retirement [member] | Germany [member]  
IfrsStatementLineItems [Line Items]  
Premise increase 3,637
Premise reduction R$ (3,797)
Life expectancy 1 year
Actuarial assumption of life expectancy after retirement [member] | Netherlands [member]  
IfrsStatementLineItems [Line Items]  
Premise increase R$ 198
Premise reduction R$ (207)
Life expectancy 1 year
Actuarial assumption of mortality rates [member] | United states of america [member]  
IfrsStatementLineItems [Line Items]  
Premise change 10.00%
Premise increase R$ 1,681
Premise reduction R$ (1,839)
XML 173 R160.htm IDEA: XBRL DOCUMENT v3.23.1
Benefits offered to employees (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Benefits Offered To Employees    
Fair value, net of taxes R$ 39,413 R$ 31,932
Sponsors expenses 92,208 68,744
Participants expenses R$ 77,263 R$ 83,599
XML 174 R161.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details)
Dec. 31, 2022
shares
IfrsStatementLineItems [Line Items]  
Shares outstanding 797,207,834
Percent of shares outstanding 100.00%
Treasury shares [member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 665,408
Percent of shares outstanding 0.08%
Authorised [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 1,152,937,970
Common shares member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 451,668,652
Percent of shares outstanding 100.00%
Common shares member | Authorised [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 535,661,731
Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 345,060,392
Percent of shares outstanding 100.00%
Class A Preference Shares [Member] | Treasury shares [member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 665,408
Percent of shares outstanding 0.19%
Class A Preference Shares [Member] | Authorised [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 616,682,421
Class B Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 478,790
Percent of shares outstanding 100.00%
Class B Preference Shares [Member] | Authorised [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 593,818
Novonor member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 305,517,121
Percent of shares outstanding 38.32%
Novonor member | Common shares member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 226,334,623
Percent of shares outstanding 50.11%
Novonor member | Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 79,182,498
Percent of shares outstanding 22.95%
Petrobras member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 288,188,691
Percent of shares outstanding 36.15%
Petrobras member | Common shares member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 212,426,952
Percent of shares outstanding 47.03%
Petrobras member | Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 75,761,739
Percent of shares outstanding 21.96%
Adrs member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 42,869,320 [1]
Percent of shares outstanding 5.38% [1]
Adrs member | Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 42,869,320 [1]
Percent of shares outstanding 12.42% [1]
Other [member] | Common shares member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 12,907,077
Percent of shares outstanding 2.86%
Other [member] | Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 146,581,427
Percent of shares outstanding 42.48%
Other [member] | Class B Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 478,790
Percent of shares outstanding 100.00%
Other2 member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 159,967,294
Percent of shares outstanding 20.07%
Total [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 796,542,426
Percent of shares outstanding 99.92%
Total [Member] | Common shares member  
IfrsStatementLineItems [Line Items]  
Shares outstanding 451,668,652
Percent of shares outstanding 100.00%
Total [Member] | Class A Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 344,394,984
Percent of shares outstanding 99.81%
Total [Member] | Class B Preference Shares [Member]  
IfrsStatementLineItems [Line Items]  
Shares outstanding 478,790
Percent of shares outstanding 100.00%
[1] American Depository Receipt ("ADR") on the New York Stock Exchange – NYSE (USA).
XML 175 R162.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details 1) - shares
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Shares outstanding 797,207,834 797,207,834 797,218,554
Changes in shares   (10,720)  
Treasury shares [member]      
IfrsStatementLineItems [Line Items]      
Shares outstanding 665,408 902,166 1,224,878
Changes in shares (236,758) (322,712)  
Total [Member]      
IfrsStatementLineItems [Line Items]      
Shares outstanding 796,542,426 796,305,668 795,993,676
Changes in shares 236,758 311,992  
Common shares member      
IfrsStatementLineItems [Line Items]      
Shares outstanding 451,668,652 451,668,652 451,668,652
Class A Preference Shares [Member]      
IfrsStatementLineItems [Line Items]      
Shares outstanding 344,394,984 344,158,226 343,824,794
Changes in shares 236,758 333,432  
Class B Preference Shares [Member]      
IfrsStatementLineItems [Line Items]      
Shares outstanding 478,790 478,790 500,230
Changes in shares   (21,440)  
XML 176 R163.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Loss for the year of the Companys shareholders R$ (335,677)  
SUDENE tax incentive supplement (108,975)  
Comprehensive income 26,883 R$ 19,404
Other 475  
Loss for allocation (417,294)  
Profit reserves retention of profits 417,294  
Profit Reserves [Member]    
IfrsStatementLineItems [Line Items]    
Profit reserves retention of profits R$ 417,294  
XML 177 R164.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details Narrative)
12 Months Ended
Dec. 31, 2021
shares
L T I Program 2018 [Member]  
IfrsStatementLineItems [Line Items]  
Shares granted 322,712
XML 178 R165.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings per share (Details) - R$ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Profit (loss) for the year attributed to Company's shareholders (335,677) 13,984,946 (6,691,720)
Profit loss from continuing operations attributable diluted to owners of parent (335,677) 13,984,946 (6,691,720)
Distribution of priority dividends attributable to basic   208,864  
Distribution of priority dividends attributable to diluted   208,864  
Distribution of 6% ??ofunit price of common shares, basic   273,729  
Distribution of 6% ??ofunit price of common shares, diluted   273,729  
Distribution of excess profits, by class basic   13,502,353  
Distribution of excess profits, by class diluted   13,502,353  
Reconciliation of income available for distribution, by class (numerator), basic (335,677) 13,984,946 (6,691,720)
Reconciliation of income available for distribution, by class (numerator), diluted (335,677) 13,984,946 (6,691,720)
Weighted average number of shares, basic 796,476,912 796,223,523 795,992,693
Weighted average shares diluted 796,476,912 797,218,524 797,218,554
Class A Preference Shares [Member]      
IfrsStatementLineItems [Line Items]      
Distribution of priority dividends attributable to basic   208,574  
Distribution of priority dividends attributable to diluted   208,574  
Distribution of excess profits, by class basic   5,838,145  
Distribution of excess profits, by class diluted   5,838,145  
Reconciliation of income available for distribution, by class (numerator), basic (145,118) 6,046,719 (2,890,445)
Reconciliation of income available for distribution, by class (numerator), diluted (145,118) 6,046,719 (2,890,444)
Weighted average number of shares, basic 344,329,470 344,054,700 343,823,811
Weighted average shares diluted 344,329,470 345,049,701 345,049,672
Profit (loss) per share, basic R$ (0.42) R$ 17.57 R$ (8.41)
Profit (loss) per share, diluted R$ (0.42) R$ 17.52 R$ (8.38)
Amount at beginning of the year 344,158,226,000    
Incentive long term plan payments with treasury shares 236,758 322,712 1,721
Amount at the end of the year 344,394,984,000 344,158,226,000  
Amount at beginning of the year 344,158,226,000 343,824,794,000  
Conversion shares class "B" into shares class "A"   10,720  
Amount at the end of the year   344,158,226,000 343,824,794,000
Amount at beginning of year   343,824,794,000 343,823,073,000
Amount at the end of the year     343,824,794,000
Class A Preference Shares [Member] | Weighted average [member]      
IfrsStatementLineItems [Line Items]      
Amount at beginning of the year 344,158,226,000    
Incentive long term plan payments with treasury shares 171,244 229,877 738
Amount at the end of the year 344,329,470,000 344,158,226,000  
Amount at beginning of the year 344,054,700,000 343,824,794,000  
Conversion shares class "B" into shares class "A"   29  
Amount at the end of the year   344,054,700,000 343,824,794,000
Amount at beginning of year   343,823,811,000 343,823,073,000
Amount at the end of the year     343,823,811,000
Class B Preference Shares [Member]      
IfrsStatementLineItems [Line Items]      
Distribution of priority dividends attributable to basic   290  
Distribution of priority dividends attributable to diluted   290  
Reconciliation of income available for distribution, by class (numerator), basic (202) 290 (4,205)
Reconciliation of income available for distribution, by class (numerator), diluted (202) 290 (4,205)
Weighted average number of shares, basic 478,790 500,171 500,230
Weighted average shares diluted 478,790 500,171 500,230
Profit (loss) per share, basic R$ (0.42) R$ 0.58 R$ (8.41)
Profit (loss) per share, diluted R$ (0.42) R$ 0.58 R$ (8.41)
Incentive long term plan payments with treasury shares    
Amount at beginning of the year 478,790,000 500,230,000  
Conversion shares class "B" into shares class "A"   (21,440)  
Amount at the end of the year   478,790,000 500,230,000
Class B Preference Shares [Member] | Weighted average [member]      
IfrsStatementLineItems [Line Items]      
Incentive long term plan payments with treasury shares    
Amount at beginning of the year 500,171,000 500,230,000  
Conversion shares class "B" into shares class "A"   (59)  
Amount at the end of the year   500,171,000 500,230,000
Common shares member      
IfrsStatementLineItems [Line Items]      
Distribution of excess profits, by class basic   7,664,208  
Distribution of excess profits, by class diluted   7,664,208  
Reconciliation of income available for distribution, by class (numerator), basic (190,357) 7,937,937 (3,797,070)
Reconciliation of income available for distribution, by class (numerator), diluted (190,357) 7,937,937 (3,797,071)
Weighted average number of shares, basic 451,668,652 451,668,652 451,668,652
Weighted average shares diluted 451,668,652 451,668,652 451,668,652
Profit (loss) per share, basic R$ (0.42) R$ 17.57 R$ (8.41)
Profit (loss) per share, diluted R$ (0.42) R$ 17.57 R$ (8.41)
XML 179 R166.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net Revenue      
Net sales and services revenue R$ 96,519,284 R$ 105,625,201 R$ 58,543,494
XML 180 R167.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue (Details 1) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Net revenue R$ 96,519,284 R$ 105,625,201 R$ 58,543,494
Brazil [member]      
IfrsStatementLineItems [Line Items]      
Net revenue 56,217,472 55,830,330 32,369,199
United states member      
IfrsStatementLineItems [Line Items]      
Net revenue 18,085,607 24,232,413 10,848,609
Mexico [member]      
IfrsStatementLineItems [Line Items]      
Net revenue 4,468,827 5,505,893 2,765,815
A r member      
IfrsStatementLineItems [Line Items]      
Net revenue 2,092,700 2,068,023 1,267,967
D E [Member]      
IfrsStatementLineItems [Line Items]      
Net revenue 1,695,009 1,912,373 1,106,877
C H [Member]      
IfrsStatementLineItems [Line Items]      
Net revenue 1,492,922 1,230,541 633,512
I t member      
IfrsStatementLineItems [Line Items]      
Net revenue 1,095,133 1,304,113 811,787
C l member      
IfrsStatementLineItems [Line Items]      
Net revenue 870,858 1,230,493 544,329
N l member      
IfrsStatementLineItems [Line Items]      
Net revenue 816,678 642,844 432,897
L u member      
IfrsStatementLineItems [Line Items]      
Net revenue 756,297 987,656 592,777
S g member      
IfrsStatementLineItems [Line Items]      
Net revenue 755,971 1,175,133 1,183,838
P e member      
IfrsStatementLineItems [Line Items]      
Net revenue 740,011 666,867 471,847
J p member      
IfrsStatementLineItems [Line Items]      
Net revenue 723,757 1,162,226 618,940
E s member      
IfrsStatementLineItems [Line Items]      
Net revenue 546,646 517,532 282,362
G b member      
IfrsStatementLineItems [Line Items]      
Net revenue 490,801 585,766 204,953
U y member      
IfrsStatementLineItems [Line Items]      
Net revenue 469,555 495,120 405,946
P l member      
IfrsStatementLineItems [Line Items]      
Net revenue 455,458 649,825 285,714
B o member      
IfrsStatementLineItems [Line Items]      
Net revenue 427,237 296,138 190,447
S e member      
IfrsStatementLineItems [Line Items]      
Net revenue 401,251 481,289 310,984
C a member      
IfrsStatementLineItems [Line Items]      
Net revenue 393,504 558,730 297,756
F r member      
IfrsStatementLineItems [Line Items]      
Net revenue 359,946 326,570 247,062
P y member      
IfrsStatementLineItems [Line Items]      
Net revenue 316,460 318,842 254,255
C o member      
IfrsStatementLineItems [Line Items]      
Net revenue 263,695 274,335 174,381
C n member      
IfrsStatementLineItems [Line Items]      
Net revenue 172,656 354,071 496,920
K r member      
IfrsStatementLineItems [Line Items]      
Net revenue 159,944 669,055 360,704
Other [member]      
IfrsStatementLineItems [Line Items]      
Net revenue R$ 2,250,890 R$ 2,149,023 R$ 1,383,616
XML 181 R168.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue (Details 2) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Net revenue R$ 96,519,284 R$ 105,625,201 R$ 58,543,494
P e p p member      
IfrsStatementLineItems [Line Items]      
Net revenue 61,145,093 73,306,089 41,137,288
Benzene toluene and xylene member      
IfrsStatementLineItems [Line Items]      
Net revenue 7,279,584 5,819,696 3,051,752
Ethylene propylene member      
IfrsStatementLineItems [Line Items]      
Net revenue 5,819,345 6,872,999 3,600,276
E t b e gasoline member      
IfrsStatementLineItems [Line Items]      
Net revenue 5,722,767 4,321,371 2,170,289
P v c caustic soda e d c member      
IfrsStatementLineItems [Line Items]      
Net revenue 5,710,838 5,806,011 3,134,617
Butadiene member      
IfrsStatementLineItems [Line Items]      
Net revenue 3,028,048 3,019,836 1,372,428
Solvents member      
IfrsStatementLineItems [Line Items]      
Net revenue 1,522,025 1,129,484 654,793
Cumene member      
IfrsStatementLineItems [Line Items]      
Net revenue 1,425,097 1,342,811 636,635
Naphtha condensate and crude oil member      
IfrsStatementLineItems [Line Items]      
Net revenue 422,359 1,648,581 915,807
Other1 member      
IfrsStatementLineItems [Line Items]      
Net revenue R$ 4,444,130 R$ 2,358,324 R$ 1,869,609
XML 182 R169.htm IDEA: XBRL DOCUMENT v3.23.1
Net revenue (Details Narrative)
12 Months Ended
Dec. 31, 2022
IfrsStatementLineItems [Line Items]  
Percentage of entity's revenue 10.00%
One client member  
IfrsStatementLineItems [Line Items]  
Percentage of entity's revenue 2.40%
XML 183 R170.htm IDEA: XBRL DOCUMENT v3.23.1
Tax incentives (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Tax Incentives    
Percentage of tax reduction 75.00%  
Realization period 10 years  
ICMS tax incentives R$ 425,913  
ICMS tax incentives R$ 87,415 R$ 176,284
XML 184 R171.htm IDEA: XBRL DOCUMENT v3.23.1
Expenses by nature and function (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Nature member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature R$ (92,282,059) R$ (79,586,298) R$ (58,595,988)
Nature member | Raw materials other inputs member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (73,181,706) (63,570,499) (37,913,921)
Nature member | Personnel expenses member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (3,223,477) (3,478,323) (3,074,305)
Nature member | Outsourced services member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (3,411,818) (3,193,970) (2,219,413)
Nature member | Depreciation amortization and depletion member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (4,733,165) (4,178,433) (4,048,081)
Nature member | Freights member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (4,034,901) (2,966,229) (2,321,740)
Nature member | Costs of idle industrial plants member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (414,441) (338,987) (518,528)
Nature member | Provision geological event in alagoas member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (1,520,019) (1,339,765) (6,901,828)
Nature member | P i s and c o f i n s credits exclusion of i c m s from the calculation basis member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature   1,031,099 310,557
Nature member | Other Incomes [Member]      
IfrsStatementLineItems [Line Items]      
Expenses, by nature 507,333 1,843,153 440,192
Nature member | Other General And Administrative Expenses [Member]      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (2,269,865) (3,394,344) (2,348,921)
Function member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (92,282,059) (79,586,298) [1] (58,595,988) [1]
Function member | Cost of products sold member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (85,160,548) (73,568,231) (47,331,414)
Function member | Selling and distribution member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (2,108,417) (2,055,640) (1,852,055)
Function member | Loss reversals for impairment of trade accounts receivable member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (38,426) (8,914) (55,252)
Function member | General and administrative member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (2,763,983) (2,522,127) (1,918,747)
Function member | Research and development member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature (374,493) (296,583) (250,648)
Function member | Other income expenses net member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature 507,333 1,534,487 [2] 750,749 [2]
Function member | Other expenses member      
IfrsStatementLineItems [Line Items]      
Expenses, by nature R$ (2,343,525) R$ (2,669,290) [1] R$ (7,938,621) [1]
[1] Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).
[2] In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.
XML 185 R172.htm IDEA: XBRL DOCUMENT v3.23.1
Financial results (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Finance income R$ 2,010,134 R$ 1,827,438 R$ 600,184
Finance costs (5,662,693) (5,907,155) (4,913,365)
Gains (losses) on exchange differences on translation of foreign operations, before tax (572,170) (4,002,807) (5,298,711)
Finance income (cost) (4,224,729) (8,082,524) (9,611,892)
Financial interest income member      
IfrsStatementLineItems [Line Items]      
Finance income 1,049,745 439,891 310,202
Monetary variations on tax credits member      
IfrsStatementLineItems [Line Items]      
Finance income [1] 16,489 1,041,917 170,857
Gain On Derivatives [Member]      
IfrsStatementLineItems [Line Items]      
Finance income 635,779 246,459  
Other financial income member      
IfrsStatementLineItems [Line Items]      
Finance income 308,121 99,171 119,125
Financial interest expenses member      
IfrsStatementLineItems [Line Items]      
Finance costs (3,125,206) (2,922,958) (2,928,803)
Monetary variations on fiscal debts member      
IfrsStatementLineItems [Line Items]      
Finance costs (266,281) (93,722) (138,410)
Discounts granted member      
IfrsStatementLineItems [Line Items]      
Finance costs (129,249) (75,677) (81,920)
Loans transaction costs member      
IfrsStatementLineItems [Line Items]      
Finance costs (260,511) (691,243) (172,269)
Adjustment to present value member      
IfrsStatementLineItems [Line Items]      
Finance costs (580,994) (179,461) (225,889)
Interest expense on leases member      
IfrsStatementLineItems [Line Items]      
Finance costs (203,257) (173,536) (164,166)
Losses on derivatives member      
IfrsStatementLineItems [Line Items]      
Finance costs (596,501) (1,003,502) (809,150)
Other financial expenses member      
IfrsStatementLineItems [Line Items]      
Finance costs (500,694) (767,056) (392,758)
Financial assets, class [member]      
IfrsStatementLineItems [Line Items]      
Gains (losses) on exchange differences on translation of foreign operations, before tax (522,251) 230,370 336,527
Financial liabilities, class [member]      
IfrsStatementLineItems [Line Items]      
Gains (losses) on exchange differences on translation of foreign operations, before tax R$ (49,919) R$ (4,233,177) R$ (5,635,238)
[1] In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).
XML 186 R173.htm IDEA: XBRL DOCUMENT v3.23.1
Financial results (Details 1) - Number
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
U s dollar brazilian real member      
IfrsStatementLineItems [Line Items]      
Closing foreign exchange rate 5.2177 5.5805  
Closing foreign exchange rate variations (6.50%)    
Average foreign exchange rate 5.1655 5.3956 5.1578
Average foreign exchange rate variations (4.26%) 4.61%  
Euro brazilian real member      
IfrsStatementLineItems [Line Items]      
Closing foreign exchange rate 5.5694 6.3210  
Closing foreign exchange rate variations (11.89%)    
Average foreign exchange rate 5.4420 6.3784 5.8989
Average foreign exchange rate variations (14.68%) 8.13%  
Mexican peso brazilian real member      
IfrsStatementLineItems [Line Items]      
Closing foreign exchange rate 0.2667 0.2730  
Closing foreign exchange rate variations (2.31%)    
Average foreign exchange rate 0.2569 0.2660 0.2402
Average foreign exchange rate variations (3.44%) 10.75%  
U s dollar mexican peso member      
IfrsStatementLineItems [Line Items]      
Closing foreign exchange rate 19.5720 20.4519  
Closing foreign exchange rate variations (4.30%)    
Average foreign exchange rate 20.1249 20.2900 21.5098
Average foreign exchange rate variations (0.81%) (5.67%)  
U s dollar euro member      
IfrsStatementLineItems [Line Items]      
Closing foreign exchange rate 0.9416 0.8853  
Closing foreign exchange rate variations 6.36%    
Average foreign exchange rate 0.9510 0.8458 0.8775
Average foreign exchange rate variations 12.44% (3.61%)  
XML 187 R174.htm IDEA: XBRL DOCUMENT v3.23.1
Segment information (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Net revenue R$ 96,519,284 R$ 105,625,201 R$ 58,543,494
Cost of products sold (85,160,548) (73,568,231) (47,331,414)
Gross profit 11,358,736 32,056,970 11,212,080
Selling, general and distribuition expenses (5,285,319) (4,883,264) (4,076,702)
Other operating income (expenses), net (1,836,192) (1,134,803) (7,187,872)
Operating profit (loss) 4,272,073 26,043,547 (71,892)
Results from equity-accounted investee 34,848 4,644 (19,398)
Reporting segments member      
IfrsStatementLineItems [Line Items]      
Net revenue 98,334,837 108,404,852 59,433,852
Cost of products sold (88,251,336) (76,066,409) (47,910,490)
Gross profit 10,083,501 32,338,443 11,523,362
Selling, general and distribuition expenses (3,143,118) (2,980,891) (2,629,772)
Other operating income (expenses), net (1,865,425) (2,251,483) (7,529,558)
Operating profit (loss) 5,074,958 27,106,069 1,364,032
Reporting segments member | Brazil [member]      
IfrsStatementLineItems [Line Items]      
Net revenue 69,079,724 69,494,923 40,794,387
Cost of products sold (63,195,629) (49,309,552) (32,498,003)
Gross profit 5,884,095 20,185,371 8,296,384
Selling, general and distribuition expenses (1,853,039) (1,608,185) (1,471,722)
Other operating income (expenses), net (1,888,999) (2,210,601) (7,082,604)
Operating profit (loss) 2,142,057 16,366,585 (257,942)
Reporting segments member | U s a and europe member      
IfrsStatementLineItems [Line Items]      
Net revenue 23,421,096 32,403,632 14,638,660
Cost of products sold (19,986,176) (23,343,205) (12,337,486)
Gross profit 3,434,920 9,060,427 2,301,174
Selling, general and distribuition expenses (838,474) (900,885) (721,191)
Other operating income (expenses), net 56,944 (25,580) (82,695)
Operating profit (loss) 2,653,390 8,133,962 1,497,288
Reporting segments member | Mexico [member]      
IfrsStatementLineItems [Line Items]      
Net revenue 5,834,017 6,506,297 4,000,805
Cost of products sold (5,069,531) (3,413,652) (3,075,001)
Gross profit 764,486 3,092,645 925,804
Selling, general and distribuition expenses (451,605) (471,821) (436,859)
Other operating income (expenses), net (33,370) (15,302) (364,259)
Operating profit (loss) 279,511 2,605,522 124,686
Other segments member      
IfrsStatementLineItems [Line Items]      
Net revenue 402,991 363,684 302,374
Cost of products sold (262,402) (233,084) (188,350)
Gross profit 140,589 130,600 114,024
Selling, general and distribuition expenses 82,498 76,830 63,874
Other operating income (expenses), net 5,644 (28,674) (320)
Operating profit (loss) 263,579 183,400 158,180
Results from equity-accounted investee 34,848 4,644 (19,398)
Corporate unit member      
IfrsStatementLineItems [Line Items]      
Selling, general and distribuition expenses (2,196,506) (1,963,137) (1,493,479)
Other operating income (expenses), net 19,375 1,161,517 359,071
Operating profit (loss) (2,177,131) (801,620) (1,134,408)
Braskem consolidated before eliminations and reclassifications member      
IfrsStatementLineItems [Line Items]      
Net revenue 98,737,828 108,768,536 59,736,226
Cost of products sold (88,513,738) (76,299,493) (48,098,840)
Gross profit 10,224,090 32,469,043 11,637,386
Selling, general and distribuition expenses (5,257,126) (4,867,198) (4,059,377)
Other operating income (expenses), net (1,840,406) (1,118,640) (7,170,807)
Operating profit (loss) 3,161,406 26,487,849 387,804
Results from equity-accounted investee 34,848 4,644 (19,398)
Eliminations and reclassifications member      
IfrsStatementLineItems [Line Items]      
Net revenue (2,218,544) (3,143,335) (1,192,732)
Cost of products sold 3,353,190 2,731,262 767,426
Gross profit 1,134,646 (412,073) (425,306)
Selling, general and distribuition expenses (28,193) (16,066) (17,325)
Other operating income (expenses), net 4,214 (16,163) (17,065)
Operating profit (loss) R$ 1,110,667 R$ (444,302) R$ (459,696)
XML 188 R175.htm IDEA: XBRL DOCUMENT v3.23.1
Segment information (Details 1) - BRL (R$)
R$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets R$ 40,785,439 R$ 40,102,429
Reporting segments member    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets 40,240,967 39,780,192
Reporting segments member | Brazil [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets 19,428,926 18,072,312
Reporting segments member | U s a and europe member    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets 7,075,743 7,688,713
Reporting segments member | Mexico [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets 13,736,298 14,019,167
Reporting segments member | Unallocated member    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment and intangible assets R$ 544,472 R$ 322,237
XML 189 R176.htm IDEA: XBRL DOCUMENT v3.23.1
Contractual obligations (Details Narrative) - BRL (R$)
Dec. 31, 2022
Dec. 31, 2021
Energy agreement member    
IfrsStatementLineItems [Line Items]    
Contractual capital commitments R$ 8,286,502 R$ 6,079,568
XML 190 R177.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent events (Details Narrative)
R$ in Millions, $ in Billions
1 Months Ended 12 Months Ended
Mar. 31, 2023
BRL (R$)
Feb. 28, 2023
BRL (R$)
Dec. 31, 2022
BRL (R$)
Feb. 28, 2023
USD ($)
IfrsStatementLineItems [Line Items]        
Gains (losses) on litigation settlements     R$ 1,700  
Key management personnel compensation, share-based payment     R$ 1,100  
Events after reporting period member        
IfrsStatementLineItems [Line Items]        
Finance issued in bonds | $       $ 1.0
Interest rate   7.25%    
Gains (losses) on litigation settlements R$ 1,700      
Key management personnel compensation, share-based payment R$ 1,100      
Events after reporting period member | Wise [Member]        
IfrsStatementLineItems [Line Items]        
Equity interest rate   61.10%    
Considerations on share transaction   R$ 138    
XML 191 bakform20f_2022_htm.xml IDEA: XBRL DOCUMENT 0001071438 2022-01-01 2022-12-31 0001071438 dei:BusinessContactMember 2022-01-01 2022-12-31 0001071438 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 2021-12-31 0001071438 2021-01-01 2021-12-31 0001071438 2020-01-01 2020-12-31 0001071438 bak:CommonSharesMember 2022-01-01 2022-12-31 0001071438 bak:CommonSharesMember 2021-01-01 2021-12-31 0001071438 bak:CommonSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassAPreferredSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferredSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassAPreferredSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassBPreferredSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassBPreferredSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferredSharesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2019-12-31 0001071438 ifrs-full:CapitalReserveMember 2019-12-31 0001071438 ifrs-full:StatutoryReserveMember 2019-12-31 0001071438 bak:TaxIncentiveMember 2019-12-31 0001071438 bak:RetentionOfProfitsMember 2019-12-31 0001071438 bak:AdditionalDividendsProposedMember 2019-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2019-12-31 0001071438 bak:LongTermIncentivePlansMember 2019-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001071438 ifrs-full:TreasurySharesMember 2019-12-31 0001071438 ifrs-full:RetainedEarningsMember 2019-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2019-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2019-12-31 0001071438 2019-12-31 0001071438 ifrs-full:IssuedCapitalMember 2020-12-31 0001071438 ifrs-full:CapitalReserveMember 2020-12-31 0001071438 ifrs-full:StatutoryReserveMember 2020-12-31 0001071438 bak:TaxIncentiveMember 2020-12-31 0001071438 bak:RetentionOfProfitsMember 2020-12-31 0001071438 bak:AdditionalDividendsProposedMember 2020-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2020-12-31 0001071438 bak:LongTermIncentivePlansMember 2020-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-12-31 0001071438 ifrs-full:RetainedEarningsMember 2020-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2020-12-31 0001071438 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2021-12-31 0001071438 ifrs-full:CapitalReserveMember 2021-12-31 0001071438 ifrs-full:StatutoryReserveMember 2021-12-31 0001071438 bak:TaxIncentiveMember 2021-12-31 0001071438 bak:RetentionOfProfitsMember 2021-12-31 0001071438 bak:AdditionalDividendsProposedMember 2021-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2021-12-31 0001071438 bak:LongTermIncentivePlansMember 2021-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-12-31 0001071438 ifrs-full:RetainedEarningsMember 2021-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001071438 ifrs-full:IssuedCapitalMember 2020-01-01 2020-12-31 0001071438 ifrs-full:CapitalReserveMember 2020-01-01 2020-12-31 0001071438 ifrs-full:StatutoryReserveMember 2020-01-01 2020-12-31 0001071438 bak:TaxIncentiveMember 2020-01-01 2020-12-31 0001071438 bak:RetentionOfProfitsMember 2020-01-01 2020-12-31 0001071438 bak:AdditionalDividendsProposedMember 2020-01-01 2020-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2020-01-01 2020-12-31 0001071438 bak:LongTermIncentivePlansMember 2020-01-01 2020-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:RetainedEarningsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-01-01 2020-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001071438 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001071438 ifrs-full:StatutoryReserveMember 2021-01-01 2021-12-31 0001071438 bak:TaxIncentiveMember 2021-01-01 2021-12-31 0001071438 bak:RetentionOfProfitsMember 2021-01-01 2021-12-31 0001071438 bak:AdditionalDividendsProposedMember 2021-01-01 2021-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2021-01-01 2021-12-31 0001071438 bak:LongTermIncentivePlansMember 2021-01-01 2021-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-01-01 2021-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001071438 ifrs-full:CapitalReserveMember 2022-01-01 2022-12-31 0001071438 ifrs-full:StatutoryReserveMember 2022-01-01 2022-12-31 0001071438 bak:TaxIncentiveMember 2022-01-01 2022-12-31 0001071438 bak:RetentionOfProfitsMember 2022-01-01 2022-12-31 0001071438 bak:AdditionalDividendsProposedMember 2022-01-01 2022-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2022-01-01 2022-12-31 0001071438 bak:LongTermIncentivePlansMember 2022-01-01 2022-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:IssuedCapitalMember 2022-12-31 0001071438 ifrs-full:CapitalReserveMember 2022-12-31 0001071438 ifrs-full:StatutoryReserveMember 2022-12-31 0001071438 bak:TaxIncentiveMember 2022-12-31 0001071438 bak:RetentionOfProfitsMember 2022-12-31 0001071438 bak:AdditionalDividendsProposedMember 2022-12-31 0001071438 ifrs-full:AdditionalPaidinCapitalMember 2022-12-31 0001071438 bak:LongTermIncentivePlansMember 2022-12-31 0001071438 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-12-31 0001071438 ifrs-full:RetainedEarningsMember 2022-12-31 0001071438 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001071438 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001071438 bak:OdebrechtSAMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-06-29 2022-06-30 0001071438 2023-03-29 2023-03-31 0001071438 bak:BraskemIdesaOneMember 2023-03-29 2023-03-31 0001071438 bak:Subsidiary1Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary1Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary1Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary2Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary2Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary2Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary3Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary3Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary4Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary4Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary4Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary5Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary5Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary6Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary6Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary6Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary7Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary7Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary7Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary8Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary8Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary8Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary9Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary9Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary9Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary10Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary101Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary11Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary11Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary11Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary12Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary13Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary13Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary13Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary14Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary14Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary14Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary15Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary15Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary15Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary16Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary16Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary16Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary17Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary17Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary17Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary18Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary18Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary18Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary19Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary19Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary19Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary20Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary20Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary20Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary21Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary21Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary21Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary22Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary22Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary23Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary23Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary23Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary24Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary25Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary26Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary26Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary26Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary27Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary27Member 2021-01-01 2021-12-31 0001071438 bak:Subsidiary27Member 2020-01-01 2020-12-31 0001071438 bak:Subsidiary28Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary29Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary30Member 2022-01-01 2022-12-31 0001071438 bak:Subsidiary30Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity1Member 2022-01-01 2022-12-31 0001071438 bak:SpecificPurposeEntity1Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity1Member 2020-01-01 2020-12-31 0001071438 bak:SpecificPurposeEntity2Member 2022-01-01 2022-12-31 0001071438 bak:SpecificPurposeEntity2Member 2021-01-01 2021-12-31 0001071438 bak:SpecificPurposeEntity2Member 2020-01-01 2020-12-31 0001071438 bak:BraskemAlemanhaMember 2022-01-01 2022-12-31 0001071438 bak:BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember 2022-01-01 2022-12-31 0001071438 bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:BraskemChileMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIndiaMember 2022-01-01 2022-12-31 0001071438 bak:CarryingAmountOneMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 bak:EarlyPaymentdebtMember ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2022-12-31 0001071438 bak:DomesticMarketMember 2022-12-31 0001071438 bak:DomesticMarketMember 2021-12-31 0001071438 bak:ForeignMarketMember 2022-12-31 0001071438 bak:ForeignMarketMember 2021-12-31 0001071438 bak:ForeignMarketMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:ForeignMarketMember bak:BraskemIdesaMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtAmortisedCostMember bak:TimeDepositInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:LFTAndLFMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:LFTAndLFMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:OtherFinancialInvestmentsMember 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:OtherFinancialInvestmentsMember 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember bak:InterbankDepositRateMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember bak:RestrictedFundsInvestmentsMember bak:InterbankDepositRateMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-01-01 2021-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartyMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartyMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:NotPastDueMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember bak:NotPastDueMember 2022-12-31 0001071438 bak:NotPastDueMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:NotPastDueMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember bak:NotPastDueMember 2021-12-31 0001071438 bak:NotPastDueMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:NotLaterThanNinetyDaysMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember bak:NotLaterThanNinetyDaysMember 2022-12-31 0001071438 bak:NotLaterThanNinetyDaysMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:NotLaterThanNinetyDaysMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember bak:NotLaterThanNinetyDaysMember 2021-12-31 0001071438 bak:NotLaterThanNinetyDaysMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:LaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember bak:LaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember bak:LaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember bak:LaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:LaterThanOneHundredAndEightyDaysMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember 2022-12-31 0001071438 bak:ExpectedCreditLossesMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember 2021-12-31 0001071438 bak:ExpectedCreditLossesMember 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2022-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2022-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2021-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2021-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2022-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:RelatedPartiesMember 2022-01-01 2022-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:RelatedPartiesMember 2021-01-01 2021-12-31 0001071438 bak:PetrobrasAndSubsidiariesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:OtherRelatedPartiesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:RelatedPartiesMember 2020-01-01 2020-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2022-01-01 2022-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2021-01-01 2021-12-31 0001071438 bak:OdebrechtAndSubsidiariesAndAssociatesMember 2020-01-01 2020-12-31 0001071438 bak:NewOrRenewedagreementsWithRelatedCompaniesMember ifrs-full:TopOfRangeMember 2022-12-31 0001071438 bak:NewOrRenewedagreementsWithRelatedCompaniesMember 2022-12-31 0001071438 bak:NovonorAndItsDirectAndIndirectSubsidiariesMember 2022-02-01 2022-02-28 0001071438 bak:PetrobrasTransporteSAMember 2021-01-01 2021-12-31 0001071438 bak:PetrocoqueSAIndustriaComercioMember 2021-03-01 2021-03-31 0001071438 bak:RefinariaAlbertoPasqualiniMember 2021-10-01 2021-10-31 0001071438 bak:AgreementWithPetrocoqueMember 2021-12-31 0001071438 bak:RefinariaDuqueDeCaxiasMember 2021-12-31 0001071438 bak:RefinariaHenriqueLageMember 2021-12-31 0001071438 bak:RefinariaPlanaltodePauliniaMember 2021-12-31 0001071438 bak:RefinariaPresidenteGetulioVargasMember 2021-12-31 0001071438 bak:ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:ICMSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:ICMSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:SocialIntegrationProgramPISAndSocialContributionOnRevenueMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:SocialIntegrationProgramPISAndSocialContributionOnRevenueMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:REINTEGRAProgramMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:REINTEGRAProgramMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:FederalSupervenienceMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:FederalSupervenienceMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:OtherTaxesRecoverableMember bak:ParentCompanysMember 2022-12-31 0001071438 bak:OtherTaxesRecoverableMember bak:ParentCompanysMember 2021-12-31 0001071438 bak:ValueAddedTaxIVAMember srt:SubsidiariesMember 2022-12-31 0001071438 bak:ValueAddedTaxIVAMember srt:SubsidiariesMember 2021-12-31 0001071438 bak:OtherTaxesRecoverableMember srt:SubsidiariesMember 2022-12-31 0001071438 bak:OtherTaxesRecoverableMember srt:SubsidiariesMember 2021-12-31 0001071438 bak:PISAndCOFINSTaxesMember 2019-12-31 0001071438 bak:Investment1Member 2022-01-01 2022-12-31 0001071438 bak:Investment1Member 2021-01-01 2021-12-31 0001071438 bak:Investment1Member 2020-01-01 2020-12-31 0001071438 bak:Investment1Member 2022-12-31 0001071438 bak:Investment1Member 2021-12-31 0001071438 bak:Investment2Member 2022-01-01 2022-12-31 0001071438 bak:Investment2Member 2022-12-31 0001071438 bak:AssociateMember 2022-01-01 2022-12-31 0001071438 bak:AssociateMember 2021-01-01 2021-12-31 0001071438 bak:AssociateMember 2020-01-01 2020-12-31 0001071438 bak:AssociateMember 2022-12-31 0001071438 bak:AssociateMember 2021-12-31 0001071438 bak:Associate1Member 2020-12-31 0001071438 bak:Associate2Member 2020-12-31 0001071438 bak:Associate3Member 2020-12-31 0001071438 bak:Associate4Member 2020-12-31 0001071438 bak:Associate1Member 2021-01-01 2021-12-31 0001071438 bak:Associate2Member 2021-01-01 2021-12-31 0001071438 bak:Associate3Member 2021-01-01 2021-12-31 0001071438 bak:Associate4Member 2021-01-01 2021-12-31 0001071438 bak:Associate1Member 2021-12-31 0001071438 bak:Associate2Member 2021-12-31 0001071438 bak:Associate3Member 2021-12-31 0001071438 bak:Associate4Member 2021-12-31 0001071438 bak:Associate1Member 2022-01-01 2022-12-31 0001071438 bak:Associate2Member 2022-01-01 2022-12-31 0001071438 bak:Associate3Member 2022-01-01 2022-12-31 0001071438 bak:Associate4Member 2022-01-01 2022-12-31 0001071438 bak:Associate1Member 2022-12-31 0001071438 bak:Associate2Member 2022-12-31 0001071438 bak:Associate3Member 2022-12-31 0001071438 bak:Associate4Member 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2021-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2022-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2021-12-31 0001071438 bak:EliminationsMember 2022-12-31 0001071438 bak:EliminationsMember 2021-12-31 0001071438 bak:TotalMember 2022-12-31 0001071438 bak:TotalMember 2021-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2022-01-01 2022-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2021-01-01 2021-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2020-01-01 2020-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2021-01-01 2021-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2020-01-01 2020-12-31 0001071438 bak:EliminationsMember 2022-01-01 2022-12-31 0001071438 bak:EliminationsMember 2021-01-01 2021-12-31 0001071438 bak:EliminationsMember 2020-01-01 2020-12-31 0001071438 bak:TotalMember 2022-01-01 2022-12-31 0001071438 bak:TotalMember 2021-01-01 2021-12-31 0001071438 bak:TotalMember 2020-01-01 2020-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2020-12-31 0001071438 bak:ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember 2019-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2020-12-31 0001071438 bak:BraskemIdesaConsolidatedMember 2019-12-31 0001071438 bak:EliminationsMember 2020-12-31 0001071438 bak:EliminationsMember 2019-12-31 0001071438 bak:TotalMember 2020-12-31 0001071438 bak:TotalMember 2019-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2022-01-01 2022-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2021-01-01 2021-12-31 0001071438 ifrs-full:BuildingsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:BuildingsMember 2021-01-01 2021-12-31 0001071438 bak:MachineryAndFacilitiesMember 2022-01-01 2022-12-31 0001071438 bak:MachineryAndFacilitiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FixturesAndFittingsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FixturesAndFittingsMember 2021-01-01 2021-12-31 0001071438 bak:ItEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:ItEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:LabEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:LabEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:SecurityEquipmentMember 2022-01-01 2022-12-31 0001071438 bak:SecurityEquipmentMember 2021-01-01 2021-12-31 0001071438 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 ifrs-full:LandMember 2020-01-01 2020-12-31 0001071438 ifrs-full:BuildingsMember 2020-01-01 2020-12-31 0001071438 bak:MachineryAndFacilitiesMember 2020-01-01 2020-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2020-01-01 2020-12-31 0001071438 bak:OtherMember 2020-01-01 2020-12-31 0001071438 ifrs-full:LandMember 2020-12-31 0001071438 ifrs-full:BuildingsMember 2020-12-31 0001071438 bak:MachineryAndFacilitiesMember 2020-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2020-12-31 0001071438 bak:OtherMember 2020-12-31 0001071438 ifrs-full:LandMember 2021-01-01 2021-12-31 0001071438 ifrs-full:LandMember 2021-12-31 0001071438 ifrs-full:BuildingsMember 2021-12-31 0001071438 bak:MachineryAndFacilitiesMember 2021-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2021-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 ifrs-full:LandMember 2022-01-01 2022-12-31 0001071438 ifrs-full:LandMember 2022-12-31 0001071438 ifrs-full:BuildingsMember 2022-12-31 0001071438 bak:MachineryAndFacilitiesMember 2022-12-31 0001071438 bak:ProjectsAndStoppageInProgressMember 2022-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:BrazilMember 2022-12-31 0001071438 bak:BrazilMember 2021-12-31 0001071438 bak:MexicoMember 2022-12-31 0001071438 bak:MexicoMember 2021-12-31 0001071438 bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 bak:UnitedStatesOfAmericaMember 2021-12-31 0001071438 bak:GermanyMember 2022-12-31 0001071438 bak:GermanyMember 2021-12-31 0001071438 bak:NetherlandMember 2022-12-31 0001071438 bak:NetherlandMember 2021-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2020-01-01 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2020-01-01 2020-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-01-01 2020-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2020-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2020-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-31 0001071438 ifrs-full:BrandNamesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2021-01-01 2021-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-01-01 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2021-12-31 0001071438 ifrs-full:BrandNamesMember 2021-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2021-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2021-01-01 2021-12-31 0001071438 ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillBasedOnExpectedFutureProfitabilityMember 2022-12-31 0001071438 ifrs-full:BrandNamesMember 2022-12-31 0001071438 ifrs-full:ComputerSoftwareMember 2022-12-31 0001071438 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001071438 bak:NortheasternPetrochemicalComplexMember 2022-12-31 0001071438 bak:SouthernPetrochemicalComplexMember 2022-12-31 0001071438 bak:VinylsUnityMember 2022-12-31 0001071438 bak:BrandsAndPatentsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:BrandsAndPatentsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:SoftwareLicensesAndRightsOfUseMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:SoftwareLicensesAndRightsOfUseMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:CustomersAndSuppliersAgreementsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:CustomersAndSuppliersAgreementsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001071438 bak:RailCarsMember 2021-12-31 0001071438 bak:RailCarsMember 2022-01-01 2022-12-31 0001071438 bak:RailCarsMember 2022-12-31 0001071438 bak:MachineryAndEquipmentsMember 2021-12-31 0001071438 bak:MachineryAndEquipmentsMember 2022-01-01 2022-12-31 0001071438 bak:MachineryAndEquipmentsMember 2022-12-31 0001071438 ifrs-full:ShipsMember 2021-12-31 0001071438 ifrs-full:ShipsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ShipsMember 2022-12-31 0001071438 bak:BuildingsAndConstructionsMember 2021-12-31 0001071438 bak:BuildingsAndConstructionsMember 2022-01-01 2022-12-31 0001071438 bak:BuildingsAndConstructionsMember 2022-12-31 0001071438 ifrs-full:VehiclesMember 2021-12-31 0001071438 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:VehiclesMember 2022-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2021-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2022-12-31 0001071438 bak:RailCarsMember 2020-12-31 0001071438 bak:RailCarsMember 2021-01-01 2021-12-31 0001071438 bak:MachineryAndEquipmentsMember 2020-12-31 0001071438 bak:MachineryAndEquipmentsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ShipsMember 2020-12-31 0001071438 ifrs-full:ShipsMember 2021-01-01 2021-12-31 0001071438 bak:BuildingsAndConstructionsMember 2020-12-31 0001071438 bak:BuildingsAndConstructionsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:VehiclesMember 2020-12-31 0001071438 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2020-12-31 0001071438 ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001071438 bak:UninitiatedLeaseArrangementsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2021-12-31 0001071438 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001071438 bak:LaterThanFiveYearsAndNotLaterThanSixYearsMember 2022-12-31 0001071438 bak:LaterThanSixYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesForfaitMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:ThirdPartiesForfaitMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:ThirdPartiesForfaitMember 2022-12-31 0001071438 bak:ThirdPartiesForfaitMember 2021-12-31 0001071438 bak:RelatedPartieMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartieMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartieForfaitMember bak:DomesticMarketMember 2022-12-31 0001071438 bak:RelatedPartieForfaitMember bak:DomesticMarketMember 2021-12-31 0001071438 bak:RelatedPartieForfaitMember 2022-12-31 0001071438 bak:RelatedPartieForfaitMember 2021-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2022-12-31 0001071438 bak:ThirdPartiesMember bak:ForeignMarketMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:BondMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:ExportPrepaymentMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:ExportPrepaymentMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherBorrowingsMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:TransactionsCostsMember 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:TransactionsCostsMember 2021-12-31 0001071438 bak:ForeignCurrencyMember 2022-12-31 0001071438 bak:ForeignCurrencyMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:AgribusinessCreditNotesMember 2022-01-01 2022-12-31 0001071438 bak:AgribusinessCreditNotesMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:BNDESMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:ExportCreditNotes1Member 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:ExportCreditNotes1Member 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherFixedInterestLoansMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2022-01-01 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:OtherVariableInterestLoansMember 2021-12-31 0001071438 bak:LocalCurrencyMember bak:TransactionsCostsMember 2022-12-31 0001071438 bak:LocalCurrencyMember bak:TransactionsCostsMember 2021-12-31 0001071438 bak:LocalCurrencyMember 2022-12-31 0001071438 bak:LocalCurrencyMember 2021-12-31 0001071438 bak:TwentyTwentyThreeMember 2021-12-31 0001071438 bak:TwentyTwentyFourMember 2022-12-31 0001071438 bak:TwentyTwentyFourMember 2021-12-31 0001071438 bak:TwentyTwentyFiveMember 2022-12-31 0001071438 bak:TwentyTwentyFiveMember 2021-12-31 0001071438 bak:TwentyTwentySixMember 2022-12-31 0001071438 bak:TwentyTwentySixMember 2021-12-31 0001071438 bak:TwentyTwentySevanMember 2022-12-31 0001071438 bak:TwentyTwentySevanMember 2021-12-31 0001071438 bak:TwentyTwentyEightMember 2022-12-31 0001071438 bak:TwentyTwentyEightMember 2021-12-31 0001071438 bak:TwentyTwentyNineMember 2022-12-31 0001071438 bak:TwentyTwentyNineMember 2021-12-31 0001071438 bak:TwentyThirtyMember 2022-12-31 0001071438 bak:TwentyThirtyMember 2021-12-31 0001071438 bak:TwentyThirtyOneMember 2022-12-31 0001071438 bak:TwentyThirtyOneMember 2021-12-31 0001071438 bak:ThirtyThreeAndThereafterMember 2022-12-31 0001071438 bak:ThirtyThreeAndThereafterMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds1Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds2Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds3Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds4Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds5Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds6Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:Bonds7Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI1Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI2Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI3Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI4Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI5Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI6Member 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI7Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI7Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI8Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherNEXI8Member 2022-12-31 0001071438 bak:ForeignCurrencyThreeMember 2022-12-31 0001071438 bak:ForeignCurrencyThreeMember 2021-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA1Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA1Member 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA2Member 2022-01-01 2022-12-31 0001071438 bak:ForeignCurrencyMember bak:OtherCRA2Member 2022-12-31 0001071438 bak:BondMember 2022-01-01 2022-12-31 0001071438 bak:BondMember 2022-12-31 0001071438 bak:BondMember 2021-12-31 0001071438 bak:BondIIMember 2022-01-01 2022-12-31 0001071438 bak:BondIIMember 2022-12-31 0001071438 bak:BondIIMember 2021-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:TransactionsCostsMember 2022-12-31 0001071438 bak:TransactionsCostsMember 2021-12-31 0001071438 bak:TwentyTwentyTwoMember 2021-12-31 0001071438 bak:DebenturesMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember 2022-12-31 0001071438 bak:DebenturesMember 2021-12-31 0001071438 bak:Debentures1Member 2022-01-01 2022-12-31 0001071438 bak:Debentures1Member 2022-12-31 0001071438 bak:Debentures1Member 2021-12-31 0001071438 bak:Debentures2Member 2022-01-01 2022-12-31 0001071438 bak:Debentures2Member 2022-12-31 0001071438 bak:Debentures3Member 2022-01-01 2022-12-31 0001071438 bak:Debentures3Member 2022-12-31 0001071438 bak:Debentures4Member 2022-01-01 2022-12-31 0001071438 bak:Debentures4Member 2022-12-31 0001071438 bak:Debentures5Member 2022-01-01 2022-12-31 0001071438 bak:Debentures5Member 2022-12-31 0001071438 bak:Debentures6Member 2022-01-01 2022-12-31 0001071438 bak:Debentures6Member 2022-12-31 0001071438 bak:Debentures7Member 2022-01-01 2022-12-31 0001071438 bak:Debentures7Member 2022-12-31 0001071438 bak:Debentures7Member 2021-12-31 0001071438 bak:TwentyTwentyThirtyMember 2022-12-31 0001071438 bak:TwentyTwentyThirtyOneMember 2022-12-31 0001071438 bak:TwentyTwentyThirtyTwoMember 2022-12-31 0001071438 bak:BorrowingMember 2021-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2021-12-31 0001071438 bak:BraskemIdesaFinancingMember 2021-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2021-12-31 0001071438 bak:LeaseMember 2021-12-31 0001071438 bak:DividendsMember 2021-12-31 0001071438 bak:BorrowingMember 2022-01-01 2022-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaFinancingMember 2022-01-01 2022-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:LeaseMember 2022-01-01 2022-12-31 0001071438 bak:DividendsMember 2022-01-01 2022-12-31 0001071438 bak:LoanToNonControllingShareholdersOfBraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:BorrowingMember 2022-12-31 0001071438 bak:BorrowingsAndDebenturesMember 2022-12-31 0001071438 bak:BraskemIdesaFinancingMember 2022-12-31 0001071438 bak:ShareholdersOfBraskemIdesaMember 2022-12-31 0001071438 bak:LeaseMember 2022-12-31 0001071438 bak:DividendsMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember bak:CashAndBanksMember ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember bak:CashAndBanksMember ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:CashAndCashEquivalentMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:CashAndCashEquivalentMember 2022-12-31 0001071438 bak:CashAndCashEquivalentMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:LetrasFinanceirasDoTesouroLFTMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember bak:LetrasFinanceirasDoTesouroLFTMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:TimeDepositInvestmentsMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:FinancialInvestmentsMember 2022-12-31 0001071438 bak:FinancialInvestmentsMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001071438 bak:TradeAccountsReceivablesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2021-12-31 0001071438 bak:TradePayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:TradePayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BorrowingMember bak:ForeignCurrencyBondMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BorrowingMember bak:LocalCurrencyMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BorrowingMember bak:LocalCurrencyMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BorrowingMember 2022-12-31 0001071438 bak:BorrowingMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:BondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:BondMember ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember bak:OtherMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraskemIdesaBorrowingsMember 2022-12-31 0001071438 bak:BraskemIdesaBorrowingsMember 2021-12-31 0001071438 bak:DebenturesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:DebenturesMember ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:LoanToNoncontrollingShareholderOfBraskemIdesaMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:LoanToNoncontrollingShareholderOfBraskemIdesaMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:LeniencyAgreementMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001071438 bak:LeniencyAgreementMember ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2021-12-31 0001071438 bak:BraksemAmericaSwapC3PGPMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraksemAmericaSwapC3PGPMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemHolandaSwapNaftaGasolinaMember bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemArgentinaExchangeSwapMember bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:NonHedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSADollarCallAndPutOptionsMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSADollarSwapCDIMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:BraskemSASwapCRAMember bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:BraskemSASwapCRAMember bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2021-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2022-01-01 2022-12-31 0001071438 bak:HedgeAccountingTransactionsMember 2022-12-31 0001071438 bak:PutOptionsMember 2022-12-31 0001071438 bak:PutOptionsMember 2021-12-31 0001071438 bak:CallOptionsMember 2022-12-31 0001071438 bak:CallOptionsMember 2021-12-31 0001071438 bak:FutureExportsMember 2017-12-31 0001071438 bak:FutureExportsMember 2019-12-31 0001071438 bak:FutureExportsOneMember 2019-12-31 0001071438 bak:FutureExportsMember 2020-12-31 0001071438 bak:FutureExportsOneMember 2020-12-31 0001071438 bak:FutureExportsMember 2020-01-01 2020-12-31 0001071438 bak:FutureExportsOneMember 2020-01-01 2020-12-31 0001071438 bak:FutureExportsMember 2021-12-31 0001071438 bak:FutureExportsOneMember 2021-12-31 0001071438 bak:FutureExportsMember 2021-01-01 2021-12-31 0001071438 bak:FutureExportsOneMember 2021-01-01 2021-12-31 0001071438 bak:FutureExportsMember 2022-12-31 0001071438 bak:FutureExportsOneMember 2022-12-31 0001071438 bak:SwapsCRAMember 2022-12-31 0001071438 bak:SwapsCRAMember 2022-01-01 2022-12-31 0001071438 bak:SwapsCRA1Member 2022-12-31 0001071438 bak:SwapsCRA1Member 2022-01-01 2022-12-31 0001071438 ifrs-full:DerivativesMember 2022-12-31 0001071438 bak:USDMember ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001071438 bak:USDMember ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 bak:USDMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001071438 bak:USDMember bak:LaterThanEightYearsAndNotLaterThanNineYearsMember 2022-12-31 0001071438 bak:USDMember ifrs-full:LaterThanSevenYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 bak:USDMember bak:LaterThanTenYears1Member 2022-12-31 0001071438 bak:USDMember ifrs-full:LaterThanTenYearsAndNotLaterThanFifteenYearsMember 2022-12-31 0001071438 currency:USD 2022-12-31 0001071438 currency:USD bak:FutureExportsMember 2021-12-31 0001071438 currency:USD bak:FutureExportsMember 2022-01-01 2022-12-31 0001071438 currency:USD bak:FutureExportsMember 2022-12-31 0001071438 currency:USD bak:FirstQuarterMember 2022-12-31 0001071438 bak:FirstQuarterMember 2022-12-31 0001071438 currency:USD bak:SecondQuarterMember 2022-12-31 0001071438 bak:SecondQuarterMember 2022-12-31 0001071438 currency:USD bak:ThirdQuarterMember 2022-12-31 0001071438 bak:ThirdQuarterMember 2022-12-31 0001071438 currency:USD bak:FourthQuarterMember 2022-12-31 0001071438 bak:FourthQuarterMember 2022-12-31 0001071438 bak:ExchangeVariationMember 2021-12-31 0001071438 bak:IRAndCSLMember 2021-12-31 0001071438 bak:ExchangeVariationMember 2022-01-01 2022-12-31 0001071438 bak:IRAndCSLMember 2022-01-01 2022-12-31 0001071438 bak:ExchangeVariationMember 2022-12-31 0001071438 bak:IRAndCSLMember 2022-12-31 0001071438 ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanSevenYearsAndNotLaterThanTenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTenYearsAndNotLaterThanFifteenYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember 2022-12-31 0001071438 ifrs-full:LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember 2022-12-31 0001071438 bak:LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember 2022-12-31 0001071438 bak:LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember bak:FirstQuarterMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:FirstQuarterMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember bak:SecondQuarterMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:SecondQuarterMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember bak:ThirdQuarterMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:ThirdQuarterMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember bak:FourthQuarterMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:FourthQuarterMember 2022-12-31 0001071438 currency:USD bak:BraskemIdesaMember 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2021-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2021-12-31 0001071438 bak:BraskemIdesaMember 2021-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:BraskemIdesaMember bak:ExchangeVariationMember 2022-12-31 0001071438 bak:BraskemIdesaMember bak:IRAndCSLMember 2022-12-31 0001071438 bak:MinimumRiskMember 2022-12-31 0001071438 bak:MinimumRiskMember 2021-12-31 0001071438 bak:LowRiskMember 2022-12-31 0001071438 bak:LowRiskMember 2021-12-31 0001071438 bak:ModerateRiskMember 2022-12-31 0001071438 bak:ModerateRiskMember 2021-12-31 0001071438 bak:HighRiskMember 2022-12-31 0001071438 bak:HighRiskMember 2021-12-31 0001071438 bak:VeryHighRiskMember 2022-12-31 0001071438 bak:VeryHighRiskMember 2021-12-31 0001071438 bak:AAAMember 2022-12-31 0001071438 bak:AAAMember 2021-12-31 0001071438 bak:AAPlusMember 2022-12-31 0001071438 bak:AAPlusMember 2021-12-31 0001071438 bak:AAMember 2022-12-31 0001071438 bak:AAMember 2021-12-31 0001071438 bak:AAMinusMember 2022-12-31 0001071438 bak:AAMinusMember 2021-12-31 0001071438 bak:APlusMember 2022-12-31 0001071438 bak:APlusMember 2021-12-31 0001071438 bak:AMember 2022-12-31 0001071438 bak:AMember 2021-12-31 0001071438 bak:AMinusMember 2022-12-31 0001071438 bak:AMinusMember 2021-12-31 0001071438 bak:BBBPlusMember 2022-12-31 0001071438 bak:BBBPlusMember 2021-12-31 0001071438 bak:BBBMember 2022-12-31 0001071438 bak:BBBMember 2021-12-31 0001071438 bak:BBBMinusMember 2021-12-31 0001071438 bak:BBPlusMember 2021-12-31 0001071438 bak:BBMember 2021-12-31 0001071438 bak:BBMinusMember 2022-12-31 0001071438 bak:SharesOfInvestmentFundsMember 2021-12-31 0001071438 bak:OtherFinancialAssetMember 2022-12-31 0001071438 bak:OtherFinancialAssetMember 2021-12-31 0001071438 bak:BondMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:InvestmentMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:SaceMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarCallAndPutOptionsMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapCDIMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:MONFORTEMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:NexiMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInvestmentsAbroadMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapIPCAMember bak:BrazilianRealUSDollarExchangeRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:NexiMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:SaceMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:MONFORTEMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:InvestmentMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:OutrosMember bak:LiborFloatingInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember bak:CDIInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInvestmentsInBrazilMember bak:CDIInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DebenturesMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:BNDESMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:BNBFINEPFUNDESFINISAFINAMEFNEMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:CRAMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:DollarSwapIPCAMember bak:IPCAInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:LeniencyAgreementMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportPrepaymentsMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:ExportCreditNotesMember bak:SelicInterestRateMember 2022-01-01 2022-12-31 0001071438 bak:IPIMember bak:DomesticMember 2022-12-31 0001071438 bak:IPIMember bak:DomesticMember 2021-12-31 0001071438 bak:ICMSMember bak:DomesticMember 2022-12-31 0001071438 bak:ICMSMember bak:DomesticMember 2021-12-31 0001071438 bak:PISAndCOFINSMember bak:DomesticMember 2022-12-31 0001071438 bak:PISAndCOFINSMember bak:DomesticMember 2021-12-31 0001071438 bak:OtherMember bak:DomesticMember 2022-12-31 0001071438 bak:OtherMember bak:DomesticMember 2021-12-31 0001071438 bak:ValueAddedTaxMember bak:OtherCountriesMember 2022-12-31 0001071438 bak:ValueAddedTaxMember bak:OtherCountriesMember 2021-12-31 0001071438 bak:OtherMember bak:OtherCountriesMember 2022-12-31 0001071438 bak:OtherMember bak:OtherCountriesMember 2021-12-31 0001071438 bak:OtherCountriesMember 2022-12-31 0001071438 bak:OtherCountriesMember 2021-12-31 0001071438 2022-08-01 2022-08-31 0001071438 bak:SubsidiaryOneMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryTwoMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryThreeMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryFourMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiaryFiveMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiarySixMember 2022-01-01 2022-12-31 0001071438 bak:SubsidiarySevenMember 2022-01-01 2022-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2020-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2021-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxLossesIRAndNegativeBaseCSLMember bak:AssetMember 2022-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2020-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2021-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:GoodwillAmortizedMember bak:AssetMember 2022-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2020-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2021-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:ExchangeVariationsMember bak:AssetMember 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2020-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:AssetMember 2022-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2020-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2021-12-31 0001071438 bak:BusinessCombinationMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2020-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:TaxCreditsMember bak:AssetMember 2022-12-31 0001071438 bak:OtherMember bak:AssetMember 2020-12-31 0001071438 bak:OtherMember bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember bak:AssetMember 2021-12-31 0001071438 bak:OtherMember bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:AssetMember 2022-12-31 0001071438 bak:AssetMember 2020-12-31 0001071438 bak:AssetMember 2021-01-01 2021-12-31 0001071438 bak:AssetMember 2021-12-31 0001071438 bak:AssetMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:TaxDepreciationMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:ExclusionOfICMSInBasisOfCalculationMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:TemporaryAdjustmentMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:PresentValueAdjustmentAndAmortizedCostMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember 2020-12-31 0001071438 bak:LiabilitiesCategoryMember 2021-01-01 2021-12-31 0001071438 bak:LiabilitiesCategoryMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember 2022-12-31 0001071438 bak:NetMember 2020-12-31 0001071438 bak:NetMember 2021-01-01 2021-12-31 0001071438 bak:NetMember 2021-12-31 0001071438 bak:NetMember 2022-01-01 2022-12-31 0001071438 bak:NetMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemSAMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemArgentinaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemAmericaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemAlemanhaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemChileMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemHolandaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemHolandaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemIdesaServicosMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemIdesaServicosMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoServicosMember 2021-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2022-12-31 0001071438 bak:AssetMember bak:BraskemMexicoMember 2021-12-31 0001071438 bak:AssetMember bak:CetrelMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:CetrelMember 2022-12-31 0001071438 bak:AssetMember bak:CetrelMember 2021-12-31 0001071438 bak:AssetMember bak:DACMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:DACMember 2022-12-31 0001071438 bak:AssetMember bak:DACMember 2021-12-31 0001071438 bak:AssetMember bak:TerminalQuimicaMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:TerminalQuimicaMember 2022-12-31 0001071438 bak:AssetMember bak:VoqenMember 2022-01-01 2022-12-31 0001071438 bak:AssetMember bak:VoqenMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemSAMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemAmericaMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemArgentinaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemArgentinaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemHolandaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemHolandaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BTCMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:BTCMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:CetrelMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:DACMember 2021-12-31 0001071438 bak:LiabilitiesCategoryMember bak:VoqenMember 2022-01-01 2022-12-31 0001071438 bak:LiabilitiesCategoryMember bak:VoqenMember 2022-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2022-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2021-12-31 0001071438 bak:ProvisionForCustomersRebatesMember 2022-12-31 0001071438 bak:ProvisionForCustomersRebatesMember 2021-12-31 0001071438 bak:OtherMember 2022-12-31 0001071438 bak:OtherMember 2021-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2020-12-31 0001071438 bak:RebateMember 2020-12-31 0001071438 bak:OtherMember 2020-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2021-01-01 2021-12-31 0001071438 bak:RebateMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 bak:RebateMember 2021-12-31 0001071438 bak:RecoveryOfEnvironmentalDamageMember 2022-01-01 2022-12-31 0001071438 bak:RebateMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:RebateMember 2022-12-31 0001071438 bak:LaborClaimsMember 2022-12-31 0001071438 bak:LaborClaimsMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:IRAndCSLMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:IRAndCSLMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:PISAndCOFINSMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:PISAndCOFINSMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:ICMSMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:ICMSMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:OtherTaxClaimsMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:OtherTaxClaimsMember bak:NormalOperationMember 2021-12-31 0001071438 bak:TaxClaimsMember bak:NormalOperationMember 2022-12-31 0001071438 bak:TaxClaimsMember bak:NormalOperationMember 2021-12-31 0001071438 bak:CorporateClaimsMember 2022-12-31 0001071438 bak:CorporateClaimsMember 2021-12-31 0001071438 bak:CivilClaimsAndOtherMember 2022-12-31 0001071438 bak:CivilClaimsAndOtherMember 2021-12-31 0001071438 bak:TaxClaimsICMSMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2021-01-01 2021-12-31 0001071438 bak:IRAndCSLMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember 2021-01-01 2021-12-31 0001071438 bak:IRPJAndCSLLForeignEarnedIncomeMember ifrs-full:TaxContingentLiabilityMember 2022-01-01 2022-12-31 0001071438 bak:IRPJAndCSLLForeignEarnedIncomeMember ifrs-full:TaxContingentLiabilityMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember bak:PISAndCOFINSTaxesMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsICMSMember bak:PISAndCOFINSTaxesMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:TaxClaimsICMSMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:PISAndCOFINSSundryMember 2022-12-31 0001071438 bak:PISAndCOFINSSundryMember 2021-12-31 0001071438 bak:IRRFIRAndCSLCommissionExpensesMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IRRFIRAndCSLCommissionExpensesMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:IsolatedFineFailureToRatifyDCOMPSMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IsolatedFineFailureToRatifyDCOMPSMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:SocialSecurityContributionsMember 2022-12-31 0001071438 ifrs-full:TaxContingentLiabilityMember bak:SocialSecurityContributionsMember 2021-12-31 0001071438 bak:PISAndCOFINSDCideFuelsTaxOffsetMember ifrs-full:TaxContingentLiabilityMember 2022-01-01 2022-12-31 0001071438 bak:PISAndCOFINSDCideFuelsTaxOffsetMember ifrs-full:TaxContingentLiabilityMember 2021-01-01 2021-12-31 0001071438 bak:CivilClaimsResaleOfSolventsMember 2022-12-31 0001071438 bak:CivilClaimsResaleOfSolventsMember 2021-12-31 0001071438 bak:EnvironmentalMember 2022-01-01 2022-12-31 0001071438 bak:EnvironmentalMember 2021-01-01 2021-12-31 0001071438 bak:SocialSecurityMember 2022-01-01 2022-12-31 0001071438 bak:SocialSecurityMember 2021-01-01 2021-12-31 0001071438 bak:IRPJCSLLNegativeBalanceOffsetMember ifrs-full:TaxContingentLiabilityMember 2022-12-31 0001071438 bak:IRPJCSLLNegativeBalanceOffsetMember ifrs-full:TaxContingentLiabilityMember 2021-12-31 0001071438 bak:LaborClaimsMember 2020-12-31 0001071438 bak:TaxClaimsNetMember 2020-12-31 0001071438 bak:CorporateClaimMember 2020-12-31 0001071438 bak:CivilClaimsAndOtherMember 2020-12-31 0001071438 bak:LaborClaimsMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsNetMember 2021-01-01 2021-12-31 0001071438 bak:CorporateClaimMember 2021-01-01 2021-12-31 0001071438 bak:CivilClaimsAndOtherMember 2021-01-01 2021-12-31 0001071438 bak:TaxClaimsNetMember 2021-12-31 0001071438 bak:CorporateClaimMember 2021-12-31 0001071438 bak:LaborClaimsMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsNetMember 2022-01-01 2022-12-31 0001071438 bak:CorporateClaimMember 2022-01-01 2022-12-31 0001071438 bak:CivilClaimsAndOtherMember 2022-01-01 2022-12-31 0001071438 bak:TaxClaimsNetMember 2022-12-31 0001071438 bak:CorporateClaimMember 2022-12-31 0001071438 bak:TaxClaimsMember 2022-12-31 0001071438 bak:TaxClaimsMember 2021-12-31 0001071438 bak:CivilClaimsOneMember 2022-12-31 0001071438 bak:CivilClaimsOneMember 2021-12-31 0001071438 bak:CivilClaimsTwoMember 2022-12-31 0001071438 bak:CivilClaimsTwoMember 2021-12-31 0001071438 bak:EnvironmentalClaimsMember 2022-12-31 0001071438 bak:EnvironmentalClaimsMember 2021-12-31 0001071438 bak:SocialSecurityClaimsMember 2022-12-31 0001071438 bak:SocialSecurityClaimsMember 2021-12-31 0001071438 bak:OtherLawsuitsMember 2022-12-31 0001071438 bak:OtherLawsuitsMember 2021-12-31 0001071438 currency:USD bak:FederalProsecutionOfficeAndUSSwissAuthoritiesMember bak:LeniencyAgreementsMember 2016-12-01 2016-12-31 0001071438 bak:FederalProsecutionOfficeAndUSSwissAuthoritiesMember bak:LeniencyAgreementsMember 2016-12-01 2016-12-31 0001071438 bak:FederalControllerGeneralAndAttorneyGenerallAgreementMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:DepartmentOfJusticeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:SwissOfficeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:FederalProsecutionOfficeMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:SecuritiesAndExchangeCommissionMember bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:LeniencyAgreementsMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasMember 2021-12-31 0001071438 bak:AlagoasMember 2020-12-31 0001071438 bak:AlagoasMember 2019-12-31 0001071438 bak:AlagoasMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasMember 2021-01-01 2021-12-31 0001071438 bak:AlagoasMember 2020-01-01 2020-12-31 0001071438 bak:AlagoasMember 2022-12-31 0001071438 bak:AlagoasStateFederalProsecutionOfficeMember bak:TechnicalCooperationAgreementMember 2022-01-01 2022-12-31 0001071438 bak:AlagoasStateFederalProsecutionOfficeMember bak:TechnicalCooperationAgreementMember 2021-01-01 2021-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2022-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2021-12-31 0001071438 bak:TechnicalCooperationAgreementMember 2022-01-01 2022-12-31 0001071438 bak:HealthCareBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:HealthCareBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:HealthCareBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:PrivatePensionBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:PrivatePensionBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:PrivatePensionBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:TransportBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:TransportBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:TransportBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:FeedingBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:FeedingBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:FeedingBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:LifeInsuranceBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:TrainingBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:TrainingBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:TrainingBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:OtherBenefitsMember 2022-01-01 2022-12-31 0001071438 bak:OtherBenefitsMember 2021-01-01 2021-12-31 0001071438 bak:OtherBenefitsMember 2020-01-01 2020-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2019Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2019Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2019Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2019Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2020Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2020Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2020Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2020Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2021Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2021Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2021Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2021Member 2021-01-01 2021-12-31 0001071438 bak:SettlementMethodologySharesMember bak:Plan2022Member 2022-01-01 2022-12-31 0001071438 bak:SettlementMethodologyCashMember bak:Plan2022Member 2022-01-01 2022-12-31 0001071438 bak:DefinedBenefitMember bak:NovamontBraskemAmericaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:NovamontBraskemAmericaMember 2021-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemIdesaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemIdesaMember 2021-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemAlemanhaAndBraskemHolandaMember 2022-12-31 0001071438 bak:DefinedBenefitMember bak:BraskemAlemanhaAndBraskemHolandaMember 2021-12-31 0001071438 bak:DefinedBenefitMember 2022-12-31 0001071438 bak:DefinedBenefitMember 2021-12-31 0001071438 bak:HealthCarePlanMember bak:BradescoSaudeMember 2022-12-31 0001071438 bak:HealthCarePlanMember bak:BradescoSaudeMember 2021-12-31 0001071438 bak:NovamontBraskemAmericaMember 2022-12-31 0001071438 bak:NovamontBraskemAmericaMember 2021-12-31 0001071438 bak:BraskemAlemanhaMember 2022-12-31 0001071438 bak:BraskemAlemanhaMember 2021-12-31 0001071438 bak:HealthInsuranceMember 2021-12-31 0001071438 bak:BenefitPlansMember 2021-12-31 0001071438 bak:HealthInsuranceMember 2020-12-31 0001071438 bak:BenefitPlansMember 2020-12-31 0001071438 bak:HealthInsuranceMember 2019-12-31 0001071438 bak:BenefitPlansMember 2019-12-31 0001071438 bak:HealthInsuranceMember 2022-01-01 2022-12-31 0001071438 bak:BenefitPlansMember 2022-01-01 2022-12-31 0001071438 bak:HealthInsuranceMember 2021-01-01 2021-12-31 0001071438 bak:BenefitPlansMember 2021-01-01 2021-12-31 0001071438 bak:HealthInsuranceMember 2020-01-01 2020-12-31 0001071438 bak:BenefitPlansMember 2020-01-01 2020-12-31 0001071438 bak:HealthInsuranceMember 2022-12-31 0001071438 bak:BenefitPlansMember 2022-12-31 0001071438 bak:UnitedStateOfAmericaMember 2022-12-31 0001071438 bak:MexicoMember 2022-12-31 0001071438 bak:GermanyMember 2022-12-31 0001071438 bak:NetherlandsMember 2022-12-31 0001071438 bak:UnitedStateOfAmericaMember 2021-12-31 0001071438 bak:MexicoMember 2021-12-31 0001071438 bak:GermanyMember 2021-12-31 0001071438 bak:NetherlandsMember 2021-12-31 0001071438 bak:UnitedStateOfAmericaMember 2020-12-31 0001071438 bak:MexicoMember 2020-12-31 0001071438 bak:GermanyMember 2020-12-31 0001071438 bak:NetherlandsMember 2020-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:MexicoMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:HealthInsuranceMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:GermanyMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:NetherlandsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:GermanyMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember bak:NetherlandsMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfMortalityRatesMember bak:UnitedStatesOfAmericaMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2022-12-31 0001071438 ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember 2022-12-31 0001071438 bak:NovonorMember bak:CommonSharesMember 2022-12-31 0001071438 bak:NovonorMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:NovonorMember 2022-12-31 0001071438 bak:PetrobrasMember bak:CommonSharesMember 2022-12-31 0001071438 bak:PetrobrasMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:PetrobrasMember 2022-12-31 0001071438 bak:AdrsMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:AdrsMember 2022-12-31 0001071438 bak:OtherMember bak:CommonSharesMember 2022-12-31 0001071438 bak:OtherMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:OtherMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:Other2Member 2022-12-31 0001071438 bak:TotalMember bak:CommonSharesMember 2022-12-31 0001071438 bak:TotalMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:TotalMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:TotalMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 ifrs-full:TreasurySharesMember 2022-12-31 0001071438 bak:CommonSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:CommonSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:ClassAPreferenceSharesMember 2022-12-31 0001071438 bak:AuthorisedMember bak:ClassBPreferenceSharesMember 2022-12-31 0001071438 bak:AuthorisedMember 2022-12-31 0001071438 bak:CommonSharesMember 2020-12-31 0001071438 bak:CommonSharesMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember 2021-12-31 0001071438 bak:TotalMember 2020-12-31 0001071438 bak:TotalMember 2021-12-31 0001071438 ifrs-full:TreasurySharesMember 2020-12-31 0001071438 ifrs-full:TreasurySharesMember 2021-12-31 0001071438 bak:LTIProgram2018Member 2021-01-01 2021-12-31 0001071438 bak:ProfitReservesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember 2021-01-01 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember 2022-01-01 2022-12-31 0001071438 bak:ClassBPreferenceSharesMember 2020-01-01 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2022-01-01 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2022-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-01-01 2021-12-31 0001071438 bak:ClassBPreferenceSharesMember ifrs-full:WeightedAverageMember 2021-12-31 0001071438 bak:ClassAPreferenceSharesMember 2019-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2019-12-31 0001071438 bak:ClassAPreferenceSharesMember ifrs-full:WeightedAverageMember 2020-01-01 2020-12-31 0001071438 bak:BrazilMember 2022-01-01 2022-12-31 0001071438 bak:BrazilMember 2021-01-01 2021-12-31 0001071438 bak:BrazilMember 2020-01-01 2020-12-31 0001071438 bak:UnitedStatesMember 2022-01-01 2022-12-31 0001071438 bak:UnitedStatesMember 2021-01-01 2021-12-31 0001071438 bak:UnitedStatesMember 2020-01-01 2020-12-31 0001071438 bak:MexicoMember 2022-01-01 2022-12-31 0001071438 bak:MexicoMember 2021-01-01 2021-12-31 0001071438 bak:MexicoMember 2020-01-01 2020-12-31 0001071438 bak:ARMember 2022-01-01 2022-12-31 0001071438 bak:ARMember 2021-01-01 2021-12-31 0001071438 bak:ARMember 2020-01-01 2020-12-31 0001071438 bak:DEMember 2022-01-01 2022-12-31 0001071438 bak:DEMember 2021-01-01 2021-12-31 0001071438 bak:DEMember 2020-01-01 2020-12-31 0001071438 bak:CHMember 2022-01-01 2022-12-31 0001071438 bak:CHMember 2021-01-01 2021-12-31 0001071438 bak:CHMember 2020-01-01 2020-12-31 0001071438 bak:ITMember 2022-01-01 2022-12-31 0001071438 bak:ITMember 2021-01-01 2021-12-31 0001071438 bak:ITMember 2020-01-01 2020-12-31 0001071438 bak:CLMember 2022-01-01 2022-12-31 0001071438 bak:CLMember 2021-01-01 2021-12-31 0001071438 bak:CLMember 2020-01-01 2020-12-31 0001071438 bak:NLMember 2022-01-01 2022-12-31 0001071438 bak:NLMember 2021-01-01 2021-12-31 0001071438 bak:NLMember 2020-01-01 2020-12-31 0001071438 bak:LUMember 2022-01-01 2022-12-31 0001071438 bak:LUMember 2021-01-01 2021-12-31 0001071438 bak:LUMember 2020-01-01 2020-12-31 0001071438 bak:SGMember 2022-01-01 2022-12-31 0001071438 bak:SGMember 2021-01-01 2021-12-31 0001071438 bak:SGMember 2020-01-01 2020-12-31 0001071438 bak:PEMember 2022-01-01 2022-12-31 0001071438 bak:PEMember 2021-01-01 2021-12-31 0001071438 bak:PEMember 2020-01-01 2020-12-31 0001071438 bak:JPMember 2022-01-01 2022-12-31 0001071438 bak:JPMember 2021-01-01 2021-12-31 0001071438 bak:JPMember 2020-01-01 2020-12-31 0001071438 bak:ESMember 2022-01-01 2022-12-31 0001071438 bak:ESMember 2021-01-01 2021-12-31 0001071438 bak:ESMember 2020-01-01 2020-12-31 0001071438 bak:GBMember 2022-01-01 2022-12-31 0001071438 bak:GBMember 2021-01-01 2021-12-31 0001071438 bak:GBMember 2020-01-01 2020-12-31 0001071438 bak:UYMember 2022-01-01 2022-12-31 0001071438 bak:UYMember 2021-01-01 2021-12-31 0001071438 bak:UYMember 2020-01-01 2020-12-31 0001071438 bak:PLMember 2022-01-01 2022-12-31 0001071438 bak:PLMember 2021-01-01 2021-12-31 0001071438 bak:PLMember 2020-01-01 2020-12-31 0001071438 bak:BOMember 2022-01-01 2022-12-31 0001071438 bak:BOMember 2021-01-01 2021-12-31 0001071438 bak:BOMember 2020-01-01 2020-12-31 0001071438 bak:SEMember 2022-01-01 2022-12-31 0001071438 bak:SEMember 2021-01-01 2021-12-31 0001071438 bak:SEMember 2020-01-01 2020-12-31 0001071438 bak:CAMember 2022-01-01 2022-12-31 0001071438 bak:CAMember 2021-01-01 2021-12-31 0001071438 bak:CAMember 2020-01-01 2020-12-31 0001071438 bak:FRMember 2022-01-01 2022-12-31 0001071438 bak:FRMember 2021-01-01 2021-12-31 0001071438 bak:FRMember 2020-01-01 2020-12-31 0001071438 bak:PYMember 2022-01-01 2022-12-31 0001071438 bak:PYMember 2021-01-01 2021-12-31 0001071438 bak:PYMember 2020-01-01 2020-12-31 0001071438 bak:COMember 2022-01-01 2022-12-31 0001071438 bak:COMember 2021-01-01 2021-12-31 0001071438 bak:COMember 2020-01-01 2020-12-31 0001071438 bak:CNMember 2022-01-01 2022-12-31 0001071438 bak:CNMember 2021-01-01 2021-12-31 0001071438 bak:CNMember 2020-01-01 2020-12-31 0001071438 bak:KRMember 2022-01-01 2022-12-31 0001071438 bak:KRMember 2021-01-01 2021-12-31 0001071438 bak:KRMember 2020-01-01 2020-12-31 0001071438 bak:OtherMember 2022-01-01 2022-12-31 0001071438 bak:OtherMember 2021-01-01 2021-12-31 0001071438 bak:OtherMember 2020-01-01 2020-12-31 0001071438 bak:PEPPMember 2022-01-01 2022-12-31 0001071438 bak:PEPPMember 2021-01-01 2021-12-31 0001071438 bak:PEPPMember 2020-01-01 2020-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2022-01-01 2022-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2021-01-01 2021-12-31 0001071438 bak:BenzeneTolueneAndXyleneMember 2020-01-01 2020-12-31 0001071438 bak:EthylenePropyleneMember 2022-01-01 2022-12-31 0001071438 bak:EthylenePropyleneMember 2021-01-01 2021-12-31 0001071438 bak:EthylenePropyleneMember 2020-01-01 2020-12-31 0001071438 bak:ETBEGasolineMember 2022-01-01 2022-12-31 0001071438 bak:ETBEGasolineMember 2021-01-01 2021-12-31 0001071438 bak:ETBEGasolineMember 2020-01-01 2020-12-31 0001071438 bak:PVCCausticSodaEDCMember 2022-01-01 2022-12-31 0001071438 bak:PVCCausticSodaEDCMember 2021-01-01 2021-12-31 0001071438 bak:PVCCausticSodaEDCMember 2020-01-01 2020-12-31 0001071438 bak:ButadieneMember 2022-01-01 2022-12-31 0001071438 bak:ButadieneMember 2021-01-01 2021-12-31 0001071438 bak:ButadieneMember 2020-01-01 2020-12-31 0001071438 bak:SolventsMember 2022-01-01 2022-12-31 0001071438 bak:SolventsMember 2021-01-01 2021-12-31 0001071438 bak:SolventsMember 2020-01-01 2020-12-31 0001071438 bak:CumeneMember 2022-01-01 2022-12-31 0001071438 bak:CumeneMember 2021-01-01 2021-12-31 0001071438 bak:CumeneMember 2020-01-01 2020-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2022-01-01 2022-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2021-01-01 2021-12-31 0001071438 bak:NaphthaCondensateAndCrudeOilMember 2020-01-01 2020-12-31 0001071438 bak:Other1Member 2022-01-01 2022-12-31 0001071438 bak:Other1Member 2021-01-01 2021-12-31 0001071438 bak:Other1Member 2020-01-01 2020-12-31 0001071438 bak:OneClientMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:RawMaterialsOtherInputsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:PersonnelExpensesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OutsourcedServicesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:DepreciationAmortizationAndDepletionMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:FreightsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:FreightsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:FreightsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:CostsOfIdleIndustrialPlantsMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:ProvisionGeologicalEventInAlagoasMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OtherIncomesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember bak:OtherGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001071438 bak:NatureMember 2022-01-01 2022-12-31 0001071438 bak:NatureMember 2021-01-01 2021-12-31 0001071438 bak:NatureMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:CostOfProductsSoldMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:SellingAndDistributionMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:LossReversalsForImpairmentOfTradeAccountsReceivableMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:GeneralAndAdministrativeMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:ResearchAndDevelopmentMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:OtherIncomeExpensesNetMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember bak:OtherExpensesMember 2020-01-01 2020-12-31 0001071438 bak:FunctionMember 2022-01-01 2022-12-31 0001071438 bak:FunctionMember 2021-01-01 2021-12-31 0001071438 bak:FunctionMember 2020-01-01 2020-12-31 0001071438 bak:FinancialInterestIncomeMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInterestIncomeMember 2021-01-01 2021-12-31 0001071438 bak:FinancialInterestIncomeMember 2020-01-01 2020-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2022-01-01 2022-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2021-01-01 2021-12-31 0001071438 bak:MonetaryVariationsOnTaxCreditsMember 2020-01-01 2020-12-31 0001071438 bak:GainOnDerivativesMember 2022-01-01 2022-12-31 0001071438 bak:GainOnDerivativesMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialIncomeMember 2022-01-01 2022-12-31 0001071438 bak:OtherFinancialIncomeMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialIncomeMember 2020-01-01 2020-12-31 0001071438 bak:FinancialInterestExpensesMember 2022-01-01 2022-12-31 0001071438 bak:FinancialInterestExpensesMember 2021-01-01 2021-12-31 0001071438 bak:FinancialInterestExpensesMember 2020-01-01 2020-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2022-01-01 2022-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2021-01-01 2021-12-31 0001071438 bak:MonetaryVariationsOnFiscalDebtsMember 2020-01-01 2020-12-31 0001071438 bak:DiscountsGrantedMember 2022-01-01 2022-12-31 0001071438 bak:DiscountsGrantedMember 2021-01-01 2021-12-31 0001071438 bak:DiscountsGrantedMember 2020-01-01 2020-12-31 0001071438 bak:LoansTransactionCostsMember 2022-01-01 2022-12-31 0001071438 bak:LoansTransactionCostsMember 2021-01-01 2021-12-31 0001071438 bak:LoansTransactionCostsMember 2020-01-01 2020-12-31 0001071438 bak:AdjustmentToPresentValueMember 2022-01-01 2022-12-31 0001071438 bak:AdjustmentToPresentValueMember 2021-01-01 2021-12-31 0001071438 bak:AdjustmentToPresentValueMember 2020-01-01 2020-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2022-01-01 2022-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2021-01-01 2021-12-31 0001071438 bak:InterestExpenseOnLeasesMember 2020-01-01 2020-12-31 0001071438 bak:LossesOnDerivativesMember 2022-01-01 2022-12-31 0001071438 bak:LossesOnDerivativesMember 2021-01-01 2021-12-31 0001071438 bak:LossesOnDerivativesMember 2020-01-01 2020-12-31 0001071438 bak:OtherFinancialExpensesMember 2022-01-01 2022-12-31 0001071438 bak:OtherFinancialExpensesMember 2021-01-01 2021-12-31 0001071438 bak:OtherFinancialExpensesMember 2020-01-01 2020-12-31 0001071438 ifrs-full:FinancialAssetsMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialAssetsMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialAssetsMember 2020-01-01 2020-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2022-01-01 2022-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2021-01-01 2021-12-31 0001071438 ifrs-full:FinancialLiabilitiesMember 2020-01-01 2020-12-31 0001071438 bak:USDollarBrazilianRealMember 2022-12-31 0001071438 bak:USDollarBrazilianRealMember 2021-12-31 0001071438 bak:USDollarBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:USDollarBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:USDollarBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:EuroBrazilianRealMember 2022-12-31 0001071438 bak:EuroBrazilianRealMember 2021-12-31 0001071438 bak:EuroBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:EuroBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:EuroBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2022-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2021-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2022-01-01 2022-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2021-01-01 2021-12-31 0001071438 bak:MexicanPesoBrazilianRealMember 2020-01-01 2020-12-31 0001071438 bak:USDollarMexicanPesoMember 2022-12-31 0001071438 bak:USDollarMexicanPesoMember 2021-12-31 0001071438 bak:USDollarMexicanPesoMember 2022-01-01 2022-12-31 0001071438 bak:USDollarMexicanPesoMember 2021-01-01 2021-12-31 0001071438 bak:USDollarMexicanPesoMember 2020-01-01 2020-12-31 0001071438 bak:USDollarEuroMember 2022-12-31 0001071438 bak:USDollarEuroMember 2021-12-31 0001071438 bak:USDollarEuroMember 2022-01-01 2022-12-31 0001071438 bak:USDollarEuroMember 2021-01-01 2021-12-31 0001071438 bak:USDollarEuroMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember 2022-01-01 2022-12-31 0001071438 bak:OtherSegmentsMember 2022-01-01 2022-12-31 0001071438 bak:CorporateUnitMember 2022-01-01 2022-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2022-01-01 2022-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2022-01-01 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember 2021-01-01 2021-12-31 0001071438 bak:OtherSegmentsMember 2021-01-01 2021-12-31 0001071438 bak:CorporateUnitMember 2021-01-01 2021-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2021-01-01 2021-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2021-01-01 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember 2020-01-01 2020-12-31 0001071438 bak:OtherSegmentsMember 2020-01-01 2020-12-31 0001071438 bak:CorporateUnitMember 2020-01-01 2020-12-31 0001071438 bak:BraskemConsolidatedBeforeEliminationsAndReclassificationsMember 2020-01-01 2020-12-31 0001071438 bak:EliminationsAndReclassificationsMember 2020-01-01 2020-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:BrazilMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:USAAndEuropeMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:MexicoMember 2021-12-31 0001071438 bak:ReportingSegmentsMember 2022-12-31 0001071438 bak:ReportingSegmentsMember 2021-12-31 0001071438 bak:ReportingSegmentsMember bak:UnallocatedMember 2022-12-31 0001071438 bak:ReportingSegmentsMember bak:UnallocatedMember 2021-12-31 0001071438 bak:EnergyAgreementMember 2022-12-31 0001071438 bak:EnergyAgreementMember 2021-12-31 0001071438 bak:EventsAfterReportingPeriodMember 2023-02-28 0001071438 bak:EventsAfterReportingPeriodMember 2023-02-02 2023-02-28 0001071438 bak:WiseMember bak:EventsAfterReportingPeriodMember 2023-02-02 2023-02-28 0001071438 bak:EventsAfterReportingPeriodMember 2023-03-02 2023-03-31 iso4217:USD shares iso4217:USD shares iso4217:BRL pure iso4217:BRL shares bak:Number iso4217:MXN 0001071438 false 2022 FY BRASKEM SA 20-F false true 2022-12-31 --12-31 false false 001-14862 D5 Rua Lemos Monteiro, 120 – 24° andar São Paulo 05501-050 BR Pedro van Langendonck Teixeira de Freitas Rua Lemos Monteiro, 120 – 24° andar São Paulo 05501-050 BR 55 11 3576-9000 55 11 3576-9532 Preferred Shares, Class A, without par value per share, each represented by American Depositary Shares BAK NYSE 451668652 345060392 478790 Yes No Yes Yes Large Accelerated Filer false true International Financial Reporting Standards false 1124 KPMG Auditores Independentes Ltda. São Paulo 12466474000 8680686000 2295497000 3492710000 3231934000 7153565000 14030064000 16335101000 1156355000 1428658000 392062000 1189812000 157906000 33816000 727364000 979097000 34457656000 39293445000 17134000 16845000 13395000 1617669000 1252058000 252995000 230069000 6358601000 8257252000 215274000 194212000 71544000 51000 170536000 365652000 149023000 58923000 37763295000 37225130000 3022144000 2877299000 3952987000 2780037000 53591202000 53270923000 88048858000 92564368000 12246782000 12053266000 1254550000 1343494000 868635000 86765000 127801000 59088000 195169000 256131000 827826000 1170346000 491051000 1012116000 381117000 1672844000 392486000 353385000 530814000 465051000 4247609000 4378071000 1039706000 675366000 1581701000 1667600000 24185247000 25193523000 3069000 111464000 31310710000 33553766000 10501683000 12224770000 3023674000 137830000 81917000 362915000 298026000 260497000 2498093000 3646538000 1153481000 1407434000 493743000 487697000 1171498000 1153830000 510654000 769911000 846133000 824212000 2378949000 3283188000 3200824000 2481048000 282940000 461917000 57755394000 61167017000 8043222000 8043222000 6175000 3473000 1825616000 3483935000 -488388000 -488388000 39413000 31932000 -2076066000 -3170158000 28173000 38197000 7321799000 7865819000 -1213582000 -1661991000 6108217000 6203828000 88048858000 92564368000 96519284000 105625201000 58543494000 85160548000 73568231000 47331414000 11358736000 32056970000 11212080000 2108417000 2055640000 1852055000 38426000 8914000 55252000 2763983000 2522127000 1918747000 374493000 296583000 250648000 34848000 4644000 -19398000 507333000 1534487000 750749000 2343525000 2669290000 7938621000 4272073000 26043547000 -71892000 5662693000 5907155000 4913365000 2010134000 1827438000 600184000 -572170000 -4002807000 -5298711000 -4224729000 -8082524000 -9611892000 47344000 17961023000 -9683784000 867735000 3999403000 -2668478000 -820391000 13961620000 -7015306000 -335677000 13984946000 -6691720000 -484714000 -23326000 -323586000 -820391000 13961620000 -7015306000 -0.42 17.57 -8.41 -0.42 17.57 -8.41 -0.42 0.58 -8.41 -0.42 17.57 -8.41 -0.42 17.52 -8.38 -0.42 0.58 -8.41 -820391000 13961620000 -7015306000 292486000 324374000 -397558000 267000 -968000 1260000 292753000 323406000 -396298000 -1121938000 1260781000 4541581000 938118000 1255983000 1448079000 -489773000 143223000 311795000 296803000 355060000 330210000 2846632000 207039000 -3075087000 -1805667000 1503148000 2658042000 1333718000 2033593000 -813343000 10670000 23014000 -647000 10670000 23014000 -647000 523997000 16018227000 -7829296000 714899000 16015874000 -7108541000 -190902000 2353000 -720755000 523997000 16018227000 -7829296000 8043222000 232472000 577476000 153478000 1174301000 -488388000 19980000 -4777519000 -49724000 4885298000 -940592000 3944706000 -6691720000 -6691720000 -323586000 -7015306000 -3079691000 -3079691000 4604000 -3075087000 -390608000 -390608000 -5690000 -396298000 -648000 -648000 1000 -647000 3054126000 3054126000 -396084000 2658042000 -416821000 -6691720000 -7108541000 -720755000 -7829296000 -26302000 26302000 -741000 741000 113000 113000 113000 8077000 8077000 8077000 11629000 11629000 -415000 11214000 3695000 -3695000 11629000 -15158000 23348000 19819000 -415000 19404000 1110000 1110000 1110000 -2450000 -2450000 -232460000 -577476000 -153478000 -1174301000 2137715000 -12000 20000 8000 8000 -232472000 -577476000 -153478000 -1174301000 20000 2138825000 1118000 -2450000 -1332000 8043222000 -488388000 31609000 -5209498000 -49704000 -4529547000 -2202306000 -1664212000 -3866518000 13984946000 13984946000 -23326000 13961620000 154080000 154080000 52959000 207039000 262726000 262726000 60680000 323406000 23028000 23028000 -14000 23014000 1591094000 1591094000 -87946000 1503148000 2030928000 13984946000 16015874000 2353000 16018227000 -26164000 26164000 -719000 719000 323000 323000 -132000 191000 -130000 -130000 -130000 35425000 35425000 35425000 323000 8412000 26883000 35618000 -132000 35486000 1653000 1653000 1653000 -6000000000 -6000000000 -6000000000 3473000 11507000 14980000 14980000 472770000 -472770000 1017546000 -1017546000 643619000 -643619000 1350000000 -1350000000 3473000 472770000 1017546000 643619000 1350000000 11507000 -9482282000 -5983367000 -5983367000 8043222000 3473000 472770000 1017546000 643619000 1350000000 -488388000 31932000 -3170158000 -38197000 7865819000 -1661991000 6203828000 8043222000 3473000 472770000 1017546000 643619000 1350000000 -488388000 31932000 -3170158000 -38197000 7865819000 -1661991000 6203828000 -335677000 -335677000 -484714000 -820391000 2649988000 2649988000 196644000 2846632000 292753000 292753000 292753000 10186000 10186000 484000 10670000 -1902351000 -1902351000 96684000 -1805667000 1050576000 -335677000 714899000 -190902000 523997000 -26164000 26164000 -719000 719000 20207000 20207000 20207000 -35000 -35000 -35000 609827000 609827000 70434000 70434000 70434000 20207000 43516000 26883000 90606000 609827000 700433000 2702000 -12726000 10024000 108975000 -108975000 30720000 30720000 475000 475000 475000 -1350000000 -1350000000 -1350000000 -417294000 417294000 -1236000 -1236000 2702000 108975000 -417294000 -1350000000 -12726000 10024000 308794000 -1349525000 29484000 -1320041000 8043222000 6175000 472770000 1126521000 226325000 -488388000 39413000 -2076066000 -28173000 7321799000 -1213582000 6108217000 47344000 17961023000 -9683784000 4733165000 4178433000 4048081000 34848000 4644000 -19398000 2702636000 6311431000 10457272000 370153000 819130000 336838000 1520019000 1339765000 6901828000 1031099000 310557000 38426000 8914000 55252000 130995000 115187000 8794000 9507890000 29698140000 11833122000 3746107000 1530050000 296957000 -1860827000 3661267000 -2175285000 -2187826000 2138161000 -7574285000 -252534000 682457000 4963587000 1532554000 310789000 -198556000 690888000 514079000 1199614000 -3001564000 -1009356000 -3007488000 449761000 317867000 389087000 349842000 406587000 314194000 145355000 2742791000 2928081000 1181931000 -390727000 805452000 14801000 13477365000 20376774000 9287354000 2904879000 2883433000 2736821000 1620747000 2706856000 257542000 8951739000 14786485000 6292991000 2438000 40353000 33140000 5660000 295000 4822000 42121000 64969000 4848281000 3421324000 2759789000 -4947273000 -3380676000 -2721827000 6418208000 16308000 13049459000 3855662000 9413909000 8734505000 7271658000 45311000 7995045000 905210000 34122000 9545000 37618000 928890000 841706000 662068000 1350293000 5993265000 2380000 21162000 534456000 225092000 -16965504000 2173222000 -443770000 377529000 1314586000 3785788000 -5182166000 7058972000 8680686000 13862852000 6803880000 12466474000 8680686000 13862852000 3785788000 -5182166000 7058972000 <p id="xdx_805_eifrs-full--DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_ztp2AgrDj4Nl" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>1 </b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_820_z0UftJfnbk34">Operations</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. is a public corporation headquartered in Camaçari, Bahia (“BA”), which, jointly with its subsidiaries (hereinafter “Braskem” or “Company”), is controlled by Novonor S.A. (“Novonor”), which directly and indirectly holds interests of <span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OdebrechtSAMember_zyV3404CgYha" title="Proportion of ownership interest">50.11</span>% and <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OdebrechtSAMember_zi1mEMz4uMN6" title="Proportion of voting rights">38.32</span>% in its voting and total capital, respectively. The ultimate parent company of Braskem is Kieppe Patrimonial S.A.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Braskem’s shares are traded on B3 S.A. Brasil, Bolsa, Balcão (“B3”), under the tickers BRKM3, BRKM5 and BRKM6, and on the New York Stock Exchange (“NYSE”) under the ticker BAK and on the Madrid Stock Exchange (“LATIBEX”) under the ticker XBRK.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem also is engaged, among others, in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air and industrial gases, as well as the provision of industrial services and the production, supply and sale of electric energy and natural gas for its own use and use by other companies. Braskem also invests in other companies.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has industrial plants in Brazil, the United States, Germany, and Mexico. The units produce thermoplastic resins, such as polyethylene (“PE”), polypropylene (“PP”), polyvinyl chloride (“PVC”) and other basic petrochemicals.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Operations of subsidiary Braskem Idesa S. A. P. I. (“Braskem Idesa”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On September 27, 2021, Braskem Idesa signed the following documents:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) amendment to the ethane supply agreement (“Amendment”) with PEMEX; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) agreement with Petróleos Mexicanos, PEMEX Logística and other Mexican government entities, establishing administrative support measures, especially to obtain of licenses, permits and rights of way for the project to build an ethane import terminal with the capacity to meet all Braskem Idesa's feedstock requirements ("Terminal Agreement”).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Amendment changed the minimum contractual volume commitment to <span id="xdx_90D_ecustom--NumberOfBarrels_c20220101__20221231_pdd" title="Number of barrels">30,000</span> barrels/day until the limit date of February 2025 (subject to extensions in the event of delay in obtaining the licenses for the terminal's construction). The terminal's startup is expected in the second half of 2024. The terminal project is designed to supplement ethane supply in Mexico by gaining access to new feedstock sources.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Amendment further established first-refusal rights for Braskem Idesa in the acquisition of all ethane that PEMEX has available and does not consume in its own production process through 2045, at prices based on international references. The approvals required for the Amendment and Terminal Agreement to come into force were obtained in October 2021 and the Amendment started producing effects retroactive to February 26, 2021, the execution date of the memorandum of understanding.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On June 14, 2022, Braskem Idesa signed agreements with Advario B.V. to sell <span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20220629__20220630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_z3l6mOy6Nj86" title="Proportion of ownership interest">50</span>% of the capital stock of Terminal Química Puerto México (“Terminal Química”), the subsidiary of Braskem Idesa responsible for developing and operating the ethane import terminal in Mexico.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">In March 2023, the conditions for the conclusion of the agreement were fulfilled and Advario B.V. made a payment of US$<span id="xdx_900_ecustom--MadePayment_pn6n6_uUSDBRL_c20230329__20230331_zXcaYs0ruZ4l" title="Made payment">56</span> million (R$<span id="xdx_908_ecustom--MadePayment_pn6n6_uBRL_c20230329__20230331_zGUo8o53wPR9" title="Made payment">292</span> million) to Braskem Idesa for the acquisition of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20230329__20230331__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaOneMember_zMmBZYQFp1e1" title="Proportion of ownership interest">50</span>% of equity interest in Terminal Química.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> 0.5011 0.3832 30000 0.50 56000000 292000000 0.50 <p id="xdx_80E_eifrs-full--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zzz3vvoSb6Ok" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>2 </b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_821_z29L0BkGPNgh">Basis of preparation of the financial statements</span></span></p> <p id="xdx_842_eifrs-full--DisclosureOfChangesInAccountingPoliciesExplanatory_zBGHArRi41mb" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.1 <span id="xdx_869_z8QzsmW6QTza">Basis of accounting</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The consolidated financial statements were prepared and presented in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).</span></p> <p id="xdx_84C_ecustom--DisclosureOfBasisOfPresentationPoliciesExplanatory_zZ1e64lsHBL6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.2 <span id="xdx_86B_zCtFF2KMwnof">Basis of presentation</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s consolidated financial statements (“financial statements”) were prepared under the historical cost basis, unless stated otherwise in the accounting policies. These consolidated financial statements have been prepared on a going concern basis.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The significant accounting policies applied in the preparation of these consolidated financial statements were included in the respective notes and are consistent in the fiscal years presented.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The issue of these consolidated financial statements was authorized by the Executive Board on April 24, 2023.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b><span id="a_0081"/> </b></span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForConsolidationExplanatory_zmv9Ff70bIG6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.3 <span id="xdx_86D_zBri2pV3PZ75">Basis of consolidation</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The consolidated financial statements include the financial statements of Braskem S.A. and the following entities:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_eifrs-full--DisclosureOfInterestsInSubsidiariesExplanatory_pn3n3_zqz1NN4jibB2" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details)"> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B7_zSyT0Cr1Mdt2" style="display: none">Schedule of consolidated financial statements</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="color: #1F497D; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="7" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total and voting interest (%)</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022, 2021 and 2020</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarter</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Subsidiary/Special Purpose Entity name">BM Insurance Company Limited ("BM Insurance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Headquarters">Bermuda</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_zGrAByYGXft7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z6Rx08kaA5Q7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z0l1SIlYkWNa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Subsidiary/Special Purpose Entity name">Braskem Argentina S.A. (“Braskem Argentina”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Headquarters">Argentina</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zCLNWVKGePy2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zgamcK2lYg2h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zcKi9Lifo7c9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_z7kXalGQcd1k" title="Subsidiary/Special Purpose Entity name">Braskem Energy Ltda.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zmC6gnslrxgd" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zBPaHE0bw3t2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Subsidiary/Special Purpose Entity name">Braskem Finance Limited (“Braskem Finance”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zWgW0z9PLIk6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zFzfyRQnGgF6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zT3q0iXZVJfg" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Subsidiary/Special Purpose Entity name">Braskem Green S.A.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_zth4MPGNeQ0c" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_ziy5HbaYXCAd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Subsidiary/Special Purpose Entity name">Braskem Incorporated Limited ("Braskem Inc.")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zlYFed7A6J84" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zu0R0uqmUJxg" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zx5TxREq3r68" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico, S. de RL de C.V. ("Braskem México") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zByqcS8uvMjj"><b>100</b></span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zzQclza7y8Ve">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zIQF0aIO93Pk">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands B.V. ("Braskem Holanda")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zmf0v0p3lLI8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zOFUJbk2v4vc" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zfNgAr9iG76d" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Subsidiary/Special Purpose Entity name">Braskem Petroquímica Chile Ltda. (“Braskem Chile”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Headquarters">Chile</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zqoThzaxyDej" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zeoRTrWYXhX2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zZKQMgv4hWN9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary10Member_fKGlpKQ_____zmtIZTrFnGWg" title="Subsidiary/Special Purpose Entity name">Braskem Ventures Ltda. ("Braskem Ventures") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____zIIYRr3VYbdh" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____z5LJlAVMG9Uj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zVVtMnUCx6L6" title="Subsidiary/Special Purpose Entity name">Lantana Trading Co. Inc. (“Lantana”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zEswMgzxx8e9" title="Headquarters">Bahamas</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zMLZbq8KI9ha" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zkmv28nZm338" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zjAH84vZHMAa" title="Subsidiary/Special Purpose Entity name">Voqen Energia Ltda. ("Voqen") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zcNhLn6IFwha" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_z2ji1ACuoTXk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Subsidiary/Special Purpose Entity name">Braskem America Finance Company ("Braskem America Finance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zUZPIQS03C0d" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zEtPvSM3m1Da" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zyg3cs81Vwta" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Subsidiary/Special Purpose Entity name">Braskem America, Inc. (“Braskem America”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zrBrbo3VaQfa" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zGNbePmK4qC8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zyaYX5XDAbM2" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Subsidiary/Special Purpose Entity name">Braskem Europe GmbH ("Braskem Alemanha")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Headquarters">Germany</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zuNXHCYg2JHb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zRGmtXc9oPD2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zpbnNjUuBOQa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa S.A.P.I. ("Braskem Idesa") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zqwVKi4zwks4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_z2CpsCb8TTp8" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zUJK5kZV4uZe" title="Total voting interest">75</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zHtTgz82lmQ2" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zYSlfre2d0d4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_z6Rt4OyNG8K" title="Total voting interest">75</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Subsidiary/Special Purpose Entity name">Braskem India Private Limited ("Braskem India") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Headquarters">India</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zl8wmGYCJ6Uc" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zkExczn7y817" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zyWk6esv72R6" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zIIuZUXSKRzl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zLfNaqfHYUgb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zxoMANQlLA3" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY69CEfyXtwk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zJkaoK1gpSUl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY3V3yRjEGmi" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlwC9PmwgI4k" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zMpjnoAUaGKd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlEnmS6vyxQl" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Green B.V. (“Braskem Holanda Green”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zYUJlxAHybSj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zQk4yVHgoZta" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zGDXpetmFwI1" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zxyoIGwrMOc5" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zQp4PBnq4nZg" title="Headquarters">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zaadVH00Jo1h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zHffzX0dNtug" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zlwdoVlsNKDf" title="Subsidiary/Special Purpose Entity name">Builder Brasil Ltda. ("Builder Brasil") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zTp9utMDxE7f" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zRKH84nHq9O5" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zN7Ost9xZabf" title="Subsidiary/Special Purpose Entity name">Builder USA LLC. ("Builder USA") </span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____z4pRrvMDAjI9" title="Headquarters">USA</span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zlshQNgdi8hi" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zX33CaZ90qFb" title="Subsidiary/Special Purpose Entity name">Cetrel S.A. ("Cetrel") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zOmRKRVB0rSl" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zHpl7MKG4saf" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_z62yEny1QfYg" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zF8gVCGtlDXf" title="Total voting interest">63.70</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zUvdMeUj0bc4" title="Subsidiary/Special Purpose Entity name">Distribuidora de Água Camaçari S.A. ("DAC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_z9GXK6MaiOW7" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zNOEtAbgmOI9" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zjuvB2Uns7J6" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zsvRkRyqEzM" title="Total voting interest">63.70</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zHBz045Tdfbe" title="Subsidiary/Special Purpose Entity name">B&amp;TC B.V. ("B&amp;TC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zXLY44576xkc" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zgiT9xA4jEAi" title="Total voting interest">60</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zFUEGzQQ1xx5" title="Subsidiary/Special Purpose Entity name">ER Plastics B.V. ("ER Plastics") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zCPa9QgncN7a" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zAJI8RxWZO1a" title="Total voting interest">60</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zjMK6TQ1m9Xb" title="Subsidiary/Special Purpose Entity name">Terminal Química Puerto México ("Terminal Química") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zAdFmAZZuz3b" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zlGxKDheXcLd" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zocZmmBtoxwc" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; font-style: italic; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Special Purpose Entities </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado <br/> Longo Prazo ("FIM Júpiter")</span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zzlH2bekpIM1" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zQyg2OwHFik6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zTsPK37M2kN1" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; vertical-align: top; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Santander Netuno Multimercado Crédito Privado <br/> <span style="font-size: 9.5pt; font-style: normal; font-weight: 400">Longo Prazo ("FIM Netuno")</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zNwA9UeZ9WL7" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zsKTIS1ar6yh" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zihGi9gIJvN9" title="Total voting interest">100</span></span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F02_zpCuEchuS5H9" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1E_zssSc7pAmNU8" style="font-family: Calibri, Helvetica, Sans-Serif">Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F07_ztMRgS58FKs1" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zYMpEIRG76oh" style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zbok52CXazva" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zOASnGPyN3a8" style="font-family: Calibri, Helvetica, Sans-Serif">Lantana was a non-operational entity that had the operations closed in November 2022.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0A_z78C02Kt3Thd" style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td id="xdx_F19_zrvHYvOvcUq6" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">B&amp;TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&amp;TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).</span></td></tr> </table> <p id="xdx_8AE_zW4cUr2VlA71" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Subsidiaries</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company controls an entity when it is exposed to, or entitled to, the variable returns originating from its involvement with the entity and has the capacity to affect such returns by exercising its power over the entity.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The financial statements of subsidiaries are included in these consolidated financial statements as from the date the Company obtains control until the date of the loss of control.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Equity method Investees</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s investments in entities with accounting treatment using the equity method consist of their interests in associates and joint ventures.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Associates are those in which the Company, directly or indirectly, has significant influence, but not control or shared control, over the financial and operating policies. To be classified as a joint venture, a contractual agreement must exist that gives the Company shared control of the entity and granting to the Company the right to the net assets of the joint venture, and not the right to its specific assets and liabilities.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Such investments are initially recognized at cost, which includes the expenses with the transaction costs. After initial recognition, the consolidated financial statements include the Company’s interest in the net profit or loss for the fiscal year profit or loss and other comprehensive income of equity-accounted investees, in the investee until the date on which the significant influence or joint control ceases to exist.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c) Conversion of functional currency to presentation currency</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The assets and liabilities of foreign operations are translated into Reais at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into Reais at the exchange rates at the dates of the transactions. Foreign currency differences (Note 2.4) from translation to presentation currency are recognized in other comprehensive income.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Since Argentina’s economy is considered hyperinflationary, to translate the financial information of the subsidiary Braskem Argentina, the assets, liabilities, equity, income and expenses are translated into Reais at the exchange rate at the reporting date.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(d) Transactions eliminated in consolidation</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Intragroup balances and transactions and any unrealized revenues or expenses arising from intragroup transactions are eliminated. Unrealized gains originating from transactions with investees recorded using the equity method are eliminated against the investment proportionately to the Company’s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_zBhZ2eXkpPxk" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.4 <span id="xdx_86E_zuAVJCNCItEe">Functional and foreign currency</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These consolidated financial statements are presented in Brazilian Real, which is the functional currency of the Company. All amounts have been rounded to the nearest thousand, unless otherwise stated.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The subsidiaries with a functional currency different from Brazilian Real (R$) are listed below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfFunctionalCurrencyExplanatory_pn3n3_zAcRXoJksc6l" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span id="xdx_8B4_zbvTMnlLaPh8" style="display: none">Schedule of subsidiaries with a functional currency</span></td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Subsidiaries</span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Functional currency</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha, B&amp;TC and ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember" title="Functional currency">Euro</span></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; width: 76%; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.</span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember" title="Functional currency">U.S.dollar ("US$")</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember" title="Functional currency">Mexican peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember" title="Functional currency">Argentinean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember" title="Functional currency">Chilenean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Índia</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIndiaMember" title="Functional currency">Rupee</span></span></td></tr> </table> <p id="xdx_8A3_zlj0navjRloc" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p id="xdx_847_eifrs-full--DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_zoGwTffIAnie" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.5 <span id="xdx_864_zOL8aWyczlEj">New standards or amendments for the current fiscal year and future requirements</span></b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) New standards and pronouncements adopted in the current fiscal year</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In the current fiscal year, the Company identified a series of amendments under the IFRS accounting standards that became effective for accounting periods starting on or after January 1, 2022:</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Onerous contracts: costs of fulfilling a contract (amendments to IAS 37).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Annual improvements of IFRS Standards 2018-2020.</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Property, Plant and Equipment: revenue before intended use (amendments to IAS 16).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Reference to the Conceptual Framework (amendments to IFRS 3).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The adoption of these amendments did not have any material impact on the disclosures or amounts presented in these consolidated financial statements.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 6pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000">(b) </span><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Future requirements</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The new and amended standards and interpretations already issued but not yet effective as of the reporting date are described below:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Classification of liabilities as current or non-current (amendments to IAS 1).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Definition of accounting estimates (amendments to IAS 8).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Definition of materiality for disclosure of accounting policies (amendments to IAS1 and IFRS Practice Statement 2).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Deferred taxes related to assets and liabilities arising from a single transaction (amendments to IAS 12).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <span style="color: black">Insurance contracts (IFRS17).</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company plans to adopt these new and amended standards and interpretations, if applicable, when they become effective. Management does not expect the adoption of the standards listed above to have a significant impact on the Company’s consolidated financial statements in future periods.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p id="xdx_844_ecustom--ImpactsFromRussiaUkraineConflictPolicyTextBlock_zinKxRdjcRx6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.6 <span id="xdx_86C_zcjLZs9rqkaj">Impacts from Russia-Ukraine conflict</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company formed a committee to monitor the consequences of sanctions applied to Russia and the developments in the conflict as well as to take any measures to minimize potential impacts on the Company, its team members and the communities where it operates.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The conflict has caused an increase in the international price of commodities related to the Company's business, such as oil and natural gas, affecting the cost of the Company's inputs used in the production process. The European geopolitical scenario also affected the demand for petrochemical products, global supply chain and pressured inflation in several countries. For this reporting period, it has not caused significant adverse impacts on the Company's equity and financial position, although it is not possible to accurately predict significant adverse effects in the future.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Further sanctions, embargoes, regional instability, geopolitical changes, dysfunctions in the logistics chain, adverse effects on macroeconomic conditions, currency exchange rates and interest rates could affect the prices of products and costs of inputs in the international market, interrupt the supply chain, reduce sales and/or affect operations of the Company. As of the reporting date, the Company has not identified any relevant impacts on its business arising from the sanctions applied to date and adverse scenario caused by the geopolitical conflict.</span></p> <p id="xdx_842_eifrs-full--DisclosureOfChangesInAccountingPoliciesExplanatory_zBGHArRi41mb" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.1 <span id="xdx_869_z8QzsmW6QTza">Basis of accounting</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The consolidated financial statements were prepared and presented in accordance with the International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).</span></p> <p id="xdx_84C_ecustom--DisclosureOfBasisOfPresentationPoliciesExplanatory_zZ1e64lsHBL6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.2 <span id="xdx_86B_zCtFF2KMwnof">Basis of presentation</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s consolidated financial statements (“financial statements”) were prepared under the historical cost basis, unless stated otherwise in the accounting policies. These consolidated financial statements have been prepared on a going concern basis.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The significant accounting policies applied in the preparation of these consolidated financial statements were included in the respective notes and are consistent in the fiscal years presented.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The issue of these consolidated financial statements was authorized by the Executive Board on April 24, 2023.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b><span id="a_0081"/> </b></span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForConsolidationExplanatory_zmv9Ff70bIG6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.3 <span id="xdx_86D_zBri2pV3PZ75">Basis of consolidation</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The consolidated financial statements include the financial statements of Braskem S.A. and the following entities:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_eifrs-full--DisclosureOfInterestsInSubsidiariesExplanatory_pn3n3_zqz1NN4jibB2" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details)"> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B7_zSyT0Cr1Mdt2" style="display: none">Schedule of consolidated financial statements</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="color: #1F497D; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="7" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total and voting interest (%)</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022, 2021 and 2020</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarter</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Subsidiary/Special Purpose Entity name">BM Insurance Company Limited ("BM Insurance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Headquarters">Bermuda</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_zGrAByYGXft7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z6Rx08kaA5Q7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z0l1SIlYkWNa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Subsidiary/Special Purpose Entity name">Braskem Argentina S.A. (“Braskem Argentina”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Headquarters">Argentina</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zCLNWVKGePy2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zgamcK2lYg2h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zcKi9Lifo7c9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_z7kXalGQcd1k" title="Subsidiary/Special Purpose Entity name">Braskem Energy Ltda.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zmC6gnslrxgd" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zBPaHE0bw3t2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Subsidiary/Special Purpose Entity name">Braskem Finance Limited (“Braskem Finance”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zWgW0z9PLIk6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zFzfyRQnGgF6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zT3q0iXZVJfg" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Subsidiary/Special Purpose Entity name">Braskem Green S.A.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_zth4MPGNeQ0c" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_ziy5HbaYXCAd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Subsidiary/Special Purpose Entity name">Braskem Incorporated Limited ("Braskem Inc.")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zlYFed7A6J84" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zu0R0uqmUJxg" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zx5TxREq3r68" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico, S. de RL de C.V. ("Braskem México") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zByqcS8uvMjj"><b>100</b></span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zzQclza7y8Ve">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zIQF0aIO93Pk">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands B.V. ("Braskem Holanda")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zmf0v0p3lLI8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zOFUJbk2v4vc" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zfNgAr9iG76d" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Subsidiary/Special Purpose Entity name">Braskem Petroquímica Chile Ltda. (“Braskem Chile”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Headquarters">Chile</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zqoThzaxyDej" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zeoRTrWYXhX2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zZKQMgv4hWN9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary10Member_fKGlpKQ_____zmtIZTrFnGWg" title="Subsidiary/Special Purpose Entity name">Braskem Ventures Ltda. ("Braskem Ventures") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____zIIYRr3VYbdh" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____z5LJlAVMG9Uj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zVVtMnUCx6L6" title="Subsidiary/Special Purpose Entity name">Lantana Trading Co. Inc. (“Lantana”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zEswMgzxx8e9" title="Headquarters">Bahamas</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zMLZbq8KI9ha" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zkmv28nZm338" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zjAH84vZHMAa" title="Subsidiary/Special Purpose Entity name">Voqen Energia Ltda. ("Voqen") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zcNhLn6IFwha" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_z2ji1ACuoTXk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Subsidiary/Special Purpose Entity name">Braskem America Finance Company ("Braskem America Finance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zUZPIQS03C0d" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zEtPvSM3m1Da" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zyg3cs81Vwta" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Subsidiary/Special Purpose Entity name">Braskem America, Inc. (“Braskem America”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zrBrbo3VaQfa" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zGNbePmK4qC8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zyaYX5XDAbM2" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Subsidiary/Special Purpose Entity name">Braskem Europe GmbH ("Braskem Alemanha")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Headquarters">Germany</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zuNXHCYg2JHb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zRGmtXc9oPD2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zpbnNjUuBOQa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa S.A.P.I. ("Braskem Idesa") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zqwVKi4zwks4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_z2CpsCb8TTp8" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zUJK5kZV4uZe" title="Total voting interest">75</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zHtTgz82lmQ2" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zYSlfre2d0d4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_z6Rt4OyNG8K" title="Total voting interest">75</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Subsidiary/Special Purpose Entity name">Braskem India Private Limited ("Braskem India") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Headquarters">India</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zl8wmGYCJ6Uc" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zkExczn7y817" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zyWk6esv72R6" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zIIuZUXSKRzl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zLfNaqfHYUgb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zxoMANQlLA3" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY69CEfyXtwk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zJkaoK1gpSUl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY3V3yRjEGmi" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlwC9PmwgI4k" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zMpjnoAUaGKd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlEnmS6vyxQl" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Green B.V. (“Braskem Holanda Green”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zYUJlxAHybSj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zQk4yVHgoZta" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zGDXpetmFwI1" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zxyoIGwrMOc5" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zQp4PBnq4nZg" title="Headquarters">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zaadVH00Jo1h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zHffzX0dNtug" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zlwdoVlsNKDf" title="Subsidiary/Special Purpose Entity name">Builder Brasil Ltda. ("Builder Brasil") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zTp9utMDxE7f" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zRKH84nHq9O5" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zN7Ost9xZabf" title="Subsidiary/Special Purpose Entity name">Builder USA LLC. ("Builder USA") </span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____z4pRrvMDAjI9" title="Headquarters">USA</span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zlshQNgdi8hi" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zX33CaZ90qFb" title="Subsidiary/Special Purpose Entity name">Cetrel S.A. ("Cetrel") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zOmRKRVB0rSl" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zHpl7MKG4saf" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_z62yEny1QfYg" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zF8gVCGtlDXf" title="Total voting interest">63.70</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zUvdMeUj0bc4" title="Subsidiary/Special Purpose Entity name">Distribuidora de Água Camaçari S.A. ("DAC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_z9GXK6MaiOW7" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zNOEtAbgmOI9" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zjuvB2Uns7J6" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zsvRkRyqEzM" title="Total voting interest">63.70</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zHBz045Tdfbe" title="Subsidiary/Special Purpose Entity name">B&amp;TC B.V. ("B&amp;TC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zXLY44576xkc" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zgiT9xA4jEAi" title="Total voting interest">60</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zFUEGzQQ1xx5" title="Subsidiary/Special Purpose Entity name">ER Plastics B.V. ("ER Plastics") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zCPa9QgncN7a" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zAJI8RxWZO1a" title="Total voting interest">60</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zjMK6TQ1m9Xb" title="Subsidiary/Special Purpose Entity name">Terminal Química Puerto México ("Terminal Química") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zAdFmAZZuz3b" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zlGxKDheXcLd" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zocZmmBtoxwc" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; font-style: italic; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Special Purpose Entities </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado <br/> Longo Prazo ("FIM Júpiter")</span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zzlH2bekpIM1" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zQyg2OwHFik6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zTsPK37M2kN1" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; vertical-align: top; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Santander Netuno Multimercado Crédito Privado <br/> <span style="font-size: 9.5pt; font-style: normal; font-weight: 400">Longo Prazo ("FIM Netuno")</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zNwA9UeZ9WL7" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zsKTIS1ar6yh" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zihGi9gIJvN9" title="Total voting interest">100</span></span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F02_zpCuEchuS5H9" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1E_zssSc7pAmNU8" style="font-family: Calibri, Helvetica, Sans-Serif">Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F07_ztMRgS58FKs1" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zYMpEIRG76oh" style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zbok52CXazva" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zOASnGPyN3a8" style="font-family: Calibri, Helvetica, Sans-Serif">Lantana was a non-operational entity that had the operations closed in November 2022.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0A_z78C02Kt3Thd" style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td id="xdx_F19_zrvHYvOvcUq6" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">B&amp;TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&amp;TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).</span></td></tr> </table> <p id="xdx_8AE_zW4cUr2VlA71" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Subsidiaries</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company controls an entity when it is exposed to, or entitled to, the variable returns originating from its involvement with the entity and has the capacity to affect such returns by exercising its power over the entity.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The financial statements of subsidiaries are included in these consolidated financial statements as from the date the Company obtains control until the date of the loss of control.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Equity method Investees</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s investments in entities with accounting treatment using the equity method consist of their interests in associates and joint ventures.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Associates are those in which the Company, directly or indirectly, has significant influence, but not control or shared control, over the financial and operating policies. To be classified as a joint venture, a contractual agreement must exist that gives the Company shared control of the entity and granting to the Company the right to the net assets of the joint venture, and not the right to its specific assets and liabilities.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Such investments are initially recognized at cost, which includes the expenses with the transaction costs. After initial recognition, the consolidated financial statements include the Company’s interest in the net profit or loss for the fiscal year profit or loss and other comprehensive income of equity-accounted investees, in the investee until the date on which the significant influence or joint control ceases to exist.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c) Conversion of functional currency to presentation currency</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The assets and liabilities of foreign operations are translated into Reais at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into Reais at the exchange rates at the dates of the transactions. Foreign currency differences (Note 2.4) from translation to presentation currency are recognized in other comprehensive income.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Since Argentina’s economy is considered hyperinflationary, to translate the financial information of the subsidiary Braskem Argentina, the assets, liabilities, equity, income and expenses are translated into Reais at the exchange rate at the reporting date.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(d) Transactions eliminated in consolidation</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Intragroup balances and transactions and any unrealized revenues or expenses arising from intragroup transactions are eliminated. Unrealized gains originating from transactions with investees recorded using the equity method are eliminated against the investment proportionately to the Company’s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_eifrs-full--DisclosureOfInterestsInSubsidiariesExplanatory_pn3n3_zqz1NN4jibB2" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details)"> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B7_zSyT0Cr1Mdt2" style="display: none">Schedule of consolidated financial statements</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="color: #1F497D; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="7" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total and voting interest (%)</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022, 2021 and 2020</span></td></tr> <tr> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarter</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Subsidiary/Special Purpose Entity name">BM Insurance Company Limited ("BM Insurance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member" title="Headquarters">Bermuda</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_zGrAByYGXft7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z6Rx08kaA5Q7" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary1Member_z0l1SIlYkWNa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Subsidiary/Special Purpose Entity name">Braskem Argentina S.A. (“Braskem Argentina”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member" title="Headquarters">Argentina</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zCLNWVKGePy2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zgamcK2lYg2h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary2Member_zcKi9Lifo7c9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_z7kXalGQcd1k" title="Subsidiary/Special Purpose Entity name">Braskem Energy Ltda.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zmC6gnslrxgd" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary3Member_fKGkp_zBPaHE0bw3t2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Subsidiary/Special Purpose Entity name">Braskem Finance Limited (“Braskem Finance”)</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zWgW0z9PLIk6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zFzfyRQnGgF6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary4Member_zT3q0iXZVJfg" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Subsidiary/Special Purpose Entity name">Braskem Green S.A.</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_zth4MPGNeQ0c" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary5Member_ziy5HbaYXCAd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Subsidiary/Special Purpose Entity name">Braskem Incorporated Limited ("Braskem Inc.")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member" title="Headquarters">Cayman Islands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zlYFed7A6J84" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zu0R0uqmUJxg" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary6Member_zx5TxREq3r68" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico, S. de RL de C.V. ("Braskem México") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zByqcS8uvMjj"><b>100</b></span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zzQclza7y8Ve">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary7Member_zIQF0aIO93Pk">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands B.V. ("Braskem Holanda")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zmf0v0p3lLI8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zOFUJbk2v4vc" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary8Member_zfNgAr9iG76d" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Subsidiary/Special Purpose Entity name">Braskem Petroquímica Chile Ltda. (“Braskem Chile”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member" title="Headquarters">Chile</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zqoThzaxyDej" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zeoRTrWYXhX2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary9Member_zZKQMgv4hWN9" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary10Member_fKGlpKQ_____zmtIZTrFnGWg" title="Subsidiary/Special Purpose Entity name">Braskem Ventures Ltda. ("Braskem Ventures") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____zIIYRr3VYbdh" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary101Member_fKGlpKQ_____z5LJlAVMG9Uj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zVVtMnUCx6L6" title="Subsidiary/Special Purpose Entity name">Lantana Trading Co. Inc. (“Lantana”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zEswMgzxx8e9" title="Headquarters">Bahamas</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zMLZbq8KI9ha" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary11Member_fKGlpaSk___zkmv28nZm338" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zjAH84vZHMAa" title="Subsidiary/Special Purpose Entity name">Voqen Energia Ltda. ("Voqen") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_zcNhLn6IFwha" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary12Member_fKGkp_z2ji1ACuoTXk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Subsidiary/Special Purpose Entity name">Braskem America Finance Company ("Braskem America Finance") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zUZPIQS03C0d" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zEtPvSM3m1Da" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary13Member_zyg3cs81Vwta" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Subsidiary/Special Purpose Entity name">Braskem America, Inc. (“Braskem America”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member" title="Headquarters">USA</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zrBrbo3VaQfa" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zGNbePmK4qC8" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary14Member_zyaYX5XDAbM2" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Subsidiary/Special Purpose Entity name">Braskem Europe GmbH ("Braskem Alemanha")</span> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member" title="Headquarters">Germany</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zuNXHCYg2JHb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zRGmtXc9oPD2" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary15Member_zpbnNjUuBOQa" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa S.A.P.I. ("Braskem Idesa") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zqwVKi4zwks4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_z2CpsCb8TTp8" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary16Member_zUJK5kZV4uZe" title="Total voting interest">75</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Subsidiary/Special Purpose Entity name">Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zHtTgz82lmQ2" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_zYSlfre2d0d4" title="Total voting interest">75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary17Member_z6Rt4OyNG8K" title="Total voting interest">75</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Subsidiary/Special Purpose Entity name">Braskem India Private Limited ("Braskem India") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member" title="Headquarters">India</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zl8wmGYCJ6Uc" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zkExczn7y817" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary18Member_zyWk6esv72R6" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zIIuZUXSKRzl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zLfNaqfHYUgb" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary19Member_zxoMANQlLA3" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Subsidiary/Special Purpose Entity name">Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY69CEfyXtwk" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zJkaoK1gpSUl" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary20Member_zY3V3yRjEGmi" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlwC9PmwgI4k" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zMpjnoAUaGKd" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary21Member_zlEnmS6vyxQl" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Green B.V. (“Braskem Holanda Green”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zYUJlxAHybSj" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary22Member_zQk4yVHgoZta" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zGDXpetmFwI1" title="Subsidiary/Special Purpose Entity name">Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”) </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zxyoIGwrMOc5" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zQp4PBnq4nZg" title="Headquarters">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zaadVH00Jo1h" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary23Member_zHffzX0dNtug" title="Total voting interest">100</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zlwdoVlsNKDf" title="Subsidiary/Special Purpose Entity name">Builder Brasil Ltda. ("Builder Brasil") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zTp9utMDxE7f" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary24Member_fKGlpKQ_____zRKH84nHq9O5" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zN7Ost9xZabf" title="Subsidiary/Special Purpose Entity name">Builder USA LLC. ("Builder USA") </span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____z4pRrvMDAjI9" title="Headquarters">USA</span></span></td> <td style="font-weight: bold; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary25Member_fKGlpKQ_____zlshQNgdi8hi" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zX33CaZ90qFb" title="Subsidiary/Special Purpose Entity name">Cetrel S.A. ("Cetrel") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zOmRKRVB0rSl" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zHpl7MKG4saf" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_z62yEny1QfYg" title="Total voting interest">63.70</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary26Member_zF8gVCGtlDXf" title="Total voting interest">63.70</span></span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zUvdMeUj0bc4" title="Subsidiary/Special Purpose Entity name">Distribuidora de Água Camaçari S.A. ("DAC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_z9GXK6MaiOW7" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zNOEtAbgmOI9" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zjuvB2Uns7J6" title="Total voting interest">63.70</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_901_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary27Member_zsvRkRyqEzM" title="Total voting interest">63.70</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zHBz045Tdfbe" title="Subsidiary/Special Purpose Entity name">B&amp;TC B.V. ("B&amp;TC") </span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zXLY44576xkc" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary28Member_fKGl2KQ_____zgiT9xA4jEAi" title="Total voting interest">60</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_902_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zFUEGzQQ1xx5" title="Subsidiary/Special Purpose Entity name">ER Plastics B.V. ("ER Plastics") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zCPa9QgncN7a" title="Headquarters">Netherlands</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary29Member_fKGl2KQ_____zAJI8RxWZO1a" title="Total voting interest">60</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_901_eifrs-full--NameOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zjMK6TQ1m9Xb" title="Subsidiary/Special Purpose Entity name">Terminal Química Puerto México ("Terminal Química") </span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zAdFmAZZuz3b" title="Headquarters">Mexico</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zlGxKDheXcLd" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--Subsidiary30Member_zocZmmBtoxwc" title="Total voting interest">75</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; font-style: italic; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Special Purpose Entities </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado <br/> Longo Prazo ("FIM Júpiter")</span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zzlH2bekpIM1" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_905_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zQyg2OwHFik6" title="Total voting interest">100</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity1Member_zTsPK37M2kN1" title="Total voting interest">100</span></span></td></tr> <tr> <td colspan="2" style="font: 9.5pt Times New Roman, Times, Serif; padding-left: 18px; vertical-align: top; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fundo de Investimento Santander Netuno Multimercado Crédito Privado <br/> <span style="font-size: 9.5pt; font-style: normal; font-weight: 400">Longo Prazo ("FIM Netuno")</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member" title="Headquarters">Brazil</span></span></td> <td style="font-family: Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_906_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zNwA9UeZ9WL7" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zsKTIS1ar6yh" title="Total voting interest">100</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_eifrs-full--ProportionOfVotingPowerHeldInSubsidiary_pid_dp_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SpecificPurposeEntity2Member_zihGi9gIJvN9" title="Total voting interest">100</span></span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F02_zpCuEchuS5H9" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1E_zssSc7pAmNU8" style="font-family: Calibri, Helvetica, Sans-Serif">Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F07_ztMRgS58FKs1" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zYMpEIRG76oh" style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zbok52CXazva" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F15_zOASnGPyN3a8" style="font-family: Calibri, Helvetica, Sans-Serif">Lantana was a non-operational entity that had the operations closed in November 2022.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0A_z78C02Kt3Thd" style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td id="xdx_F19_zrvHYvOvcUq6" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">B&amp;TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&amp;TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets).</span></td></tr> </table> BM Insurance Company Limited ("BM Insurance")  Bermuda 1 1 1 Braskem Argentina S.A. (“Braskem Argentina”) Argentina 1 1 1 Braskem Energy Ltda. Brazil 1 Braskem Finance Limited (“Braskem Finance”) Cayman Islands 1 1 1 Braskem Green S.A. Brazil 1 1 Braskem Incorporated Limited ("Braskem Inc.") Cayman Islands 1 1 1 Braskem Mexico, S. de RL de C.V. ("Braskem México")  Mexico 1 1 1 Braskem Netherlands B.V. ("Braskem Holanda") Netherlands 1 1 1 Braskem Petroquímica Chile Ltda. (“Braskem Chile”)  Chile 1 1 1 Braskem Ventures Ltda. ("Braskem Ventures")  Brazil 1 Lantana Trading Co. Inc. (“Lantana”)  Bahamas 1 1 Voqen Energia Ltda. ("Voqen")  Brazil 1 Braskem America Finance Company ("Braskem America Finance")  USA 1 1 1 Braskem America, Inc. (“Braskem America”)  USA 1 1 1 Braskem Europe GmbH ("Braskem Alemanha") Germany 1 1 1 Braskem Idesa S.A.P.I. ("Braskem Idesa")  Mexico 0.75 0.75 0.75 Braskem Idesa Servicios S.A. de C.V. ("Braskem Idesa Serviços")  Mexico 0.75 0.75 0.75 Braskem India Private Limited ("Braskem India")  India 1 1 1 Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")  Mexico 1 1 1 Braskem Mexico Servicios S. RL de C.V. ("Braskem México Serviços")  Mexico 1 1 1 Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)  Netherlands 1 1 1 Braskem Netherlands Green B.V. (“Braskem Holanda Green”)  Netherlands 1 1 Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc.”)  Netherlands 1 1 1 Builder Brasil Ltda. ("Builder Brasil")  Brazil 1 Builder USA LLC. ("Builder USA")  USA 1 Cetrel S.A. ("Cetrel")  Brazil 0.6370 0.6370 0.6370 Distribuidora de Água Camaçari S.A. ("DAC")  Brazil 0.6370 0.6370 0.6370 B&TC B.V. ("B&TC")  Netherlands 0.60 ER Plastics B.V. ("ER Plastics")  Netherlands 0.60 Terminal Química Puerto México ("Terminal Química")  Mexico 0.75 0.75 Brazil 1 1 1 Brazil 1 1 1 <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_zBhZ2eXkpPxk" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.4 <span id="xdx_86E_zuAVJCNCItEe">Functional and foreign currency</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These consolidated financial statements are presented in Brazilian Real, which is the functional currency of the Company. All amounts have been rounded to the nearest thousand, unless otherwise stated.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The subsidiaries with a functional currency different from Brazilian Real (R$) are listed below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfFunctionalCurrencyExplanatory_pn3n3_zAcRXoJksc6l" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span id="xdx_8B4_zbvTMnlLaPh8" style="display: none">Schedule of subsidiaries with a functional currency</span></td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Subsidiaries</span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Functional currency</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha, B&amp;TC and ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember" title="Functional currency">Euro</span></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; width: 76%; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.</span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember" title="Functional currency">U.S.dollar ("US$")</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember" title="Functional currency">Mexican peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember" title="Functional currency">Argentinean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember" title="Functional currency">Chilenean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Índia</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIndiaMember" title="Functional currency">Rupee</span></span></td></tr> </table> <p id="xdx_8A3_zlj0navjRloc" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfFunctionalCurrencyExplanatory_pn3n3_zAcRXoJksc6l" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Basis of preparation of the financial statements (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span id="xdx_8B4_zbvTMnlLaPh8" style="display: none">Schedule of subsidiaries with a functional currency</span></td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Subsidiaries</span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Functional currency</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha, B&amp;TC and ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember" title="Functional currency">Euro</span></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; width: 76%; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">BM Insurance, Braskem America, Braskem America Finance, Braskem Holanda,  Braskem Holanda Finance, Braskem Holanda Inc., Braskem México Proyectos, Braskem Holanda Green, Terminal Química and Builder USA.</span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember" title="Functional currency">U.S.dollar ("US$")</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember" title="Functional currency">Mexican peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember" title="Functional currency">Argentinean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember" title="Functional currency">Chilenean peso</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Índia</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--DescriptionOfFunctionalCurrency_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIndiaMember" title="Functional currency">Rupee</span></span></td></tr> </table> Euro U.S.dollar ("US$") Mexican peso Argentinean peso Chilenean peso Rupee <p id="xdx_847_eifrs-full--DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_zoGwTffIAnie" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.5 <span id="xdx_864_zOL8aWyczlEj">New standards or amendments for the current fiscal year and future requirements</span></b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) New standards and pronouncements adopted in the current fiscal year</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In the current fiscal year, the Company identified a series of amendments under the IFRS accounting standards that became effective for accounting periods starting on or after January 1, 2022:</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Onerous contracts: costs of fulfilling a contract (amendments to IAS 37).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Annual improvements of IFRS Standards 2018-2020.</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Property, Plant and Equipment: revenue before intended use (amendments to IAS 16).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Reference to the Conceptual Framework (amendments to IFRS 3).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The adoption of these amendments did not have any material impact on the disclosures or amounts presented in these consolidated financial statements.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 6pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000">(b) </span><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Future requirements</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The new and amended standards and interpretations already issued but not yet effective as of the reporting date are described below:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Classification of liabilities as current or non-current (amendments to IAS 1).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Definition of accounting estimates (amendments to IAS 8).</span></p> <p style="font: 11pt/150% Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Definition of materiality for disclosure of accounting policies (amendments to IAS1 and IFRS Practice Statement 2).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Deferred taxes related to assets and liabilities arising from a single transaction (amendments to IAS 12).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <span style="color: black">Insurance contracts (IFRS17).</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company plans to adopt these new and amended standards and interpretations, if applicable, when they become effective. Management does not expect the adoption of the standards listed above to have a significant impact on the Company’s consolidated financial statements in future periods.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p id="xdx_844_ecustom--ImpactsFromRussiaUkraineConflictPolicyTextBlock_zinKxRdjcRx6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>2.6 <span id="xdx_86C_zcjLZs9rqkaj">Impacts from Russia-Ukraine conflict</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company formed a committee to monitor the consequences of sanctions applied to Russia and the developments in the conflict as well as to take any measures to minimize potential impacts on the Company, its team members and the communities where it operates.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The conflict has caused an increase in the international price of commodities related to the Company's business, such as oil and natural gas, affecting the cost of the Company's inputs used in the production process. The European geopolitical scenario also affected the demand for petrochemical products, global supply chain and pressured inflation in several countries. For this reporting period, it has not caused significant adverse impacts on the Company's equity and financial position, although it is not possible to accurately predict significant adverse effects in the future.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Further sanctions, embargoes, regional instability, geopolitical changes, dysfunctions in the logistics chain, adverse effects on macroeconomic conditions, currency exchange rates and interest rates could affect the prices of products and costs of inputs in the international market, interrupt the supply chain, reduce sales and/or affect operations of the Company. As of the reporting date, the Company has not identified any relevant impacts on its business arising from the sanctions applied to date and adverse scenario caused by the geopolitical conflict.</span></p> <p id="xdx_80C_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_zxivjm3oQp72" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">3 <span id="xdx_824_z71SPTg1Janh">Application of estimates and judgments</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In preparing these consolidated financial statements, Management has made judgments and estimates that affect the application of the Company’ accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results can differ from these estimates due to differences in the variables, assumptions or conditions used in making estimates.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Judgments and estimates are reviewed on an ongoing basis and are based on historical experience and other factors, including expectations of future events that are deemed reasonable under the circumstances. Revision to estimates is recognized prospectively.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Critical judgments and estimates applied by the Company in the preparation of these consolidated financial statements are presented in the following notes:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>3.1 Assumptions and estimation uncertainties</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 12(b)</b></span><span style="font-family: Calibri, Helvetica, Sans-Serif">: The useful lives and discount rate of impairment testing of property, plant and equipment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 13(a)</b></span><span style="font-family: Calibri, Helvetica, Sans-Serif">: Determination of the discount rate and the recoverable amount of goodwill.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 20.2</b></span><span style="font-family: Calibri, Helvetica, Sans-Serif">: Application of hedge accounting: determining the fair value of financial instruments and judgment of highly probable forecast transaction.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 22.2</b></span><span style="font-family: Calibri, Helvetica, Sans-Serif">: Recognition of deferred tax assets, expectation of future taxable income against which deductible temporary differences and tax losses carryforward can be utilized.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 23(a):</b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif">Recognition and measurement of provisions for recovery of environmental damages: identifying potential environmental impacts, evaluate technical solutions and time of the remediation involve judgment as to the probability and magnitude of the outflow of resources.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 24:</b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif">Recognition and measurement of provisions for tax, labor and civil lawsuits: judgement on interpretation of the matter under discussion and estimate as to the probability and magnitude of the outflow of resources.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>- Note 26:</b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif">Recognition and measurement of provision for costs arising from the geological event in Alagoas: uncertainties regarding the outcome of actions to close and monitor wells, future studies by experts, changes related to the dynamics of the geological event, individual lawsuits, adherence by the municipality of Maceió and other parties, that could affect the probability and magnitude of the outflow of resources.</span></p> <p id="xdx_802_eifrs-full--DisclosureOfFinancialRiskManagementExplanatory_zB3YvPhrX6Ik" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">4 <span id="xdx_82E_z3uvO5hxTajl">Risk management</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is exposed to market risks arising from variations in commodity prices, foreign exchange rates and interest rates, credit risks of its counterparties in cash equivalents, financial investments and trade accounts receivable, and liquidity risks to meet its obligations from financial liabilities.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company adopts procedures for managing market and credit risks that are in conformity with its Financial Policy, which is reviewed by the Board of Directors quarterly. The purpose of risk management is to protect the Company’s cash flows and reduce the threats to the financing of its operating working capital and investment programs.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>4.1 Market risks</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company prepares a sensitivity analysis for foreign exchange rate and interest rate risks to which it is exposed, presented in Note 20.8.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Management of the interest rate benchmark reform and associated risks</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Overview</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The planning for an organized replacement of interbank offered rates (“IBORs”) for alternative, nearly risk-free interest rates (RFRs, or “Risk-Free Rates”) is in progress. <span style="color: black">Initiatives are being adopted to adapt the market before the discontinuation of IBORs, which is expected for June 2023.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company uses IBORs as reference rates on several of its financial instruments, and as part of these market-wide initiatives, RFRs will eventually replace such reference rates. While the transition will force modifications on contracts that use IBORs as reference rates, the Company expects no significant impact on its risk management after its completion. However, it will continue to monitor the transition and implement whatever changes or new controls are deemed to be appropriate as potential issues arise.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Derivatives </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The derivative instruments traded on over-the-counter market are governed by contracts based on the master agreements of the International Swaps and Derivatives Association (“ISDA”) and agreed with counterparties in the international banking market.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As part of the IBOR reform, the ISDA published a protocol that changed all master agreements in force to include RFRs as replacement rates (fallback) for use upon discontinuation of the various IBORs. The protocol came into force as of January 25, 2021. The Company and the subsidiaries Braskem America, Braskem Idesa and Braskem Holanda Finance already have carried out its adoption.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Liabilities</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the Company has bank loans with interest rates linked to LIBOR in US$ (see notes 16 and 17), which consequently will be subject to IBOR reform. The Company expects the benchmark interest rate of these loans to be changed to guaranteed forward rates at the Security Overnight Financing Rate (SOFR) by June 2023. The Company estimates that the updated cash flows will be economic equivalent to the original and has no expectation of material impacts.<br/></span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #BE3C00; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Exposure to commodity risks</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Most of Company’s feedstocks (naphtha, ethane, propane and propylene) and main products (PE, PP and PVC) are commodities quoted on international markets. A series of factors determine the dynamics of these quotes, nevertheless our sales prices are also impacted in a similar proportion when compared with our feedstock supply chain.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #BE3C00; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Exposure to foreign exchange risk </b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Considering the dynamics of the international petrochemical market, where prices are mostly pegged to international US dollar-denominated references, the Company’s sales in Brazil and Mexico are strongly correlated to the US$.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">To mitigate the long-term exchange risk, since September 2016, the Company started to contract financial derivatives to compose a Long-Term Foreign Exchange Hedge Program, by US dollar call and put option contracts, hedging expected cash flows over an 18-month horizon, as detailed in Note 20.5.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In addition to this program, to maintain the balance of the US dollar-denominated assets and liabilities exposure, as established in its Financial Policy, the Company will maintain at least 70% of the net debt exposed to the US dollar. If convenient, the Company may maintain a percentage of more than 70%, although subject to a sensitivity analysis of key financial indicators and proof of the inexistence of significant risk of deterioration of these indicators.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the Company prepared a sensitivity analysis for its exposure to the fluctuation in US$, as disclosed in Note 20.8.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #BE3C00; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Exposure to interest rate risk</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is exposed to the risk that a variation in floating interest rates causes an increase in its financial expenses due to payments of future interest. Debt denominated in foreign currency subject to floating rates is mainly subject to fluctuations in LIBOR. Debt denominated in R$ is mainly subject to the variation in the Interbank Certificate of Deposit (“CDI”) rate.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the Company prepared a sensitivity analysis for the exposure to the floating interest rates LIBOR, CDI, SELIC, SOFR and Extended National Consumer Price Index (“IPCA”), as disclosed in Note 20.8.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>4.2 Exposure to credit risk </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The transactions that subject the Company to the concentration of credit risks are mainly in bank checking accounts, financial investments, and trade accounts receivable in which the Company is exposed to the risk of the financial institution or customer involved. In order to manage this risk, the Company maintains bank current accounts and financial investments with major financial institutions, weighting concentrations in accordance with the credit rating and the daily prices observed in the Credit Default Swap market for the institutions, as well as netting contracts that minimize the total credit risk arising from the many financial transactions entered into by the parties.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, 33.8% of the amounts recorded as “Cash and cash equivalents” (Note 5) and “Financial Investments” (Note 6) were allocated to financial institutions that had offset agreements with the Company. The obligations under these agreements are accounted for under “Borrowings” (Note 16). The effective netting of these amounts is possible only in the event of default by one of the parties.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">With respect to the credit risk of customers, the Company protects itself by performing analysis before granting credit and obtaining secured and unsecured guarantees when considered necessary, including credit insurance.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The maximum exposure to credit risk of non-derivative financial instruments on the reporting date is the sum of their carrying amounts less any impairment losses.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>4.3 Liquidity risk</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has a calculation methodology to determine a minimum cash “monthly vision” (30-day horizon) and a minimum cash “yearly vision” (up to 12-month horizon) for the purpose of, respectively: (i) monitoring the liquidity needed to comply with obligations of the following month; and (ii) monitoring the Company´s liquidity during potential crisis.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The amounts to determine the minimum cash “yearly vision” are calculated based on the projected operating cash generation, less short-term debts and working capital needs. The amounts used for determining the minimum cash “monthly vision” consider the projected operating cash disbursement, debt service and investments in projects, as well as the planned disbursement for derivatives maturing in the period, among other items. According to its Financial Policy, the Company uses as a minimum cash the greater of these two references.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company, in keeping with its commitment to maintain its financial liquidity, renewed an international revolving credit facility in the amount of US$1 billion (R$5.22 billion), which expires in 2026. This credit line may be used without restrictions to improve the Company’s credit quality or in the event of deterioration in the macroeconomic scenario. As of December 31, 2022, this new credit line had not been used.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company's financial liabilities, including the amounts due under the Leniency Agreement (Note 25), are shown in the table below by maturity. These amounts are calculated based on cash flows not discounted that consider future financial charges and may not be reconciled with the amounts disclosed in the statement of financial position.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_pn3n3_zE1ImwD9qIFl" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Risk management (Details)"> <tr style="vertical-align: bottom"> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 44%"> <span id="xdx_8BD_zHfMLtkh1sb6" style="display: none">Schedule of financial liabilities by maturity</span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">Consolidated</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="font-weight: bold; text-align: right">Until</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">Between one</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">Between two</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">More than</td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">one year</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">and two years</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">and five years</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">five years</td> <td> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">Total</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Trade payables</td> <td> </td> <td> </td> <td id="xdx_987_ecustom--TradePayables_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">12,410,232</td> <td style="color: white; text-align: right"> </td> <td id="xdx_980_ecustom--TradePayables_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">3,069</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_98F_ecustom--TradePayables_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">  12,413,301</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Borrowings</td> <td> </td> <td> </td> <td id="xdx_98B_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  1,360,722</td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  3,139,258</td> <td style="color: white; text-align: right"> </td> <td id="xdx_986_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  3,931,315</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">57,625,391</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98E_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  66,056,686</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Debentures</td> <td> </td> <td> </td> <td id="xdx_985_ecustom--Debentures_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  136,142</td> <td style="color: white; text-align: right"> </td> <td id="xdx_980_ecustom--Debentures_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  102,090</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98F_ecustom--Debentures_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  6,167,985</td> <td style="color: white; text-align: right"> </td> <td id="xdx_989_ecustom--Debentures_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures"> 6,406,217</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Braskem Idesa borrowings</td> <td> </td> <td> </td> <td id="xdx_988_eifrs-full--OtherBorrowings_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">  996,697</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--OtherBorrowings_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">17,274,826</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_eifrs-full--OtherBorrowings_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">  18,271,523</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Derivatives</td> <td> </td> <td> </td> <td id="xdx_987_eifrs-full--DerivativeFinancialLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives">  192,226</td> <td style="color: white; text-align: right"> </td> <td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives">5,691</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives"> 88,273</td> <td style="color: white; text-align: right"> </td> <td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives"> 286,190</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Loan from non-controlling shareholder of Braskem Idesa </td> <td> </td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_983_ecustom--LoanToNoncontrollingShareholders_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Loan to noncontrolling shareholders">  4,391,832</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_ecustom--LoanToNoncontrollingShareholders_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Loan to noncontrolling shareholders"> 4,391,832</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Leniency agreement </td> <td> </td> <td> </td> <td id="xdx_98B_ecustom--LeniencyAgreements_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)">  434,804</td> <td style="color: white; text-align: right"> </td> <td id="xdx_988_ecustom--LeniencyAgreements_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)">  658,154</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_982_ecustom--LeniencyAgreements_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)"> 1,092,958</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Lease</td> <td> </td> <td> </td> <td id="xdx_986_eifrs-full--LeaseLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  1,109,048</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98B_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  855,803</td> <td style="color: white; text-align: right"> </td> <td id="xdx_982_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  581,592</td> <td style="color: white; text-align: right"> </td> <td id="xdx_983_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  2,436,734</td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease"> 4,983,177</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; font-weight: bold; text-align: left">At December 31, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">16,639,871</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">4,764,065</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">4,512,907</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">87,985,041</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">113,901,884</td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>4.4 Capital management</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s policy is to maintain capital management to ensure the continuity and development of its business and to maintain the trust of investors, creditors and the general market. The capital structure, according to the Management, considers the balance between own capital and net debt. This composition meets the Company’s policy of providing a consistent return to shareholders and other stakeholders. This structure also allows borrowing costs to maximize shareholder remuneration.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Due to the impact of US$ on the Company’s operations, Management believes that the own capital used for capital management purposes should be measured in US$. Moreover, the Company may temporarily maintain another capital structure, for example, during periods of growth, when the Company may finance a large portion of its projects through borrowings, provided that this option maximizes return for shareholders once the financed projects start operating. In order to adjust and maintain the capital structure, the Management may also consider the sale of non-strategic assets, the issue of new shares or even adjustments to dividend payments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As is the case of liquidity, capital is managed at the consolidated level, except for the liquidity and capital of the subsidiary Braskem Idesa and other subsidiaries with non-controlling interest, whose specific management is concentrated at the subsidiaries level. </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_pn3n3_zE1ImwD9qIFl" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Risk management (Details)"> <tr style="vertical-align: bottom"> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 44%"> <span id="xdx_8BD_zHfMLtkh1sb6" style="display: none">Schedule of financial liabilities by maturity</span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 10%"> </td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">Consolidated</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="font-weight: bold; text-align: right">Until</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">Between one</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">Between two</td> <td style="text-align: right"> </td> <td style="font-weight: bold; text-align: right">More than</td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">one year</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">and two years</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">and five years</td> <td style="text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">five years</td> <td> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">Total</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Trade payables</td> <td> </td> <td> </td> <td id="xdx_987_ecustom--TradePayables_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">12,410,232</td> <td style="color: white; text-align: right"> </td> <td id="xdx_980_ecustom--TradePayables_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">3,069</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_98F_ecustom--TradePayables_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Trade payables">  12,413,301</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Borrowings</td> <td> </td> <td> </td> <td id="xdx_98B_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  1,360,722</td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  3,139,258</td> <td style="color: white; text-align: right"> </td> <td id="xdx_986_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  3,931,315</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">57,625,391</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98E_eifrs-full--CurrentPortionOfLongtermBorrowings_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Borrowings">  66,056,686</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Debentures</td> <td> </td> <td> </td> <td id="xdx_985_ecustom--Debentures_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  136,142</td> <td style="color: white; text-align: right"> </td> <td id="xdx_980_ecustom--Debentures_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  102,090</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98F_ecustom--Debentures_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures">  6,167,985</td> <td style="color: white; text-align: right"> </td> <td id="xdx_989_ecustom--Debentures_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Debentures"> 6,406,217</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Braskem Idesa borrowings</td> <td> </td> <td> </td> <td id="xdx_988_eifrs-full--OtherBorrowings_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">  996,697</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--OtherBorrowings_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">17,274,826</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_eifrs-full--OtherBorrowings_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Braskem Idesa borrowings">  18,271,523</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Derivatives</td> <td> </td> <td> </td> <td id="xdx_987_eifrs-full--DerivativeFinancialLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives">  192,226</td> <td style="color: white; text-align: right"> </td> <td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives">5,691</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives"> 88,273</td> <td style="color: white; text-align: right"> </td> <td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Derivatives"> 286,190</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Loan from non-controlling shareholder of Braskem Idesa </td> <td> </td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_983_ecustom--LoanToNoncontrollingShareholders_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Loan to noncontrolling shareholders">  4,391,832</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98A_ecustom--LoanToNoncontrollingShareholders_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Loan to noncontrolling shareholders"> 4,391,832</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Leniency agreement </td> <td> </td> <td> </td> <td id="xdx_98B_ecustom--LeniencyAgreements_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)">  434,804</td> <td style="color: white; text-align: right"> </td> <td id="xdx_988_ecustom--LeniencyAgreements_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)">  658,154</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right">-</td> <td style="color: white; text-align: right"> </td> <td id="xdx_982_ecustom--LeniencyAgreements_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Leniency agreement (Note 25)"> 1,092,958</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-size: 11pt; text-align: left">Lease</td> <td> </td> <td> </td> <td id="xdx_986_eifrs-full--LeaseLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  1,109,048</td> <td style="color: white; text-align: right"> </td> <td id="xdx_98B_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  855,803</td> <td style="color: white; text-align: right"> </td> <td id="xdx_982_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  581,592</td> <td style="color: white; text-align: right"> </td> <td id="xdx_983_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease">  2,436,734</td> <td style="color: white; text-align: right"> </td> <td id="xdx_987_eifrs-full--LeaseLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="text-align: right" title="Lease"> 4,983,177</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; font-weight: bold; text-align: left">At December 31, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__custom--CarryingAmountAxis__custom--CarryingAmountOneMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">16,639,871</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">4,764,065</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">4,512,907</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--EarlyPaymentdebtMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">87,985,041</td> <td style="color: white; font-weight: bold; font-family: Arial, Helvetica, Sans-Serif"> </td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total">113,901,884</td></tr> </table> 12410232000 3069000 12413301000 1360722000 3139258000 3931315000 57625391000 66056686000 136142000 102090000 6167985000 6406217000 996697000 17274826000 18271523000 192226000 5691000 88273000 286190000 4391832000 4391832000 434804000 658154000 1092958000 1109048000 855803000 581592000 2436734000 4983177000 16639871000 4764065000 4512907000 87985041000 113901884000 <p id="xdx_80B_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zqTV8WFTArfl" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">5 <span id="xdx_824_zHiPAfllyWy7">Cash and cash equivalents</span></span></p> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_za5Eei9EBHj3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8BB_zsFZjGjVxQHb" style="display: none">Schedule of cash and cash equivalents</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 50%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Cash_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  517,236</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_zCOen0MNWAnk" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  676,083</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_983_eifrs-full--Cash_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_ziEBiK9viEhd" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,556,972</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zEA7tROr0vTh" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,374,739</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash equivalents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CashEquivalents_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,684,999</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_ztedrODJi9v3" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,141,221</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98F_eifrs-full--CashEquivalents_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zrDHrVwPGJfb" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,707,267</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zpxCgZnX5ix1" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,488,643</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CashAndCashEquivalents_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,466,474</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20211231_z5jH8Pn4JSIf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,680,686</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zPNHEYvq1MDi" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1F_zTsJ5pVCrOr8" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, it includes R$<span id="xdx_900_eifrs-full--Cash_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zqZiUGCmHQu1" title="Cash">931,991 </span></span><span style="font-family: Calibri, Helvetica, Sans-Serif">of cash and R$<span id="xdx_904_eifrs-full--CashEquivalents_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zWMhCSQGY72a" title="Cash equivalents">1,252,341 </span></span><span style="font-family: Calibri, Helvetica, Sans-Serif">of cash equivalents (2021: R$<span id="xdx_905_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zbFvUICRkgrl" title="Cash">1,267,582</span> of cash and R$<span id="xdx_909_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zrl1n1mahUSc" title="Cash equivalents">505,749</span> of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.</span></td></tr> </table> <p id="xdx_8A6_zPm0bPaPukLh" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash equivalents are represented mainly by fixed-income instruments and time deposits, such as bank deposit certificates (“CDBs”), treasury bonds, financial bills, debentures, and shares of fixed income investment funds. <span style="color: black">These assets may be directly held by the Company or through its exclusive funds, FIM Júpiter and FIM Netuno. Average yield of cash equivalents is presented jointly with financial investments (see note 6).</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The cash equivalents abroad consist of fixed income instruments (Time Deposit) and interest bearing accounts.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_za5Eei9EBHj3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8BB_zsFZjGjVxQHb" style="display: none">Schedule of cash and cash equivalents</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 50%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Cash_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  517,236</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_zCOen0MNWAnk" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  676,083</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_983_eifrs-full--Cash_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_ziEBiK9viEhd" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,556,972</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zEA7tROr0vTh" style="text-align: right" title="Cash"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,374,739</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash equivalents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CashEquivalents_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,684,999</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_ztedrODJi9v3" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,141,221</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98F_eifrs-full--CashEquivalents_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zrDHrVwPGJfb" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,707,267</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGkp_zpxCgZnX5ix1" style="text-align: right" title="Cash equivalents"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,488,643</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CashAndCashEquivalents_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,466,474</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20211231_z5jH8Pn4JSIf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,680,686</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zPNHEYvq1MDi" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1F_zTsJ5pVCrOr8" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, it includes R$<span id="xdx_900_eifrs-full--Cash_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zqZiUGCmHQu1" title="Cash">931,991 </span></span><span style="font-family: Calibri, Helvetica, Sans-Serif">of cash and R$<span id="xdx_904_eifrs-full--CashEquivalents_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zWMhCSQGY72a" title="Cash equivalents">1,252,341 </span></span><span style="font-family: Calibri, Helvetica, Sans-Serif">of cash equivalents (2021: R$<span id="xdx_905_eifrs-full--Cash_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zbFvUICRkgrl" title="Cash">1,267,582</span> of cash and R$<span id="xdx_909_eifrs-full--CashEquivalents_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zrl1n1mahUSc" title="Cash equivalents">505,749</span> of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company.</span></td></tr> </table> 517236000 676083000 5556972000 4374739000 3684999000 1141221000 2707267000 2488643000 12466474000 8680686000 931991000 1252341000 1267582000 505749000 <p id="xdx_805_eifrs-full--DisclosureOfDepositsFromBanksExplanatory_zeDRPoIUIwL1" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">6 <span id="xdx_820_zpAF0kB3rok2">Financial investments</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory_pn3n3_z9o147kxPPV6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial investments (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span id="xdx_8BA_z3Aqa1Twkh4b" style="display: none">Schedule of financial investments</span></td> <td> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 56%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Time deposit investments</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">LFT´s and LF´s</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_983_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--LFTAndLFMember_fKGkp_zhdohvG3G0P9" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--LFTAndLFMember_fKGkp_zK9mDVxUKf48" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Restricted funds investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_989_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember_fKGlpKQ_____zYeb42OAZ2al" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  305,485</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember_fKGlpKQ_____z4S0icDatYKi" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  852,362</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--OtherFinancialInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  217,771</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--OtherFinancialInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  213,751</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,312,631</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,509,555</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentInvestments_c20221231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentInvestments_c20211231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,492,710</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,134</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,845</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231_zwtcYRIuUsl7" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,312,631</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231_zzSo1Hs54Inh" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,509,555</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0E_z1OrnVznTDnl" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_z4Gz6RxhG1f" style="font-family: Calibri, Helvetica, Sans-Serif">These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F04_zbQECPrH13N1" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_F1E_zX6TAlQloctk" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Includes the following amounts: R$<span id="xdx_90E_ecustom--RestrictedFund_c20220101__20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_pn3n3" title="Restricted fund">175,153</span> (2021: R$<span id="xdx_905_ecustom--RestrictedFund_pn3n3_c20210101__20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_zqug0vumqcD8" title="Restricted fund">835,517</span>) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$<span id="xdx_906_ecustom--BankDeposits_c20220101__20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_pn3n3" title="Bank deposits">130,332</span> (2021: R$<span id="xdx_905_ecustom--BankDeposits_pn3n3_c20210101__20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_zfSGAF41l2oc" title="Bank deposits">16,845</span>) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.</span></td></tr> </table> <p id="xdx_8A7_zfRdTIvNJ7I6" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, financial investments and cash equivalents (Note 5) in Brazilian R$ had an average yield of <span id="xdx_903_ecustom--DepositsYieldsRate_pid_dp_c20220101__20221231_zDrqKxpQnkIj" title="Deposits yields rate">102.59</span>% of the CDI p.a. (2021: <span id="xdx_90B_ecustom--DepositsYieldsRate_pid_dp_c20210101__20211231_zfh1EL8eNdA2" title="Deposits yields rate">102.50</span>%) and financial investments and cash equivalents in foreign currency (Note 5) had an average yield of <span id="xdx_908_ecustom--DepositsYieldsRate_pid_dp_c20220101__20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zHiF7zYXh6cd" title="Deposits yields rate">1.18</span>% p.a. (2021: <span id="xdx_907_ecustom--DepositsYieldsRate_pid_dp_c20210101__20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zx8OVzI5OmMc" title="Deposits yields rate">0.45</span>% p.a.).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; letter-spacing: 0pt"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory_pn3n3_z9o147kxPPV6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial investments (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span id="xdx_8BA_z3Aqa1Twkh4b" style="display: none">Schedule of financial investments</span></td> <td> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="color: white"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 56%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Time deposit investments</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">LFT´s and LF´s</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_983_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--LFTAndLFMember_fKGkp_zhdohvG3G0P9" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--LFTAndLFMember_fKGkp_zK9mDVxUKf48" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Restricted funds investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_989_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember_fKGlpKQ_____zYeb42OAZ2al" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  305,485</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember_fKGlpKQ_____z4S0icDatYKi" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  852,362</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--OtherFinancialInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  217,771</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--OtherFinancialInvestmentsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  213,751</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,312,631</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,509,555</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentInvestments_c20221231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentInvestments_c20211231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,492,710</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,134</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,845</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20221231_zwtcYRIuUsl7" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,312,631</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_iI_pn3n3_c20211231_zzSo1Hs54Inh" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,509,555</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0E_z1OrnVznTDnl" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_z4Gz6RxhG1f" style="font-family: Calibri, Helvetica, Sans-Serif">These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F04_zbQECPrH13N1" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_F1E_zX6TAlQloctk" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Includes the following amounts: R$<span id="xdx_90E_ecustom--RestrictedFund_c20220101__20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_pn3n3" title="Restricted fund">175,153</span> (2021: R$<span id="xdx_905_ecustom--RestrictedFund_pn3n3_c20210101__20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_zqug0vumqcD8" title="Restricted fund">835,517</span>) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$<span id="xdx_906_ecustom--BankDeposits_c20220101__20221231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_pn3n3" title="Bank deposits">130,332</span> (2021: R$<span id="xdx_905_ecustom--BankDeposits_pn3n3_c20210101__20211231__ifrs-full--MeasurementAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--TypesOfFinancialAssetsAxis__custom--RestrictedFundsInvestmentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--InterbankDepositRateMember_zfSGAF41l2oc" title="Bank deposits">16,845</span>) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18.</span></td></tr> </table> 106271000 1789375000 2337171000 305485000 852362000 217771000 213751000 2312631000 3509555000 2295497000 3492710000 17134000 16845000 2312631000 3509555000 175153000 835517000 130332000 16845000 1.0259 1.0250 0.0118 0.0045 <p id="xdx_80B_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_z1bQATxsGQmh" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">7 <span id="xdx_82C_zDILl8Ktthwj">Trade accounts receivable</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s average receivables term is generally 30 days; therefore, the carrying value of the trade accounts receivable approximates their fair value. The Company realizes part of its trade accounts receivable through the sale of trade notes to funds and financial institutions that acquire receivables. These operations are not entitled to recourse and the risks and benefits over the receivables are transferred and the trade accounts receivable are derecognized.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the amounts of trade accounts receivable transferred and derecognized maturing after December 31, 2022, was R$3.5 billion (2021: R$3.5 billion). Loss recognized at the date of transfer of the abovementioned receivables were R$73 million (2021: R$39 million), recorded under Financial Expenses.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfTradeAccountsReceivableExplanatory_pn3n3_ztrbCMoJq6Dg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8B5_zOuEGwQk6h9" style="display: none">Schedule of trade accounts receivable</span></td> <td> </td> <td> </td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 50%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Customers</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,533,675</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,851,701</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RelatedPartyMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,791</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RelatedPartyMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,240</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,547,466</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--GrossTradeReceivables_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,863,941</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,796,559</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,434,653</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,796,559</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,434,653</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExpectedCreditLosses_iI_pn3n3_c20221231_fKGkp_zlnZVtflW5N8" style="text-align: right" title="Expected credit losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(112,091)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExpectedCreditLosses_iI_pn3n3_c20211231_fKGkp_zki59Kds4uc2" style="text-align: right" title="Expected credit losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeReceivables_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeReceivables_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,166,960</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentTradeReceivables_c20221231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CurrentTradeReceivables_c20211231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,153,565</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_c20211231_pn3n3" style="text-align: right" title="Non-current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,395</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherReceivables_iI_pn3n3_c20221231_zPZvPSq1daZ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade accounts receivable, Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--TradeAndOtherReceivables_iI_pn3n3_c20211231_zxv5PJwH3uw4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade accounts receivable, Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,166,960</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F02_zPE3S3cAoy9h" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F18_zTZSql0tOSP8" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. <span style="color: black">To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; </span>(ii) receivables past due 90 to 180 days; <span style="color: black">(iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:</span></span></td></tr> </table> <p id="xdx_8AE_zwSGG3O9xxl9" style="margin-top: 0; margin-bottom: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByMaturityExplanatory_pn3n3_zaIdUOUhxYlc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details 1)"> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left"> <span id="xdx_8B1_zRnrl6c0Ju49" style="display: none">Schedule of trade accounts receivable by maturity</span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td></tr> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left; width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td dir="ltr" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td dir="ltr" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accounts receivables not past due</span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zk3m8duevlqh" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,687,775</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zTjSH1oX04db" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (34,931)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,652,844</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zajxdd0HBbAe" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,705,123</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zgfmvojDx70a" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,291)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember_zfUflF5uBO36" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,692,832</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Past due securities:</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Up to 90 days</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zrqayyJGh0H1" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">536,289</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zD70B85KAXs3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,783)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">529,506</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zubzmFTX1bv" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">431,899</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zH0lZFF7wlcb" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,264)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember_zTDI4hEJpWf8" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">429,635</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Between 91 to 180 days</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_z03bAnabmvSa" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  25,015</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zSZ531DTEsif" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,010)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,005</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zoypmGyupiT5" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  45,134</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zkO6ukCAtw2c" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,390)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember_zhSfIDlDYre7" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  43,744</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Above 180 days</span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zAQRvlrVqzOf" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  94,946</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zow2DZtCgii4" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (67,367)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,579</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zwtQWu224FP8" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zfmvJQVzGqB6" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (115,689)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember_zp0XSkmAsgp" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 749</span></td></tr> <tr> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zPuCKK6mpgm5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,344,025</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--TradeReceivables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zO586haYtzua" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">(112,091)</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeReceivables_iI_pn3n3_c20221231_zEnxmsuqgbBe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,231,934</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zZxi4g8Bo8Yj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,298,594</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--TradeReceivables_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zR2hbduan0N8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeReceivables_iI_pn3n3_c20211231_zRsw8Jh3tru" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,166,960</span></td></tr> </table> <p id="xdx_8A9_zM5gtXnQos98" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The changes in the expected credit loss are presented below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory_pn3n3_zYHYJ4DqOprb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8B8_zGowPB8B9uQ5" style="display: none">Schedule of changes in allowance for doubtful accounts</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginning of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20220101__20221231_z8aEmRWkuDu6" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20210101__20211231_zcZnIKmSiUa7" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,007)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20200101__20201231_zpzHuKyO79F5" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(229,323)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (87,898)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_z9pAtvOh7DCk" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(144,888)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_zoYg0z4dd7lb" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (65,571)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 71,400</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_z4kO6osxqDp5" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  149,681</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_z9W0Jn6aion2" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 28,563</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Write-off of securities considered uncollectible</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 36,041</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_zHu00eXT0xq8" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 36,580</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_zkaUXwH38Pxj" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 93,324</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20220101__20221231_zXk2iW1Ffish" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (112,091)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20210101__20211231_zY2soUtesMaa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20200101__20201231_zKISIF9DNk0b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (173,007)</span></td></tr> </table> <p id="xdx_8AB_z7foA5c0xina" style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Write-off </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The gross carrying amount of a financial asset is written-off when the Company has no reasonable expectations of recovering a financial asset in its entirety or a portion thereof.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfTradeAccountsReceivableExplanatory_pn3n3_ztrbCMoJq6Dg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8B5_zOuEGwQk6h9" style="display: none">Schedule of trade accounts receivable</span></td> <td> </td> <td> </td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 50%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Customers</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,533,675</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,851,701</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RelatedPartyMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,791</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RelatedPartyMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,240</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_c20221231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,547,466</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--GrossTradeReceivables_c20211231__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,863,941</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_c20221231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,796,559</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20211231__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,434,653</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,796,559</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--GrossTradeReceivables_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,434,653</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExpectedCreditLosses_iI_pn3n3_c20221231_fKGkp_zlnZVtflW5N8" style="text-align: right" title="Expected credit losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(112,091)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExpectedCreditLosses_iI_pn3n3_c20211231_fKGkp_zki59Kds4uc2" style="text-align: right" title="Expected credit losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeReceivables_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeReceivables_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,166,960</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentTradeReceivables_c20221231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CurrentTradeReceivables_c20211231_pn3n3" style="text-align: right" title="Current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,153,565</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_c20211231_pn3n3" style="text-align: right" title="Non-current assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,395</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherReceivables_iI_pn3n3_c20221231_zPZvPSq1daZ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade accounts receivable, Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--TradeAndOtherReceivables_iI_pn3n3_c20211231_zxv5PJwH3uw4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade accounts receivable, Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,166,960</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F02_zPE3S3cAoy9h" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F18_zTZSql0tOSP8" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. <span style="color: black">To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; </span>(ii) receivables past due 90 to 180 days; <span style="color: black">(iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity:</span></span></td></tr> </table> 1533675000 2851701000 13791000 12240000 1547466000 2863941000 1796559000 4434653000 1796559000 4434653000 -112091000 -131634000 3231934000 7166960000 3231934000 7153565000 13395000 3231934000 7166960000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByMaturityExplanatory_pn3n3_zaIdUOUhxYlc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details 1)"> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left"> <span id="xdx_8B1_zRnrl6c0Ju49" style="display: none">Schedule of trade accounts receivable by maturity</span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"> </td></tr> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left; width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td dir="ltr" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expected credit losses</span></td> <td dir="ltr" style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accounts receivables not past due</span></td> <td dir="ltr" style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zk3m8duevlqh" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,687,775</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zTjSH1oX04db" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (34,931)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--NotPastDueMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,652,844</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zajxdd0HBbAe" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,705,123</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zgfmvojDx70a" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,291)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotPastDueMember_zfUflF5uBO36" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,692,832</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Past due securities:</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Up to 90 days</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zrqayyJGh0H1" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">536,289</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zD70B85KAXs3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,783)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">529,506</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zubzmFTX1bv" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">431,899</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zH0lZFF7wlcb" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,264)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--NotLaterThanNinetyDaysMember_zTDI4hEJpWf8" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">429,635</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Between 91 to 180 days</span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_z03bAnabmvSa" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  25,015</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zSZ531DTEsif" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,010)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,005</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zoypmGyupiT5" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  45,134</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zkO6ukCAtw2c" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,390)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember_zhSfIDlDYre7" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  43,744</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Above 180 days</span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zAQRvlrVqzOf" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  94,946</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--GrossTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zow2DZtCgii4" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (67,367)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--GrossTradeReceivables_c20221231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember_pn3n3" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,579</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zwtQWu224FP8" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zfmvJQVzGqB6" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (115,689)</span></td> <td style="color: white; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--GrossTradeReceivables_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--LaterThanOneHundredAndEightyDaysMember_zp0XSkmAsgp" style="vertical-align: middle; text-align: right" title="Trade accounts receivable, gross"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 749</span></td></tr> <tr> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td dir="ltr" style="font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zPuCKK6mpgm5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,344,025</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--TradeReceivables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zO586haYtzua" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">(112,091)</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeReceivables_iI_pn3n3_c20221231_zEnxmsuqgbBe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,231,934</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TradeAccountsReceivablesMember_zZxi4g8Bo8Yj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,298,594</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--TradeReceivables_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExpectedCreditLossesMember_zR2hbduan0N8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeReceivables_iI_pn3n3_c20211231_zRsw8Jh3tru" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,166,960</span></td></tr> </table> 2687775000 -34931000 2652844000 6705123000 -12291000 6692832000 536289000 -6783000 529506000 431899000 -2264000 429635000 25015000 -3010000 22005000 45134000 -1390000 43744000 94946000 -67367000 27579000 116438000 -115689000 749000 3344025000 112091000 3231934000 7298594000 131634000 7166960000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory_pn3n3_zYHYJ4DqOprb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade accounts receivable (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8B8_zGowPB8B9uQ5" style="display: none">Schedule of changes in allowance for doubtful accounts</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginning of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20220101__20221231_z8aEmRWkuDu6" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20210101__20211231_zcZnIKmSiUa7" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,007)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_pn3n3_c20200101__20201231_zpzHuKyO79F5" style="text-align: right" title="Balance of provision at the beginning of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(229,323)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (87,898)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_z9pAtvOh7DCk" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(144,888)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_zoYg0z4dd7lb" style="text-align: right" title="Provision in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (65,571)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 71,400</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_z4kO6osxqDp5" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  149,681</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ReversalAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_z9W0Jn6aion2" style="text-align: right" title="Reversal in the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 28,563</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Write-off of securities considered uncollectible</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 36,041</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20210101__20211231_zHu00eXT0xq8" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 36,580</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets_pn3n3_c20200101__20201231_zkaUXwH38Pxj" style="text-align: right" title="Write-offs"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 93,324</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20220101__20221231_zXk2iW1Ffish" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (112,091)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20210101__20211231_zY2soUtesMaa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,634)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_pn3n3_c20200101__20201231_zKISIF9DNk0b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance of provision at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (173,007)</span></td></tr> </table> -131634000 -173007000 -229323000 -87898000 -144888000 -65571000 71400000 149681000 28563000 36041000 36580000 93324000 -112091000 -131634000 -173007000 <p id="xdx_803_eifrs-full--DisclosureOfInventoriesExplanatory_zw94MQ2vARk8" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">8 <span id="xdx_820_zDtVHebuiaI9">Inventories</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Inventories are measured at the lower of cost and net realizable value. The cost of inventories is recorded at the weighted average cost. In the case of manufactured inventories, besides raw materials and other consumables, cost includes an appropriate share of production overheads based on normal operating capacity.</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfInventoryExplanatory_pn3n3_zo5bHXt3wCi4" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Inventories (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8B2_zg30i2zjNTq4" style="display: none">Schedule of inventory</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_498_20221231_zQJlnYeEGt45" style="text-align: center"> </td> <td style="text-align: right"> </td> <td id="xdx_49B_20211231_z10Oj2avniNi" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> <span/></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="font-weight: bold; text-align: right"> </td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 47%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--FinishedGoods_iI_maITzB0d_zhIMqZIXxULb" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Finished goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,558,025</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,271,708</span></td></tr> <tr id="xdx_409_ecustom--SemiFinishedGoods_iI_maITzB0d_zBVBPSYL0f1i" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Semi-finished goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">663,182</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">568,914</span></td></tr> <tr id="xdx_401_eifrs-full--RawMaterials_iI_maITzB0d_zybqXDqLkQk1" style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Raw materials, production inputs and packaging</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,747,525</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,356,660</span></td></tr> <tr id="xdx_40E_eifrs-full--CurrentPackagingAndStorageMaterials_iI_maITzB0d_z1OhY08Bbnl7" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maintenance materials</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">869,953</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">766,994</span></td></tr> <tr id="xdx_40C_eifrs-full--OtherInventories_iI_maITzB0d_zIcPULvdKA45" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Advances to suppliers</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">124,285</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  62,573</span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentInventoriesInTransit_iI_maITzB0d_z21Z4wtPRqng" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Imports in transit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,067,094</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,308,252</span></td></tr> <tr id="xdx_40C_eifrs-full--InventoriesTotal_iI_maITzB0d_zR4tyKSsfz07" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,030,064</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,335,101</span></td></tr> </table> <p id="xdx_8A0_zJSAaNTHPcil" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The effect of the provision for inventories at the year is shown below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory_pn3n3_zT9TALdUZfra" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Inventories (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zTBxp1frrjad" style="display: none">Schedule of provision for inventories</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 42%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_493_20220101__20221231_zg7thodRKSf3" style="font-family: Times New Roman, Times, Serif; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_490_20210101__20211231_zdSpdVvLQJ28" style="font-family: Times New Roman, Times, Serif; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_490_20200101__20201231_zY2rMXqpAbj8" style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ProvisionForInventories_i_pn3n3" style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginner of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  82,218</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">122,572</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">82,195</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AdditionToInventories_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span id="xdx_F43_zzIllFDpOOz1" style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">533,471</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  97,911</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">120,483</span></td></tr> <tr id="xdx_408_ecustom--ReversalToInventories_i_pn3n3" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Utilization/reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (103,583)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (138,265)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (80,106)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--ProvisionForInventoriesEnd_i_pn3n3" style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">512,106</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  82,218</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">122,572</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F09_zjBNYVBQTCud" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1D_zLfs4055PC1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: black">The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.</span></td></tr> </table> <p id="xdx_8A4_zxr93EWD14vi" style="margin-top: 0; margin-bottom: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfInventoryExplanatory_pn3n3_zo5bHXt3wCi4" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Inventories (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8B2_zg30i2zjNTq4" style="display: none">Schedule of inventory</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_498_20221231_zQJlnYeEGt45" style="text-align: center"> </td> <td style="text-align: right"> </td> <td id="xdx_49B_20211231_z10Oj2avniNi" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> <span/></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="font-weight: bold; text-align: right"> </td> <td> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 47%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--FinishedGoods_iI_maITzB0d_zhIMqZIXxULb" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Finished goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,558,025</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,271,708</span></td></tr> <tr id="xdx_409_ecustom--SemiFinishedGoods_iI_maITzB0d_zBVBPSYL0f1i" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Semi-finished goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">663,182</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">568,914</span></td></tr> <tr id="xdx_401_eifrs-full--RawMaterials_iI_maITzB0d_zybqXDqLkQk1" style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Raw materials, production inputs and packaging</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,747,525</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,356,660</span></td></tr> <tr id="xdx_40E_eifrs-full--CurrentPackagingAndStorageMaterials_iI_maITzB0d_z1OhY08Bbnl7" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maintenance materials</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">869,953</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">766,994</span></td></tr> <tr id="xdx_40C_eifrs-full--OtherInventories_iI_maITzB0d_zIcPULvdKA45" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Advances to suppliers</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">124,285</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  62,573</span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentInventoriesInTransit_iI_maITzB0d_z21Z4wtPRqng" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Imports in transit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,067,094</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,308,252</span></td></tr> <tr id="xdx_40C_eifrs-full--InventoriesTotal_iI_maITzB0d_zR4tyKSsfz07" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,030,064</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,335,101</span></td></tr> </table> 8558025000 9271708000 663182000 568914000 2747525000 3356660000 869953000 766994000 124285000 62573000 1067094000 2308252000 14030064000 16335101000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory_pn3n3_zT9TALdUZfra" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Inventories (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zTBxp1frrjad" style="display: none">Schedule of provision for inventories</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 42%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_493_20220101__20221231_zg7thodRKSf3" style="font-family: Times New Roman, Times, Serif; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_490_20210101__20211231_zdSpdVvLQJ28" style="font-family: Times New Roman, Times, Serif; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_490_20200101__20201231_zY2rMXqpAbj8" style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ProvisionForInventories_i_pn3n3" style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginner of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  82,218</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">122,572</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">82,195</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AdditionToInventories_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span id="xdx_F43_zzIllFDpOOz1" style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">533,471</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  97,911</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">120,483</span></td></tr> <tr id="xdx_408_ecustom--ReversalToInventories_i_pn3n3" style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Utilization/reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (103,583)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (138,265)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (80,106)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--ProvisionForInventoriesEnd_i_pn3n3" style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">512,106</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  82,218</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">122,572</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F09_zjBNYVBQTCud" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1D_zLfs4055PC1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: black">The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario.</span></td></tr> </table> 82218000 122572000 82195000 533471000 97911000 120483000 -103583000 -138265000 -80106000 512106000 82218000 122572000 <p id="xdx_80D_eifrs-full--DisclosureOfRelatedPartyExplanatory_zNQ0C5iA0NP3" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">9 <span id="xdx_821_zU4w4mevL626">Related parties</span></span></p> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_pn3n3_zvgDot3hkJz7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_z0yFJ8VM6dM5" style="display: none">Schedule of related party transactions</span></td> <td colspan="7" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"> </td> <td> </td> <td colspan="7" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><b> </b></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><b>Balances at December 31, 2022 </b></td> <td><b> </b></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><b>Balances at December 31, 2021 </b></td></tr> <tr style="vertical-align: bottom"> <td style="width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Novonor and</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Novonor and</span></td> <td style="text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Petrobras and</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Petrobras and</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Balance sheet</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">and associates</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other (i)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">and associates</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other (i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade accounts receivable</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,924</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  1,867</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--CurrentTradeReceivables1_c20221231_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  13,791</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zMDwaF1MNiM2" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,894</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlwaQOucB6N8" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  7,346</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--CurrentTradeReceivables1_iI_pn3n3_c20211231_zj0JlC59IeP8" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">12,240</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Inventories  (advance to suppliers)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eifrs-full--Inventories_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 61,428</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--Inventories1_c20221231_pn3n3" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  61,428</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Inventories_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zh1p59s3sAia" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">9,927</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--Inventories1_iI_pn3n3_c20211231_zx2grdan3ci" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  9,927</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Dividends and interest on capital</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eifrs-full--InterestReceivable_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Dividends and interest on capital"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,296</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivabels</span></td> <td id="xdx_98D_ecustom--OtherReceivabels_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">11,348</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--OtherReceivabels_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">287</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherReceivabels_c20221231_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  11,635</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--OtherReceivabels_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zyJHraDburFd" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">287</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--OtherReceivabels_iI_pn3n3_c20211231_zlz3KUjT4K7" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  287</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zsmNo7THcc55" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">5,657</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--OtherReceivabelsNonCurrent_c20221231_pn3n3" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 5,657</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z1Guenf4bJ99" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 38,987</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20211231_zynhvLW05fkc" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">38,987</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total assets</span></td> <td id="xdx_984_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  11,348</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  79,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,163</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--Assets1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 96,807</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z23SypP8hSAj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  54,095</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCwHjfzrht78" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,346</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--Assets1_iI_pn3n3_c20211231_zxcNHfEse8G2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 61,441</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Liabilities</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 126,014</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  137,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">14,189</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--TradeAndOtherCurrentPayables1_c20221231_pn3n3" style="text-align: right" title="Trade and other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">277,967</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_982_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_z5E9SVf92APe" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">103,259</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zApofgNZrNEj" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  134,063</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbJs4NeaEVj7" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">11,113</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--TradeAndOtherCurrentPayables1_iI_pn3n3_c20211231_z16jvmT8Rpn5" style="text-align: right" title="Trade and other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 248,435</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td id="xdx_98D_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  233,133</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  314</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherCurrentPayables1_c20221231_pn3n3" style="text-align: right" title="Other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">233,451</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zyCYHbU2DATd" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  296,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eifrs-full--OtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zFIhC8zC8Sj4" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  345</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherCurrentPayables1_iI_pn3n3_c20211231_zP9Mrg1TnXj2" style="text-align: right" title="Other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 297,329</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_984_ecustom--TradePayablesNonCurrent_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_zeoOmtGlafMa" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  3,069</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--TradePayablesNonCurrent_iI_pn3n3_c20221231_zilmjyKL1WM1" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,069</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan to non-controlling shareholders of Braskem Idesa</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--NoncurrentLoanToNoncontrollingShareholders_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,498,093</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--NoncurrentLoanToNoncontrollingShareholders_c20221231_pn3n3" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,498,093</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--NoncurrentLoanToNoncontrollingShareholders_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zVbnEUQR7xh7" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--NoncurrentLoanToNoncontrollingShareholders_iI_pn3n3_c20211231_zxckZSnBUpmj" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total liabilities</span></td> <td id="xdx_98B_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  129,087</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">370,897</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  2,512,596</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eifrs-full--Liabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,012,580</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_zNaKAE3RcWFh" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 103,259</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zS1BbUall5j4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">431,047</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z6KqQLYR2cF" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  3,657,996</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Liabilities_iI_pn3n3_c20211231_zvvrxBT1Hqjc" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,192,302</span></td></tr> </table> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"> </p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2022</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2021</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2020</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 28%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Transactions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Sales of products</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--Revenue_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  182,218</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 437,514</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_ecustom--Revenue1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">619,732</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zjON9xsEHg5c" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  171,665</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zswf4BDoPwh8" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 540,855</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--Revenue1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zPEcE6FfK854" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 712,520</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z5rrO1dgCQz9" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  182,521</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zAupc9AjX7Kb" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 326,825</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--Revenue1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zf0c6wXho6Y7" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">509,346</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Purchases of raw materials, finished goods services and utilities</span></td> <td id="xdx_988_eifrs-full--CostOfSales_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(334,363)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--CostOfSales_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (22,900,140)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--CostOfSales1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (24,813)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_ecustom--CostOfSales1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(23,259,316)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (306,426)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_eifrs-full--CostOfSales_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zKQrVhINmeX8" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (19,833,063)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--CostOfSales1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zSu1HjuMveBd" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,953)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--CostOfSales1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zKQrr5FhU5C7" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(20,146,442)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_eifrs-full--CostOfSales_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zLSAtsWVobw4" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (133,127)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--CostOfSales_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z3LxW7Vwv3J" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (14,566,840)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_ecustom--CostOfSales1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbhErzHFJ0H6" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (20,350)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--CostOfSales1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zCyoZnt3xdg6" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(14,720,317)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial income (expenses), net</span></td> <td id="xdx_98A_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (854)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (33,656)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">41,082</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_ecustom--FinanceIncomeCost1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,572</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncomeCost_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(141)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zANfyhv1sWvj" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (11,758)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQyhVaV9sUu5" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(245,819)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_ecustom--FinanceIncomeCost1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z4WEVisJgPV3" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (257,718)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_z7QUEbtlrgE9" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(452)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zVI1kKrjIh2h" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,810)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCuDAYmcv5ue" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(818)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_ecustom--FinanceIncomeCost1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z75MjrpwA3Hf" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,080)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">General and administrative expenses</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z1euqpx9WHg5" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (45,329)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zlxoe9CZwsc3" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,329)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zzLlywERRc43" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (67,273)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zGKUWHktuJrg" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (67,273)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCVZbOTKVNZ" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (46,738)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_ztkKGVDJkmql" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (46,738)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other income (expenses)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 51,248</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--OtherOperatingIncomeExpense1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Other operating income expense1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  51,248</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z2tqn9Yziuy5" style="text-align: right" title="Other expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(217,497)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_ecustom--OtherOperatingIncomeExpense1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zXD1e2WR8bYf" style="text-align: right" title="Other operating income expense1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (217,497)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(i) Borealis, Grupo Idesa, Refinaria de Petróleo Riograndense S.A e Vexty</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> </table> <p id="xdx_8AC_zT41qkQrk1O" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><b>(a)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><b>New and/or renewed agreements with related companies</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As provided for in Braskem’s bylaws, the Board of Directors has the exclusive power to approve any contract with related parties that exceed R$<span id="xdx_909_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NewOrRenewedagreementsWithRelatedCompaniesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zctCu3ax9fhh" title="Related parties amount">20,000</span> per transaction or R$<span id="xdx_902_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NewOrRenewedagreementsWithRelatedCompaniesMember_zoipql7OlzA" title="Related parties amount">60,000</span> collectively per year. This is valid for contracts between Braskem and its subsidiaries and: (i) direct or indirect subsidiaries of Braskem in whose capital an interest is held by the controlling shareholder, by any direct or indirect subsidiaries thereof or by Key Management Personnel of such entities; (ii) associates of Braskem and subsidiaries of such entities; and (iii) joint ventures in which Braskem participates and any subsidiaries thereof.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The related parties that have significant relationship with the Company are as follows:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Novonor and its direct and indirect subsidiaries:</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Tenenge Montagem e Manutenção Ltda. (“Tenenge”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In February 2022, the Company entered into an electromechanical assembly service agreement to expand the production capacity of the Ethylene-Ethanol Unit located in Trunfio, Rio Grande do Sul with Tenenge, with duration from February 9, 2022 to July 31, 2023. The estimated amount of the agreement is R$<span id="xdx_90B_ecustom--EstimatedAmount_pn6n6_c20220201__20220228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovonorAndItsDirectAndIndirectSubsidiariesMember_zsMEoCQNzm1g" title="Estimated amount">142</span> million.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Petrobras and its indirect joint ventures:</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">Petrobras</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">In June 2020, the Company entered into a sales option agreement for up to 2,850 kton/y of petrochemical naphtha to Petrobras with mandatory purchase by Braskem. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$30 billion.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In December 2020, the Company entered into a sale agreement with Petrobras for up to 2 million tons of petrochemical naphtha per year, for our industrial unit in the State of São Paulo. This term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount under the agreement is R$25 billion.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In December 2020, the Company entered into an agreement with Petrobras to purchase ethane and propane to produce up to 580,000 tons of ethylene equivalent and sell up to 58.4 million Nm³ of hydrogen. The term of the agreement is from January 1, 2021 to December 31, 2025. The estimated amount of the agreement is R$9.2 billion.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">- Petrobras Transporte S.A. (“Transpetro”)</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In January 2021, the Company entered into an agreement with Transpetro involving the provision of services to Braskem, namely tanker vessel unloading in the Madre de Deus Waterway Terminal (“TEMADRE”), tank storage, product transportation via the pipeline “ORMADRE” that connects TEMADRE to REFMAT, and the transportation of naphtha via pipeline from TEMADRE to the facilities of the carrier located in the municipality of Camaçari/BA. The duration of the agreement is from February 1, 2021 to December 31, 2025, and the total estimated amount of the agreement is R$<span id="xdx_903_ecustom--EstimatedAmount_pn6n6_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PetrobrasTransporteSAMember_z7tZ2stqSYn4" title="Estimated amount">203</span> million.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Petrocoque S.A. Indústria e Comércio (“Petrocoque”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In March 2021, the Company executed an amendment to extend the agreement with Petrocoque, for purchase of steam to be used as energy by Polyethylene plants. This amendment, summed to total amount of the original agreement, executed in September 2009, amounts to R$<span id="xdx_905_ecustom--EstimatedAmount_pn6n6_c20210301__20210331__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PetrocoqueSAIndustriaComercioMember_znudPhe96v6k" title="Estimated amount">433</span> million and is valid until March 2024.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <span style="color: windowtext">Refinaria Alberto Pasqualini </span>(“REFAP”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In June 2020, the Company entered into a naphtha supply agreement with Petrobras for 450 kton/y, from the REFAP to our unit in the State of Rio Grande do Sul. The term of the agreement is from December 23, 2020 to December 31, 2025. The estimated amount of the agreement is R$2.5 billion.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In October 2021, the Company entered into a purchase agreement with Petrobras for 108 kton/year of polymer-grade propylene from REFAP, with delivery to Braskem’s polypropylene industrial units, PP1 and PP2, in Triunfo, Rio Grande do Sul. This agreement is in force from November 1, 2021 to October 31, 2022. The maximum amount of the agreement is estimated at R$<span id="xdx_906_ecustom--EstimatedAmount_pn6n6_c20211001__20211031__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RefinariaAlbertoPasqualiniMember_zXuipn0ha3Ok" title="Estimated amount">630</span> million.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 20pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Refinaria Capuava (“RECAP”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company entered into a purchase agreement with Petrobras for 140 kton/year of polymer-grade propylene from RECAP, with delivery to Braskem’s PP4 industrial unit (“PP4”) in Mauá, São Paulo,. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$<span id="xdx_904_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn8n9_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AgreementWithPetrocoqueMember_z4o14eMpSE6d" title="Related parties estimated value">3.3</span> billion for the purchase of propylene.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Refinaria Duque de Caxias (“REDUC”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company entered into a purchase agreement with Petrobras for 100 kton per year of polymer-grade propylene from REDUC, with delivery to Braskem’s PP5 industrial unit (“PP5”) in Rio de Janeiro. The agreement is in force from January 1, 2022 to May 17, 2026. The maximum amount of the agreement is estimated at R$<span id="xdx_908_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn8n9_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RefinariaDuqueDeCaxiasMember_zPkXSM1AhI5" title="Related parties estimated value">2.4</span> billion for the purchase of propylene.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Refinaria Henrique Lage (“REVAP”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company entered into a purchase agreement with Petrobras for 120 kton per year and 40 kton per year of polymer-grade propylene from REVAP, with delivery to Braskem’s PP3 and PP4 industrial units, respectively. This agreement is in force from January 1, 2022 to May 3, 2028 for the first 120 kton/year and from May 4, 2028 to June 30, 2029 for the remaining 40 kton/year. The maximum amount of the agreement is estimated at R$<span id="xdx_904_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn8n9_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RefinariaHenriqueLageMember_zYDJyw8bmmWd" title="Related parties estimated value">4.7</span> billion.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Refinaria Planalto de Paulínia (“REPLAN”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company entered into a purchase agreement with Petrobras for 220 kton per year of polymer-grade propylene from REPLAN, with delivery to Braskem’s PP3 industrial unit (“PP3”) in Paulínia, São Paulo. The agreement is in force from January 1, 2022 to May 3, 2028. The maximum amount of the agreement is estimated at R$<span id="xdx_904_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn8n9_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RefinariaPlanaltodePauliniaMember_z6pdTQ4EH8T8" title="Related parties estimated value">8.1</span> billion for the purchase of propylene.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Refinaria Presidente Getúlio Vargas (“REPAR”)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2021, the Company entered into a purchase agreement with Petrobras for 150 kton per year of polymer-grade propylene from REPAR, with delivery to Braskem’s PP3 and PP4 industrial units. The agreement is in force from January 1, 2022 to December 6, 2029. The maximum amount of the agreement is estimated at R$<span id="xdx_90B_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn8n9_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RefinariaPresidenteGetulioVargasMember_zY8g8nVcU9L2" title="Related parties estimated value">6.8 </span>billion.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">- Companhia de Gás da Bahia (“Bahiagás”)</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In December 2021, the Company entered into an amendment to the agreement governing the supply of natural gas by Bahiagás to Braskem, via local gas pipeline, effective until December 2022. The estimated amount of the amendment is R$752 million.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">- Companhia de Gás do Estado do Rio Grande do Sul (“Sulgás”)</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In March 2022, the Company entered into the agreement with Sulgás to acquire natural gas, via a local gas distribution pipeline, its terms to June 2023. The estimated amount of the amendment is R$270 million.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">- Gás de Alagoas S.A. (“Algás”)</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In March 2022, the Company entered into an amendment with Algás for the supply of natural gas to Braskem units located in the state of Alagoas, via a local gas distribution pipeline, its terms to December 2024. The estimated value of the amendment is R$1.5 billion.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">Since July 2022, Petrobras has no more equity interest in Bahiagás, Sulgás and Algás and, upon which they ceased to be a related party to Braskem.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Non-controlling shareholders of Braskem Idesa:</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Grupo Idesa, S.A. de C.V.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Etileno XXI, S.A. de C.V.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Loan payable to the non-controlling shareholders of Braskem Idesa, with maturity in December 2029 and contractual interest rate of 7% p.a. These funds were used by Braskem Idesa to finance the construction of its operational assets.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Key management personnel compensation</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The expenses related to the remuneration of key management personnel, including the Board of Directors, the Chief Executive Officer and vice-presidents, recorded in the profit or loss for the year, are shown as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_pn3n3_zYaGr5DKVN3h" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B6_zLDXag2iCJN" style="display: none">Schedule of key management personnel</span></span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49E_20220101__20221231_zsquZonT0Eeb" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: right"> </td> <td id="xdx_493_20210101__20211231_zWELZ7vSgakc" style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49F_20200101__20201231_zpdzTk2DmNrj" style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Statement of profit or loss transactions</span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Remuneration</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_zazWUKibqyU6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Short-term benefits</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 83,466</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,734</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 74,943</span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_zROH3sKVWXxa"> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Post-employment benefit</span></td> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,636</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,121</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">961</span></td></tr> <tr id="xdx_409_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_pn3n3_zarf4YBo6ZMb"> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Long term incentive plan</span></td> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,938</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,394</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,456</span></td></tr> <tr id="xdx_402_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_zL72H8CJnAf4"> <td style="padding-left: 9px; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="padding-left: 9px; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,040</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">136,249</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  83,360</span></td></tr> </table> <p id="xdx_8A7_zHEYq8XTFin6" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Compensation of the Company’s key management personnel includes salaries, short and long-term incentives, non-cash benefits and contributions to a post-employment defined benefit plan (see Note 27).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_pn3n3_zvgDot3hkJz7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_z0yFJ8VM6dM5" style="display: none">Schedule of related party transactions</span></td> <td colspan="7" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"> </td> <td> </td> <td colspan="7" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><b> </b></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><b>Balances at December 31, 2022 </b></td> <td><b> </b></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><b>Balances at December 31, 2021 </b></td></tr> <tr style="vertical-align: bottom"> <td style="width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Novonor and</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Novonor and</span></td> <td style="text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Petrobras and</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Petrobras and</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Balance sheet</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">and associates</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other (i)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">and associates</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">subsidiaries</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other (i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade accounts receivable</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,924</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  1,867</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--CurrentTradeReceivables1_c20221231_pn3n3" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  13,791</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zMDwaF1MNiM2" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,894</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlwaQOucB6N8" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  7,346</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--CurrentTradeReceivables1_iI_pn3n3_c20211231_zj0JlC59IeP8" style="text-align: right" title="Trade accounts receivable"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">12,240</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Inventories  (advance to suppliers)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eifrs-full--Inventories_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 61,428</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--Inventories1_c20221231_pn3n3" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  61,428</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Inventories_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zh1p59s3sAia" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">9,927</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--Inventories1_iI_pn3n3_c20211231_zx2grdan3ci" style="text-align: right" title="Inventories"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  9,927</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Dividends and interest on capital</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eifrs-full--InterestReceivable_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Dividends and interest on capital"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,296</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivabels</span></td> <td id="xdx_98D_ecustom--OtherReceivabels_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">11,348</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--OtherReceivabels_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">287</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherReceivabels_c20221231_pn3n3" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  11,635</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--OtherReceivabels_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zyJHraDburFd" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">287</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--OtherReceivabels_iI_pn3n3_c20211231_zlz3KUjT4K7" style="text-align: right" title="Other receivabels"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  287</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zsmNo7THcc55" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">5,657</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--OtherReceivabelsNonCurrent_c20221231_pn3n3" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 5,657</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z1Guenf4bJ99" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 38,987</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--OtherReceivabelsNonCurrent_iI_pn3n3_c20211231_zynhvLW05fkc" style="text-align: right" title="Other receivabels non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">38,987</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total assets</span></td> <td id="xdx_984_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  11,348</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  79,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eifrs-full--Assets_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,163</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--Assets1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 96,807</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z23SypP8hSAj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  54,095</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCwHjfzrht78" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,346</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--Assets1_iI_pn3n3_c20211231_zxcNHfEse8G2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 61,441</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Liabilities</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 126,014</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  137,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eifrs-full--TradeAndOtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">14,189</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--TradeAndOtherCurrentPayables1_c20221231_pn3n3" style="text-align: right" title="Trade and other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">277,967</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_982_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_z5E9SVf92APe" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">103,259</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zApofgNZrNEj" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  134,063</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eifrs-full--TradeAndOtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbJs4NeaEVj7" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">11,113</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--TradeAndOtherCurrentPayables1_iI_pn3n3_c20211231_z16jvmT8Rpn5" style="text-align: right" title="Trade and other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 248,435</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td id="xdx_98D_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  233,133</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  314</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherCurrentPayables1_c20221231_pn3n3" style="text-align: right" title="Other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">233,451</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eifrs-full--OtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zyCYHbU2DATd" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  296,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eifrs-full--OtherCurrentPayables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zFIhC8zC8Sj4" style="text-align: right" title="Other current payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  345</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--OtherCurrentPayables1_iI_pn3n3_c20211231_zP9Mrg1TnXj2" style="text-align: right" title="Other current payables1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 297,329</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_984_ecustom--TradePayablesNonCurrent_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_zeoOmtGlafMa" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  3,069</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--TradePayablesNonCurrent_iI_pn3n3_c20221231_zilmjyKL1WM1" style="text-align: right" title="Trade payables"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,069</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan to non-controlling shareholders of Braskem Idesa</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">-</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--NoncurrentLoanToNoncontrollingShareholders_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,498,093</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--NoncurrentLoanToNoncontrollingShareholders_c20221231_pn3n3" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,498,093</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> -</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--NoncurrentLoanToNoncontrollingShareholders_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zVbnEUQR7xh7" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--NoncurrentLoanToNoncontrollingShareholders_iI_pn3n3_c20211231_zxckZSnBUpmj" style="text-align: right" title="Loan to non-controlling shareholders of Braskem Idesa"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total liabilities</span></td> <td id="xdx_98B_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  129,087</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">370,897</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eifrs-full--Liabilities_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  2,512,596</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eifrs-full--Liabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,012,580</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_zNaKAE3RcWFh" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 103,259</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zS1BbUall5j4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">431,047</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eifrs-full--Liabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z6KqQLYR2cF" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  3,657,996</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eifrs-full--Liabilities_iI_pn3n3_c20211231_zvvrxBT1Hqjc" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,192,302</span></td></tr> </table> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"> </p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2022</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2021</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Year ended December 31, 2020</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 28%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Novonor and subsidiaries and associates</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Petrobras and subsidiaries</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other (i)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Transactions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Sales of products</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--Revenue_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  182,218</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 437,514</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_ecustom--Revenue1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">619,732</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zjON9xsEHg5c" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  171,665</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zswf4BDoPwh8" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 540,855</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--Revenue1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zPEcE6FfK854" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 712,520</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z5rrO1dgCQz9" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  182,521</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zAupc9AjX7Kb" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 326,825</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--Revenue1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zf0c6wXho6Y7" style="text-align: right" title="Sales of products"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">509,346</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Purchases of raw materials, finished goods services and utilities</span></td> <td id="xdx_988_eifrs-full--CostOfSales_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(334,363)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--CostOfSales_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (22,900,140)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--CostOfSales1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (24,813)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_ecustom--CostOfSales1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(23,259,316)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (306,426)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_eifrs-full--CostOfSales_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zKQrVhINmeX8" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (19,833,063)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--CostOfSales1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zSu1HjuMveBd" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,953)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--CostOfSales1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zKQrr5FhU5C7" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(20,146,442)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_eifrs-full--CostOfSales_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zLSAtsWVobw4" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (133,127)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--CostOfSales_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z3LxW7Vwv3J" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (14,566,840)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_ecustom--CostOfSales1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbhErzHFJ0H6" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (20,350)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--CostOfSales1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zCyoZnt3xdg6" style="text-align: right" title="Purchases of raw materials, finished goods services and utilities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(14,720,317)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial income (expenses), net</span></td> <td id="xdx_98A_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (854)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (33,656)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--FinanceIncomeCost_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">41,082</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_ecustom--FinanceIncomeCost1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,572</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncomeCost_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_pn3n3" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(141)</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zANfyhv1sWvj" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (11,758)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQyhVaV9sUu5" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(245,819)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_ecustom--FinanceIncomeCost1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z4WEVisJgPV3" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (257,718)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OdebrechtAndSubsidiariesAndAssociatesMember_z7QUEbtlrgE9" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(452)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_zVI1kKrjIh2h" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,810)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCuDAYmcv5ue" style="text-align: right" title="Financial income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(818)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98E_ecustom--FinanceIncomeCost1_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z75MjrpwA3Hf" style="text-align: right" title="Finance income cost1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,080)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">General and administrative expenses</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z1euqpx9WHg5" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (45,329)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zlxoe9CZwsc3" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,329)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zzLlywERRc43" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (67,273)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zGKUWHktuJrg" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (67,273)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zCVZbOTKVNZ" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (46,738)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--GeneralAndAdministrativeExpenses_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_ztkKGVDJkmql" style="text-align: right" title="General and administrative expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (46,738)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other income (expenses)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_pn3n3" style="text-align: right" title="Other expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 51,248</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--OtherOperatingIncomeExpense1_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_pn3n3" style="text-align: right" title="Other operating income expense1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  51,248</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasAndSubsidiariesMember_z2tqn9Yziuy5" style="text-align: right" title="Other expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(217,497)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_ecustom--OtherOperatingIncomeExpense1_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zXD1e2WR8bYf" style="text-align: right" title="Other operating income expense1"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (217,497)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(i) Borealis, Grupo Idesa, Refinaria de Petróleo Riograndense S.A e Vexty</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> </table> 11924000 1867000 13791000 4894000 7346000 12240000 61428000 61428000 9927000 9927000 4296000 11348000 287000 11635000 287000 287000 5657000 5657000 38987000 38987000 11348000 79296000 6163000 96807000 54095000 7346000 61441000 126014000 137764000 14189000 277967000 103259000 134063000 11113000 248435000 4000 233133000 314000 233451000 296984000 345000 297329000 3069000 3069000 2498093000 2498093000 3646538000 3646538000 129087000 370897000 2512596000 3012580000 103259000 431047000 3657996000 4192302000 182218000 437514000 619732000 171665000 540855000 712520000 182521000 326825000 509346000 -334363000 -22900140000 -24813000 -23259316000 -306426000 -19833063000 -6953000 -20146442000 -133127000 -14566840000 -20350000 -14720317000 -854000 -33656000 41082000 6572000 -141000 -11758000 -245819000 -257718000 -452000 -3810000 -818000 -5080000 -45329000 -45329000 -67273000 -67273000 -46738000 -46738000 51248000 51248000 -217497000 -217497000 20000000 60000000 142000000 203000000 433000000 630000000 3300000000 2400000000 4700000000 8100000000 6800000000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_pn3n3_zYaGr5DKVN3h" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B6_zLDXag2iCJN" style="display: none">Schedule of key management personnel</span></span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49E_20220101__20221231_zsquZonT0Eeb" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: right"> </td> <td id="xdx_493_20210101__20211231_zWELZ7vSgakc" style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49F_20200101__20201231_zpdzTk2DmNrj" style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Statement of profit or loss transactions</span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Remuneration</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_zazWUKibqyU6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Short-term benefits</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 83,466</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,734</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 74,943</span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_zROH3sKVWXxa"> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Post-employment benefit</span></td> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,636</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,121</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">961</span></td></tr> <tr id="xdx_409_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_pn3n3_zarf4YBo6ZMb"> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Long term incentive plan</span></td> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,938</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,394</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,456</span></td></tr> <tr id="xdx_402_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_zL72H8CJnAf4"> <td style="padding-left: 9px; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="padding-left: 9px; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,040</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">136,249</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  83,360</span></td></tr> </table> 83466000 119734000 74943000 1636000 2121000 961000 16938000 14394000 7456000 102040000 136249000 83360000 <p id="xdx_803_ecustom--DisclosureOfTaxRecoverableExplanatory_z2lnydyZIdwc" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">10 <span id="xdx_822_zU8F6ev6T71d">Taxes recoverable</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_882_ecustom--DisclosureOfTaxesRecoverableExplanatory_pn3n3_z0QQOIbcAER7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Taxes recoverable (Details)"> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span id="xdx_8B6_zbUhgxe2t8Zj" style="display: none">Schedule of taxes recoverable</span></td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Parent Company and subsidiaries in Brazil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax on sales and services (ICMS) </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">410,138</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zSLfOPWw3ju9" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">291,424</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS - credits from PP&amp;E</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ICMSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">302,940</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ICMSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zLmTvizuWHqk" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">224,308</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Social integration program (PIS) and social contribution on revenue (Cofins)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td id="xdx_98C_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--SocialIntegrationProgramPISAndSocialContributionOnRevenueMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">560,002</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--SocialIntegrationProgramPISAndSocialContributionOnRevenueMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zA6oB8w1dFE1" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">250,491</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins - credits from PP&amp;E</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">546,427</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zoCs1AWr1FRd" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">447,476</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">REINTEGRA program</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--REINTEGRAProgramMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  20,504</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--REINTEGRAProgramMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zhggNym0GIhd" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,764</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Federal tax credits</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td id="xdx_98F_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--FederalSupervenienceMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">153,960</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--FederalSupervenienceMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zUKM5s5FPy82" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">948,448</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  68,514</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_z474Xc2r9hY2" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  89,205</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign subsidiaries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax ("IVA")</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxIVAMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">579,672</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxIVAMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_zvKCSFZeXaz5" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">348,021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">131,867</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_zapTHffCIPY8" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  59,579</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span> <span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,774,024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zjlebauC3Xs6" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,680,716</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,156,355</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zUSXaFmxuG6a" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,428,658</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,617,669</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zd8wzFWbh0Yf" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,252,058</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20221231_zpTnzONhiXNk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,774,024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_z3lzhO67sDud" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,680,716</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) PIS and COFINS </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Complementary Law 194/2022 was published, which reduced to zero the rates of the contributions levied on sales of fuels, which increased the respective credits.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Federal tax credits</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Up to December 31, 2021, the balance was primarily composed of federal tax credits related to exclusion of ICMS from the PIS and Cofins tax calculation base. As of December 31, 2022, of the total tax credit recorded by the Company related to this tax, since 2019, R$<span id="xdx_90F_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20191231__ifrs-full--ClassesOfAssetsAxis__custom--PISAndCOFINSTaxesMember_z7FHhQ4HT6rh" title="Taxes recoverable">5,093,151</span> has been offset, with the decision on the credit becoming final and unappealable.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; letter-spacing: 0pt"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_882_ecustom--DisclosureOfTaxesRecoverableExplanatory_pn3n3_z0QQOIbcAER7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Taxes recoverable (Details)"> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span id="xdx_8B6_zbUhgxe2t8Zj" style="display: none">Schedule of taxes recoverable</span></td> <td> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Parent Company and subsidiaries in Brazil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax on sales and services (ICMS) </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">410,138</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zSLfOPWw3ju9" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">291,424</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS - credits from PP&amp;E</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ICMSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">302,940</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ICMSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zLmTvizuWHqk" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">224,308</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Social integration program (PIS) and social contribution on revenue (Cofins)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td id="xdx_98C_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--SocialIntegrationProgramPISAndSocialContributionOnRevenueMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">560,002</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--SocialIntegrationProgramPISAndSocialContributionOnRevenueMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zA6oB8w1dFE1" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">250,491</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins - credits from PP&amp;E</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">546,427</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zoCs1AWr1FRd" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">447,476</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">REINTEGRA program</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--REINTEGRAProgramMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  20,504</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--REINTEGRAProgramMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zhggNym0GIhd" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,764</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Federal tax credits</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td id="xdx_98F_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--FederalSupervenienceMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">153,960</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--FederalSupervenienceMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_zUKM5s5FPy82" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">948,448</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  68,514</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__custom--ParentCompanysMember_z474Xc2r9hY2" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  89,205</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign subsidiaries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax ("IVA")</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxIVAMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">579,672</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--ValueAddedTaxIVAMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_zvKCSFZeXaz5" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">348,021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">131,867</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherTaxesRecoverableMember__ifrs-full--GeographicalAreasAxis__srt--SubsidiariesMember_zapTHffCIPY8" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  59,579</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span> <span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,774,024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zjlebauC3Xs6" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,680,716</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,156,355</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zUSXaFmxuG6a" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,428,658</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,617,669</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zd8wzFWbh0Yf" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,252,058</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20221231_zpTnzONhiXNk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,774,024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_z3lzhO67sDud" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,680,716</span></td></tr> </table> 410138000 291424000 302940000 224308000 560002000 250491000 546427000 447476000 20504000 21764000 153960000 948448000 68514000 89205000 579672000 348021000 131867000 59579000 2774024000 2680716000 1156355000 1428658000 1617669000 1252058000 2774024000 2680716000 5093151000 <p id="xdx_80C_eifrs-full--DisclosureOfInterestsInAssociatesExplanatory_zZq7B4Dj39ih" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">11 <span id="xdx_825_zyCU1l9W19uk">Investments</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">See the accounting policy in Note 2.3 Basis of Consolidation.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Information on investments</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfInvestmentsExplanatory_pn3n3_z7NHuBgXcSzk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_8B2_zV0lrBL9NDji" style="display: none">Schedule of Information on investments</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; font-weight: bold; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; font-weight: bold; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net profit (loss) for the year</span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity</span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 32%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Jointly-controlled investment</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">RPR</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_z9nJYBo8TRZe" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 76,450</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zKCBGaddf1d" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">312</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLoss_pn3n3_c20200101__20201231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zOfvzNKJIcee" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,525)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zb7hzsPqVvU9" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  110,040</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zEPPPcyR29Ma" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 50,064</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols LLC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment2Member_fKGlpKQ_____zsw1IQcSyCed" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,977)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment2Member_fKGlpKQ_____zZbZcWRDuAS7" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 80,757</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Associate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borealis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zJfz2fER3E33" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 53,617</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zQadyWolfIrc" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 45,490</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLoss_pn3n3_c20200101__20201231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___z6cwi4n9JLg3" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,019</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zCDhoJMHYzmi" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  252,053</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zJSVdGOn9mC1" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  205,568</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F05_zb9NkmQKzBId" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(i)</span></td><td><span id="xdx_F16_zhL3KGettL84" style="font-family: Calibri, Helvetica, Sans-Serif">RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. <span style="color: black">The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_zFREZmSWMZSe" title="Interest in total and voting capital (%)">33.20</span>% (2021: <span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_z65EMHon9yYj" title="Interest in total and voting capital (%)">33.20</span>%).</span></span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F06_zvS3hAo7GEIa" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(ii)</span></td><td><span id="xdx_F11_zuabp6X4KfQ7" style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F08_zlG20Gh8u7Y4" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(iii)</span></td><td><span id="xdx_F1D_znp3MrD4HL55" style="font-family: Calibri, Helvetica, Sans-Serif">Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. <span style="color: black">The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_zXcRmYkkpXd5" title="Interest in total and voting capital (%)">20</span>% (2021: <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_zAdtcknEZbx7" title="Interest in total and voting capital (%)">20</span>%).</span></span></td></tr></table> <p id="xdx_8AF_zfotkzN86Tld" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Changes in investments</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b/></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfChangesInInvestmentsExplanatory_pn3n3_z2A6FyKIKFLk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details 1)"> <tr style="vertical-align: bottom"> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BD_zc7bxYf52e02" style="display: none">Schedule of Changes in investments</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B5_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate1Member_zISccsUXr0yk" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B1_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate2Member_z8BLrNqvp5tg" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4BC_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate3Member_zni7R2IA38Ud" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B6_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate4Member_zMbCQDHwEcrd" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B4_zvSK9alzkKEe" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borealis</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">RPR</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols LLC</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iS_zUlsGDFkGKT2" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,272</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,697</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2794">-</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  184</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">43,153</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_iN_di_zEdMK367MW6h" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dividends and interest on equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (295)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (295)</span></td></tr> <tr id="xdx_401_eifrs-full--ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,136</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">103</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,239</span></td></tr> <tr id="xdx_403_eifrs-full--ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other comprehensive income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,825</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,825</span></td></tr> <tr id="xdx_404_ecustom--Other1_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,001</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,001</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_433_c20220101__20221231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iS_z3qudxIcvZfa" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">41,113</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,625</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl2824">–</span></span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,185</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,923</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_eifrs-full--DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_iN_di_z1zT23t1ekAb" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dividends and interest on equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,013)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,296)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (9,309)</span></td></tr> <tr id="xdx_408_eifrs-full--ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_zbXsFYXs0cQj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 25,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,832)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td></tr> <tr id="xdx_40E_eifrs-full--ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_zj6NSI7OpAyj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other comprehensive income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,174)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,299</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (788)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (663)</span></td></tr> <tr id="xdx_40A_ecustom--CapitalIncreases_zuRG3wCkF0Ic" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Capital increase</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  41,908</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 23,061</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 64,969</span></td></tr> <tr id="xdx_40B_ecustom--Other1_zx8mj3nKSzj1" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">255</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">255</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_436_c20220101__20221231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iE_zaJzwsJXiBc1" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">47,396</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">36,539</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,375</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,713</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">149,023</span></td></tr> </table> <p id="xdx_8A4_zPPjkt6Pt7C2" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Impact on the consolidation of Braskem Idesa</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company presents the financial information of the subsidiary Braskem Idesa, which holds a non-controlling interest with material effects on the Company’s consolidated statements:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfImpactOnConsolidationOfBraskemIdesaExplanatory_pn3n3_z3yeZH7fMeU9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"> <span id="xdx_8BA_zrrrCJcMSdv6" style="display: none">Schedule of financial information of the subsidiary in which the non-controlling shareholder holds interests</span></td> <td> </td> <td id="xdx_498_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zj88Y5qRWF55" style="color: red; font-weight: bold; text-align: center"> </td> <td> </td> <td id="xdx_490_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zFHdFJ6sSXjc" style="text-align: center"> </td> <td> </td> <td id="xdx_490_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zob3kbv65rvh" style="text-align: center"> </td> <td> </td> <td id="xdx_49D_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zBSqJWE7s28f" style="color: red; font-weight: bold; text-align: center"> </td> <td style="text-align: right"> </td> <td id="xdx_49A_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zB0gKwkpsAii" style="text-align: center"> </td> <td> </td> <td id="xdx_49D_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_z7oaOPXU1Dt4" style="color: red; font-weight: bold; text-align: center"> </td> <td> </td> <td id="xdx_49E_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zDApfyLeu019" style="text-align: center"> </td> <td> </td> <td id="xdx_49C_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zf9qebRxDXLh" style="color: red; font-weight: bold; text-align: center"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Statement of Financial Position </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated Braskem without the effect off Braskem Idesa consolidated </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated Braskem Idesa <span id="xdx_F59_zm9rAKMjAIC4">(i)</span></span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Eliminations </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; width: 33%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td></tr> <tr id="xdx_40A_eifrs-full--AssetsAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssetsAbstract_i01B" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Curent</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CashAndCashEquivalents_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash equivalents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,282,142</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,184,332</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,773,331</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2888">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,466,474</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 8,680,686</span></td></tr> <tr id="xdx_409_eifrs-full--CurrentInvestments_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Financial investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,492,710</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2895">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2898">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,492,710</span></td></tr> <tr id="xdx_406_eifrs-full--CurrentTradeReceivables_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade accounts receivable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,621,335</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,607,762</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  73,195</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,225,479</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(462,596)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(679,676)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,153,565</span></td></tr> <tr id="xdx_408_eifrs-full--Inventories_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 12,921,617</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 15,325,001</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,108,447</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,010,100</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2915">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2916">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  14,030,064</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  16,335,101</span></td></tr> <tr id="xdx_400_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes recoverable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">905,844</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,402,100</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">250,511</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">26,558</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2924">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2925">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,156,355</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,428,658</span></td></tr> <tr id="xdx_406_ecustom--RecoverableIncomeTaxes_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Recoverable income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">392,062</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,189,812</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2934">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 392,062</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,189,812</span></td></tr> <tr id="xdx_404_eifrs-full--CurrentDerivativeFinancialAssets_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">157,906</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  33,816</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2940">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2941">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 157,906</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">33,816</span></td></tr> <tr id="xdx_409_eifrs-full--OtherCurrentReceivables_i02I_pn3n3_z2vRzjVKxwSa" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">628,447</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">841,473</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  68,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 137,624</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 30,373</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2952">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 727,364</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 979,097</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total current assets<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 31,204,850</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 35,800,029</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,685,029</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,173,092</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (432,223)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (679,676)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  34,457,656</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  39,293,445</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--NoncurrentAssetsAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes recoverable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,328,695</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">983,655</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">288,974</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 268,403</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2979">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,617,669</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,252,058</span></td></tr> <tr id="xdx_400_ecustom--RecoverableIncomeTaxesNonCurrent_i01I_pn3n3_zBATYcmZFHYe" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Recoverable income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">252,995</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">230,069</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2985">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2986">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2987">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 252,995</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 230,069</span></td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Deferred tax assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,671,492</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,481,642</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">488,116</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,775,610</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(801,007)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,358,601</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 8,257,252</span></td></tr> <tr id="xdx_408_eifrs-full--NoncurrentReceivablesDueFromRelatedParties_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Related parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,250,756</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,064,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3003">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td> <td style="text-align: right"><span id="xdx_F4C_zPQTxLWLxc86" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(7,250,756)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (10,064,320)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3007">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td></tr> <tr id="xdx_400_ecustom--DerivativesNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  71,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">51</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3012">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3014">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3015">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">71,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 51</span></td></tr> <tr id="xdx_40E_ecustom--JudicialDepositsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Judicial deposits </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">215,274</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">194,212</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3021">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 215,274</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 194,212</span></td></tr> <tr id="xdx_40D_eifrs-full--OtherNoncurrentReceivables_i01I_pn3n3_zYmn3Pozg5p3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">187,107</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">370,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 563</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">24,964</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3032">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3033">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 187,670</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 395,892</span></td></tr> <tr id="xdx_40A_eifrs-full--InvestmentProperty_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">149,023</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  58,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3039">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3040">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3041">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 149,023</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">58,923</span></td></tr> <tr id="xdx_403_eifrs-full--PropertyPlantAndEquipment_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 24,319,015</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 23,510,588</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 14,126,939</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  14,483,720</span></td> <td style="text-align: right"><span id="xdx_F4C_zOXotO8IhiG3" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(iii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(682,659)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(769,178)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  37,763,295</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  37,225,130</span></td></tr> <tr id="xdx_401_eifrs-full--IntangibleAssetsOtherThanGoodwill_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Intangible</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,730,124</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,572,675</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">292,020</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 304,624</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3059">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3060">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,022,144</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,877,299</span></td></tr> <tr id="xdx_408_eifrs-full--RightofuseAssets_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Right of use of assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,638,507</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,427,633</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">910,900</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 352,404</span></td> <td style="text-align: right"><span id="xdx_F4C_z3vsaYb3qYo6" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(596,420)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,952,987</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,780,037</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total non current assets<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 46,814,532</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 46,894,696</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 16,107,512</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">17,209,725</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,330,842)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (10,833,498)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  53,591,202</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  53,270,923</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--Assets_iI_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 78,019,382</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 82,694,725</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 19,792,541</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">21,382,817</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,763,065)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (11,513,174)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  88,048,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  92,564,368</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--EquityAndLiabilitiesAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Liabilities and shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CurrentLiabilitiesAbstract_i01B" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TradeAndOtherCurrentPayables_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,418,031</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,861,563</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,291,347</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 871,379</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(462,596)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(679,676)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,246,782</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,053,266</span></td></tr> <tr id="xdx_407_eifrs-full--ShorttermBorrowings_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,254,550</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,343,494</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3120">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3121">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3123">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,254,550</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,343,494</span></td></tr> <tr id="xdx_40A_ecustom--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued1_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  59,088</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3130">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3131">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3132">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">59,088</span></td></tr> <tr id="xdx_400_ecustom--CurrentBraskemIdesaBorrowings_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Braskem Idesa Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3136">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3137">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">868,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">86,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3141">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 868,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">86,765</span></td></tr> <tr id="xdx_40B_ecustom--CurrentProvisionsForEmployeeBenefits1_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Payroll and related charges</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">789,441</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,095,040</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  38,385</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">75,306</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3149">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3150">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 827,826</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,170,346</span></td></tr> <tr id="xdx_408_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes payable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">481,729</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,003,813</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 9,322</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  8,303</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3158">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3159">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 491,051</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,012,116</span></td></tr> <tr id="xdx_40B_ecustom--IncomeTaxesPayable_i02I_pn3n3_zx4x18H5Hjxl" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Income taxes payable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">381,117</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,672,844</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3165">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3166">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3167">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3168">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 381,117</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,672,844</span></td></tr> <tr id="xdx_406_eifrs-full--CurrentLeaseLiabilities_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Lease</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">955,225</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">598,523</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">195,518</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">76,843</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(111,037)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3177">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,039,706</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 675,366</span></td></tr> <tr id="xdx_40E_eifrs-full--LongtermRestructuringProvision_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision - geological event in Alagoas</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,247,609</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,378,071</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3183">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,247,609</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,378,071</span></td></tr> <tr id="xdx_40E_eifrs-full--OtherPayables_i02I_pn3n3_zrYOewq8twAh" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,645,828</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,495,544</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  24,283</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 246,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 30,059</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3195">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,700,170</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,742,167</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Total current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 22,301,331</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 24,507,980</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,427,490</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  1,365,219</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (543,574)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (679,676)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  24,185,247</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  25,193,523</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentLiabilitiesAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_ecustom--LoanAgreements_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan agreements</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 31,310,710</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 33,553,766</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3221">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3222">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  31,310,710</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  33,553,766</span></td></tr> <tr id="xdx_40A_ecustom--BraskemIdesaBorrowingsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Braskem Idesa Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3226">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,501,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,224,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3230">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3231">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  10,501,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,224,770</span></td></tr> <tr id="xdx_402_ecustom--DebenturesNoncurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">137,830</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3237">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3240">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 137,830</span></td></tr> <tr id="xdx_404_eifrs-full--NoncurrentPayablesToRelatedParties_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to related parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3244">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3245">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,175,837</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  10,134,287</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(7,175,837)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (10,134,287)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3250">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></span></td></tr> <tr id="xdx_40C_ecustom--NoncurrentLoanToNoncontrollingShareholders_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan to non-controlling shareholders of Braskem Idesa</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3253">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3254">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,498,093</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3257">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3258">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,498,093</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td></tr> <tr id="xdx_405_eifrs-full--NetDeferredTaxLiabilities_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Deferred tax liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">904,521</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,407,434</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,049,967</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3265">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(801,007)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3267">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,153,481</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,407,434</span></td></tr> <tr id="xdx_406_eifrs-full--LongtermMiscellaneousOtherProvisions_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision for losses on subsidiaries</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,094,535</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">5,284,666</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3273">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3274">-</span></span></td> <td style="text-align: right"><span id="xdx_F48_z00w8ng0neAc" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(iv)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(4,094,535)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(5,284,666)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3277">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3278">-</span></span></td></tr> <tr id="xdx_40D_eifrs-full--NoncurrentLeaseLiabilities_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Lease</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,942,284</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,147,745</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">746,285</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 333,303</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(487,745)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3285">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,200,824</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,481,048</span></td></tr> <tr id="xdx_405_ecustom--ProvisionGeologicalEventInAlagoasNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision - geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,378,949</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,283,188</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3291">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3292">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3293">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3294">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,378,949</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,283,188</span></td></tr> <tr id="xdx_400_eifrs-full--OtherNoncurrentPayables_i01I_pn3n3_zgPJNs9Kti54" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,590,317</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,406,733</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  97,663</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">25,710</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3302">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3303">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,687,980</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,432,443</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--NoncurrentLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Total non current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 48,244,990</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 50,221,362</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 22,069,528</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">26,364,608</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (12,559,124)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (15,418,953)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  57,755,394</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  61,167,017</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--EquityAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--EquityAttributableToOwnersOfParent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Attributable to the  Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,321,798</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,865,819</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (4,704,477)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(6,347,010)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,704,478</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  6,347,010</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,321,799</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,865,819</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--NoncontrollingInterests_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 16pt; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-controlling interest in subsidiaries</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">151,263</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  99,564</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3336">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3337">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(1,364,845)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(1,761,555)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (1,213,582)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (1,661,991)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--Equity_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total shareholders equity<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,473,061</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,965,383</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (4,704,477)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(6,347,010)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,339,633</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,585,455</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,108,217</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  6,203,828</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--EquityAndLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total liabilities and shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 78,019,382</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 82,694,725</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 19,792,541</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">21,382,817</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,763,065)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (11,513,174)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  88,048,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  92,564,368</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F09_zJ3t2kWc49Tg" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zVtw6Ere6qxj" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Consolidation of Braskem Idesa with its subsidiaries Braskem Idesa Servicios and Terminal Química.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F08_zDahjsSbzdV4" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_zz8FHWmouaZ4" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan from Braskem Holanda to the Braskem Idesa project.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0F_zePtKjVOEPjl" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zhXTbkPkGLOa" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F06_zy4a3uX6sHs1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iv)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1E_z1coALuYjD6h" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0D_zDHoFJW37z64" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(v)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F10_zrCCLodmxRt" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"> </td> <td> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zYeJuZkxfZz1" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zxBlln0ooMp" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49E_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zDBqopkrVJs7" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_498_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zOo8QLd8U77" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_497_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z4XaQUHtTpuh" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49B_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z3uKE9bmxFNg" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zL9ygweNP2Yh" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_498_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zaPBlhzfAGa3" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_493_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zPAZv0uZR1Gj" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zlnSpZoPcIl6" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_492_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zsULntYJwHDe" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_495_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zkfY0ZX107ce" style="color: white; text-align: center"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Statement of profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="text-align: right; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Consolidated Braskem without the effect of</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr> <td style="padding-left: 8pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Braskem Idesa consolidated </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated Braskem Idesa </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Eliminations </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; width: 22%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net revenue</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  93,038,949</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  101,448,155</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">55,779,528</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">5,953,229</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,333,199</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,046,581</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,472,894)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,156,153)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,282,615)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  96,519,284</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  105,625,201</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  58,543,494</span></td></tr> <tr id="xdx_402_eifrs-full--CostOfSales_iN_di_zDs9jNldFUlb" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of products sold</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(82,624,987)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (72,471,291)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,563,723)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,074,693)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,321,601)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,112,129)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,539,132</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,224,661</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,344,438</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(85,160,548)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (73,568,231)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(47,331,414)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--GrossProfit_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Gross profit</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  10,413,962</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 28,976,864</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">10,215,805</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">878,536</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,011,598</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">934,452</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">66,238</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">68,508</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">61,823</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,358,736</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 32,056,970</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,212,080</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--MaterialIncomeAndExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income (expenses) </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_401_ecustom--DistributionCosts1_zfkzU7pDosn6" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Selling and distribution</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,890,181)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,834,303)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,609,844)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(218,236)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(221,337)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(242,211)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3424">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3425">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3426">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,108,417)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,055,640)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,852,055)</span></td></tr> <tr id="xdx_407_eifrs-full--ImpairmentLossRecognisedInProfitOrLossTradeReceivables_iN_di_znn93nfBbD8e" style="vertical-align: bottom"> <td style="padding-left: 8pt; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) reversals for impairment of trade accounts receivable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (38,248)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,736)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (55,074)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3437">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3438">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3439">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (38,426)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,914)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (55,252)</span></td></tr> <tr id="xdx_403_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zUKKqAf5NkXh" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">General and administrative </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,545,044)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,292,884)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,739,541)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(216,098)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(229,334)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(179,350)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,841)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">91</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 144</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,763,983)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,522,127)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,918,747)</span></td></tr> <tr id="xdx_401_eifrs-full--ResearchAndDevelopmentExpense_iN_di_zQpmhmtsE4te" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Research and development</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (374,493)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (296,583)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(250,648)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3460">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3461">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3462">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3463">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3464">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3465">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (374,493)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (296,583)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (250,648)</span></td></tr> <tr id="xdx_405_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_iN_di_z1196qh4sfjh" style="vertical-align: bottom"> <td colspan="2" style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Results from equity-accounted investees</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,078,115)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(82,709)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,026,922)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3474">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3475">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,112,956</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  87,353</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,007,524</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">34,848</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (19,398)</span></td></tr> <tr id="xdx_404_eifrs-full--OtherIncome_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 505,629</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,530,443</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  748,923</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,704</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,044</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,826</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3489">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3490">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3491">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 507,333</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,534,487</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">750,749</span></td></tr> <tr id="xdx_40C_eifrs-full--OtherExpenseByNature_iN_di_zZwzGgiCuzid" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other expenses</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,305,411)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,651,425)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,573,874)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (38,114)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (17,865)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(364,747)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3502">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3503">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3504">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,343,525)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,669,290)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (7,938,621)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLossFromOperatingActivities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Operating profit</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,688,099</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 23,340,667</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,291,175)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">407,621</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,546,928</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">149,792</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,176,353</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 155,952</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,069,491</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,272,073</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 26,043,547</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (71,892)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_ecustom--FinancialIncomeCostAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial results</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--FinanceCosts_iN_di_zyBCp43v2eDa" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial expenses </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,013,176)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,750,895)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,851,233)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,817,551)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,618,020)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,505,628)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,168,034</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">461,760</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">443,496</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,662,693)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,907,155)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,913,365)</span></td></tr> <tr id="xdx_402_eifrs-full--FinanceIncome_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,558,268</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,276,312</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,032,530</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  610,792</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 12,886</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 11,150</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,158,926)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (461,760)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (443,496)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,010,134</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,827,438</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">600,184</span></td></tr> <tr id="xdx_40F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_zYa6FnRZQ4ng" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Exchange rate variations, net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (643,377)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,884,292)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,823,269)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  235,314</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,164,697)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(482,125)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (164,107)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  46,182</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (572,170)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,002,807)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,298,711)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--FinanceIncomeCost_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Finance income (cost)</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,098,285)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,358,875)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,641,972)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (971,445)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,769,831)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,976,603)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (154,999)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">46,182</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,224,729)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,082,524)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,611,892)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_ecustom--LossProfitBeforeIncomeTaxAbstract_iB_zSabIrf0BVEf" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) profit before income tax</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_ecustom--ProfitLossBeforeTaxAndSocialContribution_zJyXjt2l28qj" style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">and social contribution</span></span></p> </td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(410,186)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 17,981,792</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,933,147)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (563,824)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (222,903)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,826,811)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 202,134</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 47,344</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 17,961,023</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,683,784)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--IncomeTaxExpenseContinuingOperations_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">95,651</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,991,055)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,253,684</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(963,386)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,348)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  414,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3619">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3620">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3621">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (867,735)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,999,403)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--ProfitLossFromContinuingOperations_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) net profit for the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(314,535)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,990,737</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,679,463)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,527,210)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (231,251)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,412,017)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 202,134</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(820,391)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,961,620</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (7,015,306)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_ziZRntyGAuac" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zv6LoDCmPnxk" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49D_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zC9uga89gZ64" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_493_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zg0Kjeh3rsS7" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49C_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z2ydHdCOjaD2" style="color: white; text-align: center"> </td> <td id="xdx_499_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z64SDdDjbMX5" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_49A_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zZPpkgw5UpJ7" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_497_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_ztaGKS2TiIXf" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_492_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zpzZbIvi989b" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_491_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zwmciQUqyhw3" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49B_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zmtDBoKzfOah" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_497_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_z3Du6BUYAdel" style="color: white; text-align: center"> </td></tr> <tr> <td style="font-size: 12pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Statement of cash flows </b></span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td colspan="5" style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Consolidated Braskem without the effect of</b></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b> Braskem Idesa consolidated </b></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="4" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated Braskem Idesa </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; white-space: nowrap; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Eliminations </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; white-space: nowrap; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 26%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_ecustom--LossProfitBeforeTaxes_zsJWiwyzFHNk"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) profit before taxes</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (410,186)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">18,348,774</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,933,147)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(563,824)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (222,903)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,826,811)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (164,848)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">47,344</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">17,961,023</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (9,683,784)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdjustmentsForReconcileProfitLossAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Adjustments for reconciliation of profit (loss)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr id="xdx_405_eifrs-full--AdjustmentsForDepreciationAndAmortisationExpense_i01_zQ3U9SvSXwo7" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Depreciation and amortization</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,944,259</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,432,816</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,995,609</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 901,194</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">796,861</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,114,439</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,288)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (51,244)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(61,967)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,733,165</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,178,433</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,048,081</span></td></tr> <tr id="xdx_405_ecustom--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods_i01N_di_zIQXa75xWzud" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Results from equity-accounted investees</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,078,108</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (78,567)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,026,922</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3681">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3682">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3683">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,112,956)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  73,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,007,524)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (34,848)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,644)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  19,398</span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i01_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Interest and  monetary and exchange variations, net</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,788,259</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,604,357</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,541,980</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 759,378</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,564,905</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,921,975</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">154,999</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">142,169</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (6,683)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,702,636</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,311,431</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 10,457,272</span></td></tr> <tr id="xdx_405_ecustom--ReversalOfProvisions_i01_zds30tQk0PAa" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Reversal of provisions</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,153</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  819,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  336,838</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3707">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3708">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3709">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3710">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3711">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3712">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,153</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  819,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">336,838</span></td></tr> <tr id="xdx_402_eifrs-full--OtherReversalsOfProvisions_i01_zQA0jewcKfi6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Provision - geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,520,019</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,901,828</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3720">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3721">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3722">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3723">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3724">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3725">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,520,019</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,901,828</span></td></tr> <tr id="xdx_409_eifrs-full--AdjustmentsForIncomeTaxExpense_i01_zwcY5NHlEDD" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">PIS and Cofins credits - exclusion of ICMS from the calculation basis</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3730">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,031,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(310,557)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3733">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3734">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3735">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3736">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3737">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3738">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3739">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,031,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (310,557)</span></td></tr> <tr id="xdx_402_ecustom--LossForImpairmentOfTradeAccountsReceivable_i01_zAgbraSM3wBd" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Loss for impairment of trade accounts receivable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">38,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 10,134</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 55,252</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3746">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,220)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3748">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3750">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3751">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">38,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">8,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  55,252</span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForIncreaseInOtherProvisionsArisingFromPassageOfTime_i01_z2Te6WczoUl9" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Provision for losses and write-offs of long-lived assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 130,366</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  114,148</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">8,794</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  629</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,039</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3761">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3762">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3763">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3764">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 130,995</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  115,187</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,794</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital_i01_zKPgRZ5b0wpf" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: White">Adjustments for reconciliation of profit<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,459,404</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">26,559,458</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">10,623,519</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,097,377</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,138,682</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,209,603</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3776">–</span></span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3777">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 9,507,890</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">29,698,140</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 11,833,122</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_ecustom--ChangesInOperatingWorkingCapitalAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Changes in operating working capital </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40E_ecustom--IncreaseDecreaseInOtherFinancialAssets_i01_zXQHh5iWafsh" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Judicial deposits - unfreezing (blocking) Public Civil Action</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3795">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3796">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,746,107</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3798">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3799">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3800">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3801">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3802">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3803">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3804">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3805">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,746,107</span></td></tr> <tr id="xdx_405_ecustom--AdjustmentsForDecreaseIncreaseInFinancialInvestments_i01_zIPcodNXKcua" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial investments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,530,050</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  296,957</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,860,827)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3811">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3812">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3813">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3814">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3815">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3816">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,530,050</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  296,957</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,860,827)</span></td></tr> <tr id="xdx_40F_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_i01_zwvRdwuWcez8" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Trade accounts receivable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,751,788</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,739,822)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,247,729)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,126,559</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (619,688)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (152,971)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (217,080)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">184,225</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">212,874</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,661,267</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,175,285)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,187,826)</span></td></tr> <tr id="xdx_404_eifrs-full--AdjustmentsForDecreaseIncreaseInInventories_i01_zb8hWW4wPmi9" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,246,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,176,104)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(309,492)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(108,609)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (398,181)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  56,958</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3840">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3841">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3842">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,138,161</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,574,285)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (252,534)</span></td></tr> <tr id="xdx_405_ecustom--AdjustmentsForDecreaseIncreaseInTaxesRecoverable_i01_zrQxRgTB7cda" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Taxes recoverable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 928,181</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,958,779</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,584,911</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(245,724)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,808</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(52,357)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3853">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3854">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3855">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 682,457</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,963,587</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,532,554</span></td></tr> <tr id="xdx_400_ecustom--PrepaidExpenses_i01_zrzu8IoSpf94" style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Prepaid expenses</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3860">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3861">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (172,027)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3863">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3864">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 465,812</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3866">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3867">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3868">–</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3869">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3870">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 293,785</span></td></tr> <tr id="xdx_40D_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_i01_zpE0GPouqVGe" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other receivables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 297,209</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(269,721)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 44,513</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,580</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  71,165</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">352,590</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3879">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3880">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3881">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 310,789</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(198,556)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">397,103</span></td></tr> <tr id="xdx_407_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_i01_zEPXu951hyI3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Trade payables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (73,230)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  955,475</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,926,585)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,229</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">428,364</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">137,895</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">217,080</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (184,225)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (212,874)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 514,079</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,199,614</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,001,564)</span></td></tr> <tr id="xdx_40A_ecustom--AdjustmentsForIncreaseDecreaseInTaxesPayable_i01_z6hNm8r5VRec" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Taxes payable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,085,427)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,878,056)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  965,191</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">76,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (129,432)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (515,430)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3905">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3906">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3907">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,009,356)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,007,488)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">449,761</span></td></tr> <tr id="xdx_404_ecustom--AdvancesFromCustomers_i01_zGGK0styPIO5" style="vertical-align: bottom"> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Advances from customers</span></td> <td style="text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3912">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3913">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 224,764</span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3915">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3916">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(25,776)</span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3918">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3919">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3920">–</span></span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3921">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3922">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">198,988</span></td></tr> <tr id="xdx_404_ecustom--AdjustmentsForIncreaseDecreaseInLeniencyAgreements_i01_zKddwmC8eZJ2" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Leniency agreement</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (317,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(389,087)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(349,842)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl3928">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3929">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3930">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3931">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3932">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3933">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (317,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(389,087)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (349,842)</span></td></tr> <tr id="xdx_406_eifrs-full--AdjustmentsForProvisions_i01_zI7UUnrHXh28" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Sundry provisions</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (219,313)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(482,565)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(158,915)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(187,274)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">168,371</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  13,560</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3944">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3945">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3946">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (406,587)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(314,194)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (145,355)</span></td></tr> <tr id="xdx_401_ecustom--GeologicalEventInAlagoas_i01N_di_zWGiPbwf6BRh" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,742,791)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,181,931)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl3954">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3955">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3956">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3957">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3958">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3959">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,742,791)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,181,931)</span></td></tr> <tr id="xdx_40A_eifrs-full--AdjustmentsForIncreaseDecreaseInOtherOperatingPayables_i01_zcZrlqHxQe6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other payables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (384,838)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  823,515</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(217,997)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,889)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(18,063)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  33,810</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3970">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3971">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3972">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (390,727)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  805,452</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (184,187)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--CashFlowsFromUsedInOperations_i01_z7P97m4lsXhb"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash generated from operations</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,389,936</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">17,730,748</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,763,660</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,136,320</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,646,026</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,523,694</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3984">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3985">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  13,477,365</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">20,376,774</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 9,287,354</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--InterestPaidClassifiedAsOperatingActivities_i01N_di_zTuBWNxcXOmb" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Interest paid</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,118,043)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,207,196)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,946,931)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(786,836)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (676,237)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (789,890)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3996">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3997">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3998">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,904,879)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,883,433)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,736,821)</span></td></tr> <tr id="xdx_409_eifrs-full--IncomeTaxesPaidClassifiedAsOperatingActivities_i01N_di_zxssulco6y4a" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income taxes</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,620,616)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,697,829)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(252,479)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (131)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,027)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,063)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4009">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4010">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4011">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,620,747)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,706,856)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (257,542)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_i01_zsQSwHrXQpX7"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net cash generated by operating activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,651,277</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,825,723</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,564,250</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,349,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,960,762</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 728,741</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4023">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4024">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,951,739</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">14,786,485</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,292,991</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01_zAFQpzPWPjCa"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Proceeds from the sale of fixed assets and intangible assets</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 40,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 33,140</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4032">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4033">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4034">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4035">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4037">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 40,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  33,140</span></td></tr> <tr id="xdx_408_ecustom--AdditionsToInvestmentInSubsidiaries_i01_zQDXtRSEQCDc"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Additions to investment in subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (107,090)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4043">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4045">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4046">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4048">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (107,090)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4052">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4053">–</span></span></td></tr> <tr id="xdx_400_eifrs-full--DividendsReceivedClassifiedAsInvestingActivities_i01_zDX1BJ0BRSc2"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Dividends received</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,660</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">295</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,822</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4058">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4059">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4060">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4061">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4063">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,660</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">295</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,822</span></td></tr> <tr id="xdx_40D_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_di_zrKRIIBjUZm6"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquisitions to property, plant and equipment and intangible assets</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,153,707)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,249,132)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,653,009)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(694,574)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (172,192)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (106,780)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4074">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4075">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4076">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,848,281)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,421,324)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,759,789)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01_z4pfaaF3Vu36"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net cash used in investing activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,252,699)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,208,484)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,615,047)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (694,574)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (172,192)</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (106,780)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4087">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4088">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4089">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,947,273)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,380,676)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,721,827)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_402_ecustom--ShortTermAndLongTermDebtAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Short-term and long-term debt</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_i01_zHfvlTFCa1hl" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 16,308</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,049,459</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4110">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4111">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4112">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4113">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4114">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4115">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 16,308</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,049,459</span></td></tr> <tr id="xdx_409_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_i01N_di_znZEAm4i64Ac" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(9,413,909)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,734,505)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4123">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4124">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4125">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4126">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4127">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4128">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(9,413,909)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,734,505)</span></td></tr> <tr id="xdx_407_ecustom--BraskemIdesaBorrowingsAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Braskem Idesa borrowings</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr id="xdx_40A_ecustom--ProceedsFromOtherBorrowings_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4146">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4147">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4149">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">7,271,658</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4151">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4152">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4153">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4155">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,271,658</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4157">–</span></span></td></tr> <tr id="xdx_403_ecustom--RepaymentsOfOtherBorrowings_iN_di_zrdR8GGmYuU6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4159">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4160">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,995,045)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (905,210)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4165">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4166">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,995,045)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (905,210)</span></td></tr> <tr id="xdx_404_ecustom--RelatedParts_zZfE02Lzvg5a"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Related parts</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4172">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  216,862</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (34,122)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (226,407)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4178">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4179">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (34,122)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (9,545)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4183">–</span></span></td></tr> <tr id="xdx_400_ecustom--LoanToNoncontrollingShareholdersOfBraskemIdesaPayment_zlic97ro9W4g"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Loan to non-controlling shareholders of Braskem Idesa - payment</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(37,618)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4194">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4195">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(37,618)</span></td></tr> <tr id="xdx_404_ecustom--Lease_zdRNgVphx6x9"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Lease</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (836,718)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(787,932)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(610,392)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(141,063)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(53,774)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(51,676)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  48,891</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4205">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4206">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (928,890)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(841,706)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (662,068)</span></td></tr> <tr id="xdx_400_eifrs-full--DividendsPaidClassifiedAsFinancingActivities_iN_di_z5FoAcDWdNN"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Dividends paid</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,350,293)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,993,265)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,380)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4214">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4215">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4216">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4217">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4218">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4219">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,350,293)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,993,265)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,380)</span></td></tr> <tr id="xdx_401_ecustom--NoncontrollingInterestInSubsidiaries_i_pn3n3"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Non-controlling interest in subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">21,162</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4225">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(534,456)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4227">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4229">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4230">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4231">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4232">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">21,162</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4234">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (534,456)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--CashFlowsFromUsedInFinancingActivities_zyauQpHzyJf9"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash generated (used) in financing activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  396,697</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (15,961,936)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,167,726</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (220,496)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,003,568)</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (994,504)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 48,891</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4244">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4245">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  225,092</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (16,965,504)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,173,222</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_ziygVHEFBsmb"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Exchange variation on cash of foreign subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (420,488)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  293,633</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,054,845</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (23,282)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  83,896</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">259,741</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4256">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4257">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4258">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (443,770)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  377,529</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,314,586</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_z3y9zaTXmOY"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Increase in cash and cash equivalents</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,374,787</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,051,064)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,171,774</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  411,001</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 868,898</span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,802)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4269">-</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4270">-</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4271">-</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,785,788</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,182,166)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,058,972</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Represented by</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CashEquivalents_i01S_zj28Tdn6OzD1" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash and cash equivalents at the beginning for the period</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,958,419</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,786,645</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,773,331</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">904,433</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,017,235</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4295">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4297">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,680,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,862,852</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,803,880</span></td></tr> <tr id="xdx_40F_eifrs-full--CashEquivalents_i01E_zBewfu2JDmnb" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash and cash equivalents at the end for the period</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  10,282,142</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,958,419</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,184,332</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,773,331</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">904,433</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4308">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4309">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4310">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  12,466,474</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,680,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,862,852</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_zZHWwly1Ml82"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Increase in cash and cash equivalents</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,374,787</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,051,064)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,171,774</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  411,001</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 868,898</span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,802)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4321">-</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4322">-</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4323">-</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,785,788</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,182,166)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,058,972</span></td></tr> </table> <p id="xdx_8AD_z2uMLX3p4fE9" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfInvestmentsExplanatory_pn3n3_z7NHuBgXcSzk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_8B2_zV0lrBL9NDji" style="display: none">Schedule of Information on investments</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; font-weight: bold; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; font-weight: bold; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net profit (loss) for the year</span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity</span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 32%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Jointly-controlled investment</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">RPR</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_z9nJYBo8TRZe" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 76,450</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zKCBGaddf1d" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">312</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLoss_pn3n3_c20200101__20201231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zOfvzNKJIcee" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,525)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zb7hzsPqVvU9" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  110,040</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_fKGkp_zEPPPcyR29Ma" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 50,064</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols LLC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment2Member_fKGlpKQ_____zsw1IQcSyCed" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,977)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment2Member_fKGlpKQ_____zZbZcWRDuAS7" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 80,757</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Associate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borealis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zJfz2fER3E33" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 53,617</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zQadyWolfIrc" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 45,490</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLoss_pn3n3_c20200101__20201231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___z6cwi4n9JLg3" style="text-align: right" title="Net profit (loss) for the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,019</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Equity_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zCDhoJMHYzmi" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  252,053</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_fKGlpaSk___zJSVdGOn9mC1" style="text-align: right" title="Equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">  205,568</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F05_zb9NkmQKzBId" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(i)</span></td><td><span id="xdx_F16_zhL3KGettL84" style="font-family: Calibri, Helvetica, Sans-Serif">RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. <span style="color: black">The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_zFREZmSWMZSe" title="Interest in total and voting capital (%)">33.20</span>% (2021: <span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Investment1Member_z65EMHon9yYj" title="Interest in total and voting capital (%)">33.20</span>%).</span></span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F06_zvS3hAo7GEIa" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(ii)</span></td><td><span id="xdx_F11_zuabp6X4KfQ7" style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.2pt"><span id="xdx_F08_zlG20Gh8u7Y4" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">(iii)</span></td><td><span id="xdx_F1D_znp3MrD4HL55" style="font-family: Calibri, Helvetica, Sans-Serif">Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. <span style="color: black">The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_zXcRmYkkpXd5" title="Interest in total and voting capital (%)">20</span>% (2021: <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--AssociateMember_zAdtcknEZbx7" title="Interest in total and voting capital (%)">20</span>%).</span></span></td></tr></table> 76450000 312000 -63525000 110040000 50064000 -3977000 80757000 53617000 45490000 6019000 252053000 205568000 0.3320 0.3320 0.20 0.20 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfChangesInInvestmentsExplanatory_pn3n3_z2A6FyKIKFLk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details 1)"> <tr style="vertical-align: bottom"> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BD_zc7bxYf52e02" style="display: none">Schedule of Changes in investments</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B5_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate1Member_zISccsUXr0yk" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B1_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate2Member_z8BLrNqvp5tg" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4BC_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate3Member_zni7R2IA38Ud" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B6_ifrs-full--SignificantInvestmentsInAssociatesAxis_custom--Associate4Member_zMbCQDHwEcrd" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_4B4_zvSK9alzkKEe" style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borealis</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">RPR</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bioglycols LLC</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iS_zUlsGDFkGKT2" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,272</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,697</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2794">-</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  184</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">43,153</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_iN_di_zEdMK367MW6h" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dividends and interest on equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (295)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (295)</span></td></tr> <tr id="xdx_401_eifrs-full--ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,136</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">103</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,239</span></td></tr> <tr id="xdx_403_eifrs-full--ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other comprehensive income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,825</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,825</span></td></tr> <tr id="xdx_404_ecustom--Other1_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,001</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,001</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_433_c20220101__20221231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iS_z3qudxIcvZfa" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">41,113</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,625</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl2824">–</span></span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,185</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,923</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_eifrs-full--DividendsReceivedFromAssociatesClassifiedAsInvestingActivities_iN_di_z1zT23t1ekAb" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dividends and interest on equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,013)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,296)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (9,309)</span></td></tr> <tr id="xdx_408_eifrs-full--ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_zbXsFYXs0cQj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,296</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 25,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,832)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td></tr> <tr id="xdx_40E_eifrs-full--ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_zj6NSI7OpAyj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other comprehensive income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,174)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,299</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (788)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (663)</span></td></tr> <tr id="xdx_40A_ecustom--CapitalIncreases_zuRG3wCkF0Ic" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Capital increase</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  41,908</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 23,061</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 64,969</span></td></tr> <tr id="xdx_40B_ecustom--Other1_zx8mj3nKSzj1" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">255</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">255</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_436_c20220101__20221231_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iE_zaJzwsJXiBc1" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at 2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">47,396</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">36,539</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,375</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,713</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">149,023</span></td></tr> </table> 32272000 10697000 184000 43153000 295000 295000 9136000 103000 9239000 5825000 5825000 1001000 1001000 41113000 16625000 1185000 58923000 5013000 4296000 9309000 11296000 25384000 -1832000 34848000 -1174000 1299000 -788000 -663000 41908000 23061000 64969000 255000 255000 47396000 36539000 41375000 23713000 149023000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfImpactOnConsolidationOfBraskemIdesaExplanatory_pn3n3_z3yeZH7fMeU9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investments (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"> <span id="xdx_8BA_zrrrCJcMSdv6" style="display: none">Schedule of financial information of the subsidiary in which the non-controlling shareholder holds interests</span></td> <td> </td> <td id="xdx_498_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zj88Y5qRWF55" style="color: red; font-weight: bold; text-align: center"> </td> <td> </td> <td id="xdx_490_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zFHdFJ6sSXjc" style="text-align: center"> </td> <td> </td> <td id="xdx_490_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zob3kbv65rvh" style="text-align: center"> </td> <td> </td> <td id="xdx_49D_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zBSqJWE7s28f" style="color: red; font-weight: bold; text-align: center"> </td> <td style="text-align: right"> </td> <td id="xdx_49A_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zB0gKwkpsAii" style="text-align: center"> </td> <td> </td> <td id="xdx_49D_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_z7oaOPXU1Dt4" style="color: red; font-weight: bold; text-align: center"> </td> <td> </td> <td id="xdx_49E_20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zDApfyLeu019" style="text-align: center"> </td> <td> </td> <td id="xdx_49C_20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zf9qebRxDXLh" style="color: red; font-weight: bold; text-align: center"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Statement of Financial Position </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated Braskem without the effect off Braskem Idesa consolidated </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated Braskem Idesa <span id="xdx_F59_zm9rAKMjAIC4">(i)</span></span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Eliminations </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; width: 33%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2021</span></td></tr> <tr id="xdx_40A_eifrs-full--AssetsAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssetsAbstract_i01B" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Curent</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CashAndCashEquivalents_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash equivalents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,282,142</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,184,332</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,773,331</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2888">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,466,474</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 8,680,686</span></td></tr> <tr id="xdx_409_eifrs-full--CurrentInvestments_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Financial investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,492,710</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2895">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2898">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,295,497</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,492,710</span></td></tr> <tr id="xdx_406_eifrs-full--CurrentTradeReceivables_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade accounts receivable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,621,335</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,607,762</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  73,195</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,225,479</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(462,596)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(679,676)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,231,934</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,153,565</span></td></tr> <tr id="xdx_408_eifrs-full--Inventories_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 12,921,617</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 15,325,001</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,108,447</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,010,100</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2915">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2916">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  14,030,064</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  16,335,101</span></td></tr> <tr id="xdx_400_eifrs-full--CurrentReceivablesFromTaxesOtherThanIncomeTax_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes recoverable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">905,844</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,402,100</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">250,511</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">26,558</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2924">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2925">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,156,355</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,428,658</span></td></tr> <tr id="xdx_406_ecustom--RecoverableIncomeTaxes_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Recoverable income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">392,062</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,189,812</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2934">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 392,062</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,189,812</span></td></tr> <tr id="xdx_404_eifrs-full--CurrentDerivativeFinancialAssets_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">157,906</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  33,816</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2940">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2941">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 157,906</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">33,816</span></td></tr> <tr id="xdx_409_eifrs-full--OtherCurrentReceivables_i02I_pn3n3_z2vRzjVKxwSa" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">628,447</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">841,473</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  68,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 137,624</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 30,373</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2952">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 727,364</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 979,097</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total current assets<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 31,204,850</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 35,800,029</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,685,029</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,173,092</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (432,223)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (679,676)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  34,457,656</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  39,293,445</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--NoncurrentAssetsAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--NoncurrentReceivablesFromTaxesOtherThanIncomeTax_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes recoverable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,328,695</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">983,655</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">288,974</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 268,403</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2979">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,617,669</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,252,058</span></td></tr> <tr id="xdx_400_ecustom--RecoverableIncomeTaxesNonCurrent_i01I_pn3n3_zBATYcmZFHYe" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Recoverable income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">252,995</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">230,069</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2985">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl2986">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2987">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 252,995</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 230,069</span></td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Deferred tax assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,671,492</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">6,481,642</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">488,116</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,775,610</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(801,007)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,358,601</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 8,257,252</span></td></tr> <tr id="xdx_408_eifrs-full--NoncurrentReceivablesDueFromRelatedParties_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Related parties</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,250,756</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,064,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3003">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td> <td style="text-align: right"><span id="xdx_F4C_zPQTxLWLxc86" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(7,250,756)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (10,064,320)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3007">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td></tr> <tr id="xdx_400_ecustom--DerivativesNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  71,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">51</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3012">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3014">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3015">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">71,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 51</span></td></tr> <tr id="xdx_40E_ecustom--JudicialDepositsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Judicial deposits </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">215,274</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">194,212</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3021">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 215,274</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 194,212</span></td></tr> <tr id="xdx_40D_eifrs-full--OtherNoncurrentReceivables_i01I_pn3n3_zYmn3Pozg5p3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other receivables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">187,107</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">370,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 563</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">24,964</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3032">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3033">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 187,670</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 395,892</span></td></tr> <tr id="xdx_40A_eifrs-full--InvestmentProperty_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Investments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">149,023</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  58,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3039">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3040">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3041">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 149,023</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">58,923</span></td></tr> <tr id="xdx_403_eifrs-full--PropertyPlantAndEquipment_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 24,319,015</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 23,510,588</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 14,126,939</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  14,483,720</span></td> <td style="text-align: right"><span id="xdx_F4C_zOXotO8IhiG3" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(iii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(682,659)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(769,178)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  37,763,295</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  37,225,130</span></td></tr> <tr id="xdx_401_eifrs-full--IntangibleAssetsOtherThanGoodwill_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Intangible</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,730,124</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,572,675</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">292,020</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 304,624</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3059">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3060">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,022,144</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,877,299</span></td></tr> <tr id="xdx_408_eifrs-full--RightofuseAssets_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Right of use of assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,638,507</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,427,633</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">910,900</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 352,404</span></td> <td style="text-align: right"><span id="xdx_F4C_z3vsaYb3qYo6" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(596,420)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,952,987</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,780,037</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total non current assets<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 46,814,532</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 46,894,696</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 16,107,512</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">17,209,725</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,330,842)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (10,833,498)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  53,591,202</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  53,270,923</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--Assets_iI_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 78,019,382</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 82,694,725</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 19,792,541</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">21,382,817</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,763,065)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (11,513,174)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  88,048,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  92,564,368</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--EquityAndLiabilitiesAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Liabilities and shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CurrentLiabilitiesAbstract_i01B" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TradeAndOtherCurrentPayables_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,418,031</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 11,861,563</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,291,347</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 871,379</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(462,596)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(679,676)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,246,782</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,053,266</span></td></tr> <tr id="xdx_407_eifrs-full--ShorttermBorrowings_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,254,550</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,343,494</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3120">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3121">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3123">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,254,550</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,343,494</span></td></tr> <tr id="xdx_40A_ecustom--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued1_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  59,088</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3130">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3131">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3132">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">59,088</span></td></tr> <tr id="xdx_400_ecustom--CurrentBraskemIdesaBorrowings_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Braskem Idesa Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3136">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3137">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">868,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">86,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3141">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 868,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">86,765</span></td></tr> <tr id="xdx_40B_ecustom--CurrentProvisionsForEmployeeBenefits1_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Payroll and related charges</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">789,441</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,095,040</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  38,385</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">75,306</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3149">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3150">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 827,826</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,170,346</span></td></tr> <tr id="xdx_408_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Taxes payable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">481,729</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,003,813</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 9,322</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  8,303</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3158">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3159">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 491,051</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,012,116</span></td></tr> <tr id="xdx_40B_ecustom--IncomeTaxesPayable_i02I_pn3n3_zx4x18H5Hjxl" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Income taxes payable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">381,117</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,672,844</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3165">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3166">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3167">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3168">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 381,117</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,672,844</span></td></tr> <tr id="xdx_406_eifrs-full--CurrentLeaseLiabilities_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Lease</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">955,225</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">598,523</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">195,518</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">76,843</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(111,037)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3177">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,039,706</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 675,366</span></td></tr> <tr id="xdx_40E_eifrs-full--LongtermRestructuringProvision_i02I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision - geological event in Alagoas</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,247,609</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,378,071</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3183">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,247,609</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,378,071</span></td></tr> <tr id="xdx_40E_eifrs-full--OtherPayables_i02I_pn3n3_zrYOewq8twAh" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,645,828</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,495,544</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  24,283</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 246,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 30,059</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3195">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,700,170</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,742,167</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Total current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 22,301,331</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 24,507,980</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,427,490</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  1,365,219</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (543,574)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (679,676)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  24,185,247</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  25,193,523</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentLiabilitiesAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-current</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_ecustom--LoanAgreements_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan agreements</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 31,310,710</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 33,553,766</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3221">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3222">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  31,310,710</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  33,553,766</span></td></tr> <tr id="xdx_40A_ecustom--BraskemIdesaBorrowingsNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Braskem Idesa Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3226">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 10,501,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,224,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3230">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3231">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  10,501,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  12,224,770</span></td></tr> <tr id="xdx_402_ecustom--DebenturesNoncurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">137,830</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3237">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3240">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 137,830</span></td></tr> <tr id="xdx_404_eifrs-full--NoncurrentPayablesToRelatedParties_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to related parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3244">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3245">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,175,837</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  10,134,287</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(7,175,837)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (10,134,287)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3250">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></span></td></tr> <tr id="xdx_40C_ecustom--NoncurrentLoanToNoncontrollingShareholders_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan to non-controlling shareholders of Braskem Idesa</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3253">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3254">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,498,093</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3257">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3258">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,498,093</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,646,538</span></td></tr> <tr id="xdx_405_eifrs-full--NetDeferredTaxLiabilities_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Deferred tax liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">904,521</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,407,434</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">1,049,967</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3265">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(801,007)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3267">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,153,481</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 1,407,434</span></td></tr> <tr id="xdx_406_eifrs-full--LongtermMiscellaneousOtherProvisions_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision for losses on subsidiaries</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,094,535</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">5,284,666</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3273">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3274">-</span></span></td> <td style="text-align: right"><span id="xdx_F48_z00w8ng0neAc" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(iv)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(4,094,535)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(5,284,666)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> <span style="-sec-ix-hidden: xdx2ixbrl3277">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3278">-</span></span></td></tr> <tr id="xdx_40D_eifrs-full--NoncurrentLeaseLiabilities_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Lease</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,942,284</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,147,745</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">746,285</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 333,303</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(v)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(487,745)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3285">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,200,824</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,481,048</span></td></tr> <tr id="xdx_405_ecustom--ProvisionGeologicalEventInAlagoasNonCurrent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision - geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">2,378,949</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,283,188</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3291">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3292">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3293">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3294">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 2,378,949</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,283,188</span></td></tr> <tr id="xdx_400_eifrs-full--OtherNoncurrentPayables_i01I_pn3n3_zgPJNs9Kti54" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Other payables</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,590,317</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,406,733</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  97,663</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">25,710</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3302">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3303">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 3,687,980</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 4,432,443</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--NoncurrentLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> Total non current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 48,244,990</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 50,221,362</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 22,069,528</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">26,364,608</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (12,559,124)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (15,418,953)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  57,755,394</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  61,167,017</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--EquityAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--EquityAttributableToOwnersOfParent_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Attributable to the  Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,321,798</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,865,819</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (4,704,477)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(6,347,010)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  4,704,478</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  6,347,010</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,321,799</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 7,865,819</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--NoncontrollingInterests_i01I_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 16pt; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Non-controlling interest in subsidiaries</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">151,263</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  99,564</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3336">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  <span style="-sec-ix-hidden: xdx2ixbrl3337">-</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(1,364,845)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(1,761,555)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (1,213,582)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (1,661,991)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--Equity_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Total shareholders equity<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,473,061</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">7,965,383</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (4,704,477)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">(6,347,010)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">3,339,633</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">4,585,455</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 6,108,217</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  6,203,828</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--EquityAndLiabilities_iI_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Total liabilities and shareholders' equity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 78,019,382</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 82,694,725</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> 19,792,541</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">21,382,817</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> (9,763,065)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  (11,513,174)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  88,048,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">  92,564,368</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F09_zJ3t2kWc49Tg" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zVtw6Ere6qxj" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Consolidation of Braskem Idesa with its subsidiaries Braskem Idesa Servicios and Terminal Química.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F08_zDahjsSbzdV4" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_zz8FHWmouaZ4" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Loan from Braskem Holanda to the Braskem Idesa project.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0F_zePtKjVOEPjl" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zhXTbkPkGLOa" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F06_zy4a3uX6sHs1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iv)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1E_z1coALuYjD6h" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0D_zDHoFJW37z64" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(v)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F10_zrCCLodmxRt" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 8pt">Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa.</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"> </td> <td> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zYeJuZkxfZz1" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zxBlln0ooMp" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49E_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zDBqopkrVJs7" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_498_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zOo8QLd8U77" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_497_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z4XaQUHtTpuh" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49B_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z3uKE9bmxFNg" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zL9ygweNP2Yh" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_498_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zaPBlhzfAGa3" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_493_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zPAZv0uZR1Gj" style="color: white; text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zlnSpZoPcIl6" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_492_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zsULntYJwHDe" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_495_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zkfY0ZX107ce" style="color: white; text-align: center"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Statement of profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="text-align: right; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Consolidated Braskem without the effect of</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr> <td style="padding-left: 8pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Braskem Idesa consolidated </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated Braskem Idesa </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Eliminations </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt; width: 22%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net revenue</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  93,038,949</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  101,448,155</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">55,779,528</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">5,953,229</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,333,199</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,046,581</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,472,894)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,156,153)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,282,615)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  96,519,284</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  105,625,201</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  58,543,494</span></td></tr> <tr id="xdx_402_eifrs-full--CostOfSales_iN_di_zDs9jNldFUlb" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of products sold</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(82,624,987)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (72,471,291)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,563,723)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,074,693)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,321,601)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,112,129)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,539,132</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,224,661</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,344,438</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(85,160,548)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (73,568,231)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(47,331,414)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--GrossProfit_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Gross profit</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  10,413,962</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 28,976,864</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">10,215,805</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">878,536</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,011,598</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">934,452</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">66,238</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">68,508</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">61,823</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,358,736</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 32,056,970</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,212,080</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--MaterialIncomeAndExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income (expenses) </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_401_ecustom--DistributionCosts1_zfkzU7pDosn6" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Selling and distribution</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,890,181)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,834,303)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,609,844)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(218,236)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(221,337)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(242,211)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3424">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3425">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3426">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,108,417)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,055,640)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,852,055)</span></td></tr> <tr id="xdx_407_eifrs-full--ImpairmentLossRecognisedInProfitOrLossTradeReceivables_iN_di_znn93nfBbD8e" style="vertical-align: bottom"> <td style="padding-left: 8pt; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) reversals for impairment of trade accounts receivable</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (38,248)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,736)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (55,074)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (178)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3437">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3438">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3439">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (38,426)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,914)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (55,252)</span></td></tr> <tr id="xdx_403_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zUKKqAf5NkXh" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">General and administrative </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,545,044)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,292,884)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,739,541)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(216,098)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(229,334)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(179,350)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,841)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">91</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 144</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,763,983)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,522,127)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,918,747)</span></td></tr> <tr id="xdx_401_eifrs-full--ResearchAndDevelopmentExpense_iN_di_zQpmhmtsE4te" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Research and development</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (374,493)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (296,583)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(250,648)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3460">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3461">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3462">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3463">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3464">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3465">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (374,493)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (296,583)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (250,648)</span></td></tr> <tr id="xdx_405_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_iN_di_z1196qh4sfjh" style="vertical-align: bottom"> <td colspan="2" style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Results from equity-accounted investees</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,078,115)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(82,709)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,026,922)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3474">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3475">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,112,956</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  87,353</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,007,524</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">34,848</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (19,398)</span></td></tr> <tr id="xdx_404_eifrs-full--OtherIncome_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 505,629</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,530,443</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  748,923</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,704</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,044</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,826</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3489">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3490">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3491">–</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 507,333</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,534,487</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">750,749</span></td></tr> <tr id="xdx_40C_eifrs-full--OtherExpenseByNature_iN_di_zZwzGgiCuzid" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other expenses</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,305,411)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,651,425)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,573,874)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (38,114)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (17,865)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(364,747)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3502">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3503">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3504">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,343,525)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,669,290)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (7,938,621)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLossFromOperatingActivities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Operating profit</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,688,099</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 23,340,667</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,291,175)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">407,621</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,546,928</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">149,792</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,176,353</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 155,952</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,069,491</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,272,073</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 26,043,547</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (71,892)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_ecustom--FinancialIncomeCostAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial results</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--FinanceCosts_iN_di_zyBCp43v2eDa" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial expenses </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,013,176)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,750,895)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,851,233)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,817,551)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,618,020)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,505,628)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,168,034</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">461,760</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">443,496</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,662,693)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,907,155)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,913,365)</span></td></tr> <tr id="xdx_402_eifrs-full--FinanceIncome_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,558,268</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,276,312</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,032,530</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  610,792</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 12,886</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 11,150</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,158,926)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (461,760)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (443,496)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,010,134</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,827,438</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">600,184</span></td></tr> <tr id="xdx_40F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_zYa6FnRZQ4ng" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Exchange rate variations, net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (643,377)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,884,292)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,823,269)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  235,314</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,164,697)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(482,125)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (164,107)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  46,182</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (572,170)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,002,807)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,298,711)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--FinanceIncomeCost_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt; color: White">Finance income (cost)</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,098,285)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,358,875)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,641,972)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (971,445)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,769,831)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,976,603)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (154,999)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">46,182</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,683</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,224,729)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (8,082,524)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,611,892)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_ecustom--LossProfitBeforeIncomeTaxAbstract_iB_zSabIrf0BVEf" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) profit before income tax</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_ecustom--ProfitLossBeforeTaxAndSocialContribution_zJyXjt2l28qj" style="vertical-align: bottom"> <td style="padding-left: 8pt; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">and social contribution</span></span></p> </td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(410,186)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 17,981,792</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,933,147)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (563,824)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (222,903)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,826,811)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 202,134</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 47,344</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 17,961,023</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,683,784)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--IncomeTaxExpenseContinuingOperations_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">95,651</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,991,055)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,253,684</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(963,386)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,348)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  414,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3619">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3620">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3621">-</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (867,735)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,999,403)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--ProfitLossFromContinuingOperations_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) net profit for the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(314,535)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,990,737</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,679,463)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,527,210)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (231,251)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,412,017)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 202,134</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(820,391)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,961,620</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (7,015,306)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td id="xdx_496_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_ziZRntyGAuac" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zv6LoDCmPnxk" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49D_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember_zC9uga89gZ64" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_493_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_zg0Kjeh3rsS7" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49C_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z2ydHdCOjaD2" style="color: white; text-align: center"> </td> <td id="xdx_499_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--BraskemIdesaConsolidatedMember_z64SDdDjbMX5" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_49A_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zZPpkgw5UpJ7" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_497_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_ztaGKS2TiIXf" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_492_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--EliminationsMember_zpzZbIvi989b" style="color: white; text-align: center"> </td> <td> </td> <td id="xdx_491_20220101__20221231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zwmciQUqyhw3" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49B_20210101__20211231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_zmtDBoKzfOah" style="color: white; text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_497_20200101__20201231__ifrs-full--ConsolidatedAndSeparateFinancialStatementsAxis__custom--TotalMember_z3Du6BUYAdel" style="color: white; text-align: center"> </td></tr> <tr> <td style="font-size: 12pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Statement of cash flows </b></span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td colspan="5" style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Consolidated Braskem without the effect of</b></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b> Braskem Idesa consolidated </b></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="4" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated Braskem Idesa </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; white-space: nowrap; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Eliminations </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; white-space: nowrap; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> Consolidated </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 26%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: red; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_ecustom--LossProfitBeforeTaxes_zsJWiwyzFHNk"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(Loss) profit before taxes</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (410,186)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">18,348,774</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,933,147)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(563,824)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (222,903)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,826,811)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,021,354</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (164,848)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,076,174</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">47,344</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">17,961,023</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (9,683,784)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdjustmentsForReconcileProfitLossAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Adjustments for reconciliation of profit (loss)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr id="xdx_405_eifrs-full--AdjustmentsForDepreciationAndAmortisationExpense_i01_zQ3U9SvSXwo7" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Depreciation and amortization</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,944,259</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,432,816</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,995,609</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 901,194</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">796,861</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,114,439</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,288)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (51,244)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(61,967)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,733,165</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,178,433</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,048,081</span></td></tr> <tr id="xdx_405_ecustom--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods_i01N_di_zIQXa75xWzud" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Results from equity-accounted investees</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,078,108</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (78,567)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,026,922</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3681">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3682">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3683">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,112,956)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  73,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,007,524)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (34,848)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (4,644)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  19,398</span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i01_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Interest and  monetary and exchange variations, net</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,788,259</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,604,357</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,541,980</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 759,378</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,564,905</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,921,975</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">154,999</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">142,169</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (6,683)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,702,636</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,311,431</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 10,457,272</span></td></tr> <tr id="xdx_405_ecustom--ReversalOfProvisions_i01_zds30tQk0PAa" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Reversal of provisions</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,153</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  819,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  336,838</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3707">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3708">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3709">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3710">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3711">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3712">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,153</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  819,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">336,838</span></td></tr> <tr id="xdx_402_eifrs-full--OtherReversalsOfProvisions_i01_zQA0jewcKfi6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Provision - geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,520,019</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,901,828</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3720">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3721">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3722">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3723">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3724">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3725">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,520,019</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,901,828</span></td></tr> <tr id="xdx_409_eifrs-full--AdjustmentsForIncomeTaxExpense_i01_zwcY5NHlEDD" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">PIS and Cofins credits - exclusion of ICMS from the calculation basis</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3730">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,031,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(310,557)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3733">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3734">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3735">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3736">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3737">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3738">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3739">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,031,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (310,557)</span></td></tr> <tr id="xdx_402_ecustom--LossForImpairmentOfTradeAccountsReceivable_i01_zAgbraSM3wBd" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Loss for impairment of trade accounts receivable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">38,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 10,134</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 55,252</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3746">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,220)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3748">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3750">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3751">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">38,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">8,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  55,252</span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForIncreaseInOtherProvisionsArisingFromPassageOfTime_i01_z2Te6WczoUl9" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Provision for losses and write-offs of long-lived assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 130,366</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  114,148</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">8,794</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  629</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,039</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3761">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3762">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3763">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3764">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 130,995</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  115,187</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,794</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital_i01_zKPgRZ5b0wpf" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: White">Adjustments for reconciliation of profit<span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,459,404</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">26,559,458</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">10,623,519</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,097,377</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,138,682</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,209,603</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3776">–</span></span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3777">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 9,507,890</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">29,698,140</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 11,833,122</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_406_ecustom--ChangesInOperatingWorkingCapitalAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Changes in operating working capital </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40E_ecustom--IncreaseDecreaseInOtherFinancialAssets_i01_zXQHh5iWafsh" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Judicial deposits - unfreezing (blocking) Public Civil Action</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3795">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3796">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,746,107</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3798">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3799">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3800">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3801">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3802">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3803">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3804">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3805">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">3,746,107</span></td></tr> <tr id="xdx_405_ecustom--AdjustmentsForDecreaseIncreaseInFinancialInvestments_i01_zIPcodNXKcua" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Financial investments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,530,050</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  296,957</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,860,827)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3811">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3812">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3813">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3814">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3815">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3816">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,530,050</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  296,957</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,860,827)</span></td></tr> <tr id="xdx_40F_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_i01_zwvRdwuWcez8" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Trade accounts receivable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,751,788</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,739,822)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,247,729)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,126,559</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (619,688)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (152,971)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (217,080)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">184,225</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">212,874</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,661,267</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,175,285)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,187,826)</span></td></tr> <tr id="xdx_404_eifrs-full--AdjustmentsForDecreaseIncreaseInInventories_i01_zb8hWW4wPmi9" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,246,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,176,104)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(309,492)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(108,609)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (398,181)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  56,958</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3840">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3841">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3842">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,138,161</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,574,285)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (252,534)</span></td></tr> <tr id="xdx_405_ecustom--AdjustmentsForDecreaseIncreaseInTaxesRecoverable_i01_zrQxRgTB7cda" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Taxes recoverable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 928,181</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,958,779</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,584,911</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(245,724)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,808</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(52,357)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3853">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3854">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3855">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 682,457</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,963,587</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,532,554</span></td></tr> <tr id="xdx_400_ecustom--PrepaidExpenses_i01_zrzu8IoSpf94" style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Prepaid expenses</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3860">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3861">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (172,027)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3863">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3864">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 465,812</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3866">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3867">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3868">–</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3869">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3870">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 293,785</span></td></tr> <tr id="xdx_40D_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_i01_zpE0GPouqVGe" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other receivables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 297,209</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(269,721)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 44,513</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,580</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  71,165</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">352,590</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3879">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3880">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3881">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 310,789</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(198,556)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">397,103</span></td></tr> <tr id="xdx_407_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_i01_zEPXu951hyI3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Trade payables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (73,230)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  955,475</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,926,585)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 370,229</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">428,364</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">137,895</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">217,080</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (184,225)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (212,874)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 514,079</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,199,614</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,001,564)</span></td></tr> <tr id="xdx_40A_ecustom--AdjustmentsForIncreaseDecreaseInTaxesPayable_i01_z6hNm8r5VRec" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Taxes payable</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,085,427)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,878,056)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  965,191</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">76,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (129,432)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (515,430)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3905">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3906">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3907">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,009,356)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,007,488)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">449,761</span></td></tr> <tr id="xdx_404_ecustom--AdvancesFromCustomers_i01_zGGK0styPIO5" style="vertical-align: bottom"> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Advances from customers</span></td> <td style="text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3912">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3913">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 224,764</span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3915">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3916">–</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(25,776)</span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3918">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3919">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3920">–</span></span></td> <td><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3921">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3922">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: calibri; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">198,988</span></td></tr> <tr id="xdx_404_ecustom--AdjustmentsForIncreaseDecreaseInLeniencyAgreements_i01_zKddwmC8eZJ2" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Leniency agreement</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (317,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(389,087)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(349,842)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl3928">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3929">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3930">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3931">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3932">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3933">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (317,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(389,087)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (349,842)</span></td></tr> <tr id="xdx_406_eifrs-full--AdjustmentsForProvisions_i01_zI7UUnrHXh28" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Sundry provisions</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (219,313)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(482,565)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(158,915)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(187,274)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">168,371</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  13,560</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3944">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3945">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3946">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (406,587)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(314,194)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (145,355)</span></td></tr> <tr id="xdx_401_ecustom--GeologicalEventInAlagoas_i01N_di_zWGiPbwf6BRh" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Geological event in Alagoas</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,742,791)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,181,931)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl3954">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3955">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3956">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3957">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3958">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3959">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,742,791)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (1,181,931)</span></td></tr> <tr id="xdx_40A_eifrs-full--AdjustmentsForIncreaseDecreaseInOtherOperatingPayables_i01_zcZrlqHxQe6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Other payables</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (384,838)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  823,515</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(217,997)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,889)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(18,063)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  33,810</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3970">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3971">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3972">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (390,727)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  805,452</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (184,187)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--CashFlowsFromUsedInOperations_i01_z7P97m4lsXhb"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash generated from operations</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11,389,936</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">17,730,748</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,763,660</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,136,320</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2,646,026</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,523,694</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3984">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3985">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  13,477,365</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">20,376,774</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 9,287,354</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--InterestPaidClassifiedAsOperatingActivities_i01N_di_zTuBWNxcXOmb" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Interest paid</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,118,043)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,207,196)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,946,931)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(786,836)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (676,237)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (789,890)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3996">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3997">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3998">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,904,879)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,883,433)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,736,821)</span></td></tr> <tr id="xdx_409_eifrs-full--IncomeTaxesPaidClassifiedAsOperatingActivities_i01N_di_zxssulco6y4a" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Income taxes</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,620,616)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,697,829)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(252,479)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (131)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (9,027)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (5,063)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4009">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4010">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4011">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,620,747)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,706,856)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (257,542)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_i01_zsQSwHrXQpX7"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net cash generated by operating activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,651,277</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,825,723</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,564,250</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,349,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,960,762</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 728,741</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (48,891)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4023">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4024">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,951,739</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">14,786,485</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,292,991</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01_zAFQpzPWPjCa"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Proceeds from the sale of fixed assets and intangible assets</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 40,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 33,140</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4032">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4033">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4034">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4035">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4037">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  2,438</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 40,353</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  33,140</span></td></tr> <tr id="xdx_408_ecustom--AdditionsToInvestmentInSubsidiaries_i01_zQDXtRSEQCDc"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Additions to investment in subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (107,090)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4043">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4045">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4046">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4048">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (107,090)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4052">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4053">–</span></span></td></tr> <tr id="xdx_400_eifrs-full--DividendsReceivedClassifiedAsInvestingActivities_i01_zDX1BJ0BRSc2"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Dividends received</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,660</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">295</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">4,822</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4058">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4059">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4060">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4061">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4063">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,660</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">295</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 4,822</span></td></tr> <tr id="xdx_40D_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_di_zrKRIIBjUZm6"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquisitions to property, plant and equipment and intangible assets</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,153,707)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,249,132)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(2,653,009)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(694,574)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (172,192)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (106,780)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4074">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4075">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4076">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (4,848,281)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,421,324)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,759,789)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01_z4pfaaF3Vu36"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Net cash used in investing activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,252,699)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,208,484)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,615,047)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (694,574)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (172,192)</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (106,780)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4087">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4088">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4089">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,947,273)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (3,380,676)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,721,827)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_402_ecustom--ShortTermAndLongTermDebtAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Short-term and long-term debt</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_i01_zHfvlTFCa1hl" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 16,308</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,049,459</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4110">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4111">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4112">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4113">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4114">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4115">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 16,308</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,049,459</span></td></tr> <tr id="xdx_409_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_i01N_di_znZEAm4i64Ac" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(9,413,909)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,734,505)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4123">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4124">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4125">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4126">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4127">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4128">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(9,413,909)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (8,734,505)</span></td></tr> <tr id="xdx_407_ecustom--BraskemIdesaBorrowingsAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Braskem Idesa borrowings</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td></tr> <tr id="xdx_40A_ecustom--ProceedsFromOtherBorrowings_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4146">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4147">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span style="-sec-ix-hidden: xdx2ixbrl4149">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">7,271,658</span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4151">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4152">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4153">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4155">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,271,658</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4157">–</span></span></td></tr> <tr id="xdx_403_ecustom--RepaymentsOfOtherBorrowings_iN_di_zrdR8GGmYuU6" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4159">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4160">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,995,045)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (905,210)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4165">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4166">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(7,995,045)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (905,210)</span></td></tr> <tr id="xdx_404_ecustom--RelatedParts_zZfE02Lzvg5a"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Related parts</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4172">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  216,862</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (34,122)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (226,407)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4178">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4179">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (34,122)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (9,545)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4183">–</span></span></td></tr> <tr id="xdx_400_ecustom--LoanToNoncontrollingShareholdersOfBraskemIdesaPayment_zlic97ro9W4g"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Loan to non-controlling shareholders of Braskem Idesa - payment</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(37,618)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4194">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4195">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(37,618)</span></td></tr> <tr id="xdx_404_ecustom--Lease_zdRNgVphx6x9"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Lease</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (836,718)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(787,932)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(610,392)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(141,063)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(53,774)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(51,676)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  48,891</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4205">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4206">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (928,890)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(841,706)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (662,068)</span></td></tr> <tr id="xdx_400_eifrs-full--DividendsPaidClassifiedAsFinancingActivities_iN_di_z5FoAcDWdNN"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Dividends paid</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,350,293)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,993,265)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (2,380)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4214">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4215">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4216">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4217">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4218">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4219">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,350,293)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,993,265)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (2,380)</span></td></tr> <tr id="xdx_401_ecustom--NoncontrollingInterestInSubsidiaries_i_pn3n3"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Non-controlling interest in subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">21,162</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4225">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(534,456)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4227">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">–</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4229">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4230">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4231">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4232">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">21,162</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4234">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (534,456)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--CashFlowsFromUsedInFinancingActivities_zyauQpHzyJf9"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash generated (used) in financing activities</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  396,697</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (15,961,936)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,167,726</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (220,496)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (1,003,568)</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (994,504)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 48,891</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4244">–</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4245">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  225,092</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (16,965,504)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,173,222</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_ziygVHEFBsmb"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Exchange variation on cash of foreign subsidiaries</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (420,488)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  293,633</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,054,845</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (23,282)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  83,896</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">259,741</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4256">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4257">–</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4258">–</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (443,770)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  377,529</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,314,586</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_z3y9zaTXmOY"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Increase in cash and cash equivalents</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,374,787</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,051,064)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,171,774</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  411,001</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 868,898</span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,802)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4269">-</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4270">-</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4271">-</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,785,788</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,182,166)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,058,972</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract_iB"> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Represented by</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CashEquivalents_i01S_zj28Tdn6OzD1" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash and cash equivalents at the beginning for the period</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,958,419</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,786,645</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 1,773,331</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">904,433</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,017,235</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4295">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4297">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 8,680,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">13,862,852</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">6,803,880</span></td></tr> <tr id="xdx_40F_eifrs-full--CashEquivalents_i01E_zBewfu2JDmnb" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cash and cash equivalents at the end for the period</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  10,282,142</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  6,907,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">12,958,419</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 2,184,332</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,773,331</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">904,433</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4308">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4309">–</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl4310">–</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  12,466,474</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,680,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 13,862,852</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_zZHWwly1Ml82"> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Increase in cash and cash equivalents</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,374,787</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (6,051,064)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  7,171,774</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  411,001</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 868,898</span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (112,802)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4321">-</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4322">-</span></span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span style="-sec-ix-hidden: xdx2ixbrl4323">-</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 3,785,788</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (5,182,166)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 7,058,972</span></td></tr> </table> 10282142000 6907355000 2184332000 1773331000 12466474000 8680686000 2295497000 3492710000 2295497000 3492710000 3621335000 6607762000 73195000 1225479000 -462596000 -679676000 3231934000 7153565000 12921617000 15325001000 1108447000 1010100000 14030064000 16335101000 905844000 1402100000 250511000 26558000 1156355000 1428658000 392062000 1189812000 392062000 1189812000 157906000 33816000 157906000 33816000 628447000 841473000 68544000 137624000 30373000 727364000 979097000 31204850000 35800029000 3685029000 4173092000 -432223000 -679676000 34457656000 39293445000 1328695000 983655000 288974000 268403000 1617669000 1252058000 252995000 230069000 252995000 230069000 6671492000 6481642000 488116000 1775610000 -801007000 6358601000 8257252000 7250756000 10064320000 -7250756000 -10064320000 71544000 51000 71544000 51000 215274000 194212000 215274000 194212000 187107000 370928000 563000 24964000 187670000 395892000 149023000 58923000 149023000 58923000 24319015000 23510588000 14126939000 14483720000 -682659000 -769178000 37763295000 37225130000 2730124000 2572675000 292020000 304624000 3022144000 2877299000 3638507000 2427633000 910900000 352404000 -596420000 3952987000 2780037000 46814532000 46894696000 16107512000 17209725000 -9330842000 -10833498000 53591202000 53270923000 78019382000 82694725000 19792541000 21382817000 -9763065000 -11513174000 88048858000 92564368000 11418031000 11861563000 1291347000 871379000 -462596000 -679676000 12246782000 12053266000 1254550000 1343494000 1254550000 1343494000 127801000 59088000 127801000 59088000 868635000 86765000 868635000 86765000 789441000 1095040000 38385000 75306000 827826000 1170346000 481729000 1003813000 9322000 8303000 491051000 1012116000 381117000 1672844000 381117000 1672844000 955225000 598523000 195518000 76843000 -111037000 1039706000 675366000 4247609000 4378071000 4247609000 4378071000 2645828000 2495544000 24283000 246623000 30059000 2700170000 2742167000 22301331000 24507980000 2427490000 1365219000 -543574000 -679676000 24185247000 25193523000 31310710000 33553766000 31310710000 33553766000 10501683000 12224770000 10501683000 12224770000 3023674000 137830000 3023674000 137830000 7175837000 10134287000 -7175837000 -10134287000 2498093000 3646538000 2498093000 3646538000 904521000 1407434000 1049967000 -801007000 1153481000 1407434000 4094535000 5284666000 -4094535000 -5284666000 2942284000 2147745000 746285000 333303000 -487745000 3200824000 2481048000 2378949000 3283188000 2378949000 3283188000 3590317000 4406733000 97663000 25710000 3687980000 4432443000 48244990000 50221362000 22069528000 26364608000 -12559124000 -15418953000 57755394000 61167017000 7321798000 7865819000 -4704477000 -6347010000 4704478000 6347010000 7321799000 7865819000 151263000 99564000 -1364845000 -1761555000 -1213582000 -1661991000 7473061000 7965383000 -4704477000 -6347010000 3339633000 4585455000 6108217000 6203828000 78019382000 82694725000 19792541000 21382817000 -9763065000 -11513174000 88048858000 92564368000 93038949000 101448155000 55779528000 5953229000 6333199000 4046581000 -2472894000 -2156153000 -1282615000 96519284000 105625201000 58543494000 82624987000 72471291000 45563723000 5074693000 3321601000 3112129000 -2539132000 -2224661000 -1344438000 85160548000 73568231000 47331414000 10413962000 28976864000 10215805000 878536000 3011598000 934452000 66238000 68508000 61823000 11358736000 32056970000 11212080000 -1890181000 -1834303000 -1609844000 -218236000 -221337000 -242211000 -2108417000 -2055640000 -1852055000 38248000 8736000 55074000 178000 178000 178000 38426000 8914000 55252000 2545044000 2292884000 1739541000 216098000 229334000 179350000 2841000 -91000 -144000 2763983000 2522127000 1918747000 374493000 296583000 250648000 374493000 296583000 250648000 1078115000 82709000 1026922000 -7000 -1112956000 -87353000 -1007524000 -34848000 -4644000 19398000 505629000 1530443000 748923000 1704000 4044000 1826000 507333000 1534487000 750749000 2305411000 2651425000 7573874000 38114000 17865000 364747000 2343525000 2669290000 7938621000 2688099000 23340667000 -1291175000 407621000 2546928000 149792000 1176353000 155952000 1069491000 4272073000 26043547000 -71892000 5013176000 4750895000 3851233000 1817551000 1618020000 1505628000 -1168034000 -461760000 -443496000 5662693000 5907155000 4913365000 2558268000 2276312000 1032530000 610792000 12886000 11150000 -1158926000 -461760000 -443496000 2010134000 1827438000 600184000 -643377000 -2884292000 -4823269000 235314000 -1164697000 -482125000 -164107000 46182000 6683000 -572170000 -4002807000 -5298711000 -3098285000 -5358875000 -7641972000 -971445000 -2769831000 -1976603000 -154999000 46182000 6683000 -4224729000 -8082524000 -9611892000 -410186000 17981792000 -8933147000 -563824000 -222903000 -1826811000 1021354000 202134000 1076174000 47344000 17961023000 -9683784000 95651000 -3991055000 2253684000 -963386000 -8348000 414794000 -867735000 -3999403000 2668478000 -314535000 13990737000 -6679463000 -1527210000 -231251000 -1412017000 1021354000 202134000 1076174000 -820391000 13961620000 -7015306000 -410186000 18348774000 -8933147000 -563824000 -222903000 -1826811000 1021354000 -164848000 1076174000 47344000 17961023000 -9683784000 3944259000 3432816000 2995609000 901194000 796861000 1114439000 -112288000 -51244000 -61967000 4733165000 4178433000 4048081000 -1078108000 78567000 -1026922000 1112956000 -73923000 1007524000 34848000 4644000 -19398000 1788259000 3604357000 8541980000 759378000 2564905000 1921975000 154999000 142169000 -6683000 2702636000 6311431000 10457272000 370153000 819130000 336838000 370153000 819130000 336838000 1520019000 1339765000 6901828000 1520019000 1339765000 6901828000 -1031099000 -310557000 -1031099000 -310557000 38426000 10134000 55252000 -1220000 38426000 8914000 55252000 130366000 114148000 8794000 629000 1039000 130995000 115187000 8794000 8459404000 26559458000 10623519000 1097377000 3138682000 1209603000 -48891000 9507890000 29698140000 11833122000 3746107000 3746107000 1530050000 296957000 -1860827000 1530050000 296957000 -1860827000 2751788000 -1739822000 -2247729000 1126559000 -619688000 -152971000 -217080000 184225000 212874000 3661267000 -2175285000 -2187826000 2246770000 -7176104000 -309492000 -108609000 -398181000 56958000 2138161000 -7574285000 -252534000 928181000 4958779000 1584911000 -245724000 4808000 -52357000 682457000 4963587000 1532554000 -172027000 465812000 293785000 297209000 -269721000 44513000 13580000 71165000 352590000 310789000 -198556000 397103000 -73230000 955475000 -2926585000 370229000 428364000 137895000 217080000 -184225000 -212874000 514079000 1199614000 -3001564000 -1085427000 -2878056000 965191000 76071000 -129432000 -515430000 -1009356000 -3007488000 449761000 224764000 -25776000 198988000 -317867000 -389087000 -349842000 -317867000 -389087000 -349842000 -219313000 -482565000 -158915000 -187274000 168371000 13560000 -406587000 -314194000 -145355000 2742791000 2928081000 1181931000 2742791000 2928081000 1181931000 -384838000 823515000 -217997000 -5889000 -18063000 33810000 -390727000 805452000 -184187000 11389936000 17730748000 7763660000 2136320000 2646026000 1523694000 -48891000 13477365000 20376774000 9287354000 2118043000 2207196000 1946931000 786836000 676237000 789890000 2904879000 2883433000 2736821000 1620616000 2697829000 252479000 131000 9027000 5063000 1620747000 2706856000 257542000 7651277000 12825723000 5564250000 1349353000 1960762000 728741000 -48891000 8951739000 14786485000 6292991000 2438000 40353000 33140000 2438000 40353000 33140000 -107090000 -107090000 5660000 295000 4822000 5660000 295000 4822000 4153707000 3249132000 2653009000 694574000 172192000 106780000 4848281000 3421324000 2759789000 -4252699000 -3208484000 -2615047000 -694574000 -172192000 -106780000 -4947273000 -3380676000 -2721827000 6418208000 16308000 13049459000 6418208000 16308000 13049459000 3855662000 9413909000 8734505000 3855662000 9413909000 8734505000 7271658000 7271658000 45311000 7995045000 905210000 45311000 7995045000 905210000 216862000 -34122000 -226407000 -34122000 -9545000 -37618000 -37618000 -836718000 -787932000 -610392000 -141063000 -53774000 -51676000 48891000 -928890000 -841706000 -662068000 1350293000 5993265000 2380000 1350293000 5993265000 2380000 21162000 -534456000 21162000 -534456000 396697000 -15961936000 3167726000 -220496000 -1003568000 -994504000 48891000 225092000 -16965504000 2173222000 -420488000 293633000 1054845000 -23282000 83896000 259741000 -443770000 377529000 1314586000 3374787000 -6051064000 7171774000 411001000 868898000 -112802000 3785788000 -5182166000 7058972000 6907355000 12958419000 5786645000 1773331000 904433000 1017235000 8680686000 13862852000 6803880000 10282142000 6907355000 12958419000 2184332000 1773331000 904433000 12466474000 8680686000 13862852000 3374787000 -6051064000 7171774000 411001000 868898000 -112802000 3785788000 -5182166000 7058972000 <p id="xdx_80A_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zGBwYogaeNh6" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">12 <span id="xdx_820_zAP48x6rfkQc">Property, plant and equipment</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Items of property, plant and equipment are measured at the historical cost of acquisition or construction, which includes capitalized borrowing costs, less accumulated depreciation and any accumulated impairment losses.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The machinery, equipment and facilities require inspections, replacement of components and maintenance at regular intervals. <span id="xdx_900_ecustom--DescriptionOfPropertyPlantAndEquipmentShutdownsDuration_c20220101__20221231" title="Description of property, plant and equipment shutdowns duration">The Company makes shutdowns at regular intervals that vary from two to six years to perform these activities.</span> These shutdowns can involve the plant as a whole, a part of it, or only relevant pieces of equipment, such as industrial boilers, turbines and tanks. Expenses with each scheduled shutdown are included in property, plant and equipment items that were the stoppage’s subject matter and are fully depreciated until the beginning of the following related stoppage.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation starts when the assets become available and is calculated using the straight-line method, based on the useful life estimated by the Company’s technicians in the management of the plants. The useful lives of assets are reviewed at each reporting date.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The main factors taken into consideration in the definition of the useful life of the assets that compose the Company’s industrial plants are the information of manufacturers of machinery and equipment, level of the plants’ operations, quality of preventive and corrective maintenance and the prospects of technological obsolescence of assets.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The estimated useful lives applied to the assets determined the following average percentage of rates per year:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory_zhhqU3ffNfil" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BB_z8X79lAntr" style="display: none">Schedule of estimated useful lives</span></td> <td> </td> <td> </td> <td colspan="3" style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 43%"> </td> <td style="width: 16%"> </td> <td style="width: 14%"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%">2022</td> <td style="width: 1%"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%">2021</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Buildings and improvements</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_901_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zcSRm1qYUdHg" title="Estimates useful lives">3.03</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_907_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zXpYlEwmIu5e" title="Estimates useful lives">2.92</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Machinery, equipment and installations</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90C_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zV4s9OlRnmJl" title="Estimates useful lives">7.32</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_900_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zYNnhe0DlGcf" title="Estimates useful lives">6.74</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Furniture and fixtures</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zAFYVnufq6u9" title="Estimates useful lives">10.06</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDT3y3KqYBci" title="Estimates useful lives">10.06</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">IT equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zz8yjzI917zc" title="Estimates useful lives">21.03</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90F_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zJhjv5VcVnu5" title="Estimates useful lives">21.18</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Lab equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_908_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LabEquipmentMember_zc2bKmlEmiW9" title="Estimates useful lives">9.59</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90A_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LabEquipmentMember_zUl8Q8ZpsDX" title="Estimates useful lives">9.53</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Security equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_906_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SecurityEquipmentMember_zSSNkY9Jvn5c" title="Estimates useful lives">10.50</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SecurityEquipmentMember_zYbnhy3wGWoi" title="Estimates useful lives">10.04</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Vehicles</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90C_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zflPh7OfLRa4" title="Estimates useful lives">19.51</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_905_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zScaXxsR93kc" title="Estimates useful lives">18.82</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Other</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90F_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zrVYQcmkoPzd" title="Estimates useful lives">18.09</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_905_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zT1atQUHGZOe" title="Estimates useful lives">17.05</span></td></tr> </table> <p id="xdx_8AC_zszo2FvO1JM" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borrowing costs are capitalized when associated with ongoing projects, using: (i) the average rate of the financings; and (ii) the exchange variation portion that corresponds to any positive difference between the average rate of financing in the domestic market and the rate cited in item (i).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, capitalized borrowing costs amounted to R$<span id="xdx_905_ecustom--FinancialChargesCapitalized_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_pn3n3" title="Capitalized financial charges">203,135</span> (2021: R$<span id="xdx_90A_ecustom--FinancialChargesCapitalized_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_zjOLLxkbTsYc" title="Capitalized financial charges">192,207</span>). The average rate of these charges in the year was <span id="xdx_906_ecustom--DepreciationRatePropertyPlantAndEquipments_pid_dp_c20220101__20221231_z7odXsxJMO84" title="Depreciation rate, property, plant and equipment">8.51</span>% p.a. (2021: <span id="xdx_907_ecustom--DepreciationRatePropertyPlantAndEquipments_pid_dp_c20210101__20211231_zTV53pNn59fa" title="Depreciation rate, property, plant and equipment">8.33</span>% p.a.).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the acquisition of property, plant and equipment with payment installments is R$<span id="xdx_904_ecustom--AcquisitionOfPropertyPlantAndEquipmentWithPaymentInstallments_c20220101__20221231_pn3n3" title="Acquisition of property, plant and equipment with payment installments">525,192</span> (2021: R$<span id="xdx_906_ecustom--AcquisitionOfPropertyPlantAndEquipmentWithPaymentInstallments_c20210101__20211231_pn3n3" title="Acquisition of property, plant and equipment with payment installments">295,056</span>).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Reconciliation of carrying amount</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory_pn3n3_zzneReKb6nL1" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zbQdjn68b2g8" style="display: none">Schedule of reconciliation of carrying amount</span></td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Land </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Buildings and Improvements </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Machinery, Equipment and Facilities </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Projects and Stoppage in Progress <span>(i)</span></span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Other </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Total </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_ztqu30IYPAFa" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  683,031</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIzqY2aZ7hp9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,281,424</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zZ3oJmnC7yyj" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">53,401,832</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zdEEBJoD7Qff" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,389,105</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_znpnSGOhbvLb" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,038,666</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231_zETFUfbWddoc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 68,794,058</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation and amortization</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIwo64dLgeu4" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,159,185)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zEFRNGoL6C7k" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(28,268,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zPB1dwoZdYW6" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,436,857)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231_zNdBPz6zkAKa" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(32,864,909)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2020</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zx3ZLoOpUspe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  683,031</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zQs1TEShEU9j" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,122,239</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_z50TNUqWSTqd" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,132,965</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zppn6IM2sNp9" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,389,105</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zecTZw0IkLAh" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">601,809</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231_zGwq3rET4sqa" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 35,929,149</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">338</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  160,297</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z1CfHZJQ5y16" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,388,078</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,421</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,552,134</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Capitalized financial charges</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialChargesCapitalized_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z7DKsPqFI4qk" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 192,207</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--FinancialChargesCapitalized_c20210101__20211231_pn3n3" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif">192,207</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency translation adjustment</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,046</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  287,866</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,118,655</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zkKpkwvPSYLc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">74,428</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,859</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,521,854</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(88,406)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(313,267)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,760)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(418,433)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers by concluded projects</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zdo42HPhmoYb" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">244</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,965</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,207,833</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zLlr1EwhggH9" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,412,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">190,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to inventory</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--TransfersToInventory_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zkJbrtdRbC55" style="text-align: right" title="Transfers to inventory"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,838)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--TransfersToInventory_pn3n3_c20210101__20211231_zuvmqY0zeiSe" style="text-align: right" title="Transfers to inventory"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,838)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to intangible</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zwtiVo4BhZz" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 31,495</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zshbNUSJxw2l" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(11,673)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zDJGqcE3kPec" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,397)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(11,847)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20210101__20211231_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(65,422)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,856)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,723</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(353,274)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DisposalsPropertyPlantAndEquipmentCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zeQNuAjKjobd" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(91,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(41,066)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(486,958)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">168</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,005</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,206</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">396,379</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zupSsi6Ycuk8" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(195,900)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zyb0sy8GXAji" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,038,176)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zohxcFXTtiDe" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(143,164)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231_zdKmzEw9FAUi" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,377,241)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to "non-current assets held for sale"</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zSApKPp7Wpdc" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,701)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zNw6UuBJz2j6" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zOe2mqTqpEcd" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231_zSchStiFhUW7" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,701)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers Others</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zwsJXuNfCpyc" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">  118,629</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z0gDlOnzjzd3" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_z6oGjpM2zLzd" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">(78,534)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Net book value</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,181,488</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,408,992</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zlIbEJxwgQoe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,409,338</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">537,549</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,225,130</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,591,020</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,535,343</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z8gT3o7iH663" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,449,433</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,215,503</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 73,479,063</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,409,532)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(31,126,351)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zI4ED2SuMEcf" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,677,954)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(36,253,933)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2021</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zN1rpUMQTxTl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z600060lF94j" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,181,488</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_z1l79u9V8AXc" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,408,992</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z0XXmuinFXtd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,409,338</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zmljqnmaPjZ" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">537,549</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231_ztpmBVxB8uZe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,225,130</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,709</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,719</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zR8w2EGIFVy3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,643,953</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,603</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,949,985</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions through acquisition of ER Plastics</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zNU9tP8x1Ggi" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,868</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zIfJlj2hqDSb" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,288</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zC53cCVbiMKg" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 362</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231_zp6Z3gk8m5ug" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77,518</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Capitalized financial charges</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--FinancialChargesCapitalized_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zt24ANgOlIO1" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 203,135</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialChargesCapitalized_c20220101__20221231_pn3n3" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif">203,135</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency translation adjustment</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(19,916)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,496)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zUXZyJhsdqpd" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(941,271)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zJ9hNkHJ8RU9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,966)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(28,592)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,202,241)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zpP5FTw5Qlnk" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 51,263</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zvXu1n2wGFIc" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  285,016</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  20,269</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20220101__20221231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">356,548</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers by concluded projects</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 86,609</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,688,220</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_znBiSsv1NFie" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,915,496)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">140,667</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif">–</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to intangible</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zZJLCdhvPm71" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,597)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20220101__20221231_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,597)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(926,944)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z5wjeyQSUI73" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(20,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,689)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(964,308)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zlc7s8IEzslb" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  815,220</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,715</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20220101__20221231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">828,934</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zHWAMITFOX35" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(203,358)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zVLxrgbY8zLc" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,347,376)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zxK8TVBcA0zb" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(147,074)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231_zfB1y27vZST4" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,697,809)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Net book value</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,965,077</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,334,863</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zoL2GIJIbVR4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,267,702</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">527,809</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,763,295</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,526,704</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,708,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zx3bU3t5Bwu5" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,307,797</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,318,854</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 76,529,554</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,561,627)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(33,373,492)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,791,045)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,766,259)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2022</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zKIeXdDgJKph" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zlCFRaAOfR6l" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,965,077</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zOkOhN2NKRV6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,334,863</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zVJJazSNLYql" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,267,702</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zwkoO9ubXFhl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">527,809</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231_zVIiQ2XzV24b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,763,295</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt; text-indent: -7.1pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zTb9ae6u8JUa" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zCCdyOYdffPe" style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.</span></td></tr> </table> <p id="xdx_8A4_zESpgC1BgGxb" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Property, plant and equipment by country</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfPropertyPlantAndEquipmentByCountryExplanatory_pn3n3_zxOlMXbaWmHc" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8B8_ztrPoEkDNssc" style="display: none">Schedule of property plant and equipment by country</span></td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="color: white; font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 66%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17,204,824</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_za3a5WG52mkj" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  15,867,387</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,444,279</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zw839HN7A6z4" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,714,543</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">United States of America</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,729,469</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_z3DjkX1YSYk9" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,281,077</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 294,612</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_ze17V7xOXWXl" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 356,288</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_ze1AGwgkhkLb" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">89,841</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_zMmrn4HDgd2j" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,691</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  270</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zqbu8qe5rRm8" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  144</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  37,763,295</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231_z8AQGcKjDl87" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  37,225,130</span></td></tr> </table> <p id="xdx_8AB_zEfWxiuMENHg" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Impairment loss</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Annually, or whenever there is any indication that an asset has suffered devaluation, the Company conducts an analysis to determine if there are indicators that the book value of property, plant and equipment may not be recoverable. This analysis is conducted to assess the existence of scenarios that could adversely affect its cash flow and, consequently, its ability to recover the investment in such assets. These scenarios arise from issues of a macroeconomic, legal, competitive, or technological nature.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The following are considered by the Company as relevant points and are observed in this analysis:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) the possibility of an oversupply of products manufactured by the Company or of a significant reduction in demand due to adverse economic factors;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) the prospects of material fluctuations in the prices of products and inputs;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii) the likelihood of the development of new technologies or raw materials that could materially reduce production costs and consequently impact sales prices, ultimately leading to the full or partial obsolescence of the industrial facilities of the Company; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv) changes in the general regulatory environment that make the production process of Braskem infeasible or that significantly impact the sale of its products.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The recoverable value of an asset or Cash Generating Unit (“CGU”) is the greatest of the value in use and its fair value less sales costs. The value in use is based on estimated future cash flows, discounted to present value using a discount rate before tax that reflects the current market assessments of the time value of money and the specific risks related to the asset or CGU.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When identifying whether cash inflows from an asset (or group of assets) are largely independent of cash inflows from other assets (or groups of assets), the Company considers several factors, such as: product lines, individual locations and the way Management monitors and makes decisions about its business.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">No events indicated that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt; color: #0070C0"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; letter-spacing: 0pt"><b> </b></span></p> The Company makes shutdowns at regular intervals that vary from two to six years to perform these activities. <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory_zhhqU3ffNfil" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BB_z8X79lAntr" style="display: none">Schedule of estimated useful lives</span></td> <td> </td> <td> </td> <td colspan="3" style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 43%"> </td> <td style="width: 16%"> </td> <td style="width: 14%"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%">2022</td> <td style="width: 1%"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%">2021</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Buildings and improvements</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_901_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zcSRm1qYUdHg" title="Estimates useful lives">3.03</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_907_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zXpYlEwmIu5e" title="Estimates useful lives">2.92</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Machinery, equipment and installations</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90C_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zV4s9OlRnmJl" title="Estimates useful lives">7.32</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_900_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zYNnhe0DlGcf" title="Estimates useful lives">6.74</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Furniture and fixtures</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zAFYVnufq6u9" title="Estimates useful lives">10.06</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDT3y3KqYBci" title="Estimates useful lives">10.06</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">IT equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zz8yjzI917zc" title="Estimates useful lives">21.03</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90F_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zJhjv5VcVnu5" title="Estimates useful lives">21.18</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Lab equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_908_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LabEquipmentMember_zc2bKmlEmiW9" title="Estimates useful lives">9.59</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90A_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LabEquipmentMember_zUl8Q8ZpsDX" title="Estimates useful lives">9.53</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Security equipment</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_906_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SecurityEquipmentMember_zSSNkY9Jvn5c" title="Estimates useful lives">10.50</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_90E_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SecurityEquipmentMember_zYbnhy3wGWoi" title="Estimates useful lives">10.04</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Vehicles</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90C_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zflPh7OfLRa4" title="Estimates useful lives">19.51</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_905_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zScaXxsR93kc" title="Estimates useful lives">18.82</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt">Other</td> <td> </td> <td> </td> <td style="text-align: right"> <span id="xdx_90F_ecustom--EstimatedUsefulLives_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zrVYQcmkoPzd" title="Estimates useful lives">18.09</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> <span id="xdx_905_ecustom--EstimatedUsefulLives_dtY_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zT1atQUHGZOe" title="Estimates useful lives">17.05</span></td></tr> </table> P3Y10D P2Y11M1D P7Y3M25D P6Y8M26D P10Y21D P10Y21D P21Y10D P21Y2M4D P9Y7M2D P9Y6M10D P10Y6M P10Y14D P19Y6M3D P18Y9M25D P18Y1M2D P17Y18D 203135000 192207000 0.0851 0.0833 525192000 295056000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory_pn3n3_zzneReKb6nL1" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zbQdjn68b2g8" style="display: none">Schedule of reconciliation of carrying amount</span></td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Land </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Buildings and Improvements </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Machinery, Equipment and Facilities </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Projects and Stoppage in Progress <span>(i)</span></span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Other </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Total </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_ztqu30IYPAFa" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  683,031</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIzqY2aZ7hp9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,281,424</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zZ3oJmnC7yyj" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">53,401,832</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zdEEBJoD7Qff" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,389,105</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_znpnSGOhbvLb" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,038,666</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20200101__20201231_zETFUfbWddoc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 68,794,058</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation and amortization</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIwo64dLgeu4" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,159,185)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zEFRNGoL6C7k" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(28,268,867)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zPB1dwoZdYW6" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,436,857)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20200101__20201231_zNdBPz6zkAKa" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(32,864,909)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2020</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zx3ZLoOpUspe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  683,031</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zQs1TEShEU9j" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,122,239</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_z50TNUqWSTqd" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,132,965</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zppn6IM2sNp9" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,389,105</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zecTZw0IkLAh" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">601,809</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231_zGwq3rET4sqa" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 35,929,149</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">338</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  160,297</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z1CfHZJQ5y16" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,388,078</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,421</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20210101__20211231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,552,134</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Capitalized financial charges</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialChargesCapitalized_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z7DKsPqFI4qk" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 192,207</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--FinancialChargesCapitalized_c20210101__20211231_pn3n3" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif">192,207</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency translation adjustment</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,046</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  287,866</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,118,655</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zkKpkwvPSYLc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">74,428</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,859</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,521,854</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(88,406)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(313,267)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,760)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20210101__20211231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(418,433)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers by concluded projects</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zdo42HPhmoYb" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">244</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,965</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,207,833</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zLlr1EwhggH9" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,412,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">190,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to inventory</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--TransfersToInventory_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zkJbrtdRbC55" style="text-align: right" title="Transfers to inventory"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,838)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--TransfersToInventory_pn3n3_c20210101__20211231_zuvmqY0zeiSe" style="text-align: right" title="Transfers to inventory"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,838)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to intangible</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zwtiVo4BhZz" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 31,495</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zshbNUSJxw2l" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(11,673)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zDJGqcE3kPec" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,397)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(11,847)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20210101__20211231_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(65,422)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,856)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,723</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(353,274)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DisposalsPropertyPlantAndEquipmentCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zeQNuAjKjobd" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(91,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(41,066)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(486,958)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">168</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,005</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,206</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20210101__20211231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">396,379</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zupSsi6Ycuk8" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(195,900)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zyb0sy8GXAji" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,038,176)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zohxcFXTtiDe" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(143,164)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20210101__20211231_zdKmzEw9FAUi" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,377,241)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to "non-current assets held for sale"</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zSApKPp7Wpdc" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,701)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zNw6UuBJz2j6" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zOe2mqTqpEcd" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--TransfersToNoncurrentAssetsHeldForSale_pn3n3_c20210101__20211231_zSchStiFhUW7" style="text-align: right" title="Transfers to &quot;non-current assets held for sale&quot;"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,701)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers Others</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zwsJXuNfCpyc" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">  118,629</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z0gDlOnzjzd3" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DisposalsPropertyPlantAndEquipmentTransferOthers_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_z6oGjpM2zLzd" style="text-align: right" title="Disposals property plant and equipment transfer others"><span style="font-family: Calibri, Helvetica, Sans-Serif">(78,534)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Net book value</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,181,488</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,408,992</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zlIbEJxwgQoe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,409,338</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">537,549</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,225,130</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,591,020</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,535,343</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z8gT3o7iH663" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,449,433</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,215,503</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentCostValue_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 73,479,063</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,409,532)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(31,126,351)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zI4ED2SuMEcf" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,677,954)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20210101__20211231_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(36,253,933)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2021</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zN1rpUMQTxTl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  687,764</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z600060lF94j" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,181,488</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_z1l79u9V8AXc" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,408,992</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z0XXmuinFXtd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,409,338</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zmljqnmaPjZ" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">537,549</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231_ztpmBVxB8uZe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,225,130</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,709</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,719</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zR8w2EGIFVy3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,643,953</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,603</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220101__20221231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,949,985</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions through acquisition of ER Plastics</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zNU9tP8x1Ggi" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,868</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zIfJlj2hqDSb" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,288</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zC53cCVbiMKg" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 362</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsFromAcquisitionsInvestmentProperty_pn3n3_c20220101__20221231_zp6Z3gk8m5ug" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77,518</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Capitalized financial charges</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--FinancialChargesCapitalized_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zt24ANgOlIO1" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 203,135</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialChargesCapitalized_c20220101__20221231_pn3n3" style="text-align: right" title="Capitalized financial charges"><span style="font-family: Calibri, Helvetica, Sans-Serif">203,135</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency translation adjustment</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(19,916)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,496)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zUXZyJhsdqpd" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(941,271)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zJ9hNkHJ8RU9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,966)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(28,592)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,202,241)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zpP5FTw5Qlnk" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 51,263</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zvXu1n2wGFIc" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  285,016</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  20,269</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion_c20220101__20221231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">356,548</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers by concluded projects</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 86,609</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,688,220</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_znBiSsv1NFie" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,915,496)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Transfers by concluded projects"><span style="font-family: Calibri, Helvetica, Sans-Serif">140,667</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif">–</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transfers to intangible</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zZJLCdhvPm71" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,597)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_c20220101__20221231_pn3n3" style="text-align: right" title="Transfers to intangible"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,597)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(926,944)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentCost_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_z5wjeyQSUI73" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(20,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,689)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">(964,308)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zlc7s8IEzslb" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  815,220</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,715</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DisposalsPropertyPlantAndEquipmentDepletion_c20220101__20221231_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">828,934</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zHWAMITFOX35" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(203,358)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zVLxrgbY8zLc" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,347,376)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zxK8TVBcA0zb" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(147,074)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_c20220101__20221231_zfB1y27vZST4" style="text-align: right" title="Depreciation and amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,697,809)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Net book value</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,965,077</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,334,863</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zoL2GIJIbVR4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,267,702</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">527,809</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Net book value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,763,295</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,526,704</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,708,355</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCostValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zx3bU3t5Bwu5" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,307,797</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,318,854</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentCostValue_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 76,529,554</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated depreciation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,561,627)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(33,373,492)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(40,095)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,791,045)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_c20220101__20221231_pn3n3" style="text-align: right" title="Accumulated depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,766,259)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of December 31, 2022</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zKIeXdDgJKph" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  667,845</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zlCFRaAOfR6l" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,965,077</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndFacilitiesMember_zOkOhN2NKRV6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,334,863</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ProjectsAndStoppageInProgressMember_fKGkp_zVJJazSNLYql" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,267,702</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OtherMember_zwkoO9ubXFhl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">527,809</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231_zVIiQ2XzV24b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,763,295</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt; text-indent: -7.1pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zTb9ae6u8JUa" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zCCdyOYdffPe" style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants.</span></td></tr> </table> 683031000 8281424000 53401832000 4389105000 2038666000 68794058000 -3159185000 -28268867000 -1436857000 -32864909000 683031000 5122239000 25132965000 4389105000 601809000 35929149000 338000 160297000 3388078000 3421000 3552134000 192207000 192207000 17046000 287866000 1118655000 74428000 23859000 1521854000 -88406000 -313267000 -16760000 -418433000 244000 13965000 3207833000 -3412665000 190623000 -16838000 -16838000 31495000 -11673000 -73397000 -11847000 -65422000 -10856000 9723000 -353274000 -91485000 -41066000 -486958000 168000 387005000 9206000 396379000 195900000 3038176000 143164000 3377241000 -1701000 -2000 2000 -1701000 118629000 -40095000 -78534000 687764000 5181488000 26408992000 4409338000 537549000 37225130000 687764000 8591020000 57535343000 4449433000 2215503000 73479063000 -3409532000 -31126351000 -40095000 -1677954000 -36253933000 687764000 5181488000 26408992000 4409338000 537549000 37225130000 1709000 296719000 4643953000 7603000 4949985000 20868000 56288000 362000 77518000 203135000 203135000 -19916000 -173496000 -941271000 -38966000 -28592000 -1202241000 51263000 285016000 20269000 356548000 86609000 2688220000 -2915496000 140667000 -13597000 -13597000 -3000 -7000 -926944000 -20665000 -16689000 -964308000 815220000 13715000 828934000 203358000 3347376000 147074000 3697809000 667845000 4965077000 25334863000 6267702000 527809000 37763295000 667845000 8526704000 58708355000 6307797000 2318854000 76529554000 -3561627000 -33373492000 -1791045000 -38766259000 667845000 4965077000 25334863000 6267702000 527809000 37763295000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfPropertyPlantAndEquipmentByCountryExplanatory_pn3n3_zxOlMXbaWmHc" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property plant and equipment (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8B8_ztrPoEkDNssc" style="display: none">Schedule of property plant and equipment by country</span></td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="color: white; font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 66%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17,204,824</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_za3a5WG52mkj" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  15,867,387</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,444,279</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zw839HN7A6z4" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,714,543</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">United States of America</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,729,469</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_z3DjkX1YSYk9" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,281,077</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 294,612</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_ze17V7xOXWXl" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 356,288</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_ze1AGwgkhkLb" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">89,841</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_zMmrn4HDgd2j" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,691</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_pn3n3" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  270</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zqbu8qe5rRm8" style="font-size: 10pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  144</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  37,763,295</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20211231_z8AQGcKjDl87" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  37,225,130</span></td></tr> </table> 17204824000 15867387000 13444279000 13714543000 6729469000 7281077000 294612000 356288000 89841000 5691000 270000 144000 37763295000 37225130000 <p id="xdx_805_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zERwqjkfwkz9" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">13 <span id="xdx_828_zLfnSzQeeLA3">Intangible assets</span></span></p> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfChangesInIntangibleAssetsExplanatory_pn3n3_zfvGtocmFxL5" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details)"> <tr style="vertical-align: bottom"> <td style="width: 43%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_8B0_zFQY3aBzapwd" style="display: none">Schedule of changes in intangible assets</span></span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Customers </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Brands </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Software  </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> and Suppliers </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Goodwill </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> and Patents </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> licenses </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Agreements </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Total </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zpuS9ssXpeH9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,187,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z2Q2OzAzWvcl" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  499,515</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zOt4U8iqF2x3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,010,201</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zbexJjMPAojb" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 392,246</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231_zaktTu9rggqc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,089,640</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zLOl4jVggBwh" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(214,455)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(683,157)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zWDwUc9hJddd" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(234,533)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,260,949)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zAyVeGfYDeoa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvDAmMw5pVrg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  285,060</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zfkISuRV0ZYa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  327,044</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zNCSwF8sYo36" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 157,713</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231_zka4uNM1KFUg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,828,691</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Acquisitions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">670</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 67,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zPMdRNfant22" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  420</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">68,776</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Foreign currency translation adjustment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231_zF5GQmfpS0Z9" style="color: white; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">14,271</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z7mAZ2WmGlA5" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 12,443</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUhsG2jdVf6e" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 13,023</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231_znG69PfQg569" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">25,466</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zVt70mNfDot" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,711)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJBiNjMyxhqe" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(8,484)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231_z7dvUT6r5fH1" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(11,195)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Transfers from property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zsAzWIojQGc9" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 28,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 36,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231_zuhUJTYhufAa" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">65,422</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Other write-offs, net of amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_ziDIUqDnHHth" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,393)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20210101__20211231_zwkRYh4BhG4g" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,393)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,444)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(64,008)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zLcVxQwqY1zc" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(22,016)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(96,468)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Net book value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zg5VHRQQZhq4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zoUXrfCPZYD2" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  313,789</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zpdJAbBN7nCg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  368,520</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zPvM2OclpqP7" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 136,117</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231_zpwsgueLW7bk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,877,299</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,187,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  549,196</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,123,619</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 392,666</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,253,159</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(235,408)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(755,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(256,549)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,375,860)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zHKoDBZko3L5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z5dLGeSvZEDk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  313,789</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z6wajDfm65o9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  368,520</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zv2tLExrjRLb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 136,117</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231_zQEib8o57jv1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,877,299</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Acquisitions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,307</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  144,930</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zMo0ZUDdY5Gc" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  913</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 147,150</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Additions through acquisition of ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zc8OWpYUyEuc" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 21,162</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJnLyapG9bCk" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">66,571</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231_zvOss49jXOxa" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">87,733</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Goodwill acquisition of ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--AdditionalRecognitionGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zpYwuRhULDVh" style="text-align: right" title="Goodwill acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 28,402</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--AdditionalRecognitionGoodwill_pn3n3_c20220101__20221231_zZPh2G3LNVS2" style="text-align: right" title="Goodwill acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">28,402</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Foreign currency translation adjustment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(7,407)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(19,762)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(27,170)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,711</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 14,440</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">17,150</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Transfers from property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 13,597</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20220101__20221231_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">13,597</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Other write-offs, net of amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zt1eCh6NnAr2" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,011)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20220101__20221231_zebuxQNzTL97" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,011)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,575)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(79,774)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z0TOrWNtSBwd" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(21,659)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(112,008)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Net book value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_z4rxKerr4fuk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,087,276</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYTjdm3nUVX8" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  320,986</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z8EeSwksaIOb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  431,939</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrn4Ud7hTSVd" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 181,943</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231_zYm8ONxiLJ63" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,022,144</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,216,080</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  564,258</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,252,373</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 460,150</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20220101__20221231_zVaVDDKQPYai" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,492,861</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(243,272)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(820,434)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(278,207)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,470,717)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zoQMMKGzpGKa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,087,276</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z1BrvH1l5mUd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  320,986</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zu5D4jGZdUI9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  431,939</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zYnbh7CigqHl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 181,943</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231_z29wTDxr8xb2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,022,144</span></td></tr> </table> <p id="xdx_8A8_zASMUcHamsZj" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Goodwill</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Goodwill is measured as the excess between the consideration transferred and to be transferred to obtain control and the fair value of the identified assets and liabilities assumed from the acquired entity. Goodwill is allocated to the CGUs or groups of assets that are expected to benefit from the synergies of the business combination. Goodwill arising before the adoption of the IFRS pronouncements was amortized in the accounting books until December 2008. From 2009 on, it has been subjected to annual impairment tests.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impairment testing is based on estimated cash generation in each CGU or groups of assets, extracted from the Company’s five-year Business Plan (see Note 22.2) and from the Management plan for a period greater than 5 years to reflect the industry cycle patterns, with a total projection period of 10 years.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Perpetuity is also calculated based on the long-term vision and excluding real growth. Cash flows and perpetuity are adjusted to present value at a discount rate based on the Weighted Average Cost of Capital (“WACC”).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The table below shows the results obtained in the tests conducted by the Company in December 2022:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfGoodwillImpairmentTestingExplanatory_pn3n3_zuER5BwwR4Mk" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_z47gB6OY6sNg" style="display: none">Schedule of goodwill impairment testing</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 46%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Allocated </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Recoverable </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Book  </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Discount </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> goodwill </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> amount </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> value (i) </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> CF/Book value </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> rate </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Northeastern petrochemical complex</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">475,780</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,305,045</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_fKGkp_zImMCY27VDTa" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,124,332</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2.3</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_zOMqVGPd4sgg" title="Discount rate">14.68</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Southern petrochemical complex</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,390,741</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,840,873</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_fKGkp_zptETiv6Ak9d" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,781,881</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3.1</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_zphRbNv7v2We" title="Discount rate">15.85</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vinyls</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">192,353</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,050,166</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_fKGkp_ze5ONtY44x8h" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,880,156</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1.8</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_zv4LGf1uMYo1" title="Discount rate">14.70</span>%</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F04_zySC9NIt1rQi" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F10_zZ5AbBGFXWCg" style="font-family: Calibri, Helvetica, Sans-Serif">The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.</span></td></tr> </table> <p id="xdx_8A6_zMFi2StOVJT" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The inflation rate considered for perpetuity was <span id="xdx_90B_eifrs-full--DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_iI_pid_dp_c20221231_zsnBSytXHsO" title="Inflation rate for perpetuity">3</span>%.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Given the potential impact on cash flows of the “discount rate” and “perpetuity”, the Company conducted a sensitivity analysis based on changes in these variables, with cash flows shown in the table below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity_pn3n3_zlD1fScJkV2" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 2)"> <tr style="vertical-align: bottom"> <td style="color: White; background-color: White">Schedule of potential impact on cash flows of the discount rate and perpetuity</td> <td> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%"/> <td style="width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 11%"> </td> <td style="font-weight: bold; text-align: right; width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 13%">+0.5% on</td> <td style="font-weight: bold; text-align: right; width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 12%">-0.5% on</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"> discount rate </td> <td style="font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">perpetuity</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">CGU</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td>Northeastern petrochemical complex</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_987_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Discount rate">6,822,642</td> <td style="text-align: right"> </td> <td id="xdx_983_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Perpetuity">7,044,458</td></tr> <tr style="vertical-align: bottom"> <td>Southern petrochemical complex</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_98A_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Discount rate"> 19,744,124</td> <td style="text-align: right"> </td> <td id="xdx_989_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Perpetuity"> 20,351,277</td></tr> <tr style="vertical-align: bottom"> <td>Vinyls</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_98E_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Discount rate">4,741,224</td> <td style="text-align: right"> </td> <td id="xdx_98A_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Perpetuity">4,930,076</td></tr> </table> <p id="xdx_8AF_z6VnTsgZGjR3" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The main assumptions used for projecting cash flows are related to the projection of macroeconomic indicators, international prices, and global and local demand in the countries where the Company has operational plants. Macroeconomic indicators include items such as: foreign exchange rates, inflation, and interest rates, among others.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Prices for key petrochemical products are obtained from a specialized third-party consulting firm, drawing on projections reviewed and supplemented based on Management’s experience. Final prices take into consideration the meetings of specific internal committees and the knowledge of the Company’s experts in preparing the benchmarks for each market.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Similar to prices, indicators for global demand also are prepared with specialized consulting firms. In the markets where the Company operates more directly, they consider additional variables for the local demand composition.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Intangible assets with definite useful lives</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These intangible assets are measured at historical cost of acquisition or at fair value when acquired in a business combination, deducted from accumulated amortization and, if applicable, accumulated impairment loss. Subsequent costs are capitalized only when they increase the future economic benefits incorporated into the specific asset to which they are related.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization is calculated using the straight-line method based on the estimated useful life of the items, and reviewed every reporting date, as follows, for consolidated purposes:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfAmortizationEstimatedUsefulLifeExplanatory_zpDAWI7sUQTe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 3)"> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"><span id="xdx_8B9_zc5XaSJEsAkg" style="display: none">Schedule of amortization estimated useful life</span></td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 76%">- Brands and patents</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 24%"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--BrandsAndPatentsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGbWtNilg9p4" title="Amortization estimated useful life">10</span>-<span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--BrandsAndPatentsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zN5mLqctQE5b" title="Amortization estimated useful life">20</span> years</td></tr> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif">- Software licenses and rights of use</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SoftwareLicensesAndRightsOfUseMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_znt2yikNRXo3" title="Amortization estimated useful life">5</span>-<span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SoftwareLicensesAndRightsOfUseMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQWc9b9bb4H3" title="Amortization estimated useful life">10</span> years</td></tr> <tr> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; vertical-align: middle">- Customers and suppliers’ agreements</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--CustomersAndSuppliersAgreementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zuwFDKrhFEn6" title="Amortization estimated useful life">14</span>-<span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--CustomersAndSuppliersAgreementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4IRzqi126Xj" title="Amortization estimated useful life">28</span> years </td></tr> </table> <p id="xdx_8A0_zOr7g3gIYyAk" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Expenditure on research activities is recognized in profit or loss as incurred. Development expenditure is capitalized only when the expenditure can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable and the Company intends to and has sufficient resources to complete development and to use or sell the asset.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Based on Management’s assessment, there were no events indicating that the carrying amount exceeds its recoverable amount as of December 31, 2022 and 2021.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Intangible assets by country</b></span></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfIntangibleAssetsByCountryExplanatory_pn3n3_zqYX7mPDDZJg" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 4)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8BF_z2f0JX2qCFg1" style="display: none">Schedule of intangible assets by country</span></td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="color: white; font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 66%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,571,011</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_zQVkoYjFtIZa" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,526,999</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 292,020</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zKXYbN5aflEc" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 304,624</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_zHq3puZB2RH1" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 122,447</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 10pt; text-align: center"/></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">United States of America</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,820</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_z6yPcHtIZEM5" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">24,404</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,839</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_zsfCvzNoxle4" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,253</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zzbd7VqsCwh1" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 19</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IntangibleAssetsAndGoodwill1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,022,144</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231_z1VWgPT5GoLg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,877,299</span></td></tr> </table> <p id="xdx_8A8_zDdN5uNRojI9" style="margin-top: 0; margin-bottom: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfChangesInIntangibleAssetsExplanatory_pn3n3_zfvGtocmFxL5" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details)"> <tr style="vertical-align: bottom"> <td style="width: 43%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_8B0_zFQY3aBzapwd" style="display: none">Schedule of changes in intangible assets</span></span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Customers </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Brands </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Software  </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> and Suppliers </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Goodwill </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> and Patents </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> licenses </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Agreements </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Total </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zpuS9ssXpeH9" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,187,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z2Q2OzAzWvcl" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  499,515</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zOt4U8iqF2x3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,010,201</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zbexJjMPAojb" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 392,246</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20200101__20201231_zaktTu9rggqc" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,089,640</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zLOl4jVggBwh" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(214,455)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(683,157)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_pn3n3_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zWDwUc9hJddd" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(234,533)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20200101__20201231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,260,949)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zAyVeGfYDeoa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvDAmMw5pVrg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  285,060</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zfkISuRV0ZYa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  327,044</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zNCSwF8sYo36" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 157,713</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231_zka4uNM1KFUg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,828,691</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Acquisitions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">670</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 67,686</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zPMdRNfant22" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  420</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">68,776</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Foreign currency translation adjustment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231_zF5GQmfpS0Z9" style="color: white; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">14,271</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z7mAZ2WmGlA5" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 12,443</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUhsG2jdVf6e" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 13,023</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_pn3n3_c20210101__20211231_znG69PfQg569" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">25,466</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zVt70mNfDot" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,711)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJBiNjMyxhqe" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(8,484)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231_z7dvUT6r5fH1" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(11,195)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Transfers from property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zsAzWIojQGc9" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 28,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 36,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231_zuhUJTYhufAa" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">65,422</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Other write-offs, net of amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_ziDIUqDnHHth" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,393)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20210101__20211231_zwkRYh4BhG4g" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,393)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,444)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(64,008)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zLcVxQwqY1zc" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(22,016)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20210101__20211231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(96,468)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Net book value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zg5VHRQQZhq4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zoUXrfCPZYD2" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  313,789</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zpdJAbBN7nCg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  368,520</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zPvM2OclpqP7" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 136,117</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20210101__20211231_zpwsgueLW7bk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,877,299</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,187,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  549,196</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,123,619</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 392,666</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20210101__20211231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,253,159</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 45px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(235,408)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(755,099)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(256,549)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20210101__20211231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,375,860)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zHKoDBZko3L5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,058,874</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z5dLGeSvZEDk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  313,789</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z6wajDfm65o9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  368,520</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zv2tLExrjRLb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 136,117</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231_zQEib8o57jv1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 2,877,299</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Acquisitions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,307</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  144,930</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zMo0ZUDdY5Gc" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  913</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 147,150</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Additions through acquisition of ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zc8OWpYUyEuc" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 21,162</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJnLyapG9bCk" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">66,571</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--AdditionsThroughAcquisitionOfErPlastics_pn3n3_c20220101__20221231_zvOss49jXOxa" style="text-align: right" title="Additions through acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">87,733</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Goodwill acquisition of ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--AdditionalRecognitionGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zpYwuRhULDVh" style="text-align: right" title="Goodwill acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 28,402</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--AdditionalRecognitionGoodwill_pn3n3_c20220101__20221231_zZPh2G3LNVS2" style="text-align: right" title="Goodwill acquisition of ER Plastics"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">28,402</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Foreign currency translation adjustment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(7,407)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(19,762)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost_c20220101__20221231_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(27,170)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,711</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 14,440</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization_c20220101__20221231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">17,150</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Transfers from property, plant and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 13,597</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_c20220101__20221231_pn3n3" style="text-align: right" title="Transfers from property, plant and equipment projects and stoppage in progress"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">13,597</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Other write-offs, net of amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zt1eCh6NnAr2" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,011)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--OtherWriteoffsNetOfAmortization_pn3n3_c20220101__20221231_zebuxQNzTL97" style="text-align: right" title="Other write-offs net of amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,011)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(10,575)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(79,774)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z0TOrWNtSBwd" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(21,659)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization_c20220101__20221231_pn3n3" style="text-align: right" title="Amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(112,008)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Net book value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_z4rxKerr4fuk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,087,276</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYTjdm3nUVX8" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  320,986</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z8EeSwksaIOb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  431,939</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrn4Ud7hTSVd" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 181,943</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231_zYm8ONxiLJ63" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,022,144</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,216,080</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  564,258</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,252,373</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 460,150</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1_pn3n3_c20220101__20221231_zVaVDDKQPYai" style="text-align: right" title="Cost"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 5,492,861</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 36px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Accumulated amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,128,804)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(243,272)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(820,434)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(278,207)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--AccumulatedAmortisationImpairmentIntangibleAssetsOther_c20220101__20221231_pn3n3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(2,470,717)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Balance as of December 31, 2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--GoodwillBasedOnExpectedFutureProfitabilityMember_zoQMMKGzpGKa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,087,276</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_z1BrvH1l5mUd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  320,986</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zu5D4jGZdUI9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  431,939</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zYnbh7CigqHl" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 181,943</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20220101__20221231_z29wTDxr8xb2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance as of end"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,022,144</span></td></tr> </table> 3187678000 499515000 1010201000 392246000 5089640000 -1128804000 -214455000 -683157000 -234533000 -2260949000 2058874000 285060000 327044000 157713000 2828691000 670000 67686000 420000 68776000 14271000 12443000 13023000 25466000 -2711000 -8484000 -11195000 28770000 36652000 65422000 -3393000 -3393000 -10444000 -64008000 -22016000 -96468000 2058874000 313789000 368520000 136117000 2877299000 3187678000 549196000 1123619000 392666000 5253159000 -1128804000 -235408000 -755099000 -256549000 -2375860000 2058874000 313789000 368520000 136117000 2877299000 1307000 144930000 913000 147150000 21162000 66571000 87733000 28402000 28402000 -7407000 -19762000 -27170000 2711000 14440000 17150000 13597000 13597000 -10011000 -10011000 -10575000 -79774000 -21659000 -112008000 2087276000 320986000 431939000 181943000 3022144000 3216080000 564258000 1252373000 460150000 5492861000 -1128804000 -243272000 -820434000 -278207000 -2470717000 2087276000 320986000 431939000 181943000 3022144000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfGoodwillImpairmentTestingExplanatory_pn3n3_zuER5BwwR4Mk" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_z47gB6OY6sNg" style="display: none">Schedule of goodwill impairment testing</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 46%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Allocated </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Recoverable </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Book  </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Discount </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> goodwill </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> amount </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> value (i) </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> CF/Book value </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> rate </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Northeastern petrochemical complex</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">475,780</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,305,045</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_fKGkp_zImMCY27VDTa" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,124,332</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2.3</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_zOMqVGPd4sgg" title="Discount rate">14.68</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Southern petrochemical complex</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,390,741</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,840,873</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_fKGkp_zptETiv6Ak9d" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,781,881</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3.1</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_zphRbNv7v2We" title="Discount rate">15.85</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vinyls</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AllocatedGoodwill_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Allocated goodwill"><span style="font-family: Calibri, Helvetica, Sans-Serif">192,353</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--RecoverableAmount_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Recoverable amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,050,166</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BookValue_iI_pn3n3_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_fKGkp_ze5ONtY44x8h" style="text-align: right" title="Book value"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,880,156</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1.8</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--DiscountRate_iI_pid_dp_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_zv4LGf1uMYo1" title="Discount rate">14.70</span>%</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F04_zySC9NIt1rQi" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F10_zZ5AbBGFXWCg" style="font-family: Calibri, Helvetica, Sans-Serif">The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital.</span></td></tr> </table> 475780000 7305045000 3124332000 0.1468 1390741000 20840873000 6781881000 0.1585 192353000 5050166000 2880156000 0.1470 0.03 <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity_pn3n3_zlD1fScJkV2" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 2)"> <tr style="vertical-align: bottom"> <td style="color: White; background-color: White">Schedule of potential impact on cash flows of the discount rate and perpetuity</td> <td> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%"/> <td style="width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 11%"> </td> <td style="font-weight: bold; text-align: right; width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 13%">+0.5% on</td> <td style="font-weight: bold; text-align: right; width: 1%"> </td> <td style="font-weight: bold; text-align: right; width: 12%">-0.5% on</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"> discount rate </td> <td style="font-weight: bold; text-align: right"> </td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right">perpetuity</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">CGU</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td>Northeastern petrochemical complex</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_987_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Discount rate">6,822,642</td> <td style="text-align: right"> </td> <td id="xdx_983_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--NortheasternPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Perpetuity">7,044,458</td></tr> <tr style="vertical-align: bottom"> <td>Southern petrochemical complex</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_98A_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Discount rate"> 19,744,124</td> <td style="text-align: right"> </td> <td id="xdx_989_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--SouthernPetrochemicalComplexMember_pn3n3" style="text-align: right" title="Perpetuity"> 20,351,277</td></tr> <tr style="vertical-align: bottom"> <td>Vinyls</td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td id="xdx_98E_ecustom--SensitivityAnalysisDiscountRates_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Discount rate">4,741,224</td> <td style="text-align: right"> </td> <td id="xdx_98A_ecustom--SensitivityAnalysisPerpetuityOne_c20221231__ifrs-full--SegmentsAxis__custom--VinylsUnityMember_pn3n3" style="text-align: right" title="Perpetuity">4,930,076</td></tr> </table> 6822642000 7044458000 19744124000 20351277000 4741224000 4930076000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfAmortizationEstimatedUsefulLifeExplanatory_zpDAWI7sUQTe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 3)"> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"><span id="xdx_8B9_zc5XaSJEsAkg" style="display: none">Schedule of amortization estimated useful life</span></td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 76%">- Brands and patents</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 24%"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--BrandsAndPatentsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGbWtNilg9p4" title="Amortization estimated useful life">10</span>-<span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--BrandsAndPatentsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zN5mLqctQE5b" title="Amortization estimated useful life">20</span> years</td></tr> <tr style="vertical-align: middle"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif">- Software licenses and rights of use</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SoftwareLicensesAndRightsOfUseMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_znt2yikNRXo3" title="Amortization estimated useful life">5</span>-<span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--SoftwareLicensesAndRightsOfUseMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQWc9b9bb4H3" title="Amortization estimated useful life">10</span> years</td></tr> <tr> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; vertical-align: middle">- Customers and suppliers’ agreements</td> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--CustomersAndSuppliersAgreementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zuwFDKrhFEn6" title="Amortization estimated useful life">14</span>-<span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--CustomersAndSuppliersAgreementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4IRzqi126Xj" title="Amortization estimated useful life">28</span> years </td></tr> </table> P10Y P20Y P5Y P10Y P14Y P28Y <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfIntangibleAssetsByCountryExplanatory_pn3n3_zqYX7mPDDZJg" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets (Details 4)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8BF_z2f0JX2qCFg1" style="display: none">Schedule of intangible assets by country</span></td> <td style="color: white"> </td> <td style="color: white"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="color: white; font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 66%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,571,011</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_zQVkoYjFtIZa" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,526,999</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 292,020</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zKXYbN5aflEc" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 304,624</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--NetherlandMember_zHq3puZB2RH1" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 122,447</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 10pt; text-align: center"/></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">United States of America</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,820</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaMember_z6yPcHtIZEM5" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">24,404</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,839</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--GermanyMember_zsfCvzNoxle4" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,253</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IntangibleAssetsAndGoodwill1_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_pn3n3" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="color: white; font-size: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zzbd7VqsCwh1" style="font-size: 10pt; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 19</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IntangibleAssetsAndGoodwill1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,022,144</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwill1_iI_pn3n3_c20211231_z1VWgPT5GoLg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,877,299</span></td></tr> </table> 2571011000 2526999000 292020000 304624000 122447000 22820000 24404000 13839000 21253000 7000 19000 3022144000 2877299000 <p id="xdx_80D_ecustom--DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory_z9EWLdk8IO91" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">14 <span id="xdx_82D_zEFWRdLnUHd">Right-of-use assets and lease liability</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company assesses whether a contract is or contains a lease if the contract transfers the right to control the use of an asset identified for a period in exchange for consideration. The Company leases various offices, railcars, vessels, pieces of equipment and vehicles. Such leases are negotiated individually and are subject to various terms and conditions.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As a lessee, the Company, to determine the enforceable term of the lease, considers all facts and circumstances that create an economic incentive for exercising the option to extend the lease.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Right-of-use assets</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Leases are recognized as a right-of-use asset and a corresponding liability on the date on which the leased asset becomes available to the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The right-of-use asset is measured at the cost composed of:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• The amount initially measured of the lease liabilities;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Any payment made up to the start of the lease, deducting any incentive received;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Any initial direct cost; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Renovation costs.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property and equipment.<br/></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes in right-of-use assets:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory_pn3n3_zxsR9EXJ5lDe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zAwzWZhkotkf" style="display: none">Schedule of changes in right-of-use assets</span></td> <td> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 27%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposal</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> translation adjustment</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Rail cars</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zcr1tU1H2CGk" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  986,061</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  72,506</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (173,272)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DisposalOfRightofuseAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zV8HxfLewLte" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,359)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (53,740)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--RightofuseAssets_iE_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zMY22RuqqhWj" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  826,196</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Machinery and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zPMvPZVzq564" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  793,254</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,147,145</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (330,971)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DisposalOfRightofuseAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_z95334D3ELTk" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,970)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (804)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zNkstPuDMewc" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,602,654</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vessels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zHFWuhu9RoTb" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  696,661</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">811,372</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (385,968)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,793)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zQyGtfU85fRi" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,272</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Buildings and constructions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zUrKkAtApae6" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  265,312</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,040</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(75,319)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (213)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_z1E7BnQlLF17" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  291,820</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vehicles</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z3mWGC5CU0Ke" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,449</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,827</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,158)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (120)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z0sF6pBRjUzb" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,998</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Computer equipment and goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zTYnucFY3Qx6" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,300</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 417</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,590)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zXVop3N3x05e" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,047</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zQAsg35A8zQi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,780,037</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,236,307</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (995,278)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DisposalOfRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (11,329)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">(56,750)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zgAaksklTWtf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,952,987</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">12/31/2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposal</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> translation adjustment</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Rail cars</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zAU0Kf3zCyh9" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,007,336</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zDko55jb2qDd" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,648</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zarwueKN4J6l" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (187,915)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zjxVS8eXudse" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">63,992</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iE_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zo6X9Zi1FKof" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  986,061</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Machinery and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zYHAa30mmGae" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  749,728</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zTjvVGpU8rAe" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">281,113</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zf3PHOJWqLTc" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (207,985)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zABhbGJSODf6" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (30,245)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zLyBhz1hZrX2" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  643</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zExWJuhLanPh" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  793,254</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vessels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zuS7qqPJ3Qwh" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  834,848</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zpcnxpgAQ1Q4" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">258,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_z8U5lZHBinal" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (399,677)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zVMvvDWr5hGl" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,289</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zNUtEU5REuX4" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  696,661</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Buildings and constructions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zxYfTry9Xre1" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  259,896</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zHA7202yXtta" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  52,897</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zf5afgwL3Er6" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(52,997)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zkxfQTv4Yot7" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,333)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zFTMDACO4aCh" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,849</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zKvbuHPgajDe" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  265,312</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vehicles</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zp2UDrcff7B8" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,888</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zMW3ypFaSVCe" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  51,171</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zzctytYevd32" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(24,078)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z60gCkEhpfQj" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (31,667)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zKStS9cI8FMl" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  135</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zrykKU4tylTf" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,449</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Computer equipment and goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zr9VOr2zaJV5" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,699</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zzDLh6oGBNQc" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 542</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_znuTwLyeSf8b" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,334)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zTVthrHYHQLd" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,682)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_z8tc2vzeEQFi" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_z15YYT9myRw9" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,300</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_z1JLRNnEkLV7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,902,395</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231_zCGupVcKbDn7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 746,573</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231_zsfe6FN354Ge" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (876,986)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231_zDBOyuAOwLVk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (71,928)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231_zEIuLZpKMDV9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  79,983</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_zqmFt8isQ3W6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,780,037</span></td></tr> </table> <p id="xdx_8A1_zYRt2r2o05z2" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, the expense related to the short-term and low-value leases was R$<span id="xdx_909_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn6n6_c20220101__20221231_zW8JMNNX9DO" title="Low-value leases expense">42</span> million (2021: R$<span id="xdx_90F_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn5n6_c20210101__20211231_zyxJhHgPdcdd" title="Low-value leases expense">7.2</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">To optimize lease costs during the lease term, the Company must provide guaranteed residual amounts for the leased asset. For certain lease agreements for rail cars, the Company guaranteed any difference between the flow of contractual payments and the fair value of these assets upon the end of the enforceable term, limited to R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231_zcNWC7VqAFF7" title="Contractual payments">65,529</span> as of December 31, 2022 (2021: R$<span id="xdx_90C_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231_zVS5TVEU3HXe" title="Contractual payments">70,085</span>).</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Lease liability</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease, or if that rate cannot be readily determined, the Company’s incremental borrowing rate. The lease liability considers the net present value of the following lease payments:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Fixed payments discounting any incentive received;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Variable payments based on rates or indexes;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Expected payables to the lessor referring to the guaranteed residual amount;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Exercise price of a purchase option, if it is reasonably certain that lessee will exercise such option; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Payment of fines for termination of the lease if the contractual terms provide for lessee’s exercise option.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s incremental borrowing rate corresponds to the one the Company would have pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use in a similar economic environment. The weighted average incremental rate applied in 2022 was <span id="xdx_909_ecustom--WeightedAverageIncrementalRate_pid_dp_c20220101__20221231_zRfoPbr4s9r" title="Weighted average incremental rate">5.8</span>% p.a. (2021: <span id="xdx_902_ecustom--WeightedAverageIncrementalRate_pid_dp_c20210101__20211231_zpyXEYj5NOGd" title="Weighted average incremental rate">5.18</span>% p.a.). The lease liability is measured at amortized cost.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes in lease liabilities:</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory_pn3n3_zlgdynruA8Be" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B6_zCwnqwC7yNm4" style="display: none">Schedule of changes in lease liabilities</span></td> <td id="xdx_491_20220101__20221231_zzVkJhAt7fd1" style="text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_495_20210101__20211231_zBqrPX3GBJoa" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 73%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--LeaseLiabilities_iS_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,207,886</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--AcquiredOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,232,043</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">746,573</span></td></tr> <tr id="xdx_406_ecustom--AdditionsThroughAcquisitionsOfErPlastics_zGcKcMA4PKx7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions through acquisition of ER Plastics</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,264</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--DisposalsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,568)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (50,473)</span></td></tr> <tr id="xdx_40F_ecustom--InterestsAndMonetaryAndExchangeVariationsNetOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interests and monetary and exchange variations, net</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  83,871</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">206,375</span></td></tr> <tr id="xdx_40D_ecustom--CurrancyTranslationAdjustmentsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Currancy translation adjustments </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (73,585)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  85,984</span></td></tr> <tr id="xdx_408_ecustom--PaymentsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (928,890)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (841,706)</span></td></tr> <tr id="xdx_40B_eifrs-full--InterestExpenseOnLeaseLiabilities_iN_pn3n3_di_zR4fA5fN8bXc" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest paid</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (221,019)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (198,225)</span></td></tr> <tr id="xdx_400_eifrs-full--LeaseLiabilities_iE_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31</span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,240,530</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liability</span></td> <td id="xdx_98E_ecustom--LeaseCurrentLiabilities_c20221231_pn3n3" style="text-align: right" title="Lease current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,039,706</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--LeaseCurrentLiabilities_c20211231_pn3n3" style="text-align: right" title="Lease current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">675,366</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liability</span></td> <td id="xdx_98B_ecustom--LeaseNonCurrentLiabilities_c20221231_pn3n3" style="text-align: right" title="Lease non current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,200,824</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LeaseNonCurrentLiabilities_c20211231_pn3n3" style="text-align: right" title="Lease non current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,481,048</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td id="xdx_98A_eifrs-full--LeaseLiabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,240,530</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LeaseLiabilities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td></tr> </table> <p id="xdx_8A9_zUIXPWAJT0tk" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The table below presents the obligations (minimum annual commitments) related to undiscounted lease agreements, by maturity, and therefore may not correspond to the respective operations in the statement of financial position.</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory_pn3n3_zOnmupkhkgVb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zIRM6yyjY5c2" style="display: none">Schedule of payment schedule by maturity</span></td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 38%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zuZJK2yyCYtj" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  777,410</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--MinimumAnnualCommitments_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,109,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zzk0AJmIiO48" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  633,141</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zcPKMRbUgQKg" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  855,803</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_z65qIm7ZLIvi" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  493,147</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zuF7caz6fu42" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  630,074</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zxHWKjV9kDyb" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  399,924</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026+</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z9rDCzTJf98h" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,388,252</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zeTNpMMg5Mba" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,073,620</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--MinimumAnnualCommitments_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,983,177</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231_z0tNNzMkcE47" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,377,242</span></td></tr> </table> <p id="xdx_8A6_zrBKWpHsAkOh" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Extension Options</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Some leases contain extension options that can be exercised by the Company. The extension options held are exercised only by the Company and not by the lessors. The Company assesses at lease commencement date whether it is reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control.</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(d)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Non-cash transactions</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, non-cash transactions are R$<span id="xdx_90F_eifrs-full--IncreaseDecreaseInNetInvestmentInFinanceLease_c20220101__20221231_pn3n3" title="Non-cash investing and financing activity">1,909,816</span> (2021: R$<span id="xdx_901_eifrs-full--IncreaseDecreaseInNetInvestmentInFinanceLease_c20210101__20211231_pn3n3" title="Non-cash investing and financing activity">565,774</span>).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #FE5000; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 3.8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(e)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Uninitiated lease arrangements</b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has committed to lease agreements not yet effective as of December 31, 2022. The present value of the commitments corresponds to R$ <span id="xdx_90A_ecustom--CommitmentsOfLeaseAgreement_pn6n6_c20220101__20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--UninitiatedLeaseArrangementsMember_zMxJPZHD3Qmc" title="Commitments of lease agreement">546</span> million, and the main agreements refer to: <span style="color: black">(i) construction of two vessels for ethane gas transportation; and (ii) a research and development laboratory located in Boston, United States. All have an expected completion date by 2024.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The cash flows related to the contracts are shown below:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfCashFlowtRrelatedToTheContractsExplanatory_pn3n3_zbpR1xm261Y6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B3_zH4nsLyGDn32" style="display: none">Schedule of cash flows related to the contracts</span></td> <td style="padding-left: 9px; text-align: left"> </td> <td style="text-align: right"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Discounted </span></td> <td style="color: white; font-weight: bold; text-align: center; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Undiscounted </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zglBfYTPfgI4" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,014</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zZmmO3804Chg" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,080</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zF2Q5qaJ6CGk" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">52,258</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zWIGIy7bBobh" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">55,678</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zdcpAqVWdu1" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">49,390</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zn30AFnSFQhf" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,067</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanSixYearsMember_zZITvW8Oanbj" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,687</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanSixYearsMember_z6iG8o59OWi4" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,468</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2027+</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanSixYearsAndNotLaterThanSevenYearsMember_zYUKtuqXYbBk" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 396,669</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanSixYearsAndNotLaterThanSevenYearsMember_z3NSSGTWTgAk" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 712,541</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231_z4twxQAtVMea" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  546,017</span></td> <td style="padding-right: 9px; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231_zyrL0lPjM2i4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  881,835</span></td></tr> </table> <p id="xdx_8A9_zRzml6xDEkXd" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory_pn3n3_zxsR9EXJ5lDe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zAwzWZhkotkf" style="display: none">Schedule of changes in right-of-use assets</span></td> <td> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 27%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposal</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> translation adjustment</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Rail cars</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zcr1tU1H2CGk" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  986,061</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  72,506</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (173,272)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DisposalOfRightofuseAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zV8HxfLewLte" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,359)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (53,740)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--RightofuseAssets_iE_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zMY22RuqqhWj" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  826,196</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Machinery and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zPMvPZVzq564" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  793,254</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,147,145</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (330,971)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DisposalOfRightofuseAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_z95334D3ELTk" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,970)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (804)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zNkstPuDMewc" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,602,654</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vessels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zHFWuhu9RoTb" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  696,661</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">811,372</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (385,968)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,793)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zQyGtfU85fRi" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,272</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Buildings and constructions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zUrKkAtApae6" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  265,312</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,040</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(75,319)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (213)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_z1E7BnQlLF17" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  291,820</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vehicles</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z3mWGC5CU0Ke" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,449</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,827</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,158)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (120)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z0sF6pBRjUzb" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,998</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Computer equipment and goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zTYnucFY3Qx6" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,300</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 417</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,590)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_pn3n3" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zXVop3N3x05e" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,047</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zQAsg35A8zQi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,780,037</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,236,307</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (995,278)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DisposalOfRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (11,329)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">(56,750)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zgAaksklTWtf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,952,987</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance as of</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">12/31/2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquisitions</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposal</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> translation adjustment</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">31/12/2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Rail cars</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zAU0Kf3zCyh9" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,007,336</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zDko55jb2qDd" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">102,648</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zarwueKN4J6l" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (187,915)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zjxVS8eXudse" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">63,992</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iE_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--RailCarsMember_zo6X9Zi1FKof" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  986,061</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Machinery and equipment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zYHAa30mmGae" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  749,728</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zTjvVGpU8rAe" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">281,113</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zf3PHOJWqLTc" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (207,985)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zABhbGJSODf6" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (30,245)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zLyBhz1hZrX2" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  643</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--MachineryAndEquipmentsMember_zExWJuhLanPh" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  793,254</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vessels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zuS7qqPJ3Qwh" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  834,848</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zpcnxpgAQ1Q4" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">258,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_z8U5lZHBinal" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (399,677)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zVMvvDWr5hGl" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,289</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ShipsMember_zNUtEU5REuX4" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  696,661</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Buildings and constructions</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zxYfTry9Xre1" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  259,896</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zHA7202yXtta" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  52,897</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zf5afgwL3Er6" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(52,997)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zkxfQTv4Yot7" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,333)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zFTMDACO4aCh" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,849</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--BuildingsAndConstructionsMember_zKvbuHPgajDe" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  265,312</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Vehicles</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zp2UDrcff7B8" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,888</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zMW3ypFaSVCe" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif">  51,171</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zzctytYevd32" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(24,078)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_z60gCkEhpfQj" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (31,667)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zKStS9cI8FMl" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  135</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--VehiclesMember_zrykKU4tylTf" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,449</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Computer equipment and goods</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zr9VOr2zaJV5" style="text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,699</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zzDLh6oGBNQc" style="text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 542</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_znuTwLyeSf8b" style="text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,334)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_zTVthrHYHQLd" style="text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,682)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_z8tc2vzeEQFi" style="text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--ComputerEquipmentMember_z15YYT9myRw9" style="text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,300</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_z1JLRNnEkLV7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,902,395</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--AcquisitionsRightofuseAssets_pn3n3_c20210101__20211231_zCGupVcKbDn7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Acquisitions"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 746,573</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_pn3n3_c20210101__20211231_zsfe6FN354Ge" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Depreciation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (876,986)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DisposalOfRightofuseAssets_pn3n3_c20210101__20211231_zDBOyuAOwLVk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Disposal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (71,928)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ForeignCurrencyTranslationAdjustmentRightofuseAssets_pn3n3_c20210101__20211231_zEIuLZpKMDV9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Foreign currency translation adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  79,983</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_zqmFt8isQ3W6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Right-of-use assets, Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,780,037</span></td></tr> </table> 986061000 72506000 -173272000 -5359000 -53740000 826196000 793254000 1147145000 -330971000 -5970000 -804000 1602654000 696661000 811372000 -385968000 -1793000 1120272000 265312000 102040000 -75319000 -213000 291820000 29449000 102827000 -26158000 -120000 105998000 9300000 417000 -3590000 -80000 6047000 2780037000 2236307000 -995278000 -11329000 -56750000 3952987000 1007336000 102648000 -187915000 63992000 986061000 749728000 281113000 -207985000 -30245000 643000 793254000 834848000 258201000 -399677000 3289000 696661000 259896000 52897000 -52997000 -6333000 11849000 265312000 33888000 51171000 -24078000 -31667000 135000 29449000 16699000 542000 -4334000 -3682000 75000 9300000 2902395000 746573000 -876986000 -71928000 79983000 2780037000 42000000 7200000 65529000 70085000 0.058 0.0518 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory_pn3n3_zlgdynruA8Be" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B6_zCwnqwC7yNm4" style="display: none">Schedule of changes in lease liabilities</span></td> <td id="xdx_491_20220101__20221231_zzVkJhAt7fd1" style="text-align: center"> </td> <td style="color: white"> </td> <td id="xdx_495_20210101__20211231_zBqrPX3GBJoa" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 73%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--LeaseLiabilities_iS_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,207,886</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--AcquiredOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Acquired</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,232,043</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">746,573</span></td></tr> <tr id="xdx_406_ecustom--AdditionsThroughAcquisitionsOfErPlastics_zGcKcMA4PKx7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions through acquisition of ER Plastics</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,264</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--DisposalsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Disposals</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,568)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (50,473)</span></td></tr> <tr id="xdx_40F_ecustom--InterestsAndMonetaryAndExchangeVariationsNetOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interests and monetary and exchange variations, net</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  83,871</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">206,375</span></td></tr> <tr id="xdx_40D_ecustom--CurrancyTranslationAdjustmentsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Currancy translation adjustments </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (73,585)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  85,984</span></td></tr> <tr id="xdx_408_ecustom--PaymentsOfLeaseLiabilities_i_pn3n3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (928,890)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (841,706)</span></td></tr> <tr id="xdx_40B_eifrs-full--InterestExpenseOnLeaseLiabilities_iN_pn3n3_di_zR4fA5fN8bXc" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest paid</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (221,019)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (198,225)</span></td></tr> <tr id="xdx_400_eifrs-full--LeaseLiabilities_iE_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31</span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,240,530</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liability</span></td> <td id="xdx_98E_ecustom--LeaseCurrentLiabilities_c20221231_pn3n3" style="text-align: right" title="Lease current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,039,706</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--LeaseCurrentLiabilities_c20211231_pn3n3" style="text-align: right" title="Lease current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">675,366</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liability</span></td> <td id="xdx_98B_ecustom--LeaseNonCurrentLiabilities_c20221231_pn3n3" style="text-align: right" title="Lease non current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,200,824</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LeaseNonCurrentLiabilities_c20211231_pn3n3" style="text-align: right" title="Lease non current liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,481,048</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td id="xdx_98A_eifrs-full--LeaseLiabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,240,530</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LeaseLiabilities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,156,414</span></td></tr> </table> 3156414000 3207886000 2232043000 746573000 4264000 -12568000 -50473000 83871000 206375000 -73585000 85984000 -928890000 -841706000 221019000 198225000 4240530000 3156414000 1039706000 675366000 3200824000 2481048000 4240530000 3156414000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory_pn3n3_zOnmupkhkgVb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zIRM6yyjY5c2" style="display: none">Schedule of payment schedule by maturity</span></td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 38%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zuZJK2yyCYtj" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  777,410</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--MinimumAnnualCommitments_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_pn3n3" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,109,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zzk0AJmIiO48" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  633,141</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zcPKMRbUgQKg" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  855,803</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_z65qIm7ZLIvi" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  493,147</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zuF7caz6fu42" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  630,074</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zxHWKjV9kDyb" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  399,924</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026+</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z9rDCzTJf98h" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,388,252</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zeTNpMMg5Mba" style="text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,073,620</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--MinimumAnnualCommitments_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,983,177</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--MinimumAnnualCommitments_iI_pn3n3_c20211231_z0tNNzMkcE47" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Total"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,377,242</span></td></tr> </table> 777410000 1109048000 633141000 855803000 493147000 630074000 399924000 2388252000 1073620000 4983177000 3377242000 1909816000 565774000 546000000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfCashFlowtRrelatedToTheContractsExplanatory_pn3n3_zbpR1xm261Y6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-of-use assets and lease liability (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B3_zH4nsLyGDn32" style="display: none">Schedule of cash flows related to the contracts</span></td> <td style="padding-left: 9px; text-align: left"> </td> <td style="text-align: right"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Discounted </span></td> <td style="color: white; font-weight: bold; text-align: center; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Undiscounted </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zglBfYTPfgI4" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,014</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zZmmO3804Chg" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,080</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zF2Q5qaJ6CGk" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">52,258</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zWIGIy7bBobh" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">55,678</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zdcpAqVWdu1" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">49,390</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zn30AFnSFQhf" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,067</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanSixYearsMember_zZITvW8Oanbj" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,687</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanSixYearsMember_z6iG8o59OWi4" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,468</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2027+</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanSixYearsAndNotLaterThanSevenYearsMember_zYUKtuqXYbBk" style="text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 396,669</span></td> <td style="padding-right: 9px; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--LaterThanSixYearsAndNotLaterThanSevenYearsMember_z3NSSGTWTgAk" style="text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 712,541</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CashFlowsRelatedToContractsDiscounted_iI_pn3n3_c20221231_z4twxQAtVMea" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cash flows related to the contracts discounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  546,017</span></td> <td style="padding-right: 9px; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CashFlowsRelatedToContractsUndiscounted_iI_pn3n3_c20221231_zyrL0lPjM2i4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cash flows related to the contracts undiscounted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  881,835</span></td></tr> </table> 1014000 1080000 52258000 55678000 49390000 56067000 46687000 56468000 396669000 712541000 546017000 881835000 <p id="xdx_808_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_znoBz39FrB04" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">15 <span id="xdx_826_zD7y11DVJgN6">Trade payables</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory_pn3n3_z6XA9guG1gd9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade payables (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span id="xdx_8B8_za1vDeJSvmab" style="display: none">Schedule or trade account payables</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 62%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade payables:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,748,853</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,492,223</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties (forfait)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zV64ww3UF8k3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 682,396</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zDciiHQZVnv5" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  487,806</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; font-style: italic; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total Third parties</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,431,249</span></td> <td style="color: white; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,980,029</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,440</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  208,287</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties (forfait)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zQbVToPlsgil" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,527</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zpKjbyphdQi9" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,148</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; font-style: italic; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total Related parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  277,967</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  248,435</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGlpKQ_____zxnuuLGhXJf3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,540,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGlpKQ_____z3kScSMWwEf7" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,936,266</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,249,851</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,164,730</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherCurrentPayables_c20221231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,246,782</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_c20211231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,053,266</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NoncurrentPayables_c20221231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,069</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentPayables_c20211231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  111,464</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231_z1RkLBg90VZ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,249,851</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231_zfRWkQ5jU4He" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,164,730</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F06_zGG0yyB8LNBh" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_zi6FmShbrLi2" style="font-family: Calibri, Helvetica, Sans-Serif">The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_z7J3AJpqBYjb" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zC5CrVyHnL84" style="font-family: Calibri, Helvetica, Sans-Serif">Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.</span></td></tr> </table> <p id="xdx_8AB_zllyJnqLaTL1" style="margin-top: 0; margin-bottom: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory_pn3n3_z6XA9guG1gd9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade payables (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span id="xdx_8B8_za1vDeJSvmab" style="display: none">Schedule or trade account payables</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 62%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade payables:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Domestic market</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,748,853</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,492,223</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties (forfait)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zV64ww3UF8k3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 682,396</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zDciiHQZVnv5" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  487,806</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; font-style: italic; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total Third parties</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,431,249</span></td> <td style="color: white; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,980,029</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,440</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_pn3n3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  208,287</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Related parties (forfait)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zQbVToPlsgil" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,527</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMarketMember_fKGkp_zpKjbyphdQi9" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,148</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; font-style: italic; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total Related parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">9</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--TradeAndOtherPayables_c20221231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  277,967</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_c20211231__ifrs-full--CounterpartiesAxis__custom--RelatedPartieForfaitMember_pn3n3" style="border-top: Black 0.5pt solid; font-style: italic; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  248,435</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign market</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third parties</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGlpKQ_____zxnuuLGhXJf3" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,540,635</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231__ifrs-full--CounterpartiesAxis__custom--ThirdPartiesMember__ifrs-full--GeographicalAreasAxis__custom--ForeignMarketMember_fKGlpKQ_____z3kScSMWwEf7" style="text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,936,266</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherPayables_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,249,851</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--TradeAndOtherPayables_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,164,730</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--TradeAndOtherCurrentPayables_c20221231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,246,782</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_c20211231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,053,266</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NoncurrentPayables_c20221231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,069</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentPayables_c20211231_pn3n3" style="text-align: right" title="Trade account payables, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  111,464</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231_z1RkLBg90VZ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,249,851</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20211231_zfRWkQ5jU4He" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Trade account payables"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,164,730</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F06_zGG0yyB8LNBh" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_zi6FmShbrLi2" style="font-family: Calibri, Helvetica, Sans-Serif">The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_z7J3AJpqBYjb" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zC5CrVyHnL84" style="font-family: Calibri, Helvetica, Sans-Serif">Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries.</span></td></tr> </table> 1748853000 1492223000 682396000 487806000 2431249000 1980029000 196440000 208287000 81527000 40148000 277967000 248435000 9540635000 9936266000 12249851000 12164730000 12246782000 12053266000 3069000 111464000 12249851000 12164730000 <p id="xdx_800_eifrs-full--DisclosureOfBorrowingsExplanatory_zIkTFhCKhzG7" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">16 <span id="xdx_829_zufN6C2RAUZf">Borrowings</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Borrowings</b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfBorrowingsInformationExplanatory_pn3n3_z6L0RSjTt8Bf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details)"> <tr> <td style="padding-left: 10pt; vertical-align: bottom; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B7_zXolwrlKJ1Kk" style="display: none">Schedule of borrowings</span></span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 39%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Annual financial charges (%)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (b)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember_zVZv0LrQ1rcl" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26,124,158</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember_zWc8U60FVx34" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,322,998</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayment and export credit notes</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportPrepaymentMember_fKGkp_zo8MvdDSuMKh" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$ exchange variation + Term SOFR quarterly + 1,79</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportPrepaymentMember_fKGkp_zOeskZ1P7Ude" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,514,651</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (c)</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,880,165</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,703,059</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (453,532)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">(594,048)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zXcURWDhVmOi" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,065,442</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zLs8j2STbcD3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,432,009</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermBorrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,177,144</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermBorrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,284,483</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  29,888,298</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,147,526</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,065,442</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,432,009</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Local currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 10pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Agribusiness Credit Notes ("CRA")</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--AgribusinessCreditNotesMember_z8dcz89MAR6h" style="vertical-align: bottom" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (d)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Borrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--AgribusinessCreditNotesMember_zUWEdL2Gjhba" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 763,396</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td style="padding-left: 10pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNDES</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_zUNgGuA3zvhj" style="vertical-align: bottom" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA + 6.04</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_zL0tuEVWC77f" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 386,534</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_ztauAtOcnkqd" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  435,778</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export credit notes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportCreditNotes1Member" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">100.00 of CDI + 1.30</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportCreditNotes1Member_zpPQkBHh21y5" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 348,885</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other fixed interest loans</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zo06HRj2Ugfh" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest between 3.5 and 6.5</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zUUgNhmKXo91" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,671</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zm6qWCx4m0Pj" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,864</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other variable interest loans</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_zX9k6LqnTkn2" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA + interest between 2.39 and 2.78</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_z0Uk3gteX5C9" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,525</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_zwlLvLJxcUfk" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,616</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (21,193)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_znmxMGj4DEia" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_zNgCHTp01tV" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,499,818</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_z96qbZVPMYQ" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">465,251</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermBorrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,406</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShorttermBorrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 59,011</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,422,412</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  406,240</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,499,818</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">465,251</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency and local currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermBorrowings_c20221231_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,254,550</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShorttermBorrowings_c20211231_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,343,494</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_c20221231_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,310,710</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_c20211231_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,553,766</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Borrowings_iI_pn3n3_c20221231_zUeAqMAT0s85" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  32,565,260</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Borrowings_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,897,260</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F00_zollWozWfz69" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F14_ze9MQw5sdAX9" style="font-family: Calibri, Helvetica, Sans-Serif">Maturity in June 2027.</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p id="xdx_8A5_zBHvVnlAT948" style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt; text-indent: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The maturity profile of the long-term borrowings is as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfLongTermBorrowingsMaturitiesExplanatory_pn3n3_znRjQVIjFDod" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BE_zVLjA6SnwAX1" style="display: none">Schedule of long-term maturities</span></td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 67%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_zaClIsWYxCqg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,199,143</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zbhuwTWR6tSh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,143,624</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zZ3DylKTaBle" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,965,917</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zuRupx27PmAk" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  603,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zP5YkIeElZAh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  645,517</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zL3pwRa3Skj1" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  581,625</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zCCFWlrtbdl4" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  622,032</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2027</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zJmxiJgY2bXg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,356,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_z1mtL13mn1hh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  552,171</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2028</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyEightMember_zCIqAcEmKPZg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,281,841</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyEightMember_z7me2r1ksIW7" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,081,301</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_z1XeG7cOjxtd" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  287,178</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_zq04Z9rTKXY" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  230,557</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyThirtyMember_zljNiPKkCivh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,995,727</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyThirtyMember_z8UcDf56OjS7" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,535,493</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyThirtyOneMember_zu44jD9GcKH5" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,661</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyThirtyOneMember_zgaeZiMcMGW8" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,617</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2033 and thereafter</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirtyThreeAndThereafterMember_zld93StiqnOj" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,953,633</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--ThirtyThreeAndThereafterMember_zNxzE9sFgN57" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,660,018</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231_zaYirN2HyOQb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">31,310,710</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231_zEGWxMhvmUD2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,553,766</span></td></tr> </table> <p id="xdx_8AE_zOccybzIYtaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Bonds</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfBondsExplanatory_pn3n3_ziHWYAqcwYDg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 2)"> <tr> <td style="vertical-align: bottom; text-align: left"><span id="xdx_8B9_zGqv6JwKf6E9" style="display: none">Schedule of bonds</span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: middle; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(% per year)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td colspan="2" style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zqOQKTgTQYuc" title="Issue date">Jul-2011 and jul-2012</span></span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zSGGfXGt371" title="Maturity">jul-2041</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zc0i98osmlfd" title="Interest (% per year)">7.125</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zxGWJt7ylYC4" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,044,911</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zZJm6F1VGzN7" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,296,917</span></td></tr> <tr> <td colspan="2" style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zVQLf9LaxnK4" title="Issue date">Feb-2014 and may-2014</span></span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zzgolJ9cyCh6" title="Maturity">fev-2024</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zNqIKE5xLMmj" title="Interest (% per year)">6.450</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zzKXwuygTWg8" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,588,729</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zVKbbTznOwZg" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,417,741</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zZ9UFdkEmjQj" title="Issue date">Oct-2017</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zfWKrwDtc9m7" title="Maturity">jan-2023</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zHpTGm5KrM97" title="Interest (% per year)">3.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____z0EKaBCSfG47" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 593,964</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zJECIbcpPoZa" title="Issue date">Oct-2017</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zUEdnOFKfQBb" title="Maturity">jan-2028</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zsZt1tpBzdZb" title="Interest (% per year)">4.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zEETBzaDQoN9" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,249,333</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zoDj6jdblcR1" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,695,263</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zm5myCgvRVX2" title="Issue date">Nov-2019</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_z8IljLU5HsCk" title="Maturity">jan-2030</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zgpOQztTLLX9" title="Interest (% per year)">4.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zYEHL5R4T4Gl" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,936,089</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_z646N5c3666k" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 8,527,701</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member" title="Issue date">Nov-2019</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member" title="Maturity">jan-2050</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_zdB6AmlKulM6" title="Interest (% per year)">5.875</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NetDebt_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_pn3n3" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,009,069</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_zAPSpiOXGb6g" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,287,829</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zN9Z0Y9VQfH" title="Issue date">Jul-2020</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zm1EOsUhh1c7" title="Maturity">jan-2081</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zwSF71KArXM2" title="Interest (% per year)">8.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zRYBnfGvJgKa" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,296,027</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zVfyVrQLEXT9" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,503,583</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NetDebt_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,124,158</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zmZXWo9v1dcb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  30,322,998</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0E_zVCSbjgMyHki" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_znNQVEriivD1" style="font-family: Calibri, Helvetica, Sans-Serif">Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F07_zbPkg2SqIok8" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zbfn60qTmFT" style="font-family: Calibri, Helvetica, Sans-Serif">Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zJ2b5eHHhYfg" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zLnl5FvUseKc" style="font-family: Calibri, Helvetica, Sans-Serif">The bond can be repaid by the Company at par value, with the first payment between October 2025 and January 2026 and the other payments after each period of 5 years as from the first payment.</span></td></tr> </table> <p id="xdx_8AA_z4nczJT4qsC4" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem has fully, unconditionally and irrevocably, guaranteed the bonds issued by Braskem Finance, Braskem America Finance and Braskem Holanda Finance. Braskem’s guarantees for issues carried out between 2011 and 2019 comprise senior unsecured obligations of Braskem, ranking equal in right of payment with all of its other existing and future senior unsecured debt. As for the issuance carried out in 2020, in case of default the guarantee comprises obligations subordinated to all current or future senior debts of Braskem.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Other</b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfFinancingsForInvestmentsInPlantsExplanatory_pn3n3_zZ3JjuogtMw6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B6_zL5ewjKWqkxj" style="display: none">Schedule of others</span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left; width: 48%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">nov-2018</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGlpKQ_____zaO56gHMTLUj" title="Borrowings, maturity">nov-2028</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zuH3XIujyPQe" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.90</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zammNRvi8Trh" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 929,112</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zbRDg9fGdiD5" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,154,146</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">dec-2019</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGlpKQ_____zIqQ5KtSjQea" title="Borrowings, maturity">dec-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zvd8j8OhHe84" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.90</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zOfq2jStEPJ3" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 549,610</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zcfIpNyPqcz2" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 670,124</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">dec-2019</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zJeigcFC8rD1" title="Borrowings, maturity">apr-2026</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zfLCwkFoeZu8" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor - 1.00 </span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____znAV1qsnILgf" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 197,209</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zmMShrvFGD98" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 266,403</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">sep-2017</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zvG0kbmt7fx6" title="Borrowings, maturity">mar-2027</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___z9sdR9019Ke6" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 1.61</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zVw0cfXgrcda" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 357,488</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zI8RgFnqS7t7" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 462,490</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">jul-2018</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zHcvE24D6J47" title="Borrowings, maturity">dec-2028</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zDUcGe0Woxoa" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.65</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zulAy8HSHLdb" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 757,832</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zbGJP4mxpnV5" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 947,898</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">aug-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zmj2Qtt8iFed" title="Borrowings, maturity">feb-2031</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zOmuFN0l9Ek" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 1.70</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___z7GWyuX8E1G1" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,007,067</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zqot6sz2bZNd" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,201,998</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">aug-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_ztjPLzseXuai" title="Borrowings, maturity">aug-2028 to jun-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_zv8uxb5P0eN7" title="Borrowings, interest rate basis">Euro exchange variation + interest between 2.40 and 7.41</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_zpLDChP7vrn3" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">79,698</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">nov-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_zmT3a7AsZ5F7" title="Borrowings, maturity">no maturity</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_fKHYp_zY9RcLiOw7A6" title="Borrowings, interest rate basis">Euro exchange variation + Euribor monthly + 4.10</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_fKHYp_zRyeETXiNxld" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,149</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--BorrowingsOne_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyThreeMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,880,165</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--BorrowingsTwo_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyThreeMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings two"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,703,059</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F08_z9lhj6C5ysVd" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span id="xdx_F1F_zUF06FJSGZFf" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt; color: black">Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F02_zVqxatVtskyf" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td><td><span id="xdx_F1C_z91L0ImIQWP5" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0E_zIJgLhVPIOz2" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td><td><span id="xdx_F16_z4ZwjwrD38hd" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0D_zA0oUaFQGpo7" style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td><td><span id="xdx_F13_zF8HaNwXUD65" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million. </span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0B_zOkX099cDA2h" style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td><td><span id="xdx_F16_zsEcz1RsTGf8" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.</span></td></tr></table> <p id="xdx_8A6_zVBh7e4VLNf4" style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 9pt 0 0 28.35pt; text-indent: -14.15pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000"><b>(d) </b></span><b><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #EC6607">CRA</span></b></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 9pt 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On January 5, 2022, Eco Securitizadora de Direitos Creditórios do Agronegócio S.A. issued CRA in the Brazilian debt capital markets backed by a private debenture issued by Braskem.</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfOthersCRAExplanatory_pn3n3_z6jEsjiJ3vlg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 4)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B8_zqFmMO0x4G48" style="display: none">Schedule of others - CRA</span></td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue amount</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issuer</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Series</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zkrWoGXkEdr3" title="Issue date">Jan-2022</span></span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zIhjXMJym7cl" style="text-align: right; width: 12%" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  581,602</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Braskem S.A. </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zjr4QpMO9Iu7" title="Maturity">Dec-2028</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left; width: 24%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_z4kXMogzBKxd" title="Borrowings interest rate basis">IPCA + 5.54%</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zv3qk7soEESa" style="text-align: right; width: 10%" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">616,025</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zuQNbY7kGSA8" title="Issue date">Jan-2022</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zYKUwa5UgFS2" style="text-align: right" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  139,134</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Braskem S.A. </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zS3Bz3aWE6W1" title="Maturity">Dec-2031</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zQYp52NHZYge" title="Borrowings interest rate basis">IPCA + 5.57%</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zIWi3CbeDD06" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">147,371</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zcSfVGPD6GCe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">720,736</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zF26vv6E2xsi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 763,396</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 14.2pt"/> <p id="xdx_8AD_zAjFwwgodGD8" style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 9pt 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfBorrowingsInformationExplanatory_pn3n3_z6L0RSjTt8Bf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details)"> <tr> <td style="padding-left: 10pt; vertical-align: bottom; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B7_zXolwrlKJ1Kk" style="display: none">Schedule of borrowings</span></span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 39%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Annual financial charges (%)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (b)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember_zVZv0LrQ1rcl" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26,124,158</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BondMember_zWc8U60FVx34" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,322,998</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayment and export credit notes</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportPrepaymentMember_fKGkp_zo8MvdDSuMKh" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$ exchange variation + Term SOFR quarterly + 1,79</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportPrepaymentMember_fKGkp_zOeskZ1P7Ude" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,514,651</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (c)</span></td> <td style="color: red"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,880,165</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherBorrowingsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,703,059</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (453,532)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">(594,048)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zXcURWDhVmOi" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,065,442</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zLs8j2STbcD3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,432,009</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermBorrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,177,144</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermBorrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,284,483</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  29,888,298</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,147,526</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,065,442</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,432,009</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Local currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 10pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Agribusiness Credit Notes ("CRA")</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--AgribusinessCreditNotesMember_z8dcz89MAR6h" style="vertical-align: bottom" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note 16 (d)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Borrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--AgribusinessCreditNotesMember_zUWEdL2Gjhba" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 763,396</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td style="padding-left: 10pt; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNDES</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_zUNgGuA3zvhj" style="vertical-align: bottom" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA + 6.04</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_zL0tuEVWC77f" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 386,534</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--BNDESMember_ztauAtOcnkqd" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  435,778</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export credit notes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportCreditNotes1Member" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">100.00 of CDI + 1.30</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--ExportCreditNotes1Member_zpPQkBHh21y5" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 348,885</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other fixed interest loans</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zo06HRj2Ugfh" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest between 3.5 and 6.5</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zUUgNhmKXo91" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,671</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherFixedInterestLoansMember_zm6qWCx4m0Pj" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,864</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other variable interest loans</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DescriptionOfBorrowingInterestRate_c20220101__20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_zX9k6LqnTkn2" title="Description of borrowing interest rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA + interest between 2.39 and 2.78</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_z0Uk3gteX5C9" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,525</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherVariableInterestLoansMember_zwlLvLJxcUfk" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,616</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (21,193)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_znmxMGj4DEia" style="text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_zNgCHTp01tV" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,499,818</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Borrowings_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_z96qbZVPMYQ" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">465,251</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermBorrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,406</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShorttermBorrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 59,011</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,422,412</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  406,240</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Borrowings_c20221231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,499,818</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Borrowings_c20211231__srt--CurrencyAxis__custom--LocalCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">465,251</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency and local currency</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermBorrowings_c20221231_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,254,550</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShorttermBorrowings_c20211231_pn3n3" style="text-align: right" title="Current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,343,494</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_c20221231_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,310,710</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_c20211231_pn3n3" style="text-align: right" title="Non-current portion of non-current borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,553,766</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Borrowings_iI_pn3n3_c20221231_zUeAqMAT0s85" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  32,565,260</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Borrowings_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">34,897,260</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F00_zollWozWfz69" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F14_ze9MQw5sdAX9" style="font-family: Calibri, Helvetica, Sans-Serif">Maturity in June 2027.</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> Note 16 (b) 26124158000 30322998000 US$ exchange variation + Term SOFR quarterly + 1,79 1514651000 Note 16 (c) 3880165000 4703059000 -453532000 -594048000 31065442000 34432009000 1177144000 1284483000 29888298000 33147526000 31065442000 34432009000 Note 16 (d) 763396000 IPCA + 6.04 386534000 435778000 100.00 of CDI + 1.30 348885000 Interest between 3.5 and 6.5 18671000 24864000 IPCA + interest between 2.39 and 2.78 3525000 4616000 -21193000 -7000 1499818000 465251000 77406000 59011000 1422412000 406240000 1499818000 465251000 1254550000 1343494000 31310710000 33553766000 32565260000 34897260000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfLongTermBorrowingsMaturitiesExplanatory_pn3n3_znRjQVIjFDod" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BE_zVLjA6SnwAX1" style="display: none">Schedule of long-term maturities</span></td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 67%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_zaClIsWYxCqg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,199,143</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zbhuwTWR6tSh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,143,624</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zZ3DylKTaBle" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,965,917</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zuRupx27PmAk" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  603,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zP5YkIeElZAh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  645,517</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zL3pwRa3Skj1" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  581,625</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zCCFWlrtbdl4" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  622,032</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2027</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zJmxiJgY2bXg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,356,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_z1mtL13mn1hh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  552,171</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2028</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyEightMember_zCIqAcEmKPZg" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,281,841</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyEightMember_z7me2r1ksIW7" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,081,301</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_z1XeG7cOjxtd" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  287,178</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_zq04Z9rTKXY" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  230,557</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyThirtyMember_zljNiPKkCivh" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,995,727</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyThirtyMember_z8UcDf56OjS7" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,535,493</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyThirtyOneMember_zu44jD9GcKH5" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,661</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyThirtyOneMember_zgaeZiMcMGW8" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,617</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2033 and thereafter</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirtyThreeAndThereafterMember_zld93StiqnOj" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,953,633</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--ThirtyThreeAndThereafterMember_zNxzE9sFgN57" style="text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,660,018</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn3n3_c20221231_zaYirN2HyOQb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">31,310,710</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn3n3_c20211231_zEGWxMhvmUD2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,553,766</span></td></tr> </table> 1199143000 2143624000 3965917000 603743000 645517000 581625000 622032000 2356678000 552171000 7281841000 7081301000 287178000 230557000 7995727000 8535493000 106661000 61617000 9953633000 10660018000 31310710000 33553766000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfBondsExplanatory_pn3n3_ziHWYAqcwYDg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 2)"> <tr> <td style="vertical-align: bottom; text-align: left"><span id="xdx_8B9_zGqv6JwKf6E9" style="display: none">Schedule of bonds</span></td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: middle; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(% per year)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td colspan="2" style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zqOQKTgTQYuc" title="Issue date">Jul-2011 and jul-2012</span></span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zSGGfXGt371" title="Maturity">jul-2041</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zc0i98osmlfd" title="Interest (% per year)">7.125</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zxGWJt7ylYC4" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,044,911</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds1Member_fKGkp_zZJm6F1VGzN7" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,296,917</span></td></tr> <tr> <td colspan="2" style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zVQLf9LaxnK4" title="Issue date">Feb-2014 and may-2014</span></span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zzgolJ9cyCh6" title="Maturity">fev-2024</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zNqIKE5xLMmj" title="Interest (% per year)">6.450</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zzKXwuygTWg8" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,588,729</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds2Member_fKGlpKQ_____zVKbbTznOwZg" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,417,741</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zZ9UFdkEmjQj" title="Issue date">Oct-2017</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zfWKrwDtc9m7" title="Maturity">jan-2023</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____zHpTGm5KrM97" title="Interest (% per year)">3.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="color: White; font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">–</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds3Member_fKGlpKQ_____z0EKaBCSfG47" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 593,964</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zJECIbcpPoZa" title="Issue date">Oct-2017</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zUEdnOFKfQBb" title="Maturity">jan-2028</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zsZt1tpBzdZb" title="Interest (% per year)">4.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zEETBzaDQoN9" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,249,333</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds4Member_fKGkp_zoDj6jdblcR1" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,695,263</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zm5myCgvRVX2" title="Issue date">Nov-2019</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_z8IljLU5HsCk" title="Maturity">jan-2030</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zgpOQztTLLX9" title="Interest (% per year)">4.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_zYEHL5R4T4Gl" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,936,089</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds5Member_fKGkp_z646N5c3666k" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 8,527,701</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member" title="Issue date">Nov-2019</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member" title="Maturity">jan-2050</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_zdB6AmlKulM6" title="Interest (% per year)">5.875</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NetDebt_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_pn3n3" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,009,069</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds6Member_zAPSpiOXGb6g" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,287,829</span></td></tr> <tr> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zN9Z0Y9VQfH" title="Issue date">Jul-2020</span></span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_ecustom--BorrowingsMaturity1_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zm1EOsUhh1c7" title="Maturity">jan-2081</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zwSF71KArXM2" title="Interest (% per year)">8.500</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NetDebt_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zRYBnfGvJgKa" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,296,027</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--Bonds7Member_fKGlpKQ_____zVfyVrQLEXT9" style="vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,503,583</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NetDebt_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,124,158</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zmZXWo9v1dcb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  30,322,998</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0E_zVCSbjgMyHki" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F1A_znNQVEriivD1" style="font-family: Calibri, Helvetica, Sans-Serif">Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F07_zbPkg2SqIok8" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F11_zbfn60qTmFT" style="font-family: Calibri, Helvetica, Sans-Serif">Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zJ2b5eHHhYfg" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zLnl5FvUseKc" style="font-family: Calibri, Helvetica, Sans-Serif">The bond can be repaid by the Company at par value, with the first payment between October 2025 and January 2026 and the other payments after each period of 5 years as from the first payment.</span></td></tr> </table> Jul-2011 and jul-2012 jul-2041 0.07125 3044911000 3296917000 Feb-2014 and may-2014 fev-2024 0.06450 1588729000 3417741000 Oct-2017 jan-2023 0.03500 593964000 Oct-2017 jan-2028 0.04500 6249333000 6695263000 Nov-2019 jan-2030 0.04500 7936089000 8527701000 Nov-2019 jan-2050 0.05875 4009069000 4287829000 Jul-2020 jan-2081 0.08500 3296027000 3503583000 26124158000 30322998000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfFinancingsForInvestmentsInPlantsExplanatory_pn3n3_zZ3JjuogtMw6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B6_zL5ewjKWqkxj" style="display: none">Schedule of others</span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left; width: 48%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">nov-2018</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGlpKQ_____zaO56gHMTLUj" title="Borrowings, maturity">nov-2028</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zuH3XIujyPQe" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.90</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zammNRvi8Trh" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 929,112</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI1Member_fKGkp_zbRDg9fGdiD5" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,154,146</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">dec-2019</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGlpKQ_____zIqQ5KtSjQea" title="Borrowings, maturity">dec-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zvd8j8OhHe84" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.90</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zOfq2jStEPJ3" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 549,610</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI2Member_fKGkp_zcfIpNyPqcz2" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 670,124</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">dec-2019</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zJeigcFC8rD1" title="Borrowings, maturity">apr-2026</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zfLCwkFoeZu8" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor - 1.00 </span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____znAV1qsnILgf" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 197,209</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI3Member_fKGlpKQ_____zmMShrvFGD98" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 266,403</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">sep-2017</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zvG0kbmt7fx6" title="Borrowings, maturity">mar-2027</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___z9sdR9019Ke6" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 1.61</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zVw0cfXgrcda" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 357,488</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI4Member_fKGlpaSk___zI8RgFnqS7t7" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 462,490</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">jul-2018</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zHcvE24D6J47" title="Borrowings, maturity">dec-2028</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zDUcGe0Woxoa" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 0.65</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zulAy8HSHLdb" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 757,832</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI5Member_fKGl2KQ_____zbGJP4mxpnV5" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 947,898</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">aug-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zmj2Qtt8iFed" title="Borrowings, maturity">feb-2031</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zOmuFN0l9Ek" title="Borrowings, interest rate basis">Us dollar exchange variation + semianual Libor + 1.70</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___z7GWyuX8E1G1" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,007,067</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--BorrowingsOne_iI_pn3n3_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI6Member_fKGlpaSk___zqot6sz2bZNd" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,201,998</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">aug-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_ztjPLzseXuai" title="Borrowings, maturity">aug-2028 to jun-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_zv8uxb5P0eN7" title="Borrowings, interest rate basis">Euro exchange variation + interest between 2.40 and 7.41</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI7Member_fKHYp_zpLDChP7vrn3" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">79,698</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">nov-2020</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_zmT3a7AsZ5F7" title="Borrowings, maturity">no maturity</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_fKHYp_zY9RcLiOw7A6" title="Borrowings, interest rate basis">Euro exchange variation + Euribor monthly + 4.10</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherNEXI8Member_fKHYp_zRyeETXiNxld" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,149</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--BorrowingsOne_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyThreeMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,880,165</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--BorrowingsTwo_c20211231__srt--CurrencyAxis__custom--ForeignCurrencyThreeMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings two"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,703,059</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F08_z9lhj6C5ysVd" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span id="xdx_F1F_zUF06FJSGZFf" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt; color: black">Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F02_zVqxatVtskyf" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td><td><span id="xdx_F1C_z91L0ImIQWP5" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0E_zIJgLhVPIOz2" style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td><td><span id="xdx_F16_z4ZwjwrD38hd" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0D_zA0oUaFQGpo7" style="font-family: Calibri, Helvetica, Sans-Serif">(iv)</span></td><td><span id="xdx_F13_zF8HaNwXUD65" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million. </span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 9pt; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0B_zOkX099cDA2h" style="font-family: Calibri, Helvetica, Sans-Serif">(v)</span></td><td><span id="xdx_F16_zsEcz1RsTGf8" style="font-family: Calibri, Helvetica, Sans-Serif">Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest.</span></td></tr></table> nov-2028 Us dollar exchange variation + semianual Libor + 0.90 929112000 1154146000 dec-2029 Us dollar exchange variation + semianual Libor + 0.90 549610000 670124000 apr-2026 Us dollar exchange variation + semianual Libor - 1.00  197209000 266403000 mar-2027 Us dollar exchange variation + semianual Libor + 1.61 357488000 462490000 dec-2028 Us dollar exchange variation + semianual Libor + 0.65 757832000 947898000 feb-2031 Us dollar exchange variation + semianual Libor + 1.70 1007067000 1201998000 aug-2028 to jun-2029 Euro exchange variation + interest between 2.40 and 7.41 79698000 no maturity Euro exchange variation + Euribor monthly + 4.10 2149000 3880165000 4703059000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfOthersCRAExplanatory_pn3n3_z6jEsjiJ3vlg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Borrowings (Details 4)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B8_zqFmMO0x4G48" style="display: none">Schedule of others - CRA</span></td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue amount</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issuer</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Series</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zkrWoGXkEdr3" title="Issue date">Jan-2022</span></span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zIhjXMJym7cl" style="text-align: right; width: 12%" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  581,602</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Braskem S.A. </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zjr4QpMO9Iu7" title="Maturity">Dec-2028</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left; width: 24%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_z4kXMogzBKxd" title="Borrowings interest rate basis">IPCA + 5.54%</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA1Member_zv3qk7soEESa" style="text-align: right; width: 10%" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">616,025</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zuQNbY7kGSA8" title="Issue date">Jan-2022</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zYKUwa5UgFS2" style="text-align: right" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  139,134</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Braskem S.A. </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zS3Bz3aWE6W1" title="Maturity">Dec-2031</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zQYp52NHZYge" title="Borrowings interest rate basis">IPCA + 5.57%</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember__ifrs-full--BorrowingsByNameAxis__custom--OtherCRA2Member_zIWi3CbeDD06" style="text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif">147,371</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NotionalAmount1_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zcSfVGPD6GCe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Notional amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">720,736</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BorrowingsOne_iI_pn3n3_c20221231__srt--CurrencyAxis__custom--ForeignCurrencyMember_zF26vv6E2xsi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings one"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 763,396</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 14.2pt"/> Jan-2022 581602000 Dec-2028 IPCA + 5.54% 616025000 Jan-2022 139134000 Dec-2031 IPCA + 5.57% 147371000 720736000 763396000 <p id="xdx_801_eifrs-full--DisclosureOfNoncontrollingInterestsExplanatory_zxqJVtRHV4te" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">17 <span id="xdx_820_zFrWfyZDMx4">Braskem Idesa Borrowings</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfOtherBorrowingsExplanatory_pn3n3_ziSOc7lalOsj" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Braskem Idesa Borrowings (Details)"> <tr> <td style="vertical-align: bottom; width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B0_zRuTjZVZEJZe" style="display: none">Schedule of braskem idesa financing</span></span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 44%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold; font-style: italic; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-style: italic; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond I</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zQzzw4ZGBBFg" title="Borrowings, maturity">nov-2029</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zj7CmzFaqYw4" title="Borrowings, interest rate basis">Us dollar exchange variation + 7.45</span></span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98A_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zvLLGMEZiHF5" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,690,619</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zJWCX8PqyYRa" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,104,463</span></td></tr> <tr> <td style="font-style: italic; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond II</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____z25akslq7uR7" title="Borrowings, maturity">feb-2032</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zveSyWLqroJl" title="Borrowings, interest rate basis">Us dollar exchange variation + 6.99</span></span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_98D_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zZJu4ikLxEOa" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,352,864</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zo9fawUIvux" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,834,805</span></td></tr> <tr> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BraskemIdesaBorrowings_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,043,483</span></td> <td style="color: white; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231_zsvlb0LfKBzc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,939,268</span></td></tr> <tr> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="text-decoration: underline; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Others</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zkVvxDg5tZP7" title="Borrowings, maturity">Oct-2026</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zCrOk0yp5Qbg" title="Borrowings, interest rate basis">Us dollar exchange variation + quarterly Libor + 4.00</span></span></td> <td id="xdx_F45_z39mlejZlXHf" style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td id="xdx_983_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zBRbDuRTGHse" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">734,837</span></td> <td style="color: white; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zRKF0gqA65i3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  849,859</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BraskemIdesaBorrowings_c20221231__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (408,002)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_zRo7BPTiLZV5" style="text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (477,592)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NonCurrentBraskemIdesaBorrowings3_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,370,318</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20211231_zUuS4ey2gMKd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,311,535</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CurrentBraskemIdesaBorrowings_c20221231_pn3n3" style="text-align: right" title="Current braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  868,635</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--CurrentBraskemIdesaBorrowings_iI_pn3n3_c20211231_z02DQbfnyzA5" style="text-align: right" title="Current braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">86,765</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--NonCurrentBraskemIdesaBorrowings1_c20221231_pn3n3" style="text-align: right" title="Non current braskem idesa borrowings1"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,501,683</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NonCurrentBraskemIdesaBorrowings1_iI_pn3n3_c20211231_zgcRNlqz3uw2" style="text-align: right" title="Non current braskem idesa borrowings1"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,224,770</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20221231_z8MVWymETl36" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,370,318</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20211231_zJp95hltSoAj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,311,535</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0D_z5DYSbvo0eX1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span id="xdx_F1E_z6r73yoo0Jog" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt; color: black">Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F03_zKuqIs0A2ITh" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(ii)</span></td><td><span id="xdx_F1D_zRz7IJoji533" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F02_zpk3DW7cen9g" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iii)</span></td><td><span id="xdx_F10_zDALMfhY1efc" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.</span></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zl3cQfPMADW6" style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zZ3WHUoHq74e" style="font-family: Calibri, Helvetica, Sans-Serif">Regarding this financing, on December 22, 2022 Braskem Idesa obtained the waiver related to a leverage ratio (covenant) until June 30, 2023. In this sense, even though Braskem Idesa is not in default and creditors did not request to accelerate this debt, because the waiver did not cover at least 12 months, the entire balance, in the amount of R$649,560, was reclassified from non-current liabilities to current liabilities on December 31, 2022.</span></td></tr> </table> <p id="xdx_8A8_zz1oDBT0DIpk" style="font: 1pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa is in full compliance with its debt service obligation defined in the financing agreement and maintains a cash position equivalent to R$<span id="xdx_90F_eifrs-full--CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_iI_pn3n3_c20221231_zvdyiDls9In9" title="Cash position equivalent">2,184,332</span> as of December 31, 2022.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The amount of the financings with maturities in the long term are as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfOtherBorrowingsAmortizationExplanatory_pn3n3_zFaQvyZlflrk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Braskem Idesa Borrowings (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B0_z2vdub74a6vd" style="display: none">Schedule of long-term maturities of these financing</span></td> <td style="text-align: left"> </td> <td style="color: white; text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 68%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyTwoMember_zC3iu5aIS4Sc" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">67,649</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_z3QHzvSbqyk2" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">68,694</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_ztG5W8K88pO4" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,530</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zjPQkVsEnovl" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 408,445</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zdUu6KTAJQEa" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,337,567</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zuShHBjKwaci" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,900,399</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zDTwzMyt7y1f" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,164,116</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zKvfV5b0aRs4" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,710,053</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OriginalLongtermMaturities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,501,683</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OriginalLongtermMaturities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,224,770</span></td></tr> </table> <p id="xdx_8A9_z4A0CAW5VOFd" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfOtherBorrowingsExplanatory_pn3n3_ziSOc7lalOsj" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Braskem Idesa Borrowings (Details)"> <tr> <td style="vertical-align: bottom; width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B0_zRuTjZVZEJZe" style="display: none">Schedule of braskem idesa financing</span></span></td> <td style="vertical-align: bottom; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 44%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Charges (% per year)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold; font-style: italic; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-style: italic; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond I</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zQzzw4ZGBBFg" title="Borrowings, maturity">nov-2029</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zj7CmzFaqYw4" title="Borrowings, interest rate basis">Us dollar exchange variation + 7.45</span></span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98A_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zvLLGMEZiHF5" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,690,619</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--BondMember_fKGkp_zJWCX8PqyYRa" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,104,463</span></td></tr> <tr> <td style="font-style: italic; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond II</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____z25akslq7uR7" title="Borrowings, maturity">feb-2032</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zveSyWLqroJl" title="Borrowings, interest rate basis">Us dollar exchange variation + 6.99</span></span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_98D_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zZJu4ikLxEOa" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,352,864</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--BondIIMember_fKGlpKQ_____zo9fawUIvux" style="vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,834,805</span></td></tr> <tr> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--BraskemIdesaBorrowings_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,043,483</span></td> <td style="color: white; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231_zsvlb0LfKBzc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,939,268</span></td></tr> <tr> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="text-decoration: underline; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Others</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zkVvxDg5tZP7" title="Borrowings, maturity">Oct-2026</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zCrOk0yp5Qbg" title="Borrowings, interest rate basis">Us dollar exchange variation + quarterly Libor + 4.00</span></span></td> <td id="xdx_F45_z39mlejZlXHf" style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td id="xdx_983_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zBRbDuRTGHse" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">734,837</span></td> <td style="color: white; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--OtherMember_fKGlpaSk___zRKF0gqA65i3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  849,859</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions costs</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--BraskemIdesaBorrowings_c20221231__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_pn3n3" style="text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (408,002)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--BraskemIdesaBorrowings_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--TransactionsCostsMember_zRo7BPTiLZV5" style="text-align: right" title="Braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (477,592)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NonCurrentBraskemIdesaBorrowings3_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,370,318</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20211231_zUuS4ey2gMKd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,311,535</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CurrentBraskemIdesaBorrowings_c20221231_pn3n3" style="text-align: right" title="Current braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">  868,635</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--CurrentBraskemIdesaBorrowings_iI_pn3n3_c20211231_z02DQbfnyzA5" style="text-align: right" title="Current braskem idesa borrowings"><span style="font-family: Calibri, Helvetica, Sans-Serif">86,765</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--NonCurrentBraskemIdesaBorrowings1_c20221231_pn3n3" style="text-align: right" title="Non current braskem idesa borrowings1"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,501,683</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NonCurrentBraskemIdesaBorrowings1_iI_pn3n3_c20211231_zgcRNlqz3uw2" style="text-align: right" title="Non current braskem idesa borrowings1"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,224,770</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20221231_z8MVWymETl36" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,370,318</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NonCurrentBraskemIdesaBorrowings3_iI_pn3n3_c20211231_zJp95hltSoAj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Non current braskem idesa borrowings3"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,311,535</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F0D_z5DYSbvo0eX1" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span id="xdx_F1E_z6r73yoo0Jog" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt; color: black">Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F03_zKuqIs0A2ITh" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(ii)</span></td><td><span id="xdx_F1D_zRz7IJoji533" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 14.15pt"><span id="xdx_F02_zpk3DW7cen9g" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(iii)</span></td><td><span id="xdx_F10_zDALMfhY1efc" style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral.</span></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F00_zl3cQfPMADW6" style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zZ3WHUoHq74e" style="font-family: Calibri, Helvetica, Sans-Serif">Regarding this financing, on December 22, 2022 Braskem Idesa obtained the waiver related to a leverage ratio (covenant) until June 30, 2023. In this sense, even though Braskem Idesa is not in default and creditors did not request to accelerate this debt, because the waiver did not cover at least 12 months, the entire balance, in the amount of R$649,560, was reclassified from non-current liabilities to current liabilities on December 31, 2022.</span></td></tr> </table> nov-2029 Us dollar exchange variation + 7.45 4690619000 5104463000 feb-2032 Us dollar exchange variation + 6.99 6352864000 6834805000 11043483000 11939268000 Oct-2026 Us dollar exchange variation + quarterly Libor + 4.00 734837000 849859000 -408002000 -477592000 11370318000 12311535000 868635000 86765000 10501683000 12224770000 11370318000 12311535000 2184332000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfOtherBorrowingsAmortizationExplanatory_pn3n3_zFaQvyZlflrk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Braskem Idesa Borrowings (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B0_z2vdub74a6vd" style="display: none">Schedule of long-term maturities of these financing</span></td> <td style="text-align: left"> </td> <td style="color: white; text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 68%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyTwoMember_zC3iu5aIS4Sc" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">67,649</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_z3QHzvSbqyk2" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">68,694</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_ztG5W8K88pO4" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,530</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zjPQkVsEnovl" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 408,445</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zdUu6KTAJQEa" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,337,567</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySixMember_zuShHBjKwaci" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,900,399</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zDTwzMyt7y1f" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,164,116</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OriginalLongtermMaturities_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentySevanMember_zKvfV5b0aRs4" style="text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,710,053</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OriginalLongtermMaturities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,501,683</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OriginalLongtermMaturities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Original Long-Term Maturities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,224,770</span></td></tr> </table> 67649000 68694000 69530000 408445000 4337567000 4900399000 6164116000 6710053000 10501683000 12224770000 <p id="xdx_80A_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zdbpkiTgBeWf" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">18 <span id="xdx_82A_zIP3t6iZxGK">Debentures</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfDebenturesExplanatory_pn3n3_zvHnLg1NGlb1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Debentures (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zJJwtXDoK0Af" style="display: none">Schedule of debentures</span></td> <td style="text-align: center"> </td> <td style="padding-left: 9px; text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: right"> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Annual</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="text-align: center; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issuer</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Series</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif">financial charges (%)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zF5NNgnOWYl8" title="Annual financial charges (%)">mar-2013</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zndgVpzTLJw7" title="Borrowings, maturity">mar-2025</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_ztKmZsBQuzT1" title="Annual financial charges (%)">IPCA + 6%</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zHqFNh0A9pr" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">109,877</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zUnIrnIO04Y7" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">150,352</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zdF5By5P5ox4" title="Annual financial charges (%)">sep-2013</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zk1c6j610dTa" title="Borrowings, maturity">Sep-2025</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_z9k7XgLaPpC8" title="Annual financial charges (%)">126.5% of CDI</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zbOHrKBGMt0i" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  34,604</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zenOQIicrgEi" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47,109</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zrmAp9SgSUsi" title="Annual financial charges (%)">may-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zwALrtc669Me" title="Borrowings, maturity">may-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zhPc3JQnzQ7d" title="Annual financial charges (%)">CDI + 1,75</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zPxKlwhYkS94" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">770,910</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_z9RopkZOHNN7" title="Annual financial charges (%)">may-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zTzM8JC3kcE6" title="Borrowings, maturity">may-2030 to 2032</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zC4boC7ljEog" title="Annual financial charges (%)">CDI + 2,00</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zN7ZRegOZv4k" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">248,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zg9eO5sVKJL9" title="Annual financial charges (%)">aug-2022</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zDnabCrKy8ni" title="Borrowings, maturity">aug-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_z5MsQLu8yGn9" title="Annual financial charges (%)">CDI + 1,75</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zyEOugwAQmmf" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">786,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zbL4KRNME969" title="Annual financial charges (%)">nov-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_z876LgFXhjDj" title="Borrowings, maturity">nov-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zhuzdyva0aTj" title="Annual financial charges (%)">CDI + 1,70</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zsdS9R5hPr06" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,113,987</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zhP2f16i0Wqe" title="Annual financial charges (%)">nov-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zPhnf9xl6dV9" title="Borrowings, maturity">nov-2030 to 2032</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zq9Cxo9gEX0j" title="Annual financial charges (%)">CDI + 1,95</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zdLbrsomsZPa" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  97,159</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_zrAqmjXzBp72" title="Annual financial charges (%)">Transactions costs</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NoteAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_z4Q6OrXZ2rN1" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (10,802)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NoteAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_zrjknQrU6u2a" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">(543)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NotesAndDebenturesIssued_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,151,475</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231_zJ2c6bbFDmqk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,918</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20221231_pn3n3" style="text-align: right" title="Debentures, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231_zOei0U6dvpn9" style="text-align: right" title="Debentures, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  59,088</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20221231_pn3n3" style="text-align: right" title="Debentures, non current"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231_zznMCOzxvmDa" style="text-align: right" title="Debentures, non current"><span style="font-family: Calibri, Helvetica, Sans-Serif">137,830</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231_zWlsNDYAjjQ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,151,475</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231_zHDW3nrWRng5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,918</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zoQtp82XsdK2" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zBvqj25SzGkh" style="font-family: Calibri, Helvetica, Sans-Serif">These debentures were secured by mandatory deposits as disclosed in Note 6.</span></td></tr> </table> <p id="xdx_8AE_z2DUbVEoX6F6" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The maturity profile of the long-term debentures is as follow:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDebentureMaturitiesExplanatory_pn3n3_zOPXMPucaXP6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Debentures (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BD_zATCquZGlTAj" style="display: none">Schedule of long-term debenture maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 68%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_zUkCai50FDdh" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,045</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zeE19A3Bi7Sj" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 58,550</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_z3DaPNRJpqt4" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,096</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zlpfoAAHwayd" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,059</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_z0JYTS0kp8Ql" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,689</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_z2Dw7M5S9Jgk" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,600,998</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyMember_zPw3OgCeo48i" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,291</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyOneMember_zFHCUUjJv4D5" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,360</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyTwoMember_zHNpn9RfxK7i" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,416</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231_zERsVwYVOd5j" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,023,674</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  137,830</span></td></tr> </table> <p id="xdx_8A0_zerYaCu0dgsd" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfDebenturesExplanatory_pn3n3_zvHnLg1NGlb1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Debentures (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zJJwtXDoK0Af" style="display: none">Schedule of debentures</span></td> <td style="text-align: center"> </td> <td style="padding-left: 9px; text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: right"> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Annual</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issue date</span></td> <td style="text-align: center; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Issuer</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Series</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif">financial charges (%)</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zF5NNgnOWYl8" title="Annual financial charges (%)">mar-2013</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zndgVpzTLJw7" title="Borrowings, maturity">mar-2025</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_ztKmZsBQuzT1" title="Annual financial charges (%)">IPCA + 6%</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zHqFNh0A9pr" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">109,877</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_fKGkp_zUnIrnIO04Y7" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">150,352</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zdF5By5P5ox4" title="Annual financial charges (%)">sep-2013</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_904_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zk1c6j610dTa" title="Borrowings, maturity">Sep-2025</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_z9k7XgLaPpC8" title="Annual financial charges (%)">126.5% of CDI</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zbOHrKBGMt0i" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  34,604</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--Debentures1Member_fKGkp_zenOQIicrgEi" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47,109</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zrmAp9SgSUsi" title="Annual financial charges (%)">may-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zwALrtc669Me" title="Borrowings, maturity">may-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zhPc3JQnzQ7d" title="Annual financial charges (%)">CDI + 1,75</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures2Member_zPxKlwhYkS94" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">770,910</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_z9RopkZOHNN7" title="Annual financial charges (%)">may-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zTzM8JC3kcE6" title="Borrowings, maturity">may-2030 to 2032</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zC4boC7ljEog" title="Annual financial charges (%)">CDI + 2,00</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures3Member_zN7ZRegOZv4k" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">248,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zg9eO5sVKJL9" title="Annual financial charges (%)">aug-2022</span></span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">Only</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zDnabCrKy8ni" title="Borrowings, maturity">aug-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_z5MsQLu8yGn9" title="Annual financial charges (%)">CDI + 1,75</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures4Member_fKGkp_zyEOugwAQmmf" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">786,770</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zbL4KRNME969" title="Annual financial charges (%)">nov-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">1ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_z876LgFXhjDj" title="Borrowings, maturity">nov-2029</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zhuzdyva0aTj" title="Annual financial charges (%)">CDI + 1,70</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures5Member_zsdS9R5hPr06" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,113,987</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zhP2f16i0Wqe" title="Annual financial charges (%)">nov-2022</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">2ª</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zPhnf9xl6dV9" title="Borrowings, maturity">nov-2030 to 2032</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--BorrowingsInterestRateBasis_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zq9Cxo9gEX0j" title="Annual financial charges (%)">CDI + 1,95</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures6Member_zdLbrsomsZPa" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">  97,159</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--BorrowingsIssueDate_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_zrAqmjXzBp72" title="Annual financial charges (%)">Transactions costs</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NoteAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_z4Q6OrXZ2rN1" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (10,802)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NoteAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--BorrowingsByNameAxis__custom--Debentures7Member_zrjknQrU6u2a" style="text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif">(543)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NotesAndDebenturesIssued_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,151,475</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231_zJ2c6bbFDmqk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,918</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20221231_pn3n3" style="text-align: right" title="Debentures, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">127,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231_zOei0U6dvpn9" style="text-align: right" title="Debentures, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  59,088</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20221231_pn3n3" style="text-align: right" title="Debentures, non current"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,023,674</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231_zznMCOzxvmDa" style="text-align: right" title="Debentures, non current"><span style="font-family: Calibri, Helvetica, Sans-Serif">137,830</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20221231_zWlsNDYAjjQ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,151,475</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--NotesAndDebenturesIssued_iI_pn3n3_c20211231_zHDW3nrWRng5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 196,918</span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zoQtp82XsdK2" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F13_zBvqj25SzGkh" style="font-family: Calibri, Helvetica, Sans-Serif">These debentures were secured by mandatory deposits as disclosed in Note 6.</span></td></tr> </table> mar-2013 mar-2025 IPCA + 6% 109877000 150352000 sep-2013 Sep-2025 126.5% of CDI 34604000 47109000 may-2022 may-2029 CDI + 1,75 770910000 may-2022 may-2030 to 2032 CDI + 2,00 248970000 aug-2022 aug-2029 CDI + 1,75 786770000 nov-2022 nov-2029 CDI + 1,70 1113987000 nov-2022 nov-2030 to 2032 CDI + 1,95 97159000 Transactions costs -10802000 -543000 3151475000 196918000 127801000 59088000 3023674000 137830000 3151475000 196918000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDebentureMaturitiesExplanatory_pn3n3_zOPXMPucaXP6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Debentures (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BD_zATCquZGlTAj" style="display: none">Schedule of long-term debenture maturity</span></td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 68%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyThreeMember_zUkCai50FDdh" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,045</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_zeE19A3Bi7Sj" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 58,550</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFourMember_z3DaPNRJpqt4" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,096</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_zlpfoAAHwayd" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,059</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20211231__ifrs-full--RangeAxis__custom--TwentyTwentyFiveMember_z0JYTS0kp8Ql" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,689</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyNineMember_z2Dw7M5S9Jgk" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,600,998</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyMember_zPw3OgCeo48i" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,291</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyOneMember_zFHCUUjJv4D5" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,360</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--TwentyTwentyThirtyTwoMember_zHNpn9RfxK7i" style="text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  113,416</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_iI_pn3n3_c20221231_zERsVwYVOd5j" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,023,674</span></td> <td style="color: white; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures, noncurrent"><span style="font-family: Calibri, Helvetica, Sans-Serif">  137,830</span></td></tr> </table> 57045000 58550000 57096000 24059000 23689000 2600998000 113291000 113360000 113416000 3023674000 137830000 <p id="xdx_80E_eifrs-full--DisclosureOfCashFlowStatementExplanatory_zabNJ4loc1vc" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">19 <span id="xdx_82A_zo2lvocyz9X8">Reconciliation of borrowing activities in the statement of cash flow</span></span></p> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory_pn3n3_zEAEMspf0Apk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8B1_zFPHXEfSxQ4b" style="display: none">Schedule of reconciliation of borrowing activities in the statement of cash flow</span></td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>Borrowings, debentures and Braskem Idesa financing</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 32%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Non-controlling </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Braskem Idesa</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">shareholders </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">and debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">financing</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">of Braskem Idesa</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Lease</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Dividends</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Balances at December 31, 2021 </span></td> <td id="xdx_980_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zCAKjMEM6UXl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  34,897,260</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zPHrM47yOvYl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">196,918</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zXSzvJHGdoQe" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,094,178</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zVnaMeDN4sWf" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">12,311,535</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zsHG5zr0h9W9" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,646,538</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zxi4Eb1i8rTh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,156,414</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zdmZn0eoqQEc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 10,538</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Acquired </span></td> <td id="xdx_987_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zs1dZxZsqE47" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,479,224</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,938,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_z4Mck9oVURkf" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Payments </span></td> <td id="xdx_985_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_za7pJcRe0P6i" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (3,753,427)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(102,235)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_z21G7zAWT1nj" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_z3GFjLZ9Jnjb" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z0abO9A6FB6e" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(34,122)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z6TzKv7eofA4" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(928,890)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zhs0OnLoX0vh" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,350,293)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Cash used in financing activities </span></td> <td id="xdx_98B_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zm8q7OTzt1T5" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(274,203)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DebtCashFlowsFromUsedInFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,836,749</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zwUaSQ5s7BXb" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,562,546</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zkNivhGZWa5k" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zdRgR111nepl" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (34,122)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zqvNp670YW76" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (928,890)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zAdSDbIp9N5i" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,350,293)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Other changes </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Interest paid </span></td> <td id="xdx_988_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_znLbwkmHN2pi" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,880,611)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zAb9fJ56G7Ub" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (34,548)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zlR0Zu66Emn" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,915,159)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zX8XbEODhwqk" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(752,489)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z09V2ERRubm4" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(16,212)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z5vlH9SKamjf" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(221,019)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Interest and monetary and exchange variations, net </span></td> <td id="xdx_985_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zJJIZb0CoDTl" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,524,983</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  152,356</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zxzBqy9SyIvg" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,677,339</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zsMnBlCxBY4l" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  170,180</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zbR34hHSAgS3" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(47,784)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z1GGjhDJ7MJ9" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">83,871</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> VAT on loan </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--InitialAdoptionOfLease_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LoanToNonControllingShareholdersOfBraskemIdesaMember_z7JSdEBx3A4a" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Initial adoption of lease">(75,640)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> New contracts </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--NewContracts_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zeqbT4sKkN4a" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="New contracts"> 2,232,043</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Disposal </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--LossesOnDisposalsOfInvestment_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zpzgesjqktac" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Disposal">  (12,568)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additions through acquisition of ER Plastics </span></td> <td id="xdx_982_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zYf7Ot2XtzHl" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic">  99,702</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zKmdJeMfY0Il" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic"> 99,702</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zTNOYgP39WF5" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic">  4,264</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Currency translation adjustments </span></td> <td id="xdx_985_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zUW5dpH0f3l" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,801,871)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zyXoxXxJ7Qsf" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,801,871)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zOesajwMNev3" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(313,597)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zHqi3SmrCdI6" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(84,720)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zFSHO6LULki7" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (73,585)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Fair value of financial transactions of non-controlling subsidiaries </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--FairValueOfFinancialTransactionsOfNoncontrollingSubsidiaries_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zJ8kjxzcdbV3" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Fair value of financial transactions of non-controlling subsidiaries"> (889,967)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additional dividends approved in the board meeting </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--AdditionalDividendsApprovedInBoardMeeting_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zUcLJBUPS60j" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additional dividends approved in the board meeting"> 1,350,000</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additional dividends of subsidiary </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AdditionalDividendsOfSubsidiary_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zjKyPiDJn2bf" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additional dividends of subsidiary">  1,236</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Other </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--Other_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zyQA9OGBxWra" style="text-align: right" title="Other"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(474)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z3OjY4xgBc0j" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (2,057,797)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">117,808</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zrKWsHaZESZi" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (1,939,989)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zxIUHCak17pi" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (895,906)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z6LupvNfvMS7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (1,114,323)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zRGGEfpl4ff4" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,013,006</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zBdeT0dEykwk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,350,762</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Balances at December 31, 2022 </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zXgUSyKU36d3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  32,565,260</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zxZJ0qsctFI7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,151,475</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zIzeRZ8ZoWJf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,716,735</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zgUJNBzTk7i3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,370,318</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zfOe8JWNQNqi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,498,093</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zLIZdEkY4FAf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  4,240,530</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zYl9tkEn8P8g" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td> <td id="xdx_986_ecustom--BorrowingsCurrent_iI_pn3n3_c20221231_fKGkp_zsYi4I2jn8w5" style="text-align: right" title="Borrowings current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,254,550</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--DebenturesCurrent_iI_pn3n3_c20221231_fKGkp_zr13RwqHkTF5" style="text-align: right" title="Debentures current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  127,801</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--BorrowingsAndDebenturesCurrent_iI_pn3n3_c20221231_fKGkp_zV2FeAuQtqac" style="text-align: right" title="Borrowings and debentures current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,382,351</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--FinancingCurrent_iI_pn3n3_c20221231_fKGkp_zWOVuTer9WO2" style="text-align: right" title="financing current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  868,635</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--LeaseCurrent_iI_pn3n3_c20221231_fKGkp_zaXOEXoetkkj" style="text-align: right" title="Lease current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 1,039,706</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DividendsCurrent_iI_pn3n3_c20221231_fKGkp_zrvNxPFQ7wL4" style="text-align: right" title="Dividends current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">No Current</span></td> <td id="xdx_982_ecustom--BorrowingsNonCurrent_iI_pn3n3_c20221231_z9JXfup76oU7" style="text-align: right" title="Borrowings non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 31,310,710</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--DebenturesNonCurrents_iI_pn3n3_c20221231_zGIzaz3p1iU8" style="text-align: right" title="Debentures non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,023,674</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--BorrowingsAndDebenturesNonCurrent_iI_pn3n3_c20221231_zVm7NW5BW0V1" style="text-align: right" title="Borrowings and debentures non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">34,334,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--FinancingNonCurrent_iI_pn3n3_c20221231_zJnjdhnf0NGf" style="text-align: right" title="financing non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">10,501,683</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--NoncontrollingShareholdersNonCurrent_iI_pn3n3_c20221231_z7qHE1r2XdAg" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Non-controlling shareholders non current">  2,498,093</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--LeaseNonCurrent_iI_pn3n3_c20221231_zmmehfwUnl44" style="text-align: right" title="Lease non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,200,824</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Total</span></td> <td id="xdx_985_ecustom--BorrowingsTotal_iI_pn3n3_c20221231_zvW4uANc8329" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  32,565,260</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--DebenturesTotal_iI_pn3n3_c20221231_zPUTiJK6nCGb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,151,475</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--BorrowingsAndDebenturesTotal_iI_pn3n3_c20221231_zgpzYmgMR2ol" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings and debentures total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,716,735</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--FinancingTotal_iI_pn3n3_c20221231_znjDpg2p6hfa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financing total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,370,318</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--ShareholdersTotal_iI_pn3n3_c20221231_zifx9zi6RK35" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shareholders total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,498,093</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--LeaseTotal_iI_pn3n3_c20221231_zN1zsadMkHjb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  4,240,530</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--DividendsTotal_iI_pn3n3_c20221231_zUWABSN6UMi6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Dividends total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> </table> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 20pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span id="xdx_F0C_zVYOHj7Wwunk" style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; font-weight: normal; color: black; letter-spacing: 0.25pt">(i</span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; font-weight: normal; color: black; letter-spacing: 0pt">)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F10_z1UP5zaIGctf" style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; font-weight: normal; color: black; letter-spacing: 0pt">Amount classified in "Other payables" under current liabilities.</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; font-weight: normal; color: black; letter-spacing: 0pt"> </span> <span style="font-family: Calibri, Helvetica, Sans-Serif; font-style: normal; color: #0057B8; letter-spacing: 0pt"><b><br/></b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory_pn3n3_zEAEMspf0Apk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8B1_zFPHXEfSxQ4b" style="display: none">Schedule of reconciliation of borrowing activities in the statement of cash flow</span></td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td colspan="7" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>Borrowings, debentures and Braskem Idesa financing</b></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 32%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Total</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Non-controlling </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Braskem Idesa</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">shareholders </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Borrowings</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">and debentures</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">financing</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">of Braskem Idesa</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Lease</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Dividends</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Balances at December 31, 2021 </span></td> <td id="xdx_980_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zCAKjMEM6UXl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  34,897,260</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zPHrM47yOvYl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">196,918</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zXSzvJHGdoQe" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,094,178</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zVnaMeDN4sWf" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">12,311,535</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zsHG5zr0h9W9" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,646,538</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zxi4Eb1i8rTh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,156,414</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_eifrs-full--NetDebt_iS_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zdmZn0eoqQEc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 10,538</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Acquired </span></td> <td id="xdx_987_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zs1dZxZsqE47" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,479,224</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,938,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--ProceedsFromDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_z4Mck9oVURkf" style="text-align: right" title="Proceeds from debt classified as financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  6,418,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Payments </span></td> <td id="xdx_985_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_za7pJcRe0P6i" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (3,753,427)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(102,235)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_z21G7zAWT1nj" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(3,855,662)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_z3GFjLZ9Jnjb" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z0abO9A6FB6e" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(34,122)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z6TzKv7eofA4" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(928,890)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--RepaymentsOfDebtClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zhs0OnLoX0vh" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,350,293)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Cash used in financing activities </span></td> <td id="xdx_98B_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zm8q7OTzt1T5" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(274,203)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DebtCashFlowsFromUsedInFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,836,749</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zwUaSQ5s7BXb" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,562,546</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zkNivhGZWa5k" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(45,311)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zdRgR111nepl" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (34,122)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zqvNp670YW76" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (928,890)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--DebtCashFlowsFromUsedInFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zAdSDbIp9N5i" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cash used in financing activities"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,350,293)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Other changes </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Interest paid </span></td> <td id="xdx_988_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_znLbwkmHN2pi" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,880,611)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zAb9fJ56G7Ub" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (34,548)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zlR0Zu66Emn" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,915,159)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zX8XbEODhwqk" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(752,489)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z09V2ERRubm4" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(16,212)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--InterestsPaidClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z5vlH9SKamjf" style="text-align: right" title="Interest paid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(221,019)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Interest and monetary and exchange variations, net </span></td> <td id="xdx_985_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zJJIZb0CoDTl" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,524,983</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  152,356</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zxzBqy9SyIvg" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,677,339</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zsMnBlCxBY4l" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  170,180</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zbR34hHSAgS3" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(47,784)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_z1GGjhDJ7MJ9" style="text-align: right" title="Interest and monetary and exchange variations, net"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">83,871</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> VAT on loan </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--InitialAdoptionOfLease_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LoanToNonControllingShareholdersOfBraskemIdesaMember_z7JSdEBx3A4a" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Initial adoption of lease">(75,640)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> New contracts </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_ecustom--NewContracts_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zeqbT4sKkN4a" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="New contracts"> 2,232,043</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Disposal </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--LossesOnDisposalsOfInvestment_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zpzgesjqktac" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Disposal">  (12,568)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additions through acquisition of ER Plastics </span></td> <td id="xdx_982_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zYf7Ot2XtzHl" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic">  99,702</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zKmdJeMfY0Il" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic"> 99,702</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--AdditionsThroughAcquisitionOfErPlastic_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zTNOYgP39WF5" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additions through acquisition of ER Plastic">  4,264</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Currency translation adjustments </span></td> <td id="xdx_985_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zUW5dpH0f3l" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (1,801,871)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zyXoxXxJ7Qsf" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(1,801,871)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zOesajwMNev3" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(313,597)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_988_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zHqi3SmrCdI6" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(84,720)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zFSHO6LULki7" style="text-align: right" title="Currency translation adjustments"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (73,585)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Fair value of financial transactions of non-controlling subsidiaries </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--FairValueOfFinancialTransactionsOfNoncontrollingSubsidiaries_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zJ8kjxzcdbV3" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Fair value of financial transactions of non-controlling subsidiaries"> (889,967)</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additional dividends approved in the board meeting </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_ecustom--AdditionalDividendsApprovedInBoardMeeting_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zUcLJBUPS60j" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additional dividends approved in the board meeting"> 1,350,000</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Additional dividends of subsidiary </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--AdditionalDividendsOfSubsidiary_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zjKyPiDJn2bf" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Additional dividends of subsidiary">  1,236</td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Other </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_ecustom--Other_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zyQA9OGBxWra" style="text-align: right" title="Other"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(474)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z3OjY4xgBc0j" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  (2,057,797)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">117,808</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zrKWsHaZESZi" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (1,939,989)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zxIUHCak17pi" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (895,906)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_z6LupvNfvMS7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> (1,114,323)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zRGGEfpl4ff4" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  2,013,006</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_985_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zBdeT0dEykwk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Total other changes"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,350,762</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> Balances at December 31, 2022 </span></td> <td id="xdx_98A_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zXgUSyKU36d3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  32,565,260</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DebenturesMember_zxZJ0qsctFI7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,151,475</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BorrowingsAndDebenturesMember_zIzeRZ8ZoWJf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,716,735</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_987_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--BraskemIdesaFinancingMember_zgUJNBzTk7i3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,370,318</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98B_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--ShareholdersOfBraskemIdesaMember_zfOe8JWNQNqi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,498,093</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_983_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--LeaseMember_zLIZdEkY4FAf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  4,240,530</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98D_eifrs-full--NetDebt_iE_pn3n3_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--DividendsMember_zYl9tkEn8P8g" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td> <td id="xdx_986_ecustom--BorrowingsCurrent_iI_pn3n3_c20221231_fKGkp_zsYi4I2jn8w5" style="text-align: right" title="Borrowings current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">1,254,550</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_980_ecustom--DebenturesCurrent_iI_pn3n3_c20221231_fKGkp_zr13RwqHkTF5" style="text-align: right" title="Debentures current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  127,801</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--BorrowingsAndDebenturesCurrent_iI_pn3n3_c20221231_fKGkp_zV2FeAuQtqac" style="text-align: right" title="Borrowings and debentures current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  1,382,351</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--FinancingCurrent_iI_pn3n3_c20221231_fKGkp_zWOVuTer9WO2" style="text-align: right" title="financing current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  868,635</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98A_ecustom--LeaseCurrent_iI_pn3n3_c20221231_fKGkp_zaXOEXoetkkj" style="text-align: right" title="Lease current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 1,039,706</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98E_ecustom--DividendsCurrent_iI_pn3n3_c20221231_fKGkp_zrvNxPFQ7wL4" style="text-align: right" title="Dividends current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">No Current</span></td> <td id="xdx_982_ecustom--BorrowingsNonCurrent_iI_pn3n3_c20221231_z9JXfup76oU7" style="text-align: right" title="Borrowings non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 31,310,710</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_981_ecustom--DebenturesNonCurrents_iI_pn3n3_c20221231_zGIzaz3p1iU8" style="text-align: right" title="Debentures non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  3,023,674</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--BorrowingsAndDebenturesNonCurrent_iI_pn3n3_c20221231_zVm7NW5BW0V1" style="text-align: right" title="Borrowings and debentures non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">34,334,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--FinancingNonCurrent_iI_pn3n3_c20221231_zJnjdhnf0NGf" style="text-align: right" title="financing non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">10,501,683</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_989_ecustom--NoncontrollingShareholdersNonCurrent_iI_pn3n3_c20221231_z7qHE1r2XdAg" style="font: 9pt Calibri, Helvetica, Sans-Serif; text-align: right" title="Non-controlling shareholders non current">  2,498,093</td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--LeaseNonCurrent_iI_pn3n3_c20221231_zmmehfwUnl44" style="text-align: right" title="Lease non current"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 3,200,824</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Total</span></td> <td id="xdx_985_ecustom--BorrowingsTotal_iI_pn3n3_c20221231_zvW4uANc8329" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  32,565,260</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_982_ecustom--DebenturesTotal_iI_pn3n3_c20221231_zPUTiJK6nCGb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Debentures total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">3,151,475</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--BorrowingsAndDebenturesTotal_iI_pn3n3_c20221231_zgpzYmgMR2ol" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Borrowings and debentures total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">35,716,735</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_984_ecustom--FinancingTotal_iI_pn3n3_c20221231_znjDpg2p6hfa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financing total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">11,370,318</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98F_ecustom--ShareholdersTotal_iI_pn3n3_c20221231_zifx9zi6RK35" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shareholders total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">2,498,093</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_98C_ecustom--LeaseTotal_iI_pn3n3_c20221231_zN1zsadMkHjb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Lease total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">  4,240,530</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td> <td id="xdx_986_ecustom--DividendsTotal_iI_pn3n3_c20221231_zUWABSN6UMi6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Dividends total"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> 11,007</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"> </span></td></tr> </table> 34897260000 196918000 35094178000 12311535000 3646538000 3156414000 10538000 3479224000 2938984000 6418208000 -3753427000 -102235000 -3855662000 -45311000 -34122000 -928890000 -1350293000 -274203000 2836749000 2562546000 -45311000 -34122000 -928890000 -1350293000 -1880611000 -34548000 -1915159000 -752489000 -16212000 -221019000 1524983000 152356000 1677339000 170180000 -47784000 83871000 -75640000 2232043000 -12568000 99702000 99702000 4264000 -1801871000 -1801871000 -313597000 -84720000 -73585000 -889967000 1350000000 1236000 -474000 -2057797000 117808000 -1939989000 -895906000 -1114323000 2013006000 1350762000 32565260000 3151475000 35716735000 11370318000 2498093000 4240530000 11007000 1254550000 127801000 1382351000 868635000 1039706000 11007000 31310710000 3023674000 34334384000 10501683000 2498093000 3200824000 32565260000 3151475000 35716735000 11370318000 2498093000 4240530000 11007000 <p id="xdx_802_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zyZjI977L6J9" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">20 <span id="xdx_82E_z4roMGBlsM39">Financial instruments</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.1 Initial recognition and measurement </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade receivables and bonds issued are initially recognized when they are originated. All other financial assets and liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">A financial asset (unless it is a trade receivable without a significant financing component) is initially measured at fair value, plus transaction costs directly attributable to their acquisition. A financial liability is initially recognized at fair value, excluding transaction costs. For financial assets and liabilities measured subsequently at fair value through profit or loss (“FVTPL”), transactions costs that are directly recognized in profit or loss. A trade receivable without a significant financing component is initially measured at the transaction price.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Classification, subsequent measurement and gains and losses</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial Assets</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On initial recognition, a financial asset is classified as measured at: amortized cost; fair value through other comprehensive income (“FVOCI”) or fair value through profit or loss (“FVTPL”).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as measured at fair value:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">A financial asset can also be measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) It is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. This includes all derivative financial assets (see Note 20.5).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial assets at FVTPL</b> are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial assets at amortized cost</b> are subsequently measured at amortized cost using the effective interest method and, if applicable, reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial assets at FVOCI</b> are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and, when applicable, impairment loss are recognized in profit or loss. Other net gains and losses are recognized in Other Comprehensive Income (“OCI”). On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial liabilities</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is a derivative.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss, except when the financial asset is designated as a hedge instrument (see Note 20.2). Any gain or loss on derecognition is also recognized in profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Derecognition of financial instruments</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial Asset</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire or when the Company transfers the rights to receive the contractual cash flows in a transaction in which either:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) Substantially all of the risks and rewards of ownership of the financial asset are transferred; or</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) The Company does not retain substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When the Company enters into transactions whereby it transfers assets recognized in its statement of financial position but retains either all or substantially all of the risks and rewards of the transferred assets, the financial assets are not derecognized.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Financial liabilities</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Interest rate reform</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When the base for determining the contractual cash flows of a financial asset or financial liability measured at amortized cost changes as a result of interest rate reform, the Company updates the effective interest rate of the financial asset or financial liability to reflect the change required by the reform.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">A change in the base for determining the contractual cash flows is required by the interest rate benchmark reform if the following conditions are met: (i) the change is necessary as a direct consequence of the reform; and (ii) the new base for determining contractual cash flows is economically equivalent to the previous base, i.e., the base immediately prior to the change.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When changes are made in a financial asset or financial liability in addition to changes in the base for determining the contractual cash flows required by the interest rate benchmark reform, the Company updates first the effective interest rate of the financial asset or financial liability to reflect the change required by the interest rate benchmark reform. Then the Company applies the accounting policies for changes from the additional modifications.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c) Offsetting</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial assets or financial liabilities are offset, and the net amount presented in the statement of financial position when, and only when, the Company currently has a legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realize the asset and settle the liability simultaneously.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.2 Derivative financial instruments and hedge accounting</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company holds derivative financial instruments to hedge its foreign currency and interest rate risk exposures. Embedded derivatives are separated from the host contract and accounted for separately if the host contract is not a financial asset and certain criteria are met.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives are initially measured at fair value. After initial recognition, derivatives are measured at fair value, and changes therein are generally recognized in profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company designates certain derivatives and non-derivative financial liabilities as hedging instruments to hedge the variability in cash flows associated with highly probable forecast transactions arising from changes in foreign exchange rates and interest rates.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">At inception of designated hedging relationships, the Company documents the risk management objective and strategy for undertaking the hedge. The Company also documents the economic relationship between the hedged item and the hedging instrument, including whether the changes in cash flows of the hedged item and hedging instrument are expected to offset each other.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Cash flow hedges</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When a derivative is designated as a cash flow hedging instrument, the effective portion of changes in the fair value of the derivative is recognized in OCI. The effective portion of changes in the fair value of the derivative that is recognized in OCI is limited to the cumulative change in fair value of the hedged item, determined on a present value basis, from inception of the hedge. Any ineffective portion of changes in the fair value of the derivative is recognized immediately in profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">If the hedge no longer meets the criteria for hedge accounting, or the hedging instrument is sold, expires, is terminated or is exercised, then hedge accounting is discontinued prospectively. When hedge accounting for cash flow hedges is discontinued, the amount that has been accumulated in OCI remains recognized until it is reclassified under profit or loss in the same period or periods as the expected future cash flows affect the profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">If the hedged future cash flows are no longer expected to occur, then the amounts that have been accumulated in OCI are immediately reclassified to profit or loss.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.3 Fair Value</b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Fair value measurement</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value is the price to be received in the sale of an asset or paid for the transfer of a liability in a transaction not forced between market players on the measurement date, in the main market or, in the case of a lack of one, the most advantageous market in which the Company has access on said date.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company recognizes derivative financial instruments at their fair value and the main sources of information are the stock exchanges, commodities and futures markets, published by Central Bank of Brazil (“BACEN”), Bloomberg and Reuters. Nevertheless, the volatility of the foreign exchange and interest rate markets in Brazil has been resulting in significant changes in future rates and interest rates over short periods of time, leading to significant changes in the fair value of derivatives and other financial instruments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The fair values of non-derivative quoted financial instruments are based on current bid prices. If the market for a financial asset and for unlisted securities is not active, the Company establishes fair value by using valuation techniques. These include the use of recent arm’s length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, and option pricing models that make maximum use of market inputs and rely as little as possible on information provided by the Management.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The following methods and assumptions were used to estimate the fair value:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i) Financial assets classified as VFTPL or FVOCI are measured in accordance with the fair value hierarchy (Level 1 and Level 2), with inputs used in the measurement processes obtained from sources that reflect the most recent observable market prices.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) Trade accounts receivable and trade payables, mostly classified as amortized cost, correspond to their respective carrying amounts due to the short-term maturity of these instruments. When purchase or sale prices include material financial charges, the securities are adjusted to their present value.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii) The fair value of borrowings is estimated by discounting future contractual cash flows at the market interest rate, which is available to the Company in similar financial instruments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iv) The fair value of bonds is based on prices negotiated in financial markets, plus the respective carrying amount of interest.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The fair values of the remaining assets and liabilities correspond to their carrying amount. The valuation of liabilities (Note 20.4) considers the present value of expected payments, discounted by a discount rate adjusted to the risk.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Fair value hierarchy</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Level 1</b>: fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Level 2: </b>fair value obtained from financial models using directly observable market data, such as discounted cash flow, when the instrument is a forward purchase/sale or a swap contract, or such as the Black-Scholes model, when the instrument has the characteristics of an option. To measure the credit risk of the parties involved in derivative instruments, the Company uses Credit Valuation Adjustment (“CVA”) or Debt Valuation Adjustment (“DVA”) models, applied flow by flow on the fair value of each instrument. The Company adopts the ratings of the other parties for positive flows and its own rating for negative flows, both available in the market and disclosed by renowned rating agencies, as a necessary assumption to define the probability of default.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.4 Non-derivative financial instruments and other liabilities</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory_pn3n3_z0746Fzhvr89" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details)"> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span id="xdx_8BA_zs2nO1p4aN" style="display: none">Schedule of non-derivative financial instruments and other liabilities</span></td> <td style="vertical-align: middle; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="font-weight: bold; vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Book value</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left; width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by category</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">hierarchy</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash and cash equivalents</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash and banks</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,074,208</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zynL5Zitirbc" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,050,822</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,074,208</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zz8iNV0R1mUg" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,050,822</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments in Brazil</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,392,266</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zJD2JXMf7dvk" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,629,864</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,392,266</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zoSPl46vpI8l" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,629,864</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,466,474</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zzl8akQ2zDUg" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,680,686</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,466,474</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_ze4wbP11toN4" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,680,686</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">6</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">LFT´s and LF´s</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zeDtARiwLmD5" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zjRFmSev05Ba" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Time deposit investments</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zc1X6PmLO6b" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfg95d6Mo28k" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  523,256</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zghRMZTDuDA2" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,066,113</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zD5eLaoGbAU" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  523,256</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_z1mvAB3OLGNf" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,066,113</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,312,631</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_zEW5cznK8I54" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets">3,509,555</td> <td style="color: white; vertical-align: middle; text-align: right"/> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,312,631</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_zZx8XbqRfSng" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets">3,509,555</td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJIxYytYdv83" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,199,223</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zjsZ0AaayRX9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,118,452</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zBo1vQUNJ0fl" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,199,223</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z6jKxx0vLpje" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,118,452</span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through other comprehensive income</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zXy0xTvLCZf9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,711</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zyB7GxcjYyKk" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">48,508</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpbfkR7p7HTl" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,711</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgaYvBY2zqJk" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">48,508</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade payables</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">15</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,249,851</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zMtr5BHnJCog" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,164,730</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zG8qTtIoPycb" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,249,851</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zMTHYyfSMWx5" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,164,730</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borrowings </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency - Bond</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 1</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zxCbigmRUZ9g" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,124,158</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zIglzUgSE0G7" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,322,998</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zGmcnuSjOMp4" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,165,942</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zsvokaaHhYi1" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,690,876</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency - other borrowings</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zvtuZckk41vk" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,394,816</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zouutJWXL3t" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,703,059</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zahQxNNX2JHa" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,329,174</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zdxpKu34tACj" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,696,970</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Local currency</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zqqjVat5TB15" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,521,011</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z2OZTEdsJN8e" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  465,258</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zSPG7nCoK0xh" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,937,255</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zKDru3ORUpC1" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  451,899</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zwP6yDSvJ877" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,039,985</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zm7sdwecuOO9" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">35,491,315</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zBOnLFjY6We9" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,432,371</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zoSoLu37Dxg7" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">38,839,745</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa borrowings</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">17</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 1</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,043,483</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zRuFMgEQnWhc" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,939,268</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,301,948</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zQ08oDv7EAEk" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,197,524</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Others</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  734,837</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zU00Fi6rScF2" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  849,859</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  796,510</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zAjxMYMcW9Nd" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  931,141</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,778,320</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_zYuzpudd8vLi" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,789,127</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,098,458</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_z8bW9Qt7bl0l" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,128,665</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">18</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,162,277</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zsTx40EZM1kb" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">196,918</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,190,417</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zeDvp7IOf5S9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">195,570</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Loan ton non-controlling<br/>   shareholder of Braskem Idesa</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9(a) </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,498,093</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zBz7yGLEPTPc" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,646,538</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,498,093</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zJqAFwEvbSEa" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,646,538</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Leniency agreement</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 25</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">903,140</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zaiLsWkVGKee" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,123,296</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">903,140</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z91V7XxD3LTc" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,123,296</span></td></tr> </table> <p id="xdx_8A6_zEWf1rGoPvG8" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 7.1pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.5 Derivative financial instruments</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory_pn3n3_zerdUp9M41cg" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span id="xdx_8B4_zvBSl2z96Nj" style="display: none">Schedule of changes in derivative financial instruments</span></td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operation characteristics</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 39%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; text-align: left; border-top-color: Black; border-top-width: 0.5pt; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Principal exposure</span></td> <td style="font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liability</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Change in</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liability</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">fair value</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">settlement</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-hedge </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">accounting transactions</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braksem America - Swap C3/PGP</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Propane</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Propene</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z68V8zb2VvQe" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,299</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z4g6HuvniXxe" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,158)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zrdKzK2SISU9" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,141)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda - Swap Nafta/Gasoline</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gasoline</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Naphtha </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zNLMONutWiCi" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,847)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_ziKmW40PhzO3" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (25,733)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zEpmsq7xIUYh" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,584</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zeHW8ONhHnQ3" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,996)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina - Exchange swap</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentine peso</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zuq0wdxWllG9" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">3</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z5lSVALdseDl" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">61</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zZpSBvXvkumb" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zx5y1dxhgkrd" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">1</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CreditDerivativeFairValue_c20211231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,545)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (27,830)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CreditDerivativeFinancialSettlement_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,380</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zY3DH4NTUnIc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,995)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Hedge accounting</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">transactions</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Dollar call and put options</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zBksYPGhJmyj" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 85,216</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zjCi5W6MTiL2" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (227,871)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zRaZYIkrA7Ni" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,285</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zLEp7wnlOVta" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (65,370)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Dollar swap CDI</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar+Fixed rates</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z3TLypu0VOak" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 502,508</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zK7WKAaK9Jr8" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (194,055)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z5sWpjtPDdK2" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (156,740)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zwSMH0HLdzW4" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 151,713</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Swap CRA</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar+Fixed rates</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zZBl2aaPFUEi" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (32,828)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z3zqtjlBv838" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,116</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zzfMtxTR93G7" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (22,712)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--CreditDerivativeFairValue_c20211231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 587,724</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (454,754)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--CreditDerivativeFinancialSettlement_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (69,339)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z189vLD56uda" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 63,631</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CurrentDerivativeFinancialAssets_c20211231_pn3n3" style="text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,816</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CurrentDerivativeFinancialAssets_c20221231_pn3n3" style="text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 157,906</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentDerivativeFinancialAssets_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">51</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentDerivativeFinancialAssets_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 71,544</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--DerivativeFinancialAssets_c20211231_pn3n3" style="text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,867</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DerivativeFinancialAssets_c20221231_pn3n3" style="text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 229,450</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--CurrentDerivativeFinancialLiabilities_c20211231_pn3n3" style="text-align: right" title="Current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 256,131</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentDerivativeFinancialLiabilities_c20221231_pn3n3" style="text-align: right" title="Current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 195,169</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NoncurrentDerivativeFinancialLiabilities_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 362,915</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentDerivativeFinancialLiabilities_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 81,917</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_c20211231_pn3n3" style="text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 619,046</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DerivativeFinancialLiabilities_c20221231_pn3n3" style="text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 277,086</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/Liability</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DerivativeFinancialAssetsAndLiabilities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 585,179</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DerivativeFinancialAssetsAndLiabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 47,636</span></td></tr> </table> <p id="xdx_8AF_z6mX98E5bTP4" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 14.2pt; text-indent: 7.1pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The counterparties in these contracts are constantly monitored based on the analysis of their respective ratings and Credit Default Swap (“CDS”). The Company has many bilateral risk mitigators in its derivative contracts, such as the possibility of depositing or requesting deposits of a guaranteed margin from the counterparties.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivative financial instruments held on December 31, 2022 were contracted on both international stock exchanges and on Over the Counter (“OTC”) markets with large financial counterparties under global derivative contracts in Brazil or abroad.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s Financial Policy provides for the active management and continued protection against fluctuations in currencies and rates arising from its operations and financial items, with the possibility of contracting derivative instruments (swaps, NDFs, options, etc.). The other market risks are addressed on a case-by-case basis for each transaction. In general, the Company assesses the need for hedging in the analysis of prospective transactions and seeks to customize the hedge and keeps it in place for the hedged period transaction.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In general, the Company elects to designate derivative financial instruments in a hedge accounting relationship when the application is expected to provide a significant improvement in presenting the offsetting effect on the changes in the hedged items.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #E36C0A"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #E36C0A"><span style="font-family: Calibri, Helvetica, Sans-Serif">Hedge accounting transactions</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a.i) US Dollar call and put option</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the Company holds a total notional amount of put options of US$<span id="xdx_903_ecustom--DervativeNotionalAmount_iI_pn8n9_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--PutOptionsMember_z7D7TBMjXNS3" title="Notional amount">2.1</span> billion (R$<span id="xdx_90D_ecustom--DervativeNotionalAmount_iI_pn7n9_uBRL_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--PutOptionsMember_zQR788lXLdoc" title="Notional amount">10.96</span> billion), with an average strike price of US$1/R$<span id="xdx_901_eifrs-full--AveragePriceOfHedgingInstrument_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--PutOptionsMember_zFYGrvJZBQba" title="Average strike price | Number">4.7</span> and notional amount of call options of US$<span id="xdx_904_ecustom--DervativeNotionalAmount_iI_pn8n9_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CallOptionsMember_zjowx4YJamw9" title="Notional amount">1.4</span> billion (R$<span id="xdx_905_ecustom--DervativeNotionalAmount_iI_pn8n9_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CallOptionsMember_zDVcVkjwwu0d" title="Notional amount">7.3</span> billion), with an average strike price of US$1/R$<span id="xdx_901_eifrs-full--AveragePriceOfHedgingInstrument_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CallOptionsMember_zKGj0FOJkvqd" title="Average strike price | Number">7.06</span>. The operations have a maximum term of 18 months.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">US Dollar-denominated future sales in Brazilian Real were designated for hedge accounting, with the months of revenue recognition always coinciding with the months of the options. The future elements of forward exchange contracts are excluded from the designation of hedge instrument and are separately recorded as hedging cost, recognized in the OCI.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a.ii) US Dollar Swap</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2018, the Company contracted foreign exchange derivative operations (“swaps”) in the aggregate amount of R$1.27 billion, with annual maturities over the following 5 years starting January 2019. The amount payable in January 2020 was subject to the variation in the IPCA index. The remaining maturities are subject to the variation in the CDI. These operations were designated to cash flow hedge accounting, where the hedging instruments are foreign exchange derivatives, and the hedged objects are highly probable future revenues in the domestic market subject to fluctuations in Brazilian R$/US$ price.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accordingly, the fair value adjustment of the effective portion of the hedge is recognized under shareholders equity in OCI and is recognized in the financial result upon the maturity of each installment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a.iii) US Dollar Swap - CRA</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, the Company contracted foreign exchange derivative operations (“swaps”) with semiannual maturities for the next 10 years as from March 2022. These operations were designated for cash flow hedge accounting, in which the hedge instruments are foreign exchange derivatives, and the hedge objects are highly probable future revenue subject to the R$/US$ exchange rate.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Accordingly, the </span><span style="font-family: Calibri, Helvetica, Sans-Serif">fair value <span style="color: black">adjustment in the effective hedge portion will be recorded in equity in OCI and will be recognized in financial result upon the realization of each of the hedge objects.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfFairValueAdjustmentExplanatory_pn3n3_zpDi2gCEQTMh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 2)"> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"> <span id="xdx_8B0_zPuN9RtGzjwf" style="display: none">Schedule of Fair Value Adjustment</span></td> <td style="font-style: italic; vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: top; text-align: center"> </td> <td style="color: white; vertical-align: bottom; text-align: center"> </td></tr> <tr> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Hedge</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value, net</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value R$</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 9pt; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(interest rate per year)</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font: 400 10pt Calibri, Helvetica, Sans-Serif"><i>Swaps </i><span style="font-style: normal">CRA</span></span></td> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--TotalNominal_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zJGELjVvCMSj" style="vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 600,218</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--InterestRatePerYear_pid_dp_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zI8VEXrCohU" title="Interest rate per year">3.5388</span>%</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--MaturityDate_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zqohJmWLwfHh" title="Maturity date">dec-2028</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FairValueNet_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zjudhlYRUYo6" style="vertical-align: bottom; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,603</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font: 400 10pt Calibri, Helvetica, Sans-Serif"><i>Swaps </i><span style="font-style: normal">CRA</span></span></td> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--TotalNominal_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zPCa0blXKVyb" style="vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 141,298</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--InterestRatePerYear_pid_dp_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zogvQqtRZ3U3" title="Interest rate per year">3.3742</span>%</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--MaturityDate_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zalZCKKdq5M7" title="Maturity date">dec-2031</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--FairValueNet_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_ztzQJCFwAms1" style="vertical-align: bottom; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,109</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--TotalNominal_iI_pn3n3_c20221231_zjUvPfWI3vRf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  741,516</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FairValueNet_iI_pn3n3_c20221231_ztcY070LTsf4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,712</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="text-decoration: underline; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentDerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zbZpdZy3C97j" style="vertical-align: bottom; text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,274</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-Current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentDerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_z7Kg9Lcs7dpi" style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 49,613</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zNIyn2r2j1jb" style="vertical-align: bottom; text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 62,887</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-Current liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zF6Ya0jQrmHl" style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,175</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_z0bEsNLi7pKl" style="vertical-align: bottom; text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,175</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/Liability</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DerivativeFinancialAssetsAndLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zI2L2TZVTAql" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,712</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> </table> <p id="xdx_8A8_zzH0ApPf4YEa" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.6 Non-derivative financial liabilities designated to hedge accounting</b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Future exports in US$ (Braskem S.A.)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company designated non-derivate financial liabilities in foreign currency to hedge the future cash flows generated by its exports. This decision was based on two important concepts and judgments: (i) ) the high probability of performing exports according to its business plan, (see Note 22.2), which are inherent to the market and business where it operates, and (ii) the Company’s capacity to finance its liabilities in US$, since its guidance and strategy determine the financing priority in US$ and its Financial Policy requires maintaining a minimum level of net liabilities in US$.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On May 1, 2013, Braskem designated non-derivative financial liabilities, denominated in US$, as a hedge for the flow of its highly probable future exports. Thus, the impact of exchange rates on future cash flows in US dollar derived from these exports is offset by the foreign exchange variation on the designated liabilities, partly eliminating the volatility of results. The exchange rate on the date of the designation was US$1/ R$2.0017.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The main actions carried out in the program are detailed below:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• 2017: designation of R$<span id="xdx_908_eifrs-full--HedgingInstrumentLiabilities_iI_pn7n9_c20171231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zHQIv9Zt1Pj8" title="Designated">6.52</span> billion (US$1.25 billion) of future sales with maturity in 2028 (hedged exchange rate of US$1/3.1688);</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• 2019: designations of R$<span id="xdx_903_eifrs-full--HedgingInstrumentLiabilities_iI_pn8n9_c20191231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zG8qy6dNcSvd" title="Designated">11.5</span> billion (US$<span id="xdx_900_eifrs-full--HedgingInstrumentLiabilities_iI_pn8n9_c20191231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zBWFjAxcgsW8" title="Designated">2.2</span> billion) with maturity in 2025, 2030 and 2031 (hedged exchange rate of US$1/3.9492);</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• 2020: designation of R$<span id="xdx_90F_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zXBgru25mnm2" title="Designated">3,131</span> million (US$<span id="xdx_902_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zjfkhxO7yYTl" title="Designated">600</span> million) of future sales with maturity in 2032 (hedged exchange rate of US$1/R$4.0213); discontinuation of hedge accounting of R$<span id="xdx_909_ecustom--HedgeAccountingDiscontinued_pn6n6_c20200101__20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zO7ZiuYIMg3b" title="Hedge accounting discontinued">1,889</span> million (U$$<span id="xdx_90A_ecustom--HedgeAccountingDiscontinued_pn6n6_c20200101__20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zFuEjIcHtKk4" title="Hedge accounting discontinued">362</span> million) in 2020 (discontinuation rate of US$1/R$5.1987).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• 2021: designation of hedge accounting of R$<span id="xdx_902_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zZuAxyHm11Qd" title="Designated">2,087</span> million (US$<span id="xdx_90B_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zVx5wqRWCWLj" title="Designated">400</span> million) in 2025 (hedged exchange rate of US$1/R$5.5832); discontinuation of hedge accounting of R$<span id="xdx_90E_ecustom--HedgeAccountingDiscontinued_pn6n6_c20210101__20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zize8Ji4N70e" title="Hedge accounting discontinued">2,087</span> million (US$<span id="xdx_903_ecustom--HedgeAccountingDiscontinued_pn6n6_c20210101__20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_z8l2QfsYFnAe" title="Hedge accounting discontinued">400</span> million) in 2024 (discontinuation rate of US$1/R$5.6430); discontinuation of hedge accounting of R$<span id="xdx_906_ecustom--HedgeAccountingsDiscontinued_pn6n6_c20210101__20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zQzGEqB6eRMh" title="Hedge accounting discontinued">1,044</span> million (US$<span id="xdx_906_ecustom--HedgeAccountingsDiscontinued_pn6n6_c20210101__20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zvJmqndefg15" title="Hedge accounting discontinued">200</span> million) in 2023 (discontinuation rate of US$1/R$5.1433);</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• 2022: designation of R$<span id="xdx_907_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsMember_zAwyjBoBfZGl" title="Designated">2,609</span> million (US$<span id="xdx_904_eifrs-full--HedgingInstrumentLiabilities_iI_pn6n6_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FutureExportsOneMember_zVCLdEzzCNV8" title="Designated">500</span> million) of future sales with maturity in 2029 (hedged exchange rate of US$1/R$5.5832).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Over the past two years, Braskem exported an average R$<span id="xdx_902_eifrs-full--AveragePriceOfHedgingInstrument_iI_pid_c20221231_zhVEPZAtkjZd" title="Average export">88.7</span> billion (US$<span id="xdx_903_eifrs-full--AveragePriceOfHedgingInstrument_iI_pid_c20211231_z2OFo0y29IG" title="Average export">17</span> billion) per year, which represents around 3 to 4 times the annual exports of the hedged exports.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• Hedged exports represent approximately 30% of the export flows planned by the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">• The exports of the Company are not sporadic or occasional but constitute an integral part of its strategy and of the petrochemical business, in which competition is global. Several of the products produced by the Company are primarily and recurrently intended for export.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the exports that were designated not yet realized and not discontinued and the maturities of financial liabilities designated, all consolidated, were as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory_pn3n3_z2ksNRRZrtve" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span><span id="xdx_8B3_zRMmXfKbqrYf" style="display: none">Schedule of non-derivative financial liabilities designated to hedge accounting</span></span></td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="text-align: center"> </td> <td style="color: white; text-align: right; background-color: white"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 54%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; background-color: white; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal value</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$</span></td> <td style="color: white; font-weight: bold; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__srt--CurrencyAxis__custom--USDMember_zScSJoQgFqN2" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  288,854</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__srt--CurrencyAxis__custom--USDMember_zVCkYmP1bbBk" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,507,154</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zUUt8vlQJobf" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zFy1GthcXao2" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2028</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember__srt--CurrencyAxis__custom--USDMember_zEKNkyqMCl2b" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,250,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember__srt--CurrencyAxis__custom--USDMember_zcoxuW4aqD19" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,522,125</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanEightYearsAndNotLaterThanNineYearsMember__srt--CurrencyAxis__custom--USDMember_zJn6f9N8NXwg" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  500,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanEightYearsAndNotLaterThanNineYearsMember__srt--CurrencyAxis__custom--USDMember_zrEBxvCrXuob" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,608,850</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zemme0w9ZRH3" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zQ2foKYDGot8" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTenYears1Member__srt--CurrencyAxis__custom--USDMember_zxTtAshlJHcc" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTenYears1Member__srt--CurrencyAxis__custom--USDMember_zJwk4Ac8eL2d" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember__srt--CurrencyAxis__custom--USDMember_zQfbCfa0HGLk" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember__srt--CurrencyAxis__custom--USDMember_zxjb5tdZWqqa" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif">Total nominal value</span></td> <td style="color: white; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD_zmtuvLHHRyD4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,238,854</span></td> <td style="color: white; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__srt--CurrencyAxis__currency--USD_zSPgNdHkuspd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,334,769</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The following table shows the changes in financial instruments designated for this hedge in the year:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory_pn3n3_z6fQZuaWntdg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 4)"> <tr style="vertical-align: bottom"> <td style="width: 65%"><span id="xdx_8BE_zXSzU742BGEl" style="display: none">Schedule of financial instruments designated for hedge</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-style: italic; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Designations</span></td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Designated balance</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--HedgingInstrumentLiabilities_iI_pn3n3_uUSDBRL_c20211231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_z4xXnVHPJDEb" style="vertical-align: middle; text-align: right" title="Designated balance, beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,738,854</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--HedgeInstrumentDesignations_pn3n3_uUSDBRL_c20220101__20221231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_zDydVReSp7v8" style="vertical-align: middle; text-align: right" title="Designations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,000 </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--HedgingInstrumentLiabilities_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_zAs82yW9DlC2" style="vertical-align: middle; text-align: right" title="Designated balance, beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,238,854</span></td></tr> </table> <p id="xdx_8A5_zrpyYCULhTZ" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The following table provides the balances of exchange variation recognized in the Company’s net financial income (expenses) due to the realization of exports designated, for this hedge in the fiscal year ended December 31, 2022:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfExchangeVariationExplanatory_pn3n3_zLIykqpEbO2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 5)"> <tr> <td style="vertical-align: middle"><span id="xdx_8B7_zIzW7TTDBFbf" style="display: none">Schedule of exchange variation</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 47%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion rate</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">at Inception</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Closing rate</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross nominal</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value - R$</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">First quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zzpdIHgCfzTd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 175,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zsylsS2qAlO3" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zi8R34yXVF04" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FirstQuarterMember_zHhI1pDj17B7" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  345,958</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Second quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zTFhMOki4PJd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zAd1U5rFypC2" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zYYsAvvbSw65" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--SecondQuarterMember_z7vjIgg3pta4" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  411,195</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_z5iWvVO7yGac" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 186,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zWP9up5cFwrd" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zf2DUu8trvmk" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zdLu1s3ppdL" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  367,703</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fourth quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_z6kXpveDs7Sd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 150,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_zF0y1e8Pt72c" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_zz8l4f8kCgLh" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FourthQuarterMember_zbOkzi1rjiGk" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,535</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD_zcXponghcTqf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  719,000</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExportsDesignatedForHedgeGrossNominalValue_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,421,391</span></td></tr> </table> <p id="xdx_8AF_zgcxKLdUPJ19" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The changes in foreign exchange variation and income taxes under other comprehensive income of this hedge are as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory_pn3n3_zCw9sr8PVJVh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 6)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span id="xdx_8BB_zH7c90pU8Apf" style="display: none">Schedule of changes in foreign exchange variation and income tax and social contribution</span></td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Exchange </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Net </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> variation </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> IR and CSL </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> effect </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2021</span></td> <td id="xdx_980_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zF6BJvFykEPc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,102,558)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zFwbfUPIKbo8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,454,869</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231_z9vJz60RBha2" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8,647,689)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation recorded in the period / IR and CSL</span></td> <td id="xdx_984_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,699,906</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (577,968)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,121,938</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation transferred to profit or loss / IR and CSL</span></td> <td id="xdx_98B_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,421,391</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (483,273)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">938,118</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2022</span></td> <td id="xdx_98D_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zCtlJMjpYbUj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (9,981,261)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zjUrL0FbfaT1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,393,628</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231_z42Mmuubfp1b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,587,633)</span></td></tr> </table> <p id="xdx_8AD_zLYwYjLlBJN4" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Future sales in US$ (Braskem Idesa)</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, designated and unrealized sales and financial liabilities designated to hedge them were as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDesignatedAndUnrealizedSalesExplanatory_pn3n3_zFMGJUhhjsD1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 7)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B0_z2IJVDxwwuX" style="display: none">Schedule of designated and unrealized sales</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nominal value</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">65,221</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,398</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,398</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 430,460</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,173,983</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,173,983</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,739,293</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2033</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,739,293</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2034</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__custom--LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,565,310</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2035</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,565,310</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif">Nominal value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,687,649</span></td></tr> </table> <p id="xdx_8A0_zkbVZXCpMPbf" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The following table provides the balances of exchange variation recognized in Braskem Idesa’s financial income (expenses) due to the maturity of the sales designated in this hedge for the 12-month period ended December 31, 2022:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfExchangeVariationBraskemIdesaExplanatory_pn3n3_z3H3BsIMiEI8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 8)"> <tr style="vertical-align: bottom"> <td style="width: 24%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B8_zJwktm8lRylf" style="display: none">Schedule of exchange variation - Braskem Idesa</span></span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">at Inception</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Closing rate</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross nominal</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MXN/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MXN/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value MXN</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value - R$</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">First quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zEooIB5cuISk" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,136</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zbp5pxvJLty2" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6218</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zptWIfVYLuoe" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.2827</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zFTdHf3VHVhe" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">194,072</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zTwpQBWZcZKg" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">49,302</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Second quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zE00qSJEps6f" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 72,612</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z0RVOyoHuaF5" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6507</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zylRXFnqbQgi" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1297</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zkZJ4sGGGZEj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">470,453</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zeld6FipE2Hj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,361</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zltJsZlIHyX" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 72,612</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zLggLI3D2Jf1" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6507</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z0PzeKlIPWXb" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1297</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zY1SK9JcTFx5" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">470,453</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_ze1Es7rY7P5g" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">120,341</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fourth quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zrbWEzxjZtEe" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 78,844</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z8W5bjNGi6p3" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6521</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zAuehHR9tAkh" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1224</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z74rxUXDErHb" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">510,144</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zK4aioGNPUfj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">137,999</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zfIwVmbDFVHi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">253,204</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zhzb6rC3ceu9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,645,123</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z8cyOjE5UQ49" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">424,003</span></td></tr> </table> <p id="xdx_8A7_zKDUkqNgbaEf" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The changes in foreign exchange variation and income taxes under other comprehensive at Braskem Idesa income are as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory_pn3n3_zUyb4NrlvT29" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 9)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BF_zsXAAUN86yTj" style="display: none">Schedule of changes in foreign exchange variation and income tax and social contribution - Braskem Idesa</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Exchange </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Net </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> variation </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> IR and CSL </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> effect </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2021</span></td> <td id="xdx_98C_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zC7nfwvFYMwh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,231,511)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zLb3FXahmbC8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 670,192</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zC3JauAiTuq5" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,561,319)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation recorded in the period / IR</span></td> <td id="xdx_983_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zBY0JIKLTSs" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">699,677</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zfg9BhHlRip5" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (209,903)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_ze7X7aIuqwYk" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">489,774</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation transferred to profit or loss / IR</span></td> <td id="xdx_98D_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zTYxZKO2VWCj" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">424,003</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zSmlSUPaoJx5" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (127,201)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zrcgvsm97hn7" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">296,802</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2022</span></td> <td id="xdx_98B_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zHN92sE2kvNf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,107,831)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zExo7bzthWGg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 333,088</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z1K2VGavwPi1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(774,743)</span></td></tr> </table> <p id="xdx_8AD_zIHQYdszPrBj" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effectiveness tests were conducted, and all operations were deemed effective in reducing the dispersion of revenue from sales designated for hedge, when evaluated in Mexican Pesos.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.7 Credit quality of financial assets</b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Trade accounts receivable</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s clients do not have risk ratings assigned by credit rating agencies. For this reason, the Company developed its own credit rating methodology for all accounts receivable from clients in Brazil and abroad.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Considering the expected credit losses, the percentage of trade accounts receivable by risk ratings was as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory_pn3n3_zumS99FD9LD1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 10)"> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span id="xdx_8B5_zhdFlMfeWhfi" style="display: none">Schedule of trade accounts receivable by credit ratings</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 3%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="white-space: nowrap; width: 19%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 49%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>(%)</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td> <td style="padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">1</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Minimal Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--MinimumRiskMember_zx9VwjctWAu9" title="Expected credit loss rate">72.15</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--MinimumRiskMember_zexf9vlDEYk5" title="Expected credit loss rate">65.39</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">2</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Low Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--LowRiskMember_zz4vpH8zRM26" title="Expected credit loss rate">21.65</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--LowRiskMember_z9tGkalmCHu7" title="Expected credit loss rate">26.65</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">3</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Medium Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--ModerateRiskMember_zUOVnIIAe58f" title="Expected credit loss rate">3.36</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--ModerateRiskMember_zfggr56XMj35" title="Expected credit loss rate">6.02</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">4</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">High Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--HighRiskMember_z7ohjEH1MlO2" title="Expected credit loss rate">2.56</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--HighRiskMember_zF78dTFIwDQ" title="Expected credit loss rate">1.54</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">5</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Very High Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--VeryHighRiskMember_fKGkp_zvaA3ITU6SKj" title="Expected credit loss rate">0.28</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--VeryHighRiskMember_fKGkp_zz9YDqM3Ph23" title="Expected credit loss rate">0.40</span></span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F00_zPqDvplppuj5" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F19_zQtPwpwUlUrd" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Clients in this group that are still active buy from Braskem and pay in advance.</span></td></tr> </table> <p id="xdx_8A1_zumq7AwyHqE5" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">For the export market, around 85% of the portfolio has guarantees, consisting primarily of credit insurance. For the domestic market, around 22% of the portfolio has guarantees, mainly suretyships by the partners of counterparties, complemented by credit insurance.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Cash and cash equivalents and financial investments</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In order to determine the credit ratings of counterparties classified under cash and cash equivalents, and financial investments, the Company uses the risk rating of agencies Standard &amp; Poor’s, Moody’s and Fitch Ratings, within the limits established in its Financial Policy:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory_pn3n3_zWe9uj424Aq" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 11)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BC_zAe2f3x1sYVi" style="display: none">Schedule of financial assets with and without risk assessment</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="7" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom; width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Domestic market </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Foreign market </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Domestic market </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Foreign market </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial assets with risk classification</span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AAA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zLzPlinWiSGi" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,130,140</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zAxFLjIgytNj" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,420,741</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zTQSoHId1peg" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,550,881</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_z7aggtFYSHoe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,080,884</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zPU91YLiayW6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,783,151</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zQ0zkFUWDth6" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,864,035</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zqfjKyFpzeF8" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">162,650</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zK6C9uUiWWkk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  162,650</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zyO0JBEy8saj" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">109,165</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zvp4mVaLApU2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  109,165</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zGPfIlZGAaTj" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">289,574</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_za1UEINJuGv" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">107,545</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_z4Kun2zSgCs7" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  397,119</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zwesnGb6jtM9" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">188,742</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_z6xykXENyWq4" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">629,671</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zVYQmqGpw6B2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  818,413</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_z9cQkWdntMnc" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">149,178</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_zVMBDYPEH2K3" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  149,178</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_zUCFkk0QZI8e" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  63,675</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_z8sr248v2tQc" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 63,675</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zF4LUMf7wn22" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,423</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zeJjChtdfjGb" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,459,700</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zRp2gUEugyDk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,463,123</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z8uwHp8TQo6i" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,788</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z7ax7P6HZAYa" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,914,269</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z6EMwPqPuDNl" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,920,057</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zjzZkmBwz5T5" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,650</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zedEHpcuitfe" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,392,854</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zr82Dz2wEvkk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,450,504</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zt8yM3wgPb2h" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">107,225</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zOYHUA90kOhh" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  107,225</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A-</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zQ5frOAXq7f6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">387,478</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zOytqeOcWYy7" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,478</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zqeoNgH9ZwWe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  634</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zfyD1ieyfWs6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">236,335</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zhed9Rph1YX1" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,969</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_z875CTM6dxH4" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  118</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_ztvWPyQS2z44" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  375</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zyMVdXBn5SP3" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 493</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zkljfjMQbiRg" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  856</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zYR3kiK4bava" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  38</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zgbEj6gpTa6k" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 894</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zmhWu63ZS0hf" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  788</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zCdJJn8fNSOd" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">52,389</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zBogf8WwOhr6" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 53,177</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_z9dWJ1aMMPi" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  129</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zvy8wbbzV7Yd" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,026,104</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_z0ramkOHgnn5" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,026,233</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMinusMember_zJgMIPrBhFTb" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  554</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMinusMember_zOAIJ8ZvZAmb" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 554</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBPlusMember_zHrIztz64TYe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 50</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBPlusMember_z8ghUMytsWak" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">50</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBMember_zPIyT6nDMBH7" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,479</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBMember_zpFlEjILs3Pc" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,479</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBMinusMember_ztCEYE8LwjC9" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBMinusMember_z3loyyMDShi2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231_zBVBQ7jSEUH9" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,793,521</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231_zEUfsG2jYm7e" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,821,089</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231_zdvIXcnvU4H3" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,614,610</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231_zbESzB9Xl7x7" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,559,181</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231_zHE4QOvAVMK8" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,589,568</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231_zuxjzfzdTCj5" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,148,749</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial assets without risk classification</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Shares of investment funds <br/> in credit rights</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--SharesOfInvestmentFundsMember_zKr8t9GBHVB1" style="text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,721</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--SharesOfInvestmentFundsMember_zdTUe27SG4G" style="text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,721</span></td></tr> <tr> <td style="font: 9pt Segoe UI; padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other financial assets </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zKjzA4ZejIYc" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">83,070</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_z5dNcOZyFR0i" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,425</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zh69iXFerRgd" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  164,495</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zuyWm63xzwj7" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  25,989</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zQYLJ9uwhFp2" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,782</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zH23JF71LcRb" style="vertical-align: bottom; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,771</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20221231_z7rYSw2t5jl4" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">83,070</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20221231_znmzYyfluXD1" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,425</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20221231_zllZj0xBdp24" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  164,495</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231_zhHjpgWRE41l" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,710</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20211231_zTHmZ9K38pfc" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,782</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20211231_zUAWSK0d6T4" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,492</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsDomesticMarket_iI_pn3n3_c20221231_zj0pXQG3C8y8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,876,591</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsForeignMarket_iI_pn3n3_c20221231_zt26fEpLXzIa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,902,514</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherFinancialAssets_iI_pn3n3_c20221231_z9sxVZ4vH2W2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,779,105</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsDomesticMarket_iI_pn3n3_c20211231_zBgJKqpn7Wf9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,586,891</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsForeignMarket_iI_pn3n3_c20211231_zE6iYk6g2gNj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,603,350</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--OtherFinancialAssets_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,190,241</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_zQPKngDhfIK9" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F10_z5Y6FmfCWP8h" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments approved by the Management, in accordance with the Financial Policy.</span></td></tr> </table> <p id="xdx_8A4_zBG1VTp0KgNe" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>20.8 Sensitivity analysis</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Selection of risks</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the main risks that can affect the value of Company’s financial instruments are:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">· US$/R$ exchange rate;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">· LIBOR floating interest rate;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">· IPCA inflation rate;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">· Selic and CDI interest rates; and</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">· SOFR interest rate.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">For the purposes of the risk sensitivity analysis, the Company presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Value at risk</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The value at risk of the derivatives held by the Company which is defined as the impact on <span id="xdx_908_ecustom--DecriptionOfFairValueAtRisk_c20220101__20221231" title="Decription of fair value at risk">fair value adjustment that could result in one month as from December 31, 2022, with a probability of 5%, and under normal market conditions, was estimated by the Company at R$129 million (US$24.7 million) for put options and call options (Note 20.5(a.i)) and R$96.7 million (US$18.5 million) for the US dollar swap (Note 20.5(a.ii)) and R$4.5 million (US$872 thousand) for the CRA swap (Note 20.2(a.iii)).</span></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c) Selection of scenarios</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Focus Market Readout published by BACEN was used to create the probable scenario for the US$-R$ exchange rate, the Selic interest rate and the CDI interest rate as of December 31, 2022.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">According to the Market Readout, at the end of 2023, US$1 will remain at approximately R$5.27, while the Selic rate should reach 12.25% p.a. at the end of the period. The Selic rate is used as benchmark for sensitivity analysis of the CDI rate.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Since the Market Readout report does not include consensus forecasts for the LIBOR rate, the projection of the U.S. Federal Reserve for the Federal Funds rate at the end of the year was used, whose most recent version was published in December 2022, in comparison with the current level of the Federal Funds rate on December 31, 2022.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">For each variable analyzed in the sensitivity analysis, the Company has considered estimating annualized variations corresponding to 1 and 3 standard deviations of monthly averages of the last five years. They are equivalent to approximately 15.866% and a 0.135% probability of occurrence for the reasonably possible and possible scenarios, respectively. Then, these changes are applied to the current market levels of each variable.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b><span style="text-decoration: underline">Uncertainties of the current context</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The assumptions of the future value adopted in the construction of the probable scenario and the current value of each variable in this analysis are referenced to the reporting date December 31, 2022. Given the instability in the current economic scenario caused by the COVID-19 pandemic and the global effects resulting from the conflict in Ukraine, interest rates and foreign exchange rates are affected daily. The Company’s gains and losses in these probable stress scenarios are analyzed by increasing each variable according to the aforementioned.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The sensitivity values in the table below represent the changes in the value of the financial instruments in each scenario, jointly with the absolute amounts of each of the risk factors considered:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory_pn3n3_z8qZFYxAv1H5" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 12)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B7_zEm0qarUPG64" style="display: none">The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: center"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: center"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 5.27)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 5.93)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 7.35)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazilian real/U.S. dollar exchange rate</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (37,167,641)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (372,553)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,051,899)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (15,155,696)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,028,473)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,309)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (139,792)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (419,376)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zEk71aDjPsre" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,985,932)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zakDoiexaZCl" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(19,906)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zkNiSmFXc9X9" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (269,932)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_znPEDUyy0Ig5" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (809,795)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SACE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,478,722)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14,822)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (200,991)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (602,973)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar call and put options</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zYkjyOE7r6O4" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">65,370</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zGTQUbWMGOH5" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,809</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zN6f1nEx4OJc" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (160,742)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zjgFAjhjr4gi" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,023,396)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x CDI</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (151,713)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,216)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (189,181)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (466,381)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">MONFORTE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (197,209)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,977)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,805)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80,415)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nexi</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.iii.iv)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (100,707)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,009)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,688)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(41,065)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (734,837)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,366)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(99,881)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (299,642)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments abroad</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,718,183</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  67,340</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  913,149</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,739,446</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x IPCA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zZb5x7z8W0H8" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,713</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zY7a2l7yP3Xi" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(607)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zzlAITMTEZCd" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,356)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zzj82aPW4gi4" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (194,841)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5.58%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7.89%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14.13%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Libor floating interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (35,749)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(887)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,388)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,163)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nexi</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.iii.iv)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (100,707)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,920)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14,970)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(44,909)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SACE</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.i)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,478,722)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(49,107)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (187,520)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (562,560)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">MONFORTE</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.ii)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (197,209)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,094)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(15,635)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,906)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zDtzXidwWYMf" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,985,932)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zmgZebwZe1qd" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,201)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zcLf2PETI5tg" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (241,339)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zrUq3EWyuMu4" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (724,017)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outros</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zwaFCCdldgL8" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (734,837)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zbgpSBXMr2y7" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,887)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zA1NcSDccvCl" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(64,483)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zqq9NTBmXuqe" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (193,449)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12.25%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17.6%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25.31%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">CDI interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,052,400)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  302,796</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (898,725)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,331,635)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments in local currency</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,876,590</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80,242)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  206,257</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  619,489</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5.31%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6.72%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8.35%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (109,877)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,494</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,085)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,315)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNDES</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zTEE2kLkig63" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (386,534)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zlD6vT5EInYf" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26,403</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zQtQ8xBpWuPf" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,283)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zUp1fqUjgQH1" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (121,208)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNB/ FINEP/ FUNDES/FINISA/FINAME/FNE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zciUXFomiRTl" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,525)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zIlqfGKYlPV6" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 59</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (83)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_z6NgXOpPdu34" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(252)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">CRA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zAeYHNN46TX" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (763,396)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zgk6320UvtK" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  45,429</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_z1znBlJfEwY2" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(65,630)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zXJuoL8wPZOh" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (206,889)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x IPCA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zPr7HwxG26yc" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,713</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zP13s2WMeY4f" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(99,748)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zH3l8hQhrGU4" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,958</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zK722Cz06yo1" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  99,871</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12.25%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17.6%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25.31%)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selic interest rate</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Leniency agreement</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (865,311)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,856</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17,443)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(51,656)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4.59%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10.58%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(22.57%)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selic interest rate</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zzYc2m4biaX2" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (992,725)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_z1fjHYm4UkZi" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25,698)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zm0LjigapJrh" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (195,867)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zL6s3MwkmGMl" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (587,602)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export credit notes</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zdSVUsm84Co7" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (521,926)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zrVrSonjyPA5" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,571)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_z84coWGmrPob" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (103,435)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zse1eYfagcr9" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (310,306)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_z5kFlnKKRWH5" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F16_zflIogv707Dh" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is in the short position of a possible counterparty call.</span></td></tr> </table> <p id="xdx_8AD_zb9lhxKYAXO2" style="margin-top: 0; margin-bottom: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory_pn3n3_z0746Fzhvr89" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details)"> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span id="xdx_8BA_zs2nO1p4aN" style="display: none">Schedule of non-derivative financial instruments and other liabilities</span></td> <td style="vertical-align: middle; text-align: right"> </td> <td style="font-weight: bold; vertical-align: bottom"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="font-weight: bold; vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="color: white; font-weight: bold; vertical-align: middle"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Book value</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left; width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by category</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">hierarchy</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash and cash equivalents</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">5</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cash and banks</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,074,208</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zynL5Zitirbc" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,050,822</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,074,208</span></td> <td style="color: white; font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndBanksMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zz8iNV0R1mUg" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,050,822</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments in Brazil</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,392,266</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zJD2JXMf7dvk" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,629,864</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,392,266</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zoSPl46vpI8l" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,629,864</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,466,474</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zzl8akQ2zDUg" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,680,686</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,466,474</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_ze4wbP11toN4" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,680,686</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">6</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">LFT´s and LF´s</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zeDtARiwLmD5" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,789,375</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LetrasFinanceirasDoTesouroLFTMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zjRFmSev05Ba" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,337,171</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Time deposit investments</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zc1X6PmLO6b" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TimeDepositInvestmentsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfg95d6Mo28k" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  106,271</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through profit or loss</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  523,256</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zghRMZTDuDA2" style="vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,066,113</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zD5eLaoGbAU" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  523,256</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_z1mvAB3OLGNf" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,066,113</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,312,631</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_zEW5cznK8I54" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets">3,509,555</td> <td style="color: white; vertical-align: middle; text-align: right"/> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,312,631</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FinancialInvestmentsMember_zZx8XbqRfSng" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets">3,509,555</td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJIxYytYdv83" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,199,223</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zjsZ0AaayRX9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,118,452</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zBo1vQUNJ0fl" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,199,223</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z6jKxx0vLpje" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,118,452</span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade accounts receivable </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">7</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value through other comprehensive income</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zXy0xTvLCZf9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,711</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zyB7GxcjYyKk" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">48,508</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpbfkR7p7HTl" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,711</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--TradeAccountsReceivablesMember__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgaYvBY2zqJk" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">48,508</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Trade payables</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">15</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,249,851</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zMtr5BHnJCog" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,164,730</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zG8qTtIoPycb" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,249,851</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--TradePayablesMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zMTHYyfSMWx5" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,164,730</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Borrowings </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency - Bond</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 1</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zxCbigmRUZ9g" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,124,158</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zIglzUgSE0G7" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,322,998</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zGmcnuSjOMp4" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,165,942</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zsvokaaHhYi1" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,690,876</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Foreign currency - other borrowings</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zvtuZckk41vk" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,394,816</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zouutJWXL3t" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,703,059</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zahQxNNX2JHa" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,329,174</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ForeignCurrencyBondMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zdxpKu34tACj" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,696,970</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Local currency</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zqqjVat5TB15" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,521,011</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z2OZTEdsJN8e" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  465,258</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zSPG7nCoK0xh" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,937,255</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LocalCurrencyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zKDru3ORUpC1" style="vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  451,899</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zwP6yDSvJ877" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">33,039,985</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zm7sdwecuOO9" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">35,491,315</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zBOnLFjY6We9" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">30,432,371</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BorrowingMember_zoSoLu37Dxg7" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">38,839,745</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa borrowings</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">17</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bond</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 1</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,043,483</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zRuFMgEQnWhc" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,939,268</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,301,948</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zQ08oDv7EAEk" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,197,524</span></td></tr> <tr> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Others</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  734,837</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zU00Fi6rScF2" style="vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  849,859</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  796,510</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zAjxMYMcW9Nd" style="vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  931,141</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,778,320</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_zYuzpudd8vLi" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,789,127</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,098,458</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--BraskemIdesaBorrowingsMember_z8bW9Qt7bl0l" style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,128,665</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">18</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Level 2</span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,162,277</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zsTx40EZM1kb" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">196,918</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,190,417</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--DebenturesMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zeDvp7IOf5S9" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">195,570</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Loan ton non-controlling<br/>   shareholder of Braskem Idesa</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9(a) </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,498,093</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zBz7yGLEPTPc" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,646,538</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,498,093</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LoanToNoncontrollingShareholderOfBraskemIdesaMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zJqAFwEvbSEa" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,646,538</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Leniency agreement</span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 25</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">903,140</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zaiLsWkVGKee" style="font-weight: bold; vertical-align: middle; text-align: right" title="Book value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,123,296</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinancialLiabilitiesAtFairValue_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_pn3n3" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">903,140</span></td> <td style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20211231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z91V7XxD3LTc" style="font-weight: bold; vertical-align: middle; text-align: right" title="Fair value financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,123,296</span></td></tr> </table> 6074208000 5050822000 6074208000 5050822000 6392266000 3629864000 6392266000 3629864000 12466474000 8680686000 12466474000 8680686000 1789375000 2337171000 1789375000 2337171000 106271000 106271000 523256000 1066113000 523256000 1066113000 2312631000 3509555000 2312631000 3509555000 3199223000 7118452000 3199223000 7118452000 32711000 48508000 32711000 48508000 12249851000 12164730000 12249851000 12164730000 26124158000 30322998000 23165942000 33690876000 5394816000 4703059000 5329174000 4696970000 1521011000 465258000 1937255000 451899000 33039985000 35491315000 30432371000 38839745000 11043483000 11939268000 8301948000 12197524000 734837000 849859000 796510000 931141000 11778320000 12789127000 9098458000 13128665000 3162277000 196918000 3190417000 195570000 2498093000 3646538000 2498093000 3646538000 903140000 1123296000 903140000 1123296000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory_pn3n3_zerdUp9M41cg" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span id="xdx_8B4_zvBSl2z96Nj" style="display: none">Schedule of changes in derivative financial instruments</span></td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operation characteristics</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 39%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; text-align: left; border-top-color: Black; border-top-width: 0.5pt; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Principal exposure</span></td> <td style="font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liability</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Change in</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liability</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">fair value</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">settlement</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-hedge </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">accounting transactions</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braksem America - Swap C3/PGP</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Propane</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Propene</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z68V8zb2VvQe" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 14,299</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z4g6HuvniXxe" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,158)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraksemAmericaSwapC3PGPMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zrdKzK2SISU9" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (12,141)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda - Swap Nafta/Gasoline</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gasoline</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Naphtha </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zNLMONutWiCi" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,847)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_ziKmW40PhzO3" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (25,733)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zEpmsq7xIUYh" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,584</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemHolandaSwapNaftaGasolinaMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zeHW8ONhHnQ3" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,996)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina - Exchange swap</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentine peso</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zuq0wdxWllG9" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">3</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_z5lSVALdseDl" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">61</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zZpSBvXvkumb" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemArgentinaExchangeSwapMember__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zx5y1dxhgkrd" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">1</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CreditDerivativeFairValue_c20211231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,545)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (27,830)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CreditDerivativeFinancialSettlement_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,380</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--TypesOfHedgesAxis__custom--NonHedgeAccountingTransactionsMember_zY3DH4NTUnIc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,995)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Hedge accounting</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; padding-left: 9px; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">transactions</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Dollar call and put options</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zBksYPGhJmyj" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 85,216</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zjCi5W6MTiL2" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (227,871)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zRaZYIkrA7Ni" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,285</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarCallAndPutOptionsMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zLEp7wnlOVta" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (65,370)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Dollar swap CDI</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar+Fixed rates</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20211231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z3TLypu0VOak" style="vertical-align: middle; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 502,508</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zK7WKAaK9Jr8" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (194,055)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z5sWpjtPDdK2" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (156,740)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSADollarSwapCDIMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zwSMH0HLdzW4" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 151,713</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A. - Swap CRA</span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Real</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar+Fixed rates</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zZBl2aaPFUEi" style="vertical-align: middle; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (32,828)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CreditDerivativeFinancialSettlement_pn3n3_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z3zqtjlBv838" style="vertical-align: middle; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,116</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--BraskemSASwapCRAMember__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_zzfMtxTR93G7" style="vertical-align: bottom; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (22,712)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--CreditDerivativeFairValue_c20211231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at beginning of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 587,724</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Increase (decrease) in credit derivative, fair value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (454,754)</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--CreditDerivativeFinancialSettlement_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative financial settlement"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (69,339)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CreditDerivativeFairValue_iI_pn3n3_c20221231__ifrs-full--TypesOfHedgesAxis__custom--HedgeAccountingTransactionsMember_z189vLD56uda" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Credit derivative, fair value at end of period"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 63,631</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CurrentDerivativeFinancialAssets_c20211231_pn3n3" style="text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,816</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CurrentDerivativeFinancialAssets_c20221231_pn3n3" style="text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 157,906</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentDerivativeFinancialAssets_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">51</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--NoncurrentDerivativeFinancialAssets_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 71,544</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--DerivativeFinancialAssets_c20211231_pn3n3" style="text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,867</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DerivativeFinancialAssets_c20221231_pn3n3" style="text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 229,450</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--CurrentDerivativeFinancialLiabilities_c20211231_pn3n3" style="text-align: right" title="Current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 256,131</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentDerivativeFinancialLiabilities_c20221231_pn3n3" style="text-align: right" title="Current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 195,169</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NoncurrentDerivativeFinancialLiabilities_c20211231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 362,915</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentDerivativeFinancialLiabilities_c20221231_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 81,917</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_c20211231_pn3n3" style="text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 619,046</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DerivativeFinancialLiabilities_c20221231_pn3n3" style="text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 277,086</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/Liability</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DerivativeFinancialAssetsAndLiabilities_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 585,179</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DerivativeFinancialAssetsAndLiabilities_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 47,636</span></td></tr> </table> 14299000 -2158000 -12141000 -16847000 -25733000 26584000 -15996000 3000 61000 -63000 1000 -2545000 -27830000 14380000 -15995000 85216000 -227871000 77285000 -65370000 502508000 -194055000 -156740000 151713000 -32828000 10116000 -22712000 587724000 -454754000 -69339000 63631000 33816000 157906000 51000 71544000 33867000 229450000 256131000 195169000 362915000 81917000 619046000 277086000 585179000 47636000 2100000000 10960000000 4.7 1400000000 7300000000 7.06 <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfFairValueAdjustmentExplanatory_pn3n3_zpDi2gCEQTMh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 2)"> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"> <span id="xdx_8B0_zPuN9RtGzjwf" style="display: none">Schedule of Fair Value Adjustment</span></td> <td style="font-style: italic; vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: center"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: top; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: top; text-align: center"> </td> <td style="color: white; vertical-align: bottom; text-align: center"> </td></tr> <tr> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Identification</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Hedge</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td rowspan="2" style="border-bottom: black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Maturity</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value, net</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value R$</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 9pt; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(interest rate per year)</span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font: 400 10pt Calibri, Helvetica, Sans-Serif"><i>Swaps </i><span style="font-style: normal">CRA</span></span></td> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--TotalNominal_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zJGELjVvCMSj" style="vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 600,218</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--InterestRatePerYear_pid_dp_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zI8VEXrCohU" title="Interest rate per year">3.5388</span>%</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--MaturityDate_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zqohJmWLwfHh" title="Maturity date">dec-2028</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FairValueNet_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRAMember_zjudhlYRUYo6" style="vertical-align: bottom; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,603</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: left"><span style="font: 400 10pt Calibri, Helvetica, Sans-Serif"><i>Swaps </i><span style="font-style: normal">CRA</span></span></td> <td style="font-style: italic; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--TotalNominal_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zPCa0blXKVyb" style="vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 141,298</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_ecustom--InterestRatePerYear_pid_dp_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zogvQqtRZ3U3" title="Interest rate per year">3.3742</span>%</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--MaturityDate_c20220101__20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_zalZCKKdq5M7" title="Maturity date">dec-2031</span></span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--FairValueNet_iI_pn3n3_c20221231__ifrs-full--HedgedItemsAxis__custom--SwapsCRA1Member_ztzQJCFwAms1" style="vertical-align: bottom; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,109</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--TotalNominal_iI_pn3n3_c20221231_zjUvPfWI3vRf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Total nominal"><span style="font-family: Calibri, Helvetica, Sans-Serif">  741,516</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FairValueNet_iI_pn3n3_c20221231_ztcY070LTsf4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right" title="Fair value, net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,712</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="text-decoration: underline; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Derivatives</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentDerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zbZpdZy3C97j" style="vertical-align: bottom; text-align: right" title="Current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,274</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-Current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NoncurrentDerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_z7Kg9Lcs7dpi" style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right" title="Non-current derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 49,613</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DerivativeFinancialAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zNIyn2r2j1jb" style="vertical-align: bottom; text-align: right" title="Derivative financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 62,887</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-Current liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zF6Ya0jQrmHl" style="border-bottom: Black 0.5pt solid; vertical-align: bottom; text-align: right" title="Non-current derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,175</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_z0bEsNLi7pKl" style="vertical-align: bottom; text-align: right" title="Derivative financial liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,175</span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net (Asset)/Liability</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DerivativeFinancialAssetsAndLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--DerivativesMember_zI2L2TZVTAql" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: top; text-align: right" title="Derivative financial assets and liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  22,712</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; color: white; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> </table> 600218000 0.035388 dec-2028 12603000 141298000 0.033742 dec-2031 10109000 741516000 22712000 13274000 49613000 62887000 40175000 40175000 22712000 6520000000 11500000000 2200000000 3131000000 600000000 1889000000 362000000 2087000000 400000000 2087000000 400000000 1044000000 200000000 2609000000 500000000 88.7 17 <table border="0" cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory_pn3n3_z2ksNRRZrtve" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span><span id="xdx_8B3_zRMmXfKbqrYf" style="display: none">Schedule of non-derivative financial liabilities designated to hedge accounting</span></span></td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="color: white; background-color: white"> </td> <td style="text-align: center"> </td> <td style="color: white; text-align: right; background-color: white"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 54%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; background-color: white; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal value</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$</span></td> <td style="color: white; font-weight: bold; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__srt--CurrencyAxis__custom--USDMember_zScSJoQgFqN2" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  288,854</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__srt--CurrencyAxis__custom--USDMember_zVCkYmP1bbBk" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,507,154</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zUUt8vlQJobf" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zFy1GthcXao2" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2028</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember__srt--CurrencyAxis__custom--USDMember_zEKNkyqMCl2b" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,250,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember__srt--CurrencyAxis__custom--USDMember_zcoxuW4aqD19" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,522,125</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2029</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanEightYearsAndNotLaterThanNineYearsMember__srt--CurrencyAxis__custom--USDMember_zJn6f9N8NXwg" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  500,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanEightYearsAndNotLaterThanNineYearsMember__srt--CurrencyAxis__custom--USDMember_zrEBxvCrXuob" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,608,850</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zemme0w9ZRH3" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember__srt--CurrencyAxis__custom--USDMember_zQ2foKYDGot8" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTenYears1Member__srt--CurrencyAxis__custom--USDMember_zxTtAshlJHcc" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTenYears1Member__srt--CurrencyAxis__custom--USDMember_zJwk4Ac8eL2d" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember__srt--CurrencyAxis__custom--USDMember_zQfbCfa0HGLk" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  800,000</span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember__srt--CurrencyAxis__custom--USDMember_zxjb5tdZWqqa" style="text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,174,160</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif">Total nominal value</span></td> <td style="color: white; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD_zmtuvLHHRyD4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,238,854</span></td> <td style="color: white; vertical-align: bottom; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--FinancialLiabilityMaturitiesNominalValue_iI_pn3n3_uBRL_c20221231__srt--CurrencyAxis__currency--USD_zSPgNdHkuspd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Financial liability maturities nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,334,769</span></td></tr> </table> 288854000 1507154000 800000000 4174160000 1250000000 6522125000 500000000 2608850000 800000000 4174160000 800000000 4174160000 800000000 4174160000 5238854000 27334769000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory_pn3n3_z6fQZuaWntdg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 4)"> <tr style="vertical-align: bottom"> <td style="width: 65%"><span id="xdx_8BE_zXSzU742BGEl" style="display: none">Schedule of financial instruments designated for hedge</span><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">US$</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-style: italic; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Designations</span></td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Designated balance</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--HedgingInstrumentLiabilities_iI_pn3n3_uUSDBRL_c20211231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_z4xXnVHPJDEb" style="vertical-align: middle; text-align: right" title="Designated balance, beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,738,854</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--HedgeInstrumentDesignations_pn3n3_uUSDBRL_c20220101__20221231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_zDydVReSp7v8" style="vertical-align: middle; text-align: right" title="Designations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,000 </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--HedgingInstrumentLiabilities_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--HedgingInstrumentsAxis__custom--FutureExportsMember_zAs82yW9DlC2" style="vertical-align: middle; text-align: right" title="Designated balance, beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,238,854</span></td></tr> </table> 4738854000 500000000 5238854000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfExchangeVariationExplanatory_pn3n3_zLIykqpEbO2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 5)"> <tr> <td style="vertical-align: middle"><span id="xdx_8B7_zIzW7TTDBFbf" style="display: none">Schedule of exchange variation</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: middle; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 47%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion rate</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">at Inception</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Closing rate</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross nominal</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">R$/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value - R$</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">First quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zzpdIHgCfzTd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 175,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zsylsS2qAlO3" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember_zi8R34yXVF04" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FirstQuarterMember_zHhI1pDj17B7" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  345,958</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Second quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zTFhMOki4PJd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zAd1U5rFypC2" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember_zYYsAvvbSw65" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--SecondQuarterMember_z7vjIgg3pta4" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  411,195</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_z5iWvVO7yGac" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 186,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zWP9up5cFwrd" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zf2DUu8trvmk" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirdQuarterMember_zdLu1s3ppdL" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  367,703</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fourth quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_z6kXpveDs7Sd" style="vertical-align: middle; text-align: right" title="Total nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 150,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_zF0y1e8Pt72c" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">2.0017</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember_zz8l4f8kCgLh" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">3.9786</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FourthQuarterMember_zbOkzi1rjiGk" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,535</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD_zcXponghcTqf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  719,000</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExportsDesignatedForHedgeGrossNominalValue_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,421,391</span></td></tr> </table> 175000000 2.0017 3.9786 345958000 208000000 2.0017 3.9786 411195000 186000000 2.0017 3.9786 367703000 150000000 2.0017 3.9786 296535000 719000000 1421391000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory_pn3n3_zCw9sr8PVJVh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 6)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span id="xdx_8BB_zH7c90pU8Apf" style="display: none">Schedule of changes in foreign exchange variation and income tax and social contribution</span></td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Exchange </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Net </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> variation </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> IR and CSL </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> effect </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2021</span></td> <td id="xdx_980_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zF6BJvFykEPc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,102,558)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zFwbfUPIKbo8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,454,869</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--HedgedItemLiabilities_iS_pn3n3_c20220101__20221231_z9vJz60RBha2" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8,647,689)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation recorded in the period / IR and CSL</span></td> <td id="xdx_984_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,699,906</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (577,968)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExchangeVariationRecordedInPeriodOnOciIrAndCsl_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation recorded in the period on OCI / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,121,938</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation transferred to profit or loss / IR and CSL</span></td> <td id="xdx_98B_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,421,391</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (483,273)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExchangeVariationTransferredToProfitOrLossIrAndCsl_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation transferred to profit or loss / IR and CSL"><span style="font-family: Calibri, Helvetica, Sans-Serif">938,118</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2022</span></td> <td id="xdx_98D_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zCtlJMjpYbUj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (9,981,261)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zjUrL0FbfaT1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,393,628</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--HedgedItemLiabilities_iE_pn3n3_c20220101__20221231_z42Mmuubfp1b" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,587,633)</span></td></tr> </table> -13102558000 4454869000 -8647689000 1699906000 -577968000 1121938000 1421391000 -483273000 938118000 -9981261000 3393628000 -6587633000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDesignatedAndUnrealizedSalesExplanatory_pn3n3_zFMGJUhhjsD1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 7)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B0_z2IJVDxwwuX" style="display: none">Schedule of designated and unrealized sales</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nominal value</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">65,221</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2024</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,398</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2025</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,398</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2026</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanTenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 430,460</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2030</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanSevenYearsAndNotLaterThanTenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,173,983</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2031</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTenYearsAndNotLaterThanFifteenYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,173,983</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2032</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,739,293</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2033</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,739,293</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2034</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__custom--LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,565,310</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">2035</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231__ifrs-full--MaturityAxis__custom--LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember_pn3n3" style="text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,565,310</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif">Nominal value</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DesignatedAndUnrealizedSalesNominalValue_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Designated and unrealized sales nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,687,649</span></td></tr> </table> 65221000 117398000 117398000 430460000 1173983000 1173983000 2739293000 2739293000 1565310000 1565310000 11687649000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfExchangeVariationBraskemIdesaExplanatory_pn3n3_z3H3BsIMiEI8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 8)"> <tr style="vertical-align: bottom"> <td style="width: 24%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B8_zJwktm8lRylf" style="display: none">Schedule of exchange variation - Braskem Idesa</span></span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">at Inception</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Closing rate</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total nominal</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross nominal</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MXN/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MXN/US$</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value MXN</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">value - R$</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">First quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zEooIB5cuISk" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 29,136</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zbp5pxvJLty2" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6218</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zptWIfVYLuoe" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.2827</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zFTdHf3VHVhe" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">194,072</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FirstQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zTwpQBWZcZKg" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">49,302</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Second quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zE00qSJEps6f" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 72,612</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z0RVOyoHuaF5" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6507</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zylRXFnqbQgi" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1297</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zkZJ4sGGGZEj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">470,453</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--SecondQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zeld6FipE2Hj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,361</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Third quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zltJsZlIHyX" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 72,612</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zLggLI3D2Jf1" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6507</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z0PzeKlIPWXb" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1297</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zY1SK9JcTFx5" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">470,453</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--ThirdQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_ze1Es7rY7P5g" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">120,341</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fourth quarter</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zrbWEzxjZtEe" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 78,844</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OpeningForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z8W5bjNGi6p3" style="vertical-align: middle; text-align: right" title="Opening foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">13.6521</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ClosingForeignExchangeRate_iI_pid_uN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zAuehHR9tAkh" style="vertical-align: middle; text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1224</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z74rxUXDErHb" style="vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">510,144</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--RangeAxis__custom--FourthQuarterMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zK4aioGNPUfj" style="vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">137,999</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uUSDBRL_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zfIwVmbDFVHi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: bottom; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">253,204</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExportsDesignatedForHedgeNominalValue_iI_pn3n3_uBRLMXN_c20221231__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zhzb6rC3ceu9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Exports designated for hedge nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,645,123</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExportsDesignatedForHedgeGrossNominalValue_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z8cyOjE5UQ49" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Exports designated for hedge gross nominal value"><span style="font-family: Calibri, Helvetica, Sans-Serif">424,003</span></td></tr> </table> 29136000 13.6218 20.2827 194072000 49302000 72612000 13.6507 20.1297 470453000 116361000 72612000 13.6507 20.1297 470453000 120341000 78844000 13.6521 20.1224 510144000 137999000 253204000 1645123000 424003000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory_pn3n3_zUyb4NrlvT29" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 9)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BF_zsXAAUN86yTj" style="display: none">Schedule of changes in foreign exchange variation and income tax and social contribution - Braskem Idesa</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Exchange </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Net </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> variation </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> IR and CSL </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> effect </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2021</span></td> <td id="xdx_98C_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zC7nfwvFYMwh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,231,511)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zLb3FXahmbC8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 670,192</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--HedgedItemLiabilities1_iS_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zC3JauAiTuq5" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,561,319)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation recorded in the period / IR</span></td> <td id="xdx_983_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zBY0JIKLTSs" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">699,677</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zfg9BhHlRip5" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (209,903)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExchangeVariationRecordedInPeriodIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_ze7X7aIuqwYk" style="text-align: right" title="Exchange variation recorded in the period / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">489,774</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation transferred to profit or loss / IR</span></td> <td id="xdx_98D_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zTYxZKO2VWCj" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">424,003</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zSmlSUPaoJx5" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (127,201)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExchangeVariationTransferredToProfitOrLossIr_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_zrcgvsm97hn7" style="text-align: right" title="Exchange variation transferred to profit or loss / IR"><span style="font-family: Calibri, Helvetica, Sans-Serif">296,802</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balances at December 31, 2022</span></td> <td id="xdx_98B_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--ExchangeVariationMember_zHN92sE2kvNf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,107,831)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zExo7bzthWGg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 333,088</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--HedgedItemLiabilities1_iE_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BraskemIdesaMember_z1K2VGavwPi1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(774,743)</span></td></tr> </table> -2231511000 670192000 -1561319000 699677000 -209903000 489774000 424003000 -127201000 296802000 -1107831000 333088000 -774743000 <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory_pn3n3_zumS99FD9LD1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 10)"> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span id="xdx_8B5_zhdFlMfeWhfi" style="display: none">Schedule of trade accounts receivable by credit ratings</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 3%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="white-space: nowrap; width: 19%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 49%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>(%)</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td> <td style="padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">1</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Minimal Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--MinimumRiskMember_zx9VwjctWAu9" title="Expected credit loss rate">72.15</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--MinimumRiskMember_zexf9vlDEYk5" title="Expected credit loss rate">65.39</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">2</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Low Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--LowRiskMember_zz4vpH8zRM26" title="Expected credit loss rate">21.65</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--LowRiskMember_z9tGkalmCHu7" title="Expected credit loss rate">26.65</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">3</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Medium Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--ModerateRiskMember_zUOVnIIAe58f" title="Expected credit loss rate">3.36</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--ModerateRiskMember_zfggr56XMj35" title="Expected credit loss rate">6.02</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">4</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">High Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--HighRiskMember_z7ohjEH1MlO2" title="Expected credit loss rate">2.56</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--HighRiskMember_zF78dTFIwDQ" title="Expected credit loss rate">1.54</span></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">5</span></td> <td style="white-space: nowrap; vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">Very High Risk</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--VeryHighRiskMember_fKGkp_zvaA3ITU6SKj" title="Expected credit loss rate">0.28</span></span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top; padding-bottom: 9pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedCreditLossRate_iI_pid_dp_c20211231__ifrs-full--TypesOfRisksAxis__custom--VeryHighRiskMember_fKGkp_zz9YDqM3Ph23" title="Expected credit loss rate">0.40</span></span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F00_zPqDvplppuj5" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F19_zQtPwpwUlUrd" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Clients in this group that are still active buy from Braskem and pay in advance.</span></td></tr> </table> 0.7215 0.6539 0.2165 0.2665 0.0336 0.0602 0.0256 0.0154 0.0028 0.0040 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory_pn3n3_zWe9uj424Aq" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 11)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BC_zAe2f3x1sYVi" style="display: none">Schedule of financial assets with and without risk assessment</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="7" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom; width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Domestic market </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Foreign market </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Domestic market </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Foreign market </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial assets with risk classification</span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AAA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zLzPlinWiSGi" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,130,140</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zAxFLjIgytNj" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,420,741</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zTQSoHId1peg" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,550,881</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_z7aggtFYSHoe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,080,884</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zPU91YLiayW6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,783,151</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAAMember_zQ0zkFUWDth6" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,864,035</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zqfjKyFpzeF8" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">162,650</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zK6C9uUiWWkk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  162,650</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zyO0JBEy8saj" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">109,165</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAPlusMember_zvp4mVaLApU2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  109,165</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zGPfIlZGAaTj" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">289,574</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_za1UEINJuGv" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">107,545</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_z4Kun2zSgCs7" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  397,119</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zwesnGb6jtM9" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">188,742</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_z6xykXENyWq4" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">629,671</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMember_zVYQmqGpw6B2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  818,413</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">AA-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_z9cQkWdntMnc" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">149,178</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_zVMBDYPEH2K3" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  149,178</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_zUCFkk0QZI8e" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  63,675</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AAMinusMember_z8sr248v2tQc" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 63,675</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zF4LUMf7wn22" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,423</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zeJjChtdfjGb" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,459,700</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_zRp2gUEugyDk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,463,123</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z8uwHp8TQo6i" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,788</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z7ax7P6HZAYa" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,914,269</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--APlusMember_z6EMwPqPuDNl" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,920,057</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zjzZkmBwz5T5" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">57,650</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zedEHpcuitfe" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,392,854</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zr82Dz2wEvkk" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,450,504</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zt8yM3wgPb2h" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">107,225</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMember_zOYHUA90kOhh" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  107,225</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">A-</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zQ5frOAXq7f6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">387,478</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zOytqeOcWYy7" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,478</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zqeoNgH9ZwWe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  634</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zfyD1ieyfWs6" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">236,335</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--AMinusMember_zhed9Rph1YX1" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,969</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_z875CTM6dxH4" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  118</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_ztvWPyQS2z44" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  375</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zyMVdXBn5SP3" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 493</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zkljfjMQbiRg" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  856</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zYR3kiK4bava" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  38</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBPlusMember_zgbEj6gpTa6k" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 894</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zmhWu63ZS0hf" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  788</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zCdJJn8fNSOd" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">52,389</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zBogf8WwOhr6" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 53,177</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_z9dWJ1aMMPi" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  129</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_zvy8wbbzV7Yd" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,026,104</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMember_z0ramkOHgnn5" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,026,233</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BBB-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMinusMember_zJgMIPrBhFTb" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  554</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBBMinusMember_zOAIJ8ZvZAmb" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 554</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB+</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBPlusMember_zHrIztz64TYe" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 50</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBPlusMember_z8ghUMytsWak" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">50</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBMember_zPIyT6nDMBH7" style="text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,479</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--BBMember_zpFlEjILs3Pc" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,479</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BB-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBMinusMember_ztCEYE8LwjC9" style="text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--BBMinusMember_z3loyyMDShi2" style="text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20221231_zBVBQ7jSEUH9" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,793,521</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20221231_zEUfsG2jYm7e" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,821,089</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20221231_zdvIXcnvU4H3" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,614,610</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithRiskAssessmentDomesticMarket_iI_pn3n3_c20211231_zbESzB9Xl7x7" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,559,181</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--OtherFinancialAssetsWithRiskAssessmentForeignMarket_iI_pn3n3_c20211231_zHE4QOvAVMK8" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,589,568</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithRiskAssessment_iI_pn3n3_c20211231_zuxjzfzdTCj5" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,148,749</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial assets without risk classification</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Shares of investment funds <br/> in credit rights</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--SharesOfInvestmentFundsMember_zKr8t9GBHVB1" style="text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,721</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--SharesOfInvestmentFundsMember_zdTUe27SG4G" style="text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,721</span></td></tr> <tr> <td style="font: 9pt Segoe UI; padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other financial assets </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td id="xdx_984_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zKjzA4ZejIYc" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">83,070</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_z5dNcOZyFR0i" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,425</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20221231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zh69iXFerRgd" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  164,495</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zuyWm63xzwj7" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  25,989</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zQYLJ9uwhFp2" style="vertical-align: bottom; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,782</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20211231__ifrs-full--ExternalCreditGradesAxis__custom--OtherFinancialAssetMember_fKGkp_zH23JF71LcRb" style="vertical-align: bottom; text-align: right" title="Financial assets with risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,771</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20221231_z7rYSw2t5jl4" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">83,070</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20221231_znmzYyfluXD1" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,425</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20221231_zllZj0xBdp24" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  164,495</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket_iI_pn3n3_c20211231_zhHjpgWRE41l" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,710</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--OtherFinancialAssetsWithOutRiskAssessmentForeignMarket_iI_pn3n3_c20211231_zTHmZ9K38pfc" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,782</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherFinancialAssetsWithoutRiskAssessment_iI_pn3n3_c20211231_zUAWSK0d6T4" style="border-top: Black 0.5pt solid; text-align: right" title="Financial assets without risk assessment"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,492</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherFinancialAssetsDomesticMarket_iI_pn3n3_c20221231_zj0pXQG3C8y8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,876,591</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsForeignMarket_iI_pn3n3_c20221231_zt26fEpLXzIa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,902,514</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherFinancialAssets_iI_pn3n3_c20221231_z9sxVZ4vH2W2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,779,105</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherFinancialAssetsDomesticMarket_iI_pn3n3_c20211231_zBgJKqpn7Wf9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets domestic market"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,586,891</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--OtherFinancialAssetsForeignMarket_iI_pn3n3_c20211231_zE6iYk6g2gNj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets foreign market"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,603,350</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--OtherFinancialAssets_c20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Financial assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,190,241</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_zQPKngDhfIK9" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F10_z5Y6FmfCWP8h" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments approved by the Management, in accordance with the Financial Policy.</span></td></tr> </table> 5130140000 2420741000 7550881000 4080884000 2783151000 6864035000 162650000 162650000 109165000 109165000 289574000 107545000 397119000 188742000 629671000 818413000 149178000 149178000 63675000 63675000 3423000 4459700000 4463123000 5788000 2914269000 2920057000 57650000 1392854000 1450504000 107225000 107225000 387478000 387478000 634000 236335000 236969000 118000 375000 493000 856000 38000 894000 788000 52389000 53177000 129000 1026104000 1026233000 554000 554000 50000 50000 1479000 1479000 7000 7000 5793521000 8821089000 14614610000 4559181000 7589568000 12148749000 1721000 1721000 83070000 81425000 164495000 25989000 13782000 39771000 83070000 81425000 164495000 27710000 13782000 41492000 5876591000 8902514000 14779105000 4586891000 7603350000 12190241000 fair value adjustment that could result in one month as from December 31, 2022, with a probability of 5%, and under normal market conditions, was estimated by the Company at R$129 million (US$24.7 million) for put options and call options (Note 20.5(a.i)) and R$96.7 million (US$18.5 million) for the US dollar swap (Note 20.5(a.ii)) and R$4.5 million (US$872 thousand) for the CRA swap (Note 20.2(a.iii)). <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory_pn3n3_z8qZFYxAv1H5" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial instruments (Details 12)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B7_zEm0qarUPG64" style="display: none">The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario</span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: center"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: center"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom; width: 31%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 16%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 5.27)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 5.93)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(USDBRL 7.35)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazilian real/U.S. dollar exchange rate</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bonds</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (37,167,641)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (372,553)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,051,899)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BondMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (15,155,696)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,028,473)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,309)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (139,792)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (419,376)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zEk71aDjPsre" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,985,932)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zakDoiexaZCl" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(19,906)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zkNiSmFXc9X9" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (269,932)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_znPEDUyy0Ig5" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (809,795)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SACE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,478,722)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14,822)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (200,991)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (602,973)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar call and put options</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zYkjyOE7r6O4" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">65,370</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zGTQUbWMGOH5" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,809</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zN6f1nEx4OJc" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (160,742)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarCallAndPutOptionsMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_fKGkp_zjgFAjhjr4gi" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,023,396)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x CDI</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (151,713)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,216)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (189,181)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapCDIMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (466,381)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">MONFORTE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (197,209)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,977)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,805)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80,415)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nexi</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.iii.iv)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (100,707)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,009)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,688)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(41,065)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (734,837)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,366)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(99,881)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OtherMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (299,642)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments abroad</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,718,183</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  67,340</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  913,149</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsAbroadMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,739,446</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x IPCA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zZb5x7z8W0H8" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,713</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zY7a2l7yP3Xi" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(607)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zzlAITMTEZCd" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,356)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--BrazilianRealUSDollarExchangeRateMember_zzj82aPW4gi4" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (194,841)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5.58%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7.89%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14.13%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Libor floating interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (35,749)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(887)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,388)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,163)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Nexi</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.iii.iv)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (100,707)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,920)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(14,970)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--NexiMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(44,909)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SACE</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.i)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,478,722)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(49,107)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (187,520)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--SaceMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (562,560)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">MONFORTE</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">16(c.ii)</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (197,209)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,094)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(15,635)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--MONFORTEMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,906)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Investments</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zDtzXidwWYMf" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,985,932)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zmgZebwZe1qd" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,201)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zcLf2PETI5tg" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (241,339)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--InvestmentMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zrUq3EWyuMu4" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (724,017)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outros</span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zwaFCCdldgL8" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (734,837)</span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zbgpSBXMr2y7" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,887)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zA1NcSDccvCl" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(64,483)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--OutrosMember__ifrs-full--TypesOfInterestRatesAxis__custom--LiborFloatingInterestRateMember_zqq9NTBmXuqe" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (193,449)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12.25%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17.6%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25.31%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">CDI interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,052,400)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  302,796</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (898,725)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,331,635)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial investments in local currency</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,876,590</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(80,242)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  206,257</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInvestmentsInBrazilMember__ifrs-full--TypesOfInterestRatesAxis__custom--CDIInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  619,489</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5.31%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6.72%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8.35%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPCA interest rate</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Debentures</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (109,877)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,494</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,085)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DebenturesMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,315)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNDES</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zTEE2kLkig63" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (386,534)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zlD6vT5EInYf" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26,403</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zQtQ8xBpWuPf" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,283)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNDESMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zUp1fqUjgQH1" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (121,208)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">BNB/ FINEP/ FUNDES/FINISA/FINAME/FNE</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zciUXFomiRTl" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,525)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zIlqfGKYlPV6" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 59</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (83)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--BNBFINEPFUNDESFINISAFINAMEFNEMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_z6NgXOpPdu34" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(252)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">CRA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zAeYHNN46TX" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (763,396)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zgk6320UvtK" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  45,429</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_z1znBlJfEwY2" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(65,630)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CRAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zXJuoL8wPZOh" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (206,889)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dollar swap x IPCA</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zPr7HwxG26yc" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,713</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zP13s2WMeY4f" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(99,748)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zH3l8hQhrGU4" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  31,958</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DollarSwapIPCAMember__ifrs-full--TypesOfInterestRatesAxis__custom--IPCAInterestRateMember_zK722Cz06yo1" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  99,871</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-style: italic; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12.25%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17.6%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25.31%)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selic interest rate</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Leniency agreement</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ExposureValue_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (865,311)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProbableSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,856</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(17,443)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ExtremeAdverseSensitivityGainLoss_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LeniencyAgreementMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_pn3n3" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(51,656)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain (losses)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; font-style: italic; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exposure value</span></td> <td style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Probable</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reasonably possible</span></td> <td style="font-weight: bold; font-style: italic; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Possible</span></td></tr> <tr style="vertical-align: top"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Instrument / Sensitivity</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">as December 31, 2022</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4.59%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10.58%)</span></td> <td style="font-weight: bold; font-style: italic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(22.57%)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selic interest rate</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export prepayments</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zzYc2m4biaX2" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (992,725)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_z1fjHYm4UkZi" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25,698)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zm0LjigapJrh" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (195,867)</span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportPrepaymentsMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zL6s3MwkmGMl" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (587,602)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Export credit notes</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ExposureValue_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zdSVUsm84Co7" style="text-align: right" title="Exposure value"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (521,926)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProbableSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zrVrSonjyPA5" style="text-align: right" title="Probable gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(13,571)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_z84coWGmrPob" style="text-align: right" title="Reasonably possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (103,435)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ExtremeAdverseSensitivityGainLoss_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ExportCreditNotesMember__ifrs-full--TypesOfInterestRatesAxis__custom--SelicInterestRateMember_zse1eYfagcr9" style="text-align: right" title="Possible gain (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (310,306)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_z5kFlnKKRWH5" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F16_zflIogv707Dh" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is in the short position of a possible counterparty call.</span></td></tr> </table> -37167641000 -372553000 -5051899000 -15155696000 -1028473000 -10309000 -139792000 -419376000 -1985932000 -19906000 -269932000 -809795000 -1478722000 -14822000 -200991000 -602973000 65370000 9809000 -160742000 -1023396000 -151713000 -6216000 -189181000 -466381000 -197209000 -1977000 -26805000 -80415000 -100707000 -1009000 -13688000 -41065000 -734837000 -7366000 -99881000 -299642000 6718183000 67340000 913149000 2739446000 22713000 -607000 -63356000 -194841000 -35749000 -887000 -3388000 -10163000 -100707000 -3920000 -14970000 -44909000 -1478722000 -49107000 -187520000 -562560000 -197209000 -4094000 -15635000 -46906000 -1985932000 -63201000 -241339000 -724017000 -734837000 -16887000 -64483000 -193449000 -3052400000 302796000 -898725000 -3331635000 5876590000 -80242000 206257000 619489000 -109877000 1494000 -2085000 -6315000 -386534000 26403000 -38283000 -121208000 -3525000 59000 -83000 -252000 -763396000 45429000 -65630000 -206889000 22713000 -99748000 31958000 99871000 -865311000 6856000 -17443000 -51656000 -992725000 -25698000 -195867000 -587602000 -521926000 -13571000 -103435000 -310306000 <p id="xdx_801_ecustom--DisclosureOfTaxPayableExplanatory_zbEmh52Cfq6g" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">21 <span id="xdx_821_z7zWY8pnRPV4">Taxes payable</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfDetailedInformationAboutTaxPayableExplanatory_pn3n3_zOEXeyEjHr7d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Taxes payable (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B3_z1ZJHWLiRYi9" style="display: none">Schedule of taxes payable</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 69%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPI</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--IPIMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 74,219</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--IPIMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  131,290</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ICMSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  218,179</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ICMSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  485,302</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--PISAndCOFINSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,406</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--PISAndCOFINSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,516</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,549</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 46,117</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other countries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ValueAddedTaxMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  150,260</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ValueAddedTaxMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  229,571</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax on financial income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  222,464</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zPtYTiv2uN88" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  346,817</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">789,077</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zuy67jzJ66Kc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,272,613</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  491,051</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zYzEzso5dco3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,012,116</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20221231_zRf66eKABYzc" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  298,026</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zrEgGU8y3xJl" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  260,497</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zOt9hKjopU0g" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">789,077</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zkYaSNpaKOc3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,272,613</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfDetailedInformationAboutTaxPayableExplanatory_pn3n3_zOEXeyEjHr7d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Taxes payable (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B3_z1ZJHWLiRYi9" style="display: none">Schedule of taxes payable</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td> <td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 69%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">IPI</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--IPIMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 74,219</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--IPIMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  131,290</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ICMSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  218,179</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ICMSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  485,302</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--PISAndCOFINSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,406</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--PISAndCOFINSMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,516</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,549</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--DomesticMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 46,117</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other countries</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Value-added tax</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ValueAddedTaxMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  150,260</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ValueAddedTaxMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  229,571</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax on financial income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  222,464</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherMember__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zPtYTiv2uN88" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  346,817</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">789,077</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zuy67jzJ66Kc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,272,613</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_c20221231_pn3n3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  491,051</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zYzEzso5dco3" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,012,116</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20221231_zRf66eKABYzc" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  298,026</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231_zrEgGU8y3xJl" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  260,497</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zOt9hKjopU0g" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">789,077</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--OtherCountriesMember_zkYaSNpaKOc3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,272,613</span></td></tr> </table> 74219000 131290000 218179000 485302000 20406000 33516000 103549000 46117000 150260000 229571000 222464000 346817000 789077000 1272613000 491051000 1012116000 298026000 260497000 789077000 1272613000 <p id="xdx_807_eifrs-full--DisclosureOfIncomeTaxExplanatory_zd2QYUYkqQZ8" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">22 <span id="xdx_82E_z9kFxBKvpDm1">Income taxes</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Income taxes comprises current and deferred taxes. It is recognized in profit or loss except to the extent that it relates to items directly recognized in other comprehensive income.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #00A9E0"><b>22.1 </b></span><b><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000">Current income taxes</span></b></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current income taxes comprise the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted at the reporting date. Current tax also includes any tax arising from dividends. Current tax assets and liabilities are offset only if certain criteria are met.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the amount presented as recoverable income taxes under current assets is R$<span id="xdx_90E_ecustom--IncomeTaxesCurrent_iI_pn3n3_c20221231_zY3fer5WjIrj" title="Income taxes current">392,062</span> (2021: R$<span id="xdx_907_ecustom--IncomeTaxesCurrent_iI_pn3n3_c20211231_zjMzBubNlRVd" title="Income taxes current">1,189,812</span>) and non-current assets is R$<span id="xdx_909_ecustom--IncomeTaxesNoncurrent_iI_pn3n3_c20221231_zLNIj5ILFSH2" title="Income taxes noncurrent">252,995</span> (2021: R$<span id="xdx_90B_ecustom--IncomeTaxesNoncurrent_iI_pn3n3_c20211231_zO7FBATiIjNd" title="Income taxes noncurrent">230,069</span>). In 2021: R$<span id="xdx_902_ecustom--TaxesRecoverable_iI_pn5n6_uBRL_c20211231_zlyHwerIvcXb" title="Taxes recoverable">984.4</span> million refers to taxes recoverable at Braskem America arising from the tax program offered by the U.S. government, for aid and support to U.S. companies in response to the economic impacts of Covid-19.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Exclusion of inflation adjustment by Selic (economy´s basic interest rate) on undue tax payments from taxable income</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In July 2010, Braskem and the merged companies in previous years, filed lawsuits claiming exception from the levying of Brazilian income taxes (hereinafter “IR/CSL”) on amounts they received as interest on late payment, since they do not represent any equity increase. On September 24, 2021, through Special Appeal 1.603.187, the Federal Supreme Court (“STF”) stated that “the levying of IR/CSL on amounts updated by the Selic rate, received due to repetition of undue tax payments, is unconstitutional.”</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Braskem benefited from this decision in the amount of R$540 million reduction in income taxes calculated until 2022 (R$501 million until 2021). </span><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2021, deferred tax assets amounting to R$68 million were recognized for the periods in which tax losses increased.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Exemption of IR/CSL on ICMS tax incentives and benefits</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In October 2021, the Company obtained a preliminary injunction to exclude the ICMS tax incentives and benefits applicable to its operations, granted by the governments of States and the Federal District, from the income tax calculation base as from 2021. Since it is an uncertain tax treatment, as of December 31, 2021, it remains booked in the balance sheet as income taxes payable.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In August 2022, a judgment was rendered restricting relief only to presumed ICMS credits. Accordingly, the amount related to ICMS tax incentives and benefits was paid amounting to R$<span id="xdx_90C_ecustom--PaymentOfTaxIncentives_pn3n3_c20220801__20220831_z9OxIHAOJXFf" title="Payment of tax incentives">1,038,255</span>.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c) Use of tax losses in Braskem Idesa</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico’s federal revenue service (“SAT”) has been questioning Braskem Idesa and Braskem SOFOM about the criteria and assumptions adopted in the calculation of income tax. With the intermediation from the Taxpayer Defense Attorney of Mexico (“Prodecon”), on February 3, 2023, Braskem Idesa and Braskem SOFOM signed an agreement, in which Braskem Sofom agreed to settle the income taxes proposed by SAT and Braskem Idesa reviewed the accrued tax losses in certain periods, resulting in a reduction in deferred tax credits of R$<span id="xdx_90A_ecustom--DeferredTaxCredits_iI_pn6n6_c20221231_ztFNxjxPDup1" title="Deferred tax credits">892</span> million, with a corresponding entry under deferred income tax expense.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(d) Reconciliation of effective tax rate</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory_pn3n3_zwShEkRV37Ce" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zHPxhkcuKEmf" style="display: none">Schedule of income tax and social contribution reconciliation</span></td> <td> </td> <td> </td> <td id="xdx_49D_20220101__20221231_zZeGJANNbkn1" style="text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49F_20210101__20211231_zZMitM95tzD9" style="text-align: center"> </td> <td> </td> <td id="xdx_498_20200101__20201231_zahNSA2dX764" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 61%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) before income taxes</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47,344</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,961,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (9,683,784)</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--AccountingProfit_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,097)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,106,748)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,292,487</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_401_ecustom--PermanentAdjustmentsToIRAnCSLlCalculationBasisAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Permanent adjustments to income taxes calculation basis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_402_ecustom--IncomeTaxAnsSocialContributionOnEquityInResultsOfInvestees_zWUcEgpKBRgh" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Income taxes on equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,849</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,578</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,595</span></td></tr> <tr id="xdx_405_ecustom--ThinCapitalization_zu7CGwW2Oxm7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Thin capitalization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F47_zdDFAFtb3mH8" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(359,598)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (6,628)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(695,741)</span></td></tr> <tr id="xdx_403_ecustom--TaxBenefits_zCIWOaArMNW6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax benefits (Sudene and PAT)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7005">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  137,338</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7007">-</span></span></td></tr> <tr id="xdx_409_ecustom--ReductionOfTaxLoss_zN2xMdseIOa9" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reduction of tax loss</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F4F_ziAwcHlA29M2" style="font-family: Calibri, Helvetica, Sans-Serif">22.1(c)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(891,669)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7011">-</span></span></td></tr> <tr id="xdx_404_ecustom--EffectOfRefundOfBraskemAmericasTaxBenefit_zyOZYoIFcAx6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect of the refund of Braskem America´s tax benefit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(737,841)</span></td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfForeignTaxRates_zV9KPjttB4z7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Different jurisdictional taxes rates for companies abroad and tax basis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F46_zFyEcAaGxMs9" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,029,618</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,980,358</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  994,811</span></td></tr> <tr id="xdx_408_ecustom--EffectFromRetrospectiveTaxRateOnBonusDepreciationOfBraskemAmerica_zMt3cx1QFuld" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect from the retrospective tax rate on bonus depreciation of Braskem America</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7022">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  334,460</span></td></tr> <tr id="xdx_40D_ecustom--TaxesOnDividendsDistribution_zuW2olWVtun3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Taxes on dividends distribution</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(454,663)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(265,454)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,240)</span></td></tr> <tr id="xdx_40B_ecustom--ExclusionOfInflationAdjustementBySelicOnUndueTaxPaymentsFromTaxableIncome_zHh7xXMUKC44" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exclusion of inflation adjustement by Selic on undue tax payments from taxable income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F4D_zG8IxHuUDdYb" style="font-family: Calibri, Helvetica, Sans-Serif">22.1(a)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,395</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  501,382</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_zwOevyATp7k1" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other permanent adjustments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(226,570)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(241,229)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(395,053)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_ecustom--IncomeTaxExpenseContinuingOperations12_z7Oylyv6Yutj" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect of income taxes on results of operations</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (867,735)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,999,403)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--BreakdownOfIncomeTaxes_zJPcw9OQfZ8e" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Breakdown of income taxes</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentIrAndCslExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentYearIncomeTaxAndSocialContribution_zVGzKIlvIZOd" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,705)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,834,437)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (52,830)</span></td></tr> <tr id="xdx_408_eifrs-full--CurrentTaxExpenseIncome_zt4aUBQ08e5k" style="vertical-align: bottom"> <td style="color: White">Total current expenses<span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,705)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,834,437)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (52,830)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeAbstract_iB_zcfNLLWTRk9i" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_ecustom--OriginationAndReversalOfTemporaryDifferences_zfaeKyNy4Xa6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Origination and reversal of temporary differences</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,192,438</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(246,294)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,677,328</span></td></tr> <tr id="xdx_409_eifrs-full--TaxEffectOfTaxLosses_zp18watcBdRa" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax losses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,056,468)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 81,328</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 43,980</span></td></tr> <tr id="xdx_404_eifrs-full--DeferredTaxExpenseIncome_zuvujNpci6k6" style="vertical-align: bottom"> <td style="color: White; font-weight: bold">Total Deferred income taxes<span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  135,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,966)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,721,308</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--IncomeTaxndSocialContribution_zEZIy7aJ1cUa" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (867,735)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,999,403)</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--AverageEffectiveTaxRate_pid_dp_zfPmSisPuIk5" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effective rate</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1832.8%</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">22.3%</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">27.6%</span></td></tr> </table> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zD9I3bpqepdg" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F19_z9rvSFWmFOM" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0C_z8XgtOWnRmpd" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_F1A_zfzxJmTg3lge" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:</span></td></tr> </table> <p id="xdx_8A5_zl30YlXgyjWe" style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfForeignIncomeTaxRatesExplanatory_pn3n3_zjMD8faHaUhb" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 1)"> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: left"><span id="xdx_8B4_zIEEzyBPQeh6" style="display: none">Schedule of foreign income tax rates</span></td> <td> </td> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr> <td style="color: #1F497D; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Income tax rate (%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 19%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarters (Country)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryOneMember" title="Headquarters country">Germany</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_903_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryOneMember_zYUJGrAtedHa" title="Official rate">31.09</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America and Braskem America Finance</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryTwoMember" title="Headquarters country">USA</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryTwoMember_zmwhDwe5pQb5" title="Official rate">21.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryThreeMember" title="Headquarters country">Argentina</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryThreeMember_zR5NGQHAHsLk" title="Official rate">25.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFourMember" title="Headquarters country">Chile</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFourMember_zai8o2IBHLNh" title="Official rate">27.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda, Braskem Holanda Finance, Braskem Holanda Inc, B&amp;TC and ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFiveMember" title="Headquarters country">Netherlands</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFiveMember_zeRTufUN1KEg" title="Official rate">25.80</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa, Braskem Idesa Serviços, Braskem México</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Braskem México Serviços, Braskem México Proyectos and Terminal Química</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySixMember" title="Headquarters country">Mexico</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySixMember_zSYR8Td8Iifk" title="Official rate">30.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem India</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySevenMember" title="Headquarters country">India</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySevenMember_zOuSAcfMqAUc" title="Official rate">30.00</span></span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">The effects presented in the reconciliation of the effective rate, in relation to the profit before taxes of R$47,344, resulted in an effective rate of 1,832.8%, the main effect is described in Note 22.1(c).</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #00A9E0"><b>22.2 </b></span><b> <span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000">Deferred income taxes</span></b></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets are recognized for unused tax losses and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, based on the business plans for the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The measurement of deferred taxes reflects the tax consequences that would follow from how the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. Annually, the Company revises its projection of taxable income based on its Business Plan.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Business Plan is prepared annually by the Executive Board, and its main variables include projections for the prices of the products produced by the Company, the prices of raw materials, the growth in gross domestic product of each country in which the Company operates, exchange rate variation, interest rates, inflation rates and fluctuations in supply and demand for inputs and finished goods.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In evaluating the plan, the Company uses its historical performance, strategic planning and market projections produced by third party consulting firms, which are reviewed and supplemented based on Management´s experience.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves. Unrecognized deferred tax assets are reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets and liabilities are offset only if certain criteria are met.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Movement in deferred tax balances</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfChangesInDeferredTaxesExplanatory_pn3n3_zuPeymSXx3C8" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 37%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BA_zC4JMsnIh1ue" style="display: none">Schedule of changes in balances of deferred tax assets and liabilities</span></span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax losses (IR) and negative base (CSL)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,278,184</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,532</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,354,716</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(957,184)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,397,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Goodwill amortized</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,520</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,061)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,459</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(364)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,095</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variations</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,817,615</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">696,849</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zfowBEjgFDe7" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,280,062</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">611,838</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zotGaoKRJU37" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,342,880</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,996,337</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(214,060)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,782,277</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(134,745)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,647,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Business combination</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,211</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,327)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,884</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,884)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zxqXpmtKorQ8" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,032</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zCB06wyEKX17" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(77,032)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zTDRMX2EHNz1" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zFX8cmm9DOVh" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">45,366</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">72,523</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">117,889</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,197)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,692</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,277,265</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">521,424</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zGD7P1Eah8m7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,564,287</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,126</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zMkbaSykfyC" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,204,393</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of goodwill based on future profitability</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,222</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,875</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">725,097</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,664)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,433</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax depreciation</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,737,169</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">439,781</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,176,950</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(125,488)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,051,462</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS/COFINS credit - exclusion of ICMS from the calculation basis</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_zinLiZYSRTO6" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zyK2w5SMuD34" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zLpIw4kGe4v4" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(141,830)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zTaVODnGO2li" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,649</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">158,232</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(69,239)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">88,993</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,322</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">420,315</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Present value adjustments and amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">79,920</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">74,771</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">154,691</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,906 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zX6lL8VYgqse" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">261,354 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">423,951</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">279,321</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,888)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">232,433</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(45,796)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">186,637</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,827</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,389)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z0t3w5ML7Cwl" style="vertical-align: bottom; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">29,706 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,706) </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,981,691</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">686,390</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,714,469</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">53,156</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">231,648</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,999,273</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,295,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,966)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">(280,790)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,849,818</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">135,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,780,668)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,205,120</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Presentation in the balance sheet:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets1_iI_pn3n3_c20201231_zDXblEQAvlo9" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,529,972</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets1_iI_pn3n3_c20211231_z93DbubqGtM3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,257,252</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxAssets1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,358,601</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">(-) Non-current liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxLiabilities1_c20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,234,398</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilities1_c20211231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,407,434</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,481</span></td></tr> </table> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F06_z9AGbyCRPkQf" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F15_z6s9ej1m2pUj" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.<b>  </b></span></td></tr> </table> <p id="xdx_8A8_zbRELDGhk2mh" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b) Offset for the purpose of presentation in the consolidated statement of financial position</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory_pn3n3_zUYM5Lde8mL" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 3)"> <tr> <td style="color: #1F497D; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_zBPcaEmNCbWe" style="display: none">Schedule of deferred taxes offset for the purpose of presentation in the balance sheet</span></span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarters (Country)</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax calculation</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Offsetting</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax calculation</span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Offsetting</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance</span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A.</span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zrc0seb69uEg" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,356,402</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zUzxlvcMXqu6" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,584,962)</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,771,440</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zE0bs6OHbvma" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 8,841,886</span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zRNFu4nANRXg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,496,637)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zdpnkOcKPN0i" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,345,249</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentina</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,339</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zNLkyg5Twbwj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,174)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,165</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zvhdsD8Dqcv1" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,271</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_ze7pNO1eWyr6" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,271</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">USA</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">356,598</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (356,598)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zBj0lLxOKv4l" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 294,328</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zJrQaQDe81g" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (294,328)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,038</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 23,038</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_z9hiSw96Vh4a" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">44,417</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_zCKsYLeo09c8" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 44,417</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">47</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_zRgxpEJOTRzg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 92</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_zTQimwT21C76" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  92</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zIZFneqntrMf" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zp8R07TpP6C9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">195,042</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zf4fy8piFMjj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (39,696)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">155,346</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zVxvJgfD6oNj" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zdlTPw7Fzs8d" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,078,206</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zZ7oSyVh80j9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,840,669)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvG5IWkH3dYl" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  237,537</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvxbfmWKfX7h" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,282,125</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_znUPpqJ1HBXe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,506,541)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zpmJ9w9Ibl5" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,775,584</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa Serviços</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_zhgnGOuc7D9b" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_zy9AdPOVoT3a" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 26</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_znitSVzAWAEg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem México Serviços</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zuF8tRTaRIU9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zAlXW4PSkO4h" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,628</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_z5uFc72PdpIg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,628</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zCj6DVWrzkBg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,502</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_z5vq4dQSEWYj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,502</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem México</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_zGFJtifVz1y5" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  86,368</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 86,368</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_z2czSzIhemag" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,181</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_zy4hN28pH9S" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,181</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_z26xChBHzDl9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  39,387</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,405)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,982</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zvFx6h33LJT9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">40,434</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zNVP5tnGxxR3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,586)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zoBPQaaWPG25" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 32,848</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_z3IYGJchcOk2" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  32,617</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,262)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 30,355</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zHPpWSaFCCh2" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">39,025</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zMWkMrJ1HeKa" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,943)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zIsgsRZD5MDe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,082</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Terminal Química</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zHoIIZ6ixNA7" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zHyuriU3DRCi" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,618</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zZY2lFKtOiPf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,618</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Voqen</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zZJQ6ZxzOWHl" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_z143AGtBW4hh" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 103</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zz6FNsVBJZpl" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zR0a8jnVw5xg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,204,393</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,001,138)</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,358,601</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zp3GPNibPCkf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,564,287</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zdid95qghafg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,307,035)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zf8fVt7an5m6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,257,252</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A.</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zdnsZSA4qcKe" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,584,962</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,584,962)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zllOXmp5Hrqf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,496,637</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zj2UF12h3l0e" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,496,637)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zOKsJYUKRhvg" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">USA</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,493,471</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (356,598)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,136,873</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zM5TeSYLuK57" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,701,762</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zCHLiA1tS0n7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (294,328)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zli0Uxy0mFAd" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,407,434</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zZZX95VvGhZ1" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zRG4jOjL3tbe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,174</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zCIpCU5Qzhda" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,174)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zSP6f3XYuJa9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_z0gSQVxQWKH7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  39,696</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zZ9RJvCdqfuk" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(39,696)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zYpKXejXqtQh" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zDlWOqc59pGj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,840,669</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zOPGFjBkznrd" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,840,669)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_z05iKFvqatMj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,506,541</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvU4OVDY95z2" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,506,541)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">B&amp;TC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zHZ417fOWozf" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zpOedaAErxpb" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,608</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zAQZ5YaSx8Lf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,608</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zg5AtWAWZeUl" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,405</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,405)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zdSqx62BF5w8" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,586</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zs7IBDbMOIFc" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,586)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zRUyBOfNDPJc" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,262</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,262)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zwXW2ibRtPVb" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,943</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zZHT7gjJwYz7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,943)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Voqen</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zEi46bo7W1h2" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zUtWe6jUj1vk" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">26</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zOH3BOOCgLk7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td style="padding-left: 9px; font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,999,273</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,845,792)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilities2_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,481</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z3CGakZoaooa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,714,469</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zyzel5acBRU8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,307,035)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z4WJSZClxFB4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,407,434</span></td></tr> </table> <p id="xdx_8A9_z41yY7W3FvX4" style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <b> </b></span></p> 392062000 1189812000 252995000 230069000 984400000 1038255000 892000000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory_pn3n3_zwShEkRV37Ce" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zHPxhkcuKEmf" style="display: none">Schedule of income tax and social contribution reconciliation</span></td> <td> </td> <td> </td> <td id="xdx_49D_20220101__20221231_zZeGJANNbkn1" style="text-align: center"> </td> <td style="color: white; text-align: right"> </td> <td id="xdx_49F_20210101__20211231_zZMitM95tzD9" style="text-align: center"> </td> <td> </td> <td id="xdx_498_20200101__20201231_zahNSA2dX764" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 61%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_i_pn3n3" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) before income taxes</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47,344</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,961,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (9,683,784)</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--AccountingProfit_i_pn3n3" style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,097)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(6,106,748)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,292,487</span></td></tr> <tr> <td style="vertical-align: middle"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_401_ecustom--PermanentAdjustmentsToIRAnCSLlCalculationBasisAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Permanent adjustments to income taxes calculation basis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_402_ecustom--IncomeTaxAnsSocialContributionOnEquityInResultsOfInvestees_zWUcEgpKBRgh" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Income taxes on equity in results of investees</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 11,849</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,578</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,595</span></td></tr> <tr id="xdx_405_ecustom--ThinCapitalization_zu7CGwW2Oxm7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Thin capitalization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F47_zdDFAFtb3mH8" style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(359,598)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (6,628)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(695,741)</span></td></tr> <tr id="xdx_403_ecustom--TaxBenefits_zCIWOaArMNW6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax benefits (Sudene and PAT)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7005">-</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  137,338</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7007">-</span></span></td></tr> <tr id="xdx_409_ecustom--ReductionOfTaxLoss_zN2xMdseIOa9" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reduction of tax loss</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F4F_ziAwcHlA29M2" style="font-family: Calibri, Helvetica, Sans-Serif">22.1(c)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(891,669)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7011">-</span></span></td></tr> <tr id="xdx_404_ecustom--EffectOfRefundOfBraskemAmericasTaxBenefit_zyOZYoIFcAx6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect of the refund of Braskem America´s tax benefit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(737,841)</span></td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfForeignTaxRates_zV9KPjttB4z7" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Different jurisdictional taxes rates for companies abroad and tax basis</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F46_zFyEcAaGxMs9" style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,029,618</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,980,358</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  994,811</span></td></tr> <tr id="xdx_408_ecustom--EffectFromRetrospectiveTaxRateOnBonusDepreciationOfBraskemAmerica_zMt3cx1QFuld" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect from the retrospective tax rate on bonus depreciation of Braskem America</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl7022">-</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  334,460</span></td></tr> <tr id="xdx_40D_ecustom--TaxesOnDividendsDistribution_zuW2olWVtun3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Taxes on dividends distribution</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(454,663)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(265,454)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(131,240)</span></td></tr> <tr id="xdx_40B_ecustom--ExclusionOfInflationAdjustementBySelicOnUndueTaxPaymentsFromTaxableIncome_zHh7xXMUKC44" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exclusion of inflation adjustement by Selic on undue tax payments from taxable income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span id="xdx_F4D_zG8IxHuUDdYb" style="font-family: Calibri, Helvetica, Sans-Serif">22.1(a)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,395</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  501,382</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_zwOevyATp7k1" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other permanent adjustments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(226,570)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(241,229)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(395,053)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_405_ecustom--IncomeTaxExpenseContinuingOperations12_z7Oylyv6Yutj" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effect of income taxes on results of operations</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (867,735)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,999,403)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--BreakdownOfIncomeTaxes_zJPcw9OQfZ8e" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Breakdown of income taxes</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentIrAndCslExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentYearIncomeTaxAndSocialContribution_zVGzKIlvIZOd" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,705)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,834,437)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (52,830)</span></td></tr> <tr id="xdx_408_eifrs-full--CurrentTaxExpenseIncome_zt4aUBQ08e5k" style="vertical-align: bottom"> <td style="color: White">Total current expenses<span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,705)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,834,437)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (52,830)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeAbstract_iB_zcfNLLWTRk9i" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred income taxes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_407_ecustom--OriginationAndReversalOfTemporaryDifferences_zfaeKyNy4Xa6" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Origination and reversal of temporary differences</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,192,438</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(246,294)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,677,328</span></td></tr> <tr id="xdx_409_eifrs-full--TaxEffectOfTaxLosses_zp18watcBdRa" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax losses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,056,468)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 81,328</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 43,980</span></td></tr> <tr id="xdx_404_eifrs-full--DeferredTaxExpenseIncome_zuvujNpci6k6" style="vertical-align: bottom"> <td style="color: White; font-weight: bold">Total Deferred income taxes<span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  135,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,966)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,721,308</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--IncomeTaxndSocialContribution_zEZIy7aJ1cUa" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (867,735)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,999,403)</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,668,478</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--AverageEffectiveTaxRate_pid_dp_zfPmSisPuIk5" style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Effective rate</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1832.8%</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">22.3%</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">27.6%</span></td></tr> </table> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_zD9I3bpqepdg" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F19_z9rvSFWmFOM" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0C_z8XgtOWnRmpd" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td id="xdx_F1A_zfzxJmTg3lge" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows:</span></td></tr> </table> 47344000 17961023000 -9683784000 -16097000 -6106748000 3292487000 11849000 1578000 6595000 -359598000 -6628000 -695741000 137338000 -891669000 -737841000 1029618000 1980358000 994811000 334460000 -454663000 -265454000 -131240000 39395000 501382000 -226570000 -241229000 -395053000 -867735000 -3999403000 2668478000 -1003705000 -3834437000 -52830000 -1003705000 -3834437000 -52830000 1192438000 -246294000 2677328000 -1056468000 81328000 43980000 135970000 -164966000 2721308000 -867735000 -3999403000 2668478000 18.328 0.223 0.276 <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfForeignIncomeTaxRatesExplanatory_pn3n3_zjMD8faHaUhb" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 1)"> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: left"><span id="xdx_8B4_zIEEzyBPQeh6" style="display: none">Schedule of foreign income tax rates</span></td> <td> </td> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: right"> </td> <td style="font-weight: bold; text-align: right"> </td></tr> <tr> <td style="color: #1F497D; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Income tax rate (%)</span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 63%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 19%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarters (Country)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryOneMember" title="Headquarters country">Germany</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_903_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryOneMember_zYUJGrAtedHa" title="Official rate">31.09</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America and Braskem America Finance</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryTwoMember" title="Headquarters country">USA</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_909_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryTwoMember_zmwhDwe5pQb5" title="Official rate">21.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryThreeMember" title="Headquarters country">Argentina</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryThreeMember_zR5NGQHAHsLk" title="Official rate">25.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_909_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFourMember" title="Headquarters country">Chile</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFourMember_zai8o2IBHLNh" title="Official rate">27.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda, Braskem Holanda Finance, Braskem Holanda Inc, B&amp;TC and ER Plastics</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFiveMember" title="Headquarters country">Netherlands</span></span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90E_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiaryFiveMember_zeRTufUN1KEg" title="Official rate">25.80</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa, Braskem Idesa Serviços, Braskem México</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">  Braskem México Serviços, Braskem México Proyectos and Terminal Química</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySixMember" title="Headquarters country">Mexico</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_90A_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySixMember_zSYR8Td8Iifk" title="Official rate">30.00</span></span></td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem India</span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySevenMember" title="Headquarters country">India</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_907_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SubsidiarySevenMember_zOuSAcfMqAUc" title="Official rate">30.00</span></span></td></tr> </table> <p style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(iii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">The effects presented in the reconciliation of the effective rate, in relation to the profit before taxes of R$47,344, resulted in an effective rate of 1,832.8%, the main effect is described in Note 22.1(c).</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: #00A9E0"><b>22.2 </b></span><b> <span style="font-family: Calibri, Helvetica, Sans-Serif; color: #FE5000">Deferred income taxes</span></b></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets are recognized for unused tax losses and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, based on the business plans for the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The measurement of deferred taxes reflects the tax consequences that would follow from how the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. Annually, the Company revises its projection of taxable income based on its Business Plan.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Business Plan is prepared annually by the Executive Board, and its main variables include projections for the prices of the products produced by the Company, the prices of raw materials, the growth in gross domestic product of each country in which the Company operates, exchange rate variation, interest rates, inflation rates and fluctuations in supply and demand for inputs and finished goods.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In evaluating the plan, the Company uses its historical performance, strategic planning and market projections produced by third party consulting firms, which are reviewed and supplemented based on Management´s experience.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves. Unrecognized deferred tax assets are reassessed at each reporting date and recognized to the extent that it has become probable that future taxable profits will be available against which they can be used.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Deferred tax assets and liabilities are offset only if certain criteria are met.</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a) Movement in deferred tax balances</span></p> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfChangesInDeferredTaxesExplanatory_pn3n3_zuPeymSXx3C8" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 37%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BA_zC4JMsnIh1ue" style="display: none">Schedule of changes in balances of deferred tax assets and liabilities</span></span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax losses (IR) and negative base (CSL)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,278,184</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,532</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,354,716</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(957,184)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,397,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Goodwill amortized</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,520</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,061)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,459</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(364)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,095</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variations</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,817,615</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">696,849</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zfowBEjgFDe7" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,280,062</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">611,838</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zotGaoKRJU37" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,342,880</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,996,337</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(214,060)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,782,277</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(134,745)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,647,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Business combination</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,211</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,327)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,884</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,884)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zxqXpmtKorQ8" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,032</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zCB06wyEKX17" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(77,032)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zTDRMX2EHNz1" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zFX8cmm9DOVh" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">45,366</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">72,523</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">117,889</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,197)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,692</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,277,265</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">521,424</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zGD7P1Eah8m7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,564,287</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,126</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zMkbaSykfyC" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,204,393</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of goodwill based on future profitability</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,222</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,875</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">725,097</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,664)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,433</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax depreciation</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,737,169</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">439,781</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,176,950</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(125,488)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,051,462</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS/COFINS credit - exclusion of ICMS from the calculation basis</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_zinLiZYSRTO6" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zyK2w5SMuD34" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zLpIw4kGe4v4" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(141,830)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zTaVODnGO2li" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,649</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">158,232</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(69,239)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">88,993</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,322</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">420,315</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Present value adjustments and amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">79,920</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">74,771</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">154,691</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,906 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zX6lL8VYgqse" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">261,354 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">423,951</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">279,321</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,888)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">232,433</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(45,796)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">186,637</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,827</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,389)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z0t3w5ML7Cwl" style="vertical-align: bottom; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">29,706 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,706) </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,981,691</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">686,390</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,714,469</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">53,156</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">231,648</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,999,273</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,295,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,966)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">(280,790)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,849,818</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">135,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,780,668)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,205,120</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Presentation in the balance sheet:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets1_iI_pn3n3_c20201231_zDXblEQAvlo9" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,529,972</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets1_iI_pn3n3_c20211231_z93DbubqGtM3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,257,252</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxAssets1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,358,601</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">(-) Non-current liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxLiabilities1_c20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,234,398</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilities1_c20211231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,407,434</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,481</span></td></tr> </table> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F06_z9AGbyCRPkQf" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F15_z6s9ej1m2pUj" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.<b>  </b></span></td></tr> </table> Germany 0.3109 USA 0.2100 Argentina 0.2500 Chile 0.2700 Netherlands 0.2580 Mexico 0.3000 India 0.3000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfChangesInDeferredTaxesExplanatory_pn3n3_zuPeymSXx3C8" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 37%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BA_zC4JMsnIh1ue" style="display: none">Schedule of changes in balances of deferred tax assets and liabilities</span></span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="color: white; vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Impact on the P&amp;L</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other<br/> comprehensive<br/> income</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax losses (IR) and negative base (CSL)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,278,184</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,532</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,354,716</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(957,184)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxLossesIRAndNegativeBaseCSLMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,397,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Goodwill amortized</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,520</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,061)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,459</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(364)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--GoodwillAmortizedMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,095</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variations</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,817,615</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">696,849</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zfowBEjgFDe7" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,280,062</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">611,838</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zotGaoKRJU37" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExchangeVariationsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,342,880</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,996,337</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(214,060)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,782,277</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(134,745)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,647,532</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Business combination</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,211</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,327)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,884</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--BusinessCombinationMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(26,884)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zxqXpmtKorQ8" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">77,032</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zCB06wyEKX17" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(77,032)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zTDRMX2EHNz1" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxCreditsMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_fKGkp_zFX8cmm9DOVh" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">697,662</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">45,366</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">72,523</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">117,889</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,197)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">116,692</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,277,265</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">521,424</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_pn3n3_c20210101__20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zGD7P1Eah8m7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(234,402)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,564,287</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,126</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zMkbaSykfyC" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,549,020)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,204,393</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of goodwill based on future profitability</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,222</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,875</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">725,097</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,664)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">722,433</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax depreciation</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,737,169</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">439,781</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,176,950</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(125,488)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TaxDepreciationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,051,462</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS/COFINS credit - exclusion of ICMS from the calculation basis</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">0</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_zinLiZYSRTO6" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zyK2w5SMuD34" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,479</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zLpIw4kGe4v4" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(141,830)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_iI_pn3n3_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--ExclusionOfICMSInBasisOfCalculationMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zTaVODnGO2li" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">189,649</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Temporary adjustments</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">158,232</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(69,239)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">88,993</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">331,322</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--TemporaryAdjustmentMember__ifrs-full--ClassesOfAssetsAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">420,315</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Present value adjustments and amortized cost</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">79,920</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">74,771</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">154,691</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,906 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--OtherComprehensiveIncome1_pn3n3_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zX6lL8VYgqse" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">261,354 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--PresentValueAdjustmentAndAmortizedCostMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">423,951</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amortization of fair value adjustments on  the assets from the acquisiton of Braskem Qpar</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">279,321</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,888)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">232,433</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(45,796)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">186,637</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,827</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(46,389)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_pn3n3_c20210101__20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z0t3w5ML7Cwl" style="vertical-align: bottom; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">29,706 </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(29,706) </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--AssetsAndLiabilitiesAxis__custom--OtherMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,826</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,981,691</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">686,390</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,388</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,714,469</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">53,156</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">231,648</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,999,273</span></td></tr> <tr style="vertical-align: middle"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxLiabilityAsset1_c20201231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,295,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,966)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_c20210101__20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Impact on the equity"><span style="font-family: Calibri, Helvetica, Sans-Serif">(280,790)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAsset1_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,849,818</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">135,970</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--OtherComprehensiveIncome1_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,780,668)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DeferredTaxLiabilityAsset1_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NetMember_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,205,120</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Presentation in the balance sheet:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current assets</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets1_iI_pn3n3_c20201231_zDXblEQAvlo9" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,529,972</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets1_iI_pn3n3_c20211231_z93DbubqGtM3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,257,252</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxAssets1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax assets1"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,358,601</span></td></tr> <tr> <td style="padding-left: 18px; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">(-) Non-current liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxLiabilities1_c20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,234,398</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilities1_c20211231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,407,434</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities1_c20221231_pn3n3" style="vertical-align: bottom; text-align: right" title="Deferred tax liabilities1"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,481</span></td></tr> </table> <p style="font: bold 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F06_z9AGbyCRPkQf" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F15_z6s9ej1m2pUj" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.<b>  </b></span></td></tr> </table> 3278184000 76532000 3354716000 -957184000 2397532000 6520000 -4061000 2459000 -364000 2095000 3817615000 696849000 -234402000 4280062000 611838000 -1549020000 3342880000 4996337000 -214060000 4782277000 -134745000 4647532000 56211000 -29327000 26884000 -26884000 77032000 -77032000 697662000 697662000 45366000 72523000 117889000 -1197000 116692000 12277265000 521424000 -234402000 12564287000 189126000 -1549020000 11204393000 722222000 2875000 725097000 -2664000 722433000 3737169000 439781000 4176950000 -125488000 4051462000 331479000 331479000 -141830000 189649000 158232000 -69239000 88993000 331322000 420315000 79920000 74771000 154691000 7906000 261354000 423951000 279321000 -46888000 232433000 -45796000 186637000 4827000 -46389000 46388000 4826000 29706000 -29706000 4826000 4981691000 686390000 46388000 5714469000 53156000 231648000 5999273000 7295574000 -164966000 -280790000 6849818000 135970000 -1780668000 5205120000 8529972000 8257252000 6358601000 1234398000 1407434000 1153481000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory_pn3n3_zUYM5Lde8mL" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 3)"> <tr> <td style="color: #1F497D; font-family: Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_zBPcaEmNCbWe" style="display: none">Schedule of deferred taxes offset for the purpose of presentation in the balance sheet</span></span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Headquarters (Country)</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax calculation</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Offsetting</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax calculation</span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Offsetting</span></td> <td style="font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance</span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Assets</span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A.</span></td> <td style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zrc0seb69uEg" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,356,402</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zUzxlvcMXqu6" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,584,962)</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,771,440</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zE0bs6OHbvma" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 8,841,886</span></td> <td style="color: red; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zRNFu4nANRXg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,496,637)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zdpnkOcKPN0i" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,345,249</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentina</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,339</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zNLkyg5Twbwj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,174)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,165</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zvhdsD8Dqcv1" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,271</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_ze7pNO1eWyr6" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,271</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">USA</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">356,598</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (356,598)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zBj0lLxOKv4l" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 294,328</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zJrQaQDe81g" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (294,328)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,038</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 23,038</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_z9hiSw96Vh4a" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">44,417</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_zCKsYLeo09c8" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 44,417</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Chile</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">47</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  47</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_zRgxpEJOTRzg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 92</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemChileMember_zTQimwT21C76" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  92</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zIZFneqntrMf" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zp8R07TpP6C9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">195,042</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zf4fy8piFMjj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (39,696)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">155,346</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zVxvJgfD6oNj" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zdlTPw7Fzs8d" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,078,206</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zZ7oSyVh80j9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,840,669)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvG5IWkH3dYl" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  237,537</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvxbfmWKfX7h" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 3,282,125</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_znUPpqJ1HBXe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,506,541)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zpmJ9w9Ibl5" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,775,584</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa Serviços</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_zhgnGOuc7D9b" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_zy9AdPOVoT3a" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 26</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaServicosMember_znitSVzAWAEg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  26</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem México Serviços</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zuF8tRTaRIU9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zAlXW4PSkO4h" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,628</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_z5uFc72PdpIg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 13,628</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_zCj6DVWrzkBg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,502</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoServicosMember_z5vq4dQSEWYj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,502</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem México</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_zGFJtifVz1y5" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  86,368</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 86,368</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_z2czSzIhemag" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,181</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemMexicoMember_zy4hN28pH9S" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,181</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_z26xChBHzDl9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  39,387</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,405)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 33,982</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zvFx6h33LJT9" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">40,434</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zNVP5tnGxxR3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,586)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zoBPQaaWPG25" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 32,848</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_z3IYGJchcOk2" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  32,617</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,262)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 30,355</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zHPpWSaFCCh2" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">39,025</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zMWkMrJ1HeKa" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,943)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zIsgsRZD5MDe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 37,082</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Terminal Química</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zHoIIZ6ixNA7" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zHyuriU3DRCi" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,618</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TerminalQuimicaMember_zZY2lFKtOiPf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,618</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Voqen</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zZJQ6ZxzOWHl" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_z143AGtBW4hh" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 103</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zz6FNsVBJZpl" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DeferredTaxAssets2_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zR0a8jnVw5xg" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="padding-left: 9px; font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  11,204,393</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,001,138)</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DeferredTaxAssets2_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,358,601</span></td> <td style="color: white; font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zp3GPNibPCkf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,564,287</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zdid95qghafg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSL offsetting, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,307,035)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DeferredTaxAssets2_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--AssetMember_zf8fVt7an5m6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,257,252</span></td></tr> <tr> <td style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Liabilities</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem S.A.</span></td> <td style="font-weight: bold; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zdnsZSA4qcKe" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,584,962</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,584,962)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zllOXmp5Hrqf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,496,637</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemSAMember_zj2UF12h3l0e" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,496,637)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zOKsJYUKRhvg" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">USA</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,493,471</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (356,598)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,136,873</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zM5TeSYLuK57" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,701,762</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zCHLiA1tS0n7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (294,328)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAmericaMember_zli0Uxy0mFAd" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,407,434</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Argentina</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zZZX95VvGhZ1" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zRG4jOjL3tbe" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,174</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemArgentinaMember_zCIpCU5Qzhda" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(16,174)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Holanda</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zSP6f3XYuJa9" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_z0gSQVxQWKH7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  39,696</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemHolandaMember_zZ9RJvCdqfuk" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(39,696)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zYpKXejXqtQh" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zDlWOqc59pGj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,840,669</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zOPGFjBkznrd" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,840,669)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_z05iKFvqatMj" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,506,541</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zvU4OVDY95z2" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,506,541)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">B&amp;TC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zHZ417fOWozf" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zpOedaAErxpb" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,608</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BTCMember_zAQZ5YaSx8Lf" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,608</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cetrel</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zg5AtWAWZeUl" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,405</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,405)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zdSqx62BF5w8" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,586</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CetrelMember_zs7IBDbMOIFc" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,586)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">DAC</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zRUyBOfNDPJc" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 2,262</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_pn3n3" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,262)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zwXW2ibRtPVb" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,943</span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DACMember_zZHT7gjJwYz7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,943)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td colspan="2" style="padding-left: 9px; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Voqen</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zEi46bo7W1h2" style="vertical-align: top" title="Headquarters country"><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zUtWe6jUj1vk" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">26</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--VoqenMember_zOH3BOOCgLk7" style="font-size: 10pt; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26)</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: top; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-size: 10pt; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr> <td style="padding-left: 9px; font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,999,273</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,845,792)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DeferredTaxLiabilities2_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,481</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--IncomeTaxAndSocialContributionTaxCalculationLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z3CGakZoaooa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Tax calculation, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,714,469</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_zyzel5acBRU8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="IR and CSl offsetting, liabilites"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,307,035)</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DeferredTaxLiabilities2_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LiabilitiesCategoryMember_z4WJSZClxFB4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 10pt; font-weight: bold; vertical-align: bottom; text-align: right" title="Balance, liabilities"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,407,434</span></td></tr> </table> Brazil 8356402000 -2584962000 5771440000 8841886000 -2496637000 6345249000 Argentina 21339000 -16174000 5165000 3271000 3271000 USA 356598000 -356598000 294328000 -294328000 Germany 23038000 23038000 44417000 44417000 Chile 47000 47000 92000 92000 Netherlands 195042000 -39696000 Mexico 2078206000 -1840669000 237537000 3282125000 -1506541000 1775584000 Mexico 26000 26000 Mexico 13628000 13628000 2502000 2502000 Mexico 86368000 86368000 16181000 16181000 Brazil 39387000 -5405000 33982000 40434000 -7586000 32848000 Brazil 32617000 -2262000 30355000 39025000 -1943000 37082000 Mexico 1618000 1618000 Brazil 103000 -26000 77000 11204393000 -5001138000 6358601000 12564287000 -4307035000 8257252000 Brazil 2584962000 -2584962000 2496637000 -2496637000 USA 1493471000 -356598000 1136873000 1701762000 -294328000 1407434000 Chile 16174000 -16174000 Netherlands 39696000 -39696000 Mexico 1840669000 -1840669000 1506541000 -1506541000 Netherlands 16608000 16608000 Brazil 5405000 -5405000 7586000 -7586000 Brazil 2262000 -2262000 1943000 -1943000 Brazil 26000 -26000 5999273000 -4845792000 1153481000 5714469000 -4307035000 1407434000 <p id="xdx_806_eifrs-full--DisclosureOfProvisionsExplanatory_zYHPygQDuxP8" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">23 <span id="xdx_821_zJ3PhszaseSl">Sundry provisions</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfSundryProvisionsExplanatory_pn3n3_zDLOuQqbutu4" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Sundry provisions (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8BB_z2jdZY0HSHZh" style="display: none">Schedule of sundry provisions</span></td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 61%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision for environmental damages</span></td> <td id="xdx_989_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,188</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zSpgRKLzRq71" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,035,426</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision for customers rebates</span></td> <td id="xdx_988_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionForCustomersRebatesMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,754</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionForCustomersRebatesMember_zQAzYtiWyzXj" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  101,253</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  130,005</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zzo4rnhADztl" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  152,584</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--Provisions1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--Provisions1_iI_pn3n3_c20211231_zax44fUxCZX" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CurrentProvisions_c20221231_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  530,814</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CurrentProvisions_iI_pn3n3_c20211231_zUjeuIpenXIl" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  465,051</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td id="xdx_98A_eifrs-full--NoncurrentProvisions_c20221231_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  846,133</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentProvisions_iI_pn3n3_c20211231_zBPTftzpYJL7" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  824,212</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--Provisions1_iI_pn3n3_c20221231_zoqfjs3koPkf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--Provisions1_iI_pn3n3_c20211231_zEdOzYJYJPTi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> </table> <p id="xdx_8AF_zfs0K5JVZMOf" style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Provision for environmental damages</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The provision for environmental damages is estimated based on current legal and constructive requirements, technology, price levels and expected remediation plans.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Realized costs and cash outflows may differ from current estimates due to the changes in laws and regulations, public expectations, prices, new findings by the ongoing studies and analysis of local conditions and changes in remediation technologies.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The time and value of future expenses related to environmental liabilities are reviewed annually, as well as the interest rate used for discounting them to present value.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company operates in several countries and is subject to different environmental laws and regulations inherent to the operations and activities areas. Remediation expenses are incurred over several years due to their complexity and extension. New information on websites, new technologies or future developments, such as involvement in investigations by regulatory agencies, may require that we reevaluate our potential exposure related to environmental matters.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The provision is recorded based on the areas in which remediation actions will be necessary. Due to the high complexity in identifying potential environmental impacts, alternative solutions and recovery costs estimations, these estimates can only be made with reasonable assurance after the completion of all phases of the process to identify and investigate environmental liabilities, which are in accordance with the phases and protocols established by environmental agencies.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company monitors the areas under study to capture any new facts and changes in circumstances that change the prognosis of actions to be adopted and consequently affect the estimation of provision for environmental remediations.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Rebates</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Some sales agreements of the Company provide for a rebate in products should certain sales volumes be achieved within the year, six-month period or three-month period, depending on the agreement. The bonus is recognized monthly in a provision, assuming that the minimum contractual amount will be achieved.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Changes in provisions</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfChangesInSundryProvisionsExplanatory_pn3n3_zL5uPKvyC1Za" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Sundry provisions (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zyTfAbs1IBF7" style="display: none">Schedule of changes in sundry provisions</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Recovery of</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">environmental </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">damage</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Rebate</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zUdauqsjKXqj" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">602,490</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zEXguRSUkHoh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  123,465</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zYw5BfEUAXde" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  148,253</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231_zsJsqAaO5G9" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">874,208</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  576,086</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 144,710</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 114,395</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  835,191</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zbJW5E8t9gf4" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(143,150)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zwMK6v9gISm2" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (166,922)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zIqZyeNzllc9" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (110,064)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231_z1knfoMfYOf6" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (420,136)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2021</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zXlAutAYlIU" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,035,426</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zpOZrJOg5o79" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  101,253</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zRLxniI4A0ff" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  152,584</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231_z7fpV9rYfkw3" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zcvNxkSTk4m7" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  299,241</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_z6i9VbOg655j" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 184,142</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zAxds6mVPcj8" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">19,777</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231_zHm8TCgcMMWi" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  503,161</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_z5Uuz3ELqB13" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(214,479)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zLtAa0trrk1g" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (158,641)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zwgM6NKa4K0e" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (42,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231_zcaJ1NIKWpe4" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (415,477)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zqj2EIhBGcok" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,188</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zA5ceZEuq5Ng" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,754</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zFFVvcMJqv0e" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  130,005</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231_zsQ08ej1Rmob" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td></tr> </table> <p id="xdx_8A3_zJenH8B1uzNg" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>  </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfSundryProvisionsExplanatory_pn3n3_zDLOuQqbutu4" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Sundry provisions (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span id="xdx_8BB_z2jdZY0HSHZh" style="display: none">Schedule of sundry provisions</span></td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 61%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision for environmental damages</span></td> <td id="xdx_989_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,188</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zSpgRKLzRq71" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,035,426</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision for customers rebates</span></td> <td id="xdx_988_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionForCustomersRebatesMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,754</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionForCustomersRebatesMember_zQAzYtiWyzXj" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  101,253</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--Provisions1_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  130,005</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--Provisions1_iI_pn3n3_c20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zzo4rnhADztl" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  152,584</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--Provisions1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--Provisions1_iI_pn3n3_c20211231_zax44fUxCZX" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CurrentProvisions_c20221231_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  530,814</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CurrentProvisions_iI_pn3n3_c20211231_zUjeuIpenXIl" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  465,051</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liabilities</span></td> <td id="xdx_98A_eifrs-full--NoncurrentProvisions_c20221231_pn3n3" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  846,133</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NoncurrentProvisions_iI_pn3n3_c20211231_zBPTftzpYJL7" style="text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">  824,212</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--Provisions1_iI_pn3n3_c20221231_zoqfjs3koPkf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--Provisions1_iI_pn3n3_c20211231_zEdOzYJYJPTi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Sundry provisions, current"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> </table> 1120188000 1035426000 126754000 101253000 130005000 152584000 1376947000 1289263000 530814000 465051000 846133000 824212000 1376947000 1289263000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfChangesInSundryProvisionsExplanatory_pn3n3_zL5uPKvyC1Za" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Sundry provisions (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zyTfAbs1IBF7" style="display: none">Schedule of changes in sundry provisions</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Recovery of</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">environmental </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">damage</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Rebate</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2020</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zUdauqsjKXqj" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">602,490</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zEXguRSUkHoh" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  123,465</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zYw5BfEUAXde" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  148,253</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231_zsJsqAaO5G9" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">874,208</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  576,086</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 144,710</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 114,395</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NewProvisionsOtherProvisions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  835,191</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zbJW5E8t9gf4" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(143,150)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zwMK6v9gISm2" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (166,922)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zIqZyeNzllc9" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (110,064)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProvisionUsedOtherProvision_pn3n3_c20210101__20211231_z1knfoMfYOf6" style="border-bottom: Black 0.5pt solid; text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (420,136)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2021</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zXlAutAYlIU" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,035,426</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zpOZrJOg5o79" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  101,253</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zRLxniI4A0ff" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  152,584</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231_z7fpV9rYfkw3" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,289,263</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zcvNxkSTk4m7" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  299,241</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_z6i9VbOg655j" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 184,142</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zAxds6mVPcj8" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">19,777</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NewProvisionsOtherProvisions_pn3n3_c20220101__20221231_zHm8TCgcMMWi" style="text-align: right" title="Additions, monetary adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  503,161</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reversals</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_z5Uuz3ELqB13" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(214,479)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zLtAa0trrk1g" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (158,641)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zwgM6NKa4K0e" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (42,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProvisionUsedOtherProvision_pn3n3_c20220101__20221231_zcaJ1NIKWpe4" style="text-align: right" title="Write-offs through usage and payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (415,477)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RecoveryOfEnvironmentalDamageMember_zqj2EIhBGcok" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,120,188</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--RebateMember_zA5ceZEuq5Ng" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,754</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--OtherMember_zFFVvcMJqv0e" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  130,005</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20220101__20221231_zsQ08ej1Rmob" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,376,947</span></td></tr> </table> 602490000 123465000 148253000 874208000 576086000 144710000 114395000 835191000 -143150000 -166922000 -110064000 -420136000 1035426000 101253000 152584000 1289263000 299241000 184142000 19777000 503161000 -214479000 -158641000 -42357000 -415477000 1120188000 126754000 130005000 1376947000 <p id="xdx_804_ecustom--DisclosureOfProvisionsForLegalProceedingsExplanatory_zhjSiqt2wuv8" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">24 <span id="xdx_82E_z8uma6J6Boaa">Provisions for legal proceedings and contingent liabilities</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem is a defendant in lawsuits and administrative proceedings arising from the normal course of its business. The Management, based on its assessment and that of its external legal advisors, classifies these proceedings in terms of probability of loss as follows:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Probable chance of loss</b>: present obligation for which there is a higher probability of loss than of a favorable outcome. For these claims, a provision is recognized based on an estimated amount of the obligation that reflects the expected outflow of resources (see Note 24.1).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Possible chance of loss: </b>present obligation for which the possibility of loss is greater than remote and less than probable. For these claims, the Company does not recognize a provision and discloses the most significant matters (see Note 24.2).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Management believes that the estimates related to the outcome of the proceedings and the possibility of future disbursement may change in view of the following: (i) higher courts may decide in a similar case involving another company, adopting a final interpretation of the matter and, consequently, advancing the termination of the proceeding involving the Company, without any disbursement or implying the need of any financial settlement of the proceeding; and (ii) programs encouraging the payment of the debts implemented in Brazil at the Federal and State levels, in favorable conditions that may lead to a disbursement that is lower than the one that is recognized in the provision or lower than the value of the matter.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In addition, the Company also is a plaintiff in several lawsuits. In these cases, the Company discloses the contingent asset when the receipt of economic benefits is probable. However, when the realization of the benefit is virtually certain, the related asset no longer constitutes a contingent asset, and as such amount is recognized.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Any changes in the court’s understanding of the position could cause future impacts on the consolidated financial statements of the Company due to such proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>24.1 Lawsuits with probable losses</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory_pn3n3_zMcSnmApB74e" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BC_zktRhc8dHzp5" style="display: none">Claims with probable chance of loss and contingent liabilities</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 57%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td id="xdx_984_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  212,657</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_ziEvXR0gl0w3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  268,758</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">IR and CSL</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--IRAndCSLMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 51,756</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--IRAndCSLMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zeZgb0HZmfF2" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,946</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and COFINS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--PISAndCOFINSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  311,433</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--PISAndCOFINSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_znojlmMn0pdj" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  299,202</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--ICMSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  348,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--ICMSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zjf2D8ksmyve" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  331,094</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other tax claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--OtherTaxClaimsMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,160</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--OtherTaxClaimsMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zfZBJGSRgJlf" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 22,857</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfOerationAxis__custom--NormalOperationMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">735,893</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfOerationAxis__custom--NormalOperationMember_zRhXWoXKa6jg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">715,099</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--CorporateClaimsMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,387</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CorporateClaimsMember_zSzea3zxvbca" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 94,826</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims and other</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,561</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zymhhkKKlzBc" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75,147</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,171,498</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231_zsV6EF3jnUR3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,830</span></td></tr> </table> <p id="xdx_8AA_zbXHyom8zp3e" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-align: justify; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Labor claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the provision is related to 472 labor claims, including occupational health and security cases (2021: 529). The Management, based on its assessment and that of its external legal advisors, estimate that the term for the termination of these types of claims in Brazil exceeds five years. The estimates related to the outcome of proceedings and the possibility of future disbursement may change in view of new decisions in higher courts.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Tax claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the main claims are the following:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) Non-cumulative PIS and COFINS</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is charged amounts arising from compensation of Non-Cumulative PIS and COFINS tax credits in the years 2005, 2010 and in the period from 2012 to 2018 that were not approved by the Federal Revenue Service of Brazil ("RFB"), mainly related to the following topics:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- Offsetting Statements, with credits in amounts that exceeded those declared in the respective Statement of Calculation of Social Contributions;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- freight expenses: not associated with sales operations and/or operations without proven association and contracted in the country, but concerning imported products;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- credits arising from the acquisition of property, plant and equipment mostly related to acquired companies, whose documentation was not found;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- taxation of revenues incorrectly classified as tax exempt, subject to zero tax rate or not taxed.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the balance of this provision was R$212,223 (2021: R$202,737). The Management, based on its assessment and that of its external legal advisors and considering the precedents on the matters at the Administrative Council of Tax Appeals (“CARF”), estimates that the administrative procedures will be concluded in 2026.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-align: justify; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ii) PIS and COFINS taxes</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is assessed for the payment of these taxes in many legal claims, such as:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- insufficient payment of COFINS for the period from March 1999 to December 2000, from February 2001 to March 2002, from May to July 2002 and September 2002 due to alleged calculation errors, and non-compliance with the widening the tax calculation base and increasing the contribution rate envisaged in Law 9.718/1998;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- offset of the COFINS dues relating to September and October 1999 using the credit resulting from the addition of 1% to the COFINS rate;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- rejection of the offset of PIS and COFINS dues relating to the period from February to April 2002 using the PIS credits under Decree-Laws 2.445 and 2.449, calculated between June 1990 and October 1995, under the argument that the time period for using said credits had expired; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the balance of this provision was R$69,641 (2021: R$67,403). Management, based on its assessment and that of its external legal advisors, estimates these procedures will conclude by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered guarantees in the form of bank guarantees and finished products, which, together, fully cover the amount of claims.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-align: justify; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(iii) ICMS tax on interstate purchases</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment of ICMS in view of alleged violations:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- undue use of tax credits in the amount of R$58,164, due to the recording of credits indicated in the invoices for the sale of certain products, issued by Acrinor Acrilonitrila do Nordeste S.A. and Proquigel Química S.A., since the products were to be exported, and were therefore exempt from payment of ICMS tax;</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- the fine for the abovementioned tax offense corresponds to <span id="xdx_907_ecustom--PercentageFineForTaxOffense_pid_dp_c20220101__20221231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zyV7p5ij9Jx9" title="Percentage fine for tax offense">100</span>% of the principal value recorded; </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- fine in the amount of 30% on R$<span id="xdx_90C_ecustom--AmountsIndicatedInTax_pn3n3_c20220101__20221231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zDzXThCUJ9zj" title="Amounts indicated in tax">480,389</span>, which corresponds to the sum of the amounts indicated in tax documents whose outflow of goods was not identified by the tax authority; and</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- fine due to lack of presentation of tax documents requested.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">After ending the discussions in the administrative sphere, with the partial reduction in contingency, the Company proposed lawsuits to continue the discussion, which were secured by a guarantee insurance. On December 31, 2022, the balance of this provision was R$<span id="xdx_909_ecustom--ProvisionsForFineForTaxOffense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zbI4VaSnIrw9" title="Provisions for fine for tax offense">329,125</span> (2021: R$<span id="xdx_905_ecustom--ProvisionsForFineForTaxOffense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zNrohTL1Uzid" title="Provisions for fine for tax offense">313,380</span>). The Management, based on its assessment and that of its external legal advisors, estimates the legal procedures will conclude in 2026.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Changes in claims with probable chance of loss</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory_pn3n3_zYZQ8lk3Rblf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_z6Bgj7Xt6Rch" style="display: none">Schedule of changes in claims with probable chance of loss</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">claims</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2020</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zGmejRHWFBPl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  280,066</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_z8D9ZJpH6uK3" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  692,735</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zTwSqtfK9DZ8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,057</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zl97QUQ1KO7f" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 52,229</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231_zWfXPaAb43ma" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,151,087</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, inflation adjustments and exchange variation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 172,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,849</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,357</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,111</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 309,891</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (70,968)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,659)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zEAIDSvrhZ24" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (40,109)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,770)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (117,506)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_fKCop_zdWvJS7dgTR3" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (112,914)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_fKCop_zowdSv2d4bs6" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (20,826)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_fKCop_zcgU4uakPqgh" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,479)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_fKCop_zm3gD2ZTxsOj" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (50,423)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231_fKCop_zxrH6e2RAbOj" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (189,642)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2021</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zI6ZazNW2Slc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  268,758</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zEjyCr6Xg9Fk" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  715,099</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zrH8cbQB8Hkg" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 94,826</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zZVGFmmWej8a" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75,147</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231_zfF1NQQF5IJd" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,153,830</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zJdM98ODq292" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">128,682</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zSN3iMk0XFC8" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">60,627</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zENpuyJwiB06" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zcg9j4dHz7K6" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,227</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231_zB0nM5NFzlz6" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">274,584</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zMnCevk8NpKb" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (57,750)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zlJZdKU3aJ04" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8,792)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zlIi17eMOhc5" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,243)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231_zXuT33nq34H4" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (69,785)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_fKCop_z3xqDj7saq2f" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (127,033)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_fKCop_zMgwRTsgvIlg" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (31,041)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_fKCop_zKls6yEXkd46" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">(487)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_fKCop_zK8drpvHE9Na" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (28,570)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231_fKCop_zfcT0S2tiIWf" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (187,131)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_z2MGS0NC14ye" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">212,657</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zpolW8ufNMS8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  735,893</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zS2k5MS9bpz5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,387</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zCqsa8m6q6K1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,561</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231_zZDf5sbdUad6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,171,498</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_zRuqaWOis1D6" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F16_z08AAEpd88Pf" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.</span></td></tr> </table> <p id="xdx_8AE_zi7SmAsbwAf6" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>24.2 Contingent liabilities</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 17.85pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The contingent liabilities whose loss is assessed as possible (possibility of loss greater than remote and less than probable) by the Company’s Management, based on its evaluation and that of its external legal advisors, are disclosed as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfClaimsWithProbableChanceOfLossExplanatory_pn3n3_zpDM8zUE510e" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details 2)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BE_zdNtF3qcDQm2" style="display: none">Schedule of claims with probable chance of loss</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 71%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">   18,270,680</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember_zsg8YZpRXKBc" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,224,429</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims - Alagoas</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">26</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsOneMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,489,479</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsOneMember_z8tsQ9yldTRk" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,614,344</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims - Other</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsTwoMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 786,441</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsTwoMember_zVLysSkSdzgf" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  737,083</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 605,546</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_z74sQHDkwmB2" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  763,555</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Environmental claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(d)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--EnvironmentalClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 639,880</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--EnvironmentalClaimsMember_zgfKcphTANwc" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  571,057</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Social security claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(e)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--SocialSecurityClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 515,506</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--SocialSecurityClaimsMember_zR6VSm2bVPsg" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  398,783</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other lawsuits</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(f)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--OtherLawsuitsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 380,862</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--OtherLawsuitsMember_zdS5p8qYKM19" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  337,807</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleLegalProceedingsProvision_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">   26,688,394</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231_zFSREueQz1l8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,647,058</span></td></tr> </table> <p id="xdx_8A8_zMAFzSrEifMc" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Tax claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) IR/CSL: Charges with goodwill amortization</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The subsidiaries Cetrel and DAC were notified by the Brazilian Federal Revenue Service, (Secretaria da Receita Federal do Brasil, hereinafter “RFB”), in December 2020 and June 2021, respectively, for the deduction of tax amortization charges on goodwill arising from the acquisition of equity interests in 2012.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated amount of these claims was R$<span id="xdx_90B_ecustom--AmountOfTheseClaims_iI_pn3n3_c20221231_z8DpXsZWLRmg" title="Amount of these claims">194,695</span> (2021: R$<span id="xdx_909_ecustom--AmountOfTheseClaims_iI_pn6n6_c20211231_zihqH7qe8t8h" title="Amount of these claims">179,370</span>). The cases are pending in the administrative sphere <span style="color: black">with conclusion expected by 2026.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ii) IR/CSL: Exchange variation on naphtha imports</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2017 and December 2020, the Company received a tax deficiency notice related to the disallowance of exchange variation expenses between the due date of commercial invoices and the effective payment of obligations related to naphtha imports, related to calendar years 2012 and 2015, respectively. In relation to year 2012, disallowances led to the adjustment of tax losses and social contribution tax loss carryforwards. For 2015, a tax credit was considered along with a qualified fine corresponding to <span id="xdx_90F_ecustom--PercentageAmountOfTaxDeficiencyNotice_pid_dp_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zwy9G14Nvi9k" title="Percentage amount of the tax deficiency notice">150</span>% of the tax deficiency notice amount.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The tax deficiency notice issued in December 2020 also resulted in partial disallowance of the cost of naphtha imported from its subsidiary abroad, in an amount corresponding to the profit margin calculated by the subsidiary in the naphtha resale operations, carried out in 2014 and 2015.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, this uncertain tax treatment is R$<span id="xdx_90F_ecustom--AdjustedAmountOfUncertainTaxTreatment_pn8n9_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zjmFS7TAeAj5" title="Adjusted amount of uncertain tax treatment">1.2</span> billion (2021: R$<span id="xdx_901_ecustom--AdjustedAmountOfUncertainTaxTreatment_pn8n9_c20210101__20211231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zVcFNVCO79oi" title="Adjusted amount of uncertain tax treatment">1.1</span> billion), including fiscal years already filed and non-filed. The administrative proceedings should be concluded by 2026.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(iii) ICMS: Credit reversal on output with tax deferral</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In July and December 2020, the Company was notified, by the State of Alagoas, due to the lack of ICMS tax payment arising from the alleged lack of reversal of the tax credited in operations prior to outflows with tax deferral. On December 31, 2022, the value of these cases was R$<span id="xdx_90D_ecustom--AdjustedValueOfCases_pn6n6_c20220101__20221231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zCSXLa4BLy2" title="Adjusted value of cases">639</span> million (2021: R$<span id="xdx_905_ecustom--AdjustedValueOfCases_pn6n6_c20210101__20211231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember_zezMSCHiwJId" title="Adjusted value of cases">587</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The administrative proceedings should be concluded by 2025.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(iv) IR/CSL: Foreign earned income – Braskem Holanda</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company received a deficiency notice from RFB, referring to fiscal years 2015 and 2016, stating its disagreement with applying the Agreement between Brazil and the Netherlands to avoid double taxation, which establishes that Dutch companies' profits cannot be taxed in Brazil.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the amount of the uncertain tax treatment is R$<span id="xdx_90C_ecustom--AdjustedAmountOfUncertainTaxTreatment_pn8n9_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IRPJAndCSLLForeignEarnedIncomeMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zdoBftO0rwSc" title="Adjusted amount of uncertain tax treatment">10.6</span> billion (2021: R$<span id="xdx_90E_ecustom--AdjustedAmountOfUncertainTaxTreatment_pn8n9_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IRPJAndCSLLForeignEarnedIncomeMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zlIqpK3mZSE8" title="Adjusted amount of uncertain tax treatment">8.8</span> billion), including fiscal years already filed and non-filed.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The administrative proceedings should be concluded by 2026.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(v) PIS and COFINS: taxation of liability reductions settled in connection with the installment plan under Provisional Executive Order (“MP”) 470/2009</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company received notice for not applying to PIS and COFINS taxes the reductions for fines and interest, in view of the adoption of the installment plan offered by the Federal Government under MP 470/2009.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In March 2023, the Company obtained favorable opinion from court of last resort (the Superior Chamber of the Tax Resources Administrative Board) cancelling the full collection. In accordance to the Management, based on its evaluation and that of its external legal advisor, an appeal from the National Treasury is not applicable and, hence, the probability of loss was changed from possible to remote. </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the updated value of this proceeding is R$<span id="xdx_909_ecustom--UpdatedValueOfThisProceedingAmounted_pn6n6_c20220101__20221231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember__ifrs-full--BusinessCombinationsAxis__custom--PISAndCOFINSTaxesMember_zGC733I0kHZc" title="Updated value of this proceeding amounted">967</span> million (2021: R$<span id="xdx_90C_ecustom--UpdatedValueOfThisProceedingAmounted_pn6n6_c20210101__20211231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember__ifrs-full--BusinessCombinationsAxis__custom--PISAndCOFINSTaxesMember_zvB84co7gLGf" title="Updated value of this proceeding amounted">910</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(vi) IR/CSL: Charges with goodwill amortization </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company was served by the RFB for deducting amortization charges, from 2007 to 2013, relating to goodwill originated from acquisitions of shareholding interests in 2002. In 2002, Braskem foundation was fulfilled due to petrochemical assets disposals from several business groups. On December 31, 2022, the updated contingency estimate is R$<span id="xdx_909_ecustom--AdjustedAmountOfUncertainTaxEstimate_pn8n9_c20220101__20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zZrharNnrnKg" title="Adjusted amount of uncertain tax estimate">1.1</span> billion (2021: R$<span id="xdx_908_ecustom--AdjustedAmountOfUncertainTaxEstimate_pn8n9_c20210101__20211231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zZdOKH8eTohg" title="Adjusted amount of uncertain tax estimate">1.1</span> billion).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These administrative proceedings should be concluded by 2025, while the current court proceeding should be concluded by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered a performance bond that covers the total amount involved in the court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(vii) Non-cumulative PIS and COFINS taxes</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company received a deficiency notice from the RFB due to the use of non-cumulative PIS and COFINS tax credits in the acquisition of certain goods and services consumed in its production process in matters that have already been contested at the administrative and court level and comprise the period from 2004 to 2018.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the amount under discussion of these notices is R$<span id="xdx_902_ecustom--AmountUnderDiscussion_iI_pn8n9_c20221231_zydu9j4Gv45g" title="Amount under discussion">1.4</span> (2021: R$<span id="xdx_900_ecustom--AmountUnderDiscussion_iI_pn8n9_c20211231_zaJ9earWRKYb" title="Amount under discussion">1.3</span> billion).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The administrative proceedings should be concluded by 2026, while the lawsuits should be concluded by 2032.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered a performance bond that covers the total amount involved in the court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(viii) IR/CSL: Unlimited offsetting</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2009 and March 2017, the Company received tax deficiency notices claiming that the methodology used to offset tax losses and tax loss carryforwards that failed to observe the limit of 30% of the Taxable Profit and Social Contribution calculation base when offsetting such liabilities with Corporate Income Tax and Social Contribution liabilities in merger operations, respectively, in November 2007 and August 2013.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated value of the contingency amounted to R$<span id="xdx_901_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zigjlXOU7Vsl" title="Claims with possible chance of loss">462</span> million (2021: R$<span id="xdx_90A_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__ifrs-full--TypesOfHedgesAxis__custom--IRAndCSLMember_zMfWFPeKinK1" title="Claims with possible chance of loss">430</span> million). The lawsuits should be concluded by 2031.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered performance bonds that cover the total amount involved in the court proceeding.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ix) ICMS</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company challenges ICMS collection drawn up in the States of São Paulo, Rio de Janeiro, Rio Grande do Sul, Bahia, Pernambuco and Alagoas, which materialized in administrative and court proceedings, including the following topics:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· ICMS credit on the acquisition of assets that are considered by tax authority as being for use and consumption, which as such do not produce a right to the credit because they are not physically part of the end product;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by tax authority as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· internal transfer of finished products for an amount lower than the production cost;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· omission of the entry or shipment of goods based on physical count of inventories;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· lack of evidence of exports of goods with shipment presumably taxed for the domestic market; </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· fines for the failure to register invoices; and</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">· nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market of the Electric Power Trading Chamber.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated value of these proceedings was R$<span id="xdx_906_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zy40LAZSui1k" title="Claims with possible chance of loss">768</span> million (2021: R$<span id="xdx_907_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__custom--IncomeTaxAuthorityOneAxis__custom--TaxClaimsICMSMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zCiFr4g1AXQ" title="Claims with possible chance of loss">756</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These administrative proceedings are expected to be terminated in 2027, while the court proceedings are expected to be terminated in 2031.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered performance bonds that cover the total amount involved in the current court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(x) PIS and COFINS sundry</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is involved in collection actions related to PIS and COFINS assessments in the judicial courts, which discuss the alleged undue offsetting of credits arising from other proceedings, including: (i) Income Tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees – Federal Laws 2.445 and 2.449; and (v) the COFINS tax arising from the undue payment or payment in excess.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated amounts involved of these assessments total R$<span id="xdx_907_eifrs-full--ClaimsReportedByPolicyholders_iI_pn6n6_c20221231__custom--IncomeTaxAuthorityOneAxis__custom--PISAndCOFINSSundryMember_zrKdDCz79bR7" title="Labor claims for health and security cases">136</span> million (2021: R$<span id="xdx_900_eifrs-full--ClaimsReportedByPolicyholders_iI_pn6n6_c20211231__custom--IncomeTaxAuthorityOneAxis__custom--PISAndCOFINSSundryMember_za33dXC7aK44" title="Labor claims for health and security cases">131</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These judicial proceedings are expected to be terminated in 2025.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered guarantees that cover the total amount involved in the court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(xi) IRRF and IR/CSL: Commission expenses</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In December 2017, the Company received a tax deficiency notice from the RBF arising from: (i) the disallowance of commission expenses paid by Braskem in 2011; (ii) the disallowance of commission expenses paid by Braskem Inc. in 2013 and 2014; (iii) lack of payment of withholding income tax (“IRRF”) on the payments referred to in the previous item; and (iv) the disallowance of advertising expenses incurred in 2013.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the updated amount of taxes and tax effects from disallowances of income tax losses and social contribution tax loss carryforwards in the tax deficiency notice is R$<span id="xdx_909_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__custom--IncomeTaxAuthorityOneAxis__custom--IRRFIRAndCSLCommissionExpensesMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zGHXIxjAtwU9" title="Claims with possible chance of loss">153</span> million (2021: R$<span id="xdx_900_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__custom--IncomeTaxAuthorityOneAxis__custom--IRRFIRAndCSLCommissionExpensesMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zz19osft5Wq7" title="Claims with possible chance of loss">142</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">This administrative proceeding should be concluded by 2024.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(xii) Fines on tax credits used</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2015 through 2022, the Company received notifications of individual fines imposed due to the use of credits from: (i) non-cumulative PIS/COFINS taxes; (ii) negative balances of IR/CSL taxes; (iii) REINTEGRA credits; and (iv) other credits, for offsets not approved by the RFB.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated value of these deficiency notices amounted to R$<span id="xdx_907_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__custom--IncomeTaxAuthorityOneAxis__custom--IsolatedFineFailureToRatifyDCOMPSMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_z26P4DNuavJb" title="Claims with possible chance of loss">353</span> million (2021: R$<span id="xdx_90A_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__custom--IncomeTaxAuthorityOneAxis__custom--IsolatedFineFailureToRatifyDCOMPSMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zh8Z0KZ3pf3g" title="Claims with possible chance of loss">310</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These administrative proceedings should be concluded by 2027.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(xiii) IR/CSL: Negative Balance – Offset</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company claims, at the administrative and judicial levels, that RFB denies offsets seeking to settle federal taxes with credits arising from negative balance of IR/CSL.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated value of the taxes whose offset was not approved amounted to R$<span id="xdx_90C_ecustom--OtherAdministrativeProceedings_iI_pn6n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SocialSecurityContributionsMember_zWNmVYLgjuCg" title="Other administrative proceedings">176</span> million (2021: R$<span id="xdx_90A_ecustom--OtherAdministrativeProceedings_iI_pn6n6_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SocialSecurityContributionsMember_zhUGPIAQNuo4" title="Other administrative proceedings">173</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These administrative proceedings should be concluded by 2024, while the lawsuits should be concluded by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered a performance bond that covers the total amount involved in the current court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(xiv) PIS and COFINS: Cide-Fuels Tax Offset</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is a party to lawsuits claiming PIS and COFINS tax liabilities arising from their offset using Cide-Fuels tax credits, as authorized under Federal Law 10.336/2001.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the updated value of these cases was R$<span id="xdx_90C_ecustom--AdjustedValueOfCases_pn6n6_c20220101__20221231__custom--IncomeTaxAuthorityOneAxis__custom--PISAndCOFINSDCideFuelsTaxOffsetMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_ziyRdhk2Okh5" title="Adjusted value of cases">123</span> million (2021: R$<span id="xdx_90E_ecustom--AdjustedValueOfCases_pn6n6_c20210101__20211231__custom--IncomeTaxAuthorityOneAxis__custom--PISAndCOFINSDCideFuelsTaxOffsetMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zYYdBJOkFDu7" title="Adjusted value of cases">118</span> million). The lawsuits should be concluded by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company offered a performance bond that covers the total amount involved in the court proceedings.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Civil claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) Resale of solvents</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In January 2017, the Company became defendant in a civil lawsuit filed by former reseller of solvents, claiming alleged breach of a tacit distribution agreement. The lawsuit is pending judgment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the claims prepared by the other party amounted to R$<span id="xdx_907_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--CivilClaimsResaleOfSolventsMember_zcXyWWPtulve" title="Claims with possible chance of loss">302</span> million (2021: R$<span id="xdx_901_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--CivilClaimsResaleOfSolventsMember_zwvSmnRFUJ28" title="Claims with possible chance of loss">265</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ii) Hashimoto Public-Interest Civil Action </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Public-Interest Civil Action was filed in June 2018 by the São Paulo State Public Prosecutor’s Office against the Company and other firms that operate in the Capuava Petrochemical Complex, claiming the reparation and/or remediation of environmental damages supposedly arising from the emission of pollutants into the air, as well as the joint judgement of companies that comprise said complex seeking environmental moral damages in the updated amount of R$201 million (2021: R$175 million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem filed its defense in December 2020, which is awaiting expert evidence. This lawsuit should be concluded by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Labor claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Lawsuits filed by former team members and contractors who provided services to Braskem, and are chiefly related to overtime, wage parity and other amounts established in labor laws. </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(d) Environmental claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Public-Interest Civil Action filed in September 2011 by the Local Government of the city Ulianópolis in Pará State against Braskem and other companies, claiming reparation and/or remediation of environmental damage allegedly resulting from the delivery of waste to the Brazilian Bauxite Company , which had not disposed of it properly, polluting an area of the Municipality of Ulianópolis, as well as the joint and several liability of these companies for the payment of indemnification for environmental damage in the updated amount of R$<span id="xdx_90C_ecustom--PaymentForIndemnifiction_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--EnvironmentalMember_zbW91NBrbZDd" title="Payment for indemnifiction">363</span> million (2021: R$<span id="xdx_901_ecustom--PaymentForIndemnifiction_pn6n6_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--EnvironmentalMember_zCiv2HEA8lU8" title="Payment for indemnifiction">325</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">The companies filed their defense, however, a decision was rendered determining the temporary dismissal of the action for one year. </span><span style="font-family: Calibri, Helvetica, Sans-Serif">This action should be concluded by 2030.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(e) Social security claims</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2012, the Company withdrew sponsorship of the plans Petros Copesul and Petros PQU, and, in 2009, Petros Copene, whose private pension entity was Petros, remaining the obligation established under the Sponsorship Withdrawal Instrument to pay the mathematical reserves of Members, pursuant to Complementary Law 109/2001, which was met in 2015. However, after the payment, several beneficiaries filed individual and collective action regarding various claims, such as: (i) Difference of the Individual Withdrawal Fund; (ii) Change in base date; (iii) age limiter; (iv) 90% of supplementation; (v) Return of Contributions; (vi) Difference in Savings Account Reserve; (vii) Objection against legality of Sponsorship Withdrawal.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Currently, this portfolio is composed of 729 active cases (2021: 783), of a financial contingency nature, representing an estimated amount of R$<span id="xdx_902_ecustom--EstimatedAmount_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--SocialSecurityMember_z83kZK24fFYh" title="Estimated amount">379</span> million (2021: R$<span id="xdx_90B_ecustom--EstimatedAmount_pn6n6_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--SocialSecurityMember_zijJB0DQIK5a" title="Estimated amount">332</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(f) Other lawsuits</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) Incentivized Preferred Shares </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company currently is subject to the liquidation of an award related to a lawsuit filed in 1988, whose decision required Polialden Petroquímica S.A. (“Polialden”), a company merged into Braskem, to pay certain non-controlling shareholders that hold preferred shares in Polialden the distribution of the remaining net profit of the company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The liquidation of award aims to determine the value of the dividends to be paid in accordance with the terms of the decision. The process is awaiting the start of the expert evidence.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, based on Management’s assessment and that of its external legal advisors, the Company recorded a provision of R$<span id="xdx_90A_ecustom--AmountOfProvisionForPossibilityOfOutflowOfResources_pn6n6_c20220101__20221231_zlQXGmCaGyX5" title="Amount of provision for possibility of outflow of resources">21</span> million (2021: R$<span id="xdx_90F_ecustom--AmountOfProvisionForPossibilityOfOutflowOfResources_pn6n6_c20210101__20211231_zwXWMEyKl2gc" title="Amount of provision for possibility of outflow of resources">19</span> million). The amount considered as possible loss is R$<span id="xdx_907_ecustom--AmountEvaluatedAsPossibleLoss_pn3n6_c20220101__20221231_zz20D705z8t7" title="Amount evaluated as possible loss">262</span> million, and the total amount of the lawsuit is R$<span id="xdx_900_ecustom--PossibleAmountChanceToLoss_pn6n6_c20220101__20221231_zeCJgeexylzg" title="Possible amount chance to loss">283</span> million (2021: R$<span id="xdx_903_ecustom--PossibleAmountChanceToLoss_pn6n6_c20210101__20211231_zFrro5EUHVNb" title="Possible amount chance to loss">257</span> million).</span></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; color: #425563; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.5in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ii)</b></span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Social security – hazardous agents </b></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company is a party to other proceedings, which claim payments of additional contribution for Occupational Environmental Risk to fund the special retirement plan due to the alleged exposure of workers to hazardous agents: <span style="color: black">(a) in the administrative sphere (a.1) in the period from April 1999 to February 2006, jointly with a fine due to failure to declare the generating factor of the contribution to GFIP, and (a.2) in the period from January 2016 to July 2018; (b) in the legal sphere, in the periods from November 2000 to January 2001 and November 2001 to June 2002.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the adjusted amount of these proceedings is R$<span id="xdx_90F_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20221231__custom--IncomeTaxAuthorityOneAxis__custom--IRPJCSLLNegativeBalanceOffsetMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_zOVrLHWpCObf" title="Claims with possible chance of loss">203</span> million (2021: R$<span id="xdx_90E_ecustom--ClaimsWithPossibleChanceOfLoss_iI_pn6n6_c20211231__custom--IncomeTaxAuthorityOneAxis__custom--IRPJCSLLNegativeBalanceOffsetMember__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--TaxContingentLiabilityMember_z2dbNsrnXmLl" title="Claims with possible chance of loss">187</span> million).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The administrative proceedings should be concluded by 2025, while the only current court proceeding should be concluded by 2028.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company pledged a performance bond that covers the total amount involved in the current court proceeding.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>24.3 Class action</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On August 25, 2020, an action was filed against Braskem and some of its current and former executives in the US District Court for the District of New Jersey, in the United States, on behalf of an alleged class of investors who acquired Braskem's shares. The action was grounded in the U.S. Securities Exchange Act of 1934 and its rules, based on allegations that the defendants made false statements or omissions related to the geological event in Alagoas.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 15, 2022, the parties entered into Agreement to terminate the Class Action via payment of US$3 million, which was carried out in January 2023. On December 20, 2022, as the first measure for approval of the Agreement, the lead plaintiff filed a preliminary approval motion, and the U.S. District Court for the District of New Jersey will follow the required procedure for approval of the Agreement. The extinction of Class Action will be declared only after approval of the Agreement and after the obligations assumed by the parties of the Agreement are met.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem cannot predict precisely all costs in solving this dispute. The Company may be named as a defendant in other similar legal actions.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>24.4 Contingent assets</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Contingent assets normally arise from unplanned or unexpected events that give rise to the possibility of an inflow of economic benefits to the Company. Contingent assets are not recognized in the consolidated financial statements, but they are disclosed when it is likely that an inflow of economic benefits will occur. However, when the inflow of benefits is virtually certain, the asset is recognized in the financial position statement because that asset is no longer considered contingent.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) Compulsory loans: Centrais Elétricas Brasileiras S.A. (“Eletrobras”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The compulsory loan in favor of Eletrobras was established by Federal Law 4.156/62, to finance the energy industry and remained effective until 1993. It was collected through the energy bills of industrial consumers with monthly consumption equal to or higher than 2000kwh and, after successive amendments to the law, the reimbursement was extended to 20 years, plus compensatory interest of 6% per year, which can be anticipated through conversion of credits into shares issued by Eletrobras.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Between 2001 and 2009, the companies merged into Braskem S/A filed proceedings seeking the recovery of amounts related to differences in the inflation adjustment of the compulsory loan, interest on arrears and compensatory interest and other related payments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company obtained a favorable final and unappealable decision in the cases of the merged companies Alclor Química de Alagoas Ltda., Companhia Alagoas Industrial – Cinal, Companhia Petroquímica do Sul S.A. – Copesul and Trikem S. A., which are currently in the execution phase. The cases of the merged companies Ipiranga Petroquímica S.A., Petroquímica Triunfo Ltda. and Quattor Química S.A are in the cognizance phase.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The term, form and amount to be realized are still uncertain, so it is not possible to determine the amount to be received and, for such reason, the asset does not meet the conditions to be recorded in the consolidated financial statements.</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory_pn3n3_zMcSnmApB74e" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BC_zktRhc8dHzp5" style="display: none">Claims with probable chance of loss and contingent liabilities</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="color: white; font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 57%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td id="xdx_984_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  212,657</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_ziEvXR0gl0w3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  268,758</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">IR and CSL</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--IRAndCSLMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 51,756</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--IRAndCSLMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zeZgb0HZmfF2" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,946</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and COFINS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--PISAndCOFINSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  311,433</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--PISAndCOFINSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_znojlmMn0pdj" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  299,202</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">ICMS</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--ICMSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  348,544</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--ICMSMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zjf2D8ksmyve" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  331,094</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other tax claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--OtherTaxClaimsMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,160</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfClaimAxis__custom--OtherTaxClaimsMember__custom--TypeOfOperationAxis__custom--NormalOperationMember_zfZBJGSRgJlf" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 22,857</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfOerationAxis__custom--NormalOperationMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">735,893</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember__custom--TypeOfOerationAxis__custom--NormalOperationMember_zRhXWoXKa6jg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">715,099</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--CorporateClaimsMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,387</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CorporateClaimsMember_zSzea3zxvbca" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 94,826</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims and other</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvision1_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,561</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zymhhkKKlzBc" style="text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75,147</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: #FF3333; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvision1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,171,498</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--LongtermLegalProceedingsProvision1_iI_pn3n3_c20211231_zsV6EF3jnUR3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Contingencies"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,153,830</span></td></tr> </table> 212657000 268758000 51756000 61946000 311433000 299202000 348544000 331094000 24160000 22857000 735893000 715099000 103387000 94826000 119561000 75147000 1171498000 1153830000 1 480389000 329125000 313380000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory_pn3n3_zYZQ8lk3Rblf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_z6Bgj7Xt6Rch" style="display: none">Schedule of changes in claims with probable chance of loss</span></td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 45%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">claims</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and other</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2020</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zGmejRHWFBPl" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  280,066</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_z8D9ZJpH6uK3" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  692,735</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zTwSqtfK9DZ8" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  126,057</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zl97QUQ1KO7f" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 52,229</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20210101__20211231_zWfXPaAb43ma" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,151,087</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, inflation adjustments and exchange variation</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 172,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">46,849</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,357</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,111</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvisionAdditions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 309,891</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (70,968)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,659)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zEAIDSvrhZ24" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (40,109)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,770)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--LongtermLegalProceedingsProvisionPayments_c20210101__20211231_pn3n3" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (117,506)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_fKCop_zdWvJS7dgTR3" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (112,914)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_fKCop_zowdSv2d4bs6" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (20,826)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CorporateClaimMember_fKCop_zcgU4uakPqgh" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,479)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_fKCop_zm3gD2ZTxsOj" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (50,423)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20210101__20211231_fKCop_zxrH6e2RAbOj" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (189,642)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2021</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zI6ZazNW2Slc" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  268,758</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zEjyCr6Xg9Fk" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  715,099</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zrH8cbQB8Hkg" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 94,826</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zZVGFmmWej8a" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 75,147</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--LongtermLegalProceedingsProvision_iS_pn3n3_c20220101__20221231_zfF1NQQF5IJd" style="font-weight: bold; text-align: right" title="Beginning balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,153,830</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions, monetary adjustments and exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zJdM98ODq292" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">128,682</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zSN3iMk0XFC8" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">60,627</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zENpuyJwiB06" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  9,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zcg9j4dHz7K6" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,227</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--LongtermLegalProceedingsProvisionAdditions_pn3n3_c20220101__20221231_zB0nM5NFzlz6" style="text-align: right" title="Additions, inflation adjustments and exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">274,584</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_zMnCevk8NpKb" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (57,750)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zlJZdKU3aJ04" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8,792)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zlIi17eMOhc5" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,243)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--LongtermLegalProceedingsProvisionPayments_pn3n3_c20220101__20221231_zXuT33nq34H4" style="text-align: right" title="Payments"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (69,785)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Reversals (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_fKCop_z3xqDj7saq2f" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (127,033)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_fKCop_zMgwRTsgvIlg" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (31,041)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_fKCop_zKls6yEXkd46" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">(487)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_fKCop_zK8drpvHE9Na" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (28,570)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--LongtermLegalProceedingsProvisionReversals_pn3n3_c20220101__20221231_fKCop_zfcT0S2tiIWf" style="text-align: right" title="Reversals"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (187,131)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">December 31, 2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_z2MGS0NC14ye" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">212,657</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--TaxClaimsNetMember_zpolW8ufNMS8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  735,893</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CorporateClaimMember_zS2k5MS9bpz5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  103,387</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231__custom--LitigationCasesAxis__custom--CivilClaimsAndOtherMember_zCqsa8m6q6K1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,561</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LongtermLegalProceedingsProvision_iE_pn3n3_c20220101__20221231_zZDf5sbdUad6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Ending balance"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,171,498</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F05_zRuqaWOis1D6" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F16_z08AAEpd88Pf" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount.</span></td></tr> </table> 280066000 692735000 126057000 52229000 1151087000 172574000 46849000 14357000 76111000 309891000 -70968000 -3659000 -40109000 -2770000 -117506000 -112914000 -20826000 -5479000 -50423000 -189642000 268758000 715099000 94826000 75147000 1153830000 128682000 60627000 9048000 76227000 274584000 -57750000 -8792000 -3243000 -69785000 -127033000 -31041000 -487000 -28570000 -187131000 212657000 735893000 103387000 119561000 1171498000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfClaimsWithProbableChanceOfLossExplanatory_pn3n3_zpDM8zUE510e" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Provisions for legal proceedings and contingent liabilities (Details 2)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BE_zdNtF3qcDQm2" style="display: none">Schedule of claims with probable chance of loss</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 71%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Tax claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(a)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--TaxClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">   18,270,680</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--TaxClaimsMember_zsg8YZpRXKBc" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,224,429</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims - Alagoas</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">26</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsOneMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,489,479</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsOneMember_z8tsQ9yldTRk" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,614,344</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Civil claims - Other</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(b)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--CivilClaimsTwoMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 786,441</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--CivilClaimsTwoMember_zVLysSkSdzgf" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  737,083</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Labor claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(c)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--LaborClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 605,546</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--LaborClaimsMember_z74sQHDkwmB2" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  763,555</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Environmental claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(d)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--EnvironmentalClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 639,880</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--EnvironmentalClaimsMember_zgfKcphTANwc" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  571,057</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Social security claims</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(e)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--SocialSecurityClaimsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 515,506</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--SocialSecurityClaimsMember_zR6VSm2bVPsg" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  398,783</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other lawsuits</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">(f)</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PossibleLegalProceedingsProvision_c20221231__custom--LitigationCasesAxis__custom--OtherLawsuitsMember_pn3n3" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 380,862</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231__custom--LitigationCasesAxis__custom--OtherLawsuitsMember_zdS5p8qYKM19" style="text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  337,807</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PossibleLegalProceedingsProvision_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">   26,688,394</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--PossibleLegalProceedingsProvision_iI_pn3n3_c20211231_zFSREueQz1l8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Claims with possible chance of loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,647,058</span></td></tr> </table> 18270680000 17224429000 5489479000 2614344000 786441000 737083000 605546000 763555000 639880000 571057000 515506000 398783000 380862000 337807000 26688394000 22647058000 194695000 179370000000 1.50 1200000000 1100000000 639000000 587000000 10600000000 8800000000 967000000 910000000 1100000000 1100000000 1400000000 1300000000 462000000 430000000 768000000 756000000 136000000 131000000 153000000 142000000 353000000 310000000 176000000 173000000 123000000 118000000 302000000 265000000 363000000 325000000 379000000 332000000 21000000 19000000 262000000 283000000 257000000 203000000 187000000 <p id="xdx_808_ecustom--DisclosureLeniencyAgreementExplanatory_zdS8YaOGRdr2" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">25 <span id="xdx_828_z4hX9rXlfvQe">Leniency agreement with authorities</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-weight: normal">In the context of allegations of undue payments in connection with Operation Car Wash in Brazil, the Company hired external experts in investigation to conduct an independent investigation into such allegations (“Investigation”) and to report their findings. </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-weight: normal">In December 2016, the Company entered into Leniency Agreements with the Federal Prosecution Office (<i>Ministério Público Federal</i>, hereinafter “MPF Agreement”) and with U.S. and Swiss authorities (“Global Settlement”), in the amount of US$<span id="xdx_90D_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn6n6_c20161201__20161231__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalProsecutionOfficeAndUSSwissAuthoritiesMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zlCN5I8zxCTl" title="Settlement liabilities">957</span> million (R$<span id="xdx_90E_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn8n9_uBRL_c20161201__20161231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalProsecutionOfficeAndUSSwissAuthoritiesMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zRNHK1bXjsc9" title="Settlement liabilities">3.1</span> billion, at the time), which were duly ratified. Further, the Company engaged in a process of cooperation and negotiation with the Ministry of Transparency and the Office of The Federal Controller General (<i>Controladoria-Geral da União</i>, hereinafter “CGU”) and the Office of the Attorney General (<i>Advocacia-Geral da União</i>, hereinafter “AGU”), which culminated in the execution of the leniency agreement with such authorities on May 31, 2019 (“CGU/AGU Agreement” and, jointly with the Global Settlement, “Agreements”), which addresses the same facts that are the subject of the Global Settlement and provides for an additional disbursement of R$409,877 due to the calculations and parameters adopted by CGU/AGU. In addition, in 2019, the State Prosecution Office of Bahia and the State Prosecution Office Rio Grande do Sul adhered to the MPF Agreement. Therefore, no additional payments are expected to be made by the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the Company paid R$3,070,578, distributed as shown below:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfDistributionPaid_pn3n3_z0anIrZS324g" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Leniency agreement with authorities (Details)"> <tr style="vertical-align: middle"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B7_zZ0itLhJF1Nc" style="display: none">Schedule of Company already has paid distributed as shown below:</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: middle"> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif">AGU</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: middle"> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Agreements signed with:</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">.</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">CGU and MPF</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">DoJ (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">OAG (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MPF</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">SEC (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: middle"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: middle"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Amounts paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalControllerGeneralAndAttorneyGenerallAgreementMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_z78YjU4uGHKd" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  877,763</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepartmentOfJusticeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zETneDdprynd" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,591</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SwissOfficeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zA5HnvElHOzi" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  407,300</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalProsecutionOfficeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zvdtg286IwL9" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,282,464</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SecuritiesAndExchangeCommissionMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zMyPUzGTzsEl" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  206,460</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zvy9O7KAYcr8" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,070,578</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F05_zoXpQWva3q39" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1C_zqF2tHJcEmBb" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").</span></td></tr> </table> <p id="xdx_8A2_zFmHUNTRFRm9" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the outstanding amount is R$<span id="xdx_90A_ecustom--OutstandingAmount1_iI_pn3n3_c20221231_znu9LFMUaaz7" title="Outstanding amount">903,140</span> (R$<span id="xdx_904_ecustom--CurrentLiabilities1_iI_pn3n3_c20221231_z2ughMuOYcHf" title="Current liabilities">392,486</span> and R$<span id="xdx_902_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_z4QUAvF71gah" title="Noncurrent liabilities">510,654</span> as current and non-current liabilities, respectively), under the MPF Agreement and CGU/AGU Agreement, which will be paid in three annual installments updated by the variation in the Selic rate and payable until January 30, 2025. To guarantee payment of the installments of these installments coming due, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Braskem’s activities related to the monitoring by the CGU of the Company were successfully concluded, and no pending issues involving the Company remained, the CGU will present the Final Monitoring Report and prepare the Agreement.</span> <span style="font-family: Calibri, Helvetica, Sans-Serif">Moreover, the Company is in compliance with all of its obligations under the Agreements and continues to cooperate with government authorities.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> 957000000 3100000000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfDistributionPaid_pn3n3_z0anIrZS324g" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Leniency agreement with authorities (Details)"> <tr style="vertical-align: middle"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B7_zZ0itLhJF1Nc" style="display: none">Schedule of Company already has paid distributed as shown below:</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: middle"> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif">AGU</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: middle"> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Agreements signed with:</span></td> <td style="border-bottom: Black 0.5pt solid; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif">.</span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">CGU and MPF</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">DoJ (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">OAG (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">MPF</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">SEC (i)</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: middle"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="color: white"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: middle"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Amounts paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalControllerGeneralAndAttorneyGenerallAgreementMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_z78YjU4uGHKd" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  877,763</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepartmentOfJusticeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zETneDdprynd" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  296,591</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SwissOfficeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zA5HnvElHOzi" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  407,300</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FederalProsecutionOfficeMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zvdtg286IwL9" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,282,464</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SecuritiesAndExchangeCommissionMember__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_fKGkp_zMyPUzGTzsEl" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  206,460</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--ContractDurationAxis__custom--LeniencyAgreementsMember_zvy9O7KAYcr8" style="text-align: right" title="Settlement amount"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,070,578</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td id="xdx_F05_zoXpQWva3q39" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1C_zqF2tHJcEmBb" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC").</span></td></tr> </table> 877763000 296591000 407300000 1282464000 206460000 3070578000 903140000 392486000 510654000 <p id="xdx_805_ecustom--DisclosureGeologicalPhenomenonAlagoasExplanatory_zP7TgbKNEe6g" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">26 <span id="xdx_82A_zVRSGmmGsxH4">Geological event - Alagoas</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company operated, since its formation and subsequently as the successor of the company Salgema, salt mining wells located in Maceió city, with the purpose of supplying raw material to its chlor-alkali and dichloroethane plant. In March 2018, an earthquake hit certain districts of Maceió, Alagoas, where the wells are located, and cracks were found in buildings and public streets of Pinheiro, Bebedouro, Mutange and Bom Parto districts.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In May 2019, the Geological Survey of Brazil (“CPRM”) issued a report, indicating that the geological phenomenon observed in the region, could be related to the rock salt exploration activities developed by Braskem. In view of these events, on May 9, 2019, Braskem preventively decided to suspend its salt mining activities and the operation of its chlor-alkali and dichloroethane plant.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Since then, the Company has been devoting its best efforts to understand the geological event: (i) possible surface effects; and (ii) the analyses of well’s stability. The results are being shared with the Brazilian National Mining Agency (“ANM”) and other pertinent authorities, which the Company has been maintaining constant dialogue.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem presented to ANM the measures for shutting down its salt mining fronts in Maceió, with measures for the closure of its wells, and, on November 14, 2019, it proposed the creation of a protective area surrounding certain wells as a precautionary measure to ensure public safety. These measures are based on a study conducted by the Institute of Geomechanics of Leipzig (IFG), in Germany, an international reference in the geomechanical analysis of areas of salt extraction by dissolution and are being adopted in coordination with the Civil Defense of Maceió and other authorities.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As a result of the geological phenomenon, negotiations were conducted with public and regulatory authorities that resulted in the Agreements executed, including:</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 36pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">i)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: black">Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents"), entered into with State Prosecution Office (“MPE”), the State Public Defender’s Office (“DPE”), the Federal Prosecution Office (“MPF”) and the Federal Public Defender’s Office (“DPU”), which was ratified by the court on January 3, 2020, adjusted by its resolutions and subsequent amendments, , which <span style="font-size: 11pt; color: black">establish cooperative actions for relocating residents from risk areas, defined in the Map of Sectors of Damages and Priority Action Lines by the Civil Defense of Maceió (“Civil Defense Map”), as updated in December 2020 (version 4), and guaranteed their safety, which provides support, under the Financial Compensation and Support for Relocation Program (“PCF”) implemented by Braskem to the population in the areas of the Civil Defense Map, as well as the dismissal of the Public-Interest Civil Action (Reparations for Residents), as detailed in Note 26.1 (i).</span></span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii) Agreement to Dismiss the Public-Interest Civil Action on Socio-Environmental Reparation and the Agreement to define the measures to be adopted regarding the preliminary injunctions of the Public-Interest Civil Action on Socio-Environmental Reparation (jointly referred to as “Agreement for Socio-Environmental Reparation”), signed with the MPF with the MPE as the intervening party, on December 30, 2020, in which the Company mainly undertook to: (i) adopt measures to stabilize and monitor the subsidence phenomenon arising from salt mining; (ii) repair, mitigate or compensate possible environmental impacts and damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate possible socio-environmental impacts and damages arising from salt mining in the Municipality of Maceió, as well as the termination of the Public-Interest Civil Action (Socio-environmental Reparation) related to the Company, as detailed in Note 26.1 (ii). Moreover, the Agreement for Socio-Environmental Reparation envisages the inclusion of other parties, which depends on specific negotiation with such potential parties.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Thus, the Company has been meeting all obligations assumed with the authorities and acting proactively on all fronts to resolve the issues arising from the geological event. Highlights: (i) PCF significant advances on assisting public authorities to vacate properties located in the risk areas and submitting full financial compensation offers with a high level of acceptance; (ii) the actions for closing and monitoring the salt wells, which are following the mining closure plan approved by the ANM, seeking to stabilize the subsidence phenomenon resulting from salt mining; and (iii) the social and environmental diagnoses conducted in connection with the Socio-Environmental Reparation Agreement.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As assessed by the Company and its external advisors, considering the measures recommended on technical studies in the short and long-term and the existing information and refined estimates of expenses for implementing several measures connected with the geological event in Alagoas, the provision recorded on December 31, 2022, shows the following changes in the period:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfChangesInprovisionExplanatory_pn3n3_zyxfY8NRGiX2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Geological event - Alagoas (Details)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"> <span id="xdx_8B6_zbrIgnXZdnqb" style="display: none">Schedule of following table shows the changes in the provision in the period</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 54%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginning of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LegalProceedingsProvision1_iS_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zaBlfSx11neg" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LegalProceedingsProvision1_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LegalProceedingsProvision1_c20191231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,383,067</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zzTV5XmD8N73" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,520,019</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zT32PIK5OfVh" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_z0PZawrGAwBj" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,901,827</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reclassifications (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProvisionAfterAdjustment_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_z6D6bI2APYh8" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,742,791)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProvisionAfterAdjustment_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_zCXDBNwucUZ5" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProvisionAfterAdjustment_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_zUYmUuLWhHd" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,181,931)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Realization of present value adjusment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--RealizationOfPresentValueAdjustment_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">188,071</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--RealizationOfPresentValueAdjustment_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  73,798</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--RealizationOfPresentValueAdjustment_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  72,814</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--LegalProceedingsProvision1_iE_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zPKWKvBvXly2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,626,558</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LegalProceedingsProvision1_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LegalProceedingsProvision1_iI_pn3n3_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zgCFcP2vDLGj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liability</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ShorttermLegalProceedingsProvision_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,247,609</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ShorttermLegalProceedingsProvision_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,378,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ShorttermLegalProceedingsProvision_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,349,931</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liability</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision2_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,378,949</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvision2_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,283,188</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LongtermLegalProceedingsProvision2_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,825,846</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LegalProceedingsProvision_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,626,558</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LegalProceedingsProvision_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LegalProceedingsProvision_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0D_zwlGdh3jHI33" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F13_zywSL7oqfLR7" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.</span></td></tr> </table> <p id="xdx_8A6_znNzxaw9q47k" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The current provision can be segregated into the following action fronts:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">a. Support for relocating and compensating for the residents, business and real state owners of properties located in the Civil Defense Map (version 4) updated in December 2020, including establishments that requires special measures for their relocation, such as hospitals, schools and public equipment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">These actions have a provision of R$<span id="xdx_902_ecustom--NetOfAdjustmentToPresentValue_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlagoasStateFederalProsecutionOfficeMember__ifrs-full--ContractDurationAxis__custom--TechnicalCooperationAgreementMember_z0dCUGKW2EKg" title="Net of adjustment to present value">2,087,142</span> (2021: R$<span id="xdx_90D_ecustom--NetOfAdjustmentToPresentValue_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlagoasStateFederalProsecutionOfficeMember__ifrs-full--ContractDurationAxis__custom--TechnicalCooperationAgreementMember_pn3n3" title="Net of adjustment to present value">3,390,849</span>) comprises expenses related to relocation actions, such as relocation allowance, rent allowance, household goods transportation and negotiation of individual agreements for financial compensation.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">b. Actions for closing and monitoring the salt wells, environmental actions and other technical matters. Based on the findings of sonar and technical studies, stabilization and monitoring actions were defined for all 35 existing salt mining wells. Based on studies of the specialists, the recommendation was to fill 5 more salt wells with solid material, bringing the total wells to be filled to 9, a process that should take 4 years. For the remaining 26, the recommended actions are: conventional closure using the tamponade technique, which consists of promoting the cavity pressurization, applied worldwide for post-operation cavities; confirmation of natural filling status; and, for some wells, sonar monitoring.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The provisioned amount of R$<span id="xdx_905_ecustom--ProvisionAccruedAmount_iI_pn3n3_c20221231__ifrs-full--ContractDurationAxis__custom--TechnicalCooperationAgreementMember_z9eZQe55bQL6" title="Provision accrued amount">1,367,269</span> (2021: R$<span id="xdx_904_ecustom--ProvisionAccruedAmount_iI_pn3n3_c20211231__ifrs-full--ContractDurationAxis__custom--TechnicalCooperationAgreementMember_zgocxZdM7l9a" title="Provision accrued amount">1,691,032</span>) to implement the measures described in this item was calculated based on existing techniques and the solutions planned for the current conditions of the wells, including expenses with technical studies and monitoring, as well as environmental actions already identified. The provision amount may change in the future, in accordance with the results of the monitoring of the wells, the progress of implementing the plans to close wells, possible changes that may be required in the environmental plan, the monitoring of the ongoing measures and other possible natural alterations.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The monitoring system implemented by Braskem envisages actions developed during and after the closure of wells, focusing on safety and monitoring of the region’s stability.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s actions are based on technical studies conducted by outsourced specialists, with the recommendations presented to the competent authorities. The Company is implementing the actions approved by ANM.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In June 2022, in compliance with the Agreement for Socio-environmental Reparation, Braskem submitted to the MPF the environmental diagnosis containing the assessment of the potential environmental impacts and damages arising from salt mining activities and the environmental plan with proposals of the measures required. As established in the agreement, the parties jointly defined the specialized company that will evaluate and monitor the environmental plan. In December 2022, an additional report on the environmental plan was filed with the MPF. In February 2023, MPF expressed its agreement with this environmental plan, incorporating the suggestions provided in the additional report. Braskem initiated the actions foreseen by the plan, implementing the commitments established in the agreement and sharing the results of its actions with the authorities. Also is agreed that the environmental diagnosis will be updated in December 2025.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">c. Social and urban measures, under the Agreement for Socio-environmental Reparation signed on December 30, 2020, <span id="xdx_90E_ecustom--DescriptionOfReparationForSocialenvironmental_c20220101__20221231_z8I0fywo3sY9" title="Description of reparation for social-environmental">allocating R$1,580,000 for the adoption of actions and measures in vacated areas, urban mobility and social compensation actions, of which R$300 million going to indemnification for social damages and collective pain and suffering and possible contingencies related to the actions in the vacated areas and urban mobility actions. The provision amount, updated by inflation index established in the agreement, is R$1,567,842 (2021: R$1,577,186).</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">d. Additional measures, for which the provision amounts to R$1,604,305 (2021: R$1,002,192), for expenses with: (i) actions related to the Technical Cooperation Agreements entered into by the Company; (ii) the hiring of external advisors to support the execution of the relocation actions and compensation of the families; (iii) infrastructure for assisting residents; (iv) expenses with managing the geological event in Alagoas relating to communication, compliance, legal services, etc.; (v) additional measures to assist the region and maintenance of areas, including actions for requalification and indemnification directed to Flexais region; and (vi) other matters classified as a present obligation for the Company, even if not yet formalized.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The provisions of the Company are based on current estimates and assumptions and may be updated in the future due to new facts and circumstances, including, but not limited to: changes in the execution time, scope and method; the success of action plans; new repercussions or developments arising from the geological event, including possible revision of the Civil Defense map; and possible studies that indicate recommendations from specialists, including the Technical Monitoring Committee, according to Agreement for Compensation of Residents, and other new developments in the matter.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The measures related to the mine closure plans are also subject to the analysis and approval by ANM, the monitoring of results of the measures under implementation as well as changes related to the dynamic nature of geological event.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Continuous monitoring is essential for confirming the results of the current recommendations. Accordingly, the plans to close the wells may be updated based on the need to adopt technical alternatives to stabilize the subsidence phenomena arising from the extraction of salt. In addition, the assessment of the future behavior of cavities monitored using sonar and piezometers could indicate the need for certain additional measures to stabilize them.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The actions to repair, mitigate or offset potential environmental impacts and damages, as provided for in the Socio-environmental Reparation Agreement, will be defined considering the environmental diagnosis already prepared by a specialized and independent company. After the conclusion of all discussions with authorities and regulatory agencies, as per the process established in the agreement, an action plan will be agreed to be part of the measures for a Plan to Recover Degraded Areas (“PRAD”).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Furthermore, the Socio-Environmental Reparation Agreement envisages the potential adherence by other parties, including the Municipality of Maceió.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Also in the context of understandings with the authorities to address claims related to the event in Alagoas, on October 26, 2022, the 3<sup>rd </sup>Federal Court of Alagoas ratified the Term of Agreement for Implementation of Socioeconomic Measures for the Requalification of the Flexal Area (“Flexais Agreement”), entered into by Braskem and the MPF, the MPE, the DPU, and Municipality of Maceió for the adoption of action for requalification in the Flexais region, compensation to the Municipality of Maceió and indemnities to the residents of this location. The expected disbursement amounts to the execution of the obligations defined in the Term of Agreement are part of the provision under (d) Additional Measures.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has been making progress with local authorities about other indemnification requests to understand them better, <span style="color: black">resulting in advances in the understanding between the parties that may result in an agreement</span>. Although future disbursements may occur as a result of progress in negotiations, as of the reporting date, the Company is unable to predict the results and timeframe for concluding these negotiations or its possible scope and the total associated costs in addition to those already provisioned for<span style="color: black">.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">It is not possible to anticipate all new claims, related to damages or other nature, that may be brought by individuals or groups, including public or private entities, that understand they suffered impacts or damages somehow related to the geological phenomenon and the relocation of people from risk areas, as well as new notices of infraction or administrative penalties of diverse natures. Braskem continues to face and could still face administrative procedures and various lawsuits filed by individuals or legal entities not included in the PCF or that disagree with the financial compensation offer for individual settlement, as well as new collective actions and new lawsuits filed by public utility concessionaires, entities of the direct or indirect administration of the State, Municipality or Federal level. Therefore, the number of such actions, their nature or the amounts involved cannot be estimated at this moment.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Consequently, the Company cannot eliminate the possibility of future developments related to the geological event in Alagoas, the relocation process and actions in vacated and adjacent areas, so the expenses to be incurred may differ from its estimates and provisions.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt">In February 2023, the Company signed a settlement agreement with the insurance companies related to the claim for the geological event in Alagoas. </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #00A9E0"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>26.1 Lawsuits pending</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In the context of this event, the following lawsuits were filed against the Company:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(i) Public-Interest Civil Action (“ACP”) filed by the Alagoas State Prosecution Office and the Alagoas State Public Defender’s Office – Reparation for Residents</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--DescriptionOfReparationForResidents_c20220101__20221231__ifrs-full--ContractDurationAxis__custom--TechnicalCooperationAgreementMember" title="Description of reparation for residents">Public-Interest Civil Action claiming the payment of indemnification for damages caused to the buildings and the residents of areas affected in the Pinheiro district and surrounding areas, in the total minimum amount of R$6.7 billion, with initial request for provisional measure to freeze the Company’s financial and other assets in the same amount. Successive orders to freeze funds resulted in the court blocking of R$3.7 billion in assets in 2019, and the unfreezing occurred in January 2020. Once the case was sent to the Federal Courts, the Federal Prosecution Office started to participate in the action.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The first agreement under this Public-Interest Civil Action (Reparation for Residents) was ratified on January 3, 2020. The Agreement to Support the Relocation of People in Risk Areas (“Agreement for Compensation of Residents”), entered into by Braskem and the MPE, the DPE, the MPF and the DPU (“Authorities”), establishes cooperative actions for relocating people in risk areas and guaranteeing their safety, which provides support under the Financial Compensation and Support for Relocation Program implemented by Braskem, for the population in specified risk areas.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-align: justify; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">After updates of the Civil Defense Map, two legal instruments were entered into with the Authorities, in July and October 2020, to include properties in the PCF.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 30, 2020, the Company and the Authorities executed a second amendment to the Agreement for Compensation of Residents to terminate the Public-Interest Civil Action, through which the parties agreed to include in PCF the relocation of additional properties defined in the updated version of the Civil Defense Map, of December 2020, and in the independent technical and specialized studies engaged by the Company on the potential impact of the geological event on the surface of the region (“Studies”). The Agreement for Compensation of Residents includes the area currently affected by the geological event, according to the Civil Defense, and the areas with potential future impacts indicated in the Studies.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">To implement the actions envisaged in the Public-Interest Civil Action, the Company undertook to maintain R$2.7 billion in a checking account (R$1.7 billion under the Agreement for Compensation of Residents and an additional R$1 billion under the second amendment), with minimum working capital of R$100 million, whose transactions will be verified by an external audit company. On December 31, 2022, arising from the costs incurred related to the PCF, the balance of this checking account corresponded to R$175,153 under current assets (2021: R$835,517). In addition, the Company and the Authorities agreed to: (i) create a technical group (Technical Monitoring Committee) to monitor the geological event and study the areas adjacent to the Civil Defense Map for a period of five years; and (ii) maintain a performance bond in the current amount of R$1.2 billion (down from the R$2 billion performance bond envisaged in the Agreement for Compensation of Residents).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">With the judicial ratification by the courts of the Agreement for Compensation of Residents on January 6, 2021, this Public-Interest Civil Action was terminated.<br/></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(ii) Public-Interest Civil Action filed by the Alagoas State Federal Prosecution Office – Social-environmental reparation </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Public-Interest Civil Action claiming the payment by the Company of indemnification for socio-environmental damages and other collective damages, as well as the adoption of corrective and environmental compliance measures, with preliminary injunction requiring the freezing of assets, suspension of borrowings with the BNDES, formation of an own private fund in the initial amount of R$3.1 billion and the pledging of guarantees in the amount of R$20.5 billion. The amount of the action was R$27.6 billion.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 36pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(i)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: black">On December 30, 2020, the Agreement for Socio-environmental Reparation was executed, with the Company mainly undertaking to: (i) adopt measures to stabilize and monitor the subsidence phenomenon resulting from salt mining; (ii) repair, mitigate or compensate potential impacts and environmental damages arising from salt mining in the Municipality of Maceió; and (iii) repair, mitigate or compensate potential impacts and social and urban damages arising from salt mining in the Municipality of Maceió, as detailed below: To stabilize the cavities and monitor the soil, the Company continues to implement the action plans involving the closure of mining fronts prepared by Braskem and approved by the ANM, whose measures can be adjusted until the stability of the subsidence phenomenon resulting from salt mining is verified. </span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 36pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(ii)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: black">Regarding the potential environmental impacts and damages resulting from salt mining in the Municipality of Maceió: as agreed with the MPF, the Company hired a specialized independent company to identify and recommend measures for recovering, mitigating or compensating any environmental impacts identified as the result of salt mining activities in Maceió. The study and the second opinion report on the environmental planning were delivered to the MPF on June 30, 2022 and December 7, 2022, respectively, and will follow the procedures as per the agreement for final consolidation of the actions to be adopted in the mutual agreement between the Company and the MPF, but it is not possible to predict the outcome or if it will result in additional amounts other than those already recorded in the provision.</span> <span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">Regarding potential impacts and social and urban damages arising from salt mining in the city of Maceió: to allocate the maximum amount of R$1,280 million for adopting actions and measures in vacated areas, urban mobility actions and social compensation actions. For these social compensation actions and measures, on June 30, 2022, the Company filed with the MPF the report and the respective plan of social action that will be used as base to define the measures to be adopted. Braskem also will allocate the amount of R$300 million for indemnification for social and collective pain and suffering and possible contingencies related to actions in vacated areas and in urban mobility actions.</span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company and the Federal Prosecution Office also agreed to hire a specialized consultancy to evaluate the Company’s Social and Environmental Management Program and on the pledging of security interest involving certain assets of the Company in the amount of R$2.8 billion to substitute the performance bond of R$1 billion.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Agreement for Socio-environmental Reparation was ratified by Court on January 6, 2021, with the termination of the Public-Interest Civil Action for Socio-environmental Reparation regarding to Braskem. Moreover, this agreement provides for the possibility of adhesion by other parties, including the Municipality of Maceió.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Finally, under the Agreement for Socio-environmental Reparation, on January 21, 2021 the Civil Investigation launched in June 2020 by the MPE was terminated. It aimed to: (i) calculate the extent of the urban damages caused by the geological event that occurred in Maceió; (ii) seek, from liable parties, necessary and adequate architectural solutions for the destination, restoration and/or use of the cited empty spaces left in the districts impacted; (iii) calculate, if applicable, potential compensatory liabilities for the damages caused to the urban order.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(iii) Public-Interest Civil Action filed by the Federal Public Defender’s Office (“DPU”): refusal of insurance within the scope of Housing Financial System (“SFH”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Public-interest civil action filed by DPU to question the denial of necessary insurance for contracts under the SFH to acquire properties located within a radius of 1 km outside the risk area defined by the version 4 map of Civil Defense authorities, which is the subject matter of the Residents PCA agreement – see item (i).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Insurers linked to SFH, financial agents, the regulatory agency and Braskem are the defendants. The main claim is only against the insurers, financial agents and the regulatory agency on the grounds that the refusal to contract the insurance is abusive and has no technical or legal grounds. There is a secondary and eventual claim to sentence Braskem to pay indemnification in an amount to be settled in the future, if the judge understands that the refusal somehow has grounds due to the subsidence phenomenon.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">It is not possible to estimate the indemnification amount, which will depend on the evidence of damages submitted by people whose insurance was denied.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(iv) Public-Interest Civil Action filed by the Alagoas State Public Defender’s Office – Review of terms of the Flexais Agreement</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Public-interest civil action filed by DPE against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the <sup>3r</sup>d Federal Court of Alagoas.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Through of this lawsuit, the DPE seeks, among other claims, the inclusion of residents of Flexais region, who choose to adhere the PCF, program created under the agreement in ACP (Reparation for Residents), with consequent reallocation of these residents and compensation for moral and material damages in parameters specified in the ACP.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As injunction relief, DPE also requested, that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the PCF, or, alternatively, requested the freeze of Braskem bank accounts in the amount of R$ <span id="xdx_907_eifrs-full--GainsLossesOnLitigationSettlements_pn8n9_c20220101__20221231_zr5YV4Fbg2y3" title="Lawsuit compensation">1.7</span> billion, to guarantee the compensation for moral and material damages to residents of the Flexais region, this being the amount attributed to the lawsuit. The injunction relief requests were rejected by the court; decision subjected to appeal by DPE.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Management, supported by the opinion of the external legal advisor, classifies the probability of loss in this lawsuit as possible.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(v) Indemnity Claim: Companhia Brasileira de Trens Urbanos (“CBTU”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On February 2, 2021, the Company was notified of the filing of a lawsuit by Companhia Brasileira de Trens Urbanos, formulating initially only a preliminary injunction for maintaining the terms of the cooperation agreement signed previously by the parties. The request was denied in lower and appellate courts, given the fulfillment of the obligations undertaken by Braskem. On February 24, 2021, CBTU filed an amendment to the initial request claiming the payment of compensation for losses and damages in the amount of R$222 million and for moral damages in the amount of R$500 thousand, as well as the imposition of obligations, including the construction of a new rail line to substitute the stretch that passed through the risk area.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the updated value of this lawsuit is R$1.43 billion (2021: R$1.40 billion). Braskem entered into a memorandum of understanding with CBTU to seek a consensual solution and suspend the lawsuit during the negotiation period and has made progress in the technical understanding about the topic. As a result of a joint petition filed by the parties, the lawsuit was suspended until June 2023.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Management, based on its assessment and that of its external legal advisors, classifies the probability of loss in this case as possible.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(vi) Indemnity Claim: Pinheiro District Property</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Indemnity claim filed by Construtora H. Lobo (under court-supervised reorganization), a Contractor that claimed it suffered damages and loss of profits due to an agreement to purchase from Braskem a property in the District of Pinheiro. Said agreement was terminated by Braskem due to lack of payment by the Contractor. Nevertheless, the Contractor claims that Braskem omitted information on the existence of structural problems in the deactivated salt mining wells located on said property. As of December 31, 2022, the amount of this action is R$306 million (2021: R$264 million). The lawsuit is ongoing, and Management, supported by the opinion of its external legal advisors, classifies the probability of loss in this case as possible.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(vii) Indemnity Claim: State of Alagoas</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-align: justify"><span style="font-family: Calibri, Helvetica, Sans-Serif">Indemnity claim filed by the State of Alagoas, requesting compensation for alleged damages resulting, among others claims, from the loss of properties within the risk area defined by the Civil Defense of Maceió, alleged investments initiated by the State of Alagoas and that would have become void unusable due to the evacuation of the risk area and alleged loss of tax revenue, with a request that such damages to be determined by a court appraiser.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-align: justify">As injunction relief, the State of Alagoas requested the blocking of R$ <span id="xdx_906_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn8n9_c20220101__20221231_z6puiAR8oyL7">1.1 </span>billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration, this being the amount attributed to the lawsuit. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court. </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Management, supported by the opinion of its external legal advisor, classifies the probability of loss in this lawsuit as possible.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(viii) Other individual actions: Indemnifications related to the impacts of subsidence and relocation of areas affected</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-align: justify"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, <span id="xdx_909_ecustom--DescriptionOfIndividualActions_c20220101__20221231_zQM6Uddnoac4" title="Description of individual actions">Braskem was defendant in several other actions, that, in aggregate, involve the amount of R$1 billion (2021: R$895 million), filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió.</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Management, supported by the opinion of its external legal advisor, classifies the probability of loss of the other individual lawsuits, in the total amount mentioned above, as possible.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfChangesInprovisionExplanatory_pn3n3_zyxfY8NRGiX2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Geological event - Alagoas (Details)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"> <span id="xdx_8B6_zbrIgnXZdnqb" style="display: none">Schedule of following table shows the changes in the provision in the period</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 54%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the beginning of the year</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LegalProceedingsProvision1_iS_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zaBlfSx11neg" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--LegalProceedingsProvision1_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--LegalProceedingsProvision1_c20191231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="font-weight: bold; text-align: right" title="Balance at beginning"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,383,067</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Additions</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zzTV5XmD8N73" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,520,019</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zT32PIK5OfVh" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,339,765</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--AdditionsRelatedGeologicalEvent_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_z0PZawrGAwBj" style="text-align: right" title="Additions"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,901,827</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Payments and reclassifications (*)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProvisionAfterAdjustment_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_z6D6bI2APYh8" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,742,791)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProvisionAfterAdjustment_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_zCXDBNwucUZ5" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,928,081)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProvisionAfterAdjustment_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_fKCop_zUYmUuLWhHd" style="text-align: right" title="Payments and reclassifications"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,181,931)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Realization of present value adjusment</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--RealizationOfPresentValueAdjustment_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">188,071</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--RealizationOfPresentValueAdjustment_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  73,798</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--RealizationOfPresentValueAdjustment_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Realization of present value adjustment"><span style="font-family: Calibri, Helvetica, Sans-Serif">  72,814</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--LegalProceedingsProvision1_iE_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zPKWKvBvXly2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,626,558</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LegalProceedingsProvision1_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LegalProceedingsProvision1_iI_pn3n3_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_zgCFcP2vDLGj" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at ending"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current liability</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ShorttermLegalProceedingsProvision_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,247,609</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ShorttermLegalProceedingsProvision_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,378,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ShorttermLegalProceedingsProvision_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,349,931</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Non-current liability</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--LongtermLegalProceedingsProvision2_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,378,949</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LongtermLegalProceedingsProvision2_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,283,188</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--LongtermLegalProceedingsProvision2_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="text-align: right" title="Non-current liability"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,825,846</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--LegalProceedingsProvision_c20221231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,626,558</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--LegalProceedingsProvision_c20211231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,661,259</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--LegalProceedingsProvision_c20201231__ifrs-full--GeographicalAreasAxis__custom--AlagoasMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Provision"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,175,777</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0D_zwlGdh3jHI33" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F13_zywSL7oqfLR7" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable.</span></td></tr> </table> 7661259000 9175777000 3383067000 1520019000 1339765000 6901827000 -2742791000 -2928081000 -1181931000 188071000 73798000 72814000 6626558000 7661259000 9175777000 4247609000 4378071000 4349931000 2378949000 3283188000 4825846000 6626558000 7661259000 9175777000 2087142000 3390849000 1367269000 1691032000 allocating R$1,580,000 for the adoption of actions and measures in vacated areas, urban mobility and social compensation actions, of which R$300 million going to indemnification for social damages and collective pain and suffering and possible contingencies related to the actions in the vacated areas and urban mobility actions. The provision amount, updated by inflation index established in the agreement, is R$1,567,842 (2021: R$1,577,186). Public-Interest Civil Action claiming the payment of indemnification for damages caused to the buildings and the residents of areas affected in the Pinheiro district and surrounding areas, in the total minimum amount of R$6.7 billion, with initial request for provisional measure to freeze the Company’s financial and other assets in the same amount. Successive orders to freeze funds resulted in the court blocking of R$3.7 billion in assets in 2019, and the unfreezing occurred in January 2020. Once the case was sent to the Federal Courts, the Federal Prosecution Office started to participate in the action. 1700000000 1100000000 Braskem was defendant in several other actions, that, in aggregate, involve the amount of R$1 billion (2021: R$895 million), filed in Brazil and abroad, seeking the payment of indemnifications directly or indirectly related to the geological event in Maceió. <p id="xdx_800_eifrs-full--DisclosureOfEmployeeBenefitsExplanatory_zRX0pMx5nVj1" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>27 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_826_zOlC2ChQLQlg">Benefits offered to employees</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>27.1 Short-term benefits</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The obligations of short-term benefits for employees are recognized as personnel expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered by an employee in the past and the obligation can be reliably estimated.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfShortTermBenefitsExplanatory_pn3n3_za0buHQHl4k1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BD_zvvQsS28tJie" style="display: none">Schedule of short-term benefits</span></span></td> <td colspan="3" style="font-size: 11pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Health care</span></td> <td id="xdx_98B_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">243,620</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">235,681</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">197,683</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Private pension</span></td> <td id="xdx_989_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">127,954</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">136,851</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  94,302</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transport</span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  86,217</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  66,752</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Feeding</span></td> <td id="xdx_98F_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  62,786</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  51,240</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  38,400</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Life insurance</span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  10,400</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  10,324</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,875</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Training</span></td> <td id="xdx_988_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,032</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  15,723</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,892</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,027</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,546</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,117</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 574,036</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 539,566</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 436,021</span></td></tr> </table> <p id="xdx_8AE_zFAqBpBi1YTb" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>27.2 Long-term incentive plan (“ILP Plan”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On March 21, 2018, the Extraordinary Shareholders Meeting approved the Long-Term Incentive Plan with the grant of Restricted Shares (“ILP Plan”) to align the interests of shareholders and executive officers (participants) and to promote their continued employment at the Company.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The grant is subject to the voluntary investment of own financial resources by participants in the shares issued by the Company (tickers BRKM5 or BAK). To acquire the right, participants must maintain their employment relationship with the Company and hold uninterruptedly the shares acquired during the three-year vesting period.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">When the conditions to obtain the right are met, the Company transfers to participants the number of restricted shares to which they are entitled, which are held in treasury or acquired through repurchase program.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">If the transfer is not possible, the Company will pay to participants, in cash, the amount equivalent to the shares granted at the share price traded on stock exchange on the second business day immediately prior to the respective payment date.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The fair value of shares on the grant date is recognized on a straight-line basis under personnel expenses during the vesting period, reflecting the expected number of shares that will meet the conditions to obtain the right, in such a way that the end amount recognized as an expense is based on the number of shares that effectively meet the conditions on the vesting date.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The form of settlement of the ILP Plan determines the corresponding entry of expenses, which is recognized under equity for payment of shares and recognized under liabilities for cash payment, with the liability remeasured on each reporting date and on the settlement date, based on the American Depositary Receipt price. Any changes in the fair value of the liability are recognized as personnel expenses.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The programs listed below were approved by the Board of Directors under the terms and conditions of the Long-Term Incentive Plan, which includes a list of eligible people, the period for acquisition of own shares by the participants and the number of restricted shares to be delivered to participants as consideration for each share acquired.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"> </p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--LongTermIncentivePlanTableTextBlock_pn3n3_zCBSoySpcXs" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 1)"> <tr style="vertical-align: middle"> <td style="width: 6%"><span style="font-size: 8pt"> <span id="xdx_8B6_zFq4LLoxpmtl" style="display: none">Schedule of Long-term incentive plan</span></span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 15%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 7%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 5%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 7%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-size: 8pt">Flat</span></td> <td style="font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Grant Date</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">End of Grace Period</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Settlement Method</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Granted quantities</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-) Canceled</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-)<br/> Exercised</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Qty. on 12/31/2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(+) Granted</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-) Canceled</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-)<br/> Exercised</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Qty. on 12/31/2022</span></td> <td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Fair value of the share*</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_905_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zxkxlc8ijO97" title="Name of flat">2019 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zxN1zrJoCaLl" title="Date of grant">03/19/19</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90D_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zLb9ynxxKtw" title="End of grace period">03/19/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zWnmeF7N0qJ8" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zsX32XTr7my5" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  417,234</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zHYKepL1osBd" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (71,905)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zJtGIhB5kZFg" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 345,329</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SharesCanceled_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zEETDohZTev6" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (18,802)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--SharesExercised_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z1rV9SH5wpAe" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt"> (326,527)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_907_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zIVSzjrB5UCd" title="Name of flat">2019 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_908_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_ziP1scwN20Fc" title="Date of grant">03/19/19</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_905_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z5PJpCarSd52" title="End of grace period">03/19/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zefu4dvB4855" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zJlFoWNR5v27" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt"> 82,128</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4WaQ9TRgqrg" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(8,433)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zwKXYJkrMKF7" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt">73,695</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesCanceled_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zJKs7VP4R56d" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(1,297)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesExercised_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvxg25vv3pQk" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt">(72,398)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90D_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zgWKMUI0JB4a" title="Name of flat">2020 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_905_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zoyrHBWmJcld" title="Date of grant">04/01/20</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z9fzGqlcFTkd" title="End of grace period">04/01/23</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z5IEPHQ7l8n4" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z0GxjvfP5j96" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt"> 1,007,883</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zhVNEP2027Kd" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (72,743)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesExercised_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z0zv5SK4CiK9" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt">(2,373)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_ziX21c6GTCq7" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 932,767</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_ztaFobWVD8z9" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 932,767</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_90C_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_z98rDhJPaBrj" title="Fair value of the share">16.27</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90A_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zOPEBkOes6p2" title="Name of flat">2020 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zjdqwV49h8mj" title="Date of grant">04/01/20</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_908_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zMm6bzTFGDG7" title="End of grace period">04/01/23</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zhnrHy34CoCk" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zZUchjrbZlP5" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  314,333</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zDXDCJiK7wo7" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (47,943)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zb1dNRal0jTc" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 266,390</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zCQ95lxodvEf" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 266,390</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_zIXvJunEn9tg" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_901_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zno1rdhBWoNd" title="Name of flat">2021 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zBi1Qq7bxdQ8" title="Date of grant">05/10/21</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90F_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGEuTp2aTAxk" title="End of grace period">05/10/24</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z2nP1qQg98f1" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zpXOO3VdB3lk" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  557,888</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zzsO0scO2Iyg" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(9,598)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zLIpg5UKrHfg" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 548,290</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z5x3lEU6mMI4" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 548,290</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_904_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_zWXGofoezXo7" title="Fair value of the share">51.39</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90F_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zNWEJBTP19D2" title="Name of flat">2021 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zxnOTU4e3PWi" title="Date of grant">05/10/21</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_902_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvidipethpQ7" title="End of grace period">05/10/24</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zDHU0vzT7qR5" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_98F_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4PIvTcAWtBk" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  144,779</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_znzTNXAGggS5" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 144,779</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4xTiL4ZBXX9" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 144,779</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_z0IsxlicAF7i" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_902_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zR412ZTRiqFk" title="Name of flat">2022 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90C_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGQ7obNehKS2" title="Date of grant">05/17/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zDICV9zgfi79" title="End of grace period">05/17/25</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zIpGsqADeS8l" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--GrantedQuantitiesShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGaOB6Cudpw8" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  537,870</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zOtu6qOyG1oc" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 537,870</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_90C_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_z8hBAyZGgMAc" title="Fair value of the share">44.15</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_909_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zmnjJ3orvVbk" title="Name of flat">2022 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z74AjLXcx1x5" title="Date of grant">05/17/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zeICbwz7A8Ub" title="End of grace period">05/17/25</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zKpYeL3nDj4h" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--GrantedQuantitiesShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zNUH63dOnJxa" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  132,902</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvw9l4jCYsY3" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 132,902</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_zuaHm3jF0ne4" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F04_z3QXcvgAg9O1" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F15_z3DjUwNlqUe" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Values in monetary units.</span></td></tr> </table> <p id="xdx_8AC_zztD8vURawY2" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the amount recorded in equity is R$<span id="xdx_906_eifrs-full--AdjustmentsForFairValueGainsLosses_c20220101__20221231_pn3n3" title="Fair value, net of taxes">39,413</span> (2021: R$<span id="xdx_900_eifrs-full--AdjustmentsForFairValueGainsLosses_c20210101__20211231_pn3n3" title="Fair value, net of taxes">31,932</span>).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>27.3 Post-employment benefits</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The obligations for contributions to defined contribution plans are recognized in profit or loss as personnel expenses when the related services are provided by employees. The contributions paid in advance are recognized as an asset to the extent that a cash reimbursement or a reduction in future payments is possible.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s net obligation for defined benefit plans is calculated for each of the plans based on the estimated amount of future benefit that employees will receive in return for services rendered in the current and prior periods. Such amount is discounted to its present value and is reported net of the fair value of any of the plan’s assets.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The calculation of the obligation of the defined benefit plan is made annually by a qualified accountant using the projected unit credit method. When calculations result in a potential asset for the Company, the asset to be recognized is limited to the present value of economic benefits available as future plan reimbursements or as a reduction in future contributions to the plan. To calculate the present value of economic benefits, any applicable minimum cost requirements are taken into account. Remeasurements of net obligation, which include: actuarial gains and losses, return on plan assets (excluding interest) and the effects of the asset cap (if any, excluding interest), are immediately recognized in other comprehensive income.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Braskem and subsidiaries in Brazil</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem and the subsidiaries in Brazil sponsor a defined contribution plan for its team members managed by Vexty, a private pension plan entity. Vexty offers its participants, which are employees of the sponsoring companies, an optional defined contribution plan in which monthly and additional participant contributions and monthly and annual sponsor contributions are made to individual pension savings accounts. For this plan, the sponsors pay contributions to private pension plan on contractual or voluntary bases. As soon as the contributions are paid, the sponsors do not have any further obligations related to additional payments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">As of December 31, 2022, the number of active participants in Vexty sums 6,391 (2021: 6,113) and the contributions made by the sponsors in the year amount to R$<span id="xdx_903_ecustom--SponsorsExpenses_c20220101__20221231_pn3n3" title="Sponsors expenses">92,208</span> (2021: R$<span id="xdx_901_ecustom--SponsorsExpenses_c20210101__20211231_pn3n3" title="Sponsors expenses">68,744</span>) and the contributions made by the participants amounted to R$<span id="xdx_901_ecustom--ParticipantsExpenses_c20220101__20221231_pn3n3" title="Participants expenses">77,263</span> (2021: R$<span id="xdx_903_ecustom--ParticipantsExpenses_c20210101__20211231_pn3n3" title="Participants expenses">83,599</span>).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">According to Brazilian laws, the type of health plan offered by Braskem, named contributory plan, ensures to the participant who retires or is dismissed without cause the right to remain in the plan with the same assistance coverage conditions they had during the employment term, provided they assume the full payment of the plan (Company’s part + participant’s part).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Braskem America</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem America administers the Novamont, which is a closed defined benefit pension plan for the employees of a plant located in the State of West Virginia. On December 31, 2022, there were 36 active participants, 32 employees with deferred benefits along and 101 assisted participants (2021: 36 active participants, 141 employees with deferred benefits and 173 assisted participants).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">During 2022, the number of participants in the pension plan decreased, and 173 participants received a fixed payment or opted for insurance annuity.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Due to the current funding levels of the pension plan, the subsidiary was not required to contribute to the plan during the 2022 plan year and, therefore, there were no additional cash contributions made by the subsidiary or the participants in 2022 and 2021.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Braskem Alemanha (“Germany”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha is the sponsor of the defined benefit plans and defined contribution plans of its employees. As of December 31, 2022, the plans have 172 participants (2021: 158) and no contributions were made by the subsidiary or the participants in 2022 and 2021.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Braskem Holanda (“Netherlands”)</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The subsidiary Braskem Holanda is the sponsor of the defined contribution plans of its employees. As of December 31, 2022, the plans have 12 participants (9 participants in 2021) and no contributions were made by the subsidiary or the participants in 2021 and 2020.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt; color: #009775"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Braskem Idesa</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 28.35pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa is the sponsor of defined benefit plans for its team members. As of December 31, 2022, the plan was composed of 965 active participants (2021: 936 active participants). The contributions the subsidiary made in the year amounted to R$4,370 (2021: R$3,810). During 2022 and 2021, there were no contributions from participants.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Amounts in statement of financial position</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDefinedBenefitObligationsExplanatory_pn3n3_zFYnRvx1Opu7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 2)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B4_z6py1BoJoI0j" style="display: none">Schedule of defined benefit obligations</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 37%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Defined benefit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Novamont Braskem America</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,221</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_z7VDlnXpRWzf" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,509</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DefinedBenefitObligationAtPresentValue2_iI_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zKn6hNJ3ED3a" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,053</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DefinedBenefitObligationAtPresentValue2_iI_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_z6L98wV0hc75" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,960</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha and Netherlands</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaAndBraskemHolandaMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">147,562</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaAndBraskemHolandaMember_z7ALgVFOAAd7" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 223,193</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">228,836</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember_zdgIGHPG4Vzi" style="border-top: Black 0.5pt solid; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 363,662</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health care</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bradesco saúde</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCarePlanMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BradescoSaudeMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">321,520</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCarePlanMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BradescoSaudeMember_zq5VfDR7Ufzd" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 243,706</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total obligations</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 550,356</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231_zVscu8LPTHWg" style="border-top: Black 0.5pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  607,368</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value of plan assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Novamont Braskem America</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PlanAssetsAtFairValue1_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_pn3n3" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(54,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_zaudcensaHhd" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(117,509)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--PlanAssetsAtFairValue1_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,948)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_zu134eNr2Qhd" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,162)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PlanAssetsAtFairValue1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(56,613)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231_zYXoHtPd5U6c" style="border-top: Black 0.5pt solid; text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(119,671)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Consolidated net balance (non-current liabilities)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Consolidated net balance (non-current liabilities)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 493,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_iI_pn3n3_c20211231_zyxSjLFsHz22" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Consolidated net balance (non-current liabilities)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  487,697</span></td></tr> </table> <p id="xdx_8A8_zX6JSR6OE8p2" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"><b>Change in obligations</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfChangesInDefinedBenefitObligationsExplanatory_pn3n3_z4p6Xrijkrrk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B1_zgjNZ4dbAsV4" style="display: none">Change in obligations</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at beginning of year</span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zGVLGPmROgAe" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  243,706</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zHucTjo4OaJb" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  363,662</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231_z61i615uAvod" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 607,368</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_ztGYyq8jkRO5" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  217,089</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zkdF6AYqwCx4" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 370,860</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231_zez0JBUFZIkb" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 587,949</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zftRG1Uo7gzc" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  224,852</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z8gTswQjRdUk" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 245,565</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231_zjR9F0XqJL6" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 470,417</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current service cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,732</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,817</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,498</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,164</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,200</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,114</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 15,692</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,906</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,598</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,482</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,579</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefits paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12,639)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(34,208)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (46,847)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (10,712)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,191)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (17,903)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,949)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,409)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (13,358)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actuarial losses (gain)</span></td> <td id="xdx_980_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 65,325</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (18,160)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,820</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26,668)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(9,848)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (23,589)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,803</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,214</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(36,779)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (36,779)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,074</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,074</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">87,933</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">87,933</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td id="xdx_98A_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zxltfbCRKFt8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">321,520</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z0bwx42SGaq7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">228,836</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231_zuSroVSGstq6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  550,356</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zrDrxanklRR4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">243,706</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z344npOuW7sf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">363,662</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231_zDAm16FFj9b9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">607,368</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zFD5GqPXZIQa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">217,089</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z5pNbrTFTMJ7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  370,860</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231_zzYt4xIeSS4i" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  587,949</span></td></tr> </table> <p id="xdx_8A5_zZnCPmsM0G47" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Change in fair value plan assets</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfChangesInFairValuePlanAssetsExplanatory_pn3n3_zbzmWOIwBmNg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 4)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B2_zhsI29zG3xH4" style="display: none">Change in fair value plan assets</span></td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at beginning of year</span></td> <td id="xdx_981_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20220101__20221231_zHgTUvx66L1a" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,671</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20210101__20211231_zJSwx4pV8as9" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  115,875</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20200101__20201231_zSyER5QMRYXf" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,342</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actual return on plan assets</span></td> <td id="xdx_98E_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25,929)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">722</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,791</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefits paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20220101__20221231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(32,264)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20210101__20211231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,301)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20200101__20201231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,973)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,866)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20210101__20211231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,375</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20200101__20201231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,715</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td id="xdx_982_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20220101__20221231_z4HIDX3BLDL2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,613</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20210101__20211231_zGrsjSwN9yF1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">119,671</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20200101__20201231_z4qBXKaVy3pd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  115,875</span></td></tr> </table> <p id="xdx_8A9_z4XPeKjbW8Ng" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022, the balance of the fair value of assets is represented by the assets of the Novamont defined benefit plan, which has a level-1 fair value hierarchy.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"><b>Amounts recognized in profit and loss</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfBenefitAmountsRecognizedInProfitAndLossExplanatory_pn3n3_zTnXti1311K" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BC_zfwBipy9WWEb" style="display: none">Amounts recognized in profit and loss</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current service cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zTQkn2XOEhu8" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zPbvacurfVu9" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,732</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231_zgrOFfdPdSA" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zC6BRqiggyX8" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,817</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zcEGNcSptU8j" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231_zy1uOg1bAmkf" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,498</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zU5fGQQ6lz4d" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zmB3hr12k9B7" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231_z63LWHSB8kcb" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,164</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zDgxDtqo8IJg" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,200</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zWyYo1biFtF8" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231_zbWd32oyYF47" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,114</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zZ2b7KbyGEn" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 15,692</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zbSU4d6gGIAi" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,906</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231_zICBr21NlWud" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,598</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_znPDCC9zpx06" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zGeOWAXrw1ta" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,482</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231_ziMX1i8Hyqe" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,579</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actuarial (losses) gains</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (24,203)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(24,203)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,461</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,461</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,128</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (63,839)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,711)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">20,509</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,616)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,893</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,775</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,429</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,204</span></td></tr> </table> <p id="xdx_8A4_z8I86eOFq13g" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Actuarial assumptions</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b/></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfActuarialAssumptionsExplanatory_pn3n3_z98N1mjWWVL9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 6)"> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_8B4_zoyB5YqaiWc4" style="display: none">Schedule of Actuarial assumptions</span></span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(%)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zqS4xgiaulX5" title="Discount rate">5.97</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zvhUfhfWn6Mi" title="Discount rate">5.10</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_904_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_z8hhCMBDKAPl" title="Discount rate">8.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_904_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z2GRAeXVwFn6" title="Discount rate">1.20</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_901_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zhwxtqggvI8h" title="Discount rate">3.60</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_905_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zLzavInq9RSb" title="Discount rate"> 5.33</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zORoWW2HoZid" title="Discount rate"> 2.90</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90D_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zNEokv7zsL9j" title="Discount rate">8.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zV9fmxgRtk73" title="Discount rate">1.20</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_906_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z87xPQc1mEa2" title="Discount rate">1.20</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zyJYoNyWehpe" title="Discount rate">3.99</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_905_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zyjb6mzTXnj1" title="Discount rate">2.60</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zG46Jz547rY9" title="Discount rate">7.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zLZShEmKVtlk" title="Discount rate">0.70</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z3bELdiHRnN2" title="Discount rate">0.70</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Inflation rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zstA1IE0T9Ug" title="Inflation rate">3.00</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zkCxYlMRllle" title="Inflation rate">4.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zH8VH7Ee83Ub" title="Inflation rate">2.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zVLwZEcGCc7i" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zj8hDsxPhpE9" title="Inflation rate">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90B_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_z1DoV8Q9nKqf" title="Inflation rate">4.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_904_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_znyM3kJbT7Ok" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z9EtWVhNWc2e" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_ziM4s6l0ccn1" title="Inflation rate">3.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zLQEwl1ZFbyj" title="Inflation rate">4.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_904_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zSkkuzz0oqBg" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zw1FJphl3X6j" title="Inflation rate">2.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Expected return on plan assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future salary levels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zOEo1laTdgO2" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90B_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zjKoDA5geJg2" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_900_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zXet3pbXNX5" title="Rate of increase in future salary levels">3.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_900_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zY5IyxvSI3Xa" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90B_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zZtKxwOO5Xt4" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90D_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zkRr992ZDogk" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_901_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zltFKgCwudBd" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zIE9V8wr7Ywi" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zuNkiTjiXT99" title="Rate of increase in future salary levels">3.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_905_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zHCczq5N2R1f" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zAodHj7OFNS2" title="Rate of increase in future pension plan">2.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90A_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z3RNxbUxH6zk" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z6QO5Y3u2nnk" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90D_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zJnSZHiydwdb" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_znxQw6qXy76f" title="Rate of increase in future pension plan">1.75</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Aging factor</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zB8hAyhECit2" title="Aging factor">2.50</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_908_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zIIHoVqMU3m6" title="Aging factor">2.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_908_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_z07GVB5JVvm8" title="Aging factor">2.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Medical inflation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zIX0Mu7E80T2" title="Medical inflation">3.50</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_909_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zHn8tyQAKx3b" title="Medical inflation">3.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zOj6YJSqBbxe" title="Medical inflation">3.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Duration</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zpsINpyxqDO" title="Duration">12.83</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zUAGUGkHIEEe" title="Duration">14.16</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_906_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zr65hkKcI3bk" title="Duration">14.99</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> </table> <p id="xdx_8AF_zHFHpMRLGeB2" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"><b>Sensitivity analysis</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt; color: #FE5000"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfBenefitsSensitivityAnalysisExplanatory_pn3n3_zNcCCJh1gw9f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 7)"> <tr style="vertical-align: bottom"> <td colspan="4" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_8B6_zpLyi8xVYoB5" style="display: none">Sensitivity analysis</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="29" style="border-bottom: Black 1pt solid; text-align: right; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Impact on the defined benefit obligation</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise change</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise increase</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise reduction</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zEDUq9rh3XRa" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zVxJCjigmxij" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zG1cuIY7cM9h" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zE824dE4tcri" title="Premise change">0.25</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zpHpgPh9zc8g" title="Premise change">0.25</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zAAis57LQZ62" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 32,758</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">5,536</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,646</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,477</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  297</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zJ66VfZA8hl8" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (39,621)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zoNGUagP0Gs8" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(6,605)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zZKYl2w5IW94" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,935)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zSmgAV63EmL5" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,836)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zUD2uG50Qxt2" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (315)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Real medical inflation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future salary levels</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zRPq1rB8lvFj" title="Premise change">0.5</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zJQr4VzVwp22" title="Premise change">0.5</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,604</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  468</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zEsXxJSuZgse" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,114)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (442)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zLiGcrX2WSF9" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zDnbudbfWxHk" title="Premise change">0.25</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pdd" title="Premise change">0.25</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zpuwpD6BMa84" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,740)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zD93GrQlQbl5" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,241</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  231</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zRrv7gKezHqf" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,098</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zdo6Fzj8HSCa" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,115)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (224)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Life expectancy</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zramBDyYbRob" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_ecustom--LifeExpectancy_dtY_c20220101__20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z3TZOTUMiacg" title="Life expectancy">1</span> ano</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_ecustom--LifeExpectancy_dtY_c20220101__20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zPKdwwrROWJc" title="Life expectancy">1</span> ano</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zOkSbp6FZ5m3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 48,527</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_za9OACZUHpr4" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,637</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zZm97x4Evt69" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  198</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zdRu1u0NDUB4" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (39,355)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zRqBZanOKoF5" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,797)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zKUpfyZAkMrh" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (207)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mortality rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zzxNxnPBcF7e" title="Premise change">10.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,839)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="11" style="border-bottom: Black 0.5pt solid; text-align: right; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Health insurance - Impact on cost of services and interests costs</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise change</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise increase</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise reduction</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zRwTid9zFask" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zVV38IA3CKme" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  730</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  106</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(933)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Life expectancy</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zCIIwjwpaofl" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zgnXWmKYyNll" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  542</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,441</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(464)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,602)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_z1Gu0biS5rSf" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_zFQqmy3JlUik" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  123</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  708</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(129)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (741)</span></td></tr> </table> <p id="xdx_8A2_zpA6Seco5Kfg" style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"/> <p style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfShortTermBenefitsExplanatory_pn3n3_za0buHQHl4k1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BD_zvvQsS28tJie" style="display: none">Schedule of short-term benefits</span></span></td> <td colspan="3" style="font-size: 11pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-size: 11pt; font-weight: bold; text-align: right; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-size: 11pt; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Health care</span></td> <td id="xdx_98B_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">243,620</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">235,681</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCareBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">197,683</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Private pension</span></td> <td id="xdx_989_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">127,954</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">136,851</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--PrivatePensionBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  94,302</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Transport</span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  86,217</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  77,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--TransportBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  66,752</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Feeding</span></td> <td id="xdx_98F_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  62,786</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  51,240</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--FeedingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  38,400</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Life insurance</span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  10,400</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  10,324</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--LifeInsuranceBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 9,875</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Training</span></td> <td id="xdx_988_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  27,032</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  15,723</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--TrainingBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,892</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td id="xdx_98D_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  16,027</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,546</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--OtherBenefitsMember_pn3n3" style="text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  14,117</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ShorttermEmployeeBenefitsExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 574,036</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShorttermEmployeeBenefitsExpense_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 539,566</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ShorttermEmployeeBenefitsExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-size: 11pt; font-weight: bold; text-align: right" title="Short-term benefits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 436,021</span></td></tr> </table> 243620000 235681000 197683000 127954000 136851000 94302000 86217000 77201000 66752000 62786000 51240000 38400000 10400000 10324000 9875000 27032000 15723000 14892000 16027000 12546000 14117000 574036000 539566000 436021000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--LongTermIncentivePlanTableTextBlock_pn3n3_zCBSoySpcXs" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 1)"> <tr style="vertical-align: middle"> <td style="width: 6%"><span style="font-size: 8pt"> <span id="xdx_8B6_zFq4LLoxpmtl" style="display: none">Schedule of Long-term incentive plan</span></span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 15%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 7%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 5%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 7%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td> <td style="width: 1%"><span style="font-size: 8pt"> </span></td> <td style="width: 6%"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-size: 8pt">Flat</span></td> <td style="font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Grant Date</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">End of Grace Period</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Settlement Method</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Granted quantities</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-) Canceled</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-)<br/> Exercised</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Qty. on 12/31/2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(+) Granted</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-) Canceled</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">(-)<br/> Exercised</span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Qty. on 12/31/2022</span></td> <td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">Fair value of the share*</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_905_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zxkxlc8ijO97" title="Name of flat">2019 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zxN1zrJoCaLl" title="Date of grant">03/19/19</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90D_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zLb9ynxxKtw" title="End of grace period">03/19/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zWnmeF7N0qJ8" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zsX32XTr7my5" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  417,234</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zHYKepL1osBd" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (71,905)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zJtGIhB5kZFg" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 345,329</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SharesCanceled_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zEETDohZTev6" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (18,802)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--SharesExercised_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z1rV9SH5wpAe" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt"> (326,527)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_907_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zIVSzjrB5UCd" title="Name of flat">2019 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_908_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_ziP1scwN20Fc" title="Date of grant">03/19/19</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_905_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z5PJpCarSd52" title="End of grace period">03/19/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zefu4dvB4855" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zJlFoWNR5v27" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt"> 82,128</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4WaQ9TRgqrg" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(8,433)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_985_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zwKXYJkrMKF7" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt">73,695</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesCanceled_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zJKs7VP4R56d" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(1,297)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesExercised_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2019Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvxg25vv3pQk" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt">(72,398)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90D_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zgWKMUI0JB4a" title="Name of flat">2020 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_905_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zoyrHBWmJcld" title="Date of grant">04/01/20</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z9fzGqlcFTkd" title="End of grace period">04/01/23</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z5IEPHQ7l8n4" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z0GxjvfP5j96" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt"> 1,007,883</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zhVNEP2027Kd" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (72,743)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--SharesExercised_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z0zv5SK4CiK9" style="text-align: right" title="Shares exercised"><span style="font-size: 8pt">(2,373)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_ziX21c6GTCq7" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 932,767</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98E_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_ztaFobWVD8z9" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 932,767</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_90C_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_z98rDhJPaBrj" title="Fair value of the share">16.27</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90A_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zOPEBkOes6p2" title="Name of flat">2020 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zjdqwV49h8mj" title="Date of grant">04/01/20</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_908_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zMm6bzTFGDG7" title="End of grace period">04/01/23</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zhnrHy34CoCk" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zZUchjrbZlP5" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  314,333</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zDXDCJiK7wo7" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt"> (47,943)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zb1dNRal0jTc" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 266,390</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_989_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zCQ95lxodvEf" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 266,390</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_981_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2020Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_zIXvJunEn9tg" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_901_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zno1rdhBWoNd" title="Name of flat">2021 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zBi1Qq7bxdQ8" title="Date of grant">05/10/21</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90F_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGEuTp2aTAxk" title="End of grace period">05/10/24</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_980_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z2nP1qQg98f1" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zpXOO3VdB3lk" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  557,888</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SharesCanceled_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zzsO0scO2Iyg" style="text-align: right" title="Shares canceled"><span style="font-size: 8pt">(9,598)</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zLIpg5UKrHfg" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 548,290</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_z5x3lEU6mMI4" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 548,290</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_904_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_zWXGofoezXo7" title="Fair value of the share">51.39</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_90F_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zNWEJBTP19D2" title="Name of flat">2021 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_900_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zxnOTU4e3PWi" title="Date of grant">05/10/21</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_902_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvidipethpQ7" title="End of grace period">05/10/24</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_987_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zDHU0vzT7qR5" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td id="xdx_98F_ecustom--GrantedQuantitiesShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4PIvTcAWtBk" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  144,779</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--QuantityOfAcquisitionShares_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_znzTNXAGggS5" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 144,779</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_986_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z4xTiL4ZBXX9" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 144,779</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2021Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_z0IsxlicAF7i" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_902_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zR412ZTRiqFk" title="Name of flat">2022 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_90C_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGQ7obNehKS2" title="Date of grant">05/17/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zDICV9zgfi79" title="End of grace period">05/17/25</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_988_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zIpGsqADeS8l" title="Settlement Method"><span style="font-size: 8pt">Shares</span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_982_ecustom--GrantedQuantitiesShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zGaOB6Cudpw8" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  537,870</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98B_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_zOtu6qOyG1oc" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 537,870</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt">R$ <span id="xdx_90C_ecustom--FairValueOfShare_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologySharesMember_fKCop_z8hBAyZGgMAc" title="Fair value of the share">44.15</span></span></td></tr> <tr style="vertical-align: middle"> <td><span style="font-size: 8pt"><span id="xdx_909_ecustom--NameOfFlat_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zmnjJ3orvVbk" title="Name of flat">2022 Plan</span></span></td> <td><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--DateOfGrant_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_z74AjLXcx1x5" title="Date of grant">05/17/22</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td style="text-align: right"><span style="font-size: 8pt"><span id="xdx_906_ecustom--EndOfGracePeriod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zeICbwz7A8Ub" title="End of grace period">05/17/25</span></span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98C_ecustom--SettlementMethod_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zKpYeL3nDj4h" title="Settlement Method"><span style="font-size: 8pt">Cash</span></td> <td><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_983_ecustom--GrantedQuantitiesShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zNUH63dOnJxa" style="text-align: right" title="Granted quantities, shares"><span style="font-size: 8pt">  132,902</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> -</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt">-</span></td> <td style="color: white; text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_98A_ecustom--QuantityOfAcquisitionShares_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_zvw9l4jCYsY3" style="text-align: right" title="Quantity of acquisition, shares"><span style="font-size: 8pt"> 132,902</span></td> <td style="text-align: right"><span style="font-size: 8pt"> </span></td> <td id="xdx_984_ecustom--FairValueOfShareValue_pid_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--Plan2022Member__custom--SettlementAxis__custom--SettlementMethodologyCashMember_fKCop_zuaHm3jF0ne4" style="text-align: right" title="Fair value of the share, value"><span style="font-size: 8pt">USD 9.67</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F04_z3QXcvgAg9O1" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(*)</span></td> <td id="xdx_F15_z3DjUwNlqUe" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Values in monetary units.</span></td></tr> </table> 2019 Plan 2019-03-19 03/19/22 Shares 417234000 -71905000 345329000 -18802000 -326527000 2019 Plan 2019-03-19 03/19/22 Cash 82128000 -8433000 73695000 -1297000 -72398000 2020 Plan 2020-04-01 04/01/23 Shares 1007883000 -72743000 -2373000 932767000 932767000 16.27 2020 Plan 2020-04-01 04/01/23 Cash 314333000 -47943000 266390000 266390000 9.67 2021 Plan 2021-05-10 05/10/24 Shares 557888000 -9598000 548290000 548290000 51.39 2021 Plan 2021-05-10 05/10/24 Cash 144779000 144779000 144779000 9.67 2022 Plan 2022-05-17 05/17/25 Shares 537870000 537870000 44.15 2022 Plan 2022-05-17 05/17/25 Cash 132902000 132902000 9.67 39413000 31932000 92208000 68744000 77263000 83599000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDefinedBenefitObligationsExplanatory_pn3n3_zFYnRvx1Opu7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 2)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B4_z6py1BoJoI0j" style="display: none">Schedule of defined benefit obligations</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 37%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Defined benefit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Novamont Braskem America</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,221</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_z7VDlnXpRWzf" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 117,509</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Idesa</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DefinedBenefitObligationAtPresentValue2_iI_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_zKn6hNJ3ED3a" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  23,053</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DefinedBenefitObligationAtPresentValue2_iI_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemIdesaMember_z6L98wV0hc75" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">22,960</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha and Netherlands</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaAndBraskemHolandaMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">147,562</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaAndBraskemHolandaMember_z7ALgVFOAAd7" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 223,193</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">228,836</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitMember_zdgIGHPG4Vzi" style="border-top: Black 0.5pt solid; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 363,662</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health care</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Bradesco saúde</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCarePlanMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BradescoSaudeMember_pn3n3" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">321,520</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthCarePlanMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BradescoSaudeMember_zq5VfDR7Ufzd" style="text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 243,706</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total obligations</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DefinedBenefitObligationAtPresentValue2_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 550,356</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--DefinedBenefitObligationAtPresentValue2_iI_pn3n3_c20211231_zVscu8LPTHWg" style="border-top: Black 0.5pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total obligations"><span style="font-family: Calibri, Helvetica, Sans-Serif">  607,368</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Fair value of plan assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Novamont Braskem America</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--PlanAssetsAtFairValue1_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_pn3n3" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(54,665)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NovamontBraskemAmericaMember_zaudcensaHhd" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(117,509)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem Alemanha </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--PlanAssetsAtFairValue1_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_pn3n3" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,948)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BraskemAlemanhaMember_zu134eNr2Qhd" style="text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,162)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--PlanAssetsAtFairValue1_c20221231_pn3n3" style="border-top: Black 0.5pt solid; text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(56,613)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PlanAssetsAtFairValue1_iI_pn3n3_c20211231_zYXoHtPd5U6c" style="border-top: Black 0.5pt solid; text-align: right" title="Fair value of plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(119,671)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Consolidated net balance (non-current liabilities)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Consolidated net balance (non-current liabilities)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 493,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_iI_pn3n3_c20211231_zyxSjLFsHz22" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Consolidated net balance (non-current liabilities)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  487,697</span></td></tr> </table> 58221000 117509000 23053000 22960000 147562000 223193000 228836000 363662000 321520000 243706000 550356000 607368000 -54665000 -117509000 -1948000 -2162000 -56613000 -119671000 493743000 487697000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfChangesInDefinedBenefitObligationsExplanatory_pn3n3_z4p6Xrijkrrk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B1_zgjNZ4dbAsV4" style="display: none">Change in obligations</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at beginning of year</span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zGVLGPmROgAe" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  243,706</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zHucTjo4OaJb" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  363,662</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20220101__20221231_z61i615uAvod" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 607,368</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_ztGYyq8jkRO5" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  217,089</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zkdF6AYqwCx4" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 370,860</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20210101__20211231_zez0JBUFZIkb" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 587,949</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zftRG1Uo7gzc" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  224,852</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z8gTswQjRdUk" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 245,565</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--DefinedBenefitObligationAtPresentValue_iS_pn3n3_c20200101__20201231_zjR9F0XqJL6" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 470,417</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current service cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,732</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,817</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,498</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,164</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,200</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,114</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 15,692</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,906</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,598</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,482</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,579</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefits paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(12,639)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(34,208)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--BenefitsPaidOrPayable_c20220101__20221231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (46,847)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (10,712)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,191)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--BenefitsPaidOrPayable_c20210101__20211231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (17,903)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,949)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(7,409)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--BenefitsPaidOrPayable_c20200101__20201231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (13,358)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actuarial losses (gain)</span></td> <td id="xdx_980_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 65,325</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (18,160)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,820</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (26,668)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(9,848)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (23,589)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,803</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actuarial losses (gain)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,214</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(36,779)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (36,779)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,074</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,074</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">87,933</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">87,933</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td id="xdx_98A_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zxltfbCRKFt8" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">321,520</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z0bwx42SGaq7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">228,836</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20220101__20221231_zuSroVSGstq6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  550,356</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zrDrxanklRR4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">243,706</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z344npOuW7sf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">363,662</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20210101__20211231_zDAm16FFj9b9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">607,368</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zFD5GqPXZIQa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">217,089</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_z5pNbrTFTMJ7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  370,860</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--DefinedBenefitObligationAtPresentValue_iE_pn3n3_c20200101__20201231_zzYt4xIeSS4i" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  587,949</span></td></tr> </table> 243706000 363662000 607368000 217089000 370860000 587949000 224852000 245565000 470417000 4928000 12732000 17660000 4817000 13681000 18498000 4678000 12486000 17164000 20200000 6914000 27114000 15692000 5906000 21598000 17097000 6482000 23579000 -12639000 -34208000 -46847000 -10712000 -7191000 -17903000 -5949000 -7409000 -13358000 65325000 -83485000 -18160000 16820000 -26668000 -9848000 -23589000 25803000 2214000 -36779000 -36779000 7074000 7074000 87933000 87933000 321520000 228836000 550356000 243706000 363662000 607368000 217089000 370860000 587949000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfChangesInFairValuePlanAssetsExplanatory_pn3n3_zbzmWOIwBmNg" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 4)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8B2_zhsI29zG3xH4" style="display: none">Change in fair value plan assets</span></td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 34%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at beginning of year</span></td> <td id="xdx_981_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20220101__20221231_zHgTUvx66L1a" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,671</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20210101__20211231_zJSwx4pV8as9" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  115,875</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--PlanAssetsAtFairValue_iS_pn3n3_c20200101__20201231_zSyER5QMRYXf" style="text-align: right" title="Balance at beginning of year"><span style="font-family: Calibri, Helvetica, Sans-Serif">81,342</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actual return on plan assets</span></td> <td id="xdx_98E_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">(25,929)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">722</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actual return on plan assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,791</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefits paid</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20220101__20221231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(32,264)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20210101__20211231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,301)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--FairValuePlanAssetsBenefitsPaidOrPayable_c20200101__20201231_pn3n3" style="text-align: right" title="Benefits paid"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,973)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20220101__20221231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,866)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20210101__20211231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,375</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets_c20200101__20201231_pn3n3" style="text-align: right" title="Exchange variation"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,715</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Balance at the end of the year</span></td> <td id="xdx_982_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20220101__20221231_z4HIDX3BLDL2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">56,613</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20210101__20211231_zGrsjSwN9yF1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">119,671</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--PlanAssetsAtFairValue_iE_pn3n3_c20200101__20201231_z4qBXKaVy3pd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Balance at the end of the year"><span style="font-family: Calibri, Helvetica, Sans-Serif">  115,875</span></td></tr> </table> 119671000 115875000 81342000 -25929000 722000 15791000 -32264000 -5301000 -4973000 -4866000 8375000 23715000 56613000 119671000 115875000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfBenefitAmountsRecognizedInProfitAndLossExplanatory_pn3n3_zTnXti1311K" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span id="xdx_8BC_zfwBipy9WWEb" style="display: none">Amounts recognized in profit and loss</span></td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 21%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: right; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Benefit</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">plans</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Current service cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zTQkn2XOEhu8" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,928</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zPbvacurfVu9" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 12,732</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231_zgrOFfdPdSA" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zC6BRqiggyX8" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,817</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zcEGNcSptU8j" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231_zy1uOg1bAmkf" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,498</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zU5fGQQ6lz4d" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,678</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zmB3hr12k9B7" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">12,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231_z63LWHSB8kcb" style="text-align: right" title="Current service cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">17,164</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest cost</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zDgxDtqo8IJg" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 20,200</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zWyYo1biFtF8" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,914</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20220101__20221231_zbWd32oyYF47" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,114</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zZ2b7KbyGEn" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 15,692</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zbSU4d6gGIAi" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,906</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20210101__20211231_zICBr21NlWud" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">21,598</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_znPDCC9zpx06" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 17,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_zGeOWAXrw1ta" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">  6,482</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn3n3_c20200101__20201231_ziMX1i8Hyqe" style="text-align: right" title="Interest cost"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,579</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Actuarial (losses) gains</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20220101__20221231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (83,485)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (24,203)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20210101__20211231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">(24,203)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,461</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ActuarialGainsLossesNetDefinedBenefitLiabilityAsset_c20200101__20201231_pn3n3" style="text-align: right" title="Actuarial losses"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,461</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">25,128</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (63,839)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">(38,711)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">20,509</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,616)</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20210101__20211231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">15,893</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif">  21,775</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--BenefitPlansMember_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,429</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ActuarialGainsLossesNetDefinedBenefitTotal_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Amounts recognized in profit and loss"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,204</span></td></tr> </table> 4928000 12732000 17660000 4817000 13681000 18498000 4678000 12486000 17164000 20200000 6914000 27114000 15692000 5906000 21598000 17097000 6482000 23579000 -83485000 -83485000 -24203000 -24203000 15461000 15461000 25128000 -63839000 -38711000 20509000 -4616000 15893000 21775000 34429000 56204000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfActuarialAssumptionsExplanatory_pn3n3_z98N1mjWWVL9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 6)"> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_8B4_zoyB5YqaiWc4" style="display: none">Schedule of Actuarial assumptions</span></span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(%)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2022</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2021</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zqS4xgiaulX5" title="Discount rate">5.97</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zvhUfhfWn6Mi" title="Discount rate">5.10</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_904_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_z8hhCMBDKAPl" title="Discount rate">8.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_904_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z2GRAeXVwFn6" title="Discount rate">1.20</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_901_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zhwxtqggvI8h" title="Discount rate">3.60</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_905_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zLzavInq9RSb" title="Discount rate"> 5.33</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zORoWW2HoZid" title="Discount rate"> 2.90</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90D_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zNEokv7zsL9j" title="Discount rate">8.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zV9fmxgRtk73" title="Discount rate">1.20</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_906_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z87xPQc1mEa2" title="Discount rate">1.20</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zyJYoNyWehpe" title="Discount rate">3.99</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_905_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStateOfAmericaMember_zyjb6mzTXnj1" title="Discount rate">2.60</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zG46Jz547rY9" title="Discount rate">7.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zLZShEmKVtlk" title="Discount rate">0.70</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z3bELdiHRnN2" title="Discount rate">0.70</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Inflation rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zstA1IE0T9Ug" title="Inflation rate">3.00</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zkCxYlMRllle" title="Inflation rate">4.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zH8VH7Ee83Ub" title="Inflation rate">2.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zVLwZEcGCc7i" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zj8hDsxPhpE9" title="Inflation rate">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90B_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_z1DoV8Q9nKqf" title="Inflation rate">4.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_904_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_znyM3kJbT7Ok" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z9EtWVhNWc2e" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_ziM4s6l0ccn1" title="Inflation rate">3.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zLQEwl1ZFbyj" title="Inflation rate">4.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_904_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zSkkuzz0oqBg" title="Inflation rate">2.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zw1FJphl3X6j" title="Inflation rate">2.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Expected return on plan assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future salary levels</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zOEo1laTdgO2" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90B_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zjKoDA5geJg2" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_900_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zXet3pbXNX5" title="Rate of increase in future salary levels">3.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_900_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zY5IyxvSI3Xa" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90B_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zZtKxwOO5Xt4" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90D_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zkRr992ZDogk" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_901_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zltFKgCwudBd" title="Rate of increase in future salary levels">5.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zIE9V8wr7Ywi" title="Rate of increase in future salary levels">3.00</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_ecustom--ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zuNkiTjiXT99" title="Rate of increase in future salary levels">3.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_905_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zHCczq5N2R1f" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90E_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zAodHj7OFNS2" title="Rate of increase in future pension plan">2.25</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_90A_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z3RNxbUxH6zk" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_z6QO5Y3u2nnk" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_90D_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zJnSZHiydwdb" title="Rate of increase in future pension plan">1.75</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_ecustom--ActuarialAssumptionRateOfIncreaseInFuturePensionPlan_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_znxQw6qXy76f" title="Rate of increase in future pension plan">1.75</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Aging factor</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zB8hAyhECit2" title="Aging factor">2.50</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_908_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zIIHoVqMU3m6" title="Aging factor">2.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_908_eifrs-full--OtherMaterialActuarialAssumptions_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_z07GVB5JVvm8" title="Aging factor">2.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Medical inflation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zIX0Mu7E80T2" title="Medical inflation">3.50</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_909_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zHn8tyQAKx3b" title="Medical inflation">3.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_909_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zOj6YJSqBbxe" title="Medical inflation">3.50</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Duration</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zpsINpyxqDO" title="Duration">12.83</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zUAGUGkHIEEe" title="Duration">14.16</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  <span id="xdx_906_ecustom--ActuarialAssumptionOfDuration1_iI_pid_dp_c20201231__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zr65hkKcI3bk" title="Duration">14.99</span></span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> </table> 0.0597 0.0510 0.0800 0.0120 0.0360 0.0533 0.0290 0.0800 0.0120 0.0120 0.0399 0.0260 0.0725 0.0070 0.0070 0.0300 0.0400 0.0200 0.0200 0.0300 0.0400 0.0200 0.0200 0.0325 0.0400 0.0200 0.0200 0.0500 0.0300 0.0325 0.0500 0.0300 0.0300 0.0500 0.0300 0.0300 0.0175 0.0225 0.0175 0.0175 0.0175 0.0175 0.0250 0.0250 0.0250 0.0350 0.0350 0.0350 0.1283 0.1416 0.1499 <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfBenefitsSensitivityAnalysisExplanatory_pn3n3_zNcCCJh1gw9f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Benefits offered to team members (Details 7)"> <tr style="vertical-align: bottom"> <td colspan="4" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> <span id="xdx_8B6_zpLyi8xVYoB5" style="display: none">Sensitivity analysis</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="font-family: Calibri, Helvetica, Sans-Serif"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="29" style="border-bottom: Black 1pt solid; text-align: right; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Impact on the defined benefit obligation</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise change</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise increase</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise reduction</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Health</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">United</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">insurance</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">States</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mexico</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Germany</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Netherlands</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zEDUq9rh3XRa" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zVxJCjigmxij" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zG1cuIY7cM9h" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zE824dE4tcri" title="Premise change">0.25</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zpHpgPh9zc8g" title="Premise change">0.25</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zAAis57LQZ62" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 32,758</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">5,536</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  1,646</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  5,477</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  297</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zJ66VfZA8hl8" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (39,621)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zoNGUagP0Gs8" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(6,605)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--MexicoMember_zZKYl2w5IW94" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,935)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zSmgAV63EmL5" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(5,836)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zUD2uG50Qxt2" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (315)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Real medical inflation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future salary levels</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zRPq1rB8lvFj" title="Premise change">0.5</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zJQr4VzVwp22" title="Premise change">0.5</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,604</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  468</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zEsXxJSuZgse" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(8,114)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (442)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zLiGcrX2WSF9" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zDnbudbfWxHk" title="Premise change">0.25</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pdd" title="Premise change">0.25</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zpuwpD6BMa84" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (7,740)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zD93GrQlQbl5" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,241</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  231</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zRrv7gKezHqf" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  8,098</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zdo6Fzj8HSCa" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(4,115)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (224)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Life expectancy</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zramBDyYbRob" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_ecustom--LifeExpectancy_dtY_c20220101__20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_z3TZOTUMiacg" title="Life expectancy">1</span> ano</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_ecustom--LifeExpectancy_dtY_c20220101__20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zPKdwwrROWJc" title="Life expectancy">1</span> ano</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zOkSbp6FZ5m3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> 48,527</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_za9OACZUHpr4" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  3,637</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zZm97x4Evt69" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  198</span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--HealthInsuranceMember_zdRu1u0NDUB4" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> (39,355)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--GermanyMember_zRqBZanOKoF5" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(3,797)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn3n3_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember__ifrs-full--DefinedBenefitPlansAxis__custom--NetherlandsMember_zKUpfyZAkMrh" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (207)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Mortality rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_zzxNxnPBcF7e" title="Premise change">10.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">n/a</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise increase"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">1,681</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMortalityRatesMember__ifrs-full--DefinedBenefitPlansAxis__custom--UnitedStatesOfAmericaMember_pn3n3" style="text-align: right" title="Premise reduction"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(1,839)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> n/a </span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 18%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 7%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="11" style="border-bottom: Black 0.5pt solid; text-align: right; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><b>Health insurance - Impact on cost of services and interests costs</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise change</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise increase</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Premise reduction</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Cost of</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Iterests</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">services</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">costs</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Discount rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zRwTid9zFask" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zVV38IA3CKme" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  730</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  106</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(933)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  11</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Life expectancy</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zCIIwjwpaofl" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zgnXWmKYyNll" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  542</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  4,441</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(464)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (3,602)</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">Rate of increase in future pension plan</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_ecustom--PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_z1Gu0biS5rSf" title="Premise change">1.0</span>%</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_ecustom--PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption_iI_pid_dp_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_zFQqmy3JlUik" title="Percentage of reasonably possible increase in interest cost actuarial assumption">1.0</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  123</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  708</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_98A_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">(129)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt"> </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_pn3n3" style="text-align: right" title="Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">  (741)</span></td></tr> </table> 0.010 0.010 0.010 0.0025 0.0025 32758000 5536000 1646000 5477000 297000 -39621000 -6605000 -1935000 -5836000 -315000 0.005 0.005 8604000 468000 -8114000 -442000 0.010 0.0025 0.25 -7740000 4241000 231000 8098000 -4115000 -224000 0.010 P1Y P1Y 48527000 3637000 198000 -39355000 -3797000 -207000 0.100 1681000 -1839000 0.010 0.010 730000 106000 -933000 11000 0.010 0.010 542000 4441000 -464000 -3602000 0.010 0.010 123000 708000 -129000 -741000 <p id="xdx_80B_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zafUTG5UDjJe" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>28 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_829_zqRBLmehFjy3">Equity</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.1 Capital</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On December 31, 2022 and 2021, the Company's subscribed and paid-up capital stock amounted to R$8,043,222 and comprised 797,207,834 shares with no par value, distributed as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclsoureOfSharesDistributedExplanatory_pn3n3_zLeL6CYIDeSk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_z9tsNH1xlzQ2" style="display: none">Schedule of shares distributed</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="15" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Amount of shares</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">class A</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">class B</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Novonor</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zC0d6QUNLVvd" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">226,334,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zdLvCV5gj4hj" title="Percent of shares outstanding">50.11</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zvzPhbG0KZV6" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  79,182,498</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zbBpZXZtdB7b" title="Percent of shares outstanding">22.95</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember_z2zslful3EY" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">305,517,121</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember_z7I8LavDOI3j" title="Percent of shares outstanding">38.32</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Petrobras</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4O08IHXnqLe" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">212,426,952</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zPrfko4doMo7" title="Percent of shares outstanding">47.03</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zT9su60pwZT5" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  75,761,739</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zDdmLGQY2Vo4" title="Percent of shares outstanding">21.96</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember_zCy2lPzcPYBh" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">288,188,691</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember_zrXKjY7G9Uuk" title="Percent of shares outstanding">36.15</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">ADR</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_fKGkp_zyKt6tH5ltbk" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  42,869,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_fKGkp_zulDVetbm1Ia" title="Percent of shares outstanding">12.42</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember_fKGkp_zgSWIsUKS6A1" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  42,869,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_907_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember_fKGkp_zVZuGadI1O8k" title="Percent of shares outstanding">5.38</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zWLUQRJFMryi" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,907,077</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90D_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zD03NNhlFkq5" title="Percent of shares outstanding">2.86</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zgxsYMK8MCE4" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">146,581,427</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z2iXzBo4bHz8" title="Percent of shares outstanding">42.48</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJx7LJRXzjA3" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zaULGGiKtd6g" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--Other2Member_zKbx3TCvTHv1" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">159,967,294</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--Other2Member_zC235FYwWnhi" title="Percent of shares outstanding">20.07</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zfL4tgumTskc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_909_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zSfLfXPGyKo8" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zE1GJ4NMRX99" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,394,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zy0HqOidJazb" title="Percent of shares outstanding">99.81</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zWhsoB3gteMf" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zgdtIkHKSgac" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zlI4vYq5TKic" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,542,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_z32r8EJDf2Dh" title="Percent of shares outstanding">99.92</span></span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Treasury shares</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zXT8dEBVh31g" style="vertical-align: bottom; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90E_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zQMjRf6AvBk2" title="Percent of shares outstanding">0.19</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_z9Q1tOQ27Fug" style="vertical-align: bottom; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_904_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zwPSZ2ng2QZ2" title="Percent of shares outstanding">0.08</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zctLst7g24Z5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z9iWlB1jBlG6" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zckmYEkzjpwd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,060,392</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zBZWvQiRPzz5" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zoRgtnNA1Wbf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zTnM6PsmTFF5" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231_zdUnEoNEliSg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231_zXcgZGQPwRq1" title="Percent of shares outstanding">100.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Authorised</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zMdZ123ZAeXd" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">535,661,731</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zvszTgChnOmh" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">616,682,421</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zRX7LbsKM7ac" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  593,818</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember_ztwfDCMDbXI" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,152,937,970</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> </table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F07_zNQ7WEgzArI1" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F18_zknnNfnnkrpl" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><i>American Depository Receipt </i>("ADR") on the New York Stock Exchange – NYSE (USA).</span></td></tr> </table> <p id="xdx_8A1_zyB9GFk0sGVh" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes in shares during the year:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclsoureOfChangesInSharesExplanatory_pn3n3_z52Iqit2DBZk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B2_zSaTaMcX81v1" style="display: none">Schedule of Changes in shares during the year</span></span></td> <td style="width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="9" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Amount of shares</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Commom shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zNMGRdFb6UL9" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zeobes7FXUuk" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z0zyAXVxBCR7" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class A </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">28.4</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfTIJXVxy6Fd" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">343,824,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zTfiYO1ltfV4" style="text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 333,432</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfVyVroqY0dh" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,158,226</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_ziBNUsH8aeCj" style="text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 236,758</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zE7QVT5Mrgli" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,394,984</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class B</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zdIFitz3x9ob" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zPcL8gNsfjZ5" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (21,440)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJnSyvxTZL28" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zBGJwso05bwh" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zkyZfMw4vwPh" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">795,993,676</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_z70cYEOkeAGj" style="font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  311,992</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zve4xQlTNTE2" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,305,668</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zav4OEcpaj2a" style="font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,758</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zSKbshKep6sa" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,542,426</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Treasury shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class A</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">28.4</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zBQBIKPrWHT" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,224,878</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zxfljaemTk13" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (322,712)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zvsjWyY8x2wb" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 902,166</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zvL3DAyKQb4i" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (236,758)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zmMRaIcV3mR1" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231_zmJe5xp1TVre" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,554</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ChangesInShares_iI_pid_c20211231_z3xVswOqoOh6" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,720)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231_znk33ACzeKU1" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231_zH1nNmuCIWkg" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td></tr> </table> <p id="xdx_8AB_zfWEMKupoAD8" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.2 Capital reserves</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">This reserve includes part of the shares issued in the Company’s several capital increases. This reserve can be used to absorb losses, to redeem, reimburse or purchase shares, and to incorporate into the capital stock.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.3 Profit reserves</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Legal reserve</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">Under Brazilian Corporation Law, companies must transfer 5% of net profit for the year to a legal reserve until this reserve is equivalent to 20% of the paid-up capital. The legal reserve can be used for capital increase or absorption of losses.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Tax incentive reserve</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 0 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">This reserve results from the allocation of part of net income for the year equivalent to tax incentives, arising from governmental subsidies (see Note 31). This reserve may only be used to offset losses with subsequent reconstitution or increase share capital.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 0 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; color: #009775; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Profit retention</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">Under Brazilian Corporation Law, portions of net income for the fiscal year may be allocated to reserves or retained based on the capital budget. Profits not allocated as such may be distributed to shareholders in the form of dividends. In 2022, this reserve was partially used to absorb losses for the year (Note 28.6).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.4 Share rights</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares carry no voting rights, but they ensure priority, non-cumulative annual dividend of 6% of their unit value, according to profits available for distribution. The unit value of the shares is obtained through the division of capital by the total number of outstanding shares. As common shares, only class “A” preferred shares will have the same claim on the remaining profit that exceeds the minimum mandatory dividend of 6% and will be entitled to dividends only after the priority dividend is paid to preferred shareholders. Only class “A” preferred shares also have the same claim as common shares on the distribution of shares resulting from capitalization of other reserves. Class “A” preferred shares can be converted into common shares upon resolution of majority voting shareholders present at a General Meeting. Class “B” preferred shares can be converted into class “A” preferred shares at any time, at the ratio of two class “B” preferred shares for one class “A” preferred share, upon a simple written request to the Company, provided that the non-transferability period provided for in specific legislation that allowed for the issue and payment of such shares with tax incentive funds has elapsed.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, 236,758 shares held in treasury were delivered to participants of the LTI Program 2019, which was fully settled in April 2022. In 2021, <span id="xdx_90E_ecustom--SharesGranted_pid_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--LTIProgram2018Member_zNtWYUlb2Rw2" title="Shares granted">322,712</span> shares were granted as payment of the LTI Program 2018.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.5 Payment of dividends</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">On April 19, 2022, the Annual and Extraordinary Shareholders Meeting approved distribution of the proposed additional dividends on the 2021 results, corresponding to R$1.696348838321 per outstanding common share and class “A” preferred share, in the amount of R$1.35 billion, payment of which was made as from May 2, 2022.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #FE5000"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #00A9E0; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>28.6 Accumulated losses</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">Accumulated losses in 2022 were absorbed as follows:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclsoureOfRetainedEarningsExplanatory_pn3n3_zaHBfGG4anz" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details 2)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zwupYz6yK784" style="display: none">Schedule of Accumulated losses</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Loss for the year of the Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ComprehensiveIncomeAttributableToOwnersOfParent1_pn3n3_c20220101__20221231_zsA58nTqu9I8" style="text-align: right" title="Loss for the year of the Companys shareholders"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Amounts posted directly to the Retained Earnings account:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SUDENE tax incentive supplement</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--SudeneTaxIncentiveSupplements_pn3n3_c20220101__20221231_zdpt3mqm4uA9" style="text-align: right" title="SUDENE tax incentive supplement"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (108,975)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Comprehensive income</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ComprehensiveIncome1_pn3n3_c20220101__20221231_zvMQrVnwict6" style="text-align: right" title="Comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,883</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherAccumulatedLosses_pn3n3_c20220101__20221231_zVw5ECli1K1c" style="text-align: right" title="Other"><span style="font-family: Calibri, Helvetica, Sans-Serif">  475</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LossForAllocation_pn3n3_c20220101__20221231_z7jqEmI5mmB4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Loss for allocation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(417,294)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Loss absorption using profit reserve:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit reserves - Retention of profits</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--AccumulatelossesAbsorption_pn3n3_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--ProfitReservesMember_zgJUr2aSFZZ8" style="text-align: right" title="Profit reserves retention of profits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 417,294</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AccumulatelossesAbsorption_pn3n3_c20220101__20221231_zSsEN4F8f6Fh" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Profit reserves retention of profits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  417,294</span></td></tr> </table> <p id="xdx_8A1_zUQVrGEJvAbb" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"> </p> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 1.15pt 9pt 14.2pt; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclsoureOfSharesDistributedExplanatory_pn3n3_zLeL6CYIDeSk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_z9tsNH1xlzQ2" style="display: none">Schedule of shares distributed</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 10%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="15" style="border-bottom: Black 0.5pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Amount of shares</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">class A</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">class B</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: red; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Novonor</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zC0d6QUNLVvd" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">226,334,623</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zdLvCV5gj4hj" title="Percent of shares outstanding">50.11</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zvzPhbG0KZV6" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  79,182,498</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zbBpZXZtdB7b" title="Percent of shares outstanding">22.95</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember_z2zslful3EY" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">305,517,121</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NovonorMember_z7I8LavDOI3j" title="Percent of shares outstanding">38.32</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Petrobras</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4O08IHXnqLe" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">212,426,952</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zPrfko4doMo7" title="Percent of shares outstanding">47.03</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zT9su60pwZT5" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  75,761,739</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zDdmLGQY2Vo4" title="Percent of shares outstanding">21.96</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember_zCy2lPzcPYBh" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">288,188,691</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PetrobrasMember_zrXKjY7G9Uuk" title="Percent of shares outstanding">36.15</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">ADR</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_fKGkp_zyKt6tH5ltbk" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  42,869,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_900_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_fKGkp_zulDVetbm1Ia" title="Percent of shares outstanding">12.42</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember_fKGkp_zgSWIsUKS6A1" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  42,869,320</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_907_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AdrsMember_fKGkp_zVZuGadI1O8k" title="Percent of shares outstanding">5.38</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zWLUQRJFMryi" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  12,907,077</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90D_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zD03NNhlFkq5" title="Percent of shares outstanding">2.86</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zgxsYMK8MCE4" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">146,581,427</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z2iXzBo4bHz8" title="Percent of shares outstanding">42.48</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJx7LJRXzjA3" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_908_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zaULGGiKtd6g" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--Other2Member_zKbx3TCvTHv1" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">159,967,294</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--Other2Member_zC235FYwWnhi" title="Percent of shares outstanding">20.07</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zfL4tgumTskc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_909_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zSfLfXPGyKo8" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zE1GJ4NMRX99" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,394,984</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zy0HqOidJazb" title="Percent of shares outstanding">99.81</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zWhsoB3gteMf" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90C_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zgdtIkHKSgac" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zlI4vYq5TKic" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,542,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_905_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_z32r8EJDf2Dh" title="Percent of shares outstanding">99.92</span></span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Treasury shares</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zXT8dEBVh31g" style="vertical-align: bottom; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90E_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zQMjRf6AvBk2" title="Percent of shares outstanding">0.19</span></span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_z9Q1tOQ27Fug" style="vertical-align: bottom; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_904_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zwPSZ2ng2QZ2" title="Percent of shares outstanding">0.08</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zctLst7g24Z5" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z9iWlB1jBlG6" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zckmYEkzjpwd" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,060,392</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zBZWvQiRPzz5" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zoRgtnNA1Wbf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_90B_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zTnM6PsmTFF5" title="Percent of shares outstanding">100.00</span></span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231_zdUnEoNEliSg" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  <span id="xdx_903_ecustom--PercentageOfSharesOutstanding_iI_pid_dp_c20221231_zXcgZGQPwRq1" title="Percent of shares outstanding">100.00</span></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Authorised</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zMdZ123ZAeXd" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">535,661,731</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zvszTgChnOmh" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">616,682,421</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zRX7LbsKM7ac" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">  593,818</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--AuthorisedMember_ztwfDCMDbXI" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,152,937,970</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> </table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F07_zNQ7WEgzArI1" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F18_zknnNfnnkrpl" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif"><i>American Depository Receipt </i>("ADR") on the New York Stock Exchange – NYSE (USA).</span></td></tr> </table> 226334623 0.5011 79182498 0.2295 305517121 0.3832 212426952 0.4703 75761739 0.2196 288188691 0.3615 42869320 0.1242 42869320 0.0538 12907077 0.0286 146581427 0.4248 478790 1.0000 159967294 0.2007 451668652 1.0000 344394984 0.9981 478790 1.0000 796542426 0.9992 665408 0.0019 665408 0.0008 451668652 1.0000 345060392 1.0000 478790 1.0000 797207834 1.0000 535661731 616682421 593818 1152937970 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclsoureOfChangesInSharesExplanatory_pn3n3_z52Iqit2DBZk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B2_zSaTaMcX81v1" style="display: none">Schedule of Changes in shares during the year</span></span></td> <td style="width: 25%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td> <td style="color: white"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="9" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>Amount of shares</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Note</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Changes</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Commom shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zNMGRdFb6UL9" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zeobes7FXUuk" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z0zyAXVxBCR7" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class A </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">28.4</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfTIJXVxy6Fd" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">343,824,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zTfiYO1ltfV4" style="text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 333,432</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfVyVroqY0dh" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,158,226</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_ziBNUsH8aeCj" style="text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 236,758</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zE7QVT5Mrgli" style="text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,394,984</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class B</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zdIFitz3x9ob" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zPcL8gNsfjZ5" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (21,440)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJnSyvxTZL28" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zBGJwso05bwh" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zkyZfMw4vwPh" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">795,993,676</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_z70cYEOkeAGj" style="font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  311,992</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zve4xQlTNTE2" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,305,668</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zav4OEcpaj2a" style="font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,758</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TotalMember_zSKbshKep6sa" style="font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,542,426</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Calibri, Helvetica, Sans-Serif"> Treasury shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred Class A</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">28.4</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zBQBIKPrWHT" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,224,878</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20211231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zxfljaemTk13" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (322,712)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zvsjWyY8x2wb" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 902,166</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ChangesInShares_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zvL3DAyKQb4i" style="border-bottom: Black 0.5pt solid; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (236,758)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231__ifrs-full--TypesOfFinancialAssetsAxis__ifrs-full--TreasurySharesMember_zmMRaIcV3mR1" style="border-bottom: Black 0.5pt solid; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 665,408</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--NumberOfSharesOutstanding1_iI_pid_c20201231_zmJe5xp1TVre" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,554</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ChangesInShares_iI_pid_c20211231_z3xVswOqoOh6" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Changes in shares"><span style="font-family: Calibri, Helvetica, Sans-Serif">(10,720)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--NumberOfSharesOutstanding1_iI_pid_c20211231_znk33ACzeKU1" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 2pt double; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  -</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesOutstanding1_iI_pid_c20221231_zH1nNmuCIWkg" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Shares outstanding"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,207,834</span></td></tr> </table> 451668652 451668652 451668652 343824794 333432 344158226 236758 344394984 500230 -21440 478790 478790 795993676 311992 796305668 236758 796542426 1224878 -322712 902166 -236758 665408 797218554 -10720 797207834 797207834 322712 <table border="0" cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclsoureOfRetainedEarningsExplanatory_pn3n3_zaHBfGG4anz" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details 2)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zwupYz6yK784" style="display: none">Schedule of Accumulated losses</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 17%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Loss for the year of the Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ComprehensiveIncomeAttributableToOwnersOfParent1_pn3n3_c20220101__20221231_zsA58nTqu9I8" style="text-align: right" title="Loss for the year of the Companys shareholders"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Amounts posted directly to the Retained Earnings account:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">SUDENE tax incentive supplement</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--SudeneTaxIncentiveSupplements_pn3n3_c20220101__20221231_zdpt3mqm4uA9" style="text-align: right" title="SUDENE tax incentive supplement"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (108,975)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Comprehensive income</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ComprehensiveIncome1_pn3n3_c20220101__20221231_zvMQrVnwict6" style="text-align: right" title="Comprehensive income"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,883</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--OtherAccumulatedLosses_pn3n3_c20220101__20221231_zVw5ECli1K1c" style="text-align: right" title="Other"><span style="font-family: Calibri, Helvetica, Sans-Serif">  475</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--LossForAllocation_pn3n3_c20220101__20221231_z7jqEmI5mmB4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Loss for allocation"><span style="font-family: Calibri, Helvetica, Sans-Serif">(417,294)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Loss absorption using profit reserve:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit reserves - Retention of profits</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--AccumulatelossesAbsorption_pn3n3_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--ProfitReservesMember_zgJUr2aSFZZ8" style="text-align: right" title="Profit reserves retention of profits"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 417,294</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--AccumulatelossesAbsorption_pn3n3_c20220101__20221231_zSsEN4F8f6Fh" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Profit reserves retention of profits"><span style="font-family: Calibri, Helvetica, Sans-Serif">  417,294</span></td></tr> </table> -335677000 -108975000 26883000 475000 -417294000 417294000 417294000 <p id="xdx_809_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zAZqVcV6IgB" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">29 <span id="xdx_82D_zrHxr9aGR4wi">Earnings (loss) per share</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic earnings (loss) per share is calculated by means of the division of profit (loss) for the year attributable to the Company’s common and preferred shareholders by the weighted average number of these shares held by shareholders, excluding those held in treasury and following the rules for the distribution of dividends provided for in the Company’s bylaws, as described in Note 28.4, particularly in relation to the limited rights enjoyed by class “B” preferred shares. The calculation of the diluted earnings (loss) per share is based on the weighted average of class “A” preferred shares, assuming the conversion of all preferred shares into treasury that would cause the dilution.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class A preferred shares participate in dividends with common shares after the mandatory dividends has been attributed in accordance with the formula provided for in the Company’s bylaws, as described in Note 28.4 and there is no highest limit for their participation.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The table below shows the reconciliation of profit or loss for the period adjusted for the amounts used to calculate basic and diluted earnings (losses) per share.</span></p> <p style="font: 13pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfEarningsPerShareReconciliationExplanatory_z632V26gHxue" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (Details)"> <tr style="vertical-align: bottom"> <td style="width: 40%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zt6IjRtGin8c" style="display: none">Schedule of reconciliation of profit or loss</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(Loss) profit  for the year attributed to Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20220101__20221231_zRxlpBJgOoZ7" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20220101__20221231_zfZhbZphUvMi" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20210101__20211231_z94vTfiyIcR8" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20210101__20211231_zngj9RQzFK1d" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20200101__20201231_z9v0zwViYZue" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20200101__20201231_z1ZIgUR1t7A9" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of priority dividends attributable to:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zCURdU94EFi" style="text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,574</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfZleLe0a9h9" style="text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_z0aJWpp3HeBh" style="text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zL7cJCvI0CSf" style="text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231_zthtHF3Hzc5h" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,864</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231_z5qZd5ICBLld" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,864</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of 6% ​​of unit price of common shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DistributionOfUnitValueOfCommonSharesBasic_pid_c20210101__20211231_zxafYf0K4mOb" style="text-align: right" title="Distribution of 6% ??ofunit price of common shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 273,729</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DistributionOfUnitValueOfCommonSharesDiluted_pid_c20210101__20211231_zGeo0Afwlhw" style="text-align: right" title="Distribution of 6% ??ofunit price of common shares, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 273,729</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of excess profits, by class:</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zpqLcbmGJy03" style="text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,664,208</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zphesmQVlA96" style="text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,664,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zajOwHAY23z7" style="text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,838,145</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z0WGqGTjdHL" style="text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,838,145</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231_zcfhRCSBY0V4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,502,353</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231_zg6wxAvjqQHe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,502,353</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reconciliation of income available for distribution, <br/> by class (numerator):</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zF9cFinNtrca" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (190,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zZNkPUVm9Il6" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (190,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zmNZAve4gemb" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,937,937</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zRPMqRC5KZoh" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,937,937</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zVNrfqRLl8Vj" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,797,070)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zNysjP9Ck8ia" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,797,071)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zpRGG9A1Sgd7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (145,118)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zjBU7VSVra46" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (145,118)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zOurMREOnhb9" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,046,719</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zegFOfMXmEYa" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,046,719</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z5nN2VX4shta" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,890,445)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zklzzI3ZkL1c" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,890,444)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zue2W3QWjlCi" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">(202)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_z2p5FgnpLEb7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">(202)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zXyQQW9z4R1j" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zhSfYz9OlNta" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zVPOpgJOXvI1" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,205)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zDbHQGHp8Ch7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,205)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231_zzfLxMKS0Ldj" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231_zKRJ8JSgB19f" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231_z1Ajp5XCXZ34" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231_zMD9omJQKPra" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231_zBKjIhBKxRjk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231_zaYV7hYASHul" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted average number of shares, <br/> by class (denominator):</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zjyEZ8NKjMG5" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zbRUUlcRlZBk" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zFpnk2GGGUMi" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zsEX9uxTP9ej" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zclvydRYQAB1" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zXsFCZNSKjqh" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zkDhIexO0Co2" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,329,470</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z3qI8VzA4qii" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,329,470</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_znjsO74c2ro" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,054,700</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFTHWqFM0sV8" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,049,701</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zda8cA1Ml4n4" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">343,823,811</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z6wuNWaVTuIl" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,049,672</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zQOXXq6nj4le" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zIKCvobweLUa" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJDdTGrcK958" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,171</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zhPfhWErB5Ck" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,171</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_ztwGljzidOq4" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zSmS6BORNml3" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231_zcXbBBKK31Al" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,476,912</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231_zduvRu3ucbUj" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,476,912</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231_z0WrRWlZr6Ea" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,223,523</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231_zPet3wkns0Sb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,524</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231_zMc5Hc2AeiKh" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">795,992,693</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231_ztGujBCrzaOg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,554</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) per share (in R$)</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4gUCkgviVT" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zEWaMcffL5C5" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zTuW1N0urzW9" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zUadrgiVA2c9" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4sVpHWihkJ" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z3EYuAG3CsVk" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zq0DCjtgree4" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zaE3A2n1jEii" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFQZKzRyBCX7" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zoQaSj8Y2Mwg" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.52</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zgWmsf1o2hjk" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z2RDqXyK4qe1" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.38)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zmODSu70wI4f" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zltySdcLWbQj" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_znxpUx7XiPNc" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 0.58</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zUNYSILOcNuf" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 0.58</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zxJfNcyRJfj9" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zGmQ6rY4JNt3" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b><span style="text-decoration: underline">Weighing of shares</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b/></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_495_20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zd86LX66ES36" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_498_20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zaXHKSdc7k01" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--OutstandingShares1_iS_zGmiDdYV72Je" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_zXoCYVBGl8H" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,758</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  171,244</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--OutstandingShares1_iE_zHeGE0lqxmJi" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,394,984</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,329,470</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_499_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zA9DwIbHpVR1" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_494_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zqksxDndLGm5" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_494_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zwiU5boJ7Leh" style="font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49D_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_ztmsKjNGvDf8" style="font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "B"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--OutstandingShares2_iS_zaZPQ9aSBrjk" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,230</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,230</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_zH40p61rvJF5" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  322,712</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  229,877</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl9059">-</span></b></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl9060">-</span></b></span></td></tr> <tr id="xdx_402_ecustom--ConversionSharesClassBIntoSharesClass_pid_zLdZacJYbcD3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion shares class "B" into shares class "A"</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,720</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  29</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (21,440)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(59)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OutstandingShares2_iE_zSbROkIrI1Rh" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,054,700</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">478,790</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,171</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_496_20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFgDkgJQBvj" style="color: white; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_498_20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zzPKiKwNLSH2" style="color: red; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--OutstandingShares3_iS_zbBwqa2lYtma" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,073</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,073</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_z0f7SnJtiDwj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,721</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">738</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_400_ecustom--OutstandingShares3_iE_zWPjbrCUzBb9" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,811</span></td></tr> </table> <p id="xdx_8A8_z69luzxPRUz3" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b> </span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DisclosureOfEarningsPerShareReconciliationExplanatory_z632V26gHxue" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (Details)"> <tr style="vertical-align: bottom"> <td style="width: 40%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zt6IjRtGin8c" style="display: none">Schedule of reconciliation of profit or loss</span></span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Diluted</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">(Loss) profit  for the year attributed to Company's shareholders</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20220101__20221231_zRxlpBJgOoZ7" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20220101__20221231_zfZhbZphUvMi" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20210101__20211231_z94vTfiyIcR8" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20210101__20211231_zngj9RQzFK1d" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent_pid_c20200101__20201231_z9v0zwViYZue" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent_pid_c20200101__20201231_z1ZIgUR1t7A9" style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of priority dividends attributable to:</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zCURdU94EFi" style="text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,574</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zfZleLe0a9h9" style="text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,574</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_z0aJWpp3HeBh" style="text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zL7cJCvI0CSf" style="text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DistributionOfUnitValueOPriorityDividendsBasic_pid_c20210101__20211231_zthtHF3Hzc5h" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of priority dividends attributable to basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,864</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--DistributionOfUnitValueOfPriorityDividendsDiluted_pid_c20210101__20211231_z5qZd5ICBLld" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of priority dividends attributable to diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 208,864</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 11pt; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of 6% ​​of unit price of common shares</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DistributionOfUnitValueOfCommonSharesBasic_pid_c20210101__20211231_zxafYf0K4mOb" style="text-align: right" title="Distribution of 6% ??ofunit price of common shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 273,729</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DistributionOfUnitValueOfCommonSharesDiluted_pid_c20210101__20211231_zGeo0Afwlhw" style="text-align: right" title="Distribution of 6% ??ofunit price of common shares, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 273,729</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Distribution of excess profits, by class:</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zpqLcbmGJy03" style="text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,664,208</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zphesmQVlA96" style="text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,664,208</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zajOwHAY23z7" style="text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,838,145</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z0WGqGTjdHL" style="text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,838,145</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DistributionOfPlusIncomeBasic_pid_c20210101__20211231_zcfhRCSBY0V4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of excess profits, by class basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,502,353</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DistributionOfPlusIncomeDiluted_pid_c20210101__20211231_zg6wxAvjqQHe" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Distribution of excess profits, by class diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,502,353</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="font-weight: bold; vertical-align: top"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reconciliation of income available for distribution, <br/> by class (numerator):</span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zF9cFinNtrca" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (190,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zZNkPUVm9Il6" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (190,357)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zmNZAve4gemb" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,937,937</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zRPMqRC5KZoh" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 7,937,937</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zVNrfqRLl8Vj" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,797,070)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zNysjP9Ck8ia" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,797,071)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zpRGG9A1Sgd7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (145,118)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zjBU7VSVra46" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (145,118)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zOurMREOnhb9" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,046,719</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zegFOfMXmEYa" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 6,046,719</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z5nN2VX4shta" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,890,445)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zklzzI3ZkL1c" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,890,444)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zue2W3QWjlCi" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">(202)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_z2p5FgnpLEb7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">(202)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zXyQQW9z4R1j" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zhSfYz9OlNta" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  290</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zVPOpgJOXvI1" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,205)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zDbHQGHp8Ch7" style="text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,205)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20220101__20221231_zzfLxMKS0Ldj" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20220101__20221231_zKRJ8JSgB19f" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (335,677)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20210101__20211231_z1Ajp5XCXZ34" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20210101__20211231_zMD9omJQKPra" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  13,984,946</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--ProfitLossAvailableForDistributionBasic_pid_c20200101__20201231_zBKjIhBKxRjk" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--ProfitLossAvailableForDistributionDiluted_pid_c20200101__20201231_zaYV7hYASHul" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Reconciliation of income available for distribution, by class (numerator), diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,691,720)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted average number of shares, <br/> by class (denominator):</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zjyEZ8NKjMG5" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zbRUUlcRlZBk" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zFpnk2GGGUMi" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zsEX9uxTP9ej" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zclvydRYQAB1" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zXsFCZNSKjqh" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">451,668,652</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zkDhIexO0Co2" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,329,470</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z3qI8VzA4qii" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,329,470</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_znjsO74c2ro" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">344,054,700</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFTHWqFM0sV8" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,049,701</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zda8cA1Ml4n4" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">343,823,811</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z6wuNWaVTuIl" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">345,049,672</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zQOXXq6nj4le" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zIKCvobweLUa" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 478,790</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zJDdTGrcK958" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,171</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zhPfhWErB5Ck" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,171</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_ztwGljzidOq4" style="text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zSmS6BORNml3" style="text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 500,230</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--WeightedAverageSharesBasic_pid_c20220101__20221231_zcXbBBKK31Al" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,476,912</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--WeightedAverageSharesDiluted_pid_c20220101__20221231_zduvRu3ucbUj" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,476,912</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--WeightedAverageSharesBasic_pid_c20210101__20211231_z0WrRWlZr6Ea" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">796,223,523</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--WeightedAverageSharesDiluted_pid_c20210101__20211231_zPet3wkns0Sb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,524</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--WeightedAverageSharesBasic_pid_c20200101__20201231_zMc5Hc2AeiKh" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average number of shares, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">795,992,693</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--WeightedAverageSharesDiluted_pid_c20200101__20201231_ztGujBCrzaOg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: right" title="Weighted average shares diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">797,218,554</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) per share (in R$)</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Common shares</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4gUCkgviVT" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zEWaMcffL5C5" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zTuW1N0urzW9" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_zUadrgiVA2c9" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z4sVpHWihkJ" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--CommonSharesMember_z3EYuAG3CsVk" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "A"</span></td> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zq0DCjtgree4" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zaE3A2n1jEii" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFQZKzRyBCX7" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.57</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zoQaSj8Y2Mwg" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  17.52</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zgWmsf1o2hjk" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_z2RDqXyK4qe1" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.38)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares class "B"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zmODSu70wI4f" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_ecustom--DilutedEarningsLossPerShare1_pid_c20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zltySdcLWbQj" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (0.42)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--BasicEarningsLossPerShare_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_znxpUx7XiPNc" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 0.58</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--DilutedEarningsLossPerShare1_pid_c20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zUNYSILOcNuf" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 0.58</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--BasicEarningsLossPerShare_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zxJfNcyRJfj9" style="text-align: right" title="Profit (loss) per share, basic"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--DilutedEarningsLossPerShare1_pid_c20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zGmQ6rY4JNt3" style="text-align: right" title="Profit (loss) per share, diluted"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (8.41)</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b><span style="text-decoration: underline">Weighing of shares</span></b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b/></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_495_20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zd86LX66ES36" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_498_20220101__20221231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zaXHKSdc7k01" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_409_ecustom--OutstandingShares1_iS_zGmiDdYV72Je" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_zXoCYVBGl8H" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  236,758</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  171,244</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_408_ecustom--OutstandingShares1_iE_zHeGE0lqxmJi" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,394,984</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,329,470</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: center; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_499_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zA9DwIbHpVR1" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_494_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zqksxDndLGm5" style="text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_494_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember_zwiU5boJ7Leh" style="font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_49D_20210101__20211231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassBPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_ztmsKjNGvDf8" style="font-weight: bold; text-align: center; background-color: white; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; color: white; font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "B"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--OutstandingShares2_iS_zaZPQ9aSBrjk" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,230</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,230</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_zH40p61rvJF5" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  322,712</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  229,877</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl9059">-</span></b></span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="display: none; font-family: Calibri, Helvetica, Sans-Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl9060">-</span></b></span></td></tr> <tr id="xdx_402_ecustom--ConversionSharesClassBIntoSharesClass_pid_zLdZacJYbcD3" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Conversion shares class "B" into shares class "A"</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,720</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  29</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (21,440)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(59)</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OutstandingShares2_iE_zSbROkIrI1Rh" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,158,226</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 344,054,700</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">478,790</span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">500,171</span></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #425563"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: left; width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_496_20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember_zFgDkgJQBvj" style="color: white; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_498_20200101__20201231__ifrs-full--ClassesOfOrdinarySharesAxis__custom--ClassAPreferenceSharesMember__ifrs-full--MeasurementAxis__ifrs-full--WeightedAverageMember_zzPKiKwNLSH2" style="color: red; font-weight: bold; text-align: center; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Basic</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Preferred shares</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Class "A"</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outstanding</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Weighted</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">shares</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">average</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: center; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--OutstandingShares3_iS_zbBwqa2lYtma" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at beginning of year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,073</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,073</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ConversionOfShares_pid_z0f7SnJtiDwj" style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Incentive long term plan payments with treasury shares</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,721</span></td> <td style="text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">738</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr id="xdx_400_ecustom--OutstandingShares3_iE_zWPjbrCUzBb9" style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif">Amount at the end of the year</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,824,794</span></td> <td style="font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right; background-color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 343,823,811</span></td></tr> </table> -335677 -335677 13984946 13984946 -6691720 -6691720 208574 208574 290 290 208864 208864 273729 273729 7664208 7664208 5838145 5838145 13502353 13502353 -190357 -190357 7937937 7937937 -3797070 -3797071 -145118 -145118 6046719 6046719 -2890445 -2890444 -202 -202 290 290 -4205 -4205 -335677 -335677 13984946 13984946 -6691720 -6691720 451668652 451668652 451668652 451668652 451668652 451668652 344329470 344329470 344054700 345049701 343823811 345049672 478790 478790 500171 500171 500230 500230 796476912 796476912 796223523 797218524 795992693 797218554 -0.42 -0.42 17.57 17.57 -8.41 -8.41 -0.42 -0.42 17.57 17.52 -8.41 -8.38 -0.42 -0.42 0.58 0.58 -8.41 -8.41 344158226000 344158226000 236758 171244 344394984000 344329470000 343824794000 343824794000 500230000 500230000 322712 229877 10720 29 -21440 -59 344158226000 344054700000 478790000 500171000 343823073000 343823073000 1721 738 343824794000 343823811000 <p id="xdx_800_eifrs-full--DisclosureOfRevenueExplanatory_zgXugdq30f6d" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif">30 <span id="xdx_825_zaiWSlUc9VCh">Net revenue</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfSalesAndServiceRevenueExplanatory_pn3n3_zr23oYNK8VV1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details)"> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_zVelh5btDZX8" style="display: none">Schedule of sales and service revenue</span></span></td> <td style="width: 44%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  96,519,284</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20210101__20211231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">105,625,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,543,494</span></td></tr> </table> <p id="xdx_8A8_zOicHMxCBivi" style="font: 12pt Bodoni Book 12pt; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Revenue from sales of products is recognized when the control of assets is transferred to the customer for an amount that reflects the consideration to which the Company expects to be entitled in exchange of these assets. The performance obligations are met at a specific moment in time. The Company does not make sales with continued management involvement. Most of the Company’s sales are made to industrial customers and, in a lower volume, to resellers.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 28.35pt"/><td style="width: 36pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The specific moment when the Company satisfies a performance obligation by transferring a promised good or service to the client is determined as follows: for contracts under which the Company is responsible for the freight and insurance, the legal right and the risks and benefits are transferred to the client when the risk of the goods is delivered at the destination established in the contract;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 28.35pt"/><td style="width: 36pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">(i)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(ii) for agreements under which the freight and insurance are a responsibility of the client, risks and benefits are transferred when the products are delivered to the client’s carrier; and for contracts under which product delivery involves the use of pipelines, especially basic petrochemicals, the risks and benefits are transferred immediately after the Company’s official markers, which is the point of delivery of the products and transfer of their ownership.</span></td></tr></table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Net revenue by country</b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfNetRevenueByCountryExplanatory_pn3n3_zvr2kHjIgCb9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zAS7duxBzapa" style="display: none">Schedule of revenue by country</span></span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 53%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,217,472</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_zBNJam6CZcD6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 55,830,330</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_znczgPxU9398" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 32,369,199</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">United States</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 18,085,607</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zgNex7qG8XK2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,232,413</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zcX7SMF84Rdg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,848,609</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,468,827</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zKgpC2wTJ893" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,505,893</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zoFTmI8Z335g" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,765,815</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentina</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ARMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,092,700</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ARMember_z39hHqHmhGwc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,068,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ARMember_zNzhBIl1T3E" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,267,967</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--DEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,695,009</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--DEMember_zZTa7nvoz6bl" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,912,373</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--DEMember_zTbhxkfnCuqf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,106,877</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Switzerland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zCEoNdB4y8y5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,492,922</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zeGfuCuo85K9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,230,541</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zD7lg5BrjNc3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">633,512</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Italy</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ITMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,095,133</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ITMember_zGoFRf7PUsu6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,304,113</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ITMember_zZ08evyHoKXj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">811,787</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">870,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CLMember_zxSKXG3TLFzk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,230,493</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CLMember_zsP3Oqf2vNTi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">544,329</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--NLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">816,678</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--NLMember_z4brVTP8moQa" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">642,844</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--NLMember_zE8PK73Remyk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">432,897</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Luxembourg</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--LUMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">756,297</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--LUMember_z8qG7jkUyj06" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">987,656</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--LUMember_z6Uh1f1dbRp8" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">592,777</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Singapore</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SGMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">755,971</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--SGMember_zuu2OnzsNz9b" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,175,133</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--SGMember_zjTJXg3o8X99" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,183,838</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Peru</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">740,011</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PEMember_zzaWNpBMMM04" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">666,867</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PEMember_zkO0Ml8poGjg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">471,847</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Japan</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--JPMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">723,757</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--JPMember_zMywdCk6mLS1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,162,226</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--JPMember_zZp3vGjuVNn6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">618,940</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Spain</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zuwMwQnTMPxe" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">546,646</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zVt2uTTcRBuj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">517,532</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zrX1EtBNpP25" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">282,362</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">United Kingdom</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--GBMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">490,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--GBMember_zhxVrQkN0mpg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">585,766</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--GBMember_zcVNHxy3vlT1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">204,953</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Uruguay</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--UYMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">469,555</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--UYMember_zLVCGyzYrYk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">495,120</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--UYMember_zpGuVWpitVrj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">405,946</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Poland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">455,458</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PLMember_zJ1jnpfgtXxl" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">649,825</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PLMember_zYQQaV6MRxXj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">285,714</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Bolivia</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--BOMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">427,237</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--BOMember_zc8Nwahwa4Af" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">296,138</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--BOMember_zS7oeXjEGJ4i" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">190,447</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Sweden</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">401,251</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--SEMember_zOGQAX5H4MO5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">481,289</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--SEMember_zfK2U1KMEjMf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">310,984</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Canada</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CAMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">393,504</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zNWxYKVMNQZ6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">558,730</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zqyCfB3cXEPi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">297,756</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">France</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--FRMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">359,946</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--FRMember_zFUyA3GOOIkd" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">326,570</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--FRMember_zJO18FxiPRLh" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">247,062</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Paraguay</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PYMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">316,460</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PYMember_zhvzdieTTuha" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">318,842</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PYMember_z4uEnapywj81" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">254,255</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Colombia</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--COMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">263,695</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--COMember_zuCY1dBzn0O9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">274,335</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--COMember_z8jFCT7rVh9l" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">174,381</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">China</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CNMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">172,656</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CNMember_zSk8pCT77vU2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">354,071</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CNMember_zFy3ioNZidk6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">496,920</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">South Korea</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--KRMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">159,944</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--KRMember_zDEtK9Vru5Ud" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">669,055</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--KRMember_zfC37GfEPNTb" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">360,704</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zKYmZcHvRzNg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,250,890</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_znLVH3P19Xz5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,149,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zNZVR6MVy5g9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,383,616</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231_zH1kG2rSPn23" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 96,519,284</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231_zxwuqArQDnO6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,625,201</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231_z9yjfuSzay75" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 58,543,494</span></td></tr> </table> <p id="xdx_8AE_z6Zy6tY98ihi" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Net revenue by product</b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfRevenueByProductExplanatory_pn3n3_z91zY9luQCS" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details 2)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BE_zo34haxwHJCf" style="display: none">Schedule of revenue by product</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 51%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">PE/PP</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,145,093</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_zBt9HPGltnmg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 73,306,089</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_zz06nJyFStwc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,137,288</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Benzene, toluene and xylene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,279,584</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_zRDHpatPqwq1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,819,696</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_zmzphdzvfz26" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,051,752</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Ethylene, Propylene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,819,345</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_zLZtSe6lpqPi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,872,999</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_zybFEixeZqJ2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,600,276</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">ETBE/Gasoline</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,722,767</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_zN1w8YGdPIIc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,321,371</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_zedOPXMPYeue" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,170,289</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">PVC/Caustic Soda/EDC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,710,838</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_zt8xEYiBkzaf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,806,011</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_zvzGBAL6GVE5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,134,617</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Butadiene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,028,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_zfClFbnGw4B2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,019,836</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_zzWmZAwi2ZB1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,372,428</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Solvents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,522,025</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_zsjhSZBINxej" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,129,484</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_z4419yxiPu5b" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">654,793</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Cumene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,425,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_zTdzuxqZzWS9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,342,811</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_zR7ufs8puOPf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">636,635</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Naphtha, condensate and crude oil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">422,359</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_z0ZJV3YOiFx6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,648,581</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_zs1g35CUjeu3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">915,807</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,444,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_zqb5F5DWnilc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,358,324</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_zIyo2zlOEWT2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,869,609</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20220101__20221231_zYtNBigDITck" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 96,519,284</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20210101__20211231_zQ1qfXE24376" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,625,201</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231_zCLH80eCy9I" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,543,494</span></td></tr> </table> <p id="xdx_8A0_zMXLowkcGwSe" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(c) Main clients</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company does not have any revenue arising from transactions with only one client that is equal to or higher than <span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20220101__20221231_zguHTeiY4NE6" title="Percentage of entity's revenue">10</span>% of its total net revenue. In 2022, the most significant revenue from a single client amounts to approximately <span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20220101__20221231__ifrs-full--MajorCustomersAxis__custom--OneClientMember_zg6NgXHe0pG2" title="Percentage of entity's revenue">2.4</span>% of total net revenues of the Company and refers to the sale of chemicals and resins.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfSalesAndServiceRevenueExplanatory_pn3n3_zr23oYNK8VV1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details)"> <tr style="vertical-align: bottom"> <td style="width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BF_zVelh5btDZX8" style="display: none">Schedule of sales and service revenue</span></span></td> <td style="width: 44%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 11%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  96,519,284</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20210101__20211231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">105,625,201</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231_pn3n3" style="border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net sales and services revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,543,494</span></td></tr> </table> 96519284000 105625201000 58543494000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfNetRevenueByCountryExplanatory_pn3n3_zvr2kHjIgCb9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B1_zAS7duxBzapa" style="display: none">Schedule of revenue by country</span></span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white; width: 53%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="color: white; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,217,472</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_zBNJam6CZcD6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 55,830,330</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--BrazilMember_znczgPxU9398" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 32,369,199</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">United States</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 18,085,607</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zgNex7qG8XK2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 24,232,413</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zcX7SMF84Rdg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 10,848,609</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,468,827</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zKgpC2wTJ893" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,505,893</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--MexicoMember_zoFTmI8Z335g" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,765,815</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Argentina</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ARMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,092,700</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ARMember_z39hHqHmhGwc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,068,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ARMember_zNzhBIl1T3E" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,267,967</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Germany</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--DEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,695,009</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--DEMember_zZTa7nvoz6bl" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,912,373</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--DEMember_zTbhxkfnCuqf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,106,877</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Switzerland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zCEoNdB4y8y5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,492,922</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zeGfuCuo85K9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,230,541</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CHMember_zD7lg5BrjNc3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">633,512</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Italy</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ITMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,095,133</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ITMember_zGoFRf7PUsu6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,304,113</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ITMember_zZ08evyHoKXj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">811,787</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Chile</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">870,858</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CLMember_zxSKXG3TLFzk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,230,493</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CLMember_zsP3Oqf2vNTi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">544,329</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Netherlands</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--NLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">816,678</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--NLMember_z4brVTP8moQa" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">642,844</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--NLMember_zE8PK73Remyk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">432,897</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Luxembourg</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--LUMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">756,297</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--LUMember_z8qG7jkUyj06" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">987,656</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--LUMember_z6Uh1f1dbRp8" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">592,777</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Singapore</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SGMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">755,971</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--SGMember_zuu2OnzsNz9b" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,175,133</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--SGMember_zjTJXg3o8X99" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,183,838</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Peru</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">740,011</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PEMember_zzaWNpBMMM04" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">666,867</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PEMember_zkO0Ml8poGjg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">471,847</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Japan</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--JPMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">723,757</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--JPMember_zMywdCk6mLS1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,162,226</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--JPMember_zZp3vGjuVNn6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">618,940</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Spain</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zuwMwQnTMPxe" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">546,646</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zVt2uTTcRBuj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">517,532</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--ESMember_zrX1EtBNpP25" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">282,362</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">United Kingdom</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--GBMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">490,801</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--GBMember_zhxVrQkN0mpg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">585,766</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--GBMember_zcVNHxy3vlT1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">204,953</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Uruguay</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--UYMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">469,555</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--UYMember_zLVCGyzYrYk" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">495,120</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--UYMember_zpGuVWpitVrj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">405,946</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Poland</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PLMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">455,458</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PLMember_zJ1jnpfgtXxl" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">649,825</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PLMember_zYQQaV6MRxXj" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">285,714</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Bolivia</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--BOMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">427,237</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--BOMember_zc8Nwahwa4Af" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">296,138</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--BOMember_zS7oeXjEGJ4i" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">190,447</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Sweden</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--SEMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">401,251</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--SEMember_zOGQAX5H4MO5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">481,289</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--SEMember_zfK2U1KMEjMf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">310,984</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Canada</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CAMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">393,504</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zNWxYKVMNQZ6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">558,730</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zqyCfB3cXEPi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">297,756</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">France</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--FRMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">359,946</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--FRMember_zFUyA3GOOIkd" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">326,570</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--FRMember_zJO18FxiPRLh" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">247,062</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Paraguay</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--PYMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">316,460</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--PYMember_zhvzdieTTuha" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">318,842</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--PYMember_z4uEnapywj81" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">254,255</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Colombia</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--COMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">263,695</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--COMember_zuCY1dBzn0O9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">274,335</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--COMember_z8jFCT7rVh9l" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">174,381</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">China</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--CNMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">172,656</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--CNMember_zSk8pCT77vU2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">354,071</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--CNMember_zFy3ioNZidk6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">496,920</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">South Korea</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--KRMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">159,944</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--KRMember_zDEtK9Vru5Ud" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">669,055</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--KRMember_zfC37GfEPNTb" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">360,704</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zKYmZcHvRzNg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,250,890</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_znLVH3P19Xz5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,149,023</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--GeographicalAreasAxis__custom--OtherMember_zNZVR6MVy5g9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,383,616</span></td></tr> <tr style="vertical-align: bottom"> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231_zH1kG2rSPn23" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 96,519,284</span></td> <td style="color: white; font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231_zxwuqArQDnO6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,625,201</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231_z9yjfuSzay75" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 58,543,494</span></td></tr> </table> 56217472000 55830330000 32369199000 18085607000 24232413000 10848609000 4468827000 5505893000 2765815000 2092700000 2068023000 1267967000 1695009000 1912373000 1106877000 1492922000 1230541000 633512000 1095133000 1304113000 811787000 870858000 1230493000 544329000 816678000 642844000 432897000 756297000 987656000 592777000 755971000 1175133000 1183838000 740011000 666867000 471847000 723757000 1162226000 618940000 546646000 517532000 282362000 490801000 585766000 204953000 469555000 495120000 405946000 455458000 649825000 285714000 427237000 296138000 190447000 401251000 481289000 310984000 393504000 558730000 297756000 359946000 326570000 247062000 316460000 318842000 254255000 263695000 274335000 174381000 172656000 354071000 496920000 159944000 669055000 360704000 2250890000 2149023000 1383616000 96519284000 105625201000 58543494000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfRevenueByProductExplanatory_pn3n3_z91zY9luQCS" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Net revenue (Details 2)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BE_zo34haxwHJCf" style="display: none">Schedule of revenue by product</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 51%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 5%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">PE/PP</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 61,145,093</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_zBt9HPGltnmg" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 73,306,089</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--PEPPMember_zz06nJyFStwc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 41,137,288</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Benzene, toluene and xylene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">7,279,584</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_zRDHpatPqwq1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,819,696</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--BenzeneTolueneAndXyleneMember_zmzphdzvfz26" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,051,752</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Ethylene, Propylene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,819,345</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_zLZtSe6lpqPi" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,872,999</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--EthylenePropyleneMember_zybFEixeZqJ2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,600,276</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">ETBE/Gasoline</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,722,767</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_zN1w8YGdPIIc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,321,371</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--ETBEGasolineMember_zedOPXMPYeue" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,170,289</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">PVC/Caustic Soda/EDC</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 5,710,838</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_zt8xEYiBkzaf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,806,011</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--PVCCausticSodaEDCMember_zvzGBAL6GVE5" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,134,617</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Butadiene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,028,048</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_zfClFbnGw4B2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,019,836</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--ButadieneMember_zzWmZAwi2ZB1" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,372,428</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Solvents</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,522,025</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_zsjhSZBINxej" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,129,484</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--SolventsMember_z4419yxiPu5b" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">654,793</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Cumene</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,425,097</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_zTdzuxqZzWS9" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,342,811</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--CumeneMember_zR7ufs8puOPf" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">636,635</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Naphtha, condensate and crude oil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">422,359</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_z0ZJV3YOiFx6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,648,581</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--NaphthaCondensateAndCrudeOilMember_zs1g35CUjeu3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">915,807</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 4,444,130</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_zqb5F5DWnilc" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,358,324</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--Other1Member_zIyo2zlOEWT2" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,869,609</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20220101__20221231_zYtNBigDITck" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 96,519,284</span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20210101__20211231_zQ1qfXE24376" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  105,625,201</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20200101__20201231_zCLH80eCy9I" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">  58,543,494</span></td></tr> </table> 61145093000 73306089000 41137288000 7279584000 5819696000 3051752000 5819345000 6872999000 3600276000 5722767000 4321371000 2170289000 5710838000 5806011000 3134617000 3028048000 3019836000 1372428000 1522025000 1129484000 654793000 1425097000 1342811000 636635000 422359000 1648581000 915807000 4444130000 2358324000 1869609000 96519284000 105625201000 58543494000 0.10 0.024 <p id="xdx_806_ecustom--DisclosureOfTaxIncentivesExplanatory_z2pgqMhIyQS6" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>31 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_82E_zLiPkGd2DKNk">Tax incentives</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) SUDENE–- IR</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Since 2015, the Company obtained grant in lawsuits claiming the reduction of <span id="xdx_906_eifrs-full--TaxRateEffectOfTaxLosses_pid_dp_c20220101__20221231_zzalCA7N51Ej" title="Percentage of tax reduction">75</span>% of IRPJ and additional taxes on income from the following industrial units: (i) PVC and Chlor-Alkali (<i>Cloro Soda</i>), established in the state of Alagoas; and (ii) Chemicals, PE, PVC and Chlor-Alkali units, established in the city of Camaçari (in Bahia State). The tax incentive granted by the Northeast Development Department (“SUDENE”) is calculated based on the Profit from Exploration of the incentivized activity, with an enjoyment period of <span id="xdx_909_ecustom--RealizationPeriod_dtY_c20220101__20221231_zjIREQrEtnNj" title="Realization period">10</span> years. In 2020, the operations in Brazil recorded tax loss, therefore it is not possible to make any deductions as a tax incentive.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2022, the Company recorded a tax loss and, for such reason, did not make use of tax benefits.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) PRODESIN–- ICMS</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has ICMS tax incentives granted by the state of Alagoas, through the state of Alagoas Integrated Development Program (“PRODESIN”), which are aimed at implementing and expanding a plant in that state.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company obtained a final and unappealable decision (Case No. 0042875-86.2015.4.01.3300) that exempted it from the payment of IR/CSL on tax incentives granted under PRODESIN, ensuring their treatment as a reducer of taxes on sales, in the period between the calendar years 2010 to 2017, in the accumulated amount of R$<span id="xdx_907_ecustom--TaxEffectOfRevenuesExemptFromTaxation_pn3n3_c20220101__20221231_zo9ITywPl7ag" title="ICMS tax incentives">425,913</span>. In 2022, the amount was R$<span id="xdx_90C_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_pn3n3_c20220101__20221231_zS0H5m7U2FO1" title="ICMS tax incentives">87,415</span> (2021: R$<span id="xdx_902_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_pn3n3_c20210101__20211231_zYBFBBqf3Aj9" title="ICMS tax incentives">176,284</span>).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> 0.75 P10Y 425913000 87415000 176284000 <p id="xdx_805_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zhmg6Jct0vye" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>32 </b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_82C_zV2Iv7vie0Nf">Expenses by nature and function</span></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory_pn3n3_zPpSP6UXaTrb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses by nature and function (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_8BA_zAFj2YzNv4v4" style="display: none">Schedule of Expenses by nature and function</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="3" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by nature:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Raw materials other inputs</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,181,706)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_zXl86xAoSwjc" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,570,499)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_z9VLGDQA5v48" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(37,913,921)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Personnel expenses</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,223,477)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_ziTTxcjFpGag" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,478,323)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_zsi9xJQVJhec" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,074,305)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outsourced services</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,411,818)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_zsmPo3oARbji" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,193,970)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_zoKk9H8HlNr3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,219,413)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation and amortization</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,733,165)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_zHgzyqVee3ya" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,178,433)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_zzlABjXgt3C1" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,048,081)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Freights</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,034,901)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_zZ1nHrNpVrk7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,966,229)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_zXXq26ptaFj3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,321,740)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Idle industrial plants</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (414,441)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_zMn54kpFuCad" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (338,987)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_zDGrj1zTfBql" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (518,528)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision - geological event in Alagoas (Note 26)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,520,019)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_z3QsKdKMSrJ6" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,339,765)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_zMYASd2x7lAg" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,901,828)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins credits - exclusion of ICMS from the calculation basis</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember_z0CsrnpevNQc" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,031,099</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember_z2cBaDBhmM73" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">310,557</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other income</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zKD0FCRjm2Pe" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">507,333</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zsSMzVpwuFHd" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,843,153</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zeY5AyMZGL7k" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">440,192</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other general and administrative expenses</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_zIIE5gBs0RRi" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,269,865)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_ztMKPwENzKH4" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,394,344)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_zzfizvtHPdh7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,348,921)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zaUIkI4njO95" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(92,282,059)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zNRGuFkEj5ni" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(79,586,298)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zOuyBRHUR0ya" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(58,595,988)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="3" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by function:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of products sold</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(85,160,548)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_zx8Q8p97Vdea" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,568,231)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_z47A1js6aMNa" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(47,331,414)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling and distribution</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,108,417)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_zfXRcOU5hIU5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,055,640)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_ztKF0KXIocJ" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,852,055)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">(Loss) reversals for impairment of trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (38,426)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_zSAJlkG5jUXh" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8,914)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_zbTFQAEfR5ok" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (55,252)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">General and administrative</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,763,983)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_z0E0ZA2OAZFl" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,522,127)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_zsscs5ei5Fi7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,918,747)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Research and development</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (374,493)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_z6Ara9v44Xfd" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (296,583)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_zup4JFEzc2Af" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (250,648)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other income (i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">507,333</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_fKGkp_zrgnHIPyLN64" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,534,487</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_fKGkp_z5DnmkBpSak" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">750,749</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other expenses (ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,343,525)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_fKGlpKQ_____zTYJvCI30EA5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,669,290)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_fKGlpKQ_____zcCGuQe1MsU5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,938,621)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_zKTHt8NgMfXe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(92,282,059)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_fKGlpKQ_____zOBZmu0OcVX" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(79,586,298)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_fKGlpKQ_____zoRpnYf4KwS7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(58,595,988)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_z47uwxgHbCHb" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1D_z6TTmeBH8X4f" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F04_zEeRlvY3mFWb" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F16_ztASxp736Rf6" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).</span></td></tr> </table> <p id="xdx_8A8_zs3s7YNNfjvj" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 35.45pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory_pn3n3_zPpSP6UXaTrb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses by nature and function (Details)"> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_8BA_zAFj2YzNv4v4" style="display: none">Schedule of Expenses by nature and function</span></span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 52%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 4%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="font-weight: bold; text-align: right; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-size: 8pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="3" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by nature:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Raw materials other inputs</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,181,706)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_zXl86xAoSwjc" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(63,570,499)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--RawMaterialsOtherInputsMember_z9VLGDQA5v48" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(37,913,921)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Personnel expenses</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,223,477)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_ziTTxcjFpGag" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,478,323)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PersonnelExpensesMember_zsi9xJQVJhec" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,074,305)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Outsourced services</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,411,818)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_zsmPo3oARbji" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,193,970)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OutsourcedServicesMember_zoKk9H8HlNr3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,219,413)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Depreciation and amortization</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,733,165)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_zHgzyqVee3ya" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,178,433)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--DepreciationAmortizationAndDepletionMember_zzlABjXgt3C1" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,048,081)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Freights</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,034,901)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_zZ1nHrNpVrk7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,966,229)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--FreightsMember_zXXq26ptaFj3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,321,740)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Idle industrial plants</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (414,441)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_zMn54kpFuCad" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (338,987)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--CostsOfIdleIndustrialPlantsMember_zDGrj1zTfBql" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (518,528)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Provision - geological event in Alagoas (Note 26)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,520,019)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_z3QsKdKMSrJ6" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,339,765)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--ProvisionGeologicalEventInAlagoasMember_zMYASd2x7lAg" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (6,901,828)</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="3" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">PIS and Cofins credits - exclusion of ICMS from the calculation basis</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember_z0CsrnpevNQc" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,031,099</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember_z2cBaDBhmM73" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">310,557</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other income</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zKD0FCRjm2Pe" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">507,333</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zsSMzVpwuFHd" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,843,153</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherIncomesMember_zeY5AyMZGL7k" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">440,192</span></td></tr> <tr> <td style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other general and administrative expenses</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_zIIE5gBs0RRi" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,269,865)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_ztMKPwENzKH4" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,394,344)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember__custom--TypeOfExpensesAxis__custom--OtherGeneralAndAdministrativeExpensesMember_zzfizvtHPdh7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,348,921)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zaUIkI4njO95" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(92,282,059)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zNRGuFkEj5ni" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(79,586,298)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--NatureMember_zOuyBRHUR0ya" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(58,595,988)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="3" style="font-weight: bold; vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Classification by function:</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of products sold</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(85,160,548)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_zx8Q8p97Vdea" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(73,568,231)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--CostOfProductsSoldMember_z47A1js6aMNa" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(47,331,414)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling and distribution</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,108,417)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_zfXRcOU5hIU5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,055,640)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--SellingAndDistributionMember_ztKF0KXIocJ" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,852,055)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">(Loss) reversals for impairment of trade accounts receivable</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (38,426)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_zSAJlkG5jUXh" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(8,914)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--LossReversalsForImpairmentOfTradeAccountsReceivableMember_zbTFQAEfR5ok" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (55,252)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">General and administrative</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,763,983)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_z0E0ZA2OAZFl" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,522,127)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--GeneralAndAdministrativeMember_zsscs5ei5Fi7" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,918,747)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Research and development</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (374,493)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_z6Ara9v44Xfd" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (296,583)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--ResearchAndDevelopmentMember_zup4JFEzc2Af" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (250,648)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other income (i)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">507,333</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_fKGkp_zrgnHIPyLN64" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,534,487</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherIncomeExpensesNetMember_fKGkp_z5DnmkBpSak" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">750,749</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="vertical-align: top; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other expenses (ii)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ExpenseByNature_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_pn3n3" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,343,525)</span></td> <td style="color: white; vertical-align: middle; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_fKGlpKQ_____zTYJvCI30EA5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,669,290)</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember__custom--TypeOfExpensesAxis__custom--OtherExpensesMember_fKGlpKQ_____zcCGuQe1MsU5" style="vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,938,621)</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-weight: bold; vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ExpenseByNature_pn3n3_c20220101__20221231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_zKTHt8NgMfXe" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(92,282,059)</span></td> <td style="color: white; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ExpenseByNature_pn3n3_c20210101__20211231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_fKGlpKQ_____zOBZmu0OcVX" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(79,586,298)</span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--ExpenseByNature_pn3n3_c20200101__20201231__custom--ClassificationOfExpensesAxis__custom--FunctionMember_fKGlpKQ_____zoRpnYf4KwS7" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; vertical-align: middle; text-align: right" title="Expenses, by nature"><span style="font-family: Calibri, Helvetica, Sans-Serif">(58,595,988)</span></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F0E_z47uwxgHbCHb" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F1D_z6TTmeBH8X4f" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif; color: black">In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576.</span></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F04_zEeRlvY3mFWb" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(ii)</span></td> <td style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span id="xdx_F16_ztASxp736Rf6" style="font-family: Calibri, Helvetica, Sans-Serif; color: black">Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008).</span></td></tr> </table> -73181706000 -63570499000 -37913921000 -3223477000 -3478323000 -3074305000 -3411818000 -3193970000 -2219413000 -4733165000 -4178433000 -4048081000 -4034901000 -2966229000 -2321740000 -414441000 -338987000 -518528000 -1520019000 -1339765000 -6901828000 1031099000 310557000 507333000 1843153000 440192000 -2269865000 -3394344000 -2348921000 -92282059000 -79586298000 -58595988000 -85160548000 -73568231000 -47331414000 -2108417000 -2055640000 -1852055000 -38426000 -8914000 -55252000 -2763983000 -2522127000 -1918747000 -374493000 -296583000 -250648000 507333000 1534487000 750749000 -2343525000 -2669290000 -7938621000 -92282059000 -79586298000 -58595988000 <p id="xdx_807_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zC2Ra8DhU0fl" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>33 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_826_zd4zGUe6SLt1">Financial results</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Transactions in foreign currencies are translated into the respective functional currency of the Company’s subsidiaries at the exchange rates in effect on the transaction dates.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Monetary assets and liabilities denominated and measured in foreign currency on the reporting date are re-translated into the functional currency at the exchange rate on said date. Non-monetary assets and liabilities measured at fair value in foreign currency are re-translated into the functional currency at the exchange rate on the date on which the fair value was determined. Non-monetary items that are measured based on the historical cost in foreign currencies are translated at the exchange rate on the date of the transaction. The differences in foreign currencies resulting from conversion are recognized in financial income or loss, unless the liability involves a cash flow hedge accounting relationship.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"/> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfFinancialResultsExplanatory_pn3n3_zlbRAhHTtwzc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial results (Details)"> <tr> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B2_zK1R6PanjUKc" style="display: none">Schedule of results by segment</span></span></td> <td style="vertical-align: bottom; width: 40%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial income</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_pn3n3" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,049,745</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_zz26Kp6UpZ6l" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  439,891</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_zcCFkfmweFbk" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  310,202</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Inflation indexation income on tax assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zCx6KopDBwU9" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,489</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zaafRimDxsFa" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,041,917</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zC4pZseXrU06" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  170,857</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain on derivatives</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--GainOnDerivativesMember_z0aurz27znIe" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  635,779</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--GainOnDerivativesMember_zYf3YNzmnwX7" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  246,459</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_pn3n3" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  308,121</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_zMzWgiiMPJV9" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 99,171</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_zpdSxULuNl0a" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,125</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231_zuv2LfabpUnc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,010,134</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231_zpTMUNXCLiE4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,827,438</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231_z8SLNjb6aNr9" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">600,184</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial expenses</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zDStNWBNWBwd" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,125,206)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zzsRj9GCZsK6" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,922,958)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zpITYPUNX70d" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,928,803)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Inflation indexation expenses on tax liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zLBjfyBRkEZ8" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(266,281)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zih7yLFb0bI5" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(93,722)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zClCZBS9gfc4" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(138,410)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Discounts granted</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zcQ0kq09vIv6" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(129,249)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zkx2Hh8MK3Pk" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(75,677)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zruAGUKUR5h1" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(81,920)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Loans transaction costs - amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_zHz0y3SXXg32" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(260,511)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_zxCGul7BpDW7" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(691,243)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_z6jitzXsTwGf" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(172,269)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Adjustment to present value - appropriation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_z3BuWeRoIyA8" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(580,994)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_zoCCzVuvP7q1" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(179,461)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_zV07cp54VN1h" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(225,889)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest expense on leases</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zPJVhm0axHtj" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(203,257)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zS09ZEJgzml7" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,536)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zUaD1AqgDa15" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,166)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Losses on derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zdZbFFYZdcd4" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(596,501)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zmzuzU8QMcfe" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,502)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zPDEktaQXr44" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(809,150)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_ztnmisUKi224" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(500,694)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_zzpjSR53Rq6b" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(767,056)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_zDyj6O7cKNok" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(392,758)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231_zD9j8aSJRqjf" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,662,693)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231_z080N5XMDRl2" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,907,155)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231_zUuCu5SDCtx1" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,913,365)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange rate variations, net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">On financial assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_c20220101__20221231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_pn3n3" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(522,251)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_zFfojKNgZSJg" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  230,370</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_zc9oPU3GCPe4" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  336,527</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">On financial liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_c20220101__20221231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_pn3n3" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (49,919)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_zDk6zgu9H3B1" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,233,177)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_zVJoCEcKnIbf" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,635,238)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20220101__20221231_zDe9hGmhXBeg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (572,170)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231_zWjN2O62hpC3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (4,002,807)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231_zYJUbUz6Ltxb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,298,711)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinanceIncomeCost_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (4,224,729)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231_zX7EVRI5pld4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (8,082,524)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231_zqCHYcirlMF1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (9,611,892)</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F00_zIqhQPnaeHNc" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F13_zcpr1sSZ8S11" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).</span></td></tr> </table> <p id="xdx_8AD_zKvj7sh42gBj" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The effects from exchange variation on the Company’s transactions are mainly due to the variations in the following currencies:</span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock_pn3n3_zqKq9giru203" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial results (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B6_zli0YWI3rrGe" style="display: none">Schedule of effects from exchange variation on the Companyàtransactions are mainly due to the variations</span></span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">End of year rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="9" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Average rate</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Variation</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dec/20</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022-2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021-2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Brazilian real</span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z0cxzlO2LTA2" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.2177</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zve5wOckmJf8" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.5805</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zn3d9asTcPY2" title="Closing foreign exchange rate variations">-6.50</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z4FILDX9g2A6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.1655</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zwAgyh6kU9c6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.3956</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_znncigV4xLyj" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.1578</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zrLT2OKugmo5" title="Average foreign exchange rate variations">-4.26</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z8Uc2U2pJrJe" title="Average foreign exchange rate variations">4.61</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Euro - Brazilian real</span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zdpIAyFKNPSk" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.5694</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zCkCDDwBkkuj" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">6.3210</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zkp6IJs5TSk6" title="Closing foreign exchange rate variations">-11.89</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_ziJTKNcVRd7f" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.4420</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zuC8k31mpnQl" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">6.3784</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_z1wZmXY1oZh6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.8989</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zNNvZYbZzKtg" title="Average foreign exchange rate variations">-14.68</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_z3QWuJ5zkqAd" title="Average foreign exchange rate variations">8.13</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexican peso - Brazilian real</span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zSAjTESvLvIj" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2667</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zci3recUh2Ma" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2730</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zmuyfgdRN9yk" title="Closing foreign exchange rate variations">-2.31</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zwN4PX66BRii" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2569</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_z9qSVDSCp7hc" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2660</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zujh1LZra4Q4" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2402</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zHUU37bc0Qb2" title="Average foreign exchange rate variations">-3.44</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zR79bu7GPie3" title="Average foreign exchange rate variations">10.75</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Mexican peso</span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zfhp6mFiFZG7" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">19.5720</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zq8aWbphBv39" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.4519</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zimJRhgbjKAl" title="Closing foreign exchange rate variations">-4.30</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zvyZyd5oydu7" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1249</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zxCbcDkkpJA3" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.2900</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zHbElph1kz1e" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">21.5098</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zuJ152CJiBSi" title="Average foreign exchange rate variations">-0.81</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zDgRwLEOMaB8" title="Average foreign exchange rate variations">-5.67</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Euro</span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zpp9A0JhyLwi" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.9416</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zo3ymUxJrRb5" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8853</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zOA428o6yYl4" title="Closing foreign exchange rate variations">6.36</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zlZHKCzmpqt4" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.9510</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_z8KBXpVbqoQ8" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8458</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zv4iNQEBC5yh" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8775</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zLDl5JBBtRZ9" title="Average foreign exchange rate variations">12.44</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_z2x7pzrfwCIi" title="Average foreign exchange rate variations">-3.61</span>%</span></td></tr> </table> <p id="xdx_8AF_zOoITofKk2o1" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfFinancialResultsExplanatory_pn3n3_zlbRAhHTtwzc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial results (Details)"> <tr> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 14%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B2_zK1R6PanjUKc" style="display: none">Schedule of results by segment</span></span></td> <td style="vertical-align: bottom; width: 40%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: bottom; width: 6%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="vertical-align: bottom; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; vertical-align: middle; width: 12%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial income</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest income</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_pn3n3" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,049,745</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_zz26Kp6UpZ6l" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  439,891</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestIncomeMember_zcCFkfmweFbk" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  310,202</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Inflation indexation income on tax assets</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zCx6KopDBwU9" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 16,489</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zaafRimDxsFa" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,041,917</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnTaxCreditsMember_fKGkp_zC4pZseXrU06" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  170,857</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gain on derivatives</span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--GainOnDerivativesMember_z0aurz27znIe" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  635,779</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--GainOnDerivativesMember_zYf3YNzmnwX7" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  246,459</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceIncome_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_pn3n3" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  308,121</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_zMzWgiiMPJV9" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 99,171</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialIncomeMember_zpdSxULuNl0a" style="text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">  119,125</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231_zuv2LfabpUnc" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,010,134</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231_zpTMUNXCLiE4" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,827,438</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceIncome_pn3n3_c20200101__20201231_z8SLNjb6aNr9" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance income"><span style="font-family: Calibri, Helvetica, Sans-Serif">600,184</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Financial expenses</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zDStNWBNWBwd" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(3,125,206)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zzsRj9GCZsK6" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,922,958)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--FinancialInterestExpensesMember_zpITYPUNX70d" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,928,803)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Inflation indexation expenses on tax liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zLBjfyBRkEZ8" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(266,281)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zih7yLFb0bI5" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(93,722)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--MonetaryVariationsOnFiscalDebtsMember_zClCZBS9gfc4" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(138,410)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Discounts granted</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zcQ0kq09vIv6" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(129,249)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zkx2Hh8MK3Pk" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(75,677)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--DiscountsGrantedMember_zruAGUKUR5h1" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(81,920)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Loans transaction costs - amortization</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_zHz0y3SXXg32" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(260,511)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_zxCGul7BpDW7" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(691,243)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--LoansTransactionCostsMember_z6jitzXsTwGf" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(172,269)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Adjustment to present value - appropriation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_z3BuWeRoIyA8" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(580,994)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_zoCCzVuvP7q1" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(179,461)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--AdjustmentToPresentValueMember_zV07cp54VN1h" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(225,889)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Interest expense on leases</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zPJVhm0axHtj" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(203,257)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zS09ZEJgzml7" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(173,536)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--InterestExpenseOnLeasesMember_zUaD1AqgDa15" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(164,166)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Losses on derivatives</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zdZbFFYZdcd4" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(596,501)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zmzuzU8QMcfe" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,003,502)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--LossesOnDerivativesMember_zPDEktaQXr44" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(809,150)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_ztnmisUKi224" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(500,694)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_zzpjSR53Rq6b" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(767,056)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231__custom--FinancialIncomeExpenseAxis__custom--OtherFinancialExpensesMember_zDyj6O7cKNok" style="text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(392,758)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--FinanceCosts_iN_pn3n3_di_c20220101__20221231_zD9j8aSJRqjf" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,662,693)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--FinanceCosts_iN_pn3n3_di_c20210101__20211231_z080N5XMDRl2" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,907,155)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceCosts_iN_pn3n3_di_c20200101__20201231_zUuCu5SDCtx1" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Finance costs"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,913,365)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-weight: bold; font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Exchange rate variations, net</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">On financial assets</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_c20220101__20221231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_pn3n3" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(522,251)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_zFfojKNgZSJg" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  230,370</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialAssetsMember_zc9oPU3GCPe4" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  336,527</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="2" style="font-family: Calibri, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">On financial liabilities</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_c20220101__20221231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_pn3n3" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (49,919)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_zDk6zgu9H3B1" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(4,233,177)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231__custom--FinancialIncomeExpenseAxis__ifrs-full--FinancialLiabilitiesMember_zVJoCEcKnIbf" style="text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif">(5,635,238)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20220101__20221231_zDe9hGmhXBeg" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (572,170)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20210101__20211231_zWjN2O62hpC3" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (4,002,807)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_pn3n3_c20200101__20201231_zYJUbUz6Ltxb" style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gains (losses) on exchange differences on translation of foreign operations, before tax"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,298,711)</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--FinanceIncomeCost_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (4,224,729)</span></td> <td style="color: white"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--FinanceIncomeCost_pn3n3_c20210101__20211231_zX7EVRI5pld4" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (8,082,524)</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--FinanceIncomeCost_pn3n3_c20200101__20201231_zqCHYcirlMF1" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Finance income (cost)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (9,611,892)</span></td></tr> </table> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 9pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-bottom: 9pt"> <tr style="vertical-align: top"> <td id="xdx_F00_zIqhQPnaeHNc" style="padding-left: 10pt; text-indent: -0.01pt; width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif">(i)</span></td> <td id="xdx_F13_zcpr1sSZ8S11" style="padding-left: 10pt; text-indent: -0.01pt; width: 97%"><span style="font-family: Calibri, Helvetica, Sans-Serif">In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b).</span></td></tr> </table> 1049745000 439891000 310202000 16489000 1041917000 170857000 635779000 246459000 308121000 99171000 119125000 2010134000 1827438000 600184000 3125206000 2922958000 2928803000 266281000 93722000 138410000 129249000 75677000 81920000 260511000 691243000 172269000 580994000 179461000 225889000 203257000 173536000 164166000 596501000 1003502000 809150000 500694000 767056000 392758000 5662693000 5907155000 4913365000 -522251000 230370000 336527000 -49919000 -4233177000 -5635238000 -572170000 -4002807000 -5298711000 -4224729000 -8082524000 -9611892000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock_pn3n3_zqKq9giru203" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial results (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; width: 29%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8B6_zli0YWI3rrGe" style="display: none">Schedule of effects from exchange variation on the Companyàtransactions are mainly due to the variations</span></span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">End of year rate</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="9" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Average rate</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; border-top-color: Black; border-top-width: 0.5pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Variation</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Variation</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Dec/20</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022-2021</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021-2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Brazilian real</span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z0cxzlO2LTA2" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.2177</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zve5wOckmJf8" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.5805</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zn3d9asTcPY2" title="Closing foreign exchange rate variations">-6.50</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z4FILDX9g2A6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.1655</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zwAgyh6kU9c6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.3956</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_znncigV4xLyj" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.1578</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_zrLT2OKugmo5" title="Average foreign exchange rate variations">-4.26</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarBrazilianRealMember_z8Uc2U2pJrJe" title="Average foreign exchange rate variations">4.61</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Euro - Brazilian real</span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zdpIAyFKNPSk" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.5694</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zCkCDDwBkkuj" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">6.3210</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zkp6IJs5TSk6" title="Closing foreign exchange rate variations">-11.89</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_ziJTKNcVRd7f" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.4420</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zuC8k31mpnQl" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">6.3784</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_z1wZmXY1oZh6" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">5.8989</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_zNNvZYbZzKtg" title="Average foreign exchange rate variations">-14.68</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--EuroBrazilianRealMember_z3QWuJ5zkqAd" title="Average foreign exchange rate variations">8.13</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexican peso - Brazilian real</span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zSAjTESvLvIj" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2667</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zci3recUh2Ma" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2730</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zmuyfgdRN9yk" title="Closing foreign exchange rate variations">-2.31</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zwN4PX66BRii" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2569</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_z9qSVDSCp7hc" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2660</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zujh1LZra4Q4" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.2402</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zHUU37bc0Qb2" title="Average foreign exchange rate variations">-3.44</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90E_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--MexicanPesoBrazilianRealMember_zR79bu7GPie3" title="Average foreign exchange rate variations">10.75</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Mexican peso</span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zfhp6mFiFZG7" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">19.5720</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zq8aWbphBv39" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.4519</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zimJRhgbjKAl" title="Closing foreign exchange rate variations">-4.30</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zvyZyd5oydu7" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.1249</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zxCbcDkkpJA3" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">20.2900</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zHbElph1kz1e" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">21.5098</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90C_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zuJ152CJiBSi" title="Average foreign exchange rate variations">-0.81</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarMexicanPesoMember_zDgRwLEOMaB8" title="Average foreign exchange rate variations">-5.67</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">U.S. dollar - Euro</span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zpp9A0JhyLwi" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.9416</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pid_c20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zo3ymUxJrRb5" style="text-align: right" title="Closing foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8853</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--ClosingForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zOA428o6yYl4" title="Closing foreign exchange rate variations">6.36</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pid_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zlZHKCzmpqt4" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.9510</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pid_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_z8KBXpVbqoQ8" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8458</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pid_c20200101__20201231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zv4iNQEBC5yh" style="text-align: right" title="Average foreign exchange rate"><span style="font-family: Calibri, Helvetica, Sans-Serif">0.8775</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_906_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20220101__20221231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_zLDl5JBBtRZ9" title="Average foreign exchange rate variations">12.44</span>%</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--AverageForeignExchangeRateVariations_pid_dp_c20210101__20211231__custom--ExchangeVariationEffectsAxis__custom--USDollarEuroMember_z2x7pzrfwCIi" title="Average foreign exchange rate variations">-3.61</span>%</span></td></tr> </table> 5.2177 5.5805 -0.0650 5.1655 5.3956 5.1578 -0.0426 0.0461 5.5694 6.3210 -0.1189 5.4420 6.3784 5.8989 -0.1468 0.0813 0.2667 0.2730 -0.0231 0.2569 0.2660 0.2402 -0.0344 0.1075 19.5720 20.4519 -0.0430 20.1249 20.2900 21.5098 -0.0081 -0.0567 0.9416 0.8853 0.0636 0.9510 0.8458 0.8775 0.1244 -0.0361 <p id="xdx_80C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zz6JMcKcCGE8" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>34 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_82B_zlP7i0Plv851">Segment information</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company’s organizational structure is formed by the following segments:</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 21.3pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <b>Brazil: </b>includes: (i) the production and sale of chemicals at the Camaçari Petrochemical Complex in Bahia, the Triunfo Petrochemical Complex in Rio Grande do Sul, the Capuava Petrochemical Complex in the state of São Paulo, and the Duque de Caxias Petrochemical Complex in the state of Rio de Janeiro; (ii) the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; (iii) the production and sale of PE, including the production of green PE made from renewable resources, and of PP; and (iv) the production and sale of PVC and caustic soda.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 21.3pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <b>United States and Europe: </b>operations related to PP production and sale in the United States and Europe, through the subsidiaries Braskem America and Braskem Alemanha, respectively.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 21.3pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <b>Mexico: </b>comprises the activities relation to the PE production and sale in Mexico, through the subsidiary Braskem Idesa.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 21.3pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">- <b>Other segments:</b> substantially comprises the activities of Cetrel.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(a) Presentation, measurement and reconciliation of segment results</b></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Information by segment is generated in accounting records, which are reflected in the consolidated financial statements. The operating segments are stated based on the results of operations.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The eliminations and reclassifications line are mainly represented by purchases and sales between the Company’s reportable segments.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate Unit comprises items not allocated directly to the reportable segments and are disclosed to reconcile the segments to the consolidated financial information.</span></p> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 50.2pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Results by segment</b></span></p> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 50.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"/></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfResultsBySegmentExplanatory_pn3n3_zpGmaWaLrfvf" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BB_zRagn3ndzdI2" style="display: none">Schedule of Results by segment</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 26%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,079,724</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_ziGmnzOUI9Z9" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (63,195,629)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,884,095</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,853,039)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,888,999)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,142,057</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,421,096</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zJWryB9dfmNa" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,986,176)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,434,920</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (838,474)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,944</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,653,390</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,834,017</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zktZBOKVtJp8" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,069,531)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">764,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (451,605)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (33,370)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  279,511</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">98,334,837</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zsyZkmZqAcf7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (88,251,336)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,083,501</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,143,118)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,865,425)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,074,958</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">402,991</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_z6CRKWdUU7se" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (262,402)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">140,589</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">82,498</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  263,579</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,196,506)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 19,375</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,177,131)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">98,737,828</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zB1vaA3KQgvk" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (88,513,738)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,224,090</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,257,126)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,840,406)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,161,406</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,218,544)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zIZ5zndN03Ig" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,353,190</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,134,646</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (28,193)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,214</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,110,667</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20220101__20221231_zRWlcg54D9N3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">96,519,284</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231_zWmxYrwF0vwa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (85,160,548)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,358,736</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,285,319)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,836,192)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,272,073</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_z7eV0myz1C68" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,494,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_z8Frd02tL3S4" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (49,309,552)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zRcRGlFKIUxc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">20,185,371</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zuT5AHzeG00c" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,608,185)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zxYljbQSeuc8" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,210,601)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zts0FCqsSeD7" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,366,585</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zYgEJWuGsDVa" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,403,632</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zWcni8M6JTG5" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (23,343,205)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zOFzOIdjz3pc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,060,427</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zNF8yXO2NLpl" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (900,885)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zKOEGZtNExQ9" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (25,580)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zjUtL2QFKOql" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,133,962</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zVBGQeAR6dX6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,506,297</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zcxVBj71lOwd" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,413,652)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zru2WP8olSx" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,092,645</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zQOynocIketa" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (471,821)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_ze2dncV26vze" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,302)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zThLftuSAXJf" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,605,522</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zO7p533KDX06" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 108,404,852</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zG0FdxzKpHrk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (76,066,409)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zQdWj6VgZvIe" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,338,443</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zjKZergaHFZ" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,980,891)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zqpVsddWGnqe" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,251,483)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zqXXN9KIIBz" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,106,069</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zrMvDNV9apNb" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">363,684</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zQgVYo36JgL8" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (233,084)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zXBqlnl2Qdwk" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">130,600</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zNKTPTxLWMn5" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,830</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zheR3ubzn6c6" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_z9co7poInPli" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (28,674)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zixAmsCO7Txe" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  183,400</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_zI8uCi6X2GQ4" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,963,137)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_zcsEDoroiac" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,161,517</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_fKGkp_zHEpk2yqJrt5" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (801,620)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zrkaGYS3riJ6" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 108,768,536</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zSBLfIzOjDje" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (76,299,493)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zXWLKIGo0ora" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,469,043</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_znQmARC3Yz4d" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,867,198)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zhU7Y6jx5n4c" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zgXz2IWRaKRb" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,118,640)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zE7g22EpVYx7" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,487,849</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zMsRHjlj7W63" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,143,335)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_z0JDJ9xGTy76" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,731,262</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zxLu8RKGGjxc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (412,073)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zMkS3ZrkHsNi" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (16,066)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zv5Qy5a8SYc5" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,163)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_z7B3mBvqdSDc" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (444,302)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231_zlpCou0ulOJ9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 105,625,201</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231_zonutI9wRJJ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (73,568,231)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20210101__20211231_z97o5SuOuJIb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,056,970</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231_zQIWrREL2rlk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,883,264)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231_zX8mBg5CFwUf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231_ziM6B8p9QpSi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,134,803)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231_zph3stnunE3c" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,043,547</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">40,794,387</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zIv3STRdAHG" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (32,498,003)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,296,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,471,722)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,082,604)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (257,942)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,638,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_z1zsTGndJ6ug" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (12,337,486)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,301,174</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (721,191)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (82,695)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,497,288</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,000,805</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zE1cLBzfA1q7" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,075,001)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">925,804</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (436,859)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">(364,259)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  124,686</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">59,433,852</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zKUaumsD9zRj" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (47,910,490)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,523,362</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,629,772)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,529,558)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,364,032</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">302,374</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zQAbVTzxM6w2" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (188,350)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">114,024</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">63,874</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (320)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  158,180</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,493,479)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 359,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,134,408)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">59,736,226</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zJWDdqetHWA3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (48,098,840)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,637,386</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,059,377)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,170,807)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,804</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,192,732)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zTx2bIV29gla" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">767,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (425,306)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (17,325)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (17,065)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (459,696)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231_zYv727qbqIzb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,543,494</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231_zB9o1zeuUhp2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (47,331,414)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,212,080</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,076,702)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,187,872)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(71,892)</span></td></tr> </table> <p id="xdx_8A2_z1wq8siwnlub" style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 50.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 9pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 50.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">See comment in Note 32(i).</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #FE5000; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b>(b) Property, plant and equipment and intangible assets by segment</b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory_pn3n3_zQAstl9LDp1d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zBZAp3wXV8Zj" style="display: none">Schedule of property, plant and equipment and intangible assets by segment</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">19,428,926</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_znyOuWSGZ2uh" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,072,312</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,075,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zVU93Bs830D3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,688,713</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,736,298</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zMVbHagTdRpl" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,019,167</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,240,967</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zwlfwVF5ACKk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,780,192</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Unallocated amounts</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--UnallocatedMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  544,472</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--UnallocatedMember_zN7ETvdh2vhf" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  322,237</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,785,439</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231_zQPKNiyLF0cf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,102,429</span></td></tr> </table> <p id="xdx_8AC_zWfLi8iqcAuc" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> <p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0057B8"><span style="font-family: Calibri, Helvetica, Sans-Serif"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfResultsBySegmentExplanatory_pn3n3_zpGmaWaLrfvf" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> <span id="xdx_8BB_zRagn3ndzdI2" style="display: none">Schedule of Results by segment</span></span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 26%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 8%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 9%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold; width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right; width: 13%"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,079,724</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_ziGmnzOUI9Z9" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (63,195,629)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,884,095</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,853,039)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,888,999)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,142,057</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">23,421,096</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zJWryB9dfmNa" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,986,176)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,434,920</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (838,474)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 56,944</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,653,390</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,834,017</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zktZBOKVtJp8" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (5,069,531)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">764,486</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (451,605)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (33,370)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  279,511</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">98,334,837</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zsyZkmZqAcf7" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (88,251,336)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,083,501</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (3,143,118)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,865,425)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  5,074,958</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">402,991</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_z6CRKWdUU7se" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (262,402)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">140,589</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">82,498</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">5,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  263,579</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,196,506)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 19,375</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(2,177,131)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">98,737,828</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zB1vaA3KQgvk" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (88,513,738)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">10,224,090</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,257,126)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,840,406)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  3,161,406</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--Revenue_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (2,218,544)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zIZ5zndN03Ig" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,353,190</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--GrossProfit_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">1,134,646</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (28,193)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,214</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,110,667</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20220101__20221231_zRWlcg54D9N3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">96,519,284</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_ecustom--CostOfProductsSold_pn3n3_c20220101__20221231_zWmxYrwF0vwa" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (85,160,548)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,358,736</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--SellingGeneralAndAdministrativeExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (5,285,319)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 34,848</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,836,192)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20220101__20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  4,272,073</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_z7eV0myz1C68" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">69,494,923</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_z8Frd02tL3S4" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (49,309,552)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zRcRGlFKIUxc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">20,185,371</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zuT5AHzeG00c" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,608,185)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zxYljbQSeuc8" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,210,601)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zts0FCqsSeD7" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">16,366,585</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zYgEJWuGsDVa" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,403,632</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zWcni8M6JTG5" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (23,343,205)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zOFzOIdjz3pc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">9,060,427</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zNF8yXO2NLpl" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (900,885)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zKOEGZtNExQ9" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (25,580)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zjUtL2QFKOql" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  8,133,962</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zVBGQeAR6dX6" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">6,506,297</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zcxVBj71lOwd" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,413,652)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zru2WP8olSx" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">3,092,645</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zQOynocIketa" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (471,821)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_ze2dncV26vze" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (15,302)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zThLftuSAXJf" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  2,605,522</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zO7p533KDX06" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 108,404,852</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zG0FdxzKpHrk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (76,066,409)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zQdWj6VgZvIe" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,338,443</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zjKZergaHFZ" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,980,891)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zqpVsddWGnqe" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,251,483)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zqXXN9KIIBz" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">27,106,069</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zrMvDNV9apNb" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">363,684</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zQgVYo36JgL8" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (233,084)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zXBqlnl2Qdwk" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">130,600</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zNKTPTxLWMn5" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">76,830</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zheR3ubzn6c6" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_z9co7poInPli" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (28,674)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zixAmsCO7Txe" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  183,400</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_zI8uCi6X2GQ4" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,963,137)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_zcsEDoroiac" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 1,161,517</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> (i) </span></td> <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_fKGkp_zHEpk2yqJrt5" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (801,620)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zrkaGYS3riJ6" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 108,768,536</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zSBLfIzOjDje" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (76,299,493)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zXWLKIGo0ora" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,469,043</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_znQmARC3Yz4d" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,867,198)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zhU7Y6jx5n4c" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zgXz2IWRaKRb" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,118,640)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zE7g22EpVYx7" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,487,849</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zMsRHjlj7W63" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,143,335)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_z0JDJ9xGTy76" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,731,262</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zxLu8RKGGjxc" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (412,073)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zMkS3ZrkHsNi" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (16,066)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zv5Qy5a8SYc5" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (16,163)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_z7B3mBvqdSDc" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (444,302)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20210101__20211231_zlpCou0ulOJ9" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 105,625,201</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--CostOfProductsSold_pn3n3_c20210101__20211231_zonutI9wRJJ6" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (73,568,231)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20210101__20211231_z97o5SuOuJIb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">32,056,970</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--SellingGeneralAndAdministrativeExpense_pn3n3_c20210101__20211231_zQIWrREL2rlk" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,883,264)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_pn3n3_c20210101__20211231_zX8mBg5CFwUf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,644</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_pn3n3_c20210101__20211231_ziM6B8p9QpSi" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,134,803)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231_zph3stnunE3c" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">26,043,547</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="13" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">2020</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td colspan="5" style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Operating expenses</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Cost of</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Selling, general</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Results from</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Other operating</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Profit (loss) </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">products</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">Gross</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">and distribuition</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">equity</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">income</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">before net financial </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">revenue</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">sold</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">profit</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">investments</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">(expenses), net</span></td> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">expenses and taxes</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td style="text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">40,794,387</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_zIv3STRdAHG" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (32,498,003)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">8,296,384</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,471,722)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,082,604)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (257,942)</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,638,660</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_z1zsTGndJ6ug" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (12,337,486)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">2,301,174</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (721,191)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (82,695)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,497,288</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">4,000,805</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zE1cLBzfA1q7" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (3,075,001)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">925,804</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (436,859)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">(364,259)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  124,686</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">59,433,852</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_987_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zKUaumsD9zRj" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (47,910,490)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,523,362</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (2,629,772)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,529,558)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  1,364,032</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Other segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">302,374</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_zQAbVTzxM6w2" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (188,350)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">114,024</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">63,874</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (320)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--OtherSegmentsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  158,180</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Corporate unit</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif">-</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_983_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (1,493,479)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="border-bottom: Black 0.5pt solid; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 359,071</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--CorporateUnitMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(1,134,408)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-top: Black 0.5pt solid; color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr> <td colspan="2" style="font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Braskem consolidated before <br/> eliminations and reclassifications</span></td> <td style="vertical-align: bottom"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">59,736,226</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_zJWDdqetHWA3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (48,098,840)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_984_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,637,386</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,059,377)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,170,807)</span></td> <td style="color: white; font-weight: bold; vertical-align: bottom; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--BraskemConsolidatedBeforeEliminationsAndReclassificationsMember_pn3n3" style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">  387,804</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Eliminations and reclassifications</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (1,192,732)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98A_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_zTx2bIV29gla" style="text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">767,426</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (425,306)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (17,325)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> -</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98B_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (17,065)</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__custom--EliminationsAndReclassificationsMember_pn3n3" style="text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif"> (459,696)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20200101__20201231_zYv727qbqIzb" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Net revenue"><span style="font-family: Calibri, Helvetica, Sans-Serif">58,543,494</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_ecustom--CostOfProductsSold_pn3n3_c20200101__20201231_zB9o1zeuUhp2" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Cost of products sold"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (47,331,414)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Gross profit"><span style="font-family: Calibri, Helvetica, Sans-Serif">11,212,080</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--SellingGeneralAndAdministrativeExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Selling, general and distribuition expenses"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (4,076,702)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Results from equity-accounted investee"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (19,398)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_eifrs-full--OtherOperatingIncomeExpense_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Other operating income (expenses), net"><span style="font-family: Calibri, Helvetica, Sans-Serif">  (7,187,872)</span></td> <td style="color: white; font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Operating profit (loss)"><span style="font-family: Calibri, Helvetica, Sans-Serif">(71,892)</span></td></tr> </table> 69079724000 -63195629000 5884095000 -1853039000 -1888999000 2142057000 23421096000 -19986176000 3434920000 -838474000 56944000 2653390000 5834017000 -5069531000 764486000 -451605000 -33370000 279511000 98334837000 -88251336000 10083501000 -3143118000 -1865425000 5074958000 402991000 -262402000 140589000 82498000 34848000 5644000 263579000 -2196506000 19375000 -2177131000 98737828000 -88513738000 10224090000 -5257126000 34848000 -1840406000 3161406000 -2218544000 3353190000 1134646000 -28193000 4214000 1110667000 96519284000 -85160548000 11358736000 -5285319000 34848000 -1836192000 4272073000 69494923000 -49309552000 20185371000 -1608185000 -2210601000 16366585000 32403632000 -23343205000 9060427000 -900885000 -25580000 8133962000 6506297000 -3413652000 3092645000 -471821000 -15302000 2605522000 108404852000 -76066409000 32338443000 -2980891000 -2251483000 27106069000 363684000 -233084000 130600000 76830000 4644000 -28674000 183400000 -1963137000 1161517000 -801620000 108768536000 -76299493000 32469043000 -4867198000 4644000 -1118640000 26487849000 -3143335000 2731262000 -412073000 -16066000 -16163000 -444302000 105625201000 -73568231000 32056970000 -4883264000 4644000 -1134803000 26043547000 40794387000 -32498003000 8296384000 -1471722000 -7082604000 -257942000 14638660000 -12337486000 2301174000 -721191000 -82695000 1497288000 4000805000 -3075001000 925804000 -436859000 -364259000 124686000 59433852000 -47910490000 11523362000 -2629772000 -7529558000 1364032000 302374000 -188350000 114024000 63874000 -19398000 -320000 158180000 -1493479000 359071000 -1134408000 59736226000 -48098840000 11637386000 -4059377000 -19398000 -7170807000 387804000 -1192732000 767426000 -425306000 -17325000 -17065000 -459696000 58543494000 -47331414000 11212080000 -4076702000 -19398000 -7187872000 -71892000 <table border="0" cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory_pn3n3_zQAstl9LDp1d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zBZAp3wXV8Zj" style="display: none">Schedule of property, plant and equipment and intangible assets by segment</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="color: white; text-align: right"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 3%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 64%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="width: 2%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2022</span></td> <td style="width: 1%"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="border-bottom: Black 0.5pt solid; font-weight: bold; text-align: right; width: 15%"><span style="font-family: Calibri, Helvetica, Sans-Serif">2021</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Reporting segments</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td style="font-weight: bold; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Brazil</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">19,428,926</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--BrazilMember_znyOuWSGZ2uh" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">18,072,312</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">USA and Europe</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,075,743</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--USAAndEuropeMember_zVU93Bs830D3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  7,688,713</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif">Mexico</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">13,736,298</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--MexicoMember_zMVbHagTdRpl" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">14,019,167</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_pn3n3" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,240,967</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember_zwlfwVF5ACKk" style="border-top: Black 0.5pt solid; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 39,780,192</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-left: 9px; text-align: left"><span style="font-family: Calibri, Helvetica, Sans-Serif">Unallocated amounts</span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--UnallocatedMember_pn3n3" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  544,472</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_988_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231__ifrs-full--SegmentConsolidationItemsAxis__custom--ReportingSegmentsMember__ifrs-full--SegmentsAxis__custom--UnallocatedMember_zN7ETvdh2vhf" style="text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif">  322,237</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold"><span style="font-family: Calibri, Helvetica, Sans-Serif">Total </span></td> <td><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_c20221231_pn3n3" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,785,439</span></td> <td style="color: white; text-align: right"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill_iI_pn3n3_c20211231_zQPKNiyLF0cf" style="border-top: Black 0.5pt solid; border-bottom: Black 2pt double; font-weight: bold; text-align: right" title="Property, plant and equipment and intangible assets"><span style="font-family: Calibri, Helvetica, Sans-Serif"> 40,102,429</span></td></tr> </table> 19428926000 18072312000 7075743000 7688713000 13736298000 14019167000 40240967000 39780192000 544472000 322237000 40785439000 40102429000 <p id="xdx_802_ecustom--DisclosureOfContractualObligationExplanatory_zTqSUfaVSnnh" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>35 </b></span> <span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_828_zcvgtDDuonFl">Contractual obligations</span></span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif">The Company has long-term contractual obligations arising from agreements entered into for the purchase of power inputs. As of December 31, 2022, these obligations amounted to R$<span id="xdx_90D_eifrs-full--ContractualCapitalCommitments_c20221231__ifrs-full--ContractDurationAxis__custom--EnergyAgreementMember_pp0p0" title="Contractual capital commitments">8,286,502</span> (2021: R$<span id="xdx_903_eifrs-full--ContractualCapitalCommitments_iI_pp0p0_c20211231__ifrs-full--ContractDurationAxis__custom--EnergyAgreementMember_z6dRTzruq994" title="Contractual capital commitments">6,079,568</span>) and are expected to be settled by 2044.</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt"><span style="font-family: Calibri, Helvetica, Sans-Serif"> </span></p> 8286502 6079568 <p id="xdx_80D_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zfSZS6BBIln7" style="font: bold 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 9pt 14.2pt; color: #0057B8; text-indent: 0in"><span style="font-family: Calibri, Helvetica, Sans-Serif; letter-spacing: 0pt"><b>36 </b></span><span style="font-family: Calibri, Helvetica, Sans-Serif"><span id="xdx_82B_zkhRn6j4QOGl">Subsequent events</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Bodoni Book 12pt; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In February 2023, the subsidiary Braskem Holanda Finance issued US$<span id="xdx_905_eifrs-full--BondsIssued_iI_pn8n9_uUSDBRL_c20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember_zW8iz950Ehik" title="Finance issued in bonds">1</span> billion in bonds due in 2033, with coupon of<span id="xdx_909_ecustom--InterestRate_pid_dp_c20230202__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember_zlIwpH0VLCUg" title="Interest rate"> 7.25</span>% p.a. and Braskem guarantee. </span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Bodoni Book 12pt; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(b)</span></td><td><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In February 2023, Braskem completed the process for acquiring shares and subscribing to new shares issued by Wise Plásticos S.A. (“Wise”), a Brazilian company engaged in mechanical recycling, now holding a <span id="xdx_903_ecustom--EquityInterestRate_pid_dp_c20230202__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember__dei--LegalEntityAxis__custom--WiseMember_zqElZsWMZeK9" title="Equity interest rate">61.1</span>% equity interest in Wise. In this context, Braskem disbursed R$<span id="xdx_907_eifrs-full--ConsiderationPaidReceived_pn6n6_c20230202__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember__dei--LegalEntityAxis__custom--WiseMember_z0kGqpsynJR7" title="Considerations on share transaction">138</span> million, with the usual considerations for this kind of transaction. </span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(c)</span></td><td style="text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In March 2023, according to the Note 26.1 (iv), Alagoas State Public Defender’s Office (“DPE”) filed a Public-interest civil action (“ACP”) against the Company, the Federal Government, the State of Alagoas and the Municipality of Maceió seeking, among other claims, the revision of terms of the Flexais Agreement, signed amongst Braskem, the MPF, the MPE, the DPU, and Municipality of Maceió, ratified on October 26, 2022, by the 3rd Federal Court of Alagoas. DPE attributes to the lawsuit the amount of R$<span id="xdx_90C_eifrs-full--GainsLossesOnLitigationSettlements_pn8n9_c20230302__20230331__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember_zCyyKhvBHvoe">1.7 </span></span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">billion, with a request of injunction relief so that the Municipality of Maceió and Braskem initiated the registration of all residents who requested to be relocated and their concomitant inclusion in the Financial Compensation and Support for Relocation Program (“PCF”), or, on a subsidiary basis, the freeze of bank accounts in the same amount of the lawsuit. The injunction relief requests were rejected by court; decision subjected to appeal by DPE. Braskem has already presented contestation.</span></p></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 9pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"/><td style="width: 18pt"><span style="font-family: Calibri,sans-serif; font-size: 11pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Calibri,sans-serif; font-size: 11pt">In March 2023, according to the Note 26.1 (vii), the State of Alagoas filed a lawsuit, requesting compensation for alleged damages caused to the State. In addition, as an injunction relief, the State of Alagoas requested the blocking of R$ <span id="xdx_90C_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn8n9_c20230302__20230331__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember_zPT1ygoKv9Kj">1.1 </span></span><span style="font-family: Calibri,sans-serif; font-size: 11pt">billion from Braskem bank accounts, as a guarantee to repair material and non-material damages allegedly suffered by the State Public Administration. On April 19, 2023, this injunction relief request was accepted by the court; that determined the cautionary blocking of approximately R$ 1.1 billion from Company bank accounts. Upon presentation of a performance bond by the Company, on April 23, 2023, the Appellate Court suspended the effectiveness of the decision to block Braskem bank accounts, as previously issued by the Lower Court. </span></td></tr></table> 1000000000 0.0725 0.611 138000000 1700000000 1100000000 Voqen was incorporated in 2022 and began its operations in September 2022. Its main activities include power and natural gas trading and services rendered, as well as representation in the Free Energy Contracting Environment. In July 2022, Braskem Energy Ltda., which was 100% held by Braskem, was merged into Voqen at book value. Braskem Ventures, Builder Brasil and Builder USA: entities incorporated between May 2022 and June 2022 and are part of the Oxygea group, whose purpose is to foster the creation and development of new business initiatives. Lantana was a non-operational entity that had the operations closed in November 2022. B&TC and ER Plastics: In August 2022, Braskem Holanda acquired 60% interest in B&TC, which holds 100% of the shares of ER Plastics, which undertakes mechanical recycling of mixed plastic waste into compression molded products (boards for use in construction and pallets). On December 31, 2022, it includes R$931,991 of cash and R$1,252,341 of cash equivalents (2021: R$1,267,582 of cash and R$505,749 of cash equivalents) of the subsidiary Braskem Idesa, which cannot be used by the other subsidiaries of the Company. These refer to Brazilian floating-rate government bonds ("LFTs") issued by the Brazilian federal government and floating-rate bonds ("LFs") issued by financial institutions. Includes the following amounts: R$175,153 (2021: R$835,517) in restricted funds used in the Program for Relocation of Residents in Alagoas (Note 26.1(i)); and R$130,332 (2021: R$16,845) their use depends on complying with the contractual obligations of the debentures and borrowings. See Note 18. According to the Management, the Company's Expected Credit Losses ("PCE") are considered sufficient to cover any losses on accounts receivable. To estimate this loss, the Company considers the following criteria: (i) receivables past due and falling due within 90 days, weighted by each client's operational risk; (ii) receivables in renegotiation process; (ii) receivables past due 90 to 180 days; (iv) receivables past due over 180 days; (v) receivables in collection by the courts; and (vi) receivables from clients classified with high operational risk. The table below shows PCE by maturity: The increase in the provision refers mainly to the net realizable value of inventories in certain product lines, which is explained by the lower sales prices compared to the values of inventories recorded on the balance sheet due to the current economic scenario. RPR's main activities are the refining, processing and sale and import of oil, its byproducts and correlated products. The percentage of Braskem's equity interest in the capital of RPR on December 31, 2022 is 33.20% (2021: 33.20%). Bioglycols was incorporated in March 2022, which currently is in the pre-operational phase. Its main activities will be the production and marketing of monoethylene glycol (MEG) and monopropylene glycol (MPG). Borealis' main activities are the production and commercialization of petrochemical byproducts and correlated products. The percentage of Braskem's ownership interest in the capital of Borealis on December 31, 2022 is 20% (2021: 20%). Loan from Braskem Holanda to the Braskem Idesa project. Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan. Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa. Sublease agreed between the subsidiary Braskem Holanda and Braskem Idesa. As of December 31, 2022, the main amounts recorded under this item corresponded to expenditures with scheduled maintenance shutdowns at plants in the amount of R$2,343,313 (2021: R$1,473,396), capitalized financial charges in the amount of R$365,374 (2021: R$237,519), inventories of spare parts in the amount of R$566,873 (2021: R$534,875), strategic projects ongoing in Brazil in the amount of R$713,813 (2021: R$351,657) and in Braskem America in the amount of R$126,055 (2021: R$136,342). The remainder corresponds mainly to projects for maintaining the production capacity of plants. The book value includes, in addition to goodwill, property, plant and equipment and intangible assets with defined useful lives and working capital. The Company has payment agreements with financial institutions that allow certain suppliers to opt for granting their receivables from the Company upon accepting of financial institutions by acquiring or not the related receivables, without the Company's interference. The grant operation does not imply any change in the instruments issued by suppliers, with the same conditions of the original amount and the payment term maintained. Includes R$5.8 billion (2021: R$4.7 billion) in raw material purchases due in up to 360 days for which the Company provides letters of credit issued by financial institutions that indicate the suppliers as beneficiaries. Maturity in June 2027. Prepayments were made in 2021 in the total amount of R$1.3 billion. In September 2022, a portion of the bonds was repurchased for R$83.8 million. Prepayments were made between 2019 and 2022 in the total amount of R$4.6 billion. The bond maturing in January 2023 was fully settled in June 2022. In February 2023, a prepayment was made of the total amount of the bond due in February 2024. Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc. secured by SACE, an Italian export credit agency, and guarantee from Braskem. Credit facility contracted by Braskem S.A. with a term of 7 years and guarantee of its own assets. Credit facility contracted by the subsidiaries Braskem Holanda Finance and Braskem Holanda Inc, secured by NEXI, the Japanese export credit agency, and guarantee from Braskem. Credit facility contracted by the subsidiary Braskem America, secured by Euler Hermes, the German export credit agency in the maximum amount of R$1,174 million. Credit facility contracted by the indirect subsidiary ER Plastics B.V., with guarantee of its own assets and of Braskem in the proportion of its ownership interest. Unsecured Bond, considers the same guarantees (property, plant and equipment) of Bond II. Sustainability-linked bonds. The bonds due in 10 years have an interest rate of 6.99% p.a., which may be increased by up to 0.37% p.a. if certain conditions are not met. The Braskem Idesa pledged as guarantee property, plant and equipment assets in the same value as the bond. For this financing, fixed assets and other rights (such as shares and receivables) were granted as collateral. These debentures were secured by mandatory deposits as disclosed in Note 6. Amount classified in "Other payables" under current liabilities. Clients in this group that are still active buy from Braskem and pay in advance. Investments approved by the Management, in accordance with the Financial Policy. The Company is in the short position of a possible counterparty call. Includes the amount from the adjustment of interest rates in financial operations with subsidiaries in accordance with sub-capitalization tax rules. Besides the differences on tax basis calculation, it includes the impact from the difference between Brazilian tax rate (34%) and the tax rates in countries where the subsidiaries abroad are located, as follows: Tax credits refer to the income tax paid by subsidiaries abroad, to be used by Braskem S.A. in the coming years.   A provision reversal occurs when the probability of loss or the value attributed to the lawsuit changes, or the suit is closed with a cash disbursement lower than the provisioned amount. U.S. Department of Justice ("DoJ"); Swiss Office of the Attorney General ("OAG") and U.S. Securities Exchange Commission ("SEC"). Of this amount, R$2,532,138 (2021: R$2,739,686) refers to payments made and R$210,653 (2021: R$188,395) was reclassified to other accounts payable. Values in monetary units. American Depository Receipt ("ADR") on the New York Stock Exchange – NYSE (USA). In 2021 and 2020, refers mainly to the final and unappealable decision of lawsuits claiming the exclusion of ICMS from PIS/COFINS calculation base totaling R$1,031,099 and R$310,557, respectively. In 2022, lawsuits with favorable decisions for Braskem claiming the recovery of taxes in the amount of R$123,202, and financial penalty on the feedstock supply agreement in the amount of R$119,576. Mainly refers to provisions for Alagoas in the amount of R$1,520,019 (2021: R$1,339,765 and 2020: R$6,901,828), provisions for reparation of environmental damages in the amount of R$238,700 (2021: R$588,110 and 2020: R$306,275) and financial penalties on sale agreements in the amount of R$22,453 (2021: R$344,902 and 2020: R$4,008). In 2021, R$990,877 refers to the inflation adjustment of lawsuits with final and unappealable decisions related to ICMS exclusion from PIS/COFINS calculation basis (Note 10.b). EXCEL 192 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
0SW(_YR06I[I!V!<$[9,U[?TVY >[/#(>!-G MB*'@&W%P)E/!#L4WE*40[,@T,F2'P['OT?QDS9C>@VV/'<0=/W2(DDWT;#/T MQXIU'[Q/J 7+#VUZY_G$DHOW-/58O?-!PSHRWHI,%#JI,!ZEA!H2)M62K&4" M&FPU 4H4,X[Z1OOE&#B$IA,J0)I&^ZT?'4#OBB'=:,+6 ZDIBMK(->.^T=%P M[!"Q(Z0^?7M[IHYC9:;G$@5]$L,JWA9U+G5 ,MF-@)' I#GJ7(/L_;=?',\] M381D-[%1&165_& MR%-(MB6#I:M/XMLLJ4M24"Y70 ^1F.=$&XD]6S,5D>&-FXPT91((\,H !8%W M-[\B<)F69;% _WQ:"F/7 $P-XF6\R.)Y/./(H:H7^?LRSO5$Q-F%DG;-D 80 MG2!F@D51^6(CC,6 *%(R-8F_>1A&F!=(,I^ ;+80JOK&\BF%!JYY5EC8'IZR3;M+D+[#U1PV&F[3DCDBK#*55G*KY>$JE'W@SB+=>G+@D>[ ]IX_\ MG;XZ)?U7 BI&U5]=D)KZ)/$NP[294)EP'\BLU/DAUXO6;GIRB3HG[AVD (M] MJ61VHB#,:0Y:K"N%9#Q? D9T-/K)%2XIN.5PE#7+F[0 AVI]3*, 1M)6*QN2 M*RC_@'D1DFVR!R_;2=[?C::QB^;-KZ[%4+LD$'1$^'3$GH113\Q0XO72#J#" MDEG1QT-6/@Y6CDG7*%U,-5;6%'TB++XI5;*:K!%62/S<5I"*Z-RV[C7%^E^2 MU'%I[(>O%\_5!=$S 03$46RAQ@BV_\0AD/;(OP&UH+/G84(34_*YY3HJ MY$)D/]<>=]*\^74R4[=A0&WY(J:>HP+6DT./ M>YGP+I+\7",N)46>)Y!$1:EZ(NV5]4#*[X&O&S0%T#4^_DNKH^N[RY:H4R%5U6(GAP"K--+-<; M!P2+CK?W*!04MW$N:)."-=0^W@RI&2IA(@EG@HK?9BH2YN;JS?79)Y.U*6.+ M/$1O_95FZF91MC @0T/G2#!-!=NH>L8+9,ZB32M&@T@*[Y[%.8H?G8\N>,IU M_D2B/3D_T_;3I91';;%+,_N,<2":6A<\T2PQ%JM [: S^;5NC/!=%H%3WSI5 M<8HI*R/6W=-BACS9ZK(?-K31:PX'WV6AW\2L5AS!.L%"U*=R5!;1%GM]X%43 MZ/#9Q0ZRU4KPE(;?(5B41+9D5$\OUL@]QE0FZRY8Y GJIE)'TGYJ4VT78R I M5N\P;$ EBWBA3+=CRNQE@(YO15ZU 1&+HF:T\AT Z[D$;%_FGB7H65%0+[_6 ML(DL?GK>;FU3;?*L]V3<_8&O-XT=IE0AXYMC1MTD))5TH:=I*(X7NC-%^0A;3)* M/@6;+OV,"!'A7L +^]#8+1Z(2#]T*[]C43&=VLH]IU,4P:KHC%%U[BHZ6QL= M@H(!8'VF>:*=#@WO(!JT(+4;*1KQE'^+TSK=A_= *149;8"R:6BT%SRO^3WO M'/[FZN)L.O3U84WPC^C'LYZE'[!C:B_8IY_IU'M0=74Q;.IU @'I:UY3^>6? MFEMUF*E!W:D98T?-H%8#U\B 6";3<_##2G%'FY'DLJ8X#30N0 NX]9,T M?B&0*ZE7DPZ"H6@ M$V0J58?!94/SQC,T[XW"#MZ+252ZJ M#?:9%XN-8#H]N_FIGNO_@,K.;IZHL<><]!GQLM-")WF@'4O1,'ZDNAC1GK)& M;:EV?ME;G6Q+%G%VSI<#IU%/B^;S0!'LR8K87&5L;;DM4$856;L(;@IKM0RL M:MJ2)UN@+:PA%QNK8EHGTH)/=VU7C%@AS.3#VP&=?ZQBK_P%X M&J A1!$=;L1WM5KL]GC1'B>M,LHN@._=.=T$RM!KAM : M5C([#JX@N)R3>V M5LY^'(L-HU)0],2ZA+/;FGKCT:XXW(56H]JE6,/S=A&22I;+0FW#5NK] 0. M?8;%&%=P5 &A_O[[W=8W.FXWFB/Y=@/H64?O9KM!#D/06&VH:*)0:8^-:G4* MV8!9-.80_HOE(ZXB!W+*O*9K&RMTT9L>_39[<]0/)N?J2%/HO2F9P6B:TQ%0 M(\.32#EJSZF[5 '?N#LR_@T%I"AF%MK3T:NDK;1$G:2)K-3[5!3\N]/)5D$- M-"BUZDST&UI?'J%(J^!94D=M_'UXXM;XX#(6 MYVTV+TT#(V41]0Z%]#E'L2)I8Z[LO5-OQM,Q6;F4JVQX6+9QD>DQW@VU9Z*B MCSYI'TXRO.^D$ZA:HZL["C<#<(S;I2RJ8[6]]C%W3"P)FJQ-ZCX6> M.?%<8RK+ZEBD>2+7:M*F.Z.K-@%S3!OT)X%MO)=P T60G#=3>-'&%[,#<^*. MZ4Z+JVX3>7[07/"P+<>T4!3;;F ZWH08< -+1;Y6W>WQ2A,-NR+C,70:Q=+5 M*)ZH T63<"[T-GT"'H\W><1WY5"\7/9(=$[11#L$.%59;4)!5R01 :-VG!;W ML!0"X0'.XX1'([;K&MW)X%(CRJV%NKI9,G4Q2]]O[-YVMT//]*7(OKN^6HJL ML8BAZT3,,=0:A?X!*_1U3?U0R5Q=D;R35253U5P*5'<%=<#WN02KS0--T-V9 M??T_4$L#!!0 ( #FDF%;,P^:A2 0 T) 9 >&PO=V]R:W-H965T MGZC62E'C M5(-IJXKKYW.4:G4:QN'FX%8\+*T[Z(U/&OZ ,[0_FJFF76^+4HH*:R-4#1H7 MI^%9_/D\=?)>X%[@RNRLP5DR5^JGVTS*TS!RA%!B81T"I[]'O$ I'1#1^'>- M&6Z?=(J[ZPWZE;>=;)ES@Q=*_B-*NSP-AR&4N."MM+=J]1>N[=_>09_F56SX^T6H%VDD3 MFEMX4[TVD1.U"\K,:KH5I&?'=_P)#7FW4(^H^5SB2<\2K+OL%6N(\PXB^0 B M3N!:U79IX+(NL7P-T",^6U+)AM1YLA?Q*Q;'T(\9)%&2[,'K;XWL>[S^7B-O M]QO90:3O0[C:^&P:7N!I2,EO4#]B./[T1YQ'7_803+<$TWWH_R\*>R'>)QA' MP6_0P8P*NVPE@EJ _>W6N=SY/0ZF7&-MX4)5#:^?@=[(1+RGZ#A&HV@R7!.QUB(HH2/Y@N]L$ _FAQ!G?3;*(QBE0Y:FP^"[7:*&?,BR.(7AB"51%E#WH=Y2OW;^ M6Y0C1@)!'?*$I>$#08I"1%)E@\C M-HCSX*+5/NC<&"2*,8NSG/6S#%RLABS/AL&-JH^*MV)Y/&!Y/J)5DB4L(K$/ MWW!N?W'S]ZO)S5S)8+46QI%"6 M;>$L5_ +M0(R$B@=*.-<3M-F-_8&)#X*DMZF)0DM6I1F R=JB@FU]K(#0M.@ M'Q;!.E3'+E;OQO!'$Q 'ZE=8S MLCY&+X_[1J!=2LV?O<"F]G MSHBJ4#_X06S(&6UMNVFU/=W.^K-NQ+V(=Q\*UUP_"!_5!:E&QX,L!-T-WVYC M5>,'WEQ9&I]^N:3O%=1.@.X72MG-QCVP_0(:_P=02P,$% @ .:285D(M ME-?X&@ +$4 !D !X;"]W;W)K&ULS5QK<]O( ME?V.7X%RJC)4%6VCW]WS<)6MF223\B3>\>SN9XJ$)&0H0B$@:91?O^?U&YM96)1!-"/^SCWW'L;^O:A7?_:7==U7_YVLUQUW[VX[OO;KU^_[N;7 M]]7>UBMOZZO7G>WZWJVD(=NEJ]U5?G7-[-F]>+-M_+=A_6; M;]N[?MFLZ@_KLKN[N9FM']_5R_;ANQ?JQ?C%S\W5=<\O7K_Y]G9V57^L^_^\ M_;#&;Z\WHRR:FWK5->VJ7->7W[UXJ[Y^9WF_W/!?3?W0[7PNN9.+MOV5O_RX M^.Y%Q075RWK>SZ*^_>Q%?E(OZ+COYMWS(]VK,.+_K^O9F>!B_ MWS2K_'/VVR"'G0=B=>0!/3R@9=UY(EGE][-^]N;;=?M0KGDW1N,'V:H\C<4U M*RKE8[_&U0;/]6]^7-W770\I]]VWKWL,R*]?SX>'W^6']9&'E2Y_:E?]=5?^ ML%K4B_T!7F,EF^7H<3GO],D1OZ_GKTJCIJ6NM#XQGMELS\AXYM/;*]]>=/T: M5G!HGWD4>W@4.L;7W>UL7G_W I;?U>O[^L6;/_Y!^>J;$VNTFS7:4Z-_2@4G M'SZ\-*6*W8U_K.NBOZ[A ?/V;M4WJZORMETV\\>R695_:_NZU*],^6[6-5W9 M7I;G[:K#Y<6,;O.JG,S.,%IV?_H1_FNV@QZ+V[7[673 MEY-EVW5G)6XMN:K'>K8N?_CG7=,_%M0Z5:_X3U5N?BW^VC:K?OGX<@YS6[?+ M9;THMJ,7/W_XN9PT9V7P4^LJV(\N)]Y,G79GI5+5M+)5Z?##V^)=TUXM'^DU MQ?OWYW@*CTW,-(5P5KXL8S4-+I0OB[==U\Z;65\7[UI@W1*2P:VXUYFI5Z&T M;FI35?III5*IG9Y6SF"E;NI\++@4+.FKKB J9N!I^J;NRMFZECT#>9H5]# M M(9-YW774R6RU*+L9),D/S0RJ 5#[^;CWK?JUOONK*.LL8@JQA*3V5S[7,9[=-/UOR M7LH1>H,3UC<7]7KCB"6V;\PK:$3^+41J.Y)\F'48#0O"FF5!&/JGV7I^+4]/ MRX?K!I_G=U@PM MDPT+K$-8"">_UF+7V,1-NVKK_OIQ6:_J,J^PG/STPY_/\JVXBJ=OY7*QN?SA MSV>OBJSA4>%?'=7>D]GG[%0YN3@KSJ]GJZM:M'#,EX_2[J%>++AO^L,$"N\@66TYT M:FBI]RDF( M$5-Z;V "@^'@1FBTJ[F[5,52&^"D*KV=)C_*3CO'_S\1B"YMF!JLROBI,XD# MF. X0*"4;)I6VI23.<+'#2)43[L4D]V-+SMV7OZXJ+L9_: XQUYFJ\=20AI# M&)\#9&+V1M:\$VK+2]#&KAB6/*Q'5!Z^Z7:V !?N>OP0[_AZSX,^=[W0>5XCOW^ZONX: MJ,/%0PUY#^.*X:[CQ!ST3YO9/K1=(U.=[ZYRE KW"7(NA"#O$D]O=%!D'>SM M;W>88E]7C'0_+!OP4ME1 PPN,PP(] M%AB\+K$FE1P]$-YK [S0>CUUXOP^I*D/^&2 5/ _8\M 3 2-<$+A5GV[9NC! M;A)&)O50P ",E&%*57%J;2!@03JJR@M7=EH9X3L$*RP'5U3QR^RW6E;;WB/@ M*[^%J]S,F9=B?"] HH,3@DM\\M/_U@$9;>7>EUWG_$>!C M@RE]G#INR 1HPI80@@F,!$'#6B".!(%7*102I$9&4L[$ !DK=05()86$8"I( M4"?J-#KY9(&E0,<$=FD9S[394Z$%^<2T#LM%X$FP%^N*O]&?\S0'% !;H41A M'BEB'IIS1""!S6KLQ$H0HP:@]ZGWB48D7/.$!GA#2H1A&D#:&O+^]Y#^98UE M+?C8* 8;5 TI?#0D @8L7X*(29AH$-P!8CEA:X/"QM MH#:SM= F?DM>S:A,F\2>LYEF\KVYC,_;&SCXRST3P*]KXL/:S+>_A'D'^&T%ZPCS-T*E&,JHW"_DDCJ(!$7 M(SU:P2<3PBP^6AA+()43PCKQ $7O$F7I07\"8KPA]AAB%S\2>92IL-8>I*ZA MS0#)8 @*/@(L"GB>D9LN2JX&)Z#WB-M.R>"5Y7TQ!-*(0BHWC#EWG02ZT7VF MWL#](#I +_S-&U,FK#]5]"=\5X&YW&.5P#[<("I&YD6[C'PF *0K,_HF N%3 M_[0>*&#!-;1\A 8]V <0#NJ"I( M6%^5(!HGO H;C%9GLXJ&^!TE@7.)CJ[Y M48N2S3#G,$^(3.O M'1)R6(>CHAO @3D+-!1\2(6$S@/!5UYQWE@D,IDQ@6W MJ6P$F,223]&JD1J^;V87S7)()Y )[(3W[JLQ0SL?\4+BS.WL<3!,N*;"J AP M^!@])H-IDMEA.<3 0 )V.+X@?FC(+&!+2I+5J?:>9'[=/H!F=((L$"V@CX-1 M5G9KO\^OP3,OL$1$;,:F +!4I8/5QKA]:N_K)\1A9V;>&X%V'E$S8HG>'?BJ M^#![)"429QESISF$QQ0E(*!8*ZP=3LED'W9H0,H!6*;*T21R-9HPIJ!R8_V MQH-T2\)=T$F8/X,-3!"?GZ*$0%+P', &V #.*K&9$:[++*&@56WR_9*DLZ:]('L\NUR=M4B10?B@;'[BI',T,C#%DL/7!NP M<6-_< 7+5"G2O[E&@@*>B\1'YD2&\;9R26A30/B$J/G)0ES^:KV66#&R%]QD& 6F%T)D\ M"P:[K$,)1X;+;N_=<0(6%EEBK*42LDFT. 5X<6( 8V3YEY2\N$J M8]1X?1"->"HB%6P9%YAUP%V"!<9@6QI88V KA IQ5QOE8HYP&IX0)= 29! 4 M/MMAM;ABLB2A<#.8^19>#UQ[ZK",=, ZEBLA)N H S*)I*&CC%D.^6UV.-P% M6FNM.1""=Q6%L*8M&%&2JJIF- 2QU^3W"1J,S!Y MH$F$4:&6(00 *9!BW,2 MPI(#H/E8 M3TB 3X1(6#I! TX'V[*L\4X\8R6SI;-R_#J6FR\WSZ?M\QE*MOZP5X/;,R_E M$"HAW908\+-E*1%%M,(/@"2(VBY_UJ *+@H_@4Z0_25U-DA^;TM#Y2@PP9': M#+3E60@R1W?&-#@) 8,] QNM8T;*9%'#&F"PC'$Z#K,M]TG)WNRC#OXW21&K M".>GBT)2G2&OWY/W?M'B8[V^1Q;0YDW\4J]9EEB6_W'WQS]H$[YA)?95+ET+ MT%VNVYO-+']I0<47L]&X]B>_7;?_J.?]6"!^N_C'76;\I11RN]MVM2!.#@\/ M)=F=8C"&:-?\I=@K"XW\92@)S2Z0T7%8W AX7&*1G!)XLL4+)H_K1:ZP'RE[ MC5L9^BO%JKZ2#*H\Q#6?21HS8L*/=_ T(IX$S45Y4?>J)XCZS-%657_(K6UG0 [#Z#MP-5FXR#"O$)POC M5O UX%H(&0L=T0X@F0@RAK4@4JR*P1#Q:P*\)1E,1$RHRK'V#/]5S";=0,;/VVZ4;VXR8*,+1$S--([9%0,_9Y)D@?&)C2KF MD$9"71682AGIA!'^D,_+9T6BJY%8:A9X019TF3D,X$IR 48,8#P01GD0'Q8D"61U WYX5?UY3Z8,-@'M8H$)BX&#% UR7U2J$$\72"W@_ ,<9 M3Q9$! &@)ZFPZ-(#OS K2ST(, #.2-*LI!(1^ 03'.3*8& LFS/?B=5(UB?U M;[?U"MS@K/A89WI#M%@T70XQ=#*6UQ$X551GN=1N&=DS3B.]!'.GLA3WR"1+ M J 0*DUVH/#4V!MX^I,J9L5.R=U8)M1IJSR+%';<63%Y+^U16MBZFRT[<>0& MP:Y92[.3:'&T #DQC,U4@\B"VA7U<@K6!7;_/;I(C&&UES&2LGD,[30T6*_J M]2PG8;,%7(M2R^ R81!@\I4-F:6$&&V.>3 =! B1F0?%BB(SYN=Y6?CD*GDJ M\JX$TT)F@5\90U(T]!D/Z>VX7 M\Q!#AA+<1UX!7$6Z9"S4@H1ADNLB2'; \RI6@Q51S'JIZ;$B!]XBU0"?)>L( MU/R&)!:Y/C-B8&85#.ELQ54AP9P$8@-<8=M)&/IU.]]LA2+-/LXAV05%%Y-L M&^Z.!9H,*J!,((49;#PK/#I#0E9@9/=.>19^H#-/#@FJ+LCO.8/W>@!O)TT1 M)?02L(^9D3:?[34]Q##(R $3GHF\YOZ5[-L0Y2L :I5E0P_VA%#E*FDD2OU2 MMI)7P4]Y'8P054XGQ:""Q 7/$D"TQ0^_S:697/)P0'D/[I9#\K1<(91./,8P M(2,B,(/8(1L K&.1C#X&;%=)VU,QK4A!4BP"@A!,?*>8&$*Y*K)VS6Q[PJJF M"E7.ZRH,S5N8UR$C#3#302[;5ND<451T XAB2B=W,ZC$D W9LT4:N+C$,KG- M1LJ::S19>XQC/H<*QP0I/5V4S24 QE2@:Q4);%:ZP%X-EC7@?S;NXJ(&_.^6 M^ MAZ&TFD$Q*-E'+4@&1Q3ZF+;/=MF_+"Z7[4-WN(5ZDNE^JA'[?\)TL[3'CPE)":&^9I0^(& M%8/@:L<*"PLC;$Q*#TW*I ET7\%N0R)UE5XL.S,F,>-ED8@TAR OC(CIO0]2 MPKL[>= CYEU$1\9LDXB>M& 8 9_0@]XQ6\%;V0"KIMR)( M0VZ9*P^:S[ER)QT\9%-E5,Q=6,V%JA"7OI3_'1GGL\MXQ)Q*3@HJJ0EM;6\ZP;W^/'\IX_9RG+!8CF_ M6V:COY!3H#LV4QFV51BO6!1W+GPY?SXY6D&,>9+CE"=SG)R>#*7M,NWDIM9IEN[IZN432LQ@;AHKG##RY$KP: MK#Q*1,O)Z]>>0&P-20G]]%N?(DRF$K+DE[58YMX*.+"/BC2:74#IE'H6K%F02P>2UB2=&&3")9(U#TZDK&34;*4JK<=#A 4L MO=UP9[=_-]KL\]&.G*&*"=9E:.PX(U.,I#H6?G_'1YS_ A9^B!U1)&=2M-299/D+P1 MR3V+VT%J&,$-!)FGKZ2Q>K9W7&GH-H+(\!M$1,RFVGFH@UV*;]ST'/F:2APS!2HOA>-!^)H5$ M"N0.'%O120X_8&>>)R @4) 7QX.87&[%PS*D'3R(X>#21^VUKB]@]X1$U5D?C8O ML3B=JP..I]9$22HQ';*2BE4\Y;!1[]CW9"1A6T,/62.;$UPK^R(*N3LLCLWM MB0)R69Z4!1/#[>9$8! NQ%*4SSD@VXIT#LM2@5= XWMFBP,YRV_FL#OS3$/, M[[#EYZ4_UH3]YV,!%9!B+-[7JZ9>S1^W#6P&3Q90@I14>+Q"/MF4C[N\_(+" MUHEQBH]WJ\7Z<9=005F04#Z^S-0U]W=8%I"B%J% RVEC9&L&\J?I^>.V-F%3 MTN5)&3FE"*XLDV['8N-Q1C7)IPI"RM4F>GHU5&OA\4A"U!>)X=.C/6VM0EZ6 M'/"LC!)D78;.E'*-(4:I[6$<)IUR>O&$& P359IR9 4-9$;< ](\D\.PQ964 M79D"B.UMWI>0(T%47.*)]R GNH)EYY.54^\K 4TOY^VT]-\K.0'C>*P !.5H MY(?>;."!27@L3U!ZR>[8@F 9TFYS H$]!@%NU>9*K68-2DX?072LMTEM)$1R MYGPFB?5[:4GP(&@ZY9/,&R'GD(;B$!.Q/$L@!VJXIMA+ETC/8X&4L8W, M!EA^3TF1T<[K>H$L>>3Z\H*1="%_V_+7X5V%\6S@\*V6(IZM9$V2UA^WX>?1 M^MFS0-"%G$OOBK[=X4[/NN@3'N>K3MG%5CU'[MR^AU'D&(F]NNP1B:EW/)$G M/_WYY#E0323FW78GMR>/&*NK%4Z^E#*:V3? M*N:1O&*G)_P;:TR6H6+H./)P?L@>"^*2.>['ZW;=OP3,W$C!4W(N_H:\X*+/ M.N 9(B_G2; V.>C.'T;.#%DYA?:Y*CXQ"@\>9H8O17LIMPM^2/>R2D.GC:?6 MW)>%WD^.]J04>+$]=J(Y>D-/!*FP0#]"8(]_GQVYU8$SQ7)PKS*_1DY M>DD:P+<*I,#Z9;>/Y\8+GF3;SL6>8004LCZEPL;CFYS@QQL M*W['P;;;O'$V -F8.31COC"<#YL@PDV#DBXXSU2)2[.?8K)C6)7#S82^+U[C M5#;]C._/QR<7D1 YX1L.B#\"$MLG.4DSI]SQ M1/ [-=[G'XO23#UV2C322G1?0(6WMG!XH* M1V-Y.1EY X='T (($@RLRDVM23X-[#PUF@AU3&./Z(J'[.7=$!@L\Q"Y5\LK M(QIA8VR"%9MJ*4\G"@PS'+?KNKEZ&@@M%\(DA&F?ES9LY>0P&9L7/"$"S@@@ MD3<#DS"%XYAK:7,\&Q98\97J(9LE47 [IIC+X+'28V]7$M=5J+Y-@N[:G#_X6T_0,#% MXXG7P&:Y97)17S4KOD2].>F$,-RTBYUWPZ3,6J73"CKQU.Z^)D5O:+%6^ M.6#<4>EMWB!C9 :\;0&YHD\1A>K3Z\53KIYWWU8Y<&7V786?.B]MG'!1U/& M ^^\[:SX_X>BRT-_,N'USE^P0%I])7^G@^]9WJWZ_,E.O\MSGR+WU[*W\/XZ+MD=7-)0@D !Z1#;OO@&2 MDW@-Q%G#E^1AL0\2Y>P&0<:\=%?7Y=2I[J*> MWW3]9[-5:A!?=DUK7IQLAV'_]/S<5%NU*\VJVZL6;S9=ORL'W/97YV;?J[+F M2;OF7 9!>KXK=7OR\CD_>]>_?-Z-0Z-;]:X79MSMRO[V4C7=S8N3\&1Z\%Y? M;0=Z;%R<7X=/+F,;S@-^TNC&+ M:T&6K+ON,]V\J5^6['O'MAUM?[)NR'439UD+],>H]'#\\/Q^P! T\KYRX2RM. M?D5<*,7;KAVV1OS4UJH^%G .W68%Y:3@I7Q4XH^J6HDH](4,I'Q$7C0;'+&\ MZ/\Q6/RK7)NA!U3^_9#M5G+\L&1*GZ=F7U;JQ0GRPZC^6IV\_.&[, V>/:)W M/.L=/R;]?P_4H^(>5C:4WN/N>3.HG?&ZC=@_.JSLE=BITHR]JD4YB&&KQ%8# MR[VNRD94G1D$A)059AC-V=GU>-S"]R-GJR]NMKK:"MU6S5@K(ZIRKX>RT7]" MXKKKX3S=7GDDR?BB4<9 6C7NQJ8<,*)6,*K2I4U\Z%:VMT<#]&Y?ZIZ5;3IC ME%F)CUOE[9ORDHWT!2:]/0&!NK6["VU0(->P0^5XO&PK.IV M^Z[%C>'91(Z#:LNV4N2.7EU!C5[0P_ZZ;.SBXA4F04\H\1G+F.TXU-U-:QZ< M 9?B\35H5&SZ;B>&FTX,G3#ZB[A596_H!@$BTB;O&V7ICRU8B1\7[O',4/;0 M\V:K6@Y4"7?@?JU@!.ZN2]V4ZT:Q(9H"T53.B:-!#'@.Y0S1WQ."&4(_;+O: M9[:L16?%CD9MQD8T>J.$,H/>L8CU+;]TIO_P72[#[)GQ!E5M6PT-8;ZV\W=E MBR(Q.9B>,/*<[V;IUW =0& V+P@*F068/E>UTVGC6( ME::1NK4UUZT#!XRD(9*J-_:! ^MQ]E$Z7*OFV$MN.4%96SK,_C$BGX9;P>F, M*2W51X]D54@PQ>7R&+IXQ2+[CJ'/6G"HNJ:[XM3NUJ9#-E:*QL]QL#X^1/TH M6N5^WV@\A+<7?JL5D(YZI^R2FZYI..4!2%API0C=6&6@2ZP#HR *SQC^3[T/ MV+S48\/O'E[7HWI"127T+D?=U)!MDQ74T'?7C#0CHE40";DJI/?V:]0 '@ Q M-=:K(EM%4J2K+/9^'GN !-&R!**_T+418; *4OOKO?FXD"5#7BM MO"E624$_D?=!56-/,3N\A*0D8'FQ]YL":3:T"$:'(LQ7N?3^"?_U=!T4(LQ6 M02(NC_F3 ;?D5Z8"Q*$CBJ![/6R1QE<=^1_.^0_%WK?I_U2.-5NL/I2;O- M1O6,L+4:;M3$6W?6G]>>TQ9\!BA4P'3_60TSG'E"I;DLM![^W9%-*_&F98SX M#]<>X7RWZ\9VL/!]_SWP%/EAE" TI=!)G**0[Z*(G'!=1.[&;5;(Q[3CL:W MNB\KX;>J*X=C7][RC4.?12OH&3HD,O&QOI!%X@=)*D[+,^\]V+RE$C;3257V M_2TG%%MPE#']-T?_0BK-><.D\6:9-X=L\7XZRI:?#X7TG4,2S_XP='LZ!5"P M\.*JIY).T++P_=C!2N\5;1S2//*#"%[U91[ZL8Q%$OEQ$/HY,B_VH[SP0X!< M8E#NIVF*"7Y6Q'!%[EU\98_ *L T(/!/:_,3<8I()I"5)V?B5&(UR,G3[(Q> M8=TH]?,$=Z>1Q./8+X+BS+LL&\N43(UW@QW,NB- "+V,"D&Q@H0B31:ZIV0- MTC5*_$+B45Q \QDA!AI$42ZPL?1ED8D(\W(_R')V[*\42:'_)J3.5QY..SC+M#A]])1EJ- ]ZG#C-E/U?U"N*)PV&F'F!W$J M9)[!"^ U/PSA]20160QEARDY,"G,A)/%J*0L[JEPM>AB%IWT-)YE)\M+N].&$!2;.4[](H,@=WX4I0@['!X#,$PB2*"Q1D?I15MQS5#%H0L3]*OG)XL M)'$>$^@8(+* 68$?%&1HEOM)%)]YOX*4Z?R.HM","LF2 04Q)0LE>@XPIP';BSSQ+NK:S1FV?3=>;>\6HI_> MBW=-2463Q$I %I!+8!)T _I3*6!H@@W+7V&:J3;.5W^5:9"S+F>@=D@9$5*L M"KHJD"4R(_<#U 6GBZ2(2XX#W&H1?2<=$KQ*$?L<%3),K6DR)<)-X=K\FVSS M1" E4_*QGX+ ),!U"A('D%BK$%!(TTSPKCM\]@B!6,H!8Q>.^.SE@2UFVYE= MR&!@HH@)6C*PS$8\E>8%O4,=BH+[1 %UH1II^81(,@L3D<-+172?CBDT$;B& M^2#.P D33X!G,LL3:9%1>;J?L"F>QU3(0,,8G5%UBZ(8J(E$2N0.7$KL3S); MW0CM8+TB<0GKIB-\L#$+D BHW(!_A'*") .I9RAWTH_ ("@E(D.P4!X35)7' M$S9)D9*2BS6Q'&%''B=L1A01)Q9&64I)^\UR+O^&P;2SN7A8JN^.N]@(VG9\;YX3GIO2OH'Y$7P4I3%!VF2J"PL M(&NJP]J>W\V>#B5[[DP\("A!A/)LH59"3L\2"*)6Q*!P&O7F;)V.+A!TV9=_ MZN8AD1D2(U]:"E+'1@:@L8<\FFH^P^<7.T5MK(=D4"T( -:#MT#_42S/5AXU M*7I%,: (+H\W]*RYY8;-I#!55@X7_I]:+'A9V]X8^1V[:'=R=TV0N6_G/71D M8!:#FOWMT3Y_.F<\>,Q8S%D(!;MB;$$S[ZWZHJN.&":. M8[!R863U@?!CZI8_')CTAU)'$,]LUX1X\T\E[C[$]G/HE]>QI* MYF74'"(<["(:4A1;Y3RFG71:A.Z,*S,@\?IV*NN.;\4]?<,'SL1,&AY.)F6K=T$B2U8P8Q\%"7.(0HL;>MRT>:A MXD%A,SRO+9M;H[D*S/T-H3=N02#>Q1FS[RAI2C0)D M2QA?X0@Z4%?0;,6FZ6Y('Y_;9E *&L&W/*!<:VXV836GF.MQ72M7Y)%/9JRV MRY:14=Y!!?P:9;N=VIC1]?FH"]9W=%[M=KJBWM=5V?C<<5,#]PM\ZBT?=ZG: MDAC2=J46G25J@[A^W[W6)-6 7C4(,U3=@TY<:Y6$A:.YN:(Q]D+ MM&GG E(;NRORXKC?-ZX!UUF8++I\]U2 '6RRP9Y);V!)2YWAB16P> V"@4XU MD$)1M8$2DW,\U]]\QFT8[UXGCWIDU(=$'"%R= TM1W-[Y*IU^:RJY<7].%B) M3F2C/ZM&;[NNGII -;4CN_W4NFW5S2(<)+,7?7DS+W\$MNDAO,26'O.@[W@9-DO%.4\QO;ZU@H% M%MXNO[ 'X8Y-PTE JD\GW:E)R-1HFUK...BR<-NN:]7MW$ND;*)@")#59V:, M')M33+["46U_:*Z? M,0IX"7>.G\5Q<]+)NU? F!%1[*@XV@P@&O$GNGXZ MH4O0UQ_C<\F\UC4J*ZILY7AD\M -*M3;P[<&ULE5G;8ALZDX,_,,D9"$"4EH"-"* MYNOW-$!1E&/G4C-)2!!H].7T03?T_W-Z)1NU=GX=EAX*-<;PP-7%Z]W/*UN!/F]^V''F^7DY1:MJ+34G6L M%ZM79]?A\YN$YML)?TBQT[-G1I8LE?I,+^_J5VU^Z\8[4E) M7J4:;?]F.SS5CO4T&]+HP9IJ5T,YV5%0[DR/KQ+KS-6[SO!N+9>-8%QK8?3+2P.Q]/&R M&D7<.!'1$R+"B+U7G=EH]FM7B_I4P"7TF92*#DK=1-^4^%I4"Q:'/HN"*/J& MO'@R,K;RXN\;>?VDD4Y$\K@(RHWG>LLK\>H,X->BOQ=G5__^)B\$T1CRL8QMY7HKT[)'8]X%VM6+7!1Z&9[/#_PXFW%GZBU]Y-S[M: MLSNU,CO>8T)7>W?#=MM(^OI6J7HGF\8.?^!&=$:S1E9(78B^7O="M';LDS*\ M\6Z5-BSVPR+WL[Q@25GZ:9BRT _"P(^"D,5EY$=)QE(_*$H_2P+ONJJ&=F@@ MNO9XJWHC_^$VJ9^%?A@5?A$DY^Q9%"9^DJ9XR@K(3W,:BQ,_C6-Z\J,L\,ND M//=N>,.[BNPD'P!MHEV*GA#G 7$!B_P@A= \85$!);* Q5'N!TG"(-3/PQ@S M"FR;E2%4^WN06I(VFEVP+ _PQ\^*C"60E!5^GF<>" 3TT'G5T/>BJ_;,P*&Z M<3;P^B\XFCR$]3 ARD/G([Q%?I+$+(S]((KQ'J5^DF7>]=P%%V1:'H8PL?"3 M H[ 2 B_E.FY]XGV65&05KUJV;8'F_=F[[,M/& H8$Q _^VX>T3JPMK,S]*( MK,%^4>3]SVQ$[^UZ:<2%6JVTSSH<%W =/U4$&\=^7,;GQZ>O=$6,DX2BE25^ M$!04&+@[S/!09K"N./=^$\8C'F?WO!G$+!HQ')$7)?0K_!3>#:%H&.84C3SW MH[)\B*TT*>&'C!%*8C\+2XNM+"-L12EAI/Q1;,5PA54W3P&)LJ2Q-/.Q@\56 MG*=^D07?PU;X4]8\P%;HQT$.A"1^&0>L! S#)(<-R(^Z=K,\L^G5L-[@M)N6 MDAZ_?F0?&JZ-K$A0!,LR&U\8D(<,WLKC>,IC[QN+X9 DB&RL+\:7GT W_CM M^UF.M92A8>GG660A@R0+\^ KS%AX4V8D24!N<#;_)+0O*(O2,I\>?@;5 &U M&79\? S7:4[W-$1LHC0$2*-">J/ !N>C_(,] )F(LH 3,JX9&&!?Y'X ME/>1CX@?@!V%&18%+$7V1&D!2$0I@2]F"<@-;@&P$T"\R,(?!78"J7E$[ $E MDMB.Y06(V-*GG^0!W)]_#]C13UGSC)^SZ=288")+);1F M2V%V0G1VJ +,92UZ9XL946#7(.1&8?+)*$;4TJ \I96F5XV;!TDK+OLQ%+"( M1B"W,W(ER6/V#+1S&\F7LD$ZX#3#\-!"JL4<+;&Y0OO02K-?'.V".;QI5$4! M("UH]NW;W^&^GJV1I5OKR'$?L^' ;$\6;U&PBM&23JRD\:;-]+X3_9KT&!5> M#AIU #Q4J78I.^N3F0J\1QIW:PA"^2ZD*IX+)GJ?"8-VW *'V*GA^5? MDV6\ZP8.%[5;Q,!FJ!$:W05[-XUX-$*[P8]4=]>0R&BHM0ZMN-ZP-1PT @%: M"EYMR,./.=B'8X$*N__DSEN%W;K]OW\IHC!_H=D*#<+%7O">W8Q^]4!\2!@M M!/M-&:1LM$"J$"@F(>]YA^[%VD#,P^!IQAFX2*H::@AHVU-X.Y8RDJW)?K0> MU)20,BQW2JFA"BO\9.9I0-V\+ B5RP#Z+? M"C, @9[%G5;P4%.Y]#_ZC_9K5+>^P!8MNY>VM[)4^:5JAIK<#8T;+^^1P#7 M% IMN?>6;R7,9<\H*%'PXL_KVUO[&+XX7[!/P*'A5*(NJ9UD>D.:D4#LCCY, MCZD^H=;!BC*_'FSLE_MYY&G6#,!1]/RD.EY/J7R*4[C)NYY2^Z.H%%E!:MT0 MN[\>[?:F]4BFX> ;[YD\9[=O+FFJY[Q%_O%^0[YM0'\4?#@:3$4-N$04*;FW MC?C"$A09.=@_1R& (B1)J=2)$C^.0;\+*@<66>'=H??>/"T$540)2D]0B@1^ MD> /3H\,,ICAC43CA>"CIL4%;[ A2 D"65 :X"H6@LY M"LNQ@?O M=/IL*BCZ1]">H<="L9Y$S/9>:.V^CVW47IB)G"!PQRG*HSP_ #DAT/L1OMD" MV@]0JA ZZ.K*G>M;5VD/^H",D7,MGHY$V!/=-/-C?4;.\%7+JUZ!%#H%[8C> MH:-1O4T$LM="$5IO>_3(&*6V>=VH)7>E"?%* X2W#O]CT0-']G3P[V"^. $. MG;"41I-82B4<">^?4..0F#B=10N$##@UN7Y.%MLR'D>!!9B-FU5ZS!ZKJ;,! M)'CX#&Z#?Q2%A5@UC4QH'*0PG VV!!]4V+>]1;Y%/;8E#K\(LV)UL9<-[ MSYZ^#DJS*-/T$54CEFQ50*YW6\ GEBWFCG_@;"K(1I/MGH_!ST$/,6^IQ*Q1 M"U>FV5MNVT^^F_@?VDQL955T%GN:-&L08'=WK/6),!ZMO8%.,;(XP9J* MYD,/=MI6PE)$"YO2)5I%[D FS2;/*HY&:<3A;EAJ'(TT0 H[B\93SH9.= MJ6D]CR1'):=MK+S58 ;J+0YD,#86E@I4OU6]V[,;Z6S"M'4>D=QN(P$\*WA& M?PLV[X*I\)S5G(,^8!C%+:=R[X+N+!$%LU$/2M)C63\%!=LO/ZT M)]YXO8G*.PKP:;H2G>X[K9YDKJ4'"$+=']+4Z3KUR%!T?3IR ./'>]*0+A[9 MK^ $I#-%SK._@&B4^L35E:T,Z#"01'N56G>'1@V$B+@2? DUY!!$F*YE$*O7 M<%JCW'V(.,IF-FQ/X&@^T:O0PRQG:0044"*[7#^0.W/GIFW;(=F(:M-1FD'H MF-UP ?$-!E:0)"WTGP2HHRNPF,UE')2GU3N"46O74-;V(-3#"L"59", M-R/Y8+^Q.D?\V)LXGN!@="Z:K_'[3U$5T,TDT7/4697Y:E]UY\D95B$1H" MNB6/@\3/HH1NM>"!AM0*([JPSKW?B9AK=F?H8*#-KQ%T^ /],XHZI ZJN2#Q MWJ()I3B&L5_$)5U+1FGL[N58CF+.FVZ,CI>B[+&?6RYG/X!AI[7]F4\[Z]QO M8=/H]$OBM?L![3C=_0SYGO=KB7*B$2LL#19Y>N;2^?!BU-;^G+94!NEL'U'( MXHRC"?B^4BBFQQ?:8/I]]>K_4$L#!!0 ( #FDF%8PK!XDE0P ,<= 9 M >&PO=V]R:W-H965T!^^@/$1K(%DU["3[.<6V9(ZRT-ADZ.9_?7[JIJD*'EF8& 7L$<\NJNKJUY5 MO6J^/K;=O\U>J5[[,8=. MR9(GU=5-X'G)32UU<_7V-3_[W+U]W0Y]I1OUN1-FJ&O9/;Q357M\<^5?30^^ MZ-V^IP;5O"1-7%Y/TG_F MO6,O&VG4^[;ZER[[_9NK[$J4:BN'JO_2'O^NQOW$)*]H*\-_Q=&.C;PK40RF M;^MQ,C2H=6-_Y?UHA\6$[*D)P3@A8+WM0JSE!]G+MZ^[]B@Z&@UI=,%;Y=E0 M3C?DE*]]A[<:\_JW[(47[?;%8)20QJC>"-F4HE+8JJBTW.A*]P^O;WHL1E-N MBE'P.RLX>$*P'XA?VZ;?&_&Q*55Y+N &6LZJ!I.J[X)G)7Y0Q5J$OBL"+PB> MD1?.6P]97O@]6[^U6[_%UG_AK?_RW-:MX.AQP11'+\U!%NK-%0+%J.Y.7;W] M\0<_\5X]HW8TJQT])_U_\=BS@A]7VX^<[UQ0_+97SONV/LCF@8?1/W'\1)O20%&JW M4,:J)72IFEYOM2H=I"M(/JA.MZ70C5#WQ5XV.R6V=FV#L9VDQ+ FQ<6D..MB MQ)W$Q &*;K>Z4,85G=15(3M@#,E7/=KE3>UU4RJR= MKT.QGR3*3HE&[=I>RUZ12J6^T^4@J^J!9]%[,VS^5 5O^SWLA<%DGZOR-H*L]I:%X[&VX;2*IM5W:NNT$8W.UZA/7#> MA4;JOE>0.2^[=E;R6BQQY8RXXMC#YF",#JOL&OT?&$L22KIO8&CMABUT@.N! MS(.53WBDM;%B24KC^@BO[$\ZE*.,#9:IR3]W\+"U4KLT*61QP+B&H*$C M4?V(70,S85Y+\MOM2_'C#UD0)*\<@IBLVP$0T0V\R&Z?IR]=,F] *_-JGG\+ M:![D V.LEB6@?YCTA(^Z_L*K2+@#RAW,09@^>0DV5?@MSP6/&HE2=X0^VL4K MMNTTZ(MJVCL.%GYIGK,),&P0#U@0.RP5,DEA$3_,P# (;9Y+&0A6Z/>(T6W7 MUJ,1:VRS4+Q7=MZX48+0F:4(SJXS-!0(R\=SXFB/#7[V^C#-&U"*NNJ!#<,* MG_M:;!Z>7HF2UNSD\6WW#82)J!#C&&-F*?RH$6%CC"A*3D.'G&2F0%F+3\T8 M:+SDA?A181:R46>6;>]4-^7#[5 YE=ZJIW;LCG$ 3\UYHIQ"Q19XGJ)+]+ C;U$K/PT=(,TN!:KV WCG'Y# M-XV\:Y$%B>OGB?.K+/8P87=A')'FF!E'PG?]*,7_6*S"T'/SU&=A>0H9J\R+ MKC$B\0(WB2/G#UM91)(G;@(M,M]WPS3 S PSDNQ:O(!*+D33+#_P2#?GW: K MRGQSE4!X#86U2)! ;S Q'RMXD2=6*=WG+"CP(2;(?3<+/"QM:Q8>N%&4\X0L M2#$*VXS'E0/H['M0)<^XT _ ST7MV[5M"3.ZH>>)R,?\T(USCZ=G^(%UH]3Y MK>WAE\!-,\_UPA1709A@"H;G>8Q-8;T5[3U@BR=N&F-NZ.9QX.99N@"+>!XL M>.W R7 U_.S]/\#B+\#BNYZ7NF&8L+62*(/26>KF?DS[3:!O'DR(>AHG4>ZF M02:"#![U0Q@<,O,,(E: 2Q#A(HG""4XS1+(PYFZ0IK8R1 M63Z!Z'EXQ+F;Y8F 7;,=@2,OOQ-0,5T'8C?6H>R=0U:,I8&+HBB'+JINBUJTUGZ MKP$F2J5@?4KL!@FD]0IZ@+LP#QSY@6$J=4E3U@1S42 +@S/;-X[<=8JKI)W2 M3< \7W:Q$MV6>HO22/455:0_*F4S_Q;[YC0]LF_29^0;%C@\2.I.6./8ZG+B M;<-A+"&+TGG)/%U0FUJ/IH=)@:HXR$4*7V6QL]I<6_;GG'<4EUV&-H\QJ+'4 ML'>+H@'>)0V!3D%#<6)OFC<8QV4>B(GNCY4 MNM#$ZY8,# [AAD:.PPK9T'H;PI\L-7.CJ?R>.8PXEY^^HEV"<),N<,4&%+<] M0@&'A-F.Y=(P)R9/TAK5/VZ-;5M5+.K"+B>N^K.^AT5G>TTV^!XV^0>Z%O;W M/'O#&*8#'"C.C1\Z'Y"@!;?]B, L>KLD3393:!*O(V K(-:&EWW^=/ LA8X\ MZ]"A@>,N\9)PN>0AS:05/C%M@\4?YAACU]D6ZX*Y&>KJK(ASFOQY).A8; N_ MCI',3K9EY@R0%_TN;<(V>U..H-E6@1D3LPX395STW,\#9T3AW"K-1F['/G%F MJ>U0E6(O[]B)-,K*L"Q3"H,8KF0W1C1M_ZC[O7-Z810J,0!I4;T=:*V&.F4C M.Y;7;MC <]?.OIEF6ZR.NITQ19HR#YLZ4"29.]VU#1-2[K*.? Y'*0'ZRITZ M,P<;01X0L=R"\TD29_AXC7*V]K,EI_VF'7N2T7XSDLN.8+YPRR3E PQ0;V# MT$=]]L%I(C^B2HUJGV6)P]2$$AEQ(>)JX53HG-MR;/MADJX==GLA3SR&V/+' M+^)S)4VO"R,B-T@B9Z(SADB;&Q-S7,6>&Z7AM?-IS%XVK==P/_K'!X=9R71& M0HH]"GW@@1>DL?,>3$L2TUJP)7%B2U@5M#DF#D.\-8NFP, + MU&E0#>:^$9BLEYP4LKEX%03@54115WX.;A/$UX^8$-N,/#<.O9,Q62N*OE-& MA* PIT5$0KPW29Q_M,V+XIMQY 8/=#>"]2/P,"_*1MKQR#H<AAC!$A MBH B\V#B!XF/\$;808(Q %Y$I!* F_V"X@>R&<*OX18-(@"9U5'C_.I*9<>RRXO#T.F ]6G"U=[*A.G8S@SUAN@ MAKI[)-)=H[<:>^Z%NF,L=&ZMY,9[%K9U5>"XXM:?8.9P4Y MMA@S!6_&U^+L-=D-5! $'EC)?+0B8(5I&CDK=2U^;RS3(_HUQ@4EGMU(>I?G MS2CK8WR-07491QPG#\AE"OS7!H:\3"OVRX)UR:/<:1'!RU+J6#X;1XE8Z>NS M'HMG'MOIT-@>DP)M*+H[.F(A6QS0@'" ON(LO-*0(2F"E01?X9 OX:*JM>U3 M)5&09=^BF%9M,1XFBW=H0XC2P&;TY"N%.!T4@[AP+:=3VXEGT0EEI5@]AA0@ M2:%IV03[B-H!<]DI34S%>@U]T[&Q*?"L+GZ/ "I04\+[?9']YGP23"G$\^D( MQ31*!P)EE*CZ*$1Z4_(;-0.XQN M@PHB+C6JVZ'7]")/]#9?N=;7XZ?Z6\M1_G M3L/M)\Y?9;>C3QZ5VF*JMT[C*\MQIIN^/?"GNDW;]VW-EWNT"ZJC 7B_;=M^ MNJ$%YF^W;_\+4$L#!!0 ( #FDF%8A)-3^- 0 "X) 9 >&PO=V]R M:W-H965T MK-1@!9=PIXD9NH[IEVL0:K^>);/7A7N^:ZU;B#:KGNW@ >S?_9W&632AU+P# M:;B21$.SGGU*KJXS9^\-_N&P-T=CXI1LE7IRD\_U>A8[0B"@L@Z!X=\SW( 0 M#@AI?#M@SJ:0SO%X_(K^I]>.6K;,P(T2__+:MNM9.2,U-&P0]E[M_X*#GH7# MJY0P_I?L1UM<)M5@K.H.SLB@XW+\9]\/>3AR*.,/'.C!@7K>8R#/\I99MEEI MM2?:62.:&WBIWAO)<>D.Y<%JW.7H9S>/FM5 >O;"M@+,*K*(Z7:BZN!_/?K3 M#_P32KXH:5M#_I UU&\!(B0S,:*OC*[I6<1;J.8D34)"8TK/X*63PM3CI6<5 MWIU1./IG[_N[5W%E>E;!>H;7WH!^AMGFEY^2//[]#+ML8I>=0_\?^3_K_SZ[ M9!&\Q0T>\#'7@P"B-+%^BU65&J3]8?)56? Y=S_)"/GT$]C@ ML>6ZQGUM.1B2A$56AN4BQ5&VI"&EZ5N+X (+2,.XO207_)+D)0W394ZRL@C+ M. \>E67B!).&&5X#FBT1/;E@?A",0O3Y@NPP5BYND"1\LT M#VF>!PEUU#$E"<%ADF=AD<;!S: U8-8%9ULN^*C!6>9A45(WC!>I]_^JY&_5 M.]9I&.>8D03SG&>C!O)^+*?XL05RH[J>R1?2,N/.LW.(;*LAU>ZCFH^#;%S3[-G#MS321RGH@/9Y8*O$$SWQ5JA1P=,N]Z@0&18-4RN0/T]6". MDA[&5'%C!KPJ2&S*0ACX_#E+PSH@E9(U'_FC,K>L--^A0$%8YQ\J&>!^Z"D<^R$D.-W.Y_7LQ+@LBF\0K/R7MU,SKJ81WHG>_4AO@B-;:S M:77Z&/@T]L ?YN.7Q!>F,>-.1X.N\;S WJO'[CQ.K.I]1]PJB_W5#UO\H 'M M#'"_45@+#Q,78/I$VOP'4$L#!!0 ( #FDF%;LIW)390H ,88 9 M>&PO=V]R:W-H965T\=FX<*&6JY86 M#@Y?K<527LKVR_I<8W8P4TWVSX0\F;9FO,2))Y M75_1Y"Q_/7,)D"QDUA(%@9]K>2*+@@@!QI\#S=G$D@YNCT?J;XWLD&4N&GE2 M%_]2>;MZ/4MF+)<+T17M17WS3@[RA$0OJXO&_&4W_5[/F[&L:]JZ' X#0:FJ M_E=\&_2P=2!Q'SC@#0<\@[MG9%"^$:TX?*7K&Z9I-ZC1P(AJ3@.%QK7%"5K1ZD UGC_NSW@-GN<<^U%6[:MAIE".:8^]1BF]DYC"?V\QS/>\1>OXDG6_H^7\K'?N/F#>MAA/\=Y>@/9E@-QD* MC!?-6F3R]0R>WTA]+6>'SY[PR'WY",A@ AD\1OUO3/#HV=W(>&1M"?Y<[&U- MK4N$==X5DM4+-M\L'U55)PIKH2I194H4+%L)O90X_G3/6(/^< N1 #^OK*S3 M6E;9+2A7><,^UJUD/&+/Y]@GO!_NR$ M;J4N;K'*[3C%GY '=A1RMF]]:E=2;U!E>\RWD\2U>12RP(Y=WW;#U/JL1=4( MDQT:EM5-"^9!Z-NA[^VQYV$:V&Z0[%GP1S<*[2#PF!_8@>_9KIM:)T8#+2N4 MF*M"M0K0N2%DQWPF-\2/\\L2.8L[@+TD4#%2,O>?P MT/N$>LCJ/CW/\5-#T'-B*!-Z)"-'B()=!O9@I-2'?>,]B]M!"C/PA 50MQ?R MG5:%20,W8F%JNYP_:$_0@JL'R(G8;'N!.]CR>Q[W8\A@+\BX;#+N;N_RPL . M0Q\*X13Q]'D79X=$I2(#&@G:4Q#B\+N@V@[K=I; MZ)B][RI),1\[[/-*6N7X::WKA>K3!ZP%W-5ROZ6HW"03IAHF&K:H"Y3\YL6= ME+/9/U $6FN37_#'9_L42% :#WQ:")A'0SO"R+=30$]Y3!]"%B&2X\!G41 B M^LTB#)5P[,5'V,/U/5J,0<(/(_A:PL(0Y&+#*F&0';N3@&/D8N2[YD/*O 2! MC-T>XQ4AA !N00!@P!-":#/$1V@'7$6@;.!X?O&JN3/4BP@+TOM M%%:(\ %VB2(7SI1LPOU[8U$N[;/KO91-*V-,66=-TTDK%PCTR7C/GUIK,+R5 M0F^G[O==L>^1!Q.PK_W$,]FVGY .' Z](3D& 73,,?+2R&C[K9S3_L <+L6M MF> P3B_D];ZQ4N0$QC=#I+48*H2'\ACFX=:GK*4#<7_@JZCVC9V1")!2GCU) M/,Y?(K[(N,'VYFDO@L?LIL)98JCWZB'O@M7@B2'2 M?6_1W360 )Y/!;!A-[ AE)E3IC,VHE\*JM80$67=(:QA](M?D&X9@KM )G.0 M4=FE7+>RG$MM8L=F@E'*IAHYQ*7Q$W:#, 3#3J.4-DC-:.)!+/&=!+UD3\TR M-MD-:\JPI"Z38A;9LQ/X!9=@0K>R+8M M3.68THYGQ(3;Z>F D7+3/]!Q@W*0^#X>K%D&0-X9!6_3"HS8D'M"F8D*XI*R MA,K9_-:0/*G+M:B0H-&X""I,12=M-.CMRGQ>*-W0%X/'&I4%_ZUA&&82%"EM M2^AHS JL-J5NTGF?(Z3(5@RQJ^J<) A-#/>Y5-?E]SP==JQ%<>&H!+), MC!\,X?';N[K 5%C#MPF8">[X9;-AVA@G-.Q0DX76"FQQ6]QV-CXX&[PN@PFT M:B1\I%(XV%6-1,&C,_-"+45?VZ&L@:'-P.8*[F9)=(@%&5[3Q8RV3)Y#!H1N M:$U!^;TMY#?5M.2GQ'O1P6EW,,WE'%H_ZH4@[9$@1AO;HO3A[-H86!D"CQ@- M-T5S:%+&)%YS1YRF0S'-HM\$X0\2 M1S]"O2^G3LE%:Q!%: A]JY'KJ:J!>BD,]?C'H7,'K8,?HLU,J$M$%YFZUE"A M2>G7DUY^2NNX\\0@GO@>2W'-2%")1+?X:@1;'=D_ JE0Y+7,VFVTIQ?LO! H8QF4[?SAV):Q[R.6-.K: M%(\1)6YY6PWE< 3E8Z764W@Z]+!@G5PR)%_@OT>]0WF%'2UU7(%5U1]11+-17;5JXGZ175-I0X;43RI:G[7Z#@[JB2NH. WU,K> M4OV$F<)IAAKB&:_^IV7T?7^7\?H+JNO=#43^[ F/W9?LS9CIA^>.T F#I[A8 MTD6#7EHF*MQ')?6#NU2\.U20T3=4XJ>,7IG\F![(^FM*C!XE]J/I<6C78^;! MUMLR8F!I7M#I-04ZZ9^9I]7ID?ZH?YO>;.]?^#] /0KM32$7..HZ<3CKF[-Q MTM9K\U(]K]NV+LUP)='B:]J [XNZ;L<),9C^=7'X/U!+ P04 " YI)A6 MD'#$/](% !*# &0 'AL+W=O&;-^VTMQ><*-W9Z-D M=/=PK59KYQ\FYZ<;N>+W[#YNWAG<)@>46K7<6:4[,KP\&[U*7E[DGCX0_*EX M9Q^+Y#_R78 M#EL6TO*E;OY2M5N?C68CJGDI^\9=Z]VOO+>G\'B5;FSXI-U FQ8CJGKK=+MG MA@:MZH9O>;/WPP.&6?P5AG3/D :]!T%!R]?2R?-3HW=D/#70_"&8&KBAG.I\ M4-X[@U\5^-SYA9'V$[=T5;.5=*$-^%6WLJ<3!W1/,ZGV2!<#4OH5I"2E-[IS M:TL_=S77CP$F@#WHEM[I=I$^B_B:JS%EB: T3M-G\+*#K5G R[YFZ\$Z^ELN MK#-(B7^>,G2 R9^&\67RTFYDQ6%5_W#9->TF)/I +14G6RJT 4@:ES:JDJ&8KJC72]4>Z6 M+M?2K-A&1]_3A@W=LC3'(6[^(XDN=%?;\!E=4:>W)WB=TT<;U;III"&^J=:R M6S%MI5$#](\T'><%':ECRD4YCT69S*D029R+O,SV6%>TY 7 LO1;8.5X/@<8 MT$J1%:F8E3E.LRP7L[B(DD3$>2;R648XSK.Y2,M9]-:MV5@ZDL?TMG)>Y_); M8C[WTC@VS2W]KA;:X"4?Q[$7#,E3+RV;TBR?BUDQCSX8V5D9VI.E2EL'67D\ M$W&<'N,TG8IBGAY''[23C=AJZMQ M%(+S'BT/HV30\O8$.?T)HA8^?<;T 1+"D>J>274P(62:I;7<,K#Q!N>S=62D M"WGLPXZ4',NQH-U:56LTSUM:>.X*0\QZ\%OJ-^0TQ>-L.M"26E(%M:&)-[!6 M0XBD822OHY;=H,R^E**AE#8-URNN2=I[%]"S#@"I940=8@[>V\H&QLG@SV!X M\ Q<@RF$-V7OJU'@>!,$!A0/K7W*DO&S"-ZW/0P&E$5U\D!@N&*UE8N&[3'M MX"Q:!4V#VI7/;'A0-A"*K+_FE30U)/U',)(=[9G;!:2EZ="BZ7%GT0OO/P![ MTW82P]=$ACU^[;TMJ6$\8?+[8"E-1Y7>,@0@+7KTF(9^ZSNF+ [@V9BNND$+ MBY6 !8'9/^A^M?Y",&A\E.#4_7@.AB/PM/S" [GB]KH8D*@I)Y% DU(;A)P*Q[Y'P[$(BY!5TW<=7MAJ6 M^;2\?E&B!Q1E+*(=_(Z@- @B^BI\LS2ZA8RGBQ:Z/O7\,!QW$W/\17JJD&?+ MOFF@?;L!.W3#NN'6I-Q@,ODIH?"J%XU:#3T-/@Q1W-MPR &2*\,\9#'4B0\]/W3GD$;P?-VF' >!OW M"C3:IR.;-I0CG+=$TNJ=??EH?GFJDT#U &&081](B>Y'E$\R.J%R*A :?\O] M#9UTGOM;X6\(619'80Z5Y$891Y>]"NRRE.\QB=<^XQ8&(IDC(725+B M-$7+C8OLKL<^U7_IJ15B\F"_:QESUF^QOEKAN&'5.[P>%N57PWYX3SYLV6\P MIGV0&EZ"-1Y/L9>:87,=+DYOPK:XT Z[9SBNL>RS\03X?:FUN[MX 8>_#^?_ M E!+ P04 " YI)A6,DJ4%ML# !Z" &0 'AL+W=OM7#%2DV&#EF*2^L[8!QVG1'+(--FE[IF7: M)B*)+DG%FW_?(:4X3N/-7B0..>_Q#6>HT62O]*/9"F'A>U.W9AINK=U=CL>F MVHJ&FPNU$RVNK)5NN$53;\9FIP5?>5!3CQDAV;CAL@UG$S]WIV<3U=E:MN). M@^F:ANOG*U&K_32DX36(BZ=D0HX]^! M,SQLZ8#'XQ?VWWWL&,N2&[%0]3]R9;?3L AA)=:\J^TWM?]##/&DCJ]2M?%/ MV/>^C(10=<:J9@"C@D:V_9M_'\[A"%#\", & /.Z^XV\RFMN^6RBU1ZT\T8V M-_"A>C2*DZU+RKW5N"H19V?78BE:VVEA)F.+?&YV7 W8JQ[+?H"E#&Y5:[<& M?FM78O668(Q"#FK8BYHK]B'CM:@N(*81,,+8!WSQ(;K8\\4_C0[F2V,UUL"I M,'N2Y#2)NQ:79L(M772U K;%8#]/SMNUX'=P8TXE@Q:T /]1P+[3$T[KEZ"?M,ZQER]M* MHF^UY7J#2Y_.SGUZW(,&>)-'C- 8/LESN)XOX,^V?H9^EJ5P<[>8PV?(SH"2 M,BKR'&A*HCAE@1&[5^!"6"WJ'GOO%Q!+67:1GCGAB^L;B),H(PDD>81,N.WS MR(NXTMP\B@8H)B0G7V!8*#WF,] H3R'/2512 J/W,/8&%A.P"N.*V0!G$2' MDB(J-$A1+RPS/J @6 MG=98)%!+OI2UM*X8*,L11"$M(U(4P5?5CJH3;G%$6!QE>0(T1D!,@@=E>0WO M-W''][#%@CTJ2=@++< (9!8K6+H::K$PE7Y&IYTR$M5S RMIJEH9=)$M?%58 MN-F%X\+4#A6[TVHM^X*W6P&U:C[RU)9[%5^N,6? Z&= ZZO%29I M,-P&A]^-V7]02P,$% @ .J285C2+"FAF!0 ! P !D !X;"]W;W)K M&ULM5;;;MLX$'W75Q!:8!$#3,R++E0W"9!+BP;8 MMD'2[3[3$FUS*XDN22?-W^^,)#L)D ;%HHO $6\S MM7TX2=FTZ'([PLG>]TA*E?SFQV\;6]N;:D[#M.NT?SDWK[D]2GNX6;NQJ'7%A?GJ\T2MS:^)?FVL/ ML_E>2V,[TP?K>N+-\B0]XV_.,SP_'/ABS7UX,B;HR<*YKSBY:DY2AH!,:^J( M&C1\[LR%:5M4!#"^33K3O4D4?#K>:7\W^ Z^+'0P%Z[]VS9Q?9*JE#1FJ;=M MO''W[\WD3X[Z:M>&X3^Y'\\654KJ;8BNFX0!06?[\:N_3W%X(J#8#P3$)" & MW*.A >6ECOKTV+M[XO$T:,/!X.H@#>!LCTFYC1YV+O:KPT]1&1G!+!A'A%G]S'10[ZY,_% MY=.2G._CW.YC H/O3'KZ M^V^\8'^\XD^V]R=[3?O_EN=7K;[L$Z^27X$FN84+JMFV!E?]?U:8/"K<9SC0 MI#$+V-\":*+[AIQ[';Z:CEPU)FBRM+T&:_TJ^>RB;LE'UQ^"_>A=V^+JWG;8 M"2:C8%AK;]:N;8P/3\R1RV?6GAK?FT*HSU'\:> V(I?@6V/Z!O3I%HZ:D.@( M"FO3+8S?E00G,J.J*JDH&.%502NNB,PIJS+*2T6XH))SFLN<2%ID!8Q@G_*\ MH!G/"&>XD)S5W[;6FP9VLK*B0F1$T$HJ6JF,X$E%!5/D$/^2:_V (0[D0-(R M!PE1SL@!9X(*F<]P5>4Y+0H!XRQ'\[@(< 2N5$(!7H825.:,BDK.DJ&ZML$T M"23R,3)/$GP@R@PPR!D 4[*@95;!*"_@EQ4_;><3D,23>JW[%83SJH\&4A&3 MC;8-GE.*T6*G)L_4(%SQ',)5P;C,! MPH%CYOMHD=QI/_(X4 +[!/(B,HBQ)!Q4R[R E:(LJ905X26C7#%PK:2ERF9$ M05Q+#H:^G'U.H!1:IWO$!%EEL^2CN4\&ID+, L%4",HRF5S:L'$!J'S ,5QJ MEIPUC1TP)''MW7:UAC!#]H/=%=C;&W+=ZA!M'4A5T9*)W>>00 Z*##!<;+TW M??V0@,$^M&-QZN8?>- &4P-$2JAZ*7P*5)%P+P-Y*P>V?4QJX'2P2SOF/AWSM=$/>M&:D)(M M]"MP-4P^P'NS@$<'KYXC\M(K/7_2F77&KX;^,Y :38U-VGYUW^*>C9W=X_&Q M/_Z@_&ULU7UK<]M&LO9W_(HI;[)%U8$IW"]QDBI;CC8^Y5O9 M3O;]"I&0A#5), H6_OKS]/=,\ !&4[N^=LO1]LD;CT]/3TO7N&/WZJFX_M M;5EVZO-VLVM_>G3;=?L?SL_;U6VY+=IEO2]WN'-=-]NBP]?FYKS=-V6QYI>V MF_/ \Y+S;5'M'OW\(U][V_S\8WWH-M6N?-NH]K#=%LW]LW)3?_KID?_(7'A7 MW=QV=.'\YQ_WQ4WYONQ^V[]M\.V\A[*NMN6NK>J=:LKKGQX]]7]X%M'S_,#O M5?FIM3XKFLE577^D+R_6/SWR"*%R4ZXZ@E#@SUUY46XV! AH_*%A/NJ'I!?M MSP;Z)<\=<[DJVO*BWOR]6G>W/SW*'JEU>5T<-MV[^M.OI9Y/3/!6]:;E_]4G M>38('JG5H>WJK7X9&&RKG?PM/FLZ6"]DWHD7 OU"P'C+0(SE\Z(K?OZQJ3^I MAIX&-/K 4^6W@5RUHT5YWS6X6^&][N?+:E?L5E6Q4=6N[9H#Z-VU/YYW $T/ MG*\TF&<")C@!Q@_4JWK7W;;JE]VZ7(\!G .G'K' (/8L>!#B\W*U5*'OJL + M@@?@A?U$0X87?G&B+QZ>J(")YL&0C/S0[HM5^=,C"$%;-G?EHY__^A<_\9X\ M@&34(QD]!/WK5^-!,/-(!IXS"QX$7OK.BUW5T8VF7-4W])DD9K=6V[)H#TU) M3ZH/3;$N'3Q15G?%U:9L^8FK>K=N5=6VAW*MBJ8$; :UN3? _HD;GV[+G>IN MRWM^I&ZJ&^#2E>NE>KK9J!IW&G7=HU>T;=D)^$U57%4;0*3A;.C.#'1U46_W MQ>Y>7>'>EMY0^Z+I[E57\^T5>+2!(CA@C'U3WU6D6UI57_/=@2C RIE@HQ:' M'::,F7:8+ !W1 TU4 ."V]U"[>%66P&OZVI5@&@:S.X&@V_W]0[0SPC 0"5- M8A /3Q=5H^Z*S:%TU7YS:!V,LFL+T6"KN@51UA7&[/!>T75-=77H>'"9(%XN M5G\<,"UZ ;.P:&H(>3\>W:+B9/SR\VIS6 /S8R26"BKQR^O5SZP]7+7E'P?, MG?&VA@'637VXN:7EN 9I 793@\J+O_XE"P+OR>7O']Z^Y,_^DS/7QJ35].AN M 9 XHR>,-:5J-P%,-/GS*SXEUG@J)W^R@NM(C$XJMS6<_J&);-QV3 MB*CX9&Y%1"AI[DUY2V;XCD2$Y,I:G3<7+\SJ.,02?VYAY^2M&F$\05A5UR2( MVY)H<@5,C0Q?UQOX&;)HNW4EC$($!;A=W<%@TQ*3YIF0A%%W&/4?U*(ZK,V$H&OL-#D M@HQTSZIH;]4U$&V?,'*+B@=L1P]U9;-MU0T!;BH:9Z?:?;F2]5QC"@*^!S5( M0EMO2LC!OK@7#0_:@!]!W#U1EXBQ _ 29*Q%;?9W'9#Y &:$-+0=G@0AY]8& M\J&*35M#SXYHR/SP;UH;!@<>^5=6HUC=5N4=X%W="R9Z,30.,^O!^,!IW- C M4P7WQ/G_8+$VF^ER"75/*H.I:$%291WQ&)9D!2-#SUW5F!LA/%YPK-!2?;AE MQ4CV@HPN+/JZ;*!<:1V.L5FT9:E>UUU)KD<,X1^TG#$D&O+LG0FZ\R\3_L,= MVRC-7Z6)?1N%>.(G#>P85C\?$0WV'P8*+4_A9-Z:4MW2LL0@.TCDU'*X>CF( MC7UMA-/@LRUA M>^$&OI@@2'-Q$'0BK-J1*W);[&[*8P/YP"SX$79CRGTWN(@S=F:B>*!FUC>V M.^B,.#8@3YZ#^)_/>NF3UP!R%SI M&'>W'_J?[/-.I]C/W=98#<6K;>\9#YKINJFWLY3"RE3LO!_YV^*779=-RU<' MT.)DE4>#6\.Q*K==)USX=%NM;E59$0.*_G\/7H..TTXK:1AM5*!M/PI'-.6G MHEFS JT_[8#+;;7O3<]D*L0V!F].8'B4OT=1';LH*8D$2&"T9K9CC"6HREAXC#(L!!:&X[YK\(5S*$3 MEW/$:_M:H@:858-BJY? X;DVWTB WB46&FN$W+G)BAR+#S @?$HO?A7G#]J8 MF;6:V.OZ:E/=%-H%X>"AA8II;LJU2][-"AX 4,:G)Q T+P8)MC^Q\863Q M#EB-UVMM%4"LB>!IFO6/#(",MAV(CT= 5BRBV\N+ U!0FS 'GV:QH>35VC@1 M_2""6M6># 27%'.LISIJ=L*RM@:U50GWL/M4&MU3-,T]FR/Q6LK/Y(8A5KVU MJ8'UJ#!8(4%449&[90R90[3?U;O'3#/C85L<1FK5ME%M"]VY/IO,;D8-&^/C M8&"R)Y3L'.2/" ?GM<&2$[40?VES=D*C3<@C&J>>LZ0/FDTQ>30-L!>P.VQ8 M8GO+:>'JCI(?A[UV..P)(U^35YSDP0;8P;&/^J$>^:M0#C0O&" M?J"2E?]6^O%RC4&/D;\"<]UNB^:C6:KJ=(#AB//4L1E1%O84=, ZM6W1W(O9 MEP0"\R"[-:N>3#+,$*OQ19*SV:G-3\O!@&#"7;VM5BS"-$5(&"EB;801:-]5 M]:%EL!#L9;ET!PI66S!SA?E3M-!4&-38;IZ0-A@]U]"T*<_!]O4KUYF>70OA M.%S1L+YU'1U9QV];Q'D>OJZ:MOMSG.P\S,GJ 4Y^&%,V!N-\8['?;RHM&U$!0U+%DB,@M7)TY;ZZO,0\&K<1@^:.?)+5H6DD +AE&=J4-\+< M.TQY57)ZC=U!HCROR[6LEV#4&N>(*$YY9'$X],/=ACW'+1FM@NQN7K-6O:VVT)[%KH1P;>Z7[,63WZT#L!,>-X&34,!:4MOY MH$Q/:P5R)^!03D@B"GPQ(8T0;G4_#O%%I\.;(K^C)LL ;OAEBP!\37F$?B1> M::;X#9V*.=88!&I5-N*Y-A7P MK0I&8DN^ZD!+4;A?RF[#2%P#A)K-94ZF>3)!SBAIH2*N*4E]X?F;$I[WM$0P M8_7'?J0. =M^EB,T*,R&YS&[UF.?@]>:.&66!8CB=T5C:UQ+8X+4]:KB%:4L ME[J%Y+"VKZ]8DHAY\'@W=O\!CB-L9@)+9Q]%SPW/[XCA*"G>.7"S$"=K]\Z* MB,UTFG(CZ@DA33M6UNMZ9>:I@P&8GEUQHS5+GY%C^>QHR)M[YL;#;DW$_F@, M"=-H.0K"Q-<>#6"LZ BED:_)<$BO0'<8-7B\+':.!)I-%$]O%&"P=S/>^13T M,5CF04E>FQF)S,VDGOR)64Q M)V;@R@ M8G 5XS0Z>\ZD,,J6!&9JCERVA;/<36BT,%"N#F$I)2B1J%1>Z4UR23^7S:I" M9,AV?7=L\(@/$1S7](U*O)@ 9;9IIF1*_S[[$OL[(VXMVRDDU_(#A#G@0CA7 M),. ) PP\$A3;CDC85&6QMKH?"HN#QE75BO3PI/Q>(HM%A8$K9D"\HGU-LN/ M%EOG^M =FE%T7C!;:#_]]!K"S!Z_VMA+.U(-F&C#A-B-O")-CCMR/N?IP5;6 M8BV; X@3W&$RQ,ZE\2VOS/;4F7RKCYRWP MD1I>4=#(!1Z:)8T_=B6LA-0774.I'%?--*7?3Z:M#R!(*X&_]&!Q:T93:O^] M7GWL#7SK.JMZ2[&$^"([PXQF5M !^\/51G(NB'4N2G+[-NI9L6.R/&N*?T*D M3(WVV=.+7U[WQ7?U;%/7<$6;&X;\KCQ0.G*I7I=W,.*W)75',%&=NYIT-R]R M7_J;N"+'7J_&D BOT2!J,_M+\D/4VZA$;SL[(G6]B^.,71Q5 TG5WD*C]S)/ MN%5;,,*F+-@)H*AC'OJQSI]ZA],6%FN5A3V&UWGDB3?YQZ%F%WV>2YIRR-[I MB$M=56N12U9 FF.8=4GPYAUXW'$..ZP_C=66 "6<8KQ^UNICWPX4+(1C6IL" M8!XIZ]!7X^PZQ A;XBL_?0+37^YNX.O: M+JU+D;;.(9*69-J._.F^>CK*BAH%[XJAD;!GL$/P23?W[ ;PBK$+X! -:2)< M1-:0M\5'HN9GA(U;@WFO%_:'SN2Z-YPY J-3R(E/"-G:BAQU+F,,XLJ]1NLA MO_"J]XXU;_2)*RF'"7S.7^YUBA_4($S8:F!-JBW)S)@MI5)R.4VMCTN1OU]2 M17&H\=KQ5<66IF[6E "7"&3"^+<5(JMF=7NO%B\A]AOE,Z;R.8".X)>$1@ZC M6QVK;%"#5"C)P15%6B9^-;J.E\#.TK"2%L[!*]3/QM&0,0Y:"*1^P[T]VA-I M[28?5JM\=U_<<_N:RX"QAI-B[2@-Z^)_"%R[KW?KHTLH-L2]%"QV.6 M1%-D7JS_<6@'I[IJQBXQ4TR7O,:Z[0HS9G9DS6"XC;G7R!4[>=K1.=%(T=DZ M::2-76U:J49Z5U0;6@U#,J-W6--O<>^D4EU4=_/(2S_BH#$U%7?E3=U5QH<: M@ ZF<7/0$>S)U;43\+-J75XGT\TOS??%S7'49"")N0;E"M VA(4I1D=G?*M677TJ M63)-L(ENM^;FO%_!.SF(4WDRY_)E,)87^ZRN/^J/PU6'23ANSG- CA6E)^KF MWIHBM2#3?_[PR>$(GC-0Q/)#+K]5\7#O"GY5JYX:A>)P72=QO31R R]3L>O% MG@OW:N[:H,CARL#+Z&2R@WMD3?!$KYU>$D /\\ -DD2%;A+D;I9$<]<_B5J[N()W!+GY>6'O_[%S[PG+<__Y:7^]@W(^FZ:Y6Z8QBIP MPS!U_=2?N^9\@.OFK$M.52L;BPFY'RO?2]P 4/I/CG2V?#U.<1"Z00Q:N!Y( MX?OA\14'F(%42>B#H+&7NW',V$ZOB85RYBQ4.D4]=/T\=X,@5)BRG[E1',Q= M>Q#DS"0?:.PT$PX#-_5]%65 .QM_TZ,9(ZK\>(HVIAQ$X*C8IX]^$KEIZ,U? M=9X-IL9/)H"<2XD:G#Y7_ABB;-P-J)P E \BUX^!HN>&0>#F>::P,GX2NWF$ M:8"WVX_EUGFQ+MO"QM>?!GR%,A&(A # =(0TP]3E?&"Y2K%A&/?4WGHNW[D.P"7I@ 4\+*2;/I! MJG+7RXDA 1E+$$!;)+'SO+R"5'(,ZF=33NG9#2L&]DA3Y1-I\2"Q.8CATY78 MC9G8Q0Y.PDXZ *1WAKLT\T5Q-@4,G054O#PD[18!^3";N^:\+'<5K9U3W#2E M>*?!$3_G8 $_PE0Q*4A]GLQ]FVBII2D7O:YEXL^J3J$"_U=8C1X>,8HVL4=L8)# MJ[0NMPGA8!O9[G,>S!FR@:.N?>+FCVVY!9$!=E5 #M]_*O;J(CQ_^[>WZFU3 MP_TK^6^)OSZL8IZK14!2?J86Q+.1?Z8>&ZE0O]8;F)H>SNOBNBO._U:T->V* M4?V'U\7^%H$%("1N%J4 %<300.$9:9$XBW #.B-/SGK 3^%8$_X$^A>3MVAI M#'.'$HEMK9Z#$>&FABKQU2(!1-\!OG$4TR I!,D[HWF$F:<'B<^<7R<9TR,: M,0KOET^7&%T/0&T#[.P@NM+1:ZO>E5@Z_4 &;0.EM0AHU!142J%TH&$64$-A MZIV=@,MSNGC^PH;U7Y?59[B DCN)O8#MP,*'6O1BFIZ ([V1I"J MEH]BJ!O+E32P;0\T.;FJH^,]4.,9AN9 9C4%*$RJ_UKNIJ M;FVPV[],)D2'+..(EE0-F1=BM0N\"H?HN>QSY&5U3'KPXOG[80.'7;.CQ-V6 MMV%5E+-NN-N4BH(@R4T!=%K3BVAIOGX*M$-F=6LR\I)2Z9.)VN$CB:D;[MN@ M\!160-_0W5J9"/26B7KIWY\((W'; :7)64_NQW)4I2 MQN MQ.5=!APA[@K=VS')T>IN"O7F3I<;+P2A/NOZYL-%OZ7&)$4YK;*A4-^. M_; R4)1&U5?0>$R52S6G!&M6Q>3F/Z=#Y[6**NW+;N MD*6:,(J9M?#&4)NS%G9!B@\@7C^_Q/]:H;JJ[%;+,RE"BX>H4QBZR;7AQIV& M$EBZT$CEA<=7]X^YS" =*D0FKO=::IW:#$UOPCC'2AJ)\V'2KJ-;-71)SZF. M1=:JP4U: ;@#IOPHNTUX^[!ID=$U.CSPL2SWLH]Q1Y655=FOJJY@Z?+8!'=G M%G?>7\W#]=7J+Y<]N/1S5#02-4Z=O5,<^5DWUZUI>O"E%QP MY82(:3&HA[8J*?0:E3C)]ENE92B)7RJ^.FU'"49+)53%3FPU*S6K\V"^[-R+W5:V?7-J_ZZ$[(^W$&\^ M%?M[YQ0D\P+,6QY&> !366#P6DL<63O:IV(Y29@4Z> MB4]J-VGL9+>RU1!%B#=K20*;>KJD@,VR)HW4<+SUX/)"7P$)F/5M:R M$D>U,$M<+&UGS $K*6,0S/#%#>*5&\[6];SQ[CM_B2@,*G!#;50.4[K8[0Z< MX^Q,9K@V=F013X"21K M#]SH8]*&W.7$,8O&^<7;BZ=X<5U^%I!#FM3"3M=T9@&9R<-5-14FBUY3OK6W MVZEI2.+*GHD3K1."Q@/KU+JCMB(R!(RRO'C4M:5+DR(?K:''FG:H(X@S]L6: M]M146B+ZW3D)O=Y>_)2K-4!^B87E1NFG]L#=U>ZL&PM:12 Y=*84PEJ9C<7K,800+ MU51=_KN$BB4%,6EU+"W&,N[*SQW4K"."4N@NWE>4'V8]_A4,.=,3,U*I=L?! MT1:T$4LZ7\&2W\"14X'3/#9J&_QJ7M/,W?.:(]@8COL$[:2[2$37XOECOK*? M&ICK-&-)*W"O[*73SN)M1Q-CV6=@R!A;W3!/^PE,DQ\'==[1IQ=Y1 J9@%7MF%1"(N1%:@K<3ST/@8YBX M,63#70]4I2R[&01YX]RKXEZQJP\)4X;EYAGL))-3:^O@OIO96SN5C9%BPT(5 M:LI:C%6^:6BT..V@NP; 5-3YSZ7B4:-XO9OA71X>O@L;:,;<\KI;2\Q:T_>L M>UZ.;-?@UVDM;I%E-'M*<-"6$NH1WA5])#?N,A.3H .(T41Z\,-N(<>.#DC* M0%'_'(8O6'J>GTI2A/OO^K-FBJ:A_A Z)J8RYS#4-TVQE>VCM%]VPXV+H-(/ MBEV+Y D% ND/TU@$]B%9QH']4#YZJ-5/^?XR1GQG/QEX<^!"3D7"CH#7LBRG MI*/]CG_TSI&B%#B!ZT&U1X S?*(B4@0&]FR(P1P69*YR%5M/]CFN/6]:@ 9C M_VF0!.$6W@"J"CQZS"9VY/ 8>$WO>] MK\N/:IXE3;8;NJ^TSEGVX#_<#GRKW^]3,WI?)#*GO=*< M;:VZ P5C.\[]W5#&D[C6"&.ODCCW)R/LRZZIZ8P]V@[8*TS7Z=U *M"677^: M@"3VENH]M5L6_=9KS']](#]//AS-DF< C0?E7&WN==_:L&M+]EUI[U1HP'KK M1*+"4(E;M*8.+M'IGA)ELC%KK7?-=./^\:&]=0A)K^<5GS, =WF[.9$:JGDM M5WA\SF8 MN?Q!IY$L_%7L!J'@'*1N&$9NFN23'D0Y4:R]E6-J1IFQ^73>),CI;JNV#V 8 M DG]>'F^"I#X[J X*S'UW-:07&U\/CP/V6 /@-H*9'Z&J,.,YZ;99[8)3PVD M'1G#P4X=IX&F[@MY O;4Y+0L?:1)>T:]@;1U<2YFT9)EL_P\,:\A30!.-%4B MNT?".J;U\4S@ZNZ@14B)<8 RX?0"45"_1>9B4U-&7@*9OS4U/$/]G&-+Q+GU M1ZX_)CFYY/V[?QR@#($?G'_A]K8M>X?#B *QP]' MON_Z>0R=737#LWZ6S %.4NK?<"[K0X,(OW]8"^'XX8!Z',+82:DVQW8O"GPW MS'TIO#VPK6Y@$.EJYT7OBL]]3>:!AAO6XOT*%P\HM#^#@?C#M:X6[>2\0%KT MOI[]FJ-6\_:+=]RV=?'^I0[@G6=&(HKNB,U\M:!&#RH.4VT^FT&=+#(W MH:)EEI\-(XW%B&)_DPC3Y89S#*_,\+Z;Y#F5;M4B3E,W3ZA.#(5)?2S9'%#K M'(CC[2]3V&9E%U%&@6]XI@"5VJD>G&^@%M2Q RV>^&?PN<*<6NVK=2_X#.HV/KZ>F38H!<26H5HWIS]>3T_6KE>TW]9RW.@,6G[UHMH$9UE MH%< )I+S@\=<'S&R\2?U/#7,V=A;>E]]D]X?/W?*"KSZ?Z_/[;]R!]].6P3J MJ0L3Y8?+A%)@M#$_"ZCI*W*]-*#<4^@%4\N0PD_R WX);A01 %FX(7_.\8#RFFTKN:]_RO[<<17_RY[$L!7H^0E]&N"A?%SZ%P2 M>&J/_'9C0B8D25. ]ZF:?0G#8A9TX4/WQE1^QD[#1D8] MF _K. MHT8P,AO4^9G!: --XV TR\F5R_4"4U*OR,Y77U=NRK64[ M:>KHYB#(BLG"')_U6#RT)V>N]V2UJ206J#EVY$VPW#W4MR6UA+$$NBO!0&ZI MXD;Z2>1X8E:KL&8MG2EA1\1KRMN!DI+UJS_M-!A'@Y$]6/6FUJ<4<#5_!GLY M;T&C._36\%KIYIH+O3>#._RL_<4&<7-8H^9)AFF/Z$'YJU-" M_R"4$?%:9_']F3.4)WSUBM*HG;+PI]I-$="2=SA3-D,72^ MFD["!'76*HO[[!'=!CVKFEO9^F:RUI7--M)Q-B152+L*+1','II^L+DRKQG. M"8*O&(YRD!B NG>[>SYYPZ1W*+VTXSW1UY-&,)>-A?1.C*3$0H[JG_ M3^L!]9Z.Q:6VD;\6V_T3];:N&Z-G7/6JKM>#VJ$A+ZMN!6Z4*;CFH&$:@(^G M:*W-L/UIBL-.&"D:G$IS:'VHFS+6_9GCC+HT@''Y<9# YYIQS"9XLX-!?Y7D MSM<\=+0E5%I#>.35>/_3TZ=/%?R7T./V]@"!D@LY'Q8E(?MD,3"F?0 Y=94C3L4GS,^+4P>S3@55WA8E*;T(4XX]P3 ( M!'W^Y "5QRI$M!$!!?,W0:P2A' ]$:30WSS)G6?/GH$@5-L%DE$>0LDD>$%E M>43W%.$3!VZ8Y0H>I$\;((*<4NZTM87]2?H4A"$]38/&P(S_=P@R/GG\'[XI MN@VDT]S\=>B55*4.YHU0E?Q7>+.T-07#@00)_R,"Q2"5G_$RTZHDLC#L[S4HZ[IB )+ ML%>4@ZPQ@L: M-5N9PR3N]19:][B(IVNZX\,67.D;TNVHMU(K7I>?N9C'1XGHK];633D4:Z,/ M#U"M18OC$W:.C^,ZT;LM47A;#N!U/<2<@Z?K=>2FON]_*H@\96[V/5T(X>*@ M/,0."9^(/YP0T^^^G7JW)P]XH)JAGX5/*) ^?S?IOGEB;KY\\>S-.ZIJ%?HX M#(OL_4.ZT>YZHR,D^QXF"5>$@[+G+R;+)N=;F@??7+X;WQ_\I_VAV=>MM>&9 M%$$[P[UCOUM3O3]I1\ZWDT[EH16\U0?3W4N$0YRRI_2''''%1TA);R.K(#DE M0!\-8L,EL,7\$6@]SNTLU^N3/.8/3Y/%K@\;8AVG_\D1HC:?&*I;.L3#DMZB M0FM*"G;N1E>.&%MO-IA4\/K-\NORFD]+T%LC3.%^=Z(5R\)5"SG-;ERK1[)/[>U3E"&,8RZ[T5E\1(Y^=1=?_^,!W'E])N?1?) R6,!G: M%UK>S3("-D"+AG<96)8&BIBNQ>T!E\?ZI'DR@^QC/Y!C/D59I$>"!U6HY MP_JR7AU:ZB$D KXKBS5Q].A\'CZ A^EICOZ FVTXN._F,U"M&7[W>*I"1!1% M_$=B[9B"[)%"( Z92U);O8#FU(;Q)%QS^$,IY6[*&KO<8R&=?=+YRT<>C^KW M[[Z+E[#;Q/#Z"$_!EY%I;S4G4W.?'RP#A&O[9;&DK*4UUI #$D-B0:@T&?E8 M(7.DJQR*.6-X32, J"+:[SVU&SG'LZ5V! HG^_/=S7$=?) P8JZV/[=QZ"<5 M13XL#,CPCX%/>!&7[Z%QRS47^]_)KWB9UQUS_9(\*[U8(Y*;JFO//*[^?13[ M+!63"J9G!KZKK*U.H@[$%=C3WAQNX10WQNFWNYD^*/9MCC&;VSLEQH37TIAF M(;U57/VR1:%PV1Q_06DP43KRFQ?4R6<> MIC-_2%%2UX2TIO1,L:%VEFOR1+B?A3E-.BW&ASJ/V=N/EUF2?"\)(N4M_9!8 M>-"Q5!'B ^'DX"/#*I+" H7NA_.%.+MAOO1:Q;5V\='9?!_X]%YQ@.QSH>6T M8NNP15E'4>4.+V?;]]&:Y5FJWW;Z:%3NS="D,"]3>IAZI$FQV0<7F0/ I"9F M;!0T^;#.W$#3'$;IHFT.]9H]YI85FZ"6=4E>!(>R#57N/ M].@G5?I-I<,:=+3=S;)>#-M(*SD\.[)+O'%O(M)V=RE-JB!LR3O!6I=Z]Z$M MY_HD'4UF*=VQCVXU?4UZ4D;^=G?[P)XSQLW,PE7_J"ON@2*%QGJ]N&KKS:'? M5#/(@.WG7L/GHAVL@][YP9E&+*=G80[N^]?Q=_Z&A7,6LFA4&M%^KX!Z:];N M7:\]G%YAO-4?G.&G,)US98>?[,P4[7'T0Z[0\V?O7CIDJ<^L;WDX?$N78%SSP'MVT]R?2GSZ'7,YSV<,>4GBQ5<3GHK2C,W#?BMB [LH;<\S\USPC_Q M C<''LY#>_O+-^\^&*09ZYP*5TP5H,>G(% !*^9YNI&/:;XN/U?F MC6I9W3$I@967"E::IFZ294Q2UTOPEIRHL] 'A^!&ZH8)X97GE#:D@:@8AZF- M?H742J-PQ40EF%:&B80*K!!&( RUF$2Y;@J(HF1"#@YV>>- 2%2GH1/*V3!- MZ!07L-,)47'^+:(R+R7Q,LZ^)S(LL_Q[9A&8^^_/G)?5%1W>/QO S[)T&%,2 MCM8GH[EA:DQWJC\GX1=6*Z3\IO!GGM*'"!^P?@^P,J559:4S.AF&7HH3B&+B M?8&?(M?+(Q'1)(R9#5F43LM:$DH-=1& B?ATAT5*!58_!3L=N@9VQN(G.K:# M*4#YO8P%/ _!#_E_8G4E_" ^$B&"6&SIQ:-AG8C*9'HMO0(HCH".NXI2/F(BR_#_" M^D0*+-0R#>AO!FL TNBLU"G:4&4@(XU$F=J(.@&\+&;]%I)6>O;Z^2_O0:., MFO0B/K0EHDI\F+F!<$/@T_EI].2SO']*?YZ^^N7\ M\O4O1.R8B!Y3LUK("PC-1,'\(DU$[:HH=J,@Y\-3$CK"94&DS:BG[0$-E-.1 M31!0D"./,T7:+_6_>1'4_QZ'SF4 S"E(:C@%:9%QDQ7U8;A4LP <"!O;8_ H MM.M_8$[1,A9=ZFGE"C<]3D_,:4Z7YGF@92T@)X+U:![3L2\T+VH>\X+>L= % M303TQ)YTHE<>)&+Z8CI;!VA _["J"]G7 $W(H%L^MOQG?MO_AJ?Q,_/#XSS_N M$] @ X04 !D !X;"]W M;W)K&ULA53!DMLV#+WK*S#J3$_*BJ1DR=[:GHF= M=NK#-IXX3<^T!-N<4*1+TO$F7U]0\CJ[,[ON12((O(<'2,#T;-U7?T ,\-AI MXV?I(83C?9[[YH"=]'?VB(8\.^LZ&2>52>?3_F[M MYE-["EH97#OPIZZ3[OL"M3W/4IX^77Q2^T.(%_E\>I1[W&#X^[AV9.57EE9U M:+RR!ASN9NE[?K\H8WP?\$7AV3\[0ZQD:^W7:*S:6ZAE% MOL9JWS_A/,3R,H7FY(/M+F!2T"DSO.7CI0_/ &/V!D!< *+7/23J57Z00^U!Y-XI2)'V43''D5X<+\LWQ$#T?Y76XU3O- E-&1-Q?X8H"+ M-^!#A=]-B^Y(@)RU70>))T$+<9/R S1T4/ /!A+C!5UP++'J^XF:! MZ[<+'.#EZ_ X$_?^*!NW3?,)W_^@NOV&\WQ)57<>4M]O_O_FVXX,D+ MAF1#,]N>-(+=07CAB=V,+>7)PLD?2B>K]0KJ,A-\ IS:+28L62T?-B#X../U M!,KQ*"N82-:K#4C3PM+NE/%$D96L@J+(1KQ*/H8#.N",K)(@5<9Y?;EL[,D$ MI] G7Z0^X3O9TO\110$?L4Q4#(289*.Z+P%H/HE>FD9)#9*RN@237(JMXD2Q/SJ$)H)7<*JT"Y81RPC,VXA3%N"!55?*7 M->^:5R+%9)PQ40$IRLK)FUE>^]CYL['KT.W[Y>*'RH<)O-Y>]]?[86Q_A@_+ M[T&Z?6ROQAU!V5T]2L$-"V4P@CWV0[RU@59"?SS0#D87 \B_LS8\&3'!=:O/ M_P-02P,$% @ .J285K0-BCX#% 5C$ !D !X;"]W;W)K&ULG5O9Z*_8UEC*S#5( M-DG8($!CD:P\_?^=TXV-INS,5!R2 'HYZW>6AEX\E-67>J=4([_M\Z)^>;9K MFL.SBXMZM5/[M%Z4!U7@R::L]FF#RVI[41\JE:YYTCZ_<&T[O-BG67'VZ@7? MNZE>O2C;)L\*=5/)NMWOT^KQMJ^?-P M4^'JHE]EG>U546=E(2NU>7EVZ3Q[[=-X'O#O3#W4H]^2.%F6Y1>ZN%Z_/+.) M()6K54,KI/BZ5U3 8%^ZS0W^DW(X?1 MA-A^8H)K)KA,M]Z(J7R3-NFK%U7Y("L:C=7H![/*LT%<5I!2;IL*3S/,:UY= M%ZMRKV23?E/UBXL&*]+]BY69_5K/=I^8[;CR?5DTNUJ^+=9J/5W@ J3T]+@= M/:_='Z[X1JT6TG,LZ=JN^X/UO)X_C]?S?LS?W5/\Z=G^Z=GD$<_J0[I2+\]@ M\K6J[M79J]]^<4+[^0]H\WO:_!^M_E/9_W#V:=I<5XQ7E?I"Z O\/%193;_: MJE)%(]-B32:L<+76,Q;RNI%9#7];E=LB^POWLT(>JG*3-;*L9%[6M53?5NK0 MR*:4S4[AJJ&UFEV*F0UFYFF#/? T:]2^ENL,BS7YHYBN66)NI6E2._+R>X7; M1.Y"NN["$5>&R&S,D+DI)C<[Q@PY!VRG^9&']#%=YHHHQ^XJN]=7!8_$ +XT M:W7< >GX\:-**Y906CS*=/T9SKAG1LMNMCB]?$9P51,5LMQ =NH^*]N:UX-\ M[S WW9=MP4\[33Q-+)1!VRU5W4C\GP&)%,TT-)BUQ,!VB;%8*UL/"]%M4@\0 MC^"PEFVQ4E4#S&X>C<)XXEBJELPVQ'IG$7N5UBW925MGQ9:WKEC1JDAYX[01 M1%.E#F75T) U'B\ZC6E:\YHWR=LU)I)<^2YT1^,W5;F'M=QG:U6LZZ.9=:V: MFM619^DRR[,FHR4JDL4&SZ#4_)%(-HR)507SJ[*4Q^Q5LY"7M8#<@#!JOX3I M=2ACL2B-2MB5"F9'.\&]JL9&H@VN!=I5@Q=IVB"C3_^07N):=NA*QW+BQ(J! MD&[@6DD22->S\2212>PO?#E+Y^+M-TB"PQOHRHH-],"1:K"UY:.\57FVDC.0 M4I3[1X!/;#^O*1+A+O2G*C(,TL2<[!J4M:JS)EJBUF(]LO7K0OQ?"WFYMF-; M\G65UE_4GJ5+LMBK:@L)D%NE!8F9(6!LQI;<9#F&Y.E#W6;89)6GV9Z4J+&! MV-#[8KE?+JYN_^ + MYSGSIE7$[O X&'9:#V+ (++ECG=+PJY62D]8E[(HR06,BMG\U%=0_TAH@HRF MAK5^+"#P0Z,MQ/790ARRD*ILMSMY"R?+TEQ>'@X*7\XBM+V%$T?:AMXIF 5N MW[;8 U*^*MNJD3/#T.W=NYZ;NM$N1TYI'F,!,9*49G_,=GM8\R38!&VF[8(4 M;PW"8.67Q*1JLL98UO&NLX>)/MTL/!]@"^S='W5HB::\8 M3&I+;*NT&-G-EB"MT- KFX;!O'.]3L3?I/5396MX$*]&P]:['5(Q%).3$[( MXXC;A;QEK\LX;*3%$&S(VV4# 3?:.U.FX!B0\/SD>TB9MA>;+E! M(&>KN?BSUG%^;)T]5%\C@*;RO?J6K4KR6R=Z7HN-41Z@6A5P>4H*,TBK1Z#+ MNQZ!=B!BJ50AO[:4590%D3%=G8CN[MQ^?/?QO4R7J.N8[2&Z4H)40U3L)]#W MN@1\KH51V-A2.,AUZEK(_V3-SA@6EH*HLW0:-Y"T0Z,PC#?P^P+2N&R:LBJ MY5A)L]ZS=E.5:PJ1'7\6^>D[M:Q:^);PV+ \ZZ<,UMF6/1.HNZV4TF;: T4_ MMMR 1![!&@<0-;DZC/?3%%!050]*^UZZ6E6M0;=!X\9W M.M@BL*]1=(NT$(8W1:G"6<0*47<_%)Q+3BH)PIQ2UV2@NCOND3MRB M^%^WN9KJC 56EQP!L0A<9\FQ@U%V6%,PHI,GTXYC Z /&1H/S( M\GQ?.I&5A' "UY.SQ ICSXIB?RX^E 21N?PNYV\9U@BN2=M#;D'1M86I/&)4 MA6R4.!KRU9GG_SJ7,R>T["3"C]!R[-"*_'@N/2X=#P+V M8GD.[7?6,H(6KK< .7(6)XX5A@GFB+=L%5VE@8AUTR759FN=4"B-4FL$ D M0)8!LW!B_$IBV_*"6":)CR3;Z:CML:-2355R#0:[[I5/&EF614MY# !^-?C M$5>0F>?YEA_:XJY395^9X%<]V/[,#WS(S(/TW#"P<$7&A5CF^O93*;[01J6F M.?[?3]]97RGL-;$\5!;(G"PO=L5'+JD/)TUWYKJPK\@F,GT0YR9D4C @._#F M(V5G1P8\,MLAJ8"AA)$5>0&M@>(FL7P; G AA]CRHQA&HM(OZ_*A.%[R9%7? MW^22>P8]VW!]6Z\>DQX\15K#IY5#1,ERT?Z!_@ D*R-(:_(:2V'4 +^!%&&@ R?68_@8V[,OFC0 MFR@*0E@1G#5VZ*GT/3)=P\))@N"L@95$-B&4#SP,:?$(69%GQV;>SZ3_M@=T M-GHX#WE/[+F+^%>R'0^?T2+\51"N7'?E^"B;Z=UH5(JR(D?E)@>G#217<#P8 MC$,\4&"OVV6=(:17IGY,.7'BY*U[?GZ$)'2 Z#+B(7 0+I-XF*4'*EEYP(33 M#KWP+"]7E!)RFKLI\[Q\J)]- BO%0>0;XP#+&XFA:V<(^G4N?E?I^BN2&6B@ M%K,KIN-QSOGM ,DYDN9BE\I_,@0\(J->V,DQ8D_2D [OWK$BE?SS]E(BA;?M M85:UI2RV2$>_W& \XFJ7@2']";L:/?F]1+J^3JWC&]UV0T+6/0#KN/E;NC\\ MO[MB';S])&_R%"GJJI8?%"$JBG<;AS85UG5!6W3KIN"68]T3.D=*/'+3&T*P]M1=GZ4 OWC1=*,+E[ M@"C,&NB&+@9FQBV)*2LTLRUXD5%FKUOOG(QQW7Z2P],=]HPKBZ6N]^G>IFW: MJN]G"ZUU0%26Y]0+3N_3+.?1Z99JZJ;K>U!;; 6U8TS+/8]WDX5DMQ QM%8- M6_DXX]:VJ<,E"1SFI^Y3W;%E2DYRA?)\<]0[ZC8\+86,H+=N-YMLE9D&?"]> M%$#?=X4X,K5YSD9;B,U)KBP3W(R&.C[899Q&\&:2F1) M#7*%K/H H.J/$X1I__ !@##-]"ZP3L]@AC9]%W]H+U02QBA(Y0]EFZ]-6-'A M>HHBF%Z6_3.<&HA#UR)0[\9 0GO6DA+XNB3?.N'=+M M3H4M%[",9^5G-2XZQJDLBTY0]8J1KSO1 ?$++:G)+6WZZI!67*3KC;O&UMMO M:M4R>+TNTXKB+DBE51FU[A&?:=^ZRQ!&9 UG/@<$0XV1!C[)06NA?PP]-,.E M=32G2A\D'<]@I[S6#[=5^8!L!P3@%[A8@V>*9=W:;&TIG%%G%H^CKN2X91FUN@XH>H;?)L<.[8FA<=&=7LX0'X:BO8\ G+( M"A369D)69#42%KDM2SJ1N2X$'#RG)<@YB'EH9:KYME/[#CY44G*14TG"[P]P MR$?M!(JV) -,YKX3[;5/JR^JF6AE*O:L6J,JJII'=@?= A&;K-J#6RTR#;RF MH\*]"F*0O6P,6^_3(MWRW:YX)5]!^@;R?H3HW<*-UMC4H70CC,=IFI_$[J)$ M#( *JR,4UTYJVHA#-2TZ&$=)E5- >0ZV>'M3R??D ;\P%8EIT5GO4OLI-\Q. MHR"ER!5 ,K]LQ@%K1.M=J&WH8NZ_K$<1@N=%H/N/C( _"B4R2=#F?A9*#NI MQK]]>BB_/SVD [OWD-1>5Z]3"9F^=#W)[[6GLJ=USX_!_@G*Q*6^??K$TI;7 M7-<($W!N.%W^0^KR__04LR2(Z G5IUX2T5/Q3Z ):50@PL!RR$PP#7S-?,L. M'1KJ!PGJL)"GV4E ?126IN@AK\8FL1-9H1/(, FYCS9SJ>BWW;GT+3>V^2 V MI!X;U>J.%?B)!?$1O9[O6C$5XEV %^-F">INK.AY$59TB":;5HQB%WQ&U-W! MA1_0O=#7+'5A2L"FEUT[ ;6_ZSA8(T'M'X$54 D9S?3W7')S271M6BK&H\BR M(;Z9_L8(L 86B0W];7H\?F!Y82@C%V+SI ,QQ'%"+#K4TG2V^%/Y((4:@I;<13@*J#>*X@!2Y #/?4]CZ4Q:C!^/TKZ[YGC.]P^8BF%?O*$R3A!;+FDNC#!=S*7<0PC\G@=#YS[KFUY M3B!N='$G*(RJ28>. TCO$*L2X!8E5@*WB&!ND8,M8&^)(R,KL4/AA@XYF?!= M#_)POM/,)LTJ^?TNQO\-[@R-GM77-JNS9MH-_1?B+4IZ,E^8L4]F"WF#35(7 M=3ZM* E),K W+^ILTXK=B$=[,>3 WS'?#24\(0+M,_T]%WP7GTGL,&LA5O(2 MNYN$]1WJPB8R\"PGP'Q(,_3I ;6]W,@3'P#>,/$DL(+('_7,9N3_40*],30 M*N)19PVV9%.[;(Z57#N ]=N=9K0 3YTW/A,?RN+<]!V%D6 ,#X26(E?2R1TH M">"KU)JV0ML1L_/Y>-(D^L#!/'(P:F?[=@21^M1:!*=^['!K[FYTB%-1U.BB MZ:ACQ >)R(].=*$L\RX0!42!(?WQU>)RT;465B6_M6'>3:(S[X\Z(/89L2YU MS9M,O8"&^45=YIE^,X'?:NAJFJ$UB/G\+L(D.!Z5/.5_M>M$+<-QTU--,D;9 MD:]K%CEE>6U6^OD0$Y/[CA%+470H;IP8-(Z] I!7T/\TTWC[IX M1%$ XYJ9'W0.Y"8^=Z%GY@>=\_1SCYN'P!6;SHRZ'SX\T8EPK7_T$\?M/S^B M?XF+?_WSKK4W;MXY=/#@NW0" ;\G" D0T?QP1,_XA)N2 "08KLTQ*O9M?4CE M>A1\(Q("0C/B 4ZS8XY_^ 4/3Q\ZY@-\WQZ"BN M^X+N;5=_GES"3"*,"^/NB_2*P*:_Q)5J4 -T=D7G.XC/,P0Z.M7PZ/ H<1F MK)B!^1BB QK'?BS>7%[UTQ!7'0ZO+MFA1T=E 2UF:Q$EOH>[2#%BI'BF=RE. M]2X=<]J&3_'O\FO?+I>.[5$:0PF+&#(%(M2V@6%>/!] <)QI(,'S;,IMP$V/ MEY,$XY1[]3XU<:]SV?O2Q*W.3[H#'#$!LL)I!H<@2A$=(H]L!71'O$/G&CTJ MGW!/;>W:)0?7/!_M?ILZ'YL3FU%O340%#*BWH_.I95 :Z1K>^BA->H\Y6W#G M0XP;A?>Q70S1\-0[UA>C=]WY/45ZH[_6[1/]VGM_M_^C@4O]KOPP7/_%P?NT MVM(K1KG:8*J]B((S6>FW^/5%4Q[XS?EEV33EGG_N$&%410/P?%.637=!&_1_ M2O'J_P%02P,$% @ .J285B$NOE8?!P 7A !D !X;"]W;W)K&ULG5A=;^.X%7W7KR!RXIR>^X'KW)[-/8WUPCAV7.K MM+N;-=YWG^9S5S6BY>[:=$+CS<[8EGM,[7[N.BMX'3:U:EYDV6K>_HBE#G>S?+9^.!1[AM/#^;WMQW?BR?A_]5]LYC- M)Y1:MD([:32S8G!!*$1!H_#Y@SJ8C:>/E>$3_6[ =MFRY$P]&_4?6OKF;;6:L%CO>*_]H MCG\7@SU+PJN,N=-.VP&@U;J^,N?!QTN-FRR-S84PX8B\(X' M!99?N>?WM]8LB(K MBG?P%I.1BX"W>-_(;^\:&2'*UR$H-SZYCE?B;H;@=\(>Q.S^SW_*5]E?WB%8 M3@3+]]#_F!?>A7B=8+%(?H!.GI#8=:\$,SODXO=O27+2/4\FN1AR/Q'Z(*W1 MR$?/%:MYBY1U+$_S(DOSS0:C;+%,RV+UW;X8P\(ZI/"6>]I3K-+ULF1YEJ?% M;,OG%T#EYNEBOTIMRC5&QN4F+U2)YZ*T%"Z8D MWTHEO03F$KLW>$\Q)U1-2ACM0,ZR>.8H^U7->L@A.\[4.Q@F2_]](*@G(I M\Z)JM%%F?TKA,5D);#L(Y<(^\=RAT(DZH>6UY*'F=8IK=\T>!5?ROWA7&>?C M\HJ[AJ%([U"5'0K*B=5RMX,?=M:T$ZV1L6-U+Y@W#*YB5<-UL$@SQ8\1SHI] MK\*9X-GU6R6K@='TD CC5XMCLI.ZEGKOV/84$(W>&\R9\WU-7B)$KKDZ.:B& M*%6F@CI0II8!+5IPIG%I\B02@*Z#=V"""#L.7/4AZG>][ZT(!+43%)DJN 4& MOG3>9>AP2_XXX%H0Q$[W7"DX@CMVQ)U"OV2*U%X@_3RS0&0]N9EBHI:N,KWV ML#+!LI:."FD*D0.M2/7!M!W7)X8[UP;989R#CVTP'_OM* ^$W@SWC8I&NX)X/)"4SF(7S.\DZ:D1Q2AT!!)(/B1/0DN+T, M&&G!O>V4>);^-,2JC]?Z-?L9][;4L;D@?/P[BJV3?HB5%_Y,H.3@NYHBWW1# M9KB^:L@#4A^,.H1\(>DPI0C>#]8AV@8=#&H>LE)7DHZAZ!\R#7RY!P/,!?F% MG&AZRSH#QE[".@A@'!@D;P8-+$$,#,%W+@V2XJPRMK[,?](_J$QTCXV$&9?! MS*O(_"@185L!09!##LW3-?MZ3L@&G<>EQ&1Y371W)\JJB?MW-5PBUBI2CROP MU3Q4'&=4?XX%(@RGGE@L'$,YB F-DYVXJ! 5)^^I$_%L>2U VI,UW!G-M[AN MN(-N7%3MET4#2& M*L0D]8E H)8$_'@:0>(H;ZB=(IM 6**IJBEF7N*/8?,R85NC):+*73@4-RLE M!4K:B>A7O N!2ZLIKG>D_?>%K)*VZEL<#Y(NQF)\.XJQUV:HB6-H>)- <%Z; MSH>Z%&\01#/HPAD,K=O\4O65(U$?M?! M3S)F"545)+I\_MA2LYF@:$F#'*(X I'XE,6G*UCLI$)/DZ"'%NT6TZ&/SM@J*]+R M)D/_M4C1)[&\W%#_Q39K]$+9)OE<#]=K2E((SZE(UK^B?XM>CI5[B,<#MT.- M6J)URC8KP)7I.@=\7J:+FR7;H!W,;]!&\M-YOZ4[ OYV[$->+M)\F5UAM$+S M510TRM$$KDJ,2FHK%ZNKY.,/EN3G7G/L(<>N\:)+_#^M*6ZPO<01FS+-RX+E M-^EZO6;+#&17;QM3P.AR?4,F+#?IJLR#">EBN:9!#K+K]6NV%)<=]-@7CYWP MU)6^]H4QO_CF0WN]#U^V+G8)\?-O>CI]/'^.WXSGY?'+^R=N]Q*E1(D=MF;7 MZ^6,V?@U&R?>=.$+ODP; 1*O*4%>+\SN&*&"1TP_4GA_G]02P,$% M @ .J285L7F%@S"(P NV8 !D !X;"]W;W)K&ULO5UK<]LXLOW.7\'*/FY\BU%$ZAW/3)7C278SE8?7SMS]#%&0Q E%:OBP MX_GU]W0W (*2[$R2>[=J9VU+)-!H]/-T _GAKJP^U5NMF_#S+B_J'Y]LFV;_ MXOGS.MWJG:H'Y5X7^&9=5CO5X,]J\[S>5UJM^*5=_CP9#J?/=RHKGOST W]V M5?WT0]DV>5;HJRJLV]U.5?_?@D?F(_N,XVVX8^>/[3#WNUT3>Z^75_ M5>&OYVZ45;;319V515CI]8]/+N(7+\?T/#_P/YF^J[W?0UK)LBP_T1]O5C\^ M&1)!.M=I0R,H_+C5ESK/:2"0\;L9\XF;DE[T?[>CO^:U8RU+5>O+,O]WMFJV M/SZ9/PE7>JW:O+DN[_ZIS7HF-%Y:YC7_?W@GSTZ'3\*TK9MR9UX&!;NLD)_J ML^&#]\+\H1<2\T+"=,M$3.7/JE$__5"5=V%%3V,T^H67RF^#N*R@3;EI*GR; MX;WFIZNJO,V(PW6('0YSO5%YN*_*5.M55FSJ4!6K,"V+!G_HH@GS3"VS/&LR M7?_PO $!-,SSU$SV4B9+'I@L3L)W&&I;AZ^*E5[U!W@.RAWYB27_9?+HB#_K M=!".XBA,ADGRR'@CQXX1CS?Z,CNPZ>%;9L>5QXX+L..R8\?;Q]DADXU/3T;Z M]J+>JU3_^ 0*5>OJ5C_YZ>]_B:?#\T>6,G9+&3\V^O_USCX^63(.OF.^\&6E MZD]Z%V1XBG1*%RN%1[(BS-5=W6:-O*U6T("L;BI%JMP?O,+A!^Q"/O5 &[ PO31*S9JQ!F H\%JJ[Q$'W! MTS9;U=@1].=&5P4&EO6I%=9<5G44ICG>RM:T&DQ?]ZG#0O#:KJ91\/E25GY/ M?^9E#>J)9SD,9/V"I W?YSI(MZI(M7OF"O^7'7_^@I82=$L)ESK/]"V3 ;*) M%;IN,M@O?%3I'#^QHI*_@)%.RQT/17\>;A9_QK,Z:M=MTU8Z7&7UDOC*$^[4 M?4@T;72 ==Z2)38#RIHPWHOP:786;F$A=<5; D[2:RN=9BM-[%%AG>VR7.%K M[ 0^N2WS6]I0592-O+7;J^(^ LO+?'?3%I:7A+FNV8!Y&O^_S H*? M[?;Y/=Y@*@I-4K7F!XE:S N*:]TTN7GA<,IS9OW3#/S"AYM*06IT03Q3&TO' M7MW[+Z_T$ORD>7E,S B&0J7^R/+ B,!KO=(5R2O&O@&C-.3W5N>06SRZ5K=E M12)'C%IE#>LP2P_M40Y73P*C^BOE[Z&OV&"P&7\5(E*%=E]5.BTW1?:'7I%@ MF&6*C2!&';QYJ_+6B:+LWB!\4P1J)21%_A:$*J_+D,W%/D?HT63K-2VEQJIH MG=9LT A&'TFNZOX@6% *'1*5]6T3&8 FO-MJ(0T+T=F^"4 "AU% M"5Z!L(H%N)8U[P$]F\.*JQ8,-;8 A(\&IS9B!VP3L.L2+:?8LT"!,QH,X>&OM/ZF<8S1;/O#@$GN_._SNP&X^ MXG:>!10V4.Q $RTADZD,^%2=A4F<1-/)+$RF\V@VF0'/-(U_> MO TG,1Z8AM,X6HRGP=6;&_GFP^LW[V\0G,31>#0*D\4BPD3!F\MW^' \CR;C M<3A"Z#):+43B+)WA\ =95>V@LM-@\ M'@]'T6@^"Q?C:)Y,@\OL-LOM=T2+F- X7D23:1S.)E$\G@5Q%,] VV(>XK?) M*)J/AK3P/BXSB-?/G@R*PG%9C6.!O&7 ?UPPFM(1[RX_)=L-=55JYD(GR7 MT"[@YUPV'SZ(@D4(SY[$&10N[WLN\QH&O8"-ND%\GHE=,?O^],GUZY=/SB+F M%4QX?Y<#QRU\L,]21&K/@@_K-3E_^O#&642))_PE628QA2)>-.X6OHHV&&&2 MMLO#K/5>5B(BM'5I M6<'=TB0N(6"73#*K/^O='N:K;I>_X1F:_@]=E?P=6W,PE)B/O]E5/Z:>2Y5; M+]=L)00QII@HO?XK>:\D&5D[B@^&230;S3WU.6=/@<6MJ=[=&)%^Y")5" MII6X^\*+Z/"TV-N+?BIW";:F4"E,10;J8K^'9X 7H+ D&9Y?7ER_YE_C\[,H MZ.RJ,]^G,L,5K":)99XCXB(*R06)^($9TP$'V8?NFGA?']HN80K%,\9!] -P M<@[\&D;>T2O"(.O[)!IC]<^*NEVOLS2CE[U!S.1N>,]BO5,57H\7BP7)BY,& MF+IA)$^\ULNJ5=4]?1;30_(*_DHB.\8]??Y+F_-#2T*>EW M9F%KYS;6EJQGFS=]BV(2#IHF_IOUV68RHI(HJ?1O!E#SA">FW1>0X3ZY,-W<:QOB7 M%FD9&# \Y CLYR]:$( MOM%F31?1=!QW)FLZB\;#$2S6]\1^P4.Q7P^G\6R%-104!R3#T7#0LP;89DWN M8H,=@W_171I% #E-OE3%)_]K(FQ-QFGKN31R,EFZ!5_*C:;@')K:*+Q40:!#2B2^/M?DF1V7H97JLW+4S:12/2Q(&M4;K-2 M+ (;0P@>;$XKZ-R)F*YCP/5?)W/D0^/(6BF3E)>535*[5U=9JKP@@P <1&VU M(Y,B&7Y#\NV@VY&LKEMAQ$4*1X;GZ2XJFRY(PG8V9R.#]WA*G M*(Y90T@#+8 "XU59G;:U2U).^.]Z3XR(.O="PDCA*[:Y%;-+V8G-ZM/[/JY# M06!)0NW08] M3[ MHV0=N79Z%EQV4$SZ92PCN$EA1%HCP%_WJH\)2(H?F-<0<-E?.\@@$,C@8]G MA!ZN>!@F$(WA=!I.%Q153L(XF4;#R0SY.J+.!0,*<32$"M M?FOK1@2% _3/)I>]17@OC\2S))K,QN%X&LW'&' '!)X@E\FT7A&KTZ&T3@9T3-S\DS)V1$C8HL.66C&(# &8NF %9\/ M.VAG0_[^S[ AF4?3>1).A]$TF86+:#B>$Q=@@,-D-HXF\[''A&'-XB2&TM3I7=E(_$SDO!:/K1J?F8=M[%]%L=]&"_3 MQ,8N+_]3>)D2_,DPTJM6]2W2GS!#[VDI'>KJ@ZKJ+(SG40)5GL(Z0EV39 P% M7/3AS&?A1:XV)6B FD%3H9K0UA!R2#9B/#Y\6J#5I\NS<#:?1F/$E\B"89I& M!XAO>@8EFT23,91W.HHFDTGP"LE(518, K@1GZ[PX CV!S1.(-RP>H'!5CH( MTSR*W9G +L#LA*,%=!*3"CG.+SU=GX7P!=%\FH0CT#4?S@*VN5@=V#"/1HLQ MH<#3,6B&F2%\UN<9Q8/7SR]OWKX(+QE@,^S?E.6*HUD(,#RGJ3^0I-;M$IEZ M!@N#9R]U@\R$Y>#GBTN'A0EJ801+P"ZD>P\A8E'X](;RD8:L5KA2^#[56:/< M\PB<*.[,\B@DMXX(DR,"D]M?OW[I4GMR9EZ*FTB^PMD+B4OD@5U4R;.!S\I% M!28.Z:TZ-8S!KQU;/!@I. $C$62$C>3X&F%,+:!!G'P!E6GW4O?HHBE3>S*: M(8% #"PF\+]"[;?098.> M<1;@<3*>R2;[O.W'3%SC(OA3222G!:9([UD@4GV(8<,<*+(!5KM/."\+*08V M#>7W(#@KDTD@*T%^PKKCXG0+@FM$KH)J>N%ONR)Z4IJ6F(7?!A MCL ^ L*JZAX2?*>J%9([:C<1FI27#+'(6'"--H<*@=:3_=ZJ7%25X_,NQC= M0SP9LLJ?WD^3[AQK'%56!1:1KVWL?;CC@N'6O/#^#FB#;)"%<_;F/E#+JE0K M5G)E,>YCJHT+I@+I#HI+X:T':-P;SVX'M0F$)0!C<8+G<.F(&4U,(G ZH]PX M'CL)>%2?,X);3)[(>]*06^:]SD21!PG^B[W$'&;8XDHVOBEHXCWFEF1&]D)7 M9!BAHXS)?4$U#?;,6QU9%KATW+C#7FYLL.RN,E MB3!X@/^^RLC^EK2^-44#QRM\+%_RZ_VV/!\8"PD'&TX01Y+T/M+T4V^Y'-U# M=\5F3LAFWG8V$]JELPU,DJH*7@C7WSA8BL\=*O+/$BD<')@/^'AV\5B'F(UP M8&1(:,5&A-<(E>#^;=O+[G$VT/L_D7HUV1L&'[?80:U M:;Q9&?"@, BN0QF0YR/TRIE4*A\9;-1UMF%/7WU&D,>4?JCH.UNA>'=E@YA@ M/!M23^SBM!A9R3&UGF[#RQ-E3M.9XJV WB-K7QL\7>*3R*\"BUNB)BF'3@=' M*[,XYD&Q\Q\$/W+$:];^[BJTZV'_:&L+R:AOH\HE;3<9?M=,5.ZQL2#!5'C; MBL4C5W43@&:XB? I&[*6 >:* E@6++,$"G.O\5Q;D]+.$USTA44YWG M5F$(0L5,N6GY98)52C A^RQC'+W,*/B^S"AB/\:UJLZBOK?-#1^IU-%67$&R M6YVES!KN2D/&2\$SEZA/)+WL^3FD,M[4I8Q-:7+"QQ32AJ*>F150RK6VL2XN MIK-P$0^A3E^?2OC^B;M7G3C!)+*DFL".-$]TB, M2FJ S\B0D9)6FN,L4D!O_Q]\_Z&2AZ)*$!\#(&5:EE9%N&0AAJKAU-5V MGG'O9*_>WZ. *AJWV1?[2(XKLE]VR58&O9#(U!F*+\UU5(7H)X:V;$"B:8)\ MR8(E3&]WLEX:P&#^]"(ONC8%8JF#,^NVZI9",#I-<8^=T()I,VX>GJYL2[&= M&,D-G('\O4,L5NNCRB)D?FR[7;Z0N9H]$Z/?H>-=?";LK9V4CO'?Z#L\N"^C M#@YY6":3_ZA,>K;PUR+/=AS]EEWO3C^YAJNG;;"N,9X]D%F?S,,,Z"XNS.SY M#G%=N2KS!.AQ[^20ZDZU9\(V$W>?:'YO#?)FVA\F752^?Z$!"> M>4]5+[,3#',$%^T&23D[E#\)V/2:CWWK+'(C;*22V#0)QZ/A25D\E,3:$\6O MET1*8#Z;:J\_&WPG'!57?OB[+MP)5Y6Z0\RZMT-RBE@?EVRC\#HK(8GA+ZK0 M667^_D<%UE';$R*R')Y2;3,5A5<4]NR6;5H*9VVR*4D%^:TJHP9G6S]/LNW3X /U>XD1Q]-AQ6URQIL8LI9:6J'QT3U30''>?GM? M4]B Q)Z@$RM5NG#E__-32_Q29YM=+->.V2IDQ>/M;G9)6?T89P)!%PQW#E ^ MSX?Q^;F,IC(-3=+BJYH2(:XWIY4)A\YRTWK5 ;1W'*NUW(UO(?/ &T WZ."CET$X55N['*7^4X..]1@*1BIWII^07PA MCM[E"79SI7N1TX/B%H^6A*>[D2V:HF^I+7T=@X+/^!B!:\X4$3R*K?_L M((XH24TMZ>2!VLHD+!O8!>R*!7KEG$NWEA--#J$'WA_(I>T:H5TC\U?!J4+) M64CLKM;WF'!W %K1"9?6[T)]76E*"8FU@1GQE1DQO&(Y^E@I-E8F/_T&CW)P M&LR 7+/I/*1S U^,]!7W@YB:@.B_[5!W[8RS7LQ_:'/_S!"C^'2(]9UN[8'T M@P*MST?=ES7B3ZC@QW[[I3^FY^Y4>E0(.!BN:P]SX?QO<#P&E&\KUX=E(UX? M$@VY/RGPHCZOSZAGK*55XK2+DY-O7N #/3>B#A7@8UY$ZH?+-Q=OSP5(MJ)? MZ,8 E<'3-V_?GITSI$EK?";]?[4#,"U\0PV!X4%#H#E0AC>;KHV1/<"APY&& M+*>(E?LU*[@)G^(Q M%EC."ZY?,T<=6%+NK,6Q!:^CXMM7EMJZ'/;EZ]XVB32=*K^E)ZC8JVP5++NF M/ZEAQD;LOF:4T!L%LCPP0XTLKCVVHNN:PSIK3F[.0#.!P=UIU18X)7Y:Z-3Z M+ZL@!E67+7='".%4$3T@Q=8[>UCR]O1RU I;W0C[W'I ]DD/I,H&<*7030/ MW68T@N%!ZNCG(J7!@_HU0HX,W&H?+PJZ1X)^&F>6_%#]CG5G,@KC<0+)S^J' M?<@CB?B8Y1J"_9I=MR'&M1M3V,,-I?$$M%1EN]EZ_#F);J^I ]-&#]20B2"H MI7B0)Z *8=T!;9XSMW-V@MX':\A9//=!(2/(A=[(>DT''L\KVND]AP>O7[UY M__'5/ZXO[%2>^)A#QO*Y=!:(Y:\/#P<%!ESZMCC@1/Y_D&*.L*.C>/@] .!, M]M1#,=Y;'KTT78K6<\B!I'Z&:J=>S*&+F!E.MS4;D^_):,WLW$WE@%23%&UV]F#;8AG<$JST?=L MP_@K,:[_+]SUL1 L.U%&NT32\NQUBYWEB.6$B,C!:R2W]](1;);FD*P3L*H/ M[!Q&'IE5-G/ P"/ ,T81Y9PF;:4SY8)5>J$/%19'HRD5J^)OTTXY>VK;=!*8 MUGC^'\,=EV?]WC5J[KK6-I>KZ?U"&GM^484Y\',86A @L=/]*S14F/*PMDUR MS; @1([H!V>HCQLA;^7/$G5[:Y%ZNI7CS[ 9:',%(M-!QJ$P79?],] 2#.&C$"1*V+2&SZF]VR XU,A&JUVX8T*Z^POH\&S)G=*EM"C3X*[XU)1V M8>86"()#MYE>]X^[EAP0[^AH!5A)ZL38J)7!P&9N7;?(2F[A(;)IE0-J@#W= M&7N@3D%/G9PJ^<<.X]CJT]LR[7R/N5ND^A<./1.<2/ 0'H744J.#DW MNF=5RV8IW1$&[V"O4Y1O4A)K"9FC1Z<&5SI'9%#="\))9X2:DD/%KG_VI6H_ M(VMQQMK*%QVAHU!$ZLN2+F>-P7:IR"%*)[?AT,XJRYYW;8% ;*]LX\ AIZ+@ MI%I*V=+4D)H?2WVO,8+ M>Y(G.4\F'UW]Z]=(ND2DAV$1^0\7VAY2AP6]Y=-_0(>_&NG(D.>I7D;7 M$UCN=!VT/1WO#H'>>,3^FU< VT>MBH3AR^G0DN1!"I6JH4L"&_9'Y@HS]NWO MQ'A%="RQ;I6\)0Z+I02[(P';@J,U=P@+=.\8]C+=F>X^'6X9]V4QZOHO^#J= MU+2T6T-CTTY3(1?4\-;)0(7\0DX/4K\RX0E'Q[4I _TYXX#/ZWA]TR6T'GM> M\ZT G(Y>NFLYN$9*TG\>2 )*:B'5Y,J >0LIPI+W-9P1.)W@NFO=M!5;HX-+ M&ZA7QZ>,K*JZE>OI4JE+7,M>G$N'1?AA:4XK!]9.]MMG*>@"PNH3&]2R,.8FEL0+R8S]W-$=9.T2%(OESB"EQ3.2(&T[ [$J'0A,Y M95,Z@RUY<2]/9]72 MIIUUJ05[S'I-?*Y9TUVH)]Y76"[)AVFW"?S C>MBC5^//8SD'LQ*7/&OZQQT MD?VWW#YT@)S1F6+.*&V;:2#2GL20*B0V2&[FHS"9S *V+^*" N>"+)*S57^ MRV3)U(83Q8<3]A,%"[&_; ,[^)4A5#FW>(A8D@_]X%_EU \)K[/Z$W="M]2D M0JS?ZU0.\#99I;L^5 \&M(DF%4IK*AM2)%56GUARRZ/UO> 38R?/#P=R?A@/ M#&+WB-\8)=&O1P@9'B08[2;=MM M'^0MPW^\?G,E\3E(2TZ2YN7V4^_2CGA^SH?8S!LB4O:8=&\8@T;[73%#.BG9 M#8PZ[9 %85,8?U<7OP^@E73%TM=W M,R;S/JH&/[O:_#^B:GQ6=$0WT]'=2O@YL!TD(V9Q3!N?-M2!UIGG@QD@,[Q(*JS8DX9Y*9*N5=62G>P,!?=,OH MBOH0\EKWKB"$AAI0HPX.6@LVFAKO.**EQ)/>77AT2DK379V- MKJR7=B'!;L!0'P&PTV?%MIOP;OXXL8N&'QMY))F)>I]')J-]U3 (F MI)F\;YU5D*L=-Z3+X0/!O;O$._((-A3P;EYA7I!#.1AI$F=SO+XT0/@H_LTFO]1C\/V&BAW>QJ; M$\DJ'AQ5D!27>?BG#S$T]_H:_,+L?G \0L7MG!WL9$[7[ G33ODG(A=-M/#9 M!=.V7KM;9S/I.V\;+8ID[1C= +BDDVI[[;JK33MD_0OWC_)]<_3H_<&Q=NYF%<@ZSS[1 MEO#M9U^@5VU=V&K15&ZA;BK6-V*O"Y$U72# M]&^--RG+JYQ2FB4^=V5\"^MX(X?VGF'B1?<*FS4?B( ^^16=\2">3)]/DTB.U#.0;>YJ6L0!&FJ2>[8T'$;VIRO:/4_D@US9)4PMRYR=V'%'M]NML&C.2((:G; ME'(3AB*P>RO;"V.+A/8"X&S775#!3$(V4:S$325#.5M(79]MW=V>65;=D75: MQ/1O%.3PL\:-D/DALP$KP<"ASP8LB$(?>]#!'8.@XJVDT-T-2=T.PK+)X<3 M!9;=[5,=MG"MW/%E0U4+3GKM>.0S$1C_!J4MF_!35 M$\G(XQ7!JA4?U[0'*HX9VE5J+ DV43JHV]JC<,H[#"=7E=,0;2$GQOAC!Q58 MZ\7PB:&W=W<7,?$BAZFJ^C=-(;RQ%V*\;59J$!DZM@@I[!=O.F&VV>(ET1.% MW;-'P(3I!!=E=Z]Y4.7'*N-=1.8\<-W3E>[ %1O@F1B5NV>Q/O%CCZ_TS1Z& MIMB<(DNNUCK^'.2TQ;H4+C"!_VI5@RT,#F_F8BJ=NR!#RV:E(RZ@4"V2&]TX M!) 40# )N=!;2XFE;LC\N^.N44BWDC?VQ)]_8J^/>AR,:/O!R$Q0G$,89$#' M!\N>:UB56@;>T3_78KR=N[#=CB5XPI]UAX-3_]3$<^\?%.&]H7\VI9:>9_FW M1=RG[E]FN9!_D*1[7/Y9EW=\AI_N3%CCU>%@-GDBK?3VCZ;<\S]/LBRQ63O^ M=8O@4U?T +Y?EV5C_Z )W+]7\]/_ E!+ P04 " ZI)A6A[I"G+X$ !( M"@ &0 'AL+W=OL.^V")Y]]P] M]T9>;8S]YDI$#R^5TNXZ+KVO+[M=EY=8"=28V/%EQ35<)N;U&9S77M[HWES5 M8H5S],_UHZ55]X!2R JUDT:#Q>5U/.M=W@Y8/@C\(7'CCKZ!F2R,^<:+S\5U MG+)#J##WC"#H;XUWJ!0#D1M_[C#C@TE6//[>HW\*W(G+0CB\,^JK+'QY'4]B M*' I&N6?S.87W/$9,EYNE N_L&EE^Z,8\L9Y4^V4R8-*ZO9?O.SB<*0P27^@ MD.T4LN!W:RAX^4%X<7-ES08L2Q,:?P2J09N63B7I^9O?4$O4^1;$ MRB)2M#TYX$L0C2^-E5ZBN^IZ,L3BW7P'>MN"9C\ [67P8+0O'7S4!1:O ;KD MX<'-;._F;782\0/F'>CW$LC2+#N!US_0[@>\_K_1GAUH?V7:L].T6]#!VZ#< M/Y>N%CE>Q]0@#NT:XYOW[WJC='K"Y<'!Y<$I]/^;J9.@;[N<#:/_8 P^Z\B7 M"#EE&E\\F"4(I7 EN-L<+QM=- BUV+*^ ZE95N_:,;@3%KX*5[+4 MK15_294 H]^9JA9Z"Z6T6 #90:N%H@_2;#&E7J/SLK4;><-&BB;W(/BL0!I? M!?O_2HY6).F:O'SE]-G[=Y,L2Z>?CV7#7F]Z3H %D);%VEC/WDD+2S(A]#,?0[_3(MO;6*%%0QL3/]^&L$/"L M)6EEXZF!6;$VN)%"0AU8N&D]T MA0-7FHV&!8__RVA.ETK1*.3RV",(Q;<)I9B$ ]I; -$.8';_''V/6N3D2I,4 M!^\2.G!'IYREA\=/\,'\&IW)<_@RNP__O#?_>!>^?S=>J&A6F89#'XQ.QN-D M/.I#=C%*AA<]&*3CI)^FT$NR298,1@/B/J+_% Y4 ]1S9]ZA&-7"^M F1.Q7 M&MLA73'Y$)]/8;Z1SNV32 (H0^S/8O(T;JLL@,XI^[M6^_B2 MET*O0M0KPN*:.(N)37S>.9TFNH>=%Z%&002^(!WE"R[2?M(;$)L+8C<9P;"7 M)J/A@)O/?<.*B[XWGKHH7)NM%Q:5X)Q0!3-T9;0D#HR\V+8U6C5);;L]<-70M)(&J-L =RBA$K$'NZ;51:]XX HHL\A.#M?:6-E(I M"%-+^[9S)(^&A^]N/;6=RF9(CE*$;>CW]=,A88MFC3:)CIV6NV%5U4H*33EK M9Q^9(W:2*L90P^UG!DTYBOHK7!=,\F"4FAF%H63"K-MAK=BH#@5S-%([\-8] MT3VZW2NTJ_"&<81(R6PO^L/NX9DT:U\'W\7;-]:#L"M)/BMWPL)0>5;ALZ3F1,L"=+XTQN\7;.#P>+SY&U!+ P04 " ZI)A6 MQ0$/.0,D #/;@ &0 'AL+W=OES MVT:6_]Y_!\?Z^:^73G7)9_79=7^\&S5=9NKER_;;.76MIW4 M&U?!+W=UL[8=_+-9OFPWC;,YO;0N7\Z.C\]>KFU1/?OQ>_KNIOGQ^[KORJ)R M-TW2]NNU;9[>N+)^_.'9])E^\:E8KCK\XN6/WV_LTMVZ[K?-30/_>NE'R8NU MJ]JBKI+&W?WP[/7TZLT)/D\/_'?A'MOHX>]+&SKKNOR?XJ\6_WP[.)9DKL[ MVY?=I_KQ)R?[.<7QLKILZ7^31WYV=OXLR?JVJ]?R,JQ@753\__:ST"%ZX>)X MSPLS>6%&Z^:):)5O;6=__+ZI'Y,&GX;1\ -ME=Z&Q145'LIMU\"O!;S7_?@/ M5Y?ULLALF;@'5W7)B^1U:9>U;;]_V<'X^-3+3,9ZPV/-]HPUG24?ZZI;MNZ_7&5D\)*(#&=BY/D[:H,I<479NP-B"QJG*0Z$7K_NAAB/(I M@;>[E8/OLLRU;=TD]1U]DV+&B=>4%?U:Y;V0H&*FW539(/.%N3K8#)IA_(PK]D5RDM(6ML=M_" MK_##7=U7M-E%7Y0Y[**E1S;]HBRR!.8"H::Y;HIJY8JF3LT;MW!YWY5\KPX2D NVF)1HO0U=\"@ M. "8O_85+>MY 8_@R[:RY5/K6@,;0#[% Y^>OX*==W91E"!N$]0 <$8M&#?F MXH7#E;4K^)P'663N*4!F?B:2P'(^,N%>+UV5/7F^>OUS8"M<2PUO-PE0$C8, MRS>V[U9U0X1&*0("[J81X@P41IPBJRLD2 ?TMD",WDWB8VYA6#Y;F)L&6SL+ M='&DO6 G?4?$SNO':NO8[QHP9.U($8D.&@Q#FJVL\0ME!Y+\U, NB0U_KA_< M>@&;G9XH,X).V30U*C$^S S@E#*4Q9\Z1V %"6_Q+!O4%+1E5D6J75IZW&5 M/21^\Z2+PVT#9QW+&B[P Q"Z MZ/J.]@AJ9.TRX.PB(^WT+U=L_BR6R?,/[_]QA#H"G@#K4#V1+H7CPCHJMB'1 4><&?'C)'G=&BO"H-9LI]9+D\HM081I2E'R M@9:T!#D-G A48@\ZL(93BV9CQU]\IJH[*54QR#>1N$#*OE7 M/[D6U"6LX=E1:E"Z&EH@3$=;N^U H2MHW^\>:?CM^^[V#IX'^!V=\/] ZT6MFS[3C(=[>_!:F9<7T:%N# M%N"N"!("=@W(#2OXIZUZ%,0Y@=9CD('\=X#Q_"2J!SA:8=UV!)X2"Z3/UVS M=#*'.KDLVI4!?F;+@XHAXP'PF!HY7T1!>D*HP-9)@R=,?X 1@YG/#EBO+0$8H**=ZPIBT;T6&J8.J K'V#'+2%! M@BAD)_F@0?:K#/'@@)%Q5!4/)%\D'L!)R\:N_29NK@/[%&L0FS7;E(! C,"7 M3;U!6<9!A,!>?7FE$U.#J(!*7.$R:+0U*#58K+S"[/GB XD90 $>0L[C^2>W ML8WU/&"\:#)] (U6. L.*S%R]A@?.:\H06&KQ?.J+(&36B;G%&E0X-6%F"'48J*ZO>^ M$E[_&L)\>8G/?Z\+\E/(%($&PR,$DNW4@(?'"BS=%LLJAD6@=^)_O--3)F,( M< VW"J.@6U,'$3#S8U4::.*W0!!B'U@X<7A7U_= 189]1,L302$7C%H!/QOBR:%+[MBB3H;!LM4J%R G6Y M*1 9B]X206+5+M%$ \2E>JD')%!L+()0,]0M'L1^PX):.L"_OBRS8UE;WM]( ME.&(UPH[ODJ8;WV >..P'8H-<#L,(L@=:DB%^ M8,5$GBZ@O)@-=KE9D^2G8KDJ,=37LNR!C2#QQSVC+V+S![ ZCF@!RP1WG!8B ML"_&>77R8#/BUJ8F1\CY"(BR73#@"A6 X6G NQ[WXBU<-H1JH-E:)HY-5K#8 MI$3OF5!UEKE-ARM\%?F#$9I 9X9(7N5&](8J9I(+]F[DW"U%,Q6484"\2T1CM4#OUT01_'(H4N E+BN MBFV$RP7RR:]#"F&W8GG*QE7 "N"[H 97(&D4+:"LESQ7V MZ"GK53?X*$4K'4#&=<'P]B8 T"3 M"'X&_ACORX,^C>VFN*-'5C>!H= O7(9-@Y 4=7YE;K.5R_N2L&?$?984OA]F M_+)?R& T@[/C$J9D>']^,4^/S\[-ZSPO6)ZFZ2D8GYTF9^GE\32]F)V; M&_M$6%_.)BM17=P5C$5;\_R_CI+GL_3\!/Y[.:7/E[.+]/@"/T_3Z<4TO9Q/ MCP#Z@57ZTYL;B7R8!UOVCIT/TOK3"WCW?)J7NS:LKGN 3_!T&4A4:/D))V=P)/'E_!I?LX3PJ>32URJ^;FN7F1; M[\SHR'!ZG)Z=SL.;2+WY MY>D1^G[16;%1EHA!EN'4+0Z(K$BA%J/[#>P'5@+CGZU;(NSMU(4>JP<^W[;%DBE9."Y M&/0:(Q=MKQ\7Q2:" \M4EO#&'WV!*H700JQC9/E%V"2&50@Z .57=;LI@"$ M+[39JJ[+0<0^"L@;4\T:#;G3P1<7Q?PQW82"/E?E8^Z?> M5 :E'JU*YZ6XD_K[N O$/?/38!BV,B_1I?&$Z.*$7P4Z*>>*R;,G\$D:03 0>E>Q$2 M"?0N4/T5KNRN4*,-<0-J3J=![ Q9OTT&2084%E+$'47RXO#QKQ$H!!,U %DQ_(YQ,F!DRN#]LZ^< M("3"JO!N01;;KVJ78[?/E_1Y,'4E@E>)(0N& #LP<]$BXVO>A=9,H)>FE0,* MGMV_$078D6X;C&;(H>!(.F50P!;H B(03=8E1W0>S$^P:58I)A"5'=%$ T.J M.4G)"R/\Z7*?P$9-9!Y1X3D$66A)QT&6(05PS92JC&WDC+(C5K B/,4Y5K4( MVR.0JKTC9U_/WL"AT<#OW:*AJ#,,/$_I+ '7-^R6H _BMZSO A]N3T%FNVXV ME'Y5,]\.I] @Z>*-#Y%S)&#B:(C*O459))QP*!8E9T MC!<.G1\[Q2NK-MEHPE(R<=X@[@@3 '.4;8WR2,/E(:&]1P(2.G(P4'M S^DD MR0"F!>^S;Q:V\EP91Z:_160UMCCPFGR<$"R[(D$ J>GI!;@;Q\=&02 %!C6Q M&*$2+RJP!PY"Y)HGD%77@LZ)PO5VC$%&2TF54RS@TW?SXV.08[!3\/NR1MV- MA1BPZW7E_1JQ631@'F4<,H"^DO3<8(*3PQT8R% KXF-ZJ(G@2U=E!0G[(#BF MNQ16D?OZ!8@%_H0,# 7@# 9$?" MT%?G@#G!!9DD^<3[BA$$9K,>HK_C11%.PH'.CL&U.CZ-G!0X>_!X+F='/(9W M[9'_)5(LY!E2S?SJ+>-U'5!)2#HF@VS?,,X1Q9%612.N\E;,@VLL0E*2LYA1 MB#3 ?1-SZBBPQ6C9 I<16N*H#YP,:)VN 4O>-XRO0N3-^T'X],/1D"B 2BOK ML>B!8 833.)5J)XP'BPF-1CE-"G!I0-XX9J'(L.C=%TV@8D?CF)-'P?J>:$1 MPF'YQ"H'A\$]9S05'OM4P_3?'SU8*"]@%'8:"5T.YC"3\WY?NL^V:&4ZB9X] M !G951$')8E<7(OI;P$[41C6NYH^((U42PH K74'X+SC*C$RGB,D&A)C&BN+ M<9KZS"%.12@28[Z;2(?9IY$V)M[HB0?RGDH@*O<(W*+H(RN:K%^W%/T$#]*3 M$SWDCA:->29/%6BRC'T\CZCA:I MC8X9()">4_F4>D!&>@D)&!5X3YR&#%X6X'HN_7D8)R7WQ/EM MLB4$4=V/E (1X%5MRGFC;6=$U,#"K<"SYAI4];'U3&'-['FRUTQ24K@_81VL M_RC2X"7$[Y.H+558$?[=G7R%M];,K:JQ*>^TG;NL[^Y:4)C?X$-1^L\#<@K> M5U'N8A^<#+F+U -:=7C&68E]0-B66/Y/H8X-E0."Q-B!JZ0V"+.">"KB.@'# M:2@ _4G)*I*R+'&"UBM'SEV-DGIQP93 /Z:"P&H)%7T!F=DJ5LU&B:!> ,6@ MT"7<H")W[IE8_$(AI54-Y]>O]7Z@$GROF]0KV%XC#GV M"_G7H#*'F=C 'S9?22$=1BZZ04YVJ*L/I*[9!U+EBK@:Q V?"<6F%)7\ED;NDJ6@I MB!3+(7LL:C#A3(:1 M#$8:I@66731UOUQU[*GD@ +RGF(C3;*$7S8Q6VA)*,8AF^(!9T>N8N:A,8=D M>A)/#,5)%!&"%UD5!B!7V-PP//W=9>$:U(G0/@92N29QJV8M,J%(&J!>D7%H MFB"_F 60RAS#1^ !<'$<:!VP$Q+$!E+ 5IS0K T1"G8C>^)D0\72[&^@V@?@ MB>EU^G(T-NJ8G$MGX?$',%A@FY/2/K8]-490@&;[$-@Q4#(3(_!Y!!UU<_W> M$**V6-'<$O<$T3N4ZQ?UKQ."_]%UI:J[(0TC/SMVL_ GW8/Q>Q ^ =A+R@-5 MMB,%;0MR5/UV1%6RFY'(8NAS3+Z 4JGP,QVIIL97=%*UP@050N,P9,1*HNHI M^$%M'Y@.T@@$IXL41$G@0USEHGK &H\EKHT@0,LR(7J5?4\(MAZ0":VE>-0+'S>0ZM9)*CAHS7X=?X[<"B&P5A< M6M&[ZN&R+0,V0_C'#E->,+^@I!4<78M==R0,4FE!MD_F72AIB"]3''[C!)+)>'-U\\ '>D%;U8LK] M-\3G=@E03EQPV1[%2LSAHBVM%[R^\26B7FXHQB>!@[U5T;Y64C4.L MA7*4P)Y_NEBN?;HH*->H P"/BI1+&GAZ!8/#VH "^'& M]?M<'KX Z;YG7])\^FX>-D. P<_'32)*X+ZBD>FU3$2Y"'7F& >>)+^@C-%$ MX)A1IJ"5ZEO\4O7J-:ZB'53/FQV<"8:_$0DE@",(1:$T\1)[->!SMI'@^Q!W ML<6(>^N7A_PK!19:7+]=3\^!VKB^V/S?]CJ$(M]Q#%2!A!R4^7CSCDG[5C]@ M'D:/\>W-;V'J@%RCX;W7@L[G%TO]-WYOPR)!XROF1=!#S7RRNV;^/U(R/\P0 M&Z%-ZA7[L$!>BD2Q]-LO7IQ#PR&&0Z7SW6,M> H5=].SK265OMV50BHV;BY# MV>E+SFQX;X22*92M($QFHH*8@,Y0S,R.),P@D*E:/7).M&.'S"6FG$.CATKH M5S(C/2[EQ:S)#HD9KHR\@CB;(!Y+<'=ER[A/K&4=P1!4ZB%R'9%%@@;J/&H8 M5HN#]I\>MIH,:X4X6B" (00-HD!2E0_""QK$=-42;!0Q7'P&$I8*SC)[+3M: MMQACR//:,SDH./ R>\MS!I_^UX/'9@;')C1F)YZ:^B0DAWRHUE* PW;8=Q!- MW:)JL!2L S@YKGLW DO5<=. EJ>X[ OV4QLOQ(-4FH8@@CW_ L^%DXA;%7SK M)A;BC4Q?DJT<6T:IHC///WTWC1[:ESO=+RD$D <)=AAQQWACB3S2+D^&'P8O ME:!:5$N59XQ#IB'3B5J50J6@=-N0<.:@$DB#[Q+#OG*?%0.:1U&Q7W96Q YZ M,AA$M,Q+# )&0!J$EXF_D)I.1<)CVL(X\'Z[J2OI?8;]G)^FT].YD$7#Q8)( M?'[Q8GZ:GD[/CR8FCL!^4?UY5<,I2&IVQ7*\(-\4H4B>'\XJ'!$/A2(+LR7' MI":H@35(@_>1=HD.=<%Q6(^K@P,:^O"94BW" MJ]/)S+/<%[$-2$+V!V\IRC&/";G]^^NTVC&T#P[0J+B7TT\:Z/+3H[ M:+%8S"=!$ZO& ,N3+\4W\A#6HZ_X;7 "3O5U-L/AUV"WB.W@X?/)F7_8H/[9 MC^&^J2P'AP^MV+XB:V>OGI5.EW^G6\]$4=1#S3!?UZ\W1$8<9=K#N=_0L#=* M+U"5ZMA;*=T:+,7UC4L&UN@;=270'V&2;MC$\6;AU(791#DQ?' MD9-="$J2JAR*I*JHU: 2=GCE1)Q4BSW,G4U4##U\'EI:"WS'.0@%:#9:MI;+ MJI#L;@/=SUB8O5 T@W($1_I)NW;-$&U_N?QS_S1?T09Z1==>,*:(&VY'EZI@ M >@H*[DC(TD5:OA%D?3B<(A_F_1K.]E&QB+ PZ:J(B;E.[6E4K^IQ-T_" MY30:.)/[)/84P XO'V%-Q_ &W?P(N]8;>)=.[W %J=3[4Y"ZQ+3(L/H7K7M? M.>U"GA$]O*H\5UB*T-%)4R7['H1V.E$_GFRI&S9Z*T>BM Y6COF^C=;L>,[LF M3Y5'U7#/AD(_K([V)>TB%QJG"PS,==74<\-D9WU-&3A?[=NRR&+%R\';#)13 M)\:K;2PYHG$&IS! 0L=#VA^HED6A_T]4R>Y*)N%!&@G#'"B0W1*P VB<-A^B M3*B/1^H8A1^DR^(U47A=D1;3[PK01V75@Z()\Q$+.%D3:"B2L'8U!I6H+'NZ MTZ10G\-;Y%#0PQ[OJ#AQ%P:=7'@$V]4&K:EN MQ]?->'_,<__77D.@;MI7K"*ZIZ,.=[#%]PQH.3WMRP>:0Q!XD#'%&I:6G5+S MUTM8,&9=8L+VK]77IS$59QQ\F4:A@@_5 R9)I>2UM.!*25V1MN8<*R3[>//. MC)W=#Z!WBG4<_K!EAI%PYA2," 7/9:CR)?.V)RS(6BK." V0-R$T[+%/V61@ MOVWI H$KAQDLW#-GDK&(&*,R3;8J\/8Q:CH+%Q7I">9(BTH(ASQ4AYM?7L(S M?>OCIQE6TAJWWL"9T>V3;5*ZNTZE*5RFR/;/Y5K.[2F4HBFF_KD,%Y]&&-.; M"BP&TU[B(F*U(1'UFAXF,.7L)CS;-P0BO++[YHNCKK#=N)?+?4).'$65J6&X MFAA^_:GFHL20B;GE%CP?AW[_DT\XR]I5H9F,UFY':\?,$^R?\J.%*$9 HP4O M)S!"6)A4E%+E91O%2F%NMB#47[6K:YBWA+>EV;SH29-.D_LU]=9A[R.98TWY M^,)#(;!O+,:Z97QU&*S;<45@H7>-,EERI(<&)0BLAAYPR]W@.;$(K;JI+\$@P)2 M\(!WW&& (*X^*&0)T:2&)XVR[>-YY4"7E$N72C1^DCF.^A7X*,,D=,JHJ[$U M7$)+6')7U5%4UENA^H,T4D^]M+@Y#&E@)@YG49IPI_T6P)%* M.3:MC*.XI&14T4^Z0,*:2V="@=J.+6M%&NY(Z2(- 7M=WWT5>EH@X[-3\>*U M2TBNA4.DQQZF]\$>9"(L1--Z.=]YB156G,5E/]X?#5D1%%$.ES[\]7#I%W15 M*"?QMZB"[?( 2%M%@CW]6HWS;E=9S?#:OG\@9JA"&R8O&&;6'7@O;K_UUUMD M4@-'@3"/0ZQ20LD\$?5''-R;O\6+AH*5^QSV(, 09?E_8_?W0*PB'90R;->^ MRIG-&U /E*DUFK212B5?4$ [Q5#QGGT6<37UH"9GV.]#,:,$[TY@=X;KB$," M:<,@VG"6)H^4?U"@6)-U?7.@B$-0:.;KZ>C6B3BGS'Y?,\C6#;Q$''!=8X$* M]_K(S3F!V.3()95G1'@B.5:F%(4"H:81+9\7E,M@_2 MXY>&GK%6XQZ+*.Q8@EKE_03^I@"1J-L)]LF9#ZQCX95K9.\K41ZKPM*F0,44 M#2*'Y-<&F"7Y#1%=':IZKM_\ZF$7AOI##6-(6 7/[I%LGDJHM(X4I>9$_"K) MX_J*97!:I)=604E]E* 5R-3OR\H0KT?W&JOW%OIWHJ;,((:BKO!&:ZQ!AAFT MJSK6LHF!<^@K!]=HW%E5Y(_DDEUV+)X<&IZ2[QW(FZLB6]AT^0& M]W-[?_"7N'+T1,F.!\,6PI#!'Q7 C.OX]I4J;BD)Y"HW#"_O\M=G,Q]GP4"* M5R^'7CH]/L;('F *O&QC=,L?>"UU6ZC(1V09.Z]T2S7VIJIVX%Y "YYW29$D M:DN+PP=X\WM']3J@EC:VY6NBN9)G *!'!4G3.";F"W+H'JB169'VY,G)/*2G M?1?QY.18OSV:1'=]1)55-ED[)%^5]^NM?A$N_Z7S)B#H[K' VT!X)O(JY3H M%=^[CDO6QO4^U:$A@/MG2J;YCCBXF" UK; !LIW<6[-:M M[32YU(ZA 7H#QP/;GEBI4ZF9I*[D+!Z^FI7Y&]$6TT8%&ITLJ0I-)G#2G?=5W M6)!WA^01'#_HKD'7HF^R%>Z:@AW>#U,7U^ M[5=F+VUV3Q< C>L#=&^3Y&>\/ ^^+.&!]S:I M&Z%][G@7"K! Z=:>^7-'V2-:]/X_KE'C13M%[DE#LA 7Y0WU2)Q;+_1*#=8? M\^,S5:HFW+%V=J)?2I%"R43_.7*ZW8/-^D$P.BR98(BL1+?9 MV<\)_:D.NGJ+;S)5;,!7@6$/D%*QJPWUL;+4:D6J^!3/OY^#_!&:F,.8OG;0^:@^8Y&VNE'G]Q9+CND'? MTG<71T8X%SXH Q[V=NQ&'JK-.( AT2^J^);+1/6N1-^[9>E> ]"^&UL MU5MID]M&DOV.7U'1]CK(&30;A1NRI B=MF*LL5:2[<\@6&QBA(/&T:V>7[\O MLPH@P&93\H1G=C=L-8E"5596GB\3X./;NOG4[I3JQ.>RJ-HG%[NNVS^ZNFJS MG2K3=E7O584[V[HITPZ7S?55NV]4NN%%97'E.DYX5:9Y=?'T,8^]:YX^KONN MR"OUKA%M7Y9I<_=<%?7MDPMY,0R\SZ]W'0U5V)1FV?7#R3CY[[-)\G_)JKVW;R7=!)UG7]B2[>;)Y<.,20*E36$844 M'S?JA2H*(@0V?C'T^T#]-9\=9UFGK7I1%[_EFV[WY"*^$!NU3?NB M>U_?_JC,>0*BE]5%RW_%K9[K.1368RRM2RH>NP=T.K#EO0Q*O,D'NNR;D/D).N>%M7W:X5KZJ-VLP)7(&W MD4%W8/"Y>Y;B2Y6MA"=MX3JN>X:>-Q[88WK>EP[\LSGPQUJ\.G=@3X;&3K?GV'6'YGUSU'_X]HY2^XTLVYDG=U&N-%* M6A]V==-==JHIQ7J8_7&GK'I=Y-1],>Q?E1IT>U $!)W M?<\.74>X7F"'L10RB?#I6>^:_ ;$Q=Z$6>E&=A+X0GJA'0=2)+[M.:[UL4DK MZ*'I1!S:KHQ$%-FN(T48VE'@6J^58@V%KAW%H0BD[?J.\&+;=QSKIWQ+AVY[ MT(#VI$.C].&YODCL. J(?%X1 >SN>*Z0@1VYGI"^'2>N]3,DU @9VHX;@4$[ M\$.Z)65D!9&/!=C12^P@#(7OT2Q))NM:/]75M990CHTKUN"^@'@7WWT3NZ[S M_9N?WHEW&.!+^?U2_%Q9;],FVPF7XXV,;=;.J\]=D]8-CHBT)3[L(-!=74"Y MK7B+N$N,I_M]4]\HK4W>^"-M_&;O,+!L-8XW80C,BGU666]MMCM%L:(X<4^;;H\RV'C7;O4A@<3 M;NJRAOI!,F=;QV%Z\**-E=TC[:R)>[##69I].%O;K_\!;R)2-.FF+N ))*2\ MN@%W3 ,UK>5V$)Z59;#J\!WW3=P$?*,*5N#:[1:$GG;]MI]IOZYP/1/.)'U M_/W?W@;DHL^?_6VYHC">9K_W><.G$0UE8WM.OD0Z%014NE3OE#?3D\+E="#; MY?N#JH9]26(D8]%7+/RFWT-KQ9TUX=@PL$$L:,@JZ%:W:Y2ZO%-I(T@D-(R ME]>(7;_M5&7I.(<(IV,H)%FO!_[T*3ADEJJS9_QTY));4BV'HLDQ:5;5EVLX M#63?'"S,<(GYM[L\X^/=,7&RT:Y0&]O2-VALIW!68@-0#[Y[1Y(>SX=#U?WU M#L3WT"1"IB)3@EF4*_%FRV<:^",SJ>I.[.NVS=>%FI_B-B\*'4CGA[!IZRQM M=_8TQ"IL?Y,6I"QC<>9(;)"'B,^CUKZA; $^ $0$8ANP5/8)O@%^JVM%(SQ7 MD?3%NF^1+-M6;,!,7I8(:(B+B+^@@I.;[2@;*9T+AO2QP33M%=L4]@3V>C4Z M93OLHCV&YHIYCB)@"LX0 *'I2TK8!#(QIZ?L<2HW3FQK;E V@61&N]6U-4MU M!VL83& '2;'L2P+^7[9!UD?;DVV(6\Y[1M1(?-((S3 M["A@#Q8MA'Z**[-X./-$[D#G3$QU,.(AYM#<(< #IE,>( 6?P!580.:]'45L M&_^8:THKA$RPNV-,,UC > Z+8L2]%0,ZR96&0F35PUK[$&=&$ ,*);N<%IA* M,_8S)-_AV!R+1O,=#TVW;"UIR]Q]5L(R"%&\!($VY]#\7F4JWW>"W6,EGL$+ MM4>,\7=NR'/FO@:^:;68@-!B<4M&N*8"4-PB;1VRI8GMS^NTV=!>+Q%=LJYN M!O/G0 +-Z;0V-8;MV4P[:K#*BGY#FF$N6,G(H12'P'>]'\*1=B!6#\>XEK<9 M4I>Q4L/L+-8. .X+\1: ;H.-;P@/6L?Q&C(DE)GCP!H",F FM3.!,>K. >!# MZ,9ZC2PF?N!X\Y*,Y57%HL4(HN$[?= /!ZMYJ[H=1GXP$?3W/J5D0,:ZN%R* M%X39D!GXXK\[Y'\&B5>>O&*@N?CK'UL6A:?\2_ KC+1ONIX5S+! M_^8+%AEDY$N 3L\7BTC:B1,LQ:7P_ P,L&W! .+TG:< MR(YCC]=%/F@NL#["9^)A((Q FOX;KMY_"V"[0@EVCCBSZ@'R>AX(^T#H/C/K M GY[B6-(#E>_?'@IDE7()*4A&5Q)YPI7YHL_\!L$Q"T$ /C,AQ2!'^/@ \WA M"FP&/7T^^%JRI][H!614LR78.#O)H";37(:"A,GB)N,E./C0C M9M"$8F)#0 .+38Y ^@"/J$Q\Z=$BZ)P*$Q1===M=3H#G@P7U5A>@B"?K?DS- M&\RMU&9V@SW_7FT-5A!G09FP6P'\]4"U?0L<:N!-D7+@&FI8(DBA.M_H8#V6 M\;KPGO.V3W/>,]W<<*5W/U5 16G;JA&]J<\=8SE*_ZE.C(W*RW7?M":/(QZC MD-[TNH4'XMN^ZYL1?5&1,")+G78,LJ2R24;? WMBNTEY32(=)&CD;H0'2EE: M9+T6P1B#3:;11I$/K8V MAF2<]< JE6X5:"RJDQ54\('QF-X;W&_R-J/ONG]##0%N\N"F#KA$@2$-80E" MA6H$2O.,3\!\=3$,".G!$TLE(#DV*7JTP)@C_HCE'>* M?)N3,#,^!>4OPN0:Z<((_Z&Q+#FDR""@O+-*SEVZD!(3CNB0;5]T;(VP#[(R MJCRU\9&X)S6(<>/!+M=S%R+X4N9&IIJ3J4SKK47U0UWFV<&-TYLT+U+"&+#Y MP6#IZ#/C;MFZJ=ETRL#ON?V@#:YT1T.=LF2-"KS'DLTZ!>PJ@ :),6#AO.Q+ M;--2[&* H9DBK^W23XJ8H9:#UL8*L-&@4L/[]LBS#.2R#.1Z1/WV/FU([-G!]S[9U[, MIC 8/SV-*HV6E/UP[&:C)-OI5%JB_*%$0WY2I=Z49C];28,G%DUS31+.+O.B:, CN:3&T0BAP4W5 )("O1Y$$0;7H#[MO! M8MN5]9H=G3($EP238[;<<[CG8R=E2SU9FLCVS#WA0YN+\@$"XK-6M#55\D-Y M.:&K$' 'F"=T]PH64WL'QYE)B!9A*:#B+95(5-[E,/@++ #^) M:[M.+,(86-CGIG'HB=@#V$S$LRSCGNHU%43:4W*(NTAO6WV [F[/T6RG^]A: M&>8!!3@PSF>+*BVG9EE#+UKABIK.ZA ])V9XNZLI".7E87L6>8MI7N>@DO?3IJ)1 ;1C]HB0PM_UM-MP0:%)=29#'\R5+@-W'?66:&.VRZ=-0@G M0)#*.=L: 9?NS[70D&9CVQ?%M.LP\K X!CUT5/'7Z8EGMY:'Z&8Z!/>NTPVE M"!3NC;;IO]L $:'-!&?U53=#-U#*[K>) ""R45HW/PJF;JKV;QD>N( M,U'KP)'^U2\='-#_ 78W7\1.:>Q/S=AHGSZ%B;1YG M2CNL)2.:%&#/>/"!X,^++$XN,G+G)S3&+(-8!_FJ/I(6R_1/$=F/-?C8'"3V M=T5:H[%VE!I5$Y,-S%(Q+#TOPS])4IR&+7DLJ.34.>6?*C4Y2,TY2.W-1K7I MT=5],9PVHU,X\BLDP"Y*P(\#.N8F87 JU@V1,#D="I>G^@)'LF 1W4<,.BJ\ M_]:WO<@9;/3]MYX=2V>,CJ.=<2/J. ;,M]TV=3EC;B46Z1()CM$A/\^@=#,D MT\/S2>Z4@\2LW7HL[0E,.SQWMU[.9UE#UKR77H/8AO4+*2,[S MG< 3T$\2.N.](:HPNIXX$K(/B(3@ .MDXEFN&]LQ]..%GAV&[O0] "*&+;(: M:.6[;]S ^1ZZ\"#)@-X-\#T[A$MA?&UKR+.RGA M'C[P(O#!3+ 4"W/FY;V#4<\U\6-NF6H=7'K1G:K'^@5'KN3E;VEEK!2C$KTA X.PU1EN#E@?="* \VXD3 M 2^RX]"!I5&_.(%U^'8?G\DMOTDQE@8\3P_#FF>#'WKC2F^-277007@H*9(I$^O=TA\ MR "*<$5@)^"?C ^4B&LH)P0EEQP@B)+#:TG<65Q@F]!+J,/O4U6!+WYHQSXU MZ:5C1Y*:_]@@D32 0SMD.0$=GF_X#GV"?P^)SWHV=B=T3\):4)=B*4)ZH!"( M!8H4/V9SC7$J9TGOG\0N!2;89$B;)]B;C17,QB#M!G;LP&MM5_K6J^$I\PUM MPMEIX874_UX>ON#(D6_^7@K2D^>9CZGNA\>L)O6Q]D>?-;X^>.@?M8K%>CDQ M_4D;<.K47YQPY"9G[=:X,CX#>O='Q-+V?%?KHS"-(>NX,039)BY)S-4O!R7R MV#@\R#WT6>&>0Q8 $XZ\Y4E%P)+#<"EB9)J ;"V2P9?DK2/1/>8??BPPQ*73 M#59]+-V,U= M?#XP].;&['A^UO]N6+S\OQRS#G%EH0/+TM+MST-$&;^X%,>\R9=+VL8/I?FP M8/;\>!+.'.O(%\-88=W@$"F4+#F4L&2RQL0CMB(8)<*C[R9DLJ[CBT4V#7;< M3=CKY#:%-Z=G+/YK^8"N?ZFX)W[F:J)H+NOI7;G/.9"'J9IF$.;?--=Z:1Z) MB(8:"\$*V@I6TA'QBEY!7"& >BN*ABL$7G>53&^8NPDR)TV)5L@*S@K0E/[ M8+;FX0=3]FA9=94*G[ZXXY^'QT'M_CBBE7ECYW2#G%;\B_^L][JU0NUM;A5, MGC6TB%4 YJ:@'Q8%XP%&;H^'S>'N#Y_;;=:XF'(I5Q2.IWN-H_SGY*CU[)JR MRS:EUT:P.G#NG?ZK!ZVW:@.L2G%GT*YW:NU7#UJH6C0=Z:YB[]X:Z:]D>&H4 M5G<\^H'$AH*+7G-.J[2X:W.X\&%0C(-ORCVD,;P"]'#A8KUK5)FWRC(9S/^T'L808RX'@!%23OT@:5L/XJ$BUBQ\)#NJ>!? M(/T[C 8!S@)&&4!=%)!EL+3>X^2BO&<[_U%OI7_.*N!_T[$8C/O"!P2;B#7.8C67@2>SO)8=\%O;+-:<_UE_JM M\ISA[^8!G1!Z]EQ^BM*&7H:0\J23Z%_@NU.Q#S2C! MR(R@'N7"A'^\,%UV]YU]+K>NNJTO^NE/I1C4T M ?>W==T-%[3!^/.YI_\#4$L#!!0 ( #JDF%:+KJ3E[PD %<7 9 M>&PO=V]R:W-H965T M!L9.=K= T@1.NON9(W$\VDKB5*0\<7_]GDM*<D=EL8\$@4>7D?YYY[R==[ MV?^FMD)H]K5M.O7F;*OU[N75E2JWHN7*DSO1X.WOK]2N%[PRB]KF M*O3]]*KE=7=V_=J,?>JO7\M!-W4G/O5,#6W+^\<;T?JS9E/"HE&E)HDQ*25\I&F?]L;^>&V+$X_L2 <%X1&;[N1T?(MU_SZ=2_WK*?9D$8/QE2S&LK5'07EL^[Q MM<8Z??WN]Z'6CZ^O-&31R%4YKKNQZ\(GU@4A^R [O57L75>)ZEC %928-0DG M36["9R6^%:7'HL!EH1^&S\B+9LLB(R]Z0M[G+>_%5C:5Z-5/3#QIIY42?U\* MY<1+M>.E>',&T"O1/XBSZW_\$*3^JV=TC&<=X^>D/^/]9]=]7ZLP=ZP\%N9> MX-SR7:UYPSYV#EPKVK7H9_]%>Q6MCO>/?ZDD)MK5?;U6E1FRH[7 MU>6P8^4H"W L?V.\E4.G,45+=O=C[OIQY(:CT!*B^EKA8U9D;NAG;A[%3%$L ME+.O]99U$F)[]L";0;BLJI7&?@.)XXIM9 .:4"^=SV"?:F@$DYMQ]7*JLS(J M./-'!R:T2/)/R&G1]Q V+CH=<,;Q%ZQLN%+.:GZZP=,725:^<'Z1#[*3/0O# MU(VBV$W#B"6^%P2PR@WRT(V+'!^](F&7^(O\Q$V"S W"@$6Y%X7.)Z%[N>YA M41A@-L042\?.ZPOS M-0[=/"W<*/19$'IQ>#J8>%'N?$0H>WQW"WC=SS(6>GG*@CAUDSR #AE6>'$. M+7(W*R#)]ST?/TGA%BEB5<2 A.=GCO5"G 1NFD(C*#Y.C>+8C8K8+?*8%867 M!Z>RL@*;Q<9@FE"$SA=4"C7TCU,\2/$T3=S8SQD<6IP,^/ESNR>NG_K08![Z M9OL#Y.R0LQKT5EI )E$"D>3X@*5!ZJ841T0L*2(W#W(6N$$"YT696V2^0ZY? MM:*O2]ZQMV(G5:TE[+A#+M4[S6ZWO+L'GNINQN?0U]V]2:A'P?MC#(_3V9/3 MOX7T+U(+2E)_7DP9NWP)G8^#5AIY1Y*6F=!.NRS]>/GTFW/(DUO*!K8B$HGA M<_@FC.%D/$>1&T>A04&0Y$CYE(51ZF9)OD3&-Z)ND#J^&T8^.P?AQ+%_,MR4^N#U>?\PGDO[@^.8+^B0^B=FY[_ M43%=C<8N.A^F>=PJ19,D+,L9$U M1SLA@>H&,Q9>P2/5?I0;@>S"FM!_,;G_I+R1/\6)Q*53:??3() +C:=WQAP( MM@[WV/GZPOG"O]),[(S6N1M*041P4L^21M0@LY@4+2BF,G M'&PC?^CE?A1+,!]1@Q%^+X&C#@VUB2 *?5W!Y&33:U*6&=<0\JO9W]:Y6>48CYVQ:$%X]355[#S".+KH;H7VAM55&A; M]$(4IU:IW$Y[++L8[*(6K>>4U71^(J6K^J&N1%6(&KL] M3EYWCK+Y& +GME#D7GIA4C)V3.O+>CJ0+#J@J?4I>0_.1!OV(#6!P\YS8;$F MH8\,1ZX!Z]''H7+J1Q=SN\MR:(>&&QSSKAO@H\1(L M8JH3W&*36#G\@=<-7S#:;]Q6=Y*)BC/SRV4L1 U#Y.'&@P;]I"1C0<^J]6YC=X!2-..LQ] MW31LR^$7HRD'&K&R;B= ]8+.QN2"D<3TEFLFOI9"5(IF.#C6U>W0 DQ=Q4V3 M<>):HF2S#:!&B:(;B[,92U9AOM'"XF(*W4%0K0S;V3 <63#BU',^_@VC>:/D M=XWF)[ZJ;G?(V3T#=^BL9768O#&5@JF=*.M-75(5 MKE5CB=\((N[=CQ-)J.F9''M(?:2B9E!%G#SG)2K344%DFX%R!=T.$PW?@5F) M@QW+P5.#.:[>BL8V9%./N1>@Q$HTD-/;[#,D7=:P6JN)J-Y_^1F$*^][WH+; M@\)E^VT-G8C4-P,1.FJG25_(7B%-&U,"/,?6 IS'QQ:5B#QQ/AU,.^0Z#O1V M)8F?"HA@*\O*Y)%W7^%NP[L],Q4R=53G6-^PSUMC% MD#,.U;9@6RS8BOS,M<6W,@W4G/=X/J[@H]L7US#+D)U'='#-LHOQB @FETJ; MT*';TL#4F()W4T/SCO=4<)0IOU@!O7Y]^^Z7=R?IH(8=$MKX"F><',?>Y(*. MCW#YEJY=[:F%VJLP=1'&\88ASA+G/ [,C<&%M6;1 0]J4>I&WG[YS2'ADI2U M/1^Q_-@9L%&J,_ZR[UVQ72TN.W$^OS=7NE1U8*B]]YQ'YUOCE;TL/4RW5\X? M>']?HY=LQ 9+?2]+SFPW-+UHN3-7IVNIM6S-XU8 23U-P/>-1.LUOM &\UWZ M]?\!4$L#!!0 ( #JDF%8W%W6QO08 #03 9 >&PO=V]R:W-H965T M\E-OKB3_I.]Z*Q[7&CL7-U88]\G=<_[YY:.!N,: 4 MHN*U$K(F#5]=3V[]B[L0QYL!?PB^52.9H"5+*3_BS4_%]<1#A7C):NTK+K)H$$E:MNR3YT?1A-2[\0$VDV@1F^[D-'R M-=/LYJJ16]+@:$!#P9AJ9H-RHL:@O-,-/!4P3]]\SYI:U(^*3$NIU(QL.$1L MS1I^M= CX,6>0=U9Z'H"2B?DI]EK=>*?%\7O-@'6(!>@W*T5^Z.GD5\S?,Y M"7R74(_2,WC!8&Q@\(+/&?L&;"4/8.J[4Z9:H/ X$.Z4"[5A.;^>P%90O'GB MDYMO7OFQ=WE&S7!0,SR'_L]BZ8$KG#3SX7BN2LS-N2:5Z0 MY8Y4G-6*R!71:TX*\23,?H7[32-70O<(D#_,B!U $Z9U(Y:M9LN2$RW-@WM9 M;5B]^^952OWD$E:1525KA]4%(/$5;QI8S^BPEF7!&X6+X\2MV7GPD#WQ!A() MJ=MJ"?I:E12WDQ19\](H/,9P"?^4EVT!ML)@"8/-*%$3#2E.MP@3IJV!+C>H$(H:TQG-KJ@X'6AT $H%F8H0AZQPVU.%S6CE8)+!2^'CQ')/(R.MNF3-WSO2-I;6% M.YJHK!U=;+Y5^WEH&@21&R?);"3Y@9NEH9N%\5BDRO@Y1YX3P<4MEL-&=R.R'?P8]ZJ1LEX=!"W\DI=]V4S#-_'-I#I'$X MM-A_J&G\M=G:7G#9-=#7UD([8$)N]__>'C*X20!F9T-[#!?2,E>JBPG0O\]F M%\[]"[S$C>/0!2U'TCES.P]%;AJDKA]&(ZDW'6(6>=0-HF LXM.W+V@H:C"1 M.^R)B=)$!QDTK@KN@8_DJ;@GBQQO039TLO^[)Q=4S#" M]?UT-I)BUPMC-_&SD32E;@I+AV$T>Y;#T]# D"GLJEEW[9DR16NK&$?T2^9Q3@S!T YJY8>*]D+TH=!,/Y0BS[E3:'"O/UJ=DA<;QXB!VSC)_,HZ:Y3 M*$3^K&O.$O0$!!U!!.EY(NY!>/,HM9<]'8@A$A069V".*1"V+#S#.]VS^UY# MY]=6*PT5"H\B/1N=_@1@2>G M7BP>9"%NM3%=T7S_L^;;DQ(!/Q]U!/D;WB'_V%FX76 ;9>&>?,CY?^F\@%)( M>7 R #>D26*2^/UPO'3&]$*SS;F2[/>"6WP/\Q,D/3ZP_$_,'#DZ@"(2C.5_ZUC,V#Y)@O2S3CB,KTV-Q]Z4%Z,O&15O M'LWW&GP7!'S[46/H'3X)W=HO(<_#[?>DGUD##E"DY"N8ZLV3:&)?D?H;+3?F MN\A2:BTK(ZXY@Q,=#H#G*PE'[.X&%Q@^E-W\!5!+ P04 " ZI)A6Y=WI M.#,( #=$ &0 'AL+W=O5'W>OS4^_NN*?=\$8/ M,=1H#7"VHZ1<]QZK%G;]^1_(NS>WIMN9TVD/A_1ZNC@87PS&\@7C5/)/KNO7 M@5]UC6F^=3 %DB,<.<*YD*]Z_&@6)SQ+!9>)E*_XRX[A9=%?]DIXGU\.;S!6 MSQM3/;P+6[TP9Q,(/AA_:R;G/_Z0%LG[5Z"I(S3UFO?_Q_RKQL]#RQ+VR"F[ M1@$WN]9PM^1!MR9PW36<]MJ%.>XBHHGME/Y)6%V(/*V%K!1/DUP4,A MB5QE0M5JI),MO=L<_.* K7?-;M$';@-<+]RJLU]-P^_6IN/]VO %=.*A;FS5 M(9AA8^]U%Y;&>^SLW; O2MYXCGX#O%QOW*[KL:0IL"45M1L3?F M0-:=[=>1#@L6&ZQT:'X'%[>NO8W/)RBLT!_@C>Y^_*&2:?D^C-DD.+HQ%)_M M&A#GK6[9R&!,MZ!H-4?K!:7POML80?M),VV+32?LC7U+F-GW 1U3-P830$-8 M6CKY!8KX?/^04]NM:"-48H-IV,JYAB.GH_[&?+' B0Y(?PO0 MX5W4012/IE3NT&?\TU2SJ+JP)4W,H7@RHN6ECUTY"M]V8><)L(A+K5GIEOOC M,KWS-MP,53(WG5G:/C B^3F9#K"/')'EF"V*- P1M;AQR$KW<:4Q 5D?%(M' M#>+0N:,BCS6",-_'G+RQ]BV+5;#R)HKB:?C/QA>%H1_XL*WM]R.X ;A@3T/E MWX=Z#.Y8V[3C(:AOJ!BUR18:J3?^??3]ZZ74-QS!<;<$H6 MTU!?_@95(@ZH[0!OZVP7B_.(_L#N U.DJ,.QAT6+A[L.SM9V>\+?Z+>/FS55 MSH(ZG=]_T[>?6?ZN85]X_=6V/"\$H M52I[GHLH2D64)SZ3(BEJD= IS=D'OZ*NVFF\2VJ\3Q)Z@D4BX4W(HA1U4;*?#;6*/=X4=2Z2I,93 MG0);2;O2I!!56;)K=,:OQK?$78JK1HH:D<(+@LE5RHLLP]TDV:^];LE7 E]I M1AZR1(D4^*LT%655LLNU!7U5B7#RZN!! 7FNE,AD3<2OAX,"; I1E!4OE$3P MBBMP4=4E^WUW;S9SM_,K7A*Y=8JX$;&!4.1H;S#-FO**]RS.EOP-'@,E8U HZ7=8X4%="'$G6>L2]^M]KI M/5>00I[GV >,,N$*":U5P68NXX!K-LQK92Q3468D2T@2A MB+E@/PT]*\MKP@+%8@ IL:Q*"$FRF?8Z@L^0)U5 TF"F4N @AV[SG&$<=YLY MX,DB(WEQ62+)6(8L%VGQ+^:F-_,G%7]H%R]5_+C\ M7<7/KJ:S&10"%"@FR+K,4 $%"KKF"F\SI*FJV(7IOJ(+TG7?[O 0>]+]OJ5' M["BA!8"E0J[!&YA!S"B?7+*K?AVW"3[S;CM8#/LRE7,J5I1FC0RC4R3P5+"K MORZNIC_KX*A;8V\IJ4E YB@W< 2^P1G*$;I@L[\OIY<:0PJ:^+5K]/3JXR69 M4/.!JG 0Q8):R1"* KDEN]CUNK$$ R ENHNJZ F JJR@) "0DA62B1N$[LE4 MY$"00,3@0]9"(=("F2_KC%UB!H(G=!A)]%'5953[5)T9ZBS+V1]ZN\;$*>CN M@K0Q^ SL+?P.XY9#NU5P#\E21T/#S*N4URDA+P]B0=]$KTE)Y]A7@0;H I5? MQ^;Z+\2R>,L^4>D/MVN($]J3J7*M;PG8_B@:C1N0YJXXF\?[1R^&V35.G:Y# MXW3=<7R)4S7N-///#G<=[G-<^=J://CDQ;*[BAW48 M+JGAZ_/X]OCM_F'X9'W8/GSX?])^A>$%$]D2ILE)F4^&N6S\T;MM_("=NQZ3 M;7Q<&PR^GC9@?>EP+Y]]?V )M(";H7&-M=Y:IN MNSW9:O-L2R('NTHJ.XU*Y^K+.+9Y217:GJY)\S*SB6Z<%(J>#-BFJM"\WI#4VVF41H>)A=B4SD_$LTF-&UJ2 M^UD_&1[%1Y9"5*2LT H,K:?1=7IY,_#Q(>!O05O[YAN\DY76SWYP7TRCQ LB M2;GS#,A_+S0G*3T1R_AWSQD=M_3 M]\']N_!.WM9H:6YEO^(PI73:!Q!06ML MI%OH[1^T]S/T?+F6-OS"MHWE:<@;ZW2U![."2JCV'W?[/+P!C)-/ -D>D 7= M[49!Y2TZG$V,WH+QTQ8TZ_ M$N=[_$V+SS[!IQD\:.5*"W>JH.(]04]Z*==R)(L.\'7 M/SKL![[^"8?W)QVV^,''>'\K+FV-.4TC/O:6S M%LZ]?THODZH2ZP5'=X!3[ M_\C_2?S'ZOIIYSTOG.%Y9_GS]N[Q[NN7<9:F5]_@?@%+']')DG38!5<2S'55 MHWH%O7)\G:F C4'EF @U:H+A2A :<>'_9F@L>3W M\) 5*5JSE!ZIR1X8R&KUR#0 M.G1ACVN)&XW6RS:ZV90?KK(Y1\S@"6[IA7M;S9W*P9/1/%O!F=>3)5=OY67I MU7FWLRT%FT1#P(GT>>#\5K4D#_=YY60 [5AY$490RWT)7,FA04?OG;]CL1#6 M0J$,#(W"NB:4N)+$32H7H8F>S;E_P:/N09(,LO%H^&U\T?/E[PUZ2=KK]Y/D MO-V'=E35WIQPL#:Z"DFH\368Y#3<+^+Y\D_0JO-)5AON!@8.]KO ;;PQ^W,C M##BNL@MDG$ML#Q+'MR5F&A9K41)7(3CGO"4TUA_C M!)SFMI&.CC#,\Z9J9*@35KIIU2]^@T$V[/Z>]F$\Z@[2(:2CBVXV'L!'-SI^ MTUTK,IOPAO!-\&QMHSW.'I^IZ[8[_PIOW[@'-!NA+$A:,S3IC?A5,.V[T0Z< MKD.O7FG'G3]\EOS4DO$!O+[6VAT&?H/CXSW[#U!+ P04 " ZI)A6^M:A MQ_<% "S# &0 'AL+W=OOT*2=3C*C);)DQS8%9A9V:9DINPST\BQL)=%@6ZYD$^BO[RPNL-,^ M))'M<_G.=RX^.=H8>^?62O7DH:E;=SQ9]WUW.)^[>,+>:-U.WDY"CKD2MVH_H_NRN)JOK=2Z4:U3IN66+4\GKR/#T\3+Q\$_M1J MXYZ=B8_DUI@[?W%1'4^8!Z1J5?;>@L3/O3I3=>T- <;?6YN3O4NO^/R\LWX> M8D7FEJ%[[)9I05?$+*P?6F MV2H#0:/;\5<^;'EXII"S5Q3X5H$'W*.C@/*#[.7)D34;8KTTK/E#"#5H YQN M?5)N>HNG&GK]R<<'I-(M]!/.5O6OR@R@,B8DHXX_P->V(?L@CVQ/=" M/GTDG\:0WR/D\S="'@TF+QOT?7/H.EFJXPD:PRE[KR8G/_T0+]C/;\!-]G"3 MMZS_GPR]:?!EN()'WW$4W6 @5$.MB%F2G6STBJQ/E<]7[+]8=%9+Y_12ES(\ MW2L=1M=R@W+NE=6R=I'IU\H2W79#[\@T$S3.8YJQQ8Q,%X*F&:-)4>!"9+2( M!2UX/(NNE'6F;54=J5T 4T$Y%S3),B^+WYP*+L*990D5+)U%G^'"#+945>0I MT.6HE\0QS>,\R,8%7&0,9TYY7."9F$4?%$@K]1B(CUDVQO;ZGW"#3!.:"6@N MTID_Q_"<"!'.+,DIRP'XW(91X<)-D=""Q<%%L5@ =A'.@B/NA,VBBPJ$Z[;" M)/ 415TMVZ :)S1)O*(0.2UR'VD:YS3E.2BQYE[[L1F](RME:K,"\S51]ZKM M88R\K^7*2%CY9'I%N*NBTJI* M \H[HA[*>@A3&I5Q<79Y0Y;6- 2Y)'!;#O7(#8:G=B1&S/@4!5J:T33-HL_; MI)>F421E&;P+B.4)>$P%21*&3/"MV$JURH*'P'R%@:A!C/23G3RE'^E:%#0/ M 0@J"J0\249>D810-;^;'HQ,"XCFG++4QYT5-,V1@\*G/P6710IF$?FWY;LK M],/HS+C>Q]U94PUE[R)GZHI,\Q1%@/@2;PN%G"YRRH7/5^(#C%%,R2RZP=M( MMRM/:U3Y2/3M,-81IS%#[<19@,W2E"X2%G*3I^%Z%DU_,\[-\&:\1P?X[L$K MFNBFD]HV/M$ !6HJ=&99FL%7#0I7Z7MYBY*:HFJ2D'D0$GMRX(*G?!;],C(< M,'W%,)!DZ,,B%P%5RH&29P%5@=K+DFP676.B2%NN0X8J8*M-%^"@:5&R15 M M%F ZG%*&P$#Q\R*(IGKVK!!2]$B29R2#;)846]%=MB&LMZD%RSP-YP72SPO/ M%P8%(EW\YY1["!?M.,)\)'Z,4;^%@&OBEYWZD?0FU#BZ8:2+#*WL.B5KSW!4 M84KLFJ*6&S?X9BEKJ1N?<:_X2M^@S^9GG\\O/MU\W3X*+A&#U[_^\:F1O.OK M'[?MY$&Z3H5EIWX\B,8@.'W"L-']FBSEO;&A$G8X'?'U[.3=BWXVUEPSMQELT]2D] M#+>V4VZ?7W_W:=[1K\U;U4D[Y@(V57NOK6D]HO8XSL':=Y M3N.81<_="H8BS%"\+Y&G81A.T>/JB:Z7?7&:8&3N76'L(1[^181XZ;!\=D!> M6DWFSQ;)1ME56)=1M=[#N%/N[^XW\O?C(OHD/J[SE]*N\)H@M5I"E1UDZ838 M<44>+WK3A;7TUO18&UL ME5?;Z&<++MW.]^:4S/[E9-ZT\GR[Y?OYG-_'QI5MK' MW=JT^++HW$KW&+J;F5\[H^NP:=7,9)+DLY6V[>3L),Q]=6FZ;:G$S'937RS-\N>)F9G)VM]8ZY,_\OZJ\-HMD>I[@'5JNM3<77?.;K?OEZ:2=?X M\)]MA[4"B^<;WW>K<3,8K&P[M/IN],.C#67RP@8Y;I"!]V HL'RO>WUVXKHM M<[0::-0)4L-ND+,M'(\P%" MO@ A)/O4M?W2LP]M;>JG #/PV9.2.U+G\E7$]V8>LU1P)A,I7\%+]R+3@)?^ MI8/8:^M\[A5L7QJ" M6)N01VRQ:0,$@,>-]ZQ;A%47W6JMV_N??RJE*-YZ)/RUM[75+D#W88VYFR]U M>P-(6 @TS&(!:(9,I>_] TE6TY*8@LST*!R1]MY AVYKUEA];1O;$W)MV@X9 M$AC3MY71?N,"_><:[W=FG%EWKK?M33 2=#LS/23]@-[HD!9"]MK6 3!FG[MV MNAJ)LQ>([XD";Z&M8[>ZV9B#M \3C%X@>-#9.^GUV-\N[7PY2'RPO=7DS]XX M.-34SV38WJP\=@"=^.SH1U0=ZQW\TJ)V.3LG.IWO#Z@Y$&A_S7?Q/#IB]IT^ M6D0/@9J70GJ(?CKIA>M6X-3>&A>NEL&G\^ZFM3_&:-GGC&WGW0IF'6LZ[SG; MM(WQ/G#8G2#\T=YVS2VI87/MEVR!FRY:FAH"]'S>;=I@UAEHI)Q;VG4<7>%V MK3=-4+1+S.M[YLT-;KP^HL)'U4_0O^0AB:.!4'39XFR,[\596 4[P2A1,% DO51'] M&_=[1+EHG+W55 $\RU/%BZ)B,L,N5;%I] 6.<2Q-2BY O:JX* 03 JU4D>0) M.(DT WPI"YZE)\ M3-+CPW+W"*/@Q\EW)/.1[-F5Z157FQ\ &%A.N!%G,*P&PE$P6 MDLN\.H[>U?_#K1^" )4GE/*V'[,20.NUZ];.CDBJ3'A596%_Q;.<,"5<5);5 M\9\<2.H;Y&H0G:1G?:1JG*N$C*!\,!^E9"O MR@2GJZ!^./LCA1/- Z4B+WBB"#FM)"]P4M$17)9+?"?)BE=)@;T*_0S!EO(T M5\?1AS'YHY#\MWH4B^1#^8F^M-%#=NX"5R$2I (SF28\+1*6IJ JBZ>KGYPZ MLJ425; L4\15.$BP0TC+-##%@2#XPXHDD8BN886L2E[@\*+O70]0VB\SQ UA ME3PI)0R3^HKG G%>26 AL2[;D,ZA&7Z.(U&9NJ9;YH?'IBDIILPEE M+I2]KY=7LXLO'R\_7Z%4-?/-:!*5V\(IGSMX7"3Q]7&HJM%P)?MAZ[XH[X]D M5YF?W_>/,F"H\/0X:.Y9C1 >U3X<*]7;C7W<)'U7D_QQ[F\.L5;Z(P,=V5<#$-=?R7 M^"IF-93"P)2=._T# :GI=8-04C'<5Z!!5BLVS6.58"!RI="DE5/O9_8OTW? 0>U@^ M/&<_:7=C$72-66 K>6/"W/!$' 9]MP[/LNNNQR,O=)=X51M'"_!]T2$;QP$9 MV+_3S_X/4$L#!!0 ( #JDF%8Y5Z9[A0@ )$4 9 >&PO=V]R:W-H M965T22Y2>;7[[F4Y+IIDRFPKX,@"47R7I[[<>ZE='[7M!^[;8P] MN]]5=779ZGN:OV\KPY]%59QZN6=8?=KF@?7L>JN;N8R=DT\;Z\W?8TL;P\WQ>W M\3KV'_97+9Z61RWKR5?/G:T/ZTX3]EO.M.QHPLN6F:C_3P MZ_IB)@A0K.*J)PT%_GV*;V)5D2+ ^'/4.3L>28*GXTG[+\EVV')3=/%-4_VW M7/?;BUF8L77<%(>J?]_<_3N.]EC2MVJJ+OUE=\->)69L=>CZ9C<* \&NK(?_ MQ?WHAQ.!\)2 &@54PCTQUNXN&=E/008GCI?]E!,R\O5J.3UH$0]H40J]JZI^VW'WM;KN/Y2P1*( MCK#4!.NU>E;CSW%UQK3D3 FEGM&GCV;JI$__C9F_/F_FH,1\6PGQXV6W+U;Q M8@8"=+']%&>7/_X@G?CI&8CF"-$\I_U[(_&LDF]#U";[AG+VQS9F;YK=OJ@? M?OPA*.E_ZAC87=3E7VE#4;&N;P^K_M!&5G:,)..:W3RP?AOQ5('097W+ND%W M]Y*]R%ZWQ5]E1:,/==EC]W5?]+%C1;UF;P\M:@FMO8OWY:JAT>]0U9YHF!>+ M[(J UWW"P-DN%AT )/2DI8VKIEZ553D8T6PF::QTH&)W&N,,8*=E6' ;Z]@6 M!*ND>K!J#G5/%I#.=MUQ=K6F M7(VS%/F$E"IO]8 =^\%O0XCVAW:UQ6F#>%=4&-W$_B[&X?#'@8=XT_;%316/ MP,^PJ<4LD*=HP@6[?5N23H1VU[&Z04B0!:MDV[H$R!Y(^F8T[RN-"0MA7I?= MJFK(%]@\130FL>/>4CF5 MENSW*5Y9O$>C@W'@1->3R#5:!1;XF#;54<>F;79LR-S/X;YJFPU\-(=9W2+[ M#>UTWS9KL*=C_VHQEVR'W7U;WAS*E+OQ3PP>8 H<&Q$=6!19#&L^S2YX1BJ.UM"Q?7&/T?L4D-/4'.G*7,Z%S[E7 MALV=YC*WW*E\P2P/P7"16S:7/%C-A<;LB_04 L]S/"DNC>+"^NS#]:L3GC.E MN5$2T@[[0%1H6)&*)@/4>44QP/T&<%MR%G TMVG2>RYA+ 6I^QAWV1<5 M:,P66.>UYT&%9)V5&L\A6:<4A4Z0WY2%*D6^'U"1B8!K1 J'=)*&V=N_+SJ MI22.,88$M:5<$4P"IX&AB(<*F-%DB,%.0TN XIR?H@%#8:(*R+1@<32<9@@O MHF+)%I?P8DG+_ N\&NF3P\_0ZY%O7F?@K_R'OR-_34ZT&2F=Z 8,<&3URBV.IEIJ$Z3F?""@T%Y6$SHB&< :*C\ MP2\!)<'DW\7HH?9I;&*U^(?5Q&I4: ]6ZT"\ M25V%"W(6G(LRJD-R(5''*Y7BXY&_1!NX>$XE/S<(T2-.2S@?;'$.(9'$'$^- ME&*OD9[20ZE'UY8CA4A?CM3 0;E'70X3I]%;B/K"4@8)CT9)M21'%@0!'0;E M.MCALJ#1K!6-)3J2"V[,&HO$!N42GPW HAZ97*168*G:4!HJNH=P[R?[K*+* M1OV"DU:AU5=T1F/69(5$.]0VZ<-&W&S RY 64"").? IK5HJBD_3&=R#CY,A MVM(U24Z):T1XGLK8CGZ&/DSW%,0.\0MF,-#![3K=7T 0ZOA^<0(,U/;D6TQJ M8K(PW\5DBAI16-']"&%-YRHJIXZTXT0U%&H,A;/$8YSMFIH: 0INLZ M7O*(I/T#9_NJ&%_MB'G[XXM>B5? ^K:D]P<8&I^^VN__/U7T&L#27>)I*L)2 M@P:0PZ4HLP(7$"W58VKYQ ./ NV1YBCC4D]L2=S1YHW,:2N2_43G[U@>) MYGS]N%CW;NBO2WI+31N("K.O)VQ M=O@ -CSTS3Y]=+II^K[9I>$V%NO8T@:L;QHDQ/A !QR_0E[^#U!+ P04 M" ZI)A6KA27+=?OM1 M;8WHX%D*95=1[5QS&<ZX;5'12:B.9 MHZVI8ML89$4(DB).DV0>2\95E"V#[=YD2]TZP17>&["ME,R\K%'H;A6-H[UA MPZO:>4.<+1M6X0.Z[\V]H5T\4 HN45FN%1@L5]'5^'(]]?[!X0?'SAZLP6>R MU?K1;[X4JRCQ@E!@[CR!T>\)KU$(#R(9OW;,:+C2!QZN]_3/(7?*9N7D6+" HL62O<1G>WN,MGYGFY%C9\H>M]TVD$>6N=EKM@4B"YZO_L>?<. M!P&+Y$A N@M(@^[^HJ#RACF6+8WNP'AOHOE%2#5$DSBN?%$>G*%33G$NN];* M&7J:E@G06\$KYA_++F-'<.\2YSO0N@>E1T#C%.Z(55OXI HL_@;$I&J0ENZE MK=.3Q!O,SV$R'D&:I.D)WF1(=1)XDW](]>OI5'O0]'60[Y-+V[ <5Q$U@D7S MA%'V[LUXGGP\(7,ZR)R>HO]/14Z"7I&CIN6 M)@I<66^C!.M[9; .D^:J;[ _[OV8NF.FXJ1$8$FAR?G%+ +3 MMWZ_<;H)[;;5CIHW+&N:EFB\ YV76KO]QE\PS-_L-U!+ P04 " ZI)A6 M#6-[5Y+0I&ZB5=B>CROOFPV3B1 4U=ZEI0./*RMB:>_RT MY<0U%G@1C&HUR:;3_4G-I1Z='H>YI3T]-JU74L/2,M?6-;>/9Z#,YF0T&_43 M-[*L/$U,3H\;7L(M^+MF:?%K,J 4L@;MI-',PNIDM)A].-NE_6'#/Q(V;FO, M2$ENS#U]?"I.1E,B! J$)P2._]9P#DH1$-+XUF&.AB/)<'O%FT3IOZLX8&=12Q__\ MH?/#EL'A] 6#K#/( N]X4&!YP3T_/;9FPRSM1C0:!*G!&LE)34&Y]197)=KY MT]LV=_"M!>T9K/&O.YYXA*7%B>@@SB)$]@+$+&/71OO*L4M=0/$<8()\!E)9 M3^HL>Q7Q D3*YK,QRZ99]@K>?! Y#WCS7XN\?%%DA-C].035Q@?7< $G(TQ^ M!W8-H].W;V;[TZ-7".X.!'=?0_]O47@=8KZ?_("2[/!W[)-.KB"W+98<^7,^ M9KX"+,+F;A1X-*$#&FL$.,>P;V#I?6NEE;IDKN+H/8;G! ;"RIRFO6$:-DFWVAV< M/[(OT@%;JK=OLFSOR'DIC&.WZ2)E.V_?'&;9](@VA.'LZ-V8<>+R72K)=6## M]2,#76)S*1*I60VBXEH*KK"=B$>!+BS'3&.H*J,*XL'9_BR=L=G\,-D10>LU MMZ+JA'(AC"TZOJ3Q+^.!9?MHL2/7>/Y"\=)PI.@Y+BS;7$G!+F %6!>6:,X. MCAS[O%I)=&\OX6)YV2M@*ZE0..],WTOM 1WB$R'74H4.AHVL-UR<+P=#7F+_ M=3ZP.H_*8YRO (]&P7^8-5B-W=3'^4C1K ;.%!):N&[10[+A2OI'6K_&G)<8 M@-WY4>( [H//>&W0"P;W6R84E[6+J!;6,K1K-$3JM0L#HJ'@@4O'%J4%B"R< M+#6))2ADWF51Q+E>7O6#RSBX6-Z- \=M?LES?F-FN9E! MDDNE4/086[>O,'J6BM"%'5)_;74,FP4E894X N3^5[X.6OO*DEIZR?O*LE!* MYTEJ=#17E,]8S53R;%.9G@#M-RPG"V5$L.^B+&TBC,82D9ZC%*F%:D/7UD)S+\ZNGNC1V3!'AVUT' MKU+IQ@F=ML*<^!Z2,>?Z/I192U(Z,H[7VT[?"D?*_L:/'WS1WAMBYBG2"@N)N@IWC2 DG$;)D$Z>+^BZE#TXGEDH?=K D/_87[X MH#Y-=HK_U2W64KY[H0[[%M!)'/=B"$AL!R,T5J4 FQLK>(U-SC'!6Q>U#-@I M\F*\**0/*1HJ_4>7O4!F*Y%P.<=H4_T/J3_K4Q]#:.K!8<^B&(]D)5X8F&H MY T+#<<4Q#<56$HRRBMM]/MAHM?3Z5./&*C5"H-9]$7\K,4N"GP9#361LL^: M+1J+'7/V^WBX\Z1[.5/8AD@* 8U_.J++E5"M!5 [D[KS!/J94$(>/SDEP02R MYD&2#*0<7<2>N:CKS<]=E+*[!C=TN?54UZP!&Y[==!OG1@_,A@YO>J$D<;C< MDP4FLE+DH-C?7.L:NH,B>4!/AK>PIONYJZBA(JACD*17HME0FS>M0XU/5S6! M_&FPX.*9Z<]>19.M=VH-M@RO<<<"='RR#K/#@W\1W[E/V^.O!:RT$F\\IF"% MIM/T8&_$;'R!QP]OFO#JS8W'-W085EC"8&D#KJ\,EF/W00<,/X-._P502P,$ M% @ .J285L7VBY" $0 +3, !D !X;"]W;W)K&ULK5MM<]NVLO[.7X%1S^FQ9Q39EO/6.,F,[<2M.W'C:R>]GR$2DG!# M$@I RG9__7UV 8*D3"G.S)EI'9( =A?[O@OH[9VQW]Q2J4K<%WGIWHV65;5Z MVD!5>[>+ K:R2&2\J\H/IX>'+@T+JO3G[C>;SA+^UNG.=9T$[F1GSC5XNLW>C0R)(Y2JM"(+$ M/VMUKO*< (&,[P'F***DA=WG!OH%[QU[F4FGSDW^OSJKEN]&KT1_X\)0%T[!@RG1[1$SE M!UG)]V^MN1.69@,:/?!6>36(TR4)Y;:R&-585[T_DTX[8>8"(EU)*YE5>*V6 M2LQU*53L3QT5A,#Z?3'?".(SN.&=[Q3G9\GHOK M#COP>A%9<1M9,;1_#_WY,'0RL#=N)5/U;@1V.V77:O3^UU^.7AZ>[*#]>:3] M^2[HK2AEFIJZK'2Y&")Q-Y#IY"@9 "2^+%62FM)!^!D8D TKQYVR*F@2IL@R M$[S/DA;HDN'9#,L4M+Q:LI)=8M"6S&C :OE\HU;&,FIPO,RDS:![O_[R>CH] M/+F\N+GEQZ.3_40ZH9VK@6'V, #QM-U#"^C,X)\6W.GM60-NLD,0+Z(@7CQ- M$&'S3,J0*':#F4ZFR2 H%L:Y*5:R?""ZCUZ=./%CX33;'1ILMK\AP1IF:IFI M2PU79'6*5:EQ%7E"[<9)7>;*.0\H$P8S[9UVBH1-JSH*M IN8T+48\:/Z5W* MM1(SI-936$6$XFXQQ[O260Q MAW29YG76PH)T5HH#3%*:BG!!]T$RPP/KL+*9.M>.N/B@I'6M>?@=L"+_%#'0 M?EE72XCFG]8"/MZKM"9B@J)C@Z[8LS98LZD^+H\+#Y M/PF[3$[M@G942K_?QALT3(C#T16T"X; ?2R578"4*I, IO>)F_] Q;ISO#=7 M+;T;.,-XQ'@N'PI9BDN7@S5N$.WOEAP"[Z!%V)MQ62+((':P@#J<"C@Q/!D] M"=65NM>I&0,9TCQQ\XG^GD_^GG2 7?WZR_3X^(3F :9?, CK+T6NT>,ZZ\/X MP]!GB?7=24- KE5ES?>:<+XZ*>#GQ/E20RN###:8RV,M:WGF$-2_(>0:ZMF MB80U Z!L3_<%_ DN5I8R^6)E1AI^;B;,V$A$F!#1 P!!D$N)DB*2\+?YKDJO M25I&_/R5D79QBF>M)A>*(E&C/M$L6M(W9@#8U]O38:OP,\=]\C?@Q&UL@_*Q MMBB3Q._%[(\N%3D*J'))HOT=ADDD#BV^S)3S1GD]N>P*@ =:O7KUPO^WN1 > M$_'-.&\5CY6T,XU4Y^C$N%U RPRRN+9Z#0,:M!^,8[V?M]UN ,(\("1NTG7[ M^>+SU; )B5LS-\5N0PI#W4W_T#2W[?U'AMKHES?8#=4(9OO(A_W(B+OCWIGM M!,]3=@$?!,S*O!,NS?@QS;7.D0 R"EAA=!#^L_"?!]Q#LX[,Y=.G\^X:?&H6 M!&-*SN'65)[XJ#3R;Z,([^7QY-5A]V_R ?F4U;-:9W#R"22/"NJWXY-%#7\( M]^+E+*T.<6[TX?1\%[BS7V6Q.OERGC1^.;PSF>L^)A]ODNMU3X#A7.I[*?X$O!>')RM-:<95G=.H366&<>M)R'1E MO.GC8S^\LJ2&H=^RKR?A8M=U:9X ^Y,I%_0F_Z$M7UQ>A:6C_2&T% @X*'"Z MJ[OQ'3DU)TR42LW4 A%=4VZW4CZOI]FP_A52LUG(K2;))690N\IWA)AO,5U< M&:3W# T%)-*J7"R L@IACKX[]CQ88A7M665C(:DHR'/Z%R5%MU +*?\%C%B$ MA.G GN6TB?_'<5)<]##"O:76;/Z)%Y]V+X;)\%D=>S_#8GQM%[4R/;[ M@FP6DO(TO'4P-M.Y5*_D-T4: MD"YER;6Z5>E#FI/N8E6A[X%WY1<25RKEU21% @7(U&A-"J"E6=9D=4I=@YGA MELG<6%'[RIY*H,K6:93+2N:YJMP^G*'<3V[KF=-(#BPI2Z=50>N0P.94'#?< MOULJ,EF2N[I?,<(5"8+'EWU)1:;2YI'F\JZ=07,X4ZKI2)K9=[7 MS#=F5 ]/Z(<$RK2-)L" I7,&^P\-E.3_#$;%.KBHB3B-PPEQLV+7@67> CI\ M&8L,-I96<*>&4#1O8Y9_MT^DRSF<(A*X,5Q)!2=1-5RBE6QQ6?-EW$J_+?Q) MJ8+;Z'>Y#'PCO BV!%S4#24GU-L1(H<'C7!00^AR@3C!W"O(?R#@XR_[IP6Y MM9[@^Y0E0=#!JHBFA95!)J:WD+M5=%31#)2J(KXKK[+T99-(BH:FZJ\DBZ"6 M%_$Q+&=6Y+!1G;-V(->'125=W?$V0(XZAV@@$P-)4.-*5MQ6;)Q9L!._93@& M5;I&V^@+.%8ZZ?T/+2/5F%/$"+ ;R#2!G<=/-HP>JW]HX(1X3BR#@YS#<4%) MV+K(/6YT]S:GD$9SAS3XVR4=;:W9*9B";=6;RK-@4.PF@E6.&]3-%[%IZ5TK M&%1PHH,EFS0*GBI);(4T6=7@%M)]F#XP6!>:HO.Z3$.\3&N+E"=EC]E+8Z@21NJP*",5:"K&V/9B$F6>4CF /I&200#60714R1;0.^\3PA*&(\&:.OL M@ALF$MY&7Y+_*M*,7X*%=!00NG<1D$1&9!H1A1Y!Q-Y?!N*93I[O!S<>4!/G MMG*2:.Q8!V2_77%@9GA02:^!QVH+ *4I'BBXLMOE=%4L'\ +T@J?"%DX1?($ M#4?G6/!&-5BXMFV"L<)M_U9"<9=#1@'Y1X/2>HG9;)-#_:R?>I( M1+#H'5PU(JL2W2]M$AN!". MJN-$.-+ 1S$3#+LC+JQUY2, M/\B;CDP2#GZD^5P9H+14:V@Q.[.YT"!16]X%89Z('8<:K^*AQJN=AQH7K;\C MV<\W+'OH=&,GP&VG&\^3'V#RIV1/B%O2G]>UAZR^@-;(L6%!>8RH/I8.^?-@ MUD'D"*54RA84@?P97,)G<-!G.K-OLP;)^@!5JQTV,!;A*+ ] _2'@N%HKIL) M^ZQQD);& /I[$7LW_]KG#>=TI$;%9V[N^LT=U+157VPO;^E,/ZH/'Q>,VV9R"V^<#/4[8^OU\2+N)X[%8)=IL^:' M<4]N)YG)Z.OM_\:[4=\W%5NX0\TF=O!#FV<)/ZP1^N[71#[2CF3/(HR M\4EM3O'''/SW\2"@'[XXX;[U3;U"#K7#8;R.#N/U3H?QE[HC10_W"A 3X.;* MS)MFDQ-ZG:IZN2';?$T)-CPY=P2VWBG92< V!_,B^2]3QJ5]'Z:_WX$< ^;3 M>*/,K#I.?PC^99EL&1KW"A5R]%4HG:CK%M+(SB[:VPET(:1;A[8T<@29J92B MC^(ZGS(G[#_IWA =)/Q-0:?3U"R TYP3?&G+&O*=<(EHS?B6?*Y5'"'+A9O M[HTO0WS&G,]USBV7MKH#\UJRX4$O3V_%\:O]"6"=EB75?@AFUJS;U@'OJ+VP M,CT\>OV,#H1IR34=-EG*I>""Z*X#^2-(BAMC;YH,!;NFH,*AN_2)@AJBX^@E MTW&C0LK:%HQX67%A>F&QC&[7/5I/5![O>Q_/LN]=INA,SK0O(OE2!XD7.26X M[G=.'#)>8S*H Z(Y'TBRSOHXU(MPNSHGG8-XW^:X&%!EHI::AYS>%9X[?;7F M? =(JZ9HR.G&XT.\:11:!0\H!%NMDK$^Z&>F'++@'U.K9S%J@>7GH3F0QO2Z M6S(!6F,C8 1U+YO7(2&R##^HN?95[\;M+6[60S87W!@%;GFCC=T*]Z>$],&J[)4E53RGI-:7P!04VZXD.QEVO +>,[[ M#8$A[GAD[46*:+ABC^@[>A54N/$]*]@5KV:=#@KW4QJ#.F?N+QREU+0<^TXG M #V0-S)=;S015[*4"\^6S*!F)-6BVB+UZ?J&8740ASQ(SN ZB%QO7?WZOV=> M/WUKC#K3(1H$+[DSS_XMALW?=H;-2Z8J=#9O:IB!?/;UFT4QP,*9@VW54"S< M#74Z>9D\!7)/UE3?\1%^&&.!"@D&1I50ZRC=ABC'W(JK ME"RPGHXI7*2!-E27H5/KBZ@J=$+"/;PDDD1]T536CJ]M4HUNJ3G4EGO=*Y4K MJ]-P%ZHH3.81=$RW0]U_7#RA&?L&.SG)<+P4CMB2A<2@;\(WI2S?,>P7)O\A M/JYJBONN>XF/SRG(.O ( ?F-"7\C UM9*$,^JN+C$)>J$AX$=IV[IN^OF%E) M1FD^UV%0] J@EJK@->@ I;O M2\)76FZ(7K!&:=<)$-ZJ2(HD S;]((?>=<:,FG)JBPZ -:'VYRU$,UX9%WJ@ M,J=";;$,9RV$!8-.TWD*N;D4L<4W +"9# J1#&'W+BOJL_<+V%5MJ>A+HEV, M!311VH6AOH]5"Z\VU'[PCAQ*VQ.+[^U@;O;@FF(M8LG-0OLZBSD^?D0->%'( MU!K?[M(I*76F R&QLMSLZC4NFXI8_PERRK/F,,CKE@X6'T_#:%E,]8(Z#MI( M(>TW58T3_FIK'T1ZJD.< 5#JC.2>H /..1E]IU_YJ#S?DF7TLV>R9Y)RFT4G M]!E6JM9M6&#FD?^(QZB]^.K[-@/.SF=ORO&>+7^%N04_\3B':Z_R')%32/SL1R-&%$,1?R+S_?U!+ P04 " ZI)A6 M>I7\=: ' #J% &0 'AL+W=OO(-33(@&\OJ5I>^(D0.PFK8MXZXW3GF=:HBVB$JGP8L?[ZW>&E&39 MD9T">X#6D,QHXI2SO];O=#)Z-7;FVJKB^E-2D7;*J(MEE&U6;(4KF^ M"GMAN?# EXG!A<[U94Z7;,;,CWRJX*U3H<0\8T)S*8ABBZOPIG&R2J_!32&*VH#8U#W+]E17G<0I&,M7NEZP][3D01U8;F17, MH$'&A?]+GPL[U!@^=0\P] N&OM/;"W):?J:&7E\JN28*J0$-']Q1'3:3SE.G3 MRXX!\0C2B0I10R^J?T!4KT\F4IA$DUL1LW@7H -Z5\KW2^6'_:.(GUG4)F>] M%NEW^_TC>&>5,_7TS.J;7AA^Z@R.ZOZ]T?W\,_7H&Z1K;E*'S(BFT3'D,NL:-7FQ2_M_" M!UOXX%$:6* B)BMIN%@2+@R#,QMR\O8T0&^U\+='D 0>NL%7*"A/EBH@<]XD M;MMM#2?!6&BK0 PC(YGE5&S(/<\XBC\)AQ-2;8>G9,A49F-*>MUN^3\8*JI_ ML2RX44M0#Q0FL_9-FYR\>_.IW^\.BFU2;;OUWN!TN]((=RN86H(J)J8 QD&V MHG_S=(?&AP[;ZKLGL]BO)([H)J."C'4*IM&-8K\HQH0_P5;@#L581%+E4CD' MU2Q5R(3M=OA;HB;LF4>R!<*@TI&'>_P=M7^V:V"3=V_Z9V<#I -,S]"(]2># MFJ*\K.$NQE>)RQ3XZT1-(%-FE'RR*//C(.,1):.$0U06/M@SKMO;FM91-J'^ M!"=;",\2IE*LW #-3OBN@^^I,%30X%'1&"-\)-O.L)42!4$E'@ 0@284;M5* MA9_RB0D?29Q6\MVJ$UJ72?[81G+&%)Z^#*\R+;:J[U$ V(_937-6>,K6KOI[ M.-4Q#J'<6@6= OF2S;_6M4BAAQ )NO8+)":JV,0\CIGV23EMC^L./+)^Q>:!1I^Z*&O9;$ M]7U?S([".Y)CX(W +IB/XB+%ZSI;GL9,.1&0A56!\,O$+S>4AY(/T^7^?E3G M@:62H4BF8 1EC:6!OY5"_Q96>!_.VA^[]=_@,]=&\;GE,13Y #P/;<1_SP9+ M"_40RHOW,U6\N.?"SS>C8W##=S3+!X^CH*S+Q;M3<[5KG _=X/8AF*94&QY5 ME?SV@91+!Y@>(?TA3M+@KWKUGEJFC-R)U).P)"5UTKU\#68Y[TZ3S6CSURM1^?"J:V0OX%]+\42W^C?>.2[\:1@#4^;Q.)%X"X% MLH;+@]?O=RY\PX2MU)PMX4;GT*9#+?;]*U)#]N?0FLV+WJH=C($")S8_%#F[ M(6AJX6"Y7 ,=H@D*EQ^X80DB37'-X;IVE0=8%,,SL[A%@&(-DQ7^A=89NULP MB&N?00C.$G>0Q*1HF$8P!2B4+)9P\ZVXD@+-B/)0X*X!=WI*$I7#L34G<$%3&VZX Y,VNH4,&$;K:>^&8%V[Y1!7:%YK:38@!,R3T-A)JP5.E((^+L#^E"L7/H$/'Y?? M99%P:M7R_P+=>&.7,+ON.;(LO#1ZLAS"!LK"VVHR"$!,"5EZ.9%I7/BY,)Q. M*/9I\%:36));C$9#?S&,@"BA LI&"O$8;:(48Q>X,OX,%&(*-L5/DEIVG*C#YM'QGESJM1 M[ORW9RUMYYI#FZ$P[-;<).#&A151X<'(*DC":-,TT/W?A02S.MU=11!4!/MM M7^M@E!#L%W=&NVV<5 WI@5[V142]#+%#E.[2;P5-'5+5K+UD2_M5 MHDU^M&?M6*8I55#8?\S^$YY6\EP?NL5O:$NWFS7=W"3]:E?G[T>H_SG3?/Z'U!+ P04 " ZI)A6TIG;Y8H# T!P &0 'AL M+W=O/WO2\TXLUD@FU,O'E(B'Q])DYH=K7OV.\0 MW[K6^'FR"V%_-9WZ]0X[Y2_M'@W=;*SK5"#5;:=^[U UO5/73B7GQ;13VB2+ M67]V[Q8S>PBM-GCOP!^Z3KG3$EM[G"3UXT-M=B ?3Q6ROMOB(X>O^WI$V M'5$:W:'QVAIPN)DGU^)JF47[WN!OC4?_1H:8R<1;V];WOW <;+,B@?7!!]N=G8E!I\WP5=_.=7CC4/&?.,BS@^QY#X%Z MEKA3[;V)G#:Q*8_!T:TFO[!XT/Z9\ PU@$H=X+W0LFBU]_$07_ MXP-ZV4@O^PA]\4@#UQQ:!+N!C3;*K+5JH=5JI5L=-'I8G:A5X>!T.+U'_G^$ MG]Q8XVVK&Q6PF7PU0;>PQ'!$-& -CG(X6NJZ0P@[92;QYH3*@3)-?Q45WVL; MFKVS^D9\LD&UDR>G&H2].O5_/1"298(SF4I(&2_JX2!E*1>3I75456VV9,;2 M@K-21BN1UDSF%4DU_5]2D4->LD+F+*T%% 7C><&*JIC<[@ THN2U55.4L8+)D4Y63KEG[&#SPUZ!:OOT>N:$.L21,EDF;%*%B J M$@7+94IQG'Y1<=]0H%HR2= M4?@+*APG2G5>D0/M,](%KQG/*JCRG*Q3R"M*HY9 =:J*RER6D^L M-)?8K8C5ZVR"H&)0"ZI2D&599-2VG*2<.E?S$JJ^K!1"@*!&UISX5ME[(S-] ML\DZ=-M^7WM8VX,)PU(;3\&ULK55+;]LP M#+[G5PC>,*R 4+]?66*@CPW;H5C1=MMAV$&QF5BH+:62W'3_?I2=N.F0!ABP M@V.*CT\?:9*9;:2ZUS6 (4]M(_3'K$2Z@:2P0TGC88CKCE39P7]ZA?^ISQUP63,.%;'[P MRM1S)W-(!4O6->9&;C[#-I_8XI6RT?TOV0R^(3J7G3:RW08C@Y:+XMG78 M"\B\5P*";4#0\QXNZEE>,L.*F9(;HJPWHEFA3[6/1G)0GE*0I^2P N"(WCAF'78XX7_G/5/MM!&8:_\.I3W M@!H=1K7S,]5K5L+W.(\5ET#1"X'VH?X M'R+]'V GMNZV^/[$EFYR*5O0AI?8B>H>-T?LIS0($Y*D"?6R<((#@^,@=N;W M_(3$-(X3FJM>,2/!MF_]E]V*!73*VXT*2!)89ZIVGL$#5LI>%@Y+K?! MI M<*_T8HV+')1U0/M22K,[V O&OX;B#U!+ P04 " ZI)A6EV)*'$\# , M!P &0 'AL+W=OU*V4V<$ )[@+3L%76ENW:U2]MGDTR(=8E-;0?N[M-WG +$DAV:CD1>= M4U.'<10-PX8+Z<\FW=J+GDU4:VLA\46#:9N&ZV]SK-5NZC/_L/ JUI5U"^%L MLN%K?$/[Y^9%TRP\4@K1H#1"2=!83OU']C ?./O.X"^!.W,R!I?)2JDO;O)< M3/W("<(:<^L(G%Y;?,*Z=B"2\<^>Z1]#.L?3\8&^Z'*G7%;K*:O@OSL;"$DE[G@ M-0BY16.IWM; S9*O:C2WD]!2#&<9YGO>O.?%/^"Q&#XK:2L#O\H"BW- 2.*. M"N.#PGE\E?@1\WM(6 !Q%,=7>,DQXZ3C)?^9\?-[QI<2[3&#RQAW61[,ANDV&-1;]&>__,2&T86E+;HD^'\B/5=@5V7F M/39*6_$="\B5L=Z2KB$=]8TRPIZ=DSM@T3"(,^8MN-"PY76+8"NMVG4%&ZU* MLE?:JY4QWJ?%DLHSBCX8X+* 3XO#[$;< @NRT3A(LA3B($FR@!'RE<)HD5M2 M4;:R,.S]82O4$+,LR#)&[R3(4N8ME:5$R8+%P3!A MD 1I- [2-/6>6JV)!MP8)&8%9,@ V#$:# M] K=Y;6LZ&BXYD6ZK(*YYM]%+;B$LE;<"KF^T]PBK-46M729P4JY5&]\*I?Q M;SUA3$L%6'VCLN*I/Q:H*?")IZOJ.?:=12AX1YUNO['"MJY!FGNO*^JSS.NV M0-,%+%5-;9N P!O54N$?X/5GJD :L#2!49(&*ZF4/4Q<@.,/&PO=V]R:W-H965TM>1)&Z M7^?>RT/J7%>&S+N5P(>ZZ7LL676IN%<)B:V=@N MC115I[1HQG$8\O%"J'8PN>S6[LSD4J]&OA/X4\FU/7@G M'LE4ZT<_^:VZ&H0^(-G(TGD+ L.3O)5-XPTAC+^V-@>]2Z]X^+ZS_K'##BQ3 M8>6M;KZJRLVO!OF 5+(6J\;=Z_6OQ+219/C@!SNZ'#OX\=+C&A@CP#[*>!?E37S2XGM9GI,DHB0.X_B$O:1'G73VDI.H MKW>H[WO4Q\!N3+'CIORFN;!+49)#B8__Q3Q\-V)0%D?*#ME??(9 MF[!:H1JZ)NZM4AT+^@>8#?[03G89]X\HN.VZ41H;O,=@G2K1B.91NN!AKDQ% MEL(X)2V):)HDE&1C0+H^!>-L+)O4Q!HH1F142BF,8L#*##,LHX]SH\ MH06+ NPZ[*GV+2=9P6F:%H11EC#*TR0XMO;AVQ+['YY+(ROE2*.MA?I0C<@P M@O.PB/P;>HLG;!0\:"<:DM 8"T7"2$8CSFG!0Z W1K:.".@C32]$TH2F/$6^ MVK/RI=B9QYD4Z0G#/A3?B:92[8PX3=QYN/PQ&@3"2E!J<64E\!]?6M2J5CPB62_TD#8&=71HZ6GQ5^'/R MH(DO,$A/PKVRG?R+2'HG-O"KM6Y [QY :9231HF++L=[HQ:ELXY4*_1:6Y%: M-(T7]_.U@H^6%"&IQ#/6*-_XA^!WX5DG/T-W+=,>_4'Y7$SO7:$E35 M>T0E5DCL\\4)3DE[3DG_^^8_='J,7WZPBV!/,QTW!\?D=ZT?O-S+FZWU[]2" MZ]<*EK3:[;LUICS/: 8Z&X)3B@1\@:44/,48X6"WE$9Q @X!DWDRX907^)C$ MP=W.A)6E1PG>N@ CG 5?E@%VX[;?29IP&N<%&<)8GHQ(&A!ZBI8/>M4"N!A' !E-> ;=C*89*#KBX-'<$V6*)!0CDK&B9[*$,1K&Z0&- M'K);7.0T+=B>6O>,=Z*%>=_"_!_W5SD7[6RS2X4G(=&6GH\,J?1JZNI5T_?> ML3[^/_SLF]D_PN!&-)VP?Z;J&YV#?E(<'QJK=49W?.NC,D$5^2-$K!8H>L^_A2!#@2R"OCM4] MI&.U'Q_<7G&]F'5W=!\4;VNQ??_$-\$@:YQ7$E:ZB&YQEH MRFSNY9N)T\ON+CS5#G>9[G6.7QEIO "^UQIWGNW$.^A_CB9_ U!+ P04 M" ZI)A6>I2Z^MP# !E" &0 'AL+W=O";+ H^B*1XLR9,Q?.:+8W]MYM$#T\=*UV\WCC?7^6)*[>8"?=J>E1 MT\G*V$YZVMIUXGJ+LAF4NC81:5HFG50Z7LR&;]=V,3-;WRJ-UQ;(^&!I9?I)>+F35[L$&:T,)B<'70)G)* MAZ3<>DNGBO3\XE+O4'MC%3KX=">7+;J36>().9PG]0'E8D01/T#A JZ,]AL' M?^@&F]< "5$Z\A)/O"[$AXA?L#Z%C#,0J1 ?X&5'/[,!+_L)/\^7SELJA_?\ M'%'R]U'"#3ESO:QQ'M,5<&AW&"]^_867Z>\?<,R/'/./T!>W=..:;8M@5J . M?!_?(_D?8*(0QQ!,'GU56E'!-+ VIG%0L:*H6"H*F#(QX6R25M$M=NJWU6NY MLLP8KP049<6F/(]NY)X*T:-5LG4,>FN:[7C3E.ZWWH'4#5"L[N5:Z34(-LDG MK" S&DT)]M96C%1B.C.>-D"SUF: MI72< R]9EA6,I_R#!!;'!!8_'7F*QTX-K8LZYS$/5'[O)?1_@'U.<'BDT85L MA[A*#WZ#L$3*@D8;,&@?/:*T4 DF>$6A##$48>9JRHLA-:913QLJ!5E5)XRY.W MC)#*8R0# YF"BR#WAE04.-R1C-(U#1V'0X9I_QP(:N.A(,($:A\C*I)PK&F> MD7S@2#T-=K+=OKH0H0\04HW6D]Y3]4((/17S?J/J#2@'^-"W=$Z78/DXX-(0 MHR"2LZ3?6Q7*LC9=+RV)'$P/MESTQIC%VECJC6!&_LM#-,;1VQ"[@WJ]M9:T M@.2UZ50-KJ8K8I4Y?:]"DQ>MOT.['@9*@Q16IIJ<3JDH[#K5QXTT_#)*E\326AN6&_@/0!@$Z7QGCGS;!P/'/8O$O M4$L#!!0 ( #JDF%:B"AX[2P8 +8. 9 >&PO=V]R:W-H965T]CKK%%@(TEZ_#\&?SE9A;!^ M/YOYQ6DFK#&W.M-%V[MXU_- M5I](<&$['__9XSA7U1.VV/A@^^UB,.C;8?SJ[UL['"VHTA\LD-L%,O(>-XHL M/^N@KRZMX9 M?WXQ"T"G.;/%%NEZ1)(_0!*2_6J'L/+L+T-CFN< ,]#:P%-[757$4_]%UYM1U]=4' &RUP$H0=[[M5Z8RPDRP!OW8"97;]^( M(OUP@EZVIY>=0K^Z0\(UF\XP>X]P/[CEB06G!Z]C&+_*^B3NZZS_V&;)M>[T ML# ^T8'!'::?&[=W"3LU*I*_V0<[6,?TT+ C.?&;N6^;5CN*MQL3G)T[[>.T M'P_MF+"Q5%&/]MXN6C#WS]?]/:R,2\[:<_;5!MW]+W.3C]Z;X)-/&^?,$)*O M3C<&E6-A-T/P,-3"M ^4(&S*A."US)C@55$RH7A9"_1FO*HS5G*5%4Q(+K,T M^3(\ ,O&_":K8Z$&?+G[)I_;A[8Q0S/:J1V" M@2L#0UU;Z'5+:D[C[K(NMO_3\9=$%??43>>)N4T.2167>8UA MP&,[4!!",9E5/%/Y5J4]6,:D4EPHA>@=Y2PG;X(NM,F8RG+(H"CK8]N\Y*2P M51W-?I"FR2]6#^3O@1:B0CK;(467B&3MS,IV#4* TO :H?[-].Q+8[R.:R7/ MZ@K644?2B%YD!<]5=9"V!N\.AH.%:I[")ZI,$90E,')$9 X/@!U)5;HW4X:L M3;.2\'(8, :1J"57J4S^9;1+#-7T5TK B4%Q:C!]5AZ>Y>2+?#U1(5YF^A8R M>0V2_2G(_R-+"II#@;W3%#CP_MK99K,(E%NB0N$0%9Q2PF49DJ+FI9+L[9M* M"O&!B1(Y6^3('#@V1^J0,V5Z&*^H+9A"BE02\]*:DBNYV;C%"C>8N)_3C[A' MH(RTNO.'$E2C04&F!6D82%*@4Y03-04KE<2ZMQHQ,T@S*/UF2E/&\ /$1..4J M3\?>DAJB/$]^:@?44/!&'5S8WK S\QV75"AVSI,!I\-9E6>T/T4SML\0VY5$ MWQ+P=&>I[\; ;CQD.%Z:8G MJ^' I)LEVY& !W>> !+5C/.#L!N9P@XEEV4TR%;8C1U6%_![)#0*V[+U.ZVI MB@J<-=5!V&-(4:)VE#3G(+_<:<\XANFUQ?6^:Q$5/[O-VHX%B;-;@R!!2&O< M>A.*][=O9*8^=,:RV]8N$=4-T6%W[SXRPWXSWW&9.'$MRO?7HOP/7XN^F2<$ M[8#70D]'TQJ5TPZ#Z5Z[%/UYU.0N($&H+QD3]+[%B>M89[U_=DT:2V$L>;&T MW9I^0V%"@\G=RKHP1:+U;([@ 89G%0Z8 A>$F-BX+F2\SE1R8WV8FG[=V:>X MZ78ZHQ.Z0/D6P*\+G(YV6"81$)& B11\:]R.F$!JX5! KJAX"JP+A41,!5:2O>6=V]);HC5O&%Y-G\08T/BOVO?M'VX\94T-H)=QY?)W :\M7$"JPL $FHBCJPUG;0.+-MCYD:]AI>J8E MVB96$E62BK/]]1U*MC8;)+[T(GZ]>7PSHQE.CTI_-P9G_FH$#O>EG:MCG^(DS^QX\M5:;HO M.O;8B/@H;XU5UW6#&T\ "OT,%^8GK MKN>B'W"%%#VHVAX,NJ\+4?Q*$("P01T]J[NC%QF_B/P:12%&E%!Z@2\:O(TZ MONBBM^N?WK[G9$_!WJ=P17)C&IZ+F0]58(1^%O[\TV]A0CY?$,@&@>P2^WP# M15>TD 6U0_9M:MX3^S_H/!=4%]G06W$M:HL6JFIX_0/QNH JW1I92*ZE,)ZL MT9WF_\K2>^)E*ZYX ?EUC @*RW#X77H;B(;, 3]:+AXV8\1"@L,H0W028D:9 MYW;1%7FTYUCWFCRQMTQ2P!\2EB+,4L3;SU_?+;X_WOZ]M!#B4X)@S1$*<)\[Z* M N);=M$Y,XZV8Q3&$9XD!$U8AAG+O#_M06B49#@.&%NV!X"N?_ 5!+ P04 " ZI)A6 M%-K0EZ@: [10 &0 'AL+W=OSH DXN& &0Q),[]^S[F- M>7)F)#F[6ZDX(HA'H_OVO>>>^P"_?>B6O_;73;,J?[N9+_KOGEVO5K??O'S9 M3Z^;FTG_HKMM%KARV2UO)BO\NKQZV=\NF\E,'KJ9O]1U[5_>3-K%LU??RKD/ MRU??=G>K>;MH/BS+_N[F9K)\?-/,NX?OGJEGZQ,_MU?7*YYX^>K;V\E5\[%9 M_>?MAR5^>[D99=;>-(N^[1;ELKG\[MEK]9S#H1I_&,8\]GFE7QP]W@]^H^R=JSE8M(W M;[OY?[>SU?5WS^*S^MGY?2N7W4W MP\.8P4V[R#\GOPUR^)P']/" EGGG%\DLOY^L)J^^778/Y9)W8S0>R%+E:4RN M77!3/JZ6N-KBN=6K=XO[IE]!RJN^'/TRN9@W_?C;ERN,S.LOI\,H;_(H^L0H M2I<_=8O5=5_^L)@UL_T!7F)*FWGI];S>Z+,C?M],7Y1&5:6NM3XSGMFLT\AX MYC/6^?JB7RVA#L?6F4>QQT>AA7S3WTZFS7?/8 )]L[QOGKWZZ@_*UW\\,T>[ MF:,]-_JKC["XV=V\*;O+\MTB&QPU%_^UV^D?F_7_QKC%7YM5<;OL+MM5.9IW M?3\N<6NYNF[*QV:R+'_XQUV[>BRX']P4Q7_JN7:SFC\^G4(1E-Y\W MLV([>O'SAY_+43LN@Z^LJ[&SNAQY4SGMQJ52=57;NG3XX6WQINVNYH]4[.+] M^[=X"H^-3)5"&)?/RUA7P87R>?&Z[[MI.UDUQ9L.<#1O>]Z*>YVIO JE=95- M=>FK6J52.UW5SF"FKG(^%IP*IO1U7Q"X,C:TJ[;IR\FRD34#'-I%N[BJ2LAD MVO0]CLO)8E;V$TB2!^W-;;=<4:A=.Z_*%IIU\8B;9W=3'.*.8MHME\T<4YR5 MZ_,ORE\P^&VSG$(J0#T^_F8YZ7]M;K[NRR;+&()LH%XK;(_,93JY;5>3.>^E M'+%O,(_FYJ)9;DRDQ/*->8$=D7\+D=J.)!\F/4;#A#!GF1"&_FFRG%[+TU7Y M<-WB>'J'"7,7.=SP@,)G%[#1!\4;[#&BF[8D=V#^U\7EXTPV.R M8$%>" N(_VNSH@RQB)MNT36KZ\=YLVC*/,-R]-,/?QKG6W$53]_*Y6)S^<.? MQB^*O,/K#?_ZY.X=O'W:W=Q Y"T>^N>@^Y?8!.@IG5P[Q;+^U:WK'A;-LK]N M;\_MWD933VVA6-09*'$;*'&?;?)OKR>+JT;V\Q,P\J^.N;5$JNF!'?\-LEB6 MOW001?%F,I\LIC"C5481HRL== D<\ FV7:IH2VLJY4SQ/;9VUBQF?;:Y0;8% M!)B-I1SIY @,\K/(*,5YX39XYIZSS5-L,-]4*>/Q'H,'4J5-*O*TH"#0\VN2 MC?M&#.6F*5T5MIJJY5_O=@#:JTJE+*E,I7'D]]]8>HE?HC[E418\0J MZ<]9BP-:&<"=K73R^)DJ4Z=/KDHIW@Z0JPP$-U)5-'I<&EM%&\\M$'>J8 ' M>#R5HQ C7NF]&1=O!YW%C=C1ON'J4AU+;0#1JO2V2GXM.^T<_W\@$%W:4!G, MROC*F<0!3' <(%!*-E6U-F ME&/&.YY?=(N-SR(^]=< D>MN/L/2^*/?;-11F_GWF5WQ<06\HB%RT!\W;_O0 M]:V\ZFVWZ+MY.Q-4&Y +F+VZ!EDO^++F\A)D&4]O@*UX-VOZ";1GY\G=88KU M,/D^NM4?YBUXJBRNW[]WCSJI"/8,M8>; ('WWQX\Z6;/DA MP"B1/(32X%\-A:UE"/[OR+7BE^5D!K6?3KL[/KX$L&..H-*XQVOHO7&8H,<$ M@]DG\-J M$D8FSU&P>HR4@4G5L;(V$*(@'57GB2M;U4;(%>$)T\$55?PR^:V1V7;W\.Z< M;@([BA8W5;;6\K0&)W,*FP,C=C$/A@EY$35NTY"EB\7/.X,,V+*2T0U$5'LM M,)BJ"-:W%N23*\7WS1)B8Y"&];F '05X&%SRFX?V3P_XLY5W7WJ=UQ\!-S:8 MTL?*<4$F8"=L"2&80.P/&MH"<20(O$ZA$+>TIC_E1!20CEG7 %'R50BFA@1U MXIY&)T<6Z D\3*"REAY,F[TMM&"Z>*W#=.%J$O3%NN*OM.?\FB,; %VA1*$> M*>(]5.<(UP&=U5B)%;?%'<"^5]XG*I$0VS,[P!M2(O!2 =)6D??/0_J7#:8U MXV-K 4!I@Z*:X\A&O!:69C$AA2VA=3E,I"Y'L:9'%'9.Q< "H(L14PN<'J8V M\*C)4C@:SY+$TP]3)['FK*:9Z6\NXWA[ P=_OJ;G#_6RW>.UU\6))>KQX1:<"!K@3K"'.W N5XE5&X7XGO=)"( MBY$6K6"3"8X5AQ;*$B#$S(Y''J#H7:(L/0A/@%9&G-=@<:U MU!D@&11!P4: 10'/TU?31,G.8 2T'C';BN&"LKPOAD#B4$@FAS[GKA='MS:? MRAN8'T0'Z(6]>6/*A/FGFO:$S##;+%"/.HEY'/!(!T;=:V"4=X M:)_6 P4LV(660^R@!]\ PF&[("E@"^97)XC&"9/" J/56:VB(7Y'B19=HJ%K M'FK99#.\B)^YG3P.B@G35!@5 M#@Z'T>-E4$UR.4R'&!A(N8[[%_@/#9D%+$E)9%QI[TG?P;Y ,WI!%H@6T,?! M*"N[U=^GUV"9%Y@B/#9]4P!8JM)!:V/#N>B 3&1?0(WN8 M%;WKQ@,>7BG>"]5.SM%"(2A8#V "; %J%)DZB=9DDU'8<=C&6':CAG\)6)?G M^K"- )3[5K*FS\NKIIMW5Q+A-J0/9)>OYY.K;@+[@0[ +&MZ,D,E#ULL/7)M MP,:-_L$4+(.C2/OF' D*>"X2'QD%&?K;VB6A30'N$Z+FD86X_*'/G>]8 A#& MU$JH&P8$@@ 1Z@%%F-/!)0\9*>BV@_XYVM=6M_$(8B[.GQ&12LPRF3W'^[Z; M+,K)U;)I,D[#T1M@ GD>8,'!&H+?DHZC5\_K+U$:"_ 0!2T-,PJA/GUEUWH( ML$#.D$E+-%OJ^>1*\7I-.=?*MNHVQK#VMN(8(7GLE E\O3+QM14P8\DP,TN\D00919)8,;(7U&3H!RP PGCJ_3SQVM2#![3BMA(UBWPUY M:0W7F3Q3!+NL0PE'ALEN[]TQ F8QF<]L).VR";3X"O#B1 ?"*%\C;/##MH_: M>PG"AZOT4>OK@VC$4N&IH,NXP*@#YA(L, ;+TL : UTA5(BYVB@7LX?3L(0H MCI8@ Z?PV0:KQ123)0F%F4'-M_!ZY-JAP=+3 >N8&X68@*-TR"22AH:RCG+( M;[/!X2[06FO-$1>\NU%P:]J"$25)X6IZ0Q![37Z?L(.1T0/(-M D0LG@B^ " MP#2H<4Y<6')@SF"+ /-:B"B\)/L">(_I(: M#Y+?6]*0*PH,<"0;@]WR3/V8DRMC&)R$@$&?@8W6,2)EL*BA#5!8^C@=A[?- M]TG)WMO7>_!_28J81=@F#H8DR3[(,&LA&?<]>>\G+3XVRWM$ 5U>Q"_-DFF) M>?D?=U_]09OP1Z9]7^0\N0#=Y;*[V;SESQVH^&RR5J[]E]\NN[\WT]4Z&_UZ M]O>[S/A+R1KWM]UB1IP<'A[ROSN99PS1+?E+L9<66O.7(24TN4!$QV%Q(^!Q MCDGRE<"3+5XP>%S.-*N'IOGD*\EH#T;;RU$-U:8!G\_FI\J]_-2!]SV9GCK8N,],3=7EE_S* MNAGV 5A]!^X&+3<9AA7\DX5R*]@:<"V$C(6.: >03 09PUP0*59-9PC_-0+> MD@PFHJ.63(LB.!(>:&8*%H1HR<'.Z'94[9AMAOTJ1I-N(.-ONWXMWUS1P$)G M\)B:81RC*SI^ODF"!?HG5L480QIQ=75@*&6D[$;X0SPOQXI$5R.PU$SI@BSH M,G,8P)7$ O08P'@@C/(@.I;YY,#L560^BR\*9'4 ?3LN_K3DI@\Z .YA@0J) MCH,9#W!=9JO@3A13+^#] !QG/%D0$02 GB3#HDL/_,);F>J!@P%P1I)F)9F( MP"<8X"!6!@-CHISQ3JS79'W4_';;+, -QL7')M,;HL6L[;.+H9$QH0['J:(: MY^2ZI6?/.(WP$LR=FZ6X1@99X@"%4&FR X6GUM6 PY_<8F;LE-R-:6([;9W? M(HD=-RY&[Z462PU;]I-Y+X;=! M=> @1&8>%"N*S!B?YVGAR-7R5.1=":J%R *_TH>D:.228Q9""VO%I+ X&\;% MSTW?2$U3MA "FW?# MU@A.KXLVF'@=F$NC4XP,D)*LIF9>1X,&A"S!"P8TCK$9:!UX*HY,:7(&@2%R+$9%I]:.F,QH):,P;Q3 M0$R-T,BN:T%K:^(6F9KL3O:Y\H[)8BYXAE0 &[E0&HY MBAVZ!#B*9R*UEE$2'O8:#.EON38-PQV@!/>15P!7$2X9BVU!P##*>1$$.^!Y M-;/!BBAFO>3TF)$#;Y%L@,^2=01JGB&)1:S/B!B860=#.EMS5@@P1X'8 %/8 M5A*&"MW.F:U0I+S'=TAT0='%),N&N6.")H,**!-(808;SPR/SI"0-S"R7J<\ M$S_8,T\.":HNR._Y!N_U -Y.BB)*Z"5@'V]&V#S>*WJ(8I"1 R8\ WG-]2M9 MMR'*UP#4.LN&%NP)H]!!U#B=%H8+X!<\40+3%#[]- MI7Q.Z&D/S%L9UB$@#U'20R[8X.H47E;T! M1#&DD[OI5&+(BNQ9% V<7&*:W&8E9WU+(V,&@)X<@OX\& " R/FBJS/ZW703JW$X;#@,]B= M)4V@6SXG!< VXFDR**$NL%8FX1ES2:)QO,]V6;\L+N?=0W^\A'J6Z7ZJ$/O_ MPG2SM-=-8H,JYEW>T3;92/!=^SNU30PX6L&YS].W;036R_XS*@+"S=MMK\]> M7]L)[U9\W]SBT>$I(34WC-.&P U;#(*K'3,L3(RP,"DU-$F3)M!]!;T-B=15 M:K&LS)C$B)=)(M(<@KPP(H;W/DC*@0+R3HJ)T&D)T1D3UU%]-I48F 33*V3) M?E!;X1&G6EN"3E56G;P*&+TELG!6291 JD6+!'11K-*J!42CT3UDS(I2-!:Y)* M#"+A$L&:!R=25B)JEE*5UL70$UA T[L-)V=//G^NFR"_4$>.5/*?EW>+RV73 M_)/#CB[FW90O&)G7TRTHD>HAQD MU8["@C4ZB4"B9^;_=UC,V='.]!\!)YV@[SKNC@PL&8^S6D'6J:2/ $I"GT27 M*ND UN!#CM #LR7TZE:*DDR?('@CDGLFMX/D,((;"#*[KZ2P.MYK5QJJS:'. M!2<*3EQ,S= J5^39-2(X0,5BIH4I&W<:#K6HKH*GE9#2KB?@&+6 $QSI;M(R M,OQK8F8H2"0<&1@Q[V8=!&+ID2/]*(8QY["-/19P-QR,;>PQR!XQDF+IJ0%R MS;9QWU/@8R1Y3!&LE!A..^TG4DBD0.Y(VXI.TOR E7EV0$"@("^.K9><;LUF M&=(.-F(XF/1)/6?T%TEB6(TF5S")_3#FL!N!>3YMH"DL7UOX[A%;U)@=<6/Q MF$QYLE^,;5=2P&3S458OC)[52S1.Y^R 8]>:;))*#(>LA&(UNQPVV[NN>]*3 ML*RAAZB1Q0G.E741A=@=&L?B]D@!N2Q[8\'$<+LYXQB$"S$5Y7,,R+(BC<,R M5> 5T/B>T>) SO*7.JS./-DAQG=8\M/4'W/"_O.Q@!N08BS>-XNV64P?MP5L M.D\F4(*D5-A>(4Y".KF!9^63FU/M: M0--+OYV6^GLM'3".;04@*"<]/_;-!C9,PF+90>DENF,)@FE(NXT)!/;H!+A4 MFS.UFCDHZ3Z"Z)AOD]Q(B.3,N2>)^7LI2; 1-)VS2<:-D'-(0W*(@5A^2R ' M9SIP+_-)AI(OA;Y& 0CV M.CH:"3^BDD;E[29=/.[PH9UO58)D135H&"&/<,">0(F"]-!;E88L;X*KE]YA MS4RW.KU3K*6+IV=;(&5L(Z,!IM]34F2TTZ:9(4I>OP=<*Z M-W XJR6)9VN9DX3UIW7XJ;=^\BP0="9]Z7VQZG:XTY,J^HCM?/4YO=ANSXD[ MMU]>%-E'8JTN6T1BZ!W/Q,F'/P^> ]5$8-YO5W)[MIWSN&@18[.#)4A*$G[4 M2G%MR)S3^5!366-W0^D&)C;P)C;QG3,9B>)AJ;F"9YECR4F8BH$W3&Y'9^_Z M7$G.FW&@KLQ5.MI0RG-DW2KFD;QBI2?\"W-,EJYBJ#BR.3]DBP5QR1SWXW6W M7#T'S-Q(PE-B+OZ&N.!BE?> /41>^DDP-VETYP\C/4-6NM ^=XO/C,+&P^%K M62;M)=TN^"'5RSH-E39VK;DO<[V?'.T@%7BQ;3D[%3QMQ')X UO"-!B@/T.P MUS^?W+D5P=.-9&)>Y?J,M%Z2!O"K DFP?MGMZ[[Q@IULVW>Q9A@!A&_K 1/%P5E%3!V5,E M)LUZBLF&855V-R/:OEB-4UGU,[X_'9]<1%SDB%\XP/]P0,].*[QT"W+9#S.= M6O/+@UP+2BR?Y"#-G#/',\[OW'B?WQ:E&7KLI&BDE.B^@ IO=>'X0(0[/-/K(9Q-3\[I#M:$PO)R-?X+ %+8 @0<'J7-0:Y6Y@Y[FCB5#',/;$ M7K')7KX-@<(R#I%[M7PRHN$VUD6P8I,M97>BP##=<;=LVJM#1V@Y$08A#/N\ ME&%K)\UD+%ZP0P2<$4 BWP(F80JG,==2Y]@;%ICQE>PABR51^ICEHS]F.8SL$DNF5PT5^V"7VQO.IW@AMMNMO-MF*2[V6Z1 M2B?LR%NW\YD8N:7-4N67 \:=E-[F"S)Z!J 1NS7PGL@VNEA_>JXPTLW']<,L MCW[,MC/A8]^UK2=\,F0\\LW;SHS_/3;ZV#>@+W?^H 6BZBOYLQU]*0FN_+]YXZ); M(827P^MF A? &W#]LNM6ZU_X@LW?2WGU/U!+ P04 " ZI)A6BI;X+YD( M #;$P &0 'AL+W=O=7 M-#2+@06T)?:=G;$-V+G,!MCL!DEF]F&Q#S35ECA#D1HV%O^XJS;#DW=AM<]B]OUNNSO MKD+3W9Y/Q.3^P9MZN1KHP?SB;%,NP]LP_+)YW>-NOK>RJ->AC777LC['0A.J@2R4^/,^/ U-0X;@QA\[ MFY/]DC3Q\/K>^HL4.V*Y+F-XVC7_KA?#ZGQ23-@BW)3;9GC3W?X][.(Q9*_J MFIA^V>TXUL@)J[9QZ-:[R?!@7;?CW_+##H>#"47^E0ER-T$FO\>%DI?/RJ&\ M..N[6];3:%BCBQ1JF@WGZI:2\G;H\;;&O.'B=8_\]L,=9YNF; =6M@L6_MC6 M&P _L)-WY743XO1L/F MFC&O=G:O1KOR*W:%9*^Z=EA%]KQ=A,6G!N9PRI_ROR_Y37<>C!F?\>BWVTK(];ICIZ M$C=E%,QC[_79D:H$_0BN]K6S:)NES%!5J\W??<^$&B1J5FNF)QYF;TJ MJQ46Z0'O ZAI?!N'LFE*JLG(W$Q)9F=.9R^V?5L/VSZD43?U![J.3.2SW(Z_ MVK@[> E+)D_V=/9K6-550XM@ MM&"BF!4R^]>P"CU=YYX)-\O-(RDS^Y29;X:W#U775G53)P3H257V_1WP9.6Z MV[;#L>S]A>8!%O#=YS"CNY>'.7S(7/;\D\R]*,GN4 ,PU,YOD-5Q]MNAVY" M([7T8HFT17923]D(Y;L.^=G%@ME \5X(57!:":ZF945SG@A=@@>:J\%SD MADD,*KBU%A.X\YKGIL@NJVJ[WC:)F(N NJK&$),+"*T?ZH]CS*?L1'%A8*LP M4W8BL1KL%-9-Z1765987!G"D^]] M-UQ(R:7R3.(2%KPU![Y;B@;4489[B4?:PW/ &.N1\*=,J8)!"KCTCBG,*WCN M"EQI*?!KC(15G3TM-S5PJS\&*H86KM5EPZI5V2\#6:%_PL.1W#U<96A4:$,M M&D??A[:Z8Y"P-H[%QLK%;^@GE,XQ&\+Q7%LF"P<44&-<"*!N#',:SA1,*L"$ M(N!&(B:CLV<'L!.4<%WGEG 4"ACO\+7S M14=@FQV'F-2:P0#AJ"@*L$%1"K60( %2*'S.K53L],#4T(%N[Q%+U]_MX*"E M"U5,#RX_GS"4[;)&1Z,T@ C>8*3@UBGXZY ,3ZS DT+3A37 04ZS9W7<=+%L MXHC;B<@!!^+VW$GR%"263F."A\W$.2UX;@D975CN#1SY##MAD7( GX,RIS D M(7+*6ZZ<_P)FX<&EG"!5J3"$LV.,&C2W.CU7SG&IQ6O%WI?--J!8'%B@J5BHT N0R8(K!?>>"EWGGE,9&.6XT2@6.)^J*;_7B7$Z MC -2JCZ#@2@II15-UYZ8!9V0PG"#-H#<:>>!N?JJ3HRR0"L;)1-G4<@ W(CI M03Q$!H>,)50METBM)PX_K@[B.P+^3!T(?$@+J."$QTR+)'N#"+G-*7:/V'UA MLLO%8C=G6/7==KG"_G9OB'Q\_H:];DKT\HK,2E 6E#,(";Z!_58R!&K0/+]% M:60.JBGSG*HTJD(_A!:I_*15+&9"[L&)JT)+@6T!9_JC:G#"5I"6-N(6 2Y#J!B(-(R2L!*ECKV(\_ M%%*(GQX1D%%RH-A^)WSCY8-:[&-/ZD(!@Q->$[5D/BH;Z90M/+U#'U+YET(! M=^$:>7E*(NF$8050\NI+.:;4*&A-T@/MH GW.@&=<:-.6.^H/7U9L!;/-34R MR#!&.^IN2FFP1C%+X@Y>2F:D&[L;L1VJY\VN8'?3D3[$Z'(4 CHWZ*_03E!D M$'6'=B>Y@H*@E3"'9*$]&G25QPO66)2D3,V:5(ZX(S\M6$<2HI:/^T MGUY'50UB#FB@<,(5.1QFX M%3[@G+VHQUWO;3VL6-QMZQ;)XA#:%%!<;8=%=XO"+X?QY!)IXT4+CVN29V_^ M)DDK ;4.?*-K3]D#7MR;(!=]BI\ MJ*N.]$UKC9[@1ZG3$'25_8)C8:!3!KB1"':?10@-)$1#^UTZ3Z"(LY]#OR[; M.S10M$XA4U= QR.YPQZF(4>Q42\T[>.M%[O3GG0X$FJ=/53Y08<^EI_YP0<7 M>+-,GY7B&/;X[67_=/_EZG+\8/,P?/SL]0HEAS,Q:\(-IN8SA[->/WY*&F]P MNDJ?;ZZ[8>C6Z7(52E"1!N#]3=<-]S>TP/Y[WL7_ %!+ P04 " ZI)A6 MR[GTL$4' ,$@ &0 'AL+W=O>OP*C33CP7E@@0!,C4]HSM-+EY2..QD]Z'SGV@2S65\N[++H MI]W*MG@R[]RR\)BZFUF_34_'R+"/Y(/!';>_Z1V-&GEQWW5\T>5L=3V(RR#:V]*2AP,>M/;=-0XI@ MQM\;G9/Q2-KX>+S5_CKX#E^NB]Z>=\U_ZLHOCB?9A%5V7JP;?]G=_=MN_$E) M7]DU??C/[@99HR>L7/>^6VXVPX)EW0Z?Q:<-#H\V9/$W-LC-!AGL'@X*5KXJ M?'%RY+H[YD@:VF@07 V[85S=4E"NO,/3&OO\R=O6%^U-?=U85O2]]3U[\:' MK#\XFGGH)ZE9N=%U-NB2W] E)'O7M7[1L]_:RE:?*YC!L-$ZN;7N3.[5^,J6 M4Y8(SF0LY1Y]R>AM$O0EW_?V-'B[R\E!A=JM@I+D9;\J2GL\01;TUMW:R9JZ1,)"]>F-LW89 MUCYTOFBB\Z[W+.$B,UR;C*D\YZE(F>"QB+F,!4MRR:72+.5QEG.MXNBT+-?+ M=0/5550L.^?K?XJ0RB\$%S+C6:P.V LI%%=IBI'.H#\UM)8HGB8)C;C4,<]5 M?A"=%4W1EN0G80!JV>6U=42O"/2*F>1Q"J5&,9G!"!VS1!H>*\6@E!N10"+# ML3H7,.WO==W79$W/#IDV,?ZXSC13T*0S;HR.4#90%-JH7#MGV_*>>0#:-X,/ M1?4_ $T(83]8/SI(S> M^X5UT9VKO3WLYO.>LQ:7!* K/C<$!R<\R9.#A]%7MB+&2E&TM.)QG%%@ +?0 M&.0:WF4'T>_61U2]V6W1K.VC:"0 PF0Y[,MX"G0%#!7"4#2,X3+/O^16JG+@ MH!FQ).%:Y(%;6A.W9$HX)9[E MS1?<$CR)#1BB>)[$+ <-A3+P ?E158-4Y!>N6]\L<,>-6\F.WR[915/TOBY) MD81G.L07#AC!@)9)DC&/HSV; 8B*98CUX6;R#';C9TOM%P9[*4-%SHV6@3)( M,F'BKS@3Z$V9H51,, P^/Y/:AY1%:6[&P7-8#=+&E&$/PUV\3@W5'@-_S%". MD$7$#H$T)JKO(#:0ET:CO* R4J+?$:&%19I9U[*5 M]:ZCMKLNBX:5W7+5V$],H<@81-^@$* (J91*G50\20#_E,K!5&?1%3KNQ;>5 MH(KD"*E"*8IYIO ']FCH%3S+A0$P>G/BPL>T3ONBV;=6615S65@:%",=^-L/+]21O1[*NN!%VQ M7U"WC;A5;-W;^;I!LW&+3H/DJ?-'>%A9K&HT&],]5-,CU?1>1OPY--\OM\QX M/[_HJ,>IB^8M>%'Z]^UYT2]>XZVF?S\'"-OX7R*LIVUU81TBL:[]_7]WT7'_ MX8_IN-H>&_A8HE:U\+-?L#D=31*(.ZLVIP=6!4Q6HP'1O^)I^C/M.]P,HL_% M'XF>O_GX%$YJ=$*X4I5DH4-" _9]!J)"0A+,)0HF*8J8,5NZ*:(FEW@6KCD> M&[TGAF:,H7DRC)_50LKF94CCD4ISNRM,/U)_=,@V'74(SZ9C%F@\8SP:N^RQ MA28I1R^5(1?MN1__)3)H7YE14/K;>@7G8/D-D(9/9D1[_. MS>M[%LCD[G=!^&,T;VX;]%+T6O)/W: >H8FA6YE&4O,*X\P!'Q/ 2CXRB0U^8@).!VKZ(W%FW][ M3\U#ACM-TLV;##T$0U.61^/M]M# [<)[]N@-'0?=A.\A^L&YX65]7!V_ZC@= MWO ?Q(?O2=X5[J9&9]C8.;;&4X.;S0W?/0P3WZW"^_YUYT&3,$0V5]:1 )[/ M.U24S80.&+\ .OD_4$L#!!0 ( #JDF%;2_M1@'P8 *P. 9 >&PO M=V]R:W-H965T[8:F;L--3^)NLRG[A^O0=/<7,SX[3+RK5^LA32PNS[?E M*KP/PQ_;FQZCQ>1E66]"&^NN)7VXNYA=\5?7-JW/"_ZLPWT\>B9I)[==]T\: M_+J\F+&44&A"-20/)7X^AM>A:9(CI/'OWN=L"ID,CY\/WG_.>\=>;LL87G?- M7_5R6%_,W(PLPUVY:X9WW?TO8;\?G?Q571/S?W(_KE5^1JI='+K-WA@9;.IV M_"T_[7$X,G#L*P9B;R!RWF.@G.6;?@\'5B,$5,/@M8_#; 8.GMCXZ5D\[3H)Z%;=E%2YF4$P,_<

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�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

* S\&GXG!?/(T!"G.ARD?U.D\IBQNR[V M;F/4.&_*A!<1<*T4YH';,@?P*P8EL->/#UB3H/JLE_[==__/.:-J)0)CSMPT M V0=1/-K&/8NYW?.R-M*095J,EEY59/2JQA\!RX@-)0$"*'-EU[ M3O.JS__IG?)YGI!FW%68@7*W[+T.)-:] M,TE-Q9G@A[__T9N3&#B\E_-;$4=Q".65_BV+T_)/]._4L4%OV\X9BD=W@B O M_6H,>DS.,451I8ZZ#,P92FUEI"KV(Q$$?IV%K-LQ724)M;KZ@:!>_;:D7,HK MC[EB74='2_P(XT!ICDQ\#807L<>\+A?!ON*S1[^/NZ<\VU5-K5A'\/K7J)M> MT1\IRW\IVO7C*RD/F3P$F"/2[829;_QPLDR7ARAJF&V$..J%(((J>TY*]N J M9I.+H$[(KW^)ZFHU.YYR7*EDH*MO2_J#[47.]1@_3Y@NN'"N(G":@>N0XT$@[>.H^4JYU?TRI5 M]#R.)W'V6%FB7/M@>?2Y]X57H11W[U1ON>.:[O_-??M?]^W7* M?E/-7TJJ!J@LNA:0$3DK 2Y5L"T$SE&@F,M2M;C3-8XP^/.KWT/W^F*[*JJY M>8/'LUMUAZ\A*<;+0+6B@JM]GZ5T!\H:_/"HKMG%FHD+/S6WZ"$CUO?$& MK9?OLM*K]SNR(U29B*I6P5F)&R6U*\@8J-R@14&*"2AZ-;G3\9H#D%$[?,2' M?L)DL;LS@7L"PX0!BCDQP+9&;IKTM-7.>JGRZQ3G61VI^Z;08F5E1X@-'194 M&>@HZA!7'R.BQE%)E8[I^EE%@&UN]<]9%GW$B>J'T'(Z[Q]G9@K73D[-ANA8 MQE170?9?S8?F8,;L0 ;5H9A4.?&Y6*^?%XZS,8/F7FXO9-0_]T@E\8^LWX.Z M..3MU<@W.FH7T&,\;LVNQ]^R*B?BCKS5=W$/17$F$?U34S0ARUEI MFETW8V5,BI;)2W^/XW[+Z_Q,HV;-RWX)EAFPMH'\AK2A\] ZIS:C;O+">KS< M9'F>?<3IGD^Y4!'C<6'FJG(7]OU>-T''L*9#:SO.%Y^S?%Q>4>&@='R.'8Z9 M&2,DJ9D0XLE(8:X*8'BA7U&]N\&,*3&"0:L?OO+J+M*9!&N+C +:A'#>SY.+"$96'VN0&_3;;!I9(8*-6 M3YROZZFCGFH'8+JO0;5S5Z@W_N&K/?HPLP5#:[->OS_3S::2!4^P9JNPZSP7 M:).XV>>$)?>),J3'!*X64;%BS0(Z_-3[9)2J).Q*&;94JPRI>%.@O*?3L[@: M=E/E&R#HZ+'X 0M=O>[:NMUZYZ^$-](B,G>W^G(ENTM]G@83&!3Z33M!09.. M9%VOUX355_J176U>/9_WI6J"LF,\UD_TVBT?M%G.E\TY6A.HI.RE!IJT559P M.(:E3O41&F7D6/R@N:K*5$W#'8SO!MYU&X&O<;$E";6&9.?JCKL[=9/^/F;, MCEM^6Q@TZ@5NP(G(45JHRYV--@3!+LN#)"M8&]#:D"K_PM%+\+T\C^+H(!2&(Z M<6E5$B=']7_8NGR5YQ2T&DYII/5E(DJ,,T.LH'@\>GZ+707WQ^=_&M076W5H M?LYIZ%55BA*/2(\ U4"(].*Z20--<&)$ZQP*0GMJ\'8TD(!&Z,*\#1&1LP-! MJ8+M<2!'X7V0E6IQ'4?IQ@.JF<+,BGI,B#>\#W0)C'.XYX#B;/ =Y_&!8D> MT@K/CSG\G?6%ZCUTD\Z$J>('S^>")Y:%B0VH#3<5E]4U-&Y?1U;-[#2'M=.3@VE 9[B%7' MZ'.<0D&Y*JT4PF'QF'!DCE]V&=UHR94<__PU95.6YH&.\_GIYU?<5M0.J M+ $;TN@%(K7D-DO;3:O@>L:(#T]:YR2MQ3< [*R,,07;'I?'FJDU_.I8!DR) MTS-='NIU0GJM:\*)9P@GZJUZ W$UD9QJ3#5AA9C59RQG#E ]'SYP&NLL61Y2 M4C9+!)R4T)U'<"'A.@6WQRL9>T)DL.+5=+[BB(&:LMB!$:&,%_J:&<4(6E^U MZN3=1'\YUZ5C/FMX-K3TCIRHHI6.4%O\",_*"_:?]9IK,MAZ*?C'W,(&<;CH(:Q? M[OR5\[(+BO9SGN@VI(O+//Q MYS"6A6;V2PG:IT$1HBD46V>< MU[Y8:@PJ%)@Q8_%PR:147G#5)*3'YVRTNEX=U(;N3:WD#,S0K7Z MC7GP0<](7XH8JT:2"/.Y9.TKQ4Z])*)/MI4V:71Q1V!O7/+' M!Q]/.:$[YJ@^>!&=XG,4[LHU"%7K^-9LL M#LN,7=(4U$/-1^[]>$!0<'J6(.S#:V<$BH'EUQ:!$8KBX3:\6(9OLMX.U])- M] [O,*H\2ZII=J36".T0TKE:5Y5J=A@1$&%:8U4*7LTL_4+2F*3;B[Q.L;T$ M/%N8F?JC&$79LJ'+ Y!18_&G%IJB& ? DJR(V7C.R.@0)OAI547QXYO'3L/0 M6-V'8IHL[!/(V@YD(WP;%H?/2?;!%M9?6)$-W:L8)0NJ8DAFFG(W3I0KV),4 M"$E4E7C(6C:/[^PH.$E!]RAQ=)N$11'O8A)M"N.GZ18"D+G.>38@FW&#;DF3 MA])&!N+1G&0&L@&5>QG]0)KQ7HE3-1JL;Z0,MD,/^W;I7>V'K0AO TJ#XBTA M$3/P):2+-\N59>W-GZ@MY2:-X*W%"6* /F:KZU.S(B%+?0&>[=^ZY@D*%;/O MJ)9G>*5:T&^"]VR[^#O%5-4*F96_B]M^WP8-DF>L^X:_2%]Z17N M%NZ7#;CR$O4Q]D-FO-A7 M'QNWT:X^YX+5::M'U.O"4[W\R_*21DQ'**&;I7OXYQUY*V7)@#IZ/,N"E;9< M%5-@_ 2]%)@G3RAO]5\1Y481'W3MM?HK69U191<)&(O",[A+&8(LHG\FI_#" M3G@>=S,'>)(HM!NV>=:@&.6Z$E,+5G9<)^_QKB#%K M*32#[L0-6Z!DNV#8*?934'LO#TO"%[@[XP83_H@GV.55XGYW^!3328!QF&K& MB_TDP";X'-WR_0 ' C_"B<"N$8+A*)J_7@:]Z38:_@<.4=_#9)Q'9,^-L1ZR MM>Z"0IN,$<:4'?G "0+[!^FXO4Y6[?B-374[_4XDC[/HI:2!C7JH9&JBV'#, M_,G=SHSJ)[]/-:T#3*< ^@(N=W&Q3;+B7%<]$U\1O0KJ<$P3X;:PB[UQ0RB: M\R-:E:V5YCHUMP(@0HU(&<8).ZK?9?FQ*EH9OF5G5J262?\I.(%\YMY)\PW! MGUFGQ?]<94-V7Y3Q$:(&&G50H[_$[\*[/3&9J^V42LDFP!;1>,>21K$Q7AK2 M JYT*&V0 /%:/9(EE]A94?XI3,ZB:D$F3 X[(AL:T#O^U'"@P(NQFMPN@'[N M%BN;[?9\/+,SHWYM5QNCI"*\XTACG!95$G[<&%,KS>43=-1T=>O(?=YFBNV2 MWEB*R;'N3O0*CX?HANSC-(43@+LBS\_YPOLVWM MFMM#F.])49>5BO]&(H$/5U*[6CT-5&X62@6I=P29Z<ERH#2<$/L*1P5_A;_@>1%3:;+AG+>?0J5CG; MA"RC.0UJ$R+9HRS^#=S7L8D[_S/<$_EN5B_^,5[S,"WH M;S AU)XAT7'+^KFFJR\IC<5YGQ3+V3">!"TCO(V"04G.$>08Y=E?R':E-*/V M.ZLG$E!B[B+P F(R5VY;I63C>T4TWK&B44P.@/K5"2.^8G](0<_VEW4YW^7= MH_D7X/*6MC^,G?,TE>Y]?JQFDF9F-4\#5W&I=W%QRJ#9BNVVTI31E=NU,Z1Q MQ&9Y1]]( M>9-EOUFGJ@WYO&<9B$HT,3=/DDVB%^ =M'.T5E35J8YW@K 3 XG?]\\!G1A%&6^] MU@%;)C,.Y2,2O;IW:R M)&?!UCQ3VYAKFACOWF2^[OR^LY4&'D3]/J1HA 91+74E/'=[X6>Z[98:*=PH M6#"[0ZVM01U033F18--27>4Q"#PR_DD-R76J$G:KJF*&_1J7A[JBP$-:E&&2 MR" Y4YZS2H9+F-W6.)PC# 66E[! D=FK][8?5'1372*(>\(1;UWZ+QF;QL/5 M;'[/V=9]!$GB?FSU1G2_;UHG?V3R!^[3A;M?;*M8X_Z MB6P^D Y_V78MD[G:MVQB[NLO6?65K%6ZH.*7@&O5W\U-1]3+1YEX:OJS3$H[ MU0G'='NZAF'.[N][3_XV["JL8%/UX7@*X[Q:;H<*LX-FX3H^39"[L&N.H5V\ M-46*=]\_6W752U'3*]254]FD\TJ6G29EP/I:U$1E[KUH=2!&5UA8?=^:UZ.( M8UNK-W]"S +/>/#EY\0+?0WB5Z3&/]*,UZ3:[\"R8J]LWYJ/3-VG2%O',+:9 MLQ.^ $6*].0?QBA%VEJZ]P!C-9/&\^ESEI-XGP95=LWV4B4M)'5"5]O^#OVN M<>5]Q'7N&=?<,F)9?U:R"^>[787NF]ZN8<6?:/@UUS8I1#_2TI.C_QW>UY&5 M#>.BLP6S?ST^8%LP(#.3B2(&LS'?[F7:54=:%E;(DYA9YSKUO5GSX)?]N2BS MTRG,*/H#M$_ %*2GA=&KUMQCLB_GBW=.CE+D"G4)OMN$#9$Z6ABD07\22 MJ4'%]9R'H\P1-5%8?1I.TFCE=JO5BCQ(<;G/F]QAT1V-*:?[MJM&IO"M5Y5L MF%R!GJT'&Q-XQX%**\X=-71M.M5*3?RV&76KD*=%@YZS ML+.;@,9=.S^)>EU/OQ$!BD&6:<5W]VOI8.MT7NG60_4JT\/+2^GK2EPO*'6O M)&\6>R$I>PJ^!43 ZP"!=L./'3[AYI3J/<]N/T,Q@ *%1+FN0,)>4*PRC"\D MA27[/2XO&[KL7XJXZ.LEVD+H65P-MZGR;=]X#3VFW8*AKB@0\T3R$RG/]"^/ MJ<@9Z%D\(D:HO (Q WH4CL10R3%4.AK$^\6F!=*.?"4A)/U'&S NSJ+'W6M\ ME#],D^YQ9DATN\^<;?IP#SI9G'>,+V>#ZB U($W;K:Z7UFX=%ZHX6!2_]5"1 MN\LXT"O=90[(:3$ML@9Z\HU51V^*$#O/P0OSG_/LHSQ [ #M@E^S^^]E'IXR MR+!OF@D_51>N<,HHG8*S9+HN7#?;_'$YN\D"$3G1^5;PKP/\?[0YGMJ#.O)K=X3,=46)]F2/7D#FV \%.V^T1):Q?U4_"TO55KP&)ZCQ;2N&>AYI<\(!H4IU! S9?)73=7,0ZDXL(#. M2MLU2_LJRU8^[@R\DHK8=2E*N<+CHI,\I?>(PT@]62')==KE54\[;NN7':_= MPXY-^Z[# "'3Q#AKL#?#R+;SW@096%S13/U7> Z$,3B1Y;P=D>VY/A&\N /OUMOAY&3Z'$G M^YG'4;"$V.GN0JGP8&\AI,3D6;5:"O<5E,%U'F0Q/1&R0)<)*33&(!6RN,)< M2)'./I,AE3N*PL@1*:F=E[?7NR(%*:I=A5P_:7WZM>YS"+6/W1]\S5)"E]4+ MW#[5CPG_%.;5YK9ZOV( F+D"'=X)+6!X[]9HAC04R%S$!,&54R64/80[UF*K MQW*UX."]E?P3/'9:!>:PG0IEVRDS3V@OPA64IQK7@->6'P5<)RK-E0*HQ4CV MQL4__-WO_N6?_G6=;A]5654S]*F(G?7UT"K<-O.04J+ CE8]+M^H9D!\N]!X MVOOO)Y(6Y#'5@,J*T_63=D-3N$=Z:C9\W=I,598MJ\$IC)7;4XS'12C/[Z1: M^CDL8NI49\"E>F&04KI:%32J-DN"A S%>J#6;8P 1ATT'>R2CGX])'S+4G,P M2(B=XD&I\ 20DH\J%"I)P9&FJ6VX,#HI?_9^Q@8*"<>@;6GY-ZC6_R"XMGPLH\OV:W M64IWD-NR?>E"(M&FU8S/V<&!C1GM:8$)DW?G8:LI=RY >8,=, =YQ0V]:\L# M7?@;&4'4"G$-LE_2:"+,AIP(@"8RQ0!J?3;L8!/H.@5NYW0YP#EJO_-"\O=X M2VX!'44!1W1PVK8GS&N;]]DQ$>.OH8ZYD?+..7H9WD$^4W%U+YR(E&&<4-3' MZ2[+C_4Q[%MV+H.B^H9@VWY%$/:^8ZE6."O.B/ITASF&.-V_9BQ,A=/'[(.] M'OHU2^Y_TZ.[+7#'\/BAI 4'CI(AV7IKW$[H];YD88S;MGO M0#0C5S&,VUQE'Y^8L"!AT@-2?2OBF0?+ZN.YA(65VE[]*-(?44SL=A:H%!YB M642)")$*]?AJW%6$0_=T3:O!=?;MOQ+(O231!@K#[ DK;0C?%B:22B Z!E?A MLYGB3=2LIO:.$6,5QSAIF(*PXJ*Q0LNV2,T(AT6J'])OI.R:KC^DG^,44G_9 M1%%<%UE)\5N(VLA$=>EII0CO0)ZG]QC=W[+TTQ9V@3'C@W1PR)+9,4[V7]NJ M3L8Z9PW=85I]*;[9YX0(JE%HJ9V=*>A5;L\1Y*3>462F'[]FMARP?6(!61 V M3(@=87_O^+C;T:@4H/ZXJV9('"95I&I^-J 7XN]DP-1 ^;F 3H)W^,Y26WTF MD+5"X+]VC9BF'R[^??]K'D9DDT:LD/93> %]Y=L/";5;]"I5'L)42(H(CRK] M!+T=(NH_MU7]L5--[.W*=J!Z??UL,1@C#L?OLXR>6AOI:S9*/S6W[=Z&BX9N M6Y-!XND<#XUZPBC46W D$,4?=_6A\T-WYKR!(^>;+,^S#[KN6(0AQK+\12.6 MYLJ#$D-!B* ]7?O)UQ9OK;BE(A7Q:ZY^1:36A"8_5%;AUH#)V=LN8P/:)UY: M#N_(LU*3KRG2,K*VU TK!5F=]8O\L*N;2=()V2=QZQ%YY8:.KOL<7]3$Z<87 MSFX(O 5#+X?7T4\JM@7Z^A%F]P M(6'^(V)X?2/E'7F35^UO/W<+H)%:HZ/(ZD-\X?90L6G[&S3NIO&-!O.B(_7E M9L;*REQ,0X?2O8R44X6AQVM=N&["(C8Y61'P8%C"!NJ;K&., 27:9%JJ8#@&OE^%C"[FZ"F?G+"S)P^(W2V/NT724/UNV=0P MH,"+J9:">[>VWLV;!$9_<.SVFP*14F/&0Z0DQG+S9JZH]&(:TS071[Y:'BS3 M7! =:QBN8IK+(VC]-%^G%MYC'N]C&KLWU\UU*"FN@*8B=H4FY:GK"K<+PW+%Y#L_@7Z(C\%_UQ]EECO$V)Y6X1%@$XU34!:T1Z" MIXD9*FCVQ3H%N:JNK*1<[Y'9]A#F>U($/_R]\NKY>HXLD,2P=LHN-4R^,P2R MDD!;A3OR1J?SF=K*$"DOY2-G<)Q#H%%\_+Y)3(W%*1AKRF?D-V1K70@0/3J4 ME XO"%2J]BX*1&18@*!7<1H"U@W,JLV7#+H0D-2O]ZKDY\==]Z#/;AZO\4UX M0@-'=LH1A.K!ZERL3!*%ZHG!/ M4P]RK!/[_[E"CBSOGF:$9;^_#;9+TB;1? MZU@][HZ*[.,T->R3.[TK4YYM"8D*V,.#.K=)6!3Q+J;K0?&Y*<:TJ6HQ25HU MV4IPUK]IFFEM4R<[=N\N?KK.7/NG6DH OV4043G!MA44A 5?I6NMU@//Y-3V MKIJ&3FL)KM YT;0&G9;L6*+1Z:JOU:-,4F: JM54.(?)!'5BF[IV.LC9,+LK M.V!K4%=^P)03A0>T5E=X*GTN6)$+=XZN;1SZ%,:1O9>S8W?><];"**[#K $O M"N!-4'ARF[O9,#/H>3L=A$L(=PW1Y7Z0,8#G2T8%[\7,D8+?;^?D!Z@3'R:; M**M+V8A*%*L(W2%7I6B'0A$5$D0I5./1P8B#L*9NJ\"N"NPQ)31%5[L#&F 8\:%PIE8J*<]9N?HES!ZFJT\4A@+"2U@@SG+? M7H*R$TH#I%;J.MG)4,%88&#]=V*\>Z[E;!#V*@XRD!I4NWM_F49& ME\AN[_6K2^3[-#*[0I;=UE,!:]\?=VFM=?*0P T*:-R7;!BIQZ=UUP3>)YU* M*\6+YC5K3'99'_)!%M XO-P2J]>[PQH2H!ADF5;RG)M5![G#TB AR&1:BQG< MSW&5XOR$%U&C (:1B@I7 (?FD1O0M"N^'"8\B2M@R)1KH##^',7@2Y0:#W=W M,[WF\+(C>?G0#C]V=CXJ4*H]#NU]AF(X!0IQC899-[M5UV\:C$Y5FBE!][<&7!(F&'D#*XSEH-_$- M$@848#'5TCQZ7QM';;RI1(Z0RGD<+T>'@ 0%'N1ZR0/ZM4<JS'W5!'69X6,4(RO6256;&L!I0U19= 8$S@/^X7#/_P4Q8 +51H/<4NTXI#V(T;9J IH7 VL5+UF;#D" M%,,KTVH\PGVZ%0>9!7ZRT>U_Z#3$%HYG]PF*@>34$YB<"8>DZT'0IOP?RCR3:T[^6Y&@1 MGYL+\Q>SVQHLC^--)2%R03/45\?[42TLB#MI00CB@@.3%\0@\ JV ;+R MCN3Q.[7BG>A7406'XXX?.M5'U:%EY(@ J].1>SG,Z"D<&X:?@EVW@(9E0-(( M\%H]0T,,PX=TF\-9W1VI_OFE0RW4)U@WA"\%@(0P=E>:[Y<4,49_!#5 M,GZ$[7J?XP5KP)@EY(629$4HC&B,M9)0=S$]IZ#7H6[W"STU/K07OA M;=$R^VZ>(+!,=1ZFX\*X&S'66=8C4CB$^K.,58>O*]!N.8(&C$B;$=@/(,MT MG#>(OG>8NL'E=R9R#L=[13MJ$;56VGI-P#"P4X;SB@9QXM )W>F")\62[&>)S]^DD6!, M^HDGIISNLJ6M3.FRJ(W8O./+7E>+]9HEVZZ--9:A]"T[TN\6&3?\V!5J1$HU MT.A_AF+\!0J)ZXJE%^L3R?^#A*)RB$(JUT7M!2J.J]/W2% ,L5PO M:;WXG)+"275PH<2K#'G=T_W2;PO=TWGXL:M!%BG5C&[_,Q3#*E!H/)X-21!1 MFG4>.C2'QM^(\(GSX&-GCQP$2K5/''J?H1A&@4+R1(SU>C1P<>6E!D\,+^V9 MZQ==^=BQ.G[E8FS,Z/V+E@\'<.R4E;R9Z6T(+L&Q%= L]\M08Q"G^X>T*/,S*^E,"?Z8?;P>R&6SVY%M^?D,K\/:?E?F M.2AK?KV_K)7U?U1YGLMZW^U]!GLR6)U+PZ?0E* V\IM6Q6 \E I03E:+1C5 M(?L(2JI($#)-@AU3)=A" SA6X/@*\G"X'UA^:F'*Y';ZFA@PG'0J#D13Q4!- M_H2BB/0XO4-LDKI6*^(>A%SE"1/[#3;;;79. M2ZA)8WPV)&;T=ZJC,D1^'B/B\HY7:U7GO2>ZEA.,ZB&5Z=&%@-K]F8549?ZP M@B/UT$KJI0SS\HOVP$*F*O>LLSF56+6W%-==_)E0*$7P&.^)6?68/F[CAQP. M'0OQTF GP-W:/,6P;GVVX?;N\R:KS*_3XS[P05Z+@<<]Y8'4#]8"^LGC[4/P MC\'#,SOIO7WYX@:@K+WGCN0YB5ZSISS;Q>5C#IV/;4!J(,0;4(T-E()5*P$G M8$W5-@!MV8D*RBPX,6$!C3@3"#5-08M[A7.;D&K8+E&MJH?FB=V>A6+HES0G M81+_C40O8:)-9#!G=9> :F=,EX%JQH?"+U@JJ[CA@2E^;@4$!4AP:*/J!2WLU8$'A9LSUG!XD M0Z#A/2J>&7KAC(3GQ, XX:=7>)&XUW&\.WN9013E&FBY;H"[XA'A_?<3V=*8 MJ2JZ +!37N;)R-T>$JJ5'NZAQ+3>78&A@H+[%$;TER M&H57QL+M4,'Z-AA?H*@%^+M(,3%,?J&BXD8$54N5U1$?CFX,TIP+)S.=0\FKJ6:R7YAJ"A MJ3I,:L2@!JF9[D:HA;0>3$O[X]BTJ:N[3I!O&)L9JD.Q6@IJ$!NI/AG#'A=[ M;G;.F=G^@2HUQ]K#HH:C3-NI"'0&N4F[=DQ[=/L=^97LOZ?MMGVMOE,66D1K MJO7R>1TKY:1%<=G%;\43#%V(\"1LH M]@I%3.AWR7,C:'HI,\F@\^68%1$F;?2=_(:E*]/8+]VQYN5+NC7^]SE M6SY.K?YSO?9#[Q"1:21Z=,<@L%ZJXU.>O0%47DA:Q&7\'I>7G\,XA=MK@=)* M:E<#;:!R,^P*4A0@T.LWAD3#$>PI7? #I W\N XPJ.28?M$F>B=Y88H/ R9G M,#$VH$6+E@,':$S5'&/GF81%EE+T7()3+6-U&-U_+W-RM$.1 8^[1<50_6ZA MT3"@@)"IEISW<06;.Y)79:B_91#KT(C^" ]_!:9(*1W6%%>IVJLA+B+#TBQ( MKR+?1J B"D)&A7@7M:%VAWORE,=;(BBW)XW?M7QN=TZ&9@SW3!HF[][(5M,Q M"FNN@+#Z%%[? BY8H0]A#S$C?>5/N=9[I]75A( ]_M$" MO53C$X0UC[NVC/N&W:,*PR4%M;OH4ZMR%X%*25'X$[U^_/+2<, AZ; [,UQ? M(XY)!V?#C;%?Z0;]G+.NJ(^[WOIJ< MZH^=,/BDUZOI"DISF()L1DY;E3J5H0E#0JLKJ]="6+59 H05J0@;B@ MI/*"F F$O_MN0KH4$":+P[C5G&^,K(_IZ0J1TO7[7 HLJ\@ 3I7S4<*PHHHWN3AWVB8 M32=_48;EF4+F0JGR4\9Z+E(N]JR_"'[XPS___4I7]20_ABGU5YOH+^>BK'*+ MLH?G37K[\B6Y#9/M.6$I0S=A$1>;MZ+,PZWH+FVJ(&=7^K,,;:_Y)TGQCM_9 MJG/.LA$6A)TT*#HS!'PG%# ?K]-2I5V6-VE1K>"W65KF\=N9G0>E]W\]TS7W M(7TFQ3DI"VBL]4Z*D@C;3L\1YJ[][%R#NRZU4R6A@/1L]?F>MSWT4M 2)@#J M>N65B*HQ6BUDG2[6ASB]#4]Q"74+V=01&"XB:HT"!%JE:7(]K M2DA]5Y]RG:$.O]^0E- H0N2)!I\Z&UQ>I794NX]P#">G#S>.-'YZJTF"'U[. M$?TWVWH];5[7B::>273>5K<0],LE*6HB(E?C*U>P&6:> L5H2]7B$Q5K0G#5 M$$'#?FZ=]$36U?)Q]TQVYS1ZW-%@OOB-'#='DL?;L.CP*3#'@M=9NJ*M.6W: MHBDC"B#9:LOEU5>]3 %_2_W(COX%*M#)7Z"I6-R>*>B5'YXNR.F] ]1"2?YFCY*S@\>_G/.XB.)M MG6)9!;/5.0*T78)3B#"%B[WP+<_"J#F,7'&'5EGRF8[;,RGSK(#RA?$[J2UZ M3&^R]%SM8%S!]ZW!D"O0-]22LD'AI^_]I']Z2W MAVJPO7N#;PBBWE<(//E:H3]<.-S%[S&-2B-(:6KWK>)85T'N<'.@5;JW6Y#2 MHD"?@8*"_41U+! U3)!6UG*M5>L[.1<,_ _IKCI+JP[P6*[&S>6%)/'V,?TE MCZEK1$4'Z_D M5^=A]3?49\%5$M';)6!? O/E#%_#/.^I_J+:.U=?51\:(XZ/JRO@)B2#0A30 M+R#=PMT-.S(GY0ANM\A8YLD(74%)K6@#'3$5"J@H M5>/Z*C7$8W2L H(Z+:_I#EAC69&@H&-P!0HSQ1MPJ*E1@,1(15E6I2N<_ <) M\]YU<<1?%\LM,^%UC!YSD;B\VLE*R8MHP.GX0 M9FC(Z/F7A@L1' U5Y1\TUJW?5E]2'_-X'Z?5H5(:/1,H!!,FC[M7@?:1(6Y\X5.!+M!S&LA[&:\$1-$G1S$OK%W MV5HGEYA=?/>(O5UY^1&IR<9328SER9BIHD+8(/9'=8FKRL=VR172 M62.E]U*N3*:VL$S9F!B1+U)K*#YBAUP574_7=3?Y!_D(O M\3Z-J3EARBHT/>Z^4IMRZ+W07E*;ERV:_R7^"AHM]0/)2QW-_09$,V4%L]3E MD>H.,G"ZT:^'Q!I<%MT75=VN*/VQ_JY>KL6JS11Z6YSF9[BP'^9W@NA61>RN MX)Q.X:[>G(S2.R"-U.-BNC2"*H1O(?WK%K7[EFR;(3N)(KX@T4-:I2(]YH+W M;7,$X3CPT!EJ=A BDX(OQ)UHP;H %U\[0$;;;78\Y>0 5>??:TU%WDY!Z[0Q MFTK=04,V$2$6L)@H*4X_W/89\*?Y]N;",X&:+_6.M@*]+_-+6L&5F3B>0DBB3-G[ MI*K(Q-H18A4Q:R+#ELA#1#A24! )UA3>H:%42WHM#\\?JAW%[USM!NANQ7 K M4%%ZW ?T555L H ,V_@+=%."H+>77 <)ZHPY^O=>L2=AG]&I0CP40+(T4%#X MR% ""M1-5EMTF=ZKSO730NU,I\$1:I!%MR]?'G<[J@2LK]-1*9>%!IPZ]'I)1.0M>.)>)?$4*+ A58M[4E(= M)_AU3SV?*NC,--$[#R2A<4UJ4Z"LG@'I5ECAY1^]ZNJU;9/A@(V:MVD MZZXS?T:*^A6."O(](N>^AU.0\R@M!8H!EZJEK'E;/VM:>ZR[Y@MJS?MT'D:< M5U,PZ!T1MG'G-%,.?=I2KU?Q"BX5(1>2S^T1DSBM;"50;E#-JO MO<=08,RB?Z68T5]RI\H0><*FB,L[]JQ552=65DVO3BWGJEF2G8*BN]#!I\X6 M'UZE=L7I/O(^ZF)]QD/[@UV=.,A8C2\7# \QS-8"BU7&8\?+?2Y<:)^Q'Z)(Y;WVI U!L4E\ YD3S. MHI42@@GT!*)K=H,C%@Y*04'-Y7:RLU MQ\#;1'2'4/FH8Y:2$FIW]#N[P?T ^;X]4!X2O(=YO%Y7I%;77PH2#;57Q2.2?(*+HZ \Y-EY?PC.1;BO.BTU]9Y]=K0U M73+<1AO5HG&?1L9+AK0DZ_I/+[YDZ9Z&1\*^6JL)ES1SM3ULW9ZRHHC?$F(:/QOR.#M:,56_/6#1,:"8 MXZ9::K%0IZ*1:Y*+ ML)*OZU+[S^4AR^/R\IB2S?=8\8AA1(CG MM,37%"JH C^#/\WY421$@.Z7#A MGGRF:/B<05NVQ]T.2N&(/+>*VMFJJ%>Y70_EI-Y]@)E^W+:IY0AVE(4UM88T MMZSB6@4CFR.4[:2>*(HI"]1$HFH*K)'0N<*%4LT&$4(B%%A0:<:=XE2TU(W7 MQ.#0*0Q6SB&C #7R$AH&]YEF*L7YY#,1-0J(&*G(>8PNTQ"0ZCBT%\,2%! 0:Z7V%>P['>@#;:,>.5@HE4O_'Y'H'8O2;>7 M;UD9;]5AA9+/?8!A8 8?:BB84$#'1E-%^!'V<<6\2=3*"%(F9!V_4O79CAKE M?Z%CF9=A#,OE:TY"=H\AFC%F?,Y\CXT9K3XJ([G*QP3"*!-69LKH!A8T0#%!,>%,"Q4'0,I)JUPU%)N2$_O6:O MG0V)G"]:]T49'_E.$^9L&):LL1$F*U;#@P):%HI:KU>DYE]QG_5+&I$1>2T+G=J\E47.XVQH1X8"'0C/)CNL,Q$'44J_3X9OMYJ#[0W.K=LLNQ!YW M@@+U)@S.>GD;*=XV\%928SKW-]+TO]?-9J7],SEE.?6"-Y>G+(FWET.64/S+ M7\-HN!PW]38Q8?2 4L7BW6?9Z3G&(P5WEMRP\$#"A&(3D@,+LCW#Y=2* M@3A[>K&)CG$:0]=G*-;02Q,03#H=@].V!UK%![T/I-3>(62LHKC]03C@ZD7: M*YT]5OF$G[/\@:Z[1]:?2-)(5$[JN "+5-E1"1:.#@4V-,K)RK" .XD'#*M> M/[37'U3/:D5F#8L>=X_GH MDQ CPI=:0PF22,,4A$47S"\1PBM37*MOK_8:KYD$+"IBUTFM7_K]?\S MPJWH2=EJW^)V [G*3S3<<"[Z%=YGT+IV<>5HVN^H)Y^WUR%7 M!Q0T6;5K&ZC S-J5H&FT6I1AVEUC"=LZ"HB<'6Q(%6P/,S@*[RY&J19W:-$1 M&KB(Z>?U51$L39,R(96SDWFYBNUQ/$^"Q4NHU>,.WBO*U2=X5SM-,_(R0E># MKU:T&7\Q%8H)KU1M//P=\>H(L*L>@Z%JC'FU&!Q58C3%.8PTE?2"",(R>&M* MI=3HZ2'--*;J:JM,C)NN]A-KL2+L>:VBFB(R(IJ?,W,!)EN=/#=8\1C]D>3FMG)\) MJ^,#;V-C1H>36C[O+F."LKISA8N?,E>BAH(F3&C*6G%M!O41^ZW>;GYN6*HE@K"B7O,ZZ8X4VSP^53N;9W(*<[97^9SE57MDDK['>98"*$.1 M99;\[GK433"K:U]GP8P"7U,TYIO>M3*J),5&"LMF+)B<3P-!C@'Y3(HXDE3S M->+R#S[.!#WD6A;D0!OK:0>OO.%&O/O^.8S3 K+S2/&8?HG+>,_T[[(\Y)EI M)JQN=]_FQ@PC=#V?=YQ.4)9_OO11G.,2*AN>2%HL4L%\163^.[E\#=-PSVQZ M(GF1I2E);GO*OQS"G+R%!:0O702'R3-EN<7N#'.'8)X@"!&ZIVL_ACN5%!Q; M4<&ID37 _T]! >(^,7E-:Z+U0P H9_<>1^!Q5S,%;Q1V<@'VI'LLN+H?NCZV3\#70/1:'*J@#KF%1U5P^W.I6I/D/E7*BM2IZO35 M>=4RC!-69YCN]X]UVZBW[%QBJR/?[0Y%Q>.'G^*YEE+H)G^6LG9M^&_AD0+G M04=V-;9A(4EU>#G/!3>" T^ M=;:]XE5J]U+=1RC&C]>'?HQA5B5*"OE3UR&Y)4.6LK3+ G2/_2LJ#<(!Y$E<#+%..7TBKSU$,L$0I MQ@T3__SF$1ZDQ*=AQGNC\2TKI:K UJC9C+B%#,?1JW<8(J*F# MO[;D]?'H.MGAE2ZWD*B:"$L(CPF04I"ACH]1MCHN%@B5H=CX-I?_^= MY-NX4,S['H7;B<^I-ISY[<72#K5W GU?1U,LBR/%P)G:_A%N;="HE0#KPJSU8R^C^M MF&,[O(IZ?$OJ')1-V<\+%CVS,.9T=[MM94IWS6W$A@),=KJ.X?6:E6$29"W7 M2J^'Z7=NBH*4Q:9LP2^J 2$C=):UK52TS=H64J% @U(UM6^!2^,@9+S>WMYT MM4F>R3;;IQ#-]$J:\)?DXCLK:S%X+D66,()[F$?G=9;$52^8E)1-^_G@AU3P M\HK*_A'S[:R1OY-?#QJR.[Z?M3)J=$%KQ(NI*LU$W4WJU( CNY P1PS@^IGL M"\G?XRVYS8KR&RF'/T0SS2_,E4M_O0F2''>8F&KJJ.N$K1CO2_%\W66/JXM* M4+"EDA"#_"$M"?TQRSHOJ&KS/A7GTX2YA?H<@X=HGR()$>!GJ#_&?",*.]B; M)+BG,(X>\Z?PHDP0DU"[A:M2Y2$>A:2( *?2CPL9:MK@1(D1(VJS+<]A'H=) M[SG0)H\+&N%\IB,)==?WI'A(/\ME5O],MNAW\?,,Y MLN(7(IIIZUO)%;5KOI%U"R!%\,.>?C7F[2E=[W(2%N2.5/_[>LBS\_[0_399 M3N)]>O]]R_[R3/?DDV?L*M_E.FQ:[><:1U6+?Q&BF;F>=5RB6"TB>(=YJ7MD M>NV')FZ/!96UXB;KKC@V@>LD4F7^P3]U!R@U:QZ7%)LW M:*6WY5)G]1QX#G0M]95&K#5O\)H%KR0\!E_)\8WDF-_1".\BI*B64+M=CI0J M#SV(D!3G*:M*U?\FAZK/I#SGZ6/:F3HUJ)H@R2U&)YLZQ*^U&$3ASE3=A=N+ M),B9N"!+3>] Y^?7=)J;'![9L3K/PC$TADO,T?!A6L$M=5[UW$F(K(D[ (%= M NN7%.X*G&+6X5XYS@[S$.Y+U2KNMPV<'JW$<'YH5V8-EF* MLZXDTTUL.Y78B_ >FLW36W?JZP^,+#URJJTU,RKH#0RR0ASCQ+1@66LM[EU= M0+<42*_[&ZOT !W1H80.M%%!WJ&X_0&Z:Y;''92P +/8^JR_R5&P>KJRTQHC MN7F3\F'![ 2=1?5)6!?MG!)=&S(A(61;DH@9"*79H Z$JO^'I10$>-69: != MF0CO2_P\O?G4GOKS1:"L7N [-9]9B8MFIT/W-.?RG),7&@GGER_DG22BS>]$ M.L$ [L&'-0,.X@8>Q^X?I$4JBTWW_] M,.7W&(A!!U:!D=98['ZY1>X>-L8K?LUSDSLU+W%K+ M]%?X=J+Y\G*XE@*]XWQ)*]2E(:!K-MX)OI$>. M,=W/55?EB"?$.%W@(96E)=^=R6NVU)Q9^VO]OGY8YT=4/X18]CL134XGALKF M;W,P\]]Y!G>,3F>PYFNO; 8;_8@+SV#E=_YWFL$FALIF<$ZB\W:UC?^7>$>J M*[,PW5X$^]$Q@;/N]$+%VD[T@T^]0T6J$M<UA8.[JWTJF=S(S\XU5\PN#2-^R5FA*=33EYKS-B;3%A.G'Z[K_<> M#GY2V8.0%;\:Q01V;R^?/E9/X8ATR\,G+_\1QL+O"\,VAK>?F'PEHZNT:]E7D 62/#Q MJ1^)MUY0FCTJ'8J^LV.KT@Q MD>4JZ+/N&55?Y-WROAG U8G?.K][9]\"JI?Z38F)RZWDK=[*WY.L8"';$VZ% M%HKU8N]V\FX!61^C:V10T&T!UCO@;HF>C?8WG'/N2@A4J%*=Y1S6-0UTS[&/;X'%PZ(J<%T5Q [T MD^202ZM\2N/H#,&R]7O?,J()?22OO!8<*:_.JMSO8RKV[+J=G5W^W7;%+K#K M+;)-&-/4Y *T-SM]N[ZYNX'3$;@!E*6"O"[F(2*^IG.X]/H+7%'OK0C[.4I; MPL #EWZ3[BI"&'V_=!%H$U+69,\4PG 6,/>FB4A&+GY\HP6; MV*=\SDC"1R/=&N+X]W=;D.E@U0NP]H\H^-8A,NS[MU+H;0X.A:&(80A2T*7< M@I*2)=OEGLK8''E[6W%%KYZ&$:O M[V"P^_YX!TJ42AJ!/X':B/ZO=]B)CJOM-8L!X]E[@U$OSOXPT S3>H1!Z0?L M$_::&'I%+%9[7'L0UNJ#M-9?]Q BG&OD%Z"OI.(;8OX77WF37G+-+I M6\)DOKSE?<;2C!6':_;,(II$N1@.- TX5L%[V?VTBE4&/JXT"DN>!%D3N*A6 M(E>>LC"W2U7ZV%RYF:Y!W;O:YJ97)=4O1[2*18=O"QVLWI"1&A6@MM,AU&

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

7]V3G,G)4*"!(UJ.(7$4.[](/=8;F.6AC(]U2>HA#0E!U+BQU5;,]>0'B+"GUYFBRPFIVB1]2 MS>]%EO-R8 $/9X2-8C7?FMW5/JOGINMK@U>P&U3FAHZ]*::9;'O%&<4^:WJY M23B2JP*<.E-)26^7K:=[=;6!E73O'HH,Y>BW)$4<:&]L.[&* JQ1Z40OCKT# M!WMJW:<2H)44*H3=L3[Y+1I.&62"O;Z4M(,:=PRH*&JD5RH*9N$Y!+P@)BBN M*80ZM1.\F+S!RW0AG8-:/CA9LCT(5K+'R/DH[B9#\V34;WE?9S48-1-C M7Y]GEVL:B>$,)59.VAM1FB'#KK8+J\M%7/&V,LJS^>T9F9P[+Y++FM0[,)U6 MT_?U?$>LH1<$FE3I00F>AC&8<>V)VFMLH#1>U'%)[G#(PJ@=(GO>0&CYLJC\ M:BRT+D5AM$[@%@&RG[]U*Y5BDHP;#\Y#15V37$)\K]S1YB5> MF+LY>%[%B5W$P>Q7MQF[V'#I@\8V:G!Y48,QBKE63U '6N6VL&X'SB=&GIV;J@+<04^<\"T MM_@(MM[:(_L&T^@L-+B3-V ^R)7%W.5$5XNY+S=15'N)?H;:5V46FZWM M]-Z!<\M-,OUOA!R\NPG1MD7].-%'HIP92\H/F;S/$7RB>UH86I76?.6&PA>R M339/,9IVD)$]C9ZXP@$S?4)#L\B7Y:O-"B#99&T@>PZ+_8FS_8\2H MH^J?J3#818ZPQ&31?LW#V4MIF,8]<."(8BM*HX02X.^63\NI*._%WCNZ7.C6 MN;;D*ONT3!&S0PL4(W2S M^M07C<@NIW\"0DO8)_>=K&N')>J?"AU/&)99)PP$#CO*(YKT6'7&2%?)^8*D MG\>_W6!6>-UZ@H-M*:RUR;-(M4"6!%1(!21_R\^6R_U65-,7]BPVZ37.Y<'> M !'N?;O=] +4&I-4R=AP7LAWK6 Z$\<3$X%7.#!/M8 M; %.+PSG"AYX+)G*;%ZR&488R_..:H,N79H*9SNCZ6IN]O6ERK/J6D3(Q*GW ML[S&C^L%W;&@O)>CY"*X_.C*\AD.(G/M\ A#T"TPN1VWXJM#.MX:/@5_R'L= M-O^83@.X77,TIF^6[/F"[8FR 7/F\>V4=\2D!D,%]LC7X6#PZ 32TM_DH:O1 ML:A^_[(,HUN^O[WDV[6]EUHSL#8]SW#7<8'VT8!TD MUN9]1C=!-YM&OOZ\G>)C),I)W-D>_5QO?C;RAF6N3-T.ZC\$_'== _9-N8W"4#&\T'?@\250> M\^*WS_1>LO-9_=P25Y*S9BC-N8J,F^1L99G7T,CLVG.RTYPNXFWR2]NOS*4V M:8U[*NU45<^UN=]?*^X]/,"B&?,8^!?;;H-63MF3?7N_GV:4LP1*1O>TD557S#I8P[*]3^&AG0+2S:[;D#*,K MP;;T5.76,NTH]97B7(%[NR0YRV%OBP:.:CFS-W=4:S7$C">:R"M7+@BZ!QHG MM\*Q<;3,=FT,(+4+ O;4.Q83A'-JNC2N6J52?1RY0@F# UG?U#E#!G<9HM@7 M6303)=LZ/S6-/_R" 'SEWYW('-M?\&IVH953R$BN6T75H'9FLQYM*!LCMEXX M-1]<$.S"IV]BHYN$##09=J0?G2$]I--<*#V_>2E!Y)+?%![ ?XC'%-*J),0% M.9N4ICV\*MS<<3 48T]2^:81_AN?!H089)-;T?Y1 M\\&*=I+/V6X7L[ Y.Q,*$WP QKU U2U(;:@85[J_>'X"EKI>"%.Y75L-=:0HOB,SE&JN36^&%6^XR/6K:WKQE>5 5(6_-)>8S"#UM?RX MR!\<*F19)OO+.6V(,TRXKV%06C+85%J[(89B:1=\@.6F7AJ-:F(4VG-HWDPK M@4\3E;FG$DR#F#7SA$([OR!QK+D:&['9GX(QUFP?D\:WV'H&G#G+GO0' MA>\LX4.%;FUQ!C[N>LJ> JAGW.9>"(IG:)@)<+4+I2;)=0E!E7>O5<&6FN6< M5FNXQFOLER7?G^>9X.RL;G5FJ.1T#^8]1SZ.2@[.7?ID$M_'XKZ,V%_)4XW. M8PF\D53<1![MEF8ZD"XY,==YP,;? S$2E5(;VD5Z$/+X'KP]%H#C$+Y-KT:T M]":48VHZNGO8"P.0:TC+/)1U=TWZQ,ON@7NR0817FLO$;& B]#2'^$2;E)0\ M(<,W3TI0'B?013Z@]B,W]7*G*YM#?VZ8JDO+%;GQX%BY[4N>7C^> KT.KZOA MZ&=D-IP-L [&S3/6!*8^G. MP^SP ?GI>K;1CICF[DFM;0S,"2;4;%G1'#TK'T;:S[2@S7XDWHE"KP>H_F6# M288D)0J*-A*]BIIPE0^&9R?+]K7GT [3-WZ[CV:0[KHJ*NR9WWTE90Q>&4MW MM=01;79? T9B0LD,6 T)13&S]V[R6A4(7)%LG[M3=7]X,$-F6\-_#^F\OM7 MGF&CHA%OAY[&XP>MYS0D!Q]R/ 69^/D\5S@BM.UBO9E*GGBW@O9J5;F,^;O+/JG)5\WST@VWIVFB*'HE!)[/2"T,HA'E-N=8_4^%"QBJAV%>?+R<&D M M#<[%:,TZLNW.Q.>IC C0&1'S#+O3*>JF-CY[Y1>KU6]4BNFM<0]I&8UL8@1K MXM<=KPL"_'#4O?&*$H/6K(6+I30Z71#$#'R>,G*YY0RGT0R@:;S/I=I<"XIT MZ%*2T_FVG@34)L<)@6%(9'9>FV<'D2= MNOMJ0R.'E>C+8;# MRY ZKV0'R";#N%?$8N85,JF?.%GF:X',GM(&T>C['TNJ)F08%Q0H5K(N(O.; M/9P0HC&O@I- 8#!X<:F?* P?L+P^3LU;>,/7O8/B#EB+6AJ"& 3$J;, \.FM M7.JDPGG-XW42OQGRI BQM1.*. _BYX_UQ,"O M^:-],'TB;UK9H,Z\Z;O<\_-,PUU55S6 MW@$-MKYXFI*G">TJH:#M1.9S.$6JHS&]H9^]/-_HZUHCYA6%U=4] $R@Z+?J M4(7/:P!NRW[F^GU:#O$=!HQS[,M*,-@0X/[RX^^;U-NZ*ZP&^)PS]&OQ;Z>( M#YV#&IRTF-KBJ$J/V8(M)=]:KYYVY2]9V!?#UL3]S)+@T:&W.?STEDHGE -* MP_3'OJ1W;CYBKK&2O.0ZH(9DOR#XNVOT^'/)N@38:4;DJ#YUH8G6V#+51K^8 M5!=RXMT0.V6]+QZEFJ*U.(?-X6?NCA 0)>V?;='UW?*.AXC['$F@\JX6XI=5 M2O>Y[ >\H84COW(B!H%%/%S,_)YC?-(;:[R\K7!!4)XW"%P*.CPP#'@6V*Y! M]I!?;]FI&VHY6)J2&QR<]+X^+6C8.FCPFVX%N%@A0UWDQ611K'^KK'8AA?9> M3HEF S:0^LB^>0KOU'[DU=5G,ZDA\'"/E+Z?24=:A"@(16EA>[MR8?)S]>QD MG!VU/D7(O(7X5FIX<19JF>*$A@,*D0 [[H0N"Q!R)0N\&SPVEF33*-FZU$W4I KVQPFL. MH..:3/NDFHZ/8.NR%OFXM$2H!*MTZH\:WI1S%\E.4/M3H']2/$PT*09FJ9Z* M3:6I[<>'>ZWAHP6YJ9,(Z3P;D8'-M1"ZE3-4*@$?H+>CFK(@^4U9;?0S>)N: MZ5O!2*;+#R#OT@0N0UY$OV 6?2ON,EU_A;E>R4;(4&PEA BQEA.5-[!^EX;Q MV?L'L>;-&*%9+0KPJ%:0NK6ZP4 U0:58I/^PTGNR;]@SY0K.^"NTHNCIIXDA M&_=K4S3-VAV*Q@B+)*_-=??,Q(;*5;A[*#J!QP,I?WUFK,P5'HS UV+&^MJ2/>Z/136P&.7AD0^V?/$@EX#F@ M)MG^,EYB%+A/[Q5[WU;N[8G%P$N ('EZHY8S1![GBE.'&( @,:&7._6,ASYH M]7$I/8B24;#)N=_.;%6<72?JS2:*]UZ4G:IC\[FHW:ZZ>'W&$#ZK\;),6(*/ M"^&S&CJ72_;\6[?YT3=6^O-H'*W[-TYT$Y+S=9R"@XOOYE ZH5";H.@*U[.( MN2(94NGPJ/>'F=L=HNQBLZ]"6Z1B0'2GUU.Q%?3NKK_F$EFAJ%'[#\G+,^0Y M:M\\UD[NMKWT8799^?8?S#<"=,_0KI3$[O4O'*"TS%-F)!+ FYN=L5F#YL7JP;,GOD'$]G!Z[ZV"-RI/+!0"0F?D&E&(YR<]EUGYBV#UVQ"\0 M^ST;8;@@^,(A2J[I*=H!;$2H,,TW<[51VX_:[!?T/<\NN2J3.1_X(6$1Q9>* M3%X; $;C*W"IP]]!]KPF78Y>,^Q>>."X!PH>;YY M0;"R^S]<2=80-70 [LZ6VA?H$F\K(E-=8!K\TM]R"8XFWA MH9XF\O*S[)0?1W[[^V\<9HU_T#67((V;"CHE;1,^U(SL5P@7Q+M(3SKJ(=PC M/->X2%#XI?#F*B6S<.7@1IPRK+SNK2RP'0MS (Z5<0[A#2^3^VEX!](OEMS) M[J<2M=N5/S9UTAHC3M1%MPR/?&[Y!1W[!NIH*NA[DVQ\ER=,+:9B^:ALB74> M\D+'@L&0$4UQG90H5V;/@I37(24[Y*MY;<:0S,R4/-6'0[]2:@/7776QE9PG M"Q-*JD)>7 ;A'JFYM;%4N2%I'RFES*Y!]4@H5'=+^=6U:V50:-+:L^]^8:<= M2!@/NY<>=S*VN>Z9P'!^<$M(JB/3(7D@-:/ $S]\74;(,=GT(J= B8OK7=RW/E9#779*PV+2 M[VMEX6,X44R.:^.VW_4=4#3+TV9ZB8@7D=D [DS:F.]OD99)@)"0I-H%%7RN M0(-:77=L7C#JM/J&[I^2FJ.KF[GW@-DL,VQL7DY]3BPX[)[0'C"WY&-_2;83;]QG1HF%Y3.M# MP0BXG16L9W@#+8,-IK5$FX1S6?3\T@1<$20T>&\^,H[)# MPW40>2= "?*ZJ\M**_\?:^\!U52[K0OSV05!Z1*:4J5+;P(6.H2:4 U(%4)O MH8.(=.F=4"1 @ 1"#9"$HO2NE-"[@/3>!-'?[]O[[._>_Y[_G/_9<[UR+F5JM&\#+E:>HQ=16L>QSO$61A^)^]SNQ<13?68]FY2U^ MLS^5UN8DO].0?X#RN0)>W?S.[+G9SII\P%L2)?V'UV*AXJ/QOSS5\D]/ MY?L)/0A1ZBW7)L.8RM+NXFL[; \2$N.O%.AYY!\$H.EA@]F_2#($G"I9*G\B MYRWN_A_%Y/^[<=V_/46K=TM*17 E 3[32 _[*=]*=Z_")Z[EI*(MA2AN?!O# MY#GD<_'!Z"G)E4B;>F]0W^/S?9,G65SH@7HR^)20KZ+(),I+LX8B,N]'%A < M//_N^NY_.M,?$)E\OQ,62ZV\GJ@+9>903A-!_<<%0,^#DQ*/_<06+^W-IH-M?D#\,>_^N,1F8#)K88!NMT?*G>U MO3HV'R&5@RX"ANS;^I@4AG^1V#7])1Q7/J*/&"FS,D&8_'.85FJ,Q$E]#)P\ M>D5Q=RV,+HSHT[I6GI'C?,]<0R/E_9H^+9TZ^\JB(R8:X^>LJ&V-]\DLSNP@ M5MQ]^#KXU:'6&6,$0VN[9JDYC:,HOGQ"RDD8X#MR-)EAE^R6U>74KBRG/[CS M6MWUJJN4:=18VN-)FKZ?/242[JF@=XD/Y:2POE--I-&P-NUZC S(6N1V>.H= MJGC=JF+[=%F>9('D3 ]?U7(@TS?9TVV/=+#6M?'(C, HAL"^8^>M#J:%&1V4 M8?+Z/I4HH"**]PA2WY;B3$CM)LC6SMSH^(1LK%FE^_EAM;.[=ON]8;M&]%P% M[A7(9O>^H"6.B7CX)>N;X YI3,.@)7 W7F+G%5K_;"#6L/Q]IZ%NW8ROE'-@ M"\ TA5@6=R)K@T=&(1"8XRM;8Z*FGOHUQ5I]_(SNN1N**^(UGTMDV)-$7Y80 M$J4\Z )&.ZW=@LK?^4Y'Q("RK#6R@C(M16S);"C!B9;\8EK&GI??RNC/*)6&0C!"=].20ZR-\5'KOJG)W94FI=ARFHIK$GDJ\(6>U MF+.I"A\C;&W6];0W&N.@7M)G]S93-E9DV-?[KN\Z3ST'@8&2:]&1\"9$(.KD MA17&7YCQ9EF_8[GQR0]UQ\;192FW[)74MY6++;97Q8?BIT? 0'K@TZD'X@]# M8(,.;D$[[=F-+:)>ZZ3,8>(,@R@)]APY45I4(]Q7"5)HN0L^G+V>MV%C6?? MG(YYWMI2KD?<#&5T7*RO%V1QX1)U][/CQHX@9&8!\J=572GRTA/?DL(?C6]F M"K*.U]85J6\4HKBT!+$0>5S2)>%IGJODCKAUT-/$RQBM/<\ \HM88]8$CF#+ MD<:K_TP5GN/3T.56CZ%XA]50X:$S7;(-G>8B)-J@'[#MBX[]-Z> MW[U106GIGH40M5KSQP2<842Z7V[NI@;^KU.!G4Q:1:_F&,>%>>LYA24Y7Z0; M1U:^LN^5$U<<$I\=U#\7 O?=+K94'1BKK#LI&"JVDJ"&CH@$J]>#1R"U,\W# MR77^)_[45=3VGMILX\<)8[$.=VN\7O:(-[E#L-,P]#N)!B"0P,?)1G24K@EZ]'>$LA(?__;)ZV202"1&^6'S][3SUK= M%:F7?"/)=!E+NF-476GS2A-7F5G,UED(4CKI[CPW"+F/3.F6>9W3=<6LLF\ZU M7 "E).2%K]07VQAP178J0K=X4?8(^\_S5_:,I"MP.UM+L]*N677K>SPT@&!( M:ZZCBOL^,\&]/CQ;0]Y^DWZ_>?DCTYK5]>\.NE:C4&$[QZ0P%FJ)3*ZUKFOQMA:_8=0=#'\4=\<+5 MLZ>G;HR'E#"5V5+3",RT&Y\.XRC[T1E$[T0+2U3^9"D0P75 M]V/Y?;_5S@"LCK-#:Q#'L9D>AXGC:+_BX9#Y]6E9]99FLS,ZU;]">0YH0._% M#5I=<+-YH=3>N!.>ONSW;TW#1H*ER&9S:Y]?))@O0IH*3W\O>59CK*/36P^W M_AWK'LE?/2 (VWH*+XAX8N8,&F>HM#Y+^&GS[J_]WT86@[W(<2.@0S$+65?V MG[7H\[>Q87Z1/%P^FOUQ]G+S%PG;:8J*@%U3#5.[=#F$*IXKNG$N MCOX-V;2:V MU&ZL(4-C'U<5S^+U(^56(G:(F=PP!M+O(/N'J[Y 1J9*>^^Z)!7JJZJ_('2!T?QW#&J6V6?/MB&HT28-L$V#PA EI_O(/JS6LE? MK6R]A3+27VI /W5L0@D@R#H/M\QXN]D3ZKRW*6W4>_Z"TC8]A4W?A<)<'6CY MTA+9^63I^-L2#S4H&:G7,."C1]L*K;0WY@+Z'.9Z7J4\\N*_KW,0)O%F0/4>&(TW. M@#N0"SRQ;,_6M['M:^>Y10Q2KE J&^1OLDQEQFCI5CL9^OZ4^?/!%[O,Q<)$ M,N1F%Q,9ZA6J'3F&DB!51$BXP0J>@U6VL(9[A)^MNU?MQ,HL6C=6%@W:SI6. M5>$-)?Q&J3*>C]:JBAA'*!7\7MEEYO2M],!D.O(M+ZODS!U5GID$,*SB!:?L MT9[K&L$<1B,4XZ'2['%4PK,W#C+?XS]WA*_-!0Z YQ+J8 W>W>H# M;:;59U7;X+J5/=OYO CA*S:I\?R5*P["8%9,HLDWA]K&]>*GX@2^>.8]]R\- MWYP8"Z@>@? #,FJ\HGKZ^DX1=#35R%+:[I:F+QW=MJ%"8 T#][/BK]>K6$(? M+%OW7W!G5>9+^[!54)N?=E),&W41A0LG?2KXL6IV,*"@9="U1ZB$543UC2._ M^AA:7]SI??[[O76D,[BS#GZATFD-NL%\)Y5DA/N@FK4[EI*R.Z;%QFO$C,2) MJ[W=_R[U6FS#WLD6+OL*7O"E(3@G\YSW6,C;'/"-TK&X42XD5Y[$0#C3]WI=:;A MPJ\[J!:3*X2^P!R_D#_L5X5(Z9L.K_G>$P3&,5T^+F;"MKR2Q5G6L;/QYU%5&]Z'A MQ7IHRO7WE7I%G !=2S:'JEYA4VRQOU[(=)/&%AAK[S%6U 3WCTYU!+.W1\EJ M)*89/?XJO(G.PLOFA50N7)=I9RGFS#'_R&=^Q1&-D2,UF$/755#!^%G,.$:U MYQV:Q,8+DSUD4WDIK/?JX!''LF]MDZ65 NX?G;^CVW;7S<=2,I5_6_R82T+C MWKWA-DNC":JILCWI)S?90DVY81U>VS!6GMTB.E@(BQ]&YG!W'FTXS*07M2EP MZO3;=&Y>*3+T,I"KHH2['GN<$,O],-L_9.XU/2!MW4HF";"/\-C6LY>X MH>*S<7*JCYPITJTBHX#2-_:O,L\E\RAP/U.5Y5.' M.Z0.Q%!P->H:'CYT>T/SMK\;IF LGJ60F-G>D#9?,/ \0,:D1])F>,M=B U= M<5WQ2YIC0+'$P !P/E.1,/:Z#Y3,^23&V-KE0;DR3-7\#LGY:1#]$ CU5EB(.& M#._9RN4IW6LN(MLPP6 =/Z%X4;[_P&)R'X3^!&Y_#+M5[Z",C#2\YCRUM"O6 M1AM&DGX4P.!U[41Q+4_9*GK;*,^^S@>8K/5G6;,_UP#[R->OY44F>.Z*I'(; M)<->2B-;H_CA_%E^?">>DTI$FI83>>LMWQ]<-<+<5+Q)=5:8,YU, 0%05 \? MDBE/'^@[[E?L_T+GS/]MIEVI#9L_M>"3@*S"^6&10VJ1M'.B4:RGCT,95V'U M+L3;=9UC)ACOW&_;H_P;M\;2<2?1RA;5?NMTE ?NFH]HJSI M^AVW8Q-1H-F8L5YU75N_P7S&"M,J(<8]IB;9N""FKR=DEEOM]IJB[;WD70"( M!*(M(4LU#NK])=^WL^U)@TT$V3:9\_@G/Z!>OKO61X-.E"8N:=]*@B6[L \[ ME^L//NG6YM5!KGU?*U"53[75R=AXXN/QF+_WK68WFHYJXU0:55H;A5IK^L/4 M%&99*9R.?KQX5NI<])GR!]S>06JNP? GQ6=MGS*8_*,EL5-0W'Y;Z>8P\L) M.:G["X]6S%&MI",;.A']>21?E;/PEA^BEY1I)\K^W MB<'%W(;41L9];=B5CD_N.!]T='-J>"A*959#-1I")6N2I2FCG:@4/58A6@<. M?LJH4R],N"VXKKY\61,)4G^/Q5)^00U]T"S(Y#K9K$UD_B0V%-@68K$J=%58 MO@(0$G%6[&*($MDHI3+1$N)Z6T)B/O4+-4,G"&&GXKD9PM!^/91>UGZ.4Y"D*3\J[]7C M360EU>)0D;B*4%#TR(XL12$OQ2&]GC.9-E8W]@4II%XTK<67]IIZ@&_+/+DU M0K%LG2A!K+H?61*Y/"1Y]( 16H>)@>T7:+R4*+?5*]6$.\_<+C6*/'-C'(X. MURF J*EG+[\DK3 =0K)UI.:_I!9QAT-1I>3T$2H-9CK_S%;FM3I1$LWHTOF+ MODS[0-10"W??SX$BT0W"YL2X\@C12_87B:^'@!#61'+Y>_!D[9W*?Z1(GS"7 M[TI^D50K7RI)=_V=MY":C\)'^D5V1[3K_7+Q_@*"^ZKX9+OECV@"!&9PBK(? MPI0+_O6 >68RYDILPT@8/06#/*IVM$*]K!["(=>LX2=(>/*#U$9MP\Q2Q%2O MPV<1;DS*[=KU4@,YV\ M*0\V(\AL?JN=WG7E3[A2]4I"D_K:7MI9ZXFY=BGG5Q9;$>!Q]0MC9S ]+++9 M'ZBUG3)#$.67TB:[D^E6[F8QV)5MC'V;D-I'.6UB/\?E^I?>$8&@69FVZT3= MH/E"R5\D&V)-8=0;2#;^-+)-PH^?"?,5A]/]US(-';]-]8F+6"'B(7M$L9ZKX1Q^I\EE!^@^93M)8^7*?/A"=>UKT MI-&!?D6:/Z4/LFSN6MAX4E[LL],UF0/]_1+YRUN2E2TW%0"$(%=-'Q6+((H@ M<=B/A8R]$&FO&<2.6HG9)2E/VD"$E^;AG640Y-%!)'PD;D9H=T%;+NQ,^HPX M??C6JM5@*\>$!DZ-8HZ'8:^/""8F(7HE /U=GG:H&"H 9F0\[OC;[A^5"20D M%#1$YQA.Z1LYTH9)(9+"Q_]/)"H0H1CT]A\#\FX+;9FA5&:BL/P.:-7Z M<'06+\N.NS#J5#!RE*@5'W%_.OP^5K>!1\K?J\^ J]RW,!DM0BJ[;M>'+0"# MQ2 P2)L9Z34EN='5WNO*Y0"L]+OA(:Y5=AE+]C2H8%_N"A'\&QA1:>!$%D/I MS0#/6P%-L6QUV???1_=ZTAAIJF"]'!IWHM'S>AHD7K*AI%M\R#9-T0:G'N-- M-TYCCB1=>.WHNW9%*-L^D)+:E]94FJRW*%^27:=^#_GE!?I+4\W\HVORHK#IX;T&Y:M'?CD,".F>F4F M6V?[N*S9@CGHK+Z*KL!.0Z8)^E$-JME':SKV)3G4Y,^MW%%4'*JN1FM5EN+O MH=!OTIZ*6JGZC%IXIZQ&;_5A9YF76[;GC]P/$Y:DY5*@J) AS@/BV^&&>(,. M7W\V8#HG[$H?R)8:$I4!S>*59\V'Z$KNS*DDRVDU?A@P&%L,HE*K=K,J'*Q< M9:N*HF3&E(S"HEK@SWONGZ>VN0Q9MH8:8?27+97/D[ELC6]_7CTL60$&?I!Q M<*4FG8Q.J"I*:^2:W;.V&#'6F8:5"G9N8>$RZSA)!V0QENR/RNJI=OR@D&ZY MC]XI)#"R-^P9FS2$06S$CW?]$_7,BQ;L@+_NEKLT!JBKZZ7T(E87I?_HH$_: MH*2W1^-WLF^<,1#>#EZ=SZB^2/RAJRG9BW!]4"/F(;34/T:2A-\1WW M+AA^ X_9OKSVQI+G-*S(("YI%(U,E&70!T4(R9&RI\J%XT#=6EH](RMYT@J2 M-TS, -"S*@3[_=%U0\'EJSMWWZ4L=U/K[5,;*(52LG1Q^_;@M!M( M2&@_HQA.)4DJ3@,O6*B8_ M5.X>M4P)&?V>YB9*][U1:6B&[E.4A4#GAKAE$22$O:^.VKQV?&<24@A2).IL MGI%GQ9Q<])JQ#\R*TZ9TW'E2^-GK,+?S((HAX>69;FK4< F\=G7!S:_LKK)% M6"AZ"%5?I!!_?OZ+I/M]3=.+LI76*ITN?Y.TL[0Z+N/]/UQGP]-S3K;A2L?2I^W(LA-MR)34Z7$C#'5RSR<+;RZQ.< M38<+)Z.MY9/&=G7%FM75!QWOUG0-J'7!+SNE)?)P]&\] +7M.+)J^6>N(K"L M*KTH 5?-]NS(RAPJ,[+$W^A#U'/(*/M\9\;[Y1]8'J.8S"V1BL^V=V^CDD?7 MFX$I4%J>@T3N5P?.1@G@4O)R/[1N('T V;/TN=++J.C[36Z+V[-RW-I)F:6% ML7DL)B:\^ ]=O A^)4@_>+;KN71?D)WC2\JNK5:B< V5E9J^J4DH:9Z . O' M:U[T7'2"A0N$&D;@:9MXG FL>"4(>$U-O_U2M7#8WLLO[$NED[1O- SC\%V% M7>]*@>=K%AX$0R-\41Y@:0NMH08U;P-L_.2X@BV!W*_J^%[5L>?&@: ;D>AJ M^!DR^OI19=4ODEO[?'>_6@86^*D"IY.^S%-9N@U11OT!R,*QL55D@Q07"-WG M[9^;P?LL1Q&O3,[RN>DJ6-A:WW;OS5YA>HU8K^Z.5W1(G] WH>GUZB+CS8RN M*;MM]U-Y>.=,F)6/*_J4XUH<'L$&18TJ*H&TK&52JY02VV4"0U30JZ*W2W:+ MM'KZ-=0TALT%="(84)$3NI9U +[Y@2;/4?(Z2SJ8^VQ8.J?[4+/;#7*1"I?G MUO;K1@GF=;$P^*/VD<^H;:[5#4)O$V<4.NA8R_&\H]SS<[]):I] S4$"SKON MFC*?N$H9MV DOE@9GS_.[RA4746-"H-]<6.+X'0527:HMDFP3603_AW !:8] M?$^E?8Z*ZR=X1Z><6HA6]:4TQK=]I1D8>;XLJ'^T%&&\/Z%>THF5>D#'>[$1 MNJ)"(3@)9UMO+W&%#KOY,D2ZVE@J6W,?26\K*..%DW6@=IF@Z4TYA"WV55,C<+%F%'[B]#:R&WJ.VXO.@%<=\^E^JXPF M8E/7#GD/JN'NE;HQ= "TU_20N#]A$[4OLZ41<]WUJT)#C.% D0SD@)8TF$YNMIB<6+EP]Y@95F":Y49HK";^&F_Q. M"P\MN%\) LBR;\LGTW^'^]*7)CD[5.8HW<[@%PLEE>[A7]-^5Z7;: # 4;M, MC8ZS&']=%/#"57CD:^N5 =X5)K4YIN#KQ&IK"CHF(R?\G*'0F"T&_@]F8T7U MF7U7R?QBY#/JDA90Q@&5ULVQ+V)J/3L,@H=+W+DI3$ 0D)"(-2 M;HJ@-\NZ].!L,]>V=U)/):J-5"YMCFMCK/%R

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

# M8-O8^(ZO)CWO(EX'"N[9_-ZHEZ>BC2 MP@O+>*/H9L0^2Q %AO$CDGW4C$Y_IFS.\XI M3);PZZS5S1X\7O!=.]G=(4,)>ALZ;V6I$YW0ZL \5W*]Z&(J M:V'72GUW),;#[,%N*S$A'V(-M2ZE?IMDER)-F.I_@LG5EO@]BQZABV(G6*E33T MKOOV^J?05Z4S4'ZQR3]PW3@B(8B)U0E@ MN:SP73)(B4O^3XTWB/UP$6XF"T Q%8M[BG_CMTQNH6X?C,KQT 8P>-N* M!.8H$P34>_#=L2=8#S1JR]X"N?//D6?^3E-4CXLN>I;SJ^%?'?_2+_.BH><_ MA9BFHYNXV3)L/)%2.78.A6!= 'N.Q]!Z$_Q6D\_EL.6MQH',HQ\MVXV(SHWN MP4#O[@ $?:,C\R:$8Y$Q3284:"11 23T%"9-]IIS%YM==-RUM20TM;&:6NR:\6?(A_+]E M]9[+B_FTSB\9U]0^;E_H]I=905CA3$"QX2CBF88#Y>(D:2RJ&=30MJ14A#$4 M?87O^(M^3"$XZ,38-/[LY,E6Q#?VNY! QN3 4CR\F]LN_E_[MN(-!!%@L(.L MV3JDW-ZS@=RLK3^=HH_B##!$3#<6&;Z_NM7;I>D!Q0QI/X4@Y9(?\) MSA/TT/7-[NY.! OQYQB'PQS$*9U>G4\G9$795/D;57(3B2*FTO"K)[!?M2S*QK6)UPYS M !8+/;\U)@MN80U%DR#R;>^%?4,?[ & 50FS1LWI%E'AL8%SK)SL!=ZW?O &J_9_\07K>*^7A;Q?R6JYB'VRKFMHIY^ZN8MS7>M,/24,2B MJ27G(#[_?3D^4THN1V(;()TTH7D[TL*_26"RK"0FAC_>LS37_8(V7)8;8@C_Z(@(1 M:7A%B*X'(QHTZ*0#IR\2\2S)6/'S#XT5P"*)UV7MDO3D-QCQM#K(EAF-)H0O M-"U'=MKKI2AH#3G4BB;$I;JT20LB[LO>+@/%5J.U/#4<;MY8FJ?7>1[/CZ4^ MP.Z.=P)Z?)%VN:*LPM@YL,4U]_-VZ[*7:UP0DQ?9=/L65-DR,5G$,PXZ:&W@ M]3-UA=$X4Q$3 ,N(W+6 $.'&0?R([$(J< MONL/DF:N@.7Y$T-E->3^\Z"#Q+:^Y QH" 9G7COC%A-[[.X$\>[2U6:B M(>W9!-@GE@Q%E.3AUA4=,K==?>'=\+*5P),BDJB6+/BSM(? C M,SWK/JDP$AH^WM2J@?)MHR-PSO1N5L&^%,'I=>#BFK2P?*TK+G*:;NV0A7"# MLF\0O,GE'Y SD".WYU5ZRZO6L5341L[3]UOY1!J=)C3[8TG2M([6L%B38D8V MS9T*'E!0G<]KQQ?ABXL4W9I!.@Y&+YKRA7>7IZ(1QR>0J02,&4\F>+KX^/2: MU6NS(X+^&.?"G!1DE"3O]G'IE=NQJYQB-)+V8.SN^-'8^$(C+4ZWA-G^ZM!( M#3=XG-H>,V@WG65C7V)C2^[F_30SK!BE:3LMYY;FQB:?Z$T\E>%&"B+HTJ&/ MMG:]92X0E;"VZ7% MX]M0@BPW41'U.I7!ZX>='SSS:(/O$B-G=9A@#IT?E!73$/T5HG@"XC='K@9K M'%7%PK8\UP:/Z6)--Y2(#/UIY&JU&"G[:[=CO7<8$*8H=DG1BAG8N-W$3X,# M@[%##7K"T@>!M>NSS3JOGH8%8G.4I4KU-5)I(%.G7&%M]).L,*PMJ\%%^PFG M,?(*>9T,K4"_Y.A,EG8>)7<.[HKJ\U10HKZ5B+9@W(J=(4ZP8[@G(KJY=CE(\-*ZE>M".GUQ MS 6A.X=W!5MQG>NY&?(7%#@[=GU],$\@Z9XBZHJ*6+[4D#@0\D4KVI7$"3QX M?,3\_^)+F0C '?P$PTU3]7CX/8XJ7_RR+!GYL'ML>I@<*(A"!M( M9VV=*5U*QLG:V?-;)SDC&B5.\,R<"E&SMV0@]](5!\?%=-E<6TKJT?ZV O4M M5Z".MA6H;05J6X'RX49,D^"2N?#Y<9RZ3@UT9'EJ8O IUR&85V,+D9 HPM2Z M0TQU6&MNA8_OV$ XK@&:ZN=R0+=.'\&783392!6.6'-H_TC(D,!:+G6 >0@$ M5[4:R1*(Y]^I[,@Q%Y"4.HBN1@%"/.#)I]WO#*4;R'7H6(\@S-13A^G[J+B[?YD!Z/SMNYY+F:=QF#>7$' ,OLZDI0I09O24XQ6'DQ*$-=WW&=", M8HV>YU/.='8[&L2SFR,.X@=1+[)E93+.ZDSB[5R+@00. F'-.P;:]S8]\Q8/ M*K?0%;6M%DWJ>!T8W 3.GG\\.$L6\LBZB5Z4 \)UZT8BXO[GM"B<)LQ3J6G' MJ4 4F2>A'I4+WI1CV_XO,67+)&7#VM2Z?S=5&:?UF78Q^ MH.='$JOO*6T6[ MLP,03P[Z6-O4=A=)6SL#2ZZR+QUAA#9H'V.)^!S@]+ZL] UT@CF,Y46)?W"/ M%S/33PMR9,?:\G4E?J]7N.ECD&BW)TWZ+N:V60-6#%*6X)&+L:X$.2_V< MV;P.HY?#*EJ"E@/81LGK!*C82 -[?>ZH\GHDW3K);'40VBG@^$DI0J1'O?CB MK>@ON,^Y&%'H30];+A0E,Q^[:=S=X734PFU*S%/5!Q;U'1$L3,'Q/%]4FJYR ML(P+-1N/@K18\R][U[CZ I(1/GA?:0\PAI3^0 HDT M743E$=FY^B\2^:#093>?P^]G6/7A,I%MU:%VW/T%9KQ9PR2*YW/M M:8)/(6SNW%EY44P0GPRBBF[%@#9UXH@VEB(P/V&O&,9( M%"J0-;(]PDD]=)H-F;14&_?[=JKVUM[+(; 1ZM!B!N F4F#;1.+,*+4QD4M5 MZV3(FF4.W53+0]D+!NP'PAV@D C'$%P4<@EMIXB61EO.:F0 M 9J.YT_1B;UQ&M>6Z!; BB 4GWN?YOC-KZ^>[QT\I@&DG\M6 M>Z57=-VML'W:AT)+5ZUASTM=JLO:_[CR=#5?QI@U.!2Q35R/T#X*CSL.EKF--N%WXX@77[)DK21@+ MY U2(&HP3MA1K]N,\NA@6PKXEDL!][:E@&TI8%L*V!26U7G@D0@Z,W!):#]> MZY((B9:"#CAM/5E6BD+-W0'9=E;:Q&0;W18Z?UH>*LZ6+Z9U[@HHBJXW(I&7 MZG[^9 SP> /[X\^<+9UF8&.Q+SX;_#IPG.'>8=6#D3PZ\KDZRF";N#78@8C( M3?16NSOZ4#A$KWPD[P,$?%4J-++N;:]SX919SA1:!*8#ZU\P](+):CH$ M,Z6%H1TN$9>T4K7/,6MCWH+,QKKQ)W^%GIJVZ-4>32X2=QGH^O#T''/4YH8Z"DU\,T?>A.7)/?!,.<>= M#$^M+!E>&!//RGQ!H8L[#417YAPP>R9PKD-=ZVDYC%]R*K>[FMV:N\H$:"79 MGX4)0&?41Q[X6RR,T,H[[^[D!3_=GUSWC I:&1<(((,NF^'?/.1'6D,A%%43 M_#Y7-&L&L!W-K%'Z3M92"\;->QR'!<.G0*^LD@DMJW! /W*,TB3<%3EI%!<) M?8I-4:9%ZWV0I[07*JLU[\.@9GZ=UKLDG_!5.&*N(#5M -=KC-B?POZ?.@XB>(OT?FJGSI_V6B!XEJ_EP6GQ:VS 8I!QK5Q.QR%=_%> MUY,UK7)N)UKY;JGP3)"DCUEJ, /(M2F3;9WS*"[G-N[]XRB7"GNR*O CYD . M<],78IJ0&)BM5IMF.ZV'DN(V^#<[\Y)0ZCQ-N <$I9"F]3#F@/;@7CM^(3^8 M]GRFR7#9!+<;3;-BUF._8=/V D6<"I+PKK5MWGF@@BV.#\ZL,=[)T+ COM?& MY^:L%ZQ[/WT)@T[@,C>;#?UE40J.5PKS"G+G,T9;\5T11=]5.J"=K5P]6ZGK M3M+F2V--;,]/8-QWBKNB\!<#CH-1#1\HSC]:/4&*-:C^-/'6D:S9.>Q,2_M1 M6U*^$O1U,>O?H,P$.<]=&J/SG8)?IPV?[GV;WLTN?&+V!=J/W'[B9,T#\_C8 MPSG\]<<,CFPB8D9+3ENWU2LW!K *V (Y!+D_0,TS&**?(-PYMIT91.*8&\GI MYSG::#+=513#Y?4L$UG%-BA!-35HPUF_!@^_P!K\5[T &L#?-\CC/:%7F>=[ MY$O1>L-'#[_C,X6MP&F?F0?[FO;C4S1A=[G764$VU?.**P%*YUU)(,8XO2?!X/#A'X_Y7KU+&OD M+,)O\KDHU0]V=]Y)#_U"[.KA8/\[E'V$HMJJ?YC6!0;YZ.'@ONAB)@OL&B*P M*E0-0/OM,4E9$4O@QJ^2-&AT;PPA8.&T=:M+Z,X_$PT,OL2PY/3#8@HB'-W3 M>'#M3>_O)S-[4_!0DADJ:S88+29RE1-=#!8<8'N0C,SA_L&AS>LUJTZ'VZK3 MMUQUNK^M.FVK3MNJT_I^C#ILNMC=.3I U\7AH3_NSK,Q]]["]<#>R Z$Y]+& M4<>-&V__>70_?7CP8/#0MOCD#FWY#])']^X/CNRSN^I\'[8N&!VN&H\;&8[J MG[3\*+[EP4%Z]'#?7YYO>9@>/'Q,9ZK=\F:#.7LS) O)1T*.)*3#@A?M9!R# MQ*'G9[\Z#/#9%:0Q)=?'$*! +&"HI!1POIO8.]/#>T.(X*U!Q)G@ 8(>BD*G M%%=DYVPR+2^5Q/^ZP9U[\)0!?0J'XEPA)#1*+\WEWD4H?-%;:ZN+-![L9D M")HX]SI?BM11#F]?->'=BS_%W*\HHU4XR)\X3)U7N:=<5$J41#U:'W?DG+=*7=';DJW=^"W'4_2\K5 M)'1?8H"8GSPNHX4YS+1EXJ[UC;S,,.X*.MF;Y$W8K62 M64N9J 0I-H";*4K-E'P<.GITX9+OK*^+C(;TV ID11E+#>DG+*0Y7 MXH0WZ *,89&I5Z='&MV>.T$Y.^"PT(<-7D9O,5PE0@[N\.@A 5P\FW+N,^O; M!4.,6TG==A+=U0?I-X![3Y;*X-I*&F^RCDZ-4>DQU^CNW)YJFC]G VNT3FQF MU&SKA6Z66FI!\+NRF.?QK:0QQ6WN?.@;KW1&&R"0+G.SXPTG;GAR!HW0<"';D^^;RGU/-?J'Y)#DO3!J^G&M MB[L[\'G3L,&Q:T ^OP]S2#W&(6;X;VD.O(SZ:S9#TEJ=GWK<6R+WHF37S[-5 MN0?2(X-5+&V<--4,-2W MH&%!U!M]QU+[?!,W8"RUA]<$<@TD5$=K?F:$Q"$QN>SYH=VSZ384JODI(*>) M%2V\IFF+#D!MS*^1-.)I;L," BP+8*1S0]"U!>9:5<$0O.#K>RHLJ\&+F[?" M>*X:+:)Q5SJN%$]):Q+&.9VG51869(*5+W S[CBL^NB>8A7 2J_I;ACPEU[) M/BH'N0J,;(:4DK_ &?31J%K*,#!V:V-![-HG@,]472M_?K3-GW_+^?,'V_SY M-G]^^_/GGW1'#*PJM**VE7WT#0,C^P>_T.:Q_X>]=&=6]Q MO?DYH?][]^\7R?&;UR=/?_Z_[0=@"^4I5"N]V9YF:0:HSG*X=N3[C910,EA^X\0QZ$(*([!FY;7]^O0' M*=4PM#^D]/+%I2R@ 4N.7S]EU\O>1 4.FOQ,T"J+O"%W]AQ=JMG4J:;)PS(O M2%:C%UB_X 3Q5C.AKS3B)L^^I$.5A"-U\L(_N,J/)"'[)@_W>Q3;;DZ$U!X-SG]NDRK6P9DM-WZ_4V!F7.X,*PDJ?9.R1+%@ M]#X#$ E1[PQ0W KD# AG8'CC)2H@2KN5+>FU2D9LPS3*N?1,+T")K%"_4>7_*^:9GK$?,6L_R@P9^O=G?*!0J2R[GD#I N/:O*2Z!YYVV$DRT( M[41TSZB3LHH6LGYIFF>B,PF=F7R.I1:\$E.GT=-."LVDB&E6Y0>D+E9:+Q)- M<(YZB^@%;"W[%P9&[&SE%K?;^R[+:CJ^&1,X>#1XB#-F?;6=X]*>,C"#I+S^ M%I?S&O(A@>@^"^D! EIQ7S)W#4#A@*LJ%5[)EK+4C[1H5@^2-TQ0P!3*;$)Z M*WD:X!=+,!#7W_=X3-?PPS\2Q1GYYF$(L-\),W'-J]QUN%5=5^G@X>#1_87S MC#?\?:W#<;J:#1^]#O"?M$]2?S:F %FM8\E5E,[L#WHO5X M0D=D.87"*VHEQ]'Q^6LQ7TUK-_%WW=I3=.?W'6?(.T*?V1PB"\#RZZ8:6J[V MQX0X;@KZC.3^_?9RMW!J [KT'S_<*>ZNF7R[;I_A7=,P0O=Z2,%E V 9OJ<393=<"L*IS_YV3 GV7G1>94 ME'\N46ZGTRROY@;9$:#$AEOL[KRKBN5\4G:O_K8HDQ\K<)6 (N\4]2J]TVFY M1.K\^G>A%UDLLXNL>Y-3>KW#AT_(<3W)EM/2WT(_3_ACAT R=W+3O9XO_V>) MM"C=]$.1U?TO1G_^3S8GS\C?DCX&ML ^MWL^B:.@[YV9-N0):@,K8"P#PWK\)S(TSXYUPB:^R-9V/ M-9T;MYTUV_;)BZ".HFQ9_IN>M]F\;:-J9N?:^\GD+4IH($$2!;O.!J4_Q 7[ M3_"%K?E\G/E(FR4W-O\54J.<5LE% M,PQT#Q6JED+S]O:?#QZG^P\?>QAR6'0$^1]+L&(I6%A)%WE(]_O.\3Z'P.36 MY5$%]9$1:N[B(?AT*T+A7XY?.VD0D:?10D*: M$6W$]'3S?'U*],>\HB=<*=^GVDS2L6.T;0:&G!P>I?<.#P8'WI+I>X='@T=_ MPE1=+-?9S+_L5KXUX;]HPIJB-M-M!>:B^]1ONI'EYLTY&VV:_/OYR8OD#H@E M]\80A23W%&9M7[C+/_N)OS0M+]=\Q^7.Q<;=QM@U\GBSOI\^.KHWV(\L_ &: M&_^\@0\V&_=-Y/U>S37-ATY22;;1O_;3Y/XC.G?H?PX'C[_C<;Y_?W#D7CYX MWYBN)@TSYJ(_2K/,>9U(^ 17O'= ^T6:W'LX.)!;W+LW>/A=8A)AX9@6X6,F M]I3%E?R+>-*'FYQ)5M(*_E3 MIX7A"U!602*/&Q4ND 2D:/RL.:\_/<;;;OFOXH>?&X\D6#]7/8)CKT8-S>7YN9-E&/D]A^F^;I$"(*-GU-;&^8P9RR@$ M0(KSY,2-G7FF[(J2G;,TV5C;F@\.?,?Y+$>&/6EXP![=[_^#'K;^)&;=9 M(9^I0AK=_,@N":^\9&^IC 4V!KHK55X7@9KI(C[VPNG$NC_QG#,Y[AB39:-')?7WQFOYA1ICFKWQ/0<-?VDG.6A ML2O,!<]K19DT=$>+E+ ZKE@)1_M_^M"5+37YR4%??M1D/)D)/7'WG%@'->MVG=\Y6B4*J=R MS7IYEE4TO^ Z%9Y!5+5,K ;[0%'NN5\ 4P:>.0&RN(=F_@/1:NJ]MCW;I*CH M6>@']!2^7%*2/XGCLQ2=#:F4<'=1 $B373@"',$/X#/5RY9E254.P=NEJS(Z MH$8@3S/D6AD^/P266+>'.PH/]^^%F#ZZY]&C4-W*#$YT?\Y9G2S)&EJ!0F\J MFD),#\6\JL%F%@+)W'FE4I=353BKB@4X'E#2:5:[9R^@9]0?=4DR86C* 0R^'"2K'I* JBK9N!9#QJV!:9 M%N:B<)>4T;5+RF.KYU1S0.V^,;UJ'__,'HU?:3BGY+]>F&MH@K4*OJ2U#QZT M_<&^4;X9-I9-0\]M.LS)T;C/8\*T:<'7E2$]%XCRX?[1?H]W +ZX(L)\0N3A MPP)@4ZD1'SP:W/_.>>U."M;=%A?FS2!\NZ3UR*<]RH>/SK[H0%"?+ MR.[NW->T+L->2R\NIOZ3]-K;E;WSK6A7MFC:Y&6!.5O@D3K:_WP'^3,ZQL[Q MH,D;SG&6Y)K]!OO^#;M[&]=63&_JY"\O)MCKFY3;$UX-R8 M$%H_Y9G@2C,S$+I)SLR4[/9AQ\31IV_>B9]J#3CDH-7@@P^[BM^:KD.;$LQ3 MA+LK%U)C2U,.%Z6WG>)XC#=F Q7334.=J9NA<7(+Y.#09? 5N.NLMIU3H#<_ MQP$PYK-7??_@K5U'Z:,'\/[#=P\BV2L[SW[-PL'];>'@6RX< M/-H6#K:%@Z^U+Z)BRO X7&9 MK4PPY'4Q'B/+\B)3"9P)LE'%#)$WF(Z+R:36! 6=7\M1;JUJK=1I=,09AT:! MXC@\U8K;5R6+%ETZ#=A.'&YW=R<@9),\54>21-**+JL89!"/[@_N?6>1(2<$ M["]Q9=X33W' KX-%YRV[W8PTM@*+^ AP:VZ\40X4D_RVNSM!*C^9%SA/%N9-;RK-5G0=[RTISK&PYAPSP9:VRLR94% M;84^:Q:+G(/(TR?R))UD7SW30I/$"Y)W">BXM/\MMPZXG%6DUT^KB7C(U,HL MCD-LIV0KT(X*C K?SMHALV%59K3S/ 53N>H4>?',?1NJ%0 M&F>$>Y8?_3.4H;:O:4>#XQ.Z),;7:0^HOCWIS]2/W@MK!"HI]II/Z<3F% M,R4WY:L8V6C=Y-DL&2%%P//>1 ?!6-\G.&VTOMB^H^-NC5YC=\??.:SJ8CSW MPAU5VU-X4^/#A[\1Y*H7Q2)G!G\RXCF/.3?E\@2A"51EXW6H_'+ W\/3$QQ+ M=1/O@@/)I!P\=JO2]E7N,^8)LP*_1+-G>4GOOSA7I=)I>58(&D#?J5G)4TD7 M,X[R^3@#RQXH*_G"$KM/IF2FEEILXD#YLQ>%7G/:2R$9#6I1M\)KT^Q0IA6( MO4DY6C*!6D3ZQLD;&--P64PQQ^,\7P!%R,<=S9_L:$(V3/O>.>H$;%F'Z>'A M@94WI#C"Q +KMCQ7.,D@[WC6G-/32)?;SL_VZ-R>*4TG/$TX MDK3D@F=PQ15^.28JM#U%F AD%V/68N!'1#V>56WP\KXN(,5\36"62)HU?GSX MM6Q(A#B17,1%,9_+IN]R.PN=?WVXX7?'*"NK04 MCQ,SM;M#/B8M(W% Y^6%%#2:\V+^GGD ='?5ST[=WW6Y- EDT:Z SDF?.''Z^5?M*7T+1\@E/ @PP\TBJJ-:1&[!%0IO@V6JMINID$42QTL/+1DHDODUD^ M*]% OF1= =Z1'?\BV:V1IT]I1YE[?7&O@\?1DK2M$6O>''Y5+E*]*IA^UNPCR?EADN11LBF7+9AJ(4_Y'AWEA?@ MMXJ>4;UK*Y#;FZC 4W 1(;48=%Z<)!;52/.T];D$7%M%PW MM?]@F]K_EE/[C[>I_6UJ_VM-[7_FH_:5/UMW=]Q1 *[B)9?KQ1.B?Y\+83<< M-(D[G0XZ1] M;XDH.Y6T25(64P4MPIZ+>=JBI-O=B2<_F'#&*O'[A*AUQT^16-!JU-Y%S:&G MR#\%#I_/&X;8:PEY8$ "<]Z3<)TS&W#3F"1]9())&5,I&!)O5%0\YA1R?KX M\[\1TW(V[G4VI]GCT.(=TH-L6R>"P3L5J8[D1G-%KG$:60?1%(<*@WMJ26I: MSH%30ZXUE)8" XR:HI8$QOMY>0G!V;S;EQ$E-.H@'F M,+6*Y?GXZ-'TGVR8TM44-2+UD1!QB/@33@B?U54!!-4G")K5\:5%54R!N'K M$=!IOFA<=+G/3^'U:Z8K=Y%N6')RXK,:JBZ[N_,\GS:9Q'43'/-\)F;)"CF;MP(E?^GDNTY\?P-@H#*?&)-7 MAL4Z!FSY9MO].N::R>(45&+%V%8%R7MALJ!S(VF"%V,8=M R,;+2'QI7HF[ MG[@ZA+;WEBBV6,A"71@D@+C8P4+N=,Z__>>C]/']@Y:\Y4'Z\.#^X('3FG1Q M,:-J'C(T^GH(]X9^ZA 1AB(6R@"G$%VZT4LD!W@!5+S,FCDTFD9K M1)]>[(_G2[;G"]I=.LW*&SD<1-ST\*3,SHO!3U2/LD\[: 'X-RIU@MF!.TZN!%F0 M5ID@C,IZ*5*/X-8C821FIHK:=;Z21;+N$UP\;M=I0!7M[UUZO2ZGGW21VZ!$ M9Q0;Y57&]NC:4_U@T5QG^W[I!_*3;\CR"(^N9VZ'AP.VMG>LONH>RB7EVW9" M(WK#_+\/>IC@'MT^RJ!>;8.;8Q'JEUHH?I >!MC@]^0TTG]$S$$HXRRX>,&= M';3X@'&8YV=E4_#<\WI[<@MYI;96\BFMY(3I_M5*SI=TH3T7.AN/@>@"5&#E MSP-DAD9.M4,1X->J2'=;2=''+UPYLV SMP'SE,'$E#ZAAEUQ+X% M#NMA[OME%:ZPL':K/\7X][\^=V=\RA6W? M6_]QR2F[[7'_MUJ+)YK1 )S/2!ZB.)F7*&O!E #RE)=9-0[[X_]GB8STU EQ M& Z3@NH]#\;L)Z6V2##&88WS/4F[NI[ I(DC"3R78-[V=D9LN04\NR)DQ]$ M"IL=D"O*SP^WY>=ON/S\<'];?MZ6G[^"\O/V\/WJ#]_3B+]#G6%AELF"CBU3 MX@[9RAS_79V/T)+/P'9?1@_1B09XW$;E?W=[^I&3H^+&N>X.2:TZ-XZ";SIG M:N>HM;ZG: F)P[3J';9SS#WIQC98_Q9LRF.&_/XTSJ'H6(D?+LYWN/FX]@B7 M\^_;N@)DRV>FZKYFX"ZK)WDJI84;+8M:I'ZRK.HE4#7 -_4$YZD6N4W>+ZZ. MH#(.-/%<&L=PK?P6!/"?E.'_T>#@+R[/CUTFJJ[RO^[=O__RP;,-"LKAJAVC MFLVV_KU@SO&K?_QPX"W_]JSX:S_].\_BN+OC&T/=N^B)(Z2703]'T.!K&T3- MJEC2D^*B^ AC,V,@BZL#+H*\15]Y7PD"RV6#GR)!"*S0>=B;C3],^8JNV,BP MLCS*/B2M9A1I@DF[F4FT;15:J$2]59!]#"%0%-D\7]*ZY9HY\U7=W^.XTJZ)0-V@ :XN6CIR[X@\IS^4%!.'O\$6.2Y=7RW+^ZZQ1V# G>> MP'8%]-)V476AACR(W"OL46CZK0BN!@@Q &(.N74;XZ&_HX7?+A-_A[8QP,< M7JE\]^)9E4G_]?"'[^'WM>W9,*'HR 6H>F4_$A2W:Y,*#JHDS%M'[6"\WZH= M[^X<2\$T-1A5%S-C*/5RT10S/9AN:_CUMS3AVV7#KQS3,,1AXVI):,O1IAP: MHP#DBYEP&+.O[6AWLXXY'!P MFZSVVG'%,^-W#2,)3CR$7/(<5DBV2CM5R"4N5-[,)1P\6S Z8*1#*.AD]2U) M<9M+8.S:3Z3&SH_A(DD[SU&F#>[;(.%;#!*> M+8LIN#^T73"V26YS).-_=P[F,M#5OW[SBYP5I\<_)L?6WG@WALY0M 'LC'QQ M0CNT$4_5S7)'VM1]U:\S<9+_P']K2[XRE! MNCN^;X_N! Y-BQB$"T!<7M8VWWZFE%[:$;DM10N>X+]%.D(6WZ&(^19"W?W! M0^[P7V.Y1@#PF0UWK5K]S=GM'OG (D'5PS6CF7_E2PM2]A05O'[QH\E%O#[Y M<<-FC&O^'MXJ40E=\M%/R]^+Y@^^CAHX1P!FSN1BE\Z6SZ8K"LJ2.U@"A_M/ MY!'X/PZ>B'PRONY9,'N^?^*_K_Z(+ZM&G+3;@/HF NJCKS.@?LL*.33KG8#: MU^8,Z^$#6:=&95G(&6W(F9!95'9%[< +8N(@NNX"2+J0 .[TM6MMR#*YD+\O MF.9(WH+_D&'"O8TR:JM2TTC0AY\B"$\VQ>#D0EX["+\"E?QHBTK^EE')!UM4 M\A:5?/M1R7\/Y^.VA)&WRAD_#C(.CL=2>H!<:M =Y6#":IPD /R-Z<:8DH_G M7S-RP/*Y8RMHYSBZ-PRG,=U@D/^^%U> M55ER; YND!,)\AXJG,>K12C6A'6IO-PS FL#PU[2_^3")#5A5(Q#66\-^5M, MV3WU?&5L/E!D;581.7 6F++VW%]AQP&)RS23?79<+H=3AXW<6"3:W?D-E&TG M4W!0WW\"LRWKY'3P= -7, =06,LO'GWVP48D3)]\&>0WG^64L_Q7+VY $,\ M_?;&M14%SKN(ZDPR=/ZH=S%?( MRT4)ODSA6IM/I@5%LR;I^G99UT4F6K+O*[H N=O8OZ4^"*.J"I6$IHN,3*!D M2E'[N+P4",@QS7&6C*4 CY\=O_GUU?.]@\<)*HTXDY^(@"\+$0O9DZ8%P-W3 M(K@6&5"]6E5(8:Z@QY:F /"-5AQWM)1MF<3L]0L$>-XZ5E"VG[B9NB9//ZN*,K7$ MR;"8NW2HO*NU_(C$=S"-,>V6OY*A)<)9- D& 5V:$#L3L\I>44@>1*5\3T[P M+-+:S;F=M:I!;%PIYV:J8K@,Z$G'^!5E M0R@&D_M+W@E$S;+)1(RTSI WNBBGRQDS,=;LI,BG]$L>CYK#_89&&Z,//26Q MHMI&1)L C:K! /:F_PQNX*HQ&8T1O>:4R6#/W%2WUXT#VN@ B=MMXT-#>"2M M/"7"Y8+E%,;+RLZ1*L?P@L??((Y?D!!Q_=:+_!X&DS.?+'F']Y06!KJ)O@#L M@TF5Q]G":"3;8K=UEZK4BTS1:#AY-PYY\&!BN/Y<%9EC?I+,SX*LU)8)JX$' MZHAI[T-M>B9Y*3I2'C[Z+NU=@M(U*-2EAD[NO2C_>\&R1NY MM*@QG+,!!_CNWL>VS87/MX>TK6%SYNK'@P>V;Q]@)!\>!=NX0,7%;*=9,;?C M,=ZL%'*N /&0+/(EN%Q%FMOZU3S1(3DSX 4.U!15*MU[-<.,?*6I($O&V!UO-(DOV"N M[*XE.VE/U>'B%+WU(Z>Z3X#$D/:6/)LVYRNW,,QT9%#/,Q&?GL\AQR2[HS"$ MTAY-[F[.>WQ1Z^W6+Y#2*1RV4!(ZZ>X\(VAWB__859S MHVGD<-(V@:0HM""'V?Q]+>?=;)@AJE+GTWD^[NADMZ9+FQ[YV+L[72<[PJR* M)Q_[K-"PTT:V01(MQ\1T-.F0%3KTB??3@?1>YZ<#+P1'70]R'/SLJ"O66]ZL M7D!(ER[)$]2=&!K.?],*IOTOU4-])$HV8,97$ F' .?P-?(^#YR/-RCZB)+] M!--6[6$N]YRS@57L2-P[_KS*&A;@.9C7>C#!Z%BP-;0\LPNV.W[]T.9MI1W^TMY-^)E MO NV=^LI$NE "YS"/)(=UC3=CP:/G-^&3?W!P,4.1PKOZ#E-@_.^4<\SH4B= M91/R/[(GQS; BBJW8%E4@=ZFN>U._%K[88:([6E-TJ5$5WYMV>T%*/< MVZRBB"(&E M]5C':U)4*CW*1S<8RGW P1D9&:K>_!"[12W:0DE0L#O;DVOUB54DMS1XZ:;& M9<;##)>LA V [EBCWF2,ART_-G#/4/@$ M8(M\3Y6L+H=01>(?TT7EE-B\^->R]+:=G,5//H@_\%YDK!=7511K;73R:W"S"^SE7309 NN088:P:Q<@^JW MTQ1?(1&)_[+5F#]BQH%E>O:28&Q2WQ)8*SN'UMAL-5_YC7/= M,(6<1S_7V;3!]C*=?J[T!"0C_BTJW%>G)OZ"*-:Q:6Y[.H=;H9*.=,B2BT+[ M![)!=. LF)G76!CS(OF1UM BA78?.0E5[AT<$3NM?N3F^OWEU7Z+!FO6?9 M>9%Q=/UT>8;\-+W(8>H?7+2SQ)'F^TC;$NMK-%+U0,69'12CV4 26(2AQY]/ M)>W8:9T$6XJDQ6FDUQ ,WPJ3>::;,8WT ]FO#O0GO&D$-I-)7M=T3L$I74098CO7G'DMFFAA4+87&& M?.I]A3"]3?]=(/0AK\9>0KDMON]_(SS'*9W\9%!SX<$@8W4T,%F=..%F.\E> MLP W#>%#WOU>9[P$'S]Q>V$@](8[_/%S3 MUJ8UQ.+:O/D6 /8@941OQ@514]J,$DD'^S?KL;Q3=\6/[NX.V44^/Z,AF6O" M;]TB"8J'3+I#7U_6P@R10>RF)NC"9Q_0K"@/ W M/]^6\"RGC^?F*O0:6?1$>E#>BDV!-N"7M/7#CI#$UOT@%G1MF30^.CDQPZ4/ M3I?SAL(=4 <'5U_S>7GI?F\>.JV#$^<9A0[+A&N94EN\PYKGKL[8 M7]F/O_,CZ\>L[JK@9_@DKG;&?J4R167H7<1&MG9C#!P\KU\EWU6!P3H-?P6T M*#O68?RN+5U\YE'PO?)]6M%[[>X$+^;7&(=_&)927X5^=),ZD(%]>?G$5$@D MUPLZ2B0#UT0PCTF$>62'!I5U_RZG]HVUJ?YO:WZ;VUYU$3KF7Z_572/<&BKRJU9N(5&_0?DT. MRE]3ZP6(4N5Z(2 ]S*>LQLYI4PZ9?(Z)3KEB3NL+2N0L('S"I6V-D\)S7S)E M9Y; \6>5_- =2F@:4&K+E:)P(^ @_:LJ/O USG)D?!84PW15J)/"VN-61L<&O-E_'C&RY8.# 6LX4(3]*.ZF3#L]1ZF!Y:G@A\9>9 M*D6INSL=D>B43$Z+!PXKHV;E'5(A.8-/.C,Y<]?7/*.O"EC.4YG5-$5?3C#W M>H'-83L(D;#2N&1;A%.]7A_&H3/V&&*E=0M9FM=U,,23K87! /HQ#A<\S?4O MI_]\]- +*:>R*3@&W!@T2V=J\J!'"=Q2)2WWMV5X<<+$+2S?AL]177S'8:Z# MHYD;<_4/CVY\\N.]7F;?%"*YS2E+9OFLQ%PN9QAJYBN UK/!_%7F>QU7DI$D M*6=2EW])$(FP,E $*I\7"#//5V,MNG2YG-I4-8&MM"Y>,PU!JPB,*.1,=,2[ M-LSITO!ND@5DC*CF\73I8RIKY&<%T.8L$CF\)0L=!Q T$]/41]$A2I/9L@%8 M,L-[F#W;'HC[1N^3ZK,LP%Z+BLA*8R)F9?/ZC,,2%]]H75\,KLHEW9]1Q50$ MUD$:O6"'1RAUQ:PU8?#/.5*1F)HZ>3;X=9#Z!.1&<^48T@RRCQRI!W;J^P09 M-:U+]Y%)PW>72YB6]9/:SYBTN_/33\>.64;^;,PR?V(4UE ^]8%I_<;K7Q M M$?F$&?XU6F^W NGF%X[);ZQ5@?>FB^6R*.)=-*#]Z#L&8]4:I-AW=WC6D)^> M1;.<:G_' GP&.<>25[M$S&0/RR!_>>X*]1I('.*_=L#BB$9F*W9US MS3[Q&\L.8;=3IE):++F30#7B+GK.6HN 2^&4EFFQY*>D6FV4@U94E%KEW30# M$FYM:!.)^[&'2)34UDED55RR$7ZP!GV -"=C/?<\^[6D%B%\X+:5*I#:P#K=BF[([B M?$*CV-1.!#-+8F$'SW<3HE*?,UT##?> 3X+F1K B44+;Q$JPL:AP.>4DP*H. O;4W6]@):2[(7 M\Y_KEN9%E]P)RO@;5P0;NU8IK'-N7,$QB"U&S))F#&F?[$RONISV =*+B4UCSI!.(##ABM9J7N7M-Z MC'G9?*I':4K<^^HGN6YF_6";6?^6,^OWMIGU;6;]*\RL7Y=K9?-1YY9.,:/= MO1J1#67O#_9P,8ZIS[G[-D\,!=X?AB]ER MS) &#R% <=A!-CDS;,IT3'!/ =RTSB_!7^' 5]J[JA[ C?M&IR^.'8*9X;-: M0<\;CEY>6@SD>#L_)"*5ZDB*+]A[6^=\T,!A]6"E%!.&&5 M>C>&WET.OU"YC@*72N.^W(8F IM7E4R6U;RHSY-Q.5K*E5A4L"HYOIZN+&5& M;QZB6984);QQ (+@]6G./NKUAQ+F#.CYZ-\Z"B&'AEP?B#NY@<,F(;]75@H@ M1@U%0TZ*[A$O6NKOSSS-7E7$#V0Y13^RSF;+>8"D\ .AK;Z=\6D]_J:G3Q-M M!@[ORY,WPT;%@M=964YN*;2> M[Y,OZG2V;W9-_DE"J7_\\%LN.C"9BU8PN'?^5?Q0E_\_>]_:G+B5K?V=*OZ# M*C,]U:Y7)MRQT_.FRG&[DY[J3GSZDKSGHP!A:UI(C(3L9G[]NV[[(B$PV&"@ MFSJG)HD!:5_67GM=GO6L 3@W&!F;H!9DD##\;[OSBOO;GL"VW,!10N^2Q$=B MV?>IQ(H)4/H')?QN@I2CD3%V0*/3 =OW(?.<*S 98A"21J?;<)UK?$'K52A= M0_Z3X6M[K\;$_Y##*KL,0H:_7ET[[>99HWY:K]=-,DWE=*9PC">W&&R/,HKT MJMPL6%J$PH=__3^=3K72:X!UTFB=-AOU)@_;.&E20'#GSX__G3^.4^<]FCZ$ M\6PTZPZ)<..5TVPKPJJ%V_/^H_,>WG(;<_?FKB)L SEZ[);"S#$U^$N&0"I& MI;H:GNH0.A7^^YI7KM[IU!NG]P 8:BZ^G!@Q4[ M+W^@PTA&Z$?_9LP6Z,-9Y(T<1YWCIK53[]^+)/9? @Q'O&61[4ERHKY&7>;' M+\J5:]HP&!IYDUOXFRN,*#\BNA&94;C$!6P9+,$/21EC>BSFR&;JO/SP[K<3 MC&KH:'J._UZ%:.E:G\B_.CF^G&I8"#:8(K=B.+]%$ZSW\>E5E\H MKIN,8Q6WY4@0#HM<4W]>HDI#WU_PZ4$RI)#K0SFK[?.LD$I][0\D M)]IJJ$0/'M3"YB';B9U5E#LK/]/25 7"V!%/KT A!>:TR_<7K!CYA=6*>J-T MGH2EQQL^\:E,BL .?^^>N_7>>:VG\Q\63Q+=ZSV8XPL5]BG\W.),2G4Q\SG("%Q^Y'Y9DV>4*Z7+*%B'\'\>ZK+%(<_K1AM:AZC3=]SM*ES MC#8=HTV'&6U:^1*;"\\8J;*EJ"AE:[\P)V0+A?$'FBMLBYJS635Y.]^E\+XN MWKS%76.5FUM/\R!X"9JT__>'U@]+=OT']8O) G7?)W4OHQ"-S^MPOL:Z+U!3 M?0I5X97UOW!E\4BN(O1TE='@@,V@;%(C,)M8-KU)W?:+!4NX[+"H'6Z^V/42 MHDV26Z+'K#=!]G].E&OS\$GE?V)8FZQ5]3;CV M@Q0^.V''L\"1O9DSOC4>\W-!BO]N#/6?>&?-/%;3)*5#7*:/5A7\+3S%WAE] M@N#$W! #^JGJ)G9Y>77UYLT/3Q3HC6T3NTE/VQEE36UJ3,K#7#JJU57P:U_86-LUH/#\K3 M%EDBH3^5N%%K=619RXW:6M=-W6SETTG/'D"MEHPP&J+)![3OW+9%R:S;_R(B1E!0V 9 M2$I5%\=M/K1M1CA!X(5$=*K.;)#&$ZSY [4_#)"J$^D*Q58C%?WZ\OHUF'D! MV/5BRT5Q1/^Y@IZARJ1'21\#@9< M&\\KJP>W?==:15JN+3FDRK"2R(NU^M<+5W]7D1<[*, [HACPL'@XT.3&03(\ M1=F9%5MN:8% U)6N8!7.#B&4DR]I<5_WL!K$UB3[<=<;OQ;I$I'GVN2!:W[*NPN3BB;:=*\&!+;.T7 W2>F M$0(M@9BB_<3,OOCTW[$99>_G;C4_=5+8,&_ MF$?!UF0)%R8BY): >R&U"0J&KC,,C%,BGZ$2'DH)QJ)A@7]\=#"HCW_ M N;#[@] X%I'"-SW#('K'B%P1PC<$0*WGQ"X_#]ZM7;GV\/$%>ZPGH!,MH2. M6V=%#5RN\12X7&L?(%AKPN4ZM6[IPNS?Q-9$S!W.Q)X"FGLVO?$\*#K5C)DY M5\!J?R)\;CTED%-/I_5:XPEEG*5XNM?@+U*M$WD2&X#4T85;] UL/,X33\IF M'E0B?IO&VN7_ >[1^1H[?5YK/1 \7W.KKU24:+]@>;S^[5ZOUEH^LK5TZ39' MW&ET:V>',=3V6;>PK*O)^/UM,/4/3L*O=>AS'T6\U:S7V@?4V@[,Z& MVCQKUAJ/$/%#5>.7%-/>2PEO-IJU[H%(>+/>KC4/8Z@-4.+=[T:)_Z(AD/LH MXHUNM]8Y$!%O])H'(^+-9NW\.U+B=@;SGVDV^?EEXP099B>;<+TV+O2]5KU6 M/Q"A[[4;:];-[&RHW=[WI-=_%>#L7JKU\[/&P;B?#;?>.3L4&3_OM+XKQ?X' M@GG2M65\)P%?V>MVLUWK;B2$O=-9M,YKC6]@%G4,+95$W3=]'>PV[/R):+N' MN<@S):HU1F8?;XF6VP(/]T#B(BVW4V\=2IRRY3;@_#:?\:+8!_GWOQ([Z :D M?YBST' MBOU0U _+UGX._E>??%V>C)?O-=OXQ4V<_C,\_1PL6WS MU8?1F]_R]S@J<'1 M3^,PT^477N*=?J4LY'S]UC9E95,M(3;>3V%%=N9K4S;P!F0]#*C^#KNI+JKP M<394X+,U'AH%B"^T?&:B>]UB3A4+$#%]BA5;5(,RY>9D5'SRI/(!8FT?Q]+[ M=QPCT^_P#MML#K&6P'0$7ES)MM)[I"DN5?+1"<%&3*ICH#P+E/V1P62/2U]' M2'$P]OZMVSARISM]'K7 E)'U."^QVYTJJ*0R-I<:X)E::5/;AD3[U'..CCG^ M_>18$?_MRDN1P:E45E F"CTY\1/^("]$1QGZ9F1H>@M;_I#XE%-]O:3>V)80 MK24J1W:&@Q07TU$U+RS4IWLQ\=N\L"P2C/5Y%Y[#@AQ2^PSFP\-B9T>Z;N.0 MI>+3L._O,+-92]\;EEK*GPUBQFIO@:B2KT(NVF MPX5=G@W0;WBI[[7;Y; MA/0ZM2MTOZ/"L#5#0.I9NZV+N9 .*7I+%\2W]K[JC69C3:.?.#_*:&Q^^,T6 MORW?6RVFG6?_P]#THG@U+A+I$QZ/XAW93%BS,.\]($N_%,6V?'[[S_B^ MC7+#O9C8-LH-]V)BB\L-%TE=X498[[)ZW*7T+,6&9?6%2V^6G8WJ,=I_/]*' M?[")^]-&P!&KF#FK BJ^MPK)O%!H\-Y>5$+N1 NTW/-.TZW7ZRLGN#8^A*9[ MWFBXW;/'08>VO#KU9M?MMMK[.;2>6^_5MX?GWLUA6;&H+WG [9YW=GI:& MVSAONXUF=Q]7IWE>=SNMQP$6MSVT%JBY3FN;@+_=G)<5Z]=VLNSML_IN3TNK MTT ,[?ZM3 M6YKRYAR>EU3IWVV>]+=PJG66QO.W:WQ-:,#'%3?NZ")J=7N[U8EG#; ?NJW]6YOS!K@"]3W4B6?G8&V? M+]")5JKN",?\#N"8EW&4!BDG^IZ,R%S&5-L^,M4NN;F^>:;:WI&I]LA4NYO3 ML@Y3[8)[[Q%]#!PV#%3L1=$V!B@ M6E&= 7CX@MA&=$>1_!U1'T'J1!X1WKMPNJ:WC@?R-*5V'5&:C2=Y2 DL039! M.$ZCKMHW4_8%B=T).%)S/M/G<>2?PO5VZIW>>N$(QF1_&9XB[X0G1W O.FG6 MA_E-,VF[B\)$55<2&%0! MS94A1MZ''UCM+CS56 +!Q=:J5BLP+B1=*ZZ-U4(%-B[?Z\&L\Z=YX*$:'\Z* M)LQOP\8&B,Y*-<2 ME-&SM%4)?OZ=]X%/VPY/FHP#18JP;NK4.:6'SL:M9?/G+Y7>-8*U2A5$+!H$ MD_PIS14IP+:FTSGD6+6R;F<@U>,DHWXZZL3).;"GM ES3)8:$91K:2W\3U/ MQ4.<'RC_BS$B\8?>^/0#V)G\;Q?1]-Y/)@3>P^]>?+C J0^P[Y11#ROTC3@4 M5-J*.)MN^P$Z[8_ M_SA=BAK97(QS\3)M-#= M5J?6/K1!MSH=Y(YXC)ROE_M_#BGO__P>_G3K8+^_X:;8X#>&;-KELW=)2+/! M'09/*L,*B?W26;U>K[8\";,WA[Y3;QS,4)MGM2TBDG8DP6_\?K*'(GS6;1Z, M7'2ZAS+4=K?[&!'>>S7\WDL&MWLFP0VWWC@<&>ZU#V6HS?:WJ(8O)DD0[ID$ MG]J@_?.AC@[.Q2AZ)P?COYM]KY!_?NO;._8U,_JK4.1 M"8PT'T5O8W^EHGLX]F_K[%$"O.?Z]R*[R=+IG@EP MMUL_%*GHM@_& 'ZD .^]!O[H3Z9,[;%G4MP\F,NY>W8PT>!6]ULT@_\83.,] ME.#>P5C"O>[A&!*]SC>IAW^/[_92#7R_YXD^KE;?1%(0TN,%JL8U M^4FLGUJB\S&;3,)9M8+U5HFG@/+7L.2XV%*5L,V*G74V8J7"!9K I0;9/U3' ML)'W+^&H70+:'P;I- GZ&1T966HM]&&6VJ4"$Y"O6P]K7OJSI[6!$*!_M3*' M],='W_CQ30)C" 9<>V,-+451"?PD_=8J IX$H=XU9Z*A9^5Q/#-'Z]D#-11+ METVB^V%U78/OMIZ9RV!^W?L]<=K#J[RA*P1 ]2 MG37.OJGSWVQ]4]-I[%*=;2[#BB7=SL48/AUXAWE*OBFI^K8LF,XCCL@>WB'4 M3?"@#TFS_DW)5>O;FDZC^RU<)1>C@ST>C?-O2YXZW]9TFM_&-?('DN>D!WE MOBU]^RW/YD OCW_V?_Y$K'./8718.?C;PSD-XZP?^D^/_BK00O]GS AM+*I] MG,PV)U.2AG^ 5[=SY-4MI#N^*U[=LR.O[B,EJFSCCKRZ:YR6=7AUGX[868Q@ M83".8[ X1!-[[4^3N)]X:-#N$LL"=LW-+?*58M+==,/1S!)0(5YF$'L+"%C!ANO17BA/Y'G)=1HA=DH]P M)(N[Q->XS@XL;M!NJX[/\/6$&Y_C5%+#:^O=)#[Q[*9B[_U4 N Y-K;?E\;V M]EE*>?.P0;N3PJY4*RCC0S\$(4T,G32>'4^H6_,R[!)%=(X1-W>^[)/DRFGC M_S*GJ7 $X7@/PBR%5R!P4!U;I+8E/EO-^_QJSEO*F8)'T=L_T;OW"3V8($MU MPE*G@(<@>(("@.Z?+[=\Y00*RQ]634;Z!&G/+GHC39RHJ>IE23M@&.@G:8 M@C;V9J1U_'0JFV[W+D"KQIOBO8-7H:?USR@ DVT0C\?!E*#-Y'6I/@9&TO#A M8H'"4[ WP#!(!XF/0G84EX,3%Z'N'_C(_3^!O;6Z1U"GA[Z'32:H# 4UA2?* MA'\#3K&?8&3AJ"D.<^N5XP;_DH5#["F"[DX0805#M8*&\)@HBY6%Z]]1LPU4 M(!F6*(%'Y$>@2^ AH"_@=\F,OP,:9P#>H6I70@8M:HHDF]A%33X,( 93^G0$ MOXT&V+4!S:4PZ"=!-A:OJUI1PSQ*V<%)F1^@44$U-#.Z/+2 Y;>6V_A@1 14 M"^J@>$I=-7*"%X]^4(>=.!G@U?EO'Q]HR3D^*8C@,B75.([QM;>P..=U!QZ6 MP@-:)PZ\*TI!%V);D'B$_T+NVTWFP05GR;.RH S."P;9/'&JS,Y4Z)W(N M[B,_26^#"8YQ$">3&#[#HJ8,_A7+I-1"C,) 1]+HYN O%!<=7M,YP=.>@O5! MA@$^^&4WOW%H9,[,L^B_ P_#U/;LXQ&'8@'R:#B#WI>]% M7_ R&7_QR:7.7M(#:Y+X=T&5==N[D7UA5-< M77C2+]YMX'$T%UN.%)1VOB MI*YYX8C=IE_P%VUBEK3*>K[FQEHVAC4-BBK%'[+ M'U$M-NV%;*'Q)%U'0EPDO(F=HU!2(@6W?(5Y492!@:=$(8&K\89#Z;PW.0^C M6BDID=WJ-GVN=84P3'?%)FY;5B,JDB,Q:+T^-$33']!8"R93X0Q] M<-&#/OK[_?C.IXW3)U7M62R: Y=AS,LP2N*Q,X59X$OIG_07-/QAT+86L=0/ M(RI=AVM87">/0T;)> =['*F_['IW]Z.Z?9L;;!W$)^RQWJ<'D"?=(_+D>T:> MG!^1)T?DR;>-/'GXLKDRK72ON97N+N^6J[G&OM6*E_B%MJWZADG7ZP4K#D>A MH["=IM+\1 L;Q4K08ZY3+#G^ZHUK4K,L'1?W@.4@-L9C] I5*[)$>A'T-7KG M)7@9PX]@,\ )-J%Q^!PL6;T4GVL?:\X0507<=_2=LMBY1I28A=^^*;22EUJO M@Y=Z[Q=2C'0\>2XQAI#FVT7/.7F\R@H+-+T-4A/"TF%EV\6K&]B1?@@,!=X> M@<&2^)%_;_?0W:TOO\(J.3#@519*MS"?@TVY;(VI]G+@ Z,GC*?2YJ:I5A!, MA;XPASO3(RAIGX-ARY$A.7F"(V-_38&5#'Q$G&J#'C'B]B-&G-7UZU!^A-+]"&2[\2DLQ0\"=0XS&$O,$/5OF4 Y MA;L1AQ&&YH:,[\0S#<9C?QC TT($"PP0:8#7^@BO:1K ,5]\>!*IH0+I @%C MJW)5P, QCW.(0K#)/ [G7 * MURED<*N5=5*X>H4EGV%RM_A8S-\*W:5*KKJ+7;HX]Y)O$6A; M'BDOX) G>FI1@$'KCY@LHSH*]B%KU1WA/$-UH(,:*CC6."D\C ]>GPU[)=WPSE"6>EG]YK43G\,,/ZGNPLWZXV> M5>]R*U4N=#:\B=?+%)2 *W]OT-]; M]=HY_YT>Q!_5"Q_MS%?F7=<=&$IV7>WX0/8;U1Q:G.K\\+$9@ ;XPJE:]6$BTVR:KYXR MP_ <"CL1, W./ETDL=/HO%!W$WP55I;.LPIHZ;PXZ)<:SOZ,-H;>'R3IE)Q[ M?#AENRF.P.$M5!@89BM,V\E2G.?<64A-]*CF_,'OG%)%>F%0K NL%:6T/-Q] M."Q>^@E'XF#D]5K[A:7*3.Y)Y-*%&]W^D99+2?OJO\,S&K6S%THXGRG5]T%! M)OX8C9Q?5RCU^[%1[[W8IG9X&^D(3K->[W#@J!A0*T2#C*6E*@$,M@*6F1 7 MF)6?^MZ8;S0-%0%KQ;GQ5.R($=SPPM2'LX/'0,D&!QO0>J?_Q$LF?^O!R_FV MXYHH%9YJ=*2F3_9["M"2M]MFJBMW=, M]'['B=ZS^C'1>TST'F:B]SGN>Y6>P=0,V+YV2)]ZN_ -0!$)4.\ST>HZS<79 M,J/T%7#'&Y<#,C>K?+^EE'I6AN9/KGQ4Z5_UD=AE 1ZG!7 M<5+LV#XY^;C2S(]AW.W7I@^](%>9/N]A+,U64A'R@J?!Q]F6LD!'\7F^JE'T M*(I2D:\;]1@X,R7DN&!.MUTW>I2 9RT>)1.C[ZMB4=C_'5:+FDJQHV@=I&CM M58IQ4_M;3P%7=A//&'?LG^JN54M6BZAG9'58F,1@[]P12;4$YG.XN$:^8[G8NE M$A?X.,.^C7EX+V8]*)4YYW^ 2='K2G8"Y>J&VX+Z,L.2I$33Y=!W.#J] <>: M4RS-=JVIGZ%^C#5G^(V;F?V8FM-JU1KZRT-PI*-\@DXJ9"C!@FE(+\*$S6_! M,/'#?_RMV6J]HJ<[P]AP^;Q)\/Y*!S%EK2]_N_KX!HL]>=:!!Y[Z#8*I(G3" M3KG<4\]Q$M^#",MD<*(#>NG,S<6]/?G>?$&FH+<69K1;DM'F#T$-ZF4)K,D: MKDS".;DXI06#( +GBTL=6M*$I)%(Z>H3H-GFRV(4O05K?^\G @[5Z%]R! M5AWZSA5^):#RNY/=.,Q*> N%IK NYF25B1Z)!\NK)&@B_Y[,#BFK=.E7 :R? MSI1H+-W(^CJO$MYN6#*,W]6?@0I'@V%$74=3T'O6)UZ:^C8Y(X/QU4/AO&$H M#F-E][EGQ>G]O1@G8'(?K52U?I@[MU M25#C4=Z./A9"$/B 7EMR9N1P)/Y-%I*NDJ/1G\DY#Q0? _&)&351K< =Y4=8 MU8C[K'@%)1:E@,,!%4:0V4,EXGS4(S,=E8-7 FXKYFZ+%7.U0AEL M^ $F?&@.MCY]-IGAQ@4[%1B%8GTPT0(:JK!Q?R!WK51Q@KGT1TD=Y_7".LZ]N+__\CF7,8X1'B3C M+"V%E<$CE0*&1$XY(C+!&$KA^W0UJ0=/M;\U-$&3^1=0\"J%RX(X-U2YJ0UB M-K0;^1Z9N"D7:; 9M@VFWN=_G-=:G=46\Y2_2B&)UW)U5RLL,WB\E83L'*V7 M9\?!F.,85I'"S8HIQ\UM4+IN;?(HAFW$:4=@F-_Y83S!HV+<@<0/^6FWP41% MG6@D:O/9!$3E0;!01!":7\\W"."@)!>14=6#+AY$_^(K_;N@D 6FU[>-0LKB M*)Y80J830G[> D/SC@:TD#=T+@'T3)C0JZ]HB3I[*&UO2PU@*;0B=B6R4E=< M3A4QR]*,,-)WF&/Q!@/*M]RP7B+O4D"+_&W.YY&2P;WSO[+9OEMXPE^_1M":Q4*>)2M1Q-%D@6I705[4_LA*89J( ($V7Q!X) MM,=@U!0]7\**#'&\##\)QGTO1*Y"$'1_>H]>D40&!5$K./":PT!XA/NR!(:P M(KY-RXSA&PS"372]BO),1#4LT@M2!)H7"*,AIMQCI*@&Z.BK&>*84LF*B"A9 M4!K2#O#O-Q0H#](OS^>[HY?F3VD<>V$ _&%I>TL-J].&K%JA(- P&(V"019BCKVOS@<\)TAL5@]R MCSG_H5C=$/+,46)6-\/,5RH"PWV&AP-35"B^GI7(2GTCL]4*0JL)[I'*.U2Q M$@Q;CP\N%W+'%?K8A=/#Z5ZY(&5UD$>!A#<.$5O ]4Z^/S47#I\V5R(,IC\+ M\7>PL82;PMN BA"'#\IB0%*MM".=)\&JP"(/LQ CV[@EK&K\B/A(T]ML.HSO M$5V6Z*%D$>.[,.I7&-9N]>;KS,+=H\)2(1$AE) Z%-8E=[[>9)N[[X:9%4WE M!UH-!5GD.A+N/4"D@3<^;,@8LVSZ,RY;X:=1RE0_D 07=A]6#F7PE$9A#H<< M!,GOL&YBC40_)" !2S@O%<6:$BR)HQ#F&(POP??+K-20:AQ\$^6BWE-VJ^K" M"TO0\78L(8 Q>!A81PFU^D/S*\8HFK=2P2-<#."^XQ-2NB/&P?"T6:^?J0V2 M&T9?,%;5F-PU][3RA)) (32'5X,E[474.5@4Y6F61$1=P]'>1*'_[,GJR-GB MU8DMURY_@_%T?=9R)!1ZB[@W22+W*,K=5*B\EJFNPK3]!&0BSB?5E72Z( M(%^X:_BN/;7O6JU X"L3>T%M)SW//TGQ"7MXZQ)-L<+!HN.A.G+6(W"(\&)* MJ%0K7&<$%[2?"Z,K.P EEU(FD_[1BAN+\F*'XGC,4S6.&XIBA.( , MQ1&4NZ>@7-M8L7%([UY?7X'W_X[^Z?Q&__OYM_=_X3^O_KP@V^)!\$ !'*4- M].UQ1!T%YCD$QC +K(U^?8[HLO$9J>BIG\3@@5!3@H+W0*XN1JD"XS +Z8J& M>7D( !NP 6<=D&,MW/Y+:NA1[&X4A&/>ZE$<#UT$S%+0$I%QS)1A;3=LV1$+IU[YW(]1MZ#M3J0F?]!L0AU13C23'FK4#W7(O M@X6)*>:-CO5Q'P]T'_T(UL=GZ .KY5'BG>H:(*R=@ -[-!X/=X=O8["V;N-P MR&:5)T"1O6"PU)5,6,*B*P5I))AJX\0(D3-3[ .3+7:7M-0JIR_&Q=<, ?9G M&K2!QZ"ORFBXIQN^D*F=8.14'6+E)8WDVY)>/ ESDK^6T"^,T_Q 80"0=Q4. M,'(E;V/V?_Q<9 *^X7AK'8?/YJ^BTD?4-K9C>HN[9BP6KMRR* MI/:W\6+7JX>)I=PJ/7IAA"G?:QA9D<^/O:[0N7V _\3::@:^F.Y;'BI\BY9MY M4(DDV3NB3PV<$BQBCX9XL\7)3\[?+B^OKMZ\^>'A5^?_<5[K+C?-UMRH:RNR M^L\TF_S\L@$RAO^R=+/*T@J;&E+#/6MU:DUGZ0 6;=!V!]8[.Z_U]G!<9V?= M_+A6$\+[VV#J[X4(ZJ#O#J4./)?:V3Y*7;-^MI=2U^S4:ZWUI6YUUJ^^?Q#7=\_.S6GOOQM5R&ZU>K;X]/;1,0_\/2 M]A"P9IN+>]:$*V2Y+);:_M;PRI<3_FOKDG'6;.;EXH#&WG#KG4;M[*#T*)CW M+-IV($KD>X&9OZHGV<,!#^.L'_I/=R757O5!=YRU.R3@ZWO)*WO!VQM[LX[Z M^/"&W@:KZ@R%N]2'UZ'8N4#L"F%#_6[C?3U;G/*'XNE<%BJ<"[#7)U^7>Y_R MO68;O[B)0WN&DL">W6JVSD;#\V?N M;ND\2QWXQ?+Y3& 357Y+E0E<1N:E:8!5#0-?T099U7M29<0U+NG$'R#%$[-& M8Z3?&WJ3J4J C>,AO%L51>9PY52.F,>2Z^J.O["V) S\.Q^+&J6ODD76FB^B M@-\A-S97C0NU5K7R,#WV MLT//J4O)&U.O\&W@T%>OVE@S.\6L=8VV7<#!8K)2Q06322YZ-O=*DE*)TN*( MLA(())Q;IY1B1$7W"YZOJ/Q*:BGNXP6O>42%Q;.0Z_,U"\H@OL_E,(G0?G$9 M#K63$095DA:JC)N5U?I0.:$E:(Z2,Z'A+[X#'LV5UJH/C[",'5X*LUNS F[= MM7,83WSJMI,;_9\O>.^,DER<'CB,Q*PUDW[B_"BC>2,I=9.VW53&=O6M%-GL M["A+:=?H7_-1YU&HVJSUW)JUY]UH[SR+>2FJ;_E,O[G<^<-;M7]37#.+ON84 M]P(HL#BAOD@2U56S]G(\E&%O_U#FDVTMF?[T_/GC+M"-.M-S6=N?UHK3;\:P M>#!77^97;^8T;=8,?O-Y,!A87?7CU9\7:Z3U'UZ^;4;">^<=MUY?'L=? M%26RL4%U&PVW=;9\4+M=MLY9UVW6.WL\PFZ[[?;:SPM0V)5JQFK&'ZFR\/W[.+?=)O=^OZ=RH9[UFZX]79KCZ4>QM@Y<\^:ZR72GWN,Y\V> MVVDTMYE^W">KR0"-Z%BV#O18HFSMY;%LG??^;V MF@O05<>\Z?>3-_U@NJCJ$'J>+A13:YS3*&/("HM:1H.A(4'0 M!$7'6_H9;NGF_M_2R*D;/=,U[:BL$X-S4F?H3_R(Z)=P,(-I(7?.[+#/>[T? M97F!++?V7Y8M%,W:,K,IXO<%1?8%(7OFM[^-X"F3*2?YF_5&W:U6F-IXC-9) M;AWAN!K0W=3QG A&Q%3B#R"3='L.9CZWV=(409I^,O-II]F-AP0U'OQ%M2Y+ M_($/^SC4O/_T*H3;.9>AEWC.)VZD3 SMTHJ-P#J)=P^+A)U$O% U?Z1A(Z\W MB.%R&MYFG6(7U0JFY.Q%4-3XW$["'PC->I\:(7B$GX#_E(BDHW[-''%ZNMQF ML/5\?0<^P&*\E\6 1U +0?,'/#O5RN?ILR( GP7G6)CY0TU1GFE,5R('S+YU M;0H+=]RR!2%SV.[!2>'+U'H5VV\:;GL-A[.UPP.P7!24_,?Z(X.V9!VA6W.6 M]1\2*.]R<"8QNV\$Y:F[A5(;(T_89Y?><.]+PP\S1F[ZJ7M+%^[:S[6/M6KEURQ$W]=+EXO+L^S3YRB MK&-SXRY@["INOJS81E@O$.54S .[5HON- M@2K%3?W%H]9X<+L&+-B^\Q8>&GC.1WCKNQKWG/U/AC445H-!UWE7NW9>8LP% MK XPB<*9JXPJ?J1852=4 :&ZW%+#I_LH/W!N94P#3<,L06AS;J>T*8=#*=LV M%!P17-W9FSMJ3#+5D0D^PVJ'0LM=>T]E0=#[B[/4DG;LYV3W"S/(^KG> 7DA M,3U,[-WDY5'-LLQADQ95:''JQN+H@[7V+"GGWBI[K_\,>NGP3#@,,+.[RTX?M3=A4)X>.ZI MD>$8&T5-0MM:\- OP(77';>P64@ TH9A1BH5Q1X='B5(4$L5S-Q$RO568DK&1+I M!#14D MZR? WZAGWJIK3Q;P'X-I+"+0< NG1::;V_8XXGJ4@BT[-QB>SM6;BVNY#-4' MR#2,HQ.!_#V^TS+(4FF-J"G=CX9"'3A670/%.^!.FW:[OI1O\4GBWY'TJ]?N M7(!,==FRE<[)%9TP"J'H9=:-#%T))-A7UX>KZW<7O[OPSS\OKO$?UQ.UY!?0KJ76&UFYF%9<,(TN/1:51_'< MKW;B::M6.O8/94X;Q\SI]YPY;1\SI\?,Z0%F3I_C[C$7S=B#"WK*(?"I=K#, MC8)7-CASJ,/AHH]B6&;J<\(WQ!T5'8]^/#Y17#N#IZ$*& M.+J;6VVF%L8/5PSXP8F$"J?$3#S_-.E^[+-E-HX3KON/G,99'4SE60I#:9V@ MWT?]7D?8B1Z;T>._X%WMW&0>?( Y) SV)3I<@YX%R8CPY_=#[!E,1DE&#>US M"X)W(/PE2#@V.%-K7ZWH[1(: (HNPLAA7.T3,C7#J>KT!Z]5A@,(#0@:%X8G M\)L$6[U.R>.>Q*DO'AT\:Q0&VC3<6F3(-FW7$2FPCSX%E#$!Y@5LCNY4+\ M5Y]^N7+MG)YCI_0H/$7^,8("X"ACM;UD^Y3+81QC?H_8J9PW:],3V"U2P2?U M &E:FTYB'4*BB4UAW:B+K/R37L1GRSXB8.9*"_.:\QF/.!?K&X5TST/G9N8P M(AC[?0!:H^\K7<4!+S4NDVA4:SBR)HOMHP,:@]"B8.-J#+4YY_47^OA*6E(Z MV0;68E,,C'TQ;M.+\3AO9K133ID&J3W'B'L$'A(+Z-*>DZR4 OIK?\'/SI)5W I(POD!EE0*&S;(BQ&>Q/*M[- ME?3M54VN'3@B/EU3'P>W<4QIEPO=J\9W7F+_='AT0L'BJQ2>&*?5R@6\X1]_ M:[8:KSSX;P?TASS8@S=AZZ*A!Y< ?!]L+L^\ QYA'NZ1ZFB\/'N?Z@.\YB&.:9A%J1A, 7C8 8&PY/'%,QWDX)Q08FZ3CX-P\][.._BJ+1+ MM;++O(MCIUU@*#O*NQ0&9 _D0/(N2"?):(#WN@W[MT&?]4G05LP4]6@XT^'L)6DP"@Q>S1D'@CKST#/.&OZ!% )-W3'I(M' M/BVZBG:3=W03U0UF&^"W="YS31UQ-6Q..VGV=\H)@D7-'*F!U$8.#QV<)WE& MJOD"W W,RKI[?PAW913#EN-%08!C4.\Q-=$+X^CF% UFL)1#WO+;8**<4YOJ M#RXM#'NSZ3X;A+29D4F7N*,9%_<[=E^Z"(8=V8+H!!0NY=RTY(>+* ML*>0VH=D_OVW 6@1?CF=7CC+7YQ!".YY."M9/;FU\I22CL4H241T,=I^<3+4 M0:\<\C?"V8:H'F8%R!ILSFL_G<"E@EI$3? F"]%%#2U4J0EHB^EYMX?>P2N+E=XHLFHS6>Y"A!+I+ZC7N%_'819 MBL "G *64.$OAP$:??UL&B>K,=,N&P9"4]"*)K<.,0S5BOU\,UU&,=W[YO5^ M[@+&ZRO-/ YYPN$?X^UN@KUX!=JQ6TK8> .Y/97Q#RO"A1?DG=@#,0 9)I@& MM7"LPR_B,)1V&]&?EG,'JU.5$U!7V/5 M)V),@N,")H%8!Q)3-HN#^T1J!;---[!P-V@!:6@9J<"4&V4J&XA&.U-N$SD. M@QB]G1L,%$S)(#-"!2]Q.2N6^"D\UI6Z%K),5(:FGZ YMU-S_4V&T9$$LWTN M&#VVTGP9V;__R3P20TOL/#V,*".L%+P1S- ;EIBQ/PRRL5(Y MQK?8>=PC^/F*6L7LB]>&>DTWGLU'*NR>-E3T9=QO/=EZ9 M_>(T:<.<&XI8KL:=%X1*QVAO3OD:UHLR6B(EW$8C_N!I]03_RAE]P2=6DKKP\O1AO=$,8]UX$H$&%]"<4CG D0. M# :7\($RPB_^3+NO\*44M0FG;G'@W)\7+HL^)O\0^95%P73N]ED[@T#JF&+% M^"'' %&.WOM?L4B)\R48C^?58I S(/4(0XR89Y!2UI.S':K=1]9P8O1E6J%,=$IVGV<+_3TP@U /%(R MM702R#HV6IKF19."Y.8_631('B[2P-.*73GYK%#AKL;==F69A)Z(\I8+2L:-,4KK*^0 ;J)G+AL=Y ME625U8(IQ0$OAIR,E@>]S.T)$XM@0K?@@#'<%.[(1">#E"C+*N0BLR.^Q!T_ MNJ7@#EM/J=CE75@B^4Y?PA[V2R M%4^_,4;S!QYA0T&$^EVW6 $M'$S' J(@S<&A*=!/9GWNZF&8[C(R M K)]<5P@E_";LK/B,28>,6?#.?F&(2MMH_0WQTOWP7B[3L0BP(6ENQ++YW=O MQOUEX5$8UZD"@D))A/+DZ1Y'&RC _4U5EHI- M2/;]6/62E(T]UD3W&&PG5WRJ&H+H[&A.#XK<8F@6<3AX>M#=-"X!0>S(?77@ MCH Q294/G1^%=H2?\H&1G^,TL4R-.[V F'<9UVAA,(VS!TL) I_1&DC=9V1K6B[DV2]WR:'NV$A'4O-G 7#SD?,[J6HQ2D MB^J.;,-"SL2JB8?6,?'P/2<>NL?$PS'Q< ")A[4$875S+B<7MOC5YU0<7HL/ MB0K2@Y50@_VP:-/S,*9+5:V'/:X4]FCQNAK@ZMR:[AJ\@7=E'&$67*%G5F"H MT68;VTZT&&):S@,S*$QOX$B:;L8"SN?@ER6O&W,T:.ASD(!2*O5:^X6X#KHE MG-/JU,Y>F.B:>C@/2# ^$]RUW=IAUJ(1M43.Q"GQ&FU;7E6%2,0 __0.C(M( M66H"8#+85?4!S -ILCRGKW(1&0^!N"6(Y<8F%B2M' EF*!J4RG8@W%%.S&" M(Q\A*A3C,)A0P(18#A5A%@4F#)J_A%-,@L%VU]"BSROKIHPV M!?EA])IM@VESSX[*8)X&='UJL2S;LU%_DDP$"Z9^D,I+\#PF^+N=RU3^/#.! M6NXDZR,NZT?'$AW[(8&8K,(36DI8052W2(3/H$'XSL7'3^^=U]VS;G?WSCFI MXC^#:!:"?WZ B%'$=OFJ %S'=2PU?/WGI=&UKA%G&PXEC!Y1.L7J@D'*,>63I?1_\U'F3GD0#RFL7/Y_F+W6/_B M3"6$?$/E.7GP0:Z:8G ;8I067-_-P?A7B@!F7$M(&\BHQ4DPD;T: M!5/,'@F'(#]':WA24)QWHD!U< ="FRO[L]W8.Q+^=:.*I,.M/#KL8\:XTC0> M>A9=(TX%/-],KEQSG\-S/1 ^RJE-LG#"-H(WP6)&Z_Y)8V^B@XH[#WVPT-]3 M6F5(9683F-'7 /?/Z31JH.G26\]@3HT-@=LH/CM1/9S7.F1ER-\6_$I6U<%% M55]]2.=Y$9[!LN;$^5('8^V<+-00(@8/2PNGTK; MJ_=4\+/=?3O5M$VL^_> :7,=*ME/5).MHI#D!>0Z+7M4/OYEB*4P(E,Y^.O* MFUEV]/4IGG+QSTAZV1)M$>:/A@$)W.$U5^[4NDL[\"UO6KG7;8CMAL,\DHUV M'5Z^J$18,>=.];3'/ M@/S]= \\U.A6[]'CF[H]0_]2-*7VJ[U9^QPNYK7:ABT]/ML=:J>V7H>SG0VU MT^S4>L[6FH,^@Z1>VN;[GHELO5GK'H8B5:C#5Z M0S_[(O.EVVP5E,.&I>(5>3>GMXBQ(Y>N]V)C_1ZN_C#.P#W>V/*?PZU9WX@=O]-IG+5:M<[A M3Z/7J->SB01V'.EHYARY%9[7SPY]$LU%;]R#LV[T@ =,# M/ 9X*WP+!Z'=M(R+@YU&K]4LM9&.W12?M9OB3OMWOXTPBX=$;#HYC$2/\8T/ M/\WE_4:A]T50(C$5J-[.)C'_:NIOL\?B)C-NE*)\8Y !VTZ_/0?R M-K(ZJ& MEXNAM(-KS?G#5'):V(B@/#5;X)YS!2:/-0B4YV=NO6(7R"FQ^R)W9^C=Q-[R MFN7GR)3_RXLRI,G! +Q;K:@:=B^*X()7S1)@U^'-F%1,;[.I2EF-/N$B3P,TM"66VO=N $ DQHO.M9"?2#,HC&N>]& )B(: $,[5JDEJ:N4L]4=9 MZ(3!2/2 &?G%)(�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�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�A J'2H!"6.0L++H M@1]C^"FYMJR!L#YC:W_<-^\N;8N_ITL(J,]26QWQ)B)N4,0KN*4C6YQQ+N0; M1KO5RQ'S^O?SYMEJS&]&V?6 UQ_#*$X=BOH6LZN+^RPF6N-^@;@;%_>+BN/> M#;FCH9];7N_HMQKH]:;U^EE,*HL[>GUMHS^= F[,IX#1_PWI_RLSOHU#9GP; M.F=\E0& M_TX %C\-6'@3C>)_<18G[="[C]+%UX5SQE]?/:WU1^^J+K!\96) ()J\\?BJ MHFOVLR/3KB1.?^N,XGC\>M,\M&)AZ[S*>49X%D)GCW^#D E M?0-$R8=YUW"GI&@"J+W7. M/-UTA,*5#+EF/#C3F@B?MO?U&_\EYRN260-=S]433&ZNL/?OAZ*P(6C[+6&KNWI*K+X%,MTATP#) M-$?,CY/TOT>B-_ 8A,D3]I@][[8$U88;G6&J9A@AQ#)IH\?%#WBU"'BE>6.+ M'YVAJFX@(-IX,?U"'BEF6/3C[4AETX_. M4%4WD!#DO$L+9@^P?V.QS[+K(.L2Z)P[K7/LK>O\_O:@WSZV0Z_3NZMYK%?- MK&N(]QT=0@_'HHHZ-4@18&2[+$0^J;J<5# 60#JH;X@//JIE/P:EG_.L +(0;H>N*R[(OUGO4#V'4IUO$J+C#76B67+'522^K M!_X=X$;1(XZ@LW% ;.#'.5X:_TO-N5D]+Z;F"T>)&2\<;?72Y%]<(D;1%\X0 M([.)>.UI]5N/)\QN9*S;7JSV"SN"[=B+]Y#^+7^$QD(HLXF]?D!:M[T=S%,G7AM=*LO(\)U[\/?>/SI1I0W+76K+R/2KO3I M=KM=EP!??Z0\#EG0B;GGIU]BYBU/<,X-=:LG([YU[[\/P:@V-^#L"_'"5M=Z M,:+L0E]V)<*51[>2/HSHUKKO^J$[*7K)6.=Z,>+L0G]V2' 9H;>JZ,N(_+EY>7[BBM%6/=ZLV(LS/]V9D8 M5Q[?:OHQXENG_KLEON[HKE5K78NT2P79F7J\$657(NQ$=#?4EE/)VHQ<78'J MZ@U8G&U0O0W?>9)FYMR,0L^1N.\TWJW^WDT'/+[Q0Q;V?1:TDX2G;C"0:[A; M>0#Q-RC^U5Z\%X7>Q-2ERU+^XP<^"Q\Y"_[H745!P.+9-3*/+.5U(:43,!%_ MT3_F/-P*U\>C[$.7Y<+<0_L946O ]+3(K8B6*$QIYMO5:UIDXE VN(;?2K6/ M]^N/812G#S$?LL]QH '_+OASW(6>8']/6,A@=(%=76#=3V#??O9[K,]!_2[J M%QX"[_;S/G%CAP5!._0>1FEWF%T%">VSLPOL=!IZ15UZ1>\'&W:N;M$7]O>% M%5>A!]C? [YV[V^ZCT_7@'\7_*M> O?V/5S]>":/+(SB MC[>]MOC_[:_7-_?7X'R%\[V> O_6\=]Y;(/R9?7[6,EF%K"L>?^6XUA7OUT+ MA!,0?L=#GX?]S_9KS/GF$E"/"Q\Z3'F.>\H%/2<(()UR'Z+KI!NQ_Q"DTY$^ MN9;M/DK7IPQ!^E;W@'3S2-]^I^;MP]H= E?1F_"BWZ\=R'<^>_8#/_57=:^F M>P&^\.@U9L.!WV=!.^9L1>TO>[AL2JN]PA.XN8M;!3<&WW:^]ISF;6Z_B\!5 MD=\ G,/ 59#A'FY[[=#K=&]N[YT&;],/+@)80<8#@ "P^E$_M816\D%>5<1#R>O;RQ9ZD M\]F>)/&GHV9E :;9#W-^P'Z8L=W5[/SJC9X3W_-9_-D-:[.M:TT',H<3P=QZZQ6 MBD1]R1+>Z=VM3J:WQ;>E=8%I;$PB3-XZAR[A%>JY]?FD_K1E\[8LN;W"J;9& M"5-MS7E":P)20'I(VFT>DG:;):1=$ VB#TB[):UP;->1@!206JYV032(/B#M MEK&78&T@]B6*O!]^$+3?HCCU_\,]9W',\81C"%8ZX *,@-'.@17(!;G&#* M(V"THT:( %( &GO$ GT@EX#!DF7H\0/>9)THK=G/QP/4)W%,-<7CF%8Z2 ) M0 )(>P=)H!?T&C5( I TJ)!TN:Y^\E[G>ZN'ZV[P 563=&BP,])_ Q7GA(' MDD&MX]0:6^#!*EBM>LYSRQ,(#O&F\>4#PU&K5$L".H>@,UQ!2K\, T+K2J@I M\Y. SB'HK!RB@%"'"*UV8%(KK@P/;Z6# 00: AQ4."MZ$6@(35#AFKB;7(TS MWG;2?;EA?CQ]B7NVY3GIAD\#/O%7ED&RO_3_/?(3/\U^XK]'+$VCM9'(DF;O M"#Y?H_BS+@3M'I>0>E/;R&9KTW-CYJP:1L] SS"J9]@Y?$ W0CQT6]$M6V* M(FSS5]\[40)J)\RH. O3#Y6.[< UN'9^&(A.@$Y0QQ$CN ;7S@\NT0G0">HS M#BUZ@A9O80*\?KZ$[H3F9V)^->[G*6Z#)>9K"&1=.>]@*5SE)IY0@7" /A MK8G5M,?!0*6S5%HYD@/"0'AK8JU@]%1C\.R+?Z4C%I!0-0E6CA* 3=78F*+, M04+5)%BIAH%-U=A4JT#O:_C W=9XWQOPQEVE"A.1AH+PB/7LR]--]'TVK5#H- KQVJ_L^>_AL*Z#GQ M/9_%*QBNN1PY2NTA;I#K*KDE#Y373QP 02!HBI3/A[$=OV8FA0Q,ELSDFN=1 MUPO5=7#L*,>F5GD "2!-K?EOXA?V 6;I8"[['?6^6+T'P^XQ;&RM!XQ.PVAJ MG0_X&PL'X+)T+E<_CO%K:H4'B.Z":&AM_ST*6.A!8L&S MNSR;GW*_\@_A'C!:$:/;W(^D6VB !:*=)]K4(1?0!)J6* + 60F<4 !D"@ $ M.T2PV14?*+J)HFD5OL/3F >@L2P:E_V-FGY830>S[C!K7!4'?$["9UK=OFIW MP&!9#,Z=C8I]6,4&K2[0:ERM!G:.86=:E7[B\9L?LN"_1_X;;AWZ-\\!(YEX;CD;J32PU(IB'6%6%/29NZC=_6_TI[Z$4"= MI.*)$,*'+($VT#9D5@J,@E$E1LU\4=J1VW(M1!8WDNN2#8 VF8AM;@1 M4T]B!N W(Y).) *4NV9@'NJW^D(JU!]PJDR2K$ G-W$V9KQ6DV/CML$*:[? MH$Z[@-IIJ T?EX%.T&G#6*R.)]5M@A0W?.Q,N\ 9.*LF7!/E +@$EV8+@7H> M$+:)49QR)Q8#0-IAI$L6!&ML/O)^],[CS^[+=?CNQU&86<2"*_;&7NOW/OQ# M'+W[V;\NA5[" S5'H@DD;$)"JSS;GB7F3KJ)XL[X2SQ.'OFSR.#U>Y%G&Q'[ M'>!6C@ 0)@-108;HI@,>3RQLBAB=GQVU&D3-)']R?%KS:)N1Y+4&>SK_WIS/OV/T;WZZ7YGV M;AXR[=W4.>V]GRG4"U"RCY+-@G-ZW*@Y+A46',-IR9N;1B:IT8ASWV8 B!'3 MQ8AY:_#[F4(* 27[*-D4(^7LGD$GJM]:QOGF+/4>Q\(W_ M9OG"YF3W5>J_LE3\O<.2E6U9ZU;6/,CKVZ(1Y#H-*[;WY"?VL6S\[,NWC^W0 MZ_3N5K]Z'\5O+.B*WS_V9(VI6'/+?B9D?^/3YY!W7\:?O?AMJ]ZF_F7S>"U^ MX=9 NI7= #[ KQY\"V M\Q7@ER-[YIYV$'AS,CZ !_!.9?CQ6D;.OP%]/>AO\[F#G<"W3$RXB?\,'NC=W:EWMJE@C7":LLFY4WSY_?Y+;Y[EYOH M!BH 7M?!4 /X(L#;][9UGTGH5?W"MH/<3:5(Q#^G7NORTI0=4LD&(%J1$[9 MS4ON*./V\>$?D^YV=Q/%W'\-KUD<9)THK=G M/QR/4E?RTGY7T533:NH\Q"7Z!?H%ZH7JK-2V[>/BVVR_\5>7_*#L>CDN1ZXO MJIG!-)@V.D_OV>NT1'*]18H91-LK1PS9)@5>P:LJKU4\>+)4FWJCT(OK3V.> MR6XE*@3>A,!7T.-O'Q]O9@L20J^^^4GFP.N/H?#D3)JB9,EX"37,C%0&HD%T MS7)T$@5B9.W=^"&_87XPBOE3],@$,Y]7G>[7!XPL9E#+.0I<&Y*IP36XKE.^ M5MNXUXOZ/@MZO#_* IY]>^P_C\:SQ783;>XVOD/?R=X;*D<2-P 'X/7*X/OV M RS/$EUU!$HW(QXD(I#=EY>$IU HFY-IN6Z"/JG)A@)T"G0*S9W"EAT)2\U9K[>9;C:BU$Z[;7>&(2 89-I%1J;I<>=S,-2JV& \=IJ3# M@(]!^)BG6/9EG]5!OVO\;+,>^4G=W=WS[.;8/%C=H+'729@Z,&.D!Y[!LYWCTRG/#3P+66V0&^4'>7X*XW[6_6H9 MY4TSW0KSZN6B-0[T-D,="S7NTZQST/<-QE&U,>)6N L 91^<[. $N@&L2+," MX0%J\D0JZD_ELK2,*224#R.&G97N9L$(!(O&"C?LH0* DQV_?0CK?"'K50:^@ MIZ]="E7WJ.>;ZU9?1]BK#WL%O7V\CG#'?B0CW_8;2G;&>XN=;O5O!+IV/7JR M/MH\S7Y'MCXZ^=,XY'',P_[G]S]Z5[/XWW"/QRQXB",1K_$=C]V7%[_/VZ'W M1Z_WPT^2V0E.?WY?_FR'#P_][./:KS'GXPLE[>8GB=/?.E,73<"9.>PWX;#] MM,C\CJ7SJ"SEKU%V\6;WY9&/;W1^8/'JI0('!(>\F=GMGZR?7HWB<;=:VOJ4 M$_XJUYUGT"NM.\_ZA\[="EM[(SH@.@P"Z9:"/2_NDU /PI9FK=;< ;,O SA.TH'R_Z ?R5B(_G6C/0AQZUQ_] 0M? M^>(%0I"_E-]E7(4.8%D'J#'30$?'>DT[8*\1JPTE7WCT&K/AP.^SH!USMI3P M5BRMZUK-]LN[$.1:7=8U"7+S D&N-,BS .A<==>5-ZTF$1PHJD,4%3H(.HB;8C+GF@PG(+<)HXIOU0 /YO)0Z46> M(,,T,NQ09+E _=!C#CWFB=U],Z>@QQQZS)M1W5>Y'F+_7?RVAXGWG2)HE^FH8$H5#!291Y%] ME0P4F4>1?17M*1:>'49QZA1 .5:CCJF]'@AV#&''ONH%=DQAQ[Z:=<.YYX>O M3I&SU6;4*Z5Z!6Y,X,:^6@5N3.#&OCIUY[_PVS 9B:+?=VNZ>8?EJ%E*-0L, MF<:0??4+#)G&D'VU3(Q<_= U$;3=:%0PU5E"D&, .?;5+9!C!CGV5:OQ9=]. M8;/%8M0II3H%9JIFQKX*!6:J9L:^VI0Y-+N+9/7,88^G:3 ]4I .(B\*HM?/ MWH#%O#9<78X2P562=**W9S\3/'+E^EM\?9*)UJ M&QJ!-)#>A;2QE9TB2W=8,@#0I0"]<#4RM*X,#9Q=P]G6[-QJ0'!L 7KF%I<% MAZT9&D@#Z1RD:YVE71,=%0)MB.BH=88&SJ[A;&UV;D)P; .Z"<%A;88&TD#: MP2SMG.BH#FA#1$>M,S1P=@UG:[-S"X)C&] M" YC,S0%TLYEZ.J -B1#FX?S M]LO-5[_NL+ASOW+RYS2TT,"\:T/-?0V%; MGX7I;?C.DS0S)[D->Z/GQ/=\%J^\,+ K&&637NW]ZT 6R!9!MHQ72A6R[-0[ MMQY/ &HUH&Z& !D5> )/>[)G6XP#6#A@[=";?N7W2(35 [*5(KLG+,BRP!@8 MUR ; TP'"7O.>OG@*)7/-1L$2G]1BXE94 * U M.H/6>SJZ%K/!%:0M4&$\%17DBK6QIILX;'6"6]D!'!C(01GY8*NXG=_)6Q<. M)"3LFLUNA7W9,4[$?-/@F@=\ZSN[Z.=5AKU1?MC1SVL>\.8%^KEA_7P6DC+# MCGY>VX#O.R" 'E]1CS=\)_X^;I R0(S:85%D&A,RC;&G,G.Y0:8!,6KW^"/3 MF)!IC+W+/Y<;9!H0([_G#/FE[HN>&/)4G1ZJ#?@?H9]RKY>*?-)]J=D.F)V! MSS?<+0"^\@^_'TU,;(K@G%\T6J.]8K5; M ;_GV?MGV2DI-PKZAKTU#W<3]=S<>E[!OJ4M]?SH#/6\KN'>5L^/+AHUC[USO<#=1S<^MY!?L3ETM;S4-N2!6O(,@K]:SF43:E=E<09M3N>H=[ M-O4R=\_W=C\=L=AG03M)1F_#[)+>[LN5G_2C49@^BMJ6K)Z6K^FRVQ8W3#'9 M^3U;7;6?(4*"75X2/)SB)>V6U$ZU6LORCJB Z#U$UTN%6XNP(2,$.YBMV:#" M6FA-&?#806T-QTC6DFO2^,T@>J\_AKPOI-3C1$GU6,#BS]NP'W.6( EO1UG& M9\C*]G"--&TPV\C;,G%ZF'@U!W#,Q!W@/,S-64@Z)(JIA$.C%",;(L5DNJ%2 MM@;JSG_ADV")JO;9?DEY_,A3/YX^L F-DL^XA.N@4$J_A8>.=R@5,SFO5*?8 M<66,SFX!F6-NUZA/;1I(]0*,SL$QK1(]?4DN_)4;R;=7Z,X98$P QL% M)<'>YC'L%#2)Z2T;,QSF]:!M*BY@(E&A',:&I'Z[@)'4U+W#(!$M;=0"I<73 M=E$8Q:MJJQ.]O45A;\#B^D#3$3%_C;)'J[HOCSP0?_,>6)RNOVVW< :UD.H$ M+$FRW]Z-/3]D\>?$OXO?ONEUH/A][+7V0\Q?>,S#/@>4)4.YP_\.XPGT:A[M M!Y[&T7/,$E3&C(0U=Z V&H*C\]6Q=Q#-EG/,:O!M" M#F M8K[88?B4;8H;S3J&4U5SEAMN1&8(^Y--A#S=V&.XS4,HH:8Q.\U9K>:Y M_60^?0ZU<5D+%.H\N,3H;L^JWR@=B'J><,^!F8:=)6J\)KCF#4PVF(*CP]K) M##"AF&00K>_,@R6(8O)A"Z+ KW81;T"[FR66RG@!K8F@FQ7T"IZL=40)6Z9# MJ^C] ,% $*K*"/4?>%@F^ZO*" #!,! JR @;B\\GK<91#0BP9O&Y@LZ_)>8G MV'!0TWXNLWA[[I]B*/7F(GO M:I[710CNO%QSF\EEAW_E4O#F(9>"KU%3TIWYLSL)XDCX]9$G/'ZOT? A>AM& MH?@$D4*N_ST2C5^ZD&"+Q95"8]Y-\OM2#6:CC)F-LB/]["8)LQ@@J7 A0TXR M,R<96]T:8 %: J@UK&LKC"( F@%AQ$ =2R5]* +'+KLK.M6)\Y:*4/ MI",YVT.Z^GY\\ V^EZ-8ZC[BY@66-PU=WER , N2*2 @8T%[5@!JD:T90!;( M+CO;[&7:?:M?ES'[CQ_4A=PO/-NE/QSX?1:TLS,;"V:7#<6ZD=*0&HQ@,+JO M8H(1U)I]M>:/T!?5NI>*WUB;<> .4C;-1=U1JCO@!35(I0:!%]0CE7KTE7_X M_<@!4I8-10U2JD%@!'5G7]T!(Z@U^VI-^]$!/F9&HL8HU1BP@=J25UO !FI* M7DVYNG: C9F1J"E*-05LH*;DU12P@9J2>QKV=P?8F!F)FJ*VM1YLH*;D[9@# M&Z@I.37E]LD!-F9&HJ8HU12P@9J25U/ !FI*[CCES@$V9D:BIJB-4\ &:DK> M. 5LH*;DU)1[%]BX-X$-^VH*V$!-R:LI8 ,U):^FW/WA !LS(U%3U%[2 ANH M*3DU!6R@IN35E-X7!]B8&8F:HE13P 9J2EY- 1NH*7DUY<&%/8$/)NP)M*^F M@ W4E+R: C904_)JRC\>'&!C9B1JBE)- 1NH*7DU!6R@IN35E.N> VS,C$1- M4:HI8 ,U):^F@ W4E+R:\N72 39F1J*F*-44L(&:DE=3P 9J2EY-^>-?#K Q M,Q(U1>U>8["!FI)WAS'80$W)6Z-W89_Y@PG[S.VK*6 #-25WC1YLH*;DO?_5 M=8"-F9&H*6KO?H$-U)2\][[ !FI*WOD4%_8$]DS8$VA?30$;J"FYYU/ !FI* MWGU?;0?8F!F)FJ)VWQ?80$W)N^\+;*"FY-24&Q?>UKDQX6T=^VH*V$!-R:LI M8 ,U)7>-WH7]&P\F[-^PKZ: #=24W#5ZL(&:DC?WY<):6\>$M3;[:@K80$W) MG?L"&Z@I>37EW@4V[@U@P\*: C904_)J"MA 32VE=Y M0 CJS;Y[\D$(JLS.D_@\_ \/^5,4C,1_A&__YS,0?W "FIVVHQ:IG=H'1P9R M9%_% DS85[_ CBGL6%BSGBZO MO[ D"GQ7L-DP&)5*K5*!&-0GM?H$8E"5U-:AOG4Z3/S1[_U%2JP8P@[]E4JL&,*._;5K,M1RCS?E='WFK6H46HK5V %-4EV=0JLH ;) MWD<=!>_"X,0)5%:-1052NYT:I*#^R-U5#5)0?>1N6AB]N2)3EDU%Y5&[L$X4B>(GXO<+!G7CD\:X?.,'.?@>@.BE5)Q!E M-E'V53(09391]E6]\?GFIA/L+)N*2J9^1P0H077:?SL$*$'%V5UQ0MX)?&%R M74#YROXWBCMCXWB\S,BJH2@YBL/Q=!1/9S)F7WMD/[Z*%L0^"Y)Q#[P-AR/; M5Q/&TS8!2Q+QJ7V6BJ]U7ZX_AN*?5X7OPAW[29+]O4^?0[[MM^UT-$!6G 4 MR "Y!O(.( /D6BC0;2 _".D6A2$/9JX'PM0(Y[@8)V$ MMQZRH2LT6#2*^WP^1PAZJ>G-\S&$0V'A 'P=Q;<>T@'X.HIO/<3#%1_&O.^/ M ]U^B^+4_\_DSZ)E?!CP[,\ FAIH>:]#8!06&$ "[B]1 J M-S'W7P=8UJ/'>-6S$!R%!0=0=0#5>@@'H.H JO40 )TH29/NRZT7\-O0$U_+ M]J$\!,SZJQQ,I'>OLR$3"LL$ V@:R4F #2 KI7D>(BC=S\+Q1<>!=%K]C3O M=7:=TFW8#MAKQ( U_38A.9=#?A3?L FX 7==I0C@!MPVR1*US'W;RZXC9,S!;>=K+_O4IP'OL* _"L9\7++$!_3TT!<+!3)]\4R/ MSH#.4./*H'848'(JLQ^]81NJAFVH&][%,+3X]G\@ZPZR]9 <0-8A9&LD#+[P MD,A5ZTLR[D=4H)&2@!R0%Y[\0'( 7D=Y0J(1;G? M6^X!":D&PD"XED*BQX/ #U^S*P"RZ0'_>>3*W0ME8[S+TQ 4!(("*#N/ M^3N/$Q8D-U%\^S9D?IQYJ_OR%#./M_O]:!2FXIOZ MW']GSX$3,V)E'[G033,/ 68Z6'>Y6D(#0*A 92=1[DN M(@,H.X]R703&TMG7F??O.5#6>\IXP],0& 0" R@[CW)=! 90=A[E6@F,U>.J M()B&V/+6OGSVNE^$\E]_ MW!@+,ZP9!FKF+;QA2T]C2PV(J@:B&K*L!D15 U']V-E7W^,PR^GO+'!(8 C/ MO6MV+YLAO'PL/6;]#7-[$G-K(%5Q2-6/U360JCBDZL?X/C''._>.8>Q;"CI_ M!2@J6'+#WI[$WAK@5 (XE65BA12'W#Z9K7[YV"E>=4-WGD1W&OA4"#Z5I3Z% M(G0#GPK!IW[B\HS-[>4$B#S9W%BAT(WZL;$&2)4$4OT86@.D2@*I?JPMS[CV MT0G[S#WFO==J79S9@(;-E7:"-*"J%*CJQ_(:4%4>5/5C?\>P?U3M[U/ X%@7R MSIQE-^SJ2>RJ 5"E %0_QM4 J%( JA\+Z]I_PA^X#]?^1BH"G?NRK 4]EP%,_MI7. MZR&Q[V.![6H*=RZ*D1^VK04SGTU)MS?7%8SW&=R'GITD\.A&;6WO"P M9_.P!D=5P5&]N5F#HZK@J'I\K1N>#V8-BM^NCGW79<&'@/T-N\>\2\[<^F/G MY+X_8MZ0Z_3!D\& ]R.C-/ZP -&F>5(ZIN%(J#=(*#""&@O$P$/ MN1<:+/Q\+-15K&T@5$T(U4BB;2!430C519@]B0/_U8&F8-&O2XAM3KX2)_]3 MA=<& Q5A%_436AOH5 0Z]1-6&^A4!#IU$5*_\GNGS[P+'KX^W,Q?^^L261L< M5! '/U6 ;1!1%4347)QM@%1)(-5/N&V 5$D@U4745?9L8RM? W(*E_VZ!-SF M]"MS^I4(*FAP4 '643]AMH%/A>!3/Q&V@4^%X%,WP17MW*\)+HVISW M:Q5.FY-OQ-$GB:,-8!H!]$D": .81N1\%$NZY!,_B!QO>"5V0Z:SJ:^%,;K> M2$K2]^0:CWPO]%W')DB=1GQL *I@/QY&U;-F8KS8W.F&2RX2P]^NNEW/1@HQ MJ7D=\GH@>7:_&SPO$L]D9:DY=Z\'DLV=;C"\" PW>&T0])3JHZ\0/3GK;I#S M).0<^0%<0'C?-T]MU:M 3LZZ&^0\"3F@A(4W?)QL,K<_\($?\!/7&3N>Z T. MPNTE[[LL#.&H^^*S5X2RDGO4(/)I>88-\'0>4(.OQ7L8&OM?173-RMC_*NOT M>"Z&&_O?J[;_O3@\-_:_5V?_>S$8;O#:(.@IK6->(7JJ9O^K'W(:^U\U['_U M0TYC_WO9]K_Z(;(!7IWL?Y7%5V' :&/_JXBN61G[7V5C6)^+X<;^]ZKM?R\. MSXW][]79_UX,AAN\-@AZ2M_?5XB>JMG_ZH>MOVO?HAL M@%2F( ZA% >M'QW% :#,\4'D+ M?ET$J#GS5W#/M]8W.^N=?7WFMT3V!A$/-*F]H/%?RO&?^1ZS_X35PLJ*5VN MXH$=^8GXD&>W''S(: 5Z!Y"?!BFU0THJ7$&>X]/"%3( 6THXS+,!II[[[H0O MQDGRXR'WF/G9W'GWA0^9>T+[F;P^V?H&VP78WM+8WC)%JX9XUHQX;CT'8%L+ MC?6*/4>@Z]O5\8?++S,8&7,6Q@$_=$)_N]/>PX89:CSU5?HM.&#!*ZY&+.!A MX2OD/M!#SWX'S.^BX#VV_.U9/.8@N?LY5.P)>Y"=8]ZHQDN/N>=3 M1.+\USZ\+]GWY@VLOD_MPB,V]#&@@&>>?6 7\/0#D)C G\\>'^:V=$ 4KO\E M N*L\+20Y,(*-6%]WFE]_7?Q&]2&PS./?,5OSOV[@+LBPG?D3*P!<-%+/@B! MGX*^#NQK?V=[S8I\^9GO1YX?\4U0E-N;:X>__9KY_:,'W5W&H/N+'_2@<["$ M0;?:RQAT:PF#MG<*!FV7&71O&8,6'=3S!^UL;A?M::E!%[^G,.CB]Q0&7<:> M[A2!O]2@BS\HN/M%,^V4&;1HIJ4&+8)4J4&+(/7\03N;>T4SW2HS:-%,2PU: M!/XR@^X70:K4H$60*C7H$@ZJ4T#Y.ULE(-4IH/SE!BVX424'7<;RM_/%G@[< MM.A6.W]/M[9*+'^KD[^GI0;=WLW?T^V]$M=T M>S>?H)0<-/^@2@VZMY-_3??V]LL,FG]-2PZ:3Z7*#;J;STY*#II_^B4'+3BH M_3*GOUMP4.4&+3BH_>T2@^X5'%2Y00L.JMR@10=5:M"B@WK^H%L@HN8-NK6U M^WR9'P;-I:?/'/3>ON\X:'*!<7//:@'CYE+5LIN0BX&R@^;:?!:P [G86L"X MN3) R4W8+MJ$YTN 6P6Z?]E!BY9?:M!R@1<2EU*!%Q*74H$64 MI<2@G7Q^!8,^G[/"H$7+?\Z@R4WMY//!!8Q;1%M+;4(1;2TU:!%9*;L#192E M[+A%Q*7$)FSF*Q@P:!DA(U]N+3MHT7&5&K3HK$H-6G10SQG48*[Y0G;)R>X5 M,8)2@Q91PNQI_G4K^2@^7REW* [^8)UR4'S+78E!]W*)2@E!]U>QJ#+P.E.OFVQY*!+ M@=0RZ.ENOFI==M EX'1W&>#?W5[&\I=!^G:7 :F">(+M@ZWG6T&W"URJ)0?= MRA512PVZ4Z"F[&RUGR_V[!2H$R4'W5_*H+FG7W+0@Z(]?;X#" 8M6GZ)0;?R M<;JS76;Y6_FA5.4&+?!_[>QL/5^3W"F0ISA(,"J7<)@V[GVD]W=C>?[YZ"07,]/F4'S1?/2PZ:+_26&S3?.5EV MT&7LZ5;1\LMPTWQ_=\E!\R/)R@ZZE)DN8T_S(\G*#EH$J3($)=\C5W;0HH,J M-6C10949-#\LO>2@^6'I90==QNGGAZ67W=.BY9>PH>SD1R64';1H^:4&+0)_ MF4$+S'*[F\^/RX9!B\!?9M"#HM,O-6C1094:= E[NKN5+_7M[I+EE]J MT*+EEQJT"*R@RSBHK64J[*!+.*@">KI[L/W\**3= GI:=M!\\)<<-)?QE1IT MKR#%;V]S__D'M5>0XE=VT%RG90?-)2CE!FWG\ZB] MK1(%2�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�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

  •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�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�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end

  •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end XML 193 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 194 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 195 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1543 769 1 true 538 0 false 8 false false R1.htm 00000001 - Document - Cover Sheet http://braskem.com./role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Statement of consolidated financial position Sheet http://braskem.com./role/StatementOfConsolidatedFinancialPosition Statement of consolidated financial position Statements 2 false false R3.htm 00000003 - Statement - Statement of consolidated profit or loss Sheet http://braskem.com./role/StatementOfConsolidatedProfitOrLoss Statement of consolidated profit or loss Statements 3 false false R4.htm 00000004 - Statement - Statement of consolidated comprehensive income Sheet http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome Statement of consolidated comprehensive income Statements 4 false false R5.htm 00000005 - Statement - Statement of changes in equity Sheet http://braskem.com./role/StatementOfChangesInEquity Statement of changes in equity Statements 5 false false R6.htm 00000006 - Statement - Statement of consolidated cash flow Sheet http://braskem.com./role/StatementOfConsolidatedCashFlow Statement of consolidated cash flow Statements 6 false false R7.htm 00000007 - Disclosure - Operations Sheet http://braskem.com./role/Operations Operations Notes 7 false false R8.htm 00000008 - Disclosure - Basis of preparation of the financial statements Sheet http://braskem.com./role/BasisOfPreparationOfFinancialStatements Basis of preparation of the financial statements Notes 8 false false R9.htm 00000009 - Disclosure - Application of estimates and judgments Sheet http://braskem.com./role/ApplicationOfEstimatesAndJudgments Application of estimates and judgments Notes 9 false false R10.htm 00000010 - Disclosure - Risk management Sheet http://braskem.com./role/RiskManagement Risk management Notes 10 false false R11.htm 00000011 - Disclosure - Cash and cash equivalents Sheet http://braskem.com./role/CashAndCashEquivalents Cash and cash equivalents Notes 11 false false R12.htm 00000012 - Disclosure - Financial investments Sheet http://braskem.com./role/FinancialInvestments Financial investments Notes 12 false false R13.htm 00000013 - Disclosure - Trade accounts receivable Sheet http://braskem.com./role/TradeAccountsReceivable Trade accounts receivable Notes 13 false false R14.htm 00000014 - Disclosure - Inventories Sheet http://braskem.com./role/Inventories Inventories Notes 14 false false R15.htm 00000015 - Disclosure - Related parties Sheet http://braskem.com./role/RelatedParties Related parties Notes 15 false false R16.htm 00000016 - Disclosure - Taxes recoverable Sheet http://braskem.com./role/TaxesRecoverable Taxes recoverable Notes 16 false false R17.htm 00000017 - Disclosure - Investments Sheet http://braskem.com./role/Investments Investments Notes 17 false false R18.htm 00000018 - Disclosure - Property, plant and equipment Sheet http://braskem.com./role/PropertyPlantAndEquipment Property, plant and equipment Notes 18 false false R19.htm 00000019 - Disclosure - Intangible assets Sheet http://braskem.com./role/IntangibleAssets Intangible assets Notes 19 false false R20.htm 00000020 - Disclosure - Right-of-use assets and lease liability Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiability Right-of-use assets and lease liability Notes 20 false false R21.htm 00000021 - Disclosure - Trade payables Sheet http://braskem.com./role/TradePayables Trade payables Notes 21 false false R22.htm 00000022 - Disclosure - Borrowings Sheet http://braskem.com./role/Borrowings Borrowings Notes 22 false false R23.htm 00000023 - Disclosure - Braskem Idesa Borrowings Sheet http://braskem.com./role/BraskemIdesaBorrowings Braskem Idesa Borrowings Notes 23 false false R24.htm 00000024 - Disclosure - Debentures Sheet http://braskem.com./role/Debentures Debentures Notes 24 false false R25.htm 00000025 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow Sheet http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlow Reconciliation of borrowing activities in the statement of cash flow Notes 25 false false R26.htm 00000026 - Disclosure - Financial instruments Sheet http://braskem.com./role/FinancialInstruments Financial instruments Notes 26 false false R27.htm 00000027 - Disclosure - Taxes payable Sheet http://braskem.com./role/TaxesPayable Taxes payable Notes 27 false false R28.htm 00000028 - Disclosure - Income taxes Sheet http://braskem.com./role/IncomeTaxes Income taxes Notes 28 false false R29.htm 00000029 - Disclosure - Sundry provisions Sheet http://braskem.com./role/SundryProvisions Sundry provisions Notes 29 false false R30.htm 00000030 - Disclosure - Provisions for legal proceedings and contingent liabilities Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilities Provisions for legal proceedings and contingent liabilities Notes 30 false false R31.htm 00000031 - Disclosure - Leniency agreement with authorities Sheet http://braskem.com./role/LeniencyAgreementWithAuthorities Leniency agreement with authorities Notes 31 false false R32.htm 00000032 - Disclosure - Geological event - Alagoas Sheet http://braskem.com./role/GeologicalEvent-Alagoas Geological event - Alagoas Notes 32 false false R33.htm 00000033 - Disclosure - Benefits offered to employees Sheet http://braskem.com./role/BenefitsOfferedToEmployees Benefits offered to employees Notes 33 false false R34.htm 00000034 - Disclosure - Equity Sheet http://braskem.com./role/Equity Equity Notes 34 false false R35.htm 00000035 - Disclosure - Earnings (loss) per share Sheet http://braskem.com./role/EarningsLossPerShare Earnings (loss) per share Notes 35 false false R36.htm 00000036 - Disclosure - Net revenue Sheet http://braskem.com./role/NetRevenue Net revenue Notes 36 false false R37.htm 00000037 - Disclosure - Tax incentives Sheet http://braskem.com./role/TaxIncentives Tax incentives Notes 37 false false R38.htm 00000038 - Disclosure - Expenses by nature and function Sheet http://braskem.com./role/ExpensesByNatureAndFunction Expenses by nature and function Notes 38 false false R39.htm 00000039 - Disclosure - Financial results Sheet http://braskem.com./role/FinancialResults Financial results Notes 39 false false R40.htm 00000040 - Disclosure - Segment information Sheet http://braskem.com./role/SegmentInformation Segment information Notes 40 false false R41.htm 00000041 - Disclosure - Contractual obligations Sheet http://braskem.com./role/ContractualObligations Contractual obligations Notes 41 false false R42.htm 00000042 - Disclosure - Subsequent events Sheet http://braskem.com./role/SubsequentEvents Subsequent events Notes 42 false false R43.htm 00000043 - Disclosure - Basis of preparation of the financial statements (Policies) Sheet http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies Basis of preparation of the financial statements (Policies) Policies 43 false false R44.htm 00000044 - Disclosure - Basis of preparation of the financial statements (Tables) Sheet http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables Basis of preparation of the financial statements (Tables) Tables http://braskem.com./role/BasisOfPreparationOfFinancialStatements 44 false false R45.htm 00000045 - Disclosure - Risk management (Tables) Sheet http://braskem.com./role/RiskManagementTables Risk management (Tables) Tables http://braskem.com./role/RiskManagement 45 false false R46.htm 00000046 - Disclosure - Cash and cash equivalents (Tables) Sheet http://braskem.com./role/CashAndCashEquivalentsTables Cash and cash equivalents (Tables) Tables http://braskem.com./role/CashAndCashEquivalents 46 false false R47.htm 00000047 - Disclosure - Financial investments (Tables) Sheet http://braskem.com./role/FinancialInvestmentsTables Financial investments (Tables) Tables http://braskem.com./role/FinancialInvestments 47 false false R48.htm 00000048 - Disclosure - Trade accounts receivable (Tables) Sheet http://braskem.com./role/TradeAccountsReceivableTables Trade accounts receivable (Tables) Tables http://braskem.com./role/TradeAccountsReceivable 48 false false R49.htm 00000049 - Disclosure - Inventories (Tables) Sheet http://braskem.com./role/InventoriesTables Inventories (Tables) Tables http://braskem.com./role/Inventories 49 false false R50.htm 00000050 - Disclosure - Related parties (Tables) Sheet http://braskem.com./role/RelatedPartiesTables Related parties (Tables) Tables http://braskem.com./role/RelatedParties 50 false false R51.htm 00000051 - Disclosure - Taxes recoverable (Tables) Sheet http://braskem.com./role/TaxesRecoverableTables Taxes recoverable (Tables) Tables http://braskem.com./role/TaxesRecoverable 51 false false R52.htm 00000052 - Disclosure - Investments (Tables) Sheet http://braskem.com./role/InvestmentsTables Investments (Tables) Tables http://braskem.com./role/Investments 52 false false R53.htm 00000053 - Disclosure - Property, plant and equipment (Tables) Sheet http://braskem.com./role/PropertyPlantAndEquipmentTables Property, plant and equipment (Tables) Tables http://braskem.com./role/PropertyPlantAndEquipment 53 false false R54.htm 00000054 - Disclosure - Intangible assets (Tables) Sheet http://braskem.com./role/IntangibleAssetsTables Intangible assets (Tables) Tables http://braskem.com./role/IntangibleAssets 54 false false R55.htm 00000055 - Disclosure - Right-of-use assets and lease liability (Tables) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables Right-of-use assets and lease liability (Tables) Tables http://braskem.com./role/Right-of-useAssetsAndLeaseLiability 55 false false R56.htm 00000056 - Disclosure - Trade payables (Tables) Sheet http://braskem.com./role/TradePayablesTables Trade payables (Tables) Tables http://braskem.com./role/TradePayables 56 false false R57.htm 00000057 - Disclosure - Borrowings (Tables) Sheet http://braskem.com./role/BorrowingsTables Borrowings (Tables) Tables http://braskem.com./role/Borrowings 57 false false R58.htm 00000058 - Disclosure - Braskem Idesa Borrowings (Tables) Sheet http://braskem.com./role/BraskemIdesaBorrowingsTables Braskem Idesa Borrowings (Tables) Tables http://braskem.com./role/BraskemIdesaBorrowings 58 false false R59.htm 00000059 - Disclosure - Debentures (Tables) Sheet http://braskem.com./role/DebenturesTables Debentures (Tables) Tables http://braskem.com./role/Debentures 59 false false R60.htm 00000060 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Tables) Sheet http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowTables Reconciliation of borrowing activities in the statement of cash flow (Tables) Tables http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlow 60 false false R61.htm 00000061 - Disclosure - Financial instruments (Tables) Sheet http://braskem.com./role/FinancialInstrumentsTables Financial instruments (Tables) Tables http://braskem.com./role/FinancialInstruments 61 false false R62.htm 00000062 - Disclosure - Taxes payable (Tables) Sheet http://braskem.com./role/TaxesPayableTables Taxes payable (Tables) Tables http://braskem.com./role/TaxesPayable 62 false false R63.htm 00000063 - Disclosure - Income taxes (Tables) Sheet http://braskem.com./role/IncomeTaxesTables Income taxes (Tables) Tables http://braskem.com./role/IncomeTaxes 63 false false R64.htm 00000064 - Disclosure - Sundry provisions (Tables) Sheet http://braskem.com./role/SundryProvisionsTables Sundry provisions (Tables) Tables http://braskem.com./role/SundryProvisions 64 false false R65.htm 00000065 - Disclosure - Provisions for legal proceedings and contingent liabilities (Tables) Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables Provisions for legal proceedings and contingent liabilities (Tables) Tables http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilities 65 false false R66.htm 00000066 - Disclosure - Leniency agreement with authorities (Tables) Sheet http://braskem.com./role/LeniencyAgreementWithAuthoritiesTables Leniency agreement with authorities (Tables) Tables http://braskem.com./role/LeniencyAgreementWithAuthorities 66 false false R67.htm 00000067 - Disclosure - Geological event - Alagoas (Tables) Sheet http://braskem.com./role/GeologicalEvent-AlagoasTables Geological event - Alagoas (Tables) Tables http://braskem.com./role/GeologicalEvent-Alagoas 67 false false R68.htm 00000068 - Disclosure - Benefits offered to employees (Tables) Sheet http://braskem.com./role/BenefitsOfferedToEmployeesTables Benefits offered to employees (Tables) Tables http://braskem.com./role/BenefitsOfferedToEmployees 68 false false R69.htm 00000069 - Disclosure - Equity (Tables) Sheet http://braskem.com./role/EquityTables Equity (Tables) Tables http://braskem.com./role/Equity 69 false false R70.htm 00000070 - Disclosure - Earnings (loss) per share (Tables) Sheet http://braskem.com./role/EarningsLossPerShareTables Earnings (loss) per share (Tables) Tables http://braskem.com./role/EarningsLossPerShare 70 false false R71.htm 00000071 - Disclosure - Net revenue (Tables) Sheet http://braskem.com./role/NetRevenueTables Net revenue (Tables) Tables http://braskem.com./role/NetRevenue 71 false false R72.htm 00000072 - Disclosure - Expenses by nature and function (Tables) Sheet http://braskem.com./role/ExpensesByNatureAndFunctionTables Expenses by nature and function (Tables) Tables http://braskem.com./role/ExpensesByNatureAndFunction 72 false false R73.htm 00000073 - Disclosure - Financial results (Tables) Sheet http://braskem.com./role/FinancialResultsTables Financial results (Tables) Tables http://braskem.com./role/FinancialResults 73 false false R74.htm 00000074 - Disclosure - Segment information (Tables) Sheet http://braskem.com./role/SegmentInformationTables Segment information (Tables) Tables http://braskem.com./role/SegmentInformation 74 false false R75.htm 00000075 - Disclosure - Operations (Details Narrative) Sheet http://braskem.com./role/OperationsDetailsNarrative Operations (Details Narrative) Details http://braskem.com./role/Operations 75 false false R76.htm 00000076 - Disclosure - Basis of preparation of the financial statements (Details) Sheet http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails Basis of preparation of the financial statements (Details) Details http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables 76 false false R77.htm 00000077 - Disclosure - Basis of preparation of the financial statements (Details 1) Sheet http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1 Basis of preparation of the financial statements (Details 1) Details http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables 77 false false R78.htm 00000078 - Disclosure - Risk management (Details) Sheet http://braskem.com./role/RiskManagementDetails Risk management (Details) Details http://braskem.com./role/RiskManagementTables 78 false false R79.htm 00000079 - Disclosure - Cash and cash equivalents (Details) Sheet http://braskem.com./role/CashAndCashEquivalentsDetails Cash and cash equivalents (Details) Details http://braskem.com./role/CashAndCashEquivalentsTables 79 false false R80.htm 00000080 - Disclosure - Financial investments (Details) Sheet http://braskem.com./role/FinancialInvestmentsDetails Financial investments (Details) Details http://braskem.com./role/FinancialInvestmentsTables 80 false false R81.htm 00000081 - Disclosure - Financial investments (Details Narrative) Sheet http://braskem.com./role/FinancialInvestmentsDetailsNarrative Financial investments (Details Narrative) Details http://braskem.com./role/FinancialInvestmentsTables 81 false false R82.htm 00000082 - Disclosure - Trade accounts receivable (Details) Sheet http://braskem.com./role/TradeAccountsReceivableDetails Trade accounts receivable (Details) Details http://braskem.com./role/TradeAccountsReceivableTables 82 false false R83.htm 00000083 - Disclosure - Trade accounts receivable (Details 1) Sheet http://braskem.com./role/TradeAccountsReceivableDetails1 Trade accounts receivable (Details 1) Details http://braskem.com./role/TradeAccountsReceivableTables 83 false false R84.htm 00000084 - Disclosure - Trade accounts receivable (Details 2) Sheet http://braskem.com./role/TradeAccountsReceivableDetails2 Trade accounts receivable (Details 2) Details http://braskem.com./role/TradeAccountsReceivableTables 84 false false R85.htm 00000085 - Disclosure - Inventories (Details) Sheet http://braskem.com./role/InventoriesDetails Inventories (Details) Details http://braskem.com./role/InventoriesTables 85 false false R86.htm 00000086 - Disclosure - Inventories (Details 1) Sheet http://braskem.com./role/InventoriesDetails1 Inventories (Details 1) Details http://braskem.com./role/InventoriesTables 86 false false R87.htm 00000087 - Disclosure - Related parties (Details) Sheet http://braskem.com./role/RelatedPartiesDetails Related parties (Details) Details http://braskem.com./role/RelatedPartiesTables 87 false false R88.htm 00000088 - Disclosure - Related parties (Details 1) Sheet http://braskem.com./role/RelatedPartiesDetails1 Related parties (Details 1) Details http://braskem.com./role/RelatedPartiesTables 88 false false R89.htm 00000089 - Disclosure - Related parties (Details Narrative) Sheet http://braskem.com./role/RelatedPartiesDetailsNarrative Related parties (Details Narrative) Details http://braskem.com./role/RelatedPartiesTables 89 false false R90.htm 00000090 - Disclosure - Taxes recoverable (Details) Sheet http://braskem.com./role/TaxesRecoverableDetails Taxes recoverable (Details) Details http://braskem.com./role/TaxesRecoverableTables 90 false false R91.htm 00000091 - Disclosure - Taxes recoverable (Details Narrative) Sheet http://braskem.com./role/TaxesRecoverableDetailsNarrative Taxes recoverable (Details Narrative) Details http://braskem.com./role/TaxesRecoverableTables 91 false false R92.htm 00000092 - Disclosure - Investments (Details) Sheet http://braskem.com./role/InvestmentsDetails Investments (Details) Details http://braskem.com./role/InvestmentsTables 92 false false R93.htm 00000093 - Disclosure - Investments (Details 1) Sheet http://braskem.com./role/InvestmentsDetails1 Investments (Details 1) Details http://braskem.com./role/InvestmentsTables 93 false false R94.htm 00000094 - Disclosure - Investments (Details 2) Sheet http://braskem.com./role/InvestmentsDetails2 Investments (Details 2) Details http://braskem.com./role/InvestmentsTables 94 false false R95.htm 00000095 - Disclosure - Property plant and equipment (Details) Sheet http://braskem.com./role/PropertyPlantAndEquipmentDetails Property plant and equipment (Details) Details 95 false false R96.htm 00000096 - Disclosure - Property plant and equipment (Details 1) Sheet http://braskem.com./role/PropertyPlantAndEquipmentDetails1 Property plant and equipment (Details 1) Details 96 false false R97.htm 00000097 - Disclosure - Property plant and equipment (Details 2) Sheet http://braskem.com./role/PropertyPlantAndEquipmentDetails2 Property plant and equipment (Details 2) Details 97 false false R98.htm 00000098 - Disclosure - Property, plant and equipment (Details Narrative) Sheet http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative Property, plant and equipment (Details Narrative) Details http://braskem.com./role/PropertyPlantAndEquipmentTables 98 false false R99.htm 00000099 - Disclosure - Intangible assets (Details) Sheet http://braskem.com./role/IntangibleAssetsDetails Intangible assets (Details) Details http://braskem.com./role/IntangibleAssetsTables 99 false false R100.htm 00000100 - Disclosure - Intangible assets (Details 1) Sheet http://braskem.com./role/IntangibleAssetsDetails1 Intangible assets (Details 1) Details http://braskem.com./role/IntangibleAssetsTables 100 false false R101.htm 00000101 - Disclosure - Intangible assets (Details 2) Sheet http://braskem.com./role/IntangibleAssetsDetails2 Intangible assets (Details 2) Details http://braskem.com./role/IntangibleAssetsTables 101 false false R102.htm 00000102 - Disclosure - Intangible assets (Details 3) Sheet http://braskem.com./role/IntangibleAssetsDetails3 Intangible assets (Details 3) Details http://braskem.com./role/IntangibleAssetsTables 102 false false R103.htm 00000103 - Disclosure - Intangible assets (Details 4) Sheet http://braskem.com./role/IntangibleAssetsDetails4 Intangible assets (Details 4) Details http://braskem.com./role/IntangibleAssetsTables 103 false false R104.htm 00000104 - Disclosure - Intangible assets (Details Narrative) Sheet http://braskem.com./role/IntangibleAssetsDetailsNarrative Intangible assets (Details Narrative) Details http://braskem.com./role/IntangibleAssetsTables 104 false false R105.htm 00000105 - Disclosure - Right-of-use assets and lease liability (Details) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails Right-of-use assets and lease liability (Details) Details http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables 105 false false R106.htm 00000106 - Disclosure - Right-of-use assets and lease liability (Details 1) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1 Right-of-use assets and lease liability (Details 1) Details http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables 106 false false R107.htm 00000107 - Disclosure - Right-of-use assets and lease liability (Details 2) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2 Right-of-use assets and lease liability (Details 2) Details http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables 107 false false R108.htm 00000108 - Disclosure - Right-of-use assets and lease liability (Details 3) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3 Right-of-use assets and lease liability (Details 3) Details http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables 108 false false R109.htm 00000109 - Disclosure - Right-of-use assets and lease liability (Details Narrative) Sheet http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative Right-of-use assets and lease liability (Details Narrative) Details http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables 109 false false R110.htm 00000110 - Disclosure - Trade payables (Details) Sheet http://braskem.com./role/TradePayablesDetails Trade payables (Details) Details http://braskem.com./role/TradePayablesTables 110 false false R111.htm 00000111 - Disclosure - Borrowings (Details) Sheet http://braskem.com./role/BorrowingsDetails Borrowings (Details) Details http://braskem.com./role/BorrowingsTables 111 false false R112.htm 00000112 - Disclosure - Borrowings (Details 1) Sheet http://braskem.com./role/BorrowingsDetails1 Borrowings (Details 1) Details http://braskem.com./role/BorrowingsTables 112 false false R113.htm 00000113 - Disclosure - Borrowings (Details 2) Sheet http://braskem.com./role/BorrowingsDetails2 Borrowings (Details 2) Details http://braskem.com./role/BorrowingsTables 113 false false R114.htm 00000114 - Disclosure - Borrowings (Details 3) Sheet http://braskem.com./role/BorrowingsDetails3 Borrowings (Details 3) Details http://braskem.com./role/BorrowingsTables 114 false false R115.htm 00000115 - Disclosure - Borrowings (Details 4) Sheet http://braskem.com./role/BorrowingsDetails4 Borrowings (Details 4) Details http://braskem.com./role/BorrowingsTables 115 false false R116.htm 00000116 - Disclosure - Braskem Idesa Borrowings (Details) Sheet http://braskem.com./role/BraskemIdesaBorrowingsDetails Braskem Idesa Borrowings (Details) Details http://braskem.com./role/BraskemIdesaBorrowingsTables 116 false false R117.htm 00000117 - Disclosure - Braskem Idesa Borrowings (Details 1) Sheet http://braskem.com./role/BraskemIdesaBorrowingsDetails1 Braskem Idesa Borrowings (Details 1) Details http://braskem.com./role/BraskemIdesaBorrowingsTables 117 false false R118.htm 00000118 - Disclosure - Braskem Idesa Borrowings (Details Narrative) Sheet http://braskem.com./role/BraskemIdesaBorrowingsDetailsNarrative Braskem Idesa Borrowings (Details Narrative) Details http://braskem.com./role/BraskemIdesaBorrowingsTables 118 false false R119.htm 00000119 - Disclosure - Debentures (Details) Sheet http://braskem.com./role/DebenturesDetails Debentures (Details) Details http://braskem.com./role/DebenturesTables 119 false false R120.htm 00000120 - Disclosure - Debentures (Details 1) Sheet http://braskem.com./role/DebenturesDetails1 Debentures (Details 1) Details http://braskem.com./role/DebenturesTables 120 false false R121.htm 00000121 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Details) Sheet http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails Reconciliation of borrowing activities in the statement of cash flow (Details) Details http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowTables 121 false false R122.htm 00000122 - Disclosure - Financial instruments (Details) Sheet http://braskem.com./role/FinancialInstrumentsDetails Financial instruments (Details) Details http://braskem.com./role/FinancialInstrumentsTables 122 false false R123.htm 00000123 - Disclosure - Financial instruments (Details 1) Sheet http://braskem.com./role/FinancialInstrumentsDetails1 Financial instruments (Details 1) Details http://braskem.com./role/FinancialInstrumentsTables 123 false false R124.htm 00000124 - Disclosure - Financial instruments (Details 2) Sheet http://braskem.com./role/FinancialInstrumentsDetails2 Financial instruments (Details 2) Details http://braskem.com./role/FinancialInstrumentsTables 124 false false R125.htm 00000125 - Disclosure - Financial instruments (Details 3) Sheet http://braskem.com./role/FinancialInstrumentsDetails3 Financial instruments (Details 3) Details http://braskem.com./role/FinancialInstrumentsTables 125 false false R126.htm 00000126 - Disclosure - Financial instruments (Details 4) Sheet http://braskem.com./role/FinancialInstrumentsDetails4 Financial instruments (Details 4) Details http://braskem.com./role/FinancialInstrumentsTables 126 false false R127.htm 00000127 - Disclosure - Financial instruments (Details 5) Sheet http://braskem.com./role/FinancialInstrumentsDetails5 Financial instruments (Details 5) Details http://braskem.com./role/FinancialInstrumentsTables 127 false false R128.htm 00000128 - Disclosure - Financial instruments (Details 6) Sheet http://braskem.com./role/FinancialInstrumentsDetails6 Financial instruments (Details 6) Details http://braskem.com./role/FinancialInstrumentsTables 128 false false R129.htm 00000129 - Disclosure - Financial instruments (Details 7) Sheet http://braskem.com./role/FinancialInstrumentsDetails7 Financial instruments (Details 7) Details http://braskem.com./role/FinancialInstrumentsTables 129 false false R130.htm 00000130 - Disclosure - Financial instruments (Details 8) Sheet http://braskem.com./role/FinancialInstrumentsDetails8 Financial instruments (Details 8) Details http://braskem.com./role/FinancialInstrumentsTables 130 false false R131.htm 00000131 - Disclosure - Financial instruments (Details 9) Sheet http://braskem.com./role/FinancialInstrumentsDetails9 Financial instruments (Details 9) Details http://braskem.com./role/FinancialInstrumentsTables 131 false false R132.htm 00000132 - Disclosure - Financial instruments (Details 10) Sheet http://braskem.com./role/FinancialInstrumentsDetails10 Financial instruments (Details 10) Details http://braskem.com./role/FinancialInstrumentsTables 132 false false R133.htm 00000133 - Disclosure - Financial instruments (Details 11) Sheet http://braskem.com./role/FinancialInstrumentsDetails11 Financial instruments (Details 11) Details http://braskem.com./role/FinancialInstrumentsTables 133 false false R134.htm 00000134 - Disclosure - Financial instruments (Details 12) Sheet http://braskem.com./role/FinancialInstrumentsDetails12 Financial instruments (Details 12) Details http://braskem.com./role/FinancialInstrumentsTables 134 false false R135.htm 00000135 - Disclosure - Financial instruments (Details Narrative) Sheet http://braskem.com./role/FinancialInstrumentsDetailsNarrative Financial instruments (Details Narrative) Details http://braskem.com./role/FinancialInstrumentsTables 135 false false R136.htm 00000136 - Disclosure - Taxes payable (Details) Sheet http://braskem.com./role/TaxesPayableDetails Taxes payable (Details) Details http://braskem.com./role/TaxesPayableTables 136 false false R137.htm 00000137 - Disclosure - Income taxes (Details) Sheet http://braskem.com./role/IncomeTaxesDetails Income taxes (Details) Details http://braskem.com./role/IncomeTaxesTables 137 false false R138.htm 00000138 - Disclosure - Income taxes (Details 1) Sheet http://braskem.com./role/IncomeTaxesDetails1 Income taxes (Details 1) Details http://braskem.com./role/IncomeTaxesTables 138 false false R139.htm 00000139 - Disclosure - Income taxes (Details 2) Sheet http://braskem.com./role/IncomeTaxesDetails2 Income taxes (Details 2) Details http://braskem.com./role/IncomeTaxesTables 139 false false R140.htm 00000140 - Disclosure - Income taxes (Details 3) Sheet http://braskem.com./role/IncomeTaxesDetails3 Income taxes (Details 3) Details http://braskem.com./role/IncomeTaxesTables 140 false false R141.htm 00000141 - Disclosure - Income taxes (Details Narrative) Sheet http://braskem.com./role/IncomeTaxesDetailsNarrative Income taxes (Details Narrative) Details http://braskem.com./role/IncomeTaxesTables 141 false false R142.htm 00000142 - Disclosure - Sundry provisions (Details) Sheet http://braskem.com./role/SundryProvisionsDetails Sundry provisions (Details) Details http://braskem.com./role/SundryProvisionsTables 142 false false R143.htm 00000143 - Disclosure - Sundry provisions (Details 1) Sheet http://braskem.com./role/SundryProvisionsDetails1 Sundry provisions (Details 1) Details http://braskem.com./role/SundryProvisionsTables 143 false false R144.htm 00000144 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details) Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails Provisions for legal proceedings and contingent liabilities (Details) Details http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables 144 false false R145.htm 00000145 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 1) Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1 Provisions for legal proceedings and contingent liabilities (Details 1) Details http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables 145 false false R146.htm 00000146 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 2) Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2 Provisions for legal proceedings and contingent liabilities (Details 2) Details http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables 146 false false R147.htm 00000147 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details Narrative) Sheet http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative Provisions for legal proceedings and contingent liabilities (Details Narrative) Details http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables 147 false false R148.htm 00000148 - Disclosure - Leniency agreement with authorities (Details) Sheet http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails Leniency agreement with authorities (Details) Details http://braskem.com./role/LeniencyAgreementWithAuthoritiesTables 148 false false R149.htm 00000149 - Disclosure - Leniency agreement with authorities (Details Narrative) Sheet http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative Leniency agreement with authorities (Details Narrative) Details http://braskem.com./role/LeniencyAgreementWithAuthoritiesTables 149 false false R150.htm 00000150 - Disclosure - Geological event - Alagoas (Details) Sheet http://braskem.com./role/GeologicalEvent-AlagoasDetails Geological event - Alagoas (Details) Details http://braskem.com./role/GeologicalEvent-AlagoasTables 150 false false R151.htm 00000151 - Disclosure - Geological event - Alagoas (Details Narrative) Sheet http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative Geological event - Alagoas (Details Narrative) Details http://braskem.com./role/GeologicalEvent-AlagoasTables 151 false false R152.htm 00000152 - Disclosure - Benefits offered to team members (Details) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails Benefits offered to team members (Details) Details 152 false false R153.htm 00000153 - Disclosure - Benefits offered to team members (Details 1) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1 Benefits offered to team members (Details 1) Details 153 false false R154.htm 00000154 - Disclosure - Benefits offered to team members (Details 2) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2 Benefits offered to team members (Details 2) Details 154 false false R155.htm 00000155 - Disclosure - Benefits offered to team members (Details 3) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3 Benefits offered to team members (Details 3) Details 155 false false R156.htm 00000156 - Disclosure - Benefits offered to team members (Details 4) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4 Benefits offered to team members (Details 4) Details 156 false false R157.htm 00000157 - Disclosure - Benefits offered to team members (Details 5) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5 Benefits offered to team members (Details 5) Details 157 false false R158.htm 00000158 - Disclosure - Benefits offered to team members (Details 6) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6 Benefits offered to team members (Details 6) Details 158 false false R159.htm 00000159 - Disclosure - Benefits offered to team members (Details 7) Sheet http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7 Benefits offered to team members (Details 7) Details 159 false false R160.htm 00000160 - Disclosure - Benefits offered to employees (Details Narrative) Sheet http://braskem.com./role/BenefitsOfferedToEmployeesDetailsNarrative Benefits offered to employees (Details Narrative) Details http://braskem.com./role/BenefitsOfferedToEmployeesTables 160 false false R161.htm 00000161 - Disclosure - Equity (Details) Sheet http://braskem.com./role/EquityDetails Equity (Details) Details http://braskem.com./role/EquityTables 161 false false R162.htm 00000162 - Disclosure - Equity (Details 1) Sheet http://braskem.com./role/EquityDetails1 Equity (Details 1) Details http://braskem.com./role/EquityTables 162 false false R163.htm 00000163 - Disclosure - Equity (Details 2) Sheet http://braskem.com./role/EquityDetails2 Equity (Details 2) Details http://braskem.com./role/EquityTables 163 false false R164.htm 00000164 - Disclosure - Equity (Details Narrative) Sheet http://braskem.com./role/EquityDetailsNarrative Equity (Details Narrative) Details http://braskem.com./role/EquityTables 164 false false R165.htm 00000165 - Disclosure - Earnings per share (Details) Sheet http://braskem.com./role/EarningsPerShareDetails Earnings per share (Details) Details 165 false false R166.htm 00000166 - Disclosure - Net revenue (Details) Sheet http://braskem.com./role/NetRevenueDetails Net revenue (Details) Details http://braskem.com./role/NetRevenueTables 166 false false R167.htm 00000167 - Disclosure - Net revenue (Details 1) Sheet http://braskem.com./role/NetRevenueDetails1 Net revenue (Details 1) Details http://braskem.com./role/NetRevenueTables 167 false false R168.htm 00000168 - Disclosure - Net revenue (Details 2) Sheet http://braskem.com./role/NetRevenueDetails2 Net revenue (Details 2) Details http://braskem.com./role/NetRevenueTables 168 false false R169.htm 00000169 - Disclosure - Net revenue (Details Narrative) Sheet http://braskem.com./role/NetRevenueDetailsNarrative Net revenue (Details Narrative) Details http://braskem.com./role/NetRevenueTables 169 false false R170.htm 00000170 - Disclosure - Tax incentives (Details Narrative) Sheet http://braskem.com./role/TaxIncentivesDetailsNarrative Tax incentives (Details Narrative) Details http://braskem.com./role/TaxIncentives 170 false false R171.htm 00000171 - Disclosure - Expenses by nature and function (Details) Sheet http://braskem.com./role/ExpensesByNatureAndFunctionDetails Expenses by nature and function (Details) Details http://braskem.com./role/ExpensesByNatureAndFunctionTables 171 false false R172.htm 00000172 - Disclosure - Financial results (Details) Sheet http://braskem.com./role/FinancialResultsDetails Financial results (Details) Details http://braskem.com./role/FinancialResultsTables 172 false false R173.htm 00000173 - Disclosure - Financial results (Details 1) Sheet http://braskem.com./role/FinancialResultsDetails1 Financial results (Details 1) Details http://braskem.com./role/FinancialResultsTables 173 false false R174.htm 00000174 - Disclosure - Segment information (Details) Sheet http://braskem.com./role/SegmentInformationDetails Segment information (Details) Details http://braskem.com./role/SegmentInformationTables 174 false false R175.htm 00000175 - Disclosure - Segment information (Details 1) Sheet http://braskem.com./role/SegmentInformationDetails1 Segment information (Details 1) Details http://braskem.com./role/SegmentInformationTables 175 false false R176.htm 00000176 - Disclosure - Contractual obligations (Details Narrative) Sheet http://braskem.com./role/ContractualObligationsDetailsNarrative Contractual obligations (Details Narrative) Details http://braskem.com./role/ContractualObligations 176 false false R177.htm 00000177 - Disclosure - Subsequent events (Details Narrative) Sheet http://braskem.com./role/SubsequentEventsDetailsNarrative Subsequent events (Details Narrative) Details http://braskem.com./role/SubsequentEvents 177 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - bakform20f_2022.htm 31 bakform20f_2022.htm bak-20221231.xsd bak-20221231_cal.xml bak-20221231_def.xml bak-20221231_lab.xml bak-20221231_pre.xml ex12-1.htm ex12-2.htm ex13-1.htm ex2-2.htm ex99-1.htm bak20f_001.jpg bakform20f2022_001.jpg http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true JSON 198 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bakform20f_2022.htm": { "axisCustom": 11, "axisStandard": 46, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 44, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 3152 }, "contextCount": 1543, "dts": { "calculationLink": { "local": [ "bak-20221231_cal.xml" ] }, "definitionLink": { "local": [ "bak-20221231_def.xml" ] }, "inline": { "local": [ "bakform20f_2022.htm" ] }, "labelLink": { "local": [ "bak-20221231_lab.xml" ] }, "presentationLink": { "local": [ "bak-20221231_pre.xml" ] }, "schema": { "local": [ "bak-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 1506, "entityCount": 1, "hidden": { "http://braskem.com./20221231": 611, "http://xbrl.sec.gov/dei/2022": 5, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 338, "total": 954 }, "keyCustom": 448, "keyStandard": 321, "memberCustom": 444, "memberStandard": 55, "nsprefix": "bak", "nsuri": "http://braskem.com./20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://braskem.com./role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Risk management", "menuCat": "Notes", "order": "10", "role": "http://braskem.com./role/RiskManagement", "shortName": "Risk management", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfGoodwillImpairmentTestingExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NortheasternPetrochemicalComplexMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:AllocatedGoodwill", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000100 - Disclosure - Intangible assets (Details 1)", "menuCat": "Details", "order": "100", "role": "http://braskem.com./role/IntangibleAssetsDetails1", "shortName": "Intangible assets (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfGoodwillImpairmentTestingExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NortheasternPetrochemicalComplexMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:AllocatedGoodwill", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bak:ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NortheasternPetrochemicalComplexMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:SensitivityAnalysisDiscountRates", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000101 - Disclosure - Intangible assets (Details 2)", "menuCat": "Details", "order": "101", "role": "http://braskem.com./role/IntangibleAssetsDetails2", "shortName": "Intangible assets (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bak:ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NortheasternPetrochemicalComplexMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:SensitivityAnalysisDiscountRates", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfAmortizationEstimatedUsefulLifeExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BrandsAndPatentsMember_ifrs-full_BottomOfRangeMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000102 - Disclosure - Intangible assets (Details 3)", "menuCat": "Details", "order": "102", "role": "http://braskem.com./role/IntangibleAssetsDetails3", "shortName": "Intangible assets (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfAmortizationEstimatedUsefulLifeExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BrandsAndPatentsMember_ifrs-full_BottomOfRangeMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfIntangibleAssetsByCountryExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IntangibleAssetsAndGoodwill1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000103 - Disclosure - Intangible assets (Details 4)", "menuCat": "Details", "order": "103", "role": "http://braskem.com./role/IntangibleAssetsDetails4", "shortName": "Intangible assets (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfIntangibleAssetsByCountryExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IntangibleAssetsAndGoodwill1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000104 - Disclosure - Intangible assets (Details Narrative)", "menuCat": "Details", "order": "104", "role": "http://braskem.com./role/IntangibleAssetsDetailsNarrative", "shortName": "Intangible assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000105 - Disclosure - Right-of-use assets and lease liability (Details)", "menuCat": "Details", "order": "105", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "shortName": "Right-of-use assets and lease liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "bak:AcquisitionsRightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LeaseLiabilities", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000106 - Disclosure - Right-of-use assets and lease liability (Details 1)", "menuCat": "Details", "order": "106", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1", "shortName": "Right-of-use assets and lease liability (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "bak:AcquiredOfLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:MinimumAnnualCommitments", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000107 - Disclosure - Right-of-use assets and lease liability (Details 2)", "menuCat": "Details", "order": "107", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "shortName": "Right-of-use assets and lease liability (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:MinimumAnnualCommitments", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfCashFlowtRrelatedToTheContractsExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:CashFlowsRelatedToContractsDiscounted", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000108 - Disclosure - Right-of-use assets and lease liability (Details 3)", "menuCat": "Details", "order": "108", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3", "shortName": "Right-of-use assets and lease liability (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfCashFlowtRrelatedToTheContractsExplanatory", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:CashFlowsRelatedToContractsDiscounted", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000109 - Disclosure - Right-of-use assets and lease liability (Details Narrative)", "menuCat": "Details", "order": "109", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative", "shortName": "Right-of-use assets and lease liability (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Cash and cash equivalents", "menuCat": "Notes", "order": "11", "role": "http://braskem.com./role/CashAndCashEquivalents", "shortName": "Cash and cash equivalents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherPayables", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000110 - Disclosure - Trade payables (Details)", "menuCat": "Details", "order": "110", "role": "http://braskem.com./role/TradePayablesDetails", "shortName": "Trade payables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherPayables", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfBorrowingsInformationExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Borrowings", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000111 - Disclosure - Borrowings (Details)", "menuCat": "Details", "order": "111", "role": "http://braskem.com./role/BorrowingsDetails", "shortName": "Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfBorrowingsInformationExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Borrowings", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LongtermBorrowings", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000112 - Disclosure - Borrowings (Details 1)", "menuCat": "Details", "order": "112", "role": "http://braskem.com./role/BorrowingsDetails1", "shortName": "Borrowings (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfLongTermBorrowingsMaturitiesExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31_custom_TwentyTwentyThreeMember", "decimals": "-3", "lang": null, "name": "ifrs-full:LongtermBorrowings", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfBondsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ForeignCurrencyMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NetDebt", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000113 - Disclosure - Borrowings (Details 2)", "menuCat": "Details", "order": "113", "role": "http://braskem.com./role/BorrowingsDetails2", "shortName": "Borrowings (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfBondsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ForeignCurrencyMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NetDebt", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOthersCRAExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ForeignCurrencyMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:BorrowingsOne", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000114 - Disclosure - Borrowings (Details 3)", "menuCat": "Details", "order": "114", "role": "http://braskem.com./role/BorrowingsDetails3", "shortName": "Borrowings (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfFinancingsForInvestmentsInPlantsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_ForeignCurrencyMember_custom_OtherNEXI1Member", "decimals": null, "lang": "en-US", "name": "ifrs-full:BorrowingsMaturity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOthersCRAExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ForeignCurrencyMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:NotionalAmount1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000115 - Disclosure - Borrowings (Details 4)", "menuCat": "Details", "order": "115", "role": "http://braskem.com./role/BorrowingsDetails4", "shortName": "Borrowings (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOthersCRAExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ForeignCurrencyMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:NotionalAmount1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOtherBorrowingsExplanatory", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:BraskemIdesaBorrowings", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000116 - Disclosure - Braskem Idesa Borrowings (Details)", "menuCat": "Details", "order": "116", "role": "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "shortName": "Braskem Idesa Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOtherBorrowingsExplanatory", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:BraskemIdesaBorrowings", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOtherBorrowingsAmortizationExplanatory", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OriginalLongtermMaturities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000117 - Disclosure - Braskem Idesa Borrowings (Details 1)", "menuCat": "Details", "order": "117", "role": "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "shortName": "Braskem Idesa Borrowings (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfOtherBorrowingsAmortizationExplanatory", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OriginalLongtermMaturities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000118 - Disclosure - Braskem Idesa Borrowings (Details Narrative)", "menuCat": "Details", "order": "118", "role": "http://braskem.com./role/BraskemIdesaBorrowingsDetailsNarrative", "shortName": "Braskem Idesa Borrowings (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDebenturesExplanatory", "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NotesAndDebenturesIssued", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000119 - Disclosure - Debentures (Details)", "menuCat": "Details", "order": "119", "role": "http://braskem.com./role/DebenturesDetails", "shortName": "Debentures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDebenturesExplanatory", "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NotesAndDebenturesIssued", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Financial investments", "menuCat": "Notes", "order": "12", "role": "http://braskem.com./role/FinancialInvestments", "shortName": "Financial investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000120 - Disclosure - Debentures (Details 1)", "menuCat": "Details", "order": "120", "role": "http://braskem.com./role/DebenturesDetails1", "shortName": "Debentures (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDebentureMaturitiesExplanatory", "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31_custom_TwentyTwentyThreeMember", "decimals": "-3", "lang": null, "name": "ifrs-full:NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:FairValueOfFinancialTransactionsOfNoncontrollingSubsidiaries", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000121 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Details)", "menuCat": "Details", "order": "121", "role": "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails", "shortName": "Reconciliation of borrowing activities in the statement of cash flow (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "bak:BorrowingsCurrent", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_TradePayablesMember_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000122 - Disclosure - Financial instruments (Details)", "menuCat": "Details", "order": "122", "role": "http://braskem.com./role/FinancialInstrumentsDetails", "shortName": "Financial instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_TradePayablesMember_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentDerivativeFinancialAssets", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000123 - Disclosure - Financial instruments (Details 1)", "menuCat": "Details", "order": "123", "role": "http://braskem.com./role/FinancialInstrumentsDetails1", "shortName": "Financial instruments (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NonHedgeAccountingTransactionsMember", "decimals": "-3", "lang": null, "name": "ifrs-full:CreditDerivativeFairValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFairValueAdjustmentExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:TotalNominal", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000124 - Disclosure - Financial instruments (Details 2)", "menuCat": "Details", "order": "124", "role": "http://braskem.com./role/FinancialInstrumentsDetails2", "shortName": "Financial instruments (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFairValueAdjustmentExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:TotalNominal", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_currency_USD", "decimals": "-3", "first": true, "lang": null, "name": "bak:FinancialLiabilityMaturitiesNominalValue", "reportCount": 1, "unique": true, "unitRef": "USDBRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000125 - Disclosure - Financial instruments (Details 3)", "menuCat": "Details", "order": "125", "role": "http://braskem.com./role/FinancialInstrumentsDetails3", "shortName": "Financial instruments (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_currency_USD", "decimals": "-3", "first": true, "lang": null, "name": "bak:FinancialLiabilityMaturitiesNominalValue", "reportCount": 1, "unique": true, "unitRef": "USDBRL", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_currency_USD_custom_FutureExportsMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:HedgingInstrumentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USDBRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000126 - Disclosure - Financial instruments (Details 4)", "menuCat": "Details", "order": "126", "role": "http://braskem.com./role/FinancialInstrumentsDetails4", "shortName": "Financial instruments (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_currency_USD_custom_FutureExportsMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:HedgingInstrumentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USDBRL", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfExchangeVariationExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExportsDesignatedForHedgeGrossNominalValue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000127 - Disclosure - Financial instruments (Details 5)", "menuCat": "Details", "order": "127", "role": "http://braskem.com./role/FinancialInstrumentsDetails5", "shortName": "Financial instruments (Details 5)", "subGroupType": "details", "uniqueAnchor": null }, "R128": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:HedgedItemLiabilities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000128 - Disclosure - Financial instruments (Details 6)", "menuCat": "Details", "order": "128", "role": "http://braskem.com./role/FinancialInstrumentsDetails6", "shortName": "Financial instruments (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:HedgedItemLiabilities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDesignatedAndUnrealizedSalesExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DesignatedAndUnrealizedSalesNominalValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000129 - Disclosure - Financial instruments (Details 7)", "menuCat": "Details", "order": "129", "role": "http://braskem.com./role/FinancialInstrumentsDetails7", "shortName": "Financial instruments (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDesignatedAndUnrealizedSalesExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DesignatedAndUnrealizedSalesNominalValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Trade accounts receivable", "menuCat": "Notes", "order": "13", "role": "http://braskem.com./role/TradeAccountsReceivable", "shortName": "Trade accounts receivable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfExchangeVariationExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExportsDesignatedForHedgeGrossNominalValue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000130 - Disclosure - Financial instruments (Details 8)", "menuCat": "Details", "order": "130", "role": "http://braskem.com./role/FinancialInstrumentsDetails8", "shortName": "Financial instruments (Details 8)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfExchangeVariationBraskemIdesaExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_BraskemIdesaMember", "decimals": "-3", "lang": null, "name": "bak:ExportsDesignatedForHedgeGrossNominalValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R131": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31_custom_BraskemIdesaMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:HedgedItemLiabilities1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000131 - Disclosure - Financial instruments (Details 9)", "menuCat": "Details", "order": "131", "role": "http://braskem.com./role/FinancialInstrumentsDetails9", "shortName": "Financial instruments (Details 9)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31_custom_BraskemIdesaMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:HedgedItemLiabilities1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_MinimumRiskMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ExpectedCreditLossRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000132 - Disclosure - Financial instruments (Details 10)", "menuCat": "Details", "order": "132", "role": "http://braskem.com./role/FinancialInstrumentsDetails10", "shortName": "Financial instruments (Details 10)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_MinimumRiskMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ExpectedCreditLossRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OtherFinancialAssetsWithRiskAssessmentDomesticMarket", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000133 - Disclosure - Financial instruments (Details 11)", "menuCat": "Details", "order": "133", "role": "http://braskem.com./role/FinancialInstrumentsDetails11", "shortName": "Financial instruments (Details 11)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OtherFinancialAssetsWithRiskAssessmentDomesticMarket", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R134": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BondMember_custom_BrazilianRealUSDollarExchangeRateMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExposureValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000134 - Disclosure - Financial instruments (Details 12)", "menuCat": "Details", "order": "134", "role": "http://braskem.com./role/FinancialInstrumentsDetails12", "shortName": "Financial instruments (Details 12)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BondMember_custom_BrazilianRealUSDollarExchangeRateMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExposureValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R135": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:AveragePriceOfHedgingInstrument", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000135 - Disclosure - Financial instruments (Details Narrative)", "menuCat": "Details", "order": "135", "role": "http://braskem.com./role/FinancialInstrumentsDetailsNarrative", "shortName": "Financial instruments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:AveragePriceOfHedgingInstrument", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" } }, "R136": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000136 - Disclosure - Taxes payable (Details)", "menuCat": "Details", "order": "136", "role": "http://braskem.com./role/TaxesPayableDetails", "shortName": "Taxes payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutTaxPayableExplanatory", "bak:DisclosureOfTaxPayableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_OtherCountriesMember", "decimals": "-3", "lang": null, "name": "ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R137": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLossBeforeTax", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000137 - Disclosure - Income taxes (Details)", "menuCat": "Details", "order": "137", "role": "http://braskem.com./role/IncomeTaxesDetails", "shortName": "Income taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R138": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfForeignIncomeTaxRatesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_SubsidiaryOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000138 - Disclosure - Income taxes (Details 1)", "menuCat": "Details", "order": "138", "role": "http://braskem.com./role/IncomeTaxesDetails1", "shortName": "Income taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfForeignIncomeTaxRatesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_SubsidiaryOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R139": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDeferredTaxesExplanatory", "bak:DisclosureOfForeignIncomeTaxRatesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DeferredTaxAssets1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000139 - Disclosure - Income taxes (Details 2)", "menuCat": "Details", "order": "139", "role": "http://braskem.com./role/IncomeTaxesDetails2", "shortName": "Income taxes (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDeferredTaxesExplanatory", "bak:DisclosureOfForeignIncomeTaxRatesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DeferredTaxAssets1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Inventories", "menuCat": "Notes", "order": "14", "role": "http://braskem.com./role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R140": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_LiabilitiesCategoryMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncomeTaxAndSocialContributionTaxCalculationLiabilities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000140 - Disclosure - Income taxes (Details 3)", "menuCat": "Details", "order": "140", "role": "http://braskem.com./role/IncomeTaxesDetails3", "shortName": "Income taxes (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_LiabilitiesCategoryMember", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncomeTaxAndSocialContributionTaxCalculationLiabilities", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R141": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000141 - Disclosure - Income taxes (Details Narrative)", "menuCat": "Details", "order": "141", "role": "http://braskem.com./role/IncomeTaxesDetailsNarrative", "shortName": "Income taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R142": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfSundryProvisionsExplanatory", "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:Provisions1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000142 - Disclosure - Sundry provisions (Details)", "menuCat": "Details", "order": "142", "role": "http://braskem.com./role/SundryProvisionsDetails", "shortName": "Sundry provisions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfSundryProvisionsExplanatory", "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:Provisions1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R143": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInSundryProvisionsExplanatory", "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Provisions", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000143 - Disclosure - Sundry provisions (Details 1)", "menuCat": "Details", "order": "143", "role": "http://braskem.com./role/SundryProvisionsDetails1", "shortName": "Sundry provisions (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInSundryProvisionsExplanatory", "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:Provisions", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R144": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:LongtermLegalProceedingsProvision1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000144 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details)", "menuCat": "Details", "order": "144", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "shortName": "Provisions for legal proceedings and contingent liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:LongtermLegalProceedingsProvision1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R145": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LongtermLegalProceedingsProvision", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000145 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 1)", "menuCat": "Details", "order": "145", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "shortName": "Provisions for legal proceedings and contingent liabilities (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:LongtermLegalProceedingsProvision", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R146": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfClaimsWithProbableChanceOfLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PossibleLegalProceedingsProvision", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000146 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details 2)", "menuCat": "Details", "order": "146", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2", "shortName": "Provisions for legal proceedings and contingent liabilities (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfClaimsWithProbableChanceOfLossExplanatory", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PossibleLegalProceedingsProvision", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R147": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:AmountOfTheseClaims", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000147 - Disclosure - Provisions for legal proceedings and contingent liabilities (Details Narrative)", "menuCat": "Details", "order": "147", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "shortName": "Provisions for legal proceedings and contingent liabilities (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:AmountOfTheseClaims", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R148": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:ScheduleOfDistributionPaid", "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_LeniencyAgreementsMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000148 - Disclosure - Leniency agreement with authorities (Details)", "menuCat": "Details", "order": "148", "role": "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "shortName": "Leniency agreement with authorities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:ScheduleOfDistributionPaid", "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_FederalControllerGeneralAndAttorneyGenerallAgreementMember_custom_LeniencyAgreementsMember", "decimals": "-3", "lang": null, "name": "ifrs-full:SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R149": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OutstandingAmount1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000149 - Disclosure - Leniency agreement with authorities (Details Narrative)", "menuCat": "Details", "order": "149", "role": "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative", "shortName": "Leniency agreement with authorities (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:OutstandingAmount1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Related parties", "menuCat": "Notes", "order": "15", "role": "http://braskem.com./role/RelatedParties", "shortName": "Related parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R150": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LegalProceedingsProvision", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000150 - Disclosure - Geological event - Alagoas (Details)", "menuCat": "Details", "order": "150", "role": "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "shortName": "Geological event - Alagoas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:ScheduleOfChangesInprovisionExplanatory", "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31_custom_AlagoasMember", "decimals": "-3", "lang": null, "name": "bak:LegalProceedingsProvision1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R151": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DescriptionOfReparationForSocialenvironmental", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000151 - Disclosure - Geological event - Alagoas (Details Narrative)", "menuCat": "Details", "order": "151", "role": "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "shortName": "Geological event - Alagoas (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DescriptionOfReparationForSocialenvironmental", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R152": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfShortTermBenefitsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ShorttermEmployeeBenefitsExpense", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000152 - Disclosure - Benefits offered to team members (Details)", "menuCat": "Details", "order": "152", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails", "shortName": "Benefits offered to team members (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfShortTermBenefitsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ShorttermEmployeeBenefitsExpense", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R153": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:LongTermIncentivePlanTableTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_Plan2019Member_custom_SettlementMethodologySharesMember", "decimals": null, "first": true, "lang": "en-US", "name": "bak:NameOfFlat", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000153 - Disclosure - Benefits offered to team members (Details 1)", "menuCat": "Details", "order": "153", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1", "shortName": "Benefits offered to team members (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:LongTermIncentivePlanTableTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_Plan2019Member_custom_SettlementMethodologySharesMember", "decimals": null, "first": true, "lang": "en-US", "name": "bak:NameOfFlat", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R154": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDefinedBenefitObligationsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DefinedBenefitObligationAtPresentValue2", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000154 - Disclosure - Benefits offered to team members (Details 2)", "menuCat": "Details", "order": "154", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "shortName": "Benefits offered to team members (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDefinedBenefitObligationsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:DefinedBenefitObligationAtPresentValue2", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R155": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDefinedBenefitObligationsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000155 - Disclosure - Benefits offered to team members (Details 3)", "menuCat": "Details", "order": "155", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "shortName": "Benefits offered to team members (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDefinedBenefitObligationsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R156": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInFairValuePlanAssetsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000156 - Disclosure - Benefits offered to team members (Details 4)", "menuCat": "Details", "order": "156", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4", "shortName": "Benefits offered to team members (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInFairValuePlanAssetsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R157": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDefinedBenefitObligationsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000157 - Disclosure - Benefits offered to team members (Details 5)", "menuCat": "Details", "order": "157", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "shortName": "Benefits offered to team members (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfBenefitAmountsRecognizedInProfitAndLossExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "bak:ActuarialGainsLossesNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R158": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfActuarialAssumptionsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_HealthInsuranceMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000158 - Disclosure - Benefits offered to team members (Details 6)", "menuCat": "Details", "order": "158", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "shortName": "Benefits offered to team members (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfActuarialAssumptionsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_HealthInsuranceMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R159": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfBenefitsSensitivityAnalysisExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_ifrs-full_ActuarialAssumptionOfDiscountRatesMember", "decimals": "INF", "first": true, "lang": null, "name": "bak:PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000159 - Disclosure - Benefits offered to team members (Details 7)", "menuCat": "Details", "order": "159", "role": "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "shortName": "Benefits offered to team members (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfBenefitsSensitivityAnalysisExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_ifrs-full_ActuarialAssumptionOfDiscountRatesMember", "decimals": "INF", "first": true, "lang": null, "name": "bak:PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxRecoverableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Taxes recoverable", "menuCat": "Notes", "order": "16", "role": "http://braskem.com./role/TaxesRecoverable", "shortName": "Taxes recoverable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxRecoverableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R160": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AdjustmentsForFairValueGainsLosses", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000160 - Disclosure - Benefits offered to employees (Details Narrative)", "menuCat": "Details", "order": "160", "role": "http://braskem.com./role/BenefitsOfferedToEmployeesDetailsNarrative", "shortName": "Benefits offered to employees (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AdjustmentsForFairValueGainsLosses", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R161": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfSharesDistributedExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000161 - Disclosure - Equity (Details)", "menuCat": "Details", "order": "161", "role": "http://braskem.com./role/EquityDetails", "shortName": "Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfSharesDistributedExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R162": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfChangesInSharesExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:NumberOfSharesOutstanding1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000162 - Disclosure - Equity (Details 1)", "menuCat": "Details", "order": "162", "role": "http://braskem.com./role/EquityDetails1", "shortName": "Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfChangesInSharesExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:NumberOfSharesOutstanding1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R163": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfRetainedEarningsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ComprehensiveIncomeAttributableToOwnersOfParent1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000163 - Disclosure - Equity (Details 2)", "menuCat": "Details", "order": "163", "role": "http://braskem.com./role/EquityDetails2", "shortName": "Equity (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclsoureOfRetainedEarningsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ComprehensiveIncomeAttributableToOwnersOfParent1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R164": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2021-01-012021-12-31_custom_LTIProgram2018Member", "decimals": "INF", "first": true, "lang": null, "name": "bak:SharesGranted", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000164 - Disclosure - Equity (Details Narrative)", "menuCat": "Details", "order": "164", "role": "http://braskem.com./role/EquityDetailsNarrative", "shortName": "Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2021-01-012021-12-31_custom_LTIProgram2018Member", "decimals": "INF", "first": true, "lang": null, "name": "bak:SharesGranted", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R165": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfEarningsPerShareReconciliationExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000165 - Disclosure - Earnings per share (Details)", "menuCat": "Details", "order": "165", "role": "http://braskem.com./role/EarningsPerShareDetails", "shortName": "Earnings per share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfEarningsPerShareReconciliationExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R166": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000166 - Disclosure - Net revenue (Details)", "menuCat": "Details", "order": "166", "role": "http://braskem.com./role/NetRevenueDetails", "shortName": "Net revenue (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R167": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000167 - Disclosure - Net revenue (Details 1)", "menuCat": "Details", "order": "167", "role": "http://braskem.com./role/NetRevenueDetails1", "shortName": "Net revenue (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfNetRevenueByCountryExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BrazilMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R168": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000168 - Disclosure - Net revenue (Details 2)", "menuCat": "Details", "order": "168", "role": "http://braskem.com./role/NetRevenueDetails2", "shortName": "Net revenue (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfRevenueByProductExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_PEPPMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R169": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:PercentageOfEntitysRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000169 - Disclosure - Net revenue (Details Narrative)", "menuCat": "Details", "order": "169", "role": "http://braskem.com./role/NetRevenueDetailsNarrative", "shortName": "Net revenue (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:PercentageOfEntitysRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Investments", "menuCat": "Notes", "order": "17", "role": "http://braskem.com./role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R170": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfTaxIncentivesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:TaxRateEffectOfTaxLosses", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000170 - Disclosure - Tax incentives (Details Narrative)", "menuCat": "Details", "order": "170", "role": "http://braskem.com./role/TaxIncentivesDetailsNarrative", "shortName": "Tax incentives (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfTaxIncentivesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:TaxRateEffectOfTaxLosses", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R171": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_NatureMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ExpenseByNature", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000171 - Disclosure - Expenses by nature and function (Details)", "menuCat": "Details", "order": "171", "role": "http://braskem.com./role/ExpensesByNatureAndFunctionDetails", "shortName": "Expenses by nature and function (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_NatureMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ExpenseByNature", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R172": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinanceIncome", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000172 - Disclosure - Financial results (Details)", "menuCat": "Details", "order": "172", "role": "http://braskem.com./role/FinancialResultsDetails", "shortName": "Financial results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfFinancialResultsExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_FinancialInterestIncomeMember", "decimals": "-3", "lang": null, "name": "ifrs-full:FinanceIncome", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R173": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_USDollarBrazilianRealMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ClosingForeignExchangeRate", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000173 - Disclosure - Financial results (Details 1)", "menuCat": "Details", "order": "173", "role": "http://braskem.com./role/FinancialResultsDetails1", "shortName": "Financial results (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_USDollarBrazilianRealMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ClosingForeignExchangeRate", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" } }, "R174": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000174 - Disclosure - Segment information (Details)", "menuCat": "Details", "order": "174", "role": "http://braskem.com./role/SegmentInformationDetails", "shortName": "Segment information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfResultsBySegmentExplanatory", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "bak:CostOfProductsSold", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R175": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000175 - Disclosure - Segment information (Details 1)", "menuCat": "Details", "order": "175", "role": "http://braskem.com./role/SegmentInformationDetails1", "shortName": "Segment information (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R176": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfContractualObligationExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_EnergyAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ContractualCapitalCommitments", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000176 - Disclosure - Contractual obligations (Details Narrative)", "menuCat": "Details", "order": "176", "role": "http://braskem.com./role/ContractualObligationsDetailsNarrative", "shortName": "Contractual obligations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfContractualObligationExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_EnergyAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ContractualCapitalCommitments", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R177": { "firstAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-8", "first": true, "lang": null, "name": "ifrs-full:GainsLossesOnLitigationSettlements", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000177 - Disclosure - Subsequent events (Details Narrative)", "menuCat": "Details", "order": "177", "role": "http://braskem.com./role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2023-02-28_custom_EventsAfterReportingPeriodMember", "decimals": "-8", "lang": null, "name": "ifrs-full:BondsIssued", "reportCount": 1, "unique": true, "unitRef": "USDBRL", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Property, plant and equipment", "menuCat": "Notes", "order": "18", "role": "http://braskem.com./role/PropertyPlantAndEquipment", "shortName": "Property, plant and equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Intangible assets", "menuCat": "Notes", "order": "19", "role": "http://braskem.com./role/IntangibleAssets", "shortName": "Intangible assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Statement of consolidated financial position", "menuCat": "Statements", "order": "2", "role": "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "shortName": "Statement of consolidated financial position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "bak:NonCurrentRecoverableIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Right-of-use assets and lease liability", "menuCat": "Notes", "order": "20", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiability", "shortName": "Right-of-use assets and lease liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Trade payables", "menuCat": "Notes", "order": "21", "role": "http://braskem.com./role/TradePayables", "shortName": "Trade payables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Borrowings", "menuCat": "Notes", "order": "22", "role": "http://braskem.com./role/Borrowings", "shortName": "Borrowings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Braskem Idesa Borrowings", "menuCat": "Notes", "order": "23", "role": "http://braskem.com./role/BraskemIdesaBorrowings", "shortName": "Braskem Idesa Borrowings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Debentures", "menuCat": "Notes", "order": "24", "role": "http://braskem.com./role/Debentures", "shortName": "Debentures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow", "menuCat": "Notes", "order": "25", "role": "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlow", "shortName": "Reconciliation of borrowing activities in the statement of cash flow", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Financial instruments", "menuCat": "Notes", "order": "26", "role": "http://braskem.com./role/FinancialInstruments", "shortName": "Financial instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Taxes payable", "menuCat": "Notes", "order": "27", "role": "http://braskem.com./role/TaxesPayable", "shortName": "Taxes payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Income taxes", "menuCat": "Notes", "order": "28", "role": "http://braskem.com./role/IncomeTaxes", "shortName": "Income taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Sundry provisions", "menuCat": "Notes", "order": "29", "role": "http://braskem.com./role/SundryProvisions", "shortName": "Sundry provisions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Statement of consolidated profit or loss", "menuCat": "Statements", "order": "3", "role": "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss", "shortName": "Statement of consolidated profit or loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:DistributionCosts", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Provisions for legal proceedings and contingent liabilities", "menuCat": "Notes", "order": "30", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilities", "shortName": "Provisions for legal proceedings and contingent liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureLeniencyAgreementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Leniency agreement with authorities", "menuCat": "Notes", "order": "31", "role": "http://braskem.com./role/LeniencyAgreementWithAuthorities", "shortName": "Leniency agreement with authorities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureLeniencyAgreementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Geological event - Alagoas", "menuCat": "Notes", "order": "32", "role": "http://braskem.com./role/GeologicalEvent-Alagoas", "shortName": "Geological event - Alagoas", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Benefits offered to employees", "menuCat": "Notes", "order": "33", "role": "http://braskem.com./role/BenefitsOfferedToEmployees", "shortName": "Benefits offered to employees", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Equity", "menuCat": "Notes", "order": "34", "role": "http://braskem.com./role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Earnings (loss) per share", "menuCat": "Notes", "order": "35", "role": "http://braskem.com./role/EarningsLossPerShare", "shortName": "Earnings (loss) per share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Net revenue", "menuCat": "Notes", "order": "36", "role": "http://braskem.com./role/NetRevenue", "shortName": "Net revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxIncentivesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Tax incentives", "menuCat": "Notes", "order": "37", "role": "http://braskem.com./role/TaxIncentives", "shortName": "Tax incentives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxIncentivesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Expenses by nature and function", "menuCat": "Notes", "order": "38", "role": "http://braskem.com./role/ExpensesByNatureAndFunction", "shortName": "Expenses by nature and function", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Financial results", "menuCat": "Notes", "order": "39", "role": "http://braskem.com./role/FinancialResults", "shortName": "Financial results", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Statement of consolidated comprehensive income", "menuCat": "Statements", "order": "4", "role": "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome", "shortName": "Statement of consolidated comprehensive income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Segment information", "menuCat": "Notes", "order": "40", "role": "http://braskem.com./role/SegmentInformation", "shortName": "Segment information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfContractualObligationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Contractual obligations", "menuCat": "Notes", "order": "41", "role": "http://braskem.com./role/ContractualObligations", "shortName": "Contractual obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfContractualObligationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Subsequent events", "menuCat": "Notes", "order": "42", "role": "http://braskem.com./role/SubsequentEvents", "shortName": "Subsequent events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Basis of preparation of the financial statements (Policies)", "menuCat": "Policies", "order": "43", "role": "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies", "shortName": "Basis of preparation of the financial statements (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "bak:DescriptionOfAccountingPolicyForConsolidationExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Basis of preparation of the financial statements (Tables)", "menuCat": "Tables", "order": "44", "role": "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables", "shortName": "Basis of preparation of the financial statements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DescriptionOfAccountingPolicyForConsolidationExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Risk management (Tables)", "menuCat": "Tables", "order": "45", "role": "http://braskem.com./role/RiskManagementTables", "shortName": "Risk management (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Cash and cash equivalents (Tables)", "menuCat": "Tables", "order": "46", "role": "http://braskem.com./role/CashAndCashEquivalentsTables", "shortName": "Cash and cash equivalents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Financial investments (Tables)", "menuCat": "Tables", "order": "47", "role": "http://braskem.com./role/FinancialInvestmentsTables", "shortName": "Financial investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTradeAccountsReceivableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Trade accounts receivable (Tables)", "menuCat": "Tables", "order": "48", "role": "http://braskem.com./role/TradeAccountsReceivableTables", "shortName": "Trade accounts receivable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTradeAccountsReceivableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfInventoryExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "49", "role": "http://braskem.com./role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfInventoryExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31_ifrs-full_IssuedCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statement of changes in equity", "menuCat": "Statements", "order": "5", "role": "http://braskem.com./role/StatementOfChangesInEquity", "shortName": "Statement of changes in equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31_ifrs-full_IssuedCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Related parties (Tables)", "menuCat": "Tables", "order": "50", "role": "http://braskem.com./role/RelatedPartiesTables", "shortName": "Related parties (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxesRecoverableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Taxes recoverable (Tables)", "menuCat": "Tables", "order": "51", "role": "http://braskem.com./role/TaxesRecoverableTables", "shortName": "Taxes recoverable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfTaxesRecoverableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfInvestmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "52", "role": "http://braskem.com./role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfInvestmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Property, plant and equipment (Tables)", "menuCat": "Tables", "order": "53", "role": "http://braskem.com./role/PropertyPlantAndEquipmentTables", "shortName": "Property, plant and equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfChangesInIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Intangible assets (Tables)", "menuCat": "Tables", "order": "54", "role": "http://braskem.com./role/IntangibleAssetsTables", "shortName": "Intangible assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfChangesInIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Right-of-use assets and lease liability (Tables)", "menuCat": "Tables", "order": "55", "role": "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables", "shortName": "Right-of-use assets and lease liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Trade payables (Tables)", "menuCat": "Tables", "order": "56", "role": "http://braskem.com./role/TradePayablesTables", "shortName": "Trade payables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfBorrowingsInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Borrowings (Tables)", "menuCat": "Tables", "order": "57", "role": "http://braskem.com./role/BorrowingsTables", "shortName": "Borrowings (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfBorrowingsInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfOtherBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - Braskem Idesa Borrowings (Tables)", "menuCat": "Tables", "order": "58", "role": "http://braskem.com./role/BraskemIdesaBorrowingsTables", "shortName": "Braskem Idesa Borrowings (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfOtherBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDebenturesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Debentures (Tables)", "menuCat": "Tables", "order": "59", "role": "http://braskem.com./role/DebenturesTables", "shortName": "Debentures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDebtSecuritiesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDebenturesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ProfitLossBeforeTaxAndSocialContribution", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Statement of consolidated cash flow", "menuCat": "Statements", "order": "6", "role": "http://braskem.com./role/StatementOfConsolidatedCashFlow", "shortName": "Statement of consolidated cash flow", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:ProvisionUsedOtherProvisions", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - Reconciliation of borrowing activities in the statement of cash flow (Tables)", "menuCat": "Tables", "order": "60", "role": "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowTables", "shortName": "Reconciliation of borrowing activities in the statement of cash flow (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - Financial instruments (Tables)", "menuCat": "Tables", "order": "61", "role": "http://braskem.com./role/FinancialInstrumentsTables", "shortName": "Financial instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "bak:DisclosureOfTaxPayableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutTaxPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - Taxes payable (Tables)", "menuCat": "Tables", "order": "62", "role": "http://braskem.com./role/TaxesPayableTables", "shortName": "Taxes payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureOfTaxPayableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutTaxPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - Income taxes (Tables)", "menuCat": "Tables", "order": "63", "role": "http://braskem.com./role/IncomeTaxesTables", "shortName": "Income taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfSundryProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - Sundry provisions (Tables)", "menuCat": "Tables", "order": "64", "role": "http://braskem.com./role/SundryProvisionsTables", "shortName": "Sundry provisions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfProvisionsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfSundryProvisionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - Provisions for legal proceedings and contingent liabilities (Tables)", "menuCat": "Tables", "order": "65", "role": "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables", "shortName": "Provisions for legal proceedings and contingent liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureOfProvisionsForLegalProceedingsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:ScheduleOfDistributionPaid", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - Leniency agreement with authorities (Tables)", "menuCat": "Tables", "order": "66", "role": "http://braskem.com./role/LeniencyAgreementWithAuthoritiesTables", "shortName": "Leniency agreement with authorities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureLeniencyAgreementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:ScheduleOfDistributionPaid", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:ScheduleOfChangesInprovisionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - Geological event - Alagoas (Tables)", "menuCat": "Tables", "order": "67", "role": "http://braskem.com./role/GeologicalEvent-AlagoasTables", "shortName": "Geological event - Alagoas (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bak:DisclosureGeologicalPhenomenonAlagoasExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:ScheduleOfChangesInprovisionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfShortTermBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - Benefits offered to employees (Tables)", "menuCat": "Tables", "order": "68", "role": "http://braskem.com./role/BenefitsOfferedToEmployeesTables", "shortName": "Benefits offered to employees (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfShortTermBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclsoureOfSharesDistributedExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "69", "role": "http://braskem.com./role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclsoureOfSharesDistributedExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Operations", "menuCat": "Notes", "order": "7", "role": "http://braskem.com./role/Operations", "shortName": "Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfEarningsPerShareReconciliationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - Earnings (loss) per share (Tables)", "menuCat": "Tables", "order": "70", "role": "http://braskem.com./role/EarningsLossPerShareTables", "shortName": "Earnings (loss) per share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfEarningsPerShareReconciliationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfSalesAndServiceRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - Net revenue (Tables)", "menuCat": "Tables", "order": "71", "role": "http://braskem.com./role/NetRevenueTables", "shortName": "Net revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfSalesAndServiceRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - Expenses by nature and function (Tables)", "menuCat": "Tables", "order": "72", "role": "http://braskem.com./role/ExpensesByNatureAndFunctionTables", "shortName": "Expenses by nature and function (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfFinancialResultsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - Financial results (Tables)", "menuCat": "Tables", "order": "73", "role": "http://braskem.com./role/FinancialResultsTables", "shortName": "Financial results (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfFinancialResultsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfResultsBySegmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - Segment information (Tables)", "menuCat": "Tables", "order": "74", "role": "http://braskem.com./role/SegmentInformationTables", "shortName": "Segment information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DisclosureOfResultsBySegmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:NumberOfBarrels", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - Operations (Details Narrative)", "menuCat": "Details", "order": "75", "role": "http://braskem.com./role/OperationsDetailsNarrative", "shortName": "Operations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:NumberOfBarrels", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "bak:DescriptionOfAccountingPolicyForConsolidationExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_Subsidiary1Member", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - Basis of preparation of the financial statements (Details)", "menuCat": "Details", "order": "76", "role": "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "shortName": "Basis of preparation of the financial statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory", "bak:DescriptionOfAccountingPolicyForConsolidationExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_Subsidiary1Member", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfFunctionalCurrencyExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BraskemAlemanhaMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfFunctionalCurrency", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - Basis of preparation of the financial statements (Details 1)", "menuCat": "Details", "order": "77", "role": "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "shortName": "Basis of preparation of the financial statements (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "bak:DisclosureOfFunctionalCurrencyExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_BraskemAlemanhaMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfFunctionalCurrency", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DerivativeFinancialLiabilities", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - Risk management (Details)", "menuCat": "Details", "order": "78", "role": "http://braskem.com./role/RiskManagementDetails", "shortName": "Risk management (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_ifrs-full_LiquidityRiskMember", "decimals": "-3", "lang": null, "name": "bak:TradePayables", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - Cash and cash equivalents (Details)", "menuCat": "Details", "order": "79", "role": "http://braskem.com./role/CashAndCashEquivalentsDetails", "shortName": "Cash and cash equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_DomesticMarketMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Basis of preparation of the financial statements", "menuCat": "Notes", "order": "8", "role": "http://braskem.com./role/BasisOfPreparationOfFinancialStatements", "shortName": "Basis of preparation of the financial statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory", "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - Financial investments (Details)", "menuCat": "Details", "order": "80", "role": "http://braskem.com./role/FinancialInvestmentsDetails", "shortName": "Financial investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory", "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:DepositsYieldsRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - Financial investments (Details Narrative)", "menuCat": "Details", "order": "81", "role": "http://braskem.com./role/FinancialInvestmentsDetailsNarrative", "shortName": "Financial investments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDepositsFromBanksExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "bak:DepositsYieldsRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExpectedCreditLosses", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - Trade accounts receivable (Details)", "menuCat": "Details", "order": "82", "role": "http://braskem.com./role/TradeAccountsReceivableDetails", "shortName": "Trade accounts receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ExpectedCreditLosses", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeReceivables", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - Trade accounts receivable (Details 1)", "menuCat": "Details", "order": "83", "role": "http://braskem.com./role/TradeAccountsReceivableDetails1", "shortName": "Trade accounts receivable (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTradeAccountsReceivableByMaturityExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_NotPastDueMember", "decimals": "-3", "lang": null, "name": "bak:GrossTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000084 - Disclosure - Trade accounts receivable (Details 2)", "menuCat": "Details", "order": "84", "role": "http://braskem.com./role/TradeAccountsReceivableDetails2", "shortName": "Trade accounts receivable (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfInventoryExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000085 - Disclosure - Inventories (Details)", "menuCat": "Details", "order": "85", "role": "http://braskem.com./role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfInventoryExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ProvisionForInventories", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000086 - Disclosure - Inventories (Details 1)", "menuCat": "Details", "order": "86", "role": "http://braskem.com./role/InventoriesDetails1", "shortName": "Inventories (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:ProvisionForInventories", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000087 - Disclosure - Related parties (Details)", "menuCat": "Details", "order": "87", "role": "http://braskem.com./role/RelatedPartiesDetails", "shortName": "Related parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "bak:CurrentTradeReceivables1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000088 - Disclosure - Related parties (Details 1)", "menuCat": "Details", "order": "88", "role": "http://braskem.com./role/RelatedPartiesDetails1", "shortName": "Related parties (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-02-012022-02-28_custom_NovonorAndItsDirectAndIndirectSubsidiariesMember", "decimals": "-6", "first": true, "lang": null, "name": "bak:EstimatedAmount", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000089 - Disclosure - Related parties (Details Narrative)", "menuCat": "Details", "order": "89", "role": "http://braskem.com./role/RelatedPartiesDetailsNarrative", "shortName": "Related parties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-02-012022-02-28_custom_NovonorAndItsDirectAndIndirectSubsidiariesMember", "decimals": "-6", "first": true, "lang": null, "name": "bak:EstimatedAmount", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Application of estimates and judgments", "menuCat": "Notes", "order": "9", "role": "http://braskem.com./role/ApplicationOfEstimatesAndJudgments", "shortName": "Application of estimates and judgments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTaxesRecoverableExplanatory", "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000090 - Disclosure - Taxes recoverable (Details)", "menuCat": "Details", "order": "90", "role": "http://braskem.com./role/TaxesRecoverableDetails", "shortName": "Taxes recoverable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTaxesRecoverableExplanatory", "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember_custom_ParentCompanysMember", "decimals": "-3", "lang": null, "name": "ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfTaxesRecoverableExplanatory", "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000091 - Disclosure - Taxes recoverable (Details Narrative)", "menuCat": "Details", "order": "91", "role": "http://braskem.com./role/TaxesRecoverableDetailsNarrative", "shortName": "Taxes recoverable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "bak:DisclosureOfTaxRecoverableExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2019-12-31_custom_PISAndCOFINSTaxesMember", "decimals": "-3", "lang": null, "name": "ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000092 - Disclosure - Investments (Details)", "menuCat": "Details", "order": "92", "role": "http://braskem.com./role/InvestmentsDetails", "shortName": "Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfInvestmentsExplanatory", "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_custom_Investment1Member", "decimals": "-3", "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000093 - Disclosure - Investments (Details 1)", "menuCat": "Details", "order": "93", "role": "http://braskem.com./role/InvestmentsDetails1", "shortName": "Investments (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInInvestmentsExplanatory", "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000094 - Disclosure - Investments (Details 2)", "menuCat": "Details", "order": "94", "role": "http://braskem.com./role/InvestmentsDetails2", "shortName": "Investments (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfImpactOnConsolidationOfBraskemIdesaExplanatory", "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember", "decimals": "-3", "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_ifrs-full_BuildingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "bak:EstimatedUsefulLives", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000095 - Disclosure - Property plant and equipment (Details)", "menuCat": "Details", "order": "95", "role": "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "shortName": "Property plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-012022-12-31_ifrs-full_BuildingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "bak:EstimatedUsefulLives", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PropertyPlantAndEquipmentCostValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000096 - Disclosure - Property plant and equipment (Details 1)", "menuCat": "Details", "order": "96", "role": "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "shortName": "Property plant and equipment (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:PropertyPlantAndEquipmentCostValue", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000097 - Disclosure - Property plant and equipment (Details 2)", "menuCat": "Details", "order": "97", "role": "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "shortName": "Property plant and equipment (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfPropertyPlantAndEquipmentByCountryExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "AsOf2022-12-31_custom_BrazilMember", "decimals": "-3", "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DescriptionOfPropertyPlantAndEquipmentShutdownsDuration", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000098 - Disclosure - Property, plant and equipment (Details Narrative)", "menuCat": "Details", "order": "98", "role": "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative", "shortName": "Property, plant and equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "bak:DescriptionOfPropertyPlantAndEquipmentShutdownsDuration", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000099 - Disclosure - Intangible assets (Details)", "menuCat": "Details", "order": "99", "role": "http://braskem.com./role/IntangibleAssetsDetails", "shortName": "Intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "bak:DisclosureOfChangesInIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "bakform20f_2022.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "bak:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1", "reportCount": 1, "unique": true, "unitRef": "BRL", "xsiNil": "false" } } }, "segmentCount": 538, "tag": { "bak_AAAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a a a member.", "label": "A a a member" } } }, "localname": "AAAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_AAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a a member.", "label": "A a member" } } }, "localname": "AAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_AAMinusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a a minus member.", "label": "A a minus member" } } }, "localname": "AAMinusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_AAPlusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a a plus member.", "label": "A a plus member" } } }, "localname": "AAPlusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_AMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a member.", "label": "A member" } } }, "localname": "AMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_AMinusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a minus member.", "label": "A minus member" } } }, "localname": "AMinusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_APlusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a plus member.", "label": "A plus member" } } }, "localname": "APlusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_ARMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents a r member.", "label": "A r member" } } }, "localname": "ARMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_AbsorptionOfLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents absorption of losses.", "label": "Absorption of losses" } } }, "localname": "AbsorptionOfLosses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_AbsorptionOfLossesAndAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "AbsorptionOfLossesAndAdjustments", "verboseLabel": "Absorption of losses" } } }, "localname": "AbsorptionOfLossesAndAdjustments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_AccumulatedAmortisationImpairmentIntangibleAssetsOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accumulated amortization" } } }, "localname": "AccumulatedAmortisationImpairmentIntangibleAssetsOther", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_AccumulatelossesAbsorption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Profit reserves retention of profits" } } }, "localname": "AccumulatelossesAbsorption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_AcquiredOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents acquired of lease liabilities.", "label": "Acquired of lease liabilities", "verboseLabel": "Acquired" } } }, "localname": "AcquiredOfLeaseLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_AcquisitionOfOtherInvestments": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AcquisitionOfOtherInvestments", "negatedLabel": "Acquisition of other investments" } } }, "localname": "AcquisitionOfOtherInvestments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AcquisitionOfPropertyPlantAndEquipmentWithPaymentInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents acquisition of property plant and equipment with payment installments.", "label": "Acquisition of property, plant and equipment with payment installments" } } }, "localname": "AcquisitionOfPropertyPlantAndEquipmentWithPaymentInstallments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AcquisitionOfSubsidiary": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AcquisitionOfSubsidiary", "negatedLabel": "Acquisition of subsidiary" } } }, "localname": "AcquisitionOfSubsidiary", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AcquisitionsRightofuseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents acquisitions rightofuse assets.", "label": "Acquisitions rightofuse assets", "verboseLabel": "Acquisitions" } } }, "localname": "AcquisitionsRightofuseAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "bak_ActuarialAssumptionOfDuration1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents actuarial assumption of duration1.", "label": "Duration" } } }, "localname": "ActuarialAssumptionOfDuration1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "bak_ActuarialAssumptionRateOfIncreaseInFuturePensionPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents actuarial assumption rate of increase in future pension plan.", "label": "Rate of increase in future pension plan" } } }, "localname": "ActuarialAssumptionRateOfIncreaseInFuturePensionPlan", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "bak_ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents actuarial assumption rate of increase in future salary levels.", "label": "Rate of increase in future salary levels" } } }, "localname": "ActuarialAssumptionRateOfIncreaseInFutureSalaryLevels", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "bak_ActuarialGainLossWithPostemploymentBenefitsNetOfTaxes": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Actuarial gain (loss) with post-employment benefits, net of taxes" } } }, "localname": "ActuarialGainLossWithPostemploymentBenefitsNetOfTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_ActuarialGainsLossesNetDefinedBenefitLiabilityAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents actuarial gains losses net defined benefit liability asset.", "label": "Actuarial losses" } } }, "localname": "ActuarialGainsLossesNetDefinedBenefitLiabilityAsset", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5" ], "xbrltype": "monetaryItemType" }, "bak_ActuarialGainsLossesNetDefinedBenefitTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents actuarial gains losses net defined benefit total.", "label": "Actuarial gains losses net defined benefit total", "verboseLabel": "Amounts recognized in profit and loss" } } }, "localname": "ActuarialGainsLossesNetDefinedBenefitTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5" ], "xbrltype": "monetaryItemType" }, "bak_AdditionToInventories": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents addition to inventories.", "label": "Additions" } } }, "localname": "AdditionToInventories", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_AdditionalDividendsApprovedInBoardMeeting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional dividends approved in the board meeting" } } }, "localname": "AdditionalDividendsApprovedInBoardMeeting", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_AdditionalDividendsOfSubsidiary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents additional dividends of subsidiary.", "label": "Additional dividends of subsidiary" } } }, "localname": "AdditionalDividendsOfSubsidiary", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_AdditionalDividendsProposedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Dividends Proposed [Member]" } } }, "localname": "AdditionalDividendsProposedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "bak_AdditionalProposedDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents additional proposed dividends.", "label": "Additional proposed dividends" } } }, "localname": "AdditionalProposedDividends", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_AdditionsRelatedGeologicalEvent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdditionsRelatedGeologicalEvent", "verboseLabel": "Additions" } } }, "localname": "AdditionsRelatedGeologicalEvent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "bak_AdditionsThroughAcquisitionOfErPlastic": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additions through acquisition of ER Plastic" } } }, "localname": "AdditionsThroughAcquisitionOfErPlastic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_AdditionsThroughAcquisitionOfErPlastics": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdditionsThroughAcquisitionOfErPlastics", "verboseLabel": "Additions through acquisition of ER Plastics" } } }, "localname": "AdditionsThroughAcquisitionOfErPlastics", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_AdditionsThroughAcquisitionsOfErPlastics": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdditionsThroughAcquisitionsOfErPlastics", "verboseLabel": "Additions through acquisition of ER Plastics" } } }, "localname": "AdditionsThroughAcquisitionsOfErPlastics", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_AdditionsToInvestmentInSubsidiaries": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additions to investment in subsidiaries" } } }, "localname": "AdditionsToInvestmentInSubsidiaries", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_AdjustedAmountOfUncertainTaxEstimate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Adjusted amount of uncertain tax estimate" } } }, "localname": "AdjustedAmountOfUncertainTaxEstimate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AdjustedAmountOfUncertainTaxTreatment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents adjusted amount of uncertain tax treatment.", "label": "Adjusted amount of uncertain tax treatment" } } }, "localname": "AdjustedAmountOfUncertainTaxTreatment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AdjustedValueOfCases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents adjusted value of cases.", "label": "Adjusted value of cases" } } }, "localname": "AdjustedValueOfCases", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AdjustmentToPresentValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents adjustment to present value member.", "label": "Adjustment to present value member" } } }, "localname": "AdjustmentToPresentValueMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_AdjustmentsForDecreaseIncreaseInFinancialInvestments": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdjustmentsForDecreaseIncreaseInFinancialInvestments", "terseLabel": "", "verboseLabel": "Financial investments" } } }, "localname": "AdjustmentsForDecreaseIncreaseInFinancialInvestments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AdjustmentsForDecreaseIncreaseInTaxesRecoverable": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdjustmentsForDecreaseIncreaseInTaxesRecoverable", "terseLabel": "", "verboseLabel": "Taxes recoverable" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTaxesRecoverable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AdjustmentsForIncomeTaxExpenses": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 6.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AdjustmentsForIncomeTaxExpenses", "negatedLabel": "PIS and Cofins credits - exclusion of ICMS from the calculation basis" } } }, "localname": "AdjustmentsForIncomeTaxExpenses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AdjustmentsForIncreaseDecreaseInLeniencyAgreements": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AdjustmentsForIncreaseDecreaseInLeniencyAgreements", "negatedLabel": "Leniency agreement", "verboseLabel": "" } } }, "localname": "AdjustmentsForIncreaseDecreaseInLeniencyAgreements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AdjustmentsForIncreaseDecreaseInTaxesPayable": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdjustmentsForIncreaseDecreaseInTaxesPayable", "terseLabel": "", "verboseLabel": "Taxes payable" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTaxesPayable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_AdrsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents adrs member.", "label": "Adrs member" } } }, "localname": "AdrsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "domainItemType" }, "bak_AdvancesFromCustomers": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AdvancesFromCustomers", "verboseLabel": "" } } }, "localname": "AdvancesFromCustomers", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_AgreementWithPetrocoqueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement With Petrocoque [Member]" } } }, "localname": "AgreementWithPetrocoqueMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_AgribusinessCreditNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agribusiness Credit Notes [Member]" } } }, "localname": "AgribusinessCreditNotesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_AlagoasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents alagoas member.", "label": "Alagoas member" } } }, "localname": "AlagoasMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "domainItemType" }, "bak_AlagoasStateFederalProsecutionOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents alagoas state federal prosecution office member.", "label": "Alagoas state federal prosecution office member" } } }, "localname": "AlagoasStateFederalProsecutionOfficeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_AllocatedGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents allocated goodwill.", "label": "Allocated goodwill" } } }, "localname": "AllocatedGoodwill", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents amortization of fair value adjustments on the assets from the acquisiton of braskem qpar member.", "label": "Amortization of fair value adjustments on the assets from the acquisiton of braskem qpar member" } } }, "localname": "AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfBraskemQparMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents amortization of fair value adjustments on the assets from the acquisiton of quattor member.", "label": "Amortization of fair value adjustments on the assets from the acquisiton of quattor member" } } }, "localname": "AmortizationOfFairValueAdjustmentsOnTheAssetsFromTheAcquisitonOfQuattorMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_AmountEvaluatedAsPossibleLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents amount evaluated as possible loss.", "label": "Amount evaluated as possible loss" } } }, "localname": "AmountEvaluatedAsPossibleLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AmountOfProvisionForPossibilityOfOutflowOfResources": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents amount of provision for possibility of outflow of resources.", "label": "Amount of provision for possibility of outflow of resources" } } }, "localname": "AmountOfProvisionForPossibilityOfOutflowOfResources", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AmountOfTheseClaims": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents amount of these claims.", "label": "Amount of these claims" } } }, "localname": "AmountOfTheseClaims", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AmountUnderDiscussion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents amount under discussion.", "label": "Amount under discussion" } } }, "localname": "AmountUnderDiscussion", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_AmountsIndicatedInTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amounts indicated in tax" } } }, "localname": "AmountsIndicatedInTax", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_ApplicationOfEstimatesAndJudgmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Application Of Estimates And Judgments" } } }, "localname": "ApplicationOfEstimatesAndJudgmentsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_AssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents asset member.", "label": "Asset member" } } }, "localname": "AssetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_Assets1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents assets1.", "label": "Assets1" } } }, "localname": "Assets1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_Associate1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Associate 1 [Member]" } } }, "localname": "Associate1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "domainItemType" }, "bak_Associate2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Associate 2 [Member]" } } }, "localname": "Associate2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "domainItemType" }, "bak_Associate3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Associate 3 [Member]" } } }, "localname": "Associate3Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "domainItemType" }, "bak_Associate4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Associate 4 [Member]" } } }, "localname": "Associate4Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "domainItemType" }, "bak_AssociateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents associate member.", "label": "Associate member" } } }, "localname": "AssociateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_AuthorisedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Authorised [Member]" } } }, "localname": "AuthorisedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "domainItemType" }, "bak_AverageForeignExchangeRateVariations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents average foreign exchange rate variations.", "label": "Average foreign exchange rate variations" } } }, "localname": "AverageForeignExchangeRateVariations", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "percentItemType" }, "bak_BBBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b b b member.", "label": "B b b member" } } }, "localname": "BBBMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BBBMinusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b b b minus member.", "label": "B b b minus member" } } }, "localname": "BBBMinusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BBBPlusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b b b plus member.", "label": "B b b plus member" } } }, "localname": "BBBPlusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b b member.", "label": "B b member" } } }, "localname": "BBMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BBMinusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "B B Minus [Member]" } } }, "localname": "BBMinusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BBPlusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b b plus member.", "label": "B b plus member" } } }, "localname": "BBPlusMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b m insurance braskem america braskem america finance braskem holanda braskem holanda finance braskem holanda inc and braskem mexico sofom member.", "label": "B m insurance braskem america braskem america finance braskem holanda braskem holanda finance braskem holanda inc and braskem mexico sofom member" } } }, "localname": "BMInsuranceBraskemAmericaBraskemAmericaFinanceBraskemHolandaBraskemHolandaFinanceBraskemHolandaIncAndBraskemMexicoSofomMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1" ], "xbrltype": "domainItemType" }, "bak_BNBFINEPFUNDESFINISAFINAMEFNEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b n b f i n e p f u n d e s f i n i s a f i n a m e f n e member.", "label": "B n b f i n e p f u n d e s f i n i s a f i n a m e f n e member" } } }, "localname": "BNBFINEPFUNDESFINISAFINAMEFNEMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_BNDESMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "B N D E S [Member]" } } }, "localname": "BNDESMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_BOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents b o member.", "label": "B o member" } } }, "localname": "BOMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_BTCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "B T C [Member]" } } }, "localname": "BTCMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BankDeposits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents bank deposits.", "label": "Bank deposits" } } }, "localname": "BankDeposits", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "bak_BasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings (loss) per share - R$" } } }, "localname": "BasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "bak_BasisOfPreparationOfTheFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis Of Preparation Of Financial Statements" } } }, "localname": "BasisOfPreparationOfTheFinancialStatementsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_BenefitPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents benefit plans member.", "label": "Benefit plans member" } } }, "localname": "BenefitPlansMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5" ], "xbrltype": "domainItemType" }, "bak_BenefitsOfferedToEmployeesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Benefits Offered To Employees", "verboseLabel": "Benefits Offered To Team Members" } } }, "localname": "BenefitsOfferedToEmployeesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_BenzeneTolueneAndXyleneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents benzene toluene and xylene member.", "label": "Benzene toluene and xylene member" } } }, "localname": "BenzeneTolueneAndXyleneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_BondIIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bond i i member.", "label": "Bond i i member" } } }, "localname": "BondIIMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_BondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bond member.", "label": "Bond member" } } }, "localname": "BondMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_Bonds1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds1 member.", "label": "Bonds1 member" } } }, "localname": "Bonds1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds2 member.", "label": "Bonds2 member" } } }, "localname": "Bonds2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds3 member.", "label": "Bonds3 member" } } }, "localname": "Bonds3Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds4 member.", "label": "Bonds4 member" } } }, "localname": "Bonds4Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds5 member.", "label": "Bonds5 member" } } }, "localname": "Bonds5Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds6 member.", "label": "Bonds6 member" } } }, "localname": "Bonds6Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_Bonds7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bonds7 member.", "label": "Bonds7 member" } } }, "localname": "Bonds7Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "domainItemType" }, "bak_BookValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents book value.", "label": "Book value" } } }, "localname": "BookValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowing [Member]" } } }, "localname": "BorrowingMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_BorrowingsAndDebenturesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings and debentures current" } } }, "localname": "BorrowingsAndDebenturesCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsAndDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowings And Debentures [Member]" } } }, "localname": "BorrowingsAndDebenturesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_BorrowingsAndDebenturesNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings and debentures non current" } } }, "localname": "BorrowingsAndDebenturesNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsAndDebenturesTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings and debentures total" } } }, "localname": "BorrowingsAndDebenturesTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings current" } } }, "localname": "BorrowingsCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsIssueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents borrowings issue date.", "label": "Issue date", "verboseLabel": "Annual financial charges (%)" } } }, "localname": "BorrowingsIssueDate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "stringItemType" }, "bak_BorrowingsMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents borrowings maturity1.", "label": "Maturity" } } }, "localname": "BorrowingsMaturity1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "stringItemType" }, "bak_BorrowingsNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings non current" } } }, "localname": "BorrowingsNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents borrowings one.", "label": "Borrowings one" } } }, "localname": "BorrowingsOne", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Borrowings total" } } }, "localname": "BorrowingsTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_BorrowingsTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents borrowings two.", "label": "Borrowings two" } } }, "localname": "BorrowingsTwo", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "monetaryItemType" }, "bak_BradescoSaudeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents bradesco saude member.", "label": "Bradesco saude member" } } }, "localname": "BradescoSaudeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "domainItemType" }, "bak_BraksemAmericaSwapC3PGPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braksem America Swap C 3 P G P [Member]" } } }, "localname": "BraksemAmericaSwapC3PGPMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BrandsAndPatentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Brands And Patents [Member]" } } }, "localname": "BrandsAndPatentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemAlemanhaAndBraskemHolandaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem alemanha and braskem holanda member.", "label": "Braskem alemanha and braskem holanda member" } } }, "localname": "BraskemAlemanhaAndBraskemHolandaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "domainItemType" }, "bak_BraskemAlemanhaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem alemanha member.", "label": "Braskem alemanha member" } } }, "localname": "BraskemAlemanhaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem america member.", "label": "Braskem america member" } } }, "localname": "BraskemAmericaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemArgentinaExchangeSwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Argentina Exchange Swap [Member]" } } }, "localname": "BraskemArgentinaExchangeSwapMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemArgentinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem argentina member.", "label": "Braskem argentina member" } } }, "localname": "BraskemArgentinaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemChileMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem chile member.", "label": "Braskem chile member" } } }, "localname": "BraskemChileMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemConsolidatedBeforeEliminationsAndReclassificationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem consolidated before eliminations and reclassifications member.", "label": "Braskem consolidated before eliminations and reclassifications member" } } }, "localname": "BraskemConsolidatedBeforeEliminationsAndReclassificationsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bak_BraskemHolandaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem holanda member.", "label": "Braskem holanda member" } } }, "localname": "BraskemHolandaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemHolandaSwapNaftaGasolinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Holanda Swap Nafta Gasolina [Member]" } } }, "localname": "BraskemHolandaSwapNaftaGasolinaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaBorrowings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents braskem idesa borrowings.", "label": "Braskem idesa borrowings" } } }, "localname": "BraskemIdesaBorrowings", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "bak_BraskemIdesaBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Braskem Idesa borrowings" } } }, "localname": "BraskemIdesaBorrowingsAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "bak_BraskemIdesaBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem idesa borrowings member.", "label": "Braskem idesa borrowings member" } } }, "localname": "BraskemIdesaBorrowingsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaBorrowingsNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents braskem idesa borrowings non current.", "label": "Braskem Idesa Borrowings [Default Label]", "verboseLabel": "Braskem Idesa Borrowings" } } }, "localname": "BraskemIdesaBorrowingsNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem idesa braskem idesa servicos braskem mexico and braskem mexico servicos member.", "label": "Braskem idesa braskem idesa servicos braskem mexico and braskem mexico servicos member" } } }, "localname": "BraskemIdesaBraskemIdesaServicosBraskemMexicoAndBraskemMexicoServicosMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaConsolidatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Idesa Consolidated [Member]" } } }, "localname": "BraskemIdesaConsolidatedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Idesa Financing [Member]" } } }, "localname": "BraskemIdesaFinancingMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Idesa [Member]" } } }, "localname": "BraskemIdesaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Idesa One [Member]" } } }, "localname": "BraskemIdesaOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_BraskemIdesaServicosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem idesa servicos member.", "label": "Braskem idesa servicos member" } } }, "localname": "BraskemIdesaServicosMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemIndiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem india member.", "label": "Braskem india member" } } }, "localname": "BraskemIndiaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemMexicoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Mexico [Member]" } } }, "localname": "BraskemMexicoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemMexicoServicosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem Mexico Servicos [Member]" } } }, "localname": "BraskemMexicoServicosMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemSADollarCallAndPutOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem S A Dollar Call And Put Options [Member]" } } }, "localname": "BraskemSADollarCallAndPutOptionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemSADollarSwapCDIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem S A Dollar Swap C D I [Member]" } } }, "localname": "BraskemSADollarSwapCDIMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BraskemSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents braskem s a member.", "label": "Braskem s a member" } } }, "localname": "BraskemSAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_BraskemSASwapCRAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Braskem S A Swap C R A [Member]" } } }, "localname": "BraskemSASwapCRAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_BrazilMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents brazil member.", "label": "Brazil [member]" } } }, "localname": "BrazilMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "bak_BrazilianRealUSDollarExchangeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents brazilian real u s dollar exchange rate member.", "label": "Brazilian real u s dollar exchange rate member" } } }, "localname": "BrazilianRealUSDollarExchangeRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_BreakdownOfIncomeTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents breakdown of income taxes.", "label": "Breakdown of income taxes" } } }, "localname": "BreakdownOfIncomeTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "bak_BuildingsAndConstructionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents buildings and constructions member.", "label": "Buildings and constructions member" } } }, "localname": "BuildingsAndConstructionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "bak_BusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents business combination member.", "label": "Business combination member" } } }, "localname": "BusinessCombinationMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_ButadieneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents butadiene member.", "label": "Butadiene member" } } }, "localname": "ButadieneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_CAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents c a member.", "label": "C a member" } } }, "localname": "CAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_CDIInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents c d i interest rate member.", "label": "C d i interest rate member" } } }, "localname": "CDIInterestRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_CHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "C H [Member]" } } }, "localname": "CHMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_CLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents c l member.", "label": "C l member" } } }, "localname": "CLMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_CNMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents c n member.", "label": "C n member" } } }, "localname": "CNMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_COMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents c o member.", "label": "C o member" } } }, "localname": "COMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_CRAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "C R A [Member]" } } }, "localname": "CRAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_CallOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents call options member.", "label": "Call options member" } } }, "localname": "CallOptionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_CapitalIncreases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents capital increases.", "label": "Capital increase" } } }, "localname": "CapitalIncreases", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_CarryingAmountAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Carrying Amount [Axis]" } } }, "localname": "CarryingAmountAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "stringItemType" }, "bak_CarryingAmountDomain": { "auth_ref": [], "localname": "CarryingAmountDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "bak_CarryingAmountOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Carrying Amount One [Member]" } } }, "localname": "CarryingAmountOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "bak_CashAndBanksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents cash and banks member.", "label": "Cash and banks member" } } }, "localname": "CashAndBanksMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_CashAndCashEquivalentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents cash and cash equivalent member.", "label": "Cash and cash equivalent member" } } }, "localname": "CashAndCashEquivalentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_CashFlowsRelatedToContractsDiscounted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash flows related to the contracts discounted" } } }, "localname": "CashFlowsRelatedToContractsDiscounted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "monetaryItemType" }, "bak_CashFlowsRelatedToContractsUndiscounted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash flows related to the contracts undiscounted" } } }, "localname": "CashFlowsRelatedToContractsUndiscounted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "monetaryItemType" }, "bak_CetrelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents cetrel member.", "label": "Cetrel member" } } }, "localname": "CetrelMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_ChangesInOperatingWorkingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents changes in operating working capital abstract.", "label": "Changes in operating working capital", "verboseLabel": "Changes in operating working capital" } } }, "localname": "ChangesInOperatingWorkingCapitalAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "bak_ChangesInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents changes in shares.", "label": "Changes in shares" } } }, "localname": "ChangesInShares", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails1" ], "xbrltype": "sharesItemType" }, "bak_CivilClaimsAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents civil claims and other member.", "label": "Civil claims and other member" } } }, "localname": "CivilClaimsAndOtherMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "domainItemType" }, "bak_CivilClaimsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents civil claims one member.", "label": "Civil claims one member" } } }, "localname": "CivilClaimsOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_CivilClaimsResaleOfSolventsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents civil claims resale of solvents member.", "label": "Civil claims resale of solvents member" } } }, "localname": "CivilClaimsResaleOfSolventsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_CivilClaimsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents civil claims two member.", "label": "Civil claims two member" } } }, "localname": "CivilClaimsTwoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_ClaimsWithPossibleChanceOfLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents claims with possible chance of loss.", "label": "Claims with possible chance of loss [Default Label]", "verboseLabel": "Claims with possible chance of loss" } } }, "localname": "ClaimsWithPossibleChanceOfLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_ClassAPreferenceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents class a preference shares member.", "label": "Class A Preference Shares [Member]" } } }, "localname": "ClassAPreferenceSharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Cover", "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1" ], "xbrltype": "domainItemType" }, "bak_ClassAPreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Preferred Shares [Member]" } } }, "localname": "ClassAPreferredSharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "domainItemType" }, "bak_ClassBPreferenceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents class b preference shares member.", "label": "Class B Preference Shares [Member]" } } }, "localname": "ClassBPreferenceSharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Cover", "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1" ], "xbrltype": "domainItemType" }, "bak_ClassBPreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class B Preferred Shares [Member]" } } }, "localname": "ClassBPreferredSharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "domainItemType" }, "bak_ClassificationOfExpensesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents classification of expenses axis.", "label": "Classification of expenses [axis]" } } }, "localname": "ClassificationOfExpensesAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "stringItemType" }, "bak_ClassificationOfExpensesDomain": { "auth_ref": [], "localname": "ClassificationOfExpensesDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_ClosingForeignExchangeRateVariations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents closing foreign exchange rate variations.", "label": "Closing foreign exchange rate variations" } } }, "localname": "ClosingForeignExchangeRateVariations", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "percentItemType" }, "bak_CommitmentsOfLeaseAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents commitments of lease agreement.", "label": "Commitments of lease agreement" } } }, "localname": "CommitmentsOfLeaseAgreement", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents common shares member.", "label": "Common shares member" } } }, "localname": "CommonSharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "domainItemType" }, "bak_ComprehensiveIncome1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Comprehensive income", "verboseLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncome1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_ComprehensiveIncomeAttributableToOwnersOfParent1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss for the year of the Companys shareholders" } } }, "localname": "ComprehensiveIncomeAttributableToOwnersOfParent1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Braskem Without The Effect Of Braskem Idesa Consolidated [Member]" } } }, "localname": "ConsolidatedBraskemWithoutTheEffectOfBraskemIdesaConsolidatedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "domainItemType" }, "bak_ContractualObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual Obligations" } } }, "localname": "ContractualObligationsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_ContributionsAndDistributionsToShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contributions and distributions to shareholders:" } } }, "localname": "ContributionsAndDistributionsToShareholdersAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "stringItemType" }, "bak_ContributionsToShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total Contributions to shareholders" } } }, "localname": "ContributionsToShareholders", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_ConversionOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConversionOfShares", "verboseLabel": "Incentive long term plan payments with treasury shares" } } }, "localname": "ConversionOfShares", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_ConversionSharesClassBIntoSharesClass": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion shares class \"B\" into shares class \"A\"" } } }, "localname": "ConversionSharesClassBIntoSharesClass", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_CorporateClaimMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents corporate claim member.", "label": "Corporate claim member" } } }, "localname": "CorporateClaimMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "domainItemType" }, "bak_CorporateClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents corporate claims member.", "label": "Corporate claims member" } } }, "localname": "CorporateClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_CorporateUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents corporate unit member.", "label": "Corporate unit member" } } }, "localname": "CorporateUnitMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bak_CostOfProductsSold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of products sold" } } }, "localname": "CostOfProductsSold", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "bak_CostOfProductsSoldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents cost of products sold member.", "label": "Cost of products sold member" } } }, "localname": "CostOfProductsSoldMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_CostOfSales1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents cost of sales1.", "label": "Cost of sales1", "verboseLabel": "Purchases of raw materials, finished goods services and utilities" } } }, "localname": "CostOfSales1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_CostsOfIdleIndustrialPlantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents costs of idle industrial plants member.", "label": "Costs of idle industrial plants member" } } }, "localname": "CostsOfIdleIndustrialPlantsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_CreditDerivativeFinancialSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents credit derivative financial settlement.", "label": "Credit derivative financial settlement" } } }, "localname": "CreditDerivativeFinancialSettlement", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_CumeneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents cumene member.", "label": "Cumene member" } } }, "localname": "CumeneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_CurrancyTranslationAdjustmentsOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents currancy translation adjustments of lease liabilities.", "label": "Currancy translation adjustments" } } }, "localname": "CurrancyTranslationAdjustmentsOfLeaseLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents currency translation adjustments classified as financing activities.", "label": "Currency translation adjustments" } } }, "localname": "CurrencyTranslationAdjustmentsClassifiedAsFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_CurrentBraskemIdesaBorrowings": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Braskem Idesa borrowings", "terseLabel": "Current braskem idesa borrowings", "verboseLabel": "Braskem Idesa Borrowings" } } }, "localname": "CurrentBraskemIdesaBorrowings", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_CurrentIrAndCslExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents current ir and csl expense abstract.", "label": "Current income taxes" } } }, "localname": "CurrentIrAndCslExpenseAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "bak_CurrentLeniencyAgreements": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 9.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Leniency agreement" } } }, "localname": "CurrentLeniencyAgreements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_CurrentLiabilities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents current liabilities1.", "label": "Current liabilities1", "verboseLabel": "Current liabilities" } } }, "localname": "CurrentLiabilities1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents current notes and debentures issued and current portion of noncurrent notes and debentures issued1.", "label": "Current notes and debentures issued and current portion of noncurrent notes and debentures issued1", "verboseLabel": "Debentures" } } }, "localname": "CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_CurrentProvisionsForEmployeeBenefits1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents current provisions for employee benefits1.", "label": "Current provisions for employee benefits1", "verboseLabel": "Payroll and related charges" } } }, "localname": "CurrentProvisionsForEmployeeBenefits1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_CurrentTradeReceivables1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents current trade receivables1.", "label": "Current trade receivables1", "verboseLabel": "Trade accounts receivable" } } }, "localname": "CurrentTradeReceivables1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_CurrentYearIncomeTaxAndSocialContribution": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents current year income tax and social contribution.", "label": "Current year" } } }, "localname": "CurrentYearIncomeTaxAndSocialContribution", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_CustomersAndSuppliersAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customers And Suppliers Agreements [Member]" } } }, "localname": "CustomersAndSuppliersAgreementsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3" ], "xbrltype": "domainItemType" }, "bak_DACMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents d a c member.", "label": "D a c member" } } }, "localname": "DACMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_DEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "D E [Member]" } } }, "localname": "DEMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_DateOfGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Date of grant" } } }, "localname": "DateOfGrant", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "dateItemType" }, "bak_Debentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents debentures.", "label": "Debentures [Default Label]", "verboseLabel": "Debentures" } } }, "localname": "Debentures", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "bak_Debentures1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents debentures1 member.", "label": "Debentures1 member" } } }, "localname": "Debentures1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 2 [Member]" } } }, "localname": "Debentures2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 3 [Member]" } } }, "localname": "Debentures3Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 4 [Member]" } } }, "localname": "Debentures4Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 5 [Member]" } } }, "localname": "Debentures5Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 6 [Member]" } } }, "localname": "Debentures6Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_Debentures7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 7 [Member]" } } }, "localname": "Debentures7Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "domainItemType" }, "bak_DebenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Debentures" } } }, "localname": "DebenturesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_DebenturesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debentures current" } } }, "localname": "DebenturesCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents debentures member.", "label": "Debentures member" } } }, "localname": "DebenturesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails12", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_DebenturesNonCurrents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debentures non current" } } }, "localname": "DebenturesNonCurrents", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DebenturesNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents debentures noncurrent.", "label": "Debentures noncurrent", "verboseLabel": "Debentures" } } }, "localname": "DebenturesNoncurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DebenturesTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debentures total" } } }, "localname": "DebenturesTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DebtCashFlowsFromUsedInFinancingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents debt cash flows from used in financing activities.", "label": "Cash used in financing activities" } } }, "localname": "DebtCashFlowsFromUsedInFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DecriptionOfFairValueAtRisk": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents decription of fair value at risk.", "label": "Decription of fair value at risk" } } }, "localname": "DecriptionOfFairValueAtRisk", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_DeferredTaxAssets1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax assets1.", "label": "Deferred tax assets1" } } }, "localname": "DeferredTaxAssets1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxAssets2": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax assets2.", "label": "Balance, assets" } } }, "localname": "DeferredTaxAssets2", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxAssetsNonCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax assets non current.", "label": "Deferred tax assets non current", "verboseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxCredits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred tax credits" } } }, "localname": "DeferredTaxCredits", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxLiabilities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax liabilities1.", "label": "Deferred tax liabilities1" } } }, "localname": "DeferredTaxLiabilities1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxLiabilities2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax liabilities2.", "label": "Balance, liabilities" } } }, "localname": "DeferredTaxLiabilities2", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_DeferredTaxLiabilityAsset1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax liability asset1.", "label": "Ending balance" } } }, "localname": "DeferredTaxLiabilityAsset1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents defined benefit member.", "label": "Defined benefit member" } } }, "localname": "DefinedBenefitMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "domainItemType" }, "bak_DefinedBenefitObligationAtPresentValue2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents defined benefit obligation at present value2.", "label": "Total obligations" } } }, "localname": "DefinedBenefitObligationAtPresentValue2", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DepartmentOfJusticeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents department of justice member.", "label": "Department of justice member" } } }, "localname": "DepartmentOfJusticeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails" ], "xbrltype": "domainItemType" }, "bak_DepositsYieldsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents deposits yields rate.", "label": "Deposits yields rate" } } }, "localname": "DepositsYieldsRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_DepreciationAmortizationAndDepletionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents depreciation amortization and depletion member.", "label": "Depreciation amortization and depletion member" } } }, "localname": "DepreciationAmortizationAndDepletionMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_DepreciationRatePropertyPlantAndEquipments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents depreciation rate property plant and equipments.", "label": "Depreciation rate, property, plant and equipment" } } }, "localname": "DepreciationRatePropertyPlantAndEquipments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_DerivativeFinancialAssetsAndLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents derivative financial assets and liabilities.", "label": "Derivative financial assets and liabilities" } } }, "localname": "DerivativeFinancialAssetsAndLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DerivativesNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents derivatives non current.", "label": "Derivatives non current", "verboseLabel": "Derivatives" } } }, "localname": "DerivativesNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DervativeNotionalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents dervative notional amount.", "label": "Dervative notional amount", "verboseLabel": "Notional amount" } } }, "localname": "DervativeNotionalAmount", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_DescriptionOfAccountingPolicyForConsolidationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of consolidation" } } }, "localname": "DescriptionOfAccountingPolicyForConsolidationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "bak_DescriptionOfBorrowingInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents description of borrowing interest rate.", "label": "Description of borrowing interest rate" } } }, "localname": "DescriptionOfBorrowingInterestRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "stringItemType" }, "bak_DescriptionOfIndividualActions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of individual actions" } } }, "localname": "DescriptionOfIndividualActions", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_DescriptionOfPropertyPlantAndEquipmentShutdownsDuration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents description of property plant and equipment shutdowns duration.", "label": "Description of property, plant and equipment shutdowns duration" } } }, "localname": "DescriptionOfPropertyPlantAndEquipmentShutdownsDuration", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_DescriptionOfReparationForResidents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents description of reparation for residents.", "label": "Description of reparation for residents" } } }, "localname": "DescriptionOfReparationForResidents", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_DescriptionOfReparationForSocialenvironmental": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents description of reparation for socialenvironmental.", "label": "Description of reparation for social-environmental" } } }, "localname": "DescriptionOfReparationForSocialenvironmental", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_DesignatedAndUnrealizedSalesNominalValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Designated and unrealized sales nominal value" } } }, "localname": "DesignatedAndUnrealizedSalesNominalValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "monetaryItemType" }, "bak_DilutedEarningsLossPerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit (loss) per share, diluted" } } }, "localname": "DilutedEarningsLossPerShare1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "bak_DisclosureGeologicalPhenomenonAlagoasExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geological event - Alagoas" } } }, "localname": "DisclosureGeologicalPhenomenonAlagoasExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-Alagoas" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureLeniencyAgreementExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leniency agreement with authorities" } } }, "localname": "DisclosureLeniencyAgreementExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthorities" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfActuarialAssumptionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Actuarial assumptions" } } }, "localname": "DisclosureOfActuarialAssumptionsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfAmortizationEstimatedUsefulLifeExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amortization estimated useful life" } } }, "localname": "DisclosureOfAmortizationEstimatedUsefulLifeExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfBasisOfPresentationPoliciesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of presentation" } } }, "localname": "DisclosureOfBasisOfPresentationPoliciesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfBenefitAmountsRecognizedInProfitAndLossExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amounts recognized in profit and loss" } } }, "localname": "DisclosureOfBenefitAmountsRecognizedInProfitAndLossExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfBenefitsSensitivityAnalysisExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sensitivity analysis" } } }, "localname": "DisclosureOfBenefitsSensitivityAnalysisExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfBondsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of bonds" } } }, "localname": "DisclosureOfBondsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfBorrowingsInformationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of borrowings" } } }, "localname": "DisclosureOfBorrowingsInformationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfCashFlowtRrelatedToTheContractsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of cash flows related to the contracts" } } }, "localname": "DisclosureOfCashFlowtRrelatedToTheContractsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInDeferredTaxesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureOfChangesInDeferredTaxesExplanatory", "verboseLabel": "Schedule of changes in balances of deferred tax assets and liabilities" } } }, "localname": "DisclosureOfChangesInDeferredTaxesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInDefinedBenefitObligationsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in obligations" } } }, "localname": "DisclosureOfChangesInDefinedBenefitObligationsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in derivative financial instruments" } } }, "localname": "DisclosureOfChangesInDerivativeFinancialInstrumentsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInFairValuePlanAssetsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in fair value plan assets" } } }, "localname": "DisclosureOfChangesInFairValuePlanAssetsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in foreign exchange variation and income tax and social contribution - Braskem Idesa" } } }, "localname": "DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionBraskemIdesaExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in foreign exchange variation and income tax and social contribution" } } }, "localname": "DisclosureOfChangesInForeignExchangeVariationAndIncomeTaxAndSocialContributionExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInIntangibleAssetsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in intangible assets" } } }, "localname": "DisclosureOfChangesInIntangibleAssetsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInInvestmentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Changes in investments" } } }, "localname": "DisclosureOfChangesInInvestmentsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of carrying amount" } } }, "localname": "DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfChangesInSundryProvisionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in sundry provisions" } } }, "localname": "DisclosureOfChangesInSundryProvisionsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Claims with probable chance of loss and contingent liabilities" } } }, "localname": "DisclosureOfClaimsWithProbableChanceOfLossAndClaimsArisingFromBusinessCombinationsWithPossibleLossExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfClaimsWithProbableChanceOfLossExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of claims with probable chance of loss" } } }, "localname": "DisclosureOfClaimsWithProbableChanceOfLossExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfContractualObligationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual obligations" } } }, "localname": "DisclosureOfContractualObligationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ContractualObligations" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDebentureMaturitiesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of long-term debenture maturity" } } }, "localname": "DisclosureOfDebentureMaturitiesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDebenturesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of debentures" } } }, "localname": "DisclosureOfDebenturesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of deferred taxes offset for the purpose of presentation in the balance sheet" } } }, "localname": "DisclosureOfDeferredTaxesOffsetForThePurposeOfPresentationInTheBalanceSheetExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDefinedBenefitObligationsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of defined benefit obligations" } } }, "localname": "DisclosureOfDefinedBenefitObligationsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDesignatedAndUnrealizedSalesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of designated and unrealized sales" } } }, "localname": "DisclosureOfDesignatedAndUnrealizedSalesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of cash and cash equivalents" } } }, "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of borrowing activities in the statement of cash flow" } } }, "localname": "DisclosureOfDetailedInformationAboutCashFlowStatementExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Expenses by nature and function" } } }, "localname": "DisclosureOfDetailedInformationAboutExpensesByNatureExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailedInformationAboutTaxPayableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of taxes payable" } } }, "localname": "DisclosureOfDetailedInformationAboutTaxPayableExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayableTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule or trade account payables" } } }, "localname": "DisclosureOfDetailedInformationAboutTradeAccountPayablesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradePayablesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in allowance for doubtful accounts" } } }, "localname": "DisclosureOfDetailsInformationAboutChangesInAllowanceForDoubtfulAccountsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in lease liabilities" } } }, "localname": "DisclosureOfDetailsInformationAboutChangesInLeaseLiabilityExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in right-of-use assets" } } }, "localname": "DisclosureOfDetailsInformationAboutChangesInRightofuseAssetsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial investments" } } }, "localname": "DisclosureOfDetailsInformationAboutFinancialInvestmentsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of payment schedule by maturity" } } }, "localname": "DisclosureOfDetailsInformationAboutPaymentScheduleByMaturityExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of provision for inventories" } } }, "localname": "DisclosureOfDetailsInformationAboutProvisionForInventoriesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfEarningsPerShareReconciliationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of profit or loss" } } }, "localname": "DisclosureOfEarningsPerShareReconciliationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfExchangeVariationBraskemIdesaExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of exchange variation - Braskem Idesa" } } }, "localname": "DisclosureOfExchangeVariationBraskemIdesaExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfExchangeVariationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of exchange variation" } } }, "localname": "DisclosureOfExchangeVariationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of effects from exchange variation on the Company?transactions are mainly due to the variations" } } }, "localname": "DisclosureOfExchangeVariationOnCompanyTransactionTableTextBlock", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFairValueAdjustmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Adjustment" } } }, "localname": "DisclosureOfFairValueAdjustmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial assets with and without risk assessment" } } }, "localname": "DisclosureOfFinancialAssetsWithAndWithoutRiskAssessmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario" } } }, "localname": "DisclosureOfFinancialInstrumentSensitivityAnalysisExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial instruments designated for hedge" } } }, "localname": "DisclosureOfFinancialInstrumentsDesignatedForHedgeOneExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFinancialResultsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of results by segment" } } }, "localname": "DisclosureOfFinancialResultsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFinancingsForInvestmentsInPlantsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of others" } } }, "localname": "DisclosureOfFinancingsForInvestmentsInPlantsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfForeignIncomeTaxRatesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in balances of deferred tax assets and liabilities" } } }, "localname": "DisclosureOfForeignIncomeTaxRatesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfFunctionalCurrencyExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of subsidiaries with a functional currency" } } }, "localname": "DisclosureOfFunctionalCurrencyExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfGoodwillImpairmentTestingExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of goodwill impairment testing" } } }, "localname": "DisclosureOfGoodwillImpairmentTestingExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfImpactOnConsolidationOfBraskemIdesaExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial information of the subsidiary in which the non-controlling shareholder holds interests" } } }, "localname": "DisclosureOfImpactOnConsolidationOfBraskemIdesaExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of income tax and social contribution reconciliation" } } }, "localname": "DisclosureOfIncomeTaxAndSocialContributionReconciliationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfIntangibleAssetsByCountryExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of intangible assets by country" } } }, "localname": "DisclosureOfIntangibleAssetsByCountryExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfInventoryExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of inventory" } } }, "localname": "DisclosureOfInventoryExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfInvestmentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Information on investments" } } }, "localname": "DisclosureOfInvestmentsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfLongTermBorrowingsMaturitiesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of long-term maturities" } } }, "localname": "DisclosureOfLongTermBorrowingsMaturitiesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfNetRevenueByCountryExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of revenue by country" } } }, "localname": "DisclosureOfNetRevenueByCountryExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of non-derivative financial instruments and other liabilities" } } }, "localname": "DisclosureOfNonderivativeFinancialInstrumentsAndLeniencyAgreementExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of non-derivative financial liabilities designated to hedge accounting" } } }, "localname": "DisclosureOfNonderivativeFinancialLiabilitiesDesignatedToHedgeAccountingExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfOtherBorrowingsAmortizationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of long-term maturities of these financing" } } }, "localname": "DisclosureOfOtherBorrowingsAmortizationExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfOtherBorrowingsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of braskem idesa financing" } } }, "localname": "DisclosureOfOtherBorrowingsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfOthersCRAExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of others - CRA" } } }, "localname": "DisclosureOfOthersCRAExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of property, plant and equipment and intangible assets by segment" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsBySegmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfPropertyPlantAndEquipmentByCountryExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of property plant and equipment by country" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentByCountryExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfProvisionsForLegalProceedingsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provisions for legal proceedings and contingent liabilities" } } }, "localname": "DisclosureOfProvisionsForLegalProceedingsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilities" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfResultsBySegmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Results by segment" } } }, "localname": "DisclosureOfResultsBySegmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfRevenueByProductExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of revenue by product" } } }, "localname": "DisclosureOfRevenueByProductExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfSalesAndServiceRevenueExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of sales and service revenue" } } }, "localname": "DisclosureOfSalesAndServiceRevenueExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfShortTermBenefitsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of short-term benefits" } } }, "localname": "DisclosureOfShortTermBenefitsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfSundryProvisionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of sundry provisions" } } }, "localname": "DisclosureOfSundryProvisionsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTaxIncentivesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax incentives" } } }, "localname": "DisclosureOfTaxIncentivesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxIncentives" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTaxPayableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureOfTaxPayableExplanatory", "verboseLabel": "Taxes payable" } } }, "localname": "DisclosureOfTaxPayableExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayable" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTaxRecoverableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureOfTaxRecoverableExplanatory", "verboseLabel": "Taxes recoverable" } } }, "localname": "DisclosureOfTaxRecoverableExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverable" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTaxesRecoverableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of taxes recoverable" } } }, "localname": "DisclosureOfTaxesRecoverableExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of trade accounts receivable by credit ratings" } } }, "localname": "DisclosureOfTradeAccountsReceivableByCreditRatingExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTradeAccountsReceivableByMaturityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of trade accounts receivable by maturity" } } }, "localname": "DisclosureOfTradeAccountsReceivableByMaturityExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureOfTradeAccountsReceivableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of trade accounts receivable" } } }, "localname": "DisclosureOfTradeAccountsReceivableExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right-of-use assets and lease liability" } } }, "localname": "DisclosureRightofuseAssetsAndLeaseLiabilityExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiability" ], "xbrltype": "textBlockItemType" }, "bak_DisclsoureOfChangesInSharesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Changes in shares during the year" } } }, "localname": "DisclsoureOfChangesInSharesExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclsoureOfRetainedEarningsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accumulated losses" } } }, "localname": "DisclsoureOfRetainedEarningsExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityTables" ], "xbrltype": "textBlockItemType" }, "bak_DisclsoureOfSharesDistributedExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of shares distributed" } } }, "localname": "DisclsoureOfSharesDistributedExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityTables" ], "xbrltype": "textBlockItemType" }, "bak_DiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discount rate" } } }, "localname": "DiscountRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1" ], "xbrltype": "percentItemType" }, "bak_DiscountsGrantedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents discounts granted member.", "label": "Discounts granted member" } } }, "localname": "DiscountsGrantedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_DisposalOfRightofuseAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents disposal of rightofuse assets.", "label": "Disposal" } } }, "localname": "DisposalOfRightofuseAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "bak_DisposalsOfLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents disposals of lease liabilities.", "label": "Disposals" } } }, "localname": "DisposalsOfLeaseLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_DisposalsPropertyPlantAndEquipmentCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents disposals property plant and equipment cost.", "label": "Disposals property plant and equipment cost", "verboseLabel": "Cost" } } }, "localname": "DisposalsPropertyPlantAndEquipmentCost", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_DisposalsPropertyPlantAndEquipmentDepletion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents disposals property plant and equipment depletion.", "label": "Disposals property plant and equipment depletion", "verboseLabel": "Depreciation" } } }, "localname": "DisposalsPropertyPlantAndEquipmentDepletion", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_DisposalsPropertyPlantAndEquipmentTransferOthers": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents disposals property plant and equipment transfer others.", "label": "Disposals property plant and equipment transfer others" } } }, "localname": "DisposalsPropertyPlantAndEquipmentTransferOthers", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_DistributionCosts1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents distribution costs1.", "label": "Selling and distribution" } } }, "localname": "DistributionCosts1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_DistributionOfPlusIncomeBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of plus income basic.", "label": "Distribution of excess profits, by class basic" } } }, "localname": "DistributionOfPlusIncomeBasic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DistributionOfPlusIncomeDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of plus income diluted.", "label": "Distribution of excess profits, by class diluted" } } }, "localname": "DistributionOfPlusIncomeDiluted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DistributionOfUnitValueOPriorityDividendsBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of unit value o priority dividends basic.", "label": "Distribution of priority dividends attributable to basic" } } }, "localname": "DistributionOfUnitValueOPriorityDividendsBasic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DistributionOfUnitValueOfCommonSharesBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of unit value of common shares basic.", "label": "Distribution of 6% ??ofunit price of common shares, basic" } } }, "localname": "DistributionOfUnitValueOfCommonSharesBasic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DistributionOfUnitValueOfCommonSharesDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of unit value of common shares diluted.", "label": "Distribution of 6% ??ofunit price of common shares, diluted" } } }, "localname": "DistributionOfUnitValueOfCommonSharesDiluted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DistributionOfUnitValueOfPriorityDividendsDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents distribution of unit value of priority dividends diluted.", "label": "Distribution of priority dividends attributable to diluted" } } }, "localname": "DistributionOfUnitValueOfPriorityDividendsDiluted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_DividendsCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Dividends current" } } }, "localname": "DividendsCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DividendsLapseOfStatuteOfLimitation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Dividends-lapse of statute of limitation" } } }, "localname": "DividendsLapseOfStatuteOfLimitation", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_DividendsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividends [Member]" } } }, "localname": "DividendsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_DividendsTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Dividends total" } } }, "localname": "DividendsTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_DollarCallAndPutOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents dollar call and put options member.", "label": "Dollar call and put options member" } } }, "localname": "DollarCallAndPutOptionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_DollarSwapCDIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents dollar swap c d i member.", "label": "Dollar swap c d i member" } } }, "localname": "DollarSwapCDIMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_DollarSwapIPCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dollar Swap I P C A [Member]" } } }, "localname": "DollarSwapIPCAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_DomesticMarketMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents domestic market member.", "label": "Domestic market member" } } }, "localname": "DomesticMarketMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_DomesticMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents domestic member.", "label": "Domestic member" } } }, "localname": "DomesticMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_ESMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents e s member.", "label": "E s member" } } }, "localname": "ESMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_ETBEGasolineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents e t b e gasoline member.", "label": "E t b e gasoline member" } } }, "localname": "ETBEGasolineMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_EarlyPaymentdebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents early paymentdebt member.", "label": "Early paymentdebt member" } } }, "localname": "EarlyPaymentdebtMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "bak_EarningsLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share" } } }, "localname": "EarningsLossPerShareAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_EffectFromRetrospectiveTaxRateOnBonusDepreciationOfBraskemAmerica": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents effect from retrospective tax rate on bonus depreciation of braskem america.", "label": "Effect from the retrospective tax rate on bonus depreciation of Braskem America" } } }, "localname": "EffectFromRetrospectiveTaxRateOnBonusDepreciationOfBraskemAmerica", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_EffectOfRefundOfBraskemAmericasTaxBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents effect of refund of braskem americas tax benefit.", "label": "Effect of the refund of Braskem America\u00b4s tax benefit" } } }, "localname": "EffectOfRefundOfBraskemAmericasTaxBenefit", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_EliminationsAndReclassificationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents eliminations and reclassifications member.", "label": "Eliminations and reclassifications member" } } }, "localname": "EliminationsAndReclassificationsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bak_EliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Eliminations [Member]" } } }, "localname": "EliminationsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "domainItemType" }, "bak_EndOfGracePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "End of grace period" } } }, "localname": "EndOfGracePeriod", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "stringItemType" }, "bak_EnergyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents energy agreement member.", "label": "Energy agreement member" } } }, "localname": "EnergyAgreementMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ContractualObligationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_EnvironmentalClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents environmental claims member.", "label": "Environmental claims member" } } }, "localname": "EnvironmentalClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_EnvironmentalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents environmental member.", "label": "Environmental member" } } }, "localname": "EnvironmentalMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_EquityInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity interest rate" } } }, "localname": "EquityInterestRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_EquityValuationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Equity valuation adjustments" } } }, "localname": "EquityValuationAdjustments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_EquityValuationAdjustmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity valuation adjustments:" } } }, "localname": "EquityValuationAdjustmentsAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "stringItemType" }, "bak_EstimatedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Estimated amount" } } }, "localname": "EstimatedAmount", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_EstimatedUsefulLives": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents estimated useful lives.", "label": "Estimates useful lives" } } }, "localname": "EstimatedUsefulLives", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "bak_EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives" } } }, "localname": "EstimatesUsefullLivesInPropertyPlantAndEquipmentExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "bak_EthylenePropyleneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents ethylene propylene member.", "label": "Ethylene propylene member" } } }, "localname": "EthylenePropyleneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_EuroBrazilianRealMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents euro brazilian real member.", "label": "Euro brazilian real member" } } }, "localname": "EuroBrazilianRealMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_EventsAfterReportingPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents events after reporting period member.", "label": "Events after reporting period member" } } }, "localname": "EventsAfterReportingPeriodMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_ExchangeVariationEffectsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exchange variation effects axis.", "label": "Exchange variation effects [axis]" } } }, "localname": "ExchangeVariationEffectsAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "stringItemType" }, "bak_ExchangeVariationEffectsDomain": { "auth_ref": [], "localname": "ExchangeVariationEffectsDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_ExchangeVariationInHyperinflationaryEconomyNetOfTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents exchange variation in hyperinflationary economy net of taxes.", "label": "Exchange variation in hyperinflationary economy, net of taxes" } } }, "localname": "ExchangeVariationInHyperinflationaryEconomyNetOfTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_ExchangeVariationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exchange variation member.", "label": "Exchange variation member" } } }, "localname": "ExchangeVariationMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6", "http://braskem.com./role/FinancialInstrumentsDetails9" ], "xbrltype": "domainItemType" }, "bak_ExchangeVariationRecordedInPeriodIr": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Exchange variation recorded in the period / IR" } } }, "localname": "ExchangeVariationRecordedInPeriodIr", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails9" ], "xbrltype": "monetaryItemType" }, "bak_ExchangeVariationRecordedInPeriodOnOciIrAndCsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents exchange variation recorded in period on oci ir and csl.", "label": "Exchange variation recorded in the period on OCI / IR and CSL" } } }, "localname": "ExchangeVariationRecordedInPeriodOnOciIrAndCsl", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6" ], "xbrltype": "monetaryItemType" }, "bak_ExchangeVariationTransferredToProfitOrLossIr": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Exchange variation transferred to profit or loss / IR" } } }, "localname": "ExchangeVariationTransferredToProfitOrLossIr", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails9" ], "xbrltype": "monetaryItemType" }, "bak_ExchangeVariationTransferredToProfitOrLossIrAndCsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents exchange variation transferred to profit or loss ir and csl.", "label": "Exchange variation transferred to profit or loss / IR and CSL" } } }, "localname": "ExchangeVariationTransferredToProfitOrLossIrAndCsl", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6" ], "xbrltype": "monetaryItemType" }, "bak_ExchangeVariationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exchange variations member.", "label": "Exchange variations member" } } }, "localname": "ExchangeVariationsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_ExclusionOfICMSInBasisOfCalculationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exclusion of i c m s in basis of calculation member.", "label": "Exclusion of i c m s in basis of calculation member" } } }, "localname": "ExclusionOfICMSInBasisOfCalculationMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_ExclusionOfInflationAdjustementBySelicOnUndueTaxPaymentsFromTaxableIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents exclusion of inflation adjustement by selic on undue tax payments from taxable income.", "label": "Exclusion of inflation adjustement by Selic on undue tax payments from taxable income" } } }, "localname": "ExclusionOfInflationAdjustementBySelicOnUndueTaxPaymentsFromTaxableIncome", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_ExpectedCreditLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents expected credit losses.", "label": "Expected credit losses" } } }, "localname": "ExpectedCreditLosses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "bak_ExpectedCreditLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected Credit Losses [Member]" } } }, "localname": "ExpectedCreditLossesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_ExpensesByNatureAndFunctionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses By Nature And Function" } } }, "localname": "ExpensesByNatureAndFunctionAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_ExportCreditNotes1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents export credit notes1 member.", "label": "Export credit notes1 member" } } }, "localname": "ExportCreditNotes1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_ExportCreditNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Export Credit Notes [Member]" } } }, "localname": "ExportCreditNotesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_ExportPrepaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents export prepayment member.", "label": "Export prepayment member" } } }, "localname": "ExportPrepaymentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_ExportPrepaymentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents export prepayments member.", "label": "Export prepayments member" } } }, "localname": "ExportPrepaymentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_ExportsDesignatedForHedgeGrossNominalValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents exports designated for hedge gross nominal value.", "label": "Exports designated for hedge gross nominal value" } } }, "localname": "ExportsDesignatedForHedgeGrossNominalValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "monetaryItemType" }, "bak_ExportsDesignatedForHedgeNominalValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents exports designated for hedge nominal value.", "label": "Exports designated for hedge nominal value" } } }, "localname": "ExportsDesignatedForHedgeNominalValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "monetaryItemType" }, "bak_ExposureValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents exposure value.", "label": "Exposure value" } } }, "localname": "ExposureValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "monetaryItemType" }, "bak_ExtremeAdverseSensitivityGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents extreme adverse sensitivity gain loss.", "label": "Possible gain (loss)" } } }, "localname": "ExtremeAdverseSensitivityGainLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "monetaryItemType" }, "bak_FRMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents f r member.", "label": "F r member" } } }, "localname": "FRMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_FairValueAdjustmentsOfTradeAccountsReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents fair value adjustments of trade accounts receivable.", "label": "Fair value adjustments of trade accounts receivable, net of taxes" } } }, "localname": "FairValueAdjustmentsOfTradeAccountsReceivable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_FairValueNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value, net" } } }, "localname": "FairValueNet", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_FairValueOfFinancialTransactionsOfNoncontrollingSubsidiaries": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of financial transactions of non-controlling subsidiaries" } } }, "localname": "FairValueOfFinancialTransactionsOfNoncontrollingSubsidiaries", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_FairValueOfShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value of the share" } } }, "localname": "FairValueOfShare", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "perShareItemType" }, "bak_FairValueOfShareValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value of the share, value" } } }, "localname": "FairValueOfShareValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "perShareItemType" }, "bak_FairValuePlanAssetsBenefitsPaidOrPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents fair value plan assets benefits paid or payable.", "label": "Fair value plan assets benefits paid or payable", "verboseLabel": "Benefits paid" } } }, "localname": "FairValuePlanAssetsBenefitsPaidOrPayable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4" ], "xbrltype": "monetaryItemType" }, "bak_FederalControllerGeneralAndAttorneyGenerallAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents federal controller general and attorney generall agreement member.", "label": "Federal controller general and attorney generall agreement member" } } }, "localname": "FederalControllerGeneralAndAttorneyGenerallAgreementMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails" ], "xbrltype": "domainItemType" }, "bak_FederalProsecutionOfficeAndUSSwissAuthoritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents federal prosecution office and u s swiss authorities member.", "label": "Federal prosecution office and u s swiss authorities member" } } }, "localname": "FederalProsecutionOfficeAndUSSwissAuthoritiesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_FederalProsecutionOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents federal prosecution office member.", "label": "Federal prosecution office member" } } }, "localname": "FederalProsecutionOfficeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails" ], "xbrltype": "domainItemType" }, "bak_FederalSupervenienceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents federal supervenience member.", "label": "Federal supervenience member" } } }, "localname": "FederalSupervenienceMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_FeedingBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents feeding benefits member.", "label": "Feeding benefits member" } } }, "localname": "FeedingBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_FinanceIncomeCost1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents finance income cost1.", "label": "Finance income cost1" } } }, "localname": "FinanceIncomeCost1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_FinancialChargesCapitalized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents financial charges capitalized.", "label": "Capitalized financial charges" } } }, "localname": "FinancialChargesCapitalized", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_FinancialIncomeCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial results" } } }, "localname": "FinancialIncomeCostAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "bak_FinancialIncomeExpenseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial income expense axis.", "label": "Financial income expense [axis]" } } }, "localname": "FinancialIncomeExpenseAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "stringItemType" }, "bak_FinancialIncomeExpenseDomain": { "auth_ref": [], "localname": "FinancialIncomeExpenseDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_FinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments" } } }, "localname": "FinancialInstrumentsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_FinancialInterestExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial interest expenses member.", "label": "Financial interest expenses member" } } }, "localname": "FinancialInterestExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_FinancialInterestIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial interest income member.", "label": "Financial interest income member" } } }, "localname": "FinancialInterestIncomeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_FinancialInvestmentsAbroadMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial investments abroad member.", "label": "Financial investments abroad member" } } }, "localname": "FinancialInvestmentsAbroadMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_FinancialInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Investments" } } }, "localname": "FinancialInvestmentsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_FinancialInvestmentsInBrazilMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial investments in brazil member.", "label": "Financial investments in brazil member" } } }, "localname": "FinancialInvestmentsInBrazilMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_FinancialInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents financial investments member.", "label": "Financial investments member" } } }, "localname": "FinancialInvestmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_FinancialLiabilityMaturitiesNominalValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financial liability maturities nominal value" } } }, "localname": "FinancialLiabilityMaturitiesNominalValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3" ], "xbrltype": "monetaryItemType" }, "bak_FinancialResultsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Results" } } }, "localname": "FinancialResultsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_FinancingCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "financing current" } } }, "localname": "FinancingCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_FinancingNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "financing non current" } } }, "localname": "FinancingNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_FinancingTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financing total" } } }, "localname": "FinancingTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_FirstQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Quarter [Member]" } } }, "localname": "FirstQuarterMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "domainItemType" }, "bak_ForeignCurrencyBondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Bond [Member]" } } }, "localname": "ForeignCurrencyBondMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_ForeignCurrencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents foreign currency member.", "label": "Foreign currency member" } } }, "localname": "ForeignCurrencyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4" ], "xbrltype": "domainItemType" }, "bak_ForeignCurrencyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents foreign currency three member.", "label": "Foreign currency three member" } } }, "localname": "ForeignCurrencyThreeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_ForeignCurrencyTranslationAdjustmentRightofuseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents foreign currency translation adjustment rightofuse assets.", "label": "Foreign currency translation adjustment rightofuse assets", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "ForeignCurrencyTranslationAdjustmentRightofuseAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "bak_ForeignMarketMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents foreign market member.", "label": "Foreign market member" } } }, "localname": "ForeignMarketMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_FourthQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fourth Quarter [Member]" } } }, "localname": "FourthQuarterMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "domainItemType" }, "bak_FreightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents freights member.", "label": "Freights member" } } }, "localname": "FreightsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_FunctionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents function member.", "label": "Function member" } } }, "localname": "FunctionMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_FutureExportsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents future exports member.", "label": "Future exports member" } } }, "localname": "FutureExportsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_FutureExportsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Future Exports One [Member]" } } }, "localname": "FutureExportsOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_GBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents g b member.", "label": "G b member" } } }, "localname": "GBMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_GainOnDerivativesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gain On Derivatives [Member]" } } }, "localname": "GainOnDerivativesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_GainOnTransferOfSharesInCustodyLongTermIncentivePLan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents gain on transfer of shares in custody long term incentive p lan.", "label": "Gain on transfer of shares in custody long term incentive plan" } } }, "localname": "GainOnTransferOfSharesInCustodyLongTermIncentivePLan", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_GainsLossesOnCashFlowHedgesFromJointlyControlledNetOfTax": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of cash flow hedge from jointly-controlled, net of taxes" } } }, "localname": "GainsLossesOnCashFlowHedgesFromJointlyControlledNetOfTax", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_GainsLossesOnSalesHedgesBeforeTax": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "bak_OtherComprehensiveIncomeNetOfTaxSalesHedges", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents gains losses on sales hedges before tax.", "label": "Sales Hedge - transfer to profit or loss, net of taxes" } } }, "localname": "GainsLossesOnSalesHedgesBeforeTax", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_GeneralAndAdministrativeExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpenses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_GeneralAndAdministrativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents general and administrative member.", "label": "General and administrative member" } } }, "localname": "GeneralAndAdministrativeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_GeologicalEventAlagoasAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geological Event - Alagoas" } } }, "localname": "GeologicalEventAlagoasAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_GeologicalEventInAlagoas": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "GeologicalEventInAlagoas", "negatedLabel": "Geological event in Alagoas", "negatedTerseLabel": "" } } }, "localname": "GeologicalEventInAlagoas", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_GermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents germany member.", "label": "Germany [member]" } } }, "localname": "GermanyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "domainItemType" }, "bak_GoodwillAmortizedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents goodwill amortized member.", "label": "Goodwill amortized member" } } }, "localname": "GoodwillAmortizedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_GoodwillBasedOnExpectedFutureProfitabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents goodwill based on expected future profitability member.", "label": "Goodwill based on expected future profitability member" } } }, "localname": "GoodwillBasedOnExpectedFutureProfitabilityMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "bak_GrantedQuantitiesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Granted quantities, shares" } } }, "localname": "GrantedQuantitiesShares", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "sharesItemType" }, "bak_GrossTradeReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents gross trade receivables.", "label": "Trade accounts receivable, gross" } } }, "localname": "GrossTradeReceivables", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "bak_HealthCareBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents health care benefits member.", "label": "Health care benefits member" } } }, "localname": "HealthCareBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_HealthCarePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents health care plan member.", "label": "Health care plan member" } } }, "localname": "HealthCarePlanMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "domainItemType" }, "bak_HealthInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents health insurance member.", "label": "Health insurance member" } } }, "localname": "HealthInsuranceMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "bak_HedgeAccountingDiscontinued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents hedge accounting discontinued.", "label": "Hedge accounting discontinued" } } }, "localname": "HedgeAccountingDiscontinued", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_HedgeAccountingTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents hedge accounting transactions member.", "label": "Hedge accounting transactions member" } } }, "localname": "HedgeAccountingTransactionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_HedgeAccountingsDiscontinued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "HedgeAccountingsDiscontinued", "verboseLabel": "Hedge accounting discontinued" } } }, "localname": "HedgeAccountingsDiscontinued", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_HedgeInstrumentDesignations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents hedge instrument designations.", "label": "Designations" } } }, "localname": "HedgeInstrumentDesignations", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4" ], "xbrltype": "monetaryItemType" }, "bak_HedgedItemLiabilities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents hedged item liabilities1.", "label": "Hedged item liabilities1", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "HedgedItemLiabilities1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails9" ], "xbrltype": "monetaryItemType" }, "bak_HighRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents high risk member.", "label": "High risk member" } } }, "localname": "HighRiskMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "domainItemType" }, "bak_ICMSCreditsFromPropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i c m s credits from property plant and equipment member.", "label": "I c m s credits from property plant and equipment member" } } }, "localname": "ICMSCreditsFromPropertyPlantAndEquipmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_ICMSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i c m s member.", "label": "I c m s member" } } }, "localname": "ICMSMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_IPCAInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i p c a interest rate member.", "label": "I p c a interest rate member" } } }, "localname": "IPCAInterestRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_IPIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i p i member.", "label": "I p i member" } } }, "localname": "IPIMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_IRAndCSLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i r and c s l member.", "label": "I r and c s l member" } } }, "localname": "IRAndCSLMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_IRPJAndCSLLForeignEarnedIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i r p j and c s l l foreign earned income member.", "label": "I r p j and c s l l foreign earned income member" } } }, "localname": "IRPJAndCSLLForeignEarnedIncomeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_IRPJCSLLNegativeBalanceOffsetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i r p j c s l l negative balance offset member.", "label": "I r p j c s l l negative balance offset member" } } }, "localname": "IRPJCSLLNegativeBalanceOffsetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_IRRFIRAndCSLCommissionExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i r r f i r and c s l commission expenses member.", "label": "I r r f i r and c s l commission expenses member" } } }, "localname": "IRRFIRAndCSLCommissionExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_ITMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents i t member.", "label": "I t member" } } }, "localname": "ITMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_IfrsStatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "localname": "IfrsStatementLineItems", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/ContractualObligationsDetailsNarrative", "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/DebenturesDetails1", "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/EquityDetails2", "http://braskem.com./role/EquityDetailsNarrative", "http://braskem.com./role/ExpensesByNatureAndFunctionDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails10", "http://braskem.com./role/FinancialInstrumentsDetails11", "http://braskem.com./role/FinancialInstrumentsDetails12", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails6", "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative", "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/FinancialInvestmentsDetailsNarrative", "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/FinancialResultsDetails1", "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/IncomeTaxesDetails1", "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/IntangibleAssetsDetails", "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2", "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/InvestmentsDetails1", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/NetRevenueDetails2", "http://braskem.com./role/NetRevenueDetailsNarrative", "http://braskem.com./role/OperationsDetailsNarrative", "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/RelatedPartiesDetailsNarrative", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative", "http://braskem.com./role/RiskManagementDetails", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1", "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss", "http://braskem.com./role/SubsequentEventsDetailsNarrative", "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1", "http://braskem.com./role/TaxesPayableDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TaxesRecoverableDetailsNarrative", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "stringItemType" }, "bak_IfrsStatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementTable [Table]" } } }, "localname": "IfrsStatementTable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails", "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/FinancialResultsDetails1", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "stringItemType" }, "bak_ImpactsFromRussiaUkraineConflictPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impacts from Russia-Ukraine conflict" } } }, "localname": "ImpactsFromRussiaUkraineConflictPolicyTextBlock", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "bak_IncentiveLongTermPlanPaymentsWithTreasuryShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents incentive long term plan payments with treasury shares.", "label": "Incentive long term plan payments with treasury shares" } } }, "localname": "IncentiveLongTermPlanPaymentsWithTreasuryShares", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAndSocialContributionTaxCalculationAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents income tax and social contribution tax calculation assets.", "label": "Tax calculation, assets" } } }, "localname": "IncomeTaxAndSocialContributionTaxCalculationAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAndSocialContributionTaxCalculationLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents income tax and social contribution tax calculation liabilities.", "label": "Tax calculation, liabilities" } } }, "localname": "IncomeTaxAndSocialContributionTaxCalculationLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents income tax and social contribution tax i r and c s l offsetting assets.", "label": "IR and CSL offsetting, assets" } } }, "localname": "IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents income tax and social contribution tax i r and c s l offsetting liabilies.", "label": "IR and CSl offsetting, liabilites" } } }, "localname": "IncomeTaxAndSocialContributionTaxIRAndCSLOffsettingLiabilies", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAnsSocialContributionOnEquityInResultsOfInvestees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents income tax ans social contribution on equity in results of investees.", "label": "Income taxes on equity in results of investees" } } }, "localname": "IncomeTaxAnsSocialContributionOnEquityInResultsOfInvestees", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxAuthorityOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority One [Axis]", "verboseLabel": "IncomeTaxAuthorityOneAxis [Axis]" } } }, "localname": "IncomeTaxAuthorityOneAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "bak_IncomeTaxAuthorityOneDomain": { "auth_ref": [], "localname": "IncomeTaxAuthorityOneDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_IncomeTaxExpenseContinuingOperations12": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Effect of income taxes on results of operations" } } }, "localname": "IncomeTaxExpenseContinuingOperations12", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_IncomeTaxesCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents income taxes current.", "label": "Income taxes current" } } }, "localname": "IncomeTaxesCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxesNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Income taxes noncurrent" } } }, "localname": "IncomeTaxesNoncurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncomeTaxesPayable", "verboseLabel": "Income taxes payable" } } }, "localname": "IncomeTaxesPayable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_IncomeTaxndSocialContribution": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents income taxnd social contribution.", "label": "Income taxnd social contribution", "verboseLabel": "Total" } } }, "localname": "IncomeTaxndSocialContribution", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption.", "label": "Increase decrease in defined benefit obligation due to reasonably possible decrease in cost of service actuarial assumption" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInCostOfServiceActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption.", "label": "Increase decrease in defined benefit obligation due to reasonably possible decrease in interest cost actuarial assumption" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInInterestCostActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption.", "label": "Increase decrease in defined benefit obligation due to reasonably possible increase in cost of service actuarial assumption" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption.", "label": "Increase decrease in defined benefit obligation due to reasonably possible increase in interest cost actuarial assumption" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInInterestCostActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseInOtherFinancialAssets": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Judicial deposits - unfreezing (blocking) Public Civil Action", "verboseLabel": "" } } }, "localname": "IncreaseDecreaseInOtherFinancialAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease through changes in foreign exchange rates net fair value plan assets.", "label": "Exchange variation [Default Label]", "verboseLabel": "Exchange variation" } } }, "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetFairValuePlanAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillAmortization", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease through net exchange differences intangible assets and goodwill cost.", "label": "Increase decrease through net exchange differences intangible assets and goodwill cost", "verboseLabel": "Cost" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1", "verboseLabel": "Cost" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwillCost1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease through net exchange differences property plant and equipment cost.", "label": "Increase decrease through net exchange differences property plant and equipment cost", "verboseLabel": "Cost" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentCost", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents increase decrease through net exchange differences property plant and equipment depletion.", "label": "Depreciation" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentDepletion", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_InitialAdoptionOfLease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents initial adoption of lease.", "label": "Initial adoption of lease" } } }, "localname": "InitialAdoptionOfLease", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_IntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_IntangibleAssetsAndGoodwill1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents intangible assets and goodwill1.", "label": "Intangible assets and goodwill1", "verboseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsAndGoodwill1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails4" ], "xbrltype": "monetaryItemType" }, "bak_InterbankDepositRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interbank deposit rate member.", "label": "Interbank deposit rate member" } } }, "localname": "InterbankDepositRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents interest and monetary and exchange variations net classified as financing activities.", "label": "Interest and monetary and exchange variations, net" } } }, "localname": "InterestAndMonetaryAndExchangeVariationsNetClassifiedAsFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_InterestExpenseOnLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interest expense on leases member.", "label": "Interest expense on leases member" } } }, "localname": "InterestExpenseOnLeasesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_InterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interest rate.", "label": "Interest rate" } } }, "localname": "InterestRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_InterestRatePerYear": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest rate per year" } } }, "localname": "InterestRatePerYear", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "percentItemType" }, "bak_InterestsAndMonetaryAndExchangeVariationsNetOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents interests and monetary and exchange variations net of lease liabilities.", "label": "Interests and monetary and exchange variations, net" } } }, "localname": "InterestsAndMonetaryAndExchangeVariationsNetOfLeaseLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_InterestsPaidClassifiedAsFinancingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest paid" } } }, "localname": "InterestsPaidClassifiedAsFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_Inventories1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents inventories1.", "label": "Inventories1", "verboseLabel": "Inventories" } } }, "localname": "Inventories1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_InventoriesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Inventories" } } }, "localname": "InventoriesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_Investment1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents investment1 member.", "label": "Investment1 member" } } }, "localname": "Investment1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_Investment2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment 2 [Member]" } } }, "localname": "Investment2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_InvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment [Member]" } } }, "localname": "InvestmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Investments" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_IsolatedFineFailureToRatifyDCOMPSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents isolated fine failure to ratify d c o m p s member.", "label": "Isolated fine failure to ratify d c o m p s member" } } }, "localname": "IsolatedFineFailureToRatifyDCOMPSMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_ItEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents it equipment member.", "label": "It equipment member" } } }, "localname": "ItEquipmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "bak_JPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents j p member.", "label": "J p member" } } }, "localname": "JPMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_JudicialDeposits": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Judicial deposits" } } }, "localname": "JudicialDeposits", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_JudicialDepositsNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents judicial deposits non current.", "label": "Judicial deposits non current", "verboseLabel": "Judicial deposits" } } }, "localname": "JudicialDepositsNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_KRMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents k r member.", "label": "K r member" } } }, "localname": "KRMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_LFTAndLFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents l f t and l f member.", "label": "L f t and l f member" } } }, "localname": "LFTAndLFMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_LTIProgram2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "L T I Program 2018 [Member]" } } }, "localname": "LTIProgram2018Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_LUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents l u member.", "label": "L u member" } } }, "localname": "LUMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_LabEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents lab equipment member.", "label": "Lab equipment member" } } }, "localname": "LabEquipmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "bak_LaborClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents labor claims member.", "label": "Labor claims member" } } }, "localname": "LaborClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_LaterThanEightYearsAndNotLaterThanNineYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Eight Years And Not Later Than Nine Years [Member]" } } }, "localname": "LaterThanEightYearsAndNotLaterThanNineYearsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "bak_LaterThanFiveYearsAndNotLaterThanSixYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Five Years And Not Later Than Six Years [Member]" } } }, "localname": "LaterThanFiveYearsAndNotLaterThanSixYearsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "domainItemType" }, "bak_LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Fourty Years And Not Later Than Fourtyfive Years [Member]" } } }, "localname": "LaterThanFourtyYearsAndNotLaterThanFourtyfiveYearsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "bak_LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents later than ninety days and not later than one hundred and eighty days member.", "label": "Later than ninety days and not later than one hundred and eighty days member" } } }, "localname": "LaterThanNinetyDaysAndNotLaterThanOneHundredAndEightyDaysMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_LaterThanOneHundredAndEightyDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents later than one hundred and eighty days member.", "label": "Later than one hundred and eighty days member" } } }, "localname": "LaterThanOneHundredAndEightyDaysMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_LaterThanSixYearsAndNotLaterThanSevenYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Six Years And Not Later Than Seven Years [Member]" } } }, "localname": "LaterThanSixYearsAndNotLaterThanSevenYearsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "domainItemType" }, "bak_LaterThanTenYears1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Ten Years 1 [Member]" } } }, "localname": "LaterThanTenYears1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "bak_LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Later Than Thirty Years And Not Later Than Thirtyfive Years [Member]" } } }, "localname": "LaterThanThirtyYearsAndNotLaterThanThirtyfiveYearsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "bak_Lease": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease [Default Label]", "negatedLabel": "Lease", "verboseLabel": "Lease" } } }, "localname": "Lease", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_LeaseCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease current" } } }, "localname": "LeaseCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_LeaseCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents lease current liabilities.", "label": "Lease current liabilities" } } }, "localname": "LeaseCurrentLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_LeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease [Member]" } } }, "localname": "LeaseMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_LeaseNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease non current" } } }, "localname": "LeaseNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_LeaseNonCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents lease non current liabilities.", "label": "Lease non current liabilities" } } }, "localname": "LeaseNonCurrentLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_LeaseTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease total" } } }, "localname": "LeaseTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_LegalProceedingsProvision1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents legal proceedings provision1.", "label": "Balance at ending", "periodEndLabel": "Balance at ending", "periodStartLabel": "Balance at beginning" } } }, "localname": "LegalProceedingsProvision1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "bak_LegalReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents legal reserve.", "label": "Legal reserve" } } }, "localname": "LegalReserve", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_LeniencyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents leniency agreement member.", "label": "Leniency agreement member" } } }, "localname": "LeniencyAgreementMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_LeniencyAgreementWithAuthoritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leniency Agreement With Authorities" } } }, "localname": "LeniencyAgreementWithAuthoritiesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_LeniencyAgreements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents leniency agreements.", "label": "Leniency agreement (Note 25)" } } }, "localname": "LeniencyAgreements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "bak_LeniencyAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents leniency agreements member.", "label": "Leniency agreements member" } } }, "localname": "LeniencyAgreementsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_LetrasFinanceirasDoTesouroLFTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents letras financeiras do tesouro l f t member.", "label": "Letras financeiras do tesouro l f t member" } } }, "localname": "LetrasFinanceirasDoTesouroLFTMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_LiabilitiesCategoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents liabilities category member.", "label": "Liabilities category member" } } }, "localname": "LiabilitiesCategoryMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_LiborFloatingInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents libor floating interest rate member.", "label": "Libor floating interest rate member" } } }, "localname": "LiborFloatingInterestRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_LifeExpectancy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents life expectancy.", "label": "Life expectancy" } } }, "localname": "LifeExpectancy", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "durationItemType" }, "bak_LifeInsuranceBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents life insurance benefits member.", "label": "Life insurance benefits member" } } }, "localname": "LifeInsuranceBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_LitigationCasesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents litigation cases axis.", "label": "Litigation cases [axis]" } } }, "localname": "LitigationCasesAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "stringItemType" }, "bak_LitigationCasesDomain": { "auth_ref": [], "localname": "LitigationCasesDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_LoanAgreements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents loan agreements.", "label": "Loan agreements" } } }, "localname": "LoanAgreements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_LoanPaymentToNoncontrollingShareholdersOfBraskemIdesa": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LoanPaymentToNoncontrollingShareholdersOfBraskemIdesa", "negatedLabel": "Loan payment to non-controlling shareholders of Braskem Idesa" } } }, "localname": "LoanPaymentToNoncontrollingShareholdersOfBraskemIdesa", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_LoanToNonControllingShareholdersOfBraskemIdesaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loan to non controlling shareholders of braskem idesa member.", "label": "Loan to non controlling shareholders of braskem idesa member" } } }, "localname": "LoanToNonControllingShareholdersOfBraskemIdesaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_LoanToNoncontrollingShareholderOfBraskemIdesaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loan to noncontrolling shareholder of braskem idesa member.", "label": "Loan to noncontrolling shareholder of braskem idesa member" } } }, "localname": "LoanToNoncontrollingShareholderOfBraskemIdesaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_LoanToNoncontrollingShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents loan to noncontrolling shareholders.", "label": "Loan to noncontrolling shareholders" } } }, "localname": "LoanToNoncontrollingShareholders", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "bak_LoanToNoncontrollingShareholdersOfBraskemIdesaPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loan to non-controlling shareholders of Braskem Idesa - payment" } } }, "localname": "LoanToNoncontrollingShareholdersOfBraskemIdesaPayment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_LoansTransactionCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loans transaction costs member.", "label": "Loans transaction costs member" } } }, "localname": "LoansTransactionCostsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_LocalCurrencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents local currency member.", "label": "Local currency member" } } }, "localname": "LocalCurrencyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_LongTermIncentivePlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long term incentive plan" } } }, "localname": "LongTermIncentivePlan", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_LongTermIncentivePlanNetOfTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long term incentive plan, net of taxes" } } }, "localname": "LongTermIncentivePlanNetOfTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_LongTermIncentivePlanTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Long-term incentive plan" } } }, "localname": "LongTermIncentivePlanTableTextBlock", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesTables" ], "xbrltype": "textBlockItemType" }, "bak_LongTermIncentivePlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Incentive Plans [Member]" } } }, "localname": "LongTermIncentivePlansMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "bak_LongtermLegalProceedingsProvision1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents longterm legal proceedings provision1.", "label": "Contingencies" } } }, "localname": "LongtermLegalProceedingsProvision1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_LongtermLegalProceedingsProvision2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents longterm legal proceedings provision2.", "label": "Non-current liability" } } }, "localname": "LongtermLegalProceedingsProvision2", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "bak_LongtermLegalProceedingsProvisionAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents longterm legal proceedings provision additions.", "label": "Additions, inflation adjustments and exchange variation" } } }, "localname": "LongtermLegalProceedingsProvisionAdditions", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_LongtermLegalProceedingsProvisionPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents longterm legal proceedings provision payments.", "label": "Longterm legal proceedings provision payments", "verboseLabel": "Payments" } } }, "localname": "LongtermLegalProceedingsProvisionPayments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_LongtermLegalProceedingsProvisionReversals": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents longterm legal proceedings provision reversals.", "label": "Reversals" } } }, "localname": "LongtermLegalProceedingsProvisionReversals", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_LossForAllocation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss for allocation" } } }, "localname": "LossForAllocation", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_LossForImpairmentOfTradeAccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "LossForImpairmentOfTradeAccountsReceivable", "verboseLabel": "" } } }, "localname": "LossForImpairmentOfTradeAccountsReceivable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_LossProfitBeforeIncomeTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Loss) profit before income tax" } } }, "localname": "LossProfitBeforeIncomeTaxAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "stringItemType" }, "bak_LossProfitBeforeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "(Loss) profit before taxes" } } }, "localname": "LossProfitBeforeTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_LossReversalsForImpairmentOfFinancialAssets": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 7.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss for impairment of trade accounts receivable and others from clients" } } }, "localname": "LossReversalsForImpairmentOfFinancialAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_LossReversalsForImpairmentOfTradeAccountsReceivable": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 3.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "LossReversalsForImpairmentOfTradeAccountsReceivable", "negatedLabel": "Loss\u00a0\u00a0for impairment of trade accounts receivable and others from clients" } } }, "localname": "LossReversalsForImpairmentOfTradeAccountsReceivable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "bak_LossReversalsForImpairmentOfTradeAccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loss reversals for impairment of trade accounts receivable member.", "label": "Loss reversals for impairment of trade accounts receivable member" } } }, "localname": "LossReversalsForImpairmentOfTradeAccountsReceivableMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_LossesOnDerivativesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents losses on derivatives member.", "label": "Losses on derivatives member" } } }, "localname": "LossesOnDerivativesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_LossesOnDisposalsOfInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "LossesOnDisposalsOfInvestment", "verboseLabel": "Disposal" } } }, "localname": "LossesOnDisposalsOfInvestment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_LowRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents low risk member.", "label": "Low risk member" } } }, "localname": "LowRiskMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "domainItemType" }, "bak_MONFORTEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents m o n f o r t e member.", "label": "M o n f o r t e member" } } }, "localname": "MONFORTEMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_MachineryAndEquipmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents machinery and equipments member.", "label": "Machinery and equipments member" } } }, "localname": "MachineryAndEquipmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "bak_MachineryAndFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents machinery and facilities member.", "label": "Machinery and facilities [member]" } } }, "localname": "MachineryAndFacilitiesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "bak_MadePayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Made payment" } } }, "localname": "MadePayment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_MaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maturity date" } } }, "localname": "MaturityDate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "stringItemType" }, "bak_MexicanPesoBrazilianRealMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents mexican peso brazilian real member.", "label": "Mexican peso brazilian real member" } } }, "localname": "MexicanPesoBrazilianRealMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_MexicoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents mexico member.", "label": "Mexico [member]" } } }, "localname": "MexicoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "bak_MinimumAnnualCommitments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents minimum annual commitments.", "label": "Minimum annual commitments", "verboseLabel": "Total" } } }, "localname": "MinimumAnnualCommitments", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_MinimumRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents minimum risk member.", "label": "Minimum risk member" } } }, "localname": "MinimumRiskMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "domainItemType" }, "bak_ModerateRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents moderate risk member.", "label": "Moderate risk member" } } }, "localname": "ModerateRiskMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "domainItemType" }, "bak_MonetaryVariationsOnFiscalDebtsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents monetary variations on fiscal debts member.", "label": "Monetary variations on fiscal debts member" } } }, "localname": "MonetaryVariationsOnFiscalDebtsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_MonetaryVariationsOnTaxCreditsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents monetary variations on tax credits member.", "label": "Monetary variations on tax credits member" } } }, "localname": "MonetaryVariationsOnTaxCreditsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_NLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents n l member.", "label": "N l member" } } }, "localname": "NLMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_NameOfFlat": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Name of flat" } } }, "localname": "NameOfFlat", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "stringItemType" }, "bak_NaphthaCondensateAndCrudeOilMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents naphtha condensate and crude oil member.", "label": "Naphtha condensate and crude oil member" } } }, "localname": "NaphthaCondensateAndCrudeOilMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_NatureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents nature member.", "label": "Nature member" } } }, "localname": "NatureMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_NetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents net member.", "label": "Net member" } } }, "localname": "NetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_NetOfAdjustmentToPresentValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents net of adjustment to present value.", "label": "Net of adjustment to present value" } } }, "localname": "NetOfAdjustmentToPresentValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_NetRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Revenue" } } }, "localname": "NetRevenueAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_NetherlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherland [Member]" } } }, "localname": "NetherlandMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "domainItemType" }, "bak_NetherlandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents netherlands member.", "label": "Netherlands [member]" } } }, "localname": "NetherlandsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "bak_NewContracts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "New contracts" } } }, "localname": "NewContracts", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_NewOrRenewedagreementsWithRelatedCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents new or renewedagreements with related companies member.", "label": "New or renewedagreements with related companies member" } } }, "localname": "NewOrRenewedagreementsWithRelatedCompaniesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_NexiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents nexi member.", "label": "Nexi member" } } }, "localname": "NexiMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_NonCurrentBraskemIdesaBorrowings1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents non current braskem idesa borrowings1.", "label": "Non current braskem idesa borrowings1" } } }, "localname": "NonCurrentBraskemIdesaBorrowings1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "bak_NonCurrentBraskemIdesaBorrowings3": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents non current braskem idesa borrowings3.", "label": "Non current braskem idesa borrowings3" } } }, "localname": "NonCurrentBraskemIdesaBorrowings3", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "bak_NonCurrentRecoverableIncomeTaxes": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents non current recoverable income taxes.", "label": "Non current recoverable income taxes", "verboseLabel": "Recoverable income taxes" } } }, "localname": "NonCurrentRecoverableIncomeTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_NonHedgeAccountingTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents non hedge accounting transactions member.", "label": "Non hedge accounting transactions member" } } }, "localname": "NonHedgeAccountingTransactionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "domainItemType" }, "bak_NoncontrollingInterestGainsLossesOnSalesHedgesBeforeTax": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 4.0, "parentTag": "bak_OtherComprehensiveIncomeNetOfTaxSalesHedges", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sales Hedge - transfer to profit or loss - Braskem Idesa, net of taxes" } } }, "localname": "NoncontrollingInterestGainsLossesOnSalesHedgesBeforeTax", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_NoncontrollingInterestInAcquiredEntity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-controlling interest in acquired entity" } } }, "localname": "NoncontrollingInterestInAcquiredEntity", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_NoncontrollingInterestInSubsidiaries": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "NoncontrollingInterestInSubsidiaries", "verboseLabel": "Non-controlling interest in subsidiaries" } } }, "localname": "NoncontrollingInterestInSubsidiaries", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_NoncontrollingInterestReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 3.0, "parentTag": "bak_OtherComprehensiveIncomeNetOfTaxSalesHedges", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents noncontrolling interest reclassification adjustments on exchange differences on translation before tax.", "label": "Noncontrolling interest reclassification adjustments on exchange differences on translation before tax", "negatedLabel": "Exchange variation of foreign sales hedge - Braskem Idesa, net of taxes" } } }, "localname": "NoncontrollingInterestReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_NoncontrollingShareholdersNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-controlling shareholders non current" } } }, "localname": "NoncontrollingShareholdersNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_NoncurrentLeniencyAgreements": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 11.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents noncurrent leniency agreements.", "label": "Noncurrent leniency agreements", "verboseLabel": "Leniency agreement" } } }, "localname": "NoncurrentLeniencyAgreements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_NoncurrentLiabilities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Noncurrent liabilities" } } }, "localname": "NoncurrentLiabilities1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_NoncurrentLoanToNoncontrollingShareholders": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loan from non-controlling shareholders of Braskem Idesa", "verboseLabel": "Loan to non-controlling shareholders of Braskem Idesa" } } }, "localname": "NoncurrentLoanToNoncontrollingShareholders", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_NormalOperationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents normal operation member.", "label": "Normal operation member" } } }, "localname": "NormalOperationMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_NortheasternPetrochemicalComplexMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents northeastern petrochemical complex member.", "label": "Northeastern petrochemical complex member" } } }, "localname": "NortheasternPetrochemicalComplexMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "bak_NotLaterThanNinetyDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents not later than ninety days member.", "label": "Not later than ninety days member" } } }, "localname": "NotLaterThanNinetyDaysMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_NotPastDueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents not past due member.", "label": "Not past due member" } } }, "localname": "NotPastDueMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_NoteAndDebenturesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NoteAndDebenturesIssued", "verboseLabel": "Debentures" } } }, "localname": "NoteAndDebenturesIssued", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "monetaryItemType" }, "bak_NotionalAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notional amount" } } }, "localname": "NotionalAmount1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails4" ], "xbrltype": "monetaryItemType" }, "bak_NovamontBraskemAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents novamont braskem america member.", "label": "Novamont braskem america member" } } }, "localname": "NovamontBraskemAmericaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "domainItemType" }, "bak_NovonorAndItsDirectAndIndirectSubsidiariesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Novonor And Its Direct And Indirect Subsidiaries [Member]" } } }, "localname": "NovonorAndItsDirectAndIndirectSubsidiariesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_NovonorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents novonor member.", "label": "Novonor member" } } }, "localname": "NovonorMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "domainItemType" }, "bak_NumberOfBarrels": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents number of barrels.", "label": "Number of barrels" } } }, "localname": "NumberOfBarrels", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "integerItemType" }, "bak_NumberOfSharesOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents number of shares outstanding1.", "label": "Number of shares outstanding1", "verboseLabel": "Shares outstanding" } } }, "localname": "NumberOfSharesOutstanding1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails1" ], "xbrltype": "sharesItemType" }, "bak_OdebrechtAndSubsidiariesAndAssociatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents odebrecht and subsidiaries and associates member.", "label": "Odebrecht and subsidiaries and associates [member]" } } }, "localname": "OdebrechtAndSubsidiariesAndAssociatesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "bak_OdebrechtSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents odebrecht s a member.", "label": "Odebrecht s a member" } } }, "localname": "OdebrechtSAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_OneClientMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents one client member.", "label": "One client member" } } }, "localname": "OneClientMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_OpeningForeignExchangeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Opening foreign exchange rate" } } }, "localname": "OpeningForeignExchangeRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "decimalItemType" }, "bak_OperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operations" } } }, "localname": "OperationsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_OriginalLongtermMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents original longterm maturities.", "label": "Original Long-Term Maturities" } } }, "localname": "OriginalLongtermMaturities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_OriginationAndReversalOfTemporaryDifferences": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents origination and reversal of temporary differences.", "label": "Origination and reversal of temporary differences" } } }, "localname": "OriginationAndReversalOfTemporaryDifferences", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_Other": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other [Default Label]", "verboseLabel": "Other" } } }, "localname": "Other", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_Other1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other1.", "label": "Other 1", "verboseLabel": "Other" } } }, "localname": "Other1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_Other1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other1 member.", "label": "Other1 member" } } }, "localname": "Other1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_Other2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other2 member.", "label": "Other2 member" } } }, "localname": "Other2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "domainItemType" }, "bak_OtherAccumulatedLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OtherAccumulatedLosses", "verboseLabel": "Other" } } }, "localname": "OtherAccumulatedLosses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_OtherAdministrativeProceedings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents other administrative proceedings.", "label": "Other administrative proceedings" } } }, "localname": "OtherAdministrativeProceedings", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_OtherBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other benefits member.", "label": "Other benefits member" } } }, "localname": "OtherBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_OtherBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other borrowings member.", "label": "Other borrowings member" } } }, "localname": "OtherBorrowingsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherCRA1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other C R A 1 [Member]" } } }, "localname": "OtherCRA1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails4" ], "xbrltype": "domainItemType" }, "bak_OtherCRA2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other C R A 2 [Member]" } } }, "localname": "OtherCRA2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails4" ], "xbrltype": "domainItemType" }, "bak_OtherComprehensiveIncome1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other comprehensive income1.", "label": "Other comprehensive income1", "verboseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncome1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "bak_OtherComprehensiveIncomeNetOfTaxSalesHedges": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents other comprehensive income net of tax sales hedges.", "label": "Exchange variation of foreign sales hedge, net of taxes", "totalLabel": "Sales hedges, net of tax" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxSalesHedges", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "bak_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other countries member.", "label": "Other countries member" } } }, "localname": "OtherCountriesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_OtherCurrentPayables1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents other current payables1.", "label": "Other current payables1" } } }, "localname": "OtherCurrentPayables1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_OtherEquityAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other" } } }, "localname": "OtherEquityAdjustment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_OtherExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other expenses member.", "label": "Other expenses member" } } }, "localname": "OtherExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_OtherFinancialAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Financial Asset [Member]" } } }, "localname": "OtherFinancialAssetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_OtherFinancialAssetsDomesticMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets domestic market" } } }, "localname": "OtherFinancialAssetsDomesticMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsForeignMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets foreign market" } } }, "localname": "OtherFinancialAssetsForeignMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithOutRiskAssessmentForeignMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets without risk assessment foreign market" } } }, "localname": "OtherFinancialAssetsWithOutRiskAssessmentForeignMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithRiskAssessment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other financial assets with risk assessment.", "label": "Financial assets with risk assessment" } } }, "localname": "OtherFinancialAssetsWithRiskAssessment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithRiskAssessmentDomesticMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets with risk assessment domestic market" } } }, "localname": "OtherFinancialAssetsWithRiskAssessmentDomesticMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithRiskAssessmentForeignMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets with risk assessment foreign market" } } }, "localname": "OtherFinancialAssetsWithRiskAssessmentForeignMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithoutRiskAssessment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other financial assets without risk assessment.", "label": "Financial assets without risk assessment" } } }, "localname": "OtherFinancialAssetsWithoutRiskAssessment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financial assets without risk assessment domestic market" } } }, "localname": "OtherFinancialAssetsWithoutRiskAssessmentdomesticMarket", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "bak_OtherFinancialExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other financial expenses member.", "label": "Other financial expenses member" } } }, "localname": "OtherFinancialExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherFinancialIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other financial income member.", "label": "Other financial income member" } } }, "localname": "OtherFinancialIncomeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherFinancialInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other financial investments member.", "label": "Other financial investments member" } } }, "localname": "OtherFinancialInvestmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherFinancialsLiabilities": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "OtherFinancialsLiabilities", "negatedLabel": "Other financial liabilities" } } }, "localname": "OtherFinancialsLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_OtherFixedInterestLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Fixed Interest Loans [Member]" } } }, "localname": "OtherFixedInterestLoansMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other General And Administrative Expenses [Member]" } } }, "localname": "OtherGeneralAndAdministrativeExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_OtherIncomeExpensesNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other income expenses net member.", "label": "Other income expenses net member" } } }, "localname": "OtherIncomeExpensesNetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_OtherIncomesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Incomes [Member]" } } }, "localname": "OtherIncomesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other increase decrease in intangible assets and goodwill amortization.", "label": "Other increase decrease in intangible assets and goodwill amortization", "verboseLabel": "Amortization" } } }, "localname": "OtherIncreaseDecreaseInIntangibleAssetsAndGoodwillAmortization", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_OtherLawsuitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other lawsuits member.", "label": "Other lawsuits member" } } }, "localname": "OtherLawsuitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other member.", "label": "Other [member]" } } }, "localname": "OtherMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails12", "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other n e x i1 member.", "label": "Other n e x i1 member" } } }, "localname": "OtherNEXI1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other n e x i2 member.", "label": "Other n e x i2 member" } } }, "localname": "OtherNEXI2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other n e x i3 member.", "label": "Other n e x i3 member" } } }, "localname": "OtherNEXI3Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other N E X I 4 [Member]" } } }, "localname": "OtherNEXI4Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other N E X I 5 [Member]" } } }, "localname": "OtherNEXI5Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other N E X I 6 [Member]" } } }, "localname": "OtherNEXI6Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other N E X I 7 [Member]" } } }, "localname": "OtherNEXI7Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherNEXI8Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other N E X I 8 [Member]" } } }, "localname": "OtherNEXI8Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails3" ], "xbrltype": "domainItemType" }, "bak_OtherOperatingIncomeExpense1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents other operating income expense1.", "label": "Other operating income expense1" } } }, "localname": "OtherOperatingIncomeExpense1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_OtherReceivabels": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other receivabels.", "label": "Other receivabels" } } }, "localname": "OtherReceivabels", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_OtherReceivabelsNonCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents other receivabels non current.", "label": "Other receivabels non current" } } }, "localname": "OtherReceivabelsNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_OtherSegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other segments member.", "label": "Other segments member" } } }, "localname": "OtherSegmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bak_OtherTaxClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other tax claims member.", "label": "Other tax claims member" } } }, "localname": "OtherTaxClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_OtherTaxesRecoverableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other taxes recoverable member.", "label": "Other taxes recoverable member" } } }, "localname": "OtherTaxesRecoverableMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_OtherVariableInterestLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Variable Interest Loans [Member]" } } }, "localname": "OtherVariableInterestLoansMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_OtherWriteoffsNetOfAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other write-offs net of amortization" } } }, "localname": "OtherWriteoffsNetOfAmortization", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "bak_OutrosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outros [Member]" } } }, "localname": "OutrosMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_OutsourcedServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents outsourced services member.", "label": "Outsourced services member" } } }, "localname": "OutsourcedServicesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_OutstandingAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents outstanding amount1.", "label": "Outstanding amount" } } }, "localname": "OutstandingAmount1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_OutstandingShares1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OutstandingShares1", "periodEndLabel": "Amount at the end of the year", "periodStartLabel": "Amount at beginning of the year" } } }, "localname": "OutstandingShares1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_OutstandingShares2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OutstandingShares2", "periodEndLabel": "Amount at the end of the year", "periodStartLabel": "Amount at beginning of the year" } } }, "localname": "OutstandingShares2", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_OutstandingShares3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OutstandingShares3", "periodEndLabel": "Amount at the end of the year", "periodStartLabel": "Amount at beginning of year" } } }, "localname": "OutstandingShares3", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_PEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p e member.", "label": "P e member" } } }, "localname": "PEMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_PEPPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p e p p member.", "label": "P e p p member" } } }, "localname": "PEPPMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s credits exclusion of i c m s from the calculation basis member.", "label": "P i s and c o f i n s credits exclusion of i c m s from the calculation basis member" } } }, "localname": "PISAndCOFINSCreditsExclusionOfICMSFromTheCalculationBasisMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s credits from property plant and equipment member.", "label": "P i s and c o f i n s credits from property plant and equipment member" } } }, "localname": "PISAndCOFINSCreditsFromPropertyPlantAndEquipmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSDCideFuelsTaxOffsetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s d cide fuels tax offset member.", "label": "P i s and c o f i n s d cide fuels tax offset member" } } }, "localname": "PISAndCOFINSDCideFuelsTaxOffsetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s member.", "label": "P i s and c o f i n s member" } } }, "localname": "PISAndCOFINSMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSSundryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s sundry member.", "label": "P i s and c o f i n s sundry member" } } }, "localname": "PISAndCOFINSSundryMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_PISAndCOFINSTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p i s and c o f i n s taxes member.", "label": "P i s and c o f i n s taxes member" } } }, "localname": "PISAndCOFINSTaxesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "http://braskem.com./role/TaxesRecoverableDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_PLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p l member.", "label": "P l member" } } }, "localname": "PLMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_PVCCausticSodaEDCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p v c caustic soda e d c member.", "label": "P v c caustic soda e d c member" } } }, "localname": "PVCCausticSodaEDCMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_PYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents p y member.", "label": "P y member" } } }, "localname": "PYMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_ParentCompanysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents parent companys member.", "label": "Parent companys member" } } }, "localname": "ParentCompanysMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_ParticipantsExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents participants expenses.", "label": "Participants expenses" } } }, "localname": "ParticipantsExpenses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_PaymentForIndemnifiction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents payment for indemnifiction.", "label": "Payment for indemnifiction" } } }, "localname": "PaymentForIndemnifiction", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_PaymentOfTaxIncentives": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Payment of tax incentives" } } }, "localname": "PaymentOfTaxIncentives", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_PaymentsOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents payments of lease liabilities.", "label": "Payments" } } }, "localname": "PaymentsOfLeaseLiabilities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "bak_PercentageAmountOfTaxDeficiencyNotice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents percentage amount of tax deficiency notice.", "label": "Percentage amount of the tax deficiency notice" } } }, "localname": "PercentageAmountOfTaxDeficiencyNotice", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_PercentageFineForTaxOffense": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage fine for tax offense" } } }, "localname": "PercentageFineForTaxOffense", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents percentage of reasonably possible increase in cost of service actuarial assumption.", "label": "Percentage of reasonably possible increase in cost of service actuarial assumption", "verboseLabel": "Premise change" } } }, "localname": "PercentageOfReasonablyPossibleIncreaseInCostOfServiceActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "percentItemType" }, "bak_PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents percentage of reasonably possible increase in interest cost actuarial assumption.", "label": "Percentage of reasonably possible increase in interest cost actuarial assumption" } } }, "localname": "PercentageOfReasonablyPossibleIncreaseInInterestCostActuarialAssumption", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "percentItemType" }, "bak_PercentageOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents percentage of shares outstanding.", "label": "Percent of shares outstanding" } } }, "localname": "PercentageOfSharesOutstanding", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "percentItemType" }, "bak_PermanentAdjustmentsToIRAnCSLlCalculationBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents permanent adjustments to i r an c s ll calculation basis abstract.", "label": "Permanent adjustments to income taxes calculation basis" } } }, "localname": "PermanentAdjustmentsToIRAnCSLlCalculationBasisAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "bak_PersonnelExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents personnel expenses member.", "label": "Personnel expenses member" } } }, "localname": "PersonnelExpensesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_PetrobrasAndSubsidiariesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents petrobras and subsidiaries member.", "label": "Petrobras and subsidiaries [member]" } } }, "localname": "PetrobrasAndSubsidiariesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "bak_PetrobrasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents petrobras member.", "label": "Petrobras member" } } }, "localname": "PetrobrasMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "domainItemType" }, "bak_PetrobrasTransporteSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Petrobras Transporte S A [Member]" } } }, "localname": "PetrobrasTransporteSAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_PetrocoqueSAIndustriaComercioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Petrocoque S A Industria Comercio [Member]" } } }, "localname": "PetrocoqueSAIndustriaComercioMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_Plan2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan 2019 [Member]" } } }, "localname": "Plan2019Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_Plan2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan 2020 [Member]" } } }, "localname": "Plan2020Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_Plan2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan 2021 [Member]" } } }, "localname": "Plan2021Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_Plan2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plan 2022 [Member]" } } }, "localname": "Plan2022Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_PlanAssetsAtFairValue1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents plan assets at fair value1.", "label": "Fair value of plan assets" } } }, "localname": "PlanAssetsAtFairValue1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2" ], "xbrltype": "monetaryItemType" }, "bak_PossibleAdverseSensitivityGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents possible adverse sensitivity gain loss.", "label": "Reasonably possible gain (loss)" } } }, "localname": "PossibleAdverseSensitivityGainLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "monetaryItemType" }, "bak_PossibleAmountChanceToLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents possible amount chance to loss.", "label": "Possible amount chance to loss" } } }, "localname": "PossibleAmountChanceToLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_PossibleLegalProceedingsProvision": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents possible legal proceedings provision.", "label": "Claims with possible chance of loss" } } }, "localname": "PossibleLegalProceedingsProvision", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "monetaryItemType" }, "bak_PrepaidExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid expenses", "verboseLabel": "" } } }, "localname": "PrepaidExpenses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_PresentValueAdjustmentAndAmortizedCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents present value adjustment and amortized cost member.", "label": "Present value adjustment and amortized cost member" } } }, "localname": "PresentValueAdjustmentAndAmortizedCostMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_PrivatePensionBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents private pension benefits member.", "label": "Private pension benefits member" } } }, "localname": "PrivatePensionBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_ProbableSensitivityGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents probable sensitivity gain loss.", "label": "Probable gain (loss)" } } }, "localname": "ProbableSensitivityGainLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "monetaryItemType" }, "bak_ProceedsFromDebtClassifiedAsFinancingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents proceeds from debt classified as financing activities.", "label": "Proceeds from debt classified as financing activities" } } }, "localname": "ProceedsFromDebtClassifiedAsFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_ProceedsFromOtherBorrowings": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ProceedsFromOtherBorrowings", "terseLabel": "", "verboseLabel": "Acquired" } } }, "localname": "ProceedsFromOtherBorrowings", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "totalLabel": "Profit (loss) before net financial expenses and taxes" } } }, "localname": "ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "bak_ProfitLossAvailableForDistributionBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents profit loss available for distribution basic.", "label": "Reconciliation of income available for distribution, by class (numerator), basic" } } }, "localname": "ProfitLossAvailableForDistributionBasic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_ProfitLossAvailableForDistributionDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents profit loss available for distribution diluted.", "label": "Reconciliation of income available for distribution, by class (numerator), diluted" } } }, "localname": "ProfitLossAvailableForDistributionDiluted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_ProfitLossBeforeTaxAndSocialContribution": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Profit (loss) before income taxes", "verboseLabel": "and social contribution" } } }, "localname": "ProfitLossBeforeTaxAndSocialContribution", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents profit loss from continuing operations attributable basic to owners of parent.", "label": "Profit (loss) for the year attributed to Company's shareholders" } } }, "localname": "ProfitLossFromContinuingOperationsAttributableBasicToOwnersOfParent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents profit loss from continuing operations attributable diluted to owners of parent.", "label": "Profit loss from continuing operations attributable diluted to owners of parent" } } }, "localname": "ProfitLossFromContinuingOperationsAttributableDilutedToOwnersOfParent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_ProfitReserves": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Profit reserves" } } }, "localname": "ProfitReserves", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_ProfitReservesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit Reserves [Member]" } } }, "localname": "ProfitReservesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "domainItemType" }, "bak_ProjectsAndStoppageInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents projects and stoppage in progress member.", "label": "Projects and stoppage in progress [member]" } } }, "localname": "ProjectsAndStoppageInProgressMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_PropertyPlantAndEquipmentAccumulatedDepreciation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents property plant and equipment accumulated depreciation.", "label": "Accumulated depreciation" } } }, "localname": "PropertyPlantAndEquipmentAccumulatedDepreciation", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents property plant and equipment and intangible assets and goodwill.", "label": "Property, plant and equipment and intangible assets" } } }, "localname": "PropertyPlantAndEquipmentAndIntangibleAssetsAndGoodwill", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "monetaryItemType" }, "bak_PropertyPlantAndEquipmentCostValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents property plant and equipment cost value.", "label": "Cost" } } }, "localname": "PropertyPlantAndEquipmentCostValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_PropertyPlantAndEquipmentNetBookValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents property plant and equipment net book value.", "label": "Net book value" } } }, "localname": "PropertyPlantAndEquipmentNetBookValue", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_ProposedDividends": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Proposed dividends" } } }, "localname": "ProposedDividends", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionAccruedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision accrued amount.", "label": "Provision accrued amount" } } }, "localname": "ProvisionAccruedAmount", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionAfterAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision after adjustment.", "label": "Payments and reclassifications" } } }, "localname": "ProvisionAfterAdjustment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents provision allowance accounts for credit losses of financial assets.", "label": "Provision in the year" } } }, "localname": "ProvisionAllowanceAccountsForCreditLossesOfFinancialAssets", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails2" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionForCustomersRebatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents provision for customers rebates member.", "label": "Provision for customers rebates member" } } }, "localname": "ProvisionForCustomersRebatesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails" ], "xbrltype": "domainItemType" }, "bak_ProvisionForInventories": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision for inventories.", "label": "Balance at the beginner of the year" } } }, "localname": "ProvisionForInventories", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionForInventoriesEnd": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision for inventories end.", "label": "Balance at the end of the year" } } }, "localname": "ProvisionForInventoriesEnd", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionGeologicalEventInAlagoasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents provision geological event in alagoas member.", "label": "Provision geological event in alagoas member" } } }, "localname": "ProvisionGeologicalEventInAlagoasMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_ProvisionGeologicalEventInAlagoasNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents provision geological event in alagoas non current.", "label": "Provision geological event in alagoas non current", "verboseLabel": "Provision - geological event in Alagoas" } } }, "localname": "ProvisionGeologicalEventInAlagoasNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionUsedOtherProvision": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Write-offs through usage and payments" } } }, "localname": "ProvisionUsedOtherProvision", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_Provisions1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents provisions1.", "label": "Sundry provisions, current" } } }, "localname": "Provisions1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionsForFineForTaxOffense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Provisions for fine for tax offense" } } }, "localname": "ProvisionsForFineForTaxOffense", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_ProvisionsForLegalProceedingsAndContingentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provisions For Legal Proceedings And Contingent Liabilities" } } }, "localname": "ProvisionsForLegalProceedingsAndContingentLiabilitiesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_PutOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents put options member.", "label": "Put options member" } } }, "localname": "PutOptionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_QuantityOfAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quantity of acquisition, shares" } } }, "localname": "QuantityOfAcquisitionShares", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "sharesItemType" }, "bak_REINTEGRAProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents r e i n t e g r a program member.", "label": "R e i n t e g r a program member" } } }, "localname": "REINTEGRAProgramMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_RailCarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents rail cars member.", "label": "Rail cars member" } } }, "localname": "RailCarsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "bak_RawMaterialsOtherInputsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents raw materials other inputs member.", "label": "Raw materials other inputs member" } } }, "localname": "RawMaterialsOtherInputsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_RealizationOfAdditionalPropertyPlantAndEquipmentPricelevelRestatementNetOfTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents realization of additional property plant and equipment pricelevel restatement net of taxes.", "label": "Realization of additional property, plant and equipment price-level restatement, net of taxes" } } }, "localname": "RealizationOfAdditionalPropertyPlantAndEquipmentPricelevelRestatementNetOfTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_RealizationOfDeemedCostOfJointlyControlledInvestmentNetOfTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents realization of deemed cost of jointly controlled investment net of taxes.", "label": "Realization of deemed cost of jointly-controlled investment, net of taxes" } } }, "localname": "RealizationOfDeemedCostOfJointlyControlledInvestmentNetOfTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_RealizationOfPresentValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents realization of present value adjustment.", "label": "Realization of present value adjustment" } } }, "localname": "RealizationOfPresentValueAdjustment", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "bak_RealizationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents realization period.", "label": "Realization period" } } }, "localname": "RealizationPeriod", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxIncentivesDetailsNarrative" ], "xbrltype": "durationItemType" }, "bak_RebateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents rebate member.", "label": "Rebate member" } } }, "localname": "RebateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "domainItemType" }, "bak_ReconciliationOfBorrowingActivitiesInTheStatementOfCashFlow": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation Of Borrowing Activities In Statement Of Cash Flow" } } }, "localname": "ReconciliationOfBorrowingActivitiesInTheStatementOfCashFlow", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_RecoverableAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents recoverable amount.", "label": "Recoverable amount" } } }, "localname": "RecoverableAmount", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "bak_RecoverableIncomeTaxes": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Recoverable income taxes" } } }, "localname": "RecoverableIncomeTaxes", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "bak_RecoverableIncomeTaxesNonCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "RecoverableIncomeTaxesNonCurrent", "verboseLabel": "Recoverable income taxes" } } }, "localname": "RecoverableIncomeTaxesNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_RecoveryOfEnvironmentalDamageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents recovery of environmental damage member.", "label": "Recovery of environmental damage member" } } }, "localname": "RecoveryOfEnvironmentalDamageMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "domainItemType" }, "bak_ReductionOfTaxLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reduction of tax loss" } } }, "localname": "ReductionOfTaxLoss", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_RefinariaAlbertoPasqualiniMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refinaria Alberto Pasqualini [Member]" } } }, "localname": "RefinariaAlbertoPasqualiniMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_RefinariaDuqueDeCaxiasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refinaria Duque De Caxias [Member]" } } }, "localname": "RefinariaDuqueDeCaxiasMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_RefinariaHenriqueLageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refinaria Henrique Lage [Member]" } } }, "localname": "RefinariaHenriqueLageMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_RefinariaPlanaltodePauliniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refinaria Planaltode Paulinia [Member]" } } }, "localname": "RefinariaPlanaltodePauliniaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_RefinariaPresidenteGetulioVargasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Refinaria Presidente Getulio Vargas [Member]" } } }, "localname": "RefinariaPresidenteGetulioVargasMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_RelatedPartieForfaitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents related partie forfait member.", "label": "Related partie forfait member" } } }, "localname": "RelatedPartieForfaitMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_RelatedPartieMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents related partie member.", "label": "Related partie member" } } }, "localname": "RelatedPartieMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_RelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartiesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_RelatedParts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Related parts" } } }, "localname": "RelatedParts", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents related party member.", "label": "Related party member" } } }, "localname": "RelatedPartyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "domainItemType" }, "bak_RepaymentsOfDebtClassifiedAsFinancingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents repayments of debt classified as financing activities.", "label": "Repayments of debt classified as financing activities", "verboseLabel": "Payments" } } }, "localname": "RepaymentsOfDebtClassifiedAsFinancingActivities", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_RepaymentsOfOtherBorrowings": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "RepaymentsOfOtherBorrowings", "negatedLabel": "Payments", "negatedTerseLabel": "" } } }, "localname": "RepaymentsOfOtherBorrowings", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_ReportingSegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents reporting segments member.", "label": "Reporting segments member" } } }, "localname": "ReportingSegmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "bak_ResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents research and development member.", "label": "Research and development member" } } }, "localname": "ResearchAndDevelopmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_RestrictedFund": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents restricted fund.", "label": "Restricted fund" } } }, "localname": "RestrictedFund", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "bak_RestrictedFundsInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents restricted funds investments member.", "label": "Restricted funds investments member" } } }, "localname": "RestrictedFundsInvestmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_RetentionOfProfits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents retention of profits.", "label": "Retention of profits" } } }, "localname": "RetentionOfProfits", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_RetentionOfProfitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retention Of Profits [Member]" } } }, "localname": "RetentionOfProfitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "bak_Revenue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents revenue1.", "label": "Sales of products" } } }, "localname": "Revenue1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_ReversalOfProvisions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "" } } }, "localname": "ReversalOfProvisions", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_ReversalToInventories": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents reversal to inventories.", "label": "Utilization/reversals" } } }, "localname": "ReversalToInventories", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesDetails1" ], "xbrltype": "monetaryItemType" }, "bak_RightOfUseAssetsAndLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right-of-use Assets And Lease Liability" } } }, "localname": "RightOfUseAssetsAndLeaseLiabilityAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_RiskManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk Management" } } }, "localname": "RiskManagementAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_SEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents s e member.", "label": "S e member" } } }, "localname": "SEMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_SGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents s g member.", "label": "S g member" } } }, "localname": "SGMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_SaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents sace member.", "label": "Sace member" } } }, "localname": "SaceMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in claims with probable chance of loss" } } }, "localname": "ScheduleOfChangesInClaimsWithProbableChanceOfLossExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "bak_ScheduleOfChangesInprovisionExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of following table shows the changes in the provision in the period" } } }, "localname": "ScheduleOfChangesInprovisionExplanatory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasTables" ], "xbrltype": "textBlockItemType" }, "bak_ScheduleOfDistributionPaid": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Company already has paid distributed as shown below:" } } }, "localname": "ScheduleOfDistributionPaid", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesTables" ], "xbrltype": "textBlockItemType" }, "bak_ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity]" } } }, "localname": "ScheduleOfPotentialImpactOnCashFlowsOfTheDiscountRateAndPerpetuity", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "bak_SecondQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Quarter [Member]" } } }, "localname": "SecondQuarterMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "domainItemType" }, "bak_SecuritiesAndExchangeCommissionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents securities and exchange commission member.", "label": "Securities and exchange commission member" } } }, "localname": "SecuritiesAndExchangeCommissionMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails" ], "xbrltype": "domainItemType" }, "bak_SecurityEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents security equipment member.", "label": "Security equipment member" } } }, "localname": "SecurityEquipmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "bak_SegmentInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Information" } } }, "localname": "SegmentInformationAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_SelicInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents selic interest rate member.", "label": "Selic interest rate member" } } }, "localname": "SelicInterestRateMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "bak_SellingAndDistributionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents selling and distribution member.", "label": "Selling and distribution member" } } }, "localname": "SellingAndDistributionMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_SemiFinishedGoods": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Semi-finished goods" } } }, "localname": "SemiFinishedGoods", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "bak_SensitivityAnalysisDiscountRates": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents sensitivity analysis discount rates.", "label": "Discount rate [Default Label]", "verboseLabel": "Discount rate" } } }, "localname": "SensitivityAnalysisDiscountRates", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_SensitivityAnalysisPerpetuityOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents sensitivity analysis perpetuity one.", "label": "Perpetuity" } } }, "localname": "SensitivityAnalysisPerpetuityOne", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_SettlementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement [Axis]", "verboseLabel": "SettlementAxis [Axis]" } } }, "localname": "SettlementAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "stringItemType" }, "bak_SettlementDomain": { "auth_ref": [], "localname": "SettlementDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_SettlementMethod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Method" } } }, "localname": "SettlementMethod", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "stringItemType" }, "bak_SettlementMethodologyCashMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Methodology Cash [Member]" } } }, "localname": "SettlementMethodologyCashMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_SettlementMethodologySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Methodology Shares [Member]" } } }, "localname": "SettlementMethodologySharesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "domainItemType" }, "bak_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods": { "auth_ref": [], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods", "negatedLabel": "Results from equity-accounted investees", "negatedTerseLabel": "" } } }, "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethods", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "bak_ShareholdersOfBraskemIdesaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders Of Braskem Idesa [Member]" } } }, "localname": "ShareholdersOfBraskemIdesaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "bak_ShareholdersTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shareholders total" } } }, "localname": "ShareholdersTotal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "bak_SharesCanceled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares canceled" } } }, "localname": "SharesCanceled", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "sharesItemType" }, "bak_SharesExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares exercised" } } }, "localname": "SharesExercised", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "sharesItemType" }, "bak_SharesGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares granted" } } }, "localname": "SharesGranted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "bak_SharesOfInvestmentFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares Of Investment Funds [Member]" } } }, "localname": "SharesOfInvestmentFundsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "bak_ShortTermAndLongTermDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Short-term and Long-term debt", "verboseLabel": "Short-term and long-term debt" } } }, "localname": "ShortTermAndLongTermDebtAbstract", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "bak_SocialIntegrationProgramPISAndSocialContributionOnRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents social integration program p i s and social contribution on revenue member.", "label": "Social integration program p i s and social contribution on revenue member" } } }, "localname": "SocialIntegrationProgramPISAndSocialContributionOnRevenueMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_SocialSecurityClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents social security claims member.", "label": "Social security claims member" } } }, "localname": "SocialSecurityClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_SocialSecurityContributionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents social security contributions member.", "label": "Social security contributions member" } } }, "localname": "SocialSecurityContributionsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_SocialSecurityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents social security member.", "label": "Social security member" } } }, "localname": "SocialSecurityMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_SoftwareLicensesAndRightsOfUseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software Licenses And Rights Of Use [Member]" } } }, "localname": "SoftwareLicensesAndRightsOfUseMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3" ], "xbrltype": "domainItemType" }, "bak_SolventsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents solvents member.", "label": "Solvents member" } } }, "localname": "SolventsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "bak_SouthernPetrochemicalComplexMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents southern petrochemical complex member.", "label": "Southern petrochemical complex member" } } }, "localname": "SouthernPetrochemicalComplexMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "bak_SpecificPurposeEntity1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents specific purpose entity1 member.", "label": "Specific purpose entity1 member" } } }, "localname": "SpecificPurposeEntity1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_SpecificPurposeEntity2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents specific purpose entity2 member.", "label": "Specific purpose entity2 member" } } }, "localname": "SpecificPurposeEntity2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_SponsorsExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents sponsors expenses.", "label": "Sponsors expenses" } } }, "localname": "SponsorsExpenses", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_Subsidiary101Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary101 member.", "label": "Subsidiary101 member" } } }, "localname": "Subsidiary101Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary10Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 10 [Member]" } } }, "localname": "Subsidiary10Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary11Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary11 member.", "label": "Subsidiary11 member" } } }, "localname": "Subsidiary11Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary12Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary12 member.", "label": "Subsidiary12 member" } } }, "localname": "Subsidiary12Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary13Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary13 member.", "label": "Subsidiary13 member" } } }, "localname": "Subsidiary13Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary14Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary14 member.", "label": "Subsidiary14 member" } } }, "localname": "Subsidiary14Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary15Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary15 member.", "label": "Subsidiary15 member" } } }, "localname": "Subsidiary15Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary16Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary16 member.", "label": "Subsidiary16 member" } } }, "localname": "Subsidiary16Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary17Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary17 member.", "label": "Subsidiary17 member" } } }, "localname": "Subsidiary17Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary18Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary18 member.", "label": "Subsidiary18 member" } } }, "localname": "Subsidiary18Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary19Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary19 member.", "label": "Subsidiary19 member" } } }, "localname": "Subsidiary19Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary1 member.", "label": "Subsidiary1 member" } } }, "localname": "Subsidiary1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary20Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary20 member.", "label": "Subsidiary20 member" } } }, "localname": "Subsidiary20Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary21Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary21 member.", "label": "Subsidiary21 member" } } }, "localname": "Subsidiary21Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary22Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary22 member.", "label": "Subsidiary22 member" } } }, "localname": "Subsidiary22Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary23Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 23 [Member]" } } }, "localname": "Subsidiary23Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary24Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 24 [Member]" } } }, "localname": "Subsidiary24Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary25Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 25 [Member]" } } }, "localname": "Subsidiary25Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary26Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 26 [Member]" } } }, "localname": "Subsidiary26Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary27Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 27 [Member]" } } }, "localname": "Subsidiary27Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary28Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 28 [Member]" } } }, "localname": "Subsidiary28Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary29Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 29 [Member]" } } }, "localname": "Subsidiary29Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary2 member.", "label": "Subsidiary2 member" } } }, "localname": "Subsidiary2Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary30Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 30 [Member]" } } }, "localname": "Subsidiary30Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary3 member.", "label": "Subsidiary3 member" } } }, "localname": "Subsidiary3Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary4 member.", "label": "Subsidiary4 member" } } }, "localname": "Subsidiary4Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary5 member.", "label": "Subsidiary5 member" } } }, "localname": "Subsidiary5Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary6 member.", "label": "Subsidiary6 member" } } }, "localname": "Subsidiary6Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary7 member.", "label": "Subsidiary7 member" } } }, "localname": "Subsidiary7Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary8Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary8 member.", "label": "Subsidiary8 member" } } }, "localname": "Subsidiary8Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_Subsidiary9Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary9 member.", "label": "Subsidiary9 member" } } }, "localname": "Subsidiary9Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "bak_SubsidiaryFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary five member.", "label": "Subsidiary five member" } } }, "localname": "SubsidiaryFiveMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiaryFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary four member.", "label": "Subsidiary four member" } } }, "localname": "SubsidiaryFourMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiaryOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary one member.", "label": "Subsidiary one member" } } }, "localname": "SubsidiaryOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiarySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary seven member.", "label": "Subsidiary seven member" } } }, "localname": "SubsidiarySevenMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiarySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary six member.", "label": "Subsidiary six member" } } }, "localname": "SubsidiarySixMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiaryThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary three member.", "label": "Subsidiary three member" } } }, "localname": "SubsidiaryThreeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SubsidiaryTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subsidiary two member.", "label": "Subsidiary two member" } } }, "localname": "SubsidiaryTwoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "bak_SudeneTaxIncentiveSupplement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "SUDENE tax incentive supplement" } } }, "localname": "SudeneTaxIncentiveSupplement", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_SudeneTaxIncentiveSupplements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "SudeneTaxIncentiveSupplements", "verboseLabel": "SUDENE tax incentive supplement" } } }, "localname": "SudeneTaxIncentiveSupplements", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails2" ], "xbrltype": "monetaryItemType" }, "bak_SundryProvisionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sundry Provisions" } } }, "localname": "SundryProvisionsAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_SwapsCRA1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Swaps C R A 1 [Member]" } } }, "localname": "SwapsCRA1Member", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "domainItemType" }, "bak_SwapsCRAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Swaps C R A [Member]" } } }, "localname": "SwapsCRAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "domainItemType" }, "bak_SwissOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents swiss office member.", "label": "Swiss office member" } } }, "localname": "SwissOfficeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails" ], "xbrltype": "domainItemType" }, "bak_TaxBenefits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents tax benefits.", "label": "Tax benefits (Sudene and PAT)" } } }, "localname": "TaxBenefits", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_TaxClaimsICMSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Claims I C M S [Member]" } } }, "localname": "TaxClaimsICMSMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_TaxClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents tax claims member.", "label": "Tax claims member" } } }, "localname": "TaxClaimsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails2" ], "xbrltype": "domainItemType" }, "bak_TaxClaimsNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents tax claims net member.", "label": "Tax claims net member" } } }, "localname": "TaxClaimsNetMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "domainItemType" }, "bak_TaxCreditsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents tax credits member.", "label": "Tax credits member" } } }, "localname": "TaxCreditsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_TaxDepreciationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents tax depreciation member.", "label": "Tax depreciation member" } } }, "localname": "TaxDepreciationMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_TaxEffectOfRevenuesExemptFromTaxation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ICMS tax incentives" } } }, "localname": "TaxEffectOfRevenuesExemptFromTaxation", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxIncentivesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_TaxIncentiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Incentive [Member]" } } }, "localname": "TaxIncentiveMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "bak_TaxIncentiveReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents tax incentive reserve.", "label": "Tax incentive reserve" } } }, "localname": "TaxIncentiveReserve", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "bak_TaxIncentivesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Incentives" } } }, "localname": "TaxIncentivesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_TaxLossesIRAndNegativeBaseCSLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents tax losses i r and negative base c s l member.", "label": "Tax losses i r and negative base c s l member" } } }, "localname": "TaxLossesIRAndNegativeBaseCSLMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_TaxesOnDividendsDistribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents taxes on dividends distribution.", "label": "Taxes on dividends distribution" } } }, "localname": "TaxesOnDividendsDistribution", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_TaxesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Taxes Payable" } } }, "localname": "TaxesPayableAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_TaxesRecoverable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "TaxesRecoverable", "verboseLabel": "Taxes recoverable" } } }, "localname": "TaxesRecoverable", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_TaxesRecoverableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Taxes Recoverable" } } }, "localname": "TaxesRecoverableAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_TechnicalCooperationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents technical cooperation agreement member.", "label": "Technical cooperation agreement member" } } }, "localname": "TechnicalCooperationAgreementMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_TemporaryAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents temporary adjustment member.", "label": "Temporary adjustment member" } } }, "localname": "TemporaryAdjustmentMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "bak_TerminalQuimicaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Terminal Quimica [Member]" } } }, "localname": "TerminalQuimicaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_ThinCapitalization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents thin capitalization.", "label": "Thin capitalization" } } }, "localname": "ThinCapitalization", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bak_ThirdPartiesForfaitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents third parties forfait member.", "label": "Third parties forfait member" } } }, "localname": "ThirdPartiesForfaitMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_ThirdPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents third parties member.", "label": "Third parties member" } } }, "localname": "ThirdPartiesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "bak_ThirdQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Quarter [Member]" } } }, "localname": "ThirdQuarterMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8" ], "xbrltype": "domainItemType" }, "bak_ThirtyThreeAndThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thirty Three And Thereafter [Member]" } } }, "localname": "ThirtyThreeAndThereafterMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TimeDepositInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents time deposit investments member.", "label": "Time deposit investments member" } } }, "localname": "TimeDepositInvestmentsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "bak_TotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total [Member]" } } }, "localname": "TotalMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "domainItemType" }, "bak_TotalNominal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total nominal" } } }, "localname": "TotalNominal", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "bak_TradeAccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Accounts Receivable" } } }, "localname": "TradeAccountsReceivableAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_TradeAccountsReceivablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Accounts Receivables [Member]" } } }, "localname": "TradeAccountsReceivablesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "bak_TradeAndOtherCurrentPayables1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents trade and other current payables1.", "label": "Trade and other current payables1" } } }, "localname": "TradeAndOtherCurrentPayables1", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_TradePayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents trade payables.", "label": "Trade payables [Default Label]", "verboseLabel": "Trade payables" } } }, "localname": "TradePayables", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "bak_TradePayablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Payables" } } }, "localname": "TradePayablesAbstract", "nsuri": "http://braskem.com./20221231", "xbrltype": "stringItemType" }, "bak_TradePayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents trade payables member.", "label": "Trade payables member" } } }, "localname": "TradePayablesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "bak_TradePayablesNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "TradePayablesNonCurrent", "verboseLabel": "Trade payables" } } }, "localname": "TradePayablesNonCurrent", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "bak_TrainingBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents training benefits member.", "label": "Training benefits member" } } }, "localname": "TrainingBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_TransactionsCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents transactions costs member.", "label": "Transactions costs member" } } }, "localname": "TransactionsCostsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BraskemIdesaBorrowingsDetails" ], "xbrltype": "domainItemType" }, "bak_TransfersToInventory": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents transfers to inventory.", "label": "Transfers to inventory" } } }, "localname": "TransfersToInventory", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_TransfersToNoncurrentAssetsHeldForSale": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents transfers to noncurrent assets held for sale.", "label": "Transfers to \"non-current assets held for sale\"" } } }, "localname": "TransfersToNoncurrentAssetsHeldForSale", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "bak_TransportBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents transport benefits member.", "label": "Transport benefits member" } } }, "localname": "TransportBenefitsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "domainItemType" }, "bak_TwentyThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Thirty [Member]" } } }, "localname": "TwentyThirtyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Thirty One [Member]" } } }, "localname": "TwentyThirtyOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Eight [Member]" } } }, "localname": "TwentyTwentyEightMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Five [Member]" } } }, "localname": "TwentyTwentyFiveMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Four [Member]" } } }, "localname": "TwentyTwentyFourMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Nine [Member]" } } }, "localname": "TwentyTwentyNineMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentySevanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Sevan [Member]" } } }, "localname": "TwentyTwentySevanMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Six [Member]" } } }, "localname": "TwentyTwentySixMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Thirty [Member]" } } }, "localname": "TwentyTwentyThirtyMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Thirty One [Member]" } } }, "localname": "TwentyTwentyThirtyOneMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyThirtyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Thirty Two [Member]" } } }, "localname": "TwentyTwentyThirtyTwoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Three [Member]" } } }, "localname": "TwentyTwentyThreeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1" ], "xbrltype": "domainItemType" }, "bak_TwentyTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Twenty Two [Member]" } } }, "localname": "TwentyTwentyTwoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetails1" ], "xbrltype": "domainItemType" }, "bak_TypeOfClaimAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents type of claim axis.", "label": "Type of claim [axis]" } } }, "localname": "TypeOfClaimAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "bak_TypeOfClaimDomain": { "auth_ref": [], "localname": "TypeOfClaimDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_TypeOfExpensesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents type of expenses axis.", "label": "Type of expenses [axis]" } } }, "localname": "TypeOfExpensesAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "stringItemType" }, "bak_TypeOfExpensesDomain": { "auth_ref": [], "localname": "TypeOfExpensesDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "domainItemType" }, "bak_TypeOfOerationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents type of oeration axis.", "label": "Type of oeration [axis]" } } }, "localname": "TypeOfOerationAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "bak_TypeOfOerationDomain": { "auth_ref": [], "localname": "TypeOfOerationDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_TypeOfOperationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents type of operation axis.", "label": "Type of operation [axis]" } } }, "localname": "TypeOfOperationAxis", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "bak_TypeOfOperationDomain": { "auth_ref": [], "localname": "TypeOfOperationDomain", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "bak_USAAndEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents u s a and europe member.", "label": "U s a and europe member" } } }, "localname": "USAAndEuropeMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "bak_USDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U S D [Member]" } } }, "localname": "USDMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "bak_USDollarBrazilianRealMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents u s dollar brazilian real member.", "label": "U s dollar brazilian real member" } } }, "localname": "USDollarBrazilianRealMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_USDollarEuroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents u s dollar euro member.", "label": "U s dollar euro member" } } }, "localname": "USDollarEuroMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_USDollarMexicanPesoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents u s dollar mexican peso member.", "label": "U s dollar mexican peso member" } } }, "localname": "USDollarMexicanPesoMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "domainItemType" }, "bak_UYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents u y member.", "label": "U y member" } } }, "localname": "UYMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_UnallocatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents unallocated member.", "label": "Unallocated member" } } }, "localname": "UnallocatedMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "bak_UninitiatedLeaseArrangementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents uninitiated lease arrangements member.", "label": "Uninitiated lease arrangements [member]" } } }, "localname": "UninitiatedLeaseArrangementsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "bak_UnitedStateOfAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents united state of america member.", "label": "United state of america member" } } }, "localname": "UnitedStateOfAmericaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "domainItemType" }, "bak_UnitedStatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents united states member.", "label": "United states member" } } }, "localname": "UnitedStatesMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/NetRevenueDetails1" ], "xbrltype": "domainItemType" }, "bak_UnitedStatesOfAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents united states of america member.", "label": "United states of america [member]" } } }, "localname": "UnitedStatesOfAmericaMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "domainItemType" }, "bak_UpdatedValueOfThisProceedingAmounted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents updated value of this proceeding amounted.", "label": "Updated value of this proceeding amounted" } } }, "localname": "UpdatedValueOfThisProceedingAmounted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "bak_ValueAddedTaxIVAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents value added tax i v a member.", "label": "Value added tax i v a member" } } }, "localname": "ValueAddedTaxIVAMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_ValueAddedTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents value added tax member.", "label": "Value added tax member" } } }, "localname": "ValueAddedTaxMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "bak_ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents value added tax on sales and services i c m s normal pperations member.", "label": "Value added tax on sales and services i c m s normal pperations member" } } }, "localname": "ValueAddedTaxOnSalesAndServicesICMSNormalPperationsMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" }, "bak_VeryHighRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents very high risk member.", "label": "Very high risk member" } } }, "localname": "VeryHighRiskMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "domainItemType" }, "bak_VinylsUnityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents vinyls unity member.", "label": "Vinyls unity member" } } }, "localname": "VinylsUnityMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2" ], "xbrltype": "domainItemType" }, "bak_VoqenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Voqen [Member]" } } }, "localname": "VoqenMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "domainItemType" }, "bak_WeightedAverageIncrementalRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents weighted average incremental rate.", "label": "Weighted average incremental rate" } } }, "localname": "WeightedAverageIncrementalRate", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "percentItemType" }, "bak_WeightedAverageSharesBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents weighted average shares basic.", "label": "Weighted average number of shares, basic" } } }, "localname": "WeightedAverageSharesBasic", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_WeightedAverageSharesDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents weighted average shares diluted.", "label": "Weighted average shares diluted" } } }, "localname": "WeightedAverageSharesDiluted", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "bak_WiseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Wise [Member]" } } }, "localname": "WiseMember", "nsuri": "http://braskem.com./20221231", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_USD": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States of America, Dollars" } } }, "localname": "USD", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelFaxNumber": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Fax Number of contact personnel.", "label": "Contact Personnel Fax Number" } } }, "localname": "ContactPersonnelFaxNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r339", "r341", "r342" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://braskem.com./role/Cover" ], "xbrltype": "booleanItemType" }, "ifrs-full_AccountingProfit": { "auth_ref": [ "r55", "r56" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Nominal income taxes computed based on Brazilian statutory corporate tax rates (34%)" } } }, "localname": "AccountingProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r349" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income [member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "auth_ref": [ "r361" ], "lang": { "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of discount rates", "verboseLabel": "Discount rate" } } }, "localname": "ActuarialAssumptionOfDiscountRates", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": { "auth_ref": [ "r362" ], "lang": { "en": { "role": { "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of discount rates [member]" } } }, "localname": "ActuarialAssumptionOfDiscountRatesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation": { "auth_ref": [ "r361" ], "lang": { "en": { "role": { "documentation": "The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Inflation rate" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfInflation", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember": { "auth_ref": [ "r362" ], "lang": { "en": { "role": { "documentation": "This member stands for the expected rates of pension increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of pension increases [member]" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": { "auth_ref": [ "r362" ], "lang": { "en": { "role": { "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of salary increases [member]" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember": { "auth_ref": [ "r362" ], "lang": { "en": { "role": { "documentation": "This member stands for the life expectancy after retirement used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of life expectancy after retirement [member]" } } }, "localname": "ActuarialAssumptionOfLifeExpectancyAfterRetirementMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates": { "auth_ref": [ "r361" ], "lang": { "en": { "role": { "documentation": "Medical cost trend rate used as significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Medical inflation" } } }, "localname": "ActuarialAssumptionOfMedicalCostTrendRates", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfMortalityRatesMember": { "auth_ref": [ "r362" ], "lang": { "en": { "role": { "documentation": "This member stands for the mortality rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of mortality rates [member]" } } }, "localname": "ActuarialAssumptionOfMortalityRatesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionsAxis": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Actuarial assumptions [axis]" } } }, "localname": "ActuarialAssumptionsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "stringItemType" }, "ifrs-full_ActuarialAssumptionsMember": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used." } } }, "localname": "ActuarialAssumptionsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Actuarial losses (gain)" } } }, "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalPaidinCapital": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidinCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalPaidinCapitalMember": { "auth_ref": [ "r349" ], "lang": { "en": { "role": { "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Additional paid-in capital [member]" } } }, "localname": "AdditionalPaidinCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_AdditionalProvisionsOtherProvisions": { "auth_ref": [ "r115" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of additional other provisions made. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Additional provisions, other provisions", "negatedLabel": "Sundry provisions" } } }, "localname": "AdditionalProvisionsOtherProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalRecognitionGoodwill": { "auth_ref": [ "r192" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additional goodwill recognised, except goodwill included in a disposal group that, on acquisition, meets the criteria to be classified as held for sale in accordance with IFRS 5. [Refer: Goodwill; Disposal groups classified as held for sale [member]]" } }, "en-us": { "role": { "label": "Goodwill acquisition of ER Plastics" } } }, "localname": "AdditionalRecognitionGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsFromAcquisitionsInvestmentProperty": { "auth_ref": [ "r125", "r127" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to investment property resulting from acquisitions. [Refer: Investment property]" } }, "en-us": { "role": { "label": "Additions through acquisition of ER Plastics" } } }, "localname": "AdditionsFromAcquisitionsInvestmentProperty", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "verboseLabel": "Acquisitions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Acquisitions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "auth_ref": [ "r372" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } }, "en-us": { "role": { "label": "Inventories", "verboseLabel": "" } } }, "localname": "AdjustmentsForDecreaseIncreaseInInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "auth_ref": [ "r372" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "", "verboseLabel": "Other receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "auth_ref": [ "r372" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "", "verboseLabel": "Trade accounts receivable" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "auth_ref": [ "r373" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Depreciation and amortization", "verboseLabel": "" } } }, "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForFairValueGainsLosses": { "auth_ref": [ "r373" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Fair value, net of taxes" } } }, "localname": "AdjustmentsForFairValueGainsLosses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployeesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for income tax expense", "verboseLabel": "" } } }, "localname": "AdjustmentsForIncomeTaxExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "auth_ref": [ "r372" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in other operating payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in other operating payables", "terseLabel": "", "verboseLabel": "Other payables" } } }, "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r372" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade accounts payable", "terseLabel": "", "verboseLabel": "Trade payables" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseInOtherProvisionsArisingFromPassageOfTime": { "auth_ref": [ "r374" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 8.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increases in other provisions arising from the passage of time to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Other provisions [member]]" } }, "en-us": { "role": { "label": "Write-offs of long-lived assets", "verboseLabel": "" } } }, "localname": "AdjustmentsForIncreaseInOtherProvisionsArisingFromPassageOfTime", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForProvisions": { "auth_ref": [ "r373" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for provisions", "terseLabel": "", "verboseLabel": "Provision - geological event in Alagoas" } } }, "localname": "AdjustmentsForProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments for reconciliation of profit", "verboseLabel": "Adjustments for reconciliation of profit (loss)" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "auth_ref": [ "r296", "r373" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Interest foreign exchange gain/losses", "verboseLabel": "" } } }, "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital": { "auth_ref": [ "r374" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments, other than changes in working capital, to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments to reconcile profit (loss) other than changes in working capital", "totalLabel": "Adjustments for reconciliation of profit", "verboseLabel": "" } } }, "localname": "AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedMeasurementMember": { "auth_ref": [ "r124", "r129", "r169" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "localname": "AggregatedMeasurementMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/FinancialInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r24", "r176", "r185", "r186", "r199", "r246", "r247", "r248", "r253", "r281", "r310", "r312" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3", "http://braskem.com./role/RiskManagementDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "auth_ref": [ "r73", "r170" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "localname": "AllLevelsOfFairValueHierarchyMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r262" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Allowance account for credit losses of financial assets", "periodEndLabel": "Balance of provision at the end of the year", "periodStartLabel": "Balance of provision at the beginning of the year" } } }, "localname": "AllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "auth_ref": [ "r87", "r91" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Related parties estimated value" } } }, "localname": "AmountsPayableRelatedPartyTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Official rate" } } }, "localname": "ApplicableTaxRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r21", "r169", "r170", "r171", "r233", "r236" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Total assets", "totalLabel": "Total assets", "verboseLabel": "Assets" } } }, "localname": "Assets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_AssetsAndLiabilitiesAxis": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Assets and liabilities [axis]" } } }, "localname": "AssetsAndLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_AssetsAndLiabilitiesMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]" } } }, "localname": "AssetsAndLiabilitiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_AverageEffectiveTaxRate": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Effective rate" } } }, "localname": "AverageEffectiveTaxRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_AverageForeignExchangeRate": { "auth_ref": [ "r350" ], "lang": { "en": { "role": { "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies." } }, "en-us": { "role": { "label": "Average foreign exchange rate" } } }, "localname": "AverageForeignExchangeRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_AveragePriceOfHedgingInstrument": { "auth_ref": [ "r200" ], "lang": { "en": { "role": { "documentation": "The average price of a hedging instrument. [Refer: Hedging instruments [member]]" } }, "en-us": { "role": { "label": "Average export" } } }, "localname": "AveragePriceOfHedgingInstrument", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "decimalItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r108", "r109" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Earnings (loss) per share - basic", "verboseLabel": "Profit (loss) per share, basic" } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_BenefitsPaidOrPayable": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of benefits paid or payable for retirement benefit plans." } }, "en-us": { "role": { "label": "Benefits paid" } } }, "localname": "BenefitsPaidOrPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BondsIssued": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of bonds issued by the entity." } }, "en-us": { "role": { "label": "Finance issued in bonds" } } }, "localname": "BondsIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Borrowings": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } }, "en-us": { "role": { "label": "Borrowings [Default Label]", "verboseLabel": "Borrowings" } } }, "localname": "Borrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowings [abstract]" } } }, "localname": "BorrowingsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameAxis": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Borrowings by name [axis]" } } }, "localname": "BorrowingsByNameAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameMember": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "localname": "BorrowingsByNameMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BorrowingsInterestRate": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Interest (% per year)" } } }, "localname": "BorrowingsInterestRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_BorrowingsInterestRateBasis": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, interest rate basis", "terseLabel": "Annual financial charges (%)", "verboseLabel": "Borrowings interest rate basis" } } }, "localname": "BorrowingsInterestRateBasis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsMaturity": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, maturity", "verboseLabel": "Maturity" } } }, "localname": "BorrowingsMaturity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r173", "r187", "r248", "r299", "r301", "r378" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_BrandNamesMember": { "auth_ref": [ "r289" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Brand names [member]" } } }, "localname": "BrandNamesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BuildingsMember": { "auth_ref": [ "r358" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Buildings [member]" } } }, "localname": "BuildingsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r190" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CapitalReserve": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the capital reserves." } }, "en-us": { "role": { "label": "Capital reserve" } } }, "localname": "CapitalReserve", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CapitalReserveMember": { "auth_ref": [ "r349" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } }, "en-us": { "role": { "label": "Capital reserve [member]" } } }, "localname": "CapitalReserveMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash" } } }, "localname": "Cash", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r14", "r138", "r164" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents at the end of the year", "periodStartLabel": "Cash and cash equivalents at the beginning of the year", "verboseLabel": "Total" } } }, "localname": "CashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents [abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Cash position equivalent" } } }, "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashEquivalents": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value." } }, "en-us": { "role": { "label": "Cash equivalents", "periodEndLabel": "", "periodStartLabel": "" } } }, "localname": "CashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r130", "r139" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash generated (used) in financing activities", "totalLabel": "Net cash generated (used) in financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r130", "r139" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Net cash used in investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r130", "r139" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Net cash generated by operating activities", "totalLabel": "Net cash generated from operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperations": { "auth_ref": [ "r295", "r296" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash from (used in) the entity's operations." } }, "en-us": { "role": { "label": "Cash generated from operations", "totalLabel": "Cash generated from operations" } } }, "localname": "CashFlowsFromUsedInOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOutflowForLeases": { "auth_ref": [ "r181" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for leases." } }, "en-us": { "role": { "label": "Contractual payments" } } }, "localname": "CashOutflowForLeases", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "auth_ref": [ "r225" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial assets [axis]" } } }, "localname": "CategoriesOfFinancialAssetsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": { "auth_ref": [ "r225" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial liabilities [axis]" } } }, "localname": "CategoriesOfFinancialLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r90" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/RelatedPartiesDetailsNarrative", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClaimsReportedByPolicyholders": { "auth_ref": [ "r323", "r324" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liability for claims reported by policyholders as the result of the occurrence of insured events. [Refer: Types of insurance contracts [member]]" } }, "en-us": { "role": { "label": "Labor claims for health and security cases" } } }, "localname": "ClaimsReportedByPolicyholders", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ClassesOfAssetsAxis": { "auth_ref": [ "r111", "r112", "r172", "r183" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of assets [axis]" } } }, "localname": "ClassesOfAssetsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TaxesRecoverableDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsMember": { "auth_ref": [ "r111", "r172", "r183" ], "lang": { "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "localname": "ClassesOfAssetsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TaxesRecoverableDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfContingentLiabilitiesAxis": { "auth_ref": [ "r118", "r191" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of contingent liabilities [axis]" } } }, "localname": "ClassesOfContingentLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "auth_ref": [ "r219", "r220", "r244", "r254", "r255", "r256" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial assets [axis]" } } }, "localname": "ClassesOfFinancialAssetsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "auth_ref": [ "r213", "r215", "r216", "r217" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial instruments [axis]" } } }, "localname": "ClassesOfFinancialInstrumentsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "auth_ref": [ "r213", "r215", "r216", "r217" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "localname": "ClassesOfFinancialInstrumentsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "auth_ref": [ "r219", "r220", "r244", "r255" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } } }, "localname": "ClassesOfFinancialLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "auth_ref": [ "r369" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfLiabilitiesAxis": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of liabilities [axis]" } } }, "localname": "ClassesOfLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfOrdinarySharesAxis": { "auth_ref": [ "r108" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of ordinary shares [axis]" } } }, "localname": "ClassesOfOrdinarySharesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Cover", "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r64" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfProvisionsAxis": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of other provisions [axis]" } } }, "localname": "ClassesOfProvisionsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClosingForeignExchangeRate": { "auth_ref": [ "r350" ], "lang": { "en": { "role": { "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery." } }, "en-us": { "role": { "label": "Closing foreign exchange rate" } } }, "localname": "ClosingForeignExchangeRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/FinancialResultsDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails2", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items that will be reclassified subsequently to profit or loss" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Item that will not be reclassified to profito or loss" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r1", "r35", "r143", "r145", "r160", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive income for the year" } } }, "localname": "ComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income for the year:" } } }, "localname": "ComprehensiveIncomeAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Attributable to:" } } }, "localname": "ComprehensiveIncomeAttributableToAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "auth_ref": [ "r1", "r38" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } }, "en-us": { "role": { "label": "Comprehensive income, attributable to non-controlling interests", "verboseLabel": "Non-controlling interest in subsidiaries" } } }, "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "auth_ref": [ "r1", "r39" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } }, "en-us": { "role": { "label": "Comprehensive income, attributable to owners of parent", "verboseLabel": "Company's shareholders" } } }, "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComputerEquipmentMember": { "auth_ref": [ "r358" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Computer equipment [member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ComputerSoftwareMember": { "auth_ref": [ "r290" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Computer software [member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ConsiderationPaidReceived": { "auth_ref": [ "r137" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Considerations on share transaction" } } }, "localname": "ConsiderationPaidReceived", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ConsolidatedAndSeparateFinancialStatementsAxis": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Consolidated and separate financial statements [axis]" } } }, "localname": "ConsolidatedAndSeparateFinancialStatementsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_ConsolidatedMember": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "This member stands for the financial statements of a group in which the assets, liabilities, equity, income, expenses and cash flows of the parent and its subsidiaries are presented as those of a single economic entity. It also represents the standard value for the 'Consolidated and separate financial statements' axis if no other member is used." } } }, "localname": "ConsolidatedMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_ContingentLiabilitiesMember": { "auth_ref": [ "r119", "r191" ], "lang": { "en": { "role": { "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used." } } }, "localname": "ContingentLiabilitiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ContractDurationAxis": { "auth_ref": [ "r304" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Contract duration [axis]" } } }, "localname": "ContractDurationAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ContractualObligationsDetailsNarrative", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ContractDurationMember": { "auth_ref": [ "r304" ], "lang": { "en": { "role": { "documentation": "This member stands for all durations of contracts with customers. It also represents the standard value for the 'Contract duration' axis if no other member is used." } } }, "localname": "ContractDurationMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ContractualObligationsDetailsNarrative", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ContractualCapitalCommitments": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]" } }, "en-us": { "role": { "label": "Contractual capital commitments" } } }, "localname": "ContractualCapitalCommitments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ContractualObligationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r0", "r50" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 2.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Purchases of raw materials, finished goods services and utilities", "negatedLabel": "Cost of products sold" } } }, "localname": "CostOfSales", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CounterpartiesAxis": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Counterparties [axis]" } } }, "localname": "CounterpartiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CounterpartiesMember": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "localname": "CounterpartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r99", "r103", "r148", "r152" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Headquarters", "verboseLabel": "Headquarters country" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/IncomeTaxesDetails1", "http://braskem.com./role/IncomeTaxesDetails3" ], "xbrltype": "stringItemType" }, "ifrs-full_CreditDerivativeFairValue": { "auth_ref": [ "r208" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of a credit derivative. [Refer: At fair value [member]; Derivatives [member]]" } }, "en-us": { "role": { "label": "Credit derivative, fair value at end of period" } } }, "localname": "CreditDerivativeFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r25", "r156", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Total current assets", "totalLabel": "Current Assets" } } }, "localname": "CurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets", "verboseLabel": "Curent" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Current borrowings and current portion of non-current borrowings", "verboseLabel": "Braskem Idesa borrowings" } } }, "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDerivativeFinancialAssets": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]" } }, "en-us": { "role": { "label": "Derivatives", "verboseLabel": "Current derivative financial assets" } } }, "localname": "CurrentDerivativeFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } }, "en-us": { "role": { "label": "Current derivative financial liabilities", "verboseLabel": "Derivatives" } } }, "localname": "CurrentDerivativeFinancialLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentInventoriesInTransit": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Imports in transit" } } }, "localname": "CurrentInventoriesInTransit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentInvestments": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current investments." } }, "en-us": { "role": { "label": "Financial investments", "verboseLabel": "Current assets" } } }, "localname": "CurrentInvestments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r177" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 12.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Lease" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r26", "r158", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Total current liabilities", "totalLabel": "Current Liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities", "verboseLabel": "Current" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued": { "auth_ref": [ "r350" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current notes and debentures issued and the current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]" } }, "en-us": { "role": { "label": "Debentures", "verboseLabel": "Debentures, current" } } }, "localname": "CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPackagingAndStorageMaterials": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of packaging and storage materials. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Maintenance materials" } } }, "localname": "CurrentPackagingAndStorageMaterials", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "auth_ref": [ "r354" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } }, "en-us": { "role": { "label": "Taxes payable", "verboseLabel": "Current payables on social security and taxes other than income tax" } } }, "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Current portion of non-current borrowings", "verboseLabel": "Borrowings" } } }, "localname": "CurrentPortionOfLongtermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentProvisions": { "auth_ref": [ "r16" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Sundry provisions", "verboseLabel": "Sundry provisions, current" } } }, "localname": "CurrentProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/SundryProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "auth_ref": [ "r29" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } }, "en-us": { "role": { "label": "Payroll and related charges" } } }, "localname": "CurrentProvisionsForEmployeeBenefits", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r352" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } }, "en-us": { "role": { "label": "Taxes recoverable", "verboseLabel": "Current receivables from taxes other than income tax" } } }, "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Current service cost" } } }, "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTaxExpenseIncome": { "auth_ref": [ "r275" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } }, "en-us": { "role": { "label": "Total current expenses" } } }, "localname": "CurrentTaxExpenseIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTaxLiabilitiesNoncurrent": { "auth_ref": [ "r17" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current amount of current tax liabilities. [Refer: Current tax liabilities]" } }, "en-us": { "role": { "label": "Income taxes payable" } } }, "localname": "CurrentTaxLiabilitiesNoncurrent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r269", "r270" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Trade accounts receivable", "verboseLabel": "Current assets" } } }, "localname": "CurrentTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "auth_ref": [ "r370" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } }, "en-us": { "role": { "label": "Customer-related intangible assets [member]" } } }, "localname": "CustomerrelatedIntangibleAssetsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_DeferredTaxAssets": { "auth_ref": [ "r18", "r22", "r57" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets" } } }, "localname": "DeferredTaxAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxExpenseIncome": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Total Deferred income taxes" } } }, "localname": "DeferredTaxExpenseIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxExpenseIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred income taxes" } } }, "localname": "DeferredTaxExpenseIncomeAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Deferred tax expense (income) recognised in profit or loss", "verboseLabel": "Ending balance" } } }, "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxLiabilities": { "auth_ref": [ "r18", "r22", "r57" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity": { "auth_ref": [ "r54" ], "lang": { "en": { "role": { "documentation": "The amount of deferred tax related to items credited (charged) directly to equity. [Refer: Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Impact on the equity" } } }, "localname": "DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitObligationAtPresentValue": { "auth_ref": [ "r363" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]" } }, "en-us": { "role": { "label": "Defined benefit obligation, at present value", "periodEndLabel": "Balance at the end of the year", "periodStartLabel": "Balance at beginning of year" } } }, "localname": "DefinedBenefitObligationAtPresentValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitPlansAxis": { "auth_ref": [ "r67" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Defined benefit plans [axis]" } } }, "localname": "DefinedBenefitPlansAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DefinedBenefitPlansMember": { "auth_ref": [ "r67" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } } }, "localname": "DefinedBenefitPlansMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7", "http://braskem.com./role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r62", "r65" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "label": "Depreciation, right-of-use assets", "verboseLabel": "Depreciation" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativeFinancialAssets": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Derivative financial assets" } } }, "localname": "DerivativeFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativeFinancialLiabilities": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Derivative financial liabilities", "verboseLabel": "Derivatives" } } }, "localname": "DerivativeFinancialLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativesMember": { "auth_ref": [ "r298", "r300", "r309", "r316" ], "lang": { "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Derivatives [member]" } } }, "localname": "DerivativesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "auth_ref": [ "r380", "r381" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates.\nEffective 2023-01-01: The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } }, "en-us": { "role": { "label": "Functional and foreign currency" } } }, "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have." } }, "en-us": { "role": { "label": "New standards or amendments for the current fiscal year and future requirements" } } }, "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfFunctionalCurrency": { "auth_ref": [ "r80", "r81" ], "lang": { "en": { "role": { "documentation": "The description of the currency of the primary economic environment in which the entity operates." } }, "en-us": { "role": { "label": "Functional currency" } } }, "localname": "DescriptionOfFunctionalCurrency", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": { "auth_ref": [ "r113", "r114" ], "lang": { "en": { "role": { "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Inflation rate for perpetuity" } } }, "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r108", "r109" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Earnings (loss) per share - diluted" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } }, "en-us": { "role": { "label": "Application of estimates and judgments" } } }, "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ApplicationOfEstimatesAndJudgments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "auth_ref": [ "r24" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } }, "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } } }, "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfAssetsAndLiabilitiesWithSignificantRiskOfMaterialAdjustmentTable": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to assets and liabilities with a significant risk of material adjustment." } }, "en-us": { "role": { "label": "Disclosure of assets and liabilities with significant risk of material adjustment [table]" } } }, "localname": "DisclosureOfAssetsAndLiabilitiesWithSignificantRiskOfMaterialAdjustmentTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Disclosure of borrowings [text block]", "verboseLabel": "Borrowings" } } }, "localname": "DisclosureOfBorrowingsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Borrowings" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r190" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } }, "en-us": { "role": { "label": "Reconciliation of borrowing activities in the statement of cash flow" } } }, "localname": "DisclosureOfCashFlowStatementExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlow" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of changes made to accounting policies by the entity." } }, "en-us": { "role": { "label": "Basis of accounting" } } }, "localname": "DisclosureOfChangesInAccountingPoliciesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": { "auth_ref": [ "r189", "r191" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to contingent liabilities in business combinations." } }, "en-us": { "role": { "label": "Disclosure of contingent liabilities in business combination [table]" } } }, "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDebtSecuritiesExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]" } }, "en-us": { "role": { "label": "Disclosure of debt instruments [text block]", "verboseLabel": "Debentures" } } }, "localname": "DisclosureOfDebtSecuritiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Debentures" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "auth_ref": [ "r67" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } }, "en-us": { "role": { "label": "Disclosure of defined benefit plans [table]" } } }, "localname": "DisclosureOfDefinedBenefitPlansTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6", "http://braskem.com./role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDepositsFromBanksExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of deposits from banks. [Refer: Deposits from banks]" } }, "en-us": { "role": { "label": "Disclosure of deposits from banks [text block]", "verboseLabel": "Financial investments" } } }, "localname": "DisclosureOfDepositsFromBanksExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInvestments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "auth_ref": [ "r378" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/BraskemIdesaBorrowingsDetails", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/DebenturesDetails1", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgedItemsTable": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of hedged items." } }, "en-us": { "role": { "label": "Disclosure of detailed information about hedged items [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutHedgedItemsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "auth_ref": [ "r174" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/ContractualObligationsDetailsNarrative", "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "http://braskem.com./role/IncomeTaxesDetails1", "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/NetRevenueDetails2", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "auth_ref": [ "r110" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for earnings per share." } }, "en-us": { "role": { "label": "Earnings (loss) per share" } } }, "localname": "DisclosureOfEarningsPerShareExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "auth_ref": [ "r76" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for employee benefits." } }, "en-us": { "role": { "label": "Benefits offered to employees" } } }, "localname": "DisclosureOfEmployeeBenefitsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToEmployees" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } }, "en-us": { "role": { "label": "Subsequent events" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]" } }, "en-us": { "role": { "label": "Expenses by nature and function" } } }, "localname": "DisclosureOfExpensesByNatureExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunction" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfExternalCreditExposuresTable": { "auth_ref": [ "r325", "r327" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to external credit grades." } }, "en-us": { "role": { "label": "Disclosure of external credit grades [table]" } } }, "localname": "DisclosureOfExternalCreditExposuresTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } }, "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } } }, "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/FinancialInvestmentsDetailsNarrative", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TaxesRecoverableDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of liabilities." } }, "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [table]" } } }, "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } }, "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "verboseLabel": "Financial results" } } }, "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResults" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialAssetsTable": { "auth_ref": [ "r221" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to financial assets." } }, "en-us": { "role": { "label": "Disclosure of financial assets [table]" } } }, "localname": "DisclosureOfFinancialAssetsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "auth_ref": [ "r229" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for financial instruments." } }, "en-us": { "role": { "label": "Financial instruments" } } }, "localname": "DisclosureOfFinancialInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "auth_ref": [ "r210", "r215", "r221" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } }, "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } } }, "localname": "DisclosureOfFinancialInstrumentsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "auth_ref": [ "r221" ], "lang": { "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } }, "en-us": { "role": { "label": "Schedule of financial liabilities by maturity" } } }, "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } }, "en-us": { "role": { "label": "Risk management" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } }, "en-us": { "role": { "label": "Disclosure of general information about financial statements [text block]", "verboseLabel": "Operations" } } }, "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Operations" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfHedgeAccountingTable": { "auth_ref": [ "r263" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of hedges." } }, "en-us": { "role": { "label": "Disclosure of detailed information about hedges [table]" } } }, "localname": "DisclosureOfHedgeAccountingTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r59" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Income taxes" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Schedule of key management personnel" } } }, "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the terms and conditions of hedging instruments and how they affect future cash flows." } }, "en-us": { "role": { "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]" } } }, "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r123" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "Disclosure of intangible assets [text block]", "verboseLabel": "Intangible assets" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInterestsInAssociatesExplanatory": { "auth_ref": [ "r155" ], "lang": { "en": { "role": { "documentation": "The disclosure of interests in associates. [Refer: Associates [member]]" } }, "en-us": { "role": { "label": "Disclosure of interests in associates [text block]", "verboseLabel": "Investments" } } }, "localname": "DisclosureOfInterestsInAssociatesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Investments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": { "auth_ref": [ "r154" ], "lang": { "en": { "role": { "documentation": "The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Schedule of consolidated financial statements" } } }, "localname": "DisclosureOfInterestsInSubsidiariesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for inventories." } }, "en-us": { "role": { "label": "Disclosure of inventories [text block]", "verboseLabel": "Inventories" } } }, "localname": "DisclosureOfInventoriesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Inventories" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMajorCustomersTable": { "auth_ref": [ "r243" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the entity's major customers." } }, "en-us": { "role": { "label": "Disclosure of major customers [table]" } } }, "localname": "DisclosureOfMajorCustomersTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of non-controlling interests. [Refer: Non-controlling interests]" } }, "en-us": { "role": { "label": "Braskem Idesa Borrowings" } } }, "localname": "DisclosureOfNoncontrollingInterestsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BraskemIdesaBorrowings" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } }, "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } } }, "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r233" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "Segment information" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "auth_ref": [ "r233" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } }, "en-us": { "role": { "label": "Disclosure of operating segments [table]" } } }, "localname": "DisclosureOfOperatingSegmentsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } }, "en-us": { "role": { "label": "Disclosure of other provisions [table]" } } }, "localname": "DisclosureOfOtherProvisionsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r66" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of property, plant and equipment [text block]", "verboseLabel": "Property, plant and equipment" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r64" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfProvisionsExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of provisions. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Disclosure of provisions [text block]", "verboseLabel": "Sundry provisions" } } }, "localname": "DisclosureOfProvisionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": { "auth_ref": [ "r369" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill." } }, "en-us": { "role": { "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]" } } }, "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Related parties" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue." } }, "en-us": { "role": { "label": "Disclosure of revenue [text block]", "verboseLabel": "Net revenue" } } }, "localname": "DisclosureOfRevenueExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenue" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": { "auth_ref": [ "r197" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting." } }, "en-us": { "role": { "label": "Disclosure of risk management strategy related to hedge accounting [table]" } } }, "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions." } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfServiceConcessionArrangementsTable": { "auth_ref": [ "r245" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of service concession arrangements." } }, "en-us": { "role": { "label": "Disclosure of detailed information about service concession arrangements [table]" } } }, "localname": "DisclosureOfServiceConcessionArrangementsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } }, "en-us": { "role": { "label": "Equity" } } }, "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Equity" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": { "auth_ref": [ "r101", "r105", "r168" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to associates." } }, "en-us": { "role": { "label": "Disclosure of associates [table]" } } }, "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "auth_ref": [ "r101", "r105", "r167" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "auth_ref": [ "r259" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for significant accounting policies applied by the entity." } }, "en-us": { "role": { "label": "Basis of preparation of the financial statements" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatements" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other payables [text block]", "verboseLabel": "Trade payables" } } }, "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradePayables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "auth_ref": [ "r348" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other receivables [text block]", "verboseLabel": "Trade accounts receivable" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivable" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "auth_ref": [ "r88" ], "lang": { "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Schedule of related party transactions" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [ "r90" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/RelatedPartiesDetailsNarrative", "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DistributionCosts": { "auth_ref": [ "r50", "r267" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 2.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of costs relating to the distribution of goods and services." } }, "en-us": { "role": { "label": "Distribution costs", "negatedLabel": "Selling and distribution" } } }, "localname": "DistributionCosts", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsPaid": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } }, "en-us": { "role": { "label": "Dividends" } } }, "localname": "DividendsPaid", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "auth_ref": [ "r135" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } }, "en-us": { "role": { "label": "Dividends paid, classified as financing activities", "negatedLabel": "Dividends paid" } } }, "localname": "DividendsPaidClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsReceivedClassifiedAsInvestingActivities": { "auth_ref": [ "r135" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from dividends received, classified as investing activities. [Refer: Dividends received]" } }, "en-us": { "role": { "label": "Dividends received" } } }, "localname": "DividendsReceivedClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow representing dividends received from associates, classified as investing activities. [Refer: Associates [member]; Dividends received]" } }, "en-us": { "role": { "label": "Dividends received from associates, classified as investing activities", "negatedLabel": "Dividends and interest on equity" } } }, "localname": "DividendsReceivedFromAssociatesClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EarningsPerShareTable": { "auth_ref": [ "r108" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to earnings per share." } }, "en-us": { "role": { "label": "Earnings per share [table]" } } }, "localname": "EarningsPerShareTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r133", "r134" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Exchange variation on cash of foreign subsidiaries" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Represented by" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "ifrs-full_EntitysTotalForAssociatesMember": { "auth_ref": [ "r101", "r105", "r168", "r258", "r261" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "localname": "EntitysTotalForAssociatesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r190", "r193" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails1", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForExternalCreditGradesMember": { "auth_ref": [ "r260", "r307", "r313", "r325", "r326" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'External credit grades' axis if no other member is used." } } }, "localname": "EntitysTotalForExternalCreditGradesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r90" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/RelatedPartiesDetailsNarrative", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": { "auth_ref": [ "r239" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "localname": "EntitysTotalForSegmentConsolidationItemsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r101", "r105", "r167" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/OperationsDetailsNarrative", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r21", "r30", "r142", "r144", "r169", "r170", "r171" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Total shareholders equity", "periodEndLabel": "As of December 31, 2022", "periodStartLabel": "As of December 31, 2021", "totalLabel": "Shareholders\u2019 Equity", "verboseLabel": "Equity" } } }, "localname": "Equity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' equity", "verboseLabel": "Equity [abstract]" } } }, "localname": "EquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Total liabilities and shareholders' equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "EquityAndLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and shareholders' equity" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAttributableToOwnersOfParent": { "auth_ref": [ "r20" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } }, "en-us": { "role": { "label": "Attributable to the\u00a0\u00a0Company's shareholders", "totalLabel": "Total attributable to the\u00a0\u00a0Company's shareholders" } } }, "localname": "EquityAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } }, "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } } }, "localname": "EquityAttributableToOwnersOfParentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "localname": "EquityMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails2", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ExpectedCreditLossRate": { "auth_ref": [ "r308", "r314" ], "lang": { "en": { "role": { "documentation": "The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights." } }, "en-us": { "role": { "label": "Expected credit loss rate" } } }, "localname": "ExpectedCreditLossRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseByNature": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity." } }, "en-us": { "role": { "label": "Expenses, by nature" } } }, "localname": "ExpenseByNature", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ExpensesByNatureAndFunctionDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": { "auth_ref": [ "r180" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets." } }, "en-us": { "role": { "label": "Low-value leases expense" } } }, "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExternalCreditGradesAxis": { "auth_ref": [ "r260", "r307", "r313", "r325", "r326" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "External credit grades [axis]" } } }, "localname": "ExternalCreditGradesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "stringItemType" }, "ifrs-full_FinanceCosts": { "auth_ref": [ "r41" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 1.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } }, "en-us": { "role": { "label": "Finance costs", "negatedLabel": "Financial expenses", "negatedTerseLabel": "Finance costs" } } }, "localname": "FinanceCosts", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncome": { "auth_ref": [ "r356" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 2.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Financial income", "verboseLabel": "Finance income" } } }, "localname": "FinanceIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncomeCost": { "auth_ref": [ "r356" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Financial income (expenses), net", "totalLabel": "Finance income (cost)", "verboseLabel": "Finance income (cost)" } } }, "localname": "FinanceIncomeCost", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssets": { "auth_ref": [ "r209", "r213", "r214", "r216", "r308" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Book value financial assets" } } }, "localname": "FinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember": { "auth_ref": [ "r223" ], "lang": { "en": { "role": { "documentation": "This member stands for the financial assets at amortised cost category. [Refer: Financial assets at amortised cost]" } }, "en-us": { "role": { "label": "Financial assets at amortised cost, category [member]" } } }, "localname": "FinancialAssetsAtAmortisedCostCategoryMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsAtAmortisedCostMember": { "auth_ref": [ "r226" ], "lang": { "en": { "role": { "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]" } }, "en-us": { "role": { "label": "Financial assets at amortised cost, class [member]" } } }, "localname": "FinancialAssetsAtAmortisedCostMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsAtFairValue": { "auth_ref": [ "r209" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } }, "en-us": { "role": { "label": "Fair value financial assets" } } }, "localname": "FinancialAssetsAtFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember": { "auth_ref": [ "r222" ], "lang": { "en": { "role": { "documentation": "This member stands for the financial assets at fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss]" } }, "en-us": { "role": { "label": "Financial assets at fair value through profit or loss, category [member]" } } }, "localname": "FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/FinancialInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsCategoryMember": { "auth_ref": [ "r225" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "localname": "FinancialAssetsCategoryMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsMember": { "auth_ref": [ "r219", "r220", "r244", "r254", "r255", "r256" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets, class [member]" } } }, "localname": "FinancialAssetsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative", "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialAssetsTypeMember": { "auth_ref": [ "r227", "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated types of financial assets. It also represents the standard value for the 'Types of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "localname": "FinancialAssetsTypeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialLiabilities": { "auth_ref": [ "r209" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Total", "verboseLabel": "Book value financial liabilities" } } }, "localname": "FinancialLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember": { "auth_ref": [ "r224", "r265" ], "lang": { "en": { "role": { "documentation": "This member stands for the financial liabilities at amortised cost category. [Refer: Financial liabilities at amortised cost]" } }, "en-us": { "role": { "label": "Financial liabilities at amortised cost, category [member]" } } }, "localname": "FinancialLiabilitiesAtAmortisedCostCategoryMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "auth_ref": [ "r209" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Fair value financial liabilities" } } }, "localname": "FinancialLiabilitiesAtFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesCategoryMember": { "auth_ref": [ "r225" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } } }, "localname": "FinancialLiabilitiesCategoryMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialLiabilitiesMember": { "auth_ref": [ "r219", "r220", "r244", "r255" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } }, "en-us": { "role": { "label": "Financial liabilities, class [member]" } } }, "localname": "FinancialLiabilitiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialResultsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialLiabilitiesTypeMember": { "auth_ref": [ "r227", "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated types of financial liabilities. It also represents the standard value for the 'Types of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } } }, "localname": "FinancialLiabilitiesTypeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinishedGoods": { "auth_ref": [ "r271", "r364" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Finished goods" } } }, "localname": "FinishedGoods", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FixturesAndFittingsMember": { "auth_ref": [ "r278" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Fixtures and fittings [member]" } } }, "localname": "FixturesAndFittingsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax": { "auth_ref": [ "r45", "r205", "r207", "r264" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, net of tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]" } }, "en-us": { "role": { "label": "Fair value of cash flow hedge, net of taxes" } } }, "localname": "GainsLossesOnCashFlowHedgesNetOfTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax": { "auth_ref": [ "r46" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 3.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Exchange rate variations, net", "verboseLabel": "Gains (losses) on exchange differences on translation of foreign operations, before tax" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialResultsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnLitigationSettlements": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) on settlements of litigation." } }, "en-us": { "role": { "label": "Lawsuit compensation", "verboseLabel": "Gains (losses) on litigation settlements" } } }, "localname": "GainsLossesOnLitigationSettlements", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeneralAndAdministrativeExpense": { "auth_ref": [ "r350" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 4.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administrative expense", "negatedLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r242", "r279", "r303", "r320" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "http://braskem.com./role/IncomeTaxesDetails1", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/TaxesPayableDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r242", "r279", "r303", "r320" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "localname": "GeographicalAreasMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "http://braskem.com./role/IncomeTaxesDetails1", "http://braskem.com./role/IntangibleAssetsDetails4", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/TaxesPayableDetails", "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r267" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 1.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_HedgedItemLiabilities": { "auth_ref": [ "r203" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a hedged item, recognised as a liability. [Refer: Hedged items [member]]" } }, "en-us": { "role": { "label": "Hedged item, liabilities", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "HedgedItemLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails6" ], "xbrltype": "monetaryItemType" }, "ifrs-full_HedgedItemsAxis": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Hedged items [axis]" } } }, "localname": "HedgedItemsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_HedgedItemsMember": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "This member stands for hedged items. A hedged item can be a recognised asset or liability, an unrecognised firm commitment, a forecast transaction or a net investment in a foreign operation. The hedged item can be: (a) a single item; or (b) a group of items (subject to paragraphs 6.6.1\u20136.6.6 and B6.6.1\u2013B6.6.16 of IFRS 9). A hedged item can also be a component of such an item or group of items (see paragraphs 6.3.7 and B6.3.7\u2013B6.3.25 of IFRS 9). This member also represents the standard value for the 'Hedged items' axis if no other member is used." } } }, "localname": "HedgedItemsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_HedgingInstrumentLiabilities": { "auth_ref": [ "r201" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a hedging instrument, recognised as a liability. [Refer: Hedging instruments [member]]" } }, "en-us": { "role": { "label": "Designated balance, beginning", "verboseLabel": "Designated" } } }, "localname": "HedgingInstrumentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_HedgingInstrumentsAxis": { "auth_ref": [ "r198", "r202" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Hedging instruments [axis]" } } }, "localname": "HedgingInstrumentsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4" ], "xbrltype": "stringItemType" }, "ifrs-full_HedgingInstrumentsMember": { "auth_ref": [ "r198", "r202" ], "lang": { "en": { "role": { "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used." } } }, "localname": "HedgingInstrumentsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails4" ], "xbrltype": "domainItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, trade receivables", "negatedLabel": "(Loss) reversals for impairment of trade accounts receivable" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r43", "r53", "r55", "r56", "r96", "r165", "r232" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Tax expense (income)", "negatedLabel": "Income taxes", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r375" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for income taxes paid, classified as operating activities." } }, "en-us": { "role": { "label": "Income taxes paid, classified as operating activities", "negatedLabel": "Income taxes", "negatedTerseLabel": "" } } }, "localname": "IncomeTaxesPaidClassifiedAsOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r138" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents", "totalLabel": "Increase (decrease) in cash and cash equivalents", "verboseLabel": "Increase in cash and cash equivalents" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCreditDerivativeFairValue": { "auth_ref": [ "r208" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value of a credit derivative. [Refer: Credit derivative, fair value]" } }, "en-us": { "role": { "label": "Increase (decrease) in credit derivative, fair value" } } }, "localname": "IncreaseDecreaseInCreditDerivativeFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Premise reduction" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Premise increase" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInNetInvestmentInFinanceLease": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net investment in finance lease. [Refer: Net investment in finance lease]" } }, "en-us": { "role": { "label": "Non-cash investing and financing activity" } } }, "localname": "IncreaseDecreaseInNetInvestmentInFinanceLease", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r382" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the allowance account for credit losses of financial assets resulting from adjustments arising from the passage of time. [Refer: Allowance account for credit losses of financial assets]" } }, "en-us": { "role": { "label": "Write-offs" } } }, "localname": "IncreaseDecreaseThroughAdjustmentsArisingFromPassageOfTimeAllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Exchange variation" } } }, "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill": { "auth_ref": [ "r367" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Foreign currency translation adjustment" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Transfers to intangible" } } }, "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill": { "auth_ref": [ "r368" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in intangible assets and goodwill resulting from transfers. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Transfers from property, plant and equipment projects and stoppage in progress" } } }, "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Transfers by concluded projects" } } }, "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwill": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 11.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets", "periodEndLabel": "Balance as of end", "periodStartLabel": "Balance as of beginning" } } }, "localname": "IntangibleAssetsAndGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "auth_ref": [ "r369" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "localname": "IntangibleAssetsAndGoodwillMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r10", "r121" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r69" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Interest cost" } } }, "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails3", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails5" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense on lease liabilities", "negatedLabel": "Interest paid" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r135" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } }, "en-us": { "role": { "label": "Interest paid, classified as operating activities", "negatedLabel": "Interest paid", "negatedTerseLabel": "" } } }, "localname": "InterestPaidClassifiedAsOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestRateTypesMember": { "auth_ref": [ "r377" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]" } } }, "localname": "InterestRateTypesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestReceivable": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest recognised as a receivable." } }, "en-us": { "role": { "label": "Dividends and interest on capital" } } }, "localname": "InterestReceivable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r12", "r77", "r269" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventories" } } }, "localname": "Inventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoriesTotal": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } }, "en-us": { "role": { "label": "Total" } } }, "localname": "InventoriesTotal", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentProperty": { "auth_ref": [ "r9", "r126", "r128" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } }, "en-us": { "role": { "label": "Investment property", "verboseLabel": "Investments" } } }, "localname": "InvestmentProperty", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "auth_ref": [ "r97" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 9.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } }, "en-us": { "role": { "label": "Investments", "periodEndLabel": "Balance at 2022", "periodStartLabel": "Balance at 2021" } } }, "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails1", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Investments other than investments accounted for using equity method", "verboseLabel": "Total" } } }, "localname": "InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r272" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Capital" } } }, "localname": "IssuedCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "verboseLabel": "Total" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits": { "auth_ref": [ "r84" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of other long-term employee benefits. [Refer: Other long-term employee benefits; Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, other long-term employee benefits", "verboseLabel": "Long term incentive plan" } } }, "localname": "KeyManagementPersonnelCompensationOtherLongtermBenefits", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "auth_ref": [ "r83" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Post-employment benefit" } } }, "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, share-based payment" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetailsNarrative", "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Short-term benefits" } } }, "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LandMember": { "auth_ref": [ "r276" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Land [member]" } } }, "localname": "LandMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember": { "auth_ref": [ "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than fifteen years and not later than twenty years." } }, "en-us": { "role": { "label": "Later than fifteen years and not later than twenty years [member]" } } }, "localname": "LaterThanFifteenYearsAndNotLaterThanTwentyYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember": { "auth_ref": [ "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years and not later than seven years." } }, "en-us": { "role": { "label": "Later than five years and not later than seven years [member]" } } }, "localname": "LaterThanFiveYearsAndNotLaterThanSevenYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember": { "auth_ref": [ "r310", "r315", "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years and not later than ten years." } }, "en-us": { "role": { "label": "Later than five years and not later than ten years [member]" } } }, "localname": "LaterThanFiveYearsAndNotLaterThanTenYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFiveYearsMember": { "auth_ref": [ "r185", "r186", "r253", "r310", "r311", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years." } }, "en-us": { "role": { "label": "Later than five years [member]" } } }, "localname": "LaterThanFiveYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r185", "r186", "r253", "r310", "r315", "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } }, "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } } }, "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "auth_ref": [ "r185", "r186", "r253", "r310", "r315", "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } }, "en-us": { "role": { "label": "Later than one year and not later than two years [member]" } } }, "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanSevenYearsAndNotLaterThanTenYearsMember": { "auth_ref": [ "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than seven years and not later than ten years." } }, "en-us": { "role": { "label": "Later than seven years and not later than ten years [member]" } } }, "localname": "LaterThanSevenYearsAndNotLaterThanTenYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTenYearsAndNotLaterThanFifteenYearsMember": { "auth_ref": [ "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than ten years and not later than fifteen years." } }, "en-us": { "role": { "label": "Later than ten years and not later than fifteen years [member]" } } }, "localname": "LaterThanTenYearsAndNotLaterThanFifteenYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "auth_ref": [ "r185", "r186", "r253", "r310", "r315", "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } }, "en-us": { "role": { "label": "Later than three years and not later than four years [member]" } } }, "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember": { "auth_ref": [ "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than twenty years and not later than twenty-five years." } }, "en-us": { "role": { "label": "Later than twenty years and not later than twenty-five years [member]" } } }, "localname": "LaterThanTwentyYearsAndNotLaterThanTwentyfiveYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than five years." } }, "en-us": { "role": { "label": "Later than two years and not later than five years [member]" } } }, "localname": "LaterThanTwoYearsAndNotLaterThanFiveYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r185", "r186", "r253", "r310", "r315", "r350" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } }, "en-us": { "role": { "label": "Later than two years and not later than three years [member]" } } }, "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3" ], "xbrltype": "domainItemType" }, "ifrs-full_LeaseLiabilities": { "auth_ref": [ "r177" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } }, "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "As of December 31", "periodStartLabel": "As of December 31", "verboseLabel": "Lease" } } }, "localname": "LeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails1", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LegalProceedingsProvision": { "auth_ref": [ "r286", "r287" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Legal provisions", "verboseLabel": "Provision" } } }, "localname": "LegalProceedingsProvision", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Level1OfFairValueHierarchyMember": { "auth_ref": [ "r73", "r170" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } }, "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } } }, "localname": "Level1OfFairValueHierarchyMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Level2OfFairValueHierarchyMember": { "auth_ref": [ "r170" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } }, "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } } }, "localname": "Level2OfFairValueHierarchyMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "auth_ref": [ "r73", "r170" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } } }, "localname": "LevelsOfFairValueHierarchyAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r21", "r169", "r170", "r171", "r233", "r237" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesMember": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "localname": "LiabilitiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails2", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LiquidityRiskMember": { "auth_ref": [ "r249", "r250", "r251", "r306" ], "lang": { "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } }, "en-us": { "role": { "label": "Liquidity risk [member]" } } }, "localname": "LiquidityRiskMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LongtermBorrowings": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Non-current portion of non-current borrowings", "terseLabel": "Borrowings, noncurrent", "verboseLabel": "Borrowings" } } }, "localname": "LongtermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermLegalProceedingsProvision": { "auth_ref": [ "r286", "r287" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]" } }, "en-us": { "role": { "label": "Non-current legal proceedings provision", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "LongtermLegalProceedingsProvision", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermMiscellaneousOtherProvisions": { "auth_ref": [ "r353" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of miscellaneous non-current other provisions. [Refer: Miscellaneous other provisions]" } }, "en-us": { "role": { "label": "Provision for losses on subsidiaries" } } }, "localname": "LongtermMiscellaneousOtherProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermRestructuringProvision": { "auth_ref": [ "r285" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 11.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provision for restructuring. [Refer: Restructuring provision]" } }, "en-us": { "role": { "label": "Provision - geological event in Alagoas" } } }, "localname": "LongtermRestructuringProvision", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_MajorCustomersAxis": { "auth_ref": [ "r243" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Major customers [axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_MajorCustomersMember": { "auth_ref": [ "r243" ], "lang": { "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } } }, "localname": "MajorCustomersMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_MaterialIncomeAndExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (expenses)" } } }, "localname": "MaterialIncomeAndExpenseAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r24", "r176", "r185", "r186", "r199", "r218", "r246", "r247", "r248", "r253", "r281", "r310" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails7", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails3", "http://braskem.com./role/RiskManagementDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_MeasurementAxis": { "auth_ref": [ "r124", "r129", "r169" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Measurement [axis]" } } }, "localname": "MeasurementAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/FinancialInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_NameOfSubsidiary": { "auth_ref": [ "r98", "r102", "r147", "r151" ], "lang": { "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Subsidiary/Special Purpose Entity name" } } }, "localname": "NameOfSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NetDebt": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of net debt of the entity." } }, "en-us": { "role": { "label": "Net debt", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Borrowings" } } }, "localname": "NetDebt", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NetDeferredTaxLiabilities": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Net deferred tax liabilities", "verboseLabel": "Deferred tax liabilities" } } }, "localname": "NetDeferredTaxLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NewProvisionsOtherProvisions": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised for new other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Additions, monetary adjustments and exchange variation" } } }, "localname": "NewProvisionsOtherProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsMember": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "localname": "NonadjustingEventsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncontrollingInterests": { "auth_ref": [ "r19", "r146", "r150" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Non-controlling interest in subsidiaries" } } }, "localname": "NoncontrollingInterests", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncontrollingInterestsMember": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } }, "en-us": { "role": { "label": "Non-controlling interests [member]" } } }, "localname": "NoncontrollingInterestsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentAssets": { "auth_ref": [ "r25", "r157", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Total non current assets", "totalLabel": "Non-Current Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current assets", "verboseLabel": "Non-current" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentDerivativeFinancialAssets": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]" } }, "en-us": { "role": { "label": "Non-current derivative financial assets", "verboseLabel": "Derivatives" } } }, "localname": "NoncurrentDerivativeFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentDerivativeFinancialLiabilities": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]" } }, "en-us": { "role": { "label": "Non-current derivative financial liabilities", "verboseLabel": "Derivatives" } } }, "localname": "NoncurrentDerivativeFinancialLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]" } }, "en-us": { "role": { "label": "Non current assets", "verboseLabel": "Financial investments" } } }, "localname": "NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInvestmentsDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r177" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 14.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "verboseLabel": "Lease" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilities": { "auth_ref": [ "r26", "r159", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Total non current liabilities", "totalLabel": "Non-Current Liabilities" } } }, "localname": "NoncurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "verboseLabel": "Non-current" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentPayables": { "auth_ref": [ "r15" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } }, "en-us": { "role": { "label": "Trade account payables, current", "verboseLabel": "Trade payables" } } }, "localname": "NoncurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "auth_ref": [ "r354" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } }, "en-us": { "role": { "label": "Non-current payables on social security and taxes other than income tax", "verboseLabel": "Taxes payable" } } }, "localname": "NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentPayablesToRelatedParties": { "auth_ref": [ "r354" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } }, "en-us": { "role": { "label": "Accounts payable to related parties" } } }, "localname": "NoncurrentPayablesToRelatedParties", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued": { "auth_ref": [ "r350" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]" } }, "en-us": { "role": { "label": "Debentures, non current", "terseLabel": "Debentures, noncurrent", "verboseLabel": "Debentures" } } }, "localname": "NoncurrentPortionOfNoncurrentNotesAndDebenturesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/DebenturesDetails", "http://braskem.com./role/DebenturesDetails1", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentProvisions": { "auth_ref": [ "r16" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 12.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Non-current provisions", "terseLabel": "Sundry provisions, current", "verboseLabel": "Sundry provisions" } } }, "localname": "NoncurrentProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/SundryProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentReceivablesDueFromRelatedParties": { "auth_ref": [ "r270" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current receivables due from related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Non-current receivables due from related parties", "verboseLabel": "Related parties" } } }, "localname": "NoncurrentReceivablesDueFromRelatedParties", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r352" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } }, "en-us": { "role": { "label": "Non-current receivables from taxes other than income tax", "verboseLabel": "Taxes recoverable" } } }, "localname": "NoncurrentReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 9.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]" } }, "en-us": { "role": { "label": "Post-employment benefits", "verboseLabel": "Consolidated net balance (non-current liabilities)" } } }, "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentRefundsProvision": { "auth_ref": [ "r286", "r288" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 13.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provision for refunds. [Refer: Refunds provision]" } }, "en-us": { "role": { "label": "Non-current refunds provision", "verboseLabel": "Provision - geological event in Alagoas" } } }, "localname": "NoncurrentRefundsProvision", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentTradeReceivables": { "auth_ref": [ "r270" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Non-current trade receivables", "terseLabel": "Non-current assets", "verboseLabel": "Trade accounts receivable" } } }, "localname": "NoncurrentTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NotLaterThanOneYearMember": { "auth_ref": [ "r23", "r185", "r186", "r253", "r310", "r315" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } }, "en-us": { "role": { "label": "Not later than one year [member]" } } }, "localname": "NotLaterThanOneYearMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NotesAndDebenturesIssued": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of notes and debentures issued by the entity." } }, "en-us": { "role": { "label": "Notes and debentures issued", "verboseLabel": "Debentures" } } }, "localname": "NotesAndDebenturesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/DebenturesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r31" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Shares outstanding" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_OrdinarySharesMember": { "auth_ref": [ "r108", "r355" ], "lang": { "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "localname": "OrdinarySharesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Cover", "http://braskem.com./role/EarningsPerShareDetails", "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherBorrowings": { "auth_ref": [ "r350" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Other borrowings", "verboseLabel": "Braskem Idesa borrowings" } } }, "localname": "OtherBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncome": { "auth_ref": [ "r3", "r34", "r45", "r163" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Total Comprehensive income for the period" } } }, "localname": "OtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "stringItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges": { "auth_ref": [ "r27", "r45" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, cash flow hedges", "totalLabel": "Cash flow hedges,net of tax", "verboseLabel": "Fair value of cash flow hedge, net of taxes" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "auth_ref": [ "r27", "r45", "r360" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } }, "en-us": { "role": { "label": "Actuarial gain on defined benefit and health plan, net of taxes" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "auth_ref": [ "r273", "r274" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Total" } } }, "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": { "auth_ref": [ "r273", "r274" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 3.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax", "totalLabel": "Total" } } }, "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentPayables": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 13.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other payables", "verboseLabel": "Other current payables" } } }, "localname": "OtherCurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentReceivables": { "auth_ref": [ "r270" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } }, "en-us": { "role": { "label": "Other receivables" } } }, "localname": "OtherCurrentReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherExpenseByFunction": { "auth_ref": [ "r50", "r95", "r267" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 8.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses." } }, "en-us": { "role": { "label": "Other expense, by function", "negatedLabel": "Other expenses" } } }, "localname": "OtherExpenseByFunction", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherExpenseByNature": { "auth_ref": [ "r50", "r266" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } }, "en-us": { "role": { "label": "Other expenses, by nature", "negatedLabel": "Other expenses" } } }, "localname": "OtherExpenseByNature", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherFinancialAssets": { "auth_ref": [ "r11" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets" } } }, "localname": "OtherFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails11" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherIncome": { "auth_ref": [ "r93", "r266", "r267" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 7.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other income" } } }, "localname": "OtherIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "auth_ref": [ "r132" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Total other changes" } } }, "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ReconciliationOfBorrowingActivitiesInStatementOfCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherInventories": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of inventory that the entity does not separately disclose in the same statement or note. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Advances to suppliers" } } }, "localname": "OtherInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherMaterialActuarialAssumptions": { "auth_ref": [ "r361" ], "lang": { "en": { "role": { "documentation": "Any other material assumption used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]" } }, "en-us": { "role": { "label": "Aging factor" } } }, "localname": "OtherMaterialActuarialAssumptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails6" ], "xbrltype": "percentItemType" }, "ifrs-full_OtherNoncurrentPayables": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 15.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current payables that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other non-current payables", "verboseLabel": "Other payables" } } }, "localname": "OtherNoncurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNoncurrentReceivables": { "auth_ref": [ "r270" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current other receivables. [Refer: Other receivables]" } }, "en-us": { "role": { "label": "Other non-current receivables", "verboseLabel": "Other receivables" } } }, "localname": "OtherNoncurrentReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherOperatingIncomeExpense": { "auth_ref": [ "r356" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other expenses", "verboseLabel": "Other operating income (expenses), net" } } }, "localname": "OtherOperatingIncomeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherPayables": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other payables [Default Label]", "verboseLabel": "Other payables" } } }, "localname": "OtherPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherProvisionsMember": { "auth_ref": [ "r117" ], "lang": { "en": { "role": { "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]" } } }, "localname": "OtherProvisionsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails", "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherRelatedPartiesMember": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Other related parties [member]" } } }, "localname": "OtherRelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherReversalsOfProvisions": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of reversals of provisions that the entity does not separately disclose in the same statement or note. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Other reversals of provisions", "verboseLabel": "" } } }, "localname": "OtherReversalsOfProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Other permanent adjustments" } } }, "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "auth_ref": [ "r354" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of payment due on social security and taxes other than income tax. Income taxes include all domestic and foreign taxes that are based on taxable profits. Income taxes also include taxes, such as withholding taxes, that are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity." } }, "en-us": { "role": { "label": "Payables on social security and taxes other than income tax" } } }, "localname": "PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TaxesPayableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfEntitysRevenue": { "auth_ref": [ "r379" ], "lang": { "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Percentage of entity's revenue" } } }, "localname": "PercentageOfEntitysRevenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": { "auth_ref": [ "r74" ], "lang": { "en": { "role": { "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Premise change" } } }, "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails7" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "auth_ref": [ "r188" ], "lang": { "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Interest in total and voting capital (%)" } } }, "localname": "PercentageOfVotingEquityInterestsAcquired", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PlanAssetsAtFairValue": { "auth_ref": [ "r363" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Plan assets, at fair value", "periodEndLabel": "Balance at the end of the year", "periodStartLabel": "Balance at beginning of year" } } }, "localname": "PlanAssetsAtFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r293" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Acquired", "verboseLabel": "" } } }, "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r292" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Proceeds from the sale of fixed and intangible assets", "verboseLabel": "Proceeds from the sale of fixed assets and intangible assets" } } }, "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r240", "r302" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r240", "r302" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "localname": "ProductsAndServicesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/NetRevenueDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r2", "r33", "r131", "r143", "r145", "r233", "r235", "r297", "r319", "r322" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 }, "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "(Loss) net profit for the year", "totalLabel": "(Loss) net profit for the year", "verboseLabel": "Net profit (loss) for the year" } } }, "localname": "ProfitLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Attributable to:" } } }, "localname": "ProfitLossAttributableToAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "auth_ref": [ "r36", "r149" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } }, "en-us": { "role": { "label": "Profit (loss), attributable to non-controlling interests", "verboseLabel": "Non-controlling interest in subsidiaries" } } }, "localname": "ProfitLossAttributableToNoncontrollingInterests", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Company's shareholders" } } }, "localname": "ProfitLossAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r194", "r266", "r267", "r317", "r318" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) before tax", "totalLabel": "Profit (loss) before income tax", "verboseLabel": "Profit (loss) before income taxes" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromContinuingOperations": { "auth_ref": [ "r33", "r162", "r233", "r235" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from continuing operations", "verboseLabel": "(Loss) net profit for the year" } } }, "localname": "ProfitLossFromContinuingOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromOperatingActivities": { "auth_ref": [ "r283", "r356" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Operating profit", "verboseLabel": "Operating profit (loss)" } } }, "localname": "ProfitLossFromOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r8", "r63" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r64", "r284", "r305" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/PropertyPlantAndEquipmentDetails1", "http://braskem.com./role/PropertyPlantAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r100", "r104", "r153" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_ProportionOfVotingPowerHeldInSubsidiary": { "auth_ref": [ "r100", "r104", "r153" ], "lang": { "en": { "role": { "documentation": "The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Proportion of voting rights", "verboseLabel": "Total voting interest" } } }, "localname": "ProportionOfVotingPowerHeldInSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/OperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_ProvisionUsedOtherProvisions": { "auth_ref": [ "r116" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]" } }, "en-us": { "role": { "label": "Provisions, net" } } }, "localname": "ProvisionUsedOtherProvisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Provisions": { "auth_ref": [ "r16" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits." } }, "en-us": { "role": { "label": "Provisions", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "Provisions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SundryProvisionsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r291" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Acquisitions to property, plant and equipment and intangible assets" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r173", "r187", "r248", "r299", "r301", "r378" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r173", "r187", "r248", "r299", "r301", "r378" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "localname": "RangesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails1", "http://braskem.com./role/BraskemIdesaBorrowingsDetails1", "http://braskem.com./role/DebenturesDetails1", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_RawMaterials": { "auth_ref": [ "r271", "r364" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Raw materials, production inputs and packaging" } } }, "localname": "RawMaterials", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r352" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of receivables from taxes other than income tax. Income taxes include all domestic and foreign taxes that are based on taxable profits. Income taxes also include taxes, such as withholding taxes, that are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity." } }, "en-us": { "role": { "label": "Receivables from taxes other than income tax", "verboseLabel": "Taxes recoverable" } } }, "localname": "ReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails", "http://braskem.com./role/TaxesRecoverableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax": { "auth_ref": [ "r47", "r79" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "bak_OtherComprehensiveIncomeNetOfTaxSalesHedges", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, before tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Reclassification adjustments on exchange differences on translation of foreign operations, before tax", "negatedLabel": "Exchange variation of foreign sales hedge, net of taxes" } } }, "localname": "ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Long-term incentive plans" } } }, "localname": "RecognisedLiabilitiesDefinedBenefitPlan", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RelatedPartiesMember": { "auth_ref": [ "r90" ], "lang": { "en": { "role": { "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Related parties [member]" } } }, "localname": "RelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r294" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedLabel": "Payments", "negatedTerseLabel": "" } } }, "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r122" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 5.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development expense", "negatedLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r4", "r268" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]" } }, "en-us": { "role": { "label": "Actual return on plan assets" } } }, "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails4" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r40", "r161", "r194", "r230", "r234", "r240", "r241", "r243", "r266", "r267", "r297" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 1.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Net revenue", "terseLabel": "Net sales and services revenue", "verboseLabel": "Sales of products" } } }, "localname": "Revenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/NetRevenueDetails", "http://braskem.com./role/NetRevenueDetails1", "http://braskem.com./role/NetRevenueDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReversalAllowanceAccountForCreditLossesOfFinancialAssets": { "auth_ref": [ "r382" ], "lang": { "en": { "role": { "documentation": "The decrease in an allowance account for credit losses of financial assets resulting from the reversal of impairment. [Refer: Allowance account for credit losses of financial assets]" } }, "en-us": { "role": { "label": "Reversal in the year" } } }, "localname": "ReversalAllowanceAccountForCreditLossesOfFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r182" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 12.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right of use of assets", "periodEndLabel": "Right-of-use assets, Ending balance", "periodStartLabel": "Right-of-use assets, beginning balance" } } }, "localname": "RightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SegmentConsolidationItemsAxis": { "auth_ref": [ "r233" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segment consolidation items [axis]" } } }, "localname": "SegmentConsolidationItemsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsAxis": { "auth_ref": [ "r112", "r175", "r233", "r280", "r321" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segments [axis]" } } }, "localname": "SegmentsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsMember": { "auth_ref": [ "r112", "r175", "r239", "r280", "r321" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "localname": "SegmentsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails1", "http://braskem.com./role/IntangibleAssetsDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/SegmentInformationDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r356" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "Selling, general and distribuition expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ServiceConcessionArrangementsAxis": { "auth_ref": [ "r245" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Service concession arrangements [axis]" } } }, "localname": "ServiceConcessionArrangementsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ServiceConcessionArrangementsMember": { "auth_ref": [ "r245" ], "lang": { "en": { "role": { "documentation": "This member stands for arrangements in which an entity (the operator) may enter into an arrangement with another entity (the grantor) to provide services that give the public access to major economic and social facilities. The grantor may be a public or private sector entity, including a governmental body. Examples of service concession arrangements involve water treatment and supply facilities, motorways, car parks, tunnels, bridges, airports and telecommunication networks. Examples of arrangements that are not service concession arrangements include an entity outsourcing the operation of its internal services (for example, employee cafeteria, building maintenance, and accounting or information technology functions). It also represents the standard value for the 'Service concession arrangements' axis if no other member is used. [Refer: Government [member]]" } } }, "localname": "ServiceConcessionArrangementsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions": { "auth_ref": [ "r282" ], "lang": { "en": { "role": { "documentation": "The amount of liabilities settled by the entity on behalf of a related party in related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Settlement amount", "verboseLabel": "Settlement liabilities" } } }, "localname": "SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetails", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "auth_ref": [ "r45", "r166", "r257" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The entity's share of the other comprehensive income of associates and joint ventures accounted for using the equity method, net of tax. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax", "verboseLabel": "Other comprehensive income" } } }, "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax": { "auth_ref": [ "r44" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome": { "order": 3.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax." } }, "en-us": { "role": { "label": "Foreign subsidiaries currency translation adjustment" } } }, "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity", "http://braskem.com./role/StatementOfConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": { "auth_ref": [ "r356" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]" } }, "en-us": { "role": { "label": "Equity in results of investees" } } }, "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "auth_ref": [ "r42", "r231", "r238", "r257" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss": { "order": 6.0, "parentTag": "bak_ProfitBeforeNetFinancialIncomeExpenseAndTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Results from equity-accounted investees", "negatedLabel": "Results from equity-accounted investees", "verboseLabel": "Results from equity-accounted investee" } } }, "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/SegmentInformationDetails", "http://braskem.com./role/StatementOfConsolidatedProfitOrLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShipsMember": { "auth_ref": [ "r277" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing seafaring vessels used in the entity's operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Ships [member]" } } }, "localname": "ShipsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ShorttermBorrowings": { "auth_ref": [ "r351" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings", "verboseLabel": "Current borrowings" } } }, "localname": "ShorttermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services." } }, "en-us": { "role": { "label": "Short-term employee benefits expense", "verboseLabel": "Short-term benefits" } } }, "localname": "ShorttermEmployeeBenefitsExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShorttermLegalProceedingsProvision": { "auth_ref": [ "r286", "r287" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provision for legal proceedings. [Refer: Legal proceedings provision]" } }, "en-us": { "role": { "label": "Current liability" } } }, "localname": "ShorttermLegalProceedingsProvision", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/GeologicalEvent-AlagoasDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "auth_ref": [ "r101", "r105", "r168", "r258", "r261" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Associates [axis]" } } }, "localname": "SignificantInvestmentsInAssociatesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails", "http://braskem.com./role/InvestmentsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r101", "r105", "r167" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails", "http://braskem.com./role/BasisOfPreparationOfFinancialStatementsDetails1", "http://braskem.com./role/BenefitsOfferedToTeamMembersDetails2", "http://braskem.com./role/CashAndCashEquivalentsDetails", "http://braskem.com./role/IncomeTaxesDetails3", "http://braskem.com./role/OperationsDetailsNarrative", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails2", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatutoryReserveMember": { "auth_ref": [ "r349" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing reserves created based on legal requirements." } }, "en-us": { "role": { "label": "Statutory reserve [member]" } } }, "localname": "StatutoryReserveMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_TaxContingentLiabilityMember": { "auth_ref": [ "r366" ], "lang": { "en": { "role": { "documentation": "This member stands for a contingent liability for taxes. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Tax contingent liability [member]" } } }, "localname": "TaxContingentLiabilityMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_TaxEffectOfForeignTaxRates": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Different jurisdictional taxes rates for companies abroad and tax basis" } } }, "localname": "TaxEffectOfForeignTaxRates", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "auth_ref": [ "r55" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of revenues exempt from taxation", "verboseLabel": "ICMS tax incentives" } } }, "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TaxIncentivesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfTaxLosses": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax losses" } } }, "localname": "TaxEffectOfTaxLosses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxRateEffectOfTaxLosses": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from tax losses. [Refer: Average effective tax rate; Applicable tax rate]" } }, "en-us": { "role": { "label": "Percentage of tax reduction" } } }, "localname": "TaxRateEffectOfTaxLosses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TaxIncentivesDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r173", "r187", "r248", "r299", "r301", "r378" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]" } } }, "localname": "TopOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3", "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r15" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade payables", "verboseLabel": "Trade account payables, current" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/InvestmentsDetails2", "http://braskem.com./role/RelatedPartiesDetails", "http://braskem.com./role/StatementOfConsolidatedFinancialPosition", "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "auth_ref": [ "r354" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } }, "en-us": { "role": { "label": "Related parties amount" } } }, "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayables": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } }, "en-us": { "role": { "label": "Trade account payables" } } }, "localname": "TradeAndOtherPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradePayablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivables": { "auth_ref": [ "r13", "r28" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } }, "en-us": { "role": { "label": "Trade accounts receivable, Total" } } }, "localname": "TradeAndOtherReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeReceivables": { "auth_ref": [ "r270" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } }, "en-us": { "role": { "label": "Trade receivables", "negatedLabel": "Total", "verboseLabel": "Total" } } }, "localname": "TradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/TradeAccountsReceivableDetails", "http://braskem.com./role/TradeAccountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasuryShares": { "auth_ref": [ "r107", "r272" ], "calculation": { "http://braskem.com./role/StatementOfConsolidatedFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares", "negatedLabel": "Treasury shares" } } }, "localname": "TreasuryShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/StatementOfConsolidatedFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasurySharesMember": { "auth_ref": [ "r4" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares [member]" } } }, "localname": "TreasurySharesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/StatementOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfFinancialAssetsAxis": { "auth_ref": [ "r227", "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of financial assets [axis]" } } }, "localname": "TypesOfFinancialAssetsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EquityDetails", "http://braskem.com./role/EquityDetails1", "http://braskem.com./role/FinancialInstrumentsDetails", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfFinancialLiabilitiesAxis": { "auth_ref": [ "r227", "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of financial liabilities [axis]" } } }, "localname": "TypesOfFinancialLiabilitiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfHedgesAxis": { "auth_ref": [ "r202", "r204", "r206", "r263" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of hedges [axis]" } } }, "localname": "TypesOfHedgesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails6", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfHedgesMember": { "auth_ref": [ "r202", "r204", "r206", "r263" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used." } } }, "localname": "TypesOfHedgesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails1", "http://braskem.com./role/FinancialInstrumentsDetails6", "http://braskem.com./role/FinancialInstrumentsDetails9", "http://braskem.com./role/ProvisionsForLegalProceedingsAndContingentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfInterestRatesAxis": { "auth_ref": [ "r377" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of interest rates [axis]" } } }, "localname": "TypesOfInterestRatesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails12", "http://braskem.com./role/FinancialInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksAxis": { "auth_ref": [ "r196", "r211", "r212", "r249", "r250", "r251", "r252" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of risks [axis]" } } }, "localname": "TypesOfRisksAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksMember": { "auth_ref": [ "r196", "r211", "r212", "r249", "r250", "r251", "r252" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "localname": "TypesOfRisksMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/FinancialInstrumentsDetails10", "http://braskem.com./role/RiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "auth_ref": [ "r60" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Amortization estimated useful life" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/IntangibleAssetsDetails3" ], "xbrltype": "durationItemType" }, "ifrs-full_VehiclesMember": { "auth_ref": [ "r358" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Vehicles [member]" } } }, "localname": "VehiclesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/PropertyPlantAndEquipmentDetails", "http://braskem.com./role/Right-of-useAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_WeightedAverageMember": { "auth_ref": [ "r173", "r248", "r299", "r301", "r378" ], "lang": { "en": { "role": { "documentation": "This member stands for an average in which each quantity to be averaged is assigned a weight that determines the relative effect of each quantity on the average." } }, "en-us": { "role": { "label": "Weighted average [member]" } } }, "localname": "WeightedAverageMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://braskem.com./role/EarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://braskem.com./role/BorrowingsDetails", "http://braskem.com./role/BorrowingsDetails2", "http://braskem.com./role/BorrowingsDetails3", "http://braskem.com./role/BorrowingsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails3", "http://braskem.com./role/FinancialInstrumentsDetails4", "http://braskem.com./role/FinancialInstrumentsDetails5", "http://braskem.com./role/FinancialInstrumentsDetails8", "http://braskem.com./role/LeniencyAgreementWithAuthoritiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://braskem.com./role/TaxesRecoverableDetails" ], "xbrltype": "domainItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r1": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r10": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r100": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "4", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_4&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "32", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r110": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS33_g70-73A__IAS33_g70-73A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "86", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_86&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "88", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_88&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r120": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS38_g118-128__IAS38_g118-128_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "76", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_50&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r130": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r140": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS07_g10-17__IAS07_g10-17_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "8", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "10", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2022-en-r&anchor=para_22&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r150": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "2", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "2", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_l&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r160": { "Clause": "ix", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B16", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B16_c&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r170": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r180": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_97&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r190": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d_ii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "22A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_22A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "23A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r20": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r200": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23B_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24B_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24B&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24C", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24E", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24E_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "24G", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24G_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r210": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_36&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_56&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r220": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "8", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B2", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B51&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r230": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r240": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "9", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "IssueDate": "2022-03-24", "Name": "SIC", "Number": "29", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=SIC&num=29&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_124&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r250": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "9", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39M", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r260": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "39G", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39G_a&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "39J", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39J&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_c&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "8", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_f&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r267": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r268": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r269": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r27": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r270": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r271": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r272": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r273": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r274": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r275": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r276": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r277": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r278": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r279": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r28": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r280": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r281": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r282": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "21", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_21_j&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r283": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "32", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r284": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r285": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_70&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r286": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "87", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_87&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r287": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Section": "Example 10 A court case", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r288": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Section": "Example 4 Refunds policy", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex4__IAS37_IE_C_ex4_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r289": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "119", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r29": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r290": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r291": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r292": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r293": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r294": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r295": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r296": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r297": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r298": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r299": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r3": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r30": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r300": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r301": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r302": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r303": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r304": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_e&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r305": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r306": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r307": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r308": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r309": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r31": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r310": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r311": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r312": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r313": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG20C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r314": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG20D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r315": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r316": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG40B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r317": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r318": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r319": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r32": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r320": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r321": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r322": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r323": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r324": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "IG22", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_IG22_b&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r325": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "36", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_c&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r326": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24_a&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r327": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG24", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r328": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r329": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r33": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r330": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r331": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r332": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r333": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r334": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r336": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r339": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r34": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r340": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r341": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r342": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r343": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r344": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r345": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r346": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r347": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r348": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r349": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r35": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r350": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r351": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r352": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r353": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r354": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r355": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r356": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r360": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "144", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_144&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "145", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "57", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "37", "Paragraph": "88", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_88&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r370": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r380": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Effective 2023-01-01", "Number": "1", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r40": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "92", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_92&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_107&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r50": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS12_g79-88__IAS12_g79-88_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r60": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS16_g73-79__IAS16_g73-79_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_51&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r70": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "145", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "145", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS19_g2-7__IAS19_g2-7_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "21", "Paragraph": "48", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_48&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r80": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "21", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "21", "Paragraph": "57", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_57_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r90": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_v&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 199 0001292814-23-001738-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001292814-23-001738-xbrl.zip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